archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO BLEB ASSEMBLY,1.1237e-07,1.6202,1.4836,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,4.3218e-05,1.537,1.3321,1,1
1,GO MEMBRANE RAFT ASSEMBLY,9.4334e-07,1.4257,1.6075,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,6.8936e-07,1.2317,1.0334,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,7.8282e-05,1.2056,1.0142,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,1.071e-07,1.1934,1.1733,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.6603e-06,1.1702,1.1577,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,6.5896e-07,1.1589,1.0076,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.8084e-07,1.134,1.0144,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.0207e-07,1.0912,0.96928,1,1
1,GO RESPONSE TO INTERFERON ALPHA,4.5813e-07,1.076,1.1429,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,3.9926e-07,1.0692,1.0034,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,3.6228e-06,1.0476,1.0026,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.8251e-06,1.0451,0.9169,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00017796,1.0416,0.74827,1,1
1,GO NEUTROPHIL HOMEOSTASIS,3.9926e-07,1.0348,0.98055,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.8084e-07,1.0286,1.0431,1,1
1,GO HYALURONAN CATABOLIC PROCESS,3.6563e-08,1.0272,1.1005,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,8.1192e-05,1.0145,0.8732,1,1
1,GO RESPONSE TO INTERFERON BETA,1.4044e-06,1.0058,1.0056,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,1.8958e-07,0.99939,1.0022,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,8.4155e-08,0.99651,0.92658,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,7.9801e-06,0.97653,0.82404,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.4878e-05,0.96933,0.81612,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.4772e-07,0.93268,0.98915,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,7.9801e-06,0.92892,0.80681,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,2.0033e-05,0.92141,0.81434,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,5.4272e-08,0.92007,0.9478,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,9.8628e-07,0.91994,0.86583,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,1.5201e-05,0.9193,0.8749,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,1.5816e-05,0.91599,0.78809,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00016595,0.91524,0.68482,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.2424e-08,0.91414,0.94863,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,3.4728e-06,0.90936,0.87337,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,6.5896e-07,0.90321,0.82466,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.6228e-06,0.89257,1.0796,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.6455e-05,0.88469,1.1712,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,3.0264e-07,0.87942,0.82221,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,4.9191e-08,0.87035,0.93596,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,8.628e-07,0.86993,0.81337,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00016023,0.8676,0.79602,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,1.4044e-06,0.86521,0.72344,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,8.0176e-08,0.86182,0.87975,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,5.0683e-06,0.85999,0.77134,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,6.2859e-08,0.85508,0.85239,1,1
1,GO MEMBRANE RAFT ORGANIZATION,1.3441e-06,0.85217,0.95192,1,1
1,GO BONE TRABECULA FORMATION,0.00011241,0.84028,0.79195,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,2.5122e-07,0.83422,0.79977,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.4994e-06,0.83326,0.67467,1,1
1,GO CD40 SIGNALING PATHWAY,9.2696e-08,0.82693,0.78863,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.5691e-07,0.82175,0.78534,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,1.8084e-07,0.81999,0.76049,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,1.0311e-06,0.81759,0.93372,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,9.4334e-07,0.81364,0.87121,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,5.2837e-06,0.80982,0.86645,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,1.9904e-06,0.80446,0.63411,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.9301e-06,0.80137,0.65367,1,1
1,GO ZYMOGEN INHIBITION,5.753e-07,0.79652,0.80434,1,1
1,GO PLASMINOGEN ACTIVATION,0.00010092,0.79105,0.62348,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.3763e-07,0.79033,0.73223,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,3.4728e-06,0.78315,0.65368,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.0829e-07,0.78271,0.78567,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,1.8521e-05,0.7774,0.63198,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,9.8628e-07,0.77482,0.67983,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.77167,0.65046,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.0033e-05,0.76869,0.61658,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.4044e-06,0.76756,0.72141,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.5122e-07,0.76737,0.74242,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00081984,0.76704,0.61104,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,4.4572e-08,0.76567,0.81147,1,1
1,GO ENDODERM FORMATION,6.6003e-08,0.76452,0.82532,1,1
1,GO HIPPO SIGNALING,2.0784e-06,0.75833,0.62243,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,5.8301e-05,0.75597,0.61384,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,8.2505e-07,0.75166,0.72035,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00012512,0.75149,0.63767,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.8077e-06,0.74902,0.80662,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.1776e-06,0.74323,0.65467,1,1
1,GO CYSTEINE METABOLIC PROCESS,7.547e-05,0.74235,0.59077,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.2308e-06,0.74179,0.68499,1,1
1,GO EPIBOLY,9.2696e-08,0.73565,0.79916,1,1
1,GO LATERAL MESODERM DEVELOPMENT,9.3916e-06,0.73191,0.60779,1,1
1,GO GAP JUNCTION ASSEMBLY,8.628e-07,0.73129,0.67873,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.2366e-07,0.72952,0.67823,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,5.6999e-08,0.72741,0.72055,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.6455e-05,0.72536,0.70767,1,1
1,GO CELLULAR RESPONSE TO X RAY,3.1888e-05,0.72155,0.55245,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,2.5774e-06,0.72044,0.66677,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.2424e-08,0.71993,0.71921,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,4.3763e-07,0.71959,0.66344,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.4674e-06,0.71211,0.66611,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.3441e-06,0.70893,0.67334,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,2.3418e-05,0.70463,0.61357,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,4.4712e-06,0.70343,0.72451,1,1
1,GO LEUKOCYTE AGGREGATION,0.00023468,0.69722,0.5829,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,2.2879e-07,0.69195,0.66353,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,3.4772e-07,0.68664,0.84811,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,5.2837e-06,0.68636,0.60558,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00044439,0.68562,0.62353,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,9.3916e-06,0.68372,0.6945,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,4.0073e-05,0.68327,0.5481,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,3.8131e-07,0.68278,0.6349,1,1
1,GO VASCULOGENESIS,3.6563e-08,0.68204,0.6538,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,7.889e-07,0.67903,0.81183,1,1
1,GO FIBRINOLYSIS,6.5896e-07,0.67892,0.82778,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.5331e-06,0.67604,0.59747,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.906e-06,0.66631,0.71738,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,4.0073e-05,0.66583,0.57596,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,4.3763e-07,0.66483,0.71001,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.5816e-05,0.66109,0.47875,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.5759e-05,0.66063,0.59806,1,1
1,GO T CELL EXTRAVASATION,7.6603e-06,0.66048,0.67073,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1.1964e-05,0.66029,0.73701,1,1
1,GO REGULATION OF PINOCYTOSIS,3.9418e-06,0.65699,0.66586,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,6.0504e-05,0.65196,0.59068,1,1
1,GO SKIN MORPHOGENESIS,1.7118e-05,0.65191,0.78369,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,8.3127e-06,0.64875,0.61738,1,1
1,GO SALIVARY GLAND DEVELOPMENT,2.4692e-06,0.64757,0.62551,1,1
1,GO APOPTOTIC CELL CLEARANCE,1.3605e-07,0.64512,0.72745,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,2.3654e-06,0.64366,0.64371,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,5.4121e-05,0.6423,0.51051,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00011241,0.64199,0.61132,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0001165,0.64162,0.53407,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.7578e-07,0.64148,0.62761,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.2111e-07,0.64007,0.6592,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,1.6729e-06,0.6392,0.59043,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,5.0226e-05,0.63898,0.52941,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,6.4994e-06,0.63626,0.71843,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.9841e-06,0.63346,0.67457,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,7.2754e-05,0.63336,0.53998,1,1
1,GO PIGMENT GRANULE MATURATION,5.0226e-05,0.63062,0.46882,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,2.7104e-08,0.62907,0.63903,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.6603e-06,0.62864,0.53364,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.9301e-06,0.62737,0.71842,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,1.104e-05,0.62689,0.52799,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.1617e-05,0.62645,0.52547,1,1
1,GO NOTOCHORD DEVELOPMENT,6.2985e-07,0.62633,0.70423,1,1
1,GO ENDODERM DEVELOPMENT,1.6452e-07,0.62469,0.66681,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.6452e-07,0.62358,0.678,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,2.4346e-05,0.62346,0.50282,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,3.0689e-05,0.62256,0.57686,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,9.7801e-06,0.62202,0.65902,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,7.5427e-07,0.61556,0.56702,1,1
1,GO DNA DEAMINATION,1.5816e-05,0.61555,0.60349,1,1
1,GO AMYLOID BETA CLEARANCE,8.4155e-08,0.61524,0.54825,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,9.389e-05,0.61339,0.55027,1,1
1,GO VAGINA DEVELOPMENT,3.3202e-07,0.61256,0.65971,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,2.1663e-05,0.61217,0.53119,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.4044e-06,0.61151,0.55407,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,3.0576e-06,0.61138,0.49239,1,1
1,GO SNRNA PROCESSING,0.00055855,0.60934,0.62006,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0081404,0.60817,0.41231,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00016595,0.60764,0.55067,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,7.9801e-06,0.60628,0.69415,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,5.0683e-06,0.60619,0.49758,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.2658e-06,0.60537,0.57039,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,1.4609e-05,0.60305,0.62135,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.8251e-06,0.60224,0.65497,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,9.0221e-07,0.60223,0.61496,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.17e-07,0.60211,0.64619,1,1
1,GO COLLAGEN METABOLIC PROCESS,7.889e-07,0.60033,0.59808,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.2366e-07,0.59871,0.52701,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,5.2837e-06,0.59842,0.57506,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.8251e-06,0.5982,0.58861,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,6.2985e-07,0.59693,0.70293,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,5.508e-06,0.59621,0.47806,1,1
1,GO LIVER REGENERATION,5.6999e-08,0.59611,0.6007,1,1
1,GO BIOLOGICAL PHASE,0.00030804,0.59458,0.58572,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,1.8251e-06,0.59451,0.52684,1,1
1,GO HEME METABOLIC PROCESS,1.2308e-06,0.59409,0.53114,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.001872,0.59369,0.71041,1,1
1,GO REGULATION OF FIBRINOLYSIS,3.5759e-05,0.59308,0.60062,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,2.7343e-05,0.59277,0.51514,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.8958e-07,0.59276,0.61529,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.2308e-06,0.59159,0.654,1,1
1,GO CELLULAR RESPONSE TO IRON ION,1.2962e-05,0.59125,0.54788,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,1.2962e-05,0.58993,0.51416,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.349e-05,0.58951,0.57788,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.0689e-05,0.58926,0.65964,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,1.7118e-05,0.5891,0.56174,1,1
1,GO MUCUS SECRETION,0.0028957,0.58748,0.46948,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,3.6228e-06,0.58588,0.6777,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,4.8612e-06,0.58529,0.60886,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,5.0226e-05,0.58365,0.46739,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,8.6584e-06,0.58286,0.49544,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.0829e-07,0.58243,0.58483,1,1
1,GO MACROPHAGE PROLIFERATION,4.0073e-05,0.57999,0.56675,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.00016595,0.57954,0.70907,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.0022332,0.57928,0.47339,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,8.8325e-08,0.57919,0.6336,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.3605e-07,0.57918,0.63182,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,6.2367e-06,0.57865,0.60154,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00013433,0.57848,0.48403,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,1.9904e-06,0.57823,0.50676,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,5.2837e-06,0.57606,0.63028,1,1
1,GO AORTIC VALVE DEVELOPMENT,9.3916e-06,0.57598,0.53352,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,4.1112e-06,0.57423,0.62196,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,1.0184e-05,0.57321,0.5496,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00026903,0.57251,0.61432,1,1
1,GO ENTRY INTO HOST,3.17e-07,0.57198,0.59247,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.4674e-06,0.57079,0.49872,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.104e-05,0.56938,0.502,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,2.9532e-05,0.56806,0.73866,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.6455e-05,0.56519,0.46243,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,5.0194e-07,0.5628,0.61117,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0022992,0.56159,0.39377,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.6307e-05,0.55988,0.46954,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.0784e-06,0.55959,0.50843,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,4.4712e-06,0.55853,0.53271,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,1.2862e-06,0.55774,0.48513,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.725e-07,0.557,0.57794,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.042857,0.55357,0.34697,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,9.7346e-05,0.55336,0.48007,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.00024286,0.5528,0.58782,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.0207e-07,0.55218,0.53285,1,1
1,GO TYPE 2 IMMUNE RESPONSE,7.9801e-06,0.5506,0.54977,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,2.0784e-06,0.5505,0.52172,1,1
1,GO CYTOLYSIS,1.2862e-06,0.54962,0.4966,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.4977e-07,0.5495,0.64045,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.17e-07,0.54697,0.52031,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.0576e-06,0.54645,0.5054,1,1
1,GO RESPONSE TO X RAY,5.4977e-07,0.54565,0.5777,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00042998,0.54443,0.45712,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00026903,0.54429,0.45909,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0007696,0.54281,0.3958,1,1
1,GO INTERLEUKIN 1 PRODUCTION,5.2837e-06,0.53987,0.48705,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,7.9801e-06,0.53874,0.50146,1,1
1,GO COLLAGEN CATABOLIC PROCESS,1.8251e-06,0.53677,0.57596,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,1.5331e-06,0.53434,0.46425,1,1
1,GO ZYMOGEN ACTIVATION,1.9263e-05,0.53383,0.52862,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.7955e-07,0.5333,0.57902,1,1
1,GO TOLERANCE INDUCTION,0.00020448,0.53304,0.48451,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.8084e-07,0.53268,0.54957,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.5816e-05,0.53094,0.54671,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,8.1192e-05,0.53002,0.51754,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,3.8131e-07,0.5296,0.53414,1,1
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.033166,0.52838,0.29197,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,1.4674e-06,0.52806,0.50398,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,5.2837e-06,0.52665,0.47363,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,7.2754e-05,0.52653,0.442,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.2971e-07,0.52641,0.6023,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.0012662,0.52614,0.54319,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.025414,0.52405,0.29166,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,1.2971e-07,0.52372,0.52548,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,2.4692e-06,0.52328,0.47487,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,2.8077e-06,0.52287,0.43441,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.2533e-07,0.52137,0.50961,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0001165,0.52076,0.45073,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.0311e-06,0.51992,0.47903,1,1
1,GO VIRAL GENOME REPLICATION,1.5331e-06,0.51779,0.45913,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,7.2754e-05,0.51762,0.50648,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,6.5896e-07,0.51749,0.45881,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00023468,0.51714,0.43271,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,2.9301e-06,0.51547,0.55253,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00034072,0.51399,0.49181,1,1
1,GO RESPONSE TO INTERFERON GAMMA,3.1904e-06,0.51373,0.51566,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,3.3287e-06,0.51344,0.4293,1,1
1,GO RESPONSE TO TYPE I INTERFERON,7.2754e-05,0.51342,0.60157,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0007696,0.51309,0.42695,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.001986,0.51179,0.468,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,7.5427e-07,0.51143,0.51989,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00012512,0.51114,0.43642,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,4.8379e-05,0.51054,0.50322,1,1
1,GO PULMONARY VALVE DEVELOPMENT,2.9532e-05,0.51006,0.52798,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,4.1802e-07,0.50975,0.75103,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,3.9418e-06,0.50831,0.45685,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,7.0571e-06,0.5083,0.51712,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.986e-08,0.50793,0.51951,1,1
1,GO T CELL MEDIATED IMMUNITY,5.7413e-06,0.50749,0.46847,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.8131e-07,0.50644,0.445,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,8.4205e-05,0.50559,0.48982,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,2.8418e-05,0.50512,0.6686,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,2.1702e-06,0.50384,0.64394,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,1.5201e-05,0.50369,0.49493,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,3.5759e-05,0.50344,0.39801,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,2.7578e-07,0.50231,0.50057,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.9904e-06,0.50181,0.43838,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1.4044e-06,0.50099,0.59299,1,1
1,GO NCRNA 3 END PROCESSING,0.0023671,0.50049,0.41998,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,3.1904e-06,0.49913,0.51372,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00055855,0.49904,0.43655,1,1
1,GO PEPTIDE CROSS LINKING,9.0551e-05,0.49844,0.51113,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,3.4772e-07,0.49818,0.48082,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.1267e-06,0.49778,0.5467,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,1.2862e-06,0.49739,0.54362,1,1
1,GO SNRNA METABOLIC PROCESS,0.00014935,0.49715,0.50159,1,1
1,GO LYMPHANGIOGENESIS,6.8936e-07,0.49659,0.49766,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00021909,0.49644,0.44276,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,7.013e-05,0.49636,0.51062,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0024367,0.49603,0.40703,1,1
1,GO RESPONSE TO HYPEROXIA,3.1888e-05,0.49576,0.50399,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,2.3418e-05,0.4957,0.60339,1,1
1,GO STORE OPERATED CALCIUM ENTRY,9.7801e-06,0.49539,0.40482,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00042998,0.49536,0.45955,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0006154,0.49409,0.42515,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0006154,0.49387,0.4633,1,1
1,GO PHAGOCYTOSIS RECOGNITION,4.6597e-05,0.49342,0.56282,1,1
1,GO DETECTION OF BIOTIC STIMULUS,5.9841e-06,0.49201,0.48496,1,1
1,GO GERMINAL CENTER FORMATION,0.00014935,0.49189,0.45072,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.3654e-06,0.48985,0.42737,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,8.3127e-06,0.48682,0.50153,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.0194e-07,0.4858,0.48739,1,1
1,GO PINOCYTOSIS,6.0198e-07,0.48579,0.6063,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,6.2859e-08,0.48568,0.49808,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.9904e-06,0.48502,0.45136,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00014418,0.48496,0.38321,1,1
1,GO PROTEIN OXIDATION,0.00028792,0.48447,0.48241,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,3.3287e-06,0.48156,0.47304,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.7801e-06,0.48118,0.48285,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,3.8583e-05,0.48084,0.41102,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00040247,0.48059,0.3766,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00013433,0.48017,0.48185,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,4.2876e-06,0.47981,0.5046,1,1
1,GO RESPONSE TO ANGIOTENSIN,6.0198e-07,0.47974,0.47927,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00037661,0.4782,0.39544,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,5.6174e-05,0.47789,0.43376,1,1
1,GO VIRAL RNA GENOME REPLICATION,8.8325e-08,0.47778,0.45863,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00014418,0.47666,0.37759,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,9.2696e-08,0.4766,0.42306,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00025131,0.47632,0.37753,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.00069957,0.47561,0.34712,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,9.8628e-07,0.47554,0.39637,1,1
1,GO NIK NF KAPPAB SIGNALING,4.7955e-07,0.4751,0.42039,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.2862e-06,0.47487,0.50251,1,1
1,GO CYTOKINE METABOLIC PROCESS,1.5331e-06,0.47403,0.41655,1,1
1,GO BLOOD VESSEL REMODELING,2.0833e-05,0.47379,0.43883,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00021909,0.47378,0.45168,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00011241,0.47378,0.46108,1,1
1,GO REGULATION OF TRANSPOSITION,0.00014418,0.47325,0.46463,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,2.5122e-07,0.47301,0.53275,1,1
1,GO HYALURONAN METABOLIC PROCESS,1.1237e-07,0.47297,0.52167,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0047853,0.4729,0.35353,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,5.753e-07,0.47243,0.4334,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.7955e-07,0.47221,0.49545,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.5308e-05,0.47181,0.44513,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.2962e-05,0.47136,0.48344,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.9904e-06,0.47106,0.45275,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0087944,0.47047,0.40213,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0010528,0.46949,0.46298,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0014738,0.46929,0.37036,1,1
1,GO ENAMEL MINERALIZATION,0.00072223,0.4692,0.423,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,1.7806e-05,0.46886,0.43651,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.5308e-05,0.46844,0.45581,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,4.4878e-05,0.46829,0.42022,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,4.3763e-07,0.46814,0.50586,1,1
1,GO DEFENSE RESPONSE TO VIRUS,9.3916e-06,0.46678,0.41691,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,4.6597e-05,0.46674,0.43498,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,5.4977e-07,0.46666,0.50854,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.9418e-06,0.4665,0.41569,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,1.6455e-05,0.46553,0.46816,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.001662,0.46536,0.31918,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,3.1904e-06,0.46434,0.45831,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.5308e-05,0.46346,0.50702,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0012662,0.46336,0.39519,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,6.7728e-06,0.46328,0.52107,1,1
1,GO RESPONSE TO INTERLEUKIN 12,2.7578e-07,0.4632,0.44563,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0024367,0.4632,0.38962,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,1.9904e-06,0.46315,0.41691,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00045924,0.46295,0.33024,1,1
1,GO REGULATION OF MRNA BINDING,3.3287e-06,0.4627,0.41994,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.00022676,0.46245,0.40815,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,3.4421e-05,0.46232,0.46111,1,1
1,GO BONE GROWTH,7.0571e-06,0.4616,0.52384,1,1
1,GO PROTEIN ACTIVATION CASCADE,5.0683e-06,0.46127,0.40035,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,1.1964e-05,0.46093,0.43354,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00010845,0.4598,0.52745,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.020205,0.4594,0.23727,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,6.2985e-07,0.45774,0.50017,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00022676,0.45763,0.41872,1,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.033166,0.45761,0.29427,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,5.2837e-06,0.45696,0.45234,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.5427e-07,0.45695,0.43908,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,1.8521e-05,0.45626,0.40839,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,6.2367e-06,0.45585,0.4609,1,1
1,GO RESPONSE TO PROGESTERONE,0.0017641,0.45583,0.32059,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.2658e-06,0.4558,0.46274,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.6597e-05,0.45573,0.4068,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00016023,0.45571,0.4926,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00081984,0.4554,0.34936,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,4.2876e-06,0.45535,0.36981,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,3.4421e-05,0.45525,0.39758,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,8.3127e-06,0.45515,0.49197,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,2.5774e-06,0.45481,0.39375,1,1
1,GO ANIMAL ORGAN REGENERATION,2.3975e-07,0.45455,0.50144,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.6322e-07,0.45439,0.3975,1,1
1,GO PROTEASOME ASSEMBLY,4.1617e-05,0.45437,0.3364,1,1
1,GO REGULATION OF MYOBLAST FUSION,0.00023468,0.45363,0.50937,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.4268e-07,0.45311,0.41291,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,1.2962e-05,0.45257,0.48879,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,2.2879e-07,0.4525,0.50145,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.628e-07,0.45234,0.47687,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,8.2505e-07,0.45233,0.44963,1,1
1,GO MRNA TRANSCRIPTION,1.4039e-05,0.45148,0.38383,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.3654e-06,0.45052,0.39493,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,1.5331e-06,0.45007,0.39722,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,7.889e-07,0.44967,0.50353,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00017796,0.44966,0.36998,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.00027832,0.44965,0.41466,1,1
1,GO REPLICATIVE SENESCENCE,0.00353,0.44847,0.39897,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,5.4121e-05,0.44817,0.48627,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00010845,0.44817,0.37787,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,9.4334e-07,0.44781,0.41043,1,1
1,GO VIRAL TRANSLATION,1.3441e-06,0.44742,0.46639,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00010845,0.44599,0.40653,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9904e-06,0.44516,0.41648,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,2.2658e-06,0.44452,0.37293,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,7.8282e-05,0.44444,0.4301,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.6902e-06,0.44436,0.45121,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.5308e-05,0.44397,0.53678,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00014935,0.4436,0.4002,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,4.4712e-06,0.44329,0.41603,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00031859,0.44306,0.32562,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,1.8521e-05,0.44305,0.39401,1,1
1,GO RETINAL METABOLIC PROCESS,0.0060989,0.44287,0.33196,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.725e-07,0.4425,0.43634,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.3287e-06,0.44232,0.48818,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,7.547e-05,0.44199,0.42664,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0012662,0.44186,0.37157,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,4.5813e-07,0.44172,0.37855,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.1663e-05,0.44164,0.43129,1,1
1,GO EMBRYO IMPLANTATION,2.6322e-07,0.44132,0.5358,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,4.8612e-06,0.44108,0.53545,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.1904e-06,0.44026,0.40879,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00050664,0.43989,0.47689,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.6015e-06,0.43934,0.44559,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,6.4994e-06,0.43912,0.42886,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.011047,0.43852,0.43959,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0014299,0.43804,0.52162,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00063551,0.4374,0.51307,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00063551,0.4374,0.63563,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,5.0194e-07,0.43604,0.48761,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,6.2786e-05,0.43596,0.39399,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.753e-07,0.43407,0.45456,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,5.2533e-07,0.43302,0.41205,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,3.3132e-05,0.43244,0.39143,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00029782,0.43191,0.44502,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.7343e-05,0.43171,0.38489,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.4121e-05,0.43024,0.3901,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00069957,0.43016,0.44846,1,1
1,GO RECEPTOR CATABOLIC PROCESS,2.5774e-06,0.42956,0.43152,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00040247,0.4288,0.41113,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.6015e-06,0.42879,0.42076,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.906e-06,0.42869,0.58892,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,1.104e-05,0.42862,0.4467,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,6.0504e-05,0.42837,0.37197,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00016595,0.42826,0.4472,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.7343e-05,0.42797,0.32597,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00045924,0.42784,0.37855,1,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.027188,0.42765,0.24147,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.0045306,0.42732,0.38713,1,1
1,GO RIBOSOME ASSEMBLY,0.00021909,0.42689,0.37441,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0010859,0.42653,0.33772,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.5759e-05,0.42639,0.37995,1,1
1,GO FIBROBLAST MIGRATION,1.5331e-06,0.42632,0.42232,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,2.0033e-05,0.4263,0.43865,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.2366e-07,0.42609,0.46131,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00041602,0.42578,0.43941,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0031536,0.42541,0.3265,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.2366e-07,0.42501,0.39274,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,2.5122e-07,0.42457,0.54563,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,1.8521e-05,0.42362,0.38165,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,7.0571e-06,0.42352,0.41672,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,4.1112e-06,0.42312,0.44122,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.00025131,0.42276,0.3656,1,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.045624,0.42165,0.24348,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.8301e-05,0.42162,0.37248,1,1
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0010859,0.42149,0.38134,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00045924,0.42118,0.48267,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0001547,0.42069,0.34638,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,3.1888e-05,0.42058,0.38257,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,2.1663e-05,0.42048,0.38773,1,1
1,GO CERAMIDE CATABOLIC PROCESS,6.0504e-05,0.4201,0.38148,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1776e-06,0.42008,0.42852,1,1
1,GO VIRAL LIFE CYCLE,3.0264e-07,0.41928,0.42543,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0001547,0.41923,0.36848,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.0038387,0.41914,0.53671,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,1.2454e-05,0.41881,0.36178,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,8.6584e-06,0.4188,0.38209,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,3.0689e-05,0.41844,0.39791,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,7.6603e-06,0.41807,0.49516,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00020448,0.41777,0.40296,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00014935,0.41754,0.59989,1,1
1,GO MULTI ORGANISM LOCALIZATION,4.9191e-08,0.41721,0.4244,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00010845,0.41699,0.36499,1,1
1,GO REGULATION OF GASTRULATION,2.3975e-07,0.41601,0.41245,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00032948,0.41595,0.33092,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.2524e-05,0.4159,0.39301,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00030804,0.41575,0.33338,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,4.6623e-06,0.41524,0.44584,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.4143,0.36184,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,3.4772e-07,0.4132,0.40957,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,9.3916e-06,0.4132,0.36957,1,1
1,GO IMMATURE T CELL PROLIFERATION,3.8583e-05,0.41288,0.45111,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,1.349e-05,0.41274,0.38678,1,1
1,GO REGULATION OF STEROL TRANSPORT,6.2985e-07,0.41259,0.38198,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0015653,0.41227,0.31667,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,9.8628e-07,0.41222,0.40637,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,2.5308e-05,0.41174,0.33445,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00069957,0.41129,0.29911,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4044e-06,0.41099,0.39983,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00019079,0.41069,0.37711,1,1
1,GO I KAPPAB PHOSPHORYLATION,3.3132e-05,0.41068,0.3092,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,9.0221e-07,0.41033,0.42967,1,1
1,GO RESPONSE TO SALT STRESS,2.6902e-06,0.41028,0.3857,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0028141,0.41024,0.33095,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00019753,0.40996,0.35024,1,1
1,GO MATURATION OF SSU RRNA,9.0551e-05,0.40983,0.37767,1,1
1,GO COPPER ION HOMEOSTASIS,2.0784e-06,0.40959,0.50766,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.5331e-06,0.40922,0.37514,1,1
1,GO PLATELET AGGREGATION,5.0683e-06,0.40867,0.36513,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00012964,0.40854,0.45453,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00029782,0.40834,0.342,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,2.2658e-06,0.40805,0.45816,1,1
1,GO INTERLEUKIN 17 PRODUCTION,8.2505e-07,0.40798,0.48558,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,4.1112e-06,0.40748,0.44665,1,1
1,GO INTERACTION WITH SYMBIONT,5.508e-06,0.40735,0.35444,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,2.0033e-05,0.40725,0.58454,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.1617e-05,0.40626,0.43064,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,5.7413e-06,0.40615,0.41037,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.0604e-05,0.40562,0.39872,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.9801e-06,0.4053,0.47221,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,7.013e-05,0.40486,0.43489,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,2.2524e-05,0.40417,0.49295,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00023468,0.40416,0.33159,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0036303,0.40393,0.40015,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,5.7413e-06,0.40352,0.48342,1,1
1,GO INTERLEUKIN 8 PRODUCTION,1.4609e-05,0.40344,0.37777,1,1
1,GO TRANSLATIONAL INITIATION,5.2139e-05,0.403,0.3605,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,2.1663e-05,0.40265,0.44973,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.3441e-06,0.40259,0.38901,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00037661,0.40258,0.356,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,4.1617e-05,0.40231,0.4844,1,1
1,GO CELL SUBSTRATE ADHESION,1.4044e-06,0.40222,0.41372,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,8.628e-07,0.40216,0.40876,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,6.7728e-06,0.40163,0.34615,1,1
1,GO FOREGUT MORPHOGENESIS,1.349e-05,0.40157,0.45945,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,5.4121e-05,0.40103,0.33543,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,7.8282e-05,0.39932,0.38795,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00065623,0.39931,0.39145,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,2.6902e-06,0.39927,0.36682,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.00017186,0.39849,0.49779,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.5813e-07,0.39777,0.43334,1,1
1,GO INTERFERON BETA PRODUCTION,0.0001165,0.39715,0.2995,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.00014935,0.39707,0.28036,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.7728e-06,0.39685,0.33904,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.023741,0.39657,0.31789,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,5.2139e-05,0.39652,0.36547,1,1
1,GO PRIMARY MIRNA PROCESSING,8.7323e-05,0.39624,0.38327,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,1.3441e-06,0.39594,0.33394,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.2308e-06,0.39547,0.50288,1,1
1,GO SPROUTING ANGIOGENESIS,1.2962e-05,0.3953,0.35812,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,2.1702e-06,0.39518,0.33824,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.2454e-05,0.39516,0.43612,1,1
1,GO HAIR FOLLICLE MATURATION,0.0015653,0.39467,0.32374,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00030804,0.39438,0.35727,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00090094,0.39437,0.32512,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.001191,0.39434,0.51396,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0019282,0.39327,0.3967,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.023741,0.39315,0.30851,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,2.9532e-05,0.39301,0.46268,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0030654,0.39272,0.38591,1,1
1,GO B CELL MEDIATED IMMUNITY,2.5774e-06,0.39219,0.35276,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00016595,0.39211,0.31308,1,1
1,GO PLATELET DEGRANULATION,2.6902e-06,0.39201,0.45925,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,3.3287e-06,0.39165,0.3422,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,1.104e-05,0.39129,0.34261,1,1
1,GO OSTEOCLAST DEVELOPMENT,5.9841e-06,0.39084,0.41501,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,3.9418e-06,0.39052,0.43315,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00021909,0.38987,0.34272,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0079323,0.38965,0.30906,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,8.0176e-08,0.38928,0.37665,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.4712e-06,0.38909,0.35891,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00013433,0.38888,0.32394,1,1
1,GO INTERACTION WITH HOST,6.2985e-07,0.38851,0.43434,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.9301e-06,0.38821,0.40493,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.00017186,0.38817,0.39047,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.3287e-06,0.38815,0.35503,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00059588,0.38813,0.34016,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,9.7801e-06,0.38778,0.35051,1,1
1,GO T CELL APOPTOTIC PROCESS,1.6729e-06,0.38743,0.36383,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.6455e-05,0.38722,0.39392,1,1
1,GO REGULATION OF PROTEIN IMPORT,8.3127e-06,0.38711,0.37908,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.4039e-05,0.38665,0.37537,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00098941,0.38633,0.40189,1,1
1,GO MUSCLE FILAMENT SLIDING,9.4334e-07,0.38628,0.41839,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,2.3975e-07,0.38616,0.38284,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00092958,0.3861,0.30747,1,1
1,GO RESPONSE TO ESTROGEN,1.9904e-06,0.38605,0.3778,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.001662,0.38604,0.4903,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,6.0504e-05,0.38559,0.56029,1,1
1,GO MATURATION OF 5 8S RRNA,0.00012512,0.38425,0.32521,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.00012074,0.38399,0.3414,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00028792,0.38394,0.35911,1,1
1,GO ERBB2 SIGNALING PATHWAY,0.0001547,0.38381,0.29597,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00028792,0.38332,0.32387,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0022992,0.38332,0.331,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.018836,0.3829,0.29875,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,4.9191e-08,0.38225,0.38719,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00054072,0.3818,0.35158,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0067808,0.38149,0.37362,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0010528,0.3813,0.38381,1,1
1,GO ARGININE METABOLIC PROCESS,0.00021909,0.38098,0.39643,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.0184e-05,0.38043,0.33361,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00028792,0.37978,0.38542,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0047853,0.37968,0.27982,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,1.104e-05,0.37912,0.34024,1,1
1,GO MEMBRANE INVAGINATION,1.0207e-07,0.37863,0.40224,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,4.6623e-06,0.37795,0.33384,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0015189,0.37771,0.42536,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,1.1964e-05,0.3776,0.31284,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.8251e-06,0.37732,0.36546,1,1
1,GO TYPE I INTERFERON PRODUCTION,1.4609e-05,0.37726,0.32799,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00020448,0.37719,0.3185,1,1
1,GO REGULATION OF PHAGOCYTOSIS,3.17e-07,0.37716,0.40851,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0038387,0.37671,0.42188,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0022332,0.37628,0.2832,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.1964e-05,0.37625,0.32639,1,1
1,GO GLAND MORPHOGENESIS,4.3218e-05,0.37522,0.41221,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,2.8418e-05,0.37495,0.38061,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00026003,0.37486,0.31498,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00010845,0.37483,0.30565,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,3.7145e-05,0.37481,0.35205,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,4.3218e-05,0.37455,0.41245,1,1
1,GO CARNITINE METABOLIC PROCESS,0.00040247,0.37435,0.34468,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00016023,0.37418,0.3585,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,3.7145e-05,0.37396,0.46547,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,7.8282e-05,0.37373,0.33779,1,1
1,GO VIRAL GENE EXPRESSION,1.7118e-05,0.37334,0.37695,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,1.9263e-05,0.37273,0.34379,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00029782,0.37209,0.29398,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,3.7791e-06,0.37192,0.39776,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.001872,0.3718,0.32209,1,1
1,GO FIBROBLAST PROLIFERATION,3.7145e-05,0.37164,0.3409,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,7.3528e-06,0.37147,0.36544,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,1.5201e-05,0.37096,0.33116,1,1
1,GO TRABECULA FORMATION,0.00052342,0.37094,0.45107,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.036948,0.37062,0.21831,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,3.0689e-05,0.36943,0.34969,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00065623,0.36932,0.33428,1,1
1,GO MEMBRANE DISASSEMBLY,0.00027832,0.36932,0.29925,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.5427e-07,0.36891,0.36789,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,4.0073e-05,0.3687,0.3934,1,1
1,GO RIG I SIGNALING PATHWAY,3.4421e-05,0.36825,0.37021,1,1
1,GO REGULATION OF LIPASE ACTIVITY,1.4609e-05,0.36824,0.2794,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00081984,0.36805,0.36957,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.0041716,0.3679,0.29498,1,1
1,GO GLIAL CELL ACTIVATION,3.3132e-05,0.36788,0.36745,1,1
1,GO CHONDROCYTE DIFFERENTIATION,7.0571e-06,0.36766,0.33175,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0006154,0.36671,0.35586,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0015189,0.36667,0.43241,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0021062,0.36639,0.27119,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.013e-05,0.366,0.32724,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.3127e-06,0.36579,0.42378,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0054795,0.36563,0.38914,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0034322,0.36536,0.29737,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00034072,0.36523,0.39902,1,1
1,GO ERAD PATHWAY,1.2308e-06,0.36505,0.30767,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00069957,0.36504,0.34157,1,1
1,GO REGULATION OF COAGULATION,2.7343e-05,0.3648,0.4143,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,2.9532e-05,0.36479,0.3134,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0015653,0.36442,0.38977,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,5.2837e-06,0.36359,0.35386,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.8521e-05,0.36351,0.39524,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.9418e-06,0.36329,0.49364,1,1
1,GO FOCAL ADHESION ASSEMBLY,7.3528e-06,0.36329,0.40534,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.4712e-06,0.36285,0.40413,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00016595,0.36279,0.272,1,1
1,GO MESODERM MORPHOGENESIS,2.8891e-07,0.36274,0.38224,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.4609e-05,0.36256,0.31787,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00095906,0.36245,0.35396,1,1
1,GO GENITALIA MORPHOGENESIS,0.0017641,0.36221,0.33722,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.349e-05,0.3622,0.37599,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.00038934,0.36215,0.45525,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00079435,0.36213,0.36151,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.001228,0.36203,0.28489,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00010092,0.36198,0.29342,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,2.4346e-05,0.36163,0.35248,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00079435,0.36051,0.35195,1,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.05161,0.3604,0.16368,1,1
1,GO VASCULATURE DEVELOPMENT,4.1112e-06,0.36033,0.31669,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.045624,0.36024,0.21688,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.0015189,0.36023,0.33471,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00049035,0.36016,0.43747,1,1
1,GO GASTRULATION,2.1831e-07,0.35998,0.38701,1,1
1,GO RESPONSE TO VIRUS,4.2876e-06,0.3591,0.36356,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,7.2754e-05,0.35868,0.29828,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,1.0604e-05,0.35848,0.4102,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.5308e-05,0.35847,0.29108,1,1
1,GO FOREBRAIN MORPHOGENESIS,0.027188,0.35829,0.19678,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,9.7346e-05,0.35799,0.29216,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00021909,0.35799,0.26595,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,9.7801e-06,0.35757,0.39709,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0010206,0.35754,0.31076,1,1
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.027188,0.35714,0.23848,1,1
1,GO HYPOTONIC RESPONSE,0.00016595,0.35712,0.32895,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,6.2786e-05,0.35696,0.29233,1,1
1,GO WOUND HEALING,8.6584e-06,0.35685,0.33441,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.0833e-05,0.35633,0.32695,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0036303,0.3562,0.31111,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0024367,0.35608,0.43759,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,5.2837e-06,0.35555,0.37305,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.3441e-06,0.35527,0.37314,1,1
1,GO REGULATION OF PROTEIN MATURATION,2.6902e-06,0.35515,0.36714,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00034072,0.35492,0.39162,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0062634,0.35477,0.27362,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.7118e-05,0.35458,0.31043,1,1
1,GO EPOXYGENASE P450 PATHWAY,0.0021689,0.3545,0.29184,1,1
1,GO ENDOTHELIAL CELL MIGRATION,1.5201e-05,0.35421,0.3406,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.5308e-05,0.35415,0.33292,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.0023671,0.35364,0.31022,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,8.3127e-06,0.35336,0.36198,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.6174e-05,0.35295,0.32769,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,5.2139e-05,0.35283,0.38232,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,7.9801e-06,0.35225,0.31169,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0015189,0.3522,0.35896,1,1
1,GO RESPONSE TO MANGANESE ION,7.6603e-06,0.3521,0.34046,1,1
1,GO PIGMENT ACCUMULATION,0.0001547,0.35138,0.32351,1,1
1,GO NUCLEOSIDE SALVAGE,0.00095906,0.35108,0.43139,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00044439,0.35092,0.31778,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,1.9263e-05,0.35072,0.3416,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0056288,0.3507,0.28609,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.3654e-06,0.35015,0.34466,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,3.1888e-05,0.34969,0.26324,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.4421e-05,0.34844,0.38486,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00038934,0.34802,0.30143,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,7.0571e-06,0.3479,0.32981,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.7323e-05,0.34714,0.43855,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00031859,0.34688,0.34565,1,1
1,GO L GLUTAMATE IMPORT,0.00038934,0.34672,0.35787,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,2.6902e-06,0.34652,0.36698,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.001872,0.34601,0.37409,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00045924,0.34569,0.39439,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00011241,0.34546,0.31263,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.0375e-08,0.34525,0.34067,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00042998,0.34519,0.37271,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0007696,0.34498,0.27082,1,1
1,GO NCRNA PROCESSING,2.5308e-05,0.34461,0.30403,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.3418e-05,0.34451,0.37511,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.9904e-06,0.34431,0.34938,1,1
1,GO TISSUE MIGRATION,3.8583e-05,0.34364,0.30732,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,2.0033e-05,0.34364,0.3351,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.012508,0.34348,0.37386,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.00022676,0.34331,0.37889,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0075304,0.3431,0.2846,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,2.5774e-06,0.34289,0.32212,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.6729e-06,0.34281,0.39055,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00021909,0.34226,0.37044,1,1
1,GO PEPTIDE CATABOLIC PROCESS,1.104e-05,0.34213,0.29851,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0016129,0.34158,0.34907,1,1
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0090226,0.34122,0.24725,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,6.7596e-05,0.34108,0.34712,1,1
1,GO PROTEIN HYDROXYLATION,0.0046564,0.34105,0.3742,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.010245,0.34058,0.29353,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.0779e-06,0.34036,0.42456,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00059588,0.33985,0.30223,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0073363,0.33959,0.27452,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00054072,0.33946,0.30081,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,4.4878e-05,0.33939,0.34297,1,1
1,GO T CELL MIGRATION,4.8379e-05,0.33927,0.30731,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00054072,0.33911,0.36866,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,0.33876,0.30838,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0023671,0.33853,0.39066,1,1
1,GO NADPH REGENERATION,0.00022676,0.33842,0.31369,1,1
1,GO NATURAL KILLER CELL ACTIVATION,4.4712e-06,0.33817,0.33046,1,1
1,GO CARTILAGE DEVELOPMENT,2.1663e-05,0.33751,0.29274,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.5201e-05,0.33746,0.27946,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.349e-05,0.33712,0.45658,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.0604e-05,0.33709,0.33633,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,4.5813e-07,0.33696,0.32253,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00013433,0.33692,0.27269,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,4.5813e-07,0.33631,0.34936,1,1
1,GO PROSTATIC BUD FORMATION,0.00087311,0.33585,0.45168,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,3.9418e-06,0.33546,0.31306,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021062,0.3352,0.31817,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,9.3916e-06,0.3351,0.30708,1,1
1,GO FIBROBLAST ACTIVATION,0.0010859,0.3347,0.35971,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,3.3287e-06,0.33466,0.40503,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,9.7346e-05,0.33419,0.30144,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,5.4121e-05,0.3341,0.2725,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.7806e-05,0.3341,0.39181,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.00081984,0.33395,0.21264,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00021167,0.33394,0.27285,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,4.4712e-06,0.33393,0.3397,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.3418e-05,0.33349,0.40185,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,4.5813e-07,0.33348,0.40688,1,1
1,GO IRON ION HOMEOSTASIS,1.9904e-06,0.33337,0.29119,1,1
1,GO RESPONSE TO CORTICOSTEROID,0.00012964,0.33307,0.2633,1,1
1,GO DECIDUALIZATION,0.0028141,0.33303,0.3997,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00012964,0.33299,0.35197,1,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.010245,0.3324,0.25072,1,1
1,GO MYOBLAST DIFFERENTIATION,7.9801e-06,0.33197,0.34007,1,1
1,GO AMYLOID FIBRIL FORMATION,0.0037331,0.33182,0.31092,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00044439,0.33181,0.33212,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00057693,0.3317,0.37076,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,7.547e-05,0.33161,0.29919,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00081984,0.33142,0.23567,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,6.4994e-06,0.33124,0.3086,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0041716,0.33107,0.28048,1,1
1,GO PROTEIN TARGETING TO VACUOLE,9.7801e-06,0.331,0.28905,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,5.2837e-06,0.33076,0.32005,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00079435,0.33076,0.24713,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.7145e-05,0.33059,0.28758,1,1
1,GO RESPONSE TO WOUNDING,9.7801e-06,0.33042,0.28797,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,4.3218e-05,0.33019,0.26161,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.00016023,0.33008,0.29939,1,1
1,GO TISSUE REGENERATION,5.6174e-05,0.32996,0.316,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,5.0226e-05,0.32992,0.32222,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.00035231,0.32987,0.34705,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.7413e-06,0.32971,0.2984,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00049035,0.32957,0.31638,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,3.7791e-06,0.32946,0.39779,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,8.1192e-05,0.32881,0.26985,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.8612e-06,0.3284,0.31024,1,1
1,GO PIGMENT METABOLIC PROCESS,6.2367e-06,0.32794,0.31283,1,1
1,GO REGENERATION,5.753e-07,0.32782,0.31146,1,1
1,GO TOOTH MINERALIZATION,0.0038387,0.32768,0.28371,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00081984,0.32768,0.29554,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0015653,0.32766,0.35193,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00026903,0.327,0.31905,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0022992,0.32691,0.34381,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.2658e-06,0.32652,0.35008,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00041602,0.3263,0.36731,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.0007696,0.32583,0.25501,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0032441,0.32576,0.32374,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00044439,0.32549,0.35337,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.00049035,0.3253,0.38365,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,2.0033e-05,0.32525,0.30646,1,1
1,GO MUSCLE CELL PROLIFERATION,5.9841e-06,0.32517,0.32699,1,1
1,GO COMPLEMENT ACTIVATION,2.6902e-06,0.32499,0.32038,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.2454e-05,0.32487,0.28297,1,1
1,GO ASYMMETRIC CELL DIVISION,0.00036427,0.32482,0.28376,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0025083,0.32481,0.30746,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00045924,0.32476,0.26561,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0021062,0.32454,0.25603,1,1
1,GO CELL REDOX HOMEOSTASIS,1.4609e-05,0.32449,0.29923,1,1
1,GO MACROPHAGE DIFFERENTIATION,8.4205e-05,0.32447,0.35753,1,1
1,GO REGULATION OF HEART GROWTH,2.6307e-05,0.32407,0.27893,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.3441e-06,0.32407,0.28376,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00026903,0.32306,0.33732,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00030804,0.32259,0.28955,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.02843,0.32249,0.18206,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.0021689,0.32248,0.33873,1,1
1,GO RESPONSE TO INTERLEUKIN 1,3.0576e-06,0.32236,0.35341,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00037661,0.32232,0.33249,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.049546,0.32232,0.29605,1,1
1,GO REGULATION OF RNA BINDING,1.8251e-06,0.32229,0.32726,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.015953,0.32214,0.31562,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.3287e-06,0.32205,0.35429,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.322,0.34007,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.023205,0.32195,0.22463,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.001191,0.32189,0.28596,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.2876e-06,0.32185,0.31692,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0011549,0.32181,0.23169,1,1
1,GO NEURAL CREST CELL MIGRATION,0.0042883,0.32181,0.25404,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0010206,0.32125,0.31164,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00021909,0.3212,0.30991,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00036427,0.32043,0.21272,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00042998,0.32013,0.28712,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00021167,0.319,0.3633,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.9301e-06,0.31874,0.33197,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0027346,0.31856,0.29315,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0064317,0.31838,0.19883,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,2.5308e-05,0.31838,0.3141,1,1
1,GO HISTONE PHOSPHORYLATION,1.3441e-06,0.31819,0.30491,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,9.389e-05,0.31814,0.35779,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00030804,0.31799,0.33109,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.4728e-06,0.31778,0.32173,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,9.0179e-06,0.31755,0.40472,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0033369,0.31751,0.41124,1,1
1,GO NECROTIC CELL DEATH,7.8282e-05,0.31738,0.39379,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.349e-05,0.31729,0.3179,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,5.9841e-06,0.31723,0.40967,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0025083,0.31703,0.29035,1,1
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0097392,0.31662,0.27932,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.4044e-06,0.31659,0.35182,1,1
1,GO ASTROCYTE ACTIVATION,0.0010206,0.31652,0.31038,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00032948,0.31639,0.26239,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00047456,0.31617,0.30627,1,1
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0085714,0.31575,0.30611,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0067808,0.3156,0.43487,1,1
1,GO CYTOKINETIC PROCESS,3.0689e-05,0.31522,0.29585,1,1
1,GO SYNCYTIUM FORMATION,5.4121e-05,0.31517,0.32681,1,1
1,GO PROTEIN DEGLYCOSYLATION,0.00014418,0.31509,0.32332,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0021062,0.31497,0.36082,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,2.0033e-05,0.31461,0.32994,1,1
1,GO INNATE IMMUNE RESPONSE,1.4039e-05,0.31441,0.27788,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,5.6174e-05,0.31417,0.33699,1,1
1,GO PLASMA MEMBRANE TUBULATION,1.1776e-06,0.31413,0.37146,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.1112e-06,0.31412,0.29353,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00016595,0.31346,0.23128,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.5816e-05,0.31333,0.3292,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.03939,0.31279,0.1933,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00036427,0.3127,0.29517,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00018427,0.31232,0.31437,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.00013917,0.31231,0.39721,1,1
1,GO RNA 5 END PROCESSING,0.00026903,0.31199,0.28801,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,5.9841e-06,0.31172,0.30218,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00010462,0.31172,0.29202,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00013433,0.31169,0.28328,1,1
1,GO KERATINOCYTE MIGRATION,8.7323e-05,0.31165,0.3432,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,2.2524e-05,0.31153,0.37744,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.3441e-06,0.31129,0.28248,1,1
1,GO VESICLE CARGO LOADING,0.00010845,0.31075,0.29275,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.00038934,0.31035,0.26265,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,8.1192e-05,0.30967,0.27815,1,1
1,GO RRNA METABOLIC PROCESS,0.00012964,0.30964,0.30083,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00063551,0.30959,0.29875,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,9.0551e-05,0.30957,0.37805,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.4039e-05,0.30918,0.29374,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,1.7118e-05,0.30894,0.43469,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,6.5149e-05,0.30894,0.29085,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012964,0.30883,0.30611,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.001872,0.30877,0.28226,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.2658e-06,0.30865,0.35243,1,1
1,GO GONADOTROPIN SECRETION,0.0071468,0.30838,0.26456,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.017137,0.30809,0.26241,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,2.3418e-05,0.30748,0.25106,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.0025817,0.30672,0.30695,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00031859,0.3067,0.34436,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,7.3528e-06,0.30614,0.29803,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,4.4712e-06,0.30588,0.28108,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,6.0504e-05,0.30587,0.29954,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00049035,0.30567,0.27372,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,8.1192e-05,0.30565,0.33582,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00012074,0.30545,0.25859,1,1
1,GO TRNA 5 LEADER REMOVAL,0.0001547,0.30539,0.31858,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.007729,0.30531,0.20372,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,4.0073e-05,0.30525,0.25966,1,1
1,GO RESPONSE TO DSRNA,9.8628e-07,0.30518,0.37605,1,1
1,GO MACROPHAGE MIGRATION,3.9418e-06,0.30506,0.36068,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,4.3218e-05,0.30485,0.3339,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.001872,0.30485,0.26523,1,1
1,GO NCRNA METABOLIC PROCESS,5.2139e-05,0.30479,0.26796,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,3.9418e-06,0.30478,0.307,1,1
1,GO CELL MATRIX ADHESION,1.7118e-05,0.30469,0.34271,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,1.2454e-05,0.30468,0.26794,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.6902e-06,0.30461,0.29689,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.046579,0.30444,0.39175,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,8.1192e-05,0.30437,0.34894,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,1.2962e-05,0.304,0.40382,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00029782,0.30389,0.29192,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00019753,0.30383,0.29042,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.889e-07,0.30344,0.24135,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.2524e-05,0.30341,0.28314,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0010859,0.30333,0.28202,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00044439,0.30304,0.3445,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.906e-06,0.30251,0.44456,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0014738,0.30227,0.30753,1,1
1,GO TRANSLATIONAL TERMINATION,0.00057693,0.30227,0.24308,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0081404,0.30201,0.24022,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00012074,0.30194,0.32051,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,4.1617e-05,0.30191,0.34806,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,2.1702e-06,0.30181,0.35084,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.3441e-06,0.30171,0.3822,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00055855,0.30164,0.26104,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.001191,0.30159,0.27792,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00014418,0.30158,0.24673,1,1
1,GO SELECTIVE AUTOPHAGY,3.17e-07,0.30121,0.32186,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,2.2524e-05,0.30117,0.30233,1,1
1,GO MUSCLE CELL MIGRATION,0.023205,0.30077,0.22351,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.7145e-05,0.30073,0.26853,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,1.0604e-05,0.30055,0.31976,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00067758,0.30023,0.27416,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0037331,0.30007,0.31925,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,6.4994e-06,0.30003,0.29449,1,1
1,GO T CELL CYTOKINE PRODUCTION,9.3916e-06,0.29996,0.40732,1,1
1,GO URETER DEVELOPMENT,0.011904,0.29983,0.23486,1,1
1,GO LIPID IMPORT INTO CELL,0.0032441,0.29972,0.25292,1,1
1,GO STEROL TRANSPORT,2.5308e-05,0.29969,0.26096,1,1
1,GO SPERM EGG RECOGNITION,1.3441e-06,0.29954,0.27761,1,1
1,GO ETHANOL OXIDATION,0.031059,0.2994,0.30429,1,1
1,GO RRNA MODIFICATION,0.0021689,0.2993,0.22642,1,1
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.02843,0.29922,0.36721,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,4.1112e-06,0.29899,0.25283,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,8.6584e-06,0.29871,0.3205,1,1
1,GO FOAM CELL DIFFERENTIATION,0.00034072,0.29858,0.28637,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0056288,0.29853,0.36097,1,1
1,GO LYMPHOCYTE MIGRATION,5.6174e-05,0.29851,0.24202,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00026003,0.29845,0.36124,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00084609,0.29836,0.27165,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0041716,0.29829,0.22142,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0011199,0.29795,0.27465,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,7.9801e-06,0.29783,0.28569,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.001872,0.29761,0.31318,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00026003,0.29748,0.25978,1,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.020205,0.29705,0.24385,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.6455e-05,0.2969,0.34688,1,1
1,GO RIBOSOME BIOGENESIS,0.00010092,0.29663,0.31796,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00098941,0.29649,0.28806,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00010845,0.29605,0.31195,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.2879e-07,0.296,0.29876,1,1
1,GO RNA CATABOLIC PROCESS,4.5813e-07,0.29577,0.27874,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,5.7413e-06,0.29555,0.2837,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.4421e-05,0.29543,0.27075,1,1
1,GO CHOLESTEROL EFFLUX,4.2876e-06,0.29542,0.32058,1,1
1,GO RESPONSE TO CYTOKINE,7.6603e-06,0.29539,0.30307,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00067758,0.2953,0.26988,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.2524e-05,0.29524,0.31439,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00032948,0.29502,0.23839,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,2.6902e-06,0.29489,0.25646,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0013457,0.29486,0.2767,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,3.9418e-06,0.2947,0.3112,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00021909,0.29444,0.35579,1,1
1,GO CYTOKINE PRODUCTION,1.2454e-05,0.2941,0.26883,1,1
1,GO REGULATION OF CELL AGING,1.4268e-07,0.29407,0.33608,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.014486,0.29383,0.26868,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,1.0779e-06,0.29365,0.25265,1,1
1,GO T CELL CHEMOTAXIS,4.6597e-05,0.29304,0.27183,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00012512,0.29295,0.34201,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,8.7323e-05,0.2926,0.26392,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,9.0179e-06,0.29254,0.2905,1,1
1,GO COAGULATION,1.0604e-05,0.29223,0.29182,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00038934,0.29203,0.23173,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,6.0504e-05,0.29202,0.33534,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0031536,0.29199,0.23119,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0036303,0.29141,0.2024,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00012512,0.29119,0.28939,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.628e-07,0.29105,0.33379,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00055855,0.29089,0.32118,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,1.4039e-05,0.29078,0.25405,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0053338,0.29072,0.23229,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0007696,0.29044,0.34819,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,8.3127e-06,0.29034,0.31033,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00065623,0.29023,0.18154,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.02166,0.2901,0.25645,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00035231,0.29,0.24499,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0001165,0.28977,0.30431,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00013917,0.28974,0.29384,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00018427,0.28965,0.41056,1,1
1,GO TRACHEA MORPHOGENESIS,0.0020453,0.28909,0.25979,1,1
1,GO TRNA 5 END PROCESSING,0.00010845,0.28894,0.3013,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.2139e-05,0.2886,0.28375,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0031536,0.28801,0.2376,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00012964,0.28779,0.30882,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.6597e-05,0.28766,0.26542,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.0028141,0.28759,0.26741,1,1
1,GO COPPER ION TRANSPORT,6.2786e-05,0.28722,0.31354,1,1
1,GO RESPONSE TO BACTERIUM,1.7806e-05,0.2872,0.26679,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,1.2962e-05,0.28709,0.25178,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,5.508e-06,0.28707,0.2629,1,1
1,GO SYMBIOTIC PROCESS,1.6452e-07,0.28705,0.28642,1,1
1,GO REGULATION OF WOUND HEALING,0.00034072,0.28669,0.29517,1,1
1,GO HYPEROSMOTIC RESPONSE,0.00035231,0.2865,0.27454,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.044685,0.28646,0.31554,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,9.0551e-05,0.28628,0.34389,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00013917,0.28627,0.28142,1,1
1,GO OSTEOBLAST DIFFERENTIATION,1.7806e-05,0.28589,0.29213,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0069616,0.28584,0.47379,1,1
1,GO CELL CELL RECOGNITION,5.4977e-07,0.28569,0.30051,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.012508,0.28563,0.34061,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.0025083,0.2856,0.19463,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.00040247,0.28499,0.26649,1,1
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.05161,0.28464,0.19095,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00045924,0.28445,0.31518,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00021167,0.28443,0.42295,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00016023,0.28441,0.32742,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,5.0226e-05,0.28405,0.28948,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.00090094,0.28405,0.20127,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,8.3127e-06,0.28401,0.25233,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.28401,0.33848,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,1.2454e-05,0.2838,0.26806,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.1888e-05,0.28378,0.24471,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,7.2754e-05,0.28367,0.31239,1,1
1,GO CHEMOKINE PRODUCTION,0.0019282,0.2836,0.25622,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00090094,0.28352,0.27363,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.0264e-07,0.28314,0.2503,1,1
1,GO MYOBLAST FUSION,0.00042998,0.28309,0.32007,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,2.3418e-05,0.28291,0.2761,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00019079,0.28284,0.26959,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,7.8282e-05,0.28274,0.27209,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.007729,0.28268,0.23585,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00019753,0.28267,0.31259,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.022165,0.28263,0.22768,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,3.9418e-06,0.28244,0.25902,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00016595,0.28222,0.21555,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.349e-05,0.2822,0.27405,1,1
1,GO RESPONSE TO PROTOZOAN,0.0013457,0.28213,0.28525,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.013465,0.28171,0.1997,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013917,0.28144,0.31943,1,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.011904,0.28094,0.20273,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,4.4878e-05,0.28075,0.29044,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.2754e-05,0.28061,0.36608,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00029782,0.28031,0.19958,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00010845,0.2803,0.29885,1,1
1,GO REGULATION OF GENE SILENCING,3.6228e-06,0.28012,0.24958,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0060989,0.27924,0.2909,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0019282,0.27913,0.23043,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0021062,0.2791,0.2719,1,1
1,GO TISSUE REMODELING,0.00024286,0.27882,0.26365,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.0054795,0.27822,0.21743,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00054072,0.27804,0.22018,1,1
1,GO REGULATION OF ORGAN GROWTH,3.8131e-07,0.27763,0.32653,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00087311,0.2776,0.2834,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00019079,0.27752,0.34228,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.021165,0.27745,0.32363,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00045924,0.27725,0.29284,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.2837e-06,0.27713,0.28953,1,1
1,GO PROTEIN FOLDING,3.3287e-06,0.27687,0.26021,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.00024286,0.27682,0.25774,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00092958,0.2768,0.20452,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,8.3127e-06,0.27674,0.26394,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00040247,0.27599,0.30532,1,1
1,GO ERK1 AND ERK2 CASCADE,1.4039e-05,0.27594,0.24463,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00059588,0.27529,0.19027,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00021167,0.27523,0.30172,1,1
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.046579,0.27522,0.23118,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00022676,0.27517,0.25052,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00045924,0.27502,0.29665,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,9.7346e-05,0.27492,0.28283,1,1
1,GO CELLULAR RESPONSE TO LIPID,8.4205e-05,0.27488,0.2049,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00017186,0.27479,0.28495,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.2754e-05,0.27396,0.34051,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.7118e-05,0.27379,0.41789,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,1.5201e-05,0.27378,0.22928,1,1
1,GO RESPONSE TO IONIZING RADIATION,3.9418e-06,0.27378,0.27594,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.00034072,0.2735,0.28797,1,1
1,GO TRANSPOSITION,0.017137,0.27334,0.22313,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,2.3654e-06,0.2732,0.2455,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,4.4712e-06,0.27312,0.30196,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,2.8418e-05,0.27309,0.34204,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.1192e-05,0.273,0.27723,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00069957,0.27278,0.3624,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.034637,0.27253,0.27901,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.00079435,0.27238,0.26115,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.015953,0.27228,0.21594,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.7346e-05,0.27212,0.23555,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00031859,0.27188,0.20007,1,1
1,GO MESODERM DEVELOPMENT,7.3528e-06,0.27184,0.23371,1,1
1,GO DNA LIGATION,0.00010462,0.27181,0.3051,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,7.547e-05,0.27171,0.22488,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00036427,0.27157,0.29141,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00011241,0.27149,0.22639,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.031748,0.27144,0.3077,1,1
1,GO IMMUNOGLOBULIN SECRETION,0.00057693,0.27143,0.31548,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,3.6414e-07,0.27113,0.28569,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,8.4205e-05,0.27105,0.21603,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.3441e-06,0.27062,0.34139,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.0571e-06,0.27041,0.31506,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,4.8612e-06,0.27039,0.24794,1,1
1,GO BONE MORPHOGENESIS,0.00020448,0.27018,0.27187,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00034072,0.26968,0.28374,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0028957,0.2695,0.22305,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.001228,0.26909,0.30736,1,1
1,GO ACUTE PHASE RESPONSE,0.0085714,0.26901,0.26263,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.020205,0.26879,0.20972,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0037331,0.26864,0.25061,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00045924,0.26843,0.22655,1,1
1,GO PHAGOCYTOSIS,1.0311e-06,0.26827,0.3337,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0013054,0.26819,0.2135,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.2962e-05,0.26815,0.27566,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,5.8301e-05,0.268,0.2303,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,9.0551e-05,0.26768,0.43824,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00010092,0.26759,0.25239,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00052342,0.26751,0.28039,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,5.2837e-06,0.2675,0.29041,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,1.5816e-05,0.26748,0.2561,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0014299,0.26717,0.31539,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.0779e-06,0.26716,0.2717,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00013433,0.26705,0.2505,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0036303,0.26677,0.28222,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.2754e-05,0.26676,0.24832,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00030804,0.26664,0.28785,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0016129,0.26639,0.21985,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,1.7118e-05,0.2662,0.28269,1,1
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0041716,0.26596,0.26727,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,7.013e-05,0.2657,0.37263,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001228,0.26549,0.23186,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00014418,0.2653,0.34472,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0024367,0.26525,0.26204,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0071468,0.26523,0.279,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,4.3763e-07,0.26522,0.2728,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0045306,0.2651,0.28188,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0049174,0.26495,0.24024,1,1
1,GO GTP METABOLIC PROCESS,0.00011241,0.26495,0.32762,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00050664,0.26473,0.2916,1,1
1,GO REGULATION OF PROTEOLYSIS,1.349e-05,0.26473,0.21005,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.00055855,0.2647,0.19294,1,1
1,GO SEQUESTERING OF METAL ION,0.0039469,0.26461,0.23234,1,1
1,GO CELL AGING,2.8077e-06,0.26455,0.22643,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.0013457,0.26451,0.43266,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00011241,0.26443,0.23141,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0079323,0.26441,0.24154,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0040578,0.2644,0.22187,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00010845,0.26425,0.24193,1,1
1,GO TOXIN TRANSPORT,0.0022332,0.26416,0.18484,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0025817,0.26397,0.21574,1,1
1,GO DETECTION OF OTHER ORGANISM,0.0064317,0.26393,0.28754,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.7474e-06,0.26387,0.29351,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00029782,0.26345,0.24997,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00095906,0.26343,0.22679,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.027803,0.26329,0.16236,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00016595,0.26312,0.25072,1,1
1,GO LUNG MORPHOGENESIS,0.0024367,0.26306,0.25877,1,1
1,GO PROTEIN KINASE B SIGNALING,2.2524e-05,0.26305,0.21807,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00017796,0.26292,0.20864,1,1
1,GO VIRION ASSEMBLY,0.00050664,0.26279,0.18733,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0011199,0.26272,0.28011,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.3418e-05,0.26219,0.24309,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.5774e-06,0.26207,0.25923,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00021909,0.26194,0.24287,1,1
1,GO XENOBIOTIC TRANSPORT,0.00055855,0.26183,0.258,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00019079,0.2616,0.24078,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.00016595,0.26157,0.27308,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.00010092,0.26154,0.23798,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0094949,0.2611,0.3145,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,4.4878e-05,0.261,0.21933,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,6.7596e-05,0.261,0.19902,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.018836,0.26097,0.1915,1,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.016734,0.26096,0.15377,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.010506,0.26089,0.18674,1,1
1,GO AUTOPHAGOSOME MATURATION,3.8583e-05,0.26078,0.26899,1,1
1,GO FATTY ACID BETA OXIDATION,0.00026903,0.26068,0.2486,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,4.1802e-07,0.26052,0.23059,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0083534,0.26052,0.20388,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.0047853,0.2604,0.21311,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.00035231,0.26035,0.25813,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.0045306,0.26021,0.19797,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.011326,0.26015,0.29195,1,1
1,GO RNA 3 END PROCESSING,0.00016023,0.26012,0.20803,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.012203,0.25969,0.26277,1,1
1,GO RNA DESTABILIZATION,2.8418e-05,0.25959,0.25233,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00030804,0.2593,0.27285,1,1
1,GO CHYLOMICRON ASSEMBLY,0.010245,0.25909,0.23147,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00022676,0.2588,0.20508,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0094949,0.25865,0.33269,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00050664,0.25858,0.23649,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.044685,0.25853,0.35487,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.2837e-06,0.25824,0.25679,1,1
1,GO IMMUNE EFFECTOR PROCESS,9.3916e-06,0.25819,0.28073,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,3.6228e-06,0.25786,0.23765,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,5.0683e-06,0.25781,0.26207,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00012074,0.25738,0.23465,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,4.4878e-05,0.25729,0.21329,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00035231,0.25727,0.27444,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00012964,0.25725,0.24706,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,1.1267e-06,0.25672,0.28241,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,0.0013054,0.25651,0.23903,1,1
1,GO CHONDROCYTE PROLIFERATION,0.0046564,0.25635,0.39489,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00010462,0.25612,0.29357,1,1
1,GO DE NOVO PROTEIN FOLDING,0.00042998,0.25611,0.20853,1,1
1,GO PEPTIDE METABOLIC PROCESS,1.6729e-06,0.25568,0.23244,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00040247,0.25562,0.21628,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,2.4692e-06,0.25531,0.24124,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00021167,0.25529,0.26062,1,1
1,GO MACROPHAGE CHEMOTAXIS,2.7343e-05,0.25482,0.3462,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.015203,0.25475,0.24057,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.6455e-05,0.2547,0.29413,1,1
1,GO REGULATION OF BONE DEVELOPMENT,0.00047456,0.25446,0.27334,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.3132e-05,0.2544,0.23957,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.029068,0.25432,0.19462,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00050664,0.25428,0.21171,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0017641,0.25408,0.25202,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.5774e-06,0.2537,0.31297,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00057693,0.25364,0.31053,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00026003,0.25364,0.24404,1,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0097392,0.25352,0.24873,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0026572,0.25345,0.28558,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,9.7801e-06,0.25303,0.25075,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,3.9926e-07,0.25298,0.25389,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,2.9532e-05,0.25276,0.29501,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,7.0571e-06,0.25242,0.22575,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,0.00034072,0.25227,0.2501,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.5308e-05,0.25221,0.22122,1,1
1,GO INFLAMMATORY RESPONSE,6.0504e-05,0.25125,0.25003,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.00023468,0.25104,0.24269,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.00012074,0.25096,0.25952,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00013433,0.25094,0.23384,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.027188,0.25089,0.21473,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0024367,0.25077,0.21169,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,5.508e-06,0.25066,0.24796,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00012512,0.2499,0.28194,1,1
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.0033369,0.24977,0.19764,1,1
1,GO RRNA METHYLATION,0.0038387,0.24974,0.20013,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.044685,0.24946,0.22732,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.001986,0.24934,0.25232,1,1
1,GO CERAMIDE TRANSPORT,0.0051916,0.24917,0.23399,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00081984,0.2481,0.20718,1,1
1,GO AMINO SUGAR CATABOLIC PROCESS,0.00027832,0.24798,0.26553,1,1
1,GO OSTEOCLAST DIFFERENTIATION,3.8583e-05,0.24794,0.2167,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0029794,0.24757,0.22647,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.045624,0.24744,0.26618,1,1
1,GO FACE DEVELOPMENT,0.00019753,0.24712,0.26851,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00038934,0.24708,0.21103,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.014486,0.24699,0.2645,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.3418e-05,0.24693,0.25389,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.0012662,0.24666,0.20636,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.017969,0.24652,0.32456,1,1
1,GO PODOSOME ASSEMBLY,0.00014935,0.24635,0.35735,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00017796,0.24615,0.23006,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.023741,0.24609,0.16462,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00012512,0.24601,0.25949,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.8379e-05,0.24585,0.23346,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.00027832,0.24564,0.2019,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00069957,0.24532,0.19117,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0015653,0.24528,0.22923,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.020205,0.24469,0.17548,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00019753,0.24461,0.21987,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.4039e-05,0.24432,0.24738,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0010206,0.24424,0.24016,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.00049035,0.24414,0.24841,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.00027832,0.24414,0.23153,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0006154,0.24362,0.41866,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00012512,0.24347,0.23648,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0010206,0.24322,0.27225,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.00353,0.24287,0.25971,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00032948,0.24275,0.19098,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0036303,0.24221,0.23287,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0033369,0.2422,0.2106,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0012662,0.24212,0.24947,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.1964e-05,0.24185,0.28568,1,1
1,GO REGULATION OF MITOPHAGY,0.015574,0.24166,0.19585,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00042998,0.24163,0.22332,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0015189,0.24144,0.16769,1,1
1,GO DNA DEALKYLATION,0.00090094,0.24115,0.22595,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,2.7343e-05,0.24098,0.21455,1,1
1,GO METANEPHROS DEVELOPMENT,0.00067758,0.24092,0.22046,1,1
1,GO NEURAL TUBE PATTERNING,0.0017123,0.2407,0.23859,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,2.0033e-05,0.24064,0.21516,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00041602,0.24056,0.24421,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.029719,0.24051,0.16689,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.001191,0.24048,0.22184,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00020448,0.24023,0.22474,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,3.4421e-05,0.24009,0.25435,1,1
1,GO HEART VALVE DEVELOPMENT,0.00040247,0.23972,0.29763,1,1
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,5.8301e-05,0.23944,0.23673,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,2.3654e-06,0.23932,0.25068,1,1
1,GO DEFENSE RESPONSE,4.0073e-05,0.2391,0.22623,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,9.389e-05,0.23904,0.21096,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.0021689,0.23881,0.22263,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00014935,0.2387,0.35059,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00036427,0.23868,0.24054,1,1
1,GO MEMBRANE BIOGENESIS,0.0049174,0.23859,0.23502,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.4346e-05,0.23845,0.30052,1,1
1,GO TUBE MORPHOGENESIS,6.7596e-05,0.23845,0.22029,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,5.2139e-05,0.23811,0.21855,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00069957,0.23806,0.18497,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.0032441,0.23782,0.2735,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00031859,0.23766,0.25083,1,1
1,GO TONGUE DEVELOPMENT,0.011326,0.23753,0.26438,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0013457,0.23751,0.2494,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0010206,0.23747,0.32472,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,4.6597e-05,0.23722,0.32263,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.019283,0.2372,0.18478,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00017796,0.23709,0.22861,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.6455e-05,0.23703,0.27242,1,1
1,GO PLATELET ACTIVATION,0.00057693,0.23675,0.22268,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,6.7596e-05,0.23633,0.20332,1,1
1,GO STRESS FIBER ASSEMBLY,0.00090094,0.23576,0.22714,1,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.029719,0.23566,0.16109,1,1
1,GO RESPONSE TO RETINOIC ACID,7.013e-05,0.2356,0.25855,1,1
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00019753,0.23541,0.23322,1,1
1,GO REGULATION OF ANOIKIS,0.047551,0.23482,0.21286,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0047853,0.23473,0.19888,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0067808,0.23455,0.20173,1,1
1,GO TRNA PROCESSING,0.00049035,0.23411,0.18611,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.024288,0.23397,0.35347,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.00018427,0.23384,0.18895,1,1
1,GO LIPID STORAGE,0.00059588,0.23358,0.23299,1,1
1,GO PROTEIN TARGETING,3.0689e-05,0.23319,0.20101,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,2.9301e-06,0.23313,0.25943,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0038387,0.23311,0.17584,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,3.4728e-06,0.2331,0.26174,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,0.00013917,0.23293,0.2282,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,8.7323e-05,0.23279,0.26466,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.0014738,0.23279,0.21045,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.1493e-05,0.23268,0.35401,1,1
1,GO P38MAPK CASCADE,9.7346e-05,0.23257,0.31846,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,4.6597e-05,0.23253,0.2062,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00011241,0.23229,0.24078,1,1
1,GO MYELOID CELL HOMEOSTASIS,1.349e-05,0.23169,0.22021,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,3.0689e-05,0.23146,0.36514,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.023741,0.23124,0.1539,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.0067808,0.23099,0.23929,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00036427,0.23093,0.2591,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.009256,0.23089,0.19531,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,8.628e-07,0.23084,0.22357,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00041602,0.2308,0.20351,1,1
1,GO POSITIVE CHEMOTAXIS,0.0041716,0.23075,0.22772,1,1
1,GO CRISTAE FORMATION,0.025414,0.23065,0.18741,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.0027346,0.23029,0.23109,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.010773,0.23012,0.35613,1,1
1,GO MITOPHAGY,0.00019079,0.2301,0.23929,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,3.6228e-06,0.22991,0.22802,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,2.2658e-06,0.22984,0.24722,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.00014935,0.2298,0.21116,1,1
1,GO REGULATION OF IMMUNE RESPONSE,1.9263e-05,0.22979,0.2163,1,1
1,GO PLACENTA DEVELOPMENT,0.0010528,0.22933,0.20752,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00017796,0.22927,0.33993,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0007696,0.22915,0.17588,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.00090094,0.22889,0.25738,1,1
1,GO NUCLEAR EXPORT,5.7413e-06,0.22858,0.21112,1,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.019283,0.22833,0.33345,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,6.7596e-05,0.22768,0.29144,1,1
1,GO TRABECULA MORPHOGENESIS,0.00081984,0.22732,0.27815,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,5.8301e-05,0.22731,0.20156,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00014418,0.22728,0.24797,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0024367,0.22693,0.19282,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,8.1192e-05,0.22691,0.21576,1,1
1,GO REGULATION OF HEMOPOIESIS,5.6174e-05,0.22687,0.19816,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00087311,0.22681,0.22472,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.050569,0.22679,0.20549,1,1
1,GO AGING,1.5816e-05,0.22677,0.20055,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0041716,0.22631,0.22911,1,1
1,GO STEROL IMPORT,0.00054072,0.22611,0.41555,1,1
1,GO SUPEROXIDE ANION GENERATION,0.0023671,0.22601,0.27071,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.00010845,0.22582,0.21368,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0033369,0.22574,0.20098,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,9.0551e-05,0.2257,0.26549,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.019739,0.2255,0.18337,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.00065623,0.22529,0.17424,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00050664,0.22526,0.20777,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,9.8628e-07,0.2252,0.19916,1,1
1,GO REGULATION OF BODY FLUID LEVELS,0.00021167,0.22515,0.19671,1,1
1,GO CELL PROLIFERATION IN HINDBRAIN,0.010773,0.22489,0.20424,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0001165,0.22483,0.22212,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.001228,0.22459,0.22025,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,9.0551e-05,0.22457,0.26763,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00059588,0.22453,0.26205,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,6.0504e-05,0.22409,0.20911,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0083534,0.22404,0.17624,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00017186,0.22367,0.23643,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00021167,0.22364,0.18372,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.01282,0.22344,0.19403,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.00074557,0.22337,0.16108,1,1
1,GO CELL KILLING,0.00353,0.22321,0.15694,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0016129,0.22312,0.17812,1,1
1,GO T CELL PROLIFERATION,0.00049035,0.22309,0.20584,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0011199,0.22304,0.18797,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.010506,0.2228,0.16056,1,1
1,GO PLATELET MORPHOGENESIS,0.00059588,0.22279,0.22458,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0020453,0.22265,0.21424,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00011241,0.22209,0.21219,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.010773,0.22193,0.16857,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,4.1617e-05,0.22182,0.21175,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0083534,0.2217,0.18214,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00055855,0.22142,0.17329,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00028792,0.22106,0.16628,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0014299,0.22089,0.37989,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0016129,0.22086,0.19128,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,6.0504e-05,0.22078,0.18192,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.0010859,0.22029,0.25296,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.0028141,0.22019,0.19724,1,1
1,GO REGULATION OF VASCULOGENESIS,0.0071468,0.22017,0.30944,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.1617e-05,0.21995,0.2163,1,1
1,GO BODY FLUID SECRETION,0.00024286,0.21983,0.21425,1,1
1,GO NUCLEUS LOCALIZATION,0.031059,0.2198,0.13251,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.004408,0.21975,0.20282,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,5.0194e-07,0.21971,0.20108,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,3.1888e-05,0.21957,0.19601,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00050664,0.21924,0.2112,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0021062,0.2191,0.26958,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.4609e-05,0.21904,0.23487,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,3.5759e-05,0.21884,0.21656,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0087944,0.21884,0.15379,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.017137,0.2188,0.18169,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00012074,0.21856,0.26116,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,1.2366e-07,0.21854,0.18213,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0038387,0.21852,0.19732,1,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.046579,0.21813,0.1638,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0011199,0.2181,0.20968,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.011326,0.21793,0.21866,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,2.5308e-05,0.2176,0.20256,1,1
1,GO TRNA METABOLIC PROCESS,0.00081984,0.21758,0.17844,1,1
1,GO INTERFERON GAMMA PRODUCTION,4.1617e-05,0.21747,0.26656,1,1
1,GO RNA MODIFICATION,0.00010462,0.21727,0.1981,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00042998,0.21723,0.31674,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.00036427,0.21677,0.2428,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00024286,0.21654,0.19111,1,1
1,GO REGULATION OF URINE VOLUME,0.00027832,0.21647,0.24044,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,8.628e-07,0.21628,0.21255,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00019079,0.216,0.20061,1,1
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.024846,0.21586,0.155,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.02268,0.21565,0.14186,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.015953,0.21551,0.26259,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,6.2367e-06,0.21526,0.1974,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0028957,0.21509,0.222,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,9.389e-05,0.21501,0.26076,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0013457,0.21495,0.20475,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0069616,0.21454,0.28703,1,1
1,GO GRANULOCYTE MIGRATION,0.00018427,0.21445,0.27623,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0011549,0.21418,0.18974,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.024288,0.2141,0.19236,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00353,0.2141,0.15204,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0010528,0.214,0.21006,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0067808,0.21346,0.18073,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0016129,0.21295,0.22479,1,1
1,GO T CELL ACTIVATION,0.00011241,0.21262,0.20769,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00012074,0.21229,0.19659,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00055855,0.21222,0.21259,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.012203,0.2118,0.19708,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00072223,0.21173,0.19311,1,1
1,GO CELL ACTIVATION,2.4346e-05,0.21138,0.23077,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.4692e-06,0.21113,0.24364,1,1
1,GO FIBROBLAST APOPTOTIC PROCESS,0.027803,0.21105,0.21071,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,2.2524e-05,0.21076,0.19654,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.0011199,0.21067,0.21199,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0066042,0.21061,0.18612,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0023671,0.21055,0.23087,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7145e-05,0.21022,0.21092,1,1
1,GO HEAD MORPHOGENESIS,0.001228,0.21003,0.25997,1,1
1,GO BLASTOCYST GROWTH,0.0011549,0.20993,0.25414,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,7.547e-05,0.20992,0.17176,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0020453,0.2099,0.17151,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,2.0833e-05,0.20966,0.22543,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,7.2754e-05,0.20944,0.1976,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,7.8282e-05,0.20914,0.21995,1,1
1,GO MESENCHYME DEVELOPMENT,0.00018427,0.20907,0.22643,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0075304,0.20905,0.17936,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0013457,0.20895,0.24051,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00021167,0.20871,0.19465,1,1
1,GO PROTEIN DENEDDYLATION,0.0028957,0.2087,0.18314,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0011549,0.20869,0.18418,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,7.2756e-08,0.20857,0.19434,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.023205,0.20847,0.2341,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.033166,0.20826,0.23744,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.2454e-05,0.20805,0.20492,1,1
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.014841,0.20766,0.16415,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,0.0031536,0.20744,0.17695,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,2.5774e-06,0.20742,0.26238,1,1
1,GO RESPONSE TO KETONE,0.0025817,0.2073,0.16483,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0034322,0.20702,0.16825,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,3.8583e-05,0.20697,0.27622,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,2.0833e-05,0.20677,0.22,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00084609,0.20671,0.22566,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.027803,0.2067,0.17768,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.010506,0.2065,0.20352,1,1
1,GO LEUKOCYTE MIGRATION,0.0018173,0.20628,0.19037,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.011612,0.20613,0.21261,1,1
1,GO STEROID ESTERIFICATION,0.053746,0.20559,0.20482,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,7.013e-05,0.20545,0.19957,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.00065623,0.20544,0.17946,1,1
1,GO RETINOL METABOLIC PROCESS,0.0030654,0.20526,0.20344,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,5.8301e-05,0.20521,0.20799,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.023205,0.20499,0.16649,1,1
1,GO RUFFLE ORGANIZATION,0.0049174,0.20481,0.14416,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00017186,0.2047,0.18396,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00035231,0.20436,0.16841,1,1
1,GO MYELOID CELL DIFFERENTIATION,3.1888e-05,0.20436,0.17745,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.036164,0.20434,0.1784,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1.0184e-05,0.2041,0.19524,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.019283,0.20391,0.2282,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.015953,0.20391,0.13791,1,1
1,GO NEGATIVE T CELL SELECTION,0.05161,0.20383,0.1673,1,1
1,GO CELLULAR RESPONSE TO ATP,0.00055855,0.20366,0.20191,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.016339,0.2033,0.11167,1,1
1,GO RESPONSE TO CHEMOKINE,0.0046564,0.20321,0.21045,1,1
1,GO RESPONSE TO GAMMA RADIATION,6.0504e-05,0.20319,0.24147,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.0030654,0.20285,0.25006,1,1
1,GO RRNA 3 END PROCESSING,0.0007696,0.20283,0.21338,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,7.9801e-06,0.2026,0.18922,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00011241,0.20259,0.24387,1,1
1,GO REGULATION OF LIPID STORAGE,0.00098941,0.2024,0.23675,1,1
1,GO RESPONSE TO LIPID,0.00050664,0.20226,0.17103,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0014738,0.20221,0.21435,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,9.0221e-07,0.20184,0.21059,1,1
1,GO RESPONSE TO VITAMIN A,0.033166,0.2018,0.17107,1,1
1,GO COENZYME A METABOLIC PROCESS,0.0081404,0.20169,0.16161,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,2.0833e-05,0.20137,0.20105,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,9.8628e-07,0.20085,0.19278,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001191,0.20079,0.23505,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00353,0.20072,0.22242,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00059588,0.20058,0.15261,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0037331,0.20055,0.14382,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.017969,0.20052,0.22345,1,1
1,GO OSSIFICATION,0.00035231,0.20032,0.20839,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00090094,0.20027,0.21205,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.042857,0.2002,0.21202,1,1
1,GO RESPONSE TO TUMOR CELL,0.02068,0.19979,0.18965,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00054072,0.19975,0.21189,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00059588,0.19966,0.20134,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.00098941,0.19961,0.21676,1,1
1,GO HISTONE H2B UBIQUITINATION,0.03245,0.19959,0.14264,1,1
1,GO REGULATION OF CELL ADHESION,0.0018173,0.19957,0.18596,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,2.8418e-05,0.19935,0.22296,1,1
1,GO MITOTIC CYTOKINESIS,0.00098941,0.19935,0.20065,1,1
1,GO RNA LOCALIZATION,0.00014418,0.19924,0.1994,1,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.046579,0.19912,0.13684,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0011199,0.19894,0.2288,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0010206,0.19888,0.14647,1,1
1,GO LYMPHOCYTE ACTIVATION,6.0504e-05,0.19873,0.19493,1,1
1,GO MIDBODY ABSCISSION,0.036948,0.19861,0.15932,1,1
1,GO ANIMAL ORGAN FORMATION,0.011612,0.19861,0.17696,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.04854,0.19853,0.15831,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,3.8583e-05,0.19829,0.23625,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0029794,0.19813,0.26308,1,1
1,GO DENDRITIC SPINE MAINTENANCE,0.0097392,0.19811,0.21452,1,1
1,GO REGULATION OF DEFENSE RESPONSE,0.0001547,0.19803,0.19568,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.013798,0.19799,0.13291,1,1
1,GO RNA METHYLATION,0.00036427,0.19755,0.19289,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.4039e-05,0.19732,0.21747,1,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.047551,0.19702,0.20995,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.8301e-05,0.19652,0.22774,1,1
1,GO HEART TRABECULA MORPHOGENESIS,0.0099891,0.19631,0.19245,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0013054,0.19624,0.22164,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,3.4421e-05,0.1959,0.17428,1,1
1,GO VESICLE TARGETING,0.00022676,0.19585,0.20778,1,1
1,GO RESPONSE TO PH,0.0059384,0.1958,0.22017,1,1
1,GO BODY MORPHOGENESIS,0.0034322,0.1955,0.18575,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00087311,0.19549,0.18451,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0011199,0.19541,0.16215,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00017796,0.19523,0.19532,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0017123,0.19516,0.20363,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00059588,0.1951,0.19527,1,1
1,GO PROTEIN PROCESSING,0.00026003,0.195,0.20121,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,1.4609e-05,0.19489,0.17723,1,1
1,GO ORGAN GROWTH,0.00035231,0.19464,0.20728,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.0016129,0.19399,0.29642,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00014935,0.19373,0.17788,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0017123,0.1935,0.16075,1,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.020205,0.1932,0.20995,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0085714,0.19307,0.14719,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.011047,0.19275,0.1393,1,1
1,GO PROTEIN STABILIZATION,2.5308e-05,0.19262,0.16595,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0067808,0.19166,0.33297,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0022992,0.19149,0.16246,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00021909,0.19129,0.15629,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.015203,0.19106,0.13831,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00026003,0.19102,0.18544,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.029719,0.19097,0.1667,1,1
1,GO GLOMERULUS DEVELOPMENT,0.00035231,0.1907,0.36498,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0014299,0.1906,0.18118,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.0010859,0.19057,0.25392,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00059588,0.19048,0.18427,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00045924,0.19045,0.17865,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.00031859,0.19045,0.23669,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.0011549,0.19036,0.15651,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00011241,0.19027,0.18405,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018427,0.19026,0.17321,1,1
1,GO GRANULOCYTE CHEMOTAXIS,0.0029794,0.19014,0.244,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00022676,0.19012,0.15191,1,1
1,GO SECRETION BY TISSUE,0.035393,0.18996,0.14018,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00044439,0.18992,0.16934,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.00010092,0.18989,0.18737,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00012512,0.18969,0.19343,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.00087311,0.18956,0.20799,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.011612,0.18919,0.17235,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00031859,0.18913,0.2035,1,1
1,GO RESPONSE TO REDOX STATE,0.043763,0.18902,0.19195,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.001986,0.18883,0.19264,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0013457,0.18867,0.17886,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.00065623,0.18864,0.15251,1,1
1,GO EPITHELIAL CELL PROLIFERATION,0.0012662,0.1882,0.19061,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0023671,0.18811,0.16059,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,1.5816e-05,0.1879,0.19314,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0029794,0.18769,0.15195,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,6.5149e-05,0.18746,0.15525,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00013917,0.18744,0.17949,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.8418e-05,0.18716,0.15285,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.0017641,0.18715,0.18699,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00054072,0.18713,0.22555,1,1
1,GO HISTONE DEACETYLATION,0.00084609,0.18712,0.12623,1,1
1,GO LEUKOCYTE HOMEOSTASIS,0.00031859,0.18651,0.18943,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00087311,0.18644,0.18778,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001986,0.18639,0.1638,1,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.023741,0.18616,0.14857,1,1
1,GO PROTEIN DEMANNOSYLATION,0.014841,0.18607,0.18077,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.00047456,0.18591,0.19967,1,1
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0041716,0.18589,0.21394,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0016129,0.18588,0.21972,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0046564,0.1858,0.2674,1,1
1,GO DRUG METABOLIC PROCESS,0.0033369,0.18571,0.15632,1,1
1,GO PROTEIN MATURATION,0.00012074,0.18535,0.15531,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,6.5896e-07,0.18526,0.17336,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,5.753e-07,0.18517,0.16516,1,1
1,GO RNA PROCESSING,8.4205e-05,0.18508,0.17478,1,1
1,GO ORGANELLE INHERITANCE,0.0018173,0.18502,0.17036,1,1
1,GO SULFUR COMPOUND TRANSPORT,4.0073e-05,0.18493,0.21395,1,1
1,GO ISOPRENOID METABOLIC PROCESS,0.019739,0.1848,0.14375,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00031859,0.1848,0.20281,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0046564,0.18468,0.27762,1,1
1,GO CELLULAR RESPONSE TO UV,0.00072223,0.18438,0.16825,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.029719,0.1843,0.11571,1,1
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0014299,0.18419,0.17225,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0010859,0.18419,0.15436,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00024286,0.18407,0.24352,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0085714,0.18393,0.15841,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0099891,0.18385,0.1559,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.025994,0.18383,0.14087,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.029719,0.18369,0.13253,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0036303,0.18367,0.22349,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00055855,0.18354,0.20198,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0024367,0.18333,0.15258,1,1
1,GO BONE DEVELOPMENT,9.0551e-05,0.18328,0.22452,1,1
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0038387,0.18328,0.21917,1,1
1,GO STEROL HOMEOSTASIS,0.026586,0.18324,0.1038,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0028141,0.18322,0.19665,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.02166,0.18316,0.16209,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0051916,0.18289,0.16357,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.389e-05,0.18279,0.17211,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,1.906e-06,0.18255,0.19007,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0022992,0.18244,0.26006,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.00011241,0.18229,0.17343,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0040578,0.18224,0.12682,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,6.7596e-05,0.18187,0.21036,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,1.6455e-05,0.18183,0.19656,1,1
1,GO OVULATION,0.045624,0.18151,0.21515,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0015653,0.18143,0.14491,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0012662,0.18141,0.15887,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.022165,0.18114,0.14393,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0085714,0.18102,0.14807,1,1
1,GO PROTEIN NEDDYLATION,0.0013457,0.18063,0.18757,1,1
1,GO PEPTIDYL ARGININE METHYLATION,0.016339,0.18038,0.13803,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,2.0033e-05,0.18001,0.21106,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,2.7578e-07,0.17974,0.18268,1,1
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0028141,0.17962,0.17746,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0030654,0.17955,0.20751,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,6.0504e-05,0.1795,0.21432,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00092958,0.17948,0.14115,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0090226,0.17942,0.19612,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00042998,0.17925,0.21327,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0027346,0.17916,0.17754,1,1
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.044685,0.17914,0.15418,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0025083,0.17912,0.15965,1,1
1,GO PEROXISOMAL TRANSPORT,0.0017641,0.17852,0.18946,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0013457,0.17778,0.22002,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,1.1493e-05,0.17749,0.17449,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0007696,0.17733,0.15447,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00021167,0.17714,0.15731,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0017123,0.177,0.1736,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0014738,0.1764,0.13026,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00047456,0.1761,0.19009,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00087311,0.1761,0.21891,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00020448,0.17599,0.16436,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0083534,0.17584,0.13091,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,7.8282e-05,0.17575,0.18998,1,1
1,GO TRNA TRANSPORT,0.0075304,0.17573,0.16343,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.00047456,0.17562,0.18106,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,5.2533e-07,0.17557,0.17718,1,1
1,GO RESPONSE TO HEAT,0.00014418,0.17537,0.18386,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.001662,0.17533,0.15365,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00016023,0.17514,0.19241,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,2.5774e-06,0.17487,0.17479,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,7.8282e-05,0.17459,0.20051,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00072223,0.17438,0.13207,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0013457,0.17438,0.22613,1,1
1,GO GOLGI VESICLE TRANSPORT,1.1964e-05,0.17426,0.17047,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0025083,0.17392,0.15294,1,1
1,GO RNA POLYADENYLATION,0.0013054,0.17382,0.15341,1,1
1,GO FOLIC ACID METABOLIC PROCESS,0.037747,0.17377,0.15295,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00050664,0.17367,0.17396,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0020453,0.17358,0.16878,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.023205,0.17357,0.12839,1,1
1,GO MITOTIC RECOMBINATION,0.0028957,0.17352,0.1951,1,1
1,GO AXIS ELONGATION,0.030383,0.1735,0.22014,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00031859,0.17309,0.18345,1,1
1,GO REGULATION OF MAPK CASCADE,0.00023468,0.17259,0.15864,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0010528,0.17242,0.1718,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.001191,0.17233,0.18895,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0025817,0.17231,0.16563,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.019283,0.17217,0.13673,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,4.5813e-07,0.17186,0.17112,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0018173,0.17184,0.15918,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00065623,0.17184,0.18891,1,1
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.03939,0.17179,0.24763,1,1
1,GO LYSOSOMAL TRANSPORT,0.00010845,0.17172,0.18502,1,1
1,GO PROTEIN IMPORT,7.2754e-05,0.1717,0.16619,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.001872,0.17148,0.16919,1,1
1,GO PEROXISOME ORGANIZATION,0.0010859,0.17129,0.18302,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.015203,0.17095,0.11923,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.5427e-07,0.17084,0.18106,1,1
1,GO REGULATION OF RESPONSE TO STRESS,2.7343e-05,0.17084,0.16487,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.023741,0.17062,0.14843,1,1
1,GO TRANSLESION SYNTHESIS,0.0015653,0.17043,0.15589,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.0226e-05,0.17043,0.18213,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.001191,0.17034,0.13539,1,1
1,GO VACUOLAR TRANSPORT,0.00034072,0.17011,0.15288,1,1
1,GO TUBE DEVELOPMENT,0.00052342,0.17006,0.17617,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0075304,0.1699,0.23762,1,1
1,GO SPINDLE LOCALIZATION,8.1192e-05,0.16972,0.18164,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.017969,0.16959,0.23968,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.0094949,0.16958,0.17495,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00079435,0.16955,0.15913,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0046564,0.1695,0.22304,1,1
1,GO REGULATION OF CATABOLIC PROCESS,5.4977e-07,0.1695,0.16452,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00023468,0.16919,0.13692,1,1
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00010092,0.16891,0.20301,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.001986,0.16882,0.15204,1,1
1,GO MRNA METABOLIC PROCESS,2.9532e-05,0.16862,0.16557,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0014738,0.16852,0.17512,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,0.001191,0.16847,0.18006,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0085714,0.16846,0.12952,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.00054072,0.16827,0.17205,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,3.0576e-06,0.16817,0.16602,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.055956,0.16814,0.15057,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.00019079,0.16809,0.13753,1,1
1,GO MYELOID LEUKOCYTE MIGRATION,0.011904,0.16808,0.18896,1,1
1,GO NEUTROPHIL MIGRATION,0.0021062,0.16772,0.24021,1,1
1,GO AEROBIC RESPIRATION,0.036164,0.1676,0.098627,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.019283,0.16759,0.18154,1,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.013798,0.16757,0.13045,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.001228,0.16756,0.19716,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,7.5427e-07,0.16748,0.16734,1,1
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00034072,0.16718,0.18579,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00055855,0.1671,0.15103,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00041602,0.16683,0.18232,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0027346,0.1665,0.14795,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.001872,0.16628,0.16832,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0034322,0.16628,0.12961,1,1
1,GO OXALATE TRANSPORT,0.031748,0.16623,0.1071,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.029068,0.16599,0.17541,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0022992,0.16567,0.18533,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0001547,0.16563,0.1419,1,1
1,GO PROTEIN REFOLDING,0.042857,0.1656,0.1569,1,1
1,GO NUCLEAR TRANSPORT,3.3132e-05,0.1655,0.15444,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00059588,0.16537,0.22105,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00016595,0.16514,0.21289,1,1
1,GO RNA CAPPING,0.00026003,0.16511,0.16282,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00010092,0.16495,0.28751,1,1
1,GO FATTY ACID METABOLIC PROCESS,0.001662,0.16474,0.1302,1,1
1,GO REGULATION OF MYELINATION,0.0094949,0.16445,0.14529,1,1
1,GO RESPONSE TO GONADOTROPIN,0.0059384,0.16422,0.27755,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,7.0571e-06,0.16403,0.20062,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0099891,0.16399,0.13145,1,1
1,GO VACUOLE ORGANIZATION,7.8282e-05,0.16375,0.15452,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,5.6174e-05,0.16367,0.15591,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00057693,0.16347,0.21328,1,1
1,GO RECEPTOR RECYCLING,0.0069616,0.16318,0.12983,1,1
1,GO RNA DECAPPING,0.00055855,0.16313,0.18146,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00011241,0.16287,0.16396,1,1
1,GO REGULATION OF BONE MINERALIZATION,0.0057817,0.16279,0.23497,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,1.9904e-06,0.16278,0.15446,1,1
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.053746,0.16273,0.169,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0047853,0.16261,0.15956,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0085714,0.16242,0.1752,1,1
1,GO TELOMERE ORGANIZATION,0.0006154,0.16219,0.13455,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.001191,0.16216,0.14945,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.014486,0.16215,0.15314,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.0020453,0.16205,0.17778,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.012508,0.16186,0.13872,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00030804,0.16177,0.22715,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00030804,0.16169,0.15709,1,1
1,GO BONE REMODELING,0.0028141,0.16144,0.18439,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.004408,0.16141,0.1827,1,1
1,GO ERBB SIGNALING PATHWAY,0.00041602,0.16126,0.22356,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.029719,0.16117,0.13968,1,1
1,GO PROTEIN POLYUBIQUITINATION,8.4205e-05,0.161,0.1464,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00047456,0.16094,0.14943,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00038934,0.16085,0.14692,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.019283,0.16063,0.088191,1,1
1,GO MUSCLE ADAPTATION,0.015203,0.1606,0.11148,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00079435,0.16045,0.16635,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0022992,0.16038,0.16967,1,1
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0051916,0.16024,0.27498,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0054795,0.16002,0.18112,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.0020453,0.15997,0.12801,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.041093,0.15987,0.13846,1,1
1,GO NEURAL TUBE FORMATION,0.0053338,0.15981,0.17645,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0099891,0.1596,0.17829,1,1
1,GO PROTEOLYSIS,1.104e-05,0.15947,0.14891,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.00030804,0.159,0.14214,1,1
1,GO REGULATION OF OSSIFICATION,0.0024367,0.15895,0.19695,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0011199,0.15852,0.17148,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0071468,0.15839,0.17502,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0057817,0.15826,0.13239,1,1
1,GO RESPONSE TO UV,0.00014418,0.15756,0.17273,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0085714,0.15752,0.16111,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.00021909,0.15735,0.13334,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0081404,0.15712,0.2453,1,1
1,GO TISSUE MORPHOGENESIS,0.00026903,0.15708,0.17354,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.017969,0.15703,0.128,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00027832,0.15682,0.14603,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025083,0.15681,0.1229,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00059588,0.1568,0.15164,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.052669,0.15674,0.18897,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.00095906,0.15647,0.21339,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.0031536,0.15631,0.16135,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,8.7323e-05,0.15616,0.1751,1,1
1,GO MAINTENANCE OF LOCATION,3.4421e-05,0.156,0.17106,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0015189,0.15598,0.13184,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.0030654,0.15593,0.19531,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.013465,0.15539,0.16702,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00098941,0.15513,0.13555,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.001872,0.1551,0.15889,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0037331,0.15509,0.14149,1,1
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.050569,0.15508,0.09393,1,1
1,GO PROTEIN CATABOLIC PROCESS,1.1267e-06,0.15492,0.1538,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.00353,0.15468,0.20365,1,1
1,GO POSTREPLICATION REPAIR,0.00079435,0.15468,0.13962,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.027803,0.15454,0.20689,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0029794,0.15427,0.11791,1,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.033894,0.15404,0.092987,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,5.2139e-05,0.154,0.15608,1,1
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.014841,0.15383,0.18772,1,1
1,GO LACTATION,0.0049174,0.15374,0.18083,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00072223,0.15358,0.17483,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.001986,0.15344,0.15305,1,1
1,GO RESPONSE TO DRUG,0.01282,0.15335,0.11107,1,1
1,GO MRNA TRANSPORT,0.00034072,0.15332,0.17623,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,8.2505e-07,0.15325,0.16724,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,3.0689e-05,0.15305,0.1769,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,9.0551e-05,0.15291,0.18315,1,1
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.019283,0.15289,0.10075,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0050528,0.15287,0.25269,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.0022332,0.15269,0.16893,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,2.0033e-05,0.15265,0.13936,1,1
1,GO REGULATION OF ERAD PATHWAY,9.0551e-05,0.1523,0.16679,1,1
1,GO REPLACEMENT OSSIFICATION,0.016734,0.15222,0.23853,1,1
1,GO HEART GROWTH,0.0046564,0.15184,0.1689,1,1
1,GO REGULATION OF CELL DEATH,0.00017796,0.15169,0.13612,1,1
1,GO B CELL ACTIVATION,0.001191,0.15151,0.14117,1,1
1,GO RESPONSE TO GROWTH FACTOR,0.00087311,0.15137,0.15736,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00037661,0.15137,0.13301,1,1
1,GO REGULATION OF BINDING,0.00038934,0.15112,0.13773,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00069957,0.15091,0.13695,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.8418e-05,0.15067,0.16131,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.001872,0.15055,0.11492,1,1
1,GO HUMORAL IMMUNE RESPONSE,0.0079323,0.15051,0.12664,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0013054,0.15048,0.15639,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.014138,0.15044,0.10252,1,1
1,GO RESPONSE TO LEPTIN,0.030383,0.15038,0.17542,1,1
1,GO MACROPHAGE ACTIVATION,0.015574,0.14995,0.15745,1,1
1,GO GOLGI VESICLE BUDDING,0.0011199,0.14979,0.17165,1,1
1,GO VACUOLAR ACIDIFICATION,0.0026572,0.14956,0.16886,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0031536,0.14927,0.13185,1,1
1,GO REGULATION OF LIPID TRANSPORT,0.00079435,0.14923,0.14819,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00030804,0.14921,0.14229,1,1
1,GO DNA BIOSYNTHETIC PROCESS,1.0311e-06,0.14876,0.16786,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.021165,0.14857,0.15604,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00018427,0.14825,0.1409,1,1
1,GO REGULATION OF PROTEIN BINDING,0.00036427,0.14769,0.15361,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00059588,0.14727,0.15713,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0060989,0.14723,0.10864,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.00037661,0.14712,0.14854,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.007729,0.14709,0.1382,1,1
1,GO PERICARDIUM DEVELOPMENT,0.0069616,0.147,0.23352,1,1
1,GO NCRNA CATABOLIC PROCESS,0.026586,0.14695,0.15928,1,1
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0094949,0.14694,0.11495,1,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.033166,0.14691,0.11648,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.049546,0.1468,0.096097,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0022992,0.14677,0.18254,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.043763,0.14642,0.16522,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.024288,0.14612,0.16179,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00057693,0.14579,0.11465,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0066042,0.14541,0.16472,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.016339,0.14505,0.13921,1,1
1,GO LEUKOCYTE DIFFERENTIATION,0.00079435,0.14483,0.15391,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0094949,0.14467,0.14752,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0033369,0.14453,0.17456,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00045924,0.1445,0.16244,1,1
1,GO REGULATION OF CHEMOTAXIS,0.001872,0.14433,0.1479,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00021167,0.1443,0.12773,1,1
1,GO CHROMOSOME LOCALIZATION,0.043763,0.14391,0.11104,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.00041602,0.14389,0.17786,1,1
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0064317,0.14388,0.20742,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0031536,0.14365,0.10986,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.026586,0.14317,0.16542,1,1
1,GO LAMELLIPODIUM ASSEMBLY,0.0083534,0.14304,0.16937,1,1
1,GO REGULATION OF DNA BINDING,0.054842,0.14296,0.075835,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0010528,0.14264,0.19171,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0064317,0.14253,0.1057,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00059588,0.14245,0.1825,1,1
1,GO COPII COATED VESICLE BUDDING,0.0029794,0.14234,0.16748,1,1
1,GO RESPONSE TO ANTIBIOTIC,0.0049174,0.142,0.17805,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00063551,0.14185,0.14042,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00044439,0.14181,0.13253,1,1
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0019282,0.14163,0.13483,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.020205,0.14161,0.15743,1,1
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.03245,0.14156,0.078346,1,1
1,GO RESPONSE TO STEROL,0.054842,0.14152,0.12321,1,1
1,GO GENITALIA DEVELOPMENT,0.0056288,0.14131,0.12734,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.0038387,0.14115,0.15157,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013465,0.1411,0.11921,1,1
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0062634,0.14109,0.10622,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,6.2985e-07,0.14107,0.13724,1,1
1,GO LIPID CATABOLIC PROCESS,0.0034322,0.14087,0.10094,1,1
1,GO GOLGI ORGANIZATION,0.00069957,0.14082,0.13405,1,1
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.03245,0.14059,0.18866,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0038387,0.14052,0.11408,1,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.033166,0.14051,0.12168,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00026003,0.14043,0.13401,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00030804,0.13999,0.14349,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.024846,0.13973,0.12393,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,2.0033e-05,0.13946,0.13714,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0022992,0.13909,0.16923,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00020448,0.13874,0.16069,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.033166,0.13863,0.12871,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.007729,0.1384,0.13802,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0039469,0.13829,0.1451,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0050528,0.13812,0.12281,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.00095906,0.13811,0.1162,1,1
1,GO NUCLEUS ORGANIZATION,0.0006154,0.13804,0.12879,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0028957,0.13779,0.21075,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.00079435,0.1377,0.11917,1,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.0042883,0.13749,0.26856,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00032948,0.13733,0.18307,1,1
1,GO APOPTOTIC PROCESS,8.4205e-05,0.13719,0.13308,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0050528,0.13715,0.1844,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,6.0504e-05,0.13711,0.14588,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0019282,0.13704,0.10455,1,1
1,GO MYOTUBE DIFFERENTIATION,0.038561,0.13701,0.12585,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,2.4346e-05,0.13689,0.16824,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,4.1617e-05,0.1366,0.17834,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00050664,0.13641,0.12096,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.023205,0.13631,0.16326,1,1
1,GO ENDOSOME ORGANIZATION,0.0022992,0.13593,0.14671,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00032948,0.13557,0.18446,1,1
1,GO SULFATE TRANSPORT,0.00069957,0.13554,0.14245,1,1
1,GO CELL CHEMOTAXIS,0.0041716,0.13548,0.18541,1,1
1,GO RNA SURVEILLANCE,0.00069957,0.13536,0.2054,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00036427,0.1353,0.14715,1,1
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.019739,0.13522,0.10769,1,1
1,GO REGULATION OF PROTEIN STABILITY,0.00034072,0.1351,0.11821,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00057693,0.13508,0.12335,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00090094,0.13452,0.13898,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0029794,0.13449,0.13233,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,5.9841e-06,0.13425,0.13309,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.041967,0.1342,0.20415,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.0016129,0.13385,0.1127,1,1
1,GO CENTRIOLE ASSEMBLY,0.05161,0.13348,0.093568,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.00095906,0.13325,0.10309,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.0031536,0.13314,0.10457,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.018836,0.13302,0.1737,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00031859,0.13283,0.14611,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0012662,0.13253,0.14007,1,1
1,GO STEM CELL DIFFERENTIATION,0.00021167,0.13218,0.17719,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.034637,0.13208,0.17067,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.033894,0.13204,0.095095,1,1
1,GO VIRAL BUDDING,0.013465,0.13148,0.1175,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.0046564,0.1312,0.205,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.0056288,0.13089,0.13595,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.017969,0.13082,0.12895,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.00092958,0.1301,0.1192,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00011241,0.13004,0.11411,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0060989,0.1297,0.11017,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.026586,0.12968,0.11388,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00016023,0.12951,0.1844,1,1
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.018398,0.12938,0.17737,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00037661,0.12896,0.11847,1,1
1,GO GENE SILENCING,0.00010462,0.12893,0.13271,1,1
1,GO LIPID HOMEOSTASIS,0.011904,0.12884,0.083537,1,1
1,GO ORGANELLE DISASSEMBLY,5.8301e-05,0.12868,0.13596,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00014935,0.1286,0.13625,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.0001547,0.12799,0.13751,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0013872,0.12772,0.12044,1,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.016339,0.12767,0.13858,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00079435,0.12744,0.11966,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0069616,0.12684,0.18514,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0099891,0.12646,0.12961,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00030804,0.12629,0.13249,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.0018173,0.12626,0.13275,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.0062634,0.12624,0.16516,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0014299,0.12615,0.1125,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.045624,0.12612,0.092082,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.012508,0.12584,0.12223,1,1
1,GO RESPONSE TO HORMONE,0.00092958,0.12561,0.12393,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00017796,0.12559,0.21496,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.010506,0.12549,0.1282,1,1
1,GO MEMBRANE ORGANIZATION,0.00074557,0.12522,0.1104,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.012508,0.12507,0.097319,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.00016023,0.12504,0.13887,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,0.016734,0.12489,0.16986,1,1
1,GO HEART DEVELOPMENT,0.0017641,0.12473,0.14399,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.001191,0.12398,0.11453,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,2.4346e-05,0.12394,0.12828,1,1
1,GO CELLULAR SENESCENCE,0.00092958,0.12384,0.13602,1,1
1,GO ENDOCYTOSIS,0.00030804,0.12359,0.14079,1,1
1,GO CELL DIVISION,0.0025083,0.12332,0.10628,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.00081984,0.12304,0.093322,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.021165,0.12303,0.095374,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00057693,0.12281,0.14934,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.014138,0.12254,0.085709,1,1
1,GO REGULATION OF DNA REPAIR,0.0083534,0.12235,0.094956,1,1
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0042883,0.12232,0.099417,1,1
1,GO FLUID TRANSPORT,0.0037331,0.12221,0.1533,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.011612,0.12199,0.1263,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.00353,0.12187,0.10535,1,1
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.027803,0.1217,0.1232,1,1
1,GO FAT CELL DIFFERENTIATION,0.035393,0.12163,0.090244,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.4121e-05,0.12139,0.13948,1,1
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0071468,0.12099,0.095825,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.001662,0.12047,0.10153,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.00021167,0.11983,0.12367,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0028141,0.11973,0.13848,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.0028957,0.11934,0.093252,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0013457,0.11933,0.14714,1,1
1,GO RESPONSE TO PEPTIDE,0.00059588,0.11882,0.11342,1,1
1,GO CYTOKINESIS,0.0085714,0.11861,0.10996,1,1
1,GO LAMELLIPODIUM ORGANIZATION,0.0046564,0.11799,0.18098,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.04854,0.11798,0.13077,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0054795,0.11787,0.11109,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.026586,0.11757,0.15628,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.00012964,0.11735,0.15591,1,1
1,GO REGULATION OF DNA REPLICATION,0.0031536,0.11709,0.11091,1,1
1,GO CHROMOSOME SEPARATION,0.011047,0.11668,0.133,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.011904,0.11617,0.087073,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,5.2139e-05,0.11605,0.14524,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.0057817,0.11598,0.11393,1,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.012508,0.11446,0.082696,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0073363,0.11443,0.12396,1,1
1,GO REGULATION OF AUTOPHAGY,6.0504e-05,0.11411,0.13573,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00010845,0.11372,0.122,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00021909,0.11368,0.12092,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.019283,0.1135,0.1069,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.0054795,0.11333,0.11892,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0010206,0.11315,0.11398,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0045306,0.11299,0.088532,1,1
1,GO ORGANELLE FISSION,0.0039469,0.11284,0.091543,1,1
1,GO SPINDLE ORGANIZATION,0.0047853,0.11271,0.11735,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.05161,0.11243,0.14607,1,1
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0040578,0.11225,0.088591,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.001228,0.11223,0.13113,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.017969,0.11216,0.10068,1,1
1,GO MACROAUTOPHAGY,1.349e-05,0.11204,0.1404,1,1
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.033894,0.11183,0.13326,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0010859,0.11173,0.16527,1,1
1,GO FEMALE GAMETE GENERATION,0.0032441,0.11153,0.098412,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.02268,0.11145,0.10073,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.00052342,0.11135,0.10608,1,1
1,GO MITOTIC CELL CYCLE,0.0018173,0.11133,0.10611,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.013139,0.11055,0.1361,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.02068,0.11039,0.1415,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00081984,0.11018,0.13918,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0022332,0.11003,0.11418,1,1
1,GO METAPHASE PLATE CONGRESSION,0.047551,0.11002,0.10185,1,1
1,GO ALCOHOL METABOLIC PROCESS,0.023741,0.10979,0.074936,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0030654,0.10974,0.10612,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.013139,0.10969,0.13352,1,1
1,GO NEUTROPHIL CHEMOTAXIS,0.050569,0.10966,0.19158,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.017969,0.10963,0.1815,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.030383,0.10947,0.10946,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.001872,0.10946,0.096889,1,1
1,GO CHROMOSOME CONDENSATION,0.0042883,0.10909,0.1303,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0013872,0.10813,0.10278,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,3.1888e-05,0.10751,0.11115,1,1
1,GO LEUKOCYTE CHEMOTAXIS,0.050569,0.10668,0.14072,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,2.3418e-05,0.10621,0.10747,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.00013917,0.10604,0.087885,1,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.029068,0.10572,0.088847,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0011549,0.10407,0.10852,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.0014738,0.1039,0.13318,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0011549,0.10375,0.11415,1,1
1,GO MIRNA METABOLIC PROCESS,0.0085714,0.10365,0.13932,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.03245,0.10354,0.097241,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.011047,0.10287,0.10008,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0007696,0.10224,0.088563,1,1
1,GO PROTEIN TETRAMERIZATION,0.0025817,0.10143,0.11286,1,1
1,GO SNRNA TRANSCRIPTION,0.001986,0.10116,0.10652,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.012203,0.10063,0.12057,1,1
1,GO CELLULAR LIPID METABOLIC PROCESS,0.024846,0.10034,0.063311,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.025414,0.10024,0.096378,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0075304,0.10021,0.17427,1,1
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.027188,0.10013,0.078171,1,1
1,GO TUBE FORMATION,0.034637,0.099443,0.11719,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.043763,0.09936,0.080727,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0066042,0.098738,0.10349,1,1
1,GO NCRNA TRANSCRIPTION,0.022165,0.098729,0.091303,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0097392,0.098269,0.086968,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0028957,0.097498,0.11183,1,1
1,GO CELL CYCLE PROCESS,0.0022332,0.097231,0.08863,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.01282,0.096579,0.10427,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0012662,0.09651,0.10311,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00021167,0.096419,0.11056,1,1
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00028792,0.096304,0.1058,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.00084609,0.096052,0.1549,1,1
1,GO IRON ION TRANSPORT,0.004408,0.095384,0.099605,1,1
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.049546,0.095163,0.18687,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0053338,0.095001,0.083618,1,1
1,GO MACROMOLECULE DEACYLATION,0.014486,0.094987,0.075986,1,1
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.012508,0.094728,0.073052,1,1
1,GO REGULATION OF CELL CYCLE,0.0050528,0.094704,0.075655,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.037747,0.094133,0.079676,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.00065623,0.093972,0.084718,1,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.030383,0.093569,0.10741,1,1
1,GO HEART MORPHOGENESIS,0.018836,0.093436,0.13754,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.0071468,0.093215,0.090313,1,1
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.036164,0.092595,0.089066,1,1
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.016339,0.090739,0.084969,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0030654,0.090629,0.10176,1,1
1,GO LIPID METABOLIC PROCESS,0.013465,0.090616,0.064994,1,1
1,GO NEGATIVE REGULATION OF GROWTH,0.041093,0.090583,0.074688,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00028792,0.090572,0.10451,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.033894,0.090494,0.088325,1,1
1,GO DNA METABOLIC PROCESS,0.00032948,0.090433,0.095284,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.0038387,0.089101,0.10667,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.015953,0.088978,0.088637,1,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.041093,0.088072,0.14517,1,1
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.03939,0.088046,0.052093,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00019753,0.087704,0.094827,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.001986,0.087693,0.10511,1,1
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.013465,0.087675,0.12865,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.014841,0.08742,0.1188,1,1
1,GO REGULATION OF CELL SHAPE,0.016734,0.087109,0.1521,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.033166,0.087053,0.095422,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.029719,0.08636,0.088331,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00353,0.086264,0.064463,1,1
1,GO CELL CYCLE,0.0034322,0.085642,0.074152,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00014418,0.085186,0.095811,1,1
1,GO CARBOHYDRATE METABOLIC PROCESS,0.004408,0.084723,0.075421,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00090094,0.084343,0.14786,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0042883,0.084109,0.10169,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.029068,0.083987,0.081845,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.011326,0.083256,0.071316,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0075304,0.082353,0.075734,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.023205,0.081517,0.099039,1,1
1,GO RESPONSE TO RADIATION,0.0047853,0.081251,0.082213,1,1
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.012203,0.079508,0.06525,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.033166,0.079488,0.082786,1,1
1,GO SPINDLE ASSEMBLY,0.010245,0.078785,0.089603,1,1
1,GO POSITIVE REGULATION OF SIGNALING,0.02843,0.078446,0.069587,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0064317,0.078248,0.11349,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00037661,0.077573,0.078478,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.00079435,0.07732,0.13055,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.020205,0.076802,0.11526,1,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.02843,0.076661,0.085266,1,1
1,GO MITOCHONDRION ORGANIZATION,0.0017123,0.076636,0.082978,1,1
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.033166,0.074179,0.081529,1,1
1,GO VITAMIN METABOLIC PROCESS,0.026586,0.073716,0.10658,1,1
1,GO INTRACELLULAR TRANSPORT,0.00049035,0.072534,0.081128,1,1
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.03939,0.071957,0.073794,1,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.010245,0.070289,0.10369,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.018398,0.070249,0.07561,1,1
1,GO DNA GEOMETRIC CHANGE,0.055956,0.069823,0.10365,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0025083,0.069076,0.089662,1,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.019739,0.068697,0.051409,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.037747,0.067912,0.089757,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.04854,0.064838,0.073677,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.012508,0.063461,0.09116,1,1
1,GO DNA REPAIR,0.0083534,0.062813,0.078005,1,1
1,GO DNA RECOMBINATION,0.02843,0.060878,0.088485,1,1
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.012203,0.060807,0.089537,1,1
1,GO CELL CYCLE CHECKPOINT,0.049546,0.059245,0.065995,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.019283,0.05775,0.083183,1,1
1,GO DNA MODIFICATION,0.042857,0.054972,0.070704,1,1
1,GO DNA CATABOLIC PROCESS,0.037747,0.054712,0.060438,1,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.040234,0.052268,0.055236,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.05161,0.049955,0.065985,1,1
1,GO CHROMOSOME SEGREGATION,0.054842,0.048147,0.078296,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.104e-05,0.52173,0.4982,1,0
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00074557,0.46854,0.37522,1,0
1,GO MATURATION OF LSU RRNA,2.9532e-05,0.46526,0.46768,1,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.001228,0.44661,0.47166,1,0
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00092958,0.44392,0.34085,1,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0014299,0.43786,0.51255,1,0
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,8.1192e-05,0.42292,0.43619,1,0
1,GO VASCULAR TRANSPORT,0.0028141,0.41798,0.51373,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0034322,0.40512,0.38304,1,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0015189,0.40023,0.38848,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.001191,0.39217,0.51684,1,0
1,GO RESPONSE TO INTERLEUKIN 18,0.029719,0.39009,0.47437,1,0
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00029782,0.38396,0.30278,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0018173,0.37538,0.35835,1,0
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0051916,0.36023,0.28318,1,0
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0011549,0.35931,0.45513,1,0
1,GO MONONUCLEAR CELL DIFFERENTIATION,0.00014418,0.35531,0.34179,1,0
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,3.1888e-05,0.35343,0.31825,1,0
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0041716,0.34776,0.30921,1,0
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.03245,0.34653,0.25048,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00010462,0.33824,0.41043,1,0
1,GO PROSTANOID METABOLIC PROCESS,0.0001547,0.33415,0.35904,1,0
1,GO PSEUDOURIDINE SYNTHESIS,0.0042883,0.32629,0.25695,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0024367,0.32228,0.31841,1,0
1,GO PENTOSE METABOLIC PROCESS,0.0041716,0.31918,0.20968,1,0
1,GO ETHER BIOSYNTHETIC PROCESS,0.0059384,0.31628,0.27659,1,0
1,GO EOSINOPHIL MIGRATION,0.0036303,0.31021,0.35949,1,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0062634,0.30949,0.36333,1,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0032441,0.30794,0.22841,1,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.049546,0.30564,0.16412,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.025414,0.29646,0.18417,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.043763,0.29582,0.3832,1,0
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0054795,0.28967,0.27972,1,0
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.001662,0.28595,0.2762,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00079435,0.28472,0.2809,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0049174,0.27928,0.31259,1,0
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.031059,0.27824,0.17693,1,0
1,GO RESPONSE TO THYROID HORMONE,7.2754e-05,0.27749,0.3498,1,0
1,GO MYOBLAST PROLIFERATION,0.053746,0.27701,0.15233,1,0
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0047853,0.27632,0.26325,1,0
1,GO GLYCINE METABOLIC PROCESS,0.019283,0.27465,0.2243,1,0
1,GO EOSINOPHIL CHEMOTAXIS,0.026586,0.26561,0.34202,1,0
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0066042,0.26309,0.30141,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00050664,0.26264,0.25771,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.023741,0.26256,0.30675,1,0
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0013457,0.26187,0.21405,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0046564,0.26107,0.3407,1,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0069616,0.25772,0.22689,1,0
1,GO CELLULAR RESPONSE TO ETHANOL,0.0046564,0.2558,0.26926,1,0
1,GO PROSTATE GLAND DEVELOPMENT,0.00052342,0.25454,0.37431,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0022992,0.25344,0.27368,1,0
1,GO TRANSLATIONAL ELONGATION,0.0013054,0.25147,0.20506,1,0
1,GO TRNA METHYLATION,0.00026903,0.24895,0.22958,1,0
1,GO RRNA TRANSCRIPTION,0.001872,0.24808,0.19946,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.033894,0.24701,0.19671,1,0
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0094949,0.24674,0.22534,1,0
1,GO NADP METABOLIC PROCESS,0.016339,0.24624,0.18485,1,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0020453,0.24574,0.21514,1,0
1,GO REGULATION OF CELL KILLING,0.0024367,0.24247,0.20972,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.037747,0.24242,0.14342,1,0
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0015189,0.242,0.18954,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.001191,0.24189,0.25848,1,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0040578,0.24166,0.24182,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0026572,0.23997,0.23432,1,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.041967,0.23925,0.37819,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00063551,0.23885,0.25566,1,0
1,GO NUCLEOTIDE SALVAGE,0.050569,0.23881,0.29862,1,0
1,GO BEHAVIORAL RESPONSE TO PAIN,0.013465,0.23846,0.23891,1,0
1,GO LIPID OXIDATION,0.0020453,0.23544,0.18661,1,0
1,GO AMINE CATABOLIC PROCESS,0.00050664,0.23447,0.32449,1,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.0018173,0.23404,0.30037,1,0
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00052342,0.23176,0.34295,1,0
1,GO CELL JUNCTION DISASSEMBLY,0.0059384,0.23111,0.22275,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0083534,0.23088,0.22763,1,0
1,GO HISTONE H4 DEACETYLATION,0.0071468,0.22953,0.22424,1,0
1,GO TRNA MODIFICATION,0.00069957,0.22664,0.19317,1,0
1,GO MITOCHONDRIAL TRANSLATION,0.0017641,0.22429,0.19892,1,0
1,GO RESPONSE TO ISCHEMIA,0.00020448,0.22309,0.20778,1,0
1,GO TRACHEA DEVELOPMENT,0.0079323,0.22186,0.24842,1,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.049546,0.22087,0.36547,1,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0079323,0.22059,0.2959,1,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00084609,0.21958,0.19592,1,0
1,GO PORE COMPLEX ASSEMBLY,0.0038387,0.21566,0.19658,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0099891,0.21541,0.16482,1,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.022165,0.21516,0.13492,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0047853,0.2117,0.16501,1,0
1,GO FATTY ACID HOMEOSTASIS,0.044685,0.21042,0.16108,1,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0033369,0.20959,0.24908,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00016595,0.20541,0.25169,1,0
1,GO RENAL FILTRATION,0.020205,0.20527,0.33674,1,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0025817,0.20483,0.18759,1,0
1,GO AMINO ACID ACTIVATION,0.014138,0.20154,0.18203,1,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,6.2786e-05,0.20019,0.23458,1,0
1,GO ETHANOL METABOLIC PROCESS,0.0097392,0.19997,0.26106,1,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.021165,0.19945,0.18406,1,0
1,GO REGULATION OF AMYLOID BETA FORMATION,0.0075304,0.19784,0.20477,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.013139,0.19733,0.14533,1,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.015203,0.19375,0.14972,1,0
1,GO ALDITOL METABOLIC PROCESS,0.001228,0.19338,0.206,1,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.055956,0.19337,0.17604,1,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.05161,0.19334,0.13184,1,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.011326,0.18892,0.19149,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.0067808,0.18825,0.21016,1,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.018398,0.18789,0.19833,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0054795,0.18689,0.18642,1,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.052669,0.18376,0.18849,1,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.024846,0.18372,0.21599,1,0
1,GO CAMP METABOLIC PROCESS,0.043763,0.18229,0.20689,1,0
1,GO AMYLOID BETA METABOLIC PROCESS,0.012508,0.18059,0.16335,1,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.030383,0.17493,0.20312,1,0
1,GO CELLULAR EXTRAVASATION,0.00079435,0.17306,0.20085,1,0
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0066042,0.17301,0.1936,1,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.030383,0.17268,0.12115,1,0
1,GO ANION HOMEOSTASIS,0.015203,0.17264,0.13523,1,0
1,GO AMELOGENESIS,0.05161,0.16861,0.20183,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.014486,0.1675,0.22063,1,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.041967,0.16747,0.2234,1,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.02843,0.16674,0.13176,1,0
1,GO REGULATION OF B CELL ACTIVATION,0.010506,0.16617,0.12901,1,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00079435,0.1648,0.1912,1,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.05161,0.16432,0.18166,1,0
1,GO MATURE B CELL DIFFERENTIATION,0.014841,0.16176,0.20074,1,0
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0025817,0.16095,0.4305,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.017969,0.16051,0.19455,1,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.045624,0.15992,0.35232,1,0
1,GO ETHER METABOLIC PROCESS,0.053746,0.1593,0.14514,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.033894,0.15927,0.16249,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0013872,0.15881,0.16718,1,0
1,GO THYROID HORMONE METABOLIC PROCESS,0.025414,0.15842,0.14062,1,0
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.024846,0.15781,0.17897,1,0
1,GO DETOXIFICATION,0.013465,0.15753,0.13762,1,0
1,GO AMYLOID BETA FORMATION,0.0064317,0.15602,0.19334,1,0
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0039469,0.15571,0.16732,1,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.012203,0.1552,0.25176,1,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.033166,0.15415,0.19779,1,0
1,GO POSITIVE REGULATION OF COAGULATION,0.012203,0.15371,0.24159,1,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.01282,0.15298,0.18527,1,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.036164,0.15166,0.13402,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0020453,0.15039,0.20837,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0094949,0.14874,0.15687,1,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.050569,0.14778,0.12018,1,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.036164,0.14767,0.24068,1,0
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.017969,0.14759,0.13234,1,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0037331,0.14722,0.1459,1,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.027188,0.14697,0.12425,1,0
1,GO IMPORT INTO NUCLEUS,0.00045924,0.14596,0.13361,1,0
1,GO INTEGRIN ACTIVATION,0.034637,0.14543,0.14923,1,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.036164,0.1446,0.11369,1,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.0062634,0.14338,0.11829,1,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.023741,0.14186,0.18576,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0028141,0.14165,0.14792,1,0
1,GO HISTONE MRNA METABOLIC PROCESS,0.021165,0.14132,0.11087,1,0
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.011904,0.14074,0.2006,1,0
1,GO REGULATION OF MAP KINASE ACTIVITY,0.00092958,0.14058,0.13383,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.013139,0.13972,0.13112,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.03939,0.13934,0.16737,1,0
1,GO REGULATION OF ENDOCYTOSIS,0.0017123,0.13918,0.1302,1,0
1,GO GLIAL CELL MIGRATION,0.035393,0.13905,0.16948,1,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.047551,0.13797,0.11361,1,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.025994,0.13727,0.14518,1,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.041967,0.13724,0.12701,1,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.0030654,0.13679,0.20769,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.024846,0.13608,0.17338,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.023205,0.13578,0.11766,1,0
1,GO CELLULAR RESPONSE TO KETONE,0.05161,0.13503,0.1119,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0024367,0.13337,0.18637,1,0
1,GO CELLULAR RESPIRATION,0.02068,0.13309,0.10232,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.0040578,0.13271,0.17646,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.052669,0.13238,0.15677,1,0
1,GO SEQUESTERING OF TRIGLYCERIDE,0.016339,0.13161,0.2838,1,0
1,GO REGULATION OF CELL CELL ADHESION,0.0060989,0.13034,0.13922,1,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.037747,0.13034,0.15905,1,0
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0017123,0.12972,0.16471,1,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.029068,0.12968,0.24939,1,0
1,GO ARTERY DEVELOPMENT,0.0036303,0.12903,0.27149,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.018836,0.12847,0.14073,1,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.044685,0.12759,0.11756,1,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.015203,0.12737,0.12739,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.012203,0.12687,0.13338,1,0
1,GO TERPENOID METABOLIC PROCESS,0.05161,0.12653,0.14244,1,0
1,GO EXOCYTOSIS,0.0011199,0.12645,0.13749,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.013465,0.12632,0.14395,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.02166,0.12629,0.29111,1,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.026586,0.12563,0.10721,1,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.014138,0.12504,0.10923,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0013872,0.12489,0.32379,1,0
1,GO BLASTOCYST FORMATION,0.0081404,0.12461,0.13915,1,0
1,GO REGULATION OF TELOMERE MAINTENANCE,0.010245,0.12381,0.11296,1,0
1,GO THIOESTER METABOLIC PROCESS,0.05161,0.1229,0.089181,1,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0066042,0.12249,0.17059,1,0
1,GO OXIDATION REDUCTION PROCESS,0.0038387,0.12231,0.10345,1,0
1,GO AMINE METABOLIC PROCESS,0.017137,0.12209,0.0953,1,0
1,GO T CELL DIFFERENTIATION,0.0079323,0.12035,0.12249,1,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.019283,0.11912,0.09173,1,0
1,GO MAMMARY GLAND DEVELOPMENT,0.040234,0.11908,0.13059,1,0
1,GO RESPONSE TO NUTRIENT,0.036164,0.11721,0.13005,1,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.03939,0.11677,0.21285,1,0
1,GO BIOLOGICAL ADHESION,0.016339,0.11652,0.11922,1,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.030383,0.11229,0.14186,1,0
1,GO OVULATION CYCLE,0.017137,0.11029,0.14867,1,0
1,GO LIPID LOCALIZATION,0.029068,0.10962,0.069183,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.0094949,0.10914,0.087216,1,0
1,GO RESPONSE TO ACID CHEMICAL,0.014486,0.10837,0.13675,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.010245,0.10748,0.077632,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.018398,0.10726,0.071363,1,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.052669,0.10698,0.18789,1,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.046579,0.10696,0.095753,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.0021062,0.10679,0.13185,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.011326,0.1066,0.095613,1,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.020205,0.10621,0.15414,1,0
1,GO CARDIAC CHAMBER DEVELOPMENT,0.017137,0.10418,0.1412,1,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.052669,0.10365,0.096021,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.02843,0.10328,0.12874,1,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.022165,0.10322,0.18225,1,0
1,GO MRNA CLEAVAGE,0.0057817,0.10301,0.11052,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.042857,0.10277,0.11,1,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.055956,0.10225,0.14638,1,0
1,GO ELECTRON TRANSPORT CHAIN,0.017969,0.10215,0.094669,1,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.052669,0.10153,0.097665,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.05161,0.099418,0.071503,1,0
1,GO ENDOCRINE PROCESS,0.029719,0.099355,0.12656,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,0.02068,0.098958,0.12584,1,0
1,GO HORMONE METABOLIC PROCESS,0.0081404,0.097909,0.11633,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0075304,0.09764,0.17115,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.024846,0.097413,0.074603,1,0
1,GO CELL MOTILITY,0.015203,0.097111,0.10456,1,0
1,GO LIPID MODIFICATION,0.016339,0.096851,0.088125,1,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.047551,0.096648,0.25173,1,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0087944,0.096474,0.09702,1,0
1,GO KERATINOCYTE PROLIFERATION,0.015203,0.096294,0.31457,1,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.03245,0.095908,0.10018,1,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.024288,0.095801,0.089758,1,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.050569,0.094014,0.089433,1,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.02268,0.093959,0.09118,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0087944,0.09351,0.16475,1,0
1,GO MRNA 3 END PROCESSING,0.017137,0.093093,0.10761,1,0
1,GO MULTI ORGANISM PROCESS,0.0018173,0.093044,0.074631,1,0
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0031536,0.092272,0.1241,1,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.004408,0.091877,0.12622,1,0
1,GO CELLULAR RESPONSE TO DRUG,0.041967,0.091736,0.10198,1,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.016339,0.09071,0.094423,1,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.011326,0.090522,0.12035,1,0
1,GO AORTA DEVELOPMENT,0.023741,0.090089,0.24806,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.055956,0.089743,0.1094,1,0
1,GO BASE EXCISION REPAIR,0.05161,0.089125,0.10091,1,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.017137,0.088611,0.0918,1,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.050569,0.088447,0.10241,1,0
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.010773,0.088328,0.12562,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.016339,0.088142,0.060474,1,0
1,GO VESICLE ORGANIZATION,0.017137,0.087253,0.088447,1,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.025414,0.087178,0.064114,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.015203,0.087098,0.085005,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.018836,0.086486,0.090732,1,0
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.02843,0.086378,0.084402,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.029719,0.085261,0.04751,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.037747,0.083992,0.15852,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.011904,0.082631,0.095918,1,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.044685,0.082531,0.092382,1,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.040234,0.079459,0.062077,1,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.024288,0.079178,0.093045,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.043763,0.07915,0.050442,1,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.045624,0.079118,0.13307,1,0
1,GO ATP METABOLIC PROCESS,0.029719,0.07909,0.07495,1,0
1,GO REGULATION OF HISTONE UBIQUITINATION,0.035393,0.078562,0.11506,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.041093,0.077962,0.099068,1,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0017641,0.077566,0.081889,1,0
1,GO REGULATION OF TUBE SIZE,0.007729,0.077524,0.13778,1,0
1,GO CELL CYCLE ARREST,0.040234,0.074587,0.06205,1,0
1,GO PEPTIDYL SERINE MODIFICATION,0.049546,0.073604,0.059685,1,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.00049035,0.072895,0.095778,1,0
1,GO ODONTOGENESIS,0.015953,0.072419,0.19457,1,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.05161,0.071315,0.090302,1,0
1,GO CARDIOCYTE DIFFERENTIATION,0.015574,0.071122,0.15394,1,0
1,GO ACTIN FILAMENT BASED PROCESS,0.03939,0.070808,0.086259,1,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.053746,0.070384,0.099734,1,0
1,GO POLYOL METABOLIC PROCESS,0.02843,0.069025,0.066218,1,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.031059,0.068911,0.077172,1,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.052669,0.066769,0.090084,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.049546,0.064103,0.055365,1,0
1,GO RESPONSE TO NITROGEN COMPOUND,0.036164,0.064064,0.06263,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.033166,0.061943,0.046509,1,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.023741,0.061656,0.13007,1,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0097392,0.060432,0.087471,1,0
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0087944,0.060013,0.11721,1,0
1,GO REPRODUCTION,0.049546,0.05788,0.051281,1,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.049546,0.056039,0.098058,1,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.054842,0.05439,0.11547,1,0
1,GO MITOCHONDRIAL TRANSPORT,0.036948,0.051881,0.063414,1,0
1,GO SECRETION,0.037747,0.04739,0.063146,1,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.017549,-0.04239,-0.069698,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0081404,-0.047688,-0.10675,1,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.04854,-0.050601,-0.098303,1,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.044685,-0.052999,-0.088747,1,0
1,GO PROTEIN ACETYLATION,0.026586,-0.058454,-0.068731,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.026586,-0.067037,-0.12414,1,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.044685,-0.069778,-0.10768,1,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.016339,-0.071158,-0.1175,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.0040578,-0.073284,-0.10591,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.047551,-0.073285,-0.075834,1,0
1,GO DIET INDUCED THERMOGENESIS,0.054842,-0.074351,-0.14903,1,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.029719,-0.076672,-0.094895,1,0
1,GO TRANSMEMBRANE TRANSPORT,0.055956,-0.076905,-0.056706,1,0
1,GO REGULATION OF CILIUM MOVEMENT,0.017137,-0.077314,-0.11831,1,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.029719,-0.080221,-0.090536,1,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.024846,-0.082457,-0.18198,1,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.03939,-0.082757,-0.064394,1,0
1,GO PH REDUCTION,0.045624,-0.082842,-0.087074,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.049546,-0.084312,-0.10173,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.046579,-0.084835,-0.092453,1,0
1,GO CIRCADIAN RHYTHM,0.0010528,-0.087676,-0.11046,1,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.036164,-0.087938,-0.075493,1,0
1,GO CELL PROJECTION ORGANIZATION,0.012508,-0.088703,-0.089397,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.033894,-0.090265,-0.099867,1,0
1,GO VESICLE LOCALIZATION,0.030383,-0.090324,-0.061618,1,0
1,GO METAL ION TRANSPORT,0.0064317,-0.091256,-0.093703,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.015953,-0.094651,-0.10097,1,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.022165,-0.09468,-0.13592,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.0040578,-0.095025,-0.10532,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0045306,-0.095171,-0.091079,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.022165,-0.095581,-0.088589,1,0
1,GO REGULATION OF CELL DEVELOPMENT,0.012508,-0.095759,-0.11042,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.025414,-0.095826,-0.10106,1,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.031748,-0.09704,-0.095746,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.0047853,-0.097677,-0.096812,1,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.018836,-0.098105,-0.086819,1,0
1,GO CHROMATIN REMODELING,0.047551,-0.098232,-0.080105,1,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.033894,-0.099015,-0.11186,1,0
1,GO PEPTIDE SECRETION,0.0021689,-0.099981,-0.10925,1,0
1,GO MULTICELLULAR ORGANISM AGING,0.045624,-0.10013,-0.10656,1,0
1,GO DETECTION OF STIMULUS,0.0028957,-0.10016,-0.087217,1,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.041967,-0.10024,-0.079814,1,0
1,GO FEAR RESPONSE,0.0032441,-0.1021,-0.16266,1,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.020205,-0.10333,-0.092524,1,0
1,GO REGULATION OF CELL CYCLE ARREST,0.029719,-0.10516,-0.074353,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.041093,-0.10543,-0.077868,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0083534,-0.10615,-0.12691,1,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.011326,-0.10647,-0.097479,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.025994,-0.10785,-0.1841,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.040234,-0.10913,-0.10911,1,0
1,GO NEURON APOPTOTIC PROCESS,0.0066042,-0.10999,-0.10076,1,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.019283,-0.11052,-0.10842,1,0
1,GO SOMITE DEVELOPMENT,0.0075304,-0.11212,-0.11797,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.0097392,-0.1126,-0.14954,1,0
1,GO SOMITOGENESIS,0.034637,-0.11326,-0.081634,1,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.055956,-0.11334,-0.12322,1,0
1,GO ION TRANSPORT,0.0040578,-0.1142,-0.094076,1,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.021165,-0.11465,-0.14757,1,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.020205,-0.11586,-0.077629,1,0
1,GO CELL JUNCTION ORGANIZATION,0.047551,-0.11597,-0.083167,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.02068,-0.11677,-0.14498,1,0
1,GO REGULATION OF HORMONE LEVELS,0.0040578,-0.11735,-0.12126,1,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.040234,-0.11815,-0.139,1,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0047853,-0.11876,-0.12102,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.0040578,-0.11992,-0.10525,1,0
1,GO SECRETORY GRANULE ORGANIZATION,0.018398,-0.12068,-0.1268,1,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.025414,-0.12082,-0.16526,1,0
1,GO REGULATION OF RESPONSE TO FOOD,0.02068,-0.12087,-0.14408,1,0
1,GO CELL FATE COMMITMENT,0.017549,-0.12116,-0.13743,1,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.027188,-0.12249,-0.11403,1,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.031748,-0.12298,-0.09855,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.0045306,-0.12299,-0.10305,1,0
1,GO REGULATION OF ACTIN NUCLEATION,0.004408,-0.12337,-0.18947,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0013457,-0.12405,-0.12219,1,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0022332,-0.12501,-0.14581,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0010528,-0.12579,-0.13129,1,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.034637,-0.12677,-0.12592,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.013139,-0.12711,-0.12989,1,0
1,GO DEVELOPMENTAL CELL GROWTH,0.0042883,-0.12721,-0.14284,1,0
1,GO ADULT FEEDING BEHAVIOR,0.0067808,-0.1273,-0.20657,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02843,-0.12823,-0.15957,1,0
1,GO CELL CELL SIGNALING,0.0010206,-0.12945,-0.10966,1,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.019283,-0.12999,-0.18237,1,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0022332,-0.13115,-0.128,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.029068,-0.13156,-0.15321,1,0
1,GO HEAD DEVELOPMENT,0.0021062,-0.13237,-0.14562,1,0
1,GO PEPTIDYL LYSINE METHYLATION,0.035393,-0.13319,-0.11058,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.02268,-0.13363,-0.12825,1,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.025994,-0.13372,-0.11592,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,0.0027346,-0.13392,-0.1095,1,0
1,GO POLYOL CATABOLIC PROCESS,0.02843,-0.13598,-0.12298,1,0
1,GO CHLORIDE TRANSPORT,0.0094949,-0.13774,-0.10707,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.001986,-0.13797,-0.17385,1,0
1,GO CELL MATURATION,0.0010859,-0.13811,-0.1299,1,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.014841,-0.13847,-0.12462,1,0
1,GO WATER HOMEOSTASIS,0.052669,-0.13851,-0.10502,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.0041716,-0.13896,-0.21026,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0012662,-0.13993,-0.12664,1,0
1,GO CATION TRANSPORT,0.00049035,-0.14003,-0.12643,1,0
1,GO OXIDATIVE DEMETHYLATION,0.010773,-0.14045,-0.12803,1,0
1,GO INNER EAR MORPHOGENESIS,0.023205,-0.14064,-0.15504,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.015203,-0.14154,-0.15201,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0010528,-0.14157,-0.14829,1,0
1,GO HINDBRAIN MORPHOGENESIS,0.0042883,-0.14161,-0.16047,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0025083,-0.14348,-0.15145,1,0
1,GO RENAL WATER HOMEOSTASIS,0.04854,-0.14368,-0.098269,1,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0028141,-0.14387,-0.12945,1,0
1,GO REGULATION OF SYSTEM PROCESS,0.0013457,-0.14496,-0.12491,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00047456,-0.14518,-0.15205,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0097392,-0.14578,-0.13215,1,0
1,GO LIPID DROPLET ORGANIZATION,0.007729,-0.14594,-0.16971,1,0
1,GO REGULATION OF APPETITE,0.0030654,-0.14599,-0.15257,1,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.0056288,-0.14648,-0.13561,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.0049174,-0.14698,-0.17465,1,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.02268,-0.14708,-0.18067,1,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0050528,-0.14763,-0.23513,1,0
1,GO COCHLEA DEVELOPMENT,0.012508,-0.14783,-0.22229,1,0
1,GO FOREBRAIN CELL MIGRATION,0.012508,-0.14783,-0.19009,1,0
1,GO SENSORY PERCEPTION,0.00087311,-0.14818,-0.11908,1,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.029719,-0.1489,-0.1488,1,0
1,GO STRIATUM DEVELOPMENT,0.0075304,-0.14941,-0.23216,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.001662,-0.14961,-0.17586,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.025994,-0.14969,-0.16333,1,0
1,GO REGULATION OF SECRETION,3.7145e-05,-0.15007,-0.14916,1,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.046579,-0.15203,-0.14896,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.043763,-0.15224,-0.22567,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,0.00087311,-0.15228,-0.12872,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00027832,-0.15358,-0.16167,1,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0047853,-0.15387,-0.17362,1,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00057693,-0.15408,-0.15843,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0037331,-0.15512,-0.12655,1,0
1,GO RESPONSE TO POTASSIUM ION,0.046579,-0.15523,-0.24763,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.044685,-0.15577,-0.16624,1,0
1,GO NEUROGENESIS,0.00074557,-0.15641,-0.15381,1,0
1,GO SODIUM ION TRANSPORT,0.00090094,-0.15864,-0.15385,1,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.05161,-0.15868,-0.14378,1,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.030383,-0.15886,-0.11083,1,0
1,GO TELENCEPHALON DEVELOPMENT,0.00072223,-0.15892,-0.17423,1,0
1,GO REGULATION OF RESPIRATORY BURST,0.046579,-0.15911,-0.19582,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.015203,-0.15917,-0.12335,1,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.03245,-0.15931,-0.12118,1,0
1,GO IMPORT INTO CELL,0.042857,-0.15942,-0.096739,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.035393,-0.16042,-0.21842,1,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.019739,-0.16226,-0.15605,1,0
1,GO REGULATION OF ION TRANSPORT,0.00021909,-0.16317,-0.15237,1,0
1,GO REGULATION OF GLIOGENESIS,0.018836,-0.16327,-0.12233,1,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.00044439,-0.1635,-0.17565,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00067758,-0.16379,-0.13113,1,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0036303,-0.16476,-0.14243,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.011612,-0.16535,-0.17638,1,0
1,GO HISTONE H4 ACETYLATION,0.0021062,-0.1661,-0.1413,1,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.02843,-0.16702,-0.14174,1,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.050569,-0.16881,-0.20332,1,0
1,GO HISTONE H4 K16 ACETYLATION,0.00067758,-0.16885,-0.23445,1,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.030383,-0.1689,-0.11564,1,0
1,GO REGULATION OF BLOOD CIRCULATION,0.0023671,-0.16908,-0.14164,1,0
1,GO INTESTINAL ABSORPTION,0.05161,-0.16999,-0.15892,1,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0069616,-0.17006,-0.16807,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0051916,-0.17065,-0.18108,1,0
1,GO HEART PROCESS,0.0033369,-0.1712,-0.14142,1,0
1,GO REGULATION OF AXONOGENESIS,0.00087311,-0.17133,-0.18794,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00055855,-0.17151,-0.17507,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00034072,-0.1718,-0.14226,1,0
1,GO RESPONSE TO ALKALOID,2.2524e-05,-0.17279,-0.19924,1,0
1,GO STRIATED MUSCLE CONTRACTION,0.018836,-0.17285,-0.1228,1,0
1,GO DIGESTIVE SYSTEM PROCESS,0.015203,-0.17362,-0.14104,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00037661,-0.17485,-0.18432,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.027803,-0.17496,-0.2095,1,0
1,GO RHYTHMIC BEHAVIOR,0.036948,-0.17518,-0.14917,1,0
1,GO SECONDARY PALATE DEVELOPMENT,0.025414,-0.17646,-0.16045,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.033894,-0.17683,-0.19438,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.017137,-0.17733,-0.20377,1,0
1,GO VESICLE DOCKING,0.00047456,-0.17778,-0.18095,1,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.027803,-0.179,-0.15265,1,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.055956,-0.17905,-0.098807,1,0
1,GO GDP METABOLIC PROCESS,0.037747,-0.18017,-0.23359,1,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.025414,-0.18018,-0.12321,1,0
1,GO EATING BEHAVIOR,0.0007696,-0.18045,-0.17663,1,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0017123,-0.18186,-0.18457,1,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,9.7346e-05,-0.18218,-0.19467,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0025083,-0.18267,-0.15569,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.020205,-0.1827,-0.18481,1,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.030383,-0.18279,-0.12421,1,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.020205,-0.18302,-0.16665,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.035393,-0.18351,-0.15716,1,0
1,GO HISTONE H3 K4 METHYLATION,0.0079323,-0.18389,-0.19252,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0025083,-0.18395,-0.15729,1,0
1,GO DEVELOPMENTAL INDUCTION,0.03939,-0.18433,-0.13334,1,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.0094949,-0.18441,-0.17615,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.0051916,-0.18455,-0.18711,1,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.024288,-0.18552,-0.14708,1,0
1,GO EAR DEVELOPMENT,0.0067808,-0.18571,-0.16991,1,0
1,GO NEUROMUSCULAR PROCESS,0.00047456,-0.18582,-0.19533,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.0047853,-0.18663,-0.16676,1,0
1,GO PHAGOSOME ACIDIFICATION,0.0085714,-0.18711,-0.16489,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0010206,-0.18738,-0.18526,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0094949,-0.18749,-0.17732,1,0
1,GO RESPONSE TO FOOD,9.389e-05,-0.18771,-0.18901,1,0
1,GO REGULATION OF NEURON DIFFERENTIATION,0.0001547,-0.18787,-0.20532,1,0
1,GO HISTONE H3 K9 METHYLATION,0.00353,-0.18833,-0.15521,1,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.004408,-0.18847,-0.17279,1,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.001662,-0.18861,-0.20247,1,0
1,GO NERVOUS SYSTEM PROCESS,1.5201e-05,-0.18872,-0.17779,1,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00029782,-0.18876,-0.18983,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.025414,-0.18885,-0.21724,1,0
1,GO NEURON DEVELOPMENT,0.00012512,-0.18983,-0.19276,1,0
1,GO POSTSYNAPSE ORGANIZATION,0.00065623,-0.19071,-0.22229,1,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0083534,-0.19209,-0.20439,1,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0024367,-0.19214,-0.13063,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.024846,-0.1924,-0.19375,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.00079435,-0.1926,-0.21906,1,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.0053338,-0.19303,-0.22985,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0090226,-0.19403,-0.19404,1,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.017969,-0.19487,-0.17553,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00022676,-0.19517,-0.19484,1,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00034072,-0.19555,-0.16161,1,0
1,GO DIGESTION,0.0041716,-0.19629,-0.16824,1,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0025817,-0.19681,-0.33578,1,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00041602,-0.19737,-0.26418,1,0
1,GO FOREBRAIN DEVELOPMENT,0.00017796,-0.1974,-0.1944,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.024288,-0.198,-0.18417,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0014738,-0.1989,-0.21567,1,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0022332,-0.19916,-0.16526,1,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0056288,-0.19973,-0.20355,1,0
1,GO RESPONSE TO AMPHETAMINE,0.00081984,-0.20037,-0.26149,1,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,0.00047456,-0.20068,-0.17451,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.013798,-0.20096,-0.14932,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0028141,-0.20208,-0.17352,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.024288,-0.20219,-0.22637,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0017123,-0.20226,-0.20657,1,0
1,GO ORGANIC CATION TRANSPORT,0.00047456,-0.20231,-0.22369,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00024286,-0.2027,-0.19565,1,0
1,GO LIPID TRANSLOCATION,0.0079323,-0.20292,-0.18425,1,0
1,GO DEVELOPMENTAL MATURATION,6.2786e-05,-0.20359,-0.19082,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0010859,-0.20416,-0.28759,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00014418,-0.20422,-0.18034,1,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.00081984,-0.20475,-0.2217,1,0
1,GO NEURON DIFFERENTIATION,5.4121e-05,-0.20557,-0.19862,1,0
1,GO REGULATION OF CHROMATIN BINDING,0.001228,-0.2063,-0.21695,1,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0099891,-0.20647,-0.15471,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.011326,-0.20767,-0.19841,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0007696,-0.20786,-0.20599,1,0
1,GO PROTEIN POLYGLUTAMYLATION,0.00034072,-0.20791,-0.26213,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.025414,-0.20849,-0.20315,1,0
1,GO HAIR CELL DIFFERENTIATION,0.0045306,-0.20932,-0.24711,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00059588,-0.21075,-0.16174,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00050664,-0.21077,-0.17973,1,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,2.9532e-05,-0.21122,-0.23424,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.00087311,-0.21159,-0.20346,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.012203,-0.21225,-0.19486,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0016129,-0.21249,-0.21152,1,0
1,GO THYMUS DEVELOPMENT,0.041093,-0.21346,-0.12548,1,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.015953,-0.2138,-0.19964,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0006154,-0.21384,-0.17432,1,0
1,GO ACID SECRETION,0.00027832,-0.21393,-0.20627,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0047853,-0.21519,-0.20607,1,0
1,GO SODIUM ION HOMEOSTASIS,0.00092958,-0.21594,-0.25441,1,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0010859,-0.21805,-0.28265,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0083534,-0.21806,-0.28135,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,6.7596e-05,-0.2184,-0.2288,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.0056288,-0.2194,-0.19524,1,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0030654,-0.21973,-0.18567,1,0
1,GO SLEEP,0.00050664,-0.22016,-0.20245,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,3.8583e-05,-0.22057,-0.24326,1,0
1,GO RESPONSE TO PAIN,0.0051916,-0.22152,-0.21247,1,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.0032441,-0.22278,-0.18304,1,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.018836,-0.22316,-0.18269,1,0
1,GO REGULATION OF CELL MATURATION,0.00035231,-0.2244,-0.23742,1,0
1,GO REGULATION OF HORMONE SECRETION,2.5774e-06,-0.22532,-0.2427,1,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0036303,-0.22656,-0.14291,1,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.0031536,-0.2272,-0.17862,1,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,8.4205e-05,-0.22735,-0.27144,1,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00014935,-0.22764,-0.3191,1,0
1,GO TUBULIN DEACETYLATION,0.015203,-0.2279,-0.2507,1,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.001986,-0.2298,-0.16929,1,0
1,GO AMINO ACID TRANSPORT,0.00057693,-0.2305,-0.18009,1,0
1,GO RESPONSE TO CATECHOLAMINE,3.8583e-05,-0.23128,-0.22032,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.0069616,-0.23166,-0.24471,1,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.0026572,-0.23206,-0.15772,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.044685,-0.23387,-0.29412,1,0
1,GO HORMONE TRANSPORT,1.2862e-06,-0.23408,-0.25355,1,0
1,GO REGULATION OF ICOSANOID SECRETION,0.02068,-0.23447,-0.15714,1,0
1,GO SPINAL CORD DEVELOPMENT,0.00023468,-0.23521,-0.2561,1,0
1,GO NEURON PROJECTION ARBORIZATION,0.011904,-0.23525,-0.19766,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,2.9301e-06,-0.23566,-0.21776,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,2.2524e-05,-0.23659,-0.28432,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,7.3528e-06,-0.23676,-0.22538,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0081404,-0.23684,-0.23171,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.029068,-0.23693,-0.17875,1,0
1,GO BEHAVIOR,3.0576e-06,-0.23774,-0.22722,1,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00353,-0.23841,-0.159,1,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.041093,-0.24193,-0.13258,1,0
1,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.00030804,-0.24213,-0.18869,1,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00016595,-0.24266,-0.25509,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.047551,-0.24295,-0.16983,1,0
1,GO BILE ACID METABOLIC PROCESS,0.004408,-0.24305,-0.19518,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00021909,-0.24361,-0.31529,1,0
1,GO SHORT TERM MEMORY,0.015203,-0.24447,-0.23969,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,0.00010092,-0.24679,-0.28578,1,0
1,GO CRANIAL NERVE DEVELOPMENT,0.0007696,-0.24739,-0.26609,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,0.00069957,-0.24832,-0.21345,1,0
1,GO LIMBIC SYSTEM DEVELOPMENT,0.00016023,-0.24909,-0.26132,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,0.0007696,-0.24962,-0.20541,1,0
1,GO CARDIAC CONDUCTION,0.00034072,-0.25079,-0.24279,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,2.2524e-05,-0.25245,-0.20449,1,0
1,GO FEEDING BEHAVIOR,3.9926e-07,-0.25467,-0.27215,1,0
1,GO RESPONSE TO DOPAMINE,2.6902e-06,-0.25522,-0.2476,1,0
1,GO SEX DETERMINATION,0.0013872,-0.2562,-0.25913,1,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00034072,-0.25661,-0.28255,1,0
1,GO REGULATION OF HEART RATE,0.0015189,-0.25768,-0.20987,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00092958,-0.25787,-0.24408,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0014738,-0.25824,-0.21955,1,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0012662,-0.25889,-0.25984,1,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0029794,-0.25915,-0.22741,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.011904,-0.25972,-0.22104,1,0
1,GO GENETIC IMPRINTING,0.0024367,-0.26005,-0.19143,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0027346,-0.26083,-0.27143,1,0
1,GO CAMP BIOSYNTHETIC PROCESS,0.012203,-0.26083,-0.24378,1,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.00020448,-0.26256,-0.30004,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.0053338,-0.26399,-0.22026,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,4.2876e-06,-0.26457,-0.22997,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.007729,-0.26678,-0.20231,1,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00026903,-0.26718,-0.27179,1,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.00026903,-0.26735,-0.21451,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00065623,-0.26954,-0.28059,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.017137,-0.27258,-0.32306,1,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.012508,-0.27336,-0.21137,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00014935,-0.27399,-0.29327,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00052342,-0.27463,-0.31207,1,0
1,GO PANCREAS DEVELOPMENT,0.00034072,-0.27529,-0.24106,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.022165,-0.27616,-0.23195,1,0
1,GO RELAXATION OF MUSCLE,0.041093,-0.27847,-0.17946,1,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.0032441,-0.2795,-0.29586,1,0
1,GO SIGNAL RELEASE,3.17e-07,-0.28052,-0.26837,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0059384,-0.28073,-0.32712,1,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00040247,-0.28199,-0.30126,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0013457,-0.28276,-0.25674,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0087944,-0.28297,-0.2408,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0046564,-0.28303,-0.22866,1,0
1,GO HISTONE H4 K5 ACETYLATION,0.001228,-0.28421,-0.24492,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.016339,-0.28539,-0.30039,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,5.0683e-06,-0.28568,-0.2574,1,0
1,GO PEPTIDE HORMONE SECRETION,4.5813e-07,-0.28632,-0.30753,1,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.4346e-05,-0.28664,-0.28185,1,0
1,GO REGULATION OF INSULIN SECRETION,3.4728e-06,-0.28997,-0.28229,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,4.5813e-07,-0.29115,-0.29768,1,0
1,GO SYNAPSE ORGANIZATION,4.0073e-05,-0.29118,-0.27941,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0042883,-0.29157,-0.29249,1,0
1,GO SENSORY PERCEPTION OF PAIN,5.2533e-07,-0.29383,-0.2854,1,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00052342,-0.29634,-0.26894,1,0
1,GO NOREPINEPHRINE SECRETION,0.00026903,-0.29641,-0.28632,1,0
1,GO HINDBRAIN DEVELOPMENT,5.0683e-06,-0.29671,-0.28689,1,0
1,GO LIPOXYGENASE PATHWAY,0.0057817,-0.29682,-0.31292,1,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.001662,-0.29715,-0.32045,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,4.3218e-05,-0.29722,-0.2731,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.00026003,-0.29733,-0.2695,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0015189,-0.29809,-0.24697,1,0
1,GO CELL MIGRATION IN HINDBRAIN,0.00023468,-0.29885,-0.37899,1,0
1,GO PROTEIN PALMITOYLATION,1.7806e-05,-0.29964,-0.28933,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,9.7801e-06,-0.29983,-0.28564,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.023741,-0.30127,-0.25113,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,1.5816e-05,-0.30185,-0.27375,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00021167,-0.303,-0.30788,1,0
1,GO POTASSIUM ION HOMEOSTASIS,0.0017641,-0.30379,-0.23026,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.9263e-05,-0.30427,-0.28214,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,6.0504e-05,-0.30615,-0.26789,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.011904,-0.30711,-0.20219,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.031059,-0.30827,-0.22951,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00038934,-0.30841,-0.52722,1,0
1,GO SKELETAL MUSCLE ADAPTATION,0.0023671,-0.3092,-0.23974,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.013139,-0.30929,-0.26402,1,0
1,GO ENERGY HOMEOSTASIS,0.0022992,-0.30937,-0.25599,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.022165,-0.31009,-0.21595,1,0
1,GO INSULIN SECRETION,1.4674e-06,-0.3103,-0.30265,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0028957,-0.31074,-0.25254,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.5201e-05,-0.31077,-0.2894,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,8.3127e-06,-0.31241,-0.31541,1,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,8.1192e-05,-0.31322,-0.26398,1,0
1,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.00018427,-0.31341,-0.25721,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,7.8282e-05,-0.31449,-0.26481,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.011904,-0.31657,-0.18976,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,3.17e-07,-0.31759,-0.31801,1,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.00081984,-0.32265,-0.25015,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0025817,-0.32313,-0.42419,1,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,2.6307e-05,-0.32417,-0.3718,1,0
1,GO IMMATURE B CELL DIFFERENTIATION,0.0081404,-0.32446,-0.20113,1,0
1,GO ACTION POTENTIAL,4.3218e-05,-0.32453,-0.30551,1,0
1,GO ASSOCIATIVE LEARNING,4.8379e-05,-0.32529,-0.25736,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00055855,-0.32543,-0.24489,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,4.4878e-05,-0.32726,-0.27128,1,0
1,GO NERVE DEVELOPMENT,8.1192e-05,-0.33006,-0.29638,1,0
1,GO NOREPINEPHRINE TRANSPORT,0.00092958,-0.33174,-0.27312,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,1.4044e-06,-0.33419,-0.38533,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,5.508e-06,-0.33433,-0.33617,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0036303,-0.33985,-0.36538,1,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.0094949,-0.34055,-0.24649,1,0
1,GO FOREBRAIN REGIONALIZATION,0.00040247,-0.34079,-0.36147,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,7.889e-07,-0.34233,-0.32763,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.00044439,-0.34245,-0.36527,1,0
1,GO MEMBRANE DEPOLARIZATION,7.8282e-05,-0.3426,-0.28919,1,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,9.3916e-06,-0.34713,-0.38551,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0006154,-0.3473,-0.30442,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0039469,-0.34781,-0.293,1,0
1,GO LEARNING,9.7801e-06,-0.34827,-0.30329,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.030383,-0.34925,-0.3214,1,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.0060989,-0.34953,-0.23891,1,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.02843,-0.35022,-0.25159,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,9.3916e-06,-0.35044,-0.32381,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0015653,-0.35115,-0.28398,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.9263e-05,-0.35184,-0.32008,1,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0025083,-0.35248,-0.28078,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,1.7806e-05,-0.35324,-0.3457,1,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,6.7596e-05,-0.35335,-0.39252,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,8.7323e-05,-0.3536,-0.3877,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,3.8583e-05,-0.35543,-0.37053,1,0
1,GO NEURAL RETINA DEVELOPMENT,5.6174e-05,-0.35603,-0.39614,1,0
1,GO METENCEPHALON DEVELOPMENT,7.5427e-07,-0.35615,-0.3744,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00057693,-0.35616,-0.32691,1,0
1,GO RESPONSE TO LEUCINE,0.011326,-0.35627,-0.33549,1,0
1,GO REGULATION OF EXOCYTOSIS,9.4334e-07,-0.35666,-0.3134,1,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.001228,-0.35679,-0.28916,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00032948,-0.36004,-0.29266,1,0
1,GO LOCOMOTORY BEHAVIOR,1.4963e-07,-0.36024,-0.39219,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.00017796,-0.36178,-0.33731,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,7.2754e-05,-0.36214,-0.33621,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.8521e-05,-0.36275,-0.43211,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.024288,-0.36281,-0.22426,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0036303,-0.36408,-0.28771,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0012662,-0.36429,-0.26219,1,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,1.7806e-05,-0.36675,-0.4033,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0024367,-0.36716,-0.27152,1,0
1,GO SYNAPTIC SIGNALING,8.628e-07,-0.3675,-0.32588,1,0
1,GO POTASSIUM ION TRANSPORT,1.0311e-06,-0.36758,-0.32478,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.001228,-0.37293,-0.33592,1,0
1,GO DETECTION OF MECHANICAL STIMULUS,1.7118e-05,-0.37388,-0.31484,1,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0027346,-0.37421,-0.25251,1,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,2.0784e-06,-0.37423,-0.34543,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0067808,-0.37478,-0.27086,1,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00047456,-0.3772,-0.33427,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00010092,-0.37749,-0.37194,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,7.547e-05,-0.37872,-0.32707,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.009256,-0.38066,-0.42135,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,4.2876e-06,-0.38225,-0.36383,1,0
1,GO RESPONSE TO NICOTINE,0.00036427,-0.38374,-0.27602,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00018427,-0.38397,-0.43228,1,0
1,GO OTIC VESICLE MORPHOGENESIS,0.024288,-0.38421,-0.36256,1,0
1,GO RESPONSE TO ACETYLCHOLINE,0.00024286,-0.38529,-0.3438,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,1.6455e-05,-0.38559,-0.40204,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0056288,-0.38565,-0.25323,1,0
1,GO RESPONSE TO INSECTICIDE,0.00030804,-0.38749,-0.36839,1,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00055855,-0.38826,-0.33326,1,0
1,GO LIPID DROPLET FORMATION,0.0019282,-0.38829,-0.38895,1,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,6.7728e-06,-0.38882,-0.39237,1,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.0013872,-0.39162,-0.42413,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,5.2139e-05,-0.395,-0.3991,1,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0038387,-0.39576,-0.3136,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,9.7346e-05,-0.3981,-0.38308,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0087944,-0.39973,-0.28397,1,0
1,GO MRNA SPLICE SITE SELECTION,1.8521e-05,-0.39984,-0.3636,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.001872,-0.4,-0.40829,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00032948,-0.40055,-0.34926,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0021062,-0.40175,-0.36356,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,5.9841e-06,-0.40284,-0.41833,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,1.0779e-06,-0.40323,-0.3676,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,9.0551e-05,-0.4045,-0.48556,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00081984,-0.40705,-0.36804,1,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0034322,-0.40918,-0.29233,1,0
1,GO SECRETORY GRANULE LOCALIZATION,7.2754e-05,-0.41139,-0.6171,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00010462,-0.41398,-0.32103,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,6.2786e-05,-0.41413,-0.38736,1,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0007696,-0.41427,-0.36115,1,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.0032441,-0.41594,-0.3781,1,0
1,GO N GLYCAN PROCESSING,2.6307e-05,-0.41834,-0.3964,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.017969,-0.41897,-0.36374,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,2.8077e-06,-0.42072,-0.4087,1,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.0050528,-0.42284,-0.28005,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,1.4039e-05,-0.42312,-0.42175,1,0
1,GO MALE SEX DETERMINATION,0.001662,-0.42581,-0.35079,1,0
1,GO RESPONSE TO L GLUTAMATE,0.0051916,-0.42703,-0.40315,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,8.8325e-08,-0.4272,-0.44756,1,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.0075304,-0.42721,-0.32684,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00019079,-0.43056,-0.31412,1,0
1,GO SEGMENT SPECIFICATION,8.1192e-05,-0.4322,-0.47412,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,6.8936e-07,-0.43317,-0.45998,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0024367,-0.4347,-0.38653,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.00032948,-0.43491,-0.42176,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.6729e-06,-0.43624,-0.39906,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.0006154,-0.43768,-0.35486,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,3.8131e-07,-0.43851,-0.50672,1,0
1,GO EXOCYTIC PROCESS,3.0264e-07,-0.43991,-0.42476,1,0
1,GO SUCKLING BEHAVIOR,0.00014935,-0.44493,-0.42672,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0064317,-0.4456,-0.29595,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00074557,-0.44595,-0.34491,1,0
1,GO REGULATION OF VESICLE FUSION,0.00037661,-0.44691,-0.40914,1,0
1,GO GROOMING BEHAVIOR,1.2962e-05,-0.44832,-0.42683,1,0
1,GO SYNAPSE ASSEMBLY,7.2111e-07,-0.44959,-0.44293,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00031859,-0.45103,-0.4312,1,0
1,GO DIENCEPHALON DEVELOPMENT,3.0576e-06,-0.45163,-0.39658,1,0
1,GO NEURON MATURATION,4.6623e-06,-0.45356,-0.43745,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,3.3287e-06,-0.45635,-0.4616,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,9.7801e-06,-0.45869,-0.46969,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00010462,-0.46242,-0.55984,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.071e-07,-0.46281,-0.44281,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,0.00035231,-0.46566,-0.38693,1,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.00031859,-0.46746,-0.39514,1,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00065623,-0.46871,-0.39661,1,0
1,GO OTIC VESICLE DEVELOPMENT,0.0060989,-0.47142,-0.34423,1,0
1,GO REGULATION OF CELL PROJECTION SIZE,3.4728e-06,-0.47781,-0.49878,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0017641,-0.47838,-0.36378,1,0
1,GO PYRAMIDAL NEURON DIFFERENTIATION,0.01282,-0.47917,-0.46048,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.031059,-0.48016,-0.3206,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,5.4977e-07,-0.48368,-0.48117,1,0
1,GO ENDOCARDIUM DEVELOPMENT,0.007729,-0.4843,-0.32572,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.6902e-06,-0.48487,-0.42869,1,0
1,GO CEREBELLAR CORTEX FORMATION,4.3763e-07,-0.48788,-0.52267,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.004408,-0.49498,-0.4995,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.5774e-06,-0.50169,-0.4406,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00044439,-0.50684,-0.47206,1,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0090226,-0.50717,-0.38279,1,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.019283,-0.50915,-0.31479,1,0
1,GO CGMP METABOLIC PROCESS,2.4346e-05,-0.51359,-0.48995,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,5.4977e-07,-0.51573,-0.50703,1,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.753e-07,-0.51629,-0.4797,1,0
1,GO EPITHELIAL CELL MATURATION,2.0833e-05,-0.51645,-0.50643,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,2.4346e-05,-0.52055,-0.5437,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,1.0779e-06,-0.52512,-0.51598,1,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,3.9418e-06,-0.53045,-0.50838,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,8.2505e-07,-0.5333,-0.58149,1,0
1,GO RETROGRADE TRANS SYNAPTIC SIGNALING,2.8418e-05,-0.53557,-0.6326,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00020448,-0.54045,-0.44026,1,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,2.6307e-05,-0.54165,-0.46789,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.00014418,-0.54493,-0.50024,1,0
1,GO MAST CELL MIGRATION,0.00067758,-0.5468,-0.46037,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,4.2876e-06,-0.54756,-0.55939,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00031859,-0.5476,-0.4452,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,3.17e-07,-0.54818,-0.51019,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0001165,-0.55403,-0.42037,1,0
1,GO REGULATION OF NEURON MATURATION,6.5149e-05,-0.5574,-0.53457,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS,4.5813e-07,-0.56965,-0.61318,1,0
1,GO DOPAMINE METABOLIC PROCESS,2.3975e-07,-0.57283,-0.5763,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00013917,-0.57347,-0.39674,1,0
1,GO GROWTH HORMONE SECRETION,7.889e-07,-0.57949,-0.54441,1,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,8.0176e-08,-0.58284,-0.63668,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00037661,-0.59264,-0.53252,1,0
1,GO GLIAL CELL FATE COMMITMENT,0.00016023,-0.59393,-0.60077,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,3.7791e-06,-0.59485,-0.51529,1,0
1,GO LUNG CELL DIFFERENTIATION,0.001191,-0.59552,-0.47345,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,1.2971e-07,-0.59617,-0.56701,1,0
1,GO SIALYLATION,3.9418e-06,-0.59905,-0.55149,1,0
1,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.00042998,-0.60275,-0.44502,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.4878e-05,-0.60278,-0.54555,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,7.0571e-06,-0.60295,-0.57762,1,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00032948,-0.60377,-0.56276,1,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.0042883,-0.60603,-0.39844,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00065623,-0.60694,-0.58143,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,1.9263e-05,-0.60931,-0.50677,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,9.4334e-07,-0.60951,-0.52589,1,0
1,GO SPINAL CORD PATTERNING,3.1904e-06,-0.61927,-0.60146,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,2.7578e-07,-0.62089,-0.5525,1,0
1,GO REGULATION OF SYNAPSE MATURATION,3.1888e-05,-0.62295,-0.61507,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,1.4268e-07,-0.63093,-0.64636,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00013433,-0.63525,-0.47645,1,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.036164,-0.64071,-0.35819,1,0
1,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.00011241,-0.6433,-0.5499,1,0
1,GO DENTATE GYRUS DEVELOPMENT,0.00037661,-0.64548,-0.53971,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.5691e-07,-0.65216,-0.64735,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.0604e-05,-0.66146,-0.5797,1,0
1,GO STARTLE RESPONSE,8.2505e-07,-0.66452,-0.56212,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,2.3654e-06,-0.6665,-0.73384,1,0
1,GO SYNAPTIC VESICLE MATURATION,1.8521e-05,-0.67292,-0.74302,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,1.5331e-06,-0.67601,-0.63584,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.7474e-06,-0.67671,-0.5598,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,3.17e-07,-0.67863,-0.65138,1,0
1,GO RESPONSE TO LITHIUM ION,3.7791e-06,-0.68229,-0.61168,1,0
1,GO NEURON FATE COMMITMENT,6.2985e-07,-0.68474,-0.71284,1,0
1,GO RESPONSE TO HISTAMINE,2.2658e-06,-0.68626,-0.68134,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,3.3287e-06,-0.69069,-0.74121,1,0
1,GO ADENOHYPOPHYSIS DEVELOPMENT,1.5201e-05,-0.69226,-0.67675,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,7.547e-05,-0.70575,-0.61421,1,0
1,GO THALAMUS DEVELOPMENT,1.5816e-05,-0.72111,-0.58827,1,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,2.3975e-07,-0.72341,-0.69549,1,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,2.5122e-07,-0.73801,-0.7011,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,1.7118e-05,-0.74999,-0.78632,1,0
1,GO MONOAMINE TRANSPORT,1.2971e-07,-0.75601,-0.68029,1,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.029719,-0.76739,-0.44953,1,0
1,GO AMINE TRANSPORT,1.2971e-07,-0.76842,-0.63954,1,0
1,GO INNERVATION,3.9418e-06,-0.76895,-0.62589,1,0
1,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.628e-07,-0.77378,-0.7813,1,0
1,GO SYNAPTIC VESICLE DOCKING,5.753e-07,-0.78581,-0.77385,1,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.00072223,-0.7859,-0.6657,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,1.5201e-05,-0.78722,-0.60825,1,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00067758,-0.78731,-0.6168,1,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.9418e-06,-0.79143,-0.71145,1,0
1,GO SEROTONIN METABOLIC PROCESS,1.2308e-06,-0.80773,-0.70294,1,0
1,GO PROTEIN LOCALIZATION TO AXON,4.6623e-06,-0.80917,-0.91561,1,0
1,GO SYNAPSE MATURATION,5.0683e-06,-0.81147,-0.78314,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,1.1964e-05,-0.83173,-0.79208,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,7.2756e-08,-0.83399,-0.88345,1,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,3.7791e-06,-0.8381,-0.72208,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,9.0221e-07,-0.84183,-0.77933,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,3.3287e-06,-0.85528,-0.80292,1,0
1,GO EPITHELIAL CELL FATE COMMITMENT,4.0073e-05,-0.8649,-0.76849,1,0
1,GO VOCALIZATION BEHAVIOR,2.2658e-06,-0.86899,-0.83892,1,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.1776e-06,-0.88749,-0.81773,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,2.0829e-07,-0.88784,-0.78535,1,0
1,GO SYNAPTIC VESICLE PRIMING,6.5896e-07,-0.89151,-0.80372,1,0
1,GO PREPULSE INHIBITION,1.8958e-07,-0.92547,-0.8487,1,0
1,GO DOPAMINE TRANSPORT,1.4963e-07,-0.92813,-0.80285,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,1.1493e-05,-0.93,-0.77386,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.071e-07,-0.97149,-0.89677,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,2.4346e-05,-0.97649,-0.81148,1,0
1,GO CATECHOLAMINE SECRETION,1.725e-07,-0.98425,-0.82346,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,2.5774e-06,-0.9965,-0.85668,1,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.0311e-06,-1.0061,-0.82011,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,9.4334e-07,-1.0216,-0.97465,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,8.2505e-07,-1.0254,-1.0155,1,0
1,GO GANGLION DEVELOPMENT,2.5122e-07,-1.0795,-0.92764,1,0
1,GO REGULATION OF DOPAMINE SECRETION,2.0829e-07,-1.1147,-0.99016,1,0
1,GO NOSE DEVELOPMENT,1.3441e-06,-1.1182,-0.90361,1,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,3.6228e-06,-1.3746,-1.1683,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,2.3654e-06,-1.5983,-1.5061,1,0
1,GO PHOSPHOLIPID EFFLUX,0.092194,0.41091,0.27229,0,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.14048,0.34732,0.19124,0,1
1,GO DISTAL TUBULE DEVELOPMENT,0.10654,0.3259,0.24579,0,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.060602,0.32291,0.28294,0,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.23245,0.30051,0.18787,0,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.25363,0.29855,0.1522,0,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.084046,0.28694,0.20339,0,1
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.10465,0.28208,0.16545,0,1
1,GO L SERINE METABOLIC PROCESS,0.12689,0.2806,0.13234,0,1
1,GO TONGUE MORPHOGENESIS,0.066855,0.27758,0.23927,0,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.10096,0.27359,0.17615,0,1
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.05824,0.27244,0.14538,0,1
1,GO ACTIN FILAMENT SEVERING,0.061812,0.26758,0.1701,0,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.10465,0.25701,0.15372,0,1
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.12049,0.24512,0.26749,0,1
1,GO BARBED END ACTIN FILAMENT CAPPING,0.2,0.24383,0.1178,0,1
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.24643,0.24278,0.13998,0,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.13355,0.23573,0.15056,0,1
1,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.088862,0.23563,0.15035,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.25729,0.23138,0.15456,0,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.16294,0.22283,0.11014,0,1
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.061812,0.22203,0.1124,0,1
1,GO POSITIVE REGULATION OF CELL SIZE,0.16032,0.22055,0.18248,0,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.064293,0.21642,0.14372,0,1
1,GO KINETOCHORE ASSEMBLY,0.0695,0.21428,0.15868,0,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.079444,0.21291,0.26194,0,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.077957,0.21291,0.099801,0,1
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.090515,0.21167,0.12375,0,1
1,GO LAMELLIPODIUM MORPHOGENESIS,0.42347,0.21102,0.10939,0,1
1,GO REGULATION OF CELLULAR RESPIRATION,0.060602,0.20735,0.12404,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.15015,0.20472,0.085778,0,1
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.095625,0.20203,0.28972,0,1
1,GO HINDLIMB MORPHOGENESIS,0.068167,0.19666,0.17699,0,1
1,GO RESPONSE TO CADMIUM ION,0.26847,0.19549,0.096188,0,1
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.11434,0.19504,0.16247,0,1
1,GO PROTEIN AUTOPROCESSING,0.076492,0.1944,0.11378,0,1
1,GO MITOTIC CELL CYCLE ARREST,0.076492,0.19367,0.14055,0,1
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.066855,0.19333,0.12531,0,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.33812,0.19091,0.094013,0,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.075049,0.19031,0.095579,0,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.097379,0.19028,0.13818,0,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.066855,0.18885,0.141,0,1
1,GO NUCLEAR MIGRATION,0.37932,0.18881,0.066509,0,1
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.21905,0.18505,0.24953,0,1
1,GO DNA DEMETHYLATION,0.063042,0.1819,0.13178,0,1
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.18508,0.1814,0.16455,0,1
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.065563,0.17856,0.077773,0,1
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.15015,0.17641,0.12187,0,1
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.19095,0.17576,0.12042,0,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.084046,0.17362,0.11158,0,1
1,GO VITAMIN D METABOLIC PROCESS,0.11636,0.17298,0.1818,0,1
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.41341,0.17193,0.20216,0,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.16032,0.17099,0.15932,0,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.10654,0.16954,0.11224,0,1
1,GO KINETOCHORE ORGANIZATION,0.15264,0.16938,0.10314,0,1
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.063042,0.1691,0.11849,0,1
1,GO ENDOTHELIUM DEVELOPMENT,0.26098,0.16848,0.058405,0,1
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.13355,0.16795,0.087969,0,1
1,GO ATP TRANSPORT,0.10845,0.16733,0.072705,0,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.087232,0.16629,0.091314,0,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.065563,0.16573,0.19639,0,1
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.47049,0.16538,0.071281,0,1
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.18508,0.16246,0.13948,0,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.080955,0.16126,0.18416,0,1
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.077957,0.16088,0.15083,0,1
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.27227,0.15908,0.093904,0,1
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.62113,0.15896,0.053574,0,1
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.21256,0.15864,0.085998,0,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.064293,0.1581,0.18494,0,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.18219,0.15781,0.10786,0,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.080955,0.15612,0.12798,0,1
1,GO TRICARBOXYLIC ACID CYCLE,0.23589,0.15604,0.047051,0,1
1,GO ER NUCLEUS SIGNALING PATHWAY,0.11434,0.15559,0.079452,0,1
1,GO HEART TRABECULA FORMATION,0.16294,0.15432,0.21458,0,1
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.36526,0.15208,0.070108,0,1
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.095625,0.15129,0.089573,0,1
1,GO ACETYL COA METABOLIC PROCESS,0.17099,0.15113,0.054375,0,1
1,GO CELLULAR RESPONSE TO PH,0.10465,0.15087,0.10067,0,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.099158,0.14819,0.13231,0,1
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.24643,0.14559,0.069412,0,1
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.080955,0.14491,0.12327,0,1
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.090515,0.14476,0.074886,0,1
1,GO PLASMA MEMBRANE FUSION,0.065563,0.14401,0.16588,0,1
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.11235,0.14353,0.090093,0,1
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.10654,0.14347,0.14286,0,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.10654,0.14211,0.11646,0,1
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.29586,0.14134,0.074414,0,1
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.099158,0.1408,0.074406,0,1
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.12908,0.14,0.091905,0,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.072231,0.13885,0.18379,0,1
1,GO PROTEIN LOCALIZATION TO CILIUM,0.090515,0.13613,0.11186,0,1
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.29992,0.13535,0.096652,0,1
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.33812,0.13306,0.060001,0,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.19393,0.13289,0.083251,0,1
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.21905,0.13238,0.11641,0,1
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.087232,0.13225,0.12324,0,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.060602,0.13175,0.11507,0,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.13583,0.13063,0.11134,0,1
1,GO GLYCOSIDE METABOLIC PROCESS,0.20309,0.1297,0.11222,0,1
1,GO REGULATION OF CELL DIVISION,0.065563,0.12814,0.078163,0,1
1,GO MUSCLE ORGAN MORPHOGENESIS,0.068167,0.12809,0.12619,0,1
1,GO MEIOTIC CHROMOSOME SEPARATION,0.32077,0.12792,0.097814,0,1
1,GO MUSCLE HYPERTROPHY,0.31653,0.12741,0.054268,0,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.061812,0.12445,0.062575,0,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.087232,0.12444,0.086419,0,1
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.17653,0.12381,0.19437,0,1
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.14048,0.12339,0.078942,0,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.11841,0.12287,0.14307,0,1
1,GO SPHINGOID METABOLIC PROCESS,0.060602,0.12236,0.080864,0,1
1,GO PROTEIN MONOUBIQUITINATION,0.088862,0.12216,0.062077,0,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.082489,0.12126,0.090493,0,1
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.40843,0.12121,0.026977,0,1
1,GO ADHERENS JUNCTION ASSEMBLY,0.21905,0.12107,0.094457,0,1
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.26098,0.11979,0.11047,0,1
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.10845,0.11961,0.10526,0,1
1,GO HISTONE ARGININE METHYLATION,0.093897,0.11902,0.082759,0,1
1,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.14526,0.11794,0.14647,0,1
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.26847,0.11575,0.060988,0,1
1,GO RESPIRATORY SYSTEM PROCESS,0.4978,0.11532,0.044628,0,1
1,GO RESPONSE TO PROSTAGLANDIN E,0.10096,0.11409,0.094823,0,1
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.16294,0.11385,0.060955,0,1
1,GO RNA INTERFERENCE,0.47588,0.11313,0.047255,0,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.11039,0.11248,0.11532,0,1
1,GO HISTONE H3 DEACETYLATION,0.095625,0.11159,0.09058,0,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.24288,0.11149,0.07647,0,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.0695,0.10891,0.17957,0,1
1,GO CELLULAR PIGMENTATION,0.065563,0.10743,0.080771,0,1
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.061812,0.1068,0.11833,0,1
1,GO RRNA CATABOLIC PROCESS,0.40349,0.10596,0.047524,0,1
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.084046,0.10553,0.098468,0,1
1,GO ACTIVATED T CELL PROLIFERATION,0.14526,0.10369,0.091179,0,1
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.15015,0.10166,0.10904,0,1
1,GO ANOIKIS,0.33812,0.10151,0.091582,0,1
1,GO MITOCHONDRIAL DEPOLARIZATION,0.21256,0.10073,0.11396,0,1
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.21579,0.1007,0.062891,0,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.11434,0.10048,0.091041,0,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.087232,0.10005,0.082377,0,1
1,GO CENTROSOME SEPARATION,0.17653,0.09774,0.090906,0,1
1,GO REGULATION OF PROTEIN SUMOYLATION,0.17934,0.097492,0.10078,0,1
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.23937,0.097413,0.057131,0,1
1,GO EPITHELIAL TUBE FORMATION,0.1028,0.096634,0.10247,0,1
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.12908,0.09568,0.19478,0,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.084046,0.095263,0.14685,0,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.13583,0.095015,0.055094,0,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.36064,0.093846,0.039058,0,1
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.15015,0.093582,0.047035,0,1
1,GO NEGATIVE REGULATION OF DNA BINDING,0.29184,0.092844,0.046102,0,1
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.19695,0.091926,0.095835,0,1
1,GO DNA REPLICATION INITIATION,0.20621,0.091601,0.04509,0,1
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.30402,0.091529,0.022505,0,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.082489,0.090946,0.052284,0,1
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.14769,0.089528,0.12054,0,1
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0695,0.088713,0.15202,0,1
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.21905,0.086169,0.062498,0,1
1,GO REGULATION OF PROTEIN TARGETING,0.068167,0.085933,0.06816,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.060602,0.084909,0.064357,0,1
1,GO ACTIVATION OF GTPASE ACTIVITY,0.11841,0.082716,0.077355,0,1
1,GO VIRAL LATENCY,0.47049,0.082292,0.043815,0,1
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.14526,0.080895,0.083546,0,1
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.066855,0.080703,0.065644,0,1
1,GO HEXOSE CATABOLIC PROCESS,0.24288,0.080633,0.045143,0,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.10465,0.0805,0.075437,0,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.33373,0.080209,0.073529,0,1
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.58456,0.080006,0.012092,0,1
1,GO FERTILIZATION,0.077957,0.079374,0.056512,0,1
1,GO REGULATION OF CYTOKINESIS,0.21905,0.078712,0.043404,0,1
1,GO CENTROMERE COMPLEX ASSEMBLY,0.29184,0.077648,0.077306,0,1
1,GO RESPONSE TO INSULIN,0.13583,0.076314,0.034484,0,1
1,GO HISTONE EXCHANGE,0.35153,0.075341,0.058418,0,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.061812,0.074589,0.048758,0,1
1,GO DNA INTEGRITY CHECKPOINT,0.12908,0.07389,0.068491,0,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.42347,0.071977,0.048391,0,1
1,GO CELL VOLUME HOMEOSTASIS,0.14285,0.0719,0.060031,0,1
1,GO T CELL LINEAGE COMMITMENT,0.066855,0.071521,0.098866,0,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.31653,0.06994,0.053991,0,1
1,GO CYTOSKELETON ORGANIZATION,0.10096,0.069453,0.059627,0,1
1,GO REGULATION OF MRNA POLYADENYLATION,0.28785,0.068683,0.066811,0,1
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.4598,0.066549,0.063913,0,1
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.30402,0.064887,0.026821,0,1
1,GO MISMATCH REPAIR,0.25363,0.064453,0.047312,0,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.068167,0.064174,0.095211,0,1
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.14048,0.063242,0.063586,0,1
1,GO REGULATION OF HELICASE ACTIVITY,0.35153,0.063124,0.081262,0,1
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.188,0.062551,0.041185,0,1
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.59664,0.052938,0.019751,0,1
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.32077,0.052499,0.070887,0,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.12259,0.051904,0.067015,0,1
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.13355,0.051216,0.061464,0,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.10845,0.049425,0.067792,0,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.39371,0.047304,0.0645,0,1
1,GO TRANSFERRIN TRANSPORT,0.60272,0.045175,0.0091535,0,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.1028,0.045137,0.065512,0,1
1,GO RECOMBINATIONAL REPAIR,0.48131,0.044478,0.047326,0,1
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.23245,0.042254,0.051243,0,1
1,GO DNA CONFORMATION CHANGE,0.38408,0.041136,0.040981,0,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.72969,0.038643,0.041742,0,1
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.52025,0.038074,-0.0012138,0,1
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.38888,0.037345,0.025942,0,1
1,GO DNA REPLICATION,0.13355,0.032934,0.052199,0,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00019079,0.44657,0.48508,0,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.0030654,0.40084,0.57233,0,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00065623,0.3808,0.47279,0,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00065623,0.37077,0.36764,0,0
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00012512,0.35638,0.38539,0,0
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00014418,0.3428,0.46021,0,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0059384,0.33518,0.39457,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00029782,0.3239,0.30095,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0010206,0.31534,0.31495,0,0
1,GO HEPARIN METABOLIC PROCESS,0.0032441,0.29926,0.36888,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.014486,0.29138,0.3076,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.061812,0.27628,0.21871,0,0
1,GO MIDGUT DEVELOPMENT,0.035393,0.26564,0.2437,0,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.016734,0.26253,0.23149,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.064293,0.25216,0.31284,0,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.20937,0.24979,0.16608,0,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.1028,0.2492,0.16385,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.43883,0.24453,0.20795,0,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.057089,0.24318,0.15918,0,0
1,GO OXYGEN TRANSPORT,0.59664,0.23956,0.086522,0,0
1,GO UV PROTECTION,0.073629,0.23838,0.19308,0,0
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12259,0.23509,0.23784,0,0
1,GO LEFT RIGHT AXIS SPECIFICATION,0.0695,0.22955,0.24288,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.085627,0.22893,0.22052,0,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.26847,0.22619,0.19352,0,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.013139,0.22156,0.19935,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.21905,0.22048,0.082017,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.11039,0.21476,0.15522,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.011904,0.21096,0.35243,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.30402,0.2103,0.10118,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.019283,0.20772,0.26496,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.20621,0.20562,0.20303,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.05824,0.2038,0.15727,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.69061,0.20354,-0.0055454,0,0
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.009256,0.20168,0.16842,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.092194,0.19991,0.15857,0,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.063042,0.19424,0.12207,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.14048,0.19239,0.25909,0,0
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.075049,0.19145,0.25063,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.17934,0.19132,0.16355,0,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.10845,0.1911,0.1489,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.042857,0.19062,0.20585,0,0
1,GO REGULATION OF PROTON TRANSPORT,0.019739,0.18451,0.16485,0,0
1,GO REGULATION OF PLATELET ACTIVATION,0.077957,0.1795,0.13069,0,0
1,GO GAS TRANSPORT,0.20937,0.17923,0.16146,0,0
1,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.090515,0.17916,0.17478,0,0
1,GO TRNA CATABOLIC PROCESS,0.076492,0.17911,0.21913,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.0695,0.17798,0.14099,0,0
1,GO RESPONSE TO INTERLEUKIN 6,0.13583,0.17758,0.088768,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.33373,0.17727,0.11087,0,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.090515,0.17675,0.15758,0,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.33373,0.17648,0.08274,0,0
1,GO HEPATOCYTE DIFFERENTIATION,0.26098,0.17548,0.15475,0,0
1,GO MYOBLAST MIGRATION,0.077957,0.1749,0.24952,0,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00069957,0.17452,0.31239,0,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.077957,0.17286,0.10552,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.20621,0.17225,0.24893,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.065563,0.16932,0.1555,0,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.073629,0.16894,0.15653,0,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.075049,0.16876,0.1331,0,0
1,GO MICROVILLUS ASSEMBLY,0.26847,0.16733,0.1087,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.14769,0.1672,0.18624,0,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.0041716,0.16433,0.21881,0,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.068167,0.16396,0.13194,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.092194,0.15917,0.11636,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.088862,0.15898,0.1841,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.24643,0.15862,0.076678,0,0
1,GO REGULATION OF GTP BINDING,0.12259,0.15858,0.16147,0,0
1,GO NEUROBLAST DIVISION,0.19695,0.15779,0.19496,0,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.26471,0.15701,0.21888,0,0
1,GO AMP METABOLIC PROCESS,0.095625,0.15618,0.2216,0,0
1,GO PROTEIN ADP RIBOSYLATION,0.065563,0.15502,0.12628,0,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.066855,0.15368,0.10676,0,0
1,GO REGULATION OF T CELL MIGRATION,0.087232,0.15274,0.11183,0,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.16828,0.15205,0.088799,0,0
1,GO STEM CELL DIVISION,0.084046,0.15108,0.17001,0,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.31653,0.151,0.12156,0,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.12689,0.15067,0.082765,0,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.075049,0.15036,0.18929,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.061812,0.14889,0.17047,0,0
1,GO LIPID DIGESTION,0.27227,0.14786,0.049082,0,0
1,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.92682,0.14767,-0.014322,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.13814,0.14717,0.084886,0,0
1,GO REGULATION OF GONAD DEVELOPMENT,0.70355,0.14709,-0.0072114,0,0
1,GO DENDRITIC CELL MIGRATION,0.40843,0.1466,0.089538,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.39858,0.14571,0.086969,0,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.23245,0.1452,0.062835,0,0
1,GO REGULATION OF FATTY ACID OXIDATION,0.25363,0.14451,0.075036,0,0
1,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.20309,0.14369,0.11409,0,0
1,GO CORPUS CALLOSUM DEVELOPMENT,0.10465,0.14349,0.13253,0,0
1,GO HEART VALVE FORMATION,0.66501,0.14343,0.076057,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.24643,0.14269,0.094734,0,0
1,GO RESPONSE TO UV C,0.017549,0.14159,0.19112,0,0
1,GO LIVER MORPHOGENESIS,0.16559,0.1414,0.12836,0,0
1,GO EXTRACELLULAR TRANSPORT,0.188,0.14052,0.099282,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.29992,0.14025,0.06122,0,0
1,GO MYELIN MAINTENANCE,0.17653,0.13982,0.1213,0,0
1,GO MESENCHYME MORPHOGENESIS,0.0032441,0.13908,0.30352,0,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.068167,0.13789,0.10196,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.90599,0.13668,-0.0030229,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.17099,0.13651,0.15928,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.44924,0.13597,0.036541,0,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.24643,0.13591,0.042303,0,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.20621,0.13559,0.12664,0,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.1313,0.13495,0.069388,0,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.16828,0.13463,0.097051,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.29992,0.13289,0.081423,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.10654,0.13235,0.10818,0,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.51459,0.1323,0.061387,0,0
1,GO MANGANESE ION TRANSPORT,0.066855,0.132,0.1528,0,0
1,GO MINERALOCORTICOID METABOLIC PROCESS,0.21256,0.13182,0.19766,0,0
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.61497,0.13176,0.038952,0,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.11039,0.13152,0.089862,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.56075,0.12995,-0.012385,0,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.35153,0.12957,0.13862,0,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.31653,0.12912,0.060518,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.29992,0.12852,0.095607,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.40843,0.12808,0.11379,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.42855,0.12805,0.048854,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.24288,0.12767,0.082818,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.080955,0.1273,0.15667,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.40349,0.12702,0.041698,0,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.057089,0.12702,0.181,0,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.16294,0.12676,0.12724,0,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.55487,0.12665,0.10076,0,0
1,GO REGULATION OF SENSORY PERCEPTION,0.11636,0.12648,0.086323,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.047551,0.12551,0.14491,0,0
1,GO INTRACELLULAR STEROL TRANSPORT,0.21579,0.12487,0.10851,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.50337,0.12452,0.053258,0,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.090515,0.12443,0.096655,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.2,0.12409,0.15523,0,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.05824,0.12402,0.22491,0,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.56666,0.12393,0.083784,0,0
1,GO PIRNA METABOLIC PROCESS,0.23589,0.12242,0.15848,0,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.05824,0.12176,0.12152,0,0
1,GO PROTEIN KINASE C SIGNALING,0.28785,0.12144,0.049925,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.50896,0.12101,0.055224,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16294,0.12098,0.19018,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.29992,0.12093,0.10555,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.16032,0.12091,0.12074,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.36526,0.12082,0.064178,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.19393,0.12067,0.1292,0,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.13814,0.12016,0.049563,0,0
1,GO ADHESION OF SYMBIONT TO HOST,0.070855,0.12015,0.22893,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.76948,0.11964,-0.0088294,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.34702,0.11917,0.14999,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.3746,0.11907,0.039231,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.12259,0.11864,0.12592,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.19695,0.11782,0.13988,0,0
1,GO LYSINE METABOLIC PROCESS,0.15015,0.11698,0.15391,0,0
1,GO GOLGI LOCALIZATION,0.46512,0.11647,0.037685,0,0
1,GO REGULATION OF HAIR CYCLE,0.22568,0.11642,0.16823,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.25729,0.11586,0.16869,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.22905,0.11524,0.26604,0,0
1,GO COCHLEA MORPHOGENESIS,0.54903,0.11435,0.011362,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.22235,0.1142,0.058009,0,0
1,GO PEPTIDYL HISTIDINE MODIFICATION,0.065563,0.1141,0.1657,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.11636,0.1139,0.22433,0,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.4545,0.11386,0.03644,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.29992,0.11376,0.029412,0,0
1,GO PYRUVATE METABOLIC PROCESS,0.15517,0.11358,0.064171,0,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.26847,0.11342,0.082365,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.17099,0.11337,0.079145,0,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.1028,0.11306,0.082174,0,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.28785,0.11261,0.2921,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.064293,0.11225,0.20822,0,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.079444,0.11149,0.058275,0,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.095625,0.11112,0.092937,0,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.10096,0.11109,0.092675,0,0
1,GO REGULATION OF TISSUE REMODELING,0.10845,0.11089,0.067974,0,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.11235,0.10985,0.09228,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.63354,0.10974,0.083614,0,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.087232,0.1096,0.094184,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.12908,0.10919,0.12059,0,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.60272,0.10919,0.03262,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.35153,0.10889,0.073543,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15264,0.10835,0.092693,0,0
1,GO L PHENYLALANINE METABOLIC PROCESS,0.3746,0.10809,0.037697,0,0
1,GO RESPONSE TO MUSCLE STRETCH,0.58456,0.10801,0.096262,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.26471,0.10778,0.074414,0,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.063042,0.10777,0.10637,0,0
1,GO INTRACELLULAR LIPID TRANSPORT,0.063042,0.10765,0.12903,0,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.13355,0.10764,0.12969,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.20621,0.10752,0.1184,0,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.17934,0.10704,0.17857,0,0
1,GO REGULATION OF HISTONE DEACETYLATION,0.12908,0.10638,0.091202,0,0
1,GO OVULATION CYCLE PROCESS,0.22905,0.10602,0.072839,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.40349,0.1057,0.01829,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.22568,0.10522,0.07195,0,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.32938,0.10515,0.1223,0,0
1,GO NAD METABOLIC PROCESS,0.17934,0.1047,0.11278,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.16828,0.10463,0.059157,0,0
1,GO REGULATION OF CHLORIDE TRANSPORT,0.54321,0.10383,0.055805,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.46512,0.10377,0.13561,0,0
1,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.40843,0.10361,0.14011,0,0
1,GO RESPONSE TO ATP,0.021165,0.10339,0.10377,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.25363,0.10312,0.050288,0,0
1,GO CARNITINE SHUTTLE,0.088862,0.10222,0.13629,0,0
1,GO INOSITOL METABOLIC PROCESS,0.32938,0.10174,0.052231,0,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.11235,0.10147,0.19395,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.32506,0.1012,0.096503,0,0
1,GO GLIAL CELL DEVELOPMENT,0.19095,0.10116,0.048737,0,0
1,GO LYTIC VACUOLE ORGANIZATION,0.21256,0.10115,0.041098,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.32506,0.10111,0.080235,0,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.33373,0.10069,0.038125,0,0
1,GO LEFT RIGHT PATTERN FORMATION,0.14048,0.10057,0.15163,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.40349,0.10016,0.041657,0,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.046579,0.099836,0.14041,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.35607,0.099449,0.07044,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0695,0.099125,0.19374,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.44924,0.097877,0.049624,0,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.78289,0.097818,0.043535,0,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.012203,0.097529,0.15793,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.15015,0.097103,0.11877,0,0
1,GO STEROL METABOLIC PROCESS,0.18219,0.097022,0.035726,0,0
1,GO RESPONSE TO AMYLOID BETA,0.061812,0.095805,0.18055,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.080955,0.095356,0.080615,0,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.099158,0.095028,0.064236,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.27227,0.094963,0.11673,0,0
1,GO TUMOR NECROSIS FACTOR SECRETION,0.22235,0.094639,0.11711,0,0
1,GO B CELL APOPTOTIC PROCESS,0.54903,0.093761,0.021358,0,0
1,GO RESPONSE TO VITAMIN,0.082489,0.093502,0.1481,0,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.35607,0.093484,0.045313,0,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.10465,0.093473,0.052043,0,0
1,GO ERYTHROCYTE MATURATION,0.079444,0.093218,0.15604,0,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.47588,0.093159,0.070614,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.37932,0.092743,0.060216,0,0
1,GO MITOTIC DNA REPLICATION CHECKPOINT,0.15773,0.092227,0.08648,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.4545,0.092194,0.054966,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.20621,0.091914,0.11009,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.26098,0.09183,0.038251,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.19095,0.091655,0.075665,0,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.11235,0.091513,0.10768,0,0
1,GO MUSCLE FIBER DEVELOPMENT,0.17934,0.091383,0.055078,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.62732,0.091265,0.052572,0,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.22905,0.091168,0.093017,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.12473,0.091034,0.055683,0,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.30402,0.090656,0.050346,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0695,0.090336,0.13925,0,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.22568,0.090074,0.10959,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.063042,0.090062,0.14228,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.079444,0.090014,0.12171,0,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.11841,0.089624,0.27458,0,0
1,GO RESPONSE TO IRON ION,0.1313,0.089142,0.080458,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.43883,0.089069,0.029924,0,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.092194,0.088455,0.071833,0,0
1,GO RNA STABILIZATION,0.082489,0.088289,0.089638,0,0
1,GO OOCYTE MATURATION,0.28785,0.088046,0.043114,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.060602,0.08795,0.15695,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.14285,0.087887,0.098153,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.4598,0.087698,0.014549,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.81668,0.087647,0.035025,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.67137,0.087562,0.032072,0,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.077957,0.087435,0.1164,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.5726,0.087336,0.043311,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.085627,0.087195,0.080802,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.4545,0.086978,0.048519,0,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.15015,0.086947,0.064393,0,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.21256,0.086524,0.13186,0,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.29992,0.086393,0.10574,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.48678,0.086149,0.045766,0,0
1,GO STEM CELL PROLIFERATION,0.51459,0.085335,0.011101,0,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.56075,0.085216,0.059834,0,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.41842,0.084528,0.065976,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,0.21579,0.084435,0.048922,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.73628,0.084386,0.035248,0,0
1,GO IMP METABOLIC PROCESS,0.20309,0.083899,0.18821,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.17653,0.083799,0.10775,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.25363,0.083694,0.071184,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.11841,0.083581,0.083122,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.40843,0.082734,0.059478,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.3746,0.082681,0.064785,0,0
1,GO B CELL PROLIFERATION,0.63978,0.082598,0.0089042,0,0
1,GO REGULATION OF RUFFLE ASSEMBLY,0.26847,0.082247,0.056436,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.20937,0.082075,0.14072,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.23937,0.081959,0.037269,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.12473,0.081955,0.097859,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.79636,0.081862,0.024609,0,0
1,GO SEQUESTERING OF CALCIUM ION,0.0695,0.08151,0.084882,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.52025,0.0812,0.064994,0,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.16294,0.081199,0.10016,0,0
1,GO RESPONSE TO COPPER ION,0.39371,0.081006,0.085446,0,0
1,GO RESPONSE TO WATER,0.49227,0.080941,0.085625,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.16032,0.080811,0.087124,0,0
1,GO CENTROSOME DUPLICATION,0.26847,0.080706,0.053602,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.39371,0.080675,0.032345,0,0
1,GO STEROID METABOLIC PROCESS,0.13355,0.080366,0.037702,0,0
1,GO FATTY ACID TRANSPORT,0.10654,0.080255,0.059611,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.31232,0.079948,0.066678,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.35153,0.079901,0.06039,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.42347,0.079836,0.05005,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.40349,0.079801,0.03219,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.11039,0.07979,0.077525,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.83713,0.079714,-0.10542,0,0
1,GO LACTATE METABOLIC PROCESS,0.26098,0.079638,0.068918,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.23245,0.079595,0.08073,0,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.36526,0.079467,0.081924,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.099158,0.079139,0.084821,0,0
1,GO RESPONSE TO BMP,0.087232,0.07895,0.10828,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.17099,0.078466,0.097691,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.8303,0.078313,-0.0070772,0,0
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.14285,0.078291,0.095358,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.8303,0.078073,-0.0045399,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.19095,0.077882,0.096981,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.98255,0.077465,-0.037101,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.14769,0.077431,0.067339,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.43367,0.077208,0.07622,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.4978,0.077045,0.042733,0,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.072231,0.076946,0.11722,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.33373,0.076827,0.031614,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.11039,0.076803,0.12885,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.52025,0.076624,0.022213,0,0
1,GO MALE SEX DIFFERENTIATION,0.25001,0.076574,0.067975,0,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.079444,0.076531,0.057242,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.38408,0.076511,0.054051,0,0
1,GO SULFATION,0.25363,0.076201,0.13664,0,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.13814,0.076138,0.075613,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.23245,0.076027,0.075274,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.4545,0.076024,0.18113,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.25001,0.075809,0.12966,0,0
1,GO RESPONSE TO MUSCLE INACTIVITY,0.13583,0.075588,0.14312,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.38888,0.07555,0.11008,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.59664,0.075548,0.014989,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.29586,0.075541,0.060076,0,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.17374,0.07532,0.080383,0,0
1,GO RESPONSE TO UV B,0.25001,0.075283,0.13822,0,0
1,GO NEURON PROJECTION REGENERATION,0.27611,0.075272,0.056957,0,0
1,GO MAINTENANCE OF CELL NUMBER,0.17374,0.075258,0.09713,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.32938,0.075218,0.094291,0,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.15517,0.075194,0.106,0,0
1,GO BLASTODERM SEGMENTATION,0.2,0.074614,0.18134,0,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.34702,0.074333,0.022137,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.65866,0.074193,0.036886,0,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.14769,0.074001,0.067773,0,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.38888,0.073401,0.062909,0,0
1,GO PROTEIN SUMOYLATION,0.093897,0.0731,0.070712,0,0
1,GO RECEPTOR INTERNALIZATION,0.059411,0.072695,0.082769,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.22568,0.072555,0.050026,0,0
1,GO RESPIRATORY BURST,0.54321,0.072495,0.021371,0,0
1,GO KETONE CATABOLIC PROCESS,0.52025,0.072333,0.10867,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.27227,0.072232,0.057003,0,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.2839,0.072214,0.1214,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.66501,0.072031,0.034868,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.47049,0.071956,0.07738,0,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.29586,0.071716,0.077305,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.15517,0.071422,0.067833,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.049546,0.071161,0.13307,0,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.18219,0.071149,0.10391,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.4978,0.071064,0.018704,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.10465,0.070707,0.13286,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.83713,0.070555,0.065928,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.25001,0.070513,0.12136,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.32506,0.070378,0.045585,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.18508,0.07032,0.098441,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.34256,0.069895,0.013918,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.15264,0.0698,0.080001,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.49227,0.069735,0.037069,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.57857,0.069384,0.053335,0,0
1,GO CELLULAR ION HOMEOSTASIS,0.10845,0.069289,0.045481,0,0
1,GO AMINO ACID IMPORT,0.4978,0.069211,0.092712,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.33812,0.069168,0.028534,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.079444,0.069039,0.13149,0,0
1,GO TAXIS,0.23245,0.06896,0.038442,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.11235,0.068915,0.16265,0,0
1,GO NEGATIVE CHEMOTAXIS,0.088862,0.068751,0.16457,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.15015,0.068668,0.089587,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.31653,0.068503,0.039961,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.21905,0.068451,0.096423,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.18508,0.068211,0.039988,0,0
1,GO RUFFLE ASSEMBLY,0.12473,0.068166,0.08178,0,0
1,GO CHOLESTEROL STORAGE,0.18508,0.067769,0.14357,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.11636,0.067423,0.051112,0,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.23589,0.067345,0.099048,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.31232,0.067239,0.061028,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.36526,0.066711,0.048392,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.52025,0.066645,0.072396,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.40349,0.06641,0.018665,0,0
1,GO DIOL METABOLIC PROCESS,0.4545,0.066356,0.031391,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.34702,0.066338,0.049893,0,0
1,GO NADH METABOLIC PROCESS,0.20309,0.066191,0.095729,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.12689,0.066185,0.087015,0,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.22568,0.06614,0.1502,0,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.13814,0.066134,0.055366,0,0
1,GO ACTIN FILAMENT ORGANIZATION,0.10654,0.065829,0.079107,0,0
1,GO NUCLEOTIDE TRANSPORT,0.40349,0.065817,0.020325,0,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.075049,0.065695,0.066043,0,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.8303,0.065672,0.018032,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.39858,0.065299,0.030571,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.81668,0.065117,0.05265,0,0
1,GO RESPONSE TO ESTRADIOL,0.084046,0.065103,0.096916,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.22905,0.064784,0.084844,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.53167,0.064772,0.05594,0,0
1,GO VITAMIN TRANSPORT,0.35153,0.064652,0.0513,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.16032,0.064621,0.10545,0,0
1,GO ENSHEATHMENT OF NEURONS,0.11434,0.064603,0.060257,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.29586,0.064383,0.073934,0,0
1,GO PROTEIN AUTOPHOSPHORYLATION,0.10845,0.063779,0.065475,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.014486,0.063483,0.19215,0,0
1,GO RESPONSE TO CAMP,0.080955,0.063429,0.12597,0,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.077957,0.063351,0.040766,0,0
1,GO HOMEOSTATIC PROCESS,0.10465,0.062829,0.034016,0,0
1,GO TISSUE HOMEOSTASIS,0.093897,0.062816,0.061123,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.17653,0.062748,0.097543,0,0
1,GO CELL PROJECTION ASSEMBLY,0.18219,0.062635,0.051186,0,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.18508,0.062181,0.057661,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.44924,0.062151,0.022368,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.19695,0.062121,0.099585,0,0
1,GO GOLGI RIBBON FORMATION,0.4598,0.062114,0.085967,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.5726,0.062038,0.091759,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.60272,0.061868,0.07907,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.35153,0.061701,0.037186,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.47588,0.061298,0.056106,0,0
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.070855,0.061222,0.07239,0,0
1,GO EPITHELIUM DEVELOPMENT,0.085627,0.060936,0.081422,0,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.007729,0.060909,0.1275,0,0
1,GO MUSCLE SYSTEM PROCESS,0.19695,0.060645,0.05144,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.32077,0.060584,0.12824,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.14526,0.060474,0.19562,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.092194,0.060463,0.16485,0,0
1,GO CALCINEURIN MEDIATED SIGNALING,0.21579,0.060444,0.066981,0,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.5726,0.06035,0.025762,0,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.057089,0.06006,0.070313,0,0
1,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.94073,0.059943,0.030611,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.46512,0.059861,0.030407,0,0
1,GO MEMBRANE FUSION,0.31653,0.059833,0.031151,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.70355,0.059643,0.040359,0,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.14526,0.059543,0.075951,0,0
1,GO PANCREATIC JUICE SECRETION,0.72313,0.05948,0.039394,0,0
1,GO CELL CELL ADHESION,0.22905,0.059292,0.051552,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.29184,0.05929,0.11467,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.4545,0.059125,0.047574,0,0
1,GO REGULATION OF CELL SIZE,0.23937,0.059036,0.03351,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.43883,0.058957,0.032558,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.14048,0.058788,0.038471,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.51459,0.058786,0.023884,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.70355,0.058707,0.019551,0,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.16294,0.058516,0.074805,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.11434,0.058469,0.048716,0,0
1,GO INCLUSION BODY ASSEMBLY,0.92682,0.058464,-0.042246,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.33373,0.058376,0.036211,0,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.090515,0.058204,0.05691,0,0
1,GO NEPHRON DEVELOPMENT,0.072231,0.058185,0.14623,0,0
1,GO NEPHRON TUBULE FORMATION,0.23245,0.057821,0.12818,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.17099,0.057408,0.072689,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.25363,0.057302,0.028094,0,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.17934,0.057254,0.079338,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.26098,0.05711,0.16945,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.34256,0.057029,0.041942,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.073629,0.056916,0.13325,0,0
1,GO CYTOKINE SECRETION,0.44924,0.056803,0.049403,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.26847,0.056009,0.058916,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.088862,0.055917,0.062911,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.35607,0.05568,0.069116,0,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.076492,0.0556,0.15043,0,0
1,GO BONE RESORPTION,0.0695,0.055497,0.097856,0,0
1,GO AMMONIUM TRANSPORT,0.075049,0.055347,0.15286,0,0
1,GO TRANSCYTOSIS,0.20309,0.055251,0.10446,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.41341,0.055073,0.078582,0,0
1,GO CELLULAR HOMEOSTASIS,0.082489,0.055036,0.04658,0,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.19393,0.055,0.055469,0,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.25729,0.054999,0.1023,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.54321,0.054994,0.048884,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.66501,0.054851,0.0015478,0,0
1,GO ION HOMEOSTASIS,0.18508,0.054803,0.036744,0,0
1,GO BIOMINERALIZATION,0.065563,0.054662,0.14125,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.05824,0.054589,0.056425,0,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.27611,0.054578,0.024836,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.21579,0.054531,0.050534,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.99651,0.054505,-0.022039,0,0
1,GO ARTERY MORPHOGENESIS,0.32077,0.054315,0.18312,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.11039,0.054178,0.051417,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.57857,0.054103,0.077347,0,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.55487,0.05398,0.020692,0,0
1,GO RESPONSE TO ACIDIC PH,0.29586,0.0539,0.089002,0,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.27227,0.053109,0.047921,0,0
1,GO MICROTUBULE ANCHORING,0.33812,0.053065,0.044721,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.22568,0.052901,0.070799,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.068167,0.052887,0.059528,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.40349,0.052883,0.047754,0,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.060602,0.052815,0.1292,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.12473,0.052215,0.061475,0,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.17653,0.052113,0.10665,0,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.21905,0.052079,0.080233,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.26847,0.051288,0.059017,0,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.14048,0.051219,0.06226,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.22235,0.051116,0.054363,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.10845,0.051115,0.059581,0,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.2,0.051076,0.044251,0,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.12689,0.05103,0.050526,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.8303,0.05094,0.00031261,0,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.088862,0.050509,0.058303,0,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.47588,0.050414,0.087098,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.85082,0.049971,-0.025855,0,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.35607,0.049963,0.082686,0,0
1,GO PROTEIN DESTABILIZATION,0.44402,0.04981,0.025839,0,0
1,GO HISTONE H3 K27 METHYLATION,0.56075,0.049807,0.030621,0,0
1,GO JNK CASCADE,0.070855,0.049803,0.055413,0,0
1,GO APPENDAGE DEVELOPMENT,0.33812,0.049546,0.070219,0,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.29586,0.049376,0.031138,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.32938,0.049088,0.061688,0,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.064293,0.048978,0.097548,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.42347,0.048794,0.060063,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.9686,0.048757,-0.036671,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.068167,0.048684,0.082257,0,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.092194,0.048493,0.064057,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.4978,0.048417,0.046349,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.91293,0.048383,0.0041499,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.39858,0.048339,0.051533,0,0
1,GO METAL ION HOMEOSTASIS,0.1313,0.048226,0.043729,0,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.11841,0.047968,0.034469,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.54903,0.047909,0.019642,0,0
1,GO RESPONSE TO GROWTH HORMONE,0.29184,0.047564,0.086407,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.98953,0.047498,-0.032463,0,0
1,GO INTERLEUKIN 6 PRODUCTION,0.22235,0.047199,0.086118,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.9686,0.047057,-0.0066608,0,0
1,GO SKIN DEVELOPMENT,0.27611,0.047054,0.1266,0,0
1,GO MRNA PROCESSING,0.24643,0.047,0.044769,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.075049,0.046846,0.18032,0,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.099158,0.046568,0.059426,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.17653,0.046535,0.052488,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.66501,0.046496,0.003916,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.38408,0.04648,0.039842,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.14526,0.046147,0.10604,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.25001,0.046115,0.066336,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.92682,0.045993,-0.013209,0,0
1,GO PRO B CELL DIFFERENTIATION,0.98255,0.045908,0.051957,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.48678,0.045846,0.045397,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.54321,0.045615,0.033795,0,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.71006,0.045492,0.018999,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.80312,0.045369,-0.052893,0,0
1,GO GROWTH,0.095625,0.045223,0.054926,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.56075,0.044999,0.02806,0,0
1,GO ORGANELLE ASSEMBLY,0.0079323,0.044611,0.066039,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.68418,0.044512,0.035779,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.25363,0.044339,0.028945,0,0
1,GO EMBRYO DEVELOPMENT,0.065563,0.043884,0.070105,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.59059,0.043797,0.0074132,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.32077,0.04379,0.045679,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.47049,0.043754,0.068255,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.32077,0.043531,0.052586,0,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.26847,0.043266,0.047714,0,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.38408,0.04326,0.03406,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.32077,0.043256,0.017842,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.41842,0.043041,0.086615,0,0
1,GO REGULATION OF GROWTH,0.11235,0.042678,0.047409,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.44924,0.042468,0.025226,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.97557,0.042384,-0.012269,0,0
1,GO RESPONSE TO TOXIC SUBSTANCE,0.48678,0.042183,0.024964,0,0
1,GO METHIONINE METABOLIC PROCESS,0.70355,0.042082,-0.019495,0,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.2839,0.042066,0.018463,0,0
1,GO RESPONSE TO ALCOHOL,0.47049,0.042002,0.028232,0,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.12908,0.041559,0.077696,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.43367,0.041551,0.010499,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.75615,0.041251,0.045325,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.53742,0.041054,0.026295,0,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.099158,0.040681,0.10492,0,0
1,GO PROTEIN TRIMERIZATION,0.62732,0.040629,0.050821,0,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.77618,0.040465,0.073182,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.34702,0.040354,0.10398,0,0
1,GO REGULATION OF GTPASE ACTIVITY,0.17099,0.040283,0.049729,0,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.55487,0.040038,0.018325,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.94769,0.039926,-0.00112,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.88523,0.039896,0.027284,0,0
1,GO RESPONSE TO ZINC ION,0.63354,0.03988,0.028807,0,0
1,GO MICROTUBULE NUCLEATION,0.36064,0.039848,0.053801,0,0
1,GO MRNA METHYLATION,0.50896,0.039841,0.053989,0,0
1,GO MITOCHONDRIAL FISSION,0.31653,0.039614,0.04677,0,0
1,GO RNA SPLICING,0.18219,0.039613,0.044479,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.79636,0.039598,-0.00047171,0,0
1,GO MIDBRAIN DEVELOPMENT,0.23589,0.039485,0.071921,0,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.41842,0.039242,0.082822,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.33373,0.0392,0.10489,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.10465,0.039092,0.13514,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.26847,0.039004,0.047965,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.72313,0.038999,0.063417,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.56666,0.038977,-0.043841,0,0
1,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.60883,0.038865,0.095034,0,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.65866,0.0388,0.015657,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.39858,0.038523,0.043817,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.67776,0.037951,-0.046386,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.94769,0.037924,0.015094,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.67137,0.037844,0.061106,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.59059,0.037783,0.041022,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.21579,0.037183,0.035413,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.9686,0.037055,0.019646,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.48678,0.037054,0.04506,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.48131,0.036966,0.027743,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.72313,0.036822,0.002507,0,0
1,GO ENDOSOMAL TRANSPORT,0.10654,0.036785,0.057604,0,0
1,GO ERYTHROCYTE DEVELOPMENT,0.25001,0.036614,0.078055,0,0
1,GO PROTEIN POLYMERIZATION,0.20937,0.036515,0.038404,0,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.24288,0.036487,0.03292,0,0
1,GO CERAMIDE METABOLIC PROCESS,0.29992,0.036385,0.008518,0,0
1,GO REGULATION OF B CELL PROLIFERATION,0.75615,0.036169,-0.0085888,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.72969,0.036134,0.020272,0,0
1,GO LOCOMOTOR RHYTHM,0.80989,0.036037,0.032337,0,0
1,GO HISTONE H3 ACETYLATION,0.41341,0.035782,0.031008,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.23245,0.035723,0.092212,0,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.67137,0.035562,0.043533,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.36526,0.035552,0.029641,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.46512,0.035487,0.0039001,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.42855,0.035388,0.057214,0,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.19695,0.035019,0.04465,0,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.26847,0.03497,0.028593,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.85082,0.03485,-0.017118,0,0
1,GO ONE CARBON COMPOUND TRANSPORT,0.54321,0.034774,0.08125,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.32938,0.034721,0.037417,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.68418,0.034685,-0.0060057,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.7495,0.034492,0.010329,0,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.25729,0.034261,0.11267,0,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.20937,0.03415,0.036192,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.35153,0.03407,0.050242,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.21905,0.033958,0.031688,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.52025,0.033559,0.063437,0,0
1,GO SPECIFICATION OF SYMMETRY,0.14526,0.033546,0.057825,0,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.25729,0.033433,0.038323,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.63354,0.033408,0.029261,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.21905,0.03321,0.050776,0,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.21905,0.033088,0.086087,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.94769,0.033073,-0.024108,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.51459,0.032865,0.047868,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.94769,0.032646,0.013024,0,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16294,0.032605,0.058073,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.71658,0.032526,0.025042,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.15773,0.03234,0.031136,0,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.53742,0.03221,0.034325,0,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.50896,0.032148,0.063976,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.53167,0.03173,0.12637,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.29992,0.031086,0.03566,0,0
1,GO PHOSPHATE ION TRANSPORT,0.94769,0.030929,0.0057611,0,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.51459,0.030895,0.0047151,0,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.77618,0.030814,0.0049586,0,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.22235,0.030803,0.055859,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.56075,0.030727,0.019229,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.84397,0.030713,-0.0013921,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.36064,0.030688,0.028432,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.85082,0.030653,0.023896,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.92682,0.030506,-0.0237,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.62113,0.030501,-0.038528,0,0
1,GO MUSCLE CONTRACTION,0.31232,0.030212,0.044545,0,0
1,GO RETINA HOMEOSTASIS,0.69061,0.030009,0.040449,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.13583,0.029968,0.098098,0,0
1,GO PROSTAGLANDIN SECRETION,0.20309,0.029937,0.096352,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.32938,0.029743,0.052059,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.97557,0.029486,-0.018988,0,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.4978,0.029399,0.046809,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.84397,0.029383,-0.010967,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.34702,0.029192,0.080672,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.17099,0.029191,0.13671,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.48131,0.029166,0.024113,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.89215,0.029123,0.02185,0,0
1,GO SINGLE FERTILIZATION,0.49227,0.029053,0.020016,0,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.82348,0.028968,0.011766,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,0.42855,0.028793,0.027457,0,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.18219,0.028494,0.046244,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.11636,0.028455,0.065334,0,0
1,GO THYROID GLAND DEVELOPMENT,0.9686,0.028396,-0.0091341,0,0
1,GO SECONDARY METABOLIC PROCESS,0.42855,0.028233,0.063218,0,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.24643,0.028118,0.042911,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.67137,0.028081,0.033478,0,0
1,GO DNA METHYLATION,0.79636,0.027913,0.002889,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.87144,0.027909,0.039433,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.42347,0.027669,0.041962,0,0
1,GO ESTROUS CYCLE,0.50337,0.027641,0.070549,0,0
1,GO MRNA MODIFICATION,0.5726,0.027591,0.051628,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.43367,0.027292,0.027073,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.24288,0.027286,0.048593,0,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.98255,0.027115,-0.0061949,0,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.23245,0.026993,0.05407,0,0
1,GO PHOSPHOLIPID TRANSPORT,0.60883,0.026986,0.007109,0,0
1,GO MUSCLE CELL DIFFERENTIATION,0.11039,0.026973,0.086602,0,0
1,GO MUSCLE ATROPHY,0.68418,0.026889,0.057823,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.54321,0.026834,0.067389,0,0
1,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.78289,0.026739,0.015383,0,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.50896,0.026671,0.043759,0,0
1,GO ICOSANOID METABOLIC PROCESS,0.25729,0.026669,0.070497,0,0
1,GO PIGMENT CELL DIFFERENTIATION,0.70355,0.026561,0.044592,0,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.27227,0.026336,0.072834,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.47049,0.026299,0.071542,0,0
1,GO MUSCLE CELL DEVELOPMENT,0.39371,0.026251,0.063216,0,0
1,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.56666,0.026094,0.064362,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.67137,0.026086,0.0025581,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.14048,0.026057,0.055319,0,0
1,GO SISTER CHROMATID SEGREGATION,0.34256,0.025995,0.045972,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.54321,0.025992,0.042632,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.87144,0.025909,-0.01485,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.47049,0.025704,0.036548,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.67137,0.025665,0.03054,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.50337,0.025638,0.043857,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.51459,0.025521,0.034521,0,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.59664,0.025494,0.037213,0,0
1,GO OSTEOBLAST PROLIFERATION,0.27999,0.025463,0.13897,0,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.18508,0.025185,0.16049,0,0
1,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.44924,0.02478,0.091054,0,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.12908,0.024546,0.070017,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.16032,0.024521,0.0347,0,0
1,GO APPENDAGE MORPHOGENESIS,0.59059,0.024411,0.040027,0,0
1,GO GLUCOSE IMPORT,0.77618,0.024316,0.0044689,0,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.69707,0.024289,0.044137,0,0
1,GO TEMPERATURE HOMEOSTASIS,0.68418,0.024265,0.012929,0,0
1,GO RESPONSE TO ACTIVITY,0.63354,0.024097,0.011429,0,0
1,GO QUINONE METABOLIC PROCESS,0.44402,0.024087,0.052219,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.76281,0.023973,0.0052292,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.36991,0.023827,-0.062711,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.66501,0.023612,0.032232,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.97557,0.023596,0.016205,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.95466,0.023568,0.017864,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.48678,0.023449,-0.057772,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.72313,0.023215,-0.014819,0,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.4545,0.023156,0.059532,0,0
1,GO B CELL DIFFERENTIATION,0.12049,0.022996,0.081668,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.71658,0.022558,0.011868,0,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.40349,0.022432,0.0013372,0,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.24643,0.022398,0.062535,0,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.93377,0.022252,-0.0048352,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.9686,0.02218,0.026876,0,0
1,GO DRUG CATABOLIC PROCESS,0.52594,0.02181,0.026801,0,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.84397,0.021805,-0.04598,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.80312,0.021674,-0.028188,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.20937,0.021547,0.091639,0,0
1,GO DNA REPLICATION CHECKPOINT,0.72969,0.021498,0.018642,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.63978,0.021329,0.024712,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.56075,0.021115,0.095686,0,0
1,GO AUTOPHAGIC CELL DEATH,0.4978,0.021031,0.078329,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.91987,0.020979,0.011838,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.60272,0.020908,0.02744,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.63354,0.020706,0.034423,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.41341,0.020524,0.029424,0,0
1,GO RESPONSE TO LEAD ION,0.30402,0.020473,0.077328,0,0
1,GO GLAND DEVELOPMENT,0.20937,0.020279,0.063067,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.62732,0.020045,0.047548,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.4978,0.020039,0.021872,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.65234,0.01988,0.016642,0,0
1,GO FUCOSE METABOLIC PROCESS,0.82348,0.019839,-0.0087712,0,0
1,GO SEXUAL REPRODUCTION,0.47049,0.019806,0.01523,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.64605,0.019774,0.034644,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.87144,0.01895,0.017443,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.96163,0.01884,0.0010446,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.80312,0.018377,0.016078,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.87144,0.01833,-0.014707,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.65234,0.01798,-0.057669,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.63978,0.017933,-0.024299,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.55487,0.017855,0.026044,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.27611,0.01762,0.099651,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.69707,0.017549,0.039095,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.74288,0.017512,-0.0059652,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.67776,0.017366,0.055923,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.25729,0.017127,0.067781,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.17099,0.017122,0.047461,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.95466,0.016968,-0.025477,0,0
1,GO PROSTAGLANDIN TRANSPORT,0.72969,0.016917,-0.041416,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.9686,0.016864,-0.011658,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.56666,0.016751,0.012132,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.87144,0.016669,0.042527,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.26847,0.016498,0.083072,0,0
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.69707,0.016278,-0.073643,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.89907,0.015978,0.018638,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.65866,0.015828,0.12139,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.32938,0.01538,0.063176,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.87144,0.015333,-0.050946,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.71658,0.015298,-0.03555,0,0
1,GO ACTIN NUCLEATION,0.99651,0.015165,-0.03037,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.26847,0.015127,0.075362,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.65866,0.014732,0.040651,0,0
1,GO PHOTOPERIODISM,0.98255,0.014614,-0.017117,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.93377,0.014569,0.017334,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.94073,0.014371,0.018608,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.72313,0.014292,0.020574,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.58456,0.01424,0.015304,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.3746,0.014209,0.088813,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.29184,0.014097,0.044873,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.69707,0.01409,0.0024343,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.30402,0.014047,0.076663,0,0
1,GO GLYCOSYLATION,0.98953,0.013578,-0.035192,0,0
1,GO BONE MATURATION,0.62732,0.013274,-0.00048586,0,0
1,GO EPIDERMIS DEVELOPMENT,0.67137,0.013151,0.081349,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.86455,0.013063,0.0090635,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.89215,0.013025,0.0269,0,0
1,GO ENDOCYTIC RECYCLING,0.34702,0.012798,0.038255,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.86455,0.012742,-0.008032,0,0
1,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.72313,0.012742,0.023101,0,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.41842,0.012336,0.036997,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.68418,0.012216,-0.0039007,0,0
1,GO REGULATION OF BLOOD PRESSURE,0.80989,0.012151,0.022339,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.7495,0.011855,0.038286,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.87833,0.011755,-0.00093614,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.54903,0.011485,0.018662,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.5726,0.011242,0.022298,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.76948,0.011217,-0.043937,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.78962,0.011175,0.017189,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.36526,0.011008,0.026413,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.63354,0.010834,0.019728,0,0
1,GO CHEMICAL HOMEOSTASIS,0.91293,0.010753,-0.0046869,0,0
1,GO REGULATION OF AXON GUIDANCE,0.88523,0.010747,-0.0017526,0,0
1,GO STRIATED MUSCLE ADAPTATION,0.82348,0.010629,-0.0006052,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.75615,0.010615,0.033859,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.42347,0.010583,0.074711,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.21256,0.010535,0.077667,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.79636,0.010494,-0.0045202,0,0
1,GO POSITIVE REGULATION OF WOUND HEALING,0.19095,0.010349,0.15732,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.63978,0.01034,0.020192,0,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.57857,0.010126,0.040206,0,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.88523,0.010101,-0.022333,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.84397,0.010018,-0.016458,0,0
1,GO MEIOTIC CELL CYCLE,0.67137,0.0098627,0.030904,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.43883,0.0094518,0.042136,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.83713,0.0093284,0.032557,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.88523,0.0093235,0.052737,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.31232,0.0089747,0.068486,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.53167,0.0088195,0.046216,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.87833,0.0087746,0.015708,0,0
1,GO HISTONE H2A ACETYLATION,0.97557,0.0087376,-5.7908e-05,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.5726,0.0086995,0.031191,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.37932,0.0086265,0.10933,0,0
1,GO ORGAN INDUCTION,0.38888,0.0084935,0.072143,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.47588,0.0084504,0.054788,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.77618,0.0083381,0.031444,0,0
1,GO ZINC ION HOMEOSTASIS,0.9686,0.0082495,-0.013564,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.76281,0.0082186,0.021722,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.62732,0.0081392,0.1127,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.92682,0.0080999,-0.010409,0,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.19393,0.0080051,0.07778,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.9686,0.0079761,-0.007411,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.82348,0.0079322,0.0078949,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.90599,0.0075917,0.021219,0,0
1,GO REGULATION OF CELLULAR PH,0.7495,0.0072173,-0.00074996,0,0
1,GO ADAPTIVE THERMOGENESIS,0.76948,0.0071635,0.012138,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.44924,0.0071624,0.041268,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,1,0.0069352,-0.0012087,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.76281,0.006897,0.016856,0,0
1,GO ARACHIDONIC ACID SECRETION,0.37932,0.0068792,-0.10951,0,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.68418,0.0068765,0.016013,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.62732,0.0067251,0.028581,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.88523,0.0064278,0.031091,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.82348,0.0063894,0.060252,0,0
1,GO CARBOHYDRATE TRANSPORT,0.62732,0.0062451,0.0019552,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.52025,0.0061204,-0.025308,0,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.91293,0.0058778,0.014158,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.72969,0.0057878,0.0091933,0,0
1,GO MICROTUBULE SEVERING,0.47588,0.0057291,-0.046514,0,0
1,GO STRESS GRANULE ASSEMBLY,0.56666,0.0056795,-0.031833,0,0
1,GO VASODILATION,0.7495,0.0056344,-0.062696,0,0
1,GO CELL RECOGNITION,0.90599,0.0055472,-0.010308,0,0
1,GO ZINC ION TRANSPORT,0.52594,0.0053888,0.041273,0,0
1,GO DEPHOSPHORYLATION,0.53167,0.0053724,-0.023432,0,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.91987,0.0052955,0.0057979,0,0
1,GO CELL GROWTH,0.69061,0.005276,0.022295,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.75615,0.0051197,0.015785,0,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.69707,0.0049806,-0.045266,0,0
1,GO ESTROGEN BIOSYNTHETIC PROCESS,0.55487,0.0048039,0.078177,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.78289,0.0046735,-0.0072192,0,0
1,GO LYMPH NODE DEVELOPMENT,0.69707,0.0045066,0.087621,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.62113,0.0044527,0.038925,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.78962,0.0044289,0.016802,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.95466,0.0041688,-0.0014232,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.80312,0.0041372,0.014973,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.80312,0.00371,0.034984,0,0
1,GO RESPONSE TO AXON INJURY,0.89215,0.0035183,-0.0064923,0,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.98255,0.0032863,-0.0076068,0,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.56666,0.0032315,-0.037784,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.34256,0.0028349,-0.10178,0,0
1,GO ADULT HEART DEVELOPMENT,0.80989,0.0028305,-0.045466,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.72969,0.0027542,-0.046168,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.92682,0.0027275,-0.0034792,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.7495,0.0023355,0.018217,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.98255,0.0021805,-0.022444,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.54321,0.0019989,-0.084078,0,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.99651,0.0019248,-0.022669,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.53167,0.0018253,0.0082078,0,0
1,GO BONE CELL DEVELOPMENT,0.65866,0.0015974,0.033761,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.47588,0.0014784,-0.0074061,0,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.59664,0.0013746,0.029297,0,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.94073,0.0013543,0.063092,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.8303,0.0012256,0.012845,0,0
1,GO MYELIN ASSEMBLY,0.78962,0.0008571,0.033023,0,0
1,GO EYE MORPHOGENESIS,0.91987,0.00071635,-0.0049472,0,0
1,GO MYELOID CELL DEVELOPMENT,0.44402,0.00042426,0.04944,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.71658,8.629e-05,0.061358,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.63354,-0.00014662,0.045546,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.72969,-0.00032005,-0.021766,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.72969,-0.00032378,-0.0033755,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.78962,-0.00035819,0.02935,0,0
1,GO REGULATION OF PH,0.87144,-0.00093359,-0.0018085,0,0
1,GO PRE MIRNA PROCESSING,0.79636,-0.0011086,0.016213,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.98953,-0.001125,0.039099,0,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.69707,-0.0013098,0.031358,0,0
1,GO P BODY ASSEMBLY,0.88523,-0.0014077,0.0016891,0,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.70355,-0.0014248,0.017529,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.85768,-0.0014574,0.0036518,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.1313,-0.0014924,0.097874,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.40843,-0.0016425,0.08442,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.73628,-0.0021463,0.042753,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.62732,-0.0021606,0.047602,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.48678,-0.0023118,0.041605,0,0
1,GO MOLTING CYCLE,0.56666,-0.0023157,0.11901,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.70355,-0.0023462,0.027439,0,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.50896,-0.0024082,0.048539,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.63354,-0.0024347,-0.025469,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.59059,-0.0024722,-0.12135,0,0
1,GO ALANINE TRANSPORT,0.87144,-0.0025644,0.001537,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.93377,-0.0026689,-0.00047555,0,0
1,GO HISTONE DEUBIQUITINATION,0.54321,-0.0027848,0.041969,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.69707,-0.0029491,0.014106,0,0
1,GO METHYLATION,0.91293,-0.0031648,0.0089425,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.87833,-0.0034284,-0.022724,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.52594,-0.0034603,0.10178,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.9686,-0.0034768,0.0059624,0,0
1,GO TOR SIGNALING,0.81668,-0.0036529,0.0037114,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.91987,-0.0037452,0.0021366,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.67137,-0.0040181,0.050439,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.55487,-0.0040953,-0.060728,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.43883,-0.0042239,0.069119,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.78289,-0.0044433,0.00061644,0,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.84397,-0.0046696,-0.040497,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.80312,-0.0049831,0.0059153,0,0
1,GO NEUROBLAST PROLIFERATION,0.4978,-0.0050239,-0.092343,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.83713,-0.0053613,-0.025244,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.84397,-0.0054378,-0.022239,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.51459,-0.0058327,0.049873,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.91987,-0.0059212,0.11141,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.63354,-0.0060417,0.04379,0,0
1,GO RESPONSE TO COLD,0.51459,-0.0061696,-0.071563,0,0
1,GO TELOMERIC LOOP DISASSEMBLY,0.52025,-0.0063449,-0.051595,0,0
1,GO GAMETE GENERATION,0.65866,-0.0064943,0.012383,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.76948,-0.0065039,-0.0076451,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.93377,-0.0065943,-0.041022,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.87833,-0.0069237,0.015861,0,0
1,GO REGULATION OF ODONTOGENESIS,0.96163,-0.0071364,0.033539,0,0
1,GO RESPONSE TO GLUCAGON,0.78289,-0.0073071,-0.016426,0,0
1,GO REGULATION OF RNA SPLICING,0.87833,-0.0076035,-0.020393,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.99651,-0.0077819,-0.0014634,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.87833,-0.0077865,0.017426,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.86455,-0.0078124,-0.0077478,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.92682,-0.0078851,0.0045878,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.53167,-0.007992,-0.01908,0,0
1,GO CHROMOSOME ORGANIZATION,0.85082,-0.0082947,0.019175,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.80989,-0.0083239,0.01492,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.35153,-0.0084851,-0.039055,0,0
1,GO PRENYLATION,0.99651,-0.0085747,0.030935,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.40843,-0.0087254,-0.11456,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.60272,-0.0088543,-0.040868,0,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.76948,-0.0089133,0.083223,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.68418,-0.008991,0.07102,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.92682,-0.0094784,0.0031951,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.64605,-0.0095609,-0.030874,0,0
1,GO L AMINO ACID TRANSPORT,0.98255,-0.0099714,0.043139,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.48678,-0.0099767,0.048362,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.69061,-0.010135,-0.04811,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.69707,-0.01028,0.028088,0,0
1,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.97557,-0.010309,-0.0022323,0,0
1,GO RESPONSE TO STARVATION,0.87144,-0.010607,-0.014396,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.83713,-0.010708,0.027054,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.47588,-0.010739,-0.048486,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.8303,-0.010744,-0.0374,0,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.85082,-0.010858,0.0040744,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.91987,-0.010887,-0.0068452,0,0
1,GO PROSTATE GLAND GROWTH,0.71658,-0.010952,0.15103,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.73628,-0.01138,0.073648,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.46512,-0.011467,-0.092438,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.76948,-0.011482,0.051228,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.91293,-0.011534,-0.015393,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.71006,-0.011546,-0.02029,0,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.43883,-0.011572,0.12359,0,0
1,GO DEVELOPMENTAL GROWTH,0.83713,-0.011574,0.0092621,0,0
1,GO RESPONSE TO FATTY ACID,0.83713,-0.011587,0.03662,0,0
1,GO DNA STRAND ELONGATION,0.4545,-0.011679,-0.061559,0,0
1,GO PARTURITION,0.79636,-0.011709,-0.047612,0,0
1,GO OOGENESIS,0.65866,-0.011883,-0.019255,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.90599,-0.011898,0.040048,0,0
1,GO REGULATION OF MRNA PROCESSING,0.84397,-0.012012,-0.018016,0,0
1,GO RESPONSE TO VITAMIN D,0.97557,-0.01243,0.003025,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.3746,-0.012553,-0.070236,0,0
1,GO HISTAMINE TRANSPORT,0.80989,-0.012581,-0.060585,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.68418,-0.012883,0.047702,0,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.69061,-0.013291,-0.017363,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.77618,-0.013465,-0.0051469,0,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.91293,-0.013892,0.0088972,0,0
1,GO BICARBONATE TRANSPORT,0.47049,-0.014092,0.05168,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.67776,-0.014218,-0.039093,0,0
1,GO REGULATION OF OOGENESIS,0.62732,-0.014448,-0.010605,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.47049,-0.014502,-0.015232,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.30402,-0.014565,-0.18488,0,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.84397,-0.014569,0.018628,0,0
1,GO CYTOSOLIC TRANSPORT,0.63978,-0.014764,0.027011,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.87833,-0.014805,0.016529,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.76948,-0.01509,0.043473,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.86455,-0.015104,0.029619,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.89215,-0.015148,0.0094771,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.50337,-0.015204,-0.024178,0,0
1,GO LIPID PHOSPHORYLATION,0.60272,-0.015309,-0.025637,0,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.73628,-0.015488,0.016596,0,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.79636,-0.015509,-0.0087078,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.97557,-0.015699,0.0011866,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.66501,-0.015725,0.0020463,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.91293,-0.01585,0.023709,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.84397,-0.01589,-0.016928,0,0
1,GO GMP METABOLIC PROCESS,0.9686,-0.015894,-0.0065054,0,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.24288,-0.016013,0.19271,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.41842,-0.016039,-0.10975,0,0
1,GO SNORNA 3 END PROCESSING,0.69061,-0.016105,0.010598,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.75615,-0.016181,-0.033231,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.79636,-0.016411,0.0097475,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.89907,-0.016949,-0.02049,0,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.26847,-0.016952,-0.059761,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.78289,-0.016959,0.016352,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.42347,-0.017165,-0.095474,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.65866,-0.01728,0.01943,0,0
1,GO MICROVILLUS ORGANIZATION,0.20937,-0.017527,-0.13267,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.70355,-0.017891,-0.022049,0,0
1,GO EXPLORATION BEHAVIOR,0.29586,-0.018083,-0.11944,0,0
1,GO RENAL ABSORPTION,0.93377,-0.018212,0.01712,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.44402,-0.018372,-0.10032,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.52594,-0.018417,-0.02081,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.62113,-0.018488,-0.083249,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.40843,-0.018857,-0.048535,0,0
1,GO PLASMA MEMBRANE REPAIR,0.89215,-0.018946,-0.0095235,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.95466,-0.018999,0.017064,0,0
1,GO SEX DIFFERENTIATION,0.99651,-0.019303,0.0067072,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.19095,-0.019605,-0.071354,0,0
1,GO MITOCHONDRIAL FUSION,0.49227,-0.019718,0.031667,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.67137,-0.01992,-0.02607,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.56666,-0.020034,0.035853,0,0
1,GO CELL CYCLE DNA REPLICATION,0.63354,-0.020157,-0.040676,0,0
1,GO O GLYCAN PROCESSING,0.38408,-0.0203,-0.091679,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.059411,-0.020545,-0.10352,0,0
1,GO TELOMERE CAPPING,0.94073,-0.020676,0.0048974,0,0
1,GO GLIOGENESIS,0.97557,-0.020838,-0.0055475,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.76281,-0.020866,0.019664,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.53167,-0.021174,-0.030331,0,0
1,GO CGMP MEDIATED SIGNALING,0.74288,-0.021307,-0.023633,0,0
1,GO STEROID CATABOLIC PROCESS,0.63978,-0.021345,0.025208,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.87833,-0.021439,0.0031397,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.66501,-0.021829,-0.028512,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.86455,-0.022097,0.029349,0,0
1,GO ANION TRANSPORT,0.32077,-0.022255,-0.031252,0,0
1,GO ORGANELLE FUSION,0.87833,-0.022544,-0.0083574,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.40843,-0.022562,-0.092328,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.94073,-0.022634,0.16876,0,0
1,GO MICROTUBULE BASED PROCESS,0.63978,-0.022933,-0.019494,0,0
1,GO ER OVERLOAD RESPONSE,0.59664,-0.023044,0.052632,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.30815,-0.023069,-0.058463,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.99651,-0.023156,-0.00011301,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.99651,-0.02325,0.00090104,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.86455,-0.023836,0.041798,0,0
1,GO ACTIN MEDIATED CELL CONTRACTION,0.44402,-0.023837,0.059961,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.69061,-0.02403,-0.0077309,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.97557,-0.024101,0.0051449,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.94073,-0.024104,0.0066388,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.52594,-0.024606,-0.050182,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.87144,-0.025062,-0.01684,0,0
1,GO ORGANIC ANION TRANSPORT,0.35607,-0.025167,-0.037054,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.23937,-0.025207,-0.12883,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.86455,-0.025231,0.0069601,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.95466,-0.025314,0.014436,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.87833,-0.025347,0.013183,0,0
1,GO PIGMENTATION,0.71006,-0.025498,0.0002878,0,0
1,GO AXON EXTENSION,0.62732,-0.025526,-0.025401,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.40843,-0.025529,-0.064141,0,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.63354,-0.025614,-0.010339,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.26847,-0.025693,-0.020627,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.83713,-0.025702,0.0015859,0,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.62113,-0.025755,0.10123,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.58456,-0.026097,-0.047231,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.30815,-0.026187,-0.022484,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.30402,-0.026303,-0.062469,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.54321,-0.026349,-0.011681,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.62732,-0.026431,-0.0065238,0,0
1,GO CONVERGENT EXTENSION,0.71006,-0.02683,-0.039926,0,0
1,GO MALE GAMETE GENERATION,0.87144,-0.027407,-0.00037547,0,0
1,GO HISTONE MONOUBIQUITINATION,0.75615,-0.027411,-0.01593,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.78289,-0.027633,0.0061745,0,0
1,GO BONE MINERALIZATION,0.44924,-0.028439,0.099119,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.96163,-0.028642,-0.06515,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.71006,-0.028757,-0.010384,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.48678,-0.028854,-0.062351,0,0
1,GO INORGANIC ANION TRANSPORT,0.55487,-0.028993,-0.017156,0,0
1,GO PROTEIN NITROSYLATION,0.74288,-0.02903,-0.038024,0,0
1,GO NEPHRON MORPHOGENESIS,0.95466,-0.029077,0.014064,0,0
1,GO RESPONSE TO CALCIUM ION,0.54321,-0.029673,-0.03378,0,0
1,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.97557,-0.029707,0.05016,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.31653,-0.02981,-0.057335,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.39858,-0.029938,-0.024396,0,0
1,GO HISTAMINE SECRETION,0.96163,-0.030177,-0.012065,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.42855,-0.030444,-0.051019,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.61497,-0.03059,-0.032552,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.68418,-0.030614,0.049354,0,0
1,GO THYMIC T CELL SELECTION,0.53742,-0.030702,-0.0089489,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.18219,-0.030868,-0.12544,0,0
1,GO HISTONE UBIQUITINATION,0.88523,-0.031098,0.016836,0,0
1,GO EXIT FROM MITOSIS,0.7495,-0.031313,-0.0075684,0,0
1,GO MANNOSYLATION,0.82348,-0.031358,-0.014985,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.80312,-0.031547,0.0025171,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.77618,-0.031783,-0.016684,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.38888,-0.032118,-0.034874,0,0
1,GO LYSOSOME LOCALIZATION,0.32506,-0.032155,-0.039979,0,0
1,GO ORGANELLE LOCALIZATION,0.18508,-0.032192,-0.028938,0,0
1,GO ECTODERM DEVELOPMENT,0.86455,-0.032253,0.053127,0,0
1,GO SNORNA METABOLIC PROCESS,0.73628,-0.032256,0.016425,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.32938,-0.032297,-0.11542,0,0
1,GO GLIAL CELL PROLIFERATION,0.70355,-0.032607,0.049365,0,0
1,GO AORTA MORPHOGENESIS,0.87833,-0.032652,0.095754,0,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.71006,-0.032654,0.0088795,0,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.24288,-0.032693,-0.18443,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.74288,-0.032948,-0.054706,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.74288,-0.033019,-0.0040894,0,0
1,GO COVALENT CHROMATIN MODIFICATION,0.2839,-0.033052,-0.022264,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.70355,-0.033192,-0.010677,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.50337,-0.033521,0.065389,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.43883,-0.033559,-0.044743,0,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.71006,-0.033665,-0.026287,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.38408,-0.033976,-0.073955,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.65866,-0.034003,0.030562,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.54321,-0.03401,-0.034218,0,0
1,GO BLASTOCYST DEVELOPMENT,0.43883,-0.034196,-0.023284,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.44402,-0.034277,-0.069209,0,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.76281,-0.034279,-0.00096573,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.36526,-0.034528,-0.099192,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.22905,-0.034541,-0.057712,0,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.15264,-0.034656,-0.063962,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.97557,-0.034792,0.022704,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.91293,-0.034813,0.0095113,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.43367,-0.034859,-0.10098,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.30402,-0.035,-0.067903,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.54903,-0.035175,-0.07478,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.39371,-0.035381,-0.034452,0,0
1,GO B CELL HOMEOSTASIS,0.63978,-0.035535,-0.039942,0,0
1,GO RESPONSE TO METAL ION,0.66501,-0.035558,-0.017491,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.29184,-0.035599,-0.065316,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.95466,-0.035647,0.03226,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.71006,-0.035779,0.02266,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.26098,-0.036086,-0.066628,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.78289,-0.036289,-0.0091225,0,0
1,GO REPLICATION FORK PROCESSING,0.96163,-0.036658,0.045153,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.42855,-0.036705,0.073101,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.36064,-0.036863,-0.051454,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.72969,-0.037016,-0.012127,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.39858,-0.037136,-0.041867,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.72313,-0.037282,-0.03043,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.85082,-0.037535,-0.023302,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.92682,-0.038251,0.053161,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.67137,-0.038286,0.0036856,0,0
1,GO RESPONSE TO CARBOHYDRATE,0.63354,-0.038445,-0.0073568,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.4598,-0.038515,-0.019622,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.53167,-0.038618,-0.071777,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.89907,-0.038638,0.021422,0,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.32938,-0.038727,-0.065269,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.9686,-0.038751,0.0032909,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.70355,-0.038812,0.012875,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.23589,-0.038924,-0.049109,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.71006,-0.039276,-0.016678,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.98953,-0.039457,0.031451,0,0
1,GO REGULATION OF FERTILIZATION,0.54903,-0.039479,-0.055307,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.15773,-0.039592,-0.1263,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.27227,-0.039825,-0.20215,0,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.10654,-0.040362,-0.16399,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.69061,-0.041595,-0.015751,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.35153,-0.041848,-0.14103,0,0
1,GO RENAL TUBULE DEVELOPMENT,0.87833,-0.041972,0.060245,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.40349,-0.042022,-0.077811,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.14285,-0.042151,-0.071573,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.092194,-0.042256,-0.054397,0,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.53742,-0.042322,-0.016824,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.73628,-0.042398,-0.14836,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.23937,-0.042439,-0.046716,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.13583,-0.042849,-0.057455,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.98255,-0.043184,0.024098,0,0
1,GO NODAL SIGNALING PATHWAY,0.89907,-0.043425,-0.0087826,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.64605,-0.043719,-0.018962,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.63354,-0.043721,-0.028675,0,0
1,GO RESPONSE TO SALT,0.98255,-0.043846,-0.036631,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.29586,-0.044178,-0.038873,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.72313,-0.044343,-0.023747,0,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.29992,-0.044582,-0.03003,0,0
1,GO MITOTIC DNA REPLICATION,0.59664,-0.044731,-0.03312,0,0
1,GO OOCYTE DIFFERENTIATION,0.13583,-0.044948,-0.06304,0,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.16828,-0.045065,-0.080563,0,0
1,GO T CELL SELECTION,0.63354,-0.045103,-0.003448,0,0
1,GO CALCIUM ION IMPORT,0.065563,-0.045308,-0.091995,0,0
1,GO SPERM MOTILITY,0.17374,-0.045486,-0.054944,0,0
1,GO REGULATION OF EXCRETION,0.56666,-0.045878,-0.044144,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.87144,-0.045914,-0.018473,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.23589,-0.046041,-0.062916,0,0
1,GO REGULATION OF ANION TRANSPORT,0.0695,-0.046227,-0.096598,0,0
1,GO MALE MEIOSIS I,0.48131,-0.046327,-0.074654,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.78962,-0.046362,0.033497,0,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.80989,-0.046363,0.11221,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.29586,-0.046398,-0.061973,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.68418,-0.046627,0.0005039,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.84397,-0.046683,-0.0050589,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.41341,-0.046698,-0.03446,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.31653,-0.046918,-0.047551,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.12689,-0.047028,-0.093959,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.49227,-0.047119,-0.0060786,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.71658,-0.047157,-0.019695,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.98255,-0.047212,0.028255,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.12908,-0.04773,-0.067679,0,0
1,GO REGULATION OF GLUCOSE IMPORT,0.27227,-0.047742,-0.063204,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.61497,-0.047763,-0.02638,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.39371,-0.047941,-0.099313,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.36064,-0.047946,-0.062323,0,0
1,GO WATER TRANSPORT,0.35153,-0.048059,-0.042344,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.75615,-0.048364,-0.0050303,0,0
1,GO PENILE ERECTION,0.52025,-0.048603,-0.061274,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.73628,-0.048631,-0.00066691,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.67137,-0.04867,0.0087962,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.39371,-0.048908,-0.064449,0,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.46512,-0.048919,-0.048265,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.2,-0.05027,-0.073115,0,0
1,GO SEGMENTATION,0.49227,-0.050397,-0.020663,0,0
1,GO CILIUM ORGANIZATION,0.63354,-0.050495,-0.0038867,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.3746,-0.050688,-0.098011,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.16032,-0.050834,-0.12924,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.51459,-0.050903,-0.0059819,0,0
1,GO NUCLEOSOME ORGANIZATION,0.25729,-0.051362,-0.044342,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.95466,-0.05169,0.03858,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.25729,-0.051753,-0.067448,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.41341,-0.051929,-0.085244,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.20621,-0.052189,-0.08511,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.41842,-0.052237,-0.072077,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.48131,-0.05228,-0.048752,0,0
1,GO NEURON DEATH,0.21579,-0.052422,-0.034396,0,0
1,GO DEMETHYLATION,0.46512,-0.05315,-0.013046,0,0
1,GO CILIUM MOVEMENT,0.25363,-0.053531,-0.047778,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.21579,-0.053638,-0.0664,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.51459,-0.05437,-0.070568,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.19695,-0.05439,-0.043676,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.37932,-0.054545,-0.03039,0,0
1,GO DNA PACKAGING,0.47588,-0.054598,-0.023981,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.10465,-0.054681,-0.11608,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.42855,-0.055028,-0.10955,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.13583,-0.055176,-0.11362,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.91987,-0.05554,0.03489,0,0
1,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.53742,-0.05556,-0.10049,0,0
1,GO RESPONSE TO MONOSACCHARIDE,0.39371,-0.055878,-0.021496,0,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.92682,-0.056099,0.20545,0,0
1,GO LONG TERM MEMORY,0.52025,-0.056364,-0.047945,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.31653,-0.056419,-0.1608,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.54903,-0.05658,-0.060788,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.97557,-0.056677,0.012487,0,0
1,GO REGULATION OF TRANSPORT,0.088862,-0.057008,-0.047764,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.88523,-0.057047,0.018552,0,0
1,GO RHYTHMIC PROCESS,0.093897,-0.057207,-0.051444,0,0
1,GO GERM CELL DEVELOPMENT,0.16294,-0.057315,-0.044433,0,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.53742,-0.057428,-0.0087465,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.48678,-0.057707,-0.048798,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.62732,-0.05777,-0.032899,0,0
1,GO MEMBRANE REPOLARIZATION,0.25363,-0.057917,-0.090092,0,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.16032,-0.058065,-0.0769,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.11235,-0.058347,-0.10902,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.061812,-0.058366,-0.16475,0,0
1,GO MEMBRANE DOCKING,0.23245,-0.058383,-0.040113,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.23937,-0.058497,-0.068885,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.7495,-0.05871,-0.012515,0,0
1,GO ORGANIC ACID TRANSPORT,0.072231,-0.058854,-0.06459,0,0
1,GO REGULATION OF BONE REMODELING,0.65234,-0.059218,-0.033349,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.24643,-0.059632,-0.072559,0,0
1,GO RESPONSE TO INACTIVITY,0.59059,-0.059873,-0.052567,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.86455,-0.060035,0.023647,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.70355,-0.060146,-0.023411,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.47588,-0.060283,-0.013887,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.89907,-0.060544,0.062547,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.69707,-0.060598,0.083278,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.37932,-0.060692,-0.053912,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.14285,-0.060941,-0.10322,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.18508,-0.061341,-0.1101,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.78289,-0.061478,0.043452,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.64605,-0.062254,-0.029978,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.24288,-0.062299,-0.053978,0,0
1,GO PHAGOSOME MATURATION,0.94073,-0.062975,-0.0089723,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.46512,-0.063364,-0.050298,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.51459,-0.063669,-0.056709,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.34702,-0.063895,-0.066288,0,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.029719,-0.064034,-0.085857,0,0
1,GO ACTIN CROSSLINK FORMATION,0.38408,-0.064066,-0.13,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.36064,-0.064241,-0.077395,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.46512,-0.064434,-0.060854,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.33373,-0.064487,-0.11161,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.35153,-0.064744,-0.046168,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.26847,-0.065104,-0.10746,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.8303,-0.065254,-0.0023344,0,0
1,GO HISTONE H3 K36 METHYLATION,0.32077,-0.065263,-0.076193,0,0
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23589,-0.06542,-0.2275,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.20309,-0.065431,-0.080038,0,0
1,GO FUCOSYLATION,0.2839,-0.065618,-0.071242,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.32506,-0.065682,-0.028292,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.188,-0.0657,-0.10929,0,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.62113,-0.065717,-0.046737,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.12049,-0.06573,-0.16876,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.22568,-0.065735,-0.079115,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.43367,-0.065788,-0.044999,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.30815,-0.065882,-0.04425,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.87833,-0.065934,-0.02319,0,0
1,GO CHROMATIN ORGANIZATION,0.084046,-0.066084,-0.038112,0,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.070855,-0.066268,-0.099741,0,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.10096,-0.06677,-0.085383,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.38408,-0.066974,-0.039072,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.91987,-0.066981,0.019941,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.15015,-0.067302,-0.19504,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.24288,-0.067493,-0.06132,0,0
1,GO RESPONSE TO ETHANOL,0.11636,-0.067817,-0.070071,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.84397,-0.067966,0.017486,0,0
1,GO REGULATION OF DNA METHYLATION,0.41842,-0.068081,-0.056813,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.35153,-0.068178,-0.037984,0,0
1,GO MICROTUBULE BASED MOVEMENT,0.20621,-0.068279,-0.046442,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.88523,-0.06841,0.045747,0,0
1,GO DIVALENT METAL ION EXPORT,0.94769,-0.068692,-0.0081165,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.11039,-0.068727,-0.1308,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.36064,-0.068858,-0.075591,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.87833,-0.06895,0.012385,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.26098,-0.069402,-0.12677,0,0
1,GO POSITIVE T CELL SELECTION,0.52594,-0.069519,0.012704,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.080955,-0.069727,-0.1074,0,0
1,GO DRINKING BEHAVIOR,0.13583,-0.069884,-0.13533,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.71006,-0.070081,0.0036348,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.63354,-0.07125,0.021189,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.2839,-0.071275,-0.0229,0,0
1,GO MATING BEHAVIOR,0.15015,-0.071333,-0.097774,0,0
1,GO NUCLEOSOME ASSEMBLY,0.18508,-0.071962,-0.069742,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.48678,-0.071979,-0.084626,0,0
1,GO CARDIAC CHAMBER FORMATION,0.29992,-0.072027,-0.2204,0,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.13355,-0.072032,-0.060055,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.33373,-0.072268,-0.035558,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.98953,-0.072491,-0.043896,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.41341,-0.072524,-0.020337,0,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.14526,-0.072697,-0.050387,0,0
1,GO ANIMAL ORGAN MATURATION,0.9686,-0.073221,0.0028945,0,0
1,GO RENAL SODIUM EXCRETION,0.34256,-0.073406,-0.06281,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.21256,-0.073532,-0.11173,0,0
1,GO CYTOPLASM ORGANIZATION,0.94769,-0.073681,0.025045,0,0
1,GO CELL MORPHOGENESIS,0.12473,-0.073809,-0.061307,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.62732,-0.074325,-0.039947,0,0
1,GO TRANSPORT ALONG MICROTUBULE,0.31232,-0.075087,-0.053578,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.25363,-0.075105,-0.080992,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.46512,-0.075208,-0.047968,0,0
1,GO T CELL HOMEOSTASIS,0.082489,-0.075576,-0.076248,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.24643,-0.075926,-0.051943,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.94769,-0.076207,0.0073796,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.41341,-0.076904,-0.027489,0,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.097379,-0.077231,-0.14344,0,0
1,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.65234,-0.077796,-0.034769,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.65234,-0.07788,0.050104,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.44402,-0.07798,-0.0019227,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.16828,-0.07856,-0.050066,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.31232,-0.078721,-0.067178,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.11636,-0.078871,-0.10278,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.19393,-0.079109,-0.080728,0,0
1,GO REGULATION OF TOR SIGNALING,0.13583,-0.079197,-0.039798,0,0
1,GO PROTEIN ACYLATION,0.0034322,-0.079405,-0.092299,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.96163,-0.079533,0.0044596,0,0
1,GO MITOCHONDRIAL TRNA PROCESSING,0.80989,-0.079617,0.034151,0,0
1,GO SISTER CHROMATID COHESION,0.2,-0.079684,-0.061342,0,0
1,GO CELL JUNCTION ASSEMBLY,0.51459,-0.0798,-0.023826,0,0
1,GO INTRACILIARY TRANSPORT,0.4598,-0.080075,-0.050061,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.11039,-0.080177,-0.067137,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.12689,-0.080422,-0.087075,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.20621,-0.080718,-0.11517,0,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.11636,-0.08072,-0.056741,0,0
1,GO EAR MORPHOGENESIS,0.084046,-0.080731,-0.10292,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.29992,-0.081144,-0.076852,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.25001,-0.081647,-0.05569,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.56075,-0.082091,-0.044147,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.059411,-0.082387,-0.10333,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.83713,-0.082432,0.0037183,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20309,-0.082666,-0.13673,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.22235,-0.082799,-0.070165,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.22905,-0.083063,-0.048466,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.77618,-0.08354,0.026494,0,0
1,GO MAST CELL ACTIVATION,0.072231,-0.083649,-0.12973,0,0
1,GO BRAIN MORPHOGENESIS,0.17653,-0.083676,-0.098152,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.59664,-0.083882,-0.048732,0,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.15773,-0.083988,-0.079089,0,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.21579,-0.084044,-0.083726,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.12259,-0.084298,-0.065593,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.15264,-0.084438,-0.07167,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.093897,-0.084565,-0.13475,0,0
1,GO CHROMATIN DISASSEMBLY,0.78289,-0.08462,-0.041801,0,0
1,GO RECEPTOR CLUSTERING,0.064293,-0.085227,-0.13764,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.50337,-0.085515,-0.051623,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.34256,-0.086391,-0.11581,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.14285,-0.086441,-0.065124,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.34702,-0.08665,-0.11204,0,0
1,GO REGULATION OF CILIUM BEAT FREQUENCY,0.62113,-0.086837,-0.033915,0,0
1,GO DOSAGE COMPENSATION,0.35607,-0.086906,-0.027478,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.52594,-0.087089,-0.030968,0,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.059411,-0.087115,-0.083636,0,0
1,GO MAGNESIUM ION TRANSPORT,0.15773,-0.087865,-0.08832,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.090515,-0.088025,-0.11623,0,0
1,GO SPERM CAPACITATION,0.2839,-0.088133,-0.058808,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.62113,-0.088448,-0.019282,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.40349,-0.088897,-0.11938,0,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.11039,-0.089683,-0.075363,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.41341,-0.090271,-0.020193,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.10845,-0.090304,-0.068864,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.67137,-0.090305,-0.0043268,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.29992,-0.090341,-0.045053,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.41341,-0.090348,-0.059007,0,0
1,GO RENAL SYSTEM PROCESS,0.36526,-0.090364,-0.036694,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.48131,-0.090493,-0.039901,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.37932,-0.090779,0.126,0,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.1028,-0.091076,-0.086992,0,0
1,GO SPLEEN DEVELOPMENT,0.53167,-0.091086,-0.010201,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.34256,-0.092502,-0.13622,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.99651,-0.092564,0.073317,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.25363,-0.092866,-0.14301,0,0
1,GO HORMONE CATABOLIC PROCESS,0.75615,-0.0929,-0.027047,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.52594,-0.092963,-0.039248,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.36064,-0.093351,-0.081074,0,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.42855,-0.093464,-0.02611,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.10845,-0.094324,-0.07239,0,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.11235,-0.094679,-0.17751,0,0
1,GO HISTONE H2A UBIQUITINATION,0.56666,-0.095113,-0.021238,0,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.25001,-0.095186,-0.050999,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.060602,-0.095351,-0.073073,0,0
1,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.51459,-0.095395,-0.060263,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.63978,-0.095541,-0.0064688,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.23589,-0.095753,-0.095574,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.25729,-0.095895,-0.060457,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.084046,-0.095932,-0.13627,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.22905,-0.096121,-0.022132,0,0
1,GO REGULATION OF NEURON MIGRATION,0.16294,-0.096182,-0.11467,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.7495,-0.096413,-0.011406,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.093897,-0.096597,-0.097091,0,0
1,GO MATING,0.082489,-0.097115,-0.073023,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.52025,-0.0974,-0.032324,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.065563,-0.097649,-0.15042,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.1028,-0.097832,-0.1767,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.15517,-0.09784,-0.10132,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.42347,-0.098628,-0.023244,0,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.052669,-0.098725,0.033529,0,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.14769,-0.098798,-0.10415,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.40349,-0.098819,-0.06601,0,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.060602,-0.099251,-0.12345,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.061812,-0.099387,-0.055266,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.070855,-0.099401,-0.10119,0,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0022332,-0.099592,-0.15392,0,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.51459,-0.099856,-0.030096,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.32938,-0.10008,-0.055141,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.061812,-0.10023,-0.095863,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.38408,-0.10049,-0.059109,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.15773,-0.10102,-0.094554,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.36526,-0.10133,-0.08367,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.55487,-0.10147,-0.037983,0,0
1,GO FORELIMB MORPHOGENESIS,0.29992,-0.10163,-0.072863,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.19095,-0.102,-0.052831,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.44402,-0.10218,-0.062069,0,0
1,GO CHROMATIN SILENCING,0.10845,-0.10233,-0.049267,0,0
1,GO AXO DENDRITIC TRANSPORT,0.035393,-0.10283,-0.14809,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.67776,-0.10348,-0.041814,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.44402,-0.1035,-0.060627,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.3746,-0.10401,-0.105,0,0
1,GO CELLULAR ANION HOMEOSTASIS,0.26847,-0.10425,-0.065376,0,0
1,GO NEURAL CREST FORMATION,0.35607,-0.10437,-0.061088,0,0
1,GO EXCRETION,0.188,-0.10493,-0.054331,0,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.075049,-0.10525,-0.09605,0,0
1,GO HEART INDUCTION,0.88523,-0.10538,0.0034153,0,0
1,GO RESPONSE TO FUNGUS,0.11039,-0.10566,-0.10748,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.38408,-0.10627,-0.064746,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.11841,-0.10637,-0.16668,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.68418,-0.10639,0.076351,0,0
1,GO MYOFIBRIL ASSEMBLY,0.72969,-0.10655,0.028138,0,0
1,GO UTERUS DEVELOPMENT,0.11636,-0.1068,-0.15649,0,0
1,GO MESONEPHROS DEVELOPMENT,0.68418,-0.10682,0.0071364,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.92682,-0.10692,-0.0037485,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.53167,-0.10736,0.01351,0,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.72969,-0.10774,0.0080665,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.080955,-0.10777,-0.08441,0,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.068167,-0.10811,-0.090142,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.11039,-0.10849,-0.11321,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.21579,-0.10852,-0.097115,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.068167,-0.10865,-0.15945,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.40843,-0.10914,-0.053435,0,0
1,GO REGIONALIZATION,0.20937,-0.10926,-0.089261,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.21905,-0.10936,-0.099286,0,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.036948,-0.10952,-0.13104,0,0
1,GO DENDRITE SELF AVOIDANCE,0.65234,-0.10974,-0.013857,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.024846,-0.10978,-0.11254,0,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.079444,-0.10988,-0.090947,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.26098,-0.11009,-0.046736,0,0
1,GO AXIS SPECIFICATION,0.090515,-0.11015,-0.1147,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.48131,-0.11027,-0.067503,0,0
1,GO TORC1 SIGNALING,0.070855,-0.11076,-0.065706,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.17374,-0.11101,-0.089051,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.080955,-0.11114,-0.10415,0,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.093897,-0.11188,-0.098918,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.52025,-0.11192,-0.026644,0,0
1,GO G0 TO G1 TRANSITION,0.088862,-0.11201,-0.067666,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.092194,-0.11215,-0.14005,0,0
1,GO PROTEIN MANNOSYLATION,0.32077,-0.11223,-0.054855,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.27611,-0.11254,-0.039674,0,0
1,GO SARCOMERE ORGANIZATION,0.89907,-0.1126,0.030828,0,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.12473,-0.11318,-0.1092,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.83713,-0.11327,0.044938,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.18508,-0.11395,-0.058417,0,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.22568,-0.11435,-0.091661,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.063042,-0.11439,-0.11528,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.52025,-0.11458,-0.078662,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.070855,-0.11492,-0.060521,0,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.10096,-0.11493,-0.14774,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.41842,-0.11564,-0.045744,0,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.082489,-0.11606,-0.13512,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.35153,-0.11608,-0.05792,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.50896,-0.11638,0.00095405,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.19695,-0.11652,-0.12473,0,0
1,GO SPERMATID DIFFERENTIATION,0.16032,-0.11684,-0.060121,0,0
1,GO PROTEIN DEMETHYLATION,0.065563,-0.11686,-0.13576,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.68418,-0.11792,0.15623,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.28785,-0.11804,-0.11237,0,0
1,GO REGULATION OF ACROSOME REACTION,0.21905,-0.11829,-0.11919,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.23245,-0.11833,-0.068577,0,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.42347,-0.11844,-0.053988,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.27611,-0.1187,-0.074682,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.41341,-0.11898,-0.034044,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.03245,-0.11901,-0.10851,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.16559,-0.1192,-0.063749,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.099158,-0.11958,-0.13425,0,0
1,GO COLLATERAL SPROUTING,0.21256,-0.11966,-0.073271,0,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.23937,-0.11968,-0.09618,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.17653,-0.11979,-0.12478,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.043763,-0.12006,-0.11408,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.48131,-0.12089,-0.030724,0,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.043763,-0.12105,-0.15073,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.041093,-0.12188,-0.11166,0,0
1,GO RESPONSE TO CAFFEINE,0.54903,-0.12231,-0.039991,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.17653,-0.12368,-0.063913,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.41341,-0.1238,-0.096143,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.16828,-0.12404,-0.078712,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.59059,-0.12418,-0.059399,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.12259,-0.12425,0.044579,0,0
1,GO MICROTUBULE POLYMERIZATION,0.013139,-0.12438,-0.13803,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.20621,-0.12467,-0.1167,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.061812,-0.12504,-0.12405,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.092194,-0.12521,-0.13867,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.0695,-0.12554,-0.10158,0,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.035393,-0.12608,-0.17036,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.39858,-0.12615,-0.048778,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.11841,-0.12625,-0.07555,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.65234,-0.12799,0.034252,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.39858,-0.12868,-0.066454,0,0
1,GO HISTONE METHYLATION,0.013465,-0.1288,-0.11275,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.15773,-0.1298,-0.060609,0,0
1,GO REGULATION OF BEHAVIOR,0.0097392,-0.13047,-0.1541,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.12908,-0.13075,-0.079266,0,0
1,GO LIPID EXPORT FROM CELL,0.30815,-0.13106,-0.062172,0,0
1,GO GLUTAMATE METABOLIC PROCESS,0.13355,-0.13113,-0.082797,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.073629,-0.1315,-0.11789,0,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.11636,-0.13159,-0.10803,0,0
1,GO PHOTOTRANSDUCTION,0.004408,-0.13223,-0.014165,0,0
1,GO RESPONSE TO ETHER,0.10845,-0.13289,-0.13561,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.17934,-0.1335,-0.062973,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.0054795,-0.1341,-0.128,0,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.040234,-0.13411,-0.217,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.26471,-0.13546,-0.0834,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19393,-0.13555,-0.28685,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.51459,-0.13606,-0.06858,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.16294,-0.13622,-0.11239,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.58456,-0.1364,-0.028252,0,0
1,GO BRONCHUS DEVELOPMENT,0.71006,-0.13662,-0.068777,0,0
1,GO RESPONSE TO AMINE,0.075049,-0.13686,-0.12334,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.045624,-0.13779,-0.23504,0,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0075304,-0.13832,-0.16289,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.080955,-0.13849,-0.094576,0,0
1,GO KIDNEY MORPHOGENESIS,0.28785,-0.13888,-0.046796,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.11636,-0.13889,-0.087677,0,0
1,GO FEVER GENERATION,0.16828,-0.13906,-0.022644,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.021165,-0.13963,-0.1782,0,0
1,GO METANEPHROS MORPHOGENESIS,0.34702,-0.14022,-0.089168,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.29992,-0.14118,-0.10117,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.38888,-0.14206,-0.093658,0,0
1,GO NOTCH SIGNALING PATHWAY,0.085627,-0.14254,-0.081489,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.055956,-0.14365,-0.11843,0,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0025817,-0.14472,-0.15699,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.15517,-0.14586,-0.13776,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.085627,-0.14668,-0.16492,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.25729,-0.14683,-0.087027,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.27999,-0.14684,-0.045212,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.23589,-0.14684,-0.095623,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.32077,-0.14851,-0.11744,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.099158,-0.14943,-0.086141,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.087232,-0.15023,-0.11459,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12473,-0.15129,-0.18077,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.12049,-0.15148,-0.11566,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.14048,-0.15151,-0.071366,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0059384,-0.15193,-0.13788,0,0
1,GO STEROID HORMONE SECRETION,0.13814,-0.15313,-0.12498,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.34256,-0.15315,-0.072262,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.32506,-0.15323,-0.091807,0,0
1,GO V D J RECOMBINATION,0.19695,-0.15332,-0.075713,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.35153,-0.15523,-0.060104,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.188,-0.15526,-0.12114,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0024367,-0.15532,-0.1789,0,0
1,GO AXONEME ASSEMBLY,0.084046,-0.15541,-0.13233,0,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.16294,-0.15581,-0.11575,0,0
1,GO COPULATION,0.34256,-0.15589,-0.07769,0,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.0695,-0.15614,-0.12216,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.21579,-0.1563,-0.080026,0,0
1,GO AXONAL TRANSPORT,0.010773,-0.1574,-0.19024,0,0
1,GO RESPONSE TO EPINEPHRINE,0.18508,-0.15785,-0.14905,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.070855,-0.15788,-0.11522,0,0
1,GO DETECTION OF VISIBLE LIGHT,0.0025817,-0.15811,-0.03683,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.17374,-0.15816,-0.1008,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.097379,-0.15904,-0.10593,0,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.05824,-0.15913,-0.11806,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.11235,-0.15976,-0.19639,0,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.052669,-0.15979,-0.071651,0,0
1,GO DETECTION OF LIGHT STIMULUS,0.00067758,-0.16027,-0.049026,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.21579,-0.16082,-0.049556,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.05824,-0.16091,-0.21801,0,0
1,GO PROTEIN METHYLATION,0.019283,-0.16261,-0.11422,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.065563,-0.16327,-0.092134,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.019739,-0.16335,-0.14476,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00044439,-0.16411,-0.2019,0,0
1,GO CARDIAC VENTRICLE FORMATION,0.076492,-0.16412,-0.40022,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.080955,-0.16429,-0.12669,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.011326,-0.16486,-0.19088,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.070855,-0.16535,-0.13217,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.010506,-0.1654,-0.14492,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.19095,-0.16553,-0.094257,0,0
1,GO CELL PART MORPHOGENESIS,0.00029782,-0.16633,-0.19539,0,0
1,GO NEURON REMODELING,0.85082,-0.16691,0.010241,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.034637,-0.16726,-0.20242,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.043763,-0.16889,-0.21831,0,0
1,GO NEURON PROJECTION GUIDANCE,0.009256,-0.16917,-0.16906,0,0
1,GO GASTRIC ACID SECRETION,0.23589,-0.16948,-0.078835,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.32506,-0.16954,-0.073736,0,0
1,GO AXON DEVELOPMENT,0.001986,-0.16958,-0.18423,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.10845,-0.17162,-0.11145,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.21579,-0.17178,-0.10345,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.20937,-0.17218,-0.056542,0,0
1,GO MAINTENANCE OF CELL POLARITY,0.01282,-0.17269,-0.15532,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0085714,-0.17344,-0.29607,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.15015,-0.1736,-0.098323,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.20309,-0.17521,-0.13325,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.001228,-0.17569,-0.18237,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0018173,-0.17686,-0.21621,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.038561,-0.17729,-0.20001,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.33812,-0.17763,-0.053961,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.088862,-0.17807,-0.10622,0,0
1,GO TOXIN METABOLIC PROCESS,0.12259,-0.17859,-0.16124,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.063042,-0.17891,-0.15951,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.065563,-0.17906,-0.10127,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.12259,-0.17968,-0.086796,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.76948,-0.1797,-0.031484,0,0
1,GO VASCULAR WOUND HEALING,0.17653,-0.17973,-0.16086,0,0
1,GO MEMBRANE FISSION,0.0046564,-0.17975,-0.2324,0,0
1,GO MICROTUBULE BUNDLE FORMATION,0.02166,-0.18,-0.12299,0,0
1,GO POLYOL TRANSPORT,0.073629,-0.18007,-0.1426,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.34256,-0.18059,-0.084726,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.4978,-0.18216,0.1119,0,0
1,GO REGULATION OF HISTONE METHYLATION,0.0075304,-0.18282,-0.1244,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.17934,-0.18338,-0.11737,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.052669,-0.18474,-0.090528,0,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.16294,-0.18485,-0.18225,0,0
1,GO SPERM AXONEME ASSEMBLY,0.12908,-0.18489,-0.11089,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.064293,-0.18524,-0.1783,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.092194,-0.18535,-0.17915,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.32077,-0.18569,-0.059182,0,0
1,GO CELL AGGREGATION,0.16032,-0.18579,-0.1006,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.18219,-0.18608,-0.075173,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.13814,-0.18622,-0.16351,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.034637,-0.18691,-0.18194,0,0
1,GO HEART FORMATION,0.061812,-0.18863,-0.15104,0,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.10845,-0.18966,-0.14647,0,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.017969,-0.1898,-0.19657,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0075304,-0.19062,-0.18839,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.054842,-0.19233,-0.14826,0,0
1,GO RESPONSE TO FORSKOLIN,0.11235,-0.19247,-0.16376,0,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.14048,-0.1934,-0.20057,0,0
1,GO REGULATION OF CIRCADIAN RHYTHM,7.6603e-06,-0.19511,-0.19391,0,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.02268,-0.19663,-0.24247,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.0050528,-0.19837,-0.17815,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.087232,-0.19986,-0.14757,0,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.063042,-0.20111,-0.15321,0,0
1,GO KERATINIZATION,0.14769,-0.20154,-0.076541,0,0
1,GO PROTEIN DEPOLYMERIZATION,0.00027832,-0.20159,-0.2124,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.17653,-0.20328,-0.15377,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.009256,-0.20329,-0.18855,0,0
1,GO PALLIUM DEVELOPMENT,0.00072223,-0.20428,-0.20083,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00090094,-0.20596,-0.2575,0,0
1,GO NEURON PROJECTION EXTENSION,0.0030654,-0.20769,-0.17259,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.035393,-0.2094,-0.16626,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.090515,-0.21025,-0.232,0,0
1,GO CORNIFICATION,0.23937,-0.21143,-0.051658,0,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0018173,-0.21268,-0.2147,0,0
1,GO ACROSOME REACTION,0.0099891,-0.21332,-0.16141,0,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0028141,-0.21339,-0.21704,0,0
1,GO MEMORY,0.00022676,-0.21395,-0.19021,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.11636,-0.21549,-0.13527,0,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.33812,-0.21958,-0.1972,0,0
1,GO COGNITION,4.4878e-05,-0.22067,-0.20422,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.12049,-0.22149,-0.10539,0,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.10465,-0.22188,-0.18525,0,0
1,GO VISUAL BEHAVIOR,0.00013917,-0.22191,-0.19853,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0071468,-0.22211,-0.24405,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.00353,-0.22263,-0.25621,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.038561,-0.2228,-0.14494,0,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.11039,-0.22283,-0.17364,0,0
1,GO MITOCHONDRION LOCALIZATION,0.0040578,-0.22395,-0.2312,0,0
1,GO CARTILAGE MORPHOGENESIS,0.20621,-0.22499,-0.16244,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.1313,-0.22749,-0.24518,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.17934,-0.22797,-0.15244,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.12049,-0.23005,-0.16996,0,0
1,GO REGULATION OF MICROTUBULE BINDING,0.00025131,-0.2308,-0.24996,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.034637,-0.23129,-0.18982,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.10845,-0.23265,-0.15688,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0090226,-0.234,-0.20436,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.27611,-0.23486,-0.098964,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.018836,-0.23491,-0.26904,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.0021689,-0.23587,-0.24983,0,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.11434,-0.23662,-0.15046,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00024286,-0.23746,-0.24717,0,0
1,GO RESPONSE TO HYDROXYUREA,0.0056288,-0.23848,-0.21112,0,0
1,GO LONG TERM SYNAPTIC DEPRESSION,0.00012964,-0.24141,-0.31128,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.2839,-0.24395,-0.11455,0,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00081984,-0.24438,-0.17754,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00063551,-0.2475,-0.21409,0,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00023468,-0.24868,-0.24913,0,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00013433,-0.25075,-0.26971,0,0
1,GO FILOPODIUM ASSEMBLY,0.001191,-0.25245,-0.226,0,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0097392,-0.25402,-0.28936,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.017137,-0.25481,-0.21294,0,0
1,GO MICROTUBULE DEPOLYMERIZATION,5.6174e-05,-0.25483,-0.33389,0,0
1,GO REGULATION OF ACTION POTENTIAL,0.025414,-0.25497,-0.16261,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.031059,-0.25777,-0.18002,0,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.010773,-0.25798,-0.31171,0,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.093897,-0.25824,-0.18336,0,0
1,GO CHROMATIN SILENCING AT TELOMERE,2.3418e-05,-0.25832,-0.24584,0,0
1,GO DENDRITIC TRANSPORT,0.0099891,-0.25969,-0.26482,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.00055855,-0.26042,-0.30426,0,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.060602,-0.26044,-0.15073,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.00059588,-0.26053,-0.25471,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.02843,-0.26093,-0.16802,0,0
1,GO INSEMINATION,0.13583,-0.26515,-0.13594,0,0
1,GO HEAT GENERATION,0.053746,-0.26551,-0.17596,0,0
1,GO GLYCINE TRANSPORT,0.072231,-0.26565,-0.16923,0,0
1,GO RESPONSE TO LIGHT INTENSITY,0.0011199,-0.27026,-0.25942,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.17099,-0.27306,-0.17658,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00044439,-0.27424,-0.22575,0,0
1,GO CELL FATE DETERMINATION,0.0062634,-0.27637,-0.24206,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.31653,-0.27747,-0.12107,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.016734,-0.27864,-0.22767,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,0.00057693,-0.27912,-0.20084,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.057089,-0.28037,-0.41905,0,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.066855,-0.28221,-0.23249,0,0
1,GO PRESYNAPSE ORGANIZATION,0.0010206,-0.28242,-0.26826,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.054842,-0.28697,-0.23211,0,0
1,GO ACROSOME ASSEMBLY,0.00027832,-0.28782,-0.25328,0,0
1,GO CELL JUNCTION MAINTENANCE,0.0040578,-0.28811,-0.26278,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.079444,-0.28871,-0.18902,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.9263e-05,-0.28934,-0.31502,0,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00050664,-0.29328,-0.35707,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.0028141,-0.29675,-0.25219,0,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,1.4609e-05,-0.29805,-0.31081,0,0
1,GO ACIDIC AMINO ACID TRANSPORT,0.00012512,-0.29979,-0.25334,0,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.13355,-0.30034,-0.15198,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00014418,-0.30396,-0.3342,0,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.12473,-0.30416,-0.13712,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.11039,-0.30564,-0.20269,0,0
1,GO DENDRITE DEVELOPMENT,2.0833e-05,-0.30649,-0.27792,0,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.12473,-0.30796,-0.17464,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.00084609,-0.30872,-0.28408,0,0
1,GO RESPONSE TO MAGNESIUM ION,0.0040578,-0.31211,-0.28833,0,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.0026572,-0.31503,-0.2978,0,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00025131,-0.31505,-0.35936,0,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0022992,-0.31613,-0.2781,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00353,-0.31818,-0.30072,0,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0017123,-0.31859,-0.30819,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.04854,-0.3189,-0.21783,0,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00012512,-0.31903,-0.31394,0,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.0604e-05,-0.32062,-0.29583,0,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,2.6902e-06,-0.3212,-0.32737,0,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.082489,-0.32191,-0.15509,0,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.020205,-0.32414,-0.36839,0,0
1,GO CELL FATE SPECIFICATION,0.00012074,-0.32505,-0.35332,0,0
1,GO DENDRITE MORPHOGENESIS,2.6307e-05,-0.32593,-0.30377,0,0
1,GO SYNAPTIC VESICLE RECYCLING,4.2876e-06,-0.32967,-0.34272,0,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.00047456,-0.33436,-0.31399,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.013139,-0.33443,-0.24061,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0010206,-0.33468,-0.35895,0,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,8.3127e-06,-0.33472,-0.332,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,9.0179e-06,-0.33722,-0.36097,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.001662,-0.33752,-0.24121,0,0
1,GO ADRENAL GLAND DEVELOPMENT,8.4205e-05,-0.34487,-0.37108,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.009256,-0.34672,-0.30147,0,0
1,GO NEUROTRANSMITTER REUPTAKE,0.00014935,-0.34906,-0.33557,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.073629,-0.35007,-0.18916,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0007696,-0.35315,-0.3076,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0094949,-0.35882,-0.28904,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.14285,-0.36109,-0.17585,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0050528,-0.36372,-0.32176,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,5.7413e-06,-0.36563,-0.40715,0,0
1,GO PITUITARY GLAND DEVELOPMENT,2.2524e-05,-0.36823,-0.43749,0,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.6455e-05,-0.36957,-0.33504,0,0
1,GO PARENTAL BEHAVIOR,0.00090094,-0.37643,-0.3526,0,0
1,GO WALKING BEHAVIOR,0.00011241,-0.37669,-0.33973,0,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,7.9801e-06,-0.38337,-0.35508,0,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.9263e-05,-0.3841,-0.44529,0,0
1,GO FAT CELL PROLIFERATION,0.00035231,-0.38476,-0.36049,0,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00074557,-0.38679,-0.43069,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,0.0001547,-0.39182,-0.35189,0,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,7.9801e-06,-0.39515,-0.39764,0,0
1,GO NEURON MIGRATION,1.9263e-05,-0.39576,-0.36784,0,0
1,GO PRESYNAPTIC ENDOCYTOSIS,4.2876e-06,-0.39751,-0.37477,0,0
1,GO RESPONSE TO COCAINE,1.8958e-07,-0.40183,-0.4432,0,0
1,GO NEURON RECOGNITION,4.4878e-05,-0.40331,-0.42754,0,0
1,GO HEART FIELD SPECIFICATION,0.04854,-0.40383,-0.23151,0,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00017186,-0.40913,-0.36171,0,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0056288,-0.40953,-0.28659,0,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.00090094,-0.41307,-0.30816,0,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,1.6729e-06,-0.41481,-0.4277,0,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,9.0221e-07,-0.41814,-0.41715,0,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00052342,-0.43363,-0.33332,0,0
1,GO SEROTONIN TRANSPORT,1.4044e-06,-0.43436,-0.55173,0,0
1,GO CARDIOBLAST PROLIFERATION,0.018398,-0.43478,-0.38682,0,0
1,GO ADULT BEHAVIOR,4.9191e-08,-0.43592,-0.49751,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.009256,-0.44307,-0.30449,0,0
1,GO NEUROTRANSMITTER UPTAKE,0.00026003,-0.44363,-0.31269,0,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,1.6455e-05,-0.44647,-0.52229,0,0
1,GO SOMATIC STEM CELL DIVISION,0.12908,-0.44943,-0.1843,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,8.628e-07,-0.45289,-0.42162,0,0
1,GO SYNAPTIC VESICLE LOCALIZATION,1.9904e-06,-0.45302,-0.47709,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.024846,-0.45647,-0.41362,0,0
1,GO LIMB BUD FORMATION,0.061812,-0.46115,-0.26233,0,0
1,GO SUBPALLIUM DEVELOPMENT,6.5149e-05,-0.46445,-0.42459,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.0038387,-0.47635,-0.41696,0,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,9.7801e-06,-0.47642,-0.45627,0,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00067758,-0.47981,-0.35482,0,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,4.3218e-05,-0.48067,-0.58227,0,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,7.8282e-05,-0.48187,-0.52661,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,1.4039e-05,-0.48667,-0.43757,0,0
1,GO CATECHOLAMINE UPTAKE,6.5149e-05,-0.4908,-0.39543,0,0
1,GO AXONAL FASCICULATION,0.00026903,-0.49154,-0.49463,0,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,1.2971e-07,-0.50635,-0.48296,0,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.063042,-0.51574,-0.24549,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,1.4609e-05,-0.51597,-0.51537,0,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00092958,-0.51969,-0.4152,0,0
1,GO GLUTAMATE SECRETION,5.9841e-06,-0.52209,-0.44843,0,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.0311e-06,-0.52774,-0.54284,0,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,7.5427e-07,-0.52845,-0.49894,0,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,8.2505e-07,-0.53377,-0.56898,0,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00054072,-0.53871,-0.48683,0,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,4.1802e-07,-0.55192,-0.52934,0,0
1,GO REGULATION OF HEAT GENERATION,0.0047853,-0.55323,-0.36926,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,1.349e-05,-0.55406,-0.56107,0,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,5.9841e-06,-0.55845,-0.55743,0,0
1,GO REFLEX,3.3132e-05,-0.56442,-0.54172,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,6.4994e-06,-0.56683,-0.53019,0,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,5.753e-07,-0.57696,-0.55641,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,2.6307e-05,-0.57941,-0.47478,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,5.4121e-05,-0.58472,-0.54965,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,1.8521e-05,-0.58637,-0.57317,0,0
1,GO NEURAL NUCLEUS DEVELOPMENT,6.2985e-07,-0.5896,-0.49624,0,0
1,GO DETECTION OF CALCIUM ION,1.1493e-05,-0.58999,-0.56105,0,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,1.6455e-05,-0.59767,-0.56592,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,5.2533e-07,-0.59964,-0.57798,0,0
1,GO NEUROTRANSMITTER TRANSPORT,8.628e-07,-0.60784,-0.54325,0,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,2.1831e-07,-0.61244,-0.55571,0,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,9.0179e-06,-0.61995,-0.6302,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,9.8628e-07,-0.62414,-0.57039,0,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,5.2837e-06,-0.62931,-0.63606,0,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.7728e-06,-0.63154,-0.54437,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,1.9904e-06,-0.63515,-0.69405,0,0
1,GO NEURONAL ACTION POTENTIAL,1.1237e-07,-0.63973,-0.68881,0,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,3.9926e-07,-0.66527,-0.65289,0,0
1,GO NEUROTRANSMITTER SECRETION,6.8936e-07,-0.66729,-0.601,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,1.8084e-07,-0.68947,-0.72631,0,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,2.3975e-07,-0.7019,-0.6771,0,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,9.8628e-07,-0.71008,-0.63641,0,0
1,GO DENSE CORE GRANULE TRANSPORT,2.4692e-06,-0.7241,-0.95158,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,2.5308e-05,-0.72507,-0.62334,0,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.4963e-07,-0.73184,-0.73151,0,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00063551,-0.73424,-0.52344,0,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,3.0689e-05,-0.74826,-0.67701,0,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,5.4977e-07,-0.75499,-0.71319,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,9.3916e-06,-0.76701,-0.68967,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,1.4609e-05,-0.78338,-0.75742,0,0
1,GO SEROTONIN SECRETION,3.9926e-07,-0.79114,-0.6722,0,0
1,GO NEURON CELL CELL ADHESION,5.753e-07,-0.82878,-0.93974,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,1.2971e-07,-0.86819,-0.83372,0,0
1,GO DENDRITE EXTENSION,8.4155e-08,-0.88462,-0.7895,0,0
1,GO REGULATION OF DENDRITE EXTENSION,1.5691e-07,-0.89271,-0.85146,0,0
1,GO RETINA LAYER FORMATION,2.0033e-05,-0.89975,-0.66826,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,3.8131e-07,-0.94395,-0.96679,0,0
1,GO SYNAPTIC VESICLE CLUSTERING,9.8628e-07,-0.99067,-0.92249,0,0
1,GO NEURON FATE SPECIFICATION,3.17e-07,-1.0126,-0.9849,0,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,1.0779e-06,-1.0573,-0.82442,0,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,5.2533e-07,-1.0721,-0.96372,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,9.8628e-07,-1.1203,-1.0187,0,0
1,GO MECHANOSENSORY BEHAVIOR,8.6584e-06,-1.1257,-0.94412,0,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,3.3202e-07,-1.3533,-1.214,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,2.5122e-07,-1.6695,-1.4739,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00081984,1.5054,1.0616,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0007696,1.2856,0.86473,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,9.8628e-07,1.2188,0.94324,1,1
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.0056288,1.0213,0.84327,1,1
2,GO ETHANOL OXIDATION,7.2111e-07,0.97262,0.88425,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00013917,0.96721,0.7511,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.009256,0.88518,0.54829,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00067758,0.87183,0.65941,1,1
2,GO BIOLOGICAL PHASE,1.2454e-05,0.827,0.71904,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,6.5149e-05,0.82445,0.72374,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,2.9532e-05,0.81815,0.681,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,5.4977e-07,0.8037,0.79231,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.0073e-05,0.799,0.58429,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00063551,0.78649,0.52802,1,1
2,GO RESPONSE TO INTERLEUKIN 18,1.104e-05,0.78371,0.80785,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.7578e-07,0.77703,0.68854,1,1
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00074557,0.75365,0.60603,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,1.0184e-05,0.74882,0.63449,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.011612,0.74167,0.46203,1,1
2,GO CELLULAR RESPONSE TO COPPER ION,0.0081404,0.72282,0.50375,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,5.7413e-06,0.72072,0.66202,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0010206,0.71623,0.53449,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,1.2308e-06,0.70331,0.619,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,8.4205e-05,0.70111,0.6581,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00047456,0.70096,0.48803,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,0.0090226,0.69478,0.44608,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,8.1192e-05,0.69382,0.53793,1,1
2,GO CELLULAR RESPONSE TO ZINC ION,0.015203,0.69096,0.52853,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.6623e-06,0.68144,0.51433,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,7.5427e-07,0.67989,0.60528,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,5.508e-06,0.67495,0.6345,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,5.2837e-06,0.67163,0.65817,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.9926e-07,0.67136,0.52705,1,1
2,GO MUCUS SECRETION,0.00026903,0.66447,0.64927,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,6.4994e-06,0.66368,0.58114,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00012074,0.66273,0.56182,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,7.6603e-06,0.66265,0.61104,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.00010092,0.66237,0.51745,1,1
2,GO ACTIN FILAMENT SEVERING,0.00024286,0.65998,0.5153,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0011199,0.65048,0.46681,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,7.2754e-05,0.64618,0.57749,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00052342,0.63924,0.58472,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00010845,0.62532,0.46634,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,9.7346e-05,0.62061,0.50242,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,6.0504e-05,0.6181,0.70213,1,1
2,GO MYOBLAST MIGRATION,0.0069616,0.61589,0.506,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,2.8077e-06,0.61141,0.57587,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,2.3975e-07,0.6102,0.58745,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00030804,0.60615,0.41645,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00059588,0.59988,0.46816,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.0041716,0.59711,0.48998,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.8521e-05,0.59555,0.58604,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0022992,0.59403,0.46948,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,5.4121e-05,0.59384,0.57368,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00014935,0.58485,0.53377,1,1
2,GO ETHER METABOLIC PROCESS,1.104e-05,0.58474,0.49527,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00012964,0.58454,0.44686,1,1
2,GO HAIR FOLLICLE MATURATION,2.8077e-06,0.58429,0.52615,1,1
2,GO PROSTATE GLAND GROWTH,1.6455e-05,0.58277,0.62272,1,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.040234,0.58029,0.36474,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00022676,0.57924,0.45547,1,1
2,GO PROSTANOID METABOLIC PROCESS,4.4712e-06,0.57692,0.52271,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.5331e-06,0.5727,0.44674,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00030804,0.56603,0.45909,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0001547,0.5639,0.48257,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00026003,0.56331,0.43826,1,1
2,GO RESPONSE TO INTERFERON ALPHA,0.013139,0.56251,0.28267,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0041716,0.5597,0.40562,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0071468,0.54879,0.39377,1,1
2,GO OTIC VESICLE DEVELOPMENT,5.6174e-05,0.54762,0.49438,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00014418,0.54438,0.42808,1,1
2,GO LYSINE METABOLIC PROCESS,0.00021909,0.54427,0.52111,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.00018427,0.54161,0.49314,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.0311e-06,0.54104,0.51568,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,6.5896e-07,0.54029,0.50175,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00037661,0.53478,0.51701,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00021167,0.53459,0.44668,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.001662,0.53424,0.36439,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0032441,0.53143,0.34126,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,4.2876e-06,0.53083,0.49729,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.0779e-06,0.52289,0.49522,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.6455e-05,0.51953,0.5755,1,1
2,GO ZINC ION HOMEOSTASIS,0.0071468,0.51385,0.35525,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00027832,0.51167,0.42703,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.6015e-06,0.50989,0.45418,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00081984,0.5091,0.35871,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.00026903,0.50864,0.47922,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00022676,0.5033,0.42378,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,1.6455e-05,0.50273,0.48734,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,9.389e-05,0.50121,0.5564,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00034072,0.49779,0.36491,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,8.3127e-06,0.49748,0.45719,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0015189,0.48719,0.49569,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00098941,0.48643,0.37082,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,1.9263e-05,0.48444,0.46857,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,8.1192e-05,0.48135,0.36888,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00019079,0.48059,0.48747,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.8077e-06,0.47901,0.42664,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0040578,0.47685,0.4666,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0060989,0.47543,0.42012,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00018427,0.47213,0.54063,1,1
2,GO MUSCLE ATROPHY,0.0037331,0.46832,0.37007,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.7806e-05,0.46809,0.41503,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,8.4205e-05,0.46792,0.40082,1,1
2,GO NEURAL CREST FORMATION,1.349e-05,0.46776,0.42292,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00026003,0.46656,0.37616,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.043763,0.46427,0.22669,1,1
2,GO TOLERANCE INDUCTION,0.0060989,0.46153,0.34028,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,0.00012964,0.46114,0.36601,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0019282,0.46104,0.38707,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.7343e-05,0.45356,0.35724,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00037661,0.45266,0.33998,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00018427,0.45158,0.44046,1,1
2,GO MICROVILLUS ASSEMBLY,0.0001547,0.4514,0.42248,1,1
2,GO RESPONSE TO INTERFERON BETA,0.016734,0.4508,0.29331,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00098941,0.45013,0.38732,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00027832,0.44826,0.39212,1,1
2,GO NEPHRON TUBULE FORMATION,0.0028957,0.44818,0.31059,1,1
2,GO RESPONSE TO COPPER ION,0.018398,0.44757,0.32373,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,1.2962e-05,0.44716,0.43722,1,1
2,GO ETHANOL METABOLIC PROCESS,4.2876e-06,0.44613,0.52245,1,1
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.05161,0.44602,0.32164,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00017796,0.4453,0.42189,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00037661,0.44499,0.42706,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.2139e-05,0.44416,0.39271,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00024286,0.44394,0.31663,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00017796,0.4423,0.29176,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0006154,0.44006,0.40278,1,1
2,GO OTIC VESICLE MORPHOGENESIS,0.00037661,0.43886,0.42153,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0022332,0.43843,0.4151,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,4.2876e-06,0.4377,0.43006,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,1.104e-05,0.43697,0.42542,1,1
2,GO DENDRITIC CELL MIGRATION,1.5201e-05,0.43567,0.39949,1,1
2,GO LIPID DROPLET FORMATION,0.014138,0.43462,0.36832,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,8.1192e-05,0.43392,0.49982,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0018173,0.43185,0.41357,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.0001165,0.43141,0.52034,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,1.2454e-05,0.43137,0.36932,1,1
2,GO CYTIDINE TO URIDINE EDITING,0.024288,0.43033,0.38887,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0079323,0.42715,0.27452,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,1.0604e-05,0.42388,0.36831,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,2.0833e-05,0.42156,0.43825,1,1
2,GO REGULATION OF GLOMERULAR FILTRATION,0.017969,0.42068,0.34652,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.001228,0.42048,0.29311,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,2.4692e-06,0.41888,0.40345,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,3.9418e-06,0.4178,0.3897,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0046564,0.4166,0.37787,1,1
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0019282,0.41321,0.39375,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,2.7343e-05,0.41126,0.32383,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,4.0073e-05,0.41095,0.36906,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.2962e-05,0.4109,0.36776,1,1
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.0053338,0.40971,0.34198,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.0020453,0.40915,0.33678,1,1
2,GO RETINAL METABOLIC PROCESS,0.030383,0.40901,0.28392,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0024367,0.40856,0.31171,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00016595,0.40779,0.33981,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00014935,0.40752,0.45601,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00016023,0.40692,0.40904,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0064317,0.40642,0.29103,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.022165,0.40594,0.31691,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.019739,0.40544,0.23868,1,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00040247,0.40539,0.3318,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.00027832,0.40469,0.26668,1,1
2,GO RESPONSE TO CADMIUM ION,0.00054072,0.40414,0.31455,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0006154,0.40363,0.29582,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00054072,0.40256,0.26992,1,1
2,GO REGULATION OF PROTEIN IMPORT,9.389e-05,0.40199,0.30224,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00010462,0.40029,0.31953,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00025131,0.39978,0.35106,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.1904e-06,0.39783,0.3819,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,4.8379e-05,0.39768,0.35944,1,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.013798,0.39751,0.30458,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00012512,0.39577,0.30934,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0010528,0.39496,0.34653,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0024367,0.39345,0.3306,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00063551,0.39103,0.35974,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00092958,0.39073,0.3414,1,1
2,GO PORE COMPLEX ASSEMBLY,4.2876e-06,0.39017,0.38489,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,9.0551e-05,0.38945,0.37701,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,3.1888e-05,0.38885,0.39012,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.0069616,0.38851,0.35244,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.024288,0.38821,0.24284,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.031748,0.38807,0.23201,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,1.4963e-07,0.38804,0.41069,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.0029794,0.3878,0.29031,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.024288,0.38674,0.25958,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.2962e-05,0.38659,0.34151,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00059588,0.38625,0.36174,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.012508,0.38383,0.2473,1,1
2,GO HEME METABOLIC PROCESS,0.00025131,0.38291,0.33374,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,4.6597e-05,0.3795,0.46054,1,1
2,GO OXYGEN TRANSPORT,0.052669,0.37796,0.35927,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017123,0.3771,0.2987,1,1
2,GO T CELL MEDIATED IMMUNITY,0.00027832,0.37695,0.30853,1,1
2,GO LIMB BUD FORMATION,0.0041716,0.37637,0.44951,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.6228e-06,0.37556,0.35611,1,1
2,GO RESPONSE TO TYPE I INTERFERON,0.015574,0.37514,0.24917,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.001986,0.37456,0.25527,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.5759e-05,0.37397,0.32954,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.016339,0.37372,0.24906,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0017123,0.37248,0.32492,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00026003,0.37228,0.29748,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,8.7323e-05,0.37205,0.49353,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0007696,0.37187,0.26008,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,4.1112e-06,0.3715,0.35127,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.0032441,0.37038,0.26839,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.035393,0.37,0.26802,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.5816e-05,0.36991,0.33023,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,4.4712e-06,0.36845,0.34307,1,1
2,GO RESPONSE TO TUMOR CELL,0.0023671,0.36774,0.31462,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0012662,0.36619,0.32638,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,8.3127e-06,0.36538,0.3695,1,1
2,GO PENTOSE METABOLIC PROCESS,0.00010462,0.36507,0.36149,1,1
2,GO CYTOPLASM ORGANIZATION,5.4121e-05,0.36327,0.39834,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00025131,0.36195,0.33315,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00044439,0.36173,0.31755,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00016023,0.36165,0.32376,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.4712e-06,0.36038,0.33692,1,1
2,GO CYSTEINE METABOLIC PROCESS,0.0027346,0.35924,0.29844,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0027346,0.35876,0.33954,1,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.016339,0.35757,0.31504,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.00057693,0.35743,0.24475,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00013433,0.35729,0.29084,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00016023,0.35727,0.31841,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00012074,0.35702,0.32327,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0064317,0.35689,0.34987,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.1192e-05,0.35675,0.33144,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0017123,0.35603,0.34989,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.00040247,0.35543,0.29418,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0045306,0.3545,0.27943,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.00012512,0.35413,0.31449,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.00013917,0.35359,0.30428,1,1
2,GO CARNITINE SHUTTLE,7.6603e-06,0.35351,0.37375,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00010092,0.35346,0.33155,1,1
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0087944,0.35338,0.25851,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,1.7118e-05,0.35275,0.36381,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.037747,0.35217,0.2992,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0040578,0.35152,0.27118,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.0059384,0.35118,0.27656,1,1
2,GO MICROVILLUS ORGANIZATION,0.00055855,0.35037,0.39383,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,5.0683e-06,0.3499,0.32162,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00092958,0.3485,0.27632,1,1
2,GO FATTY ACID HOMEOSTASIS,0.012203,0.34829,0.21907,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00045924,0.34785,0.30996,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00027832,0.34747,0.25525,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0029794,0.34625,0.21492,1,1
2,GO URETER DEVELOPMENT,0.0034322,0.34427,0.33211,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0037331,0.34406,0.29859,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0001165,0.3421,0.31532,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0013872,0.34153,0.27522,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00017796,0.34132,0.29219,1,1
2,GO REGULATION OF DNA METHYLATION,2.0833e-05,0.34129,0.28342,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0015189,0.3393,0.31898,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.001986,0.33906,0.25514,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0059384,0.3388,0.24726,1,1
2,GO TONGUE MORPHOGENESIS,0.011047,0.33749,0.303,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.026586,0.33733,0.21069,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,2.5308e-05,0.33665,0.34704,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.0028141,0.33597,0.23705,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0026572,0.3355,0.24165,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00029782,0.33545,0.49472,1,1
2,GO DETOXIFICATION,7.2754e-05,0.33512,0.27847,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0001165,0.33505,0.47953,1,1
2,GO ERBB2 SIGNALING PATHWAY,4.3218e-05,0.33492,0.30443,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,5.4121e-05,0.33484,0.31965,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.04854,0.33405,0.19039,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0011199,0.33393,0.39075,1,1
2,GO RNA DECAPPING,0.00013433,0.33388,0.21463,1,1
2,GO MONONUCLEAR CELL MIGRATION,7.2754e-05,0.33378,0.27952,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,7.8282e-05,0.33295,0.35289,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00019079,0.33228,0.30267,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.02268,0.33166,0.34633,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013917,0.33162,0.29239,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00095906,0.33141,0.3427,1,1
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.018836,0.33026,0.25781,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,6.5149e-05,0.3288,0.28829,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00081984,0.32825,0.26775,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.00021909,0.3282,0.32632,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00059588,0.32799,0.2687,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00069957,0.32791,0.25665,1,1
2,GO REGULATION OF CELL KILLING,0.0018173,0.32791,0.24161,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.0021062,0.32767,0.53155,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,0.00012964,0.32632,0.27534,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00026903,0.32536,0.25176,1,1
2,GO RESPIRATORY BURST,0.0011199,0.32518,0.25552,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.0014299,0.32514,0.3733,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0027346,0.32427,0.21658,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0017641,0.32395,0.26655,1,1
2,GO ARACHIDONIC ACID SECRETION,1.5201e-05,0.3226,0.32773,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00084609,0.32251,0.3487,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32232,0.29728,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.016734,0.32212,0.18412,1,1
2,GO RETINOL METABOLIC PROCESS,0.00042998,0.32205,0.28646,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0014299,0.32142,0.41259,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0031536,0.32113,0.24478,1,1
2,GO PRE MIRNA PROCESSING,0.0041716,0.32085,0.20758,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00013917,0.32056,0.27405,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0083534,0.3199,0.30743,1,1
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.0050528,0.31889,0.23593,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.011904,0.31851,0.2641,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,2.0033e-05,0.31787,0.28401,1,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.0057817,0.31773,0.33175,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,8.1192e-05,0.31732,0.29313,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0081404,0.31708,0.24972,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0022332,0.31689,0.32071,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.0062634,0.31634,0.24643,1,1
2,GO REGULATION OF PLATELET ACTIVATION,0.014486,0.31597,0.19437,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0041716,0.31534,0.20408,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0046564,0.31446,0.28646,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.013465,0.31384,0.27947,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.020205,0.31381,0.26071,1,1
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.013465,0.31361,0.33393,1,1
2,GO PIGMENT GRANULE MATURATION,0.013465,0.31312,0.24673,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00035231,0.31289,0.30129,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0069616,0.31253,0.24244,1,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.007729,0.31196,0.36739,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00010462,0.3119,0.27631,1,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.043763,0.31177,0.23316,1,1
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.02068,0.31157,0.24279,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.9263e-05,0.31107,0.25586,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.02268,0.31001,0.18323,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00035231,0.30986,0.23628,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.00092958,0.30978,0.24417,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.3218e-05,0.30971,0.29858,1,1
2,GO RENAL VESICLE DEVELOPMENT,0.0010528,0.30936,0.27827,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0032441,0.30912,0.2679,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.025994,0.30869,0.24466,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.00034072,0.30825,0.33195,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0017123,0.3082,0.33268,1,1
2,GO RESPONSE TO SALT STRESS,0.0051916,0.3082,0.23213,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0021062,0.30775,0.3256,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010206,0.30773,0.2203,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00026903,0.30761,0.27062,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.021165,0.30733,0.18588,1,1
2,GO AMP METABOLIC PROCESS,0.017969,0.30722,0.22049,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,7.8282e-05,0.30675,0.2752,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0030654,0.30673,0.21157,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00063551,0.30664,0.30688,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.001986,0.30655,0.38834,1,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.011612,0.30645,0.22615,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00042998,0.30575,0.27796,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0006154,0.30557,0.27656,1,1
2,GO OVULATION,0.00054072,0.30483,0.30405,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0071468,0.30433,0.36471,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00036427,0.30427,0.35045,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0056288,0.30369,0.26188,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00035231,0.30352,0.27679,1,1
2,GO KERATINOCYTE PROLIFERATION,0.014486,0.30281,0.30266,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.00087311,0.30237,0.2419,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,3.17e-07,0.30193,0.27736,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0013872,0.30179,0.29363,1,1
2,GO ENTRY INTO HOST,0.0011199,0.30169,0.25336,1,1
2,GO AMINE CATABOLIC PROCESS,0.0024367,0.30063,0.32948,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.027803,0.29992,0.29087,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0011549,0.2998,0.22468,1,1
2,GO REGULATION OF HAIR CYCLE,0.00019079,0.29966,0.3125,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00017796,0.29935,0.31077,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0013054,0.2993,0.33509,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.0020453,0.29848,0.30055,1,1
2,GO RESPONSE TO GONADOTROPIN,0.0040578,0.29827,0.22173,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,2.5308e-05,0.29814,0.31352,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00054072,0.29764,0.24553,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0036303,0.29721,0.32086,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00090094,0.29655,0.2436,1,1
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.040234,0.29623,0.2444,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.00022676,0.29587,0.25043,1,1
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.025994,0.29583,0.40992,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0016129,0.29582,0.1969,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00092958,0.29556,0.22302,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,2.6902e-06,0.29545,0.28057,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0017123,0.29527,0.27013,1,1
2,GO NUCLEAR PORE ORGANIZATION,1.6455e-05,0.29527,0.33608,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0010206,0.29504,0.21297,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0054795,0.29495,0.23478,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00038934,0.29478,0.2612,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,4.8379e-05,0.29462,0.27054,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00028792,0.29355,0.23338,1,1
2,GO RIG I SIGNALING PATHWAY,2.4346e-05,0.29343,0.2764,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.001191,0.29317,0.25953,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0036303,0.29291,0.20425,1,1
2,GO PODOSOME ASSEMBLY,0.001662,0.29268,0.26744,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0059384,0.29261,0.19283,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.4205e-05,0.29244,0.23692,1,1
2,GO GASTRIC ACID SECRETION,0.00067758,0.29234,0.25262,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0099891,0.29226,0.15635,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.2754e-05,0.29144,0.27489,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00032948,0.29142,0.27593,1,1
2,GO MATURATION OF LSU RRNA,0.0024367,0.29137,0.26677,1,1
2,GO ZYMOGEN INHIBITION,0.01282,0.29042,0.24983,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00042998,0.28928,0.23931,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.013465,0.289,0.22337,1,1
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0090226,0.28848,0.24004,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0054795,0.28817,0.26664,1,1
2,GO REGULATION OF ANOIKIS,0.036164,0.28745,0.20045,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0006154,0.28728,0.23404,1,1
2,GO EPIBOLY,0.052669,0.28686,0.16399,1,1
2,GO T CELL APOPTOTIC PROCESS,0.0001165,0.28681,0.26426,1,1
2,GO FEVER GENERATION,0.0056288,0.28659,0.22255,1,1
2,GO BLASTODERM SEGMENTATION,0.02268,0.28649,0.27786,1,1
2,GO FIBROBLAST ACTIVATION,0.00087311,0.28636,0.31968,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.041967,0.28634,0.16192,1,1
2,GO GAS TRANSPORT,0.031059,0.28628,0.30133,1,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.023205,0.2862,0.19931,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0054795,0.28588,0.21792,1,1
2,GO RESPONSE TO ZINC ION,0.011612,0.28585,0.24228,1,1
2,GO PEPTIDE CROSS LINKING,0.0099891,0.28569,0.23073,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,2.8418e-05,0.28525,0.28383,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.011326,0.28525,0.42507,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00044439,0.28519,0.27815,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00054072,0.28517,0.23255,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00030804,0.28461,0.28543,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,2.0833e-05,0.28428,0.30871,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00018427,0.28381,0.25371,1,1
2,GO REGULATION OF NEURON MATURATION,0.0051916,0.28348,0.28528,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00010092,0.28324,0.23119,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0032441,0.28291,0.34393,1,1
2,GO REGULATION OF CELL PROJECTION SIZE,0.052669,0.28251,0.25312,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.018398,0.28248,0.19913,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,6.2367e-06,0.28243,0.3279,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,3.4421e-05,0.28207,0.29663,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00028792,0.28197,0.24546,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0033369,0.28166,0.19945,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00017186,0.28143,0.23088,1,1
2,GO REGULATION OF LIPASE ACTIVITY,4.6597e-05,0.2814,0.22706,1,1
2,GO RESPONSE TO X RAY,4.1617e-05,0.2813,0.3526,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00013433,0.28127,0.26252,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.040234,0.28097,0.17264,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00036427,0.28074,0.2423,1,1
2,GO INTERLEUKIN 2 PRODUCTION,5.0226e-05,0.2807,0.25705,1,1
2,GO HYPEROSMOTIC RESPONSE,0.0007696,0.28062,0.29481,1,1
2,GO INTESTINAL ABSORPTION,0.0022332,0.28038,0.22953,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0018173,0.28019,0.26918,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0067808,0.28016,0.19818,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0019282,0.28014,0.23293,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,8.7323e-05,0.27956,0.23068,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.00067758,0.27951,0.19944,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,0.00030804,0.27925,0.21737,1,1
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.01282,0.27922,0.18811,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0097392,0.27921,0.2342,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00059588,0.27903,0.2003,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.001872,0.27797,0.30575,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.046579,0.27727,0.19456,1,1
2,GO CHROMATIN DISASSEMBLY,0.0012662,0.2771,0.20787,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0057817,0.27696,0.17199,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0032441,0.27671,0.21179,1,1
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.024288,0.27635,0.16237,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00019079,0.27632,0.27004,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.015203,0.27548,0.16518,1,1
2,GO REPLICATIVE SENESCENCE,0.042857,0.27533,0.19251,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0023671,0.27515,0.23931,1,1
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0027346,0.27456,0.20815,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.0010528,0.2742,0.24246,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,9.7801e-06,0.27419,0.241,1,1
2,GO RESPONSE TO OXYGEN RADICAL,8.4205e-05,0.27336,0.21684,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,6.5149e-05,0.27319,0.24784,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00023468,0.27313,0.21221,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0026572,0.27304,0.21533,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.001986,0.27218,0.19685,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.00090094,0.27151,0.29104,1,1
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0013054,0.27143,0.29048,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.038561,0.27104,0.14301,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.021165,0.27102,0.21674,1,1
2,GO VIRAL TRANSLATION,0.00072223,0.27089,0.27046,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.00030804,0.27085,0.31546,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.0045306,0.27052,0.2379,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00026003,0.27047,0.30544,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,0.00027832,0.26954,0.22588,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.0094949,0.26922,0.21313,1,1
2,GO MIRNA METABOLIC PROCESS,8.3127e-06,0.26846,0.21676,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.001662,0.26824,0.24128,1,1
2,GO NOTOCHORD DEVELOPMENT,0.0010528,0.26823,0.46365,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.0021689,0.26793,0.24776,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,2.0033e-05,0.26787,0.23936,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.00021909,0.2673,0.20979,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.029068,0.26705,0.1738,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.2754e-05,0.26701,0.24745,1,1
2,GO MRNA MODIFICATION,0.0028141,0.26692,0.18328,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.017137,0.26689,0.15688,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00037661,0.26664,0.30766,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0054795,0.26658,0.31069,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.0001165,0.26647,0.25284,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0021062,0.26638,0.24496,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00038934,0.26616,0.35106,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0010859,0.26538,0.25349,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.3132e-05,0.26504,0.23458,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0010528,0.26478,0.20545,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,7.8282e-05,0.26444,0.26943,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00021909,0.26442,0.21354,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.013798,0.26394,0.18008,1,1
2,GO NUCLEAR MIGRATION,0.00029782,0.26385,0.22599,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0029794,0.26382,0.22882,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.015574,0.26376,0.23034,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00074557,0.26309,0.24617,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.019283,0.263,0.23464,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00029782,0.26238,0.30319,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00036427,0.26237,0.28573,1,1
2,GO LAMELLIPODIUM ORGANIZATION,5.753e-07,0.26228,0.29381,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0046564,0.26208,0.23692,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.00087311,0.26198,0.23341,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.001986,0.26077,0.2725,1,1
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0039469,0.26074,0.27836,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00037661,0.26047,0.24384,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0049174,0.2603,0.21149,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.014841,0.25967,0.18575,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,9.389e-05,0.25959,0.23136,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0021689,0.25901,0.19005,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,1.2454e-05,0.25898,0.21785,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.00072223,0.25885,0.21181,1,1
2,GO RNA 5 END PROCESSING,0.00059588,0.25877,0.23397,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0060989,0.25875,0.17096,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0010528,0.25857,0.22588,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.013139,0.25807,0.14864,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0037331,0.25792,0.26815,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00027832,0.25791,0.22054,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.00057693,0.25758,0.22215,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.024288,0.2574,0.21532,1,1
2,GO ALDITOL METABOLIC PROCESS,0.0017641,0.25733,0.26785,1,1
2,GO GLYCINE METABOLIC PROCESS,0.022165,0.25724,0.18658,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00050664,0.25706,0.26133,1,1
2,GO INTERFERON ALPHA PRODUCTION,0.0051916,0.25701,0.22583,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.4039e-05,0.25683,0.25484,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0013872,0.25629,0.19146,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0013457,0.25619,0.19472,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0042883,0.25607,0.20325,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,9.7346e-05,0.25506,0.21078,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0022332,0.25469,0.24254,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00019079,0.25449,0.27585,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.0012662,0.25435,0.25095,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,3.7145e-05,0.2542,0.26065,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.0025817,0.25401,0.21436,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00098941,0.25358,0.1825,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0013457,0.25355,0.22008,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.010245,0.25313,0.16637,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.00054072,0.25309,0.2573,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0054795,0.25283,0.23433,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.038561,0.25241,0.12915,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.018398,0.2524,0.2296,1,1
2,GO DNA LIGATION,0.011612,0.25197,0.18291,1,1
2,GO HISTONE H3 K9 ACETYLATION,0.00013433,0.25194,0.23236,1,1
2,GO PINOCYTOSIS,0.0019282,0.25187,0.16377,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.025994,0.25168,0.1741,1,1
2,GO RESPONSE TO PROTOZOAN,0.0059384,0.25164,0.18841,1,1
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.017969,0.2515,0.28059,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.055956,0.25127,0.14702,1,1
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0050528,0.25126,0.29639,1,1
2,GO PLATELET MORPHOGENESIS,2.0833e-05,0.2509,0.26804,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,2.1663e-05,0.25063,0.22057,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.0011549,0.25058,0.26849,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0014299,0.25044,0.26238,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0037331,0.25033,0.17131,1,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0085714,0.25011,0.23783,1,1
2,GO TRNA METHYLATION,0.00023468,0.25004,0.21423,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00027832,0.24986,0.20468,1,1
2,GO NADP METABOLIC PROCESS,0.001662,0.2495,0.25273,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,3.8583e-05,0.24932,0.24223,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00042998,0.249,0.22342,1,1
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00054072,0.24878,0.20723,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0060989,0.2486,0.22163,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00021909,0.24817,0.21717,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00092958,0.24791,0.29018,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.036164,0.24772,0.18861,1,1
2,GO INTERFERON BETA PRODUCTION,0.0029794,0.2477,0.1947,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,4.4878e-05,0.24767,0.23244,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.00067758,0.24754,0.20423,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.021165,0.24712,0.17479,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00098941,0.24712,0.22408,1,1
2,GO VIRAL GENE EXPRESSION,0.0015189,0.24701,0.21533,1,1
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.03245,0.24699,0.23634,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.0007696,0.24684,0.21397,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.0037331,0.24683,0.18532,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.041093,0.24593,0.29827,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0032441,0.2458,0.2246,1,1
2,GO RESPONSE TO IRON ION,0.001872,0.24574,0.25941,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00079435,0.24574,0.18075,1,1
2,GO HISTAMINE SECRETION,0.022165,0.24562,0.24493,1,1
2,GO EPITHELIAL CELL MORPHOGENESIS,0.010506,0.24534,0.28793,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0037331,0.24529,0.21195,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0090226,0.24511,0.2439,1,1
2,GO PROTEASOME ASSEMBLY,0.0034322,0.24489,0.19181,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,5.0226e-05,0.24489,0.28407,1,1
2,GO AMINO ACID ACTIVATION,0.00024286,0.2448,0.26448,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.0010528,0.24478,0.22046,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00059588,0.24443,0.20218,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.00011241,0.24431,0.19351,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.031748,0.24419,0.16749,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00020448,0.24407,0.22614,1,1
2,GO NAD BIOSYNTHETIC PROCESS,0.050569,0.24401,0.15927,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00031859,0.24378,0.22801,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1964e-05,0.24378,0.21156,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028957,0.24346,0.21342,1,1
2,GO CORNIFICATION,0.00016595,0.24305,0.34965,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.00074557,0.24303,0.20213,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.0029794,0.24287,0.23281,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00020448,0.24287,0.2347,1,1
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.011612,0.24259,0.2638,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.011612,0.2422,0.22648,1,1
2,GO LAMELLIPODIUM ASSEMBLY,1.6729e-06,0.24213,0.26439,1,1
2,GO NUCLEUS LOCALIZATION,0.00011241,0.24193,0.21467,1,1
2,GO NEGATIVE T CELL SELECTION,0.015574,0.24185,0.12618,1,1
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.011047,0.24182,0.20943,1,1
2,GO CHEMOKINE PRODUCTION,0.0014299,0.24172,0.23294,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0060989,0.24167,0.27259,1,1
2,GO SECRETION BY TISSUE,0.0011549,0.24153,0.24592,1,1
2,GO NECROTIC CELL DEATH,0.0018173,0.24131,0.21896,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,9.0179e-06,0.24124,0.2168,1,1
2,GO T CELL CHEMOTAXIS,0.00032948,0.24107,0.21522,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.02843,0.24086,0.15424,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00095906,0.24081,0.25904,1,1
2,GO MATURATION OF SSU RRNA,0.001662,0.24052,0.23699,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,5.4121e-05,0.24025,0.24409,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00092958,0.24012,0.18252,1,1
2,GO HISTONE H4 DEACETYLATION,0.00059588,0.2399,0.29027,1,1
2,GO ERYTHROCYTE MATURATION,0.0050528,0.2397,0.308,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.00014418,0.23953,0.20981,1,1
2,GO LIPOXYGENASE PATHWAY,0.016339,0.23946,0.28514,1,1
2,GO LIPID OXIDATION,0.0019282,0.23939,0.17868,1,1
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.010773,0.23916,0.19708,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0010206,0.23909,0.22909,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00042998,0.239,0.22493,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00050664,0.23895,0.23704,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.00072223,0.2387,0.2128,1,1
2,GO VESICLE CARGO LOADING,9.7346e-05,0.23815,0.25402,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00012964,0.23774,0.24273,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.0094949,0.23703,0.17846,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0006154,0.23682,0.19183,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00036427,0.23639,0.24383,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00098941,0.23604,0.21593,1,1
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0037331,0.23596,0.17216,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0023671,0.23589,0.21873,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00059588,0.23544,0.21152,1,1
2,GO T CELL PROLIFERATION,0.00045924,0.23456,0.19729,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.00020448,0.2344,0.19997,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.02268,0.2343,0.20926,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.00069957,0.23381,0.22394,1,1
2,GO REGULATION OF EXIT FROM MITOSIS,0.022165,0.2338,0.12184,1,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.024846,0.23369,0.19094,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0025083,0.23348,0.19523,1,1
2,GO AEROBIC RESPIRATION,0.00065623,0.23303,0.21846,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.001191,0.23278,0.18919,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.00047456,0.23221,0.28855,1,1
2,GO RESPONSE TO MANGANESE ION,0.0011199,0.23176,0.25792,1,1
2,GO B CELL HOMEOSTASIS,0.0019282,0.23163,0.17053,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00012074,0.23162,0.20277,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.001662,0.23157,0.21089,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,5.4121e-05,0.23121,0.2159,1,1
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0042883,0.23111,0.18213,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0028957,0.23105,0.16285,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.00081984,0.23078,0.25649,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0028957,0.23034,0.23424,1,1
2,GO REGULATION OF CELL MATURATION,0.0013872,0.22995,0.20171,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00014935,0.22989,0.17389,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00018427,0.22981,0.19431,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,1.6455e-05,0.22963,0.19865,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.0015189,0.22959,0.24313,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.0025083,0.22954,0.30315,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0014738,0.22949,0.26019,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00040247,0.22941,0.22788,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00065623,0.22911,0.24343,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.020205,0.22907,0.15718,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0013457,0.22905,0.22133,1,1
2,GO LEUKOCYTE PROLIFERATION,0.00019753,0.22891,0.19614,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0037331,0.22863,0.20583,1,1
2,GO APOPTOTIC CELL CLEARANCE,0.0071468,0.22855,0.13161,1,1
2,GO RNA STABILIZATION,0.0031536,0.22835,0.14779,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0050528,0.2283,0.17589,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,7.2111e-07,0.22813,0.22725,1,1
2,GO PEPTIDYL PROLINE MODIFICATION,0.0017123,0.22811,0.17502,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0079323,0.22803,0.14413,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00024286,0.22791,0.2726,1,1
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.02068,0.22781,0.17606,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.017137,0.22749,0.18202,1,1
2,GO PIGMENT GRANULE ORGANIZATION,6.2786e-05,0.22725,0.23686,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.031059,0.22724,0.16795,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.02068,0.22713,0.20259,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,7.0571e-06,0.2271,0.20948,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00055855,0.22708,0.21194,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.010773,0.22703,0.19146,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.001986,0.22678,0.22454,1,1
2,GO THYMUS DEVELOPMENT,0.00010845,0.22665,0.23047,1,1
2,GO PIGMENT METABOLIC PROCESS,0.0028957,0.22658,0.16121,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,7.013e-05,0.22629,0.20706,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.03245,0.2261,0.14778,1,1
2,GO RIBOSOME BIOGENESIS,0.00027832,0.22553,0.21984,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00016595,0.22491,0.17755,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00027832,0.22488,0.23015,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.010506,0.22487,0.20303,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0046564,0.22477,0.24392,1,1
2,GO MATURATION OF 5 8S RRNA,0.0011199,0.22463,0.24671,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0014738,0.22448,0.22367,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0019282,0.22434,0.19006,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.00074557,0.22431,0.24672,1,1
2,GO DETECTION OF OTHER ORGANISM,0.03939,0.22431,0.20817,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0006154,0.2243,0.16535,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028957,0.22393,0.24439,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.010245,0.22382,0.21489,1,1
2,GO PLACENTA DEVELOPMENT,0.0036303,0.22381,0.16946,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00028792,0.22377,0.2177,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0017641,0.22354,0.23738,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0017123,0.22342,0.19961,1,1
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0018173,0.22337,0.26141,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0042883,0.22298,0.1981,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0029794,0.22289,0.19369,1,1
2,GO MAST CELL ACTIVATION,0.014841,0.22042,0.16004,1,1
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.019283,0.22038,0.23344,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,2.7343e-05,0.22038,0.26778,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0032441,0.22023,0.21029,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0010206,0.22014,0.21034,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0021689,0.21939,0.23804,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.013139,0.21926,0.16534,1,1
2,GO MAINTENANCE OF CELL NUMBER,2.4346e-05,0.21917,0.2196,1,1
2,GO B CELL PROLIFERATION,0.00040247,0.21914,0.18678,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.013798,0.21912,0.18772,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00079435,0.21894,0.21932,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.00063551,0.21841,0.21004,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00030804,0.21791,0.20269,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.00045924,0.2177,0.21014,1,1
2,GO POSITIVE CHEMOTAXIS,0.010506,0.21763,0.1521,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.016734,0.21762,0.23038,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.00084609,0.21743,0.21065,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0027346,0.21726,0.15326,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.033894,0.2165,0.1815,1,1
2,GO ALPHA BETA T CELL ACTIVATION,0.00034072,0.21648,0.20019,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00074557,0.21629,0.19606,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,3.7145e-05,0.2162,0.20935,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.0060989,0.21601,0.19606,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.001662,0.2155,0.2018,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0014299,0.21502,0.2156,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.044685,0.21489,0.2091,1,1
2,GO RNA INTERFERENCE,0.0017123,0.21481,0.21314,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0037331,0.21452,0.15839,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0040578,0.2144,0.24133,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,9.7801e-06,0.21428,0.1977,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00012512,0.21418,0.23636,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0049174,0.21407,0.16715,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0071468,0.21405,0.1425,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0097392,0.21398,0.23344,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0054795,0.21338,0.19382,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0019282,0.21293,0.21543,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.022165,0.21288,0.23621,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.00084609,0.21254,0.27225,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00028792,0.21224,0.17853,1,1
2,GO LIVER REGENERATION,0.030383,0.21218,0.15223,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.0057817,0.21216,0.23094,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0049174,0.2118,0.19778,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0071468,0.21164,0.15244,1,1
2,GO B CELL APOPTOTIC PROCESS,0.012203,0.21164,0.15541,1,1
2,GO INTERACTION WITH HOST,0.00055855,0.21138,0.20796,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00098941,0.21117,0.32828,1,1
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.041967,0.21084,0.14995,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0020453,0.21046,0.1734,1,1
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.024846,0.21016,0.15304,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.016339,0.21009,0.16263,1,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.041093,0.20962,0.18583,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0001547,0.20948,0.22336,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.012203,0.20947,0.22035,1,1
2,GO REGULATION OF WATER LOSS VIA SKIN,0.019739,0.20888,0.27086,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.036948,0.20869,0.17986,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0017641,0.20863,0.1711,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.027803,0.20821,0.1536,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,0.0039469,0.20814,0.20148,1,1
2,GO PIGMENT ACCUMULATION,0.0045306,0.20811,0.21149,1,1
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.014138,0.2081,0.2393,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0059384,0.20774,0.27602,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0001547,0.20735,0.24373,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0046564,0.2073,0.19149,1,1
2,GO RRNA MODIFICATION,0.0034322,0.20725,0.18976,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.00031859,0.20714,0.27185,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00035231,0.2071,0.21002,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0010206,0.207,0.15996,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,0.0013872,0.20672,0.17267,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.014138,0.20661,0.19401,1,1
2,GO PERICARDIUM DEVELOPMENT,0.022165,0.20653,0.19549,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0075304,0.20642,0.15073,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0010859,0.20632,0.20475,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0025083,0.20625,0.21288,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.017137,0.20598,0.17327,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0015189,0.20592,0.20876,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.026586,0.20571,0.12543,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0038387,0.20555,0.20768,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.023741,0.20547,0.12743,1,1
2,GO SKIN DEVELOPMENT,0.001986,0.20541,0.22053,1,1
2,GO REGULATION OF IMMUNE RESPONSE,0.0013054,0.20516,0.14625,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.045624,0.20513,0.17134,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00023468,0.20513,0.1746,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00081984,0.20511,0.21547,1,1
2,GO VIRAL GENOME REPLICATION,0.0099891,0.2051,0.18221,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0053338,0.20464,0.22031,1,1
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.001986,0.20434,0.25067,1,1
2,GO BLASTOCYST FORMATION,0.00025131,0.20426,0.20032,1,1
2,GO NCRNA PROCESSING,0.00035231,0.20423,0.1893,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.00045924,0.20416,0.18162,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,1.7806e-05,0.20398,0.23825,1,1
2,GO MAST CELL MEDIATED IMMUNITY,0.02268,0.20373,0.16666,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00063551,0.20371,0.17875,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.001662,0.20357,0.22121,1,1
2,GO L SERINE METABOLIC PROCESS,0.055956,0.20349,0.21095,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.0019282,0.20329,0.23509,1,1
2,GO NAD METABOLIC PROCESS,0.031059,0.20321,0.1746,1,1
2,GO COPPER ION TRANSPORT,0.0046564,0.2032,0.22689,1,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.007729,0.20314,0.20924,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0049174,0.20306,0.23644,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.0020453,0.20281,0.18023,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.001872,0.20275,0.16731,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0025083,0.20259,0.14419,1,1
2,GO ANOIKIS,0.038561,0.20251,0.14436,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00065623,0.20244,0.18112,1,1
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0060989,0.2022,0.18738,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.013798,0.20216,0.19854,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.019739,0.20196,0.13861,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,2.1663e-05,0.20166,0.2097,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0051916,0.20159,0.16163,1,1
2,GO TRNA 5 LEADER REMOVAL,0.00067758,0.20129,0.24237,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.011047,0.20114,0.14344,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00030804,0.20085,0.21447,1,1
2,GO RESPONSE TO ESTROGEN,0.0073363,0.20081,0.16582,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,5.508e-06,0.20069,0.19438,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0069616,0.20066,0.2302,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0067808,0.20049,0.12568,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00016595,0.19988,0.18865,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00031859,0.19984,0.19042,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0010528,0.19979,0.156,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0014738,0.19943,0.13455,1,1
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0059384,0.19935,0.13661,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.040234,0.19931,0.12318,1,1
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.009256,0.19912,0.15568,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0025817,0.19911,0.19752,1,1
2,GO RIBOSOME ASSEMBLY,0.0067808,0.199,0.19992,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.02843,0.19854,0.1354,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00049035,0.19835,0.17979,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0037331,0.1983,0.16934,1,1
2,GO FOREGUT MORPHOGENESIS,0.009256,0.19825,0.3116,1,1
2,GO LENS FIBER CELL DEVELOPMENT,0.038561,0.19816,0.18863,1,1
2,GO RNA METHYLATION,0.0015653,0.19798,0.14932,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00057693,0.19779,0.19057,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.016339,0.19763,0.13289,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00020448,0.1976,0.20678,1,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.036164,0.19752,0.16611,1,1
2,GO T CELL DIFFERENTIATION,0.00032948,0.19752,0.16702,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0014299,0.19743,0.17276,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.027803,0.19717,0.13809,1,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.011326,0.19686,0.19925,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0024367,0.1966,0.16787,1,1
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.021165,0.19626,0.14354,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.038561,0.19613,0.12612,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0073363,0.19613,0.15399,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.019739,0.19535,0.15663,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.019739,0.19525,0.12771,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.00353,0.19519,0.20761,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.013139,0.19516,0.28637,1,1
2,GO FATTY ACID BETA OXIDATION,0.011047,0.19511,0.14123,1,1
2,GO INNATE IMMUNE RESPONSE,0.001986,0.19506,0.1691,1,1
2,GO RRNA METABOLIC PROCESS,0.00027832,0.1949,0.20374,1,1
2,GO REGULATION OF GENE SILENCING,4.8612e-06,0.19462,0.20349,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.009256,0.19456,0.14542,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,8.4205e-05,0.19414,0.21816,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.023205,0.19381,0.1956,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0011199,0.19372,0.13216,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0010206,0.19365,0.17161,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.0022992,0.19339,0.21419,1,1
2,GO TRANSLATIONAL TERMINATION,0.0027346,0.19306,0.19887,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0087944,0.19283,0.17801,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.016339,0.19272,0.16795,1,1
2,GO INTERACTION WITH SYMBIONT,0.00026903,0.19257,0.20834,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0062634,0.1925,0.15555,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.9904e-06,0.19239,0.18629,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.050569,0.19232,0.11235,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.013465,0.19219,0.13922,1,1
2,GO AXIS ELONGATION,0.0097392,0.19211,0.2848,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.001228,0.19208,0.19615,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.011047,0.19184,0.20818,1,1
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0062634,0.19174,0.17703,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0060989,0.19174,0.2469,1,1
2,GO T CELL CYTOKINE PRODUCTION,0.0024367,0.19156,0.20594,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.0050528,0.19154,0.16458,1,1
2,GO RESPONSE TO ANTIBIOTIC,2.8418e-05,0.19137,0.23197,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.00020448,0.19126,0.21776,1,1
2,GO AMYLOID BETA CLEARANCE,0.019739,0.19123,0.13591,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.050569,0.19099,0.12503,1,1
2,GO REGULATION OF CELL CELL ADHESION,0.0017641,0.19091,0.16072,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00079435,0.19076,0.16418,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.02268,0.19061,0.21531,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0028141,0.19059,0.16051,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00040247,0.19058,0.16171,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00022676,0.19043,0.19647,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,0.00055855,0.19033,0.15573,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,8.3127e-06,0.19023,0.1871,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.021165,0.19022,0.26321,1,1
2,GO TRNA METABOLIC PROCESS,0.00016023,0.19017,0.18126,1,1
2,GO CELL CELL JUNCTION ASSEMBLY,0.0051916,0.18995,0.16379,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.018398,0.1897,0.17229,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00034072,0.18938,0.18439,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0038387,0.18892,0.16421,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00090094,0.18885,0.1903,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0042883,0.18878,0.17805,1,1
2,GO NCRNA METABOLIC PROCESS,0.00032948,0.18855,0.17732,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0023671,0.18838,0.16374,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.0015653,0.18805,0.19001,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0037331,0.18792,0.17383,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0028957,0.18782,0.16711,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00087311,0.18768,0.16801,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0069616,0.18723,0.14593,1,1
2,GO COPPER ION HOMEOSTASIS,0.013139,0.18705,0.16522,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,4.0073e-05,0.18692,0.19612,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0030654,0.1868,0.14439,1,1
2,GO LUNG MORPHOGENESIS,0.036948,0.18659,0.24343,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00026003,0.18629,0.21795,1,1
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.03245,0.18627,0.1601,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.02268,0.18611,0.12704,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.00010462,0.18602,0.20369,1,1
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00063551,0.18586,0.15521,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.015574,0.18579,0.16367,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00012512,0.18563,0.20959,1,1
2,GO DETERMINATION OF ADULT LIFESPAN,0.007729,0.18552,0.22702,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,4.8379e-05,0.18533,0.23102,1,1
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.03245,0.18516,0.17653,1,1
2,GO RENAL TUBULE DEVELOPMENT,0.011047,0.18513,0.16739,1,1
2,GO HAIR CELL DIFFERENTIATION,0.017549,0.18506,0.15097,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.010506,0.18495,0.12317,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,3.8583e-05,0.18464,0.21591,1,1
2,GO REGULATION OF CELL ACTIVATION,0.0010859,0.18456,0.14835,1,1
2,GO TRANSLATIONAL INITIATION,0.045624,0.18407,0.13832,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.019739,0.18404,0.14282,1,1
2,GO TRNA TRANSPORT,2.0833e-05,0.18397,0.22942,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0053338,0.18396,0.19912,1,1
2,GO HIPPO SIGNALING,0.0018173,0.18384,0.32016,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00098941,0.18306,0.1447,1,1
2,GO B CELL MEDIATED IMMUNITY,0.0087944,0.1829,0.14051,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0085714,0.18284,0.1169,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00035231,0.18279,0.17709,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017549,0.18274,0.15102,1,1
2,GO MITOTIC CYTOKINETIC PROCESS,0.02268,0.18272,0.13994,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0007696,0.18267,0.19543,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.00081984,0.18251,0.16062,1,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.015574,0.18228,0.15129,1,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.022165,0.18227,0.12265,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0023671,0.18222,0.14845,1,1
2,GO TRNA MODIFICATION,0.00090094,0.18139,0.15525,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0064317,0.18127,0.16999,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.045624,0.18121,0.1291,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,0.013139,0.18094,0.14169,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.00014935,0.18092,0.17464,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0027346,0.18087,0.17964,1,1
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.009256,0.18057,0.19352,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00014935,0.18052,0.20123,1,1
2,GO T HELPER CELL LINEAGE COMMITMENT,0.046579,0.18045,0.14899,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028141,0.18025,0.16434,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.022165,0.18014,0.17917,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.00055855,0.18012,0.21663,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0024367,0.17973,0.17892,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.043763,0.1796,0.11918,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.019739,0.17949,0.14288,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00036427,0.17903,0.21535,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00025131,0.17881,0.18496,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00011241,0.17868,0.18554,1,1
2,GO CYTOKINETIC PROCESS,0.0071468,0.17864,0.15921,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0045306,0.17854,0.1458,1,1
2,GO FATTY ACID TRANSPORT,9.389e-05,0.17825,0.19755,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0057817,0.17817,0.17704,1,1
2,GO RESPONSE TO CYTOKINE,0.0041716,0.17803,0.1391,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0010206,0.17797,0.25,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,0.00027832,0.17781,0.15193,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,9.7346e-05,0.1777,0.18996,1,1
2,GO RNA MODIFICATION,0.00040247,0.17762,0.15024,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.054842,0.17757,0.093414,1,1
2,GO T CELL ACTIVATION,0.0013872,0.17736,0.15861,1,1
2,GO SYMBIOTIC PROCESS,6.7596e-05,0.17731,0.17533,1,1
2,GO EMBRYO IMPLANTATION,0.050569,0.17722,0.13585,1,1
2,GO LIPID MODIFICATION,0.0014299,0.17696,0.14774,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001662,0.17693,0.18314,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0019282,0.17658,0.1454,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,9.0551e-05,0.17655,0.16811,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.03245,0.17633,0.15215,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00049035,0.17614,0.20246,1,1
2,GO TONGUE DEVELOPMENT,0.025994,0.176,0.22322,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,0.023741,0.17591,0.1246,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0030654,0.17587,0.15364,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0047853,0.17583,0.16438,1,1
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0030654,0.17578,0.20225,1,1
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.03245,0.17563,0.13733,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0054795,0.17553,0.14544,1,1
2,GO TRANSLATIONAL ELONGATION,0.02068,0.17542,0.14399,1,1
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.045624,0.17541,0.1787,1,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.011047,0.17538,0.14702,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0028957,0.17527,0.16111,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0083534,0.17514,0.13257,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.019739,0.17509,0.17737,1,1
2,GO ERBB SIGNALING PATHWAY,0.0010206,0.17493,0.15465,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0030654,0.1743,0.1551,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.011047,0.17429,0.13322,1,1
2,GO RNA POLYADENYLATION,0.00063551,0.17428,0.14933,1,1
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.020205,0.17427,0.17278,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00092958,0.17409,0.1513,1,1
2,GO HISTONE DEUBIQUITINATION,0.00052342,0.17402,0.15329,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0073363,0.17385,0.12521,1,1
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.05161,0.17372,0.12184,1,1
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,6.2786e-05,0.1737,0.20019,1,1
2,GO SPLEEN DEVELOPMENT,0.017137,0.17344,0.15127,1,1
2,GO VIRAL LIFE CYCLE,0.00079435,0.17329,0.18862,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.046579,0.17327,0.11651,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0011549,0.17325,0.20163,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0066042,0.17321,0.23783,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0062634,0.1732,0.15691,1,1
2,GO FATTY ACID CATABOLIC PROCESS,0.019283,0.17318,0.12077,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.019739,0.17289,0.20208,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.00047456,0.17257,0.20396,1,1
2,GO ANIMAL ORGAN REGENERATION,0.03939,0.17246,0.10909,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0024367,0.17229,0.15263,1,1
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0079323,0.17227,0.15365,1,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.022165,0.17223,0.1857,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.054842,0.17214,0.11679,1,1
2,GO B CELL DIFFERENTIATION,0.0012662,0.1721,0.1543,1,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.0042883,0.17195,0.19675,1,1
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.013798,0.17195,0.22173,1,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0040578,0.17174,0.13136,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.0073363,0.17144,0.19473,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0051916,0.17113,0.15462,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.010245,0.17097,0.15359,1,1
2,GO TRNA PROCESSING,0.00050664,0.17067,0.16296,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0010859,0.17018,0.16709,1,1
2,GO MYOBLAST DIFFERENTIATION,0.019283,0.17004,0.17795,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.03245,0.16996,0.11762,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00065623,0.16995,0.19388,1,1
2,GO METANEPHROS DEVELOPMENT,0.017137,0.16974,0.16431,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0022992,0.16972,0.16695,1,1
2,GO REGULATION OF PROTEIN MATURATION,0.03939,0.16966,0.15048,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00353,0.16937,0.12769,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0024367,0.16922,0.22885,1,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0012662,0.16906,0.18904,1,1
2,GO REGULATION OF T CELL ACTIVATION,0.0015189,0.16902,0.15855,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.00034072,0.16901,0.16887,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.00059588,0.16894,0.29366,1,1
2,GO SIGNAL PEPTIDE PROCESSING,0.013139,0.16886,0.23377,1,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.041093,0.16862,0.16206,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00050664,0.1686,0.17277,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.012508,0.16844,0.13182,1,1
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.010773,0.16839,0.13461,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00017186,0.16832,0.16593,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.015574,0.16811,0.14101,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0016129,0.16808,0.19014,1,1
2,GO RESPONSE TO SALT,0.00353,0.16808,0.20725,1,1
2,GO REGULATION OF PHAGOCYTOSIS,0.010773,0.16808,0.13078,1,1
2,GO VIRAL RELEASE FROM HOST CELL,0.0015189,0.16801,0.18842,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.011326,0.16774,0.13903,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.0042883,0.16737,0.22011,1,1
2,GO IRON ION HOMEOSTASIS,0.0047853,0.16724,0.1627,1,1
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.014841,0.16685,0.15409,1,1
2,GO IMPORT INTO NUCLEUS,0.012508,0.16674,0.12874,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.010245,0.16661,0.16121,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.001662,0.16659,0.15018,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0022992,0.16654,0.17107,1,1
2,GO CELL KILLING,0.0030654,0.16644,0.16663,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.02843,0.16641,0.13771,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.047551,0.16589,0.22103,1,1
2,GO CYTOKINE PRODUCTION,0.0022992,0.16587,0.1566,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0037331,0.16577,0.16,1,1
2,GO PHOTOPERIODISM,0.0069616,0.16576,0.13363,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.040234,0.16539,0.25299,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0041716,0.16538,0.17239,1,1
2,GO POSITIVE REGULATION OF CELL SIZE,0.0079323,0.16538,0.26635,1,1
2,GO REGULATION OF B CELL ACTIVATION,0.0067808,0.16527,0.13221,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,6.0504e-05,0.1652,0.17858,1,1
2,GO PROTEIN IMPORT,0.001228,0.1648,0.14491,1,1
2,GO IMMUNE EFFECTOR PROCESS,0.0030654,0.16469,0.15468,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.001228,0.16464,0.16989,1,1
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0094949,0.16446,0.18271,1,1
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0062634,0.16431,0.16322,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0014738,0.16408,0.16873,1,1
2,GO RRNA TRANSCRIPTION,0.001662,0.16402,0.21177,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.016734,0.16398,0.1212,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00074557,0.16389,0.22936,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0051916,0.16388,0.13998,1,1
2,GO PHAGOCYTOSIS,0.0045306,0.16382,0.15065,1,1
2,GO ELECTRON TRANSPORT CHAIN,0.0079323,0.16371,0.15018,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0059384,0.16363,0.16907,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.024288,0.1636,0.11428,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.0013054,0.16319,0.13445,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00042998,0.16318,0.15111,1,1
2,GO LEUKOCYTE HOMEOSTASIS,0.01282,0.16306,0.11663,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0015189,0.16303,0.14265,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.035393,0.16299,0.1054,1,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.041093,0.16298,0.094875,1,1
2,GO CYTOKINE METABOLIC PROCESS,0.0024367,0.16281,0.1635,1,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.025994,0.16269,0.2116,1,1
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.029068,0.1624,0.12845,1,1
2,GO POLYAMINE METABOLIC PROCESS,0.0094949,0.16206,0.16189,1,1
2,GO LYMPHOCYTE ACTIVATION,0.0025083,0.16202,0.13023,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.00044439,0.16199,0.20401,1,1
2,GO THIOESTER METABOLIC PROCESS,0.0022992,0.16194,0.20262,1,1
2,GO TRNA 5 END PROCESSING,0.0013457,0.16194,0.20727,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.036164,0.16192,0.18974,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.023205,0.16189,0.13018,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.001662,0.16187,0.13651,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.031748,0.16183,0.087815,1,1
2,GO RNA CATABOLIC PROCESS,0.00027832,0.16163,0.15185,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00054072,0.16152,0.14389,1,1
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0053338,0.16149,0.19295,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.013798,0.1614,0.12187,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.0099891,0.16111,0.11016,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0029794,0.16065,0.13605,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.033166,0.16064,0.17827,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.03245,0.16054,0.15567,1,1
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.042857,0.16028,0.12737,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.041093,0.16015,0.14217,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.001986,0.16015,0.17369,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.044685,0.16011,0.13661,1,1
2,GO TERPENOID METABOLIC PROCESS,0.03245,0.16011,0.12261,1,1
2,GO P BODY ASSEMBLY,0.00052342,0.1601,0.14872,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.001986,0.16009,0.16039,1,1
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.038561,0.16006,0.15004,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0023671,0.1598,0.146,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00081984,0.15975,0.1474,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.001986,0.15962,0.18271,1,1
2,GO GOLGI RIBBON FORMATION,0.0021062,0.15955,0.19872,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.018836,0.15937,0.16294,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.030383,0.15928,0.13488,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00013917,0.15906,0.18565,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.0071468,0.15898,0.12212,1,1
2,GO UBIQUINONE METABOLIC PROCESS,0.02843,0.1588,0.15779,1,1
2,GO HISTONE PHOSPHORYLATION,0.00029782,0.15873,0.14946,1,1
2,GO TISSUE REGENERATION,0.031059,0.15829,0.14439,1,1
2,GO MAMMARY GLAND DEVELOPMENT,0.02166,0.15813,0.13956,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.010506,0.15797,0.14907,1,1
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.055956,0.15794,0.09165,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0085714,0.15793,0.13361,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.0087944,0.15766,0.12523,1,1
2,GO VIRAL RNA GENOME REPLICATION,0.020205,0.15725,0.15004,1,1
2,GO PROTEIN KINASE B SIGNALING,0.015953,0.15722,0.11051,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.0021689,0.15707,0.12169,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.033166,0.15673,0.16502,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0014299,0.15651,0.14866,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.03245,0.15643,0.1097,1,1
2,GO DIGESTION,0.0062634,0.15626,0.13163,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.01282,0.15614,0.12126,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0069616,0.15607,0.13117,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,0.0047853,0.15558,0.14622,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.0013054,0.15536,0.149,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.00036427,0.15532,0.16348,1,1
2,GO INTERLEUKIN 17 PRODUCTION,0.014486,0.15451,0.12793,1,1
2,GO RESPONSE TO ACTIVITY,0.0099891,0.15424,0.11843,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0069616,0.15421,0.14414,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.001872,0.15414,0.16769,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.025414,0.15345,0.10906,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00084609,0.15318,0.17793,1,1
2,GO REGULATION OF HEMOPOIESIS,0.0017123,0.15288,0.13745,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.00035231,0.15285,0.14871,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0022992,0.15279,0.16871,1,1
2,GO REGULATION OF CELL ADHESION,0.0090226,0.15271,0.13805,1,1
2,GO CHYLOMICRON ASSEMBLY,0.026586,0.15267,0.077236,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0038387,0.15267,0.17561,1,1
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.052669,0.15256,0.11892,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0032441,0.15244,0.1509,1,1
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.049546,0.15236,0.096959,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.014486,0.15235,0.15604,1,1
2,GO TRANSCYTOSIS,0.02843,0.15227,0.15234,1,1
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0075304,0.15206,0.17528,1,1
2,GO TOXIN TRANSPORT,0.0079323,0.15187,0.15844,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.013139,0.15155,0.16032,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.014841,0.15144,0.13068,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0067808,0.15115,0.11335,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.001872,0.15105,0.13347,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.00011241,0.15103,0.14014,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.011047,0.15094,0.13957,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,2.1663e-05,0.15066,0.16142,1,1
2,GO GLUCOSE CATABOLIC PROCESS,0.055956,0.15003,0.15935,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.00087311,0.14995,0.15194,1,1
2,GO RECEPTOR CATABOLIC PROCESS,0.01282,0.14971,0.1652,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0010528,0.14967,0.14455,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0021062,0.14964,0.13687,1,1
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0042883,0.14943,0.14726,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0021689,0.14938,0.13876,1,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.025994,0.14926,0.11798,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.010245,0.14916,0.095732,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0028957,0.14896,0.19544,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0011549,0.14883,0.12387,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0024367,0.1487,0.14633,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0026572,0.14853,0.14809,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.0081404,0.14849,0.16018,1,1
2,GO PLATELET ACTIVATION,0.017969,0.14845,0.10847,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00054072,0.14839,0.1388,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0038387,0.14829,0.19003,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00022676,0.14828,0.17852,1,1
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.0022992,0.14824,0.13889,1,1
2,GO GOLGI VESICLE BUDDING,0.0013457,0.1476,0.13131,1,1
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.024288,0.14734,0.18708,1,1
2,GO STEROL METABOLIC PROCESS,0.013465,0.14728,0.12129,1,1
2,GO ERK1 AND ERK2 CASCADE,0.01282,0.14694,0.12869,1,1
2,GO VIRION ASSEMBLY,0.021165,0.14681,0.10152,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.033894,0.14679,0.094209,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.4421e-05,0.14657,0.14489,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0017641,0.14623,0.168,1,1
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.025994,0.14615,0.12304,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00030804,0.14612,0.14149,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,2.9532e-05,0.146,0.15406,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.0067808,0.14588,0.11925,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.035393,0.14583,0.1003,1,1
2,GO HOMOTYPIC CELL CELL ADHESION,0.031748,0.14577,0.17538,1,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00054072,0.1457,0.15254,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00092958,0.14555,0.1381,1,1
2,GO VESICLE TARGETING,0.0027346,0.1451,0.13652,1,1
2,GO GMP METABOLIC PROCESS,0.036164,0.14505,0.14499,1,1
2,GO CELL CHEMOTAXIS,0.017969,0.14491,0.12429,1,1
2,GO INNER EAR MORPHOGENESIS,0.029068,0.14476,0.12327,1,1
2,GO POLYOL METABOLIC PROCESS,0.00087311,0.14471,0.16548,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.022165,0.1447,0.14348,1,1
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0013457,0.14463,0.11285,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.034637,0.14463,0.10995,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.0007696,0.14451,0.13514,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,0.0050528,0.14415,0.13121,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0056288,0.14399,0.1108,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.042857,0.14396,0.15176,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0029794,0.14395,0.20978,1,1
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.054842,0.14392,0.10897,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0041716,0.14388,0.14338,1,1
2,GO IMMATURE B CELL DIFFERENTIATION,0.023741,0.14351,0.18956,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00098941,0.14312,0.154,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.012508,0.14273,0.10702,1,1
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.03939,0.14268,0.14454,1,1
2,GO CD40 SIGNALING PATHWAY,0.020205,0.14264,0.14615,1,1
2,GO EXIT FROM MITOSIS,0.0026572,0.14252,0.12075,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.02268,0.14238,0.16093,1,1
2,GO REGULATION OF SPINDLE ASSEMBLY,0.014486,0.14233,0.15209,1,1
2,GO MALE SEX DIFFERENTIATION,0.001872,0.14224,0.16476,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,3.3132e-05,0.14217,0.19739,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,0.042857,0.14191,0.13632,1,1
2,GO HISTONE H2B UBIQUITINATION,0.013798,0.14186,0.13822,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.052669,0.14184,0.12774,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,5.2139e-05,0.14169,0.17265,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.015953,0.14149,0.13049,1,1
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.01282,0.14133,0.16015,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,2.2524e-05,0.14127,0.13324,1,1
2,GO KERATINOCYTE MIGRATION,0.013139,0.14119,0.16026,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.7118e-05,0.14079,0.15426,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.043763,0.14062,0.12946,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.022165,0.14045,0.14705,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017969,0.14017,0.094122,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0014738,0.13998,0.14186,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.0019282,0.13994,0.15827,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00081984,0.13989,0.17331,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.054842,0.13984,0.085853,1,1
2,GO HISTONE MONOUBIQUITINATION,0.031748,0.13944,0.10114,1,1
2,GO ACTIN NUCLEATION,0.00067758,0.13929,0.17911,1,1
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.030383,0.13926,0.15113,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0069616,0.13915,0.12918,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0057817,0.13914,0.18873,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.055956,0.13866,0.11968,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.0064317,0.13859,0.12636,1,1
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.042857,0.13849,0.22445,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.013465,0.1384,0.12927,1,1
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.023205,0.13839,0.11433,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0073363,0.13836,0.16754,1,1
2,GO REGULATION OF SPINDLE ORGANIZATION,0.026586,0.13835,0.095179,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0041716,0.13793,0.12864,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0085714,0.13782,0.2011,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0020453,0.13778,0.14114,1,1
2,GO INTERLEUKIN 12 PRODUCTION,0.017549,0.13763,0.13812,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0085714,0.13728,0.11616,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.010773,0.13725,0.12264,1,1
2,GO COPII COATED VESICLE BUDDING,0.0010206,0.13715,0.13686,1,1
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.014841,0.13707,0.12927,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.044685,0.13672,0.12212,1,1
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.047551,0.13657,0.072919,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.02166,0.13654,0.12687,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0079323,0.1365,0.1359,1,1
2,GO DEFENSE RESPONSE,0.0075304,0.13626,0.11674,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.00026903,0.13617,0.14444,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.010245,0.13553,0.18123,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0099891,0.1355,0.12225,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.0006154,0.13545,0.14312,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.010773,0.1353,0.11569,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0062634,0.13512,0.17283,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0006154,0.13502,0.12979,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033894,0.13475,0.089668,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.047551,0.13454,0.12382,1,1
2,GO B CELL ACTIVATION,0.0015189,0.13441,0.1286,1,1
2,GO RUFFLE ORGANIZATION,0.010773,0.13434,0.11869,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.026586,0.13434,0.10025,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.027803,0.13417,0.14261,1,1
2,GO DNA GEOMETRIC CHANGE,2.1663e-05,0.13397,0.16621,1,1
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.049546,0.13391,0.10921,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0087944,0.1333,0.14897,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.042857,0.13323,0.13823,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.011326,0.13318,0.11449,1,1
2,GO LIPID METABOLIC PROCESS,0.0014299,0.13283,0.1207,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0022332,0.13275,0.13341,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.010506,0.13272,0.17081,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0036303,0.13268,0.14574,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.036948,0.13211,0.12918,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0017641,0.13208,0.12141,1,1
2,GO CELL ACTIVATION,0.0054795,0.13196,0.1239,1,1
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.018836,0.13121,0.16463,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00014418,0.13118,0.1271,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0015189,0.13063,0.15281,1,1
2,GO CELLULAR PIGMENTATION,0.031748,0.13024,0.13277,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.016339,0.13007,0.11868,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0015189,0.13005,0.11681,1,1
2,GO MRNA TRANSCRIPTION,0.040234,0.12997,0.11816,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0010206,0.12983,0.13545,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00079435,0.12967,0.13235,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0006154,0.12964,0.12101,1,1
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.036948,0.12935,0.10367,1,1
2,GO HISTONE UBIQUITINATION,0.026586,0.12923,0.082941,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.021165,0.12915,0.16777,1,1
2,GO HISTONE H3 DEACETYLATION,0.010245,0.12913,0.12561,1,1
2,GO RESPONSE TO OXYGEN LEVELS,0.01282,0.12907,0.10345,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.015203,0.12902,0.13593,1,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.030383,0.12901,0.12823,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.019739,0.12876,0.13475,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0045306,0.12854,0.11938,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.0053338,0.12848,0.13295,1,1
2,GO NUCLEAR EXPORT,9.7346e-05,0.12813,0.15174,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0041716,0.12802,0.16291,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.015953,0.12784,0.17694,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0032441,0.12779,0.18548,1,1
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.04854,0.12769,0.12032,1,1
2,GO OXIDATIVE DEMETHYLATION,0.02843,0.12765,0.089576,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.0036303,0.12758,0.10873,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0054795,0.12758,0.16716,1,1
2,GO REGULATION OF CELL SHAPE,0.0066042,0.1275,0.15283,1,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.045624,0.1275,0.12351,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.004408,0.1274,0.11354,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0083534,0.12738,0.11286,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0094949,0.1272,0.17817,1,1
2,GO CELL CELL RECOGNITION,0.018836,0.12718,0.11169,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.014841,0.12693,0.14321,1,1
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0046564,0.12692,0.14815,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,0.046579,0.12664,0.097661,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.001872,0.12657,0.12684,1,1
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.041967,0.12621,0.10457,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.025414,0.12617,0.089846,1,1
2,GO MRNA 3 END PROCESSING,0.00040247,0.12614,0.13639,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.0032441,0.1258,0.1349,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.024846,0.12579,0.13586,1,1
2,GO RNA PROCESSING,6.0504e-05,0.12572,0.14203,1,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.014138,0.12563,0.11821,1,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.010245,0.12547,0.12739,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.052669,0.12542,0.09348,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0038387,0.12539,0.091273,1,1
2,GO STEM CELL DIFFERENTIATION,0.0028141,0.12501,0.13406,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.015953,0.12492,0.12201,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.021165,0.12463,0.10483,1,1
2,GO NEPHRON DEVELOPMENT,0.027188,0.12458,0.14006,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.020205,0.12455,0.10261,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.013798,0.12449,0.095218,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.013465,0.12444,0.10184,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0083534,0.12424,0.097072,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.038561,0.124,0.12453,1,1
2,GO BILE ACID METABOLIC PROCESS,0.024288,0.12396,0.13638,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.0029794,0.12386,0.13038,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0025083,0.12344,0.12209,1,1
2,GO RENAL SYSTEM PROCESS,0.030383,0.12339,0.10369,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00095906,0.12331,0.14853,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.017137,0.12326,0.21791,1,1
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0013054,0.12322,0.16026,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00084609,0.12308,0.1176,1,1
2,GO OXIDATION REDUCTION PROCESS,0.0027346,0.12301,0.1333,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0017641,0.12295,0.11378,1,1
2,GO LIPID LOCALIZATION,0.038561,0.12285,0.095788,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0018173,0.12279,0.11406,1,1
2,GO PROTEIN SUMOYLATION,8.4205e-05,0.12271,0.1279,1,1
2,GO RESPONSE TO ETHANOL,0.013139,0.12265,0.11975,1,1
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.014486,0.12263,0.10606,1,1
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0069616,0.12258,0.11553,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00026003,0.12257,0.16349,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.00014418,0.12256,0.15438,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010245,0.12248,0.11397,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0066042,0.12222,0.1239,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0075304,0.12222,0.14242,1,1
2,GO TELOMERE ORGANIZATION,0.0007696,0.12211,0.12203,1,1
2,GO RESPONSE TO STEROID HORMONE,0.034637,0.12193,0.11159,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0056288,0.12183,0.19859,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0011199,0.12162,0.10937,1,1
2,GO CELL CELL ADHESION,0.034637,0.12159,0.091482,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0039469,0.12135,0.12336,1,1
2,GO LEUKOCYTE CHEMOTAXIS,0.030383,0.12124,0.10563,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0053338,0.1206,0.10277,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0045306,0.12049,0.10181,1,1
2,GO RESPONSE TO MUSCLE ACTIVITY,0.027188,0.12038,0.17645,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00012964,0.12029,0.1396,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.010506,0.12024,0.12087,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.018836,0.1202,0.099386,1,1
2,GO EAR MORPHOGENESIS,0.015203,0.12018,0.13486,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0085714,0.1201,0.11336,1,1
2,GO LIPID CATABOLIC PROCESS,0.019739,0.12006,0.090662,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.015953,0.11976,0.099221,1,1
2,GO ENDOCRINE PROCESS,0.0031536,0.11959,0.16383,1,1
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.023205,0.11958,0.13524,1,1
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.016339,0.1194,0.1114,1,1
2,GO BODY FLUID SECRETION,0.0023671,0.11914,0.15461,1,1
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.018836,0.11887,0.09318,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.034637,0.11882,0.094082,1,1
2,GO EPITHELIAL TUBE FORMATION,0.0023671,0.11855,0.15916,1,1
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.025414,0.11843,0.071009,1,1
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.004408,0.11826,0.13239,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.0034322,0.11812,0.10832,1,1
2,GO RESPONSE TO ALCOHOL,0.012203,0.11809,0.11121,1,1
2,GO NUCLEAR TRANSPORT,0.0013872,0.11762,0.1187,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.025414,0.11746,0.21302,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0030654,0.11728,0.12688,1,1
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.03939,0.11727,0.18199,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0069616,0.11667,0.10538,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.02268,0.11658,0.11802,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.017137,0.11644,0.12768,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.0085714,0.11621,0.098042,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.0056288,0.11587,0.11974,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.0015653,0.11565,0.095857,1,1
2,GO REGULATION OF BLOOD PRESSURE,0.054842,0.11563,0.068166,1,1
2,GO GENE SILENCING,7.6603e-06,0.11563,0.13681,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0021689,0.11562,0.11887,1,1
2,GO REGULATION OF ATP METABOLIC PROCESS,0.0085714,0.11552,0.10497,1,1
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0019282,0.11549,0.10724,1,1
2,GO RESPONSE TO UV,0.001228,0.11535,0.13866,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0001547,0.11492,0.13954,1,1
2,GO MRNA CLEAVAGE,0.0014299,0.11434,0.12299,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.019283,0.11418,0.098194,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0028957,0.11405,0.13883,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.047551,0.11371,0.1078,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.0059384,0.11357,0.10836,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00044439,0.11356,0.10551,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00353,0.1134,0.10467,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.04854,0.11334,0.15244,1,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.027188,0.1133,0.11002,1,1
2,GO FATTY ACYL COA METABOLIC PROCESS,0.011326,0.11296,0.21216,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001228,0.11277,0.13123,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.012508,0.11264,0.18798,1,1
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.010245,0.11246,0.12304,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.049546,0.11227,0.096385,1,1
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0034322,0.11225,0.10385,1,1
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.02068,0.11196,0.084379,1,1
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00090094,0.11191,0.11728,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.029068,0.11186,0.085897,1,1
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.011904,0.11181,0.13339,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0060989,0.11169,0.14357,1,1
2,GO TUBE FORMATION,0.0032441,0.11134,0.14733,1,1
2,GO CRISTAE FORMATION,0.043763,0.1113,0.14932,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0053338,0.11128,0.13714,1,1
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.024846,0.11108,0.15877,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0017123,0.11104,0.11219,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.036164,0.11103,0.099056,1,1
2,GO NEURAL TUBE FORMATION,0.017549,0.11103,0.14996,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0099891,0.11076,0.11164,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.054842,0.11037,0.14268,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.009256,0.1101,0.1101,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.042857,0.10998,0.1015,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.020205,0.10997,0.10994,1,1
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0045306,0.10989,0.14065,1,1
2,GO REGULATION OF BODY FLUID LEVELS,0.053746,0.10963,0.078519,1,1
2,GO BASE EXCISION REPAIR,0.0017641,0.10948,0.12533,1,1
2,GO RNA CAPPING,0.012508,0.10943,0.08959,1,1
2,GO CELLULAR RESPIRATION,0.0069616,0.10918,0.16174,1,1
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.05161,0.10809,0.11227,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0027346,0.10774,0.09237,1,1
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.017969,0.10714,0.13318,1,1
2,GO LYMPHOCYTE HOMEOSTASIS,0.042857,0.10707,0.079203,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0097392,0.10676,0.098097,1,1
2,GO MITOCHONDRIAL TRANSPORT,0.0030654,0.10672,0.10737,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.00050664,0.10622,0.14548,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.038561,0.10612,0.10364,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.029719,0.10605,0.11745,1,1
2,GO LIPID PHOSPHORYLATION,0.0067808,0.10597,0.10856,1,1
2,GO RESPONSE TO ISCHEMIA,0.047551,0.10592,0.11868,1,1
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.037747,0.10586,0.10854,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0053338,0.10573,0.088047,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.0025083,0.10567,0.10112,1,1
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.027188,0.10555,0.11587,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00027832,0.10552,0.096532,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0066042,0.10549,0.10086,1,1
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.007729,0.10498,0.095321,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,5.8301e-05,0.10498,0.10638,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.0053338,0.10436,0.10881,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00038934,0.10379,0.096177,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.038561,0.10359,0.098317,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0085714,0.10328,0.084485,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0017123,0.10273,0.10806,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0075304,0.1026,0.11498,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0051916,0.10225,0.10844,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0064317,0.10219,0.10255,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.012203,0.10206,0.089116,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00063551,0.10158,0.13107,1,1
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.055956,0.10157,0.077527,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.013139,0.1014,0.079748,1,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.03939,0.10133,0.076749,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0060989,0.10133,0.12978,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.018398,0.1009,0.11184,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.0079323,0.10071,0.12949,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0045306,0.1007,0.09882,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0010206,0.1005,0.10835,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.03939,0.10048,0.081631,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.02843,0.1002,0.11699,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.013798,0.099889,0.10101,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00024286,0.099248,0.09759,1,1
2,GO MRNA METABOLIC PROCESS,5.0226e-05,0.099237,0.13127,1,1
2,GO PROTEIN MONOUBIQUITINATION,0.021165,0.099211,0.077634,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0025083,0.099083,0.12397,1,1
2,GO MRNA TRANSPORT,0.0025083,0.098822,0.11438,1,1
2,GO POSTREPLICATION REPAIR,0.011047,0.098455,0.085054,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.02843,0.098177,0.078866,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.023741,0.097938,0.092809,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.00028792,0.097545,0.11667,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0033369,0.097412,0.13462,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0046564,0.097258,0.12516,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.016734,0.097231,0.12292,1,1
2,GO POSITIVE REGULATION OF CELL DEATH,0.052669,0.097132,0.079351,1,1
2,GO REGULATION OF CELL DEATH,0.025414,0.097105,0.083289,1,1
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.055956,0.096919,0.061632,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.02166,0.096858,0.06368,1,1
2,GO RNA LOCALIZATION,0.00055855,0.096699,0.12365,1,1
2,GO REGULATION OF CATABOLIC PROCESS,0.0037331,0.096121,0.083705,1,1
2,GO RUFFLE ASSEMBLY,0.054842,0.096081,0.085619,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00081984,0.095996,0.11381,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0025083,0.095835,0.12501,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.031059,0.09533,0.14395,1,1
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.035393,0.094804,0.083684,1,1
2,GO HISTONE DEACETYLATION,0.0039469,0.094723,0.095636,1,1
2,GO DNA METHYLATION,0.0021062,0.09471,0.10823,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.00092958,0.094627,0.095186,1,1
2,GO ENDOSOME ORGANIZATION,0.033894,0.093945,0.10952,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0033369,0.093801,0.10712,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.0028141,0.09369,0.12623,1,1
2,GO SNRNA PROCESSING,0.011612,0.093359,0.040115,1,1
2,GO RESPONSE TO HEAT,0.014841,0.093356,0.12238,1,1
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.03939,0.092935,0.13944,1,1
2,GO DNA CONFORMATION CHANGE,0.0034322,0.092533,0.091714,1,1
2,GO CHROMATIN REMODELING,0.00057693,0.092448,0.11089,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0099891,0.092377,0.10194,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0047853,0.092202,0.12466,1,1
2,GO CELL AGING,0.0094949,0.092119,0.093273,1,1
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0067808,0.0921,0.10134,1,1
2,GO RNA 3 END PROCESSING,0.0030654,0.091576,0.1054,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.014138,0.091224,0.11103,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0007696,0.091177,0.11006,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0087944,0.090846,0.092875,1,1
2,GO REGULATION OF PROTEIN STABILITY,0.0067808,0.090253,0.088782,1,1
2,GO ORGANELLE INHERITANCE,0.054842,0.090197,0.063203,1,1
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.036948,0.089617,0.084111,1,1
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.034637,0.089486,0.069304,1,1
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.047551,0.089093,0.081,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.029719,0.089026,0.12551,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.0085714,0.08902,0.095826,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.00014935,0.088133,0.12202,1,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.023741,0.087968,0.070738,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.036948,0.08791,0.078041,1,1
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0013872,0.087903,0.082981,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.0066042,0.087286,0.11619,1,1
2,GO APOPTOTIC SIGNALING PATHWAY,0.019739,0.08671,0.091473,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0021689,0.086349,0.08411,1,1
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.030383,0.086166,0.083673,1,1
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0041716,0.086131,0.092557,1,1
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.018398,0.085607,0.098805,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0045306,0.085542,0.085438,1,1
2,GO SNRNA METABOLIC PROCESS,0.0028141,0.085496,0.061217,1,1
2,GO MACROMOLECULE CATABOLIC PROCESS,0.0039469,0.084422,0.077314,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.030383,0.08426,0.10566,1,1
2,GO MRNA PROCESSING,0.00090094,0.083295,0.10965,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0010206,0.0828,0.095519,1,1
2,GO HISTONE H3 ACETYLATION,0.00098941,0.082508,0.09296,1,1
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0083534,0.082147,0.10142,1,1
2,GO ARTERY MORPHOGENESIS,0.045624,0.082101,0.12536,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0028957,0.081934,0.10897,1,1
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.031059,0.081626,0.059374,1,1
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.046579,0.081609,0.058324,1,1
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.014841,0.081109,0.085621,1,1
2,GO ERAD PATHWAY,0.018398,0.081021,0.074764,1,1
2,GO NUCLEOTIDE EXCISION REPAIR,0.0075304,0.080918,0.073666,1,1
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.014138,0.080462,0.064576,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.03245,0.079849,0.074503,1,1
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.033166,0.079151,0.082339,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0046564,0.078644,0.093823,1,1
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.011047,0.078536,0.080816,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015574,0.078474,0.086071,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0019282,0.078376,0.093717,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.041967,0.07808,0.083339,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.034637,0.077976,0.098315,1,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.034637,0.077836,0.081767,1,1
2,GO GLUCOSE METABOLIC PROCESS,0.024846,0.077599,0.080629,1,1
2,GO MITOTIC NUCLEAR DIVISION,0.016339,0.07741,0.077965,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.019739,0.077301,0.071534,1,1
2,GO PROTEIN AUTOUBIQUITINATION,0.044685,0.076321,0.072237,1,1
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.049546,0.076054,0.068742,1,1
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.014486,0.075931,0.071861,1,1
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.052669,0.075743,0.079593,1,1
2,GO CELLULAR COMPONENT DISASSEMBLY,0.025994,0.075331,0.071377,1,1
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0094949,0.075052,0.113,1,1
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.014841,0.073885,0.072754,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.014486,0.073541,0.10033,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.02268,0.07269,0.073747,1,1
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.016339,0.072404,0.09783,1,1
2,GO REGULATION OF NUCLEAR DIVISION,0.043763,0.072165,0.067623,1,1
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.010773,0.071944,0.080364,1,1
2,GO RESPONSE TO RADIATION,0.0081404,0.071316,0.065715,1,1
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.05161,0.071034,0.06528,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.011047,0.070441,0.097044,1,1
2,GO MITOTIC CELL CYCLE,0.015953,0.069715,0.066429,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.033894,0.069367,0.059596,1,1
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.025994,0.069301,0.071551,1,1
2,GO REGULATION OF MITOTIC CELL CYCLE,0.011326,0.069181,0.072448,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.02268,0.068676,0.074553,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.0071468,0.067742,0.090376,1,1
2,GO APOPTOTIC PROCESS,0.045624,0.067658,0.066561,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.016734,0.067237,0.085578,1,1
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.029068,0.067231,0.053402,1,1
2,GO DNA MODIFICATION,0.0053338,0.066692,0.070712,1,1
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.011326,0.066442,0.065536,1,1
2,GO RNA SPLICING,0.0022992,0.066339,0.10726,1,1
2,GO PROTEIN CATABOLIC PROCESS,0.03939,0.066325,0.055375,1,1
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.017969,0.066089,0.088841,1,1
2,GO MACROAUTOPHAGY,0.017137,0.065165,0.075515,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.023205,0.064551,0.089223,1,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0040578,0.063603,0.094614,1,1
2,GO REGULATION OF GTPASE ACTIVITY,0.03245,0.063435,0.074552,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.0090226,0.063418,0.067239,1,1
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.038561,0.063063,0.047798,1,1
2,GO DNA METABOLIC PROCESS,0.0013054,0.062911,0.071136,1,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.0083534,0.061012,0.095274,1,1
2,GO REGULATION OF CELL CYCLE PROCESS,0.011612,0.059601,0.069967,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.013798,0.058985,0.076267,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0031536,0.058792,0.067964,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0081404,0.058541,0.069333,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.044685,0.057948,0.047075,1,1
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.027188,0.057595,0.051873,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.012508,0.056633,0.059545,1,1
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.021165,0.056371,0.060009,1,1
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.029068,0.056067,0.06714,1,1
2,GO DNA REPAIR,0.0040578,0.055207,0.073507,1,1
2,GO RESPONSE TO LIGHT STIMULUS,0.03245,0.053593,0.04543,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.040234,0.05087,0.082004,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0039469,0.050312,0.073846,1,1
2,GO REGULATION OF RNA SPLICING,0.043763,0.049487,0.081919,1,1
2,GO DNA METHYLATION OR DEMETHYLATION,0.042857,0.048029,0.061711,1,1
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.02166,0.047228,0.063103,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.020205,0.047121,0.056704,1,1
2,GO CELL CYCLE CHECKPOINT,0.035393,0.046495,0.074418,1,1
2,GO CELL CYCLE PROCESS,0.02068,0.044945,0.057149,1,1
2,GO MITOCHONDRION ORGANIZATION,0.02843,0.044294,0.073419,1,1
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.015203,0.043246,0.075882,1,1
2,GO DNA RECOMBINATION,0.036164,0.043162,0.070728,1,1
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.052669,0.043142,0.081552,1,1
2,GO CHROMOSOME ORGANIZATION,0.012508,0.040902,0.061612,1,1
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.018836,0.040675,0.054048,1,1
2,GO CELL CYCLE,0.036948,0.039103,0.046036,1,1
2,GO COVALENT CHROMATIN MODIFICATION,0.030383,0.036669,0.051737,1,1
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.04854,0.035657,0.048834,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0053338,0.49721,0.39089,1,0
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0006154,0.45211,0.42604,1,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0027346,0.4296,0.38523,1,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.0029794,0.36683,0.45932,1,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.0022332,0.34229,0.33191,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.016339,0.32977,0.33436,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.018836,0.32549,0.25812,1,0
2,GO ENAMEL MINERALIZATION,0.015203,0.31836,0.33205,1,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.019739,0.31618,0.24526,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0017123,0.31043,0.28681,1,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.007729,0.30686,0.2917,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00087311,0.30612,0.27807,1,0
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0045306,0.30532,0.29142,1,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.02068,0.30518,0.32486,1,0
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0083534,0.28927,0.228,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.017137,0.28904,0.22214,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0081404,0.28901,0.23824,1,0
2,GO NADPH REGENERATION,0.001228,0.28635,0.28397,1,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.041967,0.27889,0.25331,1,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0041716,0.27504,0.2264,1,0
2,GO MUSCLE CELL FATE COMMITMENT,0.047551,0.2733,0.23129,1,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.038561,0.27298,0.24242,1,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.023741,0.27233,0.24202,1,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.0085714,0.26511,0.21149,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.009256,0.26253,0.23213,1,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0085714,0.26036,0.26089,1,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.031059,0.25944,0.26543,1,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0014738,0.25733,0.25631,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.010245,0.25369,0.21465,1,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0069616,0.24836,0.31296,1,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.029719,0.24726,0.21941,1,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.049546,0.24275,0.20874,1,0
2,GO CHONDROCYTE PROLIFERATION,0.0066042,0.24022,0.33604,1,0
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00081984,0.23779,0.2466,1,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.053746,0.23499,0.18785,1,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.018398,0.23281,0.33574,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.020205,0.2321,0.2469,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.010773,0.23187,0.19022,1,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0090226,0.23053,0.29403,1,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00055855,0.22963,0.21331,1,0
2,GO GTP METABOLIC PROCESS,0.0047853,0.22831,0.23331,1,0
2,GO TRACHEA DEVELOPMENT,0.013798,0.22787,0.21033,1,0
2,GO HEMIDESMOSOME ASSEMBLY,0.03245,0.21791,0.43331,1,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.054842,0.21779,0.17242,1,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.001872,0.21556,0.23836,1,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.041967,0.21476,0.17827,1,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.036164,0.21353,0.181,1,0
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.03245,0.20715,0.22425,1,0
2,GO SERTOLI CELL DEVELOPMENT,0.0033369,0.2059,0.29154,1,0
2,GO PRO B CELL DIFFERENTIATION,0.038561,0.2057,0.22332,1,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.017969,0.20446,0.17622,1,0
2,GO EPIDERMIS DEVELOPMENT,0.00081984,0.20254,0.22179,1,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0015653,0.20161,0.22526,1,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.043763,0.20136,0.34864,1,0
2,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.024846,0.2011,0.27874,1,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.0079323,0.20095,0.25913,1,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0033369,0.20067,0.17225,1,0
2,GO RENAL ABSORPTION,0.052669,0.19954,0.23913,1,0
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.019283,0.19913,0.14212,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.011047,0.19848,0.18167,1,0
2,GO VASCULOGENESIS,0.04854,0.1984,0.15322,1,0
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.017969,0.19698,0.18296,1,0
2,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.050569,0.19683,0.27294,1,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.018398,0.19643,0.18412,1,0
2,GO EPIDERMAL CELL DIFFERENTIATION,0.00098941,0.1957,0.23398,1,0
2,GO LEFT RIGHT PATTERN FORMATION,0.0057817,0.19557,0.25133,1,0
2,GO POSITIVE REGULATION OF CELL AGING,0.042857,0.19285,0.124,1,0
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.022165,0.19158,0.28384,1,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0018173,0.19051,0.19653,1,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0024367,0.18731,0.18422,1,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.012203,0.18625,0.18954,1,0
2,GO REGULATION OF FATTY ACID OXIDATION,0.014841,0.1857,0.17453,1,0
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.024846,0.18414,0.24789,1,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.0071468,0.18118,0.2891,1,0
2,GO INTERLEUKIN 1 PRODUCTION,0.0090226,0.18054,0.22187,1,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00087311,0.18026,0.16038,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.045624,0.17807,0.13271,1,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.041093,0.17777,0.18323,1,0
2,GO STEM CELL DIVISION,0.004408,0.17471,0.21073,1,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.014841,0.17464,0.16642,1,0
2,GO SPROUTING ANGIOGENESIS,0.014486,0.17307,0.14714,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0060989,0.17122,0.13658,1,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0039469,0.17104,0.15897,1,0
2,GO KERATINIZATION,0.0021689,0.17046,0.24939,1,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.020205,0.16959,0.16849,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.016339,0.16897,0.1822,1,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.044685,0.16858,0.19263,1,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.05161,0.16396,0.18926,1,0
2,GO RESPONSE TO VIRUS,0.010506,0.1634,0.14653,1,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.046579,0.16154,0.12199,1,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.014138,0.16101,0.19763,1,0
2,GO AMELOGENESIS,0.036948,0.15995,0.21045,1,0
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0028141,0.15965,0.16199,1,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.010773,0.15963,0.16808,1,0
2,GO STEROL HOMEOSTASIS,0.033894,0.15773,0.11643,1,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0022332,0.15563,0.1462,1,0
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00059588,0.15548,0.17923,1,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.023205,0.15485,0.19636,1,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0028957,0.15296,0.21283,1,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.053746,0.1525,0.11597,1,0
2,GO MALE SEX DETERMINATION,0.04854,0.15167,0.17923,1,0
2,GO MACROPHAGE MIGRATION,0.013798,0.15037,0.15053,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.023205,0.14915,0.14519,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.037747,0.1481,0.14193,1,0
2,GO MUSCLE CELL MIGRATION,0.024846,0.14797,0.17633,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.055956,0.14728,0.082417,1,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.029068,0.14637,0.34284,1,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.054842,0.1458,0.16692,1,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.014486,0.14448,0.1689,1,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.016339,0.14444,0.13343,1,0
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0099891,0.14348,0.12508,1,0
2,GO GRANULOCYTE MIGRATION,0.052669,0.14284,0.10359,1,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0054795,0.1415,0.19667,1,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0038387,0.14128,0.12604,1,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.015953,0.14105,0.15423,1,0
2,GO MOLTING CYCLE,0.0040578,0.14048,0.18307,1,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.046579,0.1398,0.11357,1,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016734,0.13858,0.12876,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.029719,0.13821,0.11378,1,0
2,GO RNA DESTABILIZATION,0.027803,0.13709,0.11383,1,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.033166,0.13678,0.094691,1,0
2,GO TISSUE HOMEOSTASIS,0.0094949,0.1354,0.1151,1,0
2,GO MITOCHONDRIAL TRNA PROCESSING,0.052669,0.13522,0.14231,1,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.037747,0.1351,0.1542,1,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.05161,0.13408,0.09524,1,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.030383,0.13107,0.13429,1,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.055956,0.13065,0.1067,1,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.0075304,0.12813,0.11446,1,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0087944,0.12783,0.11937,1,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.053746,0.12746,0.11386,1,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.050569,0.127,0.124,1,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0094949,0.12675,0.23373,1,0
2,GO RESPONSE TO BACTERIUM,0.012508,0.12668,0.11647,1,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.033166,0.12644,0.36526,1,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0071468,0.12586,0.17499,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.013465,0.12427,0.12987,1,0
2,GO NEGATIVE REGULATION OF SECRETION,0.0066042,0.12399,0.10803,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.029719,0.12194,0.15119,1,0
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.011612,0.12185,0.12812,1,0
2,GO STRESS GRANULE ASSEMBLY,0.009256,0.12125,0.12201,1,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.025414,0.12124,0.12448,1,0
2,GO RESPONSE TO INTERLEUKIN 4,0.0067808,0.12064,0.1284,1,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.049546,0.12053,0.11139,1,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.011047,0.11931,0.15664,1,0
2,GO NEPHRON MORPHOGENESIS,0.047551,0.11913,0.10269,1,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.011612,0.11889,0.14128,1,0
2,GO STEROL IMPORT,0.031748,0.11834,0.11328,1,0
2,GO LIPID HOMEOSTASIS,0.018836,0.11811,0.09909,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.014486,0.11793,0.10914,1,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.024288,0.11365,0.19468,1,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.041093,0.113,0.11647,1,0
2,GO GLOMERULUS DEVELOPMENT,0.041967,0.1128,0.20078,1,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.035393,0.11019,0.16635,1,0
2,GO REGULATION OF PROTEOLYSIS,0.052669,0.10884,0.091403,1,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.029068,0.1086,0.082497,1,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.041967,0.10814,0.14387,1,0
2,GO TISSUE MIGRATION,0.014486,0.10609,0.14359,1,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.046579,0.1055,0.13986,1,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.055956,0.10542,0.16783,1,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.031748,0.1036,0.12603,1,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.004408,0.10307,0.11888,1,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.031748,0.10238,0.1616,1,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.02166,0.10205,0.14419,1,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.05161,0.10149,0.11787,1,0
2,GO INTERLEUKIN 6 PRODUCTION,0.035393,0.10046,0.11466,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.04854,0.10036,0.10632,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.033166,0.098583,0.1115,1,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.03939,0.097259,0.10761,1,0
2,GO TRANSLESION SYNTHESIS,0.02166,0.096559,0.081948,1,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.0047853,0.096287,0.1132,1,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.055956,0.095245,0.094244,1,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.044685,0.094327,0.066034,1,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.042857,0.094058,0.11731,1,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.03245,0.093353,0.0917,1,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.041967,0.092029,0.069465,1,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.020205,0.091594,0.10511,1,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.031748,0.090515,0.13531,1,0
2,GO REGULATION OF MYELINATION,0.041093,0.090341,0.10471,1,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.052669,0.090256,0.12098,1,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0022332,0.090022,0.12716,1,0
2,GO NCRNA CATABOLIC PROCESS,0.019739,0.088972,0.1249,1,0
2,GO CELLULAR RESPONSE TO UV,0.0051916,0.087743,0.11683,1,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.042857,0.08723,0.077232,1,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.033894,0.085918,0.09146,1,0
2,GO PEROXISOMAL TRANSPORT,0.011326,0.085778,0.11992,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.033894,0.085051,0.13742,1,0
2,GO STEROID METABOLIC PROCESS,0.0090226,0.08392,0.10813,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.019283,0.083406,0.10701,1,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.04854,0.082895,0.16025,1,0
2,GO ALCOHOL CATABOLIC PROCESS,0.02268,0.082823,0.13565,1,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.037747,0.082479,0.12199,1,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.026586,0.082136,0.10108,1,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.041093,0.081521,0.10389,1,0
2,GO RRNA METHYLATION,0.033166,0.081485,0.13694,1,0
2,GO PROTEOLYSIS,0.052669,0.081447,0.070869,1,0
2,GO LACTATION,0.019283,0.081276,0.14747,1,0
2,GO CELLULAR RESPONSE TO LIPID,0.018836,0.081244,0.10733,1,0
2,GO NCRNA TRANSCRIPTION,0.010245,0.080268,0.091852,1,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.03245,0.080134,0.11109,1,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.043763,0.080071,0.08941,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.026586,0.079934,0.15795,1,0
2,GO SELECTIVE AUTOPHAGY,0.013139,0.079739,0.1158,1,0
2,GO DEFENSE RESPONSE TO BACTERIUM,0.033166,0.078703,0.09417,1,0
2,GO CHROMOSOME SEPARATION,0.036164,0.077005,0.074175,1,0
2,GO MITOTIC CYTOKINESIS,0.040234,0.076313,0.10393,1,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.045624,0.076005,0.156,1,0
2,GO PEROXISOME ORGANIZATION,0.014138,0.075617,0.10793,1,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.044685,0.075409,0.12545,1,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.038561,0.075355,0.1049,1,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.02068,0.074771,0.074256,1,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.034637,0.074162,0.11505,1,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.045624,0.073317,0.098905,1,0
2,GO REGULATION OF GLUCONEOGENESIS,0.041093,0.073296,0.084687,1,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.05161,0.071603,0.086981,1,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.031059,0.066359,0.10405,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.014486,0.065011,0.087551,1,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.036948,0.062876,0.1146,1,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.050569,0.061175,0.13203,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.036948,0.06108,0.077471,1,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.03939,0.058723,0.074702,1,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0064317,0.057979,0.063878,1,0
2,GO SNRNA TRANSCRIPTION,0.011047,0.05122,0.07499,1,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.03939,0.049854,0.097429,1,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.050569,0.049709,0.13616,1,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.023205,0.049354,0.072853,1,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.041093,0.045261,0.086085,1,0
2,GO METHYLATION,0.0059384,0.04502,0.064887,1,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.022165,0.036689,0.053543,1,0
2,GO ATP METABOLIC PROCESS,0.042857,0.036376,0.089938,1,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.047551,0.031532,0.056757,1,0
2,GO CELL CELL SIGNALING,0.049546,-0.046865,-0.07592,1,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.037747,-0.05111,-0.21621,1,0
2,GO CELL PROJECTION ORGANIZATION,0.049546,-0.05194,-0.072337,1,0
2,GO SPERM MOTILITY,0.019283,-0.053545,-0.11647,1,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.02268,-0.06174,-0.11154,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.050569,-0.063664,-0.12116,1,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.040234,-0.065196,-0.096031,1,0
2,GO NEUROGENESIS,0.0087944,-0.06645,-0.096307,1,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0071468,-0.067962,-0.12013,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.052669,-0.068924,-0.059652,1,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.025994,-0.070591,-0.093415,1,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.019739,-0.071532,-0.099963,1,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.015953,-0.072869,-0.10718,1,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.020205,-0.074277,-0.094243,1,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.038561,-0.075727,-0.085961,1,0
2,GO MICROTUBULE BASED MOVEMENT,0.010245,-0.076697,-0.093024,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0094949,-0.077544,-0.16596,1,0
2,GO GERM CELL DEVELOPMENT,0.0067808,-0.077626,-0.092656,1,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.05161,-0.078264,-0.12111,1,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.014841,-0.078943,-0.10049,1,0
2,GO REGULATION OF CELL DEVELOPMENT,0.031059,-0.079303,-0.084123,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.03245,-0.080862,-0.071375,1,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.037747,-0.082479,-0.10181,1,0
2,GO REGULATION OF ION TRANSPORT,0.052669,-0.087607,-0.081063,1,0
2,GO REGULATION OF SYSTEM PROCESS,0.031059,-0.089125,-0.091937,1,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.019739,-0.090757,-0.10243,1,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.047551,-0.09106,-0.12316,1,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.016339,-0.091465,-0.1266,1,0
2,GO CILIUM MOVEMENT,0.016339,-0.091854,-0.11563,1,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.04854,-0.092418,-0.20183,1,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.031748,-0.094911,-0.117,1,0
2,GO REGULATION OF AXONOGENESIS,0.0039469,-0.095234,-0.16415,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.041967,-0.097119,-0.15403,1,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.041967,-0.09865,-0.15428,1,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.024846,-0.099253,-0.11601,1,0
2,GO NEURON DIFFERENTIATION,0.0025817,-0.099481,-0.12408,1,0
2,GO DEVELOPMENTAL CELL GROWTH,0.0036303,-0.099627,-0.13953,1,0
2,GO HEAD DEVELOPMENT,0.012508,-0.099665,-0.099579,1,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.055956,-0.099758,-0.091359,1,0
2,GO SPERMATID DIFFERENTIATION,0.0073363,-0.10126,-0.098946,1,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.036164,-0.10136,-0.11137,1,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.050569,-0.10191,-0.10603,1,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.014138,-0.10244,-0.13916,1,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.03245,-0.10401,-0.10655,1,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.029719,-0.10409,-0.16919,1,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.016734,-0.10417,-0.10306,1,0
2,GO CELL MATURATION,0.036164,-0.10483,-0.087049,1,0
2,GO NEURON DEVELOPMENT,0.0028141,-0.10536,-0.1328,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.022165,-0.10569,-0.16132,1,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.009256,-0.10578,-0.11797,1,0
2,GO NEUROBLAST PROLIFERATION,0.035393,-0.10695,-0.14396,1,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0099891,-0.10772,-0.15263,1,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.054842,-0.10794,-0.086915,1,0
2,GO CHLORIDE TRANSPORT,0.053746,-0.1081,-0.0862,1,0
2,GO RESPONSE TO ALKALOID,0.023205,-0.10916,-0.1214,1,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.004408,-0.1101,-0.14588,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.025994,-0.11016,-0.096821,1,0
2,GO NERVOUS SYSTEM PROCESS,0.029719,-0.11061,-0.08657,1,0
2,GO COLLATERAL SPROUTING,0.02166,-0.11128,-0.20222,1,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.035393,-0.11498,-0.12889,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.03245,-0.11525,-0.078256,1,0
2,GO L AMINO ACID TRANSPORT,0.02166,-0.11595,-0.12229,1,0
2,GO SPERM CAPACITATION,0.053746,-0.11638,-0.1093,1,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.042857,-0.11668,-0.10903,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.030383,-0.11721,-0.14334,1,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0097392,-0.11764,-0.095361,1,0
2,GO IMPORT INTO CELL,0.038561,-0.11792,-0.099211,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0087944,-0.11977,-0.12539,1,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.03245,-0.12009,-0.16754,1,0
2,GO POSTSYNAPSE ORGANIZATION,0.015574,-0.12143,-0.14075,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0007696,-0.1217,-0.15475,1,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.018836,-0.12349,-0.17481,1,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.044685,-0.12536,-0.16531,1,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.0025817,-0.12577,-0.13584,1,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.055956,-0.12585,-0.17537,1,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.0051916,-0.12736,-0.13307,1,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.024288,-0.12902,-0.1023,1,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.02166,-0.1294,-0.14667,1,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.017969,-0.13235,-0.13173,1,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.03939,-0.13416,-0.12523,1,0
2,GO REPRODUCTIVE BEHAVIOR,0.026586,-0.13508,-0.1595,1,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0027346,-0.13543,-0.13985,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0066042,-0.13645,-0.13807,1,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.037747,-0.13694,-0.14178,1,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.040234,-0.13715,-0.090483,1,0
2,GO SODIUM ION TRANSPORT,0.015953,-0.13835,-0.10142,1,0
2,GO REGULATION OF APPETITE,0.012203,-0.14222,-0.12646,1,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0079323,-0.14309,-0.13599,1,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.023205,-0.1444,-0.10806,1,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.038561,-0.14469,-0.19658,1,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.029719,-0.14519,-0.28951,1,0
2,GO HINDBRAIN DEVELOPMENT,0.0012662,-0.14683,-0.17515,1,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.035393,-0.14695,-0.11006,1,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.029068,-0.14873,-0.11521,1,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0025083,-0.15077,-0.29914,1,0
2,GO ASSOCIATIVE LEARNING,0.047551,-0.15174,-0.14446,1,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0053338,-0.15203,-0.14668,1,0
2,GO NEUROMUSCULAR PROCESS,0.027188,-0.1521,-0.12876,1,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.010506,-0.15413,-0.18812,1,0
2,GO RESPONSE TO CALCIUM ION,0.0075304,-0.15485,-0.14065,1,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.027803,-0.15561,-0.15567,1,0
2,GO PROTEIN KINASE C SIGNALING,0.0054795,-0.15703,-0.21427,1,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.045624,-0.15706,-0.12898,1,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0071468,-0.15716,-0.16625,1,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.052669,-0.15738,-0.10859,1,0
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.031059,-0.15755,-0.11656,1,0
2,GO NEURAL RETINA DEVELOPMENT,0.0025817,-0.15844,-0.20108,1,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0038387,-0.15857,-0.13849,1,0
2,GO FOREBRAIN DEVELOPMENT,0.001191,-0.15944,-0.14463,1,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0090226,-0.15953,-0.15351,1,0
2,GO MEMBRANE BIOGENESIS,0.029719,-0.16057,-0.17315,1,0
2,GO ADULT HEART DEVELOPMENT,0.029068,-0.1607,-0.17556,1,0
2,GO SPINAL CORD DEVELOPMENT,0.0057817,-0.1611,-0.16163,1,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.025994,-0.16133,-0.18213,1,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.0022332,-0.16153,-0.19034,1,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0083534,-0.16203,-0.13923,1,0
2,GO MITOCHONDRION DISTRIBUTION,0.043763,-0.16235,-0.17033,1,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.019283,-0.16364,-0.13355,1,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0069616,-0.16423,-0.10656,1,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0053338,-0.16507,-0.12478,1,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.0029794,-0.16688,-0.19177,1,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.00098941,-0.16837,-0.19484,1,0
2,GO COCHLEA DEVELOPMENT,0.0064317,-0.16868,-0.16855,1,0
2,GO SKELETAL MUSCLE CONTRACTION,0.010245,-0.16924,-0.16985,1,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.010245,-0.16994,-0.14192,1,0
2,GO DEVELOPMENTAL MATURATION,0.0014738,-0.17061,-0.14944,1,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.036948,-0.17113,-0.11201,1,0
2,GO SIGNAL RELEASE,0.0085714,-0.17235,-0.12166,1,0
2,GO SYNAPSE ORGANIZATION,0.011612,-0.17435,-0.14642,1,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.012203,-0.17494,-0.12662,1,0
2,GO BEHAVIOR,0.0011549,-0.1758,-0.15018,1,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0029794,-0.17806,-0.17105,1,0
2,GO TELENCEPHALON DEVELOPMENT,0.00041602,-0.17888,-0.16297,1,0
2,GO ANDROGEN METABOLIC PROCESS,0.038561,-0.17903,-0.12474,1,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0049174,-0.17959,-0.27696,1,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0079323,-0.18115,-0.28062,1,0
2,GO PEPTIDE HORMONE SECRETION,0.020205,-0.18146,-0.11662,1,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0083534,-0.18272,-0.21957,1,0
2,GO AMINO ACID TRANSPORT,0.00081984,-0.1863,-0.1803,1,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00042998,-0.18682,-0.1918,1,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.0021689,-0.18711,-0.15377,1,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.017549,-0.18746,-0.11624,1,0
2,GO THALAMUS DEVELOPMENT,0.036164,-0.18826,-0.18532,1,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0073363,-0.18851,-0.1908,1,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00090094,-0.18892,-0.19339,1,0
2,GO LEARNING,0.011047,-0.18903,-0.17807,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0081404,-0.18961,-0.19936,1,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.00353,-0.19044,-0.18798,1,0
2,GO REGULATION OF EXOCYTOSIS,0.033166,-0.19061,-0.16053,1,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.037747,-0.19142,-0.26131,1,0
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.044685,-0.19174,-0.18771,1,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00353,-0.19204,-0.16062,1,0
2,GO RESPONSE TO ACETYLCHOLINE,0.023741,-0.19337,-0.23393,1,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.020205,-0.19377,-0.28451,1,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.013798,-0.19449,-0.15937,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0037331,-0.19591,-0.16007,1,0
2,GO FOREBRAIN CELL MIGRATION,0.00069957,-0.19595,-0.19843,1,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.025414,-0.19696,-0.15572,1,0
2,GO RESPONSE TO AMINO ACID STARVATION,7.547e-05,-0.19858,-0.22793,1,0
2,GO POTASSIUM ION TRANSPORT,0.0020453,-0.19867,-0.17965,1,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.001986,-0.19882,-0.15421,1,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.013139,-0.19898,-0.15536,1,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00087311,-0.20122,-0.26663,1,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0033369,-0.2013,-0.18901,1,0
2,GO STRIATUM DEVELOPMENT,0.0045306,-0.20188,-0.23839,1,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.035393,-0.2021,-0.19189,1,0
2,GO RESPONSE TO CAFFEINE,0.053746,-0.20251,-0.14009,1,0
2,GO CALCIUM ION IMPORT,0.0025817,-0.20475,-0.17791,1,0
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.0079323,-0.20515,-0.18504,1,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0022332,-0.20592,-0.21513,1,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.00090094,-0.20646,-0.24908,1,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0049174,-0.20677,-0.20423,1,0
2,GO RESPONSE TO AMYLOID BETA,0.0025083,-0.20699,-0.19828,1,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00037661,-0.20751,-0.23684,1,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00087311,-0.20811,-0.25143,1,0
2,GO REGULATION OF FERTILIZATION,0.00017796,-0.20823,-0.18738,1,0
2,GO METENCEPHALON DEVELOPMENT,0.001228,-0.20847,-0.19578,1,0
2,GO REGULATION OF CILIUM MOVEMENT,1.4039e-05,-0.20956,-0.21098,1,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.027188,-0.21052,-0.20139,1,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.00079435,-0.21056,-0.22307,1,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.03939,-0.21069,-0.19055,1,0
2,GO RESPONSE TO PH,0.0097392,-0.21215,-0.17004,1,0
2,GO VESICLE DOCKING,0.001662,-0.21217,-0.20045,1,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00055855,-0.21561,-0.22089,1,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0042883,-0.21883,-0.28731,1,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.025994,-0.2195,-0.15083,1,0
2,GO SYNAPSE ASSEMBLY,0.0075304,-0.21984,-0.16207,1,0
2,GO EPITHELIAL CELL MATURATION,0.029719,-0.22031,-0.21281,1,0
2,GO CAMP METABOLIC PROCESS,0.029068,-0.22123,-0.15866,1,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00037661,-0.2218,-0.23199,1,0
2,GO COPULATION,0.016734,-0.22384,-0.1586,1,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.007729,-0.22386,-0.18192,1,0
2,GO NEURON MATURATION,0.015953,-0.22494,-0.17005,1,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0017123,-0.22798,-0.21649,1,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0071468,-0.2301,-0.20113,1,0
2,GO NEURON PROJECTION ARBORIZATION,0.00063551,-0.23069,-0.28538,1,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0024367,-0.23742,-0.22138,1,0
2,GO RESPONSE TO CATECHOLAMINE,0.00052342,-0.23774,-0.21322,1,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.00026903,-0.23998,-0.23579,1,0
2,GO RESPONSE TO POTASSIUM ION,0.0025817,-0.24077,-0.24977,1,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,2.2524e-05,-0.24101,-0.29995,1,0
2,GO CELL MIGRATION IN HINDBRAIN,0.044685,-0.24139,-0.20266,1,0
2,GO INSEMINATION,0.027188,-0.24222,-0.21098,1,0
2,GO DIENCEPHALON DEVELOPMENT,0.0040578,-0.24243,-0.20533,1,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0022332,-0.2434,-0.18854,1,0
2,GO SECRETORY GRANULE ORGANIZATION,0.0011199,-0.24354,-0.22964,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0007696,-0.24451,-0.24834,1,0
2,GO PROTEIN PALMITOYLATION,0.036164,-0.24462,-0.15221,1,0
2,GO RESPONSE TO DOPAMINE,3.7145e-05,-0.24468,-0.24954,1,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.014486,-0.24513,-0.28338,1,0
2,GO VITAMIN CATABOLIC PROCESS,0.0085714,-0.24538,-0.26695,1,0
2,GO SIALYLATION,0.046579,-0.24585,-0.19702,1,0
2,GO REGULATION OF MEMBRANE POTENTIAL,0.00069957,-0.24929,-0.20487,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.02068,-0.25088,-0.1968,1,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.025414,-0.25457,-0.22255,1,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.014841,-0.25526,-0.18993,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0010859,-0.25681,-0.34383,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.013798,-0.25755,-0.16976,1,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0029794,-0.25936,-0.21193,1,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.025994,-0.26024,-0.32398,1,0
2,GO AMMONIUM ION METABOLIC PROCESS,0.021165,-0.26083,-0.20036,1,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.0047853,-0.26098,-0.21656,1,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.014486,-0.26291,-0.31206,1,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.04854,-0.2631,-0.21747,1,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.5308e-05,-0.26323,-0.24586,1,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0031536,-0.26351,-0.20578,1,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0062634,-0.26423,-0.21899,1,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0021689,-0.2646,-0.22014,1,0
2,GO MEMBRANE DEPOLARIZATION,0.0019282,-0.26538,-0.244,1,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0067808,-0.26629,-0.22276,1,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0031536,-0.26645,-0.27088,1,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.024846,-0.26745,-0.25381,1,0
2,GO SYNAPTIC SIGNALING,0.00020448,-0.26788,-0.23239,1,0
2,GO NERVE DEVELOPMENT,0.00020448,-0.26862,-0.25817,1,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.010773,-0.26914,-0.20527,1,0
2,GO TUBULIN DEACETYLATION,0.0066042,-0.27037,-0.22416,1,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.00054072,-0.27231,-0.27478,1,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0014738,-0.27791,-0.27793,1,0
2,GO LOCOMOTORY BEHAVIOR,0.00025131,-0.27899,-0.22656,1,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.042857,-0.28049,-0.21989,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0050528,-0.28299,-0.30376,1,0
2,GO ALANINE TRANSPORT,0.016339,-0.28426,-0.18492,1,0
2,GO DORSAL AORTA DEVELOPMENT,0.0028957,-0.28591,-0.27023,1,0
2,GO SKELETAL MUSCLE ADAPTATION,0.033894,-0.2861,-0.19731,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0014738,-0.28742,-0.25893,1,0
2,GO PYRAMIDAL NEURON DIFFERENTIATION,0.0087944,-0.28767,-0.30305,1,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0027346,-0.28787,-0.24671,1,0
2,GO CGMP METABOLIC PROCESS,0.02268,-0.28838,-0.23278,1,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00081984,-0.29025,-0.28216,1,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.017137,-0.29095,-0.18108,1,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02068,-0.29096,-0.29001,1,0
2,GO NOREPINEPHRINE SECRETION,0.001872,-0.29198,-0.29399,1,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.017137,-0.29231,-0.20117,1,0
2,GO CAMP BIOSYNTHETIC PROCESS,0.0026572,-0.2953,-0.28466,1,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.030383,-0.29651,-0.22821,1,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00027832,-0.29848,-0.27686,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.054842,-0.29913,-0.25697,1,0
2,GO GROOMING BEHAVIOR,0.014486,-0.29981,-0.23867,1,0
2,GO ADULT LOCOMOTORY BEHAVIOR,0.00012074,-0.30148,-0.25422,1,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0059384,-0.30192,-0.2606,1,0
2,GO NOREPINEPHRINE TRANSPORT,0.0025817,-0.30369,-0.23837,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0031536,-0.3054,-0.29754,1,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00010462,-0.309,-0.26397,1,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.05161,-0.30914,-0.22472,1,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.022165,-0.31125,-0.23667,1,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0001165,-0.31141,-0.3416,1,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00059588,-0.31143,-0.3233,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.011326,-0.31191,-0.25352,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00010092,-0.31485,-0.36385,1,0
2,GO PROTEIN POLYGLUTAMYLATION,8.4205e-05,-0.31768,-0.27778,1,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.9263e-05,-0.32017,-0.32125,1,0
2,GO EXOCYTIC PROCESS,0.0029794,-0.32101,-0.23061,1,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00065623,-0.32139,-0.21704,1,0
2,GO RESPONSE TO MUSCLE STRETCH,0.00047456,-0.32156,-0.36854,1,0
2,GO REGULATION OF CILIUM BEAT FREQUENCY,2.2524e-05,-0.32295,-0.30478,1,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.00018427,-0.32373,-0.2899,1,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0013872,-0.32642,-0.22562,1,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0025817,-0.32647,-0.31151,1,0
2,GO REGULATION OF ACROSOME REACTION,0.0013054,-0.32707,-0.27082,1,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00072223,-0.32843,-0.27105,1,0
2,GO DORSAL VENTRAL PATTERN FORMATION,0.0011549,-0.32902,-0.25671,1,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00092958,-0.32973,-0.31412,1,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0069616,-0.3314,-0.25462,1,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,5.6174e-05,-0.33144,-0.3423,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00074557,-0.33317,-0.29348,1,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0006154,-0.33443,-0.35618,1,0
2,GO FOREBRAIN REGIONALIZATION,6.2786e-05,-0.33698,-0.39078,1,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.012203,-0.33784,-0.26509,1,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.011612,-0.3393,-0.29737,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0081404,-0.33967,-0.3017,1,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0010859,-0.34441,-0.28356,1,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.023741,-0.34447,-0.20538,1,0
2,GO CEREBELLAR CORTEX FORMATION,0.00025131,-0.3447,-0.30763,1,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00035231,-0.35149,-0.29837,1,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00022676,-0.35363,-0.30444,1,0
2,GO MOTILE CILIUM ASSEMBLY,0.0046564,-0.3543,-0.23855,1,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0013457,-0.35493,-0.35127,1,0
2,GO RESPONSE TO LITHIUM ION,0.004408,-0.356,-0.26664,1,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00035231,-0.35701,-0.29166,1,0
2,GO RESPONSE TO DIETARY EXCESS,0.0014299,-0.36072,-0.35144,1,0
2,GO EXPLORATION BEHAVIOR,2.9532e-05,-0.36184,-0.42159,1,0
2,GO REGULATION OF VESICLE FUSION,0.02166,-0.36413,-0.25509,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00016023,-0.36793,-0.34535,1,0
2,GO TRANSMISSION OF NERVE IMPULSE,0.00036427,-0.36797,-0.31113,1,0
2,GO SPERM AXONEME ASSEMBLY,0.00032948,-0.36814,-0.31942,1,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,7.2754e-05,-0.37203,-0.34557,1,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.024288,-0.37705,-0.23131,1,0
2,GO AXONEME ASSEMBLY,0.00011241,-0.37792,-0.32461,1,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00018427,-0.38303,-0.33647,1,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0036303,-0.39131,-0.32804,1,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00021167,-0.3931,-0.3405,1,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.001872,-0.3931,-0.30228,1,0
2,GO SPINAL CORD PATTERNING,0.00029782,-0.39587,-0.40652,1,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.00079435,-0.39982,-0.42527,1,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,2.8418e-05,-0.40008,-0.35599,1,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.0001547,-0.40016,-0.35891,1,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.0018173,-0.40321,-0.32616,1,0
2,GO STARTLE RESPONSE,0.0013054,-0.41089,-0.35538,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.00019753,-0.41407,-0.40685,1,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00055855,-0.41444,-0.3591,1,0
2,GO REGULATION OF SYNAPSE MATURATION,0.013798,-0.41602,-0.32144,1,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0037331,-0.4163,-0.43983,1,0
2,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.011326,-0.41804,-0.32394,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,6.2786e-05,-0.41824,-0.39811,1,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00019079,-0.4209,-0.30689,1,0
2,GO NEURON FATE COMMITMENT,0.00072223,-0.42309,-0.31139,1,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.018398,-0.42591,-0.33574,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00025131,-0.42884,-0.34079,1,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00028792,-0.43245,-0.45037,1,0
2,GO PLASMA MEMBRANE REPAIR,0.00035231,-0.43524,-0.53671,1,0
2,GO DOPAMINE METABOLIC PROCESS,0.0033369,-0.43623,-0.31189,1,0
2,GO GLIAL CELL FATE COMMITMENT,0.0042883,-0.43853,-0.38329,1,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00024286,-0.43879,-0.35238,1,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,3.4421e-05,-0.44475,-0.45426,1,0
2,GO PROTEIN LOCALIZATION TO AXON,0.0090226,-0.44697,-0.46113,1,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.0023671,-0.44827,-0.32214,1,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.001228,-0.45259,-0.42308,1,0
2,GO ADENOHYPOPHYSIS DEVELOPMENT,0.02843,-0.46231,-0.31259,1,0
2,GO RESPONSE TO HISTAMINE,0.0028141,-0.46331,-0.45409,1,0
2,GO NEURONAL ION CHANNEL CLUSTERING,9.7346e-05,-0.46621,-0.54329,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,2.0033e-05,-0.47011,-0.47935,1,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,9.3916e-06,-0.47079,-0.48852,1,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0046564,-0.47903,-0.33843,1,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.009256,-0.4825,-0.28003,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,4.6597e-05,-0.48594,-0.3937,1,0
2,GO TELENCEPHALON REGIONALIZATION,0.0011199,-0.48665,-0.42406,1,0
2,GO SEROTONIN METABOLIC PROCESS,0.0045306,-0.48882,-0.35972,1,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00019753,-0.48889,-0.38274,1,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,4.1617e-05,-0.49149,-0.44335,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0007696,-0.49182,-0.40461,1,0
2,GO PREPULSE INHIBITION,0.02268,-0.49237,-0.37213,1,0
2,GO RESPONSE TO AUDITORY STIMULUS,0.00090094,-0.50115,-0.40478,1,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.011326,-0.50198,-0.34972,1,0
2,GO POSTSYNAPSE ASSEMBLY,0.00040247,-0.52009,-0.48532,1,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,7.547e-05,-0.53423,-0.52288,1,0
2,GO SYNAPTIC VESICLE DOCKING,0.00055855,-0.53475,-0.52786,1,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,5.0226e-05,-0.542,-0.43764,1,0
2,GO AMINE TRANSPORT,0.00042998,-0.54371,-0.40843,1,0
2,GO MONOAMINE TRANSPORT,0.00055855,-0.54621,-0.41534,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00023468,-0.56306,-0.51797,1,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0007696,-0.57481,-0.46526,1,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00084609,-0.57497,-0.37443,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0010528,-0.58765,-0.54124,1,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0001165,-0.59611,-0.52338,1,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.7145e-05,-0.59663,-0.59612,1,0
2,GO SYNAPTIC MEMBRANE ADHESION,3.1888e-05,-0.5996,-0.56035,1,0
2,GO SYNAPSE MATURATION,0.00023468,-0.60092,-0.5523,1,0
2,GO RESPONSE TO INSECTICIDE,0.0006154,-0.61199,-0.41635,1,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00092958,-0.61345,-0.64195,1,0
2,GO NOSE DEVELOPMENT,0.0017641,-0.61521,-0.44807,1,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,3.7145e-05,-0.61572,-0.63445,1,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,9.7346e-05,-0.62043,-0.50831,1,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,9.7801e-06,-0.62059,-0.57006,1,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,8.3127e-06,-0.62092,-0.52242,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0037331,-0.62161,-0.55898,1,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,7.013e-05,-0.62242,-0.56634,1,0
2,GO DOPAMINE TRANSPORT,0.0045306,-0.6269,-0.45564,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00067758,-0.63843,-0.55189,1,0
2,GO GROWTH HORMONE SECRETION,3.3287e-06,-0.64066,-0.54054,1,0
2,GO CATECHOLAMINE SECRETION,0.0015189,-0.64398,-0.50082,1,0
2,GO REGULATION OF DOPAMINE SECRETION,0.0054795,-0.64538,-0.52984,1,0
2,GO SYNAPTIC VESICLE PRIMING,9.0551e-05,-0.64903,-0.54687,1,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,1.0184e-05,-0.67077,-0.61745,1,0
2,GO INNERVATION,5.508e-06,-0.69684,-0.66351,1,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,1.4039e-05,-0.70774,-0.62763,1,0
2,GO VOCALIZATION BEHAVIOR,6.0504e-05,-0.71991,-0.61802,1,0
2,GO GANGLION DEVELOPMENT,0.00010845,-0.72045,-0.64061,1,0
2,GO SYNAPTIC VESICLE MATURATION,1.7118e-05,-0.74219,-0.75684,1,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.031059,-0.76874,-0.75867,1,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00035231,-0.79022,-0.64621,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,1.1493e-05,-0.79358,-0.75401,1,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.5759e-05,-0.8109,-0.7259,1,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,7.0571e-06,-0.89308,-0.72154,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.349e-05,-0.98847,-0.91249,1,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,9.3916e-06,-1.1228,-1.1389,1,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.064293,0.37946,0.3216,0,1
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.088862,0.3338,0.20971,0,1
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.2839,0.3324,0.097219,0,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.1028,0.32508,0.11691,0,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.21579,0.29599,0.12203,0,1
2,GO IMP METABOLIC PROCESS,0.072231,0.27992,0.1718,0,1
2,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.2839,0.27931,0.08205,0,1
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.23245,0.27713,0.14967,0,1
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.099158,0.27371,0.18882,0,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.097379,0.27271,0.25405,0,1
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.22235,0.27188,0.073988,0,1
2,GO RESPONSE TO HYDROPEROXIDE,0.088862,0.26878,0.20656,0,1
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.11841,0.25265,0.18065,0,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.057089,0.24602,0.17478,0,1
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.25363,0.241,0.11488,0,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.080955,0.23319,0.12903,0,1
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.059411,0.23252,0.14278,0,1
2,GO MYELIN ASSEMBLY,0.099158,0.231,0.13199,0,1
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.15773,0.2302,0.12405,0,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.37932,0.23013,0.08261,0,1
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.2,0.22857,0.09284,0,1
2,GO SOMATIC STEM CELL DIVISION,0.11636,0.22672,0.21983,0,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.066855,0.22464,0.14429,0,1
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.39858,0.22361,0.04566,0,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.060602,0.21955,0.12704,0,1
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.15773,0.21944,0.22257,0,1
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.057089,0.21909,0.16585,0,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.060602,0.21901,0.20537,0,1
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.25363,0.21717,0.12887,0,1
2,GO RESPONSE TO UV B,0.090515,0.21293,0.16183,0,1
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.1028,0.20974,0.11193,0,1
2,GO CARNITINE METABOLIC PROCESS,0.11235,0.20885,0.10853,0,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.082489,0.20751,0.13621,0,1
2,GO DENDRITIC CELL DIFFERENTIATION,0.25001,0.20668,0.08503,0,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.061812,0.20663,0.12329,0,1
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0695,0.20395,0.27514,0,1
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.092194,0.20077,0.14158,0,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.12259,0.19812,0.090229,0,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.088862,0.19724,0.11951,0,1
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.097379,0.19591,0.1619,0,1
2,GO PIGMENT CELL DIFFERENTIATION,0.05824,0.19319,0.09703,0,1
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.17653,0.19236,0.047646,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.14769,0.19232,0.10765,0,1
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.32077,0.19149,0.076965,0,1
2,GO VIRAL LATENCY,0.26471,0.19147,0.080419,0,1
2,GO PARAXIAL MESODERM DEVELOPMENT,0.54321,0.19032,0.095519,0,1
2,GO GDP METABOLIC PROCESS,0.1313,0.19002,0.12825,0,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.068167,0.18991,0.11306,0,1
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.087232,0.18848,0.20211,0,1
2,GO KETONE BODY METABOLIC PROCESS,0.084046,0.18683,0.16221,0,1
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.10465,0.18445,0.12283,0,1
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.21579,0.18192,0.077653,0,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.066855,0.18097,0.14621,0,1
2,GO ZYMOGEN ACTIVATION,0.082489,0.17968,0.23445,0,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.075049,0.17892,0.12492,0,1
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.082489,0.17744,0.15273,0,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.087232,0.177,0.11221,0,1
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.14769,0.17587,0.095199,0,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.066855,0.17442,0.13343,0,1
2,GO CELLULAR DEFENSE RESPONSE,0.075049,0.17434,0.10219,0,1
2,GO ARGININE METABOLIC PROCESS,0.082489,0.17404,0.1908,0,1
2,GO DNA DEAMINATION,0.065563,0.17374,0.17976,0,1
2,GO RESPONSE TO LEPTIN,0.13814,0.17362,0.11427,0,1
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.25729,0.17353,0.11618,0,1
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.079444,0.17312,0.14357,0,1
2,GO AORTA MORPHOGENESIS,0.12259,0.17149,0.11792,0,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.31232,0.16831,0.061392,0,1
2,GO EPITHELIAL CELL FATE COMMITMENT,0.26847,0.16765,0.1137,0,1
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23245,0.16699,0.11824,0,1
2,GO FOREBRAIN MORPHOGENESIS,0.21256,0.16695,0.099425,0,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.14285,0.16628,0.11874,0,1
2,GO CERAMIDE TRANSPORT,0.17099,0.16584,0.16497,0,1
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.19095,0.16536,0.098547,0,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.059411,0.16487,0.13562,0,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.080955,0.16435,0.093216,0,1
2,GO RESPONSE TO TESTOSTERONE,0.11841,0.16252,0.10592,0,1
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.059411,0.16247,0.15446,0,1
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.073629,0.15994,0.10008,0,1
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.17934,0.15855,0.12062,0,1
2,GO DEVELOPMENTAL PIGMENTATION,0.13355,0.15818,0.06859,0,1
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.13355,0.15654,0.21506,0,1
2,GO OSTEOBLAST PROLIFERATION,0.077957,0.15616,0.14422,0,1
2,GO REGULATION OF WOUND HEALING,0.10465,0.15613,0.12384,0,1
2,GO RESPONSE TO HYPEROXIA,0.27227,0.156,0.065989,0,1
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.18508,0.15558,0.10092,0,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.072231,0.15543,0.086622,0,1
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.14769,0.15443,0.082032,0,1
2,GO POSITIVE REGULATION OF MYELINATION,0.097379,0.1543,0.098729,0,1
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.072231,0.15352,0.10343,0,1
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.12908,0.1529,0.07067,0,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.12049,0.15173,0.12607,0,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.14526,0.15138,0.16327,0,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.22905,0.15079,0.056184,0,1
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.18508,0.15067,0.093415,0,1
2,GO MESODERMAL CELL FATE COMMITMENT,0.27227,0.15059,0.10081,0,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.14285,0.1502,0.089328,0,1
2,GO GOLGI TO VACUOLE TRANSPORT,0.25001,0.15007,0.092788,0,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.10845,0.14968,0.071531,0,1
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.057089,0.14909,0.16652,0,1
2,GO PROTEIN ACTIVATION CASCADE,0.13814,0.14869,0.088433,0,1
2,GO LIVER MORPHOGENESIS,0.10096,0.14785,0.12239,0,1
2,GO PROTEIN AUTOPROCESSING,0.32938,0.14778,0.048189,0,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.087232,0.14753,0.16086,0,1
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.066855,0.1464,0.14261,0,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.20621,0.1459,0.07468,0,1
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.188,0.14517,0.077611,0,1
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.21256,0.14472,0.080173,0,1
2,GO DENTATE GYRUS DEVELOPMENT,0.19095,0.14427,0.12847,0,1
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.99651,0.14426,-0.05897,0,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.064293,0.14407,0.096182,0,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.082489,0.14405,0.08876,0,1
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.40349,0.14401,0.08882,0,1
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.092194,0.14358,0.099756,0,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.095625,0.1434,0.10384,0,1
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.1028,0.14322,0.093295,0,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0695,0.14137,0.10752,0,1
2,GO RESPONSE TO CORTICOSTEROID,0.064293,0.14093,0.12232,0,1
2,GO REGULATION OF CALCIUM ION IMPORT,0.20621,0.1405,0.07389,0,1
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.14526,0.13994,0.10044,0,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.41341,0.13924,0.091414,0,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.072231,0.13848,0.12181,0,1
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.11636,0.13847,0.07073,0,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.095625,0.13829,0.11469,0,1
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.057089,0.13794,0.10411,0,1
2,GO REGULATION OF RESPONSE TO WOUNDING,0.10845,0.13724,0.10649,0,1
2,GO GLIAL CELL APOPTOTIC PROCESS,0.16032,0.13707,0.15327,0,1
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.15517,0.13621,0.11506,0,1
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.21579,0.13518,0.11542,0,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.088862,0.13486,0.092693,0,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.060602,0.1348,0.12621,0,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.095625,0.13404,0.135,0,1
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.14769,0.13401,0.074011,0,1
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.12259,0.13364,0.079126,0,1
2,GO RESPONSE TO DEXAMETHASONE,0.090515,0.13357,0.12658,0,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.13814,0.13206,0.21115,0,1
2,GO CELLULAR RESPONSE TO DSRNA,0.099158,0.13163,0.091733,0,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.4545,0.13115,0.11085,0,1
2,GO COAGULATION,0.11235,0.13102,0.066844,0,1
2,GO RESPONSE TO UV C,0.19095,0.12988,0.131,0,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.076492,0.1298,0.17383,0,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.2,0.12941,0.08375,0,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.063042,0.12912,0.11559,0,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.059411,0.12901,0.15999,0,1
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.19393,0.12762,0.097949,0,1
2,GO RRNA 3 END PROCESSING,0.079444,0.12745,0.10652,0,1
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.24643,0.12608,0.10859,0,1
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.084046,0.12434,0.11016,0,1
2,GO COPII COATED VESICLE CARGO LOADING,0.063042,0.12353,0.071199,0,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.065563,0.12334,0.12001,0,1
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0695,0.12282,0.097259,0,1
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.47588,0.12209,0.030119,0,1
2,GO GENITALIA MORPHOGENESIS,0.14526,0.12151,0.13546,0,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.059411,0.12139,0.073074,0,1
2,GO STRESS FIBER ASSEMBLY,0.060602,0.12101,0.12161,0,1
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.47049,0.12032,0.052512,0,1
2,GO PROTEIN MATURATION,0.0695,0.11988,0.093303,0,1
2,GO AUTOPHAGIC CELL DEATH,0.24643,0.11554,0.06004,0,1
2,GO REGULATION OF ORGAN GROWTH,0.1028,0.11531,0.10408,0,1
2,GO O GLYCAN PROCESSING,0.072231,0.11441,0.12817,0,1
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.21579,0.11388,0.11617,0,1
2,GO MESONEPHROS DEVELOPMENT,0.095625,0.11324,0.108,0,1
2,GO MYOTUBE DIFFERENTIATION,0.064293,0.11267,0.077954,0,1
2,GO ACUTE INFLAMMATORY RESPONSE,0.23245,0.11183,0.061983,0,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.2,0.11153,0.12217,0,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.16559,0.11022,0.052654,0,1
2,GO SEQUESTERING OF METAL ION,0.076492,0.11012,0.13525,0,1
2,GO PROTEIN PROCESSING,0.22568,0.11005,0.088051,0,1
2,GO FOCAL ADHESION ASSEMBLY,0.073629,0.10992,0.14583,0,1
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.24288,0.10891,0.080288,0,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.059411,0.10815,0.10354,0,1
2,GO RESPONSE TO DSRNA,0.10465,0.10786,0.067994,0,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.11235,0.10753,0.072325,0,1
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.56075,0.10701,0.049958,0,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.11235,0.10676,0.10052,0,1
2,GO LEUKOCYTE MIGRATION,0.064293,0.10673,0.088298,0,1
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.092194,0.10616,0.11145,0,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.076492,0.10615,0.079433,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.12908,0.1042,0.064226,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.063042,0.10418,0.063801,0,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.065563,0.1038,0.079731,0,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.13814,0.10379,0.060147,0,1
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.68418,0.10316,0.022439,0,1
2,GO REGULATION OF TISSUE REMODELING,0.4545,0.10292,0.052519,0,1
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.16559,0.10286,0.082232,0,1
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.14769,0.10261,0.070497,0,1
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.21905,0.10226,0.10291,0,1
2,GO ACUTE PHASE RESPONSE,0.099158,0.10216,0.10694,0,1
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.082489,0.10166,0.093203,0,1
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.076492,0.10138,0.099941,0,1
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.093897,0.099172,0.070102,0,1
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.19393,0.098404,0.10449,0,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.079444,0.098078,0.14242,0,1
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.21905,0.097972,0.077874,0,1
2,GO PIGMENTATION,0.12689,0.097502,0.076134,0,1
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.1313,0.097191,0.070622,0,1
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.10845,0.097181,0.064253,0,1
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.49227,0.09674,0.034864,0,1
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.71006,0.096537,0.025621,0,1
2,GO REGULATION OF LIPID TRANSPORT,0.076492,0.096441,0.099285,0,1
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.065563,0.096202,0.1495,0,1
2,GO LIPID STORAGE,0.077957,0.096141,0.096758,0,1
2,GO MAINTENANCE OF LOCATION IN CELL,0.13814,0.095764,0.059168,0,1
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.1028,0.095561,0.059489,0,1
2,GO RESPONSE TO LIPID,0.063042,0.095417,0.082862,0,1
2,GO LYSOSOME LOCALIZATION,0.11636,0.095085,0.060837,0,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.10845,0.095002,0.070463,0,1
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.05824,0.094681,0.080004,0,1
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.15264,0.093857,0.077234,0,1
2,GO RESPONSE TO DRUG,0.059411,0.093337,0.094552,0,1
2,GO CENTRIOLE ASSEMBLY,0.061812,0.092614,0.090359,0,1
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.17653,0.091694,0.063329,0,1
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.13355,0.091642,0.051537,0,1
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.11235,0.091458,0.067818,0,1
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.065563,0.091024,0.054796,0,1
2,GO CELLULAR RESPONSE TO X RAY,0.21905,0.090927,0.15665,0,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.092194,0.090472,0.078559,0,1
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.38888,0.089479,0.062515,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.075049,0.089418,0.095517,0,1
2,GO PROTEIN STABILIZATION,0.093897,0.089151,0.066051,0,1
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.31232,0.088681,0.089875,0,1
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.11434,0.088213,0.13937,0,1
2,GO MITOTIC SPINDLE ASSEMBLY,0.087232,0.087478,0.071092,0,1
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.21905,0.087298,0.065284,0,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.52025,0.08698,0.018893,0,1
2,GO AGING,0.12689,0.086057,0.068554,0,1
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.12689,0.085984,0.094118,0,1
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.10845,0.084876,0.070413,0,1
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.15517,0.084534,0.064016,0,1
2,GO PROTEIN DESTABILIZATION,0.064293,0.083107,0.084832,0,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.066855,0.082941,0.074056,0,1
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.29992,0.082711,0.037407,0,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.47588,0.082092,0.026475,0,1
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.079444,0.081489,0.050566,0,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.092194,0.081074,0.063489,0,1
2,GO BLASTOCYST DEVELOPMENT,0.075049,0.080835,0.058705,0,1
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.17934,0.08068,0.058304,0,1
2,GO REGULATION OF LIPID STORAGE,0.17934,0.0806,0.056998,0,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.080955,0.080543,0.080928,0,1
2,GO PROTEIN POLYMERIZATION,0.061812,0.080403,0.052766,0,1
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.29184,0.079767,0.037813,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.48131,0.079612,0.019921,0,1
2,GO CELLULAR SENESCENCE,0.17934,0.079575,0.052841,0,1
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.063042,0.079093,0.073793,0,1
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.092194,0.078706,0.073706,0,1
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.66501,0.078565,0.040294,0,1
2,GO REGULATION OF JUN KINASE ACTIVITY,0.15517,0.078008,0.071813,0,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.14769,0.077857,0.059215,0,1
2,GO RESPONSE TO ESTRADIOL,0.15517,0.077788,0.060714,0,1
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.080955,0.077561,0.062617,0,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.22235,0.076984,0.045857,0,1
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.095625,0.07689,0.063412,0,1
2,GO HORMONE METABOLIC PROCESS,0.099158,0.076369,0.079614,0,1
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.47588,0.076145,0.10415,0,1
2,GO PROTEIN O LINKED GLYCOSYLATION,0.14285,0.076092,0.077253,0,1
2,GO POSITIVE T CELL SELECTION,0.22905,0.075774,0.071582,0,1
2,GO REGULATION OF PROTEIN BINDING,0.15517,0.075153,0.064378,0,1
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.47049,0.074669,0.021681,0,1
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.26847,0.074234,0.05335,0,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.070855,0.073917,0.079008,0,1
2,GO REGULATION OF CELL AGING,0.21256,0.073724,0.049376,0,1
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.92682,0.073125,0.0020517,0,1
2,GO PROTEIN INSERTION INTO MEMBRANE,0.17374,0.073052,0.044362,0,1
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.19095,0.072616,0.040294,0,1
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.27999,0.072222,0.084292,0,1
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.059411,0.071859,0.055641,0,1
2,GO URONIC ACID METABOLIC PROCESS,0.25363,0.071851,0.067076,0,1
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.11039,0.071689,0.060723,0,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.10096,0.071651,0.074917,0,1
2,GO PROTEIN N LINKED GLYCOSYLATION,0.27999,0.071639,0.047514,0,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.34256,0.071261,0.052035,0,1
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.27227,0.070782,0.041672,0,1
2,GO POSITIVE REGULATION OF RNA SPLICING,0.53167,0.070624,0.01085,0,1
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.093897,0.070615,0.073087,0,1
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.075049,0.070007,0.058894,0,1
2,GO SPINDLE ASSEMBLY,0.088862,0.069507,0.051834,0,1
2,GO REGULATION OF CENTROSOME DUPLICATION,0.12908,0.068751,0.083293,0,1
2,GO RESPONSE TO HORMONE,0.19695,0.068508,0.048579,0,1
2,GO REGULATION OF ISOTYPE SWITCHING,0.47049,0.067826,0.044914,0,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.077957,0.067698,0.13689,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.20621,0.067498,0.074851,0,1
2,GO REGULATION OF CELL DIVISION,0.31232,0.066157,0.03849,0,1
2,GO POSITIVE REGULATION OF JNK CASCADE,0.30815,0.065628,0.050843,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.05824,0.065619,0.0578,0,1
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.15773,0.065527,0.063557,0,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.20309,0.064825,0.057725,0,1
2,GO FEMALE GAMETE GENERATION,0.075049,0.064636,0.05605,0,1
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.16559,0.064257,0.069706,0,1
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.059411,0.064047,0.07362,0,1
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.15264,0.063841,0.070104,0,1
2,GO GLYCOSYLATION,0.25363,0.063382,0.047371,0,1
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.41341,0.062882,0.039492,0,1
2,GO SARCOMERE ORGANIZATION,0.23937,0.062076,0.06608,0,1
2,GO HOMEOSTATIC PROCESS,0.10654,0.06184,0.041315,0,1
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.32077,0.06123,0.061047,0,1
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.18219,0.061069,0.042852,0,1
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.27999,0.060831,0.068714,0,1
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.2839,0.06078,0.030627,0,1
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.21579,0.060709,0.072685,0,1
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.075049,0.060705,0.10392,0,1
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.22235,0.060694,0.026337,0,1
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,1,0.059265,-0.020056,0,1
2,GO G2 DNA DAMAGE CHECKPOINT,0.23589,0.05912,0.076838,0,1
2,GO T CELL HOMEOSTASIS,0.25729,0.05906,0.048182,0,1
2,GO REGULATION OF DNA REPAIR,0.068167,0.058792,0.061373,0,1
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.29586,0.058235,0.035743,0,1
2,GO REGULATION OF PROTEIN LOCALIZATION,0.17374,0.057012,0.035414,0,1
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.23245,0.05669,0.054896,0,1
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.14526,0.055294,0.043097,0,1
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.60272,0.05523,0.058035,0,1
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.58456,0.055077,0.018178,0,1
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.51459,0.054746,0.0068867,0,1
2,GO MITOTIC SPINDLE ORGANIZATION,0.43367,0.053946,0.032589,0,1
2,GO NUCLEOSOME ORGANIZATION,0.47049,0.05388,0.032403,0,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.093897,0.053679,0.058583,0,1
2,GO T CELL SELECTION,0.16294,0.053341,0.073332,0,1
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.090515,0.053265,0.055842,0,1
2,GO NEUTROPHIL CHEMOTAXIS,0.12259,0.052233,0.046803,0,1
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.21905,0.051016,0.050729,0,1
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.095625,0.048649,0.057937,0,1
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.56075,0.048118,0.025328,0,1
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.1028,0.048006,0.056693,0,1
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.11434,0.047717,0.061673,0,1
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.11636,0.046952,0.030637,0,1
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.52025,0.04641,0.066847,0,1
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0695,0.046231,0.03771,0,1
2,GO REGULATION OF AUTOPHAGY,0.082489,0.045736,0.056002,0,1
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.084046,0.045672,0.039615,0,1
2,GO REGULATION OF PROTEIN ACETYLATION,0.079444,0.045625,0.064251,0,1
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.064293,0.045496,0.083229,0,1
2,GO VESICLE ORGANIZATION,0.33812,0.045192,0.038528,0,1
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.061812,0.04472,0.039549,0,1
2,GO INTRACELLULAR TRANSPORT,0.079444,0.042005,0.046541,0,1
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.11636,0.041171,0.061559,0,1
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.31232,0.04002,0.038785,0,1
2,GO POSITIVE REGULATION OF SIGNALING,0.4545,0.039265,0.017184,0,1
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.10096,0.039102,0.039246,0,1
2,GO CYTOSKELETON ORGANIZATION,0.16559,0.038501,0.037535,0,1
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.16559,0.03792,0.04875,0,1
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.24288,0.037287,0.03076,0,1
2,GO REGULATION OF HISTONE MODIFICATION,0.095625,0.036639,0.044428,0,1
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.10654,0.036351,0.045114,0,1
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.48131,0.036146,0.015272,0,1
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.72969,0.035498,0.01077,0,1
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.46512,0.035312,0.0067607,0,1
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.3746,0.034442,0.040031,0,1
2,GO CHROMATIN ORGANIZATION,0.082489,0.0298,0.042433,0,1
2,GO CELL DIVISION,0.095625,0.028089,0.062126,0,1
2,GO REGULATION OF CELL CYCLE,0.1028,0.027883,0.042673,0,1
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.42347,0.027481,0.019845,0,1
2,GO CHROMATIN SILENCING,0.28785,0.026643,0.06526,0,1
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.32938,0.024814,0.053123,0,1
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.17934,0.021488,0.037963,0,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.0034322,0.3381,0.26143,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.30815,0.33091,0.10104,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.71006,0.32217,0.14209,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.031059,0.30275,0.20201,0,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.093897,0.30145,0.18957,0,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.14048,0.29623,0.12686,0,0
2,GO GERMINAL CENTER FORMATION,0.095625,0.28057,0.12805,0,0
2,GO NEUROBLAST DIVISION,0.0027346,0.26468,0.26889,0,0
2,GO LEYDIG CELL DIFFERENTIATION,0.42347,0.26187,0.068727,0,0
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0090226,0.25953,0.20894,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.29586,0.2577,0.095981,0,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.13355,0.25044,0.25295,0,0
2,GO PHAGOCYTOSIS RECOGNITION,0.070855,0.25013,0.15771,0,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.12473,0.24569,0.1765,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.11039,0.24107,0.14633,0,0
2,GO MEMBRANE RAFT ASSEMBLY,0.56666,0.23692,-0.0098028,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.77618,0.23637,0.12424,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.14526,0.22851,0.13734,0,0
2,GO HEART VALVE FORMATION,0.12908,0.22788,0.19195,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.00021909,0.22725,0.27704,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.54903,0.22019,0.025997,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.068167,0.21984,0.17979,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.24288,0.21975,0.16029,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.061812,0.21927,0.12586,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.18508,0.21861,0.18206,0,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.36991,0.21596,0.096595,0,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.077957,0.21317,0.17935,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.12908,0.21126,0.12359,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.188,0.2105,0.1454,0,0
2,GO LIPID IMPORT INTO CELL,0.066855,0.20551,0.17323,0,0
2,GO HETEROTYPIC CELL CELL ADHESION,0.031748,0.20456,0.15384,0,0
2,GO GAP JUNCTION ASSEMBLY,0.25363,0.20448,0.12371,0,0
2,GO BLEB ASSEMBLY,0.31653,0.20093,0.086906,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.21579,0.19997,0.094604,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.076492,0.19993,0.25248,0,0
2,GO REGULATION OF PLATELET AGGREGATION,0.57857,0.19814,0.052469,0,0
2,GO V D J RECOMBINATION,0.0026572,0.19736,0.26298,0,0
2,GO INTERLEUKIN 5 PRODUCTION,0.075049,0.19522,0.18374,0,0
2,GO IMMATURE T CELL PROLIFERATION,0.0695,0.19518,0.1412,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.12689,0.19376,0.11208,0,0
2,GO SKIN MORPHOGENESIS,0.33812,0.19185,0.096711,0,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.05824,0.19024,0.15032,0,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.34256,0.19012,0.046296,0,0
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.04854,0.18906,0.19103,0,0
2,GO EPOXYGENASE P450 PATHWAY,0.060602,0.18786,0.15785,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.02166,0.18784,0.16557,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.30815,0.18683,0.057716,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.13583,0.18589,0.12691,0,0
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.4545,0.18349,0.084632,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13814,0.1825,0.14233,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.15015,0.18182,0.13133,0,0
2,GO BRONCHUS DEVELOPMENT,0.095625,0.18138,0.19684,0,0
2,GO HISTAMINE TRANSPORT,0.1028,0.1811,0.16082,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.10465,0.17878,0.16292,0,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.25729,0.17875,0.10097,0,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.13355,0.17733,0.18585,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.13355,0.1773,0.1134,0,0
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.2,0.17713,0.1143,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.085627,0.17551,0.14521,0,0
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.03939,0.17496,0.13443,0,0
2,GO CYTOPLASMIC TRANSLATION,0.068167,0.17488,0.12013,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.40349,0.17437,0.11494,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.10096,0.17417,0.1263,0,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.15517,0.17338,0.099975,0,0
2,GO CELL AGGREGATION,0.12049,0.1722,0.12536,0,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0695,0.1718,0.20134,0,0
2,GO RENAL FILTRATION,0.14048,0.17063,0.13903,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.42855,0.16987,0.05274,0,0
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.15264,0.16986,0.17844,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.1313,0.1694,0.20842,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.27999,0.16833,0.07581,0,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.13583,0.16673,0.13198,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.1313,0.16669,0.11537,0,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.093897,0.16663,0.14796,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.064293,0.16552,0.23946,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.13814,0.16528,0.1401,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.36064,0.16438,0.12982,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.085627,0.16428,0.13257,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.48678,0.16366,0.038975,0,0
2,GO ASTROCYTE DEVELOPMENT,0.17934,0.16352,0.093469,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.42347,0.16216,0.080558,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.20309,0.1621,0.10112,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.39371,0.16203,0.060818,0,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.073629,0.16197,0.18474,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.87833,0.16001,0.045474,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.041093,0.16001,0.16443,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.059411,0.15974,0.14728,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.20621,0.15934,0.098707,0,0
2,GO NATURAL KILLER CELL PROLIFERATION,0.080955,0.15881,0.15523,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.085627,0.15829,0.12178,0,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.080955,0.15725,0.26697,0,0
2,GO BONE GROWTH,0.11235,0.1567,0.14868,0,0
2,GO GOLGI LOCALIZATION,0.054842,0.15656,0.14166,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.066855,0.15369,0.14229,0,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.4598,0.15339,0.061642,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.11841,0.15304,0.12641,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.087232,0.15273,0.32682,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.12259,0.15261,0.15987,0,0
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.17099,0.15229,0.071951,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.38888,0.15223,0.06311,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.13355,0.15222,0.12042,0,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.53167,0.15166,0.017929,0,0
2,GO TRNA CATABOLIC PROCESS,0.13583,0.15153,0.18197,0,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.16294,0.15066,0.10429,0,0
2,GO MIDGUT DEVELOPMENT,0.85768,0.15043,0.03103,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.079444,0.14993,0.12678,0,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.057089,0.14902,0.098223,0,0
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.21905,0.14901,0.077456,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.099158,0.14872,0.21906,0,0
2,GO HYPOTONIC RESPONSE,0.079444,0.14825,0.13539,0,0
2,GO RESPONSE TO THYROID HORMONE,0.077957,0.14797,0.1441,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.11039,0.14729,0.21671,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.054842,0.14703,0.11361,0,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.19095,0.14681,0.12041,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.19095,0.14626,0.13691,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.16032,0.14577,0.079932,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.32506,0.14575,0.067128,0,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.10845,0.14541,0.20618,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.14048,0.14504,0.087764,0,0
2,GO TRACHEA MORPHOGENESIS,0.20937,0.14488,0.0578,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.11434,0.14453,0.12899,0,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.30815,0.14426,0.086666,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.28785,0.14406,0.050524,0,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.075049,0.14405,0.17505,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.16294,0.1429,0.12397,0,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.10465,0.14268,0.12521,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.23589,0.14186,0.078573,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.11235,0.14171,0.10775,0,0
2,GO FILOPODIUM ASSEMBLY,0.11235,0.14163,0.09184,0,0
2,GO REGULATION OF TRANSPOSITION,0.47588,0.14092,0.045357,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.30815,0.13967,0.053671,0,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.088862,0.13956,0.10124,0,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.4545,0.13933,0.084011,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.11434,0.13914,0.19447,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.49227,0.1385,0.062494,0,0
2,GO NUCLEOTIDE SALVAGE,0.4545,0.13847,0.058013,0,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.080955,0.13818,0.10246,0,0
2,GO COCHLEA MORPHOGENESIS,0.20309,0.13809,0.073907,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.27611,0.13774,0.10531,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.60272,0.13768,0.011387,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.060602,0.1375,0.11553,0,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.22905,0.13727,0.10154,0,0
2,GO PLASMA MEMBRANE FUSION,0.12259,0.13713,0.10216,0,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.16559,0.13672,0.15919,0,0
2,GO PLASMINOGEN ACTIVATION,0.12259,0.1366,0.18666,0,0
2,GO ASYMMETRIC CELL DIVISION,0.095625,0.13609,0.1201,0,0
2,GO PROGESTERONE METABOLIC PROCESS,0.29184,0.13587,0.059125,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.075049,0.13587,0.14532,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.26847,0.1355,0.16659,0,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.1028,0.13494,0.091749,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.36991,0.13482,0.066016,0,0
2,GO WOUND HEALING,0.073629,0.13475,0.10238,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.63354,0.13437,0.034075,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.17934,0.13388,0.13212,0,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.57857,0.13287,0.042496,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.16294,0.13265,0.065506,0,0
2,GO CYTOLYSIS,0.39371,0.13231,0.08281,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.076492,0.13209,0.084914,0,0
2,GO ACTIN CROSSLINK FORMATION,0.54321,0.13198,0.019549,0,0
2,GO PANCREATIC JUICE SECRETION,0.40349,0.13186,0.070239,0,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.50337,0.13148,0.046441,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.66501,0.13123,0.03513,0,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.068167,0.12996,0.09657,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.19695,0.12957,0.10703,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.16559,0.12935,0.057962,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.53167,0.1293,0.084106,0,0
2,GO PROTEIN HYDROXYLATION,0.16559,0.12911,0.096086,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.36064,0.12893,0.068807,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.11434,0.12886,0.13994,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.014841,0.12859,0.1922,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.073629,0.1283,0.12712,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.15015,0.12816,0.094268,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.22235,0.1279,0.15217,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.25729,0.12736,0.068767,0,0
2,GO MRNA METHYLATION,0.11841,0.12734,0.10227,0,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.11235,0.12666,0.14149,0,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.17099,0.12649,0.11832,0,0
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.036948,0.12627,0.17868,0,0
2,GO DIOL METABOLIC PROCESS,0.1313,0.12605,0.14097,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.71658,0.12505,0.052122,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.21256,0.12452,0.10192,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.27999,0.12295,0.073051,0,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.077957,0.1225,0.1227,0,0
2,GO RESPONSE TO VITAMIN,0.23937,0.12242,0.069465,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.092194,0.12218,0.1572,0,0
2,GO PENILE ERECTION,0.59664,0.12159,0.014568,0,0
2,GO LIPID DROPLET ORGANIZATION,0.063042,0.12153,0.13734,0,0
2,GO MYOBLAST FUSION,0.18508,0.12085,0.060529,0,0
2,GO PLATELET AGGREGATION,0.066855,0.12083,0.11973,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.51459,0.12081,0.020054,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.023741,0.12022,0.11013,0,0
2,GO SEGMENTATION,0.038561,0.12006,0.10411,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.26471,0.11999,0.081979,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.54903,0.1196,0.036418,0,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.090515,0.11931,0.1725,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.22568,0.11925,0.11126,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.33373,0.11917,0.07245,0,0
2,GO T CELL MIGRATION,0.35153,0.11896,0.049936,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.12908,0.11885,0.061863,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.38888,0.11704,0.032087,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.090515,0.11702,0.087891,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.41842,0.11663,0.080735,0,0
2,GO ANION HOMEOSTASIS,0.072231,0.11649,0.11766,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.27611,0.11635,0.065978,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.34256,0.11612,0.16433,0,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.068167,0.11596,0.15525,0,0
2,GO FORELIMB MORPHOGENESIS,0.84397,0.11567,-0.014364,0,0
2,GO TRANSEPITHELIAL TRANSPORT,0.095625,0.11561,0.063868,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.10096,0.11472,0.095617,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.088862,0.1147,0.15114,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.73628,0.11446,0.039977,0,0
2,GO RESPONSE TO NUTRIENT,0.30402,0.11372,0.057316,0,0
2,GO OOCYTE DIFFERENTIATION,0.13583,0.1134,0.065368,0,0
2,GO REGULATION OF COAGULATION,0.50337,0.11302,0.058065,0,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.3746,0.11275,0.072261,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.94073,0.11229,-0.025472,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.14285,0.11215,0.11927,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.17934,0.11211,0.056779,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.41341,0.11202,0.089047,0,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.070855,0.11197,0.076713,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.43883,0.11157,0.052559,0,0
2,GO MEMBRANE RAFT ORGANIZATION,0.57857,0.11151,0.03045,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.041093,0.1114,0.13755,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.41842,0.11135,0.068827,0,0
2,GO OLIGOPEPTIDE TRANSPORT,0.26847,0.11127,0.077507,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.14285,0.11093,0.10117,0,0
2,GO EPITHELIUM DEVELOPMENT,0.097379,0.11079,0.085584,0,0
2,GO ALPHA BETA T CELL PROLIFERATION,0.070855,0.11073,0.12183,0,0
2,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.29992,0.11065,0.056112,0,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.090515,0.11053,0.15099,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.092194,0.1105,0.082819,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.58456,0.10984,0.04385,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.20937,0.10965,0.085395,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.10654,0.10946,0.12587,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.070855,0.10943,0.12618,0,0
2,GO SYNCYTIUM FORMATION,0.16294,0.10938,0.067156,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.11039,0.10925,0.15175,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.25001,0.10921,0.10989,0,0
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.30815,0.1092,0.047616,0,0
2,GO REGULATION OF MYOBLAST FUSION,0.27611,0.10909,0.041031,0,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.059411,0.10895,0.076953,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.32077,0.10882,0.092152,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.18219,0.10869,0.10817,0,0
2,GO NATURAL KILLER CELL ACTIVATION,0.30815,0.10817,0.064722,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.68418,0.10798,0.0048762,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.48131,0.10764,0.044523,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.29586,0.10751,0.068028,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.49227,0.10729,0.017291,0,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.22235,0.10723,0.11373,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.1028,0.10715,0.176,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.16032,0.10696,0.092589,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.29586,0.10693,0.058675,0,0
2,GO RESPONSE TO INACTIVITY,0.34256,0.10681,0.064174,0,0
2,GO TISSUE REMODELING,0.63354,0.10681,0.032036,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.21256,0.10671,0.13488,0,0
2,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.14048,0.10656,0.14913,0,0
2,GO VASCULATURE DEVELOPMENT,0.16828,0.10645,0.081504,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.11636,0.10579,0.073105,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.58456,0.10576,0.063782,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.2,0.10529,0.096897,0,0
2,GO TRNA WOBBLE BASE MODIFICATION,0.20937,0.10514,0.04516,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.15015,0.10512,0.098642,0,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.11636,0.10503,0.12144,0,0
2,GO FIBROBLAST PROLIFERATION,0.25001,0.10502,0.086277,0,0
2,GO MACROPHAGE DIFFERENTIATION,0.10845,0.10474,0.096817,0,0
2,GO RESPONSE TO WATER,0.78289,0.1047,0.035816,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.21905,0.1045,0.12663,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.23589,0.1042,0.083868,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.11841,0.10405,0.14252,0,0
2,GO LYMPHANGIOGENESIS,0.29586,0.10379,0.085135,0,0
2,GO CYTOKINE SECRETION,0.12049,0.10345,0.09544,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.24288,0.10341,0.065362,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.2,0.10324,0.079547,0,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.19095,0.10315,0.10968,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.26471,0.1027,0.12071,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.019283,0.10235,0.17287,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.12473,0.10226,0.12608,0,0
2,GO METHIONINE METABOLIC PROCESS,0.12908,0.102,0.1016,0,0
2,GO ENDODERM DEVELOPMENT,0.23245,0.10189,0.12832,0,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.14526,0.10163,0.11053,0,0
2,GO HISTONE H2A UBIQUITINATION,0.097379,0.10155,0.077069,0,0
2,GO RESPONSE TO WOUNDING,0.17099,0.10035,0.072395,0,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.099158,0.1002,0.065823,0,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.084046,0.10015,0.084706,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.43367,0.09975,-0.072598,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0695,0.099305,0.16225,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.36991,0.099267,0.055161,0,0
2,GO MUSCLE CELL PROLIFERATION,0.14285,0.099239,0.08338,0,0
2,GO LYMPHOCYTE MIGRATION,0.43883,0.099218,0.03989,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.53742,0.099176,0.039161,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.61497,0.099032,0.028108,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.4545,0.09897,0.036017,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.22235,0.098849,0.12855,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.20937,0.098845,0.1577,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.10845,0.098564,0.069157,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.14048,0.098529,0.070043,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.51459,0.098522,0.020535,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.89907,0.098219,-0.02504,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.10654,0.098053,0.22535,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.23245,0.09797,0.15253,0,0
2,GO COLLAGEN METABOLIC PROCESS,0.31232,0.097741,0.036412,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.27999,0.097736,0.027855,0,0
2,GO THYROID GLAND DEVELOPMENT,0.31653,0.097518,0.039435,0,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.48131,0.097471,0.030302,0,0
2,GO REGENERATION,0.099158,0.097338,0.08482,0,0
2,GO INTERLEUKIN 4 PRODUCTION,0.093897,0.097106,0.099794,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.092194,0.097102,0.085718,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.065563,0.096951,0.086368,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.14285,0.096939,0.11278,0,0
2,GO INFLAMMATORY RESPONSE,0.072231,0.096851,0.077918,0,0
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.24643,0.096809,0.090066,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.19393,0.096697,0.11214,0,0
2,GO RESPONSE TO RETINOIC ACID,0.14769,0.096686,0.11544,0,0
2,GO RESPONSE TO FATTY ACID,0.11235,0.0966,0.090031,0,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.15264,0.096531,0.07558,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.32938,0.096344,0.09839,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.29586,0.096115,0.041389,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.15264,0.096082,0.065256,0,0
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.10465,0.096072,0.091278,0,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.65234,0.095571,0.009493,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.17099,0.095412,0.09534,0,0
2,GO NEURAL TUBE DEVELOPMENT,0.073629,0.095297,0.12072,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.26098,0.095088,0.034564,0,0
2,GO MANGANESE ION TRANSPORT,0.25363,0.094835,0.083094,0,0
2,GO REGULATION OF HEAT GENERATION,0.085627,0.094723,0.15814,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.39371,0.094719,0.072548,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.075049,0.094585,0.16367,0,0
2,GO GLIAL CELL DEVELOPMENT,0.21905,0.094356,0.050659,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.12473,0.094323,0.12934,0,0
2,GO COENZYME A METABOLIC PROCESS,0.14769,0.094107,0.08271,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.35607,0.094096,0.052936,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.31653,0.093876,0.16449,0,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.14048,0.093351,0.095746,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.33373,0.093293,0.023759,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.65234,0.093292,0.0066802,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.1028,0.093224,0.14928,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.52025,0.092954,0.087796,0,0
2,GO TUBE MORPHOGENESIS,0.2,0.09289,0.076196,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.64605,0.092866,0.0024579,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.63978,0.092791,0.0090104,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.42347,0.092534,0.094796,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.53742,0.092287,0.042203,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.52594,0.092135,0.051577,0,0
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.32938,0.092106,0.069013,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.71006,0.091871,0.030339,0,0
2,GO HUMORAL IMMUNE RESPONSE,0.077957,0.091782,0.066506,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.16559,0.091709,0.10081,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.10654,0.09164,0.22048,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.50896,0.091438,0.036452,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.25729,0.091125,0.047285,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.56666,0.090913,0.00064642,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.2839,0.090459,0.073832,0,0
2,GO BIOLOGICAL ADHESION,0.084046,0.090027,0.074728,0,0
2,GO DENDRITIC SPINE MAINTENANCE,0.44924,0.089854,0.028541,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.10654,0.089698,0.11056,0,0
2,GO PEPTIDYL HISTIDINE MODIFICATION,0.43367,0.089527,0.032108,0,0
2,GO HEAT GENERATION,0.064293,0.08897,0.12936,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.2,0.088959,0.063476,0,0
2,GO EXOCYTOSIS,0.13814,0.088959,0.059566,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.23589,0.088921,0.0619,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.38888,0.088852,0.058578,0,0
2,GO NEGATIVE REGULATION OF CELL SIZE,0.10654,0.088843,0.092623,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.28785,0.088799,0.066489,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.10654,0.088675,0.20513,0,0
2,GO MIDBODY ABSCISSION,0.1028,0.088595,0.1647,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.89907,0.088383,-0.010427,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.39371,0.08831,0.020904,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.51459,0.087947,0.082929,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.26098,0.08737,0.060155,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.10654,0.087322,0.078885,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.65866,0.08732,-0.023665,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.33373,0.08728,0.051242,0,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.17099,0.087117,0.076535,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.56666,0.08688,0.03822,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.13814,0.08674,0.083736,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.23589,0.086738,0.049179,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.30815,0.086575,0.052955,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.27999,0.086477,0.10052,0,0
2,GO RESPONSE TO KETONE,0.10654,0.086286,0.074518,0,0
2,GO RESPONSE TO ETHER,0.15015,0.086192,0.078658,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.52025,0.08618,0.029353,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.27999,0.085946,0.065415,0,0
2,GO RESPONSE TO VITAMIN A,0.17934,0.08591,0.092627,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.077957,0.085503,0.12223,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.19095,0.085487,0.088286,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.084046,0.085418,0.10089,0,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.32938,0.085388,0.094457,0,0
2,GO BONE REMODELING,0.4978,0.085333,0.044408,0,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.51459,0.084925,0.026934,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.80312,0.084787,-0.010457,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.10465,0.084775,0.12369,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.19095,0.084302,0.090455,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.082489,0.084164,0.094513,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.10096,0.084042,0.19324,0,0
2,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.39858,0.084034,0.10841,0,0
2,GO RNA SURVEILLANCE,0.11636,0.0839,0.076486,0,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.082489,0.083856,0.073372,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.32938,0.083844,0.064487,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.28785,0.083764,0.061816,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.17374,0.083717,0.078344,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.62113,0.083659,0.047421,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.53167,0.083631,0.042006,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.35607,0.083463,0.031203,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.14769,0.083441,0.066753,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.90599,0.082847,-0.01235,0,0
2,GO REGULATION OF RECEPTOR BINDING,0.20621,0.082811,0.1465,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.16032,0.08254,0.1104,0,0
2,GO REGULATION OF T CELL CHEMOTAXIS,0.10096,0.082454,0.12544,0,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.16559,0.082288,0.058691,0,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.52594,0.082174,0.051401,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.16032,0.082106,0.07026,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.16559,0.082068,0.11045,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.41842,0.081927,0.094637,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.41842,0.081884,0.069795,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.70355,0.08188,0.01266,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.188,0.081828,0.15268,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.27611,0.08142,0.1285,0,0
2,GO MACROPHAGE ACTIVATION,0.093897,0.081392,0.07512,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.31653,0.081213,0.13044,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.21579,0.081075,0.051763,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.30815,0.081065,0.053145,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.58456,0.080884,0.040261,0,0
2,GO NADH METABOLIC PROCESS,0.11235,0.080592,0.11708,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.16032,0.080585,0.10227,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.13355,0.08043,0.093162,0,0
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.33373,0.080136,0.10707,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.2839,0.079992,0.067154,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.16559,0.079916,0.054372,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.35153,0.07987,0.045904,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.15773,0.079784,0.070084,0,0
2,GO CHOLESTEROL STORAGE,0.46512,0.079746,0.035747,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.085627,0.079566,0.078273,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.11841,0.079399,0.095557,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.079444,0.079271,0.40542,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.11636,0.079253,0.095421,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.99651,0.079179,-0.010979,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.11235,0.079117,0.092905,0,0
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.073629,0.079017,0.10047,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.22905,0.078723,0.096504,0,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.070855,0.078537,0.080378,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.97557,0.078311,-0.0098981,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.61497,0.078228,0.042422,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.43367,0.078009,0.058547,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.38888,0.077943,0.074914,0,0
2,GO STEROID ESTERIFICATION,0.19393,0.077939,0.085986,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.17099,0.077747,0.073079,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.32506,0.077381,0.074878,0,0
2,GO PH REDUCTION,0.099158,0.077266,0.089296,0,0
2,GO GLAND DEVELOPMENT,0.26847,0.077157,0.062671,0,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.8303,0.077114,-0.019334,0,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.2839,0.077066,0.032672,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.12473,0.076841,0.081019,0,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.43883,0.076566,0.07835,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.077957,0.07648,0.10212,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.52594,0.076404,0.047509,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.27999,0.076113,0.089179,0,0
2,GO HISTONE H2A ACETYLATION,0.27227,0.075935,0.04538,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.188,0.075738,0.061065,0,0
2,GO XENOBIOTIC TRANSPORT,0.69061,0.075706,0.031254,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.67137,0.075582,0.076669,0,0
2,GO NCRNA 3 END PROCESSING,0.087232,0.075565,0.031846,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.25363,0.075529,0.050677,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.50337,0.075435,0.10873,0,0
2,GO HISTONE ARGININE METHYLATION,0.32077,0.075256,0.052168,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.26471,0.075213,0.11622,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.055956,0.075091,0.14088,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.53742,0.075068,0.055035,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.188,0.07503,0.05697,0,0
2,GO DNA STRAND ELONGATION,0.075049,0.074949,0.10194,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.66501,0.074782,0.032874,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.030383,0.074759,0.13526,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.12908,0.074671,0.14176,0,0
2,GO PHOSPHOLIPID TRANSPORT,0.15773,0.07446,0.067961,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.1313,0.074418,0.11184,0,0
2,GO KIDNEY MORPHOGENESIS,0.080955,0.074182,0.090909,0,0
2,GO PROTEIN OXIDATION,0.50337,0.074105,0.04697,0,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.077957,0.073954,0.13384,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.33812,0.073924,0.052417,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.24643,0.07354,0.14108,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.079444,0.07342,0.088475,0,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.092194,0.073097,0.091475,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.1313,0.072932,0.08595,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.14048,0.072879,0.073667,0,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.059411,0.072709,0.084297,0,0
2,GO POLYOL CATABOLIC PROCESS,0.075049,0.072673,0.080134,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.17099,0.072562,0.048008,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.27227,0.072368,0.10557,0,0
2,GO REGULATION OF URINE VOLUME,0.24288,0.072355,0.10556,0,0
2,GO MEMBRANE INVAGINATION,0.32506,0.072228,0.048313,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.17653,0.07219,0.053827,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.25729,0.071668,0.070065,0,0
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.59664,0.071665,0.036939,0,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.13814,0.071614,0.088847,0,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.10465,0.071435,0.058672,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.11636,0.071272,0.052152,0,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.15773,0.071232,0.075923,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.13355,0.071191,0.14003,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.32506,0.071096,0.061525,0,0
2,GO LIPID EXPORT FROM CELL,0.087232,0.070966,0.098339,0,0
2,GO RESPONSE TO PAIN,0.50337,0.070922,0.067186,0,0
2,GO AUTOPHAGOSOME MATURATION,0.17934,0.070855,0.080844,0,0
2,GO GLIAL CELL ACTIVATION,0.19695,0.070847,0.069451,0,0
2,GO QUINONE METABOLIC PROCESS,0.35153,0.070759,0.021514,0,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.20621,0.070746,0.058008,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.42855,0.070742,0.06566,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.39371,0.070572,0.039056,0,0
2,GO REGULATION OF GASTRULATION,0.34702,0.070505,0.053178,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.26098,0.0705,0.086892,0,0
2,GO NEURAL CREST CELL MIGRATION,0.34256,0.070272,0.068597,0,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.30402,0.070234,0.029034,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.25001,0.070182,0.084944,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.11235,0.070162,0.13023,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.11434,0.070051,0.065339,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.29586,0.069843,0.055031,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.35607,0.069698,0.066131,0,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.099158,0.069657,0.1803,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.10096,0.06961,0.07746,0,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.079444,0.069308,0.12552,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.98255,0.06929,-0.017509,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.19695,0.069256,0.054874,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.23589,0.069187,0.091044,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.3746,0.069085,0.032573,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.42347,0.068916,0.029146,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.32506,0.068886,0.043658,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.188,0.068885,0.097203,0,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.17653,0.068864,0.085051,0,0
2,GO TISSUE MORPHOGENESIS,0.22905,0.068581,0.06319,0,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.16032,0.068553,0.075598,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.16828,0.068537,0.089806,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.63354,0.068361,0.061051,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.097379,0.068312,0.10808,0,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.12259,0.067782,0.11046,0,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.090515,0.067631,0.073736,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.29586,0.067564,0.04938,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.12908,0.067371,0.048462,0,0
2,GO SUPEROXIDE ANION GENERATION,0.16032,0.067255,0.14448,0,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.36064,0.067245,0.068495,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.42855,0.067167,0.047184,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.16294,0.067118,0.050767,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.50896,0.067088,0.05196,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.099158,0.067027,0.10795,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.30815,0.067022,0.034015,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.53742,0.066847,0.043616,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.32077,0.066832,0.031018,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.066855,0.066803,0.0662,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.53742,0.066778,0.0085729,0,0
2,GO ASTROCYTE ACTIVATION,0.75615,0.066599,0.011655,0,0
2,GO DECIDUALIZATION,0.61497,0.066474,0.0064357,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.16032,0.066446,0.06353,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.24643,0.066335,0.075772,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.11841,0.06624,0.12249,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.62732,0.066224,0.024645,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.14769,0.066119,0.041214,0,0
2,GO MEMBRANE DISASSEMBLY,0.62113,0.065998,0.027813,0,0
2,GO CELL MOTILITY,0.21905,0.065809,0.044308,0,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.19695,0.0658,0.068935,0,0
2,GO CELLULAR EXTRAVASATION,0.079444,0.065606,0.080548,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.25729,0.065516,0.069953,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.12473,0.0654,0.066265,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.090515,0.065334,0.086028,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.079444,0.065301,0.099114,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.088862,0.065103,0.084342,0,0
2,GO GONADOTROPIN SECRETION,0.36064,0.065099,0.070852,0,0
2,GO TUBE DEVELOPMENT,0.42347,0.065078,0.053784,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.64605,0.064931,-0.006246,0,0
2,GO NEUTROPHIL MIGRATION,0.15517,0.064782,0.053166,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.69707,0.064764,0.0029454,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.32077,0.064502,0.043497,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.19393,0.064466,0.057194,0,0
2,GO ER OVERLOAD RESPONSE,0.63978,0.06436,0.047077,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.78289,0.064359,0.057268,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.19695,0.064125,0.053442,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.072231,0.064064,0.086925,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.88523,0.064041,0.030131,0,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.092194,0.064012,0.069014,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.43367,0.063774,0.025124,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.22905,0.063597,0.1509,0,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.62113,0.063472,0.014904,0,0
2,GO REGULATION OF GTP BINDING,0.23937,0.063438,0.099939,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.43883,0.063309,0.053186,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.91987,0.063251,-0.028667,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.12473,0.063073,0.10933,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.92682,0.063049,0.0045693,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.057089,0.062912,0.11662,0,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.12049,0.062861,0.11282,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.43883,0.062748,0.073997,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.32506,0.062656,0.0506,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.077957,0.062614,0.064307,0,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.34256,0.062435,0.021078,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.35153,0.062398,0.069056,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.63354,0.062281,0.0041897,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.21579,0.062272,0.038011,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.19393,0.062264,0.061841,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.35153,0.062231,0.04773,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.57857,0.062215,0.025496,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.15015,0.062195,0.062626,0,0
2,GO CELL SUBSTRATE ADHESION,0.20621,0.062118,0.0835,0,0
2,GO MAINTENANCE OF LOCATION,0.11636,0.062004,0.058531,0,0
2,GO LIPOPROTEIN LOCALIZATION,0.43367,0.061791,0.033217,0,0
2,GO RENAL SODIUM EXCRETION,0.29586,0.06162,0.096911,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.40349,0.061588,0.040531,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.11434,0.061527,0.056721,0,0
2,GO DE NOVO PROTEIN FOLDING,0.72969,0.061453,0.032297,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.43367,0.061447,0.047578,0,0
2,GO ORGAN GROWTH,0.13355,0.06143,0.11115,0,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.44402,0.061213,0.076959,0,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.36526,0.061197,0.057398,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.32938,0.061148,0.042652,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.16032,0.061073,0.13903,0,0
2,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.51459,0.060976,0.034694,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.47049,0.060971,0.0269,0,0
2,GO RESPONSE TO CHEMOKINE,0.17934,0.060617,0.037611,0,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.070855,0.060539,0.074899,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,0.82348,0.060458,-0.031202,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.13814,0.060219,0.10053,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.30815,0.060207,0.073808,0,0
2,GO GENITALIA DEVELOPMENT,0.26847,0.0602,0.04837,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.53167,0.060186,0.067411,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.16828,0.060158,0.068826,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.48131,0.059982,0.049345,0,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.011904,0.059879,0.096459,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.59664,0.059871,0.058022,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.30402,0.059839,0.13783,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.48678,0.059825,0.083662,0,0
2,GO VAGINA DEVELOPMENT,0.71006,0.059747,-0.084776,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.14285,0.059703,0.066329,0,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.55487,0.059548,0.061276,0,0
2,GO LIPID DIGESTION,0.80312,0.059464,-0.010911,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.10845,0.05904,0.071608,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.41842,0.059025,0.038947,0,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.5726,0.058995,0.065208,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.27611,0.058764,0.083856,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.53167,0.058755,0.02458,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.27999,0.058738,0.044208,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.31232,0.058544,0.042258,0,0
2,GO HINDLIMB MORPHOGENESIS,0.17374,0.058536,0.10037,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.084046,0.058521,0.16331,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.16828,0.058502,0.064702,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.60272,0.058315,0.10897,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.4545,0.05816,0.064237,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.11434,0.057789,0.065289,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.24643,0.057675,0.065977,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.40843,0.057503,0.03633,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.092194,0.057446,0.11744,0,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.19393,0.057418,0.11169,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.079444,0.057373,0.13247,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.12473,0.057363,0.10949,0,0
2,GO RETINA HOMEOSTASIS,0.17374,0.057135,0.03621,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.059411,0.057022,0.065593,0,0
2,GO BLASTOCYST GROWTH,0.11039,0.056992,0.10089,0,0
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.67137,0.056898,0.036486,0,0
2,GO RESPONSE TO INSULIN,0.0695,0.056716,0.051502,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.19695,0.05665,0.03697,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.69707,0.05643,0.0096036,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.42347,0.056396,0.048857,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.15264,0.056373,0.22245,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.4598,0.056334,0.014258,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.86455,0.056328,-0.012653,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.29586,0.05631,0.052729,0,0
2,GO VIRAL BUDDING,0.33373,0.056281,0.062781,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.48131,0.056214,0.070977,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.084046,0.056201,0.050723,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.71006,0.056172,0.014252,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.16294,0.056087,0.052213,0,0
2,GO AXONAL FASCICULATION,0.50337,0.055958,0.037614,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.41341,0.055956,0.10224,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.47049,0.05584,0.03913,0,0
2,GO FOLIC ACID METABOLIC PROCESS,0.20621,0.055791,0.10366,0,0
2,GO MESODERM DEVELOPMENT,0.13355,0.055791,0.07685,0,0
2,GO CARTILAGE MORPHOGENESIS,0.58456,0.055791,0.035789,0,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.13583,0.055654,0.046158,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.55487,0.055628,0.0845,0,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.17934,0.055576,0.15945,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.75615,0.055363,0.0033386,0,0
2,GO METANEPHROS MORPHOGENESIS,0.44402,0.055324,0.041621,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.22905,0.055312,0.07679,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.17099,0.055305,0.13076,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.40349,0.055072,0.01561,0,0
2,GO SECRETION,0.38408,0.055045,0.027329,0,0
2,GO UV PROTECTION,0.70355,0.055043,0.0094715,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.31232,0.054957,0.046704,0,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.13583,0.054932,0.10299,0,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.26471,0.054826,0.061347,0,0
2,GO PROTEIN NEDDYLATION,0.059411,0.054672,0.086507,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.36991,0.054672,0.056526,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.057089,0.054671,0.13244,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.19695,0.054646,0.0941,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.39371,0.054538,0.053798,0,0
2,GO DNA DEPENDENT DNA REPLICATION,0.0695,0.054484,0.079645,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.40349,0.054472,0.03752,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.35153,0.054363,0.082316,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.28785,0.054257,0.037291,0,0
2,GO PEPTIDYL ARGININE N METHYLATION,0.31232,0.054112,0.082864,0,0
2,GO SEX DIFFERENTIATION,0.25729,0.053986,0.039714,0,0
2,GO JNK CASCADE,0.11039,0.053822,0.063429,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.65866,0.053687,0.00073065,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.78289,0.053661,0.0042012,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.23245,0.053661,0.037916,0,0
2,GO PROTEIN TARGETING,0.14526,0.053461,0.05513,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.77618,0.053311,-0.059055,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.13583,0.053108,0.046465,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.30402,0.052992,0.045157,0,0
2,GO FOAM CELL DIFFERENTIATION,0.54321,0.052945,0.021288,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.17653,0.052857,0.044659,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.31653,0.052806,0.034746,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.76281,0.052616,0.033972,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.12259,0.052608,0.082048,0,0
2,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.12259,0.052601,0.12696,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.36991,0.052499,0.033689,0,0
2,GO ATP TRANSPORT,0.87144,0.052492,0.0082245,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.31653,0.052491,0.1168,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.27227,0.052447,0.06344,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.27999,0.052414,0.088844,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.35153,0.052412,0.044488,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.32077,0.05238,0.076138,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.1028,0.052316,0.058494,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.29184,0.052285,0.03419,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.23937,0.052258,0.10078,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.20621,0.052253,0.069646,0,0
2,GO SPERM EGG RECOGNITION,0.16559,0.052163,0.067324,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.29184,0.052049,0.04609,0,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.2,0.051829,0.066447,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.35153,0.051709,0.047985,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.47588,0.051655,0.025634,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.89215,0.051597,-0.033048,0,0
2,GO BONE RESORPTION,0.60883,0.051587,0.029429,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.16559,0.051585,0.082306,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.13583,0.051573,0.052191,0,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.1028,0.051528,0.042725,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.15264,0.05149,0.060839,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.35153,0.051349,0.043611,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.21579,0.051345,0.062835,0,0
2,GO TRABECULA FORMATION,0.41341,0.051266,0.05676,0,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.087232,0.051068,0.10748,0,0
2,GO REGULATION OF PINOCYTOSIS,0.36991,0.051012,0.064045,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.30402,0.050991,0.038021,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.15773,0.050902,0.054929,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.47588,0.050894,0.043238,0,0
2,GO REGULATION OF MRNA BINDING,0.31232,0.050872,0.038633,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.59664,0.050841,0.026234,0,0
2,GO FAT CELL DIFFERENTIATION,0.34256,0.050777,0.049189,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.50337,0.050764,0.049257,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.1313,0.05069,0.046172,0,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.99651,0.050566,-0.052207,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.29184,0.05055,0.060039,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.60272,0.050544,0.046855,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.78962,0.050415,0.016942,0,0
2,GO REPLICATION FORK PROCESSING,0.10845,0.050351,0.09196,0,0
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.44402,0.050222,0.026579,0,0
2,GO MACROMOLECULE DEACYLATION,0.15015,0.050151,0.041567,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.78962,0.050104,-0.0039703,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.32506,0.050057,0.045262,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.32506,0.049976,0.12155,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.26471,0.049794,0.036933,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.2839,0.049785,0.067977,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.28785,0.049664,0.05882,0,0
2,GO MYOBLAST PROLIFERATION,0.54903,0.049606,0.034793,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.44402,0.049284,0.075538,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.56075,0.049167,0.032736,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.015203,0.049035,0.074228,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.87833,0.049016,-0.0090988,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.11636,0.048946,0.067784,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.32938,0.048945,0.062454,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.77618,0.048933,0.059482,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.36064,0.048879,0.031936,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.97557,0.048754,-0.0069219,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.78289,0.048727,0.022377,0,0
2,GO GLAND MORPHOGENESIS,0.13583,0.048528,0.17669,0,0
2,GO REPLACEMENT OSSIFICATION,0.29992,0.048461,0.12535,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.13814,0.048443,0.064392,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.44924,0.048278,0.042794,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.16559,0.048275,0.046709,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.24288,0.048142,0.057606,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.75615,0.048125,0.010011,0,0
2,GO RESPONSE TO NICOTINE,0.63978,0.048124,0.031532,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.77618,0.048049,-0.012217,0,0
2,GO MUSCLE HYPERTROPHY,0.74288,0.047933,0.023591,0,0
2,GO SISTER CHROMATID COHESION,0.41842,0.047877,0.058233,0,0
2,GO NODAL SIGNALING PATHWAY,0.26098,0.047805,0.054842,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.12473,0.047777,0.070344,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.30402,0.04763,0.050491,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.28785,0.047599,0.029176,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.8303,0.047589,0.0093518,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.65234,0.04753,0.0075508,0,0
2,GO REGULATION OF ERAD PATHWAY,0.33373,0.047491,0.026022,0,0
2,GO BONE MORPHOGENESIS,0.17099,0.047478,0.10409,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.33812,0.047411,0.081677,0,0
2,GO G0 TO G1 TRANSITION,0.63354,0.047383,0.036252,0,0
2,GO RECOMBINATIONAL REPAIR,0.23245,0.047318,0.065467,0,0
2,GO REGULATION OF T CELL MIGRATION,0.35153,0.047276,0.03235,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.23589,0.047132,0.057861,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.73628,0.047059,-0.048068,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.59059,0.046968,0.026706,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.10465,0.046921,0.093967,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.54321,0.046802,0.067365,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.061812,0.046702,0.084,0,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.13355,0.046618,0.062008,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.26471,0.046593,0.067095,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.34256,0.046263,0.073817,0,0
2,GO RESPONSE TO AMINE,0.90599,0.046229,-0.0026783,0,0
2,GO GASTRULATION,0.30815,0.046065,0.091052,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.097379,0.045971,0.12883,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.29992,0.045903,0.059035,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.4978,0.045814,0.033959,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.20937,0.045448,0.057424,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.17099,0.045424,0.046655,0,0
2,GO AMMONIUM TRANSPORT,0.47588,0.045406,0.06112,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.50896,0.045314,0.045087,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.47588,0.045272,0.037685,0,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.4545,0.045223,0.0025365,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.19695,0.045149,0.047809,0,0
2,GO GLIAL CELL PROLIFERATION,0.072231,0.045013,0.1248,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.28785,0.044923,0.16212,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.19095,0.044901,0.063486,0,0
2,GO RECEPTOR RECYCLING,0.53742,0.044887,0.033435,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.40843,0.044881,0.034655,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.52025,0.044822,-0.05293,0,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.12689,0.044759,0.057645,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.36064,0.044493,0.03673,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.97557,0.044492,-0.020599,0,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.37932,0.044383,0.063624,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.30402,0.044345,0.074102,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.16559,0.044309,0.10967,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.98255,0.044179,-0.025996,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.71658,0.044178,0.0079146,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.14285,0.044084,0.058932,0,0
2,GO RECEPTOR INTERNALIZATION,0.42855,0.043949,0.039436,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.49227,0.043885,0.029103,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.23937,0.043665,0.1539,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.21579,0.043512,0.045601,0,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.36064,0.043295,0.047208,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.32938,0.04327,0.075257,0,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.96163,0.043253,-0.046446,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.19695,0.043204,0.040658,0,0
2,GO REGULATION OF CELLULAR PH,0.2839,0.043055,0.049344,0,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.44924,0.043014,0.041169,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.37932,0.042952,0.02658,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.54903,0.042892,0.022145,0,0
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.092194,0.042833,0.11759,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.39858,0.042558,0.019582,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.4545,0.04255,0.040202,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.18508,0.042512,0.072206,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.24288,0.042461,0.039424,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.20937,0.042412,0.057759,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.56075,0.042409,0.079481,0,0
2,GO EMBRYO DEVELOPMENT,0.15773,0.042375,0.054676,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.41341,0.042338,0.01934,0,0
2,GO APPENDAGE DEVELOPMENT,0.22235,0.042154,0.08439,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.56075,0.042047,0.043814,0,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.24643,0.04183,0.050754,0,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.16828,0.041715,0.087445,0,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.15264,0.041699,0.05972,0,0
2,GO CHROMOSOME CONDENSATION,0.17653,0.041532,0.055854,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.51459,0.041504,0.022116,0,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.38888,0.041338,0.068039,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.54903,0.041223,-0.072784,0,0
2,GO MATING BEHAVIOR,0.65234,0.041203,0.01504,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.12689,0.041174,0.20542,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.32938,0.040989,0.061777,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.38888,0.040934,0.022132,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.36991,0.040832,0.1354,0,0
2,GO CELL MATRIX ADHESION,0.2839,0.040787,0.07514,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.71006,0.040784,0.012411,0,0
2,GO ARTERY DEVELOPMENT,0.40349,0.040717,0.067382,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.71658,0.040666,0.015731,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.26471,0.040642,0.048529,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.48678,0.04061,0.067202,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.43367,0.040595,0.044107,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.49227,0.040577,0.016185,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.90599,0.040532,-0.019676,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16559,0.040517,0.076856,0,0
2,GO P38MAPK CASCADE,0.65866,0.040479,0.013581,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.23589,0.040418,0.069041,0,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.47049,0.0404,0.018087,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.99651,0.040301,-0.014091,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.59664,0.040286,0.013766,0,0
2,GO SISTER CHROMATID SEGREGATION,0.063042,0.040261,0.078034,0,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.76948,0.040232,-0.036101,0,0
2,GO DNA REPLICATION INITIATION,0.41341,0.04018,0.058988,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.48678,0.040175,0.059895,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.89215,0.040048,-0.0013108,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.19393,0.039908,0.058216,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.87833,0.039891,-0.0031628,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.50896,0.039868,0.067365,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.077957,0.03978,0.11982,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.84397,0.039659,0.0057431,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.41341,0.039652,0.02731,0,0
2,GO CELLULAR RESPONSE TO ATP,0.71658,0.0395,-0.030893,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.92682,0.039446,0.023553,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.41842,0.039428,0.052625,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.72969,0.039216,0.027238,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.54321,0.039017,0.04013,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.60272,0.038958,0.042426,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.85768,0.03867,2.3728e-05,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.88523,0.038642,0.051091,0,0
2,GO ENDOTHELIAL CELL MIGRATION,0.17374,0.038631,0.083256,0,0
2,GO INOSITOL METABOLIC PROCESS,0.67137,0.03863,0.042387,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.70355,0.038597,0.003412,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.48131,0.038378,0.03819,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.98255,0.038124,0.012487,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.63354,0.038058,0.069205,0,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.42347,0.038056,0.01419,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.86455,0.03805,0.049739,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.41842,0.037893,0.022833,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.22905,0.037582,0.083471,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.085627,0.037446,0.30196,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.25729,0.037413,0.04907,0,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.17653,0.037373,0.13886,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.96163,0.037244,-0.0057047,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.25729,0.037176,0.064686,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.12259,0.03715,0.044361,0,0
2,GO CELL JUNCTION ASSEMBLY,0.29586,0.037149,0.039641,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.48131,0.037112,0.021951,0,0
2,GO PROTEIN NITROSYLATION,0.83713,0.037074,0.032765,0,0
2,GO REGULATION OF MAPK CASCADE,0.17653,0.036943,0.056269,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.40349,0.036794,0.032072,0,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.61497,0.036654,0.021219,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.65866,0.036635,0.071916,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.93377,0.036604,-0.026749,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.30815,0.036552,0.063603,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.48678,0.036531,0.01892,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.87144,0.036392,0.050318,0,0
2,GO BODY MORPHOGENESIS,0.82348,0.036375,-0.023712,0,0
2,GO PROTEIN TRIMERIZATION,0.2839,0.036297,0.08647,0,0
2,GO DRUG CATABOLIC PROCESS,0.47049,0.036215,0.073079,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.81668,0.036148,-0.050879,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.93377,0.036143,-0.020704,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.67137,0.0359,0.0070226,0,0
2,GO RESPONSE TO PROGESTERONE,0.30402,0.035701,0.11473,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.41842,0.035671,0.027517,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.26847,0.035637,0.12157,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.42347,0.035516,0.094223,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.65234,0.035167,0.04765,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.4598,0.035083,0.037654,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.22235,0.03508,0.025614,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.81668,0.035076,0.0065268,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.33812,0.034913,0.036385,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.42347,0.034825,0.036246,0,0
2,GO VASCULAR WOUND HEALING,0.69061,0.034642,0.058592,0,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.53167,0.034595,0.083922,0,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.78289,0.034519,-0.019746,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.50337,0.03433,0.018667,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.42347,0.034092,0.024815,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.26471,0.033946,0.057425,0,0
2,GO REGULATION OF PH,0.51459,0.03388,0.031773,0,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.54321,0.03378,0.026539,0,0
2,GO DNA REPLICATION CHECKPOINT,0.37932,0.033755,0.081223,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.51459,0.033696,0.0397,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.98953,0.033655,-0.01079,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.62732,0.033339,0.0090765,0,0
2,GO RESPONSE TO VITAMIN D,0.75615,0.033304,-0.012849,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.65234,0.03327,0.017896,0,0
2,GO EAR DEVELOPMENT,0.36064,0.03324,0.036443,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.49227,0.033169,0.041189,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.59664,0.033141,-0.0026698,0,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.40843,0.033078,0.02838,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.58456,0.03301,0.053736,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.82348,0.032932,0.014161,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.89907,0.032918,0.013914,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.74288,0.032908,0.037223,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.25363,0.032883,0.034632,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.49227,0.032877,0.046181,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.5726,0.032781,-0.0504,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.80312,0.032752,-0.0040342,0,0
2,GO REGULATION OF RNA BINDING,0.63978,0.032718,0.018392,0,0
2,GO PEPTIDYL SERINE MODIFICATION,1,0.032703,0.0012025,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.47049,0.032675,0.018664,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.84397,0.032534,-0.01119,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.98255,0.032516,-0.019236,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.16032,0.032262,0.074579,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.11235,0.032262,0.057656,0,0
2,GO PHOSPHOLIPID EFFLUX,0.74288,0.032237,-0.0043623,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.1028,0.032126,0.053114,0,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.41842,0.032053,0.05181,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.24643,0.031869,0.037972,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.47049,0.03173,0.028062,0,0
2,GO MYOFIBRIL ASSEMBLY,0.21905,0.031644,0.052997,0,0
2,GO PLATELET DEGRANULATION,0.7495,0.031469,0.011304,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.74288,0.031422,0.018714,0,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.31653,0.031354,0.12238,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.27999,0.031265,0.031642,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.33373,0.031199,0.046346,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.52025,0.031131,0.020981,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.88523,0.031104,-0.013763,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.63354,0.030965,0.0020748,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.67137,0.030943,0.02175,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.73628,0.030891,-0.0040581,0,0
2,GO VISUAL BEHAVIOR,0.73628,0.030877,0.0149,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.94073,0.030771,-0.0056169,0,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.98953,0.030763,-0.0052222,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.74288,0.030758,-0.016102,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.32077,0.030673,0.074295,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.32506,0.030563,0.042333,0,0
2,GO PRENYLATION,0.53742,0.030561,0.02121,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.043763,0.030525,0.083606,0,0
2,GO REGULATION OF ODONTOGENESIS,0.54903,0.030479,0.01845,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.72313,0.030472,0.0091023,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.86455,0.030352,0.010507,0,0
2,GO SPECIFICATION OF SYMMETRY,0.42855,0.03033,0.028149,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.42855,0.030327,0.049271,0,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.80312,0.03025,-0.017923,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.46512,0.030238,0.019368,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.76281,0.029968,0.015776,0,0
2,GO RESPONSE TO STEROL,0.33373,0.029937,0.056428,0,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.64605,0.029788,0.04629,0,0
2,GO LIPID TRANSLOCATION,0.61497,0.029699,0.030448,0,0
2,GO MESENCHYME DEVELOPMENT,0.78289,0.029672,0.029804,0,0
2,GO SINGLE FERTILIZATION,0.87144,0.029667,-0.0057811,0,0
2,GO TRANSPOSITION,0.67776,0.029594,-0.050946,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.5726,0.029586,0.035614,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.83713,0.029323,-0.028934,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.35607,0.029292,0.056207,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.56666,0.029187,0.031272,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.37932,0.029015,0.028045,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.38408,0.028991,0.051011,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.35607,0.028888,0.051167,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.36526,0.028797,0.027073,0,0
2,GO T CELL LINEAGE COMMITMENT,0.21905,0.028778,0.093344,0,0
2,GO MYELOID CELL DEVELOPMENT,0.31232,0.028776,0.053463,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.77618,0.028768,0.025162,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.27227,0.028766,0.04603,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.44402,0.028702,0.078267,0,0
2,GO GROWTH,0.63354,0.028665,0.0076975,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.63978,0.028601,0.014245,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.23245,0.028601,0.069689,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.79636,0.028455,-0.094623,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.47049,0.028387,0.0081119,0,0
2,GO FERTILIZATION,0.58456,0.028316,0.0066802,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.84397,0.028202,0.022907,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.57857,0.028176,0.013194,0,0
2,GO EXCRETION,0.54903,0.028115,0.028868,0,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.34256,0.027942,0.08305,0,0
2,GO ENDOSOMAL TRANSPORT,0.099158,0.027939,0.060913,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.4545,0.02788,0.028463,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.31653,0.027841,0.042142,0,0
2,GO REGULATION OF CHEMOTAXIS,0.65866,0.027756,0.013363,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.38408,0.027701,0.033629,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.74288,0.027672,0.0012586,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.58456,0.027658,0.013894,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.23245,0.027626,0.044812,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.79636,0.027371,0.0073951,0,0
2,GO CHOLESTEROL EFFLUX,0.64605,0.027359,0.003994,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.60272,0.027349,0.022162,0,0
2,GO STEROL TRANSPORT,0.62113,0.02726,0.016604,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.18219,0.027256,0.080896,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.23589,0.02723,0.050619,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.23589,0.027174,0.039515,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.72969,0.027137,-0.018765,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.5726,0.027118,-0.055034,0,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.64605,0.027113,0.031976,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.54321,0.02696,0.040888,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.83713,0.026824,0.0040571,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.23589,0.026824,0.052946,0,0
2,GO VACUOLE ORGANIZATION,0.59059,0.026761,0.026919,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.34702,0.026715,0.036604,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.88523,0.026669,-0.0064593,0,0
2,GO REGULATION OF DNA REPLICATION,0.56666,0.026616,0.036082,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.59664,0.02659,0.017342,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.39371,0.026536,0.18873,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.59059,0.026513,0.019878,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.65234,0.026485,0.01269,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.51459,0.026476,0.02093,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.63978,0.026404,0.047293,0,0
2,GO TAXIS,0.56075,0.026345,0.0070092,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.21905,0.026081,0.039812,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.31653,0.026007,0.059395,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.62732,0.025945,0.049038,0,0
2,GO SPINDLE ORGANIZATION,0.3746,0.025868,0.02954,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.56666,0.025851,0.01394,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.3746,0.025832,0.030378,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.63354,0.025795,0.012599,0,0
2,GO NEGATIVE CHEMOTAXIS,0.89907,0.025563,-0.069263,0,0
2,GO HEAD MORPHOGENESIS,0.93377,0.02554,-0.017352,0,0
2,GO RESPONSE TO ATP,0.71658,0.025382,0.023483,0,0
2,GO DRINKING BEHAVIOR,0.59059,0.025362,0.075585,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.23589,0.025187,0.04124,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.41842,0.025151,0.059183,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.77618,0.025079,0.013557,0,0
2,GO METAPHASE PLATE CONGRESSION,0.20621,0.025045,0.060782,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.79636,0.025025,0.02454,0,0
2,GO NEURON REMODELING,0.60272,0.024973,0.046397,0,0
2,GO CELL CELL SIGNALING BY WNT,0.50896,0.024929,0.040708,0,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.46512,0.024857,-0.063882,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.37932,0.024799,0.034274,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.93377,0.024784,-0.017103,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.38888,0.024756,0.019608,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.94073,0.024674,0.022466,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.97557,0.024631,-0.0083284,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.74288,0.024479,0.017135,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.53742,0.024376,0.026385,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.69061,0.024316,0.033836,0,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.85082,0.024138,-0.0049837,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.56075,0.024102,0.08956,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.65234,0.024086,-0.083766,0,0
2,GO VACUOLAR ACIDIFICATION,0.65866,0.02404,0.055518,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.24288,0.023914,0.074172,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.44924,0.023766,0.029126,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.60883,0.023754,0.027564,0,0
2,GO HISTONE H4 ACETYLATION,0.94073,0.023726,0.010173,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.36526,0.023717,0.063423,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.11235,0.023703,0.063982,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.73628,0.023465,-0.027054,0,0
2,GO ADAPTIVE THERMOGENESIS,0.83713,0.023373,0.010661,0,0
2,GO DNA PACKAGING,0.53167,0.023279,0.026351,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.63354,0.023198,0.023968,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.099158,0.023027,0.052496,0,0
2,GO BONE TRABECULA FORMATION,0.37932,0.023025,0.1325,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.17099,0.02277,0.031434,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.67137,0.02271,0.022059,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.73628,0.022626,-0.015693,0,0
2,GO ORGANELLE FUSION,0.91293,0.022597,0.015706,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.94769,0.022551,-0.021219,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.41341,0.022534,0.02564,0,0
2,GO CENTROSOME SEPARATION,0.69707,0.022386,0.026845,0,0
2,GO NOTCH SIGNALING PATHWAY,0.94073,0.02237,-0.0014642,0,0
2,GO CELL JUNCTION ORGANIZATION,0.94073,0.022337,-0.012387,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.70355,0.022205,0.032469,0,0
2,GO REPRODUCTION,0.74288,0.022142,0.004883,0,0
2,GO RESPONSE TO LEAD ION,0.21905,0.022123,0.082948,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.30402,0.022112,0.049382,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.44402,0.022072,0.077261,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.76948,0.02204,0.041095,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.47588,0.02195,0.069618,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.99651,0.021945,-0.0070964,0,0
2,GO RESPONSE TO EPINEPHRINE,0.80989,0.021891,0.042682,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,1,0.021872,-0.010499,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.56075,0.021801,0.019733,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.89907,0.021796,-0.03293,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.54321,0.021724,0.061297,0,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.39858,0.021675,0.038583,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.47588,0.021638,0.023604,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.56666,0.021596,0.012968,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.89215,0.021369,0.0039885,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.98953,0.021362,0.05068,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.61497,0.021202,-0.056087,0,0
2,GO CHROMOSOME SEGREGATION,0.23937,0.021176,0.046693,0,0
2,GO REGULATION OF EXCRETION,0.67137,0.02111,0.054227,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.65866,0.020916,0.01195,0,0
2,GO SEX DETERMINATION,0.5726,0.020867,0.034007,0,0
2,GO GOLGI ORGANIZATION,0.41341,0.02072,0.043937,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.32506,0.020627,0.04131,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.61497,0.020625,0.036544,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.96163,0.020615,0.014981,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.38408,0.02061,0.027349,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.077957,0.020604,0.042769,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.81668,0.020441,0.005489,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.36526,0.020394,0.05496,0,0
2,GO MUSCLE ADAPTATION,0.91987,0.020365,0.016573,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.56075,0.020293,0.010796,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.99651,0.020288,-0.022691,0,0
2,GO TELOMERE CAPPING,0.5726,0.020199,0.016473,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.9686,0.020108,-0.018025,0,0
2,GO METAL ION HOMEOSTASIS,0.62113,0.020034,0.02485,0,0
2,GO EATING BEHAVIOR,0.23589,0.019967,0.071016,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.22235,0.019865,0.065021,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.4598,0.019819,0.044184,0,0
2,GO ENSHEATHMENT OF NEURONS,0.67137,0.019815,0.0076342,0,0
2,GO WATER HOMEOSTASIS,0.29586,0.019705,0.064554,0,0
2,GO REGULATION OF BONE REMODELING,0.65866,0.019617,0.026977,0,0
2,GO MESODERM MORPHOGENESIS,0.35153,0.019545,0.068477,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.51459,0.019476,0.0031012,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.87833,0.019393,-0.002268,0,0
2,GO BLOOD VESSEL REMODELING,0.50896,0.019247,0.013791,0,0
2,GO CGMP MEDIATED SIGNALING,0.84397,0.019229,-0.030934,0,0
2,GO HISTONE EXCHANGE,0.63354,0.019187,0.022454,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.76948,0.019178,0.029688,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.43883,0.019089,0.060519,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.22905,0.018993,0.075456,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.7495,0.018982,-0.022133,0,0
2,GO THYMIC T CELL SELECTION,0.91293,0.018928,-0.00024781,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.5726,0.018916,-0.017321,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.87144,0.018744,-0.0071445,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.80312,0.018742,0.045385,0,0
2,GO COMPLEMENT ACTIVATION,0.71006,0.018705,-0.0011589,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.50896,0.018696,0.020287,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.065563,0.018651,0.14819,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.98255,0.018508,-0.006845,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.32077,0.018146,0.097234,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.63354,0.018054,0.02103,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.44924,0.017962,0.020604,0,0
2,GO VESICLE LOCALIZATION,0.47588,0.017917,0.017916,0,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1,0.017886,-0.029514,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.72969,0.017735,0.011433,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.7495,0.017701,0.0082692,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.56666,0.017697,0.038545,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.44402,0.017621,0.020623,0,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.88523,0.017475,0.018656,0,0
2,GO CELL PROJECTION ASSEMBLY,0.91293,0.017455,0.0031264,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.69061,0.017293,0.026496,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.69707,0.017278,0.025903,0,0
2,GO DNA CATABOLIC PROCESS,0.53167,0.01726,0.0185,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.48678,0.016923,0.023382,0,0
2,GO MEMBRANE FUSION,0.71658,0.016755,0.017125,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.67776,0.016716,0.01419,0,0
2,GO SENSORY PERCEPTION,0.94073,0.016695,-0.0026067,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.98953,0.016662,0.0032659,0,0
2,GO ORGANELLE FISSION,0.38888,0.01665,0.023291,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.43883,0.016647,0.026768,0,0
2,GO WALKING BEHAVIOR,0.65866,0.016566,-0.039248,0,0
2,GO PROTEIN REFOLDING,0.56666,0.016486,0.045013,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.27611,0.016159,0.026515,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.54321,0.016125,0.017273,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.5726,0.016069,0.021853,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.82348,0.016055,0.017739,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.82348,0.015853,0.016871,0,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,1,0.015818,0.0077979,0,0
2,GO CYTOKINESIS,0.65234,0.015762,0.013574,0,0
2,GO ORGANELLE ASSEMBLY,0.64605,0.015732,0.0074027,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.85768,0.015578,0.014338,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.60272,0.015524,0.017495,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.36064,0.015485,0.028354,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.91987,0.015424,-0.010411,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.55487,0.015421,0.025269,0,0
2,GO APPENDAGE MORPHOGENESIS,0.54321,0.015397,0.06498,0,0
2,GO GLIAL CELL MIGRATION,0.76281,0.015312,-0.024243,0,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.44924,0.01517,0.062814,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.51459,0.015062,0.063285,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.91987,0.015025,0.034257,0,0
2,GO DEPHOSPHORYLATION,0.67776,0.014852,0.0095513,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.75615,0.014842,0.058517,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.60272,0.014694,-0.044875,0,0
2,GO CELLULAR HOMEOSTASIS,0.52594,0.014606,0.022804,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.87833,0.01459,-0.0020861,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.79636,0.014581,0.013459,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.59664,0.014563,0.019201,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.56075,0.014455,0.044651,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.91987,0.014438,0.030923,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.47588,0.014437,0.042518,0,0
2,GO NEURAL TUBE PATTERNING,0.85082,0.014338,0.00074206,0,0
2,GO PROTEIN KINASE A SIGNALING,0.41842,0.014278,0.030091,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.30815,0.014258,0.047559,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.63978,0.014219,0.0094833,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.62732,0.014172,-0.093694,0,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.48678,0.014087,0.032003,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.77618,0.013951,-0.030329,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.4598,0.013943,0.051301,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.60272,0.013915,0.023538,0,0
2,GO SOMITOGENESIS,0.31232,0.013905,0.071842,0,0
2,GO TOR SIGNALING,0.97557,0.013798,-0.0047857,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.7495,0.013769,0.064572,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.62113,0.013759,0.028365,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.5726,0.013495,0.024475,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.94073,0.013359,-0.023703,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.89907,0.013338,-0.0074129,0,0
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.86455,0.013006,0.060237,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.76281,0.012926,0.0066905,0,0
2,GO PHOTOTRANSDUCTION,0.41341,0.012838,0.017815,0,0
2,GO REGULATION OF MRNA PROCESSING,0.36064,0.012787,0.037924,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.74288,0.012748,0.027926,0,0
2,GO PROTEIN ACYLATION,0.83713,0.012622,-0.0011029,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.91293,0.012399,0.023578,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.56666,0.01239,0.077581,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.98953,0.012203,-0.0041086,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.72313,0.012192,0.018652,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.55487,0.012091,0.022116,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.81668,0.012039,-0.0083069,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.72969,0.012006,0.0043089,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.78962,0.011969,0.021486,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.7495,0.0119,0.032086,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.84397,0.011822,-0.0085742,0,0
2,GO RESPONSE TO PEPTIDE,0.42855,0.011765,0.023464,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.48131,0.011764,0.044635,0,0
2,GO LACTATE METABOLIC PROCESS,0.27227,0.011697,0.075276,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.80312,0.01157,0.012723,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.96163,0.011535,-0.0040339,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.97557,0.01144,0.00071335,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.67137,0.011413,0.017833,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.11235,0.011381,0.064792,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.18508,0.011261,0.1571,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.50896,0.011251,-0.058132,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.94769,0.011244,-0.00084393,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.64605,0.011152,-0.030704,0,0
2,GO MAGNESIUM ION TRANSPORT,0.91293,0.011143,0.0030203,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.54321,0.011111,0.038701,0,0
2,GO CHEMICAL HOMEOSTASIS,0.73628,0.011002,0.013064,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.86455,0.010946,-0.00093125,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.69061,0.010826,-0.02596,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.86455,0.010683,0.001936,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.54903,0.010525,0.034664,0,0
2,GO DEVELOPMENTAL GROWTH,0.78289,0.010374,-0.013047,0,0
2,GO REGULATION OF CHLORIDE TRANSPORT,0.8303,0.010318,0.043961,0,0
2,GO REGULATION OF TOR SIGNALING,0.95466,0.010233,-0.007103,0,0
2,GO MEMBRANE ORGANIZATION,0.68418,0.010177,0.014087,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.59059,0.010063,-0.046143,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.85082,0.0099104,0.025039,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.15015,0.0099098,0.075131,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.67776,0.0098922,0.015751,0,0
2,GO CYTOSOLIC TRANSPORT,0.64605,0.0098905,0.027301,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.77618,0.0098787,0.063772,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.52594,0.0097307,0.034352,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.5726,0.0096105,0.019852,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.65234,0.0096056,0.1152,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.82348,0.0094649,0.019233,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.93377,0.009406,0.0016043,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.97557,0.0092565,-0.017041,0,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.9686,0.0091789,-0.013396,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.58456,0.0091779,0.039174,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.54321,0.0091775,0.043369,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.88523,0.009107,0.010597,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.23589,0.0090997,0.14677,0,0
2,GO PHAGOSOME ACIDIFICATION,0.95466,0.0090918,0.034567,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.50337,0.0090263,0.028272,0,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.94769,0.00886,0.0426,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.65866,0.0088352,0.10534,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.87833,0.0087607,-0.055271,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.3746,0.00876,0.085514,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.69061,0.0084545,0.011167,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.60272,0.0083358,0.032233,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.82348,0.0081348,0.0048071,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.89907,0.0080181,-0.028762,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.52025,0.0079577,0.031997,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.30402,0.0079046,0.056497,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.85768,0.0077811,0.016706,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.47049,0.0077749,-0.057558,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.79636,0.0077134,0.02727,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.70355,0.00751,-0.028253,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.91987,0.0074276,0.0019583,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.65234,0.0073766,0.021587,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.94073,0.0073751,0.010419,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.22905,0.00734,0.18244,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.8303,0.0072137,0.020331,0,0
2,GO REGULATION OF AXON GUIDANCE,0.93377,0.0071827,-0.029404,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.86455,0.0071708,-0.003824,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.80312,0.0066768,-0.022167,0,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.62732,0.0066367,0.055615,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.4545,0.0066104,0.06784,0,0
2,GO MACROPHAGE PROLIFERATION,0.64605,0.0065063,0.005202,0,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.65866,0.0064,0.080978,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.71006,0.0063797,0.018053,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.69061,0.0063539,0.04472,0,0
2,GO FLUID TRANSPORT,0.99651,0.0062741,0.0083876,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.72969,0.0061897,-0.0097337,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.40349,0.005949,0.13205,0,0
2,GO OSSIFICATION,1,0.0058105,0.0077072,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.60272,0.0058041,-0.049006,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.85768,0.005787,-0.044824,0,0
2,GO SODIUM ION HOMEOSTASIS,0.87833,0.0057869,0.0034242,0,0
2,GO STEM CELL PROLIFERATION,0.99651,0.00577,0.0026886,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.53742,0.0056767,0.029641,0,0
2,GO KETONE CATABOLIC PROCESS,0.80989,0.005628,-0.0046519,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.59664,0.0053241,0.022671,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.98953,0.0053055,0.0048536,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.76281,0.005232,0.0024253,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.96163,0.0051401,0.0019875,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.59664,0.0050441,0.02683,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.5726,0.0049932,0.00082756,0,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.77618,0.0047212,0.0078299,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.64605,0.0046943,0.013278,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.47588,0.00465,-0.058774,0,0
2,GO MICROTUBULE NUCLEATION,0.95466,0.0045685,-0.035501,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.96163,0.0045674,0.022375,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.80989,0.0044655,0.00077845,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.67137,0.0040938,-0.048539,0,0
2,GO OOCYTE MATURATION,0.71658,0.0040174,-0.039073,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.33812,0.00398,0.09267,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.99651,0.0037383,-0.01184,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.59059,0.0037126,0.011281,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.65234,0.003595,0.010669,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.53167,0.0033468,0.0266,0,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.83713,0.003297,0.0045373,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.90599,0.0029314,0.01573,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.30815,0.0027861,0.056956,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.63978,0.0027692,0.015924,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.65234,0.0026657,-0.018195,0,0
2,GO REGULATION OF BINDING,0.89215,0.0025468,0.0086865,0,0
2,GO BICARBONATE TRANSPORT,0.86455,0.0025355,-0.0013835,0,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.78289,0.0023926,-0.054316,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.71658,0.0021654,-0.037116,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.69707,0.0021253,0.098773,0,0
2,GO BONE DEVELOPMENT,0.71006,0.0021137,0.036434,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,1,0.0020557,-0.008015,0,0
2,GO WATER TRANSPORT,0.59664,0.0020258,-0.036655,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.89907,0.0019425,0.0034508,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.82348,0.0018274,-0.012256,0,0
2,GO ORGANELLE DISASSEMBLY,0.54321,0.0017757,0.038313,0,0
2,GO REGULATION OF GROWTH,0.94769,0.0015982,-0.0033184,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.90599,0.0014445,-0.01575,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.73628,0.0012242,0.0095273,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.91293,0.0011613,-0.015895,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.94073,0.0011231,0.025612,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.58456,0.0011085,-0.042855,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.52025,0.0010619,-0.024286,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.46512,0.0010595,0.028551,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.5726,0.00092343,0.066194,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.97557,0.00056386,-0.026703,0,0
2,GO PROTEIN ACETYLATION,0.68418,0.00053783,0.020226,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.74288,0.00043195,-0.015189,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.72969,0.0003751,-0.056596,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.9686,0.00036424,0.0064486,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.9686,0.00034541,0.010265,0,0
2,GO REGULATION OF METAL ION TRANSPORT,0.94769,0.00024665,-0.0039517,0,0
2,GO DNA REPLICATION,0.44402,7.0285e-05,0.050031,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.69707,-4.9541e-05,0.024599,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.48131,-5.0289e-05,0.064774,0,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.90599,-0.0001191,0.0027152,0,0
2,GO RHYTHMIC BEHAVIOR,0.85082,-0.00024643,-0.020826,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.68418,-0.00037734,-0.010785,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.84397,-0.00054266,-0.014461,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.92682,-0.00063021,-0.017868,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.80312,-0.0007684,0.026694,0,0
2,GO TRABECULA MORPHOGENESIS,0.63978,-0.00078504,0.04768,0,0
2,GO POSITIVE REGULATION OF BINDING,0.85082,-0.00089924,0.010277,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.35153,-0.0010306,-0.076206,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.76948,-0.0012294,0.0062624,0,0
2,GO MUSCLE CONTRACTION,0.72313,-0.0012409,-0.023434,0,0
2,GO RESPONSE TO METAL ION,0.87144,-0.0013704,-0.0020908,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.56666,-0.0013866,0.013264,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.97557,-0.0014555,-0.0072489,0,0
2,GO ION HOMEOSTASIS,0.76281,-0.0014913,0.019346,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.68418,-0.0015183,0.035208,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,1,-0.0015718,-0.0036847,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.98255,-0.0017244,0.0013484,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.4598,-0.0017304,0.071292,0,0
2,GO CELL GROWTH,0.36064,-0.001976,-0.04319,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.97557,-0.0020074,-0.0052541,0,0
2,GO HISTONE H3 K9 METHYLATION,0.95466,-0.0020835,0.012509,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.80989,-0.0021736,0.035016,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.52025,-0.0021773,-0.026531,0,0
2,GO AMINE METABOLIC PROCESS,0.37932,-0.0022021,0.065535,0,0
2,GO SNORNA METABOLIC PROCESS,0.94769,-0.0022261,-0.021049,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.87833,-0.0022879,-0.0077374,0,0
2,GO ENDOCYTOSIS,0.50337,-0.0023516,0.021699,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.43367,-0.0025183,-0.039414,0,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.89215,-0.0026851,-0.018855,0,0
2,GO RRNA CATABOLIC PROCESS,0.69061,-0.0027738,0.01404,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.46512,-0.0028035,-0.041381,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.64605,-0.0028604,0.017051,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.66501,-0.0028913,0.0061748,0,0
2,GO SOMITE DEVELOPMENT,0.98953,-0.0029096,0.023946,0,0
2,GO AMYLOID BETA FORMATION,0.42855,-0.0029539,0.061452,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.84397,-0.002971,-0.024663,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.92682,-0.0029798,-0.0022351,0,0
2,GO CHROMOSOME LOCALIZATION,0.97557,-0.003004,0.009066,0,0
2,GO CENTROSOME DUPLICATION,0.56075,-0.0030178,0.048816,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.83713,-0.0032039,0.014515,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.69707,-0.0033138,-0.024498,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.50896,-0.0033211,0.066639,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.67776,-0.0033442,0.014551,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.64605,-0.0033693,-0.025822,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.55487,-0.0036193,0.050577,0,0
2,GO PROTEIN TETRAMERIZATION,0.77618,-0.0036673,0.010169,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.8303,-0.0037721,-0.0037374,0,0
2,GO NUCLEUS ORGANIZATION,0.56666,-0.0037733,0.02671,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.72969,-0.003832,-0.016125,0,0
2,GO VASODILATION,0.89907,-0.0038696,0.0043701,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.69707,-0.0039408,0.042711,0,0
2,GO CARTILAGE DEVELOPMENT,0.9686,-0.0040566,0.0099347,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.64605,-0.0041563,-0.032806,0,0
2,GO STEROID HORMONE SECRETION,0.32077,-0.0042609,0.084724,0,0
2,GO MANNOSYLATION,0.95466,-0.0042661,0.004898,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.9686,-0.0043499,0.0015351,0,0
2,GO VITAMIN METABOLIC PROCESS,0.32077,-0.0043602,0.040966,0,0
2,GO SULFATE TRANSPORT,0.91987,-0.0045515,0.0085689,0,0
2,GO CELL CYCLE ARREST,0.43367,-0.0046931,0.030031,0,0
2,GO DEMETHYLATION,0.80989,-0.0047309,0.013979,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.65234,-0.0047903,-0.044083,0,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.69707,-0.0047939,0.013758,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.60883,-0.0048152,0.026128,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.30815,-0.0050276,-0.19255,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.77618,-0.0051075,0.012284,0,0
2,GO RESPONSE TO HYDROXYUREA,0.33812,-0.0053339,0.094147,0,0
2,GO ACID SECRETION,0.75615,-0.0053629,0.026924,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.77618,-0.0054368,-0.027789,0,0
2,GO CELL MORPHOGENESIS,0.31232,-0.0055123,-0.051284,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.47588,-0.0056226,-0.051261,0,0
2,GO DNA DEALKYLATION,0.56075,-0.0057092,0.037393,0,0
2,GO AORTA DEVELOPMENT,0.85768,-0.005808,0.0085898,0,0
2,GO KINETOCHORE ASSEMBLY,0.83713,-0.0058688,-0.0073236,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.65234,-0.0058966,0.046467,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.89215,-0.0059148,-0.010248,0,0
2,GO SECONDARY METABOLIC PROCESS,0.61497,-0.0059259,-0.040056,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.29586,-0.0060491,0.13175,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.77618,-0.0061222,0.019305,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.35153,-0.0065622,0.09289,0,0
2,GO MUSCLE FILAMENT SLIDING,0.77618,-0.006673,-0.053537,0,0
2,GO AXIS SPECIFICATION,0.84397,-0.0067562,0.011762,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.67137,-0.0069095,0.0074211,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.79636,-0.0070384,-0.02165,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.77618,-0.0070769,0.014442,0,0
2,GO TOOTH MINERALIZATION,0.53167,-0.0071022,0.10739,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.94769,-0.0072357,0.0052362,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.36526,-0.0073265,-0.0786,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.91293,-0.0076107,-0.0083358,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.70355,-0.0078298,0.014702,0,0
2,GO IRON ION TRANSPORT,0.71658,-0.0079143,0.046231,0,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.91293,-0.0080912,0.012138,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.89215,-0.0082577,-0.011265,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.55487,-0.008264,0.028284,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.60883,-0.0083356,0.015661,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.76281,-0.0083756,-0.036187,0,0
2,GO RESPONSE TO FOOD,0.36064,-0.0084502,-0.048627,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.89907,-0.0085666,-0.0050943,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.46512,-0.0086112,-0.03484,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.49227,-0.0086299,-0.056288,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.93377,-0.008701,-0.0059832,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.69061,-0.0087234,0.020737,0,0
2,GO CELL FATE COMMITMENT,0.62732,-0.0087515,-0.023619,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.90599,-0.0088427,0.010065,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.5726,-0.0088892,-0.047432,0,0
2,GO OOGENESIS,0.96163,-0.0092334,-0.022195,0,0
2,GO RESPONSE TO LIGHT INTENSITY,0.88523,-0.0093108,0.014732,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.8303,-0.0093159,-0.015505,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.77618,-0.0093751,-0.049612,0,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.67137,-0.0095387,-0.029088,0,0
2,GO BRAIN MORPHOGENESIS,0.70355,-0.0096226,-0.036861,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.71658,-0.0097713,-0.036703,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.59059,-0.0098818,0.035428,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.97557,-0.0099735,-0.00046628,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.85082,-0.010051,0.033075,0,0
2,GO EOSINOPHIL MIGRATION,0.82348,-0.01006,-0.0062016,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.9686,-0.010098,0.00028637,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.97557,-0.010147,-0.019712,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.9686,-0.010197,0.0020855,0,0
2,GO RESPONSE TO REDOX STATE,0.66501,-0.010237,0.018777,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.81668,-0.010267,-0.031989,0,0
2,GO VACUOLAR TRANSPORT,0.78962,-0.010383,0.02868,0,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.77618,-0.010426,0.033984,0,0
2,GO EYE MORPHOGENESIS,0.94769,-0.010561,0.010154,0,0
2,GO FACE DEVELOPMENT,0.87833,-0.010696,0.030308,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.43367,-0.010839,-0.11052,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.27611,-0.010882,-0.068948,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.89215,-0.010906,-0.017525,0,0
2,GO FUCOSYLATION,0.74288,-0.010946,0.066989,0,0
2,GO REGULATION OF OSSIFICATION,0.65866,-0.010977,0.04566,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.53742,-0.010998,0.054595,0,0
2,GO MUSCLE SYSTEM PROCESS,0.99651,-0.010999,-0.0080057,0,0
2,GO DETECTION OF STIMULUS,0.87144,-0.011115,-0.0034158,0,0
2,GO MISMATCH REPAIR,0.90599,-0.011126,0.0050322,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.27999,-0.011295,-0.047303,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.72313,-0.011298,-0.021344,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.89907,-0.011427,0.010087,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.84397,-0.011454,0.01447,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.67137,-0.011486,0.033169,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.80989,-0.011859,0.013928,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.94769,-0.012062,-0.019628,0,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1,-0.012111,0.0074031,0,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.20309,-0.01225,-0.056769,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.81668,-0.012344,-0.017076,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.64605,-0.012366,0.019859,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.67137,-0.012383,-0.068289,0,0
2,GO ORGANELLE LOCALIZATION,0.96163,-0.012823,-0.0052341,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.78962,-0.012829,-0.024061,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.53742,-0.012923,-0.046933,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.53742,-0.012924,-0.027432,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.94073,-0.01297,0.012741,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.87144,-0.013032,-0.0015403,0,0
2,GO RESPONSE TO BMP,0.84397,-0.013092,0.00016379,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.92682,-0.013204,0.03187,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.83713,-0.013262,0.021609,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.80989,-0.013267,-0.015741,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.67776,-0.013369,-0.016786,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.8303,-0.013481,-0.028462,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.39371,-0.013666,-0.034103,0,0
2,GO PROSTATIC BUD FORMATION,0.95466,-0.01373,0.0068993,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.83713,-0.013871,-0.0013827,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.84397,-0.013938,0.018225,0,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.72969,-0.014019,-0.017465,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.98255,-0.014225,0.0072871,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.75615,-0.01436,-0.029839,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.91987,-0.014458,-0.0042357,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.59664,-0.014877,-0.03875,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.27999,-0.014922,-0.05197,0,0
2,GO UTERUS DEVELOPMENT,0.4598,-0.015328,-0.07725,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.62732,-0.015443,-0.069918,0,0
2,GO ZINC ION TRANSPORT,0.53167,-0.015523,0.040593,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.46512,-0.015669,-0.032256,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.70355,-0.015822,-0.017006,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.75615,-0.015848,0.024789,0,0
2,GO FUCOSE METABOLIC PROCESS,0.39858,-0.015903,0.11545,0,0
2,GO MITOCHONDRIAL FUSION,0.86455,-0.015912,0.0082137,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.43883,-0.015918,-0.039185,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.55487,-0.015941,-0.017989,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.8303,-0.015953,-0.0040913,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.44402,-0.016028,-0.020879,0,0
2,GO MULTI ORGANISM PROCESS,0.57857,-0.016092,-0.019122,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.25001,-0.016125,-0.046611,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.94073,-0.016205,0.0058289,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.92682,-0.016252,-0.00082357,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.85768,-0.01639,-0.0096671,0,0
2,GO SPINDLE LOCALIZATION,0.80312,-0.016421,-0.015486,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.91293,-0.016685,0.0046806,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.62113,-0.016694,-0.0043696,0,0
2,GO RESPONSE TO STARVATION,0.56666,-0.016949,-0.025512,0,0
2,GO INTEGRIN ACTIVATION,0.85082,-0.017089,0.018624,0,0
2,GO RENAL WATER HOMEOSTASIS,0.76281,-0.017155,-0.013797,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.87144,-0.017571,-0.011858,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.98255,-0.017592,0.025969,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.82348,-0.017593,0.023518,0,0
2,GO HEART DEVELOPMENT,0.95466,-0.017664,0.010948,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.80312,-0.01768,-0.010839,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.90599,-0.017796,0.0096015,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.35607,-0.017808,-0.045656,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.32077,-0.017911,-0.053854,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.92682,-0.017913,0.01183,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.72969,-0.017935,0.049842,0,0
2,GO ENDOCYTIC RECYCLING,0.38888,-0.018,0.042992,0,0
2,GO SULFATION,0.8303,-0.018056,0.056617,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.29184,-0.018147,-0.042549,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.76281,-0.018262,0.040635,0,0
2,GO ACTIVATED T CELL PROLIFERATION,0.67137,-0.018334,0.052941,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.66501,-0.018462,0.013925,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.38408,-0.018484,-0.041647,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.51459,-0.018538,0.030681,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.63354,-0.0186,-0.018754,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.76281,-0.01881,-0.10265,0,0
2,GO HEART GROWTH,0.80989,-0.01894,0.0065354,0,0
2,GO MICROTUBULE ANCHORING,0.53167,-0.019147,-0.032925,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.80989,-0.019162,-0.0057842,0,0
2,GO DOSAGE COMPENSATION,0.94769,-0.019385,0.044262,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.78289,-0.019415,-0.0011526,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.98255,-0.019467,0.021845,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.64605,-0.019648,-0.043056,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.92682,-0.019666,0.0044317,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.30402,-0.020195,-0.091825,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.78962,-0.020273,0.050118,0,0
2,GO PROTEIN DENEDDYLATION,0.85768,-0.02029,-0.011108,0,0
2,GO ENDODERM FORMATION,0.59059,-0.020382,0.083791,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.87833,-0.020486,0.033648,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.99651,-0.020655,0.052989,0,0
2,GO REGULATION OF TRANSPORT,0.41842,-0.020694,-0.025903,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.26098,-0.021302,-0.049542,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.4978,-0.021389,-0.040564,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.59664,-0.021416,-0.032622,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.63354,-0.021446,-0.0096905,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.98255,-0.021563,0.0028976,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.39371,-0.021674,-0.034359,0,0
2,GO HEART VALVE DEVELOPMENT,0.8303,-0.021698,-0.013061,0,0
2,GO NEURON DEATH,0.29992,-0.021856,-0.033468,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.31232,-0.022033,0.078772,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.87144,-0.022262,0.053375,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.60272,-0.022372,-0.023063,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.81668,-0.022392,0.0012895,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.80989,-0.022594,-0.0068339,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.43367,-0.022631,-0.025571,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.81668,-0.022757,0.016828,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.69707,-0.02276,-0.019908,0,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.69707,-0.022891,-0.0094777,0,0
2,GO NEURON APOPTOTIC PROCESS,0.56666,-0.022917,-0.015537,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.78962,-0.022936,-0.042936,0,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.72969,-0.023053,0.0010176,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.55487,-0.023082,-0.030247,0,0
2,GO REGULATION OF CELL SIZE,0.35153,-0.023268,-0.050125,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.80312,-0.023327,-0.010864,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.66501,-0.023909,-0.034061,0,0
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.91293,-0.024007,0.023265,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.78289,-0.024123,-0.04087,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.98255,-0.024143,0.013258,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.67137,-0.02417,-0.020632,0,0
2,GO MITOCHONDRIAL FISSION,0.3746,-0.024205,-0.057186,0,0
2,GO GAMETE GENERATION,0.43367,-0.024278,-0.031119,0,0
2,GO SEXUAL REPRODUCTION,0.41341,-0.024443,-0.031143,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.2,-0.024447,-0.10374,0,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.38408,-0.024451,0.10405,0,0
2,GO PROTEIN FOLDING,0.96163,-0.024472,0.0027063,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.69707,-0.024572,0.0013616,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.54321,-0.024607,-0.052257,0,0
2,GO CELL CYCLE DNA REPLICATION,0.94769,-0.025105,0.020159,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.53167,-0.025364,-0.034392,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.70355,-0.025424,-0.018909,0,0
2,GO L GLUTAMATE IMPORT,0.25729,-0.025648,-0.1235,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.92682,-0.025741,0.02194,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.85082,-0.02576,0.0030253,0,0
2,GO GLIOGENESIS,0.83713,-0.025818,-0.016688,0,0
2,GO RESPONSE TO GLUCAGON,0.52594,-0.026052,-0.035719,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.76948,-0.026107,-0.020407,0,0
2,GO MEIOTIC CELL CYCLE,0.60883,-0.026213,-0.014,0,0
2,GO MIDBRAIN DEVELOPMENT,0.93377,-0.026276,0.046611,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.70355,-0.026299,-0.015036,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.11434,-0.02647,-0.13361,0,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.91987,-0.026599,-0.028953,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.3746,-0.026618,0.052832,0,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.28785,-0.02678,-0.056645,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.30402,-0.026855,-0.032072,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.49227,-0.026882,-0.022039,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.99651,-0.027086,0.0045537,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.41341,-0.027356,-0.047287,0,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.93377,-0.027458,0.019313,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.76281,-0.027679,0.029413,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.85082,-0.027704,-0.0018321,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.97557,-0.027728,-0.011616,0,0
2,GO LEUKOCYTE AGGREGATION,0.85082,-0.027752,0.02537,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.87833,-0.028138,0.0051298,0,0
2,GO ORGANIC ANION TRANSPORT,0.83713,-0.028141,0.008853,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.54903,-0.028147,-0.040373,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.88523,-0.028239,0.0051291,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.58456,-0.028264,-0.0061216,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.84397,-0.028352,-0.0031506,0,0
2,GO CELL RECOGNITION,0.12473,-0.028368,-0.069464,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.27611,-0.028689,-0.05176,0,0
2,GO GLUCOSE IMPORT,0.20309,-0.02869,-0.051371,0,0
2,GO TRANSFERRIN TRANSPORT,0.67137,-0.028693,-0.00049719,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.65234,-0.02876,0.046047,0,0
2,GO HEART TRABECULA FORMATION,0.56666,-0.029148,-0.068216,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.24288,-0.029197,-0.064264,0,0
2,GO MITOPHAGY,0.8303,-0.029367,0.006647,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.47588,-0.029542,-0.020762,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.63978,-0.029568,-0.0075649,0,0
2,GO MICROTUBULE BASED PROCESS,0.088862,-0.029858,-0.050197,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.64605,-0.029948,-0.013615,0,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.8303,-0.030076,0.0025859,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.29184,-0.030114,-0.089094,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.72969,-0.030118,-0.010048,0,0
2,GO MALE GAMETE GENERATION,0.42347,-0.030132,-0.033708,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.58456,-0.030165,-0.022455,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.24288,-0.03029,0.1451,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.67137,-0.030451,-0.009189,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.84397,-0.030539,-0.0062848,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.80312,-0.030662,0.04301,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.34702,-0.030726,-0.030784,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.78289,-0.030886,0.013828,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.53742,-0.030932,0.106,0,0
2,GO INORGANIC ANION TRANSPORT,0.32938,-0.030947,-0.025718,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.85082,-0.030971,0.0056635,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.90599,-0.031069,-2.8217e-06,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.48678,-0.03109,-0.021928,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.69061,-0.031142,-0.071914,0,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.97557,-0.031144,0.010041,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.98953,-0.031472,0.016297,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.34256,-0.031527,0.19512,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.40843,-0.031668,-0.049683,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.98255,-0.031808,0.020382,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.85082,-0.031832,-0.0219,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.4598,-0.031925,-0.043238,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.89907,-0.032183,0.012212,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.55487,-0.032218,-0.040983,0,0
2,GO MATING,0.28785,-0.032222,-0.058486,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.65234,-0.03246,-0.0088409,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.33812,-0.032652,-0.044202,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.85768,-0.032696,0.025349,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.79636,-0.032709,0.0031179,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.55487,-0.032828,-0.027873,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.64605,-0.032955,-0.077687,0,0
2,GO REGULATION OF CYTOKINESIS,0.94073,-0.03311,-0.00036012,0,0
2,GO ANION TRANSPORT,0.63978,-0.033115,-0.0040271,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.67776,-0.033567,0.04109,0,0
2,GO FEAR RESPONSE,0.43367,-0.033747,-0.050451,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.98953,-0.033783,0.010415,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.39858,-0.033875,-0.033547,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.041967,-0.033913,-0.064958,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.93377,-0.033971,0.02407,0,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.30815,-0.033978,-0.029626,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.62732,-0.034227,-0.046214,0,0
2,GO PIRNA METABOLIC PROCESS,0.35607,-0.034305,-0.099396,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.48131,-0.034358,-0.09444,0,0
2,GO CELLULAR ANION HOMEOSTASIS,0.61497,-0.034471,-0.037713,0,0
2,GO REGULATION OF MITOPHAGY,0.77618,-0.034605,-0.005984,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.74288,-0.034617,-0.01099,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.4978,-0.034632,-0.05036,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.64605,-0.034654,-0.017526,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.93377,-0.034752,0.012371,0,0
2,GO ODONTOGENESIS,0.75615,-0.03503,0.039802,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.76948,-0.035198,-0.12245,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.87144,-0.035443,0.0054816,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.56666,-0.035448,-0.0052285,0,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.39371,-0.035497,-0.060492,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.3746,-0.035593,-0.025818,0,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.18219,-0.035599,-0.053346,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.67776,-0.035817,-0.0083536,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.5726,-0.035896,-0.015869,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.74288,-0.035927,-0.061859,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.90599,-0.036244,0.010443,0,0
2,GO OXALATE TRANSPORT,0.38888,-0.03635,-0.06763,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.94073,-0.036458,-0.009995,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.48678,-0.036477,-0.027373,0,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.39371,-0.036518,-0.031933,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.50337,-0.036757,-0.013808,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.49227,-0.036764,-0.051909,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.33812,-0.036863,-0.066666,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.79636,-0.036932,-0.01102,0,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.05824,-0.03721,-0.060675,0,0
2,GO OVULATION CYCLE PROCESS,0.53742,-0.037392,-0.026957,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.2839,-0.037407,-0.038048,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.55487,-0.037521,-0.021381,0,0
2,GO BIOMINERALIZATION,0.93377,-0.037551,-0.0057612,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.91293,-0.037755,0.041937,0,0
2,GO DIET INDUCED THERMOGENESIS,0.47049,-0.03804,-0.071757,0,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.23589,-0.038101,-0.032411,0,0
2,GO BONE MATURATION,0.36991,-0.03817,-0.065393,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.50337,-0.038172,-0.026438,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.8303,-0.038326,-0.0051075,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.74288,-0.038376,-0.026476,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.98953,-0.038444,0.018499,0,0
2,GO ELASTIC FIBER ASSEMBLY,0.42347,-0.038737,0.12043,0,0
2,GO VASCULAR TRANSPORT,0.97557,-0.038771,-0.018711,0,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.12049,-0.039056,-0.054062,0,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.50337,-0.039176,-0.019653,0,0
2,GO BONE MINERALIZATION,0.67776,-0.039265,-0.026343,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.36991,-0.039487,-0.028736,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.62732,-0.039578,-0.073494,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.47588,-0.039642,0.083392,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.59664,-0.039694,-0.01149,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.95466,-0.03981,-0.0062291,0,0
2,GO REGULATION OF HEART GROWTH,0.98255,-0.039859,-0.0010483,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.099158,-0.040161,-0.082905,0,0
2,GO RESPONSE TO MUSCLE INACTIVITY,0.5726,-0.040402,-0.041008,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.4545,-0.040409,-0.076095,0,0
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,1,-0.040678,-0.016665,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.34702,-0.040692,-0.07027,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.71658,-0.040953,0.015752,0,0
2,GO ANIMAL ORGAN MATURATION,0.69061,-0.040957,-0.01504,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.91293,-0.040976,0.0068712,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.73628,-0.040999,-0.0092167,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.61497,-0.041275,-0.014375,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.50337,-0.041353,-0.027799,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.48131,-0.041376,-0.063052,0,0
2,GO HISTONE METHYLATION,0.48131,-0.041377,-0.0019045,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.58456,-0.041419,-0.027167,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.43367,-0.041443,-0.039279,0,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.27999,-0.041497,-0.11984,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.8303,-0.041556,-0.026834,0,0
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.78962,-0.041662,-0.0019452,0,0
2,GO REGULATION OF TUBE SIZE,0.17099,-0.041671,-0.066075,0,0
2,GO RESPONSE TO INTERLEUKIN 6,0.26847,-0.042278,-0.075575,0,0
2,GO CIRCADIAN RHYTHM,0.13583,-0.042287,-0.041867,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.79636,-0.04257,0.0028359,0,0
2,GO IMMUNOGLOBULIN SECRETION,0.39371,-0.042681,-0.084045,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.75615,-0.042759,-0.014578,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.37932,-0.042787,-0.032961,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1,-0.042829,0.011907,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.34256,-0.043108,-0.030615,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.62732,-0.043119,0.054159,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.56075,-0.043126,-0.01178,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.15264,-0.043336,-0.069211,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.52025,-0.043523,-0.010907,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.38408,-0.043753,-0.026248,0,0
2,GO VITAMIN TRANSPORT,0.60272,-0.043911,-0.026877,0,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.073629,-0.043934,-0.075227,0,0
2,GO REGULATION OF PEPTIDE SECRETION,0.39371,-0.043983,-0.028933,0,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.54321,-0.044201,0.048128,0,0
2,GO T CELL EXTRAVASATION,0.76948,-0.044242,-0.03652,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.53742,-0.044317,-0.038676,0,0
2,GO NUCLEOTIDE TRANSPORT,0.50896,-0.044327,-0.037083,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.22905,-0.04448,-0.053466,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.53167,-0.044658,-0.021257,0,0
2,GO REGULATION OF HORMONE LEVELS,0.53167,-0.044674,-0.028198,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.96163,-0.044845,-0.010471,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.79636,-0.044921,-0.0090078,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.36064,-0.045096,-0.058671,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.52594,-0.045332,-0.053847,0,0
2,GO REGULATION OF DNA BINDING,0.11235,-0.045335,-0.084297,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.42855,-0.045397,-0.018469,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.42347,-0.045566,-0.10745,0,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.16032,-0.045595,-0.054798,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.56075,-0.046309,-0.060617,0,0
2,GO SLEEP,0.98953,-0.04635,0.034953,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.22905,-0.046361,-0.098154,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.67137,-0.046377,-0.0059343,0,0
2,GO PROTEIN METHYLATION,0.23937,-0.046383,-0.0071746,0,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.066855,-0.046407,-0.080669,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.56666,-0.046539,-0.036639,0,0
2,GO HISTONE H3 K36 METHYLATION,0.79636,-0.046666,0.011775,0,0
2,GO SENSORY PERCEPTION OF SMELL,0.48678,-0.046736,-0.010265,0,0
2,GO RHYTHMIC PROCESS,0.41842,-0.046817,-0.023125,0,0
2,GO REGULATION OF GLIOGENESIS,0.76948,-0.04685,-0.016971,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.93377,-0.046978,0.029674,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.77618,-0.046986,-0.04177,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.41842,-0.047042,-0.066618,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.80989,-0.047479,-0.051891,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.26847,-0.047875,-0.045707,0,0
2,GO HEART MORPHOGENESIS,0.75615,-0.047897,0.0072147,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.65866,-0.048061,-0.019791,0,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.36526,-0.04812,-0.053618,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.4545,-0.048275,-0.03138,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.48678,-0.048316,-0.0080445,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.33373,-0.048366,-0.017942,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.66501,-0.048399,-0.043406,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.98255,-0.048464,-0.041413,0,0
2,GO ORGANIC ACID TRANSPORT,0.44402,-0.04865,-0.0064291,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.54903,-0.048882,-0.062314,0,0
2,GO REGULATION OF VASCULOGENESIS,0.66501,-0.048933,-0.05076,0,0
2,GO PHOSPHATE ION TRANSPORT,0.188,-0.049287,-0.061996,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.36991,-0.049432,-0.059391,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.8303,-0.049444,0.042414,0,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.39371,-0.049604,-0.047348,0,0
2,GO MRNA SPLICE SITE SELECTION,0.24288,-0.04968,-0.09015,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.78289,-0.049686,-0.016696,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.48678,-0.04979,-0.069826,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.7495,-0.049923,0.056059,0,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.66501,-0.049977,-0.020032,0,0
2,GO AXON DEVELOPMENT,0.024288,-0.05,-0.12122,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.70355,-0.050726,-0.030592,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.31232,-0.050746,-0.018353,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.40349,-0.050831,-0.046214,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.22905,-0.050863,-0.15815,0,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.72969,-0.051066,0.0013572,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.47049,-0.051195,-0.034459,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.83713,-0.051286,-0.0033102,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.56666,-0.051368,-0.039571,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.12908,-0.051408,-0.086437,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.30402,-0.051519,-0.048292,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.15773,-0.051596,-0.10426,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.68418,-0.051598,-0.025244,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.95466,-0.051928,0.014548,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.10096,-0.052115,-0.086663,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.93377,-0.052147,-0.014594,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.91293,-0.052333,0.029245,0,0
2,GO GENETIC IMPRINTING,0.4978,-0.052394,-0.034421,0,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.079444,-0.052667,-0.08004,0,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.35153,-0.052842,-0.041156,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.69061,-0.05297,0.0020685,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.78962,-0.053109,0.086764,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.81668,-0.053137,0.0020879,0,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.67137,-0.053209,-0.038557,0,0
2,GO SEGMENT SPECIFICATION,0.58456,-0.053396,-0.050216,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.69061,-0.053439,-0.016695,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.31653,-0.053648,-0.069311,0,0
2,GO CONVERGENT EXTENSION,0.56666,-0.053874,0.090834,0,0
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.29184,-0.054034,-0.090453,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.34702,-0.054117,-0.053249,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.69061,-0.054349,0.060119,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.54321,-0.054518,-0.0088808,0,0
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.72313,-0.054615,-0.056047,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.18219,-0.054799,-0.055492,0,0
2,GO N GLYCAN PROCESSING,0.39858,-0.054817,-0.10038,0,0
2,GO PROSTAGLANDIN SECRETION,0.66501,-0.05485,0.036639,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.69061,-0.054866,-0.0017657,0,0
2,GO DNA DEMETHYLATION,0.38408,-0.055037,-0.036262,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.34702,-0.05523,-0.046964,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.8303,-0.055477,-0.013184,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.4545,-0.055647,-0.046464,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.56666,-0.055798,-0.032432,0,0
2,GO SNORNA 3 END PROCESSING,0.4545,-0.055832,-0.067015,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.31232,-0.055891,-0.093813,0,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.4545,-0.056077,-0.045798,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.71006,-0.05614,-0.02163,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.42855,-0.056203,-0.019329,0,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.063042,-0.056255,-0.088877,0,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.10096,-0.056357,-0.058804,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.88523,-0.05661,0.030668,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.72969,-0.057038,-0.016751,0,0
2,GO REGULATION OF BEHAVIOR,0.34702,-0.057051,-0.048462,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.41341,-0.057092,-0.10945,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.8303,-0.057243,-0.014499,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.25001,-0.057401,-0.033356,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.67137,-0.057514,-0.0049664,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.62113,-0.057519,-0.036477,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.67137,-0.057588,-0.010918,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.75615,-0.057599,-0.020764,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.5726,-0.057701,-0.041478,0,0
2,GO ENERGY HOMEOSTASIS,0.31653,-0.057777,-0.079884,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.43367,-0.057795,-0.053745,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.21905,-0.057844,-0.040704,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.24643,-0.058063,-0.080596,0,0
2,GO CARBOHYDRATE TRANSPORT,0.17653,-0.058121,-0.036862,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.16294,-0.058171,-0.082167,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.28785,-0.058238,-0.045697,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.34702,-0.058322,-0.039718,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.74288,-0.058476,0.0045434,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.30402,-0.058538,-0.066125,0,0
2,GO BONE CELL DEVELOPMENT,0.50337,-0.058575,-0.026009,0,0
2,GO NUCLEOSOME ASSEMBLY,0.25729,-0.058719,-0.039997,0,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.084046,-0.058789,-0.13842,0,0
2,GO RESPONSE TO LEUCINE,0.17099,-0.058793,-0.14347,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.11636,-0.058893,-0.085622,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.50337,-0.05919,-0.071845,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.20309,-0.059198,-0.057208,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.36064,-0.059266,-0.067569,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.34256,-0.0593,-0.06732,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.84397,-0.059328,0.0035244,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.95466,-0.059622,-0.023411,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.40843,-0.06011,-0.091429,0,0
2,GO DRUG METABOLIC PROCESS,0.49227,-0.060116,-0.0040733,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.78962,-0.060124,0.018425,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.36526,-0.060165,-0.029955,0,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.56075,-0.060523,-0.055701,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.79636,-0.060615,-0.025041,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.32938,-0.060697,-0.044333,0,0
2,GO SUCKLING BEHAVIOR,0.12259,-0.060704,-0.15054,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.068167,-0.060744,-0.16289,0,0
2,GO REGULATION OF RESPONSE TO FOOD,0.077957,-0.060924,-0.12686,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.62113,-0.061162,-0.039972,0,0
2,GO NEURON PROJECTION GUIDANCE,0.045624,-0.0612,-0.11578,0,0
2,GO CELL FATE SPECIFICATION,0.43883,-0.061208,-0.042811,0,0
2,GO PEPTIDE SECRETION,0.12259,-0.061332,-0.053238,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.95466,-0.061412,0.042889,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.42855,-0.061596,-0.05487,0,0
2,GO LYSOSOMAL TRANSPORT,0.71658,-0.061674,0.0024661,0,0
2,GO LOCOMOTOR RHYTHM,0.72969,-0.061696,-0.023877,0,0
2,GO AXON EXTENSION,0.049546,-0.0617,-0.11996,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.44924,-0.06172,-0.11155,0,0
2,GO HISTONE H3 K27 METHYLATION,0.33812,-0.061843,-0.038794,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.59664,-0.061967,-0.018801,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.85082,-0.062097,0.013346,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.37932,-0.06223,-0.094042,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.18219,-0.062234,-0.050842,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.69061,-0.062237,-0.0071148,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.75615,-0.062439,-0.0197,0,0
2,GO AMYLOID FIBRIL FORMATION,0.27227,-0.062709,-0.10202,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.42347,-0.063321,-0.061871,0,0
2,GO MEMBRANE REPOLARIZATION,0.10845,-0.063438,-0.10875,0,0
2,GO FIBRINOLYSIS,0.43883,-0.06357,-0.075835,0,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.39371,-0.063827,-0.055056,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.72313,-0.063886,-0.012361,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.32077,-0.064142,-0.066974,0,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.23589,-0.064187,-0.048981,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.40349,-0.064641,-0.030521,0,0
2,GO PROTEIN DEMETHYLATION,0.96163,-0.064642,0.010154,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.21905,-0.064745,-0.065907,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.90599,-0.065314,-0.021527,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.32506,-0.065508,-0.12186,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.36991,-0.065549,-0.0079262,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.32938,-0.065554,-0.055018,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.40349,-0.066175,-0.06187,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.62732,-0.066247,-0.018634,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.22235,-0.066365,-0.050429,0,0
2,GO ION TRANSPORT,0.20937,-0.066432,-0.030834,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.53742,-0.066681,-0.0036476,0,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0062634,-0.066696,-0.12949,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.25001,-0.066795,-0.11162,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.34702,-0.067159,-0.05642,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.29184,-0.067555,-0.072429,0,0
2,GO RESPONSE TO COLD,0.17934,-0.067722,-0.1122,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.04854,-0.06778,-0.0776,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.30815,-0.067855,-0.047208,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.69061,-0.067937,-0.022815,0,0
2,GO MESENCHYME MORPHOGENESIS,0.57857,-0.067983,-0.0083575,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.31232,-0.068006,-0.13676,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.26098,-0.06816,-0.11212,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.62113,-0.068467,-0.048185,0,0
2,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.82348,-0.068683,0.016762,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.67776,-0.068932,-0.033292,0,0
2,GO REGULATION OF TORC1 SIGNALING,0.012203,-0.068965,-0.10922,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.19095,-0.069389,-0.066202,0,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.025994,-0.069796,-0.12167,0,0
2,GO HISTONE H3 K4 METHYLATION,0.87833,-0.069888,0.027306,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.14048,-0.069904,-0.062602,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.2839,-0.069981,-0.14212,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.44924,-0.070224,-0.092001,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.15264,-0.070235,-0.044892,0,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.22235,-0.070246,-0.082976,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.18508,-0.070428,-0.070403,0,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.43883,-0.070492,-0.047916,0,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.43883,-0.070502,-0.11308,0,0
2,GO ECTODERM DEVELOPMENT,0.27999,-0.070568,-0.032227,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.81668,-0.071148,0.002517,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.26847,-0.071309,-0.082781,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.23937,-0.07136,-0.082622,0,0
2,GO RESPONSE TO CAMP,0.24643,-0.071387,-0.062819,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.11039,-0.07141,-0.10837,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.57857,-0.0718,-0.00022751,0,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.075049,-0.071935,-0.1123,0,0
2,GO PANCREAS DEVELOPMENT,0.50896,-0.072176,-0.046627,0,0
2,GO CELL JUNCTION MAINTENANCE,0.68418,-0.072356,0.0029082,0,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.077957,-0.072464,-0.15753,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.30402,-0.072739,-0.056773,0,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.10654,-0.072846,-0.075777,0,0
2,GO FEMALE SEX DIFFERENTIATION,0.21579,-0.073008,-0.055925,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.31232,-0.07312,-0.047216,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.19695,-0.073121,-0.11054,0,0
2,GO METAL ION TRANSPORT,0.077957,-0.073308,-0.056095,0,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.11235,-0.073358,-0.061359,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.073629,-0.073443,-0.074721,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.63354,-0.073491,-0.0081315,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.29992,-0.073651,-0.086102,0,0
2,GO NUCLEOSIDE SALVAGE,0.53167,-0.073677,-0.050527,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.70355,-0.073952,-0.00257,0,0
2,GO FEEDING BEHAVIOR,0.24288,-0.07401,-0.043297,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.12259,-0.074043,-0.11835,0,0
2,GO ONE CARBON COMPOUND TRANSPORT,0.80989,-0.074057,0.0037041,0,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.092194,-0.074169,-0.085061,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.092194,-0.074222,-0.11664,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.58456,-0.074266,-0.022074,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.20309,-0.074315,-0.041377,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.75615,-0.074469,-0.013302,0,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.16294,-0.074542,-0.06113,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.059411,-0.074709,-0.10007,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.23589,-0.074749,-0.090522,0,0
2,GO REGULATION OF SECRETION,0.11636,-0.074804,-0.058935,0,0
2,GO PROTEIN MANNOSYLATION,0.27227,-0.074832,-0.071387,0,0
2,GO KINETOCHORE ORGANIZATION,0.38888,-0.074957,-0.047977,0,0
2,GO HINDBRAIN MORPHOGENESIS,0.093897,-0.075251,-0.09943,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.92682,-0.075679,0.014458,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.36991,-0.075713,-0.053064,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.0094949,-0.07612,-0.092085,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.87144,-0.076246,0.038891,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.27227,-0.076281,-0.044743,0,0
2,GO CATION TRANSPORT,0.085627,-0.076805,-0.056869,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.88523,-0.076836,-0.013104,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.066855,-0.07685,-0.094661,0,0
2,GO RESPONSE TO AMPHETAMINE,0.4598,-0.076912,-0.039628,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.36064,-0.077356,-0.037558,0,0
2,GO FIBROBLAST MIGRATION,0.46512,-0.078012,-0.012951,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.30815,-0.078016,-0.035962,0,0
2,GO REGIONALIZATION,0.22568,-0.078053,-0.059086,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.43883,-0.0781,-0.049783,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.91293,-0.078245,-0.0022133,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.064293,-0.07905,-0.098727,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.25363,-0.079057,-0.076277,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.28785,-0.079082,-0.086301,0,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.1313,-0.079344,-0.07899,0,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.36064,-0.079661,-0.049574,0,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.29586,-0.079715,-0.048768,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.23245,-0.079781,-0.040825,0,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.26471,-0.080014,-0.038433,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.33373,-0.080031,-0.10144,0,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.088862,-0.080135,-0.11927,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.87833,-0.080138,0.028302,0,0
2,GO ADULT FEEDING BEHAVIOR,0.20621,-0.080306,-0.10259,0,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.13583,-0.080463,-0.057967,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.56666,-0.080661,-0.027789,0,0
2,GO HEART PROCESS,0.11039,-0.080969,-0.074629,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.47049,-0.081153,-0.036788,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.076492,-0.081179,-0.081065,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.35607,-0.081529,-0.093678,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.32077,-0.081628,-0.039175,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.42855,-0.082113,-0.044369,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.64605,-0.082126,-0.08302,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.22235,-0.082143,-0.06186,0,0
2,GO DEVELOPMENTAL INDUCTION,0.13814,-0.082158,-0.12257,0,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.080955,-0.0823,-0.11546,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.15773,-0.082405,-0.073839,0,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.023741,-0.082475,-0.15175,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.36526,-0.082546,-0.018057,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.41341,-0.082588,-0.036192,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.084046,-0.082943,-0.055764,0,0
2,GO CELL PART MORPHOGENESIS,0.0034322,-0.08337,-0.12878,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.83713,-0.083455,0.057671,0,0
2,GO AMINO ACID IMPORT,0.32506,-0.083962,-0.067695,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.29184,-0.083998,-0.16058,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.19393,-0.084116,-0.11169,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.53742,-0.084202,-0.062272,0,0
2,GO HEPARIN METABOLIC PROCESS,0.78962,-0.084552,-0.029288,0,0
2,GO AXO DENDRITIC TRANSPORT,0.03245,-0.084586,-0.089771,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.090515,-0.08489,-0.065923,0,0
2,GO ORGAN INDUCTION,0.15264,-0.084934,-0.11787,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.12259,-0.08512,-0.075516,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.38408,-0.085308,-0.056667,0,0
2,GO TORC1 SIGNALING,0.085627,-0.085562,-0.066804,0,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.10096,-0.085654,-0.2176,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.23937,-0.085873,-0.084679,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.34256,-0.085941,-0.15515,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.17099,-0.086103,-0.074975,0,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.13814,-0.086642,-0.1004,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.0056288,-0.08669,-0.090521,0,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.080955,-0.087141,-0.080225,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.045624,-0.087448,-0.11755,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.2,-0.087656,-0.053609,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.76281,-0.087694,-0.033788,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.23245,-0.087964,-0.057731,0,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.10845,-0.088069,-0.1021,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.061812,-0.088221,-0.076891,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.12473,-0.088323,-0.091468,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.42855,-0.088426,-0.062611,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.65234,-0.08855,0.011996,0,0
2,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.17374,-0.088682,-0.17143,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.17934,-0.088713,-0.062325,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.19393,-0.088728,-0.074839,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.60272,-0.088881,-0.034436,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.78289,-0.088961,-0.028525,0,0
2,GO REGULATION OF ANION TRANSPORT,0.075049,-0.08903,-0.068319,0,0
2,GO MEMBRANE DOCKING,0.0066042,-0.089337,-0.086775,0,0
2,GO MICROTUBULE POLYMERIZATION,0.073629,-0.089429,-0.10817,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.25363,-0.089595,-0.081157,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.53742,-0.089715,-0.034176,0,0
2,GO CILIUM ORGANIZATION,0.011612,-0.089797,-0.099917,0,0
2,GO CHEMOSENSORY BEHAVIOR,0.16559,-0.090001,-0.090021,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.35153,-0.090186,-0.10214,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.054842,-0.09029,-0.093873,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.39371,-0.090649,-0.056965,0,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.097379,-0.090756,-0.066955,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.060602,-0.090832,-0.066617,0,0
2,GO CRANIAL NERVE DEVELOPMENT,0.057089,-0.091186,-0.1167,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.14526,-0.09124,-0.12659,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.20309,-0.091461,-0.096245,0,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.19393,-0.091747,-0.05442,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.98953,-0.092246,0.072095,0,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.11636,-0.092497,-0.1295,0,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.31653,-0.092517,-0.036852,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.81668,-0.092926,-0.01019,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.50896,-0.092962,-0.042555,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.188,-0.093027,-0.072919,0,0
2,GO RECEPTOR CLUSTERING,0.15773,-0.093228,-0.09265,0,0
2,GO REGULATION OF HEART RATE,0.24643,-0.093261,-0.060383,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.11636,-0.093438,-0.14608,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.070855,-0.093587,-0.13198,0,0
2,GO ANIMAL ORGAN FORMATION,0.36526,-0.094013,-0.034981,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.027188,-0.094066,-0.19973,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.16032,-0.09424,-0.0922,0,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.12908,-0.09428,-0.06293,0,0
2,GO STEROID CATABOLIC PROCESS,0.12908,-0.094284,-0.11173,0,0
2,GO MYELIN MAINTENANCE,0.099158,-0.094505,-0.15925,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.60272,-0.094871,-0.033356,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.20937,-0.094938,-0.063397,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.32077,-0.095521,-0.043923,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.48131,-0.096055,-0.013038,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.22235,-0.09646,-0.089916,0,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.099158,-0.096467,-0.078407,0,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.46512,-0.096837,-0.06932,0,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.057089,-0.097186,-0.13317,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.42855,-0.097338,-0.13144,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.8303,-0.097601,0.041524,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.19393,-0.097875,-0.057032,0,0
2,GO PATTERN SPECIFICATION PROCESS,0.1028,-0.098039,-0.078923,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.073629,-0.098206,-0.075893,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.10465,-0.098244,-0.07247,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.5726,-0.098341,-0.066328,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.22905,-0.09848,-0.11559,0,0
2,GO REGULATION OF BLOOD CIRCULATION,0.093897,-0.098506,-0.077656,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.20309,-0.098799,-0.075352,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.62732,-0.098841,-0.0021489,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.4545,-0.099435,-0.10515,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.11636,-0.09944,-0.10861,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.188,-0.099475,-0.12291,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.23589,-0.099545,-0.070549,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.065563,-0.099636,-0.12797,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.17099,-0.099707,-0.10603,0,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.35153,-0.099953,-0.050383,0,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.12908,-0.099978,-0.074876,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.17934,-0.099982,-0.12314,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.21256,-0.10011,-0.044846,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.76948,-0.10014,0.01681,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.38408,-0.10023,-0.15452,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.093897,-0.10036,-0.074354,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.040234,-0.10046,-0.087014,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.19393,-0.1008,-0.12515,0,0
2,GO PARTURITION,0.47049,-0.10091,-0.070604,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.19095,-0.10135,-0.068762,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.78289,-0.10188,-0.037087,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.025994,-0.10225,-0.095646,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.27999,-0.10245,-0.10529,0,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.5726,-0.10284,0.010887,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.26847,-0.10318,-0.11361,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.55487,-0.10374,-0.058576,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.063042,-0.10398,-0.070703,0,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.12689,-0.104,-0.089819,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.44402,-0.10421,-0.06204,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.2839,-0.10496,-0.11295,0,0
2,GO RESPONSE TO FORSKOLIN,0.25729,-0.10506,-0.16057,0,0
2,GO ACTION POTENTIAL,0.12908,-0.10524,-0.089906,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.036164,-0.1054,-0.13764,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.36064,-0.10541,-0.11322,0,0
2,GO ORGANIC CATION TRANSPORT,0.42855,-0.10543,-0.046357,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.33812,-0.10547,-0.11062,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.05824,-0.10584,-0.09647,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.20309,-0.10595,-0.042956,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.27999,-0.10618,-0.12594,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0013872,-0.10625,-0.16473,0,0
2,GO RELAXATION OF MUSCLE,0.19393,-0.10667,-0.099838,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.24288,-0.10712,-0.10071,0,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.20937,-0.10715,-0.079714,0,0
2,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.093897,-0.10747,-0.12869,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.070855,-0.10765,-0.093247,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.10654,-0.10794,-0.11089,0,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.077957,-0.10802,-0.21769,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.05161,-0.10804,-0.096645,0,0
2,GO REGULATION OF HORMONE SECRETION,0.075049,-0.10835,-0.069168,0,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.066855,-0.10847,-0.088628,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.34256,-0.10864,-0.073213,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.87833,-0.10881,0.046432,0,0
2,GO NEUROTRANSMITTER UPTAKE,0.24288,-0.10918,-0.1119,0,0
2,GO EXTRACELLULAR TRANSPORT,0.3746,-0.10923,-0.08086,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.39858,-0.10946,-0.087497,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.11235,-0.11003,-0.096283,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.17374,-0.11013,-0.099278,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.26847,-0.11015,-0.073196,0,0
2,GO LUNG CELL DIFFERENTIATION,0.53167,-0.11026,-0.089884,0,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.02068,-0.11072,-0.11901,0,0
2,GO ESTROUS CYCLE,0.36526,-0.11138,-0.078166,0,0
2,GO AXONAL TRANSPORT,0.018398,-0.11144,-0.11705,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.085627,-0.11206,-0.077009,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.076492,-0.1123,-0.20446,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.4545,-0.11288,-0.037577,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.063042,-0.113,-0.14275,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.54321,-0.11307,-0.03949,0,0
2,GO OVULATION CYCLE,0.4598,-0.11331,-0.037699,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.63354,-0.11395,-0.010818,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.22235,-0.11409,-0.11375,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.10654,-0.11416,-0.12744,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.085627,-0.11428,-0.073127,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.58456,-0.11464,-0.079437,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.2839,-0.11483,-0.04177,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.27999,-0.11577,-0.08003,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.14769,-0.11592,-0.095189,0,0
2,GO MITOTIC DNA REPLICATION,0.20937,-0.11598,-0.055013,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.54903,-0.1161,-0.038026,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.23937,-0.11652,-0.12163,0,0
2,GO LYMPH NODE DEVELOPMENT,0.05824,-0.11664,-0.12674,0,0
2,GO ESTROGEN BIOSYNTHETIC PROCESS,0.14526,-0.1168,-0.12186,0,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.23937,-0.11698,-0.075247,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.036164,-0.11728,-0.1563,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.17374,-0.11728,-0.065583,0,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.50896,-0.11741,-0.054523,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.43367,-0.11757,-0.07426,0,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.092194,-0.11792,-0.11085,0,0
2,GO CARDIAC CONDUCTION,0.0695,-0.11793,-0.11491,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.16294,-0.11795,-0.077365,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.066855,-0.11802,-0.11607,0,0
2,GO SHORT TERM MEMORY,0.32077,-0.11815,-0.088006,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.11636,-0.11871,-0.097448,0,0
2,GO PHAGOSOME MATURATION,0.32506,-0.11937,-0.011673,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.42347,-0.11939,-0.069553,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.89907,-0.11941,0.072281,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.085627,-0.11949,-0.1048,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.11434,-0.11962,-0.093907,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.22905,-0.12072,-0.054216,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.26847,-0.12125,-0.061576,0,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.12689,-0.12126,-0.073931,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0010206,-0.12149,-0.24338,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.55487,-0.12171,-0.089032,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.39858,-0.12173,-0.032388,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.066855,-0.12224,-0.11454,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.29184,-0.12262,-0.039273,0,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.93377,-0.12277,0.00019085,0,0
2,GO REGULATION OF NEURON MIGRATION,0.041093,-0.12298,-0.15145,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.78962,-0.12303,-0.023912,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.22905,-0.12312,-0.1197,0,0
2,GO MITOTIC RECOMBINATION,0.26847,-0.12319,-0.042309,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.17099,-0.12338,-0.13293,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.71658,-0.12353,-0.057593,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.0038387,-0.12377,-0.13877,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.013139,-0.12379,-0.086618,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.068167,-0.12408,-0.08876,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.10654,-0.12434,-0.14671,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.41341,-0.12442,-0.10534,0,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.29184,-0.12475,-0.12259,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.36991,-0.12479,-0.061793,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.37932,-0.12528,-0.052065,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.60272,-0.12545,0.057231,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.14285,-0.12554,-0.093651,0,0
2,GO SECRETORY GRANULE LOCALIZATION,0.075049,-0.12635,-0.23735,0,0
2,GO REGULATION OF INSULIN SECRETION,0.097379,-0.12662,-0.080231,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.94769,-0.12679,0.0073794,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.016339,-0.12681,-0.11764,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.32938,-0.1269,-0.042732,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.092194,-0.12748,-0.091783,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.34702,-0.12865,-0.073729,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.26471,-0.12877,-0.14716,0,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.084046,-0.13126,-0.088805,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.19695,-0.13165,-0.081178,0,0
2,GO MITOCHONDRION LOCALIZATION,0.0023671,-0.13198,-0.15381,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.031748,-0.13219,-0.11909,0,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.24643,-0.13263,-0.081003,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.14769,-0.13273,-0.068282,0,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.080955,-0.13294,-0.09906,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.16828,-0.13373,-0.10727,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.23937,-0.13384,-0.13404,0,0
2,GO HORMONE TRANSPORT,0.070855,-0.134,-0.078116,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.86455,-0.13422,0.022358,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.11841,-0.1346,-0.08231,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.32506,-0.13492,-0.15106,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.22235,-0.13577,-0.1321,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.19393,-0.1358,-0.084193,0,0
2,GO DENDRITE MORPHOGENESIS,0.0071468,-0.13581,-0.13612,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.31232,-0.13589,-0.089389,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.86455,-0.13609,0.080678,0,0
2,GO POLYOL TRANSPORT,0.27999,-0.13684,-0.039858,0,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.1028,-0.13691,-0.099168,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.29184,-0.13722,-0.051071,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.16032,-0.13748,-0.065379,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.2,-0.13793,-0.062291,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.16032,-0.13959,-0.1562,0,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.079444,-0.14155,-0.16674,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.057089,-0.14183,-0.10868,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.090515,-0.14219,-0.10679,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.20937,-0.14229,-0.071288,0,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.068167,-0.14257,-0.090473,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.51459,-0.14283,-0.052187,0,0
2,GO INSULIN SECRETION,0.12689,-0.14317,-0.081279,0,0
2,GO NEUROTRANSMITTER REUPTAKE,0.13814,-0.14363,-0.135,0,0
2,GO MEMBRANE FISSION,0.084046,-0.14421,-0.14473,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.26471,-0.14433,-0.12439,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.29184,-0.14435,-0.094947,0,0
2,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.097379,-0.14445,-0.14178,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0087944,-0.14452,-0.14187,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.23245,-0.1456,-0.056616,0,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.26098,-0.14591,-0.042128,0,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.13355,-0.14684,-0.13546,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.20937,-0.14701,-0.13783,0,0
2,GO RESPONSE TO AXON INJURY,0.068167,-0.14712,-0.11482,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.27999,-0.14775,-0.17727,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00054072,-0.14859,-0.241,0,0
2,GO NEURON PROJECTION REGENERATION,0.068167,-0.14919,-0.11821,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.12259,-0.14983,-0.093073,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.4978,-0.14989,-0.057172,0,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.05824,-0.15047,-0.20518,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.10845,-0.15233,-0.10978,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.085627,-0.15285,-0.20148,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.34702,-0.15295,-0.12036,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.27999,-0.1534,-0.077769,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.22905,-0.15342,-0.075268,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.065563,-0.15378,-0.15193,0,0
2,GO NEURON PROJECTION EXTENSION,0.00084609,-0.15451,-0.18213,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.2,-0.15687,-0.079132,0,0
2,GO RESPONSE TO INTERLEUKIN 2,0.38888,-0.15742,-0.026881,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.36991,-0.15812,-0.086883,0,0
2,GO REGULATION OF OOGENESIS,0.019283,-0.15987,-0.1319,0,0
2,GO DENDRITE SELF AVOIDANCE,0.019739,-0.1599,-0.22281,0,0
2,GO RESPONSE TO COCAINE,0.015574,-0.16101,-0.16624,0,0
2,GO SEROTONIN SECRETION,0.22568,-0.16105,-0.10459,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.090515,-0.16212,-0.154,0,0
2,GO LONG TERM MEMORY,0.017137,-0.16264,-0.15862,0,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.26471,-0.1635,-0.11935,0,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.12259,-0.16358,-0.20323,0,0
2,GO SEROTONIN TRANSPORT,0.054842,-0.16362,-0.15661,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.025994,-0.16417,-0.12695,0,0
2,GO CELLULAR RESPONSE TO PH,0.0010528,-0.16477,-0.18078,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.25001,-0.16574,-0.1229,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.13583,-0.16606,-0.15772,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.85768,-0.16619,0.003578,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.079444,-0.16765,-0.19535,0,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.59059,-0.16875,-0.082353,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.092194,-0.16879,-0.15882,0,0
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.013465,-0.1689,-0.18058,0,0
2,GO CARDIAC CHAMBER FORMATION,0.68418,-0.16921,-0.02291,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.26847,-0.17029,-0.13102,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0025817,-0.17069,-0.19258,0,0
2,GO RESPONSE TO ACIDIC PH,0.21905,-0.17072,-0.070206,0,0
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.26098,-0.17136,-0.18504,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.073629,-0.17249,-0.23714,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.0031536,-0.17286,-0.26186,0,0
2,GO FAT CELL PROLIFERATION,0.043763,-0.17292,-0.15993,0,0
2,GO MICROTUBULE SEVERING,0.095625,-0.17333,-0.14694,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0025817,-0.17397,-0.16887,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.15517,-0.17615,-0.10444,0,0
2,GO DENDRITE DEVELOPMENT,0.0032441,-0.17664,-0.14549,0,0
2,GO MEMORY,0.0010206,-0.17697,-0.18677,0,0
2,GO PALLIUM DEVELOPMENT,0.0014738,-0.17805,-0.14749,0,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0060989,-0.17808,-0.21037,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0099891,-0.17978,-0.18527,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.18508,-0.18088,-0.11257,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.13355,-0.18526,-0.12252,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.16032,-0.18582,-0.087765,0,0
2,GO RESPONSE TO L GLUTAMATE,0.67137,-0.18838,-0.043545,0,0
2,GO COGNITION,0.0017123,-0.18865,-0.16382,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.020205,-0.18877,-0.156,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.22568,-0.1915,-0.10391,0,0
2,GO OPTIC NERVE DEVELOPMENT,0.076492,-0.19185,-0.16139,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.060602,-0.19244,-0.19705,0,0
2,GO RESPONSE TO FUNGUS,0.072231,-0.19379,-0.10114,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.080955,-0.19448,-0.12635,0,0
2,GO DIVALENT METAL ION EXPORT,0.057089,-0.19513,-0.16857,0,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.066855,-0.19517,-0.12975,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.053746,-0.19537,-0.17832,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.00353,-0.19601,-0.24246,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.02843,-0.19607,-0.14912,0,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0054795,-0.19701,-0.21363,0,0
2,GO GLYCINE TRANSPORT,0.066855,-0.19857,-0.2153,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.31232,-0.19871,-0.10869,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.061812,-0.19873,-0.10104,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.22905,-0.1997,-0.10464,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.079444,-0.20054,-0.1181,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.12689,-0.20129,-0.13192,0,0
2,GO ACROSOME ASSEMBLY,0.0066042,-0.20363,-0.2013,0,0
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.085627,-0.20486,-0.1865,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.0054795,-0.20511,-0.17457,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.082489,-0.20562,-0.15259,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.065563,-0.20605,-0.19344,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.27227,-0.20625,-0.14346,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.27227,-0.20747,-0.043776,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.019283,-0.20849,-0.2884,0,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0042883,-0.20868,-0.19154,0,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.37932,-0.2092,-0.085104,0,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.010773,-0.21109,-0.29817,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.21905,-0.21459,-0.079906,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.017969,-0.21596,-0.17783,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0083534,-0.21891,-0.27887,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.12259,-0.22085,-0.12538,0,0
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.188,-0.22088,-0.11481,0,0
2,GO CELL FATE DETERMINATION,0.0087944,-0.22129,-0.18459,0,0
2,GO FACIAL NERVE MORPHOGENESIS,0.085627,-0.22246,-0.25249,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.11434,-0.22333,-0.11602,0,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0075304,-0.22368,-0.25984,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.00098941,-0.22432,-0.27677,0,0
2,GO HEART FORMATION,0.0023671,-0.22657,-0.30895,0,0
2,GO REFLEX,0.020205,-0.22841,-0.29908,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.12049,-0.23015,-0.20547,0,0
2,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.11434,-0.23265,-0.24255,0,0
2,GO MALE MEIOSIS I,0.0059384,-0.23344,-0.2088,0,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.065563,-0.23414,-0.13492,0,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.10654,-0.23516,-0.15465,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.188,-0.23701,-0.1476,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00032948,-0.2395,-0.20953,0,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.075049,-0.2423,-0.20419,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.025414,-0.24343,-0.25962,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00052342,-0.24626,-0.24296,0,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.00014935,-0.24761,-0.28478,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.188,-0.2503,-0.080726,0,0
2,GO PRESYNAPSE ORGANIZATION,0.0030654,-0.25142,-0.24029,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.46512,-0.25202,-0.057626,0,0
2,GO MICROTUBULE BUNDLE FORMATION,0.00014935,-0.25738,-0.25281,0,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.00021909,-0.25787,-0.24587,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.013139,-0.25862,-0.2363,0,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00092958,-0.2593,-0.21744,0,0
2,GO REGULATION OF MICROTUBULE BINDING,2.1663e-05,-0.25951,-0.32296,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.073629,-0.26195,-0.24706,0,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.00032948,-0.2633,-0.26692,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.11039,-0.26521,-0.15366,0,0
2,GO ACROSOME REACTION,0.00095906,-0.26545,-0.20313,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.00020448,-0.26577,-0.24953,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.14526,-0.26578,-0.172,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.010506,-0.26706,-0.2221,0,0
2,GO NOTCH RECEPTOR PROCESSING,0.044685,-0.26756,-0.23288,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,2.1663e-05,-0.26796,-0.27097,0,0
2,GO DENDRITIC TRANSPORT,0.012203,-0.26821,-0.20347,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.014841,-0.27012,-0.20477,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.12908,-0.27185,-0.14899,0,0
2,GO INTRACILIARY TRANSPORT,0.0013054,-0.27382,-0.23708,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,4.4878e-05,-0.27411,-0.30277,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.0085714,-0.27503,-0.26634,0,0
2,GO NEURON MIGRATION,0.00037661,-0.2767,-0.24139,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.018836,-0.27993,-0.24938,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00010462,-0.28027,-0.31023,0,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0090226,-0.2813,-0.2867,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.015203,-0.2815,-0.29211,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.061812,-0.2825,-0.24756,0,0
2,GO HORMONE CATABOLIC PROCESS,0.065563,-0.28425,-0.2093,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00059588,-0.28704,-0.24554,0,0
2,GO NEURON RECOGNITION,0.00026903,-0.28817,-0.30884,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0029794,-0.29001,-0.27839,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.00063551,-0.29028,-0.33691,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0049174,-0.29182,-0.2368,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00057693,-0.29452,-0.35149,0,0
2,GO RETINA LAYER FORMATION,0.0038387,-0.29491,-0.28954,0,0
2,GO TOXIN METABOLIC PROCESS,0.16032,-0.29526,-0.11818,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.00041602,-0.29704,-0.27437,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.014841,-0.2989,-0.1758,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0025083,-0.30175,-0.31297,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.00013433,-0.30255,-0.23805,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.001191,-0.30258,-0.26698,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0015189,-0.30462,-0.26781,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.014841,-0.30721,-0.19259,0,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.00069957,-0.30824,-0.24209,0,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0049174,-0.30917,-0.28088,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.33812,-0.31103,-0.026798,0,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0011199,-0.31355,-0.25393,0,0
2,GO PITUITARY GLAND DEVELOPMENT,0.0025083,-0.32156,-0.2841,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.5816e-05,-0.32164,-0.32296,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.0041716,-0.32266,-0.4299,0,0
2,GO MAST CELL MIGRATION,0.34256,-0.32279,-0.090827,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0010206,-0.32348,-0.29685,0,0
2,GO NEURONAL ACTION POTENTIAL,0.0081404,-0.32385,-0.26548,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0024367,-0.32945,-0.36633,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0059384,-0.33274,-0.26305,0,0
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.075049,-0.33291,-0.35009,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.00055855,-0.33336,-0.31057,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,3.1888e-05,-0.34598,-0.31275,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00022676,-0.34831,-0.34553,0,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0050528,-0.3485,-0.3048,0,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00074557,-0.34864,-0.31104,0,0
2,GO ADULT BEHAVIOR,4.0073e-05,-0.34936,-0.27627,0,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.099158,-0.35229,-0.2308,0,0
2,GO SYNAPTIC VESICLE RECYCLING,0.00021909,-0.35283,-0.30421,0,0
2,GO NEUROTRANSMITTER TRANSPORT,0.00084609,-0.35804,-0.32717,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.001872,-0.36015,-0.4597,0,0
2,GO HEART INDUCTION,0.0046564,-0.36336,-0.51157,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00021909,-0.36844,-0.33594,0,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00069957,-0.36955,-0.34537,0,0
2,GO ADRENAL GLAND DEVELOPMENT,0.00016595,-0.36984,-0.37044,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.00084609,-0.37208,-0.37943,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0059384,-0.37489,-0.27786,0,0
2,GO CATECHOLAMINE UPTAKE,0.027188,-0.37505,-0.19291,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,1.1964e-05,-0.37709,-0.36149,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.0011199,-0.38784,-0.29638,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00087311,-0.38797,-0.46217,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,1.4039e-05,-0.3892,-0.39648,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.010506,-0.39304,-0.29403,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.00016595,-0.39449,-0.40491,0,0
2,GO CARDIOBLAST PROLIFERATION,0.037747,-0.39484,-0.34023,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.015953,-0.3971,-0.29568,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.0014738,-0.39999,-0.42007,0,0
2,GO INCLUSION BODY ASSEMBLY,0.0021689,-0.40508,-0.3049,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.349e-05,-0.40639,-0.48231,0,0
2,GO NEUROTRANSMITTER SECRETION,0.00050664,-0.41827,-0.36511,0,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0040578,-0.42355,-0.45034,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0053338,-0.42483,-0.38754,0,0
2,GO DETECTION OF CALCIUM ION,0.00036427,-0.43533,-0.37673,0,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00042998,-0.44238,-0.38357,0,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00012964,-0.45657,-0.44761,0,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00026003,-0.45971,-0.40034,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,2.5308e-05,-0.46481,-0.4192,0,0
2,GO HEART FIELD SPECIFICATION,0.00032948,-0.46716,-0.49264,0,0
2,GO DENSE CORE GRANULE TRANSPORT,0.0021689,-0.46829,-0.46539,0,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.001228,-0.46937,-0.41863,0,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00023468,-0.47204,-0.40741,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,3.1904e-06,-0.4756,-0.5085,0,0
2,GO PARENTAL BEHAVIOR,0.0006154,-0.48049,-0.38894,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.014138,-0.48268,-0.39597,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,2.9532e-05,-0.49248,-0.5614,0,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.05161,-0.49935,-0.2625,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,4.1617e-05,-0.51025,-0.43422,0,0
2,GO NEURON FATE SPECIFICATION,0.0028957,-0.5165,-0.35277,0,0
2,GO GLUTAMATE SECRETION,1.6455e-05,-0.52196,-0.44398,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0069616,-0.53173,-0.50428,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,1.8521e-05,-0.54634,-0.56486,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,7.6603e-06,-0.55224,-0.47719,0,0
2,GO SUBPALLIUM DEVELOPMENT,2.9532e-05,-0.55564,-0.48041,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0001547,-0.56019,-0.54558,0,0
2,GO DENDRITE EXTENSION,1.4609e-05,-0.56063,-0.47069,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,5.8301e-05,-0.5753,-0.46365,0,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,4.8612e-06,-0.57592,-0.64334,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.9801e-06,-0.59177,-0.50308,0,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,5.2139e-05,-0.59905,-0.49883,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00036427,-0.6017,-0.52232,0,0
2,GO NEURON CELL CELL ADHESION,0.00023468,-0.60445,-0.5674,0,0
2,GO REGULATION OF DENDRITE EXTENSION,1.9263e-05,-0.63373,-0.60364,0,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.0022992,-0.63626,-0.53998,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0050528,-0.65138,-0.4608,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,7.2754e-05,-0.66093,-0.50897,0,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00030804,-0.68225,-0.60653,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,1.4609e-05,-0.68298,-0.60032,0,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00038934,-0.69392,-0.49051,0,0
2,GO MECHANOSENSORY BEHAVIOR,0.00045924,-0.71598,-0.64292,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,1.7806e-05,-0.79706,-0.78602,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.00059588,-0.84794,-0.67172,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.00032948,-0.91408,-0.64566,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00035231,-1.1141,-0.83744,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.00028792,-1.3429,-0.94119,0,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
3,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
3,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
3,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
3,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
3,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
3,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
3,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
3,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
3,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
3,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
3,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
3,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
3,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
3,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
3,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
3,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
3,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
3,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
3,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
3,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
3,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
3,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010773,0.38101,0.2694,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
3,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
3,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
3,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
3,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
3,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
3,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
3,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
3,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
3,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
3,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
3,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
3,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
3,GO GLYCINE METABOLIC PROCESS,0.054842,0.29931,0.20115,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
3,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
3,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
3,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
3,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
3,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.054842,0.29297,0.1712,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,1,1
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
3,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
3,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,1
3,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
3,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
3,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
3,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
3,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
3,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
3,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
3,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
3,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
3,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
3,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0053338,0.25352,0.22196,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.054842,0.24402,0.13174,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
3,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
3,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
3,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
3,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
3,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
3,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
3,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
3,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
3,GO SYNAPTIC VESICLE DOCKING,0.023741,0.22255,0.26474,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
3,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
3,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
3,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
3,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
3,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
3,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,1,1
3,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
3,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
3,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
3,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
3,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
3,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
3,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,1,1
3,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
3,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0030654,0.17692,0.23384,1,1
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.02166,0.1762,0.13534,1,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
3,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,1,1
3,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
3,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
3,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
3,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.041967,0.16632,0.17031,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
3,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
3,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,1
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
3,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
3,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,1
3,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,1,1
3,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.0046564,0.14683,0.19829,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.047551,0.14515,0.10055,1,1
3,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
3,GO PROTEIN DENEDDYLATION,0.033166,0.14066,0.13452,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
3,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
3,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,1,1
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.036164,0.13815,0.12703,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
3,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.043763,0.13544,0.12947,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
3,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
3,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
3,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,1,1
3,GO LIMBIC SYSTEM DEVELOPMENT,0.04854,0.13163,0.11612,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
3,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
3,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,1
3,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
3,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
3,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
3,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
3,GO MATING,0.033166,0.12237,0.091484,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
3,GO RESPONSE TO NITRIC OXIDE,0.0060989,0.11975,0.1029,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.014486,0.11788,0.11892,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.053746,0.11627,0.18126,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
3,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,1,1
3,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0047853,0.11257,0.11194,1,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
3,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
3,GO TRNA METABOLIC PROCESS,0.0034322,0.10892,0.14407,1,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,1,1
3,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
3,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
3,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
3,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015953,0.09826,0.081023,1,1
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.044685,0.097259,0.12093,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,1
3,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.041967,0.09449,0.13653,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
3,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.017137,0.089889,0.14576,1,1
3,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING,0.044685,0.082305,0.1067,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,1,1
3,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
3,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.024846,0.067091,0.096255,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.05161,0.059969,0.059967,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,1,1
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.038561,0.038589,0.066038,1,1
3,GO METHYLATION,0.033166,0.032322,0.058393,1,1
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00081984,0.49751,0.48283,1,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.00038934,0.44341,0.47686,1,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.020205,0.4197,0.32519,1,0
3,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0027346,0.38146,0.25967,1,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.0049174,0.37793,0.30971,1,0
3,GO REGULATION OF VESICLE FUSION,4.4878e-05,0.36279,0.4105,1,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.0081404,0.35604,0.31425,1,0
3,GO SHORT TERM MEMORY,0.0022332,0.35017,0.32134,1,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03939,0.33738,0.25131,1,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00031859,0.32762,0.38047,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.013798,0.32666,0.44768,1,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.053746,0.31706,0.17246,1,0
3,GO PREPULSE INHIBITION,0.011047,0.31329,0.33627,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0073363,0.30895,0.2251,1,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0010528,0.30801,0.47087,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.01282,0.30544,0.21362,1,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.18672,1,0
3,GO PHAGOCYTOSIS RECOGNITION,0.052669,0.29655,0.16095,1,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.031748,0.29573,0.37958,1,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013465,0.29312,0.23126,1,0
3,GO BONE TRABECULA FORMATION,0.016339,0.29217,0.28867,1,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,1,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0010859,0.28339,0.25764,1,0
3,GO VOCALIZATION BEHAVIOR,0.030383,0.27735,0.35457,1,0
3,GO ARGININE METABOLIC PROCESS,0.0079323,0.27497,0.29089,1,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.018398,0.27165,0.20893,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0031536,0.26779,0.27331,1,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011199,0.26595,0.24764,1,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.03245,0.26305,0.1703,1,0
3,GO GTP METABOLIC PROCESS,0.0021689,0.26286,0.23585,1,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,0
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,0
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.0038387,0.25753,0.34078,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00019753,0.25151,0.27618,1,0
3,GO REGULATION OF DOPAMINE SECRETION,0.025414,0.24193,0.30834,1,0
3,GO COLLAGEN METABOLIC PROCESS,0.020205,0.24009,0.14035,1,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0056288,0.23754,0.21434,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.23302,0.20211,1,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0026572,0.23251,0.2819,1,0
3,GO POLYOL TRANSPORT,0.0079323,0.23114,0.18719,1,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.034637,0.2307,0.16896,1,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.03939,0.22828,0.26749,1,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0016129,0.22746,0.18799,1,0
3,GO EXPLORATION BEHAVIOR,0.0081404,0.22547,0.28578,1,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00019753,0.22483,0.2524,1,0
3,GO LATERAL VENTRICLE DEVELOPMENT,0.0083534,0.22406,0.22513,1,0
3,GO SYNAPSE ORGANIZATION,9.0551e-05,0.22201,0.22157,1,0
3,GO POSTSYNAPSE ORGANIZATION,7.8282e-05,0.22101,0.24513,1,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.0037331,0.21351,0.17163,1,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00021909,0.20953,0.26645,1,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.031059,0.20867,0.18668,1,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.019283,0.20829,0.13889,1,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.00087311,0.20663,0.2178,1,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0046564,0.20437,0.16281,1,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.20276,0.20538,1,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0062634,0.20156,0.21024,1,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0079323,0.20082,0.20231,1,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.047551,0.19713,0.17411,1,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.014486,0.19694,0.17506,1,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.015203,0.19653,0.20902,1,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.014138,0.19562,0.16247,1,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.00012074,0.19017,0.20882,1,0
3,GO FOREBRAIN CELL MIGRATION,0.00049035,0.18415,0.23235,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0016129,0.18413,0.17665,1,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.024846,0.18345,0.22184,1,0
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.05161,0.1833,0.11631,1,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.045624,0.18289,0.16825,1,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.013798,0.18278,0.18877,1,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0045306,0.18258,0.17858,1,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00026003,0.18249,0.2041,1,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.013798,0.18198,0.12879,1,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.049546,0.18136,0.15569,1,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.045624,0.18131,0.1476,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0099891,0.18129,0.18737,1,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.011904,0.18024,0.16927,1,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.045624,0.17967,0.12845,1,0
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.055956,0.17964,0.1357,1,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.014841,0.17909,0.14522,1,0
3,GO ALDITOL METABOLIC PROCESS,0.0056288,0.17726,0.17885,1,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,0
3,GO EXCRETION,0.0056288,0.17257,0.13673,1,0
3,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,0
3,GO POSITIVE REGULATION OF HEART RATE,0.040234,0.16813,0.18861,1,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0041716,0.16648,0.13209,1,0
3,GO FATTY ACID HOMEOSTASIS,0.044685,0.16644,0.20355,1,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0075304,0.16634,0.16894,1,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.010506,0.16562,0.19049,1,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0079323,0.16511,0.13868,1,0
3,GO RESPONSE TO ACETYLCHOLINE,0.04854,0.16384,0.18446,1,0
3,GO CARDIAC CONDUCTION,0.010773,0.16145,0.15299,1,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.041967,0.16069,0.13783,1,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0059384,0.16057,0.19391,1,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00081984,0.15747,0.20098,1,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.042857,0.15679,0.097057,1,0
3,GO COPPER ION HOMEOSTASIS,0.024846,0.15663,0.14424,1,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.02068,0.15485,0.11071,1,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.015203,0.15295,0.097831,1,0
3,GO IMPORT INTO CELL,0.00031859,0.15268,0.16949,1,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.042857,0.15178,0.12137,1,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.024846,0.15042,0.12439,1,0
3,GO MEMBRANE REPOLARIZATION,0.014138,0.14965,0.13738,1,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0069616,0.14894,0.15764,1,0
3,GO SYNAPSE ASSEMBLY,0.012203,0.1488,0.16867,1,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0087944,0.14827,0.14805,1,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.017137,0.14759,0.15602,1,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.054842,0.14706,0.17956,1,0
3,GO COLLATERAL SPROUTING,0.02843,0.14592,0.15473,1,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.013798,0.14497,0.14402,1,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0026572,0.14459,0.15038,1,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.007729,0.14423,0.10342,1,0
3,GO DEVELOPMENTAL CELL GROWTH,0.00074557,0.14342,0.149,1,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.04854,0.13973,0.12553,1,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,1,0
3,GO REGULATION OF AXONOGENESIS,0.012203,0.13962,0.14762,1,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0011549,0.13884,0.15637,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.03939,0.13858,0.17548,1,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.041093,0.13814,0.09988,1,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.033894,0.13709,0.18228,1,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0094949,0.13631,0.16419,1,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.009256,0.13573,0.11999,1,0
3,GO LIVER REGENERATION,0.040234,0.13541,0.077176,1,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0090226,0.13417,0.19615,1,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0026572,0.13362,0.13974,1,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0038387,0.13277,0.1505,1,0
3,GO NEUROMUSCULAR PROCESS,0.0060989,0.13239,0.14602,1,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.0087944,0.13195,0.11512,1,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.054842,0.12954,0.15753,1,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.02166,0.12912,0.12848,1,0
3,GO COCHLEA DEVELOPMENT,0.0085714,0.12808,0.14509,1,0
3,GO SYNAPTIC SIGNALING,0.001986,0.12747,0.172,1,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0025083,0.12726,0.12677,1,0
3,GO METENCEPHALON DEVELOPMENT,0.0054795,0.12488,0.16011,1,0
3,GO MRNA SPLICE SITE SELECTION,0.042857,0.123,0.13568,1,0
3,GO GLUTAMINE METABOLIC PROCESS,0.0031536,0.12242,0.15681,1,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.011904,0.11981,0.10207,1,0
3,GO PEPTIDE METABOLIC PROCESS,0.024846,0.11942,0.091635,1,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.015574,0.11796,0.081204,1,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.026586,0.11785,0.1383,1,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.036164,0.11708,0.11111,1,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.041967,0.11561,0.11825,1,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.052669,0.11532,0.078129,1,0
3,GO RNA 5 END PROCESSING,0.035393,0.11506,0.12281,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.022165,0.11502,0.13665,1,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.010506,0.11484,0.11228,1,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.043763,0.1138,0.13072,1,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.001986,0.11376,0.13349,1,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.03245,0.11289,0.1031,1,0
3,GO GLIAL CELL MIGRATION,0.052669,0.11218,0.13199,1,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.0037331,0.11212,0.17851,1,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.033166,0.1119,0.10784,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.018836,0.11181,0.17577,1,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.036948,0.11156,0.096039,1,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.11143,0.084827,1,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.045624,0.11137,0.11873,1,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0069616,0.11107,0.10628,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0094949,0.10875,0.096243,1,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.047551,0.1078,0.085432,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.009256,0.1067,0.12313,1,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.029068,0.10605,0.11104,1,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.015953,0.10552,0.11118,1,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.031059,0.10453,0.11387,1,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.016734,0.1037,0.11503,1,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.016734,0.10328,0.12458,1,0
3,GO RESPONSE TO AMYLOID BETA,0.0094949,0.10326,0.1324,1,0
3,GO POTASSIUM ION TRANSPORT,0.035393,0.10273,0.1169,1,0
3,GO REGULATION OF SYSTEM PROCESS,0.016734,0.10271,0.089714,1,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0023671,0.10243,0.09872,1,0
3,GO MITOTIC RECOMBINATION,0.03939,0.10239,0.12336,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.011047,0.10155,0.11642,1,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024846,0.10018,0.11791,1,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.024846,0.099707,0.083464,1,0
3,GO METAL ION TRANSPORT,0.031059,0.098552,0.068972,1,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.031059,0.098422,0.099572,1,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0060989,0.098297,0.099857,1,0
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,0
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.029068,0.097005,0.08091,1,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.038561,0.096255,0.11449,1,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.020205,0.095754,0.083423,1,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0079323,0.09519,0.12173,1,0
3,GO RNA MODIFICATION,0.0075304,0.09438,0.12402,1,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.021165,0.093074,0.086229,1,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.010773,0.092962,0.11854,1,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.054842,0.092556,0.08351,1,0
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,0
3,GO SODIUM ION TRANSPORT,0.04854,0.090093,0.07834,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.089731,0.099952,1,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.02843,0.089345,0.091656,1,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.036164,0.089277,0.11426,1,0
3,GO RESPONSE TO CALCIUM ION,0.050569,0.088902,0.089481,1,0
3,GO RESPONSE TO HEAT,0.017969,0.088863,0.079789,1,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.029068,0.08883,0.090382,1,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.010245,0.088589,0.06583,1,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.033166,0.088546,0.11543,1,0
3,GO RECEPTOR INTERNALIZATION,0.049546,0.088196,0.094469,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.033894,0.086043,0.089639,1,0
3,GO ORGANIC CATION TRANSPORT,0.02268,0.085963,0.1203,1,0
3,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.083289,0.099556,1,0
3,GO LACTATION,0.036948,0.081867,0.11724,1,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.041093,0.080665,0.085237,1,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.026586,0.073598,0.10531,1,0
3,GO LOCOMOTORY BEHAVIOR,0.036164,0.072435,0.13478,1,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.054842,0.070652,0.070367,1,0
3,GO NUCLEAR EXPORT,0.024846,0.070434,0.06326,1,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.047551,0.068477,0.092842,1,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.054842,0.06832,0.13079,1,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.03245,0.066848,0.090725,1,0
3,GO NEURON DEVELOPMENT,0.015574,0.066648,0.10551,1,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.055956,0.064814,0.067937,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.016734,0.063443,0.10185,1,0
3,GO RNA EXPORT FROM NUCLEUS,0.041967,0.063385,0.083155,1,0
3,GO BEHAVIOR,0.013139,0.062013,0.11244,1,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.036164,0.061913,0.066182,1,0
3,GO NEURON DIFFERENTIATION,0.033166,0.061143,0.09311,1,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.049546,0.060199,0.081212,1,0
3,GO REGULATION OF CELL SIZE,0.027803,0.06009,0.078054,1,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.044685,0.060003,0.063979,1,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.045624,0.057252,0.082736,1,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031059,0.056379,0.062983,1,0
3,GO DNA GEOMETRIC CHANGE,0.054842,0.055228,0.060255,1,0
3,GO NUCLEAR TRANSPORT,0.023741,0.052646,0.053247,1,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.035393,0.052448,0.055266,1,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.041093,0.036656,0.074008,1,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.031748,0.035939,0.067457,1,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.050569,0.032713,0.064769,1,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.019739,-0.024923,-0.086715,1,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.049546,-0.031431,-0.054434,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.031059,-0.036167,-0.13545,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.047551,-0.037358,-0.049977,1,0
3,GO VESICLE ORGANIZATION,0.053746,-0.037366,-0.070643,1,0
3,GO CYTOKINESIS,0.046579,-0.038365,-0.070188,1,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.049546,-0.03837,-0.055105,1,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.049546,-0.04202,-0.041943,1,0
3,GO TISSUE MORPHOGENESIS,0.047551,-0.042047,-0.080539,1,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.004408,-0.042958,-0.071349,1,0
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.054842,-0.045134,-0.14388,1,0
3,GO NEGATIVE REGULATION OF CELL DEATH,0.055956,-0.046016,-0.073182,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.027803,-0.046405,-0.057805,1,0
3,GO PROTEIN O LINKED GLYCOSYLATION,0.025414,-0.046584,-0.13269,1,0
3,GO METAPHASE PLATE CONGRESSION,0.014138,-0.047354,-0.09609,1,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.030383,-0.047395,-0.0479,1,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.025994,-0.047781,-0.15593,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.042857,-0.048096,-0.056265,1,0
3,GO NON RECOMBINATIONAL REPAIR,0.029719,-0.049058,-0.070112,1,0
3,GO EPITHELIAL CELL PROLIFERATION,0.053746,-0.050618,-0.10607,1,0
3,GO ACTIN FILAMENT BASED PROCESS,0.036948,-0.05139,-0.072544,1,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.047551,-0.052509,-0.059863,1,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,-0.052873,-0.041961,1,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.037747,-0.053669,-0.068959,1,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.014138,-0.053852,-0.15297,1,0
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.037747,-0.055403,-0.066143,1,0
3,GO CYTOSKELETON ORGANIZATION,0.04854,-0.055548,-0.051262,1,0
3,GO POSITIVE REGULATION OF SIGNALING,0.033166,-0.055813,-0.065149,1,0
3,GO MALE GAMETE GENERATION,0.0045306,-0.056225,-0.08556,1,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.009256,-0.056332,-0.085675,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.03245,-0.056358,-0.056157,1,0
3,GO MACROAUTOPHAGY,0.0054795,-0.057538,-0.080368,1,0
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.019283,-0.057979,-0.084699,1,0
3,GO ACTIN FILAMENT ORGANIZATION,0.017549,-0.058128,-0.094691,1,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.042857,-0.058243,-0.13615,1,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.038561,-0.058545,-0.10222,1,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.019739,-0.058587,-0.081149,1,0
3,GO SEXUAL REPRODUCTION,0.0025817,-0.059443,-0.071044,1,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.024288,-0.059497,-0.077715,1,0
3,GO ORGANELLE FISSION,0.019283,-0.060777,-0.053453,1,0
3,GO HISTONE UBIQUITINATION,0.041093,-0.061309,-0.066636,1,0
3,GO PROTEIN AUTOUBIQUITINATION,0.027188,-0.061491,-0.065572,1,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.013139,-0.061745,-0.099152,1,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.05161,-0.061757,-0.075136,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.03939,-0.061936,-0.17826,1,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.045624,-0.0624,-0.12938,1,0
3,GO CELLULAR LIPID METABOLIC PROCESS,0.053746,-0.062759,-0.071512,1,0
3,GO REGULATION OF HYDROLASE ACTIVITY,0.012203,-0.062843,-0.080199,1,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.019739,-0.062998,-0.085776,1,0
3,GO HUMORAL IMMUNE RESPONSE,0.0013872,-0.063414,-0.13611,1,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.042857,-0.06359,-0.11612,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.023741,-0.063699,-0.12651,1,0
3,GO VACUOLE ORGANIZATION,0.049546,-0.063873,-0.080909,1,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0067808,-0.064341,-0.1042,1,0
3,GO CELL MOTILITY,0.036948,-0.064481,-0.079393,1,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.053746,-0.064966,-0.079914,1,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.024288,-0.065264,-0.08581,1,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.042857,-0.065369,-0.13007,1,0
3,GO TUBE MORPHOGENESIS,0.041093,-0.06564,-0.099175,1,0
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.033894,-0.065921,-0.067849,1,0
3,GO LEUKOCYTE DIFFERENTIATION,0.011047,-0.066015,-0.10214,1,0
3,GO MULTICELLULAR ORGANISM AGING,0.017549,-0.066565,-0.12547,1,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.05161,-0.067007,-0.10693,1,0
3,GO SECRETION,0.012508,-0.067035,-0.08332,1,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.03245,-0.067433,-0.079096,1,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.026586,-0.06747,-0.092176,1,0
3,GO GLYCEROLIPID METABOLIC PROCESS,0.024846,-0.067811,-0.070702,1,0
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.030383,-0.067849,-0.11162,1,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.055956,-0.069583,-0.079324,1,0
3,GO TUBE DEVELOPMENT,0.033894,-0.069626,-0.094207,1,0
3,GO MUSCLE ADAPTATION,0.05161,-0.070042,-0.090495,1,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0079323,-0.070156,-0.080998,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.04854,-0.07016,-0.070453,1,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.001872,-0.070793,-0.12646,1,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.02166,-0.071389,-0.099685,1,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.025994,-0.071424,-0.085065,1,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.014138,-0.071536,-0.11367,1,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0038387,-0.072065,-0.074907,1,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.03245,-0.072305,-0.11245,1,0
3,GO LYMPHOCYTE ACTIVATION,0.0075304,-0.072443,-0.11104,1,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0085714,-0.072665,-0.087308,1,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.013139,-0.074079,-0.11156,1,0
3,GO MULTI ORGANISM PROCESS,0.009256,-0.074202,-0.06881,1,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.015203,-0.074726,-0.069842,1,0
3,GO PEPTIDE SECRETION,0.025414,-0.074792,-0.08505,1,0
3,GO NEGATIVE T CELL SELECTION,0.0027346,-0.075183,-0.16075,1,0
3,GO REGULATION OF RESPONSE TO STRESS,0.0064317,-0.075297,-0.092052,1,0
3,GO SPERM MOTILITY,0.012203,-0.075329,-0.091459,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.038561,-0.076032,-0.079738,1,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.017969,-0.07604,-0.099561,1,0
3,GO EAR DEVELOPMENT,0.035393,-0.0763,-0.099769,1,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.023205,-0.076905,-0.071375,1,0
3,GO KIDNEY MORPHOGENESIS,0.054842,-0.077294,-0.10155,1,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.031059,-0.07751,-0.091504,1,0
3,GO DEPHOSPHORYLATION,0.021165,-0.077657,-0.058171,1,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.0097392,-0.07785,-0.076389,1,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011326,-0.077982,-0.078376,1,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.041967,-0.078097,-0.11692,1,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.041967,-0.078222,-0.095114,1,0
3,GO POSITIVE REGULATION OF SECRETION,0.031748,-0.078364,-0.079138,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.03245,-0.078499,-0.10286,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0039469,-0.078562,-0.08408,1,0
3,GO EXOCYTOSIS,0.011047,-0.078638,-0.10281,1,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.018836,-0.078865,-0.058864,1,0
3,GO MACROPHAGE DIFFERENTIATION,0.045624,-0.079261,-0.13395,1,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.017549,-0.079405,-0.10827,1,0
3,GO IMMUNE SYSTEM DEVELOPMENT,0.0015653,-0.079454,-0.10403,1,0
3,GO CHROMOSOME LOCALIZATION,0.0025817,-0.079572,-0.11324,1,0
3,GO DETECTION OF STIMULUS,0.0010859,-0.079666,-0.097326,1,0
3,GO PROTEIN MONOUBIQUITINATION,0.0049174,-0.079687,-0.077954,1,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.049546,-0.08022,-0.12088,1,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.015574,-0.080753,-0.10773,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.037747,-0.080788,-0.11695,1,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.019739,-0.080956,-0.12703,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.042857,-0.081063,-0.10309,1,0
3,GO GAMETE GENERATION,0.0010206,-0.081244,-0.088169,1,0
3,GO TUBE FORMATION,0.023205,-0.081475,-0.096162,1,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0021062,-0.081483,-0.10326,1,0
3,GO REGULATION OF HEMOPOIESIS,0.010773,-0.081738,-0.105,1,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.044685,-0.081822,-0.10828,1,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0064317,-0.08192,-0.10728,1,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.045624,-0.081921,-0.088216,1,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.016339,-0.081932,-0.096147,1,0
3,GO ENDOSOMAL TRANSPORT,0.00028792,-0.082157,-0.10138,1,0
3,GO REGULATION OF IMMUNE RESPONSE,0.010773,-0.082422,-0.11106,1,0
3,GO VACUOLAR TRANSPORT,0.0094949,-0.082562,-0.1011,1,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.049546,-0.082713,-0.09224,1,0
3,GO FATTY ACID METABOLIC PROCESS,0.031059,-0.082955,-0.10209,1,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.038561,-0.083001,-0.11834,1,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.012508,-0.083325,-0.12337,1,0
3,GO FAT CELL DIFFERENTIATION,0.0067808,-0.083727,-0.12377,1,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014486,-0.084075,-0.1136,1,0
3,GO MAST CELL MEDIATED IMMUNITY,0.019739,-0.084268,-0.18989,1,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.027803,-0.08431,-0.14589,1,0
3,GO GLUCOSE METABOLIC PROCESS,0.044685,-0.084349,-0.067101,1,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0075304,-0.084664,-0.10493,1,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.035393,-0.084752,-0.069618,1,0
3,GO EXIT FROM MITOSIS,0.022165,-0.084988,-0.10847,1,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.010773,-0.085104,-0.11029,1,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.013139,-0.085154,-0.12442,1,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0056288,-0.08531,-0.10888,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.011904,-0.08548,-0.080851,1,0
3,GO RESPONSE TO ANTIBIOTIC,0.037747,-0.085625,-0.11302,1,0
3,GO INNER EAR MORPHOGENESIS,0.055956,-0.085652,-0.10908,1,0
3,GO CILIUM MOVEMENT,0.0020453,-0.085741,-0.127,1,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.04854,-0.085844,-0.10889,1,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.011047,-0.085863,-0.17353,1,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.050569,-0.086101,-0.12924,1,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0094949,-0.086271,-0.12897,1,0
3,GO REGULATION OF PROTEOLYSIS,0.0057817,-0.086679,-0.112,1,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.014486,-0.086788,-0.13458,1,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.041967,-0.08685,-0.069253,1,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.009256,-0.087266,-0.095113,1,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.013798,-0.087488,-0.13861,1,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.036948,-0.08754,-0.090013,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00081984,-0.087676,-0.10881,1,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033166,-0.087948,-0.13159,1,0
3,GO EMBRYONIC MORPHOGENESIS,0.012203,-0.088139,-0.10272,1,0
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.047551,-0.088301,-0.081081,1,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.014841,-0.088522,-0.1165,1,0
3,GO LYMPHOCYTE DIFFERENTIATION,0.0021062,-0.088558,-0.11587,1,0
3,GO CELLULAR SENESCENCE,0.017549,-0.088653,-0.11054,1,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.053746,-0.089326,-0.087658,1,0
3,GO PROTEOLYSIS,0.00044439,-0.089362,-0.10478,1,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.04854,-0.089702,-0.075698,1,0
3,GO NATURAL KILLER CELL ACTIVATION,0.011904,-0.089745,-0.13561,1,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.043763,-0.089812,-0.09272,1,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.02268,-0.089912,-0.090142,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION,0.018398,-0.090064,-0.10809,1,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.030383,-0.090119,-0.20065,1,0
3,GO ACTIVATION OF GTPASE ACTIVITY,0.0064317,-0.090415,-0.098557,1,0
3,GO REGULATION OF CELLULAR PH,0.0049174,-0.090578,-0.097889,1,0
3,GO CELL CELL ADHESION,0.004408,-0.09071,-0.12249,1,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0069616,-0.09084,-0.1134,1,0
3,GO CELLULAR PIGMENTATION,0.0036303,-0.09092,-0.13554,1,0
3,GO REGULATION OF NUCLEAR DIVISION,0.0050528,-0.091131,-0.08089,1,0
3,GO CELL MATRIX ADHESION,0.038561,-0.091166,-0.1199,1,0
3,GO GERM CELL DEVELOPMENT,0.0056288,-0.091316,-0.088962,1,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.054842,-0.091353,-0.054921,1,0
3,GO REGULATION OF PH,0.0062634,-0.091444,-0.094954,1,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.02268,-0.091575,-0.10198,1,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.010245,-0.091642,-0.12579,1,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.030383,-0.091662,-0.14272,1,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.015953,-0.091744,-0.12223,1,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.016339,-0.092052,-0.097263,1,0
3,GO MALE SEX DIFFERENTIATION,0.0069616,-0.092178,-0.10836,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.012508,-0.092218,-0.10432,1,0
3,GO RESPONSE TO GAMMA RADIATION,0.036948,-0.092257,-0.093986,1,0
3,GO GLAND DEVELOPMENT,0.013139,-0.092267,-0.099714,1,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0099891,-0.092299,-0.10271,1,0
3,GO ERBB SIGNALING PATHWAY,0.02843,-0.092544,-0.11082,1,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.042857,-0.092571,-0.14696,1,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.012203,-0.092747,-0.12479,1,0
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0028957,-0.092966,-0.091004,1,0
3,GO PROTEIN MATURATION,0.015574,-0.092989,-0.10116,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.017137,-0.093242,-0.1859,1,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.019739,-0.093259,-0.14598,1,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.018836,-0.093434,-0.18171,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0024367,-0.093456,-0.1471,1,0
3,GO LIPID LOCALIZATION,0.0079323,-0.09371,-0.11778,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.017969,-0.093974,-0.093809,1,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0042883,-0.09409,-0.12622,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013798,-0.094359,-0.11699,1,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.04854,-0.094558,-0.099281,1,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010245,-0.094843,-0.12706,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0025083,-0.094888,-0.15669,1,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.02268,-0.095105,-0.13525,1,0
3,GO RESPONSE TO ALCOHOL,0.044685,-0.095276,-0.077525,1,0
3,GO GOLGI VESICLE BUDDING,0.0081404,-0.095367,-0.11661,1,0
3,GO ACTIVATION OF IMMUNE RESPONSE,0.0097392,-0.095573,-0.10692,1,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0013872,-0.095585,-0.121,1,0
3,GO MITOCHONDRIAL FUSION,0.031748,-0.0959,-0.098395,1,0
3,GO POSTREPLICATION REPAIR,0.011904,-0.096376,-0.08894,1,0
3,GO COPII COATED VESICLE BUDDING,0.0053338,-0.096385,-0.11379,1,0
3,GO RESPONSE TO BMP,0.042857,-0.096422,-0.11419,1,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.052669,-0.096441,-0.12145,1,0
3,GO REGULATION OF BODY FLUID LEVELS,0.0010859,-0.096588,-0.1364,1,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.038561,-0.09677,-0.13006,1,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.03939,-0.096774,-0.14335,1,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.041967,-0.097474,-0.17357,1,0
3,GO GENITALIA DEVELOPMENT,0.031748,-0.097801,-0.11878,1,0
3,GO GOLGI ORGANIZATION,0.0025083,-0.097875,-0.11643,1,0
3,GO ECTODERM DEVELOPMENT,0.015574,-0.09795,-0.11081,1,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.015574,-0.098282,-0.13644,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.027803,-0.098302,-0.10269,1,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.050569,-0.098544,-0.10396,1,0
3,GO AUTOPHAGY OF NUCLEUS,0.054842,-0.098654,-0.13863,1,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.001986,-0.098769,-0.11462,1,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.017549,-0.098956,-0.093767,1,0
3,GO ORGANELLE DISASSEMBLY,0.0087944,-0.099028,-0.092583,1,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.023205,-0.099219,-0.1092,1,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0069616,-0.099376,-0.12092,1,0
3,GO COAGULATION,0.0051916,-0.099857,-0.13878,1,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.009256,-0.099859,-0.13181,1,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00044439,-0.099918,-0.12903,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.022165,-0.099988,-0.15007,1,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.010773,-0.099989,-0.13459,1,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0023671,-0.1002,-0.15959,1,0
3,GO APOPTOTIC SIGNALING PATHWAY,0.0041716,-0.10043,-0.1099,1,0
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.022165,-0.1009,-0.15697,1,0
3,GO ERAD PATHWAY,0.010506,-0.10131,-0.11486,1,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.011904,-0.10153,-0.12119,1,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00050664,-0.1016,-0.097924,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.03939,-0.10185,-0.078305,1,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00054072,-0.10187,-0.1406,1,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0060989,-0.10191,-0.14091,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0013054,-0.10192,-0.14426,1,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0054795,-0.10192,-0.097993,1,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.014486,-0.10213,-0.14414,1,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.034637,-0.10216,-0.10785,1,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.047551,-0.10217,-0.13505,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.045624,-0.10218,-0.10611,1,0
3,GO REGULATION OF CELL ADHESION,0.0026572,-0.10247,-0.1538,1,0
3,GO REGULATION OF CELL ACTIVATION,0.0022992,-0.10248,-0.13089,1,0
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0023671,-0.10265,-0.10487,1,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.015574,-0.10293,-0.1546,1,0
3,GO ENDOCYTIC RECYCLING,0.0020453,-0.10297,-0.1284,1,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0053338,-0.10314,-0.1281,1,0
3,GO EAR MORPHOGENESIS,0.012203,-0.1035,-0.12465,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0085714,-0.10358,-0.137,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00092958,-0.10358,-0.14937,1,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0025083,-0.10375,-0.13773,1,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00092958,-0.10393,-0.11064,1,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.026586,-0.10435,-0.085846,1,0
3,GO PH REDUCTION,0.0021689,-0.10437,-0.14997,1,0
3,GO CELL ACTIVATION,0.0027346,-0.10443,-0.13744,1,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.033166,-0.10445,-0.079391,1,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.041093,-0.10467,-0.12192,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.015574,-0.10467,-0.13052,1,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.03245,-0.10489,-0.13769,1,0
3,GO ADAPTIVE THERMOGENESIS,0.02268,-0.10497,-0.09286,1,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.043763,-0.10516,-0.10536,1,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.0060989,-0.10518,-0.13486,1,0
3,GO HISTONE MONOUBIQUITINATION,0.00026903,-0.10577,-0.13101,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.02166,-0.10578,-0.18634,1,0
3,GO DIGESTIVE SYSTEM PROCESS,0.033894,-0.10582,-0.12398,1,0
3,GO T CELL DIFFERENTIATION,0.0046564,-0.10597,-0.12217,1,0
3,GO PROTEIN POLYUBIQUITINATION,7.547e-05,-0.10635,-0.12601,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.10682,-0.21834,1,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.038561,-0.10693,-0.11031,1,0
3,GO SPERMATID DIFFERENTIATION,0.0087944,-0.1071,-0.10775,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.011326,-0.10731,-0.18883,1,0
3,GO RESPONSE TO OSMOTIC STRESS,0.023205,-0.10739,-0.11405,1,0
3,GO SEX DETERMINATION,0.033894,-0.10741,-0.13898,1,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0069616,-0.10748,-0.13913,1,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.040234,-0.10761,-0.18224,1,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.012508,-0.10772,-0.16527,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.033894,-0.10795,-0.1079,1,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.00049035,-0.10805,-0.13497,1,0
3,GO PROTEIN KINASE B SIGNALING,0.0042883,-0.10819,-0.13353,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0049174,-0.10864,-0.10882,1,0
3,GO LIPID DIGESTION,0.012508,-0.10865,-0.28191,1,0
3,GO INTERLEUKIN 17 PRODUCTION,0.030383,-0.10907,-0.14524,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.026586,-0.10914,-0.17042,1,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.025414,-0.1093,-0.17811,1,0
3,GO PEPTIDYL TYROSINE MODIFICATION,0.0037331,-0.10936,-0.13087,1,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.042857,-0.10946,-0.09126,1,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.053746,-0.10949,-0.15808,1,0
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,8.7323e-05,-0.10953,-0.14344,1,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016734,-0.1097,-0.10881,1,0
3,GO REPRODUCTION,0.0007696,-0.10999,-0.092536,1,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.016734,-0.11011,-0.10868,1,0
3,GO REGULATION OF PEPTIDE SECRETION,0.0083534,-0.11015,-0.099042,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.031748,-0.11072,-0.18395,1,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.00087311,-0.11132,-0.14441,1,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.041093,-0.1115,-0.082264,1,0
3,GO REPLACEMENT OSSIFICATION,0.035393,-0.11165,-0.16091,1,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00095906,-0.11176,-0.15167,1,0
3,GO RESPONSE TO BIOTIC STIMULUS,0.0023671,-0.11176,-0.13851,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.020205,-0.11203,-0.13579,1,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00042998,-0.11209,-0.15393,1,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.041093,-0.1121,-0.089285,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0071468,-0.11215,-0.088894,1,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00087311,-0.11217,-0.14572,1,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.0023671,-0.11228,-0.11441,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00090094,-0.11244,-0.15274,1,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.010506,-0.11274,-0.16972,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.014486,-0.11296,-0.11908,1,0
3,GO INNATE IMMUNE RESPONSE,0.00092958,-0.11297,-0.16868,1,0
3,GO LEUKOCYTE CELL CELL ADHESION,0.001662,-0.11298,-0.15534,1,0
3,GO CARBOHYDRATE TRANSPORT,0.0067808,-0.11335,-0.10615,1,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00052342,-0.11337,-0.19464,1,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.014138,-0.11384,-0.10532,1,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.044685,-0.11432,-0.19369,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0037331,-0.11433,-0.10729,1,0
3,GO MYELOID CELL DIFFERENTIATION,0.00025131,-0.11435,-0.12563,1,0
3,GO MITOTIC CYTOKINESIS,0.0030654,-0.11455,-0.12727,1,0
3,GO PLATELET MORPHOGENESIS,0.0051916,-0.11539,-0.20988,1,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.049546,-0.11558,-0.19466,1,0
3,GO REGULATION OF T CELL ACTIVATION,0.00087311,-0.11577,-0.14916,1,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0019282,-0.11619,-0.11366,1,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.042857,-0.11675,-0.12906,1,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.017969,-0.11697,-0.13148,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0064317,-0.11699,-0.1915,1,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.02268,-0.11734,-0.11495,1,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0036303,-0.11734,-0.21546,1,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.02166,-0.11741,-0.21897,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0021689,-0.11744,-0.21493,1,0
3,GO MYOBLAST DIFFERENTIATION,0.00353,-0.1177,-0.18566,1,0
3,GO DENDRITIC CELL MIGRATION,0.03939,-0.11815,-0.17082,1,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0042883,-0.11821,-0.15809,1,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.020205,-0.11829,-0.15136,1,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0030654,-0.1183,-0.175,1,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0071468,-0.11846,-0.13149,1,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00079435,-0.11849,-0.1507,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0046564,-0.11865,-0.10903,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.00037661,-0.11881,-0.14684,1,0
3,GO LYMPHOCYTE COSTIMULATION,0.016734,-0.1192,-0.12062,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00012074,-0.11925,-0.16242,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014138,-0.11938,-0.17878,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.030383,-0.1196,-0.11207,1,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.054842,-0.11977,-0.10854,1,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00057693,-0.1198,-0.17694,1,0
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0062634,-0.12015,-0.103,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00065623,-0.12034,-0.1434,1,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.049546,-0.12065,-0.13147,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.036948,-0.12079,-0.19372,1,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.016339,-0.12098,-0.13489,1,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.036948,-0.12122,-0.16682,1,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.038561,-0.12132,-0.16502,1,0
3,GO DIGESTION,0.0037331,-0.12135,-0.15953,1,0
3,GO NOTCH SIGNALING PATHWAY,0.0041716,-0.12161,-0.12592,1,0
3,GO T CELL ACTIVATION,0.00084609,-0.1218,-0.15324,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.010245,-0.12181,-0.091078,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.027188,-0.12199,-0.11447,1,0
3,GO RESPONSE TO WOUNDING,0.0097392,-0.12206,-0.13851,1,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.043763,-0.12209,-0.13789,1,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.052669,-0.12216,-0.15298,1,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.036164,-0.12218,-0.12394,1,0
3,GO SPINDLE LOCALIZATION,0.001228,-0.12219,-0.14155,1,0
3,GO RESPONSE TO BACTERIUM,0.011612,-0.12235,-0.12854,1,0
3,GO PROTEIN DESTABILIZATION,0.0045306,-0.1224,-0.12012,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.036164,-0.12245,-0.17099,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0073363,-0.1225,-0.12381,1,0
3,GO TISSUE MIGRATION,0.052669,-0.12264,-0.10693,1,0
3,GO CYTOKINE PRODUCTION,0.00021167,-0.12282,-0.17499,1,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.0045306,-0.1229,-0.11055,1,0
3,GO TISSUE HOMEOSTASIS,5.508e-06,-0.12321,-0.18363,1,0
3,GO EPITHELIUM DEVELOPMENT,4.6597e-05,-0.12322,-0.15616,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00014418,-0.12327,-0.15893,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0045306,-0.12336,-0.10713,1,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.012508,-0.12338,-0.14282,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.00041602,-0.12341,-0.1536,1,0
3,GO BONE CELL DEVELOPMENT,0.021165,-0.12346,-0.13918,1,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00010845,-0.12354,-0.12675,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.015203,-0.12356,-0.19931,1,0
3,GO REGULATION OF DEFENSE RESPONSE,0.00049035,-0.12387,-0.14928,1,0
3,GO VIRAL LATENCY,0.024288,-0.12407,-0.12119,1,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.038561,-0.12409,-0.20943,1,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00013433,-0.12422,-0.14223,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.0026572,-0.12426,-0.16489,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.0028141,-0.12432,-0.19311,1,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0036303,-0.12448,-0.13972,1,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0085714,-0.1248,-0.21404,1,0
3,GO TRANSLESION SYNTHESIS,0.004408,-0.12481,-0.11409,1,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.031748,-0.12484,-0.12044,1,0
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.04854,-0.12484,-0.15094,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0037331,-0.1252,-0.19543,1,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.0064317,-0.12528,-0.19474,1,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.04854,-0.12536,-0.11375,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.042857,-0.12547,-0.24358,1,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0014738,-0.12559,-0.16921,1,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.00017186,-0.12589,-0.15114,1,0
3,GO VESICLE TARGETING,0.0010859,-0.12596,-0.15258,1,0
3,GO DEFENSE RESPONSE,0.00067758,-0.12607,-0.14936,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.054842,-0.12653,-0.11945,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.054842,-0.12674,-0.11463,1,0
3,GO POLYAMINE METABOLIC PROCESS,0.05161,-0.12688,-0.10507,1,0
3,GO RESPIRATORY BURST,0.0030654,-0.12709,-0.24633,1,0
3,GO DNA DEALKYLATION,0.021165,-0.12709,-0.13663,1,0
3,GO REGULATION OF MUSCLE ADAPTATION,0.0073363,-0.12709,-0.13064,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0050528,-0.12729,-0.17163,1,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.00024286,-0.12733,-0.1873,1,0
3,GO REGULATION OF PINOCYTOSIS,0.0049174,-0.12742,-0.21435,1,0
3,GO VIRAL LIFE CYCLE,0.0006154,-0.12754,-0.18525,1,0
3,GO INFLAMMATORY RESPONSE,0.0010528,-0.12767,-0.14813,1,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.029719,-0.1277,-0.13862,1,0
3,GO RESPONSE TO IRON ION,0.017969,-0.12784,-0.15696,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0014738,-0.12842,-0.14968,1,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.013465,-0.12854,-0.12884,1,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.0046564,-0.12856,-0.12382,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01282,-0.1286,-0.17838,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023468,-0.12895,-0.16558,1,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.042857,-0.12913,-0.2315,1,0
3,GO WOUND HEALING,0.0054795,-0.1293,-0.15726,1,0
3,GO FIBROBLAST MIGRATION,0.007729,-0.12942,-0.17907,1,0
3,GO REGULATION OF CELL SHAPE,0.007729,-0.12957,-0.13399,1,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.014138,-0.12982,-0.14473,1,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00084609,-0.12995,-0.18643,1,0
3,GO RESPONSE TO INTERLEUKIN 6,0.0012662,-0.13027,-0.18833,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00042998,-0.13033,-0.17338,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.024288,-0.13054,-0.14495,1,0
3,GO PHAGOSOME ACIDIFICATION,0.011047,-0.13061,-0.16997,1,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.004408,-0.13062,-0.18148,1,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.019739,-0.13104,-0.13652,1,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.042857,-0.13113,-0.13624,1,0
3,GO SPECIFICATION OF SYMMETRY,0.001986,-0.13171,-0.11453,1,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.05161,-0.13174,-0.18714,1,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00050664,-0.132,-0.16849,1,0
3,GO REGULATION OF CHEMOTAXIS,0.0025817,-0.13201,-0.13346,1,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0083534,-0.13223,-0.22541,1,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.042857,-0.13227,-0.10183,1,0
3,GO NEURAL TUBE DEVELOPMENT,0.00079435,-0.13232,-0.14758,1,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.013465,-0.13233,-0.11869,1,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.00067758,-0.13237,-0.17463,1,0
3,GO HISTONE H2A UBIQUITINATION,0.0036303,-0.13238,-0.12349,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0032441,-0.13243,-0.12134,1,0
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.052669,-0.13279,-0.10656,1,0
3,GO PEPTIDE CROSS LINKING,0.031059,-0.1329,-0.19153,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0031536,-0.1334,-0.14323,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0083534,-0.13365,-0.18128,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.004408,-0.13383,-0.18717,1,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00067758,-0.13394,-0.14216,1,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00079435,-0.13405,-0.18566,1,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00037661,-0.1343,-0.18074,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0071468,-0.13466,-0.25989,1,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.0010206,-0.13467,-0.13057,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.00045924,-0.13472,-0.18616,1,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.01282,-0.1348,-0.14885,1,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.03245,-0.13487,-0.15042,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0073363,-0.13507,-0.13492,1,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.0034322,-0.1352,-0.20747,1,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0010206,-0.13529,-0.18728,1,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.00012512,-0.13531,-0.11985,1,0
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028957,-0.13533,-0.18301,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.017549,-0.1354,-0.11915,1,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.00044439,-0.13553,-0.14304,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.035393,-0.13556,-0.122,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.00040247,-0.13585,-0.15198,1,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.018398,-0.13599,-0.16919,1,0
3,GO B CELL ACTIVATION,1.349e-05,-0.13627,-0.16989,1,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00034072,-0.13627,-0.17261,1,0
3,GO REGULATION OF MAST CELL ACTIVATION,0.025994,-0.13635,-0.1584,1,0
3,GO PIGMENT GRANULE LOCALIZATION,0.01282,-0.13658,-0.1564,1,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0057817,-0.13663,-0.16375,1,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.044685,-0.13707,-0.10245,1,0
3,GO RESPONSE TO CYTOKINE,0.0015653,-0.13722,-0.15304,1,0
3,GO LEUKOCYTE PROLIFERATION,5.2139e-05,-0.13752,-0.18262,1,0
3,GO CYTOKINE SECRETION,0.00036427,-0.13774,-0.16718,1,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.00059588,-0.13782,-0.13632,1,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.017969,-0.13784,-0.13105,1,0
3,GO ATP BIOSYNTHETIC PROCESS,0.017137,-0.13838,-0.12921,1,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0015653,-0.13838,-0.16625,1,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0036303,-0.13851,-0.13108,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.13857,-0.19007,1,0
3,GO B CELL PROLIFERATION,0.0047853,-0.13915,-0.14366,1,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.025414,-0.13941,-0.14385,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION,0.0013457,-0.13943,-0.17667,1,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.0011199,-0.13949,-0.21885,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.13965,-0.1945,1,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.00026003,-0.13967,-0.1549,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.019283,-0.14022,-0.1494,1,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.0085714,-0.14029,-0.15571,1,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0081404,-0.14034,-0.14479,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0011549,-0.14036,-0.19254,1,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.019739,-0.14046,-0.16668,1,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001547,-0.14116,-0.15776,1,0
3,GO T CELL PROLIFERATION,0.00047456,-0.14122,-0.17393,1,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0028141,-0.14125,-0.16001,1,0
3,GO GRANULOCYTE MIGRATION,0.0039469,-0.14139,-0.1513,1,0
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.030383,-0.14149,-0.14655,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.016734,-0.14167,-0.18334,1,0
3,GO RESPONSE TO ETHER,0.024288,-0.14185,-0.11441,1,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0057817,-0.14203,-0.15264,1,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00035231,-0.14214,-0.22517,1,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00012512,-0.14214,-0.20648,1,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.013465,-0.14252,-0.17536,1,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.052669,-0.14262,-0.11501,1,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00029782,-0.14289,-0.16849,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.0025083,-0.14291,-0.18684,1,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0047853,-0.14328,-0.23072,1,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0024367,-0.14331,-0.18293,1,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.035393,-0.14355,-0.18871,1,0
3,GO BLOOD VESSEL REMODELING,0.0053338,-0.14366,-0.2213,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0028957,-0.1439,-0.19045,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0011549,-0.14393,-0.18759,1,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.00013917,-0.14424,-0.15291,1,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.02068,-0.14432,-0.21244,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.009256,-0.14442,-0.18871,1,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.014486,-0.14453,-0.12149,1,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.042857,-0.14456,-0.15514,1,0
3,GO INTERLEUKIN 4 PRODUCTION,0.0014299,-0.14457,-0.20697,1,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0037331,-0.14465,-0.17389,1,0
3,GO EPITHELIAL TUBE FORMATION,0.00022676,-0.14479,-0.15709,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14492,-0.17924,1,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00022676,-0.14503,-0.1583,1,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.014841,-0.14516,-0.13223,1,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.035393,-0.14517,-0.18809,1,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.017137,-0.14525,-0.11333,1,0
3,GO CHEMOKINE PRODUCTION,0.00035231,-0.14531,-0.21654,1,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0018173,-0.14548,-0.14576,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0014738,-0.14601,-0.16132,1,0
3,GO MAST CELL ACTIVATION,0.0090226,-0.14638,-0.18771,1,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.017549,-0.14655,-0.14279,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0010528,-0.14678,-0.18093,1,0
3,GO MYELOID CELL DEVELOPMENT,0.00041602,-0.14679,-0.14912,1,0
3,GO SENSORY PERCEPTION OF TASTE,0.00087311,-0.14694,-0.17863,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,-0.14704,-0.21074,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00019079,-0.14753,-0.18056,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00027832,-0.14789,-0.19066,1,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001872,-0.14792,-0.17967,1,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.033166,-0.14877,-0.19191,1,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.05161,-0.1488,-0.1726,1,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.9904e-06,-0.14883,-0.18084,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0015653,-0.14894,-0.18765,1,0
3,GO ENDOTHELIUM DEVELOPMENT,0.0013872,-0.14899,-0.16446,1,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.011904,-0.14926,-0.19602,1,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.015574,-0.1494,-0.12683,1,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.009256,-0.14942,-0.17523,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00353,-0.14945,-0.15172,1,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.00057693,-0.14947,-0.2105,1,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14956,-0.1439,1,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.6174e-05,-0.14956,-0.17964,1,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00059588,-0.14964,-0.12514,1,0
3,GO RENAL TUBULE DEVELOPMENT,0.001191,-0.14991,-0.17985,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0025817,-0.14994,-0.20246,1,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0075304,-0.14999,-0.11888,1,0
3,GO NUCLEOTIDE TRANSPORT,0.033166,-0.15011,-0.098094,1,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00032948,-0.15014,-0.18851,1,0
3,GO SECRETION BY TISSUE,0.013465,-0.15017,-0.16291,1,0
3,GO SECONDARY METABOLIC PROCESS,0.0029794,-0.15038,-0.21197,1,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.02166,-0.15049,-0.19718,1,0
3,GO REGULATION OF B CELL ACTIVATION,0.00028792,-0.15059,-0.17344,1,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0038387,-0.15116,-0.14668,1,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00027832,-0.15117,-0.17891,1,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.0075304,-0.1512,-0.1891,1,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.0015653,-0.15155,-0.14694,1,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0032441,-0.15164,-0.14705,1,0
3,GO LEUKOCYTE MIGRATION,0.00052342,-0.15167,-0.16869,1,0
3,GO CYTOKINE METABOLIC PROCESS,0.0007696,-0.15171,-0.20216,1,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013433,-0.15188,-0.18461,1,0
3,GO CELL PROJECTION ASSEMBLY,5.4121e-05,-0.15189,-0.12875,1,0
3,GO PINOCYTOSIS,0.017549,-0.15217,-0.18144,1,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00037661,-0.15284,-0.21262,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00019079,-0.15285,-0.22724,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.007729,-0.15288,-0.25354,1,0
3,GO MICROTUBULE SEVERING,0.024846,-0.15297,-0.14641,1,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.031748,-0.15312,-0.2892,1,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0028957,-0.15332,-0.18154,1,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.045624,-0.15342,-0.1403,1,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.03939,-0.15348,-0.13741,1,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0039469,-0.15351,-0.21867,1,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00012074,-0.15356,-0.20431,1,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0049174,-0.15376,-0.16147,1,0
3,GO REGULATION OF CELL CELL ADHESION,0.00019753,-0.15387,-0.18583,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00036427,-0.15402,-0.19018,1,0
3,GO MYOFIBRIL ASSEMBLY,0.0013054,-0.15403,-0.1654,1,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.15411,-0.20674,1,0
3,GO INTESTINAL LIPID ABSORPTION,0.0057817,-0.15426,-0.30133,1,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0066042,-0.15435,-0.18217,1,0
3,GO GRANULOCYTE CHEMOTAXIS,0.004408,-0.15444,-0.14176,1,0
3,GO DEFENSE RESPONSE TO BACTERIUM,5.0226e-05,-0.15451,-0.18967,1,0
3,GO IMMUNE EFFECTOR PROCESS,0.00027832,-0.15462,-0.18866,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0010528,-0.15478,-0.19313,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0032441,-0.15482,-0.23943,1,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.01282,-0.15482,-0.17457,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00027832,-0.15485,-0.20869,1,0
3,GO ACTIN NUCLEATION,9.3916e-06,-0.15517,-0.17974,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054795,-0.15535,-0.19323,1,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.00084609,-0.15538,-0.14248,1,0
3,GO EYE MORPHOGENESIS,0.0007696,-0.15573,-0.15378,1,0
3,GO GENETIC IMPRINTING,0.001662,-0.1559,-0.18531,1,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.012508,-0.15608,-0.25662,1,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.020205,-0.15641,-0.32179,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.001191,-0.15661,-0.24229,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0056288,-0.15663,-0.43877,1,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.020205,-0.15667,-0.12284,1,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00021909,-0.15674,-0.17691,1,0
3,GO RESPONSE TO REDOX STATE,0.042857,-0.15686,-0.15179,1,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00074557,-0.15704,-0.18448,1,0
3,GO INTERACTION WITH HOST,0.00019079,-0.15709,-0.20914,1,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0037331,-0.15743,-0.14227,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00079435,-0.15766,-0.18699,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0014299,-0.15773,-0.2157,1,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.014486,-0.15774,-0.12947,1,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00057693,-0.15783,-0.1292,1,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00016023,-0.15786,-0.21085,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00067758,-0.15788,-0.18079,1,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.035393,-0.15803,-0.10595,1,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0026572,-0.15807,-0.2037,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0087944,-0.15853,-0.16251,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0038387,-0.15858,-0.15479,1,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.041967,-0.15888,-0.19555,1,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00034072,-0.1591,-0.19399,1,0
3,GO FOAM CELL DIFFERENTIATION,0.019283,-0.15919,-0.17345,1,0
3,GO RESPONSE TO DSRNA,0.0051916,-0.1593,-0.15298,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00016023,-0.15932,-0.20877,1,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.054842,-0.1597,-0.22913,1,0
3,GO HISTAMINE TRANSPORT,0.02843,-0.15977,-0.22185,1,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0060989,-0.15995,-0.27992,1,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00010092,-0.16008,-0.19963,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00017796,-0.16016,-0.18245,1,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.8379e-05,-0.16017,-0.21337,1,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.020205,-0.16021,-0.17337,1,0
3,GO MALE GENITALIA DEVELOPMENT,0.036164,-0.16024,-0.16504,1,0
3,GO CELL KILLING,0.00074557,-0.16039,-0.18127,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00023468,-0.16045,-0.19554,1,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.5816e-05,-0.16078,-0.24415,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.017549,-0.16089,-0.24785,1,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0025083,-0.16094,-0.13679,1,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00026903,-0.16179,-0.2271,1,0
3,GO ENDOTHELIAL CELL MIGRATION,0.017137,-0.16179,-0.13681,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0036303,-0.16222,-0.20852,1,0
3,GO RESPONSE TO VIRUS,7.2754e-05,-0.16236,-0.22056,1,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,8.7323e-05,-0.16304,-0.15477,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.023205,-0.16307,-0.22829,1,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0037331,-0.16314,-0.18802,1,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00024286,-0.16323,-0.17159,1,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0039469,-0.16341,-0.16958,1,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.017549,-0.16375,-0.15881,1,0
3,GO BONE RESORPTION,0.001662,-0.16393,-0.2021,1,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0050528,-0.16395,-0.16202,1,0
3,GO EPITHELIAL CELL DEVELOPMENT,4.0073e-05,-0.16412,-0.20926,1,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.4121e-05,-0.16446,-0.21357,1,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0033369,-0.16459,-0.23974,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.014138,-0.16466,-0.14851,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,8.6584e-06,-0.16481,-0.16849,1,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.019739,-0.16498,-0.16212,1,0
3,GO PROTEIN PROCESSING,0.00031859,-0.16503,-0.17643,1,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.016339,-0.16508,-0.20976,1,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.030383,-0.16509,-0.17813,1,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0099891,-0.16521,-0.21723,1,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.011904,-0.16609,-0.13149,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00035231,-0.16611,-0.20067,1,0
3,GO PROTEIN DEMANNOSYLATION,0.016734,-0.16667,-0.1826,1,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00012512,-0.16682,-0.20585,1,0
3,GO REGULATION OF ICOSANOID SECRETION,0.043763,-0.16685,-0.13495,1,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0053338,-0.16686,-0.18038,1,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,5.4121e-05,-0.16691,-0.21403,1,0
3,GO MEGAKARYOCYTE DIFFERENTIATION,4.4712e-06,-0.1672,-0.18873,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0090226,-0.16723,-0.18053,1,0
3,GO ALPHA BETA T CELL ACTIVATION,1.5816e-05,-0.16759,-0.22358,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00072223,-0.16822,-0.19688,1,0
3,GO RESPONSE TO ISCHEMIA,0.001986,-0.16838,-0.16397,1,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0042883,-0.1685,-0.20823,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0087944,-0.16857,-0.18176,1,0
3,GO T CELL CYTOKINE PRODUCTION,0.0037331,-0.16864,-0.19095,1,0
3,GO RESPONSE TO PROGESTERONE,0.0049174,-0.1687,-0.22083,1,0
3,GO MESONEPHROS DEVELOPMENT,0.012508,-0.16888,-0.15112,1,0
3,GO REGULATION OF CHROMATIN BINDING,0.00095906,-0.16935,-0.21586,1,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.0014299,-0.16935,-0.16125,1,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.6455e-05,-0.16944,-0.1757,1,0
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0033369,-0.16957,-0.33203,1,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.038561,-0.17029,-0.16591,1,0
3,GO ZYMOGEN ACTIVATION,0.0051916,-0.17036,-0.27421,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.049546,-0.17037,-0.23522,1,0
3,GO RIG I SIGNALING PATHWAY,0.0025083,-0.17043,-0.18276,1,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0010859,-0.17043,-0.23775,1,0
3,GO EXECUTION PHASE OF APOPTOSIS,1.0184e-05,-0.17048,-0.1646,1,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.025414,-0.17053,-0.3756,1,0
3,GO ENTRY INTO HOST,0.00050664,-0.17066,-0.26205,1,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00035231,-0.17079,-0.15974,1,0
3,GO ACUTE PHASE RESPONSE,0.0031536,-0.17081,-0.1885,1,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.013465,-0.17095,-0.14719,1,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0022332,-0.17123,-0.19664,1,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0028141,-0.17125,-0.20777,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.1617e-05,-0.17141,-0.24649,1,0
3,GO RESPONSE TO ANGIOTENSIN,0.0024367,-0.17178,-0.21932,1,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0015653,-0.17192,-0.16732,1,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00037661,-0.17193,-0.21364,1,0
3,GO DIOL METABOLIC PROCESS,0.019739,-0.17195,-0.17019,1,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.004408,-0.17196,-0.17018,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.00055855,-0.17215,-0.159,1,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0025817,-0.17218,-0.21653,1,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00063551,-0.17254,-0.21976,1,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.033894,-0.17272,-0.17615,1,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0029794,-0.17299,-0.21201,1,0
3,GO REGULATION OF B CELL PROLIFERATION,0.0017123,-0.17333,-0.18159,1,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.036164,-0.17361,-0.19823,1,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0028957,-0.17377,-0.17369,1,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.012508,-0.17408,-0.20794,1,0
3,GO ERYTHROCYTE DEVELOPMENT,0.0032441,-0.17411,-0.13457,1,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0051916,-0.1742,-0.17726,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0014738,-0.17422,-0.17904,1,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.019283,-0.17445,-0.2578,1,0
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0075304,-0.17471,-0.2284,1,0
3,GO CYTOLYSIS,0.0054795,-0.17473,-0.22888,1,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0013872,-0.17476,-0.1755,1,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.0037331,-0.17487,-0.14148,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0045306,-0.17502,-0.19628,1,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0022992,-0.17542,-0.16577,1,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,6.7596e-05,-0.17559,-0.19025,1,0
3,GO MYOTUBE CELL DEVELOPMENT,0.016339,-0.17563,-0.15797,1,0
3,GO ENDOCRINE HORMONE SECRETION,0.0056288,-0.17573,-0.15316,1,0
3,GO O GLYCAN PROCESSING,0.0031536,-0.17579,-0.2369,1,0
3,GO REGULATION OF RUFFLE ASSEMBLY,0.00079435,-0.17596,-0.1982,1,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0025083,-0.17613,-0.17621,1,0
3,GO RETINA HOMEOSTASIS,0.00032948,-0.17619,-0.14676,1,0
3,GO DNA DEMETHYLATION,0.00029782,-0.17626,-0.19988,1,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.001228,-0.17636,-0.17727,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,5.2139e-05,-0.17658,-0.2252,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.015574,-0.17694,-0.22061,1,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0047853,-0.17737,-0.19456,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0001165,-0.17743,-0.194,1,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.00052342,-0.17744,-0.15958,1,0
3,GO EPOXYGENASE P450 PATHWAY,0.03939,-0.17744,-0.19399,1,0
3,GO PLATELET ACTIVATION,4.1617e-05,-0.17749,-0.21602,1,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.018836,-0.17791,-0.15795,1,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.013465,-0.17804,-0.23875,1,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.17827,-0.19891,1,0
3,GO B CELL DIFFERENTIATION,4.1112e-06,-0.17886,-0.20911,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.1663e-05,-0.1789,-0.24823,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.17895,-0.21136,1,0
3,GO SPERM AXONEME ASSEMBLY,0.018398,-0.17897,-0.14658,1,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00036427,-0.17899,-0.16736,1,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.7806e-05,-0.17912,-0.19717,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00017186,-0.17933,-0.24299,1,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.036164,-0.17974,-0.1366,1,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0036303,-0.17976,-0.23816,1,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00067758,-0.1798,-0.18452,1,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0034322,-0.17994,-0.15644,1,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0011549,-0.18011,-0.26679,1,0
3,GO REGULATION OF CILIUM BEAT FREQUENCY,0.013139,-0.18018,-0.17527,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0018173,-0.18039,-0.20622,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0031536,-0.18041,-0.17537,1,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0056288,-0.1806,-0.16351,1,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0067808,-0.18146,-0.20684,1,0
3,GO PHOSPHOLIPID TRANSPORT,9.7346e-05,-0.18173,-0.18523,1,0
3,GO NEPHRON DEVELOPMENT,0.00034072,-0.18181,-0.18869,1,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00052342,-0.18189,-0.2359,1,0
3,GO CELLULAR RESPONSE TO VIRUS,3.5759e-05,-0.18208,-0.22268,1,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0081404,-0.18208,-0.18681,1,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00081984,-0.18246,-0.19194,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.18284,-0.21292,1,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00019753,-0.18286,-0.20857,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00017796,-0.18323,-0.26212,1,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0053338,-0.1835,-0.18746,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00049035,-0.18353,-0.2607,1,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0046564,-0.18402,-0.23911,1,0
3,GO MYELOID CELL HOMEOSTASIS,1.7806e-05,-0.18416,-0.19416,1,0
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00090094,-0.18552,-0.17905,1,0
3,GO DEFENSE RESPONSE TO VIRUS,3.6228e-06,-0.18591,-0.29096,1,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0011549,-0.18602,-0.16315,1,0
3,GO ENDOSOME ORGANIZATION,5.7413e-06,-0.18602,-0.1872,1,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0027346,-0.18632,-0.20252,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.7118e-05,-0.18636,-0.21519,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00032948,-0.18658,-0.16686,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0056288,-0.18666,-0.16861,1,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0046564,-0.18693,-0.22136,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0028957,-0.18694,-0.3128,1,0
3,GO REGULATION OF TISSUE REMODELING,0.00353,-0.18727,-0.18813,1,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,6.2786e-05,-0.18748,-0.24241,1,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00017796,-0.18756,-0.15865,1,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00010845,-0.18759,-0.23729,1,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.010245,-0.18772,-0.19643,1,0
3,GO PRO B CELL DIFFERENTIATION,0.03939,-0.18773,-0.17599,1,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0039469,-0.18868,-0.22033,1,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.029068,-0.18875,-0.28838,1,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,3.6228e-06,-0.18876,-0.24018,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0087944,-0.18891,-0.22537,1,0
3,GO IMMUNOGLOBULIN SECRETION,5.8301e-05,-0.18902,-0.32871,1,0
3,GO KERATINOCYTE PROLIFERATION,0.023741,-0.18905,-0.1901,1,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.020205,-0.18916,-0.18951,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0053338,-0.18936,-0.20841,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00026003,-0.18937,-0.20372,1,0
3,GO REGULATION OF SYMBIOTIC PROCESS,2.3418e-05,-0.19054,-0.23827,1,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.042857,-0.19116,-0.1446,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.1617e-05,-0.19125,-0.20666,1,0
3,GO MATURE B CELL DIFFERENTIATION,0.0079323,-0.19127,-0.24139,1,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00042998,-0.19132,-0.18364,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00045924,-0.19145,-0.25472,1,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033166,-0.19155,-0.18675,1,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.0039469,-0.19155,-0.20908,1,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.009256,-0.1917,-0.21063,1,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0014738,-0.19173,-0.19582,1,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0007696,-0.19186,-0.24411,1,0
3,GO CELL MIGRATION IN HINDBRAIN,0.041093,-0.19215,-0.19747,1,0
3,GO HISTONE H4 DEACETYLATION,0.0083534,-0.19221,-0.18168,1,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011549,-0.19228,-0.17259,1,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0040578,-0.19241,-0.17525,1,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.019283,-0.19244,-0.19172,1,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.025994,-0.19261,-0.19316,1,0
3,GO MACROPHAGE MIGRATION,0.016734,-0.19285,-0.15018,1,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,-0.19285,-0.19495,1,0
3,GO REGULATION OF GASTRULATION,0.0036303,-0.19303,-0.19391,1,0
3,GO TYPE I INTERFERON PRODUCTION,0.00012512,-0.19307,-0.22172,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.0073e-05,-0.19317,-0.20567,1,0
3,GO SEGMENT SPECIFICATION,0.016734,-0.1934,-0.22752,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,-0.19418,-0.24207,1,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.0030654,-0.19429,-0.21205,1,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0053338,-0.1944,-0.18269,1,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.030383,-0.19452,-0.19046,1,0
3,GO RESPONSE TO INTERLEUKIN 2,0.0024367,-0.19464,-0.21173,1,0
3,GO LEUKOCYTE CHEMOTAXIS,0.00034072,-0.19467,-0.17473,1,0
3,GO RESPONSE TO INTERFERON GAMMA,0.0022992,-0.19468,-0.25638,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00020448,-0.19474,-0.22513,1,0
3,GO LIPID DROPLET ORGANIZATION,0.00057693,-0.19506,-0.24384,1,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00072223,-0.19512,-0.22377,1,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0083534,-0.19517,-0.14355,1,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00052342,-0.19534,-0.26544,1,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0041716,-0.19545,-0.23709,1,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.013798,-0.19553,-0.16904,1,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0028141,-0.19558,-0.17657,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0011549,-0.19644,-0.24342,1,0
3,GO B CELL MEDIATED IMMUNITY,4.1617e-05,-0.19658,-0.25168,1,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.013465,-0.19668,-0.20185,1,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.0027346,-0.19669,-0.18498,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0053338,-0.19672,-0.37465,1,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0001165,-0.19674,-0.23763,1,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0090226,-0.19698,-0.16844,1,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0025817,-0.19709,-0.1548,1,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0034322,-0.1971,-0.17857,1,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,2.8418e-05,-0.19715,-0.20872,1,0
3,GO RESPONSE TO OXYGEN RADICAL,0.00031859,-0.19742,-0.19113,1,0
3,GO MICROVILLUS ASSEMBLY,0.053746,-0.19753,-0.20991,1,0
3,GO ADAPTIVE IMMUNE RESPONSE,1.5201e-05,-0.19811,-0.24424,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0024367,-0.19818,-0.25076,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001228,-0.19822,-0.26604,1,0
3,GO SARCOMERE ORGANIZATION,0.0040578,-0.19847,-0.18119,1,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.021165,-0.19857,-0.19446,1,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0031536,-0.19869,-0.15963,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0034322,-0.19925,-0.25923,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.050569,-0.19937,-0.14583,1,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00035231,-0.1996,-0.20529,1,0
3,GO VIRAL GENOME REPLICATION,0.00019079,-0.19966,-0.25058,1,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.017549,-0.19969,-0.24726,1,0
3,GO CELL CHEMOTAXIS,0.00014935,-0.19992,-0.19702,1,0
3,GO MICROVILLUS ORGANIZATION,0.0040578,-0.20036,-0.24987,1,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0047853,-0.20082,-0.23713,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0038387,-0.20094,-0.21145,1,0
3,GO VASCULAR WOUND HEALING,0.047551,-0.20094,-0.1695,1,0
3,GO MOVEMENT IN HOST ENVIRONMENT,4.0073e-05,-0.20127,-0.26159,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00010092,-0.20136,-0.21635,1,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.0689e-05,-0.20164,-0.24896,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0027346,-0.20192,-0.23749,1,0
3,GO ERYTHROCYTE HOMEOSTASIS,3.1888e-05,-0.20196,-0.18645,1,0
3,GO ETHANOL METABOLIC PROCESS,0.018836,-0.20221,-0.22088,1,0
3,GO ENDOCRINE PROCESS,0.0021689,-0.20277,-0.19742,1,0
3,GO MONONUCLEAR CELL MIGRATION,0.0015189,-0.2029,-0.20107,1,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,-0.20301,-0.21454,1,0
3,GO VIRION ASSEMBLY,4.8612e-06,-0.20303,-0.20821,1,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.019739,-0.20305,-0.31241,1,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.018836,-0.2032,-0.29272,1,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0032441,-0.20377,-0.19792,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1702e-06,-0.20405,-0.22395,1,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00090094,-0.20412,-0.23801,1,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.035393,-0.20415,-0.19456,1,0
3,GO RESPONSE TO COPPER ION,0.0094949,-0.20454,-0.28372,1,0
3,GO MACROPHAGE CHEMOTAXIS,0.015574,-0.20459,-0.15958,1,0
3,GO POSITIVE REGULATION OF CELL KILLING,0.00027832,-0.20468,-0.24762,1,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,8.3127e-06,-0.20517,-0.19981,1,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00090094,-0.20534,-0.19398,1,0
3,GO BONE REMODELING,0.0067808,-0.20576,-0.18857,1,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.043763,-0.20577,-0.115,1,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.036948,-0.2058,-0.3584,1,0
3,GO CELLULAR DEFENSE RESPONSE,3.0576e-06,-0.20588,-0.28847,1,0
3,GO REGULATION OF RESPIRATORY BURST,0.0011549,-0.20635,-0.22913,1,0
3,GO CYTOKINETIC PROCESS,1.1493e-05,-0.20698,-0.2535,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.001872,-0.20732,-0.23,1,0
3,GO RESPONSE TO MECHANICAL STIMULUS,4.3218e-05,-0.20756,-0.21244,1,0
3,GO LIPID STORAGE,0.0019282,-0.20795,-0.18547,1,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0016129,-0.20814,-0.22175,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0006154,-0.20853,-0.23021,1,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.00031859,-0.2086,-0.20416,1,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.033166,-0.20879,-0.1891,1,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030804,-0.2088,-0.23571,1,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.00014935,-0.2089,-0.20287,1,0
3,GO REPLICATIVE SENESCENCE,0.037747,-0.2091,-0.18202,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00072223,-0.20911,-0.22309,1,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015653,-0.20922,-0.2255,1,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0034322,-0.20965,-0.15386,1,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00010092,-0.20979,-0.26298,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00030804,-0.21007,-0.19438,1,0
3,GO REGULATORY T CELL DIFFERENTIATION,0.0024367,-0.21051,-0.25494,1,0
3,GO REGULATION OF ACTIN NUCLEATION,7.013e-05,-0.21059,-0.23706,1,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010462,-0.21082,-0.26754,1,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.026586,-0.21085,-0.2233,1,0
3,GO MONOCYTE CHEMOTAXIS,0.00098941,-0.21086,-0.24741,1,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001662,-0.21109,-0.17954,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00022676,-0.21165,-0.21018,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.017969,-0.21172,-0.29752,1,0
3,GO B CELL APOPTOTIC PROCESS,0.00049035,-0.21179,-0.25333,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00081984,-0.21195,-0.26482,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9841e-06,-0.21209,-0.27498,1,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0013054,-0.2125,-0.18284,1,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.024846,-0.21262,-0.19456,1,0
3,GO POSITIVE T CELL SELECTION,0.0020453,-0.21266,-0.17666,1,0
3,GO HORMONE CATABOLIC PROCESS,0.0040578,-0.21298,-0.268,1,0
3,GO REGULATION OF CENTROSOME CYCLE,7.6603e-06,-0.21304,-0.1946,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00016595,-0.21323,-0.23457,1,0
3,GO ACTIVATED T CELL PROLIFERATION,0.00090094,-0.21349,-0.20102,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0039469,-0.2135,-0.28308,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00030804,-0.21379,-0.2708,1,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.8301e-05,-0.21386,-0.22757,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0033e-05,-0.21438,-0.24567,1,0
3,GO CELLULAR RESPONSE TO DSRNA,0.0015189,-0.21458,-0.24055,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0027346,-0.21505,-0.19654,1,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0022332,-0.21511,-0.20742,1,0
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0073363,-0.21563,-0.22312,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00023468,-0.21583,-0.2611,1,0
3,GO NEURAL TUBE FORMATION,5.508e-06,-0.21605,-0.21581,1,0
3,GO ERBB2 SIGNALING PATHWAY,2.0833e-05,-0.21644,-0.26576,1,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.05161,-0.21646,-0.16836,1,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,7.547e-05,-0.21684,-0.28659,1,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0028141,-0.21714,-0.20972,1,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.5149e-05,-0.21721,-0.20417,1,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.036948,-0.21748,-0.15889,1,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.00026903,-0.21769,-0.26574,1,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.21769,-0.26093,1,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.018836,-0.21834,-0.1872,1,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0067808,-0.2186,-0.188,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.023741,-0.21892,-0.25559,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.040234,-0.21923,-0.20719,1,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.044685,-0.21924,-0.23152,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00024286,-0.21992,-0.23488,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.018836,-0.22005,-0.2922,1,0
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0085714,-0.22029,-0.24136,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.013139,-0.22034,-0.24011,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0020453,-0.22041,-0.21338,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00014935,-0.22042,-0.22091,1,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00074557,-0.22052,-0.23118,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,6.7596e-05,-0.22062,-0.24206,1,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.0014738,-0.22117,-0.26106,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0042883,-0.22129,-0.15994,1,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0050528,-0.22173,-0.1835,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.7343e-05,-0.22194,-0.24205,1,0
3,GO INTERLEUKIN 12 PRODUCTION,3.4728e-06,-0.22211,-0.29373,1,0
3,GO REGULATION OF CELL KILLING,4.8379e-05,-0.22214,-0.25679,1,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0032441,-0.22215,-0.3142,1,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00063551,-0.22233,-0.19661,1,0
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0083534,-0.22244,-0.24134,1,0
3,GO MALE SEX DETERMINATION,0.0038387,-0.22247,-0.24751,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,5.8301e-05,-0.22287,-0.2445,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.011326,-0.22309,-0.29545,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.046579,-0.2238,-0.16822,1,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.017137,-0.22444,-0.21637,1,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.508e-06,-0.22459,-0.26358,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.016734,-0.22463,-0.21877,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.012203,-0.2247,-0.24322,1,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0038387,-0.2247,-0.22273,1,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00021167,-0.22558,-0.22814,1,0
3,GO REGULATION OF CENTROSOME DUPLICATION,9.0179e-06,-0.22561,-0.22652,1,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00084609,-0.22566,-0.24754,1,0
3,GO MEMBRANE RAFT ORGANIZATION,0.015203,-0.22589,-0.30842,1,0
3,GO AUTOPHAGOSOME MATURATION,8.3127e-06,-0.22632,-0.24604,1,0
3,GO AMYLOID BETA CLEARANCE,0.00098941,-0.22633,-0.22719,1,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,3.5759e-05,-0.22635,-0.21966,1,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.8583e-05,-0.22652,-0.25966,1,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00011241,-0.22664,-0.19871,1,0
3,GO PANCREAS DEVELOPMENT,0.00079435,-0.22667,-0.21684,1,0
3,GO ICOSANOID METABOLIC PROCESS,4.8612e-06,-0.22668,-0.29497,1,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.011326,-0.2269,-0.28724,1,0
3,GO HAIR CELL DIFFERENTIATION,0.00067758,-0.22705,-0.30225,1,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00018427,-0.22775,-0.31642,1,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.034637,-0.22817,-0.22697,1,0
3,GO EOSINOPHIL CHEMOTAXIS,0.015574,-0.22819,-0.32833,1,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.011047,-0.22869,-0.19893,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION,1.349e-05,-0.22914,-0.21975,1,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0025083,-0.22917,-0.21106,1,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00019079,-0.22951,-0.28921,1,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00013433,-0.22958,-0.24524,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00018427,-0.22973,-0.26764,1,0
3,GO INTERFERON BETA PRODUCTION,7.8282e-05,-0.22975,-0.2223,1,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.0011199,-0.23004,-0.21837,1,0
3,GO SPERM CAPACITATION,0.00035231,-0.23005,-0.20641,1,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0014299,-0.23007,-0.22609,1,0
3,GO TISSUE REMODELING,0.00045924,-0.23097,-0.22321,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8282e-05,-0.23157,-0.25202,1,0
3,GO ESTROUS CYCLE,0.0071468,-0.23163,-0.24358,1,0
3,GO T CELL MEDIATED IMMUNITY,0.00022676,-0.23181,-0.28114,1,0
3,GO LIVER MORPHOGENESIS,0.0060989,-0.23202,-0.26133,1,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.001872,-0.23253,-0.22796,1,0
3,GO SMOOTH MUSCLE CELL MIGRATION,6.5149e-05,-0.23294,-0.30385,1,0
3,GO PLACENTA DEVELOPMENT,5.2837e-06,-0.23308,-0.24538,1,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.011612,-0.23334,-0.22078,1,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.05161,-0.23341,-0.20904,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.4346e-05,-0.23393,-0.25058,1,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.02268,-0.23406,-0.20338,1,0
3,GO REGULATION OF COAGULATION,0.00042998,-0.23454,-0.28661,1,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0018173,-0.23487,-0.22772,1,0
3,GO GLOMERULUS DEVELOPMENT,0.00040247,-0.23508,-0.27223,1,0
3,GO PIGMENT ACCUMULATION,0.00069957,-0.23533,-0.24213,1,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00011241,-0.23554,-0.26285,1,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0020453,-0.23597,-0.2163,1,0
3,GO REGULATION OF RESPONSE TO WOUNDING,0.00016595,-0.2363,-0.24885,1,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.0032441,-0.23642,-0.22832,1,0
3,GO SKELETAL MUSCLE ADAPTATION,0.04854,-0.23652,-0.1312,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.011326,-0.23688,-0.29969,1,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00084609,-0.23692,-0.31663,1,0
3,GO RESPONSE TO LEPTIN,0.014841,-0.23696,-0.21683,1,0
3,GO BILE ACID METABOLIC PROCESS,0.0001547,-0.23739,-0.24479,1,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0040578,-0.23753,-0.29836,1,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0099891,-0.23757,-0.19277,1,0
3,GO MULTIVESICULAR BODY ORGANIZATION,1.0311e-06,-0.23775,-0.24534,1,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.029068,-0.23779,-0.17505,1,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.6455e-05,-0.23804,-0.24279,1,0
3,GO REGULATION OF BONE REMODELING,0.0059384,-0.23806,-0.20804,1,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.013798,-0.23846,-0.24683,1,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0011549,-0.2385,-0.23034,1,0
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0016129,-0.23864,-0.21939,1,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0024367,-0.2387,-0.29907,1,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.6584e-06,-0.23954,-0.27036,1,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.03245,-0.23999,-0.22587,1,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.001191,-0.24059,-0.28135,1,0
3,GO REGULATION OF VIRAL LIFE CYCLE,9.3916e-06,-0.24069,-0.31282,1,0
3,GO RUFFLE ORGANIZATION,5.753e-07,-0.2416,-0.25942,1,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0066042,-0.24254,-0.23492,1,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00023468,-0.24255,-0.22243,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.007729,-0.24275,-0.27836,1,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,5.2139e-05,-0.24295,-0.32085,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,1.8521e-05,-0.24306,-0.24897,1,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.4421e-05,-0.24328,-0.26399,1,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00044439,-0.24388,-0.23842,1,0
3,GO REGULATION OF RECEPTOR BINDING,0.0051916,-0.24406,-0.24122,1,0
3,GO CELL CELL JUNCTION ORGANIZATION,3.4728e-06,-0.24465,-0.27055,1,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0047853,-0.24528,-0.28865,1,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00049035,-0.24546,-0.21638,1,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.017549,-0.24561,-0.25071,1,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00081984,-0.24588,-0.26629,1,0
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0053338,-0.24622,-0.29305,1,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0031536,-0.24657,-0.19922,1,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00069957,-0.2476,-0.32612,1,0
3,GO RUFFLE ASSEMBLY,7.889e-07,-0.24772,-0.25036,1,0
3,GO MAGNESIUM ION TRANSPORT,5.7413e-06,-0.24806,-0.30052,1,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00011241,-0.24842,-0.29403,1,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00032948,-0.24865,-0.22503,1,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0013457,-0.24887,-0.22264,1,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.00092958,-0.24896,-0.26571,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.016734,-0.24956,-0.38989,1,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00018427,-0.24982,-0.23766,1,0
3,GO INTERLEUKIN 6 PRODUCTION,1.0311e-06,-0.24986,-0.25164,1,0
3,GO SKIN DEVELOPMENT,3.1888e-05,-0.25008,-0.24267,1,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.014486,-0.25132,-0.20024,1,0
3,GO INTERLEUKIN 8 PRODUCTION,3.4421e-05,-0.25161,-0.26375,1,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0067808,-0.25167,-0.24715,1,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00050664,-0.25182,-0.21858,1,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.040234,-0.25236,-0.22468,1,0
3,GO REGULATION OF EXOSOMAL SECRETION,5.7413e-06,-0.25266,-0.30234,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00016023,-0.25312,-0.30547,1,0
3,GO EOSINOPHIL MIGRATION,0.0039469,-0.25314,-0.33673,1,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.040234,-0.25318,-0.31809,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.031748,-0.2535,-0.21394,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,8.2505e-07,-0.25363,-0.32642,1,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.03245,-0.25371,-0.31817,1,0
3,GO REGULATION OF SPINDLE ASSEMBLY,7.3528e-06,-0.25391,-0.26491,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,4.8379e-05,-0.25406,-0.28955,1,0
3,GO EPIDERMIS DEVELOPMENT,2.2524e-05,-0.2541,-0.2431,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00041602,-0.25555,-0.29162,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0038387,-0.25562,-0.29218,1,0
3,GO SPINAL CORD PATTERNING,0.0087944,-0.25563,-0.24283,1,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0015189,-0.25565,-0.26237,1,0
3,GO BIOLOGICAL PHASE,0.033166,-0.2559,-0.32727,1,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.054842,-0.25594,-0.24168,1,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00036427,-0.25617,-0.26599,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0045306,-0.25629,-0.38517,1,0
3,GO EMBRYONIC HEMOPOIESIS,0.001228,-0.2566,-0.21903,1,0
3,GO GERMINAL CENTER FORMATION,0.017969,-0.25681,-0.28634,1,0
3,GO TRANSCYTOSIS,6.7596e-05,-0.25794,-0.24346,1,0
3,GO VIRAL RELEASE FROM HOST CELL,4.5813e-07,-0.25822,-0.27857,1,0
3,GO T CELL SELECTION,0.0025817,-0.25841,-0.17252,1,0
3,GO BROWN FAT CELL DIFFERENTIATION,5.0226e-05,-0.25842,-0.31036,1,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0016129,-0.25925,-0.26186,1,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.5331e-06,-0.25932,-0.29812,1,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.016734,-0.26101,-0.26029,1,0
3,GO NECROTIC CELL DEATH,0.00069957,-0.26175,-0.24807,1,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0007696,-0.2618,-0.30188,1,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00013917,-0.26277,-0.25581,1,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,7.013e-05,-0.26277,-0.25226,1,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,4.4712e-06,-0.26339,-0.28481,1,0
3,GO ER OVERLOAD RESPONSE,0.033166,-0.26405,-0.20384,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042998,-0.26408,-0.32444,1,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00012074,-0.26412,-0.24638,1,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.012203,-0.26518,-0.2249,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.26547,-0.32186,1,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.015574,-0.26558,-0.25503,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0010528,-0.26567,-0.28976,1,0
3,GO WATER HOMEOSTASIS,0.0010859,-0.2666,-0.24307,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0030654,-0.26752,-0.26249,1,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.00087311,-0.26765,-0.27725,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0099891,-0.26796,-0.43197,1,0
3,GO REGULATION OF WOUND HEALING,6.5149e-05,-0.26837,-0.28992,1,0
3,GO INTERLEUKIN 10 PRODUCTION,1.1964e-05,-0.26843,-0.2883,1,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.029719,-0.26862,-0.19443,1,0
3,GO ENDOCARDIUM DEVELOPMENT,0.018398,-0.2693,-0.2307,1,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.0006154,-0.26939,-0.31114,1,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0017123,-0.26948,-0.25984,1,0
3,GO INTERLEUKIN 13 PRODUCTION,0.0059384,-0.26991,-0.26897,1,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.27,-0.25704,1,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0046564,-0.27219,-0.35907,1,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.00050664,-0.2724,-0.26348,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0018173,-0.27289,-0.32491,1,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.036164,-0.2733,-0.22995,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.0576e-06,-0.27331,-0.32003,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.00036427,-0.27386,-0.27448,1,0
3,GO SIGNAL PEPTIDE PROCESSING,6.2786e-05,-0.27455,-0.35918,1,0
3,GO CELL CELL JUNCTION ASSEMBLY,1.8251e-06,-0.2747,-0.28631,1,0
3,GO GDP METABOLIC PROCESS,0.0099891,-0.27545,-0.23466,1,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.2533e-07,-0.27599,-0.30411,1,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0060989,-0.27599,-0.27453,1,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.043763,-0.2761,-0.25581,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.1112e-06,-0.27697,-0.2946,1,0
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.019739,-0.27818,-0.22433,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.9532e-05,-0.27823,-0.2547,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,6.2367e-06,-0.27843,-0.31747,1,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.02068,-0.2801,-0.36336,1,0
3,GO REGULATION OF PLATELET ACTIVATION,6.0504e-05,-0.28027,-0.3648,1,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0010528,-0.28029,-0.33755,1,0
3,GO INTERLEUKIN 5 PRODUCTION,0.011047,-0.28092,-0.21074,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00072223,-0.28173,-0.30843,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.7145e-05,-0.2822,-0.29097,1,0
3,GO ACTIN FILAMENT SEVERING,0.0047853,-0.2824,-0.31525,1,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,1.4674e-06,-0.28415,-0.31777,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,6.7596e-05,-0.28487,-0.29067,1,0
3,GO CELLULAR RESPONSE TO ALKALOID,0.00014418,-0.2852,-0.26135,1,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00019079,-0.28537,-0.35242,1,0
3,GO DENDRITIC CELL DIFFERENTIATION,2.7343e-05,-0.28633,-0.34976,1,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.041967,-0.28645,-0.22356,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0075304,-0.28692,-0.30594,1,0
3,GO EXTRACELLULAR TRANSPORT,1.104e-05,-0.28703,-0.35817,1,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026903,-0.28802,-0.26272,1,0
3,GO INTERLEUKIN 1 PRODUCTION,2.2658e-06,-0.2884,-0.34316,1,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0024367,-0.28859,-0.21119,1,0
3,GO PLATELET AGGREGATION,2.6307e-05,-0.28918,-0.28722,1,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.1702e-06,-0.28972,-0.2868,1,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00019079,-0.28997,-0.36913,1,0
3,GO POSITIVE REGULATION OF CELL SIZE,0.00012512,-0.29019,-0.33138,1,0
3,GO MUSCLE CELL MIGRATION,5.0226e-05,-0.29145,-0.2889,1,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00013433,-0.29179,-0.3439,1,0
3,GO INTESTINAL ABSORPTION,0.00014935,-0.29193,-0.32136,1,0
3,GO OLIGOPEPTIDE TRANSPORT,0.0013872,-0.29235,-0.36432,1,0
3,GO REGULATION OF INTEGRIN ACTIVATION,0.00010462,-0.29321,-0.32558,1,0
3,GO HOMOTYPIC CELL CELL ADHESION,4.1617e-05,-0.29375,-0.31832,1,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.018836,-0.29395,-0.20767,1,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.027803,-0.29423,-0.30208,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00067758,-0.29434,-0.31884,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,7.0571e-06,-0.29463,-0.30316,1,0
3,GO SPLEEN DEVELOPMENT,1.4044e-06,-0.29584,-0.28265,1,0
3,GO OSTEOBLAST PROLIFERATION,0.00010462,-0.29629,-0.3177,1,0
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,9.0179e-06,-0.29686,-0.29205,1,0
3,GO DECIDUALIZATION,0.0038387,-0.29723,-0.29606,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.9904e-06,-0.29804,-0.33319,1,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00038934,-0.2983,-0.32016,1,0
3,GO ANOIKIS,1.104e-05,-0.29847,-0.32652,1,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.020205,-0.29852,-0.27063,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00054072,-0.29897,-0.33388,1,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.019283,-0.29926,-0.345,1,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.023205,-0.29949,-0.23421,1,0
3,GO T HELPER CELL LINEAGE COMMITMENT,4.8379e-05,-0.30004,-0.27867,1,0
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0075304,-0.30162,-0.26013,1,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0028957,-0.3024,-0.25799,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.0184e-05,-0.30264,-0.28678,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0054795,-0.30381,-0.29111,1,0
3,GO ALPHA BETA T CELL PROLIFERATION,1.7806e-05,-0.30409,-0.34839,1,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0059384,-0.30429,-0.41633,1,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00042998,-0.30511,-0.32144,1,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.02843,-0.30537,-0.18731,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.9926e-07,-0.3054,-0.31235,1,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.017137,-0.30542,-0.47191,1,0
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00037661,-0.30585,-0.29082,1,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0079323,-0.30608,-0.25945,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.7145e-05,-0.30622,-0.36877,1,0
3,GO AXONEME ASSEMBLY,3.1888e-05,-0.30878,-0.31671,1,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.3132e-05,-0.30958,-0.33903,1,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0087944,-0.31152,-0.43355,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.0504e-05,-0.31164,-0.4274,1,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,6.2367e-06,-0.31241,-0.29558,1,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.00010092,-0.31387,-0.41922,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.00052342,-0.31439,-0.28122,1,0
3,GO IMMATURE B CELL DIFFERENTIATION,0.0019282,-0.31535,-0.23545,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,9.7801e-06,-0.316,-0.30444,1,0
3,GO T CELL LINEAGE COMMITMENT,3.7145e-05,-0.31675,-0.28651,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010528,-0.31782,-0.3985,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.014138,-0.31831,-0.24614,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.2754e-05,-0.3189,-0.30745,1,0
3,GO NATURAL KILLER CELL PROLIFERATION,0.00022676,-0.31933,-0.35296,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00012512,-0.31948,-0.27264,1,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,9.7346e-05,-0.32053,-0.26301,1,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,2.5774e-06,-0.32067,-0.35368,1,0
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00013433,-0.32067,-0.4067,1,0
3,GO ETHER METABOLIC PROCESS,0.00024286,-0.32158,-0.3238,1,0
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0081404,-0.32171,-0.29305,1,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.00013433,-0.32177,-0.30842,1,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00010092,-0.32231,-0.41032,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.00022676,-0.32293,-0.31857,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,-0.32306,-0.3267,1,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0053338,-0.32368,-0.23044,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00087311,-0.32478,-0.33323,1,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,2.4346e-05,-0.32514,-0.37414,1,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.17e-07,-0.32574,-0.36739,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.906e-06,-0.32644,-0.35873,1,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,9.0551e-05,-0.32649,-0.49659,1,0
3,GO LIPOXYGENASE PATHWAY,0.0015653,-0.32839,-0.35137,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0062634,-0.32858,-0.25416,1,0
3,GO LEFT RIGHT PATTERN FORMATION,0.00012964,-0.32909,-0.30426,1,0
3,GO KERATINOCYTE DEVELOPMENT,0.025414,-0.33042,-0.28399,1,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.031059,-0.33255,-0.23364,1,0
3,GO BILE ACID AND BILE SALT TRANSPORT,3.5759e-05,-0.33346,-0.36409,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,9.3916e-06,-0.33422,-0.36738,1,0
3,GO PROGESTERONE METABOLIC PROCESS,0.00044439,-0.3345,-0.46742,1,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,7.3528e-06,-0.33772,-0.40042,1,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00063551,-0.33785,-0.39231,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.8301e-05,-0.33818,-0.3144,1,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.4044e-06,-0.33845,-0.33214,1,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0010206,-0.33953,-0.36921,1,0
3,GO SUPEROXIDE ANION GENERATION,0.00017186,-0.34021,-0.32774,1,0
3,GO TRANSPOSITION,1.7118e-05,-0.34022,-0.41665,1,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0019282,-0.34024,-0.27362,1,0
3,GO ZYMOGEN INHIBITION,0.00018427,-0.34126,-0.40275,1,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00054072,-0.3422,-0.34746,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.0024367,-0.34261,-0.46016,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,4.3218e-05,-0.34314,-0.35544,1,0
3,GO PROSTANOID METABOLIC PROCESS,2.3418e-05,-0.34391,-0.43093,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.017969,-0.34458,-0.29141,1,0
3,GO DETECTION OF OTHER ORGANISM,4.3218e-05,-0.34508,-0.39188,1,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,8.1192e-05,-0.34512,-0.34359,1,0
3,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.0069616,-0.34711,-0.41594,1,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,6.7596e-05,-0.34729,-0.42145,1,0
3,GO LIPID TRANSLOCATION,1.8251e-06,-0.34769,-0.32187,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,8.1192e-05,-0.34789,-0.33195,1,0
3,GO EPIDERMAL CELL DIFFERENTIATION,9.7801e-06,-0.34994,-0.32441,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0031536,-0.3503,-0.31511,1,0
3,GO HISTAMINE SECRETION,0.004408,-0.35224,-0.34449,1,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00010462,-0.35389,-0.41795,1,0
3,GO MITOTIC CYTOKINETIC PROCESS,5.1671e-08,-0.35462,-0.38135,1,0
3,GO KERATINOCYTE DIFFERENTIATION,1.104e-05,-0.35542,-0.33714,1,0
3,GO GONADOTROPIN SECRETION,0.00055855,-0.35713,-0.35836,1,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0021062,-0.35735,-0.34442,1,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.8891e-07,-0.35749,-0.37725,1,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.35752,-0.4848,1,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,7.2754e-05,-0.35926,-0.38583,1,0
3,GO PROTEIN ADP RIBOSYLATION,1.1493e-05,-0.35936,-0.31088,1,0
3,GO POSITIVE REGULATION OF COAGULATION,2.8077e-06,-0.35968,-0.36426,1,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.0039469,-0.35989,-0.27633,1,0
3,GO VIRAL BUDDING,4.1802e-07,-0.36018,-0.30959,1,0
3,GO REGULATION OF ANOIKIS,3.5759e-05,-0.36079,-0.41494,1,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0014299,-0.36235,-0.41913,1,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0021062,-0.36436,-0.37608,1,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00016595,-0.36442,-0.39438,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0079323,-0.36585,-0.46838,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,5.4977e-07,-0.36655,-0.37184,1,0
3,GO HEPATOCYTE DIFFERENTIATION,0.00072223,-0.36744,-0.33667,1,0
3,GO MOTILE CILIUM ASSEMBLY,0.00059588,-0.36813,-0.30731,1,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,4.0073e-05,-0.36865,-0.39858,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0021062,-0.36881,-0.41526,1,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0025083,-0.36907,-0.34298,1,0
3,GO RESPONSE TO INTERFERON BETA,0.0015189,-0.36925,-0.47942,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.2837e-06,-0.36938,-0.38245,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00016595,-0.3702,-0.37092,1,0
3,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0099891,-0.37217,-0.32764,1,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,7.3528e-06,-0.37291,-0.4365,1,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00027832,-0.37409,-0.36678,1,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.6455e-05,-0.37503,-0.39173,1,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.0010528,-0.37541,-0.29342,1,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,2.9532e-05,-0.37623,-0.38386,1,0
3,GO GAP JUNCTION ASSEMBLY,3.8583e-05,-0.37954,-0.47572,1,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.4039e-05,-0.37995,-0.37162,1,0
3,GO MEGAKARYOCYTE DEVELOPMENT,0.00028792,-0.38116,-0.38153,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.9263e-05,-0.3813,-0.36927,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,3.3132e-05,-0.38141,-0.47901,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0014738,-0.38151,-0.48088,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.5201e-05,-0.3827,-0.38461,1,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0017641,-0.38506,-0.33924,1,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00017186,-0.38724,-0.38847,1,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.2879e-07,-0.38762,-0.46097,1,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0059384,-0.3883,-0.31908,1,0
3,GO POSITIVE REGULATION OF CELL MATURATION,7.8282e-05,-0.38891,-0.42751,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,6.0504e-05,-0.38909,-0.49545,1,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00092958,-0.39007,-0.34123,1,0
3,GO INTERFERON ALPHA PRODUCTION,9.4334e-07,-0.39028,-0.38184,1,0
3,GO TOXIN METABOLIC PROCESS,0.010506,-0.39189,-0.28136,1,0
3,GO DNA DEAMINATION,0.001191,-0.39408,-0.37956,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.5816e-05,-0.3966,-0.39359,1,0
3,GO RESPONSE TO TYPE I INTERFERON,1.5816e-05,-0.3972,-0.51811,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.0194e-07,-0.40082,-0.44143,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,3.0689e-05,-0.40384,-0.38688,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,2.5774e-06,-0.40399,-0.41128,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.3287e-06,-0.40454,-0.44126,1,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.038561,-0.40676,-0.32394,1,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.00040247,-0.4106,-0.35141,1,0
3,GO GLIAL CELL FATE COMMITMENT,0.0079323,-0.41107,-0.33351,1,0
3,GO VASCULAR TRANSPORT,0.00032948,-0.41351,-0.43145,1,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,4.6623e-06,-0.41442,-0.5307,1,0
3,GO REGULATION OF PLATELET AGGREGATION,7.8282e-05,-0.41461,-0.4927,1,0
3,GO REGULATION OF TRANSPOSITION,7.9801e-06,-0.4174,-0.47822,1,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.1888e-05,-0.41765,-0.35528,1,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,2.2879e-07,-0.41917,-0.37594,1,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0025817,-0.41948,-0.3296,1,0
3,GO TOLERANCE INDUCTION,0.00035231,-0.41976,-0.4532,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.4994e-06,-0.42159,-0.52534,1,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,6.2786e-05,-0.42252,-0.46546,1,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0085714,-0.42279,-0.3354,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.6015e-06,-0.4252,-0.49017,1,0
3,GO KERATINIZATION,2.7343e-05,-0.42753,-0.36981,1,0
3,GO POSITIVE REGULATION OF WOUND HEALING,5.2533e-07,-0.42842,-0.47284,1,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,3.7145e-05,-0.4294,-0.39364,1,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012512,-0.43125,-0.3942,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,8.1192e-05,-0.4321,-0.41443,1,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.2366e-07,-0.43419,-0.49423,1,0
3,GO ADENOHYPOPHYSIS DEVELOPMENT,0.04854,-0.43791,-0.27687,1,0
3,GO GLIAL CELL APOPTOTIC PROCESS,0.00017796,-0.43898,-0.42635,1,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0019282,-0.43953,-0.34183,1,0
3,GO LEYDIG CELL DIFFERENTIATION,0.001986,-0.44113,-0.40441,1,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00074557,-0.44239,-0.4068,1,0
3,GO REGULATION OF TOLERANCE INDUCTION,2.6902e-06,-0.44317,-0.50979,1,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.4268e-07,-0.44578,-0.45789,1,0
3,GO RESPONSE TO INTERLEUKIN 18,0.00017796,-0.44644,-0.5171,1,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,6.7728e-06,-0.44842,-0.39402,1,0
3,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012662,-0.45043,-0.52504,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.7801e-06,-0.45496,-0.55607,1,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00042998,-0.45839,-0.45926,1,0
3,GO CORNIFICATION,3.5759e-05,-0.45883,-0.41776,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.0226e-05,-0.45926,-0.63387,1,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,7.2754e-05,-0.46042,-0.40321,1,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,5.7413e-06,-0.46129,-0.46877,1,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,1.2962e-05,-0.46211,-0.39934,1,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00017186,-0.46555,-0.43602,1,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00065623,-0.46852,-0.37734,1,0
3,GO RESPONSE TO WATER,6.7596e-05,-0.46905,-0.42596,1,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0013872,-0.4696,-0.39297,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0833e-05,-0.47305,-0.4793,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.508e-06,-0.47602,-0.47528,1,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.00036427,-0.48016,-0.39339,1,0
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,1.1964e-05,-0.48384,-0.45744,1,0
3,GO MIDBODY ABSCISSION,1.5691e-07,-0.48641,-0.48507,1,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.9418e-06,-0.49691,-0.52259,1,0
3,GO RESPONSE TO LITHIUM ION,3.7145e-05,-0.49709,-0.47986,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00095906,-0.50367,-0.36502,1,0
3,GO RESPONSE TO FORSKOLIN,4.2876e-06,-0.50527,-0.46257,1,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,9.3916e-06,-0.50832,-0.45937,1,0
3,GO SEROTONIN METABOLIC PROCESS,0.011326,-0.50881,-0.31563,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,2.4692e-06,-0.51142,-0.47635,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00050664,-0.52989,-0.49198,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.6597e-05,-0.5309,-0.47422,1,0
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0045306,-0.53873,-0.35833,1,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.00024286,-0.54336,-0.47666,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,5.2837e-06,-0.55036,-0.52776,1,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,2.2524e-05,-0.55124,-0.4387,1,0
3,GO EPITHELIAL CELL MORPHOGENESIS,4.1112e-06,-0.5572,-0.53601,1,0
3,GO APICAL JUNCTION ASSEMBLY,4.9191e-08,-0.56098,-0.52845,1,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00021909,-0.56212,-0.45463,1,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00016595,-0.56502,-0.52614,1,0
3,GO REGULATION OF WATER LOSS VIA SKIN,0.00032948,-0.57307,-0.47633,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.4712e-06,-0.57605,-0.58621,1,0
3,GO NEGATIVE REGULATION OF ANOIKIS,2.8077e-06,-0.57759,-0.60574,1,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,2.3418e-05,-0.57882,-0.57934,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00049035,-0.5793,-0.43966,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.389e-05,-0.58673,-0.52029,1,0
3,GO PSEUDOPODIUM ORGANIZATION,0.00020448,-0.5905,-0.44339,1,0
3,GO GAMMA DELTA T CELL ACTIVATION,1.4044e-06,-0.59862,-0.56138,1,0
3,GO MUCUS SECRETION,0.00084609,-0.60014,-0.52376,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,2.1702e-06,-0.61866,-0.60316,1,0
3,GO CYTIDINE TO URIDINE EDITING,0.0001165,-0.61921,-0.65655,1,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0025817,-0.63422,-0.53362,1,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,6.4994e-06,-0.63775,-0.59594,1,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.3218e-05,-0.64222,-0.63275,1,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,7.2754e-05,-0.64706,-0.7541,1,0
3,GO LUNG CELL DIFFERENTIATION,0.00012074,-0.65646,-0.51701,1,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,8.3127e-06,-0.66246,-0.65678,1,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,9.4334e-07,-0.67958,-0.63089,1,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,7.6603e-06,-0.72682,-0.57253,1,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.6322e-07,-0.74931,-0.65572,1,0
3,GO EPITHELIAL CELL CELL ADHESION,1.5691e-07,-0.7504,-0.79986,1,0
3,GO LIPID DROPLET FORMATION,7.3528e-06,-0.767,-0.68572,1,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,3.1904e-06,-0.77652,-0.71411,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,6.0504e-05,-0.8094,-0.88752,1,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.8891e-07,-0.92382,-0.82664,1,0
3,GO NOSE DEVELOPMENT,0.0001547,-0.96706,-0.65925,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,5.0194e-07,-0.96787,-0.81736,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,7.8282e-05,-0.99536,-1.0952,1,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,1.8084e-07,-0.99605,-1.0676,1,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,3.0264e-07,-1.0047,-0.89157,1,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.2308e-06,-1.1075,-0.9977,1,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.14048,0.3332,0.13527,0,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.079444,0.32819,0.20651,0,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.060602,0.30348,0.18271,0,1
3,GO TOOTH MINERALIZATION,0.075049,0.29597,0.14282,0,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.10465,0.27498,0.12566,0,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.079444,0.23858,0.17847,0,1
3,GO THALAMUS DEVELOPMENT,0.42347,0.211,0.095315,0,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.05824,0.2088,0.19463,0,1
3,GO AMP METABOLIC PROCESS,0.14769,0.19832,0.097326,0,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.14285,0.19643,0.11303,0,1
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.10654,0.19335,0.18023,0,1
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.30402,0.18828,0.071766,0,1
3,GO NEURAL CREST CELL MIGRATION,0.064293,0.18719,0.12956,0,1
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.2839,0.18712,0.13208,0,1
3,GO COCHLEA MORPHOGENESIS,0.070855,0.185,0.11256,0,1
3,GO RESPONSE TO VITAMIN A,0.15015,0.18388,0.10886,0,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.12908,0.18381,0.11776,0,1
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0695,0.18298,0.16604,0,1
3,GO DETECTION OF TEMPERATURE STIMULUS,0.15264,0.18144,0.16619,0,1
3,GO MIDDLE EAR MORPHOGENESIS,0.41341,0.17478,0.035279,0,1
3,GO BASIC AMINO ACID TRANSPORT,0.13583,0.17471,0.16587,0,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.092194,0.1745,0.11047,0,1
3,GO PROSTATE GLAND GROWTH,0.17099,0.17216,0.068806,0,1
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.51459,0.17098,0.078423,0,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.20937,0.16977,0.091043,0,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.099158,0.1652,0.11653,0,1
3,GO POST ANAL TAIL MORPHOGENESIS,0.13583,0.16295,0.09286,0,1
3,GO ODONTOGENESIS,0.13814,0.16051,0.075846,0,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.061812,0.15431,0.10314,0,1
3,GO NUCLEUS LOCALIZATION,0.082489,0.15271,0.095375,0,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.072231,0.14838,0.1029,0,1
3,GO BONE MORPHOGENESIS,0.10654,0.1475,0.072442,0,1
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.26098,0.14593,0.088138,0,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.11235,0.13913,0.10017,0,1
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.26471,0.13871,0.055067,0,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.097379,0.13833,0.14589,0,1
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.10096,0.13825,0.077172,0,1
3,GO MESODERMAL CELL FATE COMMITMENT,0.28785,0.13813,0.055579,0,1
3,GO PARENTAL BEHAVIOR,0.27611,0.13494,0.093322,0,1
3,GO T CELL HOMEOSTASIS,0.12689,0.13464,0.053061,0,1
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.064293,0.1315,0.14118,0,1
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.075049,0.12975,0.11657,0,1
3,GO AORTIC VALVE DEVELOPMENT,0.18508,0.12903,0.083409,0,1
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.52594,0.12846,0.04104,0,1
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.13583,0.12709,0.104,0,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.12908,0.1266,0.11207,0,1
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.057089,0.12452,0.17914,0,1
3,GO SMOOTH MUSCLE CONTRACTION,0.11636,0.12434,0.063471,0,1
3,GO NEUROBLAST PROLIFERATION,0.14048,0.12256,0.087126,0,1
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.093897,0.12094,0.068757,0,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.19695,0.12009,0.063184,0,1
3,GO LYMPH VESSEL DEVELOPMENT,0.14769,0.11937,0.073455,0,1
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.16294,0.11889,0.09017,0,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.070855,0.11661,0.15768,0,1
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.066855,0.11658,0.080127,0,1
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.30402,0.11099,0.064195,0,1
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.25001,0.11002,0.084059,0,1
3,GO SLEEP,0.29184,0.10954,0.05629,0,1
3,GO HEART VALVE DEVELOPMENT,0.27227,0.10804,0.063939,0,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.21905,0.1076,0.065025,0,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.26847,0.10608,0.07133,0,1
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.59059,0.10414,0.032692,0,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.075049,0.10372,0.095769,0,1
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17099,0.10112,0.059583,0,1
3,GO RESPONSE TO LEAD ION,0.2,0.099167,0.066486,0,1
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.70355,0.098621,0.01751,0,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.10654,0.096015,0.079689,0,1
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.068167,0.09548,0.080124,0,1
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.05824,0.095351,0.080819,0,1
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.070855,0.095187,0.082986,0,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.070855,0.093583,0.11512,0,1
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.44402,0.093148,0.037235,0,1
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.072231,0.09215,0.069895,0,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.095625,0.091975,0.14316,0,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.12908,0.091841,0.068493,0,1
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.27999,0.091737,0.027537,0,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.073629,0.090744,0.0655,0,1
3,GO RRNA 3 END PROCESSING,0.1313,0.090271,0.099363,0,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.15264,0.089392,0.1084,0,1
3,GO RNA STABILIZATION,0.13583,0.088143,0.071223,0,1
3,GO CELLULAR RESPONSE TO UV,0.090515,0.086893,0.060283,0,1
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.30815,0.085366,0.044127,0,1
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.075049,0.084777,0.056319,0,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.38408,0.084446,0.047501,0,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.29184,0.083715,0.0484,0,1
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.11434,0.082719,0.083548,0,1
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.32077,0.080729,0.029259,0,1
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.3746,0.078174,0.024524,0,1
3,GO MITOTIC CHROMOSOME CONDENSATION,0.084046,0.078058,0.085615,0,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.082489,0.076793,0.056017,0,1
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.55487,0.076436,0.026264,0,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.17653,0.075733,0.040967,0,1
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.77618,0.074206,-0.012709,0,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.068167,0.073734,0.06478,0,1
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.60272,0.070872,0.029586,0,1
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.37932,0.069578,0.054866,0,1
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.12908,0.069332,0.057547,0,1
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.059411,0.068576,0.062462,0,1
3,GO MITOCHONDRIAL FISSION,0.17934,0.066962,0.067096,0,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.092194,0.066661,0.065468,0,1
3,GO RECOMBINATIONAL REPAIR,0.084046,0.066379,0.049275,0,1
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.060602,0.065935,0.06487,0,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.063042,0.064006,0.038941,0,1
3,GO EMBRYONIC AXIS SPECIFICATION,0.42855,0.063734,0.056971,0,1
3,GO MISMATCH REPAIR,0.26098,0.061634,0.040266,0,1
3,GO RNA CAPPING,0.087232,0.061067,0.064207,0,1
3,GO PRENYLATION,0.43883,0.060469,0.026651,0,1
3,GO HISTONE DEUBIQUITINATION,0.22905,0.058474,0.029267,0,1
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.088862,0.057756,0.05304,0,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.56666,0.056407,0.022729,0,1
3,GO CHROMOSOME CONDENSATION,0.10465,0.056019,0.064779,0,1
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.25363,0.050937,0.02684,0,1
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.11434,0.050566,0.041946,0,1
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.15015,0.049344,0.041168,0,1
3,GO REGULATION OF HISTONE UBIQUITINATION,0.33373,0.048465,0.043883,0,1
3,GO MRNA TRANSPORT,0.095625,0.047191,0.05429,0,1
3,GO CHROMATIN SILENCING,0.46512,0.044804,0.026672,0,1
3,GO HISTONE METHYLATION,0.1028,0.044139,0.047003,0,1
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.14285,0.041947,0.040574,0,1
3,GO MITOCHONDRION ORGANIZATION,0.17653,0.038028,0.029368,0,1
3,GO DNA REPAIR,0.077957,0.037393,0.035463,0,1
3,GO REGULATION OF HISTONE METHYLATION,0.15773,0.036244,0.048961,0,1
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.17099,0.0333,0.029814,0,1
3,GO DNA CONFORMATION CHANGE,0.16032,0.032404,0.03942,0,1
3,GO DNA PACKAGING,0.33373,0.029913,0.028574,0,1
3,GO DNA REPLICATION,0.17653,0.028502,0.033985,0,1
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.16828,0.022592,0.024635,0,1
3,GO DNA RECOMBINATION,0.50896,0.020447,0.011395,0,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.3418e-05,0.58202,0.62154,0,0
3,GO DENSE CORE GRANULE TRANSPORT,0.00041602,0.57831,0.51559,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00059588,0.56333,0.5821,0,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.1617e-05,0.52422,0.50849,0,0
3,GO NEURON CELLULAR HOMEOSTASIS,1.5331e-06,0.49745,0.49407,0,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0047853,0.45378,0.36699,0,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.0551e-05,0.37466,0.4369,0,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00028792,0.37316,0.34224,0,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.00090094,0.36122,0.49279,0,0
3,GO PROTEIN TRIMERIZATION,0.00022676,0.3573,0.36141,0,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,0,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.013e-05,0.3558,0.41317,0,0
3,GO DENDRITIC SPINE MORPHOGENESIS,2.1663e-05,0.32993,0.32988,0,0
3,GO REGULATION OF NEURON MIGRATION,0.00036427,0.32467,0.28077,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0067808,0.32231,0.3593,0,0
3,GO NEUROTRANSMITTER REUPTAKE,0.00029782,0.31881,0.30582,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.027188,0.31677,0.24137,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0047853,0.3128,0.27844,0,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,0.30979,0.37234,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00017186,0.30909,0.303,0,0
3,GO REGULATION OF HIPPO SIGNALING,0.087232,0.30609,0.1616,0,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.21256,0.29727,0.11575,0,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.4878e-05,0.2951,0.38378,0,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.2876e-06,0.28722,0.38318,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0075304,0.28483,0.24571,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.015953,0.28339,0.195,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0027346,0.28208,0.29485,0,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.9263e-05,0.2812,0.29651,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,9.389e-05,0.27784,0.31439,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.029068,0.27701,0.172,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0064317,0.27528,0.21508,0,0
3,GO GLUTAMATE SECRETION,0.00029782,0.27482,0.30144,0,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00016023,0.27422,0.2883,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0010859,0.27257,0.30115,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.077957,0.2721,0.20978,0,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.012203,0.2705,0.32617,0,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,9.0551e-05,0.2694,0.31875,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.013465,0.26825,0.30375,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.019739,0.2609,0.27203,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.2,0.25982,0.18244,0,0
3,GO MITOCHONDRION LOCALIZATION,3.4421e-05,0.24872,0.21481,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.11235,0.2487,0.20634,0,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.00035231,0.24686,0.23419,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0015653,0.2416,0.24139,0,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,2.0033e-05,0.2415,0.25324,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0059384,0.24118,0.17636,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.0012662,0.23757,0.23734,0,0
3,GO RESPONSE TO HYPEROXIA,0.21905,0.23675,0.093777,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.033166,0.2364,0.23571,0,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,6.7596e-05,0.22515,0.29582,0,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.097379,0.22447,0.14673,0,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,3.1888e-05,0.22368,0.30447,0,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.0087944,0.2208,0.20689,0,0
3,GO ENAMEL MINERALIZATION,0.19393,0.22049,0.12673,0,0
3,GO CELLULAR RESPONSE TO PH,0.00013433,0.21743,0.2188,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.05824,0.21712,0.14067,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0027346,0.2165,0.26938,0,0
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.095625,0.21504,0.16926,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.033894,0.21116,0.18694,0,0
3,GO NEURON RECOGNITION,0.014841,0.21085,0.20202,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.097379,0.21014,0.1369,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.00016023,0.20566,0.23771,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.1028,0.20502,0.1412,0,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00044439,0.20471,0.21521,0,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0056288,0.20426,0.24748,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.036948,0.20256,0.14063,0,0
3,GO NEUROBLAST DIVISION,0.10465,0.20113,0.16202,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.0695,0.20112,0.27288,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.29586,0.20077,0.089066,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.3746,0.20026,0.1234,0,0
3,GO SEROTONIN TRANSPORT,0.092194,0.19987,0.13843,0,0
3,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.066855,0.19852,0.15497,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.12689,0.19843,0.1108,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0022332,0.1974,0.26312,0,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.064293,0.197,0.15482,0,0
3,GO CGMP MEDIATED SIGNALING,0.022165,0.19695,0.13884,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.15773,0.19313,0.1908,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.26471,0.19306,0.087065,0,0
3,GO DENDRITE SELF AVOIDANCE,0.041967,0.19194,0.1856,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00024286,0.19188,0.24956,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0006154,0.18942,0.15551,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.01282,0.18917,0.28102,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.31232,0.18914,0.10494,0,0
3,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,0,0
3,GO AXONAL FASCICULATION,0.066855,0.18785,0.20241,0,0
3,GO RESPONSE TO MANGANESE ION,0.095625,0.18754,0.10711,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.18219,0.18645,0.15957,0,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0013054,0.18509,0.20822,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.011047,0.18468,0.17127,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.25001,0.18443,0.067083,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.11434,0.18411,0.11316,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.013139,0.18303,0.13074,0,0
3,GO NEURON PROJECTION GUIDANCE,0.0056288,0.18235,0.16389,0,0
3,GO PRESYNAPSE ORGANIZATION,0.007729,0.18186,0.20793,0,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.030383,0.18146,0.16576,0,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.18508,0.18137,0.13887,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.12473,0.18122,0.10465,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.19095,0.1812,0.11729,0,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.065563,0.17947,0.11335,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.012203,0.17899,0.17322,0,0
3,GO NEUROTRANSMITTER TRANSPORT,0.00084609,0.17881,0.23235,0,0
3,GO NEURON PROJECTION EXTENSION,0.00065623,0.1778,0.17702,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.1313,0.17674,0.16827,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00069957,0.17671,0.2571,0,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0081404,0.17668,0.20275,0,0
3,GO ACIDIC AMINO ACID TRANSPORT,0.00014935,0.17661,0.21319,0,0
3,GO LONG TERM MEMORY,0.0041716,0.17645,0.19976,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.1313,0.17567,0.12315,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.092194,0.17496,0.12255,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0028957,0.17417,0.18703,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.21256,0.17362,0.047425,0,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.20309,0.17338,0.15988,0,0
3,GO RELAXATION OF MUSCLE,0.082489,0.17281,0.12867,0,0
3,GO LEUKOCYTE AGGREGATION,0.077957,0.17168,0.13519,0,0
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.077957,0.17053,0.092339,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.027803,0.17038,0.1883,0,0
3,GO MINERALOCORTICOID METABOLIC PROCESS,0.22905,0.17035,0.096224,0,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0011549,0.17007,0.27365,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00353,0.16997,0.15308,0,0
3,GO NEUROTRANSMITTER SECRETION,0.0013054,0.16961,0.24314,0,0
3,GO NADH METABOLIC PROCESS,0.0020453,0.16892,0.23118,0,0
3,GO HEME METABOLIC PROCESS,0.13814,0.16832,0.099533,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0073363,0.1681,0.19008,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.059411,0.16806,0.13846,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.092194,0.16715,0.09528,0,0
3,GO DENDRITIC TRANSPORT,0.010506,0.16695,0.24093,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.10654,0.163,0.088909,0,0
3,GO DENDRITE MORPHOGENESIS,0.0014738,0.16149,0.18245,0,0
3,GO RESPONSE TO AMINE,0.0094949,0.16148,0.17707,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.082489,0.16141,0.11853,0,0
3,GO RECEPTOR CLUSTERING,0.065563,0.16141,0.10745,0,0
3,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.12908,0.16023,0.13459,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.18508,0.16014,0.11315,0,0
3,GO RESPONSE TO PROTOZOAN,0.55487,0.15933,0.020455,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.11235,0.1591,0.15054,0,0
3,GO HEPARIN METABOLIC PROCESS,0.045624,0.15858,0.22973,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.015203,0.15686,0.17096,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.046579,0.15659,0.12563,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.033894,0.15562,0.12154,0,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.1313,0.15494,0.20744,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.060602,0.15474,0.11877,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.20937,0.15455,0.1298,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.30815,0.15376,0.0535,0,0
3,GO THYROID GLAND DEVELOPMENT,0.022165,0.15356,0.18117,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.13814,0.15332,0.096099,0,0
3,GO VASCULOGENESIS,0.32077,0.15279,0.034338,0,0
3,GO RESPONSE TO CAFFEINE,0.10096,0.15263,0.1189,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.029068,0.15185,0.30318,0,0
3,GO NERVE DEVELOPMENT,0.11841,0.15175,0.09633,0,0
3,GO DENDRITE DEVELOPMENT,0.00087311,0.15132,0.17742,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.010506,0.14997,0.14022,0,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15517,0.14983,0.13446,0,0
3,GO XENOBIOTIC TRANSPORT,0.23937,0.14962,0.036327,0,0
3,GO AXON EXTENSION,0.0028957,0.14933,0.15833,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.043763,0.14864,0.13656,0,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.044685,0.1478,0.14767,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.12908,0.14773,0.09882,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.68418,0.14644,0.042439,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.34702,0.14582,0.067119,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.12259,0.14555,0.1142,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.2839,0.14515,0.061047,0,0
3,GO FIBRINOLYSIS,0.27227,0.14489,-0.014555,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.084046,0.14438,0.14979,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.16294,0.14334,0.094518,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.20621,0.14262,0.15547,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.47588,0.14236,-0.15827,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.68418,0.14226,-0.019158,0,0
3,GO REGULATION OF AXON GUIDANCE,0.059411,0.14205,0.091043,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.18219,0.14187,0.077712,0,0
3,GO LIPID IMPORT INTO CELL,0.27999,0.14127,0.061506,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.24643,0.14089,0.051468,0,0
3,GO CELL AGGREGATION,0.073629,0.13892,0.10884,0,0
3,GO ALANINE TRANSPORT,0.14048,0.13877,0.13747,0,0
3,GO RESPONSE TO UV B,0.89215,0.13872,-0.044541,0,0
3,GO SYNAPTIC VESICLE RECYCLING,0.029719,0.13856,0.14167,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.060602,0.13743,0.11847,0,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.47049,0.13733,-0.044057,0,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0033369,0.13635,0.21006,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13583,0.13599,0.14502,0,0
3,GO STARTLE RESPONSE,0.22235,0.13404,0.12204,0,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.092194,0.1338,0.0909,0,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.18219,0.13362,0.096613,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.15773,0.13179,0.072583,0,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.0030654,0.13151,0.15901,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.11841,0.13124,0.05568,0,0
3,GO PROTEIN OXIDATION,0.12049,0.13088,0.072808,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.17374,0.13022,0.10472,0,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.034637,0.13006,0.14386,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.20621,0.12996,0.08712,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.085627,0.12959,0.12237,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.49227,0.12951,0.027337,0,0
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.27999,0.1293,0.10607,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.20937,0.12905,0.064557,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.54903,0.12856,0.062475,0,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0695,0.1279,0.11656,0,0
3,GO CATECHOLAMINE UPTAKE,0.16828,0.12781,0.13783,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0010528,0.12762,0.16732,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.27611,0.12734,0.10221,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.8303,0.1273,0.00708,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.077957,0.12711,0.08124,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.064293,0.12701,0.11209,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.077957,0.127,0.090624,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.23589,0.12658,0.067219,0,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.29184,0.12632,0.084081,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.20937,0.1263,0.14382,0,0
3,GO ENDODERM DEVELOPMENT,0.2839,0.12617,0.025249,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.099158,0.12532,0.16393,0,0
3,GO MEMORY,0.0067808,0.12525,0.13818,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.13355,0.12514,0.23131,0,0
3,GO REGULATION OF ODONTOGENESIS,0.40843,0.12506,0.031587,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.097379,0.12458,0.11837,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.070855,0.12428,0.11219,0,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.53167,0.12415,0.026669,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.10096,0.12406,0.11849,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.59059,0.12406,0.0070754,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.10654,0.12351,0.24502,0,0
3,GO REGULATION OF HEART RATE,0.10465,0.12348,0.095051,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.39858,0.12348,0.09055,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.11039,0.12311,0.08545,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.041093,0.12291,0.091021,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.11235,0.12275,0.11146,0,0
3,GO NEURAL CREST FORMATION,0.36991,0.12272,0.07721,0,0
3,GO CAMP METABOLIC PROCESS,0.31232,0.12264,0.054026,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.17099,0.12222,0.077015,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.34702,0.12148,0.1034,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.20937,0.12099,0.079371,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.070855,0.12077,0.10228,0,0
3,GO RESPONSE TO LIGHT INTENSITY,0.14769,0.12009,0.1245,0,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.014841,0.11988,0.19226,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.11938,0.12948,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.099158,0.11908,0.091544,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.12689,0.11897,0.11581,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.20937,0.11875,0.13745,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.188,0.11867,0.089562,0,0
3,GO MECHANOSENSORY BEHAVIOR,0.36526,0.1182,0.17894,0,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.10096,0.11796,0.079862,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.080955,0.1175,0.098141,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.23245,0.11711,0.078572,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.11235,0.11693,0.064552,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.014138,0.1168,0.11783,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.14285,0.11668,0.19877,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.44402,0.11647,0.034577,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.91987,0.11642,0.029245,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.14526,0.11641,0.08259,0,0
3,GO AXON DEVELOPMENT,0.0050528,0.11594,0.15111,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.059411,0.11573,0.1537,0,0
3,GO CELL PART MORPHOGENESIS,0.0024367,0.11485,0.1479,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.21256,0.11469,0.12975,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.066855,0.11431,0.13884,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.1313,0.11422,0.1157,0,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.015574,0.11325,0.13457,0,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.017137,0.11306,0.15792,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.26098,0.11301,0.14473,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.12908,0.11274,0.14697,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.35607,0.11239,0.068419,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.17653,0.11182,0.05138,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.20621,0.11179,0.051553,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.25729,0.1117,0.072017,0,0
3,GO URETER DEVELOPMENT,0.41842,0.11161,0.072538,0,0
3,GO COGNITION,0.0031536,0.11159,0.15657,0,0
3,GO SEQUESTERING OF METAL ION,0.11841,0.11155,0.077539,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.34256,0.11099,0.048058,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.061812,0.11097,0.13005,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.16828,0.11045,0.16887,0,0
3,GO NEURON MIGRATION,0.042857,0.11025,0.14875,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.2,0.11014,0.02765,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.26471,0.10971,0.089985,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.088862,0.10951,0.10544,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.015203,0.10934,0.19385,0,0
3,GO MYELIN MAINTENANCE,0.46512,0.10871,0.05417,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.10845,0.10842,0.17539,0,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.10831,0.12606,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.066855,0.10823,0.083208,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.30402,0.10773,0.091316,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.064293,0.10773,0.10406,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.004408,0.10765,0.16898,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.079444,0.10761,0.13606,0,0
3,GO DORSAL AORTA DEVELOPMENT,0.24288,0.10736,0.086646,0,0
3,GO ANION HOMEOSTASIS,0.17934,0.10723,0.076362,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.19393,0.10666,0.1672,0,0
3,GO DOPAMINE TRANSPORT,0.33812,0.10662,0.15678,0,0
3,GO ASYMMETRIC CELL DIVISION,0.39371,0.10648,0.0629,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.14526,0.10629,0.11146,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.39858,0.10609,0.041172,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.22568,0.10553,0.055856,0,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.15264,0.10543,0.064202,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.20621,0.10501,0.038164,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.11434,0.105,0.12598,0,0
3,GO TOXIN TRANSPORT,0.10096,0.10474,0.067394,0,0
3,GO GROWTH HORMONE SECRETION,0.16294,0.10466,0.10545,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.27227,0.10464,0.079484,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12908,0.10451,0.12432,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.076492,0.1043,0.078154,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.36064,0.10427,0.032545,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.34702,0.10387,0.057386,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19695,0.10371,0.094687,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.19095,0.10319,0.058589,0,0
3,GO TRNA 5 END PROCESSING,0.12473,0.10284,0.079239,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.60272,0.1027,0.03177,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.084046,0.10254,0.11759,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.097379,0.10248,0.094569,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.05824,0.10243,0.090781,0,0
3,GO WALKING BEHAVIOR,0.004408,0.10242,0.20944,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.26098,0.10238,0.15396,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.060602,0.10188,0.083724,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38408,0.10184,0.054856,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.44924,0.1016,0.14169,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.32506,0.10158,0.057278,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.082489,0.10141,0.067514,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.049546,0.10137,0.11162,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.19393,0.10101,-0.010585,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.22235,0.10099,0.074943,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.14048,0.1007,0.081393,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.23589,0.10064,0.1404,0,0
3,GO AXO DENDRITIC TRANSPORT,0.043763,0.10041,0.10129,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.65866,0.10026,0.046327,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.57857,0.10015,-0.021418,0,0
3,GO PROSTAGLANDIN SECRETION,0.17099,0.10012,0.085141,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.5726,0.099913,0.02916,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.29992,0.099778,0.059685,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.63978,0.099585,0.039394,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.41341,0.099415,0.015277,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.17653,0.099388,0.090573,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.22235,0.099251,0.049878,0,0
3,GO ACROSOME ASSEMBLY,0.15773,0.098843,0.14126,0,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.14285,0.098716,0.046371,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.4545,0.097984,0.073768,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.25363,0.097836,0.044028,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.16032,0.097756,0.10818,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.31653,0.097516,0.041001,0,0
3,GO REGULATION OF ATP METABOLIC PROCESS,0.065563,0.097368,0.064835,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.23245,0.097273,0.072781,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.18219,0.09686,0.12136,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17374,0.09671,0.085387,0,0
3,GO LATERAL MESODERM DEVELOPMENT,0.99651,0.096493,-0.042264,0,0
3,GO REVERSE CHOLESTEROL TRANSPORT,0.72969,0.096301,-0.0135,0,0
3,GO RENAL SODIUM EXCRETION,0.095625,0.096118,0.077543,0,0
3,GO BICARBONATE TRANSPORT,0.16828,0.095931,0.057661,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.36526,0.095619,0.024502,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.18508,0.095579,0.15747,0,0
3,GO ENDODERM FORMATION,0.25363,0.095455,0.025382,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.060602,0.095126,0.071842,0,0
3,GO PIGMENT METABOLIC PROCESS,0.13355,0.094987,0.079327,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.18219,0.094937,0.063127,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.29586,0.094911,0.033694,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011326,0.094873,0.17996,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.4978,0.094615,0.011696,0,0
3,GO CELL RECOGNITION,0.057089,0.094592,0.072826,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.14048,0.094365,0.078247,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.54903,0.09376,0.037638,0,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.2,0.093725,0.074412,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.32938,0.093651,0.17063,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.27227,0.0934,0.11352,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0024367,0.092894,0.131,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.44402,0.092883,0.11071,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.092194,0.09236,0.080909,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.11636,0.092058,0.10672,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.0695,0.091905,0.040213,0,0
3,GO MEMBRANE DEPOLARIZATION,0.14769,0.091862,0.10733,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.63354,0.09169,0.023899,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.85768,0.091628,-0.035297,0,0
3,GO AMELOGENESIS,0.72313,0.091497,0.017454,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.29992,0.091025,0.062368,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.079444,0.090943,0.089883,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.12908,0.090858,0.07639,0,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.19393,0.090771,0.067024,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.42855,0.090715,0.051687,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.36526,0.090547,0.066859,0,0
3,GO NUCLEOTIDE SALVAGE,0.16032,0.090474,0.12384,0,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.14769,0.090338,0.086928,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.045624,0.089295,0.096514,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.079444,0.089231,0.081202,0,0
3,GO AMINO ACID ACTIVATION,0.17099,0.089177,0.096164,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.020205,0.089143,0.079149,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.17653,0.089087,0.13757,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.2,0.088542,0.06317,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.064293,0.088449,0.097257,0,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.43367,0.088351,0.053667,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.15773,0.088278,0.063281,0,0
3,GO CATECHOLAMINE SECRETION,0.070855,0.088274,0.21533,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.94769,0.088241,-0.017123,0,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.060602,0.088074,0.064686,0,0
3,GO GROOMING BEHAVIOR,0.20621,0.088031,0.11623,0,0
3,GO COPPER ION TRANSPORT,0.19695,0.087859,0.074573,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.47588,0.087791,0.047237,0,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.39371,0.087635,0.037074,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.25363,0.087382,0.067867,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.72969,0.087255,0.00042408,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.32938,0.087207,0.028107,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.39858,0.086961,0.037733,0,0
3,GO PALLIUM DEVELOPMENT,0.011612,0.086703,0.12236,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.047551,0.086679,0.097788,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.11039,0.086276,0.085481,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.36526,0.085893,0.021861,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.13814,0.08582,0.079721,0,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.17099,0.085525,0.043005,0,0
3,GO REGULATION OF ION TRANSPORT,0.14285,0.085163,0.060629,0,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0099891,0.085126,0.18506,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.28785,0.085014,0.067548,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.74288,0.084953,-0.011379,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.5726,0.084937,0.0074552,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.25729,0.084792,0.1637,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.14526,0.084508,0.05929,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.10845,0.084391,0.088945,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.38408,0.084332,0.03121,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.34256,0.084212,0.065424,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.088862,0.084073,0.16487,0,0
3,GO BLASTOCYST FORMATION,0.10465,0.083901,0.07186,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.093897,0.083683,0.095142,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.67776,0.083643,-0.0021424,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.3746,0.083425,0.053785,0,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.016734,0.083355,0.11394,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.31232,0.082899,0.010792,0,0
3,GO PLASMINOGEN ACTIVATION,0.46512,0.082181,-0.039713,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.75615,0.082149,-0.074696,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.25363,0.081677,0.04365,0,0
3,GO PODOSOME ASSEMBLY,0.67137,0.081675,-0.064838,0,0
3,GO ZINC ION TRANSPORT,0.23937,0.081671,0.059316,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.28785,0.081668,0.10687,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.25001,0.081626,0.029616,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.74288,0.08162,0.0065297,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.23937,0.081615,0.073582,0,0
3,GO TONGUE MORPHOGENESIS,0.4598,0.081393,0.12758,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.17934,0.081261,0.082883,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.064293,0.081174,0.14722,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.60272,0.080998,0.035328,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.059411,0.080954,0.067854,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.42347,0.080935,0.03634,0,0
3,GO OTIC VESICLE MORPHOGENESIS,0.22235,0.080834,0.17572,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.32077,0.080806,0.049153,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.50896,0.080652,0.027984,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.31232,0.08065,0.072418,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.095625,0.080499,0.080015,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.55487,0.080271,0.037342,0,0
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.2,0.080203,0.10426,0,0
3,GO GLIAL CELL ACTIVATION,0.69707,0.080002,0.010975,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.14526,0.079913,0.088509,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.52594,0.079881,0.033788,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.23245,0.079584,0.11512,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.36991,0.079189,0.044649,0,0
3,GO REGULATION OF DNA METHYLATION,0.55487,0.078676,0.022381,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.18508,0.078595,0.066106,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.12049,0.078554,0.08366,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.31653,0.078538,0.044265,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.5726,0.07847,0.015,0,0
3,GO CELL GROWTH,0.075049,0.078358,0.049189,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0695,0.078322,0.089378,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.11039,0.078308,0.051503,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.30402,0.078271,0.048713,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.10845,0.078262,0.069084,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.60272,0.078197,0.048157,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.21905,0.07805,0.047038,0,0
3,GO NUCLEAR MIGRATION,0.093897,0.077994,0.098162,0,0
3,GO TRABECULA FORMATION,0.22568,0.077658,0.066652,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.043763,0.077645,0.10789,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.25729,0.077515,0.06121,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.29184,0.077403,0.034278,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.87833,0.077391,-0.031794,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.4598,0.077289,0.012326,0,0
3,GO ADULT BEHAVIOR,0.055956,0.077249,0.14414,0,0
3,GO DRUG CATABOLIC PROCESS,0.085627,0.077231,0.084308,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.070855,0.077169,0.095196,0,0
3,GO AXONAL TRANSPORT,0.070855,0.077143,0.10062,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.26098,0.077094,0.10614,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.56075,0.077027,0.080368,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.4545,0.076803,0.039002,0,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.19095,0.076794,0.038257,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.47049,0.076733,0.087098,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.46512,0.076668,0.05701,0,0
3,GO MAINTENANCE OF CELL POLARITY,0.23937,0.076611,0.073465,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61497,0.076578,0.019408,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.52594,0.076353,0.023953,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.67776,0.076184,0.045548,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.88523,0.076182,-0.051929,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.31653,0.075882,0.091314,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.32938,0.075861,0.085015,0,0
3,GO REGULATION OF EXCRETION,0.12259,0.075844,0.11051,0,0
3,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.3746,0.075674,0.0491,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.35607,0.075559,0.08742,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.37932,0.075513,0.046886,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.082489,0.07523,0.11739,0,0
3,GO CATION TRANSPORT,0.05824,0.075116,0.060237,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.30815,0.07504,0.048406,0,0
3,GO IRON ION HOMEOSTASIS,0.20309,0.074902,0.055373,0,0
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.14769,0.074629,0.10781,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.76281,0.074518,0.0086407,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.66501,0.074091,-0.012677,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.085627,0.074082,0.062271,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.11636,0.07407,0.079286,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.1313,0.073811,0.11994,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.21905,0.073492,0.093333,0,0
3,GO THIOESTER METABOLIC PROCESS,0.25729,0.073276,0.052488,0,0
3,GO CELL CYCLE DNA REPLICATION,0.044685,0.07298,0.079722,0,0
3,GO PROTEIN KINASE A SIGNALING,0.2839,0.07278,0.047207,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.94073,0.072656,-0.016114,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.33812,0.072441,0.057914,0,0
3,GO HISTONE H3 K36 METHYLATION,0.51459,0.07244,0.031562,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.23245,0.072351,0.14897,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.48131,0.072182,0.03863,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.085627,0.07167,0.091229,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.27999,0.071191,0.043413,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.12049,0.071179,0.052823,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.17099,0.07079,0.06219,0,0
3,GO RESPONSE TO COCAINE,0.47049,0.070694,0.053782,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.32506,0.070677,0.023749,0,0
3,GO CELL JUNCTION ORGANIZATION,0.188,0.07046,0.04718,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.17934,0.070351,0.051365,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.34702,0.070264,0.030359,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.4545,0.070237,0.023566,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.14526,0.070001,0.11623,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.075049,0.069941,0.066948,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.090515,0.069754,0.13252,0,0
3,GO TRABECULA MORPHOGENESIS,0.68418,0.069601,0.00042882,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.32506,0.069519,0.047766,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.065563,0.069382,0.070423,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.78962,0.069356,-0.046214,0,0
3,GO RESPONSE TO ACIDIC PH,0.61497,0.069269,-0.0041426,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.33812,0.068977,0.040546,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.32506,0.068946,0.054595,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.05824,0.068821,0.071223,0,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.22905,0.068786,0.12685,0,0
3,GO REGULATION OF DNA BINDING,0.32506,0.068703,0.035944,0,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.092194,0.068576,0.10112,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.40349,0.068368,0.034789,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.40349,0.067964,0.057793,0,0
3,GO INTRACELLULAR LIPID TRANSPORT,0.32506,0.067907,0.051331,0,0
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.39371,0.067675,0.031582,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.16559,0.067378,0.083294,0,0
3,GO ACTION POTENTIAL,0.31653,0.066927,0.062919,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.11039,0.066519,0.060207,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.4545,0.066267,0.05857,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.22235,0.066172,0.060251,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.63354,0.066041,-0.0040107,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.14048,0.065507,0.039674,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.85768,0.065444,-0.0028137,0,0
3,GO HIPPO SIGNALING,0.68418,0.065365,-0.024942,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.024288,0.065336,0.096793,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.4598,0.065182,0.035594,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.17653,0.065071,0.077566,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.3746,0.064971,0.040328,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.41842,0.064863,0.016317,0,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.073629,0.064843,0.15596,0,0
3,GO HISTONE H3 K27 METHYLATION,0.40349,0.064767,0.041694,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.30402,0.064586,0.12124,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.12689,0.064443,0.07886,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.21905,0.064149,0.10092,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.11434,0.063924,0.11139,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.93377,0.063732,-0.0072338,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.72969,0.063652,0.0051246,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.082489,0.063571,0.083382,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.05824,0.063493,0.061114,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.39371,0.063293,0.046665,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.54903,0.063118,0.086518,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.32938,0.062669,0.024869,0,0
3,GO RESPONSE TO SALT,0.92682,0.062643,0.00048644,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.22235,0.06263,0.0745,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.28785,0.062444,0.041102,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.58456,0.062265,0.054427,0,0
3,GO NEURON MATURATION,0.073629,0.062192,0.1618,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.50337,0.062074,0.015222,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.90599,0.062055,-0.0055476,0,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.31232,0.062028,0.069046,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.52025,0.062015,0.00011165,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.3746,0.06199,0.028828,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.15264,0.061525,0.032862,0,0
3,GO SNRNA PROCESSING,0.15773,0.061408,-0.0063667,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.63978,0.061342,0.018724,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.44924,0.061284,0.069574,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.58456,0.061271,0.021532,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.76281,0.061217,0.038906,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13355,0.061175,0.11112,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.40349,0.061015,0.054946,0,0
3,GO HEART PROCESS,0.12259,0.06089,0.068836,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.2,0.060871,0.062917,0,0
3,GO CERAMIDE TRANSPORT,0.11434,0.060835,0.045107,0,0
3,GO OPTIC NERVE DEVELOPMENT,0.32938,0.060655,0.088409,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10654,0.060355,0.045853,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.060279,-0.055547,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.5726,0.060194,0.011848,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.041093,0.060038,0.10921,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.12049,0.060029,0.062462,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.36526,0.059805,0.094879,0,0
3,GO NUCLEOSIDE METABOLIC PROCESS,0.12908,0.059782,0.047589,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.26098,0.059782,0.039865,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.49227,0.059684,0.069472,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.87144,0.059626,-0.016596,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.12689,0.059588,0.062803,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.38888,0.059495,0.059975,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.96163,0.059474,0.0074326,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.1028,0.059414,0.067347,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.71006,0.059403,-0.061317,0,0
3,GO REGULATION OF EXOCYTOSIS,0.12908,0.059169,0.083328,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.69061,0.059045,0.016918,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.23245,0.058912,0.051956,0,0
3,GO PROTEIN FOLDING,0.19695,0.058895,0.037073,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.21905,0.05883,0.18293,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.39858,0.058732,0.057713,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.36991,0.058589,0.04793,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.48678,0.058587,0.043292,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.42855,0.058445,0.01996,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.40349,0.058248,0.034762,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.17934,0.057919,0.052955,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.059411,0.057863,0.069993,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.188,0.057766,0.070135,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.67137,0.057761,-0.0024584,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.32938,0.057662,0.027942,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41341,0.057564,0.03109,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.12908,0.057514,0.096921,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.83713,0.057268,-0.011995,0,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.25001,0.057197,0.081448,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.12689,0.056973,0.054069,0,0
3,GO FEEDING BEHAVIOR,0.088862,0.056843,0.084705,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.92682,0.056737,-0.0044084,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.44924,0.056697,0.032179,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.72969,0.05629,-0.0008014,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.11636,0.05621,0.064125,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.14526,0.056149,0.057714,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.85768,0.056012,-0.042994,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.47049,0.055942,0.047177,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.16032,0.055811,0.040261,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.48678,0.055774,-0.077812,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.05573,0.0054114,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.23589,0.055727,0.111,0,0
3,GO NEPHRON TUBULE FORMATION,0.79636,0.055653,0.036197,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.079444,0.055331,0.075593,0,0
3,GO NOREPINEPHRINE SECRETION,0.37932,0.055307,0.052206,0,0
3,GO REGULATION OF HEART GROWTH,0.23589,0.055286,0.066202,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.25729,0.055025,0.049114,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.065563,0.055002,0.04809,0,0
3,GO ANIMAL ORGAN REGENERATION,0.4978,0.054878,-0.0026538,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.81668,0.054837,-0.034905,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.71006,0.054812,0.0049911,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.68418,0.0548,0.015893,0,0
3,GO G0 TO G1 TRANSITION,0.43367,0.05475,0.036869,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.24643,0.054744,0.073746,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.40349,0.054687,0.035538,0,0
3,GO TRACHEA DEVELOPMENT,0.4598,0.054649,0.060868,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.34702,0.054639,0.074693,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.29992,0.054492,0.03947,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.56666,0.054206,0.020814,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.58456,0.05399,0.016902,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.26471,0.053979,0.072737,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.71658,0.053975,0.017606,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.71658,0.053807,-0.021909,0,0
3,GO PROTEASOME ASSEMBLY,0.2,0.053773,0.053468,0,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.76948,0.053703,0.016269,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.11841,0.053664,0.080307,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.14526,0.053577,0.068468,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.42347,0.053419,0.04701,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.14526,0.053381,0.070599,0,0
3,GO PROTEIN NEDDYLATION,0.12049,0.053309,0.067427,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.26098,0.053132,0.13369,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.14048,0.05306,0.053304,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.33373,0.052918,0.067288,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.1313,0.052863,0.075474,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.29184,0.052824,0.043541,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.41842,0.05282,0.050627,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.84397,0.052755,-0.028331,0,0
3,GO NEURON CELL CELL ADHESION,0.61497,0.052642,0.10326,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.36064,0.052559,0.035699,0,0
3,GO MYELIN ASSEMBLY,0.49227,0.052436,0.042426,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.83713,0.05231,-0.055094,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.63354,0.052278,0.024987,0,0
3,GO NUCLEOSOME ORGANIZATION,0.14526,0.052174,0.050352,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.72969,0.052144,0.013265,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.32506,0.052067,0.043894,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.47588,0.051724,0.0425,0,0
3,GO MUSCLE CONTRACTION,0.13814,0.051623,0.053266,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.63978,0.05139,0.023118,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.14769,0.05134,0.11065,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.2839,0.051251,0.057719,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.59664,0.051103,-0.044502,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.71658,0.051083,0.0022241,0,0
3,GO MONOAMINE TRANSPORT,0.55487,0.051073,0.10533,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.16294,0.051029,0.064254,0,0
3,GO RESPONSE TO POTASSIUM ION,0.59059,0.050913,0.052922,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.96163,0.050771,-0.026791,0,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.24288,0.050528,0.091945,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.38408,0.050521,0.079565,0,0
3,GO ADHESION OF SYMBIONT TO HOST,0.5726,0.050321,0.033531,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.15015,0.050316,0.06293,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.33812,0.050176,0.083192,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.94769,0.050105,-0.0076313,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.53167,0.050087,0.016322,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.40349,0.049989,0.026336,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.25363,0.049893,0.036914,0,0
3,GO RHYTHMIC BEHAVIOR,0.47049,0.049745,0.042894,0,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.11434,0.049733,0.11575,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.69061,0.049532,0.0085766,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.98953,0.049408,-0.006554,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.70355,0.049297,-0.011863,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.11841,0.049215,0.040787,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.98255,0.049192,-0.017618,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.16294,0.049185,0.099555,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.83713,0.049162,-0.0024512,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.91987,0.049093,-0.019411,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.42347,0.049075,0.01986,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.72313,0.048968,0.017815,0,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.86455,0.048931,0.016773,0,0
3,GO CHROMATIN DISASSEMBLY,0.22235,0.048408,0.125,0,0
3,GO ACYLGLYCEROL HOMEOSTASIS,0.42347,0.048374,0.038189,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.33812,0.048365,0.058467,0,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.43883,0.048133,0.06176,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.087232,0.048035,0.062806,0,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.17099,0.048005,0.046503,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.81668,0.047761,0.0094245,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.38888,0.04765,0.031904,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.42855,0.047545,0.038869,0,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.58456,0.04754,0.013204,0,0
3,GO REGULATION OF ORGAN GROWTH,0.35607,0.04754,0.035379,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.25729,0.047341,0.061132,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.23937,0.047273,0.047214,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.62732,0.047146,0.030781,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.62113,0.047105,0.047123,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.69061,0.04698,0.0037934,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.86455,0.046963,-0.036538,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.22905,0.046955,0.076249,0,0
3,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.62113,0.046823,0.028654,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.9686,0.046602,-0.055373,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.43883,0.046447,0.052152,0,0
3,GO ACROSOME REACTION,0.54321,0.046437,0.028279,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.65234,0.046422,-0.0089847,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.41842,0.046411,0.052284,0,0
3,GO NEUROGENESIS,0.075049,0.046395,0.071918,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.55487,0.046293,0.032767,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.15773,0.046282,0.068317,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.60883,0.046193,0.036286,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.35153,0.046032,0.060186,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.082489,0.045935,0.10175,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.60883,0.04592,0.03141,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.25729,0.045851,0.068885,0,0
3,GO MICROTUBULE POLYMERIZATION,0.044685,0.045838,0.11001,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.63978,0.045735,0.048536,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.10465,0.045604,0.064125,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.71006,0.045453,-0.0036157,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.33812,0.045402,0.066379,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.21905,0.045383,0.045223,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.95466,0.045349,-0.026062,0,0
3,GO MYOBLAST FUSION,0.89215,0.045198,-0.025843,0,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.69707,0.045174,0.0098476,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.31232,0.044919,0.059493,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.093897,0.044885,0.10197,0,0
3,GO RESPONSE TO DOPAMINE,0.61497,0.044837,0.033992,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.71006,0.044783,0.016251,0,0
3,GO ORGAN GROWTH,0.54903,0.044716,0.018631,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.86455,0.044645,-0.072866,0,0
3,GO RRNA CATABOLIC PROCESS,0.62732,0.044437,0.04833,0,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.78962,0.044324,0.0072863,0,0
3,GO HEART TRABECULA FORMATION,0.95466,0.044239,-0.0041626,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.81668,0.044039,-0.020328,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.16828,0.043899,0.12862,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.061812,0.043714,0.131,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.32077,0.043609,0.049395,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.95466,0.043547,-0.012278,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.42347,0.04348,0.037169,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.38888,0.043411,0.05894,0,0
3,GO MICROTUBULE NUCLEATION,0.67137,0.043043,0.030211,0,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.10654,0.042921,0.09844,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.22905,0.042914,0.041127,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.48678,0.042716,0.033185,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.042581,0.023569,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.50896,0.042552,-0.11406,0,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.20621,0.042531,0.072654,0,0
3,GO PROTEIN HYDROXYLATION,0.78289,0.042499,0.014227,0,0
3,GO PROTEIN PALMITOYLATION,0.30815,0.042405,0.061275,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.21256,0.04236,0.096539,0,0
3,GO BONE DEVELOPMENT,0.3746,0.042278,0.014209,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.89907,0.042198,-0.021191,0,0
3,GO TRNA 5 LEADER REMOVAL,0.63354,0.041775,0.01211,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.092194,0.041691,0.050936,0,0
3,GO PROTEIN STABILIZATION,0.52025,0.041628,0.017604,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.69707,0.041617,0.042231,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,1,0.041609,-0.013308,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.60272,0.04137,-0.015169,0,0
3,GO LYMPHANGIOGENESIS,0.26098,0.041195,0.057051,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.41341,0.041186,0.027773,0,0
3,GO NADP METABOLIC PROCESS,0.70355,0.041152,-0.016033,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.05824,0.041143,0.037228,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.37932,0.040798,0.031763,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.10654,0.040787,0.053955,0,0
3,GO CARTILAGE MORPHOGENESIS,0.35153,0.04077,0.14204,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.4598,0.040627,0.046269,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.75615,0.040613,-0.040405,0,0
3,GO SNRNA METABOLIC PROCESS,0.25001,0.040524,-0.0053469,0,0
3,GO PROTEIN IMPORT,0.58456,0.040337,0.0071906,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.64605,0.039969,-0.042298,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.91987,0.039865,-0.0085776,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.86455,0.039813,-0.0023915,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.78962,0.039672,-0.0087641,0,0
3,GO RESPONSE TO UV,0.12259,0.039584,0.042676,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.99651,0.039419,-0.019693,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.80989,0.03933,0.024745,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.84397,0.039168,-0.0045513,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.91293,0.039067,-0.013666,0,0
3,GO CELL MORPHOGENESIS,0.14526,0.038997,0.058199,0,0
3,GO REGULATION OF URINE VOLUME,0.65234,0.038963,0.011216,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.95466,0.038951,-0.010853,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.29184,0.038797,0.040875,0,0
3,GO POLYOL METABOLIC PROCESS,0.24288,0.038771,0.036067,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.96163,0.03877,-0.010743,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.42855,0.038761,0.046427,0,0
3,GO OXIDATIVE DEMETHYLATION,0.15517,0.038625,0.072435,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.20621,0.038547,0.030599,0,0
3,GO ION TRANSPORT,0.23937,0.038322,0.031685,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.25729,0.038216,0.080229,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.76948,0.038215,0.0055821,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.78962,0.03819,-0.0078515,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.33373,0.038161,0.031432,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.76948,0.038053,0.035254,0,0
3,GO IMMATURE T CELL PROLIFERATION,0.72969,0.038013,-0.01894,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.30402,0.037981,0.042514,0,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.9686,0.037969,-0.025374,0,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.41842,0.03795,0.046741,0,0
3,GO CELL CELL SIGNALING,0.13355,0.037895,0.047582,0,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.17099,0.037849,0.099701,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.50896,0.037847,0.02657,0,0
3,GO REGULATION OF GENE SILENCING,0.28785,0.037828,0.031926,0,0
3,GO PROTEIN KINASE C SIGNALING,0.98953,0.037794,-0.0076044,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.090515,0.037701,0.056622,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.073629,0.037433,0.12602,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.68418,0.037332,0.015243,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.67137,0.037196,0.016443,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.49227,0.037067,0.057624,0,0
3,GO DEVELOPMENTAL GROWTH,0.14285,0.037026,0.047565,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.38888,0.037015,0.016176,0,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.78289,0.036885,0.008726,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.71658,0.036778,-0.0092596,0,0
3,GO BLASTOCYST GROWTH,0.47049,0.036748,0.016377,0,0
3,GO COENZYME A METABOLIC PROCESS,0.80312,0.03672,0.013962,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.56075,0.036493,0.040761,0,0
3,GO RESPONSE TO RETINOIC ACID,0.76948,0.036452,-0.016635,0,0
3,GO RESPONSE TO LEUCINE,0.4978,0.03628,0.078433,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.52025,0.036273,0.026461,0,0
3,GO GMP METABOLIC PROCESS,0.80989,0.03627,0.042603,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.8303,0.036212,0.032197,0,0
3,GO REGULATION OF DNA REPAIR,0.7495,0.036026,0.0030106,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.67776,0.036019,0.00746,0,0
3,GO REGULATION OF ACROSOME REACTION,0.39371,0.035938,0.070154,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.13814,0.035896,0.10478,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.4598,0.035834,0.062649,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.89907,0.035827,-0.026239,0,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.21905,0.035753,0.10856,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.69707,0.035704,-0.011069,0,0
3,GO CRANIAL NERVE DEVELOPMENT,0.67137,0.035667,-0.061516,0,0
3,GO CHLORIDE TRANSPORT,0.49227,0.035636,0.025545,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.29184,0.035526,0.036014,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.47588,0.03537,0.020826,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.34702,0.035361,0.020919,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.47049,0.035198,0.041503,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98953,0.035074,-0.014027,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.63354,0.035062,0.0040174,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.17099,0.034998,0.078447,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.61497,0.034779,-0.010887,0,0
3,GO RESPONSE TO ESTROGEN,0.48678,0.034711,0.0087973,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.98953,0.034662,-0.030051,0,0
3,GO AMYLOID BETA FORMATION,0.84397,0.034629,0.0047639,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.16828,0.034385,0.030482,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.11434,0.034342,0.062309,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.71006,0.034128,0.023519,0,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.36991,0.034056,0.024522,0,0
3,GO AORTA MORPHOGENESIS,0.89215,0.034007,-0.028269,0,0
3,GO GROWTH,0.51459,0.033947,0.014628,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.63978,0.033925,0.0085486,0,0
3,GO REGULATION OF FERTILIZATION,0.39371,0.033886,0.034041,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.50337,0.033874,-0.070401,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.89907,0.033782,0.011946,0,0
3,GO TORC1 SIGNALING,0.088862,0.033763,0.062223,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.26847,0.033624,0.05577,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.48678,0.03326,0.034975,0,0
3,GO CHOLESTEROL EFFLUX,0.70355,0.033257,-0.045448,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.12473,0.033246,0.058581,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.43367,0.033047,0.036882,0,0
3,GO CELLULAR HOMEOSTASIS,0.23589,0.033012,0.031681,0,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.74288,0.032724,-0.042776,0,0
3,GO CARTILAGE DEVELOPMENT,0.73628,0.032683,-0.0058453,0,0
3,GO PORE COMPLEX ASSEMBLY,0.80989,0.032664,-0.034393,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.85768,0.032642,-0.01039,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.56075,0.032546,0.027683,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.70355,0.032357,-0.046804,0,0
3,GO RNA INTERFERENCE,0.20621,0.03234,0.069483,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.47588,0.032237,0.011778,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.4978,0.032095,0.0372,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.55487,0.03197,0.044068,0,0
3,GO PROTEIN ACETYLATION,0.26847,0.031965,0.017669,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.52594,0.031952,0.059015,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.3746,0.031909,0.033044,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59664,0.031803,0.021365,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.71658,0.031783,0.0052435,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.24643,0.031667,0.018889,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.85082,0.031627,9.4196e-05,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.75615,0.031621,-0.0013877,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.097379,0.031562,0.062583,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.53167,0.031557,0.022321,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.2,0.031533,0.02891,0,0
3,GO NADPH REGENERATION,0.97557,0.03146,-0.014396,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.68418,0.031428,0.018659,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.86455,0.031386,0.010408,0,0
3,GO FOREBRAIN DEVELOPMENT,0.15773,0.031358,0.064155,0,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.25001,0.031311,0.038895,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.44402,0.031263,0.018939,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.67137,0.031137,0.014411,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.26847,0.030901,0.038266,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.42855,0.030871,0.025901,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.92682,0.030773,0.0029153,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.80989,0.030645,-0.0048553,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.78962,0.030489,0.0047626,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.51459,0.030433,0.023195,0,0
3,GO MUSCLE SYSTEM PROCESS,0.23937,0.030397,0.038068,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.78962,0.030362,0.0039012,0,0
3,GO ION HOMEOSTASIS,0.53742,0.030339,0.017595,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.20937,0.030078,0.067402,0,0
3,GO OVULATION CYCLE PROCESS,0.40349,0.030026,0.040106,0,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.81668,0.029894,-0.012265,0,0
3,GO ENERGY HOMEOSTASIS,0.55487,0.029863,0.050136,0,0
3,GO QUINONE METABOLIC PROCESS,0.32938,0.029856,-0.15592,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.50896,0.029631,0.028245,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.58456,0.029594,0.057225,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.94769,0.029519,0.0078431,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.96163,0.029503,-0.013801,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.14769,0.02944,0.043423,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.9686,0.029394,-0.0081614,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.44924,0.029312,0.026918,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.91987,0.029294,-0.067343,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.71006,0.029261,-0.043304,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.82348,0.029227,0.024267,0,0
3,GO RESPONSE TO GONADOTROPIN,0.92682,0.029167,-0.018143,0,0
3,GO MIRNA METABOLIC PROCESS,0.95466,0.029152,-0.00043178,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.66501,0.029119,0.0058449,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.94073,0.029071,-0.037658,0,0
3,GO DEVELOPMENTAL MATURATION,0.22905,0.028994,0.059102,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.96163,0.028993,0.013514,0,0
3,GO HISTONE EXCHANGE,0.31653,0.028887,0.039289,0,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.62113,0.028843,-0.063157,0,0
3,GO LYMPH NODE DEVELOPMENT,0.87144,0.028811,-0.013562,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.94769,0.028809,-0.0032546,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.67137,0.028734,0.051423,0,0
3,GO CONVERGENT EXTENSION,0.56666,0.028632,0.041216,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.4978,0.028512,0.02142,0,0
3,GO CHYLOMICRON ASSEMBLY,0.78962,0.028507,-0.019807,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.29184,0.028124,0.017059,0,0
3,GO MIDBRAIN DEVELOPMENT,0.76281,0.028068,-0.035876,0,0
3,GO OXIDATION REDUCTION PROCESS,0.68418,0.028046,0.0095475,0,0
3,GO INORGANIC ANION TRANSPORT,0.42347,0.027832,0.015758,0,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.42855,0.027774,0.047455,0,0
3,GO METAL ION HOMEOSTASIS,0.84397,0.02774,0.0037628,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.23245,0.027726,0.10127,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.94073,0.027714,0.004058,0,0
3,GO CELL CYCLE ARREST,0.33373,0.027653,0.025913,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.42347,0.027639,0.031295,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.61497,0.027606,0.0067171,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.89907,0.027545,-0.023932,0,0
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.56075,0.027486,0.042877,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.52594,0.027418,0.038913,0,0
3,GO IRON ION TRANSPORT,0.77618,0.027225,-0.0098631,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.47049,0.027036,0.011729,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.46512,0.027007,0.03849,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.36526,0.026823,0.032309,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.5726,0.026772,0.026549,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.22568,0.026735,-0.14412,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.42347,0.026586,0.049709,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.25363,0.026583,0.047106,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.42347,0.026536,0.024151,0,0
3,GO PROTEIN ACYLATION,0.13583,0.026497,0.027667,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.80989,0.026417,0.0048714,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.88523,0.026403,-0.0021909,0,0
3,GO MRNA CLEAVAGE,0.22235,0.026381,0.051584,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.72969,0.026187,0.014482,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.72313,0.026019,-0.0023432,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.56075,0.026014,0.010009,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.12689,0.025895,0.046954,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.55487,0.025797,0.023933,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.55487,0.025671,0.027042,0,0
3,GO SEGMENTATION,0.48678,0.025492,0.021605,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.87833,0.025299,-0.040874,0,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.92682,0.025244,-0.012407,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.41842,0.025238,0.03403,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.87144,0.025062,-0.039824,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.58456,0.024944,-0.06273,0,0
3,GO NERVOUS SYSTEM PROCESS,0.34702,0.024861,0.038292,0,0
3,GO REGULATION OF GLIOGENESIS,0.78289,0.024815,0.012054,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.38408,0.024716,0.01842,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.54321,0.02446,0.042752,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.82348,0.024273,0.004358,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.9686,0.02426,-0.035691,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.70355,0.02423,-0.006168,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.81668,0.024143,-0.031975,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.68418,0.024101,-0.09294,0,0
3,GO FILOPODIUM ASSEMBLY,0.46512,0.023969,0.037676,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.88523,0.023937,-0.016667,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.63978,0.02391,0.020487,0,0
3,GO CHROMOSOME SEPARATION,0.42855,0.02386,0.025272,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.98255,0.023852,-0.025406,0,0
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.39371,0.023753,0.024745,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.72969,0.023648,0.032474,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.34256,0.023635,0.060195,0,0
3,GO HISTONE H3 K4 METHYLATION,0.95466,0.023547,0.0012104,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.65234,0.023542,0.012827,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.83713,0.023357,-0.018905,0,0
3,GO REGULATION OF GROWTH,0.90599,0.023354,-0.00044268,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.96163,0.023258,-0.033939,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.13814,0.023166,0.084946,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.96163,0.02307,-0.010031,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.86455,0.023017,-0.017188,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.13583,0.022928,0.060352,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.70355,0.022912,0.010331,0,0
3,GO INTERACTION WITH SYMBIONT,0.4545,0.022889,0.0019219,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.72313,0.022857,-0.06373,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.62732,0.022769,0.022613,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.98953,0.022752,-0.017444,0,0
3,GO WATER TRANSPORT,0.91293,0.022676,-0.0035743,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.61497,0.022614,-0.038741,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.64605,0.022425,0.03981,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.61497,0.022396,0.049255,0,0
3,GO REGULATION OF RNA SPLICING,0.2,0.021959,0.036933,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.61497,0.021905,0.09446,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.95466,0.021783,-0.0027989,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.37932,0.02162,0.035968,0,0
3,GO DNA METABOLIC PROCESS,0.39858,0.021597,0.015568,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.60272,0.021583,0.044211,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.72313,0.021456,0.004522,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.60272,0.021411,-0.075543,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.79636,0.021405,-0.0081328,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.71006,0.021397,-0.059285,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.73628,0.021363,-0.015008,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.26471,0.021339,0.07162,0,0
3,GO PROTEIN METHYLATION,0.59059,0.021317,0.020162,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.39371,0.021265,0.10921,0,0
3,GO REGULATION OF BEHAVIOR,0.67137,0.021183,0.017133,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.98953,0.021103,0.002342,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.13814,0.020855,0.082401,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.53167,0.020774,0.023525,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.70355,0.020711,0.020402,0,0
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.36064,0.020512,0.024503,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.70355,0.020481,0.0053225,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.17653,0.020436,0.12032,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.32938,0.02037,-0.10796,0,0
3,GO SNRNA TRANSCRIPTION,0.23937,0.020297,0.025213,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.85082,0.02027,0.0037798,0,0
3,GO FOREGUT MORPHOGENESIS,0.8303,0.02027,-0.019063,0,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.72313,0.020237,-0.00023766,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.39371,0.020216,0.097113,0,0
3,GO CHROMATIN REMODELING,0.23589,0.020082,0.036679,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.36991,0.020018,0.057893,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.57857,0.019838,0.017424,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.94769,0.019723,-0.004214,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.56666,0.01962,-0.096087,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.68418,0.019617,0.028103,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.66501,0.019419,0.0024772,0,0
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.27999,0.019343,0.048686,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.42347,0.019231,0.069953,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.31653,0.01916,0.034708,0,0
3,GO NEURAL TUBE PATTERNING,0.98953,0.019061,-0.0099716,0,0
3,GO REGULATION OF MYELINATION,0.51459,0.019049,0.051814,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.78962,0.018996,-0.01939,0,0
3,GO SECONDARY PALATE DEVELOPMENT,0.53167,0.018966,-0.057617,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.91293,0.018898,0.0007021,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.30402,0.018874,0.14205,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.95466,0.018871,-0.019809,0,0
3,GO BRAIN MORPHOGENESIS,0.67776,0.018857,0.044687,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.67776,0.018855,0.01276,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.48678,0.018828,0.059431,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.50896,0.018781,0.026803,0,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.92682,0.0187,0.014684,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.67776,0.018616,-0.066419,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.42855,0.018591,0.029812,0,0
3,GO DENDRITE EXTENSION,0.34702,0.018508,0.14333,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.43883,0.018494,0.025655,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.42347,0.018441,0.05027,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.4598,0.018052,0.021581,0,0
3,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.94073,0.018001,0.039363,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.87833,0.017889,-0.011816,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.24643,0.017792,0.042424,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.47588,0.017532,0.01762,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.86455,0.017507,-0.0079791,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.27611,0.017285,0.039654,0,0
3,GO PROSTATIC BUD FORMATION,0.83713,0.017271,-0.094231,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.63354,0.017071,-0.059135,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.80312,0.017066,-0.0033325,0,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.85768,0.017032,-0.022861,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.46512,0.016925,0.02599,0,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.56075,0.016895,0.015071,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.84397,0.016853,0.0044396,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.26847,0.016798,0.038712,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.27611,0.016703,0.053101,0,0
3,GO REGULATION OF OOGENESIS,0.44924,0.01662,-0.056119,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.90599,0.01645,0.007407,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.71006,0.016362,0.020384,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.53167,0.016183,0.025218,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.63354,0.016057,0.035845,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.48131,0.0159,0.044241,0,0
3,GO ORGANELLE FUSION,0.80989,0.015796,-0.0066239,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.89215,0.015664,-0.032996,0,0
3,GO NODAL SIGNALING PATHWAY,0.9686,0.015654,-0.016513,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.42347,0.015603,0.049487,0,0
3,GO VESICLE DOCKING,0.48678,0.015435,0.035588,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.85082,0.015429,-0.010858,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.35607,0.015387,0.027589,0,0
3,GO ENSHEATHMENT OF NEURONS,0.75615,0.015249,0.0062892,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.38888,0.015212,0.045411,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.38888,0.015163,0.026909,0,0
3,GO SOMATIC STEM CELL DIVISION,0.87144,0.015116,0.024833,0,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.95466,0.015107,-0.01713,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.69707,0.015035,-0.00017288,0,0
3,GO RESPONSE TO CAMP,0.29184,0.014955,0.047401,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.64605,0.014931,0.018597,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.78289,0.014886,-0.048514,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.99651,0.014794,-0.053607,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.82348,0.014788,0.015365,0,0
3,GO COMPLEMENT ACTIVATION,0.8303,0.014705,-0.056068,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.4598,0.014615,0.040127,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.94073,0.014529,-0.013746,0,0
3,GO LYSOSOME LOCALIZATION,0.43883,0.014507,-0.054235,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.54903,0.014507,0.016201,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.93377,0.014461,-0.018421,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.92682,0.014395,-0.020453,0,0
3,GO HISTONE DEACETYLATION,0.86455,0.014311,-0.0095593,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.81668,0.014272,-0.058788,0,0
3,GO SYNCYTIUM FORMATION,0.91293,0.014208,-0.00773,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.78962,0.014174,0.0070492,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.98953,0.014172,-0.014974,0,0
3,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.63354,0.014161,0.030027,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.36064,0.014122,0.06788,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.91987,0.01403,-0.0022613,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.73628,0.014016,-0.00043295,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.78962,0.013994,-0.0028564,0,0
3,GO MEMBRANE BIOGENESIS,0.91293,0.013919,-0.016019,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.56075,0.013905,0.031828,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.97557,0.013786,-0.000796,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.98953,0.013741,9.2521e-05,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.99651,0.013716,0.0016867,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.23937,0.013563,0.0867,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.63354,0.013491,0.030871,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.48131,0.013438,0.010475,0,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.49227,0.013319,-0.052704,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.41341,0.013302,0.020149,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.65234,0.012963,0.019026,0,0
3,GO TERPENOID METABOLIC PROCESS,0.53167,0.012959,-0.048455,0,0
3,GO CELL CELL SIGNALING BY WNT,0.67776,0.012924,0.0040329,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,1,0.012924,-0.010853,0,0
3,GO SOMITOGENESIS,0.75615,0.012884,-0.013891,0,0
3,GO NCRNA CATABOLIC PROCESS,0.92682,0.012874,-0.00061769,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.50337,0.012845,-0.03428,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.8303,0.012791,-0.0018795,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.68418,0.012757,0.015022,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.93377,0.012426,-0.011165,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.5726,0.012155,-0.022016,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.22905,0.01208,0.023931,0,0
3,GO HINDBRAIN DEVELOPMENT,0.34702,0.012054,0.056454,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.97557,0.011896,-0.010103,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.85768,0.011887,0.0023157,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.82348,0.01186,0.010332,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.79636,0.011832,-0.0006604,0,0
3,GO VASODILATION,0.30402,0.011816,0.058037,0,0
3,GO MITOCHONDRIAL TRNA PROCESSING,0.29184,0.011812,0.1047,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.68418,0.011693,0.037641,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.72313,0.011683,0.0096705,0,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.62732,0.011669,-0.044504,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.52025,0.011663,-0.060471,0,0
3,GO MANNOSYLATION,0.72313,0.01166,-0.041711,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.57857,0.011623,0.0083721,0,0
3,GO MESENCHYME DEVELOPMENT,0.92682,0.011533,-0.017653,0,0
3,GO HEAD DEVELOPMENT,0.38888,0.011522,0.035896,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.85768,0.011515,-0.0063422,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.97557,0.011501,-0.0084849,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.70355,0.011466,0.010564,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.76948,0.011348,0.00081077,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.40843,0.011263,-0.051516,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.95466,0.011262,-0.0044998,0,0
3,GO RESPONSE TO ATP,0.54321,0.011184,0.023555,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.90599,0.011106,-0.077073,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.57857,0.011054,-0.021601,0,0
3,GO VISUAL BEHAVIOR,0.48678,0.011038,0.036199,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.76948,0.011037,-0.010956,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.9686,0.010961,-0.042987,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.92682,0.010889,-0.0036678,0,0
3,GO DNA LIGATION,0.97557,0.010881,-0.0011536,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.71006,0.010711,0.0058404,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.9686,0.0107,-0.01829,0,0
3,GO SOMITE DEVELOPMENT,0.72969,0.010665,0.01032,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.57857,0.010611,0.05109,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.69707,0.010605,0.01992,0,0
3,GO CELL FATE COMMITMENT,0.77618,0.01056,-0.019383,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.56666,0.010495,0.017299,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.98953,0.010484,-0.0071665,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.5726,0.010333,0.045606,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.19095,0.010159,0.10225,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.87833,0.010127,-0.010742,0,0
3,GO MITOTIC DNA REPLICATION,0.90599,0.010126,-0.013772,0,0
3,GO THYMUS DEVELOPMENT,0.93377,0.010049,-0.0022784,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.78289,0.010027,0.0062207,0,0
3,GO RHYTHMIC PROCESS,0.90599,0.0097994,0.002983,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.0097513,0.011355,0,0
3,GO STEM CELL DIFFERENTIATION,0.76281,0.0096906,-0.018138,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.76948,0.0096897,-0.0073922,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.65866,0.0095956,0.0069814,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.81668,0.0094596,0.0014535,0,0
3,GO GLIAL CELL PROLIFERATION,0.72969,0.0093701,-0.038691,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.59059,0.0093476,0.01958,0,0
3,GO RESPONSE TO DRUG,0.57857,0.0091927,0.020593,0,0
3,GO INTRACELLULAR TRANSPORT,0.9686,0.0091498,-0.0026833,0,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.89907,0.0091333,-0.010242,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.91987,0.0091104,0.0022079,0,0
3,GO HEAD MORPHOGENESIS,0.73628,0.0090675,-0.054164,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.82348,0.0090306,0.012044,0,0
3,GO INSEMINATION,0.56666,0.0090097,-0.071983,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.83713,0.0088583,-0.029768,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.60272,0.0086388,-0.036803,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.78289,0.0085554,-0.042887,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.86455,0.0083696,-0.047653,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,0.0083209,-0.041158,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.63978,0.0083131,-0.031907,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.73628,0.0082851,0.011449,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.52594,0.0082561,0.044908,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.9686,0.0081832,-0.010798,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.87144,0.0081344,-0.0070383,0,0
3,GO FIBROBLAST ACTIVATION,0.80312,0.0081279,-0.041497,0,0
3,GO NUCLEOSOME ASSEMBLY,0.55487,0.0080678,0.024743,0,0
3,GO RESPONSE TO FATTY ACID,0.63354,0.007977,0.014849,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.32077,0.0079634,-0.06499,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.5726,0.0078482,0.013017,0,0
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.39858,0.0078203,-0.050042,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.96163,0.0078085,-0.0010393,0,0
3,GO REGULATION OF DENDRITE EXTENSION,0.5726,0.0077551,0.11384,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.62732,0.0077524,0.039512,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.61497,0.0077184,-0.037848,0,0
3,GO POSITIVE REGULATION OF BINDING,0.89215,0.0076239,0.005204,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.76948,0.0075946,-0.023653,0,0
3,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.59059,0.007441,-0.043833,0,0
3,GO ENDOCYTOSIS,0.73628,0.0073062,0.0071156,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.41341,0.0072445,0.032636,0,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.78289,0.0070853,0.00025501,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.91987,0.0070363,-0.024636,0,0
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.43883,0.0069035,0.021505,0,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.96163,0.0068807,-0.025694,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.91987,0.0068506,-0.020342,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.72969,0.0068365,0.021299,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.90599,0.0067852,-0.0039021,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.73628,0.0067294,-0.0023183,0,0
3,GO DNA STRAND ELONGATION,0.79636,0.0066817,0.033476,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.40349,0.006628,0.032395,0,0
3,GO SPINAL CORD DEVELOPMENT,0.56666,0.0065917,0.036106,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.8303,0.0064893,-0.02342,0,0
3,GO ISOPRENOID METABOLIC PROCESS,0.41842,0.0064745,-0.050097,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.39858,0.0064415,-0.082113,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.71006,0.0064107,-0.062065,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.81668,0.0064007,-0.0014967,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.3746,0.0063876,0.036079,0,0
3,GO TRANSITION METAL ION TRANSPORT,0.9686,0.0062893,-0.012317,0,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.69707,0.0062535,-0.03318,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.9686,0.0061402,0.0075368,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.85768,0.0060765,-0.0030939,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.71658,0.0059511,-0.039991,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.50337,0.0059337,-0.048614,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.96163,0.0058761,-0.011583,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.74288,0.005827,0.038529,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.74288,0.005808,-0.056682,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.98953,0.0056344,0.0085193,0,0
3,GO VESICLE CARGO LOADING,0.96163,0.0055976,-0.034602,0,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.47049,0.0055959,-0.076542,0,0
3,GO STEROL TRANSPORT,0.5726,0.0055668,-0.042278,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.84397,0.0055293,0.0032237,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.98953,0.0053946,0.0052026,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.85768,0.0053581,-0.0010191,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.79636,0.005149,-0.026913,0,0
3,GO MIDGUT DEVELOPMENT,0.96163,0.0051445,-0.015151,0,0
3,GO CHONDROCYTE PROLIFERATION,0.91987,0.0051153,0.0016201,0,0
3,GO CELLULAR RESPONSE TO ATP,0.3746,0.0050817,0.047175,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.41842,0.0050806,0.031823,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.72969,0.0050624,-0.043073,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.94073,0.0050359,-0.0048989,0,0
3,GO HEART GROWTH,0.2839,0.0050315,0.056927,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.30815,0.0050261,0.037477,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.63354,0.0049954,0.013793,0,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.61497,0.0049698,0.037935,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.97557,0.0049425,-0.0017851,0,0
3,GO CHROMATIN ORGANIZATION,0.98255,0.004924,-0.0017387,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.85082,0.0049136,-0.061184,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.48131,0.0048492,0.023663,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.52025,0.0048344,0.01364,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.66501,0.0047222,-0.063692,0,0
3,GO MACROMOLECULE DEACYLATION,0.65866,0.0047171,0.015379,0,0
3,GO CELL CYCLE PROCESS,0.89215,0.0046228,-0.003076,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.74288,0.0046221,-0.027191,0,0
3,GO RECEPTOR RECYCLING,0.91293,0.004562,-0.012386,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.38408,0.0044266,0.080401,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.31653,0.0043766,0.044046,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.69061,0.0042673,-0.0027631,0,0
3,GO REGULATION OF BINDING,0.62732,0.0042594,-0.01871,0,0
3,GO HYPEROSMOTIC RESPONSE,0.78289,0.0042529,-0.031204,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.90599,0.004252,0.011128,0,0
3,GO PEPTIDYL SERINE MODIFICATION,0.33812,0.0041312,-0.028558,0,0
3,GO REGULATION OF PROTEIN STABILITY,0.62732,0.0041212,-0.016858,0,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.90599,0.0039969,-0.011779,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.52594,0.0038315,0.034647,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.85082,0.0037939,-0.0089701,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.7495,0.0037598,0.0014151,0,0
3,GO DRUG METABOLIC PROCESS,0.7495,0.0037539,-0.0068088,0,0
3,GO METHIONINE METABOLIC PROCESS,0.91293,0.0036902,-0.018883,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.73628,0.0036781,-0.043312,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.63978,0.0034803,-0.040616,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.63354,0.0034268,0.01767,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.72313,0.0033832,0.014453,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.97557,0.0033497,-0.0034348,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.33812,0.0033183,0.048085,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.77618,0.0032772,-0.0396,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.53167,0.0032278,0.045445,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.91293,0.0032274,-0.017486,0,0
3,GO MAST CELL MIGRATION,0.79636,0.0030541,-0.057608,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.9686,0.0030387,-0.0057029,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.72969,0.0030025,0.01727,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.75615,0.0029931,0.03214,0,0
3,GO MITOTIC CELL CYCLE,0.87144,0.0029303,-0.009113,0,0
3,GO DOPAMINE METABOLIC PROCESS,0.96163,0.0028974,0.028137,0,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.93377,0.0028891,-0.0074689,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.89215,0.0028527,-0.012984,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.59059,0.0027225,-0.033148,0,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.68418,0.0026018,0.0055043,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.75615,0.0024251,0.011794,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.56666,0.0021858,0.027748,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.66501,0.0021491,-0.012893,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.96163,0.0020983,-0.00019962,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.42855,0.0020975,0.092799,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.65234,0.0019754,0.060867,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.49227,0.0019008,-0.065546,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.76948,0.0018088,-0.0023158,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.91987,0.0017719,0.0062413,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.69061,0.001762,0.016804,0,0
3,GO CELL PROJECTION ORGANIZATION,0.66501,0.0017527,0.018766,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.71658,0.0017109,0.023363,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.75615,0.0015939,-0.042717,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.9686,0.0014908,-0.0014358,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.9686,0.0014733,-0.0091945,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.85082,0.0014074,-0.034616,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.52025,0.0012349,0.026247,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.89907,0.0012121,-0.012278,0,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.31232,0.0011984,-0.059052,0,0
3,GO RESPONSE TO INTERLEUKIN 4,0.59059,0.0011784,-0.036901,0,0
3,GO IMPORT INTO NUCLEUS,0.93377,0.0011547,-0.0035695,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.78289,0.0011132,-0.048874,0,0
3,GO LIPID PHOSPHORYLATION,0.50337,0.0010831,0.041144,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.53167,0.0010643,-0.039973,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.65866,0.0010595,0.033711,0,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.44402,0.00094454,0.029056,0,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.78962,0.00092425,-0.029875,0,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.72969,0.00085306,-0.076354,0,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.87144,0.00066066,0.0056869,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.97557,0.00061569,-0.001468,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.80312,0.00058415,0.013009,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.83713,0.00054748,-0.013983,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.85768,0.00049936,-0.030225,0,0
3,GO RESPONSE TO NICOTINE,0.69061,0.00045567,0.027831,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.54321,0.00034335,-0.014881,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.41341,0.00014907,0.021634,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.91293,0.00013118,0.00040004,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.75615,0.00011039,0.014211,0,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.83713,5.2757e-05,-0.039116,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.5726,-4.8057e-05,-0.016782,0,0
3,GO MAINTENANCE OF LOCATION,0.78289,-6.148e-05,0.0098354,0,0
3,GO PROTEIN AUTOPROCESSING,0.98953,-0.00016379,-0.022545,0,0
3,GO PIRNA METABOLIC PROCESS,0.48131,-0.0002303,-0.10914,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.52025,-0.00023226,-0.028183,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.77618,-0.00036335,0.0048093,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.63354,-0.000428,-0.044165,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.96163,-0.00048452,0.0017186,0,0
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.80312,-0.00049308,-0.05234,0,0
3,GO MUSCLE HYPERTROPHY,0.72969,-0.00058105,-0.028925,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.41842,-0.0007005,-0.034803,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1,-0.00076563,-0.031239,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.76948,-0.00085104,-0.029858,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.62732,-0.00086836,0.019572,0,0
3,GO FEVER GENERATION,0.53742,-0.0010039,0.030955,0,0
3,GO REGULATION OF RESPONSE TO FOOD,0.69061,-0.001153,-0.019731,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.80989,-0.0011931,-0.0028538,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0012676,-0.044833,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.79636,-0.0012742,0.0056948,0,0
3,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.96163,-0.0012755,-0.0061296,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.52594,-0.0013027,0.025534,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.78962,-0.001415,-0.014481,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.89215,-0.0014205,0.011426,0,0
3,GO BODY FLUID SECRETION,0.81668,-0.0014761,0.0029811,0,0
3,GO RESPONSE TO GLUCAGON,0.91987,-0.0015068,-0.014708,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.60883,-0.0015098,-0.030795,0,0
3,GO OVULATION CYCLE,0.4978,-0.0015213,0.032306,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.97557,-0.0016361,0.0037829,0,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.63354,-0.0016612,-0.02543,0,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.85768,-0.0016885,-0.0014084,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.94769,-0.0017264,-0.012812,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.67137,-0.0017465,-0.066126,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.59664,-0.0019113,-0.030114,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.39858,-0.0019951,0.039776,0,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.85768,-0.0020953,-0.059625,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.78962,-0.0021106,-0.043574,0,0
3,GO REGULATION OF CYTOKINESIS,0.43883,-0.002141,-0.032988,0,0
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.78289,-0.0021447,0.0050345,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.97557,-0.0021541,-0.011407,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.7495,-0.0021752,-0.039342,0,0
3,GO NUCLEOSIDE SALVAGE,0.36991,-0.0022156,0.039444,0,0
3,GO EXOCYTIC PROCESS,0.56666,-0.002245,0.062948,0,0
3,GO PIGMENT GRANULE MATURATION,0.85768,-0.0023048,-0.054706,0,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.97557,-0.0023323,-0.0083782,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.84397,-0.0023651,-0.025005,0,0
3,GO TAXIS,0.7495,-0.0024014,-0.010814,0,0
3,GO NEURON DEATH,0.92682,-0.0025196,-0.0017035,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.95466,-0.0026231,-0.013383,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.83713,-0.0030017,0.0066233,0,0
3,GO DOSAGE COMPENSATION,0.8303,-0.0030349,-0.013877,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.58456,-0.0030703,-0.15633,0,0
3,GO CHROMOSOME ORGANIZATION,0.87833,-0.0030851,0.0056816,0,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.37932,-0.0032129,-0.048803,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.40349,-0.003424,0.021385,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.93377,-0.0035655,-0.017228,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.60883,-0.0037699,0.020089,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.80989,-0.0038033,0.010839,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.68418,-0.0038524,-0.013559,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.53742,-0.0038826,0.035653,0,0
3,GO CHEMICAL HOMEOSTASIS,0.95466,-0.003967,-0.0080533,0,0
3,GO HEART MORPHOGENESIS,0.99651,-0.0041449,-0.018148,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.54903,-0.0041466,-0.019115,0,0
3,GO ORGANIC ACID TRANSPORT,0.55487,-0.0042215,0.017458,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.94073,-0.004325,-0.0048182,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.97557,-0.0043475,-0.013154,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.94769,-0.0043516,-0.016717,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.80312,-0.0043878,-0.024818,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.67776,-0.0045072,0.0046049,0,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.52025,-0.0047153,-0.030987,0,0
3,GO RESPONSE TO PH,0.76948,-0.004738,-0.027486,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.69707,-0.0047639,-0.021699,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.71658,-0.0048014,-0.013175,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.80312,-0.0048961,-0.015413,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.75615,-0.0049049,-0.025801,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.97557,-0.005009,0.0067403,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.72313,-0.005061,-0.052126,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.55487,-0.0050735,0.08997,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.90599,-0.0050959,-0.0070516,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.61497,-0.0051145,-0.021377,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.87144,-0.0051889,0.013658,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.72313,-0.0052208,-0.050558,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.82348,-0.0052434,-0.0048747,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.65866,-0.0052449,-0.048825,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.66501,-0.005382,-0.043445,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.20621,-0.0057439,-0.059669,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.87144,-0.0061845,-0.014707,0,0
3,GO LIPID CATABOLIC PROCESS,0.47588,-0.0062484,-0.037588,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.65234,-0.0063962,-0.022471,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.56666,-0.0064213,-0.021922,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.3746,-0.0064736,0.045386,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.91293,-0.0065886,-0.010019,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.95466,-0.0066102,-0.030804,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.85768,-0.0067242,0.0015205,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.48131,-0.0067761,0.044148,0,0
3,GO HEAT GENERATION,0.62113,-0.0067979,-0.041792,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.76281,-0.0068298,-0.040138,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.49227,-0.0068596,-0.061985,0,0
3,GO BLASTODERM SEGMENTATION,0.4978,-0.0069007,0.08959,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.44402,-0.0069391,-0.061373,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.31232,-0.006964,-0.10786,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.58456,-0.0069784,-0.030028,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.76948,-0.0071088,-0.0088894,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.86455,-0.0071364,0.018294,0,0
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.87833,-0.007325,-0.045401,0,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.7495,-0.0073674,-0.011251,0,0
3,GO HINDLIMB MORPHOGENESIS,0.66501,-0.0074091,0.010561,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.86455,-0.0074578,-0.016199,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.84397,-0.0076558,-0.01464,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.76281,-0.0076769,-0.0092746,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.92682,-0.0077309,-0.018139,0,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.80989,-0.008001,-0.01596,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.89907,-0.0080193,-0.0045908,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.70355,-0.0080197,-0.011913,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.65234,-0.0080541,-0.025212,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.89215,-0.0080773,0.020725,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.83713,-0.0081249,-0.022048,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,-0.0081736,-0.041355,0,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.61497,-0.008546,0.029044,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.80989,-0.0085715,-0.015401,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.54321,-0.0086583,-0.029287,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.82348,-0.0088617,-0.082832,0,0
3,GO ERK1 AND ERK2 CASCADE,0.51459,-0.0089105,-0.046951,0,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.85768,-0.0089968,-0.012245,0,0
3,GO TRACHEA MORPHOGENESIS,0.89907,-0.0091072,-0.018687,0,0
3,GO DRINKING BEHAVIOR,0.7495,-0.0093318,-0.0030326,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.97557,-0.0093498,0.0090277,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.69707,-0.009508,-0.004935,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.87144,-0.00953,-0.011361,0,0
3,GO RESPONSE TO X RAY,0.60272,-0.0096007,-0.065705,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0096237,-0.068419,0,0
3,GO FIBROBLAST PROLIFERATION,0.54903,-0.0097005,0.024163,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.59664,-0.00975,-0.0624,0,0
3,GO PERICARDIUM DEVELOPMENT,0.94073,-0.0097832,-0.011658,0,0
3,GO RESPONSE TO ETHANOL,0.99651,-0.0098929,-0.00047781,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.60883,-0.010035,-0.049841,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.65866,-0.01009,-0.037508,0,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.62732,-0.010112,-0.030351,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.53167,-0.010163,-0.041355,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.69707,-0.010221,-0.027857,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.49227,-0.010278,0.037499,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.8303,-0.010279,-0.010079,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.73628,-0.010351,-0.018502,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.81668,-0.010369,0.0030049,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.65234,-0.010619,-0.0232,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.97557,-0.010684,-0.013915,0,0
3,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.60272,-0.010713,-0.10836,0,0
3,GO HEART DEVELOPMENT,0.48678,-0.010727,-0.037599,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.36064,-0.010749,-0.084745,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.99651,-0.010795,-0.023231,0,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.31653,-0.010802,-0.029142,0,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.80989,-0.010999,-0.0041155,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.95466,-0.011084,0.01409,0,0
3,GO GENE SILENCING,0.40843,-0.011122,-0.021814,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.44924,-0.011182,-0.034949,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.67776,-0.011203,-0.1668,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.68418,-0.011264,-0.036411,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.64605,-0.011307,0.058723,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.19095,-0.011431,-0.080238,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.4545,-0.011468,-0.032258,0,0
3,GO RESPONSE TO AXON INJURY,0.91293,-0.011778,-0.0012456,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.62113,-0.011837,-0.034786,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.44402,-0.011893,0.12852,0,0
3,GO VESICLE LOCALIZATION,0.26847,-0.012029,-0.033037,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.47049,-0.012085,-0.032097,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.69061,-0.012213,-0.018482,0,0
3,GO CELLULAR RESPONSE TO STARVATION,0.40843,-0.012282,-0.041562,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.44924,-0.012391,-0.031789,0,0
3,GO MESODERM DEVELOPMENT,0.44924,-0.012459,-0.050142,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.56075,-0.012515,-0.022809,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.62732,-0.012588,0.025694,0,0
3,GO PROTEIN SUMOYLATION,0.77618,-0.012736,-0.0075734,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.50337,-0.012781,-0.022183,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.87833,-0.012867,-0.0079675,0,0
3,GO BIOMINERALIZATION,0.89215,-0.012871,-0.020201,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.34256,-0.012913,-0.031051,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.55487,-0.012973,0.085402,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.17934,-0.013086,-0.058279,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.21579,-0.013223,-0.045768,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.33812,-0.01325,-0.059833,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.93377,-0.013264,0.0035065,0,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.57857,-0.013331,-0.027579,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.65866,-0.013388,-0.013358,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.76948,-0.013403,0.024341,0,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.20309,-0.013471,-0.05008,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.56666,-0.013499,-0.066469,0,0
3,GO POLYOL CATABOLIC PROCESS,0.78962,-0.013535,-0.024826,0,0
3,GO GASTRULATION,0.65866,-0.013544,-0.044904,0,0
3,GO MICROTUBULE ANCHORING,0.63978,-0.013549,-0.024947,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.56666,-0.013641,-0.035936,0,0
3,GO PHOTOPERIODISM,0.88523,-0.013648,-0.015083,0,0
3,GO BLASTOCYST DEVELOPMENT,0.60272,-0.013652,-0.018421,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.98255,-0.013772,-0.0020253,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.36064,-0.013815,-0.055739,0,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.7495,-0.013861,-0.027981,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.96163,-0.013871,-5.346e-05,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.93377,-0.013925,0.012308,0,0
3,GO REGULATION OF FATTY ACID OXIDATION,0.65866,-0.013971,0.046057,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.8303,-0.013999,0.0024329,0,0
3,GO HISTONE H3 K9 MODIFICATION,0.36526,-0.014096,-0.039662,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.72969,-0.014098,-0.032344,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.59664,-0.014158,-0.038722,0,0
3,GO MITOPHAGY,0.33812,-0.014368,-0.059769,0,0
3,GO VITAMIN TRANSPORT,0.78289,-0.01444,0.035671,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.96163,-0.014539,-0.053293,0,0
3,GO HISTONE PHOSPHORYLATION,0.5726,-0.014694,-0.040065,0,0
3,GO HISTONE H3 K9 METHYLATION,0.59664,-0.01473,-0.027067,0,0
3,GO CELL DIVISION,0.48131,-0.014868,-0.022416,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.80312,-0.015031,-0.031949,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.60272,-0.015053,-0.043052,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.60272,-0.015136,-0.0088106,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.89215,-0.015318,-0.0092663,0,0
3,GO REGULATION OF T CELL MIGRATION,0.42347,-0.015403,-0.054232,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.40843,-0.015546,-0.019983,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.87144,-0.015547,-0.015575,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.81668,-0.015593,-0.0057824,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.15517,-0.015865,-0.045594,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.98255,-0.015901,-0.023011,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.39371,-0.015977,-0.05669,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.4545,-0.016055,-0.03357,0,0
3,GO SPINDLE ORGANIZATION,0.39858,-0.016137,-0.028088,0,0
3,GO GLIOGENESIS,0.74288,-0.016142,-0.017504,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.59664,-0.016208,-0.068997,0,0
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.61497,-0.016301,0.028317,0,0
3,GO RESPONSE TO STEROL,0.77618,-0.016342,-0.017548,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.56666,-0.016354,-0.024477,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.39371,-0.016433,-0.052615,0,0
3,GO ORGAN INDUCTION,0.4978,-0.016484,-0.074804,0,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.15264,-0.016519,-0.058883,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.24288,-0.016529,-0.032371,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.50337,-0.016546,-0.015016,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.50896,-0.016593,-0.053644,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.20937,-0.016604,-0.065645,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.44924,-0.016703,-0.027995,0,0
3,GO SISTER CHROMATID COHESION,0.92682,-0.016719,0.0106,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.68418,-0.016808,-0.052488,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.72313,-0.016871,-0.073009,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.46512,-0.016947,-0.030799,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.80312,-0.01708,-0.062657,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.4545,-0.017094,-0.030825,0,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.83713,-0.017231,-0.034079,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.33373,-0.017298,-0.048122,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.72969,-0.017307,-0.013092,0,0
3,GO AUTOPHAGIC CELL DEATH,0.52594,-0.017344,-0.05563,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.70355,-0.017345,-0.030833,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.76281,-0.017359,-0.012146,0,0
3,GO REGULATION OF TRANSPORT,0.61497,-0.017377,-0.014246,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.53742,-0.017379,-0.029342,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.5726,-0.01739,-0.0339,0,0
3,GO GLAND MORPHOGENESIS,0.46512,-0.017413,-0.092293,0,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.27611,-0.017446,-0.045449,0,0
3,GO CALCIUM ION IMPORT,0.65866,-0.017459,0.027533,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.89907,-0.01748,0.01167,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.53167,-0.017485,-0.019121,0,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.77618,-0.017605,-0.041129,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.86455,-0.017617,-0.029001,0,0
3,GO ACETYL COA METABOLIC PROCESS,0.74288,-0.017803,0.024424,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.58456,-0.017903,-0.012086,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.72313,-0.017932,-0.0043403,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.47049,-0.017987,-0.049102,0,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.36991,-0.01823,-0.09678,0,0
3,GO SISTER CHROMATID SEGREGATION,0.60272,-0.018329,-0.011517,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.91293,-0.01838,-0.080202,0,0
3,GO ANION TRANSPORT,0.7495,-0.018423,-0.010151,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.94769,-0.018629,0.018076,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.88523,-0.018726,-0.024389,0,0
3,GO RESPONSE TO ZINC ION,0.62113,-0.018737,-0.069647,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.58456,-0.018831,0.020753,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.53742,-0.018839,-0.060528,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.71006,-0.018859,-0.010004,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.34702,-0.018873,-0.071356,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.32506,-0.018886,-0.078006,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.53167,-0.01915,-0.046456,0,0
3,GO REGULATION OF CELL CYCLE,0.30815,-0.019229,-0.020215,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.41341,-0.019283,-0.022807,0,0
3,GO ORGANELLE INHERITANCE,0.49227,-0.019439,-0.037226,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.48131,-0.019447,-0.032394,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.49227,-0.019517,-0.042666,0,0
3,GO VASCULATURE DEVELOPMENT,0.25363,-0.019522,-0.066452,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.48678,-0.019665,-0.050587,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.58456,-0.019705,0.028858,0,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.23589,-0.019711,-0.054555,0,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.39858,-0.019807,-0.060449,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.56666,-0.019892,-0.028081,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.2,-0.019967,-0.071375,0,0
3,GO REGULATION OF AUTOPHAGY,0.4978,-0.019997,-0.022612,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.68418,-0.020077,-0.014108,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.50896,-0.020125,0.067618,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.67776,-0.020305,-0.012599,0,0
3,GO REGULATION OF PHOSPHORYLATION,0.20937,-0.020325,-0.042632,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.15264,-0.020357,-0.080097,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.23245,-0.020431,-0.059592,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.77618,-0.02049,-0.033878,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.65234,-0.020664,-0.02965,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.24643,-0.020679,-0.10669,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.65866,-0.021099,-0.030584,0,0
3,GO MEMBRANE FUSION,0.27999,-0.021176,-0.048341,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.89907,-0.021317,0.071593,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25363,-0.02133,-0.028237,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.27227,-0.021344,-0.033256,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.89907,-0.021446,-0.0045247,0,0
3,GO MUSCLE FILAMENT SLIDING,0.91987,-0.021468,-0.016047,0,0
3,GO ORGANIC ACID METABOLIC PROCESS,0.81668,-0.021567,-0.016558,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.4598,-0.021573,-0.051162,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.67776,-0.021645,-0.032571,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.51459,-0.021663,-0.03962,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.4545,-0.021732,-0.015393,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.53167,-0.021734,-0.026713,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.67776,-0.021846,-0.0047164,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.70355,-0.021862,-0.021587,0,0
3,GO REGULATION OF VASCULOGENESIS,0.33373,-0.021997,-0.093101,0,0
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.50337,-0.022015,-0.027923,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.78289,-0.022044,-0.03604,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.67137,-0.022119,-0.031084,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.72313,-0.02213,-0.051099,0,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.59664,-0.022203,-0.017086,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.21905,-0.022287,-0.090021,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.47588,-0.022386,-0.021315,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.80312,-0.022407,-0.038593,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.93377,-0.022455,-0.013078,0,0
3,GO FERTILIZATION,0.26098,-0.022487,-0.028927,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.188,-0.022569,-0.04408,0,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.29586,-0.022607,-0.034894,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.18219,-0.02268,-0.13403,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.50337,-0.022701,-0.035619,0,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.89907,-0.022744,-0.020357,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.92682,-0.022747,-0.0033542,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.77618,-0.02277,-0.02659,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.61497,-0.02287,-0.023392,0,0
3,GO CELLULAR RESPONSE TO KETONE,0.32938,-0.022926,-0.066363,0,0
3,GO BODY MORPHOGENESIS,0.31653,-0.022946,-0.081159,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.72313,-0.023015,-0.049528,0,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.59664,-0.023039,-0.081571,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.21579,-0.023048,-0.1047,0,0
3,GO P BODY ASSEMBLY,0.61497,-0.023064,-0.018746,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.95466,-0.023077,0.00022288,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.36991,-0.023133,-0.057583,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.32506,-0.023137,-0.056151,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.78962,-0.023186,-0.082528,0,0
3,GO DNA INTEGRITY CHECKPOINT,0.29586,-0.023214,-0.038719,0,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.36064,-0.02324,-0.063778,0,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.40349,-0.023243,-0.049346,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.17374,-0.023355,-0.046619,0,0
3,GO FATTY ACID TRANSPORT,0.72969,-0.023384,-0.024542,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.49227,-0.023425,-0.050692,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.49227,-0.023635,-0.021057,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.38408,-0.023652,-0.068116,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.15773,-0.024099,-0.049024,0,0
3,GO AMINE CATABOLIC PROCESS,0.44924,-0.024209,-0.093456,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.30402,-0.024269,-0.1025,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.27611,-0.024315,-0.054826,0,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.32938,-0.024508,-0.030476,0,0
3,GO RESPONSE TO ABIOTIC STIMULUS,0.52025,-0.024594,-0.023625,0,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35607,-0.024607,-0.033533,0,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.80989,-0.024674,-0.0090311,0,0
3,GO REGULATION OF DNA REPLICATION,0.92682,-0.02468,-0.0045385,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.65866,-0.024829,-0.01931,0,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.36064,-0.024879,-0.07039,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.41341,-0.024891,-0.055045,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.67137,-0.024914,-0.030866,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.30815,-0.024951,-0.031347,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.98255,-0.024992,0.01505,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35153,-0.025158,-0.071753,0,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.38888,-0.025203,-0.024403,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.41842,-0.025215,-0.021795,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.43367,-0.025222,-0.056351,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.78962,-0.025276,-0.01593,0,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.2839,-0.025285,-0.029132,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.44924,-0.025338,-0.030402,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.60272,-0.025653,-0.045093,0,0
3,GO AMINE TRANSPORT,0.99651,-0.025839,0.064469,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.98953,-0.025852,0.045742,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.53742,-0.025889,-0.011043,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.99651,-0.025897,0.0025506,0,0
3,GO CELLULAR KETONE METABOLIC PROCESS,0.5726,-0.02593,-0.053479,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.11841,-0.025953,-0.040729,0,0
3,GO CELL CYCLE,0.25001,-0.025977,-0.022523,0,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.27227,-0.026075,-0.049069,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.24288,-0.026102,-0.018355,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.72313,-0.02615,0.0020184,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.87144,-0.026156,-0.015939,0,0
3,GO MEMBRANE DOCKING,0.20309,-0.026247,-0.029645,0,0
3,GO MAMMARY GLAND DEVELOPMENT,0.20621,-0.026289,-0.071253,0,0
3,GO RESPONSE TO RADIATION,0.65866,-0.02629,-0.0067871,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.24643,-0.026311,-0.028875,0,0
3,GO MUSCLE CELL DIFFERENTIATION,0.40349,-0.026345,-0.042672,0,0
3,GO MACROPHAGE ACTIVATION,0.84397,-0.026365,-0.024553,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.56075,-0.026375,-0.047339,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,1,-0.026387,-0.012159,0,0
3,GO T CELL MIGRATION,0.43367,-0.026446,-0.06959,0,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.9686,-0.026471,0.027409,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.25363,-0.026567,-0.076366,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.36064,-0.026647,-0.055413,0,0
3,GO BLEB ASSEMBLY,0.33373,-0.026684,-0.25347,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15773,-0.026729,-0.097364,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.43367,-0.026904,-0.028678,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.50337,-0.026967,-0.044751,0,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.36064,-0.027007,-0.033968,0,0
3,GO AXIS SPECIFICATION,0.69707,-0.027023,-0.00131,0,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.46512,-0.027051,-0.040504,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.62732,-0.027099,-0.023682,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.87144,-0.027157,-0.0027098,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.85082,-0.02721,-0.0089129,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.17934,-0.027252,-0.048935,0,0
3,GO HOMEOSTATIC PROCESS,0.26847,-0.02729,-0.030685,0,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15264,-0.027331,-0.13456,0,0
3,GO MUSCLE ATROPHY,0.51459,-0.027353,-0.093716,0,0
3,GO FACE DEVELOPMENT,0.2,-0.027398,-0.098459,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.81668,-0.02754,-0.022786,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.34256,-0.027581,-0.03578,0,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.33373,-0.027635,-0.03034,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.67776,-0.027651,-0.017569,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.78289,-0.027837,-0.022079,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.56075,-0.027854,-0.10173,0,0
3,GO RESPONSE TO INSULIN,0.23937,-0.027872,-0.040946,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.95466,-0.027884,0.0057815,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.7495,-0.027931,-0.0022154,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.96163,-0.028046,-0.020998,0,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.34256,-0.028056,-0.028641,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.61497,-0.028077,-0.044532,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.68418,-0.028218,-0.021905,0,0
3,GO RESPONSE TO STARVATION,0.69707,-0.028266,-0.019755,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.32077,-0.028559,-0.044567,0,0
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.32938,-0.028631,-0.061288,0,0
3,GO CHROMOSOME SEGREGATION,0.4598,-0.028657,-0.022158,0,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.12473,-0.028662,-0.054169,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.83713,-0.028844,-0.0091235,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.67776,-0.028846,0.028935,0,0
3,GO ORGANIC ANION TRANSPORT,0.52594,-0.028995,-0.022643,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.87144,-0.029194,-0.039638,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.69707,-0.0292,-0.0099276,0,0
3,GO CELL SUBSTRATE ADHESION,0.56666,-0.029225,-0.050192,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.88523,-0.029295,-0.023462,0,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.5726,-0.029314,-0.027981,0,0
3,GO OSSIFICATION,0.33373,-0.029494,-0.057957,0,0
3,GO REGULATION OF CELL DIVISION,0.25729,-0.029523,-0.04194,0,0
3,GO MUSCLE CELL PROLIFERATION,0.61497,-0.029577,-0.039756,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.43883,-0.029639,-0.064164,0,0
3,GO LEUKOCYTE HOMEOSTASIS,0.28785,-0.02964,-0.067543,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.20937,-0.029771,-0.10267,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.27227,-0.029816,-0.030102,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.25729,-0.029835,-0.058054,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.25729,-0.029843,-0.056505,0,0
3,GO NIK NF KAPPAB SIGNALING,0.27227,-0.029898,-0.085049,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.059411,-0.02991,-0.065,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.070855,-0.030125,-0.036356,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.25001,-0.030207,-0.042938,0,0
3,GO MOLTING CYCLE,0.63354,-0.030221,-0.044955,0,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.31653,-0.03029,-0.057567,0,0
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.62113,-0.030407,-0.03705,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.21256,-0.030434,-0.071756,0,0
3,GO CELL JUNCTION ASSEMBLY,0.31232,-0.030441,-0.050339,0,0
3,GO STEM CELL DIVISION,0.94769,-0.03047,-0.0068845,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.4978,-0.030495,-0.053634,0,0
3,GO ACID SECRETION,0.90599,-0.030511,-0.0013233,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.77618,-0.030557,-0.010788,0,0
3,GO CELLULAR EXTRAVASATION,0.56075,-0.030612,-0.031455,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.50896,-0.030648,-0.056695,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.91987,-0.030648,-0.02002,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.40349,-0.030654,-0.052955,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.30402,-0.030756,-0.068411,0,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.080955,-0.030783,-0.083591,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.76948,-0.030822,-0.021881,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.69707,-0.030851,-0.027205,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.14526,-0.03092,-0.079507,0,0
3,GO REGULATION OF CELL AGING,0.32506,-0.030984,-0.064828,0,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.14526,-0.031013,-0.041615,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.20621,-0.031033,-0.058887,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.22568,-0.031154,-0.053133,0,0
3,GO AGING,0.1028,-0.031162,-0.074528,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.54321,-0.031173,-0.040351,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.23589,-0.031365,-0.062076,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.69707,-0.031397,-0.026546,0,0
3,GO HAIR FOLLICLE MATURATION,0.27611,-0.031505,-0.10466,0,0
3,GO PROTEIN CATABOLIC PROCESS,0.095625,-0.031539,-0.052693,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.47588,-0.031565,-0.039208,0,0
3,GO SKIN MORPHOGENESIS,0.39371,-0.031647,-0.14764,0,0
3,GO SULFATE TRANSPORT,0.073629,-0.031684,-0.062673,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.69061,-0.03171,-0.032563,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.38888,-0.031726,-0.06098,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.068167,-0.031776,-0.037793,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.4545,-0.031787,-0.045034,0,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0695,-0.031794,-0.043171,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.44402,-0.031798,-0.036458,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.65234,-0.031911,-0.028526,0,0
3,GO DNA CATABOLIC PROCESS,0.15773,-0.032259,-0.067355,0,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.23245,-0.032418,-0.05419,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.78962,-0.032572,-0.052148,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.15264,-0.03268,-0.16772,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.51459,-0.032754,-0.026166,0,0
3,GO REGULATION OF PHAGOCYTOSIS,0.22235,-0.032766,-0.090831,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.24643,-0.032795,-0.071503,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.90599,-0.032901,-0.019411,0,0
3,GO SODIUM ION HOMEOSTASIS,0.27999,-0.032947,-0.046438,0,0
3,GO REGULATION OF PROTEIN BINDING,0.36064,-0.03295,-0.037602,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.89907,-0.033011,0.01014,0,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.22568,-0.033062,-0.068204,0,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.61497,-0.033134,-0.010585,0,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.23245,-0.033202,-0.07845,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.11039,-0.033212,-0.03158,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.60272,-0.033233,-0.022539,0,0
3,GO HISTONE H2B UBIQUITINATION,0.19095,-0.033276,-0.077911,0,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.36064,-0.033339,-0.15957,0,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.15517,-0.033368,-0.037576,0,0
3,GO DNA METHYLATION,0.59664,-0.033528,-0.014798,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.60883,-0.033558,-0.077682,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.85768,-0.03357,0.0008337,0,0
3,GO LYSOSOMAL TRANSPORT,0.32506,-0.033694,-0.053499,0,0
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.46512,-0.033767,-0.044268,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.32938,-0.033798,-0.055461,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.5726,-0.033834,-0.029344,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.22905,-0.033836,-0.080209,0,0
3,GO RESPONSE TO METAL ION,0.29184,-0.033855,-0.042174,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17099,-0.033886,-0.03698,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.89907,-0.033909,0.016014,0,0
3,GO ALCOHOL METABOLIC PROCESS,0.69707,-0.033941,-0.029167,0,0
3,GO DETOXIFICATION,0.53167,-0.033965,-0.044965,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.48678,-0.033968,-0.067663,0,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.35607,-0.034059,-0.10266,0,0
3,GO FLUID TRANSPORT,0.25363,-0.034061,-0.074638,0,0
3,GO SIGNAL RELEASE,0.65866,-0.034071,-0.0010474,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.20309,-0.034174,-0.10134,0,0
3,GO INTRACELLULAR STEROL TRANSPORT,0.57857,-0.034258,-0.055949,0,0
3,GO MICROTUBULE BASED PROCESS,0.38408,-0.034271,-0.014227,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.12259,-0.034518,-0.043649,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.81668,-0.034534,0.0091153,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.62113,-0.03477,-0.047274,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.38408,-0.034804,-0.028389,0,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.99651,-0.034977,-0.0036248,0,0
3,GO CYTOSOLIC TRANSPORT,0.36526,-0.03502,-0.030797,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.51459,-0.035137,-0.030078,0,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.2,-0.035363,-0.031391,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.79636,-0.03559,-0.02196,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.39371,-0.035609,-0.026577,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.67776,-0.035659,-0.014561,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.43367,-0.035699,-0.042587,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.21256,-0.035736,-0.040174,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.093897,-0.035767,-0.054094,0,0
3,GO RESPONSE TO PEPTIDE,0.25729,-0.035808,-0.036664,0,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.22235,-0.035875,-0.065438,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.89215,-0.035892,0.015056,0,0
3,GO CIRCADIAN RHYTHM,0.24643,-0.035946,-0.029111,0,0
3,GO RESPONSE TO HYDROXYUREA,0.27999,-0.035971,-0.074191,0,0
3,GO REGULATION OF HEAT GENERATION,0.54903,-0.036122,-0.056632,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.58456,-0.036219,-0.018153,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.31653,-0.036249,-0.052113,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.55487,-0.03626,-0.098518,0,0
3,GO CELL REDOX HOMEOSTASIS,0.92682,-0.036266,-0.024957,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.54321,-0.03635,-0.019318,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.38408,-0.036384,-0.055867,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.95466,-0.03645,-0.0058813,0,0
3,GO NEURON APOPTOTIC PROCESS,0.63978,-0.036481,-0.0072482,0,0
3,GO RESPONSE TO THYROID HORMONE,0.82348,-0.036511,-0.029967,0,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.38408,-0.036559,-0.050379,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.72313,-0.036686,0.025592,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.13583,-0.036791,-0.10331,0,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.38408,-0.036805,-0.071526,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.26471,-0.036864,-0.060497,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.36991,-0.036872,-0.066441,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.80989,-0.036963,-0.013388,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE,0.14769,-0.037064,-0.045112,0,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.27999,-0.037255,-0.097812,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.93377,-0.03729,-0.0008696,0,0
3,GO NEPHRON MORPHOGENESIS,0.20309,-0.037413,-0.073062,0,0
3,GO LIPID MODIFICATION,0.061812,-0.037429,-0.071872,0,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.28785,-0.037451,-0.044029,0,0
3,GO GLIAL CELL DEVELOPMENT,0.40349,-0.037506,-0.044883,0,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.73628,-0.037519,-0.033958,0,0
3,GO LOCOMOTOR RHYTHM,0.94073,-0.037552,0.010264,0,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.51459,-0.037629,-0.069764,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.12049,-0.037645,-0.032588,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.29992,-0.03767,-0.062206,0,0
3,GO RENAL SYSTEM PROCESS,0.084046,-0.037818,-0.092098,0,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.84397,-0.038001,-0.039616,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.2,-0.038061,-0.10665,0,0
3,GO DE NOVO PROTEIN FOLDING,0.31653,-0.038069,-0.038373,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.59664,-0.038191,-0.018397,0,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.53167,-0.038201,-0.051807,0,0
3,GO RESPONSE TO ACTIVITY,0.23937,-0.03821,-0.067827,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.54903,-0.038384,-0.041155,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.20309,-0.03839,-0.059884,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.51459,-0.038394,-0.014103,0,0
3,GO N GLYCAN PROCESSING,0.39858,-0.038396,-0.10408,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.11841,-0.038424,-0.059097,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.49227,-0.038452,-0.11563,0,0
3,GO APPENDAGE DEVELOPMENT,0.12689,-0.038465,-0.09591,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.3746,-0.038467,-0.10747,0,0
3,GO CARNITINE SHUTTLE,0.91293,-0.038579,0.013771,0,0
3,GO ORGANELLE LOCALIZATION,0.05824,-0.038687,-0.039002,0,0
3,GO TRANSFERRIN TRANSPORT,0.2839,-0.038787,-0.062721,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.084046,-0.038791,-0.06953,0,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.073629,-0.038847,-0.04078,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.48678,-0.038902,-0.067253,0,0
3,GO DIET INDUCED THERMOGENESIS,0.73628,-0.038937,0.06081,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.29586,-0.039185,-0.04237,0,0
3,GO DNA MODIFICATION,0.17653,-0.039344,-0.043046,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.057089,-0.039424,-0.10535,0,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.12473,-0.039426,-0.062679,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.099158,-0.03947,-0.056999,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.84397,-0.039504,0.013789,0,0
3,GO REGENERATION,0.44924,-0.039542,-0.050252,0,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.061812,-0.039547,-0.085658,0,0
3,GO PEROXISOMAL TRANSPORT,0.33812,-0.039597,-0.047467,0,0
3,GO REGULATION OF INSULIN SECRETION,0.91987,-0.039604,-0.00057665,0,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.22905,-0.039639,-0.047706,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.59664,-0.039711,-0.031453,0,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.86455,-0.03972,-0.00070276,0,0
3,GO NEURON PROJECTION REGENERATION,0.89215,-0.039762,0.010796,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.84397,-0.039803,-0.0012998,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.71658,-0.039815,-0.06205,0,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.11039,-0.0399,-0.060889,0,0
3,GO AXIS ELONGATION,0.43883,-0.039958,-0.092542,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.27611,-0.039994,-0.057518,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.80312,-0.039999,-0.020449,0,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.26847,-0.04001,-0.029269,0,0
3,GO LIPID OXIDATION,0.39371,-0.040258,-0.057369,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.51459,-0.040537,-0.031294,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.20309,-0.040573,-0.078009,0,0
3,GO METANEPHROS DEVELOPMENT,0.18219,-0.040599,-0.08717,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.59664,-0.040689,-0.083843,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.9686,-0.040872,-0.0072722,0,0
3,GO VAGINA DEVELOPMENT,0.66501,-0.040942,-0.065526,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.30402,-0.040996,-0.030411,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.74288,-0.041092,-0.053444,0,0
3,GO ANIMAL ORGAN FORMATION,0.64605,-0.041307,-0.04753,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.62113,-0.041312,-0.014243,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.070855,-0.041433,-0.062038,0,0
3,GO CHOLESTEROL STORAGE,0.55487,-0.041642,-0.043475,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.43367,-0.041695,-0.070172,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.31232,-0.041744,-0.037809,0,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.11841,-0.041768,-0.1354,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.41341,-0.041783,-0.041813,0,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.5726,-0.041792,-0.0294,0,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.13355,-0.041859,-0.046722,0,0
3,GO PROTEIN AUTOPHOSPHORYLATION,0.47588,-0.04197,-0.025186,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.65234,-0.041986,-0.10079,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.98953,-0.042116,0.020262,0,0
3,GO CERAMIDE METABOLIC PROCESS,0.12049,-0.042272,-0.079071,0,0
3,GO PEROXISOME ORGANIZATION,0.22905,-0.04234,-0.053457,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.75615,-0.042351,-0.032161,0,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.26847,-0.042466,-0.059192,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.71658,-0.042635,0.017626,0,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.19695,-0.042642,-0.054506,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.96163,-0.042652,-0.013778,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.21256,-0.042748,-0.068053,0,0
3,GO OOGENESIS,0.093897,-0.042759,-0.089788,0,0
3,GO VITAMIN D METABOLIC PROCESS,0.53167,-0.042766,-0.062195,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.53742,-0.042845,-0.027221,0,0
3,GO CD40 SIGNALING PATHWAY,0.34702,-0.042873,-0.12019,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.1313,-0.04288,-0.061497,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.061812,-0.042892,-0.10529,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.61497,-0.04295,-0.0063505,0,0
3,GO REGULATION OF APPETITE,0.31232,-0.042951,-0.063649,0,0
3,GO ZINC ION HOMEOSTASIS,0.52594,-0.042958,-0.094631,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.72969,-0.043058,-0.013679,0,0
3,GO ASTROCYTE ACTIVATION,0.30402,-0.043064,-0.078155,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.38408,-0.043199,-0.024521,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.29184,-0.043241,-0.051012,0,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.19095,-0.043286,-0.058209,0,0
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.064293,-0.04336,-0.054893,0,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.53167,-0.043416,-0.034598,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.1028,-0.043477,-0.074725,0,0
3,GO MEMBRANE ORGANIZATION,0.33812,-0.043611,-0.030583,0,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.082489,-0.043676,-0.056599,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.79636,-0.043696,-0.0084209,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.78289,-0.043801,-0.027243,0,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.36991,-0.043886,-0.054294,0,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.16294,-0.044033,-0.045415,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.46512,-0.044044,-0.047773,0,0
3,GO REGULATION OF MITOPHAGY,0.25729,-0.044058,-0.068177,0,0
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.55487,-0.044097,-0.048412,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.56666,-0.04418,-0.033172,0,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.21256,-0.044222,-0.038824,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.14526,-0.044224,-0.094239,0,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.44924,-0.044239,-0.077296,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.05824,-0.044253,-0.04826,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.14769,-0.044285,-0.058075,0,0
3,GO PROTEIN POLYMERIZATION,0.42855,-0.044392,-0.022277,0,0
3,GO TOR SIGNALING,0.15517,-0.044434,-0.034649,0,0
3,GO RESPONSE TO HORMONE,0.29184,-0.044482,-0.03894,0,0
3,GO REGULATION OF SECRETION,0.17099,-0.044584,-0.046648,0,0
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.31232,-0.044735,-0.068603,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.04854,-0.044763,-0.052471,0,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.52025,-0.044783,-0.023919,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.29586,-0.044801,-0.12579,0,0
3,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.78962,-0.044913,0.036864,0,0
3,GO SPINDLE ASSEMBLY,0.05824,-0.044964,-0.053659,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.41842,-0.04497,-0.073289,0,0
3,GO RESPONSE TO INTERLEUKIN 1,0.088862,-0.044973,-0.10864,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.85082,-0.045019,-0.013569,0,0
3,GO POSITIVE REGULATION OF CELL DEATH,0.21905,-0.045074,-0.044078,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.8303,-0.045257,-0.051683,0,0
3,GO ORGANELLE ASSEMBLY,0.0066042,-0.045259,-0.058024,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.42347,-0.045265,-0.037511,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.72969,-0.04527,-0.037436,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.17099,-0.045311,-0.073217,0,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.1313,-0.045372,-0.06962,0,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.14769,-0.045383,-0.037579,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.83713,-0.045384,-0.031136,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.94769,-0.045392,-0.018674,0,0
3,GO RECEPTOR CATABOLIC PROCESS,0.44402,-0.045482,-0.055209,0,0
3,GO RESPONSE TO KETONE,0.17099,-0.045567,-0.077068,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.69061,-0.045643,-0.045265,0,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.079444,-0.045653,-0.065112,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0695,-0.045681,-0.090317,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20309,-0.045849,-0.066294,0,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.22568,-0.045864,-0.093317,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.62113,-0.046024,0.076036,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.48678,-0.046026,-0.060973,0,0
3,GO ASTROCYTE DEVELOPMENT,0.43883,-0.046047,-0.057739,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.73628,-0.046056,-0.023494,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.17653,-0.04608,-0.052696,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.23937,-0.046175,-0.13623,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.18219,-0.046193,-0.029822,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.24643,-0.046277,-0.050009,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12259,-0.0464,-0.055246,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.60272,-0.046604,-0.025664,0,0
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.27999,-0.046728,-0.2537,0,0
3,GO BONE MINERALIZATION,0.59664,-0.046734,-0.031952,0,0
3,GO RESPONSE TO NUTRIENT,0.32938,-0.046753,-0.060608,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.29586,-0.046767,-0.05418,0,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.44402,-0.046786,-0.032654,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.24643,-0.046825,-0.039587,0,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.22235,-0.046875,-0.044578,0,0
3,GO RESPONSE TO PAIN,0.65866,-0.047002,-0.062546,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.077957,-0.047005,-0.087691,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.13814,-0.047021,-0.037595,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.13583,-0.047041,-0.062751,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.25363,-0.047043,-0.053979,0,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.085627,-0.047119,-0.056345,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.7495,-0.047182,0.022279,0,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.11039,-0.047234,-0.072339,0,0
3,GO LIPID HOMEOSTASIS,0.18508,-0.047324,-0.072075,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.54903,-0.047375,-0.017306,0,0
3,GO JNK CASCADE,0.17653,-0.047471,-0.046982,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.9686,-0.047642,0.0054404,0,0
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.092194,-0.047734,-0.074036,0,0
3,GO NUCLEUS ORGANIZATION,0.066855,-0.047765,-0.048761,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.43367,-0.047786,-0.033608,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.59664,-0.047815,-0.013753,0,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.077957,-0.048062,-0.084675,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.25729,-0.048159,-0.055455,0,0
3,GO CELLULAR RESPONSE TO STEROL,0.98255,-0.048185,0.0053542,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.29992,-0.048244,-0.041564,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.8303,-0.048266,-0.017858,0,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.15015,-0.048332,-0.12801,0,0
3,GO GLUCOSE IMPORT,0.25363,-0.048497,-0.047554,0,0
3,GO PENILE ERECTION,0.74288,-0.048522,-0.028242,0,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.12049,-0.048531,-0.082053,0,0
3,GO VACUOLAR ACIDIFICATION,0.16294,-0.048637,-0.11439,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.18219,-0.048821,-0.045107,0,0
3,GO MANGANESE ION TRANSPORT,0.72313,-0.048862,-0.010146,0,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.21905,-0.048885,-0.066053,0,0
3,GO HISTONE H3 ACETYLATION,0.13583,-0.048885,-0.042872,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.092194,-0.049001,-0.069983,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.3746,-0.049032,-0.15971,0,0
3,GO RESPONSE TO TUMOR CELL,0.26098,-0.049036,-0.1034,0,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.64605,-0.049193,-0.053361,0,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.11039,-0.049196,-0.049893,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.82348,-0.049413,-0.061782,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.26847,-0.049473,-0.043069,0,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.060602,-0.049595,-0.054655,0,0
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.22905,-0.049611,-0.14107,0,0
3,GO INTEGRIN ACTIVATION,0.35153,-0.049632,-0.079514,0,0
3,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.83713,-0.049665,0.00089528,0,0
3,GO MEMBRANE INVAGINATION,0.20937,-0.049668,-0.072821,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.15517,-0.049676,-0.13311,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.10096,-0.049693,-0.16087,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.43883,-0.04979,-0.039119,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.22568,-0.049796,-0.044982,0,0
3,GO SINGLE FERTILIZATION,0.090515,-0.049836,-0.05013,0,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.1313,-0.04992,-0.059113,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.77618,-0.049942,-0.013333,0,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.075049,-0.049967,-0.085534,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.44402,-0.049996,-0.022489,0,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.7495,-0.050075,-0.022681,0,0
3,GO BIOLOGICAL ADHESION,0.13355,-0.050117,-0.073472,0,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.23589,-0.050222,-0.094412,0,0
3,GO LYMPHOCYTE MIGRATION,0.24288,-0.050246,-0.078135,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.21905,-0.050306,-0.091423,0,0
3,GO ARACHIDONIC ACID SECRETION,0.26847,-0.050416,-0.084436,0,0
3,GO REGIONALIZATION,0.29992,-0.050447,-0.039031,0,0
3,GO KINETOCHORE ORGANIZATION,0.41341,-0.050601,-0.055677,0,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.20937,-0.050746,-0.1183,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.70355,-0.050754,-0.029724,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.93377,-0.050779,0.004387,0,0
3,GO RESPONSE TO ALKALOID,0.33373,-0.050782,-0.045193,0,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.17653,-0.050807,-0.069296,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.26471,-0.05083,-0.039678,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.12689,-0.050997,-0.040191,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.99651,-0.051017,-0.015055,0,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.11434,-0.051027,-0.046379,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.91987,-0.051057,-0.0029276,0,0
3,GO STRESS FIBER ASSEMBLY,0.40349,-0.051068,-0.051594,0,0
3,GO REGULATION OF LIPID TRANSPORT,0.32077,-0.051105,-0.056605,0,0
3,GO REGULATION OF TUBE SIZE,0.19393,-0.051248,-0.067098,0,0
3,GO CELL CYCLE CHECKPOINT,0.082489,-0.05134,-0.045361,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.19393,-0.051372,-0.079947,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.28785,-0.051375,-0.076763,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.50337,-0.051386,-0.034784,0,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.14526,-0.051479,-0.072734,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.48678,-0.05157,-0.073262,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.25729,-0.051725,-0.090823,0,0
3,GO PIGMENTATION,0.12908,-0.051755,-0.068555,0,0
3,GO OVULATION,0.44402,-0.051842,-0.081234,0,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.20309,-0.05186,-0.10054,0,0
3,GO RESPONSE TO CHEMOKINE,0.54903,-0.051865,-0.045098,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.093897,-0.051995,-0.11452,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.24643,-0.052098,-0.041733,0,0
3,GO REGULATION OF CELL DEATH,0.079444,-0.052102,-0.059277,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.15517,-0.052159,-0.046643,0,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.33373,-0.052205,-0.060209,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.35153,-0.052596,-0.088513,0,0
3,GO RESPONSE TO VITAMIN,0.55487,-0.052661,-0.045344,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.54321,-0.052702,-0.047104,0,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.3746,-0.052811,-0.037548,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.71006,-0.052823,-0.083316,0,0
3,GO RESPONSE TO PEPTIDE HORMONE,0.17374,-0.052919,-0.042604,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.75615,-0.053214,-0.024949,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.13583,-0.053266,-0.066299,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.38888,-0.0533,-0.023923,0,0
3,GO PHAGOCYTOSIS,0.2839,-0.053521,-0.068683,0,0
3,GO NEGATIVE REGULATION OF SECRETION,0.12473,-0.053615,-0.055788,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.46512,-0.053724,-0.024273,0,0
3,GO ATP TRANSPORT,0.89907,-0.053776,0.0065594,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.52594,-0.053879,-0.040107,0,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.10096,-0.053887,-0.04293,0,0
3,GO EMBRYO DEVELOPMENT,0.1028,-0.053924,-0.053059,0,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.22235,-0.053968,-0.061382,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.27227,-0.054029,-0.073494,0,0
3,GO THYMIC T CELL SELECTION,0.20309,-0.054055,-0.050215,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.27999,-0.054061,-0.15296,0,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.5726,-0.05411,-0.066397,0,0
3,GO SYMBIOTIC PROCESS,0.087232,-0.054117,-0.079782,0,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.20309,-0.054237,-0.035746,0,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.093897,-0.054293,-0.060521,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.63354,-0.054364,-0.021443,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.43367,-0.054601,-0.011595,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11039,-0.054657,-0.054942,0,0
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.25729,-0.054699,-0.077944,0,0
3,GO MESENCHYME MORPHOGENESIS,0.092194,-0.054741,-0.13341,0,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.48131,-0.054777,-0.025516,0,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.43367,-0.054815,-0.060493,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.32938,-0.054824,-0.034578,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.2,-0.05483,-0.098465,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.69061,-0.055013,-0.013454,0,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.2,-0.055256,-0.055429,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.076492,-0.055397,-0.065251,0,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.39858,-0.055449,-0.042461,0,0
3,GO PRE MIRNA PROCESSING,0.51459,-0.055494,-0.034901,0,0
3,GO SELECTIVE AUTOPHAGY,0.19695,-0.055543,-0.07192,0,0
3,GO APOPTOTIC PROCESS,0.1028,-0.055601,-0.054798,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.41842,-0.055681,-0.052568,0,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.25001,-0.055796,-0.043774,0,0
3,GO DEVELOPMENTAL PIGMENTATION,0.14769,-0.055822,-0.076351,0,0
3,GO DEMETHYLATION,0.088862,-0.055835,-0.051845,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.47588,-0.05587,-0.023843,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.2839,-0.056102,-0.05852,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.10654,-0.056109,-0.057024,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.13355,-0.056217,-0.044563,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.53742,-0.056224,0.12115,0,0
3,GO CELL CELL RECOGNITION,0.11841,-0.056289,-0.073026,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.93377,-0.056476,-0.015392,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.34702,-0.05653,-0.031693,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.43367,-0.056572,-0.024253,0,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.14048,-0.056629,-0.12413,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.74288,-0.056701,-0.022079,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.38408,-0.056713,-0.047228,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.22235,-0.056787,-0.051562,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.60272,-0.057025,-0.0053905,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.16032,-0.05722,-0.075605,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.12259,-0.057266,-0.061562,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.32506,-0.057299,-0.06991,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.065563,-0.05744,-0.13976,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.43367,-0.057444,-0.057828,0,0
3,GO RESPONSE TO TESTOSTERONE,0.4598,-0.057452,-0.053363,0,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.33812,-0.057477,-0.081057,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.11039,-0.057543,-0.13967,0,0
3,GO PROTEIN MANNOSYLATION,0.69707,-0.057564,-0.020375,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.16828,-0.05759,-0.040918,0,0
3,GO HISTONE H4 ACETYLATION,0.087232,-0.057684,-0.047474,0,0
3,GO SENSORY PERCEPTION,0.11841,-0.057936,-0.04304,0,0
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.32077,-0.058163,-0.063558,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.12908,-0.058167,-0.06074,0,0
3,GO AMYLOID BETA METABOLIC PROCESS,0.30402,-0.058198,-0.055448,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.38408,-0.058241,-0.092118,0,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.077957,-0.058284,-0.05069,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.49227,-0.058314,-0.050802,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.18219,-0.058361,-0.082675,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.91987,-0.058464,0.0099453,0,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.15517,-0.058631,-0.077146,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.31653,-0.05865,-0.095502,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.059411,-0.058702,-0.086829,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.11434,-0.058703,-0.11516,0,0
3,GO GLYCOSYLATION,0.15517,-0.058708,-0.07068,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.32077,-0.058723,-0.035755,0,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.16828,-0.058764,-0.069985,0,0
3,GO FATTY ACID BETA OXIDATION,0.32077,-0.058862,-0.064597,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.085627,-0.059026,-0.091971,0,0
3,GO CAMP BIOSYNTHETIC PROCESS,0.36064,-0.059118,-0.096058,0,0
3,GO NEURONAL ACTION POTENTIAL,0.25001,-0.059138,-0.076407,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.76948,-0.059148,-0.0038809,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.19095,-0.05917,-0.1236,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.35607,-0.059229,-0.048949,0,0
3,GO TONGUE DEVELOPMENT,0.41341,-0.059263,-0.085089,0,0
3,GO GOLGI RIBBON FORMATION,0.38888,-0.059418,-0.062741,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.48678,-0.059444,-0.068701,0,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.24643,-0.059615,-0.15713,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.12049,-0.059713,-0.082747,0,0
3,GO RESPONSE TO FUNGUS,0.30815,-0.059877,-0.047315,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.18219,-0.05992,-0.097341,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.095625,-0.059945,-0.069165,0,0
3,GO T CELL CHEMOTAXIS,0.12049,-0.059949,-0.082357,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.98953,-0.059995,0.029895,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.23937,-0.060031,-0.081232,0,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.059411,-0.060173,-0.10032,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.26098,-0.06027,-0.040523,0,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.12473,-0.060364,-0.082909,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.13583,-0.06039,-0.067139,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.20309,-0.0604,-0.10067,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.12259,-0.060446,-0.085593,0,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.36991,-0.060454,-0.041694,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.92682,-0.060632,0.0018042,0,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.12908,-0.060711,-0.11151,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.14048,-0.060887,-0.052195,0,0
3,GO RESPONSE TO INTERLEUKIN 15,0.17653,-0.060934,-0.11468,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.44402,-0.061,-0.041059,0,0
3,GO APPENDAGE MORPHOGENESIS,0.15773,-0.061007,-0.10467,0,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.53742,-0.061014,-0.037754,0,0
3,GO SEX DIFFERENTIATION,0.11636,-0.061016,-0.050249,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19095,-0.061072,-0.057507,0,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.36991,-0.061221,-0.056979,0,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.082489,-0.061364,-0.077825,0,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.2,-0.061378,-0.1525,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.25729,-0.061488,-0.067297,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.63978,-0.061547,-0.025898,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.15517,-0.061581,-0.11519,0,0
3,GO REGULATION OF TOR SIGNALING,0.15015,-0.061624,-0.047396,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.11841,-0.0617,-0.068346,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.25001,-0.061778,-0.080982,0,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.24288,-0.061829,-0.1638,0,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.059411,-0.061852,-0.081493,0,0
3,GO RENAL FILTRATION,0.55487,-0.061867,-0.041388,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.33812,-0.06193,-0.0471,0,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.51459,-0.062005,-0.030543,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.16294,-0.062178,-0.10012,0,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.22235,-0.062194,-0.090051,0,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.16559,-0.062198,-0.044743,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.80312,-0.062241,-0.021675,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.44402,-0.062587,-0.02347,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.33373,-0.062824,-0.10819,0,0
3,GO REGULATION OF VASOCONSTRICTION,0.19695,-0.062861,-0.070382,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.32077,-0.063034,-0.033723,0,0
3,GO HYALURONAN METABOLIC PROCESS,0.35153,-0.063039,-0.069863,0,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.15015,-0.063307,-0.057595,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.1028,-0.063568,-0.11919,0,0
3,GO OOCYTE MATURATION,0.66501,-0.063675,-0.020409,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.065563,-0.063757,-0.063544,0,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.13583,-0.0638,-0.086583,0,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.25001,-0.063803,-0.094649,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.85768,-0.063809,0.0040887,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.36064,-0.063845,-0.049305,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.23589,-0.063872,-0.10514,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.70355,-0.064012,-0.031214,0,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.14048,-0.06404,-0.070882,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.13583,-0.064134,-0.12509,0,0
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.27611,-0.064153,-0.061548,0,0
3,GO REGULATION OF CELL MATURATION,0.087232,-0.064441,-0.072833,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.55487,-0.064485,0.094908,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.066855,-0.06483,-0.10504,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.18219,-0.064888,-0.10029,0,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.43367,-0.065007,-0.031353,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.18219,-0.065068,-0.11325,0,0
3,GO LIPID BIOSYNTHETIC PROCESS,0.060602,-0.065325,-0.070494,0,0
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.16294,-0.065333,-0.050958,0,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.065418,-0.049418,0,0
3,GO PRIMARY MIRNA PROCESSING,0.48131,-0.065474,-0.048068,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.52594,-0.065615,-0.050706,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.49227,-0.065623,-0.042442,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.14048,-0.065695,-0.089292,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.76948,-0.065715,0.0055686,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.18219,-0.065767,-0.079642,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.11434,-0.065784,-0.15275,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.068167,-0.065843,-0.055671,0,0
3,GO FATTY ACID CATABOLIC PROCESS,0.088862,-0.066178,-0.098585,0,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.059411,-0.066245,-0.086528,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.12259,-0.066303,-0.10011,0,0
3,GO REGULATION OF ANION TRANSPORT,0.092194,-0.066316,-0.072435,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.24643,-0.066361,-0.08214,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.22568,-0.06646,-0.10443,0,0
3,GO EPIBOLY,0.29184,-0.066593,-0.129,0,0
3,GO EATING BEHAVIOR,0.21905,-0.066676,-0.069817,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.69061,-0.06671,0.0053828,0,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.061812,-0.066742,-0.086157,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.05824,-0.066789,-0.083841,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.65866,-0.066992,-0.020116,0,0
3,GO INTERFERON GAMMA PRODUCTION,0.12049,-0.06706,-0.076101,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.59664,-0.067076,-0.059338,0,0
3,GO VITAMIN METABOLIC PROCESS,0.98255,-0.067183,0.0024998,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.74288,-0.067271,-0.035863,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.78289,-0.067299,-0.0081928,0,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.082489,-0.067305,-0.089652,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.4598,-0.067345,-0.088499,0,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.095625,-0.067411,-0.069622,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.095625,-0.067649,-0.063693,0,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.10845,-0.067715,-0.05579,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.4545,-0.06773,-0.059121,0,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.064293,-0.067756,-0.080653,0,0
3,GO HISTONE H2A ACETYLATION,0.22235,-0.067757,-0.061376,0,0
3,GO REGULATION OF BONE DEVELOPMENT,0.16559,-0.067791,-0.08264,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.81668,-0.067959,0.006514,0,0
3,GO REGULATION OF MAPK CASCADE,0.21256,-0.068029,-0.055321,0,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.097379,-0.068033,-0.14833,0,0
3,GO MEMBRANE RAFT ASSEMBLY,0.4598,-0.068115,-0.19913,0,0
3,GO STEROID HORMONE SECRETION,0.25001,-0.068121,-0.099478,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.39858,-0.068122,-0.048999,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.25363,-0.068167,-0.091611,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.27611,-0.068202,-0.070329,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.94769,-0.06822,0.063735,0,0
3,GO STEROID CATABOLIC PROCESS,0.4545,-0.068223,-0.067968,0,0
3,GO LIPID METABOLIC PROCESS,0.082489,-0.06838,-0.061218,0,0
3,GO BONE MATURATION,0.39371,-0.068413,-0.070685,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.10465,-0.068465,-0.090477,0,0
3,GO CELLULAR RESPONSE TO LIPID,0.17653,-0.068646,-0.067613,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.38888,-0.068737,-0.15186,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.24643,-0.068763,-0.17683,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.11636,-0.068841,-0.13751,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.11039,-0.068864,-0.084924,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.15773,-0.068878,-0.087709,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.49227,-0.069196,-0.09461,0,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.25729,-0.069239,-0.044835,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.44924,-0.069307,-0.059768,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.32938,-0.069376,-0.083875,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.14048,-0.069387,-0.10439,0,0
3,GO RESPONSE TO CORTICOSTEROID,0.10845,-0.069552,-0.097558,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.063042,-0.069572,-0.07148,0,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.14285,-0.06961,-0.12077,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.52025,-0.069614,-0.072431,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.65866,-0.069665,-0.029161,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.42347,-0.069711,-0.12189,0,0
3,GO STEM CELL PROLIFERATION,0.085627,-0.069873,-0.088511,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.49227,-0.069902,-0.047194,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.14048,-0.069984,-0.069522,0,0
3,GO RESPONSE TO EPINEPHRINE,1,-0.070059,0.0084342,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.36526,-0.070127,-0.11902,0,0
3,GO L PHENYLALANINE METABOLIC PROCESS,0.34256,-0.070147,-0.16427,0,0
3,GO RESPONSE TO SALT STRESS,0.17099,-0.070179,-0.097227,0,0
3,GO CELLULAR RESPONSE TO FATTY ACID,0.55487,-0.07019,-0.051358,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.32077,-0.070281,-0.075533,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.21579,-0.070396,-0.15765,0,0
3,GO OOCYTE DIFFERENTIATION,0.088862,-0.070457,-0.11075,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.23589,-0.070469,-0.048612,0,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.077957,-0.070546,-0.10172,0,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.076492,-0.070944,-0.075557,0,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.52025,-0.071008,-0.14249,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.18508,-0.071112,-0.073072,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.12473,-0.071121,-0.13684,0,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.088862,-0.07116,-0.081142,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.26471,-0.071183,-0.050459,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.41842,-0.07124,-0.038872,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.34702,-0.071327,-0.081445,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.66501,-0.071361,-0.014335,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.19393,-0.071443,-0.10888,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.12908,-0.071506,-0.057411,0,0
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.16032,-0.071682,-0.19393,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.20309,-0.071726,-0.19148,0,0
3,GO RESPONSE TO STEROID HORMONE,0.090515,-0.071862,-0.082773,0,0
3,GO REGULATION OF ERAD PATHWAY,0.11039,-0.072218,-0.056497,0,0
3,GO NEUTROPHIL CHEMOTAXIS,0.088862,-0.072555,-0.076916,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.079444,-0.072652,-0.096508,0,0
3,GO CELL MATURATION,0.095625,-0.072739,-0.059033,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.26098,-0.072774,-0.040754,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.22905,-0.072841,-0.10171,0,0
3,GO FEMALE GAMETE GENERATION,0.05824,-0.072977,-0.071017,0,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.14526,-0.073112,-0.063294,0,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.11636,-0.073163,-0.12615,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.38888,-0.073195,-0.069182,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.42855,-0.073636,-0.063622,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.31232,-0.073693,-0.086789,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.19695,-0.073724,-0.14012,0,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.084046,-0.073751,-0.072273,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.059411,-0.073851,-0.076544,0,0
3,GO REGULATION OF HORMONE SECRETION,0.17653,-0.074032,-0.05161,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.13583,-0.074207,-0.10346,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.19695,-0.074241,-0.085051,0,0
3,GO SPERM EGG RECOGNITION,0.14526,-0.07425,-0.060326,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.25729,-0.074747,-0.10372,0,0
3,GO FUCOSE METABOLIC PROCESS,0.33812,-0.074971,-0.086857,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.082489,-0.075002,-0.073294,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.27999,-0.075064,-0.074805,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.29586,-0.075212,-0.11366,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10654,-0.075306,-0.11015,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.16559,-0.075576,-0.098151,0,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.077957,-0.075608,-0.077803,0,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.42347,-0.075615,-0.030029,0,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.095625,-0.075639,-0.089565,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.076492,-0.075751,-0.2086,0,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.10096,-0.075787,-0.081429,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.34256,-0.075824,-0.063825,0,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.66501,-0.075893,-0.013919,0,0
3,GO HISTONE H3 DEACETYLATION,0.16294,-0.076023,-0.060796,0,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.068167,-0.07605,-0.079694,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.27227,-0.076241,-0.12255,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.188,-0.076252,-0.099063,0,0
3,GO OXALATE TRANSPORT,0.18508,-0.076339,-0.070137,0,0
3,GO STEROL METABOLIC PROCESS,0.36991,-0.076559,-0.044179,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.28785,-0.076608,-0.048475,0,0
3,GO GOLGI VESICLE TRANSPORT,0.064293,-0.076635,-0.067156,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.12259,-0.076699,-0.13211,0,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.14285,-0.076791,-0.075534,0,0
3,GO PEPTIDE HORMONE SECRETION,0.53167,-0.077103,-0.0186,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.25363,-0.077124,-0.059487,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16032,-0.077268,-0.064251,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.12049,-0.077274,-0.06012,0,0
3,GO RESPONSE TO LIPID,0.13355,-0.077308,-0.066226,0,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.070855,-0.077435,-0.099518,0,0
3,GO RESPONSE TO VITAMIN D,0.80989,-0.077594,0.039877,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.53167,-0.077645,-0.031668,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.40349,-0.077647,-0.11588,0,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.19095,-0.077662,-0.098862,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.084046,-0.077666,-0.067344,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.16294,-0.077716,-0.099133,0,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.21905,-0.077791,-0.1154,0,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.63354,-0.07786,0.021852,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.16559,-0.077919,-0.073781,0,0
3,GO NEUTROPHIL MIGRATION,0.082489,-0.078095,-0.096768,0,0
3,GO CELL AGING,0.061812,-0.078269,-0.080006,0,0
3,GO ARTERY MORPHOGENESIS,0.11039,-0.078324,-0.10161,0,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.1313,-0.078506,-0.057484,0,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.093897,-0.078605,-0.17566,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.21579,-0.078614,-0.08538,0,0
3,GO REGULATION OF HORMONE LEVELS,0.095625,-0.078628,-0.068587,0,0
3,GO DEVELOPMENTAL INDUCTION,0.17099,-0.078658,-0.1118,0,0
3,GO REGULATION OF OSSIFICATION,0.12049,-0.078785,-0.0924,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.10845,-0.07879,-0.13168,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.15517,-0.078833,-0.093369,0,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.077957,-0.078852,-0.08791,0,0
3,GO FOREBRAIN MORPHOGENESIS,0.82348,-0.078887,-0.0056324,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.17653,-0.078912,-0.081512,0,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.087232,-0.079113,-0.065285,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.13814,-0.079144,-0.091213,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.072231,-0.079169,-0.082162,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.39858,-0.079174,-0.063072,0,0
3,GO INCLUSION BODY ASSEMBLY,0.89907,-0.079179,0.033338,0,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.082489,-0.079539,-0.095341,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.62732,-0.079689,-0.12377,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.17653,-0.079723,-0.071325,0,0
3,GO STEROID ESTERIFICATION,0.11434,-0.079851,-0.19435,0,0
3,GO EMBRYO IMPLANTATION,0.24643,-0.079902,-0.10811,0,0
3,GO CENTRIOLE ASSEMBLY,0.13814,-0.079905,-0.068935,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.10096,-0.079933,-0.089764,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.15517,-0.079957,-0.097999,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.66501,-0.079977,-0.12878,0,0
3,GO PHOSPHOLIPID EFFLUX,0.21905,-0.080125,-0.1366,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.088862,-0.080256,-0.13641,0,0
3,GO HORMONE TRANSPORT,0.19695,-0.080339,-0.05185,0,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.027188,-0.080418,-0.06057,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.32938,-0.080418,-0.079,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.21256,-0.08045,-0.092696,0,0
3,GO KERATINOCYTE MIGRATION,0.61497,-0.08049,-0.039674,0,0
3,GO AMINE METABOLIC PROCESS,0.12049,-0.080577,-0.079885,0,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.60883,-0.080587,-0.0053089,0,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.11434,-0.08078,-0.068347,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.14285,-0.08084,-0.24794,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.17934,-0.080883,-0.082861,0,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.38888,-0.081216,-0.039415,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.89907,-0.08135,0.012913,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.79636,-0.081497,-0.014733,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.36064,-0.081499,-0.088131,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.46512,-0.081511,-0.043248,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.21905,-0.081737,-0.10744,0,0
3,GO MALE MEIOSIS I,0.14526,-0.081746,-0.16335,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.0018173,-0.081769,-0.08676,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.27999,-0.081823,-0.079765,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.36991,-0.081949,-0.11858,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.11039,-0.081967,-0.073009,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.17934,-0.082008,-0.068604,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.98953,-0.082031,0.0090464,0,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.057089,-0.082351,-0.1822,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.12908,-0.082473,-0.10733,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.11636,-0.082782,-0.07921,0,0
3,GO REGULATION OF LIPID STORAGE,0.087232,-0.082949,-0.091851,0,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.14526,-0.082951,-0.092192,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.21579,-0.082956,-0.10327,0,0
3,GO ERYTHROCYTE MATURATION,0.12049,-0.08344,-0.088107,0,0
3,GO PROTEIN DEGLYCOSYLATION,0.11039,-0.08417,-0.14361,0,0
3,GO REGULATION OF HAIR CYCLE,0.20937,-0.084269,-0.10289,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.20937,-0.084536,-0.056248,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.39858,-0.084864,-0.049769,0,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.12473,-0.0849,-0.10945,0,0
3,GO GASTRIC ACID SECRETION,0.60883,-0.08499,-0.037888,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.20309,-0.085085,-0.06729,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.55487,-0.085163,-0.041185,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.10654,-0.085236,-0.081822,0,0
3,GO B CELL HOMEOSTASIS,0.32506,-0.085482,-0.0654,0,0
3,GO P38MAPK CASCADE,0.095625,-0.085628,-0.11232,0,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.18508,-0.085753,-0.10198,0,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.076492,-0.086105,-0.076304,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.36064,-0.086299,-0.092187,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.29586,-0.086473,-0.083811,0,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.082489,-0.086596,-0.067863,0,0
3,GO TEMPERATURE HOMEOSTASIS,0.087232,-0.086657,-0.064314,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.25363,-0.086693,-0.11179,0,0
3,GO INOSITOL METABOLIC PROCESS,0.060602,-0.086994,-0.11438,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.13814,-0.087059,-0.083389,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.059411,-0.0872,-0.13205,0,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.67776,-0.087223,-0.074606,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.092194,-0.087339,-0.18318,0,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.13814,-0.087407,-0.19943,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.057089,-0.087547,-0.16547,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.68418,-0.087736,-0.044953,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.080955,-0.087739,-0.094854,0,0
3,GO ACTIN CROSSLINK FORMATION,0.87144,-0.087869,0.077755,0,0
3,GO STEROL HOMEOSTASIS,0.20621,-0.088167,-0.089323,0,0
3,GO TISSUE REGENERATION,0.1028,-0.088299,-0.11001,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.13814,-0.088552,-0.066869,0,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.13583,-0.088655,-0.096032,0,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.10096,-0.088765,-0.076278,0,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.095625,-0.088786,-0.10801,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.13355,-0.088807,-0.1344,0,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.072231,-0.089101,-0.11879,0,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.16559,-0.089316,-0.093759,0,0
3,GO POSITIVE CHEMOTAXIS,0.068167,-0.089478,-0.12492,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.15015,-0.089579,-0.11969,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.28785,-0.089763,-0.11846,0,0
3,GO RNA DESTABILIZATION,0.087232,-0.090047,-0.076442,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.91987,-0.090175,-0.0011283,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.87144,-0.090279,-0.050626,0,0
3,GO FUCOSYLATION,0.42347,-0.090311,-0.05878,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.12473,-0.090507,-0.078158,0,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.31653,-0.090544,-0.089967,0,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.26098,-0.09056,-0.093363,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.084046,-0.09068,-0.10219,0,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.21256,-0.090789,-0.040896,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.89907,-0.090943,-0.0083277,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.087232,-0.091064,-0.091989,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.0087944,-0.091301,-0.11058,0,0
3,GO INSULIN SECRETION,0.41842,-0.091501,-0.034162,0,0
3,GO MEIOTIC CELL CYCLE,0.00037661,-0.091734,-0.09741,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.072231,-0.091962,-0.18076,0,0
3,GO MACROPHAGE PROLIFERATION,0.43883,-0.091977,-0.11518,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.073629,-0.092056,-0.086216,0,0
3,GO LUNG MORPHOGENESIS,0.072231,-0.092227,-0.14341,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.015203,-0.092248,-0.10601,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.21256,-0.092277,-0.063994,0,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.095625,-0.092371,-0.060268,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.12908,-0.092676,-0.074987,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.063042,-0.0929,-0.13949,0,0
3,GO RNA DECAPPING,0.063042,-0.093165,-0.084048,0,0
3,GO RESPONSE TO FOOD,0.064293,-0.093167,-0.092211,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.12689,-0.093304,-0.11504,0,0
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.38408,-0.093305,-0.080008,0,0
3,GO PHAGOSOME MATURATION,0.14526,-0.093437,-0.085654,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.14285,-0.093568,-0.094321,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.10096,-0.093605,-0.091261,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.48678,-0.093985,-0.065317,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.12049,-0.094103,-0.18566,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.75615,-0.09437,-0.026685,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.080955,-0.094409,-0.083872,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.21905,-0.094589,-0.086714,0,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.063042,-0.094642,-0.11428,0,0
3,GO KINETOCHORE ASSEMBLY,0.57857,-0.094721,-0.053244,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.15264,-0.095036,-0.13654,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.090515,-0.095162,-0.13351,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.44402,-0.095188,-0.03795,0,0
3,GO STEROID METABOLIC PROCESS,0.079444,-0.095191,-0.083801,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.099158,-0.095222,-0.11135,0,0
3,GO PROTEIN REFOLDING,0.29586,-0.09544,-0.053965,0,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.99651,-0.095512,-0.06923,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.18508,-0.095779,-0.12623,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.30402,-0.096014,-0.34622,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.16294,-0.096559,-0.099548,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.44402,-0.09674,-0.097956,0,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.23937,-0.097144,-0.072208,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.20309,-0.097336,-0.073089,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.070855,-0.097522,-0.078017,0,0
3,GO CYTOPLASM ORGANIZATION,0.084046,-0.097634,-0.12684,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.0032441,-0.097681,-0.12134,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.64605,-0.097792,-0.053434,0,0
3,GO RENAL WATER HOMEOSTASIS,0.13355,-0.097948,-0.091902,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.15264,-0.09813,-0.10051,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.81668,-0.098187,0.018086,0,0
3,GO SPROUTING ANGIOGENESIS,0.073629,-0.098418,-0.10615,0,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.19695,-0.098759,-0.10064,0,0
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.5726,-0.098813,-0.040628,0,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.12473,-0.098825,-0.1131,0,0
3,GO MESODERM MORPHOGENESIS,0.077957,-0.098903,-0.11643,0,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.060602,-0.099032,-0.18398,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.080955,-0.099088,-0.11472,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.47588,-0.09924,-0.057015,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.23937,-0.099259,-0.062738,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.26098,-0.099356,-0.063304,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.25363,-0.099511,-0.10718,0,0
3,GO T CELL APOPTOTIC PROCESS,0.084046,-0.099884,-0.11709,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.12259,-0.099893,-0.08762,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.62732,-0.10003,-0.082911,0,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.085627,-0.10012,-0.096106,0,0
3,GO HEART INDUCTION,0.36064,-0.10018,-0.082211,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.4978,-0.10032,-0.068885,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.33812,-0.10033,-0.061251,0,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.072231,-0.10036,-0.1479,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.32938,-0.10056,-0.14047,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.097379,-0.10059,-0.072517,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.64605,-0.10088,-0.066347,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.20309,-0.10109,-0.14733,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.092194,-0.10111,-0.078679,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.60883,-0.10114,-0.049575,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.34256,-0.10131,-0.11721,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.46512,-0.10141,-0.083864,0,0
3,GO NOTOCHORD DEVELOPMENT,0.39371,-0.10143,-0.12899,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.11434,-0.10143,-0.12999,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.11636,-0.1018,-0.11731,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.15773,-0.10298,-0.10393,0,0
3,GO GOLGI LOCALIZATION,0.095625,-0.10299,-0.088866,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.35607,-0.10336,-0.057254,0,0
3,GO RESPONSE TO COLD,0.090515,-0.10342,-0.13864,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.20621,-0.10359,-0.083018,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.34256,-0.10408,-0.054531,0,0
3,GO SULFATION,0.11235,-0.10413,-0.13199,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.16828,-0.10432,-0.20675,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.23937,-0.10438,-0.14381,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.023741,-0.10443,-0.11891,0,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.10845,-0.10455,-0.077879,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.85768,-0.10474,-0.010847,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.7495,-0.10487,-0.049168,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.05824,-0.10505,-0.15867,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.47049,-0.10567,-0.069096,0,0
3,GO PANCREATIC JUICE SECRETION,0.24288,-0.10591,-0.073648,0,0
3,GO RESPONSE TO ESTRADIOL,0.093897,-0.10593,-0.083027,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.55487,-0.10596,-0.081441,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.40843,-0.10605,-0.070457,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.22235,-0.10614,-0.084726,0,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.12049,-0.1064,-0.078279,0,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.1313,-0.1066,-0.088014,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.7495,-0.10672,-0.023395,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.092194,-0.10818,-0.10951,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.25363,-0.10856,-0.05197,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.38408,-0.10867,-0.090366,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.27227,-0.10892,-0.076187,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.097379,-0.10894,-0.1109,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.24643,-0.1092,-0.076207,0,0
3,GO MRNA TRANSCRIPTION,0.25363,-0.10935,-0.072209,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.41341,-0.10941,-0.042975,0,0
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.63978,-0.10983,-0.14513,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.082489,-0.11013,-0.081344,0,0
3,GO FAT CELL PROLIFERATION,0.26098,-0.11081,-0.081584,0,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.16828,-0.11097,-0.14394,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.072231,-0.11222,-0.16981,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.75615,-0.11251,-0.048589,0,0
3,GO KETONE CATABOLIC PROCESS,0.070855,-0.11282,-0.1894,0,0
3,GO RESPONSE TO INSECTICIDE,0.80989,-0.11311,-0.013078,0,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.079444,-0.11333,-0.084827,0,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.12049,-0.1136,-0.28901,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.068167,-0.11386,-0.18963,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.031748,-0.11388,-0.22195,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.47588,-0.11402,-0.045653,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.21579,-0.1141,-0.11565,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.099158,-0.11447,-0.17675,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.91293,-0.11454,0.022408,0,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.12259,-0.11456,-0.16197,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.0085714,-0.1146,-0.11829,0,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.060602,-0.11507,-0.16772,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.14285,-0.11514,-0.10287,0,0
3,GO RESPONSE TO UV C,0.030383,-0.11551,-0.1629,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.072231,-0.11557,-0.12803,0,0
3,GO MYOTUBE DIFFERENTIATION,0.10096,-0.11618,-0.088465,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.12049,-0.11621,-0.17828,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.23937,-0.11666,-0.12927,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.088862,-0.11691,-0.12826,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.25001,-0.11722,-0.16384,0,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.2,-0.11725,-0.11246,0,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.092194,-0.11832,-0.1604,0,0
3,GO NEURON FATE COMMITMENT,0.41341,-0.11835,-0.040205,0,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.15015,-0.11851,-0.15717,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.095625,-0.11896,-0.12616,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.17934,-0.11901,-0.068565,0,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.090515,-0.11902,-0.13531,0,0
3,GO HORMONE METABOLIC PROCESS,0.11434,-0.1193,-0.098397,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.72313,-0.11935,-0.041044,0,0
3,GO STEROL IMPORT,0.34702,-0.11938,-0.055777,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.085627,-0.11962,-0.18799,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.25729,-0.11971,-0.079686,0,0
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.27611,-0.12024,-0.076403,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.087232,-0.12111,-0.15455,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.11434,-0.12172,-0.08329,0,0
3,GO HEART FORMATION,0.25001,-0.12187,-0.08206,0,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.41842,-0.12194,-0.056898,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.085627,-0.12254,-0.10509,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.33373,-0.12264,-0.19267,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.36064,-0.12265,-0.09638,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.16828,-0.12326,-0.14239,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.25001,-0.12327,-0.12467,0,0
3,GO NEGATIVE REGULATION OF CELL SIZE,0.082489,-0.12343,-0.094469,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.15015,-0.12357,-0.10189,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.63354,-0.12361,-0.079345,0,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.22568,-0.12369,-0.10727,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.35153,-0.12382,-0.085274,0,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.084046,-0.12411,-0.18517,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.14285,-0.12419,-0.11158,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.13583,-0.12451,-0.12157,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.21579,-0.12457,-0.073951,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.12908,-0.125,-0.10917,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.10096,-0.12573,-0.1186,0,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.18219,-0.126,-0.11398,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.036948,-0.12609,-0.18719,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.05161,-0.12619,-0.18499,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.56666,-0.12668,-0.065246,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.46512,-0.12681,-0.073083,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.15264,-0.12731,-0.085475,0,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.076492,-0.1274,-0.17121,0,0
3,GO RESPONSE TO CADMIUM ION,0.11039,-0.12778,-0.12653,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.075049,-0.12815,-0.11737,0,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.060602,-0.12853,-0.15283,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.29992,-0.12898,-0.14992,0,0
3,GO CILIUM ORGANIZATION,0.00052342,-0.12901,-0.13345,0,0
3,GO REGULATION OF GTP BINDING,0.40843,-0.12916,-0.069615,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.090515,-0.12965,-0.19235,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.12689,-0.12983,-0.19409,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.076492,-0.1303,-0.10402,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.095625,-0.13039,-0.10267,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.017549,-0.13045,-0.11113,0,0
3,GO AMMONIUM TRANSPORT,0.10845,-0.13054,-0.19741,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.072231,-0.1308,-0.1429,0,0
3,GO LIPID EXPORT FROM CELL,0.076492,-0.1312,-0.11281,0,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.057089,-0.13195,-0.10423,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.077957,-0.13235,-0.13666,0,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12908,-0.13297,-0.23336,0,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.12689,-0.13369,-0.12255,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.13355,-0.13395,-0.18851,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.099158,-0.13406,-0.087686,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.32938,-0.13435,-0.081308,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.010245,-0.13504,-0.138,0,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.066855,-0.1352,-0.15909,0,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.072231,-0.13536,-0.10553,0,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.1313,-0.13603,-0.097823,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.29992,-0.13626,-0.13545,0,0
3,GO REGULATION OF NEURON MATURATION,0.4598,-0.13662,-0.043819,0,0
3,GO RETINOL METABOLIC PROCESS,0.057089,-0.13684,-0.17424,0,0
3,GO PLASMA MEMBRANE FUSION,0.13814,-0.13697,-0.13578,0,0
3,GO FORELIMB MORPHOGENESIS,0.15264,-0.137,-0.11631,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19695,-0.13708,-0.070767,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.2839,-0.13874,-0.069496,0,0
3,GO UTERUS DEVELOPMENT,0.27999,-0.14048,-0.068691,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.12473,-0.14058,-0.11492,0,0
3,GO MEMBRANE FISSION,0.055956,-0.14069,-0.11701,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.0028957,-0.14073,-0.1457,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24288,-0.14184,-0.10259,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.37932,-0.1419,-0.095205,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.05824,-0.14226,-0.10691,0,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.097379,-0.14286,-0.1077,0,0
3,GO PHOTOTRANSDUCTION,0.0073363,-0.14296,-0.14348,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057817,-0.14298,-0.17715,0,0
3,GO V D J RECOMBINATION,0.011904,-0.14309,-0.19634,0,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.21905,-0.14358,-0.11073,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.16294,-0.14358,-0.17508,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.082489,-0.14419,-0.11358,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.24288,-0.14552,-0.19843,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.15264,-0.14566,-0.16436,0,0
3,GO ANIMAL ORGAN MATURATION,0.13355,-0.14576,-0.10707,0,0
3,GO CARNITINE METABOLIC PROCESS,0.38888,-0.14588,-0.064017,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.26847,-0.14619,-0.090231,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.53742,-0.14649,-0.16679,0,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.10845,-0.14707,-0.17964,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.35607,-0.1471,-0.082958,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.066855,-0.14727,-0.1549,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.19393,-0.14817,-0.10305,0,0
3,GO PLATELET DEGRANULATION,0.20621,-0.1483,-0.1132,0,0
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.21256,-0.14852,-0.17387,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.48131,-0.14951,-0.075744,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.32506,-0.14965,-0.11279,0,0
3,GO MICROTUBULE BUNDLE FORMATION,0.00087311,-0.14969,-0.16357,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.093897,-0.14977,-0.11086,0,0
3,GO COPULATION,0.068167,-0.1504,-0.11843,0,0
3,GO REGULATION OF MYOBLAST FUSION,0.12049,-0.15075,-0.17769,0,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.20309,-0.15141,-0.14563,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.26098,-0.15142,-0.14635,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.21579,-0.15203,-0.12687,0,0
3,GO DETECTION OF CALCIUM ION,0.2,-0.15249,-0.13043,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.22568,-0.15254,-0.10321,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.023205,-0.15258,-0.1816,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.20309,-0.15304,-0.15205,0,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.12689,-0.15324,-0.15939,0,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.070855,-0.15402,-0.13608,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.15015,-0.15425,-0.13189,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0049174,-0.1545,-0.18074,0,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.17099,-0.1547,-0.067165,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.29586,-0.15483,-0.054061,0,0
3,GO AMYLOID FIBRIL FORMATION,0.33373,-0.15512,-0.11336,0,0
3,GO SEROTONIN SECRETION,0.14526,-0.15553,-0.095884,0,0
3,GO GANGLION DEVELOPMENT,0.1313,-0.15648,-0.18093,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.20309,-0.15652,-0.16605,0,0
3,GO EPITHELIAL CELL MATURATION,0.070855,-0.1566,-0.13123,0,0
3,GO T CELL EXTRAVASATION,0.13583,-0.15669,-0.23466,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.073629,-0.15673,-0.15122,0,0
3,GO TELOMERE CAPPING,0.0041716,-0.15682,-0.11467,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.23589,-0.15705,-0.067929,0,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.019739,-0.1571,-0.15153,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.007729,-0.1573,-0.18045,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.18508,-0.15763,-0.13072,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0017641,-0.15846,-0.16745,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.12259,-0.15903,-0.20717,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.25363,-0.15953,-0.13287,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.070855,-0.16018,-0.14161,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.033894,-0.16114,-0.19282,0,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.25001,-0.16144,-0.11423,0,0
3,GO TYPE 2 IMMUNE RESPONSE,0.065563,-0.16191,-0.19482,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.42347,-0.1623,-0.10631,0,0
3,GO CELL FATE DETERMINATION,0.0094949,-0.16255,-0.18638,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.21256,-0.16348,-0.1121,0,0
3,GO LACTATE METABOLIC PROCESS,0.077957,-0.16484,-0.14518,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.74288,-0.16555,-0.03071,0,0
3,GO LYSINE METABOLIC PROCESS,0.082489,-0.16717,-0.21034,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.20621,-0.16786,-0.12081,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.080955,-0.16839,-0.11155,0,0
3,GO TRNA CATABOLIC PROCESS,0.24643,-0.16872,-0.13514,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.10465,-0.16995,-0.22625,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.024846,-0.17045,-0.16178,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.18219,-0.17115,-0.077585,0,0
3,GO CENTROSOME DUPLICATION,9.389e-05,-0.17204,-0.17864,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.53167,-0.17269,-0.038424,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.23245,-0.17407,-0.10281,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.044685,-0.17453,-0.14119,0,0
3,GO METANEPHROS MORPHOGENESIS,0.25001,-0.17581,-0.075415,0,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.11039,-0.17905,-0.12555,0,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.14769,-0.17951,-0.12749,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.21256,-0.17955,-0.1377,0,0
3,GO BRONCHUS DEVELOPMENT,0.20309,-0.18006,-0.13595,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.27999,-0.18063,-0.10727,0,0
3,GO CELL FATE SPECIFICATION,0.013798,-0.18077,-0.14292,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.12689,-0.18205,-0.097632,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.10654,-0.18215,-0.1864,0,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.080955,-0.18238,-0.2116,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00036427,-0.18249,-0.21438,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0029794,-0.18274,-0.23216,0,0
3,GO RESPONSE TO INACTIVITY,0.02166,-0.18324,-0.15967,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.0025083,-0.18534,-0.14784,0,0
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.12689,-0.18625,-0.15532,0,0
3,GO INTRACILIARY TRANSPORT,0.0025083,-0.18655,-0.20942,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.16032,-0.1866,-0.18686,0,0
3,GO GENITALIA MORPHOGENESIS,0.1028,-0.18737,-0.14642,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0069616,-0.18822,-0.15997,0,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.072231,-0.18966,-0.20207,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.22235,-0.18976,-0.20246,0,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,4.6597e-05,-0.18985,-0.20809,0,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.080955,-0.18988,-0.14246,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.32938,-0.18998,-0.11467,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.11235,-0.19042,-0.13911,0,0
3,GO RENAL ABSORPTION,0.082489,-0.19141,-0.23081,0,0
3,GO ETHANOL OXIDATION,0.15773,-0.19142,-0.23688,0,0
3,GO REGULATION OF CHLORIDE TRANSPORT,0.05824,-0.19226,-0.1733,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.10465,-0.19284,-0.15601,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.17934,-0.19379,-0.14419,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.0062634,-0.19384,-0.15592,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0094949,-0.19414,-0.17633,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.18508,-0.19669,-0.13112,0,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.17934,-0.19725,-0.1207,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.12473,-0.1974,-0.18682,0,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.073629,-0.19844,-0.1825,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.075049,-0.20108,-0.12896,0,0
3,GO CARDIOBLAST DIFFERENTIATION,0.10654,-0.20179,-0.12994,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.11636,-0.20224,-0.095155,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.1313,-0.20253,-0.1455,0,0
3,GO PARTURITION,0.082489,-0.2036,-0.1589,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0016129,-0.20414,-0.21579,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.070855,-0.20441,-0.18912,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.17374,-0.20468,-0.1526,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.017549,-0.20492,-0.26988,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.049546,-0.20493,-0.15013,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,9.389e-05,-0.2064,-0.21255,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.11039,-0.20747,-0.10216,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.25729,-0.20766,-0.15062,0,0
3,GO CENTROSOME SEPARATION,0.0067808,-0.20902,-0.19563,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.12259,-0.20926,-0.10614,0,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.13583,-0.20935,-0.15585,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.40349,-0.21308,-0.034826,0,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.12473,-0.2133,-0.15283,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.16828,-0.21457,-0.11528,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.0049174,-0.21697,-0.17376,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.076492,-0.21747,-0.23213,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.059411,-0.21796,-0.28744,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.22055,-0.073047,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.10845,-0.22751,-0.16087,0,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.060602,-0.22914,-0.31862,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.063042,-0.22994,-0.19183,0,0
3,GO CELL JUNCTION MAINTENANCE,0.0011549,-0.23176,-0.2268,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.079444,-0.23252,-0.16641,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.12689,-0.23289,-0.19345,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.21905,-0.23403,-0.11081,0,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0013457,-0.23426,-0.22204,0,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.084046,-0.23463,-0.20178,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.076492,-0.23651,-0.24512,0,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.17934,-0.23766,-0.081558,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.23937,-0.23921,-0.13675,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.15264,-0.23973,-0.14753,0,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0014738,-0.24015,-0.29273,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011904,-0.2446,-0.21774,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.027188,-0.24568,-0.13963,0,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00084609,-0.24956,-0.22203,0,0
3,GO RETINAL METABOLIC PROCESS,0.077957,-0.25064,-0.21635,0,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0001165,-0.25592,-0.26039,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.001986,-0.25694,-0.27516,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.19393,-0.25813,-0.1016,0,0
3,GO MYOBLAST MIGRATION,0.082489,-0.2586,-0.2141,0,0
3,GO HEART FIELD SPECIFICATION,0.060602,-0.26833,-0.17541,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.061812,-0.26905,-0.21526,0,0
3,GO FRUCTOSE METABOLIC PROCESS,0.079444,-0.2717,-0.24901,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.00055855,-0.27266,-0.22664,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.068167,-0.27576,-0.22095,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0081404,-0.28721,-0.20979,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.070855,-0.29173,-0.17678,0,0
3,GO HETEROTYPIC CELL CELL ADHESION,3.0576e-06,-0.29252,-0.34378,0,0
3,GO CARDIOBLAST PROLIFERATION,0.43883,-0.2964,-0.11467,0,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.011612,-0.3153,-0.23936,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.057089,-0.31534,-0.16377,0,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00081984,-0.31857,-0.24577,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.095625,-0.32207,-0.1348,0,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.097379,-0.32331,-0.24581,0,0
3,GO REFLEX,0.00087311,-0.34684,-0.36676,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,5.2533e-07,-0.35314,-0.34367,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,7.0571e-06,-0.35948,-0.3418,0,0
3,GO ADRENAL GLAND DEVELOPMENT,0.00045924,-0.36996,-0.30908,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.035393,-0.37892,-0.28382,0,0
3,GO RESPONSE TO MUSCLE INACTIVITY,2.9532e-05,-0.38095,-0.37791,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.12689,-0.38618,-0.17745,0,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00013917,-0.43491,-0.44366,0,0
3,GO NEURON FATE SPECIFICATION,0.0081404,-0.43561,-0.28917,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00016595,-0.44235,-0.4661,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,9.0551e-05,-0.45104,-0.41235,0,0
3,GO RETINA LAYER FORMATION,0.00010845,-0.48066,-0.42623,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0050528,-0.48127,-0.48072,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.038561,-0.49499,-0.24544,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.0027346,-0.52433,-0.42865,0,0
3,GO NOTCH RECEPTOR PROCESSING,8.6584e-06,-0.52724,-0.48523,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00020448,-0.53073,-0.48748,0,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,5.6174e-05,-0.53712,-0.45348,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,5.7413e-06,-0.53986,-0.59671,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00019079,1.6395,1.2286,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00029782,1.3107,0.97108,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.0021062,1.144,0.82209,1,1
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.1776e-06,0.98529,1.0912,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.2454e-05,0.94013,0.65639,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,2.4346e-05,0.89005,0.66802,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00025131,0.88801,0.72849,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,7.889e-07,0.88248,0.81443,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0022992,0.77947,0.47976,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,7.6603e-06,0.77585,0.66157,1,1
4,GO PROGESTERONE METABOLIC PROCESS,3.1888e-05,0.76646,0.87236,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00041602,0.76582,0.5488,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.4044e-06,0.75649,0.69385,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.00072223,0.75633,0.76785,1,1
4,GO TOLERANCE INDUCTION,0.001228,0.75474,0.58494,1,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0037331,0.74921,0.571,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,8.4205e-05,0.74598,0.6829,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,1.349e-05,0.74407,0.65166,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,9.7346e-05,0.73435,0.66802,1,1
4,GO LIPID DROPLET FORMATION,3.17e-07,0.72388,0.77405,1,1
4,GO HISTAMINE SECRETION,2.7578e-07,0.72337,0.76568,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00047456,0.71125,0.47508,1,1
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00010462,0.70248,0.5343,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,1.5331e-06,0.6893,0.80752,1,1
4,GO HISTAMINE TRANSPORT,2.0829e-07,0.68894,0.73484,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0038387,0.688,0.55211,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,9.4334e-07,0.68318,0.6227,1,1
4,GO MUCUS SECRETION,0.00021167,0.67366,0.5936,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0067808,0.66632,0.4427,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0007696,0.65651,0.48029,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.00017186,0.65565,0.57282,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,1.7806e-05,0.65554,0.6946,1,1
4,GO RESPONSE TO TYPE I INTERFERON,1.5201e-05,0.65391,0.60966,1,1
4,GO GERMINAL CENTER FORMATION,0.00013433,0.65307,0.5237,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.2962e-05,0.64631,0.66159,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0083534,0.64046,0.45957,1,1
4,GO CYTIDINE TO URIDINE EDITING,0.00047456,0.63072,0.59968,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.00032948,0.62683,0.42283,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.0010528,0.6241,0.43116,1,1
4,GO RESPONSE TO INTERFERON BETA,0.00025131,0.62376,0.55155,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0015653,0.6148,0.42998,1,1
4,GO MATURE B CELL DIFFERENTIATION,3.7145e-05,0.61019,0.44121,1,1
4,GO RENAL ABSORPTION,5.0226e-05,0.60893,0.56118,1,1
4,GO T CELL EXTRAVASATION,0.00038934,0.60292,0.56408,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,2.1663e-05,0.60185,0.59654,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00011241,0.59911,0.49596,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,2.2658e-06,0.59804,0.61535,1,1
4,GO RESPONSE TO INTERFERON ALPHA,0.0033369,0.59665,0.33966,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.0053338,0.59562,0.46225,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,3.8131e-07,0.5899,0.62779,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,4.4878e-05,0.5861,0.51219,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,2.6902e-06,0.58576,0.60644,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,5.7413e-06,0.58341,0.58283,1,1
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.025414,0.58035,0.2881,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00021909,0.57878,0.57457,1,1
4,GO TOXIN METABOLIC PROCESS,9.0221e-07,0.57472,0.57751,1,1
4,GO DETECTION OF OTHER ORGANISM,2.6307e-05,0.57053,0.56439,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.004408,0.57053,0.60963,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.6414e-07,0.56988,0.59241,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,5.4121e-05,0.56985,0.52903,1,1
4,GO SIGNAL PEPTIDE PROCESSING,3.0264e-07,0.56665,0.51859,1,1
4,GO QUINONE METABOLIC PROCESS,9.0551e-05,0.56322,0.59681,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00036427,0.56304,0.46563,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.0017123,0.56093,0.40681,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,1.349e-05,0.55998,0.58929,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,5.753e-07,0.5582,0.60188,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,6.2367e-06,0.55553,0.52974,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00034072,0.55433,0.3858,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,2.7343e-05,0.5529,0.50911,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,2.9301e-06,0.55164,0.52287,1,1
4,GO NEGATIVE REGULATION OF CELL KILLING,0.0097392,0.55064,0.39733,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,4.5813e-07,0.54811,0.57419,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,1.4609e-05,0.54704,0.58994,1,1
4,GO RESPONSE TO COLD,1.2366e-07,0.54652,0.49592,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.00016595,0.54275,0.48642,1,1
4,GO KETONE CATABOLIC PROCESS,0.00013917,0.54254,0.4409,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0017123,0.54225,0.41913,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,1.2962e-05,0.54197,0.46735,1,1
4,GO RESPONSE TO EPINEPHRINE,0.00026003,0.54178,0.42578,1,1
4,GO O GLYCAN PROCESSING,7.2754e-05,0.54033,0.43144,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,5.7413e-06,0.53787,0.53877,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,3.9418e-06,0.53709,0.47915,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.8583e-05,0.53608,0.55573,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00098941,0.53454,0.37286,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0006154,0.53289,0.392,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00023468,0.53059,0.5574,1,1
4,GO SEROTONIN METABOLIC PROCESS,1.4039e-05,0.5302,0.56611,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.00057693,0.52941,0.54566,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.7118e-05,0.52794,0.56779,1,1
4,GO ADHESION OF SYMBIONT TO HOST,0.014486,0.52551,0.33002,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00038934,0.52315,0.44381,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00016595,0.52109,0.39504,1,1
4,GO EOSINOPHIL MIGRATION,0.00019753,0.52013,0.41872,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,3.6228e-06,0.51952,0.54478,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,3.8583e-05,0.51559,0.62467,1,1
4,GO INTESTINAL ABSORPTION,5.0683e-06,0.51544,0.56545,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,9.7346e-05,0.51491,0.41058,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00019753,0.51477,0.38523,1,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,2.9532e-05,0.51337,0.46534,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00030804,0.5131,0.46527,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0028141,0.51132,0.36548,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,4.4712e-06,0.51091,0.48915,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00026003,0.51062,0.44872,1,1
4,GO REGULATION OF ANOIKIS,3.5759e-05,0.50987,0.51943,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00021167,0.50777,0.44811,1,1
4,GO CELLULAR DEFENSE RESPONSE,2.3654e-06,0.50736,0.4523,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.0184e-05,0.50655,0.48887,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,9.7346e-05,0.50422,0.38861,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00074557,0.50368,0.42269,1,1
4,GO RETINAL METABOLIC PROCESS,0.00023468,0.50162,0.5686,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,3.7791e-06,0.49974,0.50299,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,1.104e-05,0.49798,0.41876,1,1
4,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.0019282,0.49722,0.43035,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.349e-05,0.49511,0.44734,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0017123,0.49308,0.40012,1,1
4,GO ACTIN FILAMENT SEVERING,0.00020448,0.49226,0.45175,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.9263e-05,0.49225,0.50472,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,1.1964e-05,0.49158,0.5992,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0013872,0.48856,0.37422,1,1
4,GO REGULATION OF BONE REMODELING,9.4334e-07,0.48769,0.48627,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.0013872,0.48767,0.4083,1,1
4,GO PROTEIN DEMANNOSYLATION,2.1702e-06,0.48749,0.47468,1,1
4,GO REGULATION OF TISSUE REMODELING,1.906e-06,0.48624,0.42413,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00027832,0.48564,0.59312,1,1
4,GO RESPONSE TO PAIN,4.2876e-06,0.48465,0.46455,1,1
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.014841,0.48376,0.45215,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,2.0833e-05,0.48323,0.44516,1,1
4,GO RESPONSE TO DIETARY EXCESS,1.2862e-06,0.48098,0.531,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.043763,0.48024,0.2635,1,1
4,GO BONE RESORPTION,6.2985e-07,0.47907,0.46851,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,0.001986,0.47897,0.36796,1,1
4,GO GALACTOSE METABOLIC PROCESS,8.4205e-05,0.47842,0.5644,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00029782,0.47755,0.4914,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.2505e-07,0.47377,0.44035,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.3763e-07,0.4733,0.46842,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00023468,0.47287,0.48179,1,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,1.4039e-05,0.47113,0.51442,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,4.2876e-06,0.4705,0.52576,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,2.0784e-06,0.47038,0.47614,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00049035,0.47021,0.41942,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00022676,0.46942,0.41931,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,6.0504e-05,0.46621,0.40486,1,1
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.041093,0.46512,0.24104,1,1
4,GO PLASMINOGEN ACTIVATION,0.00049035,0.46443,0.49411,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0047853,0.46365,0.42824,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0011549,0.46226,0.43355,1,1
4,GO ZYMOGEN ACTIVATION,1.7806e-05,0.46214,0.48577,1,1
4,GO REGULATION OF PLATELET ACTIVATION,0.00016023,0.46091,0.37134,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0020453,0.46003,0.46472,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00020448,0.45942,0.37653,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.00021167,0.45856,0.4351,1,1
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00029782,0.45776,0.58386,1,1
4,GO RESPONSE TO REDOX STATE,0.00010462,0.4565,0.36022,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,1.9263e-05,0.45339,0.39923,1,1
4,GO RESPONSE TO ACIDIC PH,0.0012662,0.45304,0.33621,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.0013457,0.45264,0.36734,1,1
4,GO VASODILATION,2.8077e-06,0.45088,0.5993,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.020205,0.44998,0.36982,1,1
4,GO STEROID ESTERIFICATION,0.00012074,0.44914,0.54943,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00011241,0.44534,0.4759,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.8936e-07,0.44507,0.49502,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00011241,0.44485,0.59222,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00098941,0.44414,0.37809,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,7.0571e-06,0.44332,0.39451,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00081984,0.44317,0.3723,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.0571e-06,0.44309,0.52089,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0022992,0.44204,0.44082,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,0.00010462,0.4411,0.49932,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.010506,0.44101,0.34837,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011549,0.44036,0.36146,1,1
4,GO REGULATION OF PLATELET AGGREGATION,0.0028141,0.44001,0.34517,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,2.0033e-05,0.43968,0.43461,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0010528,0.43959,0.36218,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.0011199,0.43944,0.45693,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00025131,0.4388,0.3721,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0015189,0.43848,0.32371,1,1
4,GO REGULATION OF NEURON MATURATION,0.00024286,0.43841,0.35539,1,1
4,GO INSEMINATION,8.7323e-05,0.43836,0.41126,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0059384,0.4382,0.31847,1,1
4,GO LIVER MORPHOGENESIS,7.2754e-05,0.43779,0.40448,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,6.7728e-06,0.43736,0.48482,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0001165,0.43712,0.37338,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,3.0689e-05,0.43705,0.42363,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,3.8583e-05,0.43678,0.4599,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00030804,0.43652,0.40584,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.1964e-05,0.43605,0.4444,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00069957,0.4352,0.38626,1,1
4,GO INTESTINAL LIPID ABSORPTION,1.9263e-05,0.43461,0.59141,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.7118e-05,0.43409,0.64355,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.8077e-06,0.43393,0.34499,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,1.8521e-05,0.43262,0.41688,1,1
4,GO SUPEROXIDE ANION GENERATION,0.00012512,0.43076,0.44281,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,4.1617e-05,0.43061,0.37173,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.1192e-05,0.43023,0.38334,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,4.4878e-05,0.42981,0.42314,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00013917,0.42835,0.32935,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0094949,0.42765,0.2724,1,1
4,GO PROTEIN DEGLYCOSYLATION,6.7728e-06,0.4275,0.44457,1,1
4,GO BASIC AMINO ACID TRANSPORT,0.0030654,0.42711,0.42717,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0001165,0.42694,0.36929,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00059588,0.42637,0.34202,1,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0017123,0.42594,0.37661,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,1.4609e-05,0.42576,0.36783,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0018173,0.42564,0.37341,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.0198e-07,0.42523,0.3534,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,2.0784e-06,0.42452,0.36336,1,1
4,GO ACUTE PHASE RESPONSE,8.3127e-06,0.42389,0.38251,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,3.0264e-07,0.42369,0.45014,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,1.6455e-05,0.42364,0.3938,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00063551,0.42101,0.3711,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.5816e-05,0.42012,0.35892,1,1
4,GO B CELL APOPTOTIC PROCESS,5.2533e-07,0.41876,0.47908,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00069957,0.41729,0.38649,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0021689,0.41689,0.35002,1,1
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.03245,0.41662,0.23238,1,1
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00019079,0.4141,0.37564,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.00029782,0.4138,0.34436,1,1
4,GO RESPONSE TO THYROID HORMONE,0.00084609,0.41285,0.28661,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,6.5149e-05,0.41212,0.35351,1,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0025083,0.41176,0.27253,1,1
4,GO T CELL MEDIATED IMMUNITY,0.00090094,0.41129,0.2862,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,8.1192e-05,0.41117,0.4114,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00098941,0.41069,0.4163,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0014738,0.40997,0.31705,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,6.5149e-05,0.40938,0.39161,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,7.3528e-06,0.40923,0.33909,1,1
4,GO IMMUNOGLOBULIN SECRETION,1.1964e-05,0.40877,0.40831,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,4.2876e-06,0.40863,0.38223,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0017123,0.40826,0.27711,1,1
4,GO FOAM CELL DIFFERENTIATION,1.2454e-05,0.40809,0.34523,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.019739,0.40734,0.2992,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0040578,0.40728,0.2871,1,1
4,GO LIPOXYGENASE PATHWAY,0.033166,0.40676,0.25849,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00044439,0.40623,0.38683,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.00087311,0.40528,0.405,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.906e-06,0.40491,0.40754,1,1
4,GO REGULATION OF COAGULATION,0.00016595,0.40474,0.33444,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.00045924,0.40435,0.40488,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00030804,0.40318,0.34198,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00036427,0.40302,0.36038,1,1
4,GO CYSTEINE METABOLIC PROCESS,0.037747,0.40267,0.36512,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,6.2367e-06,0.40213,0.44317,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,9.0551e-05,0.40196,0.36711,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,0.00013433,0.40142,0.35633,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.4994e-06,0.40127,0.39015,1,1
4,GO VACUOLAR ACIDIFICATION,3.0264e-07,0.40117,0.42567,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.0013457,0.401,0.3021,1,1
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0069616,0.40061,0.30319,1,1
4,GO BONE REMODELING,7.9801e-06,0.40058,0.37083,1,1
4,GO TISSUE REMODELING,1.7118e-05,0.39932,0.32267,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.00067758,0.39859,0.30558,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,3.7791e-06,0.39768,0.40461,1,1
4,GO MUSCLE ATROPHY,0.011612,0.39736,0.2565,1,1
4,GO LIPID DIGESTION,9.389e-05,0.39705,0.52685,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00022676,0.39685,0.36961,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,0.00025131,0.39602,0.33571,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.00050664,0.39552,0.40801,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.007729,0.39545,0.28449,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.00014935,0.39535,0.35489,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,5.508e-06,0.39533,0.41935,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0031536,0.39519,0.3436,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00041602,0.39459,0.39783,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0042883,0.39438,0.24825,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,5.0226e-05,0.39393,0.29972,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0014738,0.39378,0.45189,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,9.0551e-05,0.39264,0.30581,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,8.628e-07,0.39147,0.39321,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.00065623,0.39135,0.30959,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0017641,0.39027,0.33651,1,1
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00019079,0.38921,0.32786,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,1.9904e-06,0.38905,0.38829,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.00019753,0.38855,0.34315,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00014935,0.38851,0.37093,1,1
4,GO RESPONSE TO LITHIUM ION,5.0683e-06,0.38849,0.49377,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0012662,0.38815,0.27498,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.00084609,0.38804,0.52236,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.00098941,0.38802,0.28841,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00072223,0.38709,0.25765,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00022676,0.38638,0.37595,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.00017186,0.38637,0.43281,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0073363,0.38633,0.37422,1,1
4,GO DEFENSE RESPONSE TO VIRUS,0.00021167,0.38613,0.26314,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.5816e-05,0.38574,0.35197,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.0036303,0.38548,0.35595,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00031859,0.38508,0.30718,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00032948,0.38504,0.32823,1,1
4,GO RESPONSE TO MINERALOCORTICOID,6.7596e-05,0.38486,0.3132,1,1
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0013054,0.38409,0.32457,1,1
4,GO BLOOD VESSEL REMODELING,0.0001165,0.38388,0.33576,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00065623,0.38387,0.28584,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00050664,0.38334,0.33876,1,1
4,GO REGULATION OF MYOBLAST FUSION,3.4421e-05,0.38326,0.38546,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0011199,0.38309,0.3546,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.0024367,0.38236,0.34191,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.6729e-06,0.38176,0.38008,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.4121e-05,0.3805,0.43702,1,1
4,GO INTEGRIN ACTIVATION,5.508e-06,0.38045,0.37797,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,3.4728e-06,0.38006,0.46064,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.00014418,0.38006,0.3385,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0018173,0.37983,0.31255,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.0033e-05,0.37888,0.42724,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,4.4712e-06,0.37864,0.33879,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,4.8379e-05,0.37847,0.36345,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0032441,0.37811,0.32083,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.00045924,0.37743,0.40393,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0021689,0.37731,0.29356,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.0010206,0.37726,0.32082,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0017641,0.37714,0.37517,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,4.4878e-05,0.37695,0.3508,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.2754e-05,0.37616,0.31371,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00063551,0.3757,0.30571,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,5.0226e-05,0.37551,0.34373,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,5.6174e-05,0.37483,0.31013,1,1
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.044685,0.37425,0.3111,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00012964,0.37394,0.27335,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.0551e-05,0.37386,0.25332,1,1
4,GO LIPID DROPLET ORGANIZATION,2.2658e-06,0.37349,0.35568,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,4.3218e-05,0.37312,0.31782,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,5.2837e-06,0.37223,0.34114,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0083534,0.37208,0.21057,1,1
4,GO CYCLOOXYGENASE PATHWAY,0.00084609,0.372,0.49582,1,1
4,GO PHAGOSOME ACIDIFICATION,4.3763e-07,0.37138,0.39764,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.2754e-05,0.37138,0.31877,1,1
4,GO SNARE COMPLEX ASSEMBLY,6.7596e-05,0.37085,0.315,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00037661,0.37058,0.33336,1,1
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00019079,0.37055,0.34167,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00079435,0.37011,0.29085,1,1
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014138,0.36842,0.27284,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,5.0226e-05,0.36822,0.29739,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00087311,0.36746,0.27342,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0011549,0.36738,0.35876,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00011241,0.36737,0.33822,1,1
4,GO L PHENYLALANINE METABOLIC PROCESS,0.001662,0.36733,0.50745,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.00024286,0.36648,0.31947,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.00057693,0.36633,0.25939,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00081984,0.36632,0.32844,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0006154,0.36623,0.26772,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00012512,0.36595,0.31573,1,1
4,GO ENTRY INTO HOST,0.001228,0.36551,0.23928,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.00074557,0.36476,0.3193,1,1
4,GO DIGESTIVE SYSTEM PROCESS,0.00014418,0.36402,0.27597,1,1
4,GO NATURAL KILLER CELL PROLIFERATION,0.0075304,0.36392,0.28595,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.00059588,0.36387,0.26848,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00036427,0.3635,0.33904,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.013465,0.36299,0.34138,1,1
4,GO LIPID TRANSLOCATION,0.00030804,0.36272,0.26746,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00040247,0.36269,0.3214,1,1
4,GO REGULATION OF ICOSANOID SECRETION,1.4039e-05,0.36244,0.38482,1,1
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0042883,0.36228,0.27806,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0037331,0.36217,0.26252,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,2.4346e-05,0.36074,0.45365,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0014299,0.36074,0.42709,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,5.2139e-05,0.3607,0.30926,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0021062,0.36019,0.35998,1,1
4,GO STEROID HORMONE SECRETION,7.8282e-05,0.35939,0.373,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,1.1964e-05,0.35892,0.32137,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00026003,0.35842,0.38926,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00036427,0.35821,0.33216,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00018427,0.35794,0.2915,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,8.7323e-05,0.35792,0.30339,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00030804,0.3579,0.27733,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00027832,0.35746,0.38589,1,1
4,GO B CELL MEDIATED IMMUNITY,0.00019753,0.35743,0.25874,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00069957,0.35719,0.27781,1,1
4,GO REGULATION OF B CELL ACTIVATION,8.3127e-06,0.35688,0.27408,1,1
4,GO RESPONSE TO GONADOTROPIN,9.389e-05,0.3564,0.30512,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00079435,0.35632,0.29212,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0001165,0.35593,0.33564,1,1
4,GO VASCULAR TRANSPORT,0.0034322,0.35533,0.34077,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,7.8282e-05,0.35533,0.2669,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,3.5759e-05,0.35501,0.32122,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00057693,0.35432,0.35463,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,7.547e-05,0.35408,0.38385,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00010462,0.35321,0.37955,1,1
4,GO NUCLEOTIDE SALVAGE,0.0047853,0.35245,0.29422,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00044439,0.35172,0.28403,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.010506,0.35171,0.26391,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00038934,0.3516,0.28798,1,1
4,GO RESPONSE TO INTERLEUKIN 2,0.00024286,0.35096,0.28155,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.00028792,0.35066,0.33413,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.628e-07,0.35063,0.38181,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00027832,0.35049,0.26369,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,3.1888e-05,0.3503,0.36584,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.0025817,0.35016,0.30608,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00021909,0.35016,0.32217,1,1
4,GO MAGNESIUM ION TRANSPORT,6.2786e-05,0.34988,0.31362,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0099891,0.34984,0.22622,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,1.9263e-05,0.34972,0.31479,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.2308e-06,0.34958,0.34783,1,1
4,GO DIGESTION,3.0689e-05,0.34933,0.32164,1,1
4,GO ETHER METABOLIC PROCESS,0.0031536,0.34896,0.22527,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0001547,0.34864,0.26324,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00017796,0.34841,0.23528,1,1
4,GO N GLYCAN PROCESSING,0.00067758,0.34777,0.31382,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0010206,0.34747,0.35209,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.8077e-06,0.34628,0.34855,1,1
4,GO LYSINE METABOLIC PROCESS,0.021165,0.34619,0.24565,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.025414,0.34616,0.36961,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00055855,0.34613,0.40929,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00038934,0.34574,0.30143,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00035231,0.3454,0.27126,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.001662,0.34521,0.23171,1,1
4,GO LYTIC VACUOLE ORGANIZATION,5.2533e-07,0.34517,0.35485,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.02268,0.34515,0.19345,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0010206,0.3446,0.33342,1,1
4,GO STEROL HOMEOSTASIS,0.00032948,0.34439,0.31945,1,1
4,GO PROTEIN AUTOPROCESSING,3.0689e-05,0.34438,0.37254,1,1
4,GO ANOIKIS,1.8521e-05,0.34435,0.37908,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,1.349e-05,0.34392,0.30184,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.010245,0.34391,0.20331,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0017123,0.34369,0.20959,1,1
4,GO OPTIC NERVE DEVELOPMENT,4.0073e-05,0.34367,0.47758,1,1
4,GO PARTURITION,0.0062634,0.34299,0.28809,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0001547,0.34296,0.31145,1,1
4,GO NADP METABOLIC PROCESS,0.0039469,0.34278,0.27287,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.349e-05,0.34257,0.29342,1,1
4,GO ALANINE TRANSPORT,0.00050664,0.34242,0.35703,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00016595,0.34234,0.32658,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.6729e-06,0.34233,0.33151,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0020453,0.34168,0.35296,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,7.9801e-06,0.34125,0.30124,1,1
4,GO ZYMOGEN INHIBITION,0.0030654,0.34115,0.24339,1,1
4,GO REGULATION OF FERTILIZATION,0.00010092,0.34114,0.34428,1,1
4,GO ICOSANOID METABOLIC PROCESS,5.4121e-05,0.34061,0.33961,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00063551,0.34022,0.29372,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0019282,0.34016,0.26811,1,1
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0025083,0.34002,0.34108,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0019282,0.33986,0.44313,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.7118e-05,0.33943,0.31475,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00013433,0.33936,0.35877,1,1
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0030654,0.339,0.39101,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00050664,0.3389,0.22679,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00034072,0.33886,0.33824,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,9.389e-05,0.33857,0.3183,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,1.5816e-05,0.33825,0.3492,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.00020448,0.33817,0.31461,1,1
4,GO CELLULAR RESPONSE TO STARVATION,1.9904e-06,0.33812,0.27695,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,9.7801e-06,0.33806,0.30278,1,1
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0024367,0.3378,0.34004,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.4346e-05,0.33776,0.2682,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.014841,0.33773,0.33325,1,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.024846,0.33732,0.25172,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.00021909,0.33726,0.33117,1,1
4,GO DIET INDUCED THERMOGENESIS,0.004408,0.33721,0.2333,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00057693,0.33629,0.23059,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00035231,0.33577,0.28214,1,1
4,GO REGULATION OF CELL KILLING,4.6597e-05,0.33559,0.31506,1,1
4,GO POLYOL TRANSPORT,0.00031859,0.33533,0.34987,1,1
4,GO RESPONSE TO MUSCLE STRETCH,0.0007696,0.33499,0.36856,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0020453,0.33496,0.29546,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.0184e-05,0.33473,0.29323,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00084609,0.3347,0.36639,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00074557,0.33447,0.27298,1,1
4,GO PROTEIN PROCESSING,1.2862e-06,0.33412,0.30171,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,6.0504e-05,0.33395,0.30577,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.00030804,0.33393,0.25874,1,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.00063551,0.33334,0.28052,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,9.7801e-06,0.33317,0.33997,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00011241,0.33225,0.34828,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00023468,0.33189,0.25058,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0001165,0.33154,0.34792,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0025083,0.3313,0.21309,1,1
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00047456,0.33124,0.34526,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,2.0833e-05,0.33109,0.29504,1,1
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.00084609,0.33104,0.41268,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,3.0689e-05,0.33091,0.37727,1,1
4,GO INNATE IMMUNE RESPONSE,3.4421e-05,0.3304,0.24732,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.00090094,0.33039,0.23182,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,8.7323e-05,0.33032,0.26339,1,1
4,GO CELL KILLING,7.0571e-06,0.33,0.27345,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.013798,0.32991,0.31278,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0013872,0.32973,0.26863,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00047456,0.3293,0.28408,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0046564,0.32923,0.1833,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.104e-05,0.32867,0.31747,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00074557,0.32867,0.34145,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.014486,0.32854,0.213,1,1
4,GO TYPE I INTERFERON PRODUCTION,0.00010462,0.32848,0.24518,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00012512,0.32844,0.26472,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.1663e-05,0.32745,0.26454,1,1
4,GO REGULATION OF B CELL PROLIFERATION,2.5774e-06,0.32693,0.35223,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00028792,0.32672,0.32824,1,1
4,GO REGULATION OF WOUND HEALING,0.00036427,0.32558,0.27049,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.016339,0.32541,0.21662,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,9.7346e-05,0.32525,0.30653,1,1
4,GO IMMUNE EFFECTOR PROCESS,4.8379e-05,0.32513,0.2447,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00010462,0.325,0.23206,1,1
4,GO OSTEOBLAST PROLIFERATION,0.00028792,0.3249,0.3062,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00045924,0.32461,0.26065,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00042998,0.32418,0.23356,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,9.3916e-06,0.32365,0.29238,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32351,0.2624,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.015203,0.32345,0.30355,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.00037661,0.32341,0.2786,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0025083,0.3234,0.32311,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,8.1192e-05,0.3228,0.26823,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0060989,0.3227,0.39852,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00013433,0.32242,0.25226,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,2.5308e-05,0.32218,0.23878,1,1
4,GO LIPID LOCALIZATION,2.1702e-06,0.32195,0.28957,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.00030804,0.32192,0.31023,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00010092,0.3216,0.3522,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.0011549,0.32157,0.21998,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0062634,0.32144,0.22642,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.012508,0.32118,0.25497,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,8.4205e-05,0.32118,0.32218,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.1192e-05,0.32055,0.31183,1,1
4,GO STEROID METABOLIC PROCESS,6.4994e-06,0.32019,0.30785,1,1
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0054795,0.32005,0.20727,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,1.9263e-05,0.32001,0.31591,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00052342,0.31981,0.2602,1,1
4,GO PLATELET DEGRANULATION,0.00074557,0.31951,0.25676,1,1
4,GO DRUG METABOLIC PROCESS,4.3218e-05,0.31944,0.35594,1,1
4,GO MAST CELL ACTIVATION,1.6455e-05,0.31927,0.30518,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0081404,0.31918,0.26708,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,2.6307e-05,0.31915,0.25974,1,1
4,GO THYMOCYTE APOPTOTIC PROCESS,0.0083534,0.31912,0.24084,1,1
4,GO ENDOCRINE PROCESS,7.9801e-06,0.31905,0.30465,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00017796,0.31884,0.30744,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0022992,0.31865,0.2758,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0051916,0.31828,0.22243,1,1
4,GO MAST CELL MEDIATED IMMUNITY,3.1888e-05,0.31812,0.29928,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.029719,0.31785,0.18703,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,2.6902e-06,0.31782,0.30255,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,5.4121e-05,0.3178,0.3264,1,1
4,GO VIRAL GENOME REPLICATION,0.00098941,0.31749,0.21784,1,1
4,GO RESPONSE TO FATTY ACID,0.00021167,0.31726,0.25247,1,1
4,GO RETINOL METABOLIC PROCESS,0.00010092,0.31713,0.39625,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,1.5816e-05,0.31709,0.27005,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0046564,0.31684,0.22685,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.017549,0.31679,0.21085,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00013917,0.31646,0.32494,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,8.7323e-05,0.31628,0.27887,1,1
4,GO RESPONSE TO COPPER ION,0.010245,0.31625,0.31915,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,3.7145e-05,0.31584,0.31932,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.00072223,0.3158,0.31932,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0028141,0.31579,0.21084,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.019739,0.31565,0.27737,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,5.0226e-05,0.31562,0.37447,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00029782,0.31533,0.33998,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.547e-05,0.31512,0.22685,1,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0071468,0.31507,0.21307,1,1
4,GO RESPONSE TO INTERLEUKIN 6,7.0571e-06,0.31491,0.36126,1,1
4,GO STEROL METABOLIC PROCESS,0.0001547,0.31479,0.24891,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.6228e-06,0.3142,0.2563,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0015189,0.31395,0.27744,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,1.7806e-05,0.3137,0.33259,1,1
4,GO B CELL HOMEOSTASIS,5.2139e-05,0.31324,0.2869,1,1
4,GO REGULATION OF CHLORIDE TRANSPORT,0.0021689,0.31314,0.35882,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0022992,0.31311,0.28562,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00020448,0.31307,0.23943,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0094949,0.31306,0.17934,1,1
4,GO RESPONSE TO STARVATION,2.9301e-06,0.31296,0.26502,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00050664,0.31257,0.29767,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0011549,0.31235,0.2291,1,1
4,GO AMINO ACID IMPORT,0.00353,0.31229,0.22444,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,4.0073e-05,0.31213,0.27885,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0031536,0.31206,0.28303,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00024286,0.31186,0.32023,1,1
4,GO MITOCHONDRIAL RNA PROCESSING,0.011326,0.31178,0.20643,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00079435,0.31141,0.20386,1,1
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0040578,0.31137,0.35407,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.8251e-06,0.31042,0.2609,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00029782,0.3103,0.22448,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.049546,0.31012,0.24962,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.024846,0.31003,0.17761,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4039e-05,0.30999,0.27895,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00016023,0.30925,0.3477,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00018427,0.30907,0.28642,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.024288,0.3087,0.28164,1,1
4,GO FATTY ACID CATABOLIC PROCESS,6.2367e-06,0.30858,0.29751,1,1
4,GO METHIONINE METABOLIC PROCESS,4.1617e-05,0.30855,0.29805,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0081404,0.30814,0.19147,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00016595,0.30798,0.31054,1,1
4,GO RESPONSE TO INSECTICIDE,0.0012662,0.30798,0.38231,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,1.5816e-05,0.30788,0.3349,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00044439,0.30775,0.32265,1,1
4,GO GLYCOSYLATION,3.7145e-05,0.30755,0.28388,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.349e-05,0.30749,0.25408,1,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0016129,0.30745,0.34559,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.041093,0.30697,0.22766,1,1
4,GO RESPONSE TO GROWTH HORMONE,3.3132e-05,0.3068,0.35079,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.040234,0.30674,0.21419,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,0.0011549,0.30661,0.32056,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,4.1617e-05,0.30658,0.26981,1,1
4,GO HORMONE METABOLIC PROCESS,6.5149e-05,0.30638,0.30472,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.025994,0.3059,0.21017,1,1
4,GO PHOSPHOLIPID TRANSPORT,3.7791e-06,0.30588,0.26104,1,1
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00084609,0.30582,0.28466,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.3132e-05,0.30579,0.31886,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0081404,0.30545,0.24104,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.0010206,0.30539,0.24159,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.0689e-05,0.30526,0.25622,1,1
4,GO APICAL JUNCTION ASSEMBLY,0.00069957,0.30515,0.31201,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.1964e-05,0.3051,0.27667,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00045924,0.30487,0.22066,1,1
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0018173,0.30484,0.23541,1,1
4,GO FUCOSYLATION,0.0028141,0.30467,0.29708,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00072223,0.30448,0.27414,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00065623,0.30445,0.2527,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0046564,0.30443,0.30839,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0029794,0.30385,0.23454,1,1
4,GO UBIQUINONE METABOLIC PROCESS,3.5759e-05,0.30333,0.3092,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00057693,0.30301,0.26833,1,1
4,GO TRICARBOXYLIC ACID CYCLE,0.013465,0.3023,0.23599,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0011199,0.30225,0.27485,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0073363,0.30217,0.33601,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0017641,0.30187,0.28997,1,1
4,GO PHOSPHOLIPID EFFLUX,0.00081984,0.30176,0.3556,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,6.8936e-07,0.30129,0.33949,1,1
4,GO POSITIVE REGULATION OF CELL SIZE,0.00017796,0.30124,0.31698,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0013872,0.30083,0.29101,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.6597e-05,0.30069,0.25512,1,1
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0024367,0.30053,0.30426,1,1
4,GO B CELL PROLIFERATION,3.4728e-06,0.30034,0.28525,1,1
4,GO ORGANELLE MEMBRANE FUSION,4.4878e-05,0.29998,0.24501,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00016023,0.29986,0.22531,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00059588,0.29982,0.25352,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00035231,0.29977,0.33958,1,1
4,GO T CELL CYTOKINE PRODUCTION,0.0079323,0.29969,0.20753,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.0015189,0.29937,0.20664,1,1
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.053746,0.29921,0.22805,1,1
4,GO TYPE 2 IMMUNE RESPONSE,0.010506,0.2991,0.18842,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.00059588,0.29897,0.2339,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.1192e-05,0.29888,0.30648,1,1
4,GO PROTEIN HYDROXYLATION,0.0021689,0.29878,0.28001,1,1
4,GO RESPIRATORY BURST,0.00016023,0.29868,0.27474,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,0.00057693,0.29868,0.25122,1,1
4,GO LIPID STORAGE,0.00011241,0.29846,0.27122,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.030383,0.29815,0.20461,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.00016023,0.29811,0.29621,1,1
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.023205,0.29804,0.16875,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.024846,0.29781,0.21228,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,2.3654e-06,0.29756,0.27169,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.9263e-05,0.2975,0.2526,1,1
4,GO DETECTION OF BIOTIC STIMULUS,0.00017796,0.29707,0.33411,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,4.4878e-05,0.29683,0.23399,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0025817,0.29681,0.36877,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00057693,0.29681,0.20225,1,1
4,GO LYMPHOCYTE MIGRATION,0.00022676,0.29677,0.20838,1,1
4,GO RESPONSE TO VIRUS,0.00019079,0.29659,0.22669,1,1
4,GO REGULATION OF ACROSOME REACTION,0.0081404,0.29638,0.34493,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00019753,0.29619,0.28886,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00011241,0.29608,0.30068,1,1
4,GO INTERLEUKIN 8 PRODUCTION,9.0551e-05,0.29592,0.27828,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.00026903,0.2957,0.29937,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,5.9841e-06,0.29563,0.25758,1,1
4,GO BILE ACID METABOLIC PROCESS,3.4421e-05,0.29526,0.35495,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,4.3218e-05,0.29516,0.25158,1,1
4,GO WATER HOMEOSTASIS,0.00047456,0.29514,0.25695,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0001165,0.29483,0.2551,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,5.6174e-05,0.29482,0.22517,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.8418e-05,0.29417,0.34474,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.019283,0.29384,0.28346,1,1
4,GO LUNG CELL DIFFERENTIATION,0.010245,0.29383,0.34557,1,1
4,GO RESPONSE TO PH,0.00050664,0.29371,0.22486,1,1
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.015953,0.29352,0.23373,1,1
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.012203,0.29334,0.24215,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.0001547,0.29297,0.25088,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00081984,0.29271,0.23451,1,1
4,GO DEFENSE RESPONSE,2.1663e-05,0.29261,0.23307,1,1
4,GO KERATINIZATION,0.00052342,0.29252,0.23727,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00047456,0.29232,0.26122,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0010206,0.29231,0.25892,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.00031859,0.29231,0.31107,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0021689,0.29227,0.33194,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.0073e-05,0.29225,0.3206,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00045924,0.29205,0.21732,1,1
4,GO ANDROGEN METABOLIC PROCESS,3.4421e-05,0.29201,0.43097,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0015189,0.29162,0.30549,1,1
4,GO MYOBLAST FUSION,0.00081984,0.29144,0.24839,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00011241,0.29135,0.29461,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,3.4728e-06,0.2912,0.26283,1,1
4,GO INTERLEUKIN 6 PRODUCTION,0.00023468,0.29113,0.21786,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.019283,0.29111,0.15996,1,1
4,GO TRANSFERRIN TRANSPORT,7.889e-07,0.29095,0.34936,1,1
4,GO REGULATION OF AMINO ACID TRANSPORT,0.0022992,0.29089,0.2475,1,1
4,GO REGULATION OF RESPIRATORY BURST,0.00020448,0.29029,0.31787,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00065623,0.29026,0.2959,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,8.3127e-06,0.28994,0.30213,1,1
4,GO CELL REDOX HOMEOSTASIS,0.00010092,0.28984,0.30321,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.00065623,0.28963,0.28166,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00036427,0.28954,0.21059,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00042998,0.28952,0.33721,1,1
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00044439,0.28946,0.30409,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00084609,0.28933,0.20809,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,7.2754e-05,0.28927,0.2524,1,1
4,GO INTERLEUKIN 12 PRODUCTION,2.1663e-05,0.289,0.29436,1,1
4,GO T CELL MIGRATION,0.0014738,0.28883,0.2079,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,2.7343e-05,0.28871,0.30374,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.0033e-05,0.28863,0.26382,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0012662,0.28853,0.21695,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0019282,0.2885,0.26075,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.7596e-05,0.28845,0.23747,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0023671,0.28842,0.25238,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,6.7596e-05,0.28828,0.24044,1,1
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0079323,0.28806,0.31318,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00010092,0.28802,0.29587,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,1.1493e-05,0.28746,0.25385,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.036948,0.28593,0.20889,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00067758,0.28538,0.25977,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.00017186,0.2853,0.24753,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0020453,0.28525,0.18403,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00024286,0.28508,0.24329,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00353,0.28498,0.20598,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.001872,0.28454,0.20834,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,5.7413e-06,0.28426,0.33194,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00059588,0.28416,0.23529,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0073363,0.28416,0.21302,1,1
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.037747,0.2839,0.15285,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,2.6307e-05,0.28348,0.24177,1,1
4,GO VESICLE TARGETING,0.00092958,0.28289,0.22313,1,1
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0079323,0.28266,0.26423,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.00030804,0.28242,0.25129,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.010773,0.282,0.26704,1,1
4,GO AMINE METABOLIC PROCESS,5.2533e-07,0.28177,0.30584,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,3.5759e-05,0.28169,0.27105,1,1
4,GO RESPONSE TO PROTOZOAN,0.00050664,0.2816,0.22483,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.018836,0.28123,0.23631,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,1.349e-05,0.28112,0.25636,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00052342,0.28096,0.24747,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00057693,0.28085,0.22821,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0069616,0.28075,0.21424,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,3.7145e-05,0.28073,0.21758,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.0073e-05,0.28051,0.28912,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010462,0.28048,0.22747,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.00092958,0.28033,0.23902,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.00023468,0.28032,0.27912,1,1
4,GO PH REDUCTION,1.4674e-06,0.28021,0.28413,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.00019753,0.28,0.29529,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,8.6584e-06,0.27985,0.29847,1,1
4,GO MEMBRANE RAFT ORGANIZATION,0.037747,0.27974,0.18503,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.025414,0.27962,0.241,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00040247,0.27943,0.19253,1,1
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00044439,0.27902,0.44044,1,1
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.041967,0.27902,0.13817,1,1
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0046564,0.27892,0.21512,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00067758,0.27886,0.25281,1,1
4,GO RESPONSE TO NUTRIENT,0.0028957,0.27866,0.17843,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.9532e-05,0.27852,0.25086,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00036427,0.27822,0.18793,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.009256,0.27804,0.16441,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,2.3418e-05,0.27784,0.2836,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0083534,0.27772,0.20532,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.0001165,0.27763,0.23148,1,1
4,GO MICROVILLUS ORGANIZATION,0.011047,0.27674,0.26828,1,1
4,GO RESPONSE TO CYTOKINE,8.4205e-05,0.2767,0.20796,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.00054072,0.2764,0.2274,1,1
4,GO RESPONSE TO PROSTAGLANDIN,0.02843,0.27629,0.17234,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,7.013e-05,0.27626,0.20492,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.0017123,0.27608,0.18549,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00050664,0.27605,0.21703,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,2.0833e-05,0.27585,0.22775,1,1
4,GO AMINO ACID ACTIVATION,0.0071468,0.27574,0.20581,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00047456,0.27567,0.22129,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0013054,0.27545,0.25346,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,7.013e-05,0.27503,0.25224,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.00069957,0.27502,0.27401,1,1
4,GO DOPAMINE TRANSPORT,0.00063551,0.27494,0.35161,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00011241,0.27464,0.22574,1,1
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0057817,0.27462,0.26774,1,1
4,GO CARNITINE METABOLIC PROCESS,0.010245,0.27461,0.22977,1,1
4,GO REGULATION OF LIPID STORAGE,0.00021167,0.27446,0.22474,1,1
4,GO PHAGOSOME MATURATION,4.8379e-05,0.27445,0.28694,1,1
4,GO CYTOKINE PRODUCTION,7.8282e-05,0.27399,0.22041,1,1
4,GO STEROL TRANSPORT,0.00018427,0.27395,0.25564,1,1
4,GO RESPONSE TO BACTERIUM,0.00013433,0.2738,0.20818,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00027832,0.27346,0.25534,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0024367,0.27342,0.29972,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00010845,0.27341,0.23416,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00041602,0.27337,0.22383,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0039469,0.27309,0.27036,1,1
4,GO INTERLEUKIN 10 PRODUCTION,8.4205e-05,0.27291,0.25008,1,1
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.011904,0.27287,0.23073,1,1
4,GO RESPONSE TO KETONE,0.00049035,0.27287,0.18998,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00052342,0.27219,0.39342,1,1
4,GO B CELL ACTIVATION,3.5759e-05,0.27207,0.20681,1,1
4,GO FUCOSE METABOLIC PROCESS,0.024846,0.27183,0.27437,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0094949,0.27164,0.23518,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00021167,0.2716,0.21118,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0038387,0.27146,0.22081,1,1
4,GO LIPID EXPORT FROM CELL,0.00028792,0.2713,0.31981,1,1
4,GO RESPONSE TO FORSKOLIN,0.01282,0.27115,0.26364,1,1
4,GO CHYLOMICRON ASSEMBLY,0.015953,0.271,0.28027,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.5201e-05,0.27076,0.31175,1,1
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.030383,0.27065,0.27436,1,1
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.0094949,0.27058,0.21852,1,1
4,GO RESPONSE TO METAL ION,0.00017186,0.2701,0.20519,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00011241,0.26988,0.24114,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.017969,0.26985,0.19132,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00040247,0.26983,0.21654,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.4039e-05,0.26976,0.23969,1,1
4,GO VASCULAR WOUND HEALING,0.0037331,0.26969,0.37732,1,1
4,GO CHEMOKINE PRODUCTION,0.0027346,0.26967,0.18537,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00029782,0.26952,0.20516,1,1
4,GO OXALATE TRANSPORT,0.00067758,0.26949,0.242,1,1
4,GO ETHANOL METABOLIC PROCESS,0.01282,0.26925,0.2265,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0056288,0.26907,0.2488,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0028141,0.26898,0.21893,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0010859,0.26882,0.23526,1,1
4,GO PEPTIDE SECRETION,7.3528e-06,0.26868,0.21497,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0031536,0.26861,0.23893,1,1
4,GO RESPONSE TO ANGIOTENSIN,0.0090226,0.26859,0.23901,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,1.104e-05,0.26853,0.25952,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.906e-06,0.26821,0.27791,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0075304,0.26793,0.18687,1,1
4,GO RESPONSE TO MUSCLE ACTIVITY,0.023741,0.26786,0.20148,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,7.2754e-05,0.26766,0.22886,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,1.2962e-05,0.26765,0.26208,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.00013433,0.26763,0.21586,1,1
4,GO CORNIFICATION,0.00069957,0.2676,0.2669,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.0018173,0.26744,0.27588,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00011241,0.26695,0.21882,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0025083,0.26689,0.17622,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.9532e-05,0.26685,0.25517,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.037747,0.26655,0.18971,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00044439,0.2665,0.20863,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.00019079,0.26624,0.25255,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0041716,0.26602,0.21723,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,4.6623e-06,0.26598,0.25404,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00079435,0.26567,0.22131,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.0053338,0.2656,0.24862,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001191,0.26535,0.21812,1,1
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.015203,0.26505,0.16117,1,1
4,GO GOLGI VESICLE BUDDING,2.3418e-05,0.26471,0.24974,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00026903,0.26458,0.2661,1,1
4,GO PROTEIN MATURATION,3.1904e-06,0.26456,0.24296,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010092,0.26456,0.19801,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.00034072,0.26456,0.20376,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0013872,0.26449,0.21946,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,7.3528e-06,0.26448,0.39098,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0059384,0.26432,0.24886,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00090094,0.26409,0.38228,1,1
4,GO LEUKOCYTE MIGRATION,0.00011241,0.26403,0.21631,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.7343e-05,0.2639,0.24176,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00014935,0.26357,0.21407,1,1
4,GO TISSUE HOMEOSTASIS,0.00095906,0.26355,0.18708,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,5.4121e-05,0.26347,0.21237,1,1
4,GO INFLAMMATORY RESPONSE,3.1888e-05,0.2634,0.22966,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.018836,0.26339,0.20364,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.0015189,0.26338,0.2425,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00081984,0.26326,0.29879,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00032948,0.2632,0.2235,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,8.4205e-05,0.26276,0.27223,1,1
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.034637,0.26253,0.15802,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00063551,0.26243,0.27955,1,1
4,GO REGULATION OF HORMONE LEVELS,9.0179e-06,0.26243,0.24103,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.054842,0.2623,0.18346,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0025817,0.26224,0.24295,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.00019079,0.26209,0.18264,1,1
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.036948,0.26206,0.17114,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.00087311,0.26162,0.28809,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.6455e-05,0.26146,0.24949,1,1
4,GO INACTIVATION OF MAPK ACTIVITY,0.02068,0.26134,0.21313,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00036427,0.26133,0.26884,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00084609,0.26117,0.22653,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,4.8379e-05,0.26078,0.2013,1,1
4,GO MUSCLE CELL MIGRATION,0.011047,0.26071,0.18108,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,2.7343e-05,0.26066,0.24568,1,1
4,GO CYTOKINE METABOLIC PROCESS,0.00057693,0.26064,0.18612,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,1.1964e-05,0.26048,0.24697,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00067758,0.26047,0.24167,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00098941,0.26044,0.18683,1,1
4,GO CARBOHYDRATE TRANSPORT,4.4878e-05,0.26034,0.24452,1,1
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.041967,0.26032,0.18369,1,1
4,GO NEUTROPHIL MIGRATION,8.3127e-06,0.26013,0.2292,1,1
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,4.8379e-05,0.26009,0.23939,1,1
4,GO LIPID HOMEOSTASIS,0.00072223,0.25977,0.22569,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00036427,0.25968,0.19226,1,1
4,GO RESPONSE TO CALCIUM ION,0.00042998,0.25965,0.20558,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00044439,0.25919,0.24335,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,9.7346e-05,0.25917,0.24489,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.00041602,0.2585,0.17651,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0085714,0.25849,0.28084,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.0006154,0.25843,0.24945,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00054072,0.2581,0.19927,1,1
4,GO RENAL SYSTEM PROCESS,7.013e-05,0.25789,0.23216,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.001662,0.25773,0.22076,1,1
4,GO LEUKOCYTE PROLIFERATION,0.00024286,0.25766,0.20124,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0022992,0.25766,0.19547,1,1
4,GO FLUID TRANSPORT,3.7145e-05,0.25713,0.24153,1,1
4,GO REGULATION OF ANION TRANSPORT,1.1493e-05,0.25712,0.27644,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0010859,0.25706,0.24638,1,1
4,GO REGULATION OF DEFENSE RESPONSE,2.8418e-05,0.257,0.21475,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00012074,0.25693,0.29194,1,1
4,GO AMELOGENESIS,0.010245,0.25685,0.22033,1,1
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00024286,0.25673,0.19524,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.0064317,0.25671,0.22086,1,1
4,GO HEMOGLOBIN METABOLIC PROCESS,0.025414,0.25635,0.18986,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.3127e-06,0.25616,0.21423,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00012964,0.25594,0.19724,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.00019753,0.2558,0.31585,1,1
4,GO RESPONSE TO CAFFEINE,0.0049174,0.25558,0.22815,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.8612e-06,0.25558,0.27079,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.011326,0.25557,0.2404,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.014138,0.25537,0.24173,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.0059384,0.25502,0.21891,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.0011549,0.25494,0.25223,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,9.0179e-06,0.25479,0.23216,1,1
4,GO EXOCYTOSIS,3.5759e-05,0.2547,0.20415,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013917,0.25464,0.22833,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,9.0551e-05,0.25428,0.24853,1,1
4,GO MYELIN MAINTENANCE,0.043763,0.25392,0.21122,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0013457,0.25353,0.18667,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.024288,0.25345,0.16659,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.0040578,0.25325,0.18834,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00079435,0.25314,0.2177,1,1
4,GO COAGULATION,0.00079435,0.25275,0.17552,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.024288,0.2523,0.13907,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0029794,0.25226,0.18869,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,3.5759e-05,0.25184,0.3466,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,2.9301e-06,0.25174,0.23179,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,9.0551e-05,0.25173,0.26289,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.0016129,0.25144,0.29226,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,1.4609e-05,0.25131,0.21974,1,1
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00079435,0.2512,0.1898,1,1
4,GO COPII COATED VESICLE BUDDING,6.2786e-05,0.25118,0.23523,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0099891,0.25112,0.23292,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.00014418,0.25101,0.21811,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.7323e-05,0.25096,0.17398,1,1
4,GO MUSCLE HYPERTROPHY,0.0001547,0.25089,0.23031,1,1
4,GO ANIMAL ORGAN REGENERATION,0.0017641,0.25043,0.18301,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00057693,0.25042,0.17691,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.013798,0.25039,0.15607,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,2.6902e-06,0.24994,0.24962,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.001191,0.24972,0.20475,1,1
4,GO REGULATION OF CELLULAR PH,1.4674e-06,0.24968,0.23818,1,1
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.007729,0.24955,0.21046,1,1
4,GO AUTOPHAGOSOME MATURATION,0.00011241,0.24941,0.25326,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0067808,0.24903,0.16367,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0073363,0.24901,0.22149,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0011549,0.24897,0.391,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.02068,0.24892,0.16426,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00010845,0.24881,0.25111,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00019753,0.24878,0.28301,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0016129,0.24805,0.22063,1,1
4,GO LEUKOCYTE CHEMOTAXIS,2.9532e-05,0.24804,0.21881,1,1
4,GO MEMBRANE FUSION,6.2786e-05,0.248,0.21239,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0017123,0.24796,0.20572,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.026586,0.24778,0.11808,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0056288,0.24752,0.20383,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0010859,0.24721,0.23455,1,1
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00016023,0.2472,0.26956,1,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.029719,0.24701,0.16729,1,1
4,GO MONOCYTE CHEMOTAXIS,0.0079323,0.24701,0.17357,1,1
4,GO ORGANELLE FUSION,4.0073e-05,0.24683,0.21146,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.012508,0.24682,0.19856,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0099891,0.24661,0.23949,1,1
4,GO RESPONSE TO LEUCINE,0.0037331,0.24658,0.27673,1,1
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.049546,0.24658,0.28648,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.0034322,0.24629,0.23845,1,1
4,GO REPLICATIVE SENESCENCE,0.0030654,0.24611,0.2532,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.00092958,0.24605,0.23918,1,1
4,GO VACUOLE ORGANIZATION,3.6228e-06,0.24597,0.23814,1,1
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.042857,0.24586,0.19144,1,1
4,GO SYNCYTIUM FORMATION,0.0017641,0.2457,0.18301,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.4121e-05,0.24569,0.20595,1,1
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0017641,0.24565,0.21589,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00079435,0.24563,0.1982,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0014299,0.24559,0.17946,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00057693,0.24553,0.22756,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.004408,0.24546,0.17045,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00087311,0.24531,0.23925,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0067808,0.24522,0.21162,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.009256,0.24484,0.17435,1,1
4,GO RESPONSE TO ALCOHOL,0.00014935,0.24479,0.17928,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,8.4205e-05,0.24476,0.24992,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0025817,0.24465,0.26205,1,1
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.010506,0.24462,0.18389,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0025083,0.24436,0.20395,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0021062,0.24427,0.23602,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,6.2786e-05,0.24422,0.19121,1,1
4,GO NECROTIC CELL DEATH,0.00028792,0.24409,0.27539,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.00079435,0.24407,0.18823,1,1
4,GO SECRETION,4.4878e-05,0.24388,0.18187,1,1
4,GO LIPID OXIDATION,0.0001165,0.24357,0.22269,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0001547,0.24351,0.23138,1,1
4,GO XENOBIOTIC TRANSPORT,0.00045924,0.24348,0.32257,1,1
4,GO CAMP BIOSYNTHETIC PROCESS,0.012203,0.24342,0.23,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.012203,0.24327,0.2009,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.00065623,0.24321,0.25198,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00012512,0.24299,0.19354,1,1
4,GO RESPONSE TO PROGESTERONE,0.0067808,0.24299,0.19615,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001165,0.24294,0.20908,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.00019079,0.24255,0.25844,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00052342,0.2425,0.30049,1,1
4,GO GRANULOCYTE MIGRATION,4.3218e-05,0.24249,0.22353,1,1
4,GO COPULATION,0.0079323,0.2422,0.19047,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00026903,0.24216,0.23983,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.001986,0.24212,0.19945,1,1
4,GO MACROPHAGE APOPTOTIC PROCESS,0.036948,0.24204,0.18246,1,1
4,GO GLUCOSE METABOLIC PROCESS,1.2862e-06,0.2419,0.26171,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0039469,0.24168,0.20691,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.00013917,0.24164,0.2474,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.0046564,0.24144,0.20286,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0013054,0.24141,0.19976,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,2.1663e-05,0.24128,0.25807,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.0016129,0.24122,0.20549,1,1
4,GO RESPONSE TO ACTIVITY,0.00020448,0.24111,0.23072,1,1
4,GO REGULATION OF VASCULOGENESIS,0.013139,0.24091,0.26744,1,1
4,GO SECRETION BY TISSUE,0.0069616,0.24085,0.18011,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.3127e-06,0.24066,0.27732,1,1
4,GO CELL ACTIVATION,0.00019079,0.24057,0.18463,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0079323,0.24034,0.25147,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.0057817,0.24005,0.19814,1,1
4,GO RESPONSE TO INSULIN,0.00030804,0.23993,0.17283,1,1
4,GO CELL CHEMOTAXIS,5.4121e-05,0.23979,0.21323,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,0.0018173,0.23972,0.20923,1,1
4,GO INOSITOL METABOLIC PROCESS,0.00019079,0.23955,0.29043,1,1
4,GO PIGMENTATION,0.00013917,0.23952,0.18372,1,1
4,GO REGULATION OF DOPAMINE SECRETION,0.019739,0.23951,0.32538,1,1
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0021062,0.23945,0.22475,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.00012964,0.23928,0.18252,1,1
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.001986,0.23916,0.18924,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00021167,0.23888,0.18231,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.00014418,0.23883,0.22356,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0062634,0.23859,0.25821,1,1
4,GO REGULATION OF HORMONE SECRETION,7.013e-05,0.23842,0.20031,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00023468,0.23839,0.21585,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.00012074,0.23838,0.16341,1,1
4,GO LOCOMOTOR RHYTHM,0.0099891,0.23835,0.19413,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0081404,0.23808,0.20527,1,1
4,GO ALDEHYDE CATABOLIC PROCESS,0.036164,0.23802,0.16312,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00092958,0.23801,0.27438,1,1
4,GO INTERLEUKIN 17 PRODUCTION,0.0062634,0.23789,0.19038,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00021167,0.2378,0.23102,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0018173,0.23778,0.21882,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00025131,0.23773,0.18551,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0013872,0.23759,0.24169,1,1
4,GO MUSCLE ADAPTATION,0.00059588,0.23754,0.19351,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00027832,0.23751,0.23959,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0022992,0.237,0.1911,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,3.7145e-05,0.23695,0.21833,1,1
4,GO ALCOHOL METABOLIC PROCESS,2.7343e-05,0.23674,0.24093,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.023205,0.23673,0.22212,1,1
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00095906,0.23657,0.2815,1,1
4,GO REGULATION OF BLOOD PRESSURE,5.7413e-06,0.23643,0.23298,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0069616,0.23635,0.19519,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,4.3218e-05,0.23599,0.23464,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00024286,0.23541,0.17372,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.8282e-05,0.23536,0.18436,1,1
4,GO ER OVERLOAD RESPONSE,0.0046564,0.23509,0.25076,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00092958,0.23508,0.19956,1,1
4,GO POSITIVE CHEMOTAXIS,0.0022992,0.2349,0.16997,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0062634,0.23479,0.19656,1,1
4,GO POSITIVE REGULATION OF SECRETION,1.9263e-05,0.23471,0.20973,1,1
4,GO INTERACTION WITH HOST,0.0022332,0.2347,0.17022,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0036303,0.23459,0.17979,1,1
4,GO RESPONSE TO STEROL,0.0012662,0.23429,0.23919,1,1
4,GO ENERGY HOMEOSTASIS,0.0038387,0.23418,0.20757,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,1.1964e-05,0.23412,0.26115,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.017969,0.234,0.19317,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0022332,0.23372,0.18537,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0024367,0.23371,0.21905,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0011199,0.23365,0.27652,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00069957,0.23363,0.22688,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00013917,0.23359,0.21876,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0029794,0.23354,0.22447,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,2.4346e-05,0.23285,0.22436,1,1
4,GO AEROBIC RESPIRATION,0.00087311,0.2326,0.23877,1,1
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0094949,0.23255,0.16557,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,5.6174e-05,0.23254,0.26461,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.7145e-05,0.23253,0.18548,1,1
4,GO PROTEIN KINASE C SIGNALING,0.027188,0.23245,0.18322,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0011199,0.23244,0.26025,1,1
4,GO REGULATION OF PH,1.5331e-06,0.23234,0.23615,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.00040247,0.23227,0.1794,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00024286,0.23196,0.19429,1,1
4,GO CYTOLYSIS,0.027188,0.23194,0.15609,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0064317,0.23188,0.15795,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0045306,0.23181,0.21328,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00010462,0.23176,0.22648,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,0.00021167,0.23167,0.18134,1,1
4,GO RESPONSE TO ISCHEMIA,0.00055855,0.23166,0.23048,1,1
4,GO VESICLE ORGANIZATION,0.00026903,0.23165,0.17939,1,1
4,GO RESPONSE TO CADMIUM ION,0.025994,0.23163,0.16518,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.5308e-05,0.23162,0.19226,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.00087311,0.23159,0.26348,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00023468,0.2314,0.182,1,1
4,GO RESPONSE TO INTERLEUKIN 1,0.00013433,0.23137,0.19064,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.00090094,0.23103,0.17155,1,1
4,GO SODIUM ION HOMEOSTASIS,0.00050664,0.23091,0.19931,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00065623,0.23072,0.18837,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,6.0504e-05,0.23066,0.20015,1,1
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.027803,0.23045,0.16508,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.001191,0.23029,0.20054,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00090094,0.23006,0.18898,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00035231,0.22999,0.19909,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.031748,0.22995,0.19255,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.00081984,0.22995,0.19988,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,2.3418e-05,0.22988,0.19956,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.027188,0.22965,0.1542,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,6.5149e-05,0.22959,0.18227,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00017796,0.22927,0.20139,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.023205,0.22915,0.20878,1,1
4,GO REGULATION OF PEPTIDE SECRETION,1.4609e-05,0.22915,0.20645,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00079435,0.22911,0.22156,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.4039e-05,0.22906,0.26604,1,1
4,GO FATTY ACID BETA OXIDATION,0.00029782,0.22904,0.24545,1,1
4,GO MANNOSYLATION,2.1663e-05,0.22889,0.26125,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,7.547e-05,0.22883,0.18883,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00017796,0.22881,0.24797,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.02068,0.22866,0.24608,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0025817,0.22864,0.32785,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0099891,0.22848,0.18633,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0012662,0.22835,0.19407,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0030654,0.22814,0.16574,1,1
4,GO MACROPHAGE DIFFERENTIATION,0.0012662,0.22794,0.23283,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.5759e-05,0.22773,0.19218,1,1
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.016734,0.22755,0.12927,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00057693,0.22754,0.16146,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00031859,0.22747,0.21616,1,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.027188,0.22729,0.15961,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0073363,0.22725,0.20416,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0083534,0.22713,0.15332,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,5.4121e-05,0.22695,0.24479,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.011326,0.2269,0.17194,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0042883,0.22674,0.18658,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00017186,0.22656,0.28844,1,1
4,GO REGULATION OF T CELL MIGRATION,0.00353,0.22642,0.19915,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.0017123,0.22641,0.1684,1,1
4,GO COMPLEMENT ACTIVATION,0.0051916,0.22638,0.18882,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0017123,0.22598,0.18413,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.0018173,0.22593,0.30742,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0011549,0.22589,0.15998,1,1
4,GO DIOL METABOLIC PROCESS,0.0042883,0.2255,0.26112,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.007729,0.2254,0.25318,1,1
4,GO B CELL DIFFERENTIATION,2.3418e-05,0.22535,0.21258,1,1
4,GO REGULATION OF HEART RATE,0.0023671,0.22515,0.18958,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,8.7323e-05,0.22512,0.26197,1,1
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.0032441,0.22503,0.28413,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0010206,0.22466,0.24124,1,1
4,GO ESTROGEN METABOLIC PROCESS,0.0094949,0.22459,0.19322,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,0.00024286,0.22425,0.20957,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.0097392,0.22424,0.19278,1,1
4,GO HORMONE TRANSPORT,3.1888e-05,0.22403,0.21764,1,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00087311,0.22365,0.16951,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0019282,0.22349,0.17397,1,1
4,GO INSULIN SECRETION,0.00025131,0.2234,0.1916,1,1
4,GO INTERFERON BETA PRODUCTION,0.0087944,0.2234,0.16007,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.0041716,0.22335,0.19006,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.025994,0.22329,0.13334,1,1
4,GO WOUND HEALING,0.0053338,0.2232,0.14569,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0016129,0.22289,0.13347,1,1
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0097392,0.22288,0.1487,1,1
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.030383,0.22273,0.1606,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0034322,0.22272,0.20974,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0016129,0.22266,0.17824,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00036427,0.22266,0.22187,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0017641,0.22233,0.16132,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00079435,0.22229,0.1638,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00025131,0.22226,0.21646,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,1.5201e-05,0.22216,0.23457,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0010206,0.22151,0.15424,1,1
4,GO MITOCHONDRIAL TRNA PROCESSING,0.02843,0.22143,0.18172,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0057817,0.22112,0.19261,1,1
4,GO ADAPTIVE THERMOGENESIS,1.0604e-05,0.22078,0.21753,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0030654,0.22049,0.18476,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.001662,0.2204,0.26216,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.001191,0.22021,0.22525,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.0069616,0.22008,0.16751,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.00072223,0.21997,0.19275,1,1
4,GO PANCREAS DEVELOPMENT,0.02843,0.21972,0.14547,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.02843,0.21935,0.22733,1,1
4,GO NEUTROPHIL CHEMOTAXIS,4.0073e-05,0.21918,0.17734,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0045306,0.21913,0.21265,1,1
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.020205,0.21911,0.20865,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00032948,0.2191,0.15738,1,1
4,GO BONE CELL DEVELOPMENT,0.041093,0.21906,0.15053,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.017549,0.21897,0.25044,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.0018173,0.21881,0.17625,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00054072,0.21853,0.16569,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00095906,0.21827,0.29535,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00034072,0.2182,0.23328,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.00047456,0.21813,0.21872,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,1.4039e-05,0.21799,0.26707,1,1
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00025131,0.21796,0.22958,1,1
4,GO REGULATION OF GLUCONEOGENESIS,0.00092958,0.21777,0.23321,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.0059384,0.21777,0.21182,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00055855,0.21771,0.20113,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0001165,0.21768,0.19695,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.0033369,0.21767,0.17116,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.026586,0.21723,0.13925,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0015653,0.21718,0.1654,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00012964,0.21715,0.17449,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.00090094,0.21697,0.23899,1,1
4,GO LIPID METABOLIC PROCESS,8.7323e-05,0.21694,0.19289,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0010528,0.2166,0.20274,1,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.04854,0.21638,0.13356,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,0.00054072,0.21635,0.28315,1,1
4,GO PEROXISOMAL TRANSPORT,0.00049035,0.21633,0.22118,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.0034322,0.21614,0.28676,1,1
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0022992,0.216,0.23779,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.012508,0.21599,0.18568,1,1
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0020453,0.21584,0.28112,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0007696,0.21573,0.21825,1,1
4,GO HAIR CELL DIFFERENTIATION,0.0071468,0.21562,0.16187,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,7.013e-05,0.21554,0.19355,1,1
4,GO PLATELET AGGREGATION,0.013798,0.21534,0.14703,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.025414,0.21529,0.36391,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.001191,0.21527,0.19258,1,1
4,GO REGULATION OF PROTEOLYSIS,0.00028792,0.21521,0.17022,1,1
4,GO SELECTIVE AUTOPHAGY,0.0001165,0.21513,0.22577,1,1
4,GO CHEMICAL HOMEOSTASIS,8.4205e-05,0.21488,0.16937,1,1
4,GO GOLGI RIBBON FORMATION,0.0021689,0.21485,0.20947,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0017123,0.21481,0.15182,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.00079435,0.21461,0.17853,1,1
4,GO AMYLOID BETA CLEARANCE,0.0026572,0.21441,0.19525,1,1
4,GO ORGANIC ANION TRANSPORT,1.2454e-05,0.21429,0.21406,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.00055855,0.2142,0.1972,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.05161,0.21402,0.1978,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,7.8282e-05,0.21399,0.20014,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0011199,0.21396,0.17334,1,1
4,GO REGULATION OF CELL ACTIVATION,0.0010206,0.21375,0.1527,1,1
4,GO CAMP METABOLIC PROCESS,0.022165,0.21364,0.18346,1,1
4,GO RIG I SIGNALING PATHWAY,0.011047,0.21352,0.13608,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0013054,0.21331,0.1637,1,1
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.021165,0.2132,0.19704,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,7.8282e-05,0.21319,0.17503,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.011904,0.21307,0.15705,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0014299,0.21298,0.17737,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,9.7801e-06,0.21281,0.2311,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0069616,0.21277,0.15971,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0099891,0.21252,0.1396,1,1
4,GO PLATELET ACTIVATION,0.0025083,0.21231,0.16415,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.0013457,0.21227,0.19115,1,1
4,GO ACID SECRETION,0.0026572,0.21225,0.18861,1,1
4,GO RESPONSE TO CHEMOKINE,1.7118e-05,0.2119,0.2046,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0017123,0.21183,0.1671,1,1
4,GO KERATINOCYTE DIFFERENTIATION,0.0016129,0.21171,0.19677,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,1.349e-05,0.21164,0.23332,1,1
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.02843,0.21161,0.13568,1,1
4,GO RESPONSE TO TUMOR CELL,0.030383,0.21157,0.23608,1,1
4,GO PLATELET MORPHOGENESIS,0.0033369,0.21157,0.21804,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0010528,0.21143,0.19599,1,1
4,GO RESPONSE TO IRON ION,0.0034322,0.2114,0.20631,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,2.6307e-05,0.21123,0.21133,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00050664,0.21122,0.22585,1,1
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0054795,0.2111,0.18514,1,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.052669,0.21104,0.20395,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,8.1192e-05,0.21103,0.19367,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.4346e-05,0.21069,0.24516,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,8.7323e-05,0.21065,0.20469,1,1
4,GO RESPONSE TO DSRNA,0.00028792,0.2106,0.18121,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00040247,0.21059,0.22214,1,1
4,GO VIRION ASSEMBLY,0.0011549,0.21033,0.15062,1,1
4,GO CERAMIDE TRANSPORT,0.041967,0.21031,0.28491,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00059588,0.21027,0.1583,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.001228,0.21013,0.20063,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,3.7145e-05,0.20998,0.22007,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.00025131,0.20977,0.24187,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0011199,0.20976,0.17411,1,1
4,GO PROTEOLYSIS,7.547e-05,0.20967,0.15151,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00057693,0.20924,0.1736,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.001986,0.20924,0.2286,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,7.013e-05,0.20922,0.24451,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00098941,0.20897,0.15325,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0017641,0.20895,0.18277,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0039469,0.20865,0.1423,1,1
4,GO EXOCYTIC PROCESS,0.0037331,0.20849,0.19733,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00067758,0.20845,0.24007,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.035393,0.20823,0.13048,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,3.3132e-05,0.20807,0.24392,1,1
4,GO T CELL ACTIVATION,0.00090094,0.20803,0.1646,1,1
4,GO REGULATION OF TUBE SIZE,8.7323e-05,0.20798,0.22647,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0045306,0.20789,0.18747,1,1
4,GO REGULATION OF BONE DEVELOPMENT,0.046579,0.20767,0.12134,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0085714,0.20763,0.19968,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0021062,0.20755,0.16845,1,1
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0013054,0.20672,0.18953,1,1
4,GO VIRAL LIFE CYCLE,0.00072223,0.20636,0.16265,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00090094,0.20616,0.20428,1,1
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0079323,0.20615,0.15609,1,1
4,GO NUCLEOTIDE TRANSPORT,0.00030804,0.20614,0.20693,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0026572,0.20575,0.16082,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00031859,0.20566,0.16532,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.012203,0.20547,0.18187,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00087311,0.20545,0.1549,1,1
4,GO CHOLESTEROL STORAGE,0.0049174,0.2054,0.2287,1,1
4,GO FIBROBLAST PROLIFERATION,0.029068,0.20518,0.12487,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0067808,0.20515,0.17845,1,1
4,GO PIRNA METABOLIC PROCESS,0.020205,0.20506,0.24608,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.0073363,0.205,0.14799,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.00025131,0.2049,0.17195,1,1
4,GO REGULATION OF APPETITE,0.0040578,0.20482,0.14276,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00047456,0.20477,0.18844,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.036948,0.2047,0.22705,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,9.7801e-06,0.20469,0.22864,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0013872,0.20439,0.14723,1,1
4,GO RESPONSE TO TESTOSTERONE,0.0081404,0.20436,0.16147,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,1.1964e-05,0.20427,0.21599,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0020453,0.20421,0.20345,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00045924,0.20401,0.20975,1,1
4,GO ANION TRANSPORT,1.8521e-05,0.20387,0.1955,1,1
4,GO LYMPHOCYTE ACTIVATION,0.00081984,0.20383,0.1467,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,6.0504e-05,0.20375,0.16632,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.010245,0.20331,0.1573,1,1
4,GO NATURAL KILLER CELL ACTIVATION,0.00041602,0.20326,0.18665,1,1
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0045306,0.20322,0.13844,1,1
4,GO REGULATION OF VESICLE FUSION,0.050569,0.20305,0.19715,1,1
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.045624,0.20298,0.15467,1,1
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.031059,0.20296,0.2139,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.014486,0.20295,0.16078,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,0.00029782,0.20283,0.21319,1,1
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.025994,0.20273,0.16259,1,1
4,GO SEQUESTERING OF TRIGLYCERIDE,0.015574,0.20233,0.21793,1,1
4,GO CYTOKINE SECRETION,0.00092958,0.20228,0.19796,1,1
4,GO NIK NF KAPPAB SIGNALING,0.00038934,0.20215,0.17045,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00067758,0.20211,0.18383,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00021909,0.20178,0.23021,1,1
4,GO DENDRITIC CELL MIGRATION,0.011612,0.20167,0.15495,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0017123,0.20163,0.1356,1,1
4,GO TRANSCYTOSIS,0.0013054,0.20161,0.23666,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0013872,0.20158,0.18874,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0050528,0.20157,0.15651,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0049174,0.20155,0.17091,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.00037661,0.2015,0.13711,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0020453,0.20148,0.18816,1,1
4,GO INORGANIC ANION TRANSPORT,3.7145e-05,0.20132,0.17173,1,1
4,GO REGULATION OF SECRETION,0.00016023,0.20122,0.16682,1,1
4,GO T CELL HOMEOSTASIS,0.00353,0.2011,0.15368,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.001191,0.20106,0.19223,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0030654,0.20086,0.14781,1,1
4,GO FATTY ACID METABOLIC PROCESS,9.389e-05,0.20076,0.22924,1,1
4,GO REGULATION OF CELL ADHESION,0.0028141,0.20069,0.15283,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00024286,0.20062,0.18219,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.016734,0.20062,0.15028,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.01282,0.20054,0.14796,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.00098941,0.20038,0.2291,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00045924,0.20024,0.13738,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.0036303,0.20011,0.20607,1,1
4,GO MITOCHONDRIAL GENE EXPRESSION,0.031748,0.20009,0.14034,1,1
4,GO RESPONSE TO LEPTIN,0.025414,0.19969,0.17236,1,1
4,GO AMYLOID BETA FORMATION,0.0050528,0.19963,0.18881,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.0062634,0.1995,0.22489,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0036303,0.19938,0.21399,1,1
4,GO IMMUNOGLOBULIN PRODUCTION,5.2139e-05,0.19929,0.18447,1,1
4,GO SULFUR COMPOUND TRANSPORT,7.547e-05,0.19923,0.22126,1,1
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.011047,0.19862,0.13914,1,1
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0028141,0.19856,0.18796,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0028141,0.19832,0.19324,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.044685,0.19816,0.13194,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.00032948,0.19791,0.16993,1,1
4,GO PROTEIN ADP RIBOSYLATION,0.024846,0.19787,0.14514,1,1
4,GO T CELL DIFFERENTIATION,0.00040247,0.19787,0.15262,1,1
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.031748,0.19786,0.28794,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0001547,0.19776,0.21375,1,1
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.004408,0.19774,0.17742,1,1
4,GO PROTEIN DESTABILIZATION,0.0016129,0.19767,0.16048,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0047853,0.19757,0.16779,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.00042998,0.19752,0.15875,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0038387,0.19752,0.16852,1,1
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0025817,0.19749,0.18252,1,1
4,GO ENDOCYTIC RECYCLING,0.0012662,0.19748,0.15211,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,8.7323e-05,0.19739,0.16905,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.035393,0.19733,0.17143,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.011047,0.197,0.12024,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0021062,0.1968,0.15153,1,1
4,GO DRINKING BEHAVIOR,0.020205,0.19673,0.17527,1,1
4,GO ZINC ION TRANSPORT,0.0057817,0.19661,0.18154,1,1
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.036948,0.19651,0.12153,1,1
4,GO MEMBRANE DEPOLARIZATION,0.017137,0.19639,0.1603,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.053746,0.19631,0.16884,1,1
4,GO GROOMING BEHAVIOR,0.046579,0.19631,0.17228,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.016734,0.19617,0.16094,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.00032948,0.19612,0.21738,1,1
4,GO ACTIN NUCLEATION,0.00081984,0.19608,0.19147,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0017123,0.19599,0.20272,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0012662,0.1959,0.16666,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.04854,0.19589,0.18629,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.024846,0.19584,0.1215,1,1
4,GO CELL MATRIX ADHESION,0.014138,0.19581,0.1271,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00017186,0.19576,0.19417,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00014418,0.19575,0.1863,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00098941,0.19558,0.19581,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00017796,0.19549,0.23437,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.013139,0.19543,0.16207,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0041716,0.1954,0.20248,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.00034072,0.19535,0.22496,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0041716,0.1953,0.20154,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,1.1493e-05,0.19529,0.21437,1,1
4,GO METAL ION HOMEOSTASIS,0.00018427,0.19511,0.14694,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,5.6174e-05,0.19481,0.17139,1,1
4,GO PEROXISOME ORGANIZATION,0.00042998,0.19471,0.2091,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.0030654,0.1947,0.16926,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0056288,0.19455,0.17074,1,1
4,GO GLIAL CELL PROLIFERATION,0.042857,0.19437,0.15089,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,3.5759e-05,0.19435,0.18643,1,1
4,GO HUMORAL IMMUNE RESPONSE,9.7801e-06,0.19426,0.22995,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,5.0226e-05,0.19423,0.19716,1,1
4,GO CHLORIDE TRANSPORT,5.6174e-05,0.19408,0.17755,1,1
4,GO RENAL WATER HOMEOSTASIS,0.015953,0.19403,0.11199,1,1
4,GO ION HOMEOSTASIS,0.00016023,0.19384,0.15192,1,1
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.027188,0.19375,0.18418,1,1
4,GO CELLULAR EXTRAVASATION,0.02166,0.1936,0.11396,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.020205,0.19353,0.15846,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00084609,0.19332,0.23758,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00034072,0.19327,0.19209,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.00052342,0.19312,0.13702,1,1
4,GO TEMPERATURE HOMEOSTASIS,3.4421e-05,0.19296,0.18908,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0014738,0.1929,0.17733,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.001228,0.19256,0.1371,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0049174,0.19231,0.17531,1,1
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.047551,0.19224,0.19727,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.0013054,0.19217,0.17451,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,6.2786e-05,0.19204,0.22473,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0025817,0.19202,0.14439,1,1
4,GO ACETYL COA METABOLIC PROCESS,0.012508,0.19201,0.16651,1,1
4,GO PEPTIDE HORMONE SECRETION,0.0001547,0.19181,0.19449,1,1
4,GO SENSORY PERCEPTION OF SMELL,2.8077e-06,0.19148,0.20183,1,1
4,GO WHITE FAT CELL DIFFERENTIATION,0.0026572,0.19146,0.19842,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.00049035,0.19146,0.16806,1,1
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.02166,0.19128,0.1572,1,1
4,GO AMYLOID FIBRIL FORMATION,0.05161,0.19106,0.15339,1,1
4,GO OXIDATION REDUCTION PROCESS,2.6307e-05,0.19069,0.21956,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.0028141,0.19068,0.15715,1,1
4,GO ION TRANSPORT,0.0001547,0.19058,0.15584,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00050664,0.19052,0.13644,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.0036303,0.19046,0.15588,1,1
4,GO FATTY ACID TRANSPORT,6.7596e-05,0.19038,0.22446,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.009256,0.19024,0.1385,1,1
4,GO SECRETORY GRANULE ORGANIZATION,0.0069616,0.19024,0.15891,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0034322,0.19021,0.21898,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00016595,0.19016,0.15368,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0006154,0.18987,0.18235,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0027346,0.18983,0.136,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,5.6174e-05,0.18977,0.20637,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.00057693,0.18975,0.13842,1,1
4,GO LYMPH NODE DEVELOPMENT,0.0016129,0.1896,0.23355,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.00038934,0.18956,0.14904,1,1
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.015574,0.18921,0.14952,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0013872,0.18915,0.27467,1,1
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0038387,0.18908,0.25914,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.012203,0.18907,0.11674,1,1
4,GO RESPONSE TO HORMONE,0.00040247,0.1889,0.15581,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.020205,0.18885,0.14268,1,1
4,GO PROTEIN KINASE B SIGNALING,0.0064317,0.18885,0.13346,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0028141,0.18816,0.23003,1,1
4,GO LIPID CATABOLIC PROCESS,1.6455e-05,0.1881,0.23365,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.0036303,0.18795,0.17388,1,1
4,GO ARACHIDONIC ACID SECRETION,0.00042998,0.18785,0.22793,1,1
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.019283,0.18784,0.16534,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.00040247,0.1878,0.15304,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0010206,0.18741,0.14339,1,1
4,GO HOMEOSTATIC PROCESS,8.4205e-05,0.18733,0.1407,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.0025083,0.18722,0.15637,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.0028141,0.18713,0.14081,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0016129,0.18699,0.18571,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00059588,0.1869,0.14044,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.016339,0.18645,0.11802,1,1
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0027346,0.18636,0.14876,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.0033369,0.18621,0.16351,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,3.7145e-05,0.18617,0.17373,1,1
4,GO IRON ION TRANSPORT,3.7145e-05,0.18597,0.24259,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00016023,0.18543,0.17657,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00047456,0.18538,0.14771,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0054795,0.18515,0.13893,1,1
4,GO REGULATION OF HEMOPOIESIS,0.00052342,0.18515,0.14079,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,3.7145e-05,0.18511,0.19476,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.001986,0.18494,0.25409,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.0021689,0.18466,0.18599,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00032948,0.18464,0.16487,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.014841,0.18435,0.15987,1,1
4,GO AGING,0.00010092,0.18431,0.16066,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.001228,0.18423,0.13644,1,1
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.038561,0.18423,0.1172,1,1
4,GO RESPONSE TO LIPID,0.0011549,0.1842,0.1479,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.033894,0.18408,0.12744,1,1
4,GO RESPONSE TO DRUG,0.0017123,0.18402,0.15273,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0067808,0.18392,0.31322,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.0013054,0.18374,0.17921,1,1
4,GO REGULATION OF INSULIN SECRETION,0.00079435,0.18372,0.16717,1,1
4,GO REGULATION OF STEROL TRANSPORT,0.010506,0.18362,0.15708,1,1
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.0017123,0.18351,0.18487,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00010092,0.18325,0.21617,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00016595,0.18306,0.14892,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.031059,0.183,0.18861,1,1
4,GO RESPONSE TO WOUNDING,0.009256,0.18272,0.12649,1,1
4,GO VITAMIN METABOLIC PROCESS,0.0053338,0.18266,0.1966,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.011904,0.18257,0.14087,1,1
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0073363,0.18248,0.22088,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0031536,0.18238,0.18189,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,8.7323e-05,0.18234,0.15435,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.00069957,0.18222,0.18036,1,1
4,GO SPERM CAPACITATION,0.0022332,0.18207,0.21889,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0071468,0.182,0.13946,1,1
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0051916,0.18191,0.25441,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0054795,0.18168,0.15611,1,1
4,GO CELLULAR RESPIRATION,0.0011199,0.18136,0.20335,1,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.033166,0.18121,0.11848,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00045924,0.18111,0.21202,1,1
4,GO VITAMIN TRANSPORT,0.02268,0.18111,0.192,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.0039469,0.18081,0.13892,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.0028141,0.18055,0.14653,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00041602,0.18046,0.13612,1,1
4,GO ANION HOMEOSTASIS,0.052669,0.18042,0.13597,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0053338,0.18028,0.13462,1,1
4,GO POLYAMINE METABOLIC PROCESS,0.022165,0.18026,0.15073,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.011047,0.18025,0.12616,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.015574,0.18019,0.12507,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.00079435,0.18017,0.1216,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00079435,0.17993,0.12832,1,1
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.027188,0.17974,0.1913,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0094949,0.17973,0.16419,1,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.03939,0.17961,0.10027,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.022165,0.17939,0.20146,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0016129,0.17918,0.2709,1,1
4,GO EPIDERMIS DEVELOPMENT,0.0050528,0.17902,0.14586,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0018173,0.17894,0.14895,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00098941,0.17882,0.16323,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0042883,0.17877,0.12302,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.029068,0.17869,0.13829,1,1
4,GO GANGLIOSIDE METABOLIC PROCESS,0.034637,0.17855,0.16217,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0011549,0.17825,0.17756,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0050528,0.17812,0.12312,1,1
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.026586,0.17806,0.27612,1,1
4,GO L AMINO ACID TRANSPORT,0.0090226,0.17802,0.17262,1,1
4,GO RESPONSE TO ETHER,0.0051916,0.17797,0.17615,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.049546,0.17782,0.11684,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0049174,0.17777,0.12413,1,1
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0022992,0.17777,0.1736,1,1
4,GO MANGANESE ION TRANSPORT,0.0064317,0.17775,0.17138,1,1
4,GO SPLEEN DEVELOPMENT,0.0050528,0.17746,0.17586,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.0057817,0.17733,0.13006,1,1
4,GO INTERFERON GAMMA PRODUCTION,0.0069616,0.17698,0.13317,1,1
4,GO EATING BEHAVIOR,0.0022332,0.17685,0.18858,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.02068,0.17675,0.16168,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00029782,0.17661,0.14869,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.0011549,0.17653,0.13461,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.0021689,0.1763,0.14033,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,7.547e-05,0.17614,0.19286,1,1
4,GO DENDRITIC CELL CHEMOTAXIS,0.018836,0.17611,0.1424,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0053338,0.17609,0.21239,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0033369,0.17586,0.20606,1,1
4,GO REGULATION OF PROTEIN MATURATION,0.043763,0.1755,0.102,1,1
4,GO CARDIAC CELL DEVELOPMENT,0.0025083,0.1753,0.16368,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00035231,0.17522,0.14514,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00019079,0.17478,0.19142,1,1
4,GO ELECTRON TRANSPORT CHAIN,0.00042998,0.17475,0.23572,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.001191,0.17468,0.14553,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.00031859,0.17441,0.13784,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0023671,0.17431,0.21669,1,1
4,GO LIPID MODIFICATION,0.00017186,0.1741,0.17826,1,1
4,GO MITOPHAGY,0.0017641,0.17405,0.17791,1,1
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.02166,0.17401,0.15902,1,1
4,GO METAL ION TRANSPORT,0.0024367,0.17359,0.11997,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0038387,0.17359,0.26959,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0021689,0.17341,0.23329,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0014738,0.17332,0.18117,1,1
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.022165,0.17329,0.17375,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,1.349e-05,0.17316,0.18015,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.0019282,0.17312,0.13093,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00098941,0.17289,0.14709,1,1
4,GO ORGANELLE DISASSEMBLY,7.8282e-05,0.17281,0.18259,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00023468,0.17269,0.18193,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00016595,0.17259,0.1906,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,0.00067758,0.17239,0.18951,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.019739,0.17218,0.16537,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.00023468,0.1717,0.1657,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0020453,0.1717,0.17029,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0020453,0.17158,0.12808,1,1
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.017137,0.17147,0.15605,1,1
4,GO GOLGI ORGANIZATION,6.7596e-05,0.17139,0.18346,1,1
4,GO AMINE TRANSPORT,0.0027346,0.17131,0.24194,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,4.3218e-05,0.17119,0.19525,1,1
4,GO MONOAMINE TRANSPORT,0.0059384,0.17118,0.24986,1,1
4,GO NEUROINFLAMMATORY RESPONSE,0.036948,0.17107,0.1116,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0011549,0.17089,0.1303,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.0045306,0.1708,0.10585,1,1
4,GO DETECTION OF STIMULUS,1.8521e-05,0.17072,0.14829,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,8.1192e-05,0.17065,0.14699,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.01282,0.17064,0.16447,1,1
4,GO BIOMINERALIZATION,0.011612,0.17062,0.12669,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.00092958,0.17033,0.18962,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.01282,0.17024,0.16259,1,1
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.042857,0.17022,0.10055,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.029068,0.16972,0.11032,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.007729,0.16942,0.13801,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.022165,0.16925,0.15269,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,9.0551e-05,0.16914,0.22107,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.0025817,0.16909,0.1526,1,1
4,GO T CELL LINEAGE COMMITMENT,0.00012512,0.16898,0.20639,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,8.1192e-05,0.1689,0.16895,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0090226,0.16886,0.2079,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0028141,0.16884,0.14689,1,1
4,GO CELLULAR PIGMENTATION,0.0018173,0.16859,0.16629,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.00090094,0.16851,0.15779,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.0028141,0.16842,0.12612,1,1
4,GO PHAGOCYTOSIS,0.007729,0.16841,0.128,1,1
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0039469,0.16801,0.17677,1,1
4,GO VIRAL RELEASE FROM HOST CELL,0.0090226,0.16781,0.15691,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00050664,0.16772,0.19212,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.001872,0.1675,0.13884,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00037661,0.16743,0.26506,1,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.016339,0.16735,0.13588,1,1
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.011904,0.16725,0.14579,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.012508,0.16722,0.12837,1,1
4,GO T CELL PROLIFERATION,0.0022332,0.16714,0.17127,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00072223,0.16708,0.15259,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.011326,0.16678,0.16935,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0034322,0.16666,0.15998,1,1
4,GO ORGANIC ACID TRANSPORT,4.6597e-05,0.16659,0.21271,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.00065623,0.16658,0.14929,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0012662,0.16642,0.12956,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.013798,0.16638,0.14905,1,1
4,GO OXIDATIVE PHOSPHORYLATION,0.0036303,0.16623,0.18923,1,1
4,GO CARNITINE SHUTTLE,0.0010206,0.16616,0.25103,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0031536,0.16611,0.1793,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.047551,0.16608,0.10854,1,1
4,GO SKIN DEVELOPMENT,0.0064317,0.16599,0.14126,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.010245,0.16597,0.19196,1,1
4,GO REGULATION OF PROTEIN BINDING,0.0018173,0.1657,0.14262,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.02068,0.16558,0.16899,1,1
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.02166,0.16554,0.14013,1,1
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0069616,0.16554,0.18033,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00052342,0.16537,0.16526,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.001662,0.16521,0.1283,1,1
4,GO MACROPHAGE CHEMOTAXIS,0.017549,0.16477,0.10516,1,1
4,GO PROTEIN MANNOSYLATION,0.0079323,0.16477,0.17178,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0033369,0.16469,0.14552,1,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.033894,0.16458,0.14387,1,1
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.010245,0.16453,0.21014,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00047456,0.16443,0.15139,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.027803,0.16417,0.13726,1,1
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0020453,0.16412,0.13729,1,1
4,GO HEPATOCYTE DIFFERENTIATION,0.037747,0.16385,0.19257,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0036303,0.16384,0.17307,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.00010092,0.16382,0.15503,1,1
4,GO GLUCOSE IMPORT,0.0085714,0.16372,0.15688,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.0099891,0.16357,0.1155,1,1
4,GO MAINTENANCE OF LOCATION,0.0023671,0.16349,0.12448,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0023671,0.1634,0.12481,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.029719,0.16325,0.1253,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,4.1617e-05,0.16296,0.22957,1,1
4,GO RESPONSE TO FUNGUS,0.0024367,0.16283,0.14223,1,1
4,GO CATION TRANSPORT,0.0010206,0.16249,0.13113,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0010859,0.16238,0.13249,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0017123,0.16237,0.11728,1,1
4,GO SYMBIOTIC PROCESS,0.0017641,0.16228,0.11807,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0038387,0.16199,0.20145,1,1
4,GO T CELL APOPTOTIC PROCESS,0.024846,0.1619,0.13659,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00038934,0.16187,0.15329,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.00037661,0.16186,0.19366,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.0041716,0.16163,0.15828,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0090226,0.16155,0.11546,1,1
4,GO MYOTUBE DIFFERENTIATION,0.00042998,0.16144,0.18682,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0079323,0.16131,0.1276,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.00067758,0.16084,0.13511,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0014738,0.16048,0.12555,1,1
4,GO MEMBRANE ORGANIZATION,0.0028141,0.16037,0.1094,1,1
4,GO RENAL SODIUM EXCRETION,0.0083534,0.15976,0.18059,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.00010845,0.15967,0.21058,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0087944,0.15963,0.13838,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.019739,0.15957,0.12924,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.013139,0.15953,0.20475,1,1
4,GO REGULATION OF ION TRANSPORT,0.00353,0.15927,0.11931,1,1
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0054795,0.1592,0.37815,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0056288,0.15904,0.12081,1,1
4,GO PIGMENT CELL DIFFERENTIATION,0.014138,0.15902,0.12143,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00087311,0.15892,0.13082,1,1
4,GO REGULATION OF TRANSPORT,0.0022992,0.15889,0.10664,1,1
4,GO NEGATIVE T CELL SELECTION,0.018836,0.15874,0.098772,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00079435,0.15873,0.18591,1,1
4,GO MACROPHAGE ACTIVATION,0.0006154,0.15822,0.16932,1,1
4,GO ERK1 AND ERK2 CASCADE,0.025414,0.15818,0.11459,1,1
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0049174,0.15813,0.14137,1,1
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.018836,0.158,0.17873,1,1
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0016129,0.15791,0.14064,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00095906,0.15771,0.17826,1,1
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.030383,0.15755,0.25937,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.054842,0.15744,0.13663,1,1
4,GO MYELOID CELL HOMEOSTASIS,0.001872,0.15727,0.13632,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00017796,0.15726,0.14335,1,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0059384,0.15722,0.15558,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.00029782,0.15718,0.18128,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.027803,0.15716,0.21868,1,1
4,GO SIGNAL RELEASE,0.0012662,0.15664,0.14234,1,1
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.054842,0.15652,0.12255,1,1
4,GO EPITHELIAL CELL PROLIFERATION,0.027188,0.15632,0.10291,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0037331,0.15613,0.1483,1,1
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.025414,0.15582,0.23881,1,1
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.047551,0.15567,0.22326,1,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.023741,0.15544,0.13119,1,1
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.007729,0.15509,0.16252,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.00065623,0.15494,0.13971,1,1
4,GO PROSTAGLANDIN SECRETION,0.012508,0.15466,0.22141,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.007729,0.15448,0.18023,1,1
4,GO REGULATION OF MAPK CASCADE,0.0054795,0.15443,0.12184,1,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.029068,0.15433,0.090241,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.00079435,0.15428,0.11941,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.041093,0.1542,0.15983,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00067758,0.15416,0.16648,1,1
4,GO FEEDING BEHAVIOR,0.001872,0.15381,0.15774,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.0025817,0.15371,0.1651,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0036303,0.1537,0.13558,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.00079435,0.15368,0.20356,1,1
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.022165,0.15355,0.16174,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.00063551,0.15346,0.12099,1,1
4,GO REGULATION OF MITOPHAGY,0.017969,0.15345,0.13974,1,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0028957,0.15327,0.10763,1,1
4,GO FC RECEPTOR SIGNALING PATHWAY,0.0014299,0.15321,0.13647,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0053338,0.15321,0.12185,1,1
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.010773,0.15308,0.11596,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.0023671,0.15304,0.13262,1,1
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.033894,0.15303,0.16956,1,1
4,GO INTERLEUKIN 4 PRODUCTION,0.042857,0.15279,0.144,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0067808,0.15248,0.19132,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0087944,0.15237,0.11412,1,1
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0034322,0.15233,0.17546,1,1
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.027188,0.15221,0.084962,1,1
4,GO COPPER ION TRANSPORT,0.013139,0.15205,0.18299,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0020453,0.15181,0.16496,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,7.547e-05,0.15173,0.14428,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0073363,0.15172,0.14419,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00024286,0.15156,0.16025,1,1
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.015953,0.15155,0.14394,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0028141,0.15155,0.12343,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0097392,0.15152,0.18923,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0019282,0.15146,0.1102,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.0031536,0.15135,0.11077,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0067808,0.15126,0.11152,1,1
4,GO RESPONSE TO PEPTIDE,0.0011549,0.15119,0.12427,1,1
4,GO CALCIUM ION IMPORT,0.0099891,0.15116,0.11193,1,1
4,GO VIRAL BUDDING,0.0037331,0.15107,0.14641,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.043763,0.15096,0.10043,1,1
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.054842,0.15075,0.098,1,1
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0056288,0.15068,0.13087,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.007729,0.15064,0.11717,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.02843,0.15013,0.11733,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.0021689,0.1496,0.14857,1,1
4,GO ENDOSOME ORGANIZATION,0.00057693,0.14931,0.17262,1,1
4,GO CHOLESTEROL EFFLUX,0.015574,0.14909,0.17275,1,1
4,GO MITOTIC CYTOKINETIC PROCESS,0.042857,0.14902,0.11576,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0024367,0.14883,0.13101,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.001228,0.14877,0.10712,1,1
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.03245,0.1487,0.11225,1,1
4,GO MUSCLE CELL DEVELOPMENT,0.010506,0.14857,0.11663,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00016023,0.1483,0.18732,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00079435,0.148,0.20565,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0054795,0.14782,0.1198,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.017549,0.14776,0.093357,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.029719,0.14755,0.13948,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0040578,0.14739,0.1145,1,1
4,GO MUSCLE CELL PROLIFERATION,0.03939,0.14708,0.086008,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00044439,0.14669,0.1277,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.030383,0.14648,0.1481,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.00059588,0.14629,0.18279,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0022332,0.1462,0.11078,1,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.012203,0.1462,0.19273,1,1
4,GO OOCYTE DIFFERENTIATION,0.0037331,0.14594,0.13907,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.030383,0.14587,0.11101,1,1
4,GO POLYOL CATABOLIC PROCESS,0.0026572,0.1458,0.16657,1,1
4,GO NCRNA CATABOLIC PROCESS,0.019283,0.14573,0.12256,1,1
4,GO VESICLE DOCKING,0.044685,0.14564,0.12879,1,1
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.00084609,0.14555,0.15943,1,1
4,GO EXCRETION,0.0014299,0.14507,0.16968,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0085714,0.14496,0.10927,1,1
4,GO CELLULAR HOMEOSTASIS,0.00038934,0.14495,0.13083,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.016339,0.14443,0.11094,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.021165,0.14441,0.11212,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0049174,0.14428,0.16308,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.02166,0.14417,0.11503,1,1
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.016339,0.14417,0.13213,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0013457,0.14405,0.14496,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0027346,0.14404,0.10739,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.033894,0.14398,0.23163,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0031536,0.14372,0.14478,1,1
4,GO LYSOSOME LOCALIZATION,0.0006154,0.14364,0.1653,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,6.5149e-05,0.14353,0.17795,1,1
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0069616,0.14328,0.16075,1,1
4,GO CELL MATURATION,0.00040247,0.14327,0.14469,1,1
4,GO RESPONSE TO ETHANOL,0.0039469,0.14321,0.13404,1,1
4,GO BICARBONATE TRANSPORT,0.030383,0.14311,0.14398,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00047456,0.14273,0.16279,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.00084609,0.14268,0.17769,1,1
4,GO SODIUM ION TRANSPORT,0.0028957,0.14268,0.14514,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00044439,0.14233,0.15631,1,1
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0087944,0.14232,0.14263,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0062634,0.14231,0.10355,1,1
4,GO RESPONSE TO ALKALOID,0.02166,0.1423,0.12168,1,1
4,GO CELL CELL ADHESION,0.0099891,0.14226,0.12491,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0010859,0.14226,0.16226,1,1
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.018398,0.14203,0.20049,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.011326,0.14186,0.10263,1,1
4,GO HEART PROCESS,0.041093,0.14179,0.089795,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.0067808,0.14179,0.16809,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.00065623,0.14155,0.14363,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0079323,0.14155,0.14673,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0027346,0.14142,0.12799,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.037747,0.14137,0.074608,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00025131,0.1413,0.18702,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00079435,0.14125,0.12545,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.010245,0.14108,0.18585,1,1
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.012508,0.14102,0.17371,1,1
4,GO REGULATION OF TOR SIGNALING,0.00011241,0.141,0.1352,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00049035,0.14093,0.14399,1,1
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.0085714,0.14093,0.14609,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0073363,0.14091,0.094392,1,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.0057817,0.14081,0.20391,1,1
4,GO RUFFLE ORGANIZATION,0.037747,0.14073,0.12651,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.014138,0.14066,0.10612,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.021165,0.14066,0.10047,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.011612,0.14061,0.10801,1,1
4,GO REGULATION OF MACROPHAGE MIGRATION,0.031059,0.14043,0.11457,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.018398,0.1404,0.090281,1,1
4,GO NOTCH SIGNALING PATHWAY,0.001986,0.14035,0.16239,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.01282,0.1403,0.097563,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,5.4121e-05,0.14009,0.17131,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.017137,0.13977,0.13,1,1
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.02268,0.13947,0.11102,1,1
4,GO ENDOTHELIUM DEVELOPMENT,0.013139,0.13895,0.14181,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.041093,0.13892,0.13612,1,1
4,GO CYTOKINETIC PROCESS,0.019739,0.13889,0.11289,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0017641,0.1388,0.11946,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.011612,0.13869,0.10279,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.025994,0.13868,0.16044,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.054842,0.13847,0.13363,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.00049035,0.13839,0.13669,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00017186,0.13837,0.21275,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0049174,0.13821,0.10467,1,1
4,GO PYRUVATE METABOLIC PROCESS,0.009256,0.13796,0.12889,1,1
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.024288,0.13794,0.14619,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00069957,0.13781,0.10989,1,1
4,GO RESPONSE TO ESTRADIOL,0.027188,0.13777,0.091097,1,1
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.011047,0.13763,0.13613,1,1
4,GO RESPONSE TO GAMMA RADIATION,0.030383,0.13757,0.098875,1,1
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.041967,0.13756,0.1356,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0069616,0.13745,0.10637,1,1
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.044685,0.13743,0.11749,1,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.05161,0.13742,0.092955,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00034072,0.1374,0.12746,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.018398,0.13731,0.21295,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.011612,0.13728,0.14293,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0024367,0.13726,0.14389,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00055855,0.1367,0.1365,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0083534,0.13648,0.13451,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0030654,0.13641,0.10518,1,1
4,GO EPITHELIUM DEVELOPMENT,0.0039469,0.13634,0.11378,1,1
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0071468,0.13618,0.18415,1,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00045924,0.13617,0.17885,1,1
4,GO TISSUE MIGRATION,0.0090226,0.13569,0.14207,1,1
4,GO ACTION POTENTIAL,0.031748,0.13568,0.13065,1,1
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.036948,0.13565,0.10549,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.0012662,0.13553,0.14432,1,1
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.033894,0.13538,0.13484,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0081404,0.13534,0.14627,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.0006154,0.13527,0.15034,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.011612,0.13523,0.17673,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0017123,0.1351,0.16687,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.001191,0.13507,0.14577,1,1
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.04854,0.13505,0.080709,1,1
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.014486,0.1349,0.10455,1,1
4,GO T CELL SELECTION,0.00052342,0.13482,0.14353,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00013917,0.13477,0.15979,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0049174,0.13466,0.10309,1,1
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.041093,0.13462,0.11636,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.033894,0.1346,0.091334,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00095906,0.13415,0.15963,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.0045306,0.13404,0.17173,1,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.040234,0.13394,0.10655,1,1
4,GO CATECHOLAMINE SECRETION,0.015953,0.13389,0.2602,1,1
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0027346,0.13349,0.14887,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.00054072,0.13315,0.12154,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0051916,0.1328,0.18845,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0071468,0.13279,0.09791,1,1
4,GO POLYOL METABOLIC PROCESS,0.011612,0.13277,0.12466,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0030654,0.13274,0.10409,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,0.025414,0.13268,0.1014,1,1
4,GO VESICLE LOCALIZATION,0.013139,0.13268,0.10764,1,1
4,GO BIOLOGICAL ADHESION,0.022165,0.13147,0.10555,1,1
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0083534,0.13126,0.10751,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00049035,0.13123,0.13087,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.001986,0.13087,0.1187,1,1
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.04854,0.13018,0.094082,1,1
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.03939,0.12994,0.095014,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.012508,0.12979,0.13695,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.036164,0.12977,0.10453,1,1
4,GO GLUTATHIONE METABOLIC PROCESS,0.02268,0.12976,0.2619,1,1
4,GO ORGANELLE INHERITANCE,0.01282,0.12959,0.11241,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0031536,0.12893,0.13228,1,1
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.023741,0.12891,0.17989,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.00087311,0.12889,0.12138,1,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.029068,0.12884,0.10825,1,1
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.027188,0.12878,0.13956,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0026572,0.12848,0.10045,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.024846,0.12845,0.12082,1,1
4,GO POSITIVE REGULATION OF BINDING,0.03245,0.12806,0.077368,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.0039469,0.12806,0.11003,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.010506,0.1277,0.15238,1,1
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.011612,0.12766,0.14104,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.014841,0.12757,0.08792,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00087311,0.12754,0.13236,1,1
4,GO SINGLE FERTILIZATION,0.025994,0.12747,0.083277,1,1
4,GO REGULATION OF METAL ION TRANSPORT,0.037747,0.12732,0.077124,1,1
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.031748,0.12728,0.14061,1,1
4,GO DRUG CATABOLIC PROCESS,0.021165,0.127,0.21297,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.0066042,0.12698,0.11044,1,1
4,GO REGULATION OF CELL DEATH,0.0021062,0.12694,0.10961,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.019283,0.12687,0.1608,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0056288,0.12684,0.096769,1,1
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.0010859,0.12679,0.13261,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.0021062,0.12638,0.10542,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.001986,0.1259,0.13096,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0056288,0.12531,0.14525,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.023741,0.12494,0.11751,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0042883,0.12489,0.13432,1,1
4,GO REGULATION OF CHEMOTAXIS,0.0090226,0.12479,0.10357,1,1
4,GO REGULATION OF AUTOPHAGY,0.00024286,0.12429,0.13227,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0021689,0.1242,0.18041,1,1
4,GO VACUOLAR TRANSPORT,0.0018173,0.12414,0.15024,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0033369,0.12407,0.11408,1,1
4,GO TOR SIGNALING,4.4878e-05,0.12378,0.11875,1,1
4,GO THIOESTER METABOLIC PROCESS,0.0026572,0.12366,0.17109,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.02068,0.12363,0.095475,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.004408,0.12354,0.12044,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030383,0.12354,0.10491,1,1
4,GO IMPORT INTO CELL,0.043763,0.12322,0.10459,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.040234,0.1228,0.076829,1,1
4,GO ORGANIC CATION TRANSPORT,0.011047,0.12273,0.16563,1,1
4,GO CELL CELL RECOGNITION,0.035393,0.12265,0.12505,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.0051916,0.12263,0.13985,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.044685,0.12261,0.13849,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.017137,0.12217,0.097801,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0023671,0.12212,0.12173,1,1
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.033166,0.12201,0.14434,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.014486,0.1217,0.12846,1,1
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.024846,0.12133,0.094681,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.014138,0.12127,0.15307,1,1
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.011047,0.12106,0.088295,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.019739,0.12098,0.15611,1,1
4,GO CELL AGING,0.0050528,0.12076,0.10003,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0027346,0.1207,0.20423,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.01282,0.12028,0.13532,1,1
4,GO NEURON MATURATION,0.054842,0.11988,0.14673,1,1
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0028141,0.11985,0.1442,1,1
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0094949,0.11976,0.10903,1,1
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00024286,0.11963,0.17833,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.0037331,0.11936,0.10075,1,1
4,GO ATP METABOLIC PROCESS,0.0015653,0.11883,0.14352,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.014486,0.11775,0.079799,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.052669,0.11729,0.14202,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.0038387,0.11724,0.088148,1,1
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.03245,0.1171,0.073336,1,1
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013465,0.11692,0.11144,1,1
4,GO FAT CELL DIFFERENTIATION,0.0062634,0.11682,0.13744,1,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.02068,0.11678,0.079585,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.018836,0.11639,0.089718,1,1
4,GO MITOCHONDRIAL FUSION,0.047551,0.11637,0.11623,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0028957,0.1163,0.11436,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.011612,0.11581,0.12921,1,1
4,GO GLAND DEVELOPMENT,0.0099891,0.11572,0.10371,1,1
4,GO FEMALE SEX DIFFERENTIATION,0.041093,0.1157,0.082878,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.00092958,0.11562,0.10586,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.0051916,0.11518,0.10143,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.036948,0.11471,0.09615,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.049546,0.11465,0.1117,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.034637,0.11442,0.11285,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0064317,0.11432,0.11272,1,1
4,GO CIRCADIAN RHYTHM,0.0022992,0.11423,0.11151,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.013139,0.11408,0.086606,1,1
4,GO APOPTOTIC PROCESS,0.0017123,0.11407,0.11256,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0094949,0.11337,0.086549,1,1
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0097392,0.11221,0.15284,1,1
4,GO FATTY ACYL COA METABOLIC PROCESS,0.030383,0.11218,0.15272,1,1
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.013465,0.11207,0.16297,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.0099891,0.11155,0.11747,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.013139,0.11138,0.085694,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0056288,0.11117,0.10219,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0038387,0.1111,0.094234,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.015574,0.11093,0.12412,1,1
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.013139,0.11058,0.098681,1,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.026586,0.11032,0.086256,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.014841,0.11012,0.16528,1,1
4,GO NEGATIVE REGULATION OF SECRETION,0.047551,0.1099,0.077842,1,1
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.023205,0.10976,0.10674,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0049174,0.10954,0.093796,1,1
4,GO WATER TRANSPORT,0.033894,0.10952,0.086903,1,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.019283,0.10947,0.09684,1,1
4,GO CYTOSOLIC TRANSPORT,0.00026003,0.10866,0.12763,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0030654,0.10855,0.11184,1,1
4,GO POSITIVE REGULATION OF NEURON DEATH,0.0060989,0.10837,0.1285,1,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.038561,0.10817,0.085759,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0075304,0.10796,0.13331,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.025414,0.10795,0.083648,1,1
4,GO CELL MOTILITY,0.025994,0.10751,0.090159,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.038561,0.10736,0.10664,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.02268,0.10729,0.090239,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0090226,0.10678,0.090179,1,1
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.03245,0.10647,0.10911,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.014486,0.10598,0.086852,1,1
4,GO BODY FLUID SECRETION,0.035393,0.10578,0.086569,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0059384,0.10553,0.10208,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.027803,0.10522,0.094972,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.010245,0.10514,0.11203,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.044685,0.10476,0.061005,1,1
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.011904,0.10458,0.1332,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0071468,0.10449,0.10306,1,1
4,GO POSITIVE T CELL SELECTION,0.023205,0.10441,0.09886,1,1
4,GO SOMITOGENESIS,0.019739,0.10429,0.092647,1,1
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.050569,0.10402,0.083395,1,1
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045624,0.10391,0.094471,1,1
4,GO ENDOSOMAL TRANSPORT,0.00020448,0.10357,0.10885,1,1
4,GO MUSCLE SYSTEM PROCESS,0.018836,0.10293,0.093489,1,1
4,GO GOLGI VESICLE TRANSPORT,0.0042883,0.10241,0.11474,1,1
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.0075304,0.10221,0.10016,1,1
4,GO CELLULAR SENESCENCE,0.0075304,0.10209,0.10322,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.018398,0.10161,0.15317,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.0057817,0.1015,0.090537,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.044685,0.10134,0.10521,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.015574,0.10131,0.10791,1,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.014841,0.10115,0.10306,1,1
4,GO MACROAUTOPHAGY,0.00027832,0.10096,0.13842,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.036164,0.10089,0.073167,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0047853,0.1008,0.10581,1,1
4,GO MULTI ORGANISM PROCESS,0.036948,0.10004,0.066406,1,1
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.04854,0.099358,0.073646,1,1
4,GO PROTEIN STABILIZATION,0.024846,0.099169,0.084727,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.016734,0.099146,0.11407,1,1
4,GO MYELOID CELL DEVELOPMENT,0.024846,0.098561,0.1011,1,1
4,GO NEURON DEATH,0.025414,0.098287,0.067113,1,1
4,GO SENSORY PERCEPTION,0.0066042,0.098146,0.082117,1,1
4,GO SPERM EGG RECOGNITION,0.027803,0.097501,0.10718,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0033369,0.097117,0.11658,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0087944,0.096729,0.14507,1,1
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.023741,0.094897,0.06738,1,1
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.027188,0.094836,0.098921,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0071468,0.094603,0.13392,1,1
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0067808,0.094521,0.064777,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.017549,0.094521,0.12263,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0073363,0.094422,0.083362,1,1
4,GO AMINO ACID TRANSPORT,0.015953,0.094372,0.14867,1,1
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0097392,0.093413,0.098666,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.026586,0.09294,0.15073,1,1
4,GO SENSORY PERCEPTION OF PAIN,0.026586,0.092504,0.11611,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.049546,0.091426,0.10143,1,1
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0028141,0.091356,0.14077,1,1
4,GO REGULATION OF EXOCYTOSIS,0.019739,0.090565,0.12076,1,1
4,GO NEGATIVE REGULATION OF TRANSPORT,0.017137,0.090155,0.089232,1,1
4,GO TRANSLESION SYNTHESIS,0.042857,0.089613,0.086678,1,1
4,GO JNK CASCADE,0.0079323,0.089573,0.11036,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.012203,0.08899,0.093695,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.043763,0.088279,0.05158,1,1
4,GO MITOCHONDRION ORGANIZATION,0.0013054,0.088263,0.11707,1,1
4,GO REGULATION OF OSSIFICATION,0.014138,0.088222,0.11217,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.025414,0.087039,0.073459,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.044685,0.086596,0.06364,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00353,0.08643,0.08358,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0007696,0.085808,0.10877,1,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.012508,0.08542,0.084689,1,1
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.054842,0.085357,0.037444,1,1
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.036948,0.085264,0.067413,1,1
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.017137,0.084686,0.079934,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.017137,0.084624,0.078879,1,1
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.053746,0.084093,0.12323,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.027188,0.083285,0.080689,1,1
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.037747,0.081873,0.075125,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.050569,0.080916,0.056677,1,1
4,GO MUSCLE CONTRACTION,0.044685,0.080896,0.075502,1,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.02166,0.080894,0.079658,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.02166,0.080525,0.090615,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0047853,0.080434,0.065783,1,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.023205,0.080106,0.077845,1,1
4,GO REGULATION OF BINDING,0.024846,0.080038,0.079593,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.02268,0.079325,0.068056,1,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.023741,0.079065,0.070818,1,1
4,GO FERTILIZATION,0.052669,0.078343,0.064668,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.023741,0.078293,0.091668,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.022165,0.077415,0.064201,1,1
4,GO INTRACELLULAR TRANSPORT,0.0025817,0.07664,0.077431,1,1
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.036164,0.07659,0.14915,1,1
4,GO PROTEIN TETRAMERIZATION,0.033166,0.076134,0.083074,1,1
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0090226,0.075727,0.11355,1,1
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.02268,0.074799,0.068369,1,1
4,GO RHYTHMIC PROCESS,0.02068,0.071908,0.07549,1,1
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.024846,0.07171,0.05084,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.043763,0.071341,0.078608,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.014841,0.066,0.055626,1,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.023741,0.063856,0.055776,1,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.035393,0.063334,0.054152,1,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.05161,0.063116,0.047068,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.027188,0.061828,0.079279,1,1
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.050569,0.056847,0.067938,1,1
4,GO TORC1 SIGNALING,0.02268,0.056692,0.080556,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.010506,0.048722,0.080508,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.0037331,0.043162,0.11027,1,1
4,GO DNA CATABOLIC PROCESS,0.014841,0.041586,0.097555,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,9.0551e-05,0.37126,0.38578,1,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.00036427,0.36932,0.34898,1,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0081404,0.35136,0.29717,1,0
4,GO ETHANOL OXIDATION,0.0031536,0.35129,0.46996,1,0
4,GO GAP JUNCTION ASSEMBLY,0.012508,0.32824,0.27562,1,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.035393,0.32658,0.23983,1,0
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0045306,0.32072,0.33515,1,0
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.0027346,0.31905,0.20436,1,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00095906,0.29489,0.42113,1,0
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.035393,0.28756,0.25113,1,0
4,GO HYALURONAN CATABOLIC PROCESS,0.010773,0.28521,0.16484,1,0
4,GO RESPONSE TO HISTAMINE,0.022165,0.27986,0.33091,1,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.045624,0.27958,0.17491,1,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.011326,0.27462,0.30353,1,0
4,GO ARGININE METABOLIC PROCESS,0.010773,0.27294,0.34941,1,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.012203,0.26851,0.22366,1,0
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.035393,0.26598,0.20679,1,0
4,GO REGULATION OF EXOSOMAL SECRETION,0.0041716,0.26576,0.21286,1,0
4,GO CD40 SIGNALING PATHWAY,0.0027346,0.26411,0.19404,1,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.033894,0.2629,0.22378,1,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.037747,0.26279,0.28673,1,0
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.029068,0.26082,0.21248,1,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.011047,0.25097,0.29507,1,0
4,GO EPITHELIAL CELL MORPHOGENESIS,0.0099891,0.25038,0.28668,1,0
4,GO PROTEIN ACTIVATION CASCADE,0.019739,0.24997,0.25534,1,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00026903,0.24952,0.21311,1,0
4,GO MACROPHAGE PROLIFERATION,0.042857,0.24819,0.21399,1,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.034637,0.24704,0.17308,1,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0028141,0.24158,0.31325,1,0
4,GO REVERSE CHOLESTEROL TRANSPORT,0.0030654,0.24016,0.39457,1,0
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0066042,0.24007,0.16029,1,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00019079,0.24006,0.28748,1,0
4,GO HYALURONAN METABOLIC PROCESS,0.00079435,0.23783,0.18231,1,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.031059,0.23735,0.19377,1,0
4,GO FIBRINOLYSIS,0.054842,0.23592,0.27567,1,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.020205,0.2341,0.19721,1,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0046564,0.23074,0.20743,1,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.013798,0.22566,0.14731,1,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.018398,0.22533,0.20398,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.02843,0.22191,0.17475,1,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.0053338,0.22091,0.2805,1,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.018398,0.21878,0.28189,1,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.0059384,0.21717,0.12136,1,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.012508,0.21619,0.16421,1,0
4,GO PROTEIN TARGETING TO LYSOSOME,0.023741,0.21416,0.20799,1,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0037331,0.21323,0.23558,1,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.018836,0.20884,0.17136,1,0
4,GO DISACCHARIDE METABOLIC PROCESS,0.041093,0.20861,0.23916,1,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0087944,0.20667,0.19452,1,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0064317,0.20565,0.16498,1,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.011612,0.20502,0.17877,1,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.018836,0.20465,0.17168,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.036948,0.20055,0.15224,1,0
4,GO DNA DEAMINATION,0.033166,0.19978,0.2187,1,0
4,GO LIPID IMPORT INTO CELL,0.0069616,0.19866,0.23172,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.036164,0.19785,0.32773,1,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.02166,0.19741,0.35569,1,0
4,GO PEPTIDE CATABOLIC PROCESS,0.0087944,0.19506,0.21583,1,0
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.013139,0.19407,0.13072,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0090226,0.18787,0.19843,1,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0079323,0.18723,0.19656,1,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0090226,0.18444,0.13983,1,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.043763,0.18353,0.23785,1,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0054795,0.18094,0.29092,1,0
4,GO TRANSMISSION OF NERVE IMPULSE,0.0064317,0.18084,0.2164,1,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.040234,0.17971,0.15184,1,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.031748,0.17883,0.17142,1,0
4,GO HORMONE BIOSYNTHETIC PROCESS,0.010245,0.17762,0.20306,1,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.050569,0.17758,0.1639,1,0
4,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.050569,0.17671,0.26949,1,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.055956,0.17457,0.14703,1,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0094949,0.1733,0.14914,1,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.011326,0.17149,0.099044,1,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0087944,0.17073,0.13868,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.054842,0.1704,0.14983,1,0
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.031059,0.16996,0.14521,1,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.027188,0.16968,0.11659,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.030383,0.16819,0.19593,1,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.046579,0.16688,0.11814,1,0
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.023741,0.16593,0.17062,1,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.016734,0.16581,0.20576,1,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.041093,0.16425,0.19755,1,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0040578,0.1626,0.26399,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.035393,0.15989,0.2139,1,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.00054072,0.15922,0.18073,1,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.0054795,0.15912,0.18831,1,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.030383,0.15908,0.2321,1,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.047551,0.15864,0.11059,1,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.014841,0.15809,0.11669,1,0
4,GO EPITHELIAL CELL CELL ADHESION,0.030383,0.15799,0.29048,1,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.031059,0.15754,0.099181,1,0
4,GO IRON ION HOMEOSTASIS,0.0090226,0.15743,0.15413,1,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.036948,0.1565,0.19195,1,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.031748,0.1564,0.13004,1,0
4,GO STRIATED MUSCLE ADAPTATION,0.02843,0.15487,0.16486,1,0
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.02068,0.1543,0.13364,1,0
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0016129,0.15318,0.19683,1,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0069616,0.15308,0.15289,1,0
4,GO PIGMENT METABOLIC PROCESS,0.02166,0.15292,0.16423,1,0
4,GO PROTEIN TARGETING TO VACUOLE,0.0085714,0.15153,0.15325,1,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.037747,0.15073,0.17713,1,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.050569,0.15072,0.20677,1,0
4,GO COPPER ION HOMEOSTASIS,0.023205,0.15052,0.16015,1,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.023205,0.14955,0.1321,1,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.043763,0.14842,0.21064,1,0
4,GO PROTEIN FOLDING,0.009256,0.14827,0.13565,1,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.015953,0.14765,0.14872,1,0
4,GO MIDBODY ABSCISSION,0.0034322,0.14736,0.2152,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.019283,0.14728,0.17039,1,0
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0022332,0.14496,0.21252,1,0
4,GO CELLULAR RESPONSE TO IRON ION,0.037747,0.14389,0.18883,1,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.03245,0.1438,0.19491,1,0
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0022992,0.14378,0.17377,1,0
4,GO POTASSIUM ION HOMEOSTASIS,0.050569,0.14254,0.11713,1,0
4,GO REGULATION OF CELL MATURATION,0.012508,0.14072,0.13754,1,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.013139,0.14046,0.15173,1,0
4,GO REGULATION OF VASOCONSTRICTION,0.00047456,0.14026,0.20839,1,0
4,GO ERAD PATHWAY,0.014138,0.13989,0.12523,1,0
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.019283,0.1395,0.10916,1,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.045624,0.1393,0.076349,1,0
4,GO AMINE CATABOLIC PROCESS,0.016734,0.13918,0.24784,1,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.025994,0.1388,0.10237,1,0
4,GO DETERMINATION OF ADULT LIFESPAN,0.0090226,0.13796,0.22448,1,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.014841,0.13794,0.2092,1,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.041967,0.13794,0.10949,1,0
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.038561,0.13758,0.10074,1,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.049546,0.13748,0.095728,1,0
4,GO PROTEIN REFOLDING,0.017969,0.13695,0.18728,1,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.033894,0.13677,0.1993,1,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.013798,0.13636,0.2114,1,0
4,GO PROTEASOME ASSEMBLY,0.041967,0.13597,0.13557,1,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.022165,0.13594,0.1237,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.050569,0.13528,0.19563,1,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0025817,0.13493,0.25526,1,0
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0064317,0.13457,0.12405,1,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.024288,0.13347,0.13248,1,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.044685,0.13201,0.14777,1,0
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.04854,0.13117,0.19087,1,0
4,GO RESPONSE TO INTERLEUKIN 7,0.024288,0.1308,0.11614,1,0
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.034637,0.13062,0.15449,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.02843,0.13037,0.13521,1,0
4,GO RESPONSE TO MISFOLDED PROTEIN,0.0069616,0.12886,0.17402,1,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.042857,0.12835,0.12198,1,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.037747,0.12829,0.14675,1,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0049174,0.12826,0.15482,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0040578,0.12791,0.14738,1,0
4,GO POSITIVE REGULATION OF MITOPHAGY,0.033894,0.12694,0.13099,1,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.041093,0.1262,0.19279,1,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.023741,0.12435,0.17049,1,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.024288,0.12391,0.20552,1,0
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0018173,0.12361,0.14542,1,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.013139,0.12229,0.18675,1,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.041967,0.12152,0.13636,1,0
4,GO PEPTIDE METABOLIC PROCESS,0.050569,0.12125,0.088911,1,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.019739,0.11988,0.15967,1,0
4,GO TOXIN TRANSPORT,0.0075304,0.11902,0.17608,1,0
4,GO RESPONSE TO TOXIC SUBSTANCE,0.018398,0.11892,0.15423,1,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.009256,0.11839,0.10483,1,0
4,GO STEROL IMPORT,0.024846,0.11787,0.2251,1,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.015203,0.11742,0.13866,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.029068,0.11622,0.087524,1,0
4,GO HEME METABOLIC PROCESS,0.027803,0.11481,0.24929,1,0
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.0073363,0.11454,0.11942,1,0
4,GO DE NOVO PROTEIN FOLDING,0.0056288,0.11343,0.15823,1,0
4,GO P38MAPK CASCADE,0.027803,0.11278,0.15954,1,0
4,GO NUCLEOTIDE PHOSPHORYLATION,0.015574,0.11056,0.1108,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.011047,0.1096,0.087801,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.045624,0.10926,0.12201,1,0
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.019739,0.10855,0.11579,1,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.023741,0.10637,0.1229,1,0
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.027803,0.10595,0.15399,1,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.02843,0.10518,0.11219,1,0
4,GO REGULATION OF HISTONE DEACETYLATION,0.019739,0.10477,0.1531,1,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.010245,0.10372,0.1266,1,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.04854,0.10181,0.066094,1,0
4,GO OSSIFICATION,0.045624,0.1007,0.07884,1,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.04854,0.099085,0.16339,1,0
4,GO URONIC ACID METABOLIC PROCESS,0.018836,0.098422,0.14587,1,0
4,GO MACROMOLECULE CATABOLIC PROCESS,0.0081404,0.098371,0.074311,1,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.0069616,0.097043,0.11179,1,0
4,GO POSITIVE REGULATION OF JNK CASCADE,0.0022992,0.094436,0.13674,1,0
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.019283,0.094206,0.12433,1,0
4,GO LYSOSOMAL TRANSPORT,0.009256,0.093333,0.14256,1,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.031748,0.092465,0.093071,1,0
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.015203,0.091899,0.10783,1,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.034637,0.090164,0.097647,1,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.043763,0.089458,0.12757,1,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.009256,0.089076,0.068895,1,0
4,GO MULTICELLULAR ORGANISM AGING,0.015203,0.089021,0.11625,1,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.050569,0.086222,0.08867,1,0
4,GO REGULATION OF CATABOLIC PROCESS,0.0083534,0.080875,0.079255,1,0
4,GO REGULATION OF MUSCLE CONTRACTION,0.041967,0.080143,0.089211,1,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.042857,0.077434,0.082456,1,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.023741,0.076955,0.1419,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.015953,0.076674,0.10613,1,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0071468,0.074901,0.086834,1,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.036948,0.074386,0.18734,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.018398,0.070315,0.11932,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.049546,0.069178,0.15349,1,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.05161,0.068727,0.12036,1,0
4,GO MATING,0.027803,0.065799,0.10929,1,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.018398,0.065107,0.078493,1,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0090226,0.062181,0.097673,1,0
4,GO PROTEIN HOMOOLIGOMERIZATION,0.015203,0.062168,0.074426,1,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.046579,0.060734,0.11529,1,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.0090226,0.060241,0.060167,1,0
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.043763,0.054727,0.12666,1,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.036948,0.049726,0.097723,1,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.025414,0.044528,0.19598,1,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.052669,-0.033621,-0.088373,1,0
4,GO COVALENT CHROMATIN MODIFICATION,0.024846,-0.039766,-0.064867,1,0
4,GO DNA REPAIR,0.03245,-0.047041,-0.050236,1,0
4,GO RNA EXPORT FROM NUCLEUS,0.05161,-0.050385,-0.082826,1,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.026586,-0.052028,-0.04892,1,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.018836,-0.053497,-0.091591,1,0
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.009256,-0.053629,-0.10496,1,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.0090226,-0.059996,-0.066299,1,0
4,GO DNA RECOMBINATION,0.041093,-0.064925,-0.054274,1,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.05161,-0.064981,-0.093564,1,0
4,GO CHROMATIN ORGANIZATION,0.018836,-0.06503,-0.059479,1,0
4,GO DNA GEOMETRIC CHANGE,0.013139,-0.066069,-0.095353,1,0
4,GO CHROMOSOME ORGANIZATION,0.024288,-0.066927,-0.047673,1,0
4,GO PEPTIDYL LYSINE METHYLATION,0.04854,-0.066973,-0.076403,1,0
4,GO MRNA EXPORT FROM NUCLEUS,0.017549,-0.067734,-0.093246,1,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.041967,-0.068544,-0.10311,1,0
4,GO MRNA PROCESSING,0.004408,-0.070771,-0.080488,1,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.02166,-0.070864,-0.12336,1,0
4,GO PEPTIDYL LYSINE ACETYLATION,0.033894,-0.071458,-0.057819,1,0
4,GO REGULATION OF RNA SPLICING,0.0028141,-0.071811,-0.085433,1,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.045624,-0.072998,-0.089454,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0085714,-0.075538,-0.090053,1,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.043763,-0.07601,-0.10521,1,0
4,GO DOUBLE STRAND BREAK REPAIR,0.0067808,-0.076661,-0.085295,1,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.023205,-0.078362,-0.1059,1,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.044685,-0.079477,-0.099916,1,0
4,GO MAINTENANCE OF CELL NUMBER,0.046579,-0.080069,-0.097086,1,0
4,GO ANIMAL ORGAN FORMATION,0.043763,-0.080646,-0.12282,1,0
4,GO DNA CONFORMATION CHANGE,0.0045306,-0.081497,-0.084734,1,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015203,-0.081894,-0.10754,1,0
4,GO HISTONE UBIQUITINATION,0.0081404,-0.082399,-0.094602,1,0
4,GO MICROTUBULE BASED MOVEMENT,0.03939,-0.083386,-0.061496,1,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.029068,-0.083545,-0.07105,1,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.020205,-0.083968,-0.16663,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0006154,-0.085642,-0.10214,1,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.049546,-0.086213,-0.074305,1,0
4,GO BASE EXCISION REPAIR,0.017969,-0.086332,-0.095272,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0097392,-0.086378,-0.085288,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.012203,-0.086734,-0.088624,1,0
4,GO RNA SPLICING,0.0010859,-0.087869,-0.096531,1,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.017137,-0.088434,-0.083585,1,0
4,GO SPINDLE ORGANIZATION,0.0085714,-0.089541,-0.074172,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.025994,-0.091865,-0.16747,1,0
4,GO POSITIVE REGULATION OF DNA REPAIR,0.00030804,-0.092379,-0.13179,1,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.027188,-0.092761,-0.074873,1,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.044685,-0.093419,-0.090865,1,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.027188,-0.094375,-0.13739,1,0
4,GO MRNA 3 END PROCESSING,0.011904,-0.094611,-0.098856,1,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.027188,-0.095651,-0.091158,1,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.050569,-0.095716,-0.12292,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.023741,-0.098779,-0.15765,1,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.014486,-0.099446,-0.14063,1,0
4,GO RECOMBINATIONAL REPAIR,0.0027346,-0.099849,-0.11102,1,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.019739,-0.10031,-0.071409,1,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.036164,-0.10094,-0.073268,1,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.031059,-0.10196,-0.07743,1,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.023205,-0.10202,-0.15083,1,0
4,GO REGULATION OF DNA RECOMBINATION,0.011047,-0.10246,-0.099384,1,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.033166,-0.10397,-0.1736,1,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0034322,-0.10458,-0.11251,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00353,-0.1047,-0.10917,1,0
4,GO HISTONE H2A UBIQUITINATION,0.023741,-0.10547,-0.12763,1,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.027188,-0.10587,-0.21846,1,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.023741,-0.10705,-0.1588,1,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.0037331,-0.1071,-0.13137,1,0
4,GO MRNA TRANSPORT,0.0097392,-0.10818,-0.098931,1,0
4,GO RNA STABILIZATION,0.0049174,-0.10886,-0.14106,1,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.049546,-0.10968,-0.12969,1,0
4,GO CHROMOSOME SEPARATION,0.023205,-0.11053,-0.092275,1,0
4,GO CHROMOSOME SEGREGATION,0.0056288,-0.11082,-0.07878,1,0
4,GO CELLULAR RESPONSE TO X RAY,0.0079323,-0.1111,-0.20978,1,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.011326,-0.11141,-0.08669,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.029068,-0.1117,-0.12504,1,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0053338,-0.11181,-0.10163,1,0
4,GO SMOOTHENED SIGNALING PATHWAY,0.031059,-0.1121,-0.093326,1,0
4,GO DNA REPLICATION INITIATION,0.00055855,-0.1128,-0.17917,1,0
4,GO HISTONE EXCHANGE,0.038561,-0.11322,-0.095426,1,0
4,GO CELL DIVISION,0.029719,-0.11449,-0.059116,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.015953,-0.11487,-0.11362,1,0
4,GO STRESS GRANULE ASSEMBLY,0.033166,-0.11487,-0.11837,1,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.017549,-0.11645,-0.23156,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.041967,-0.11685,-0.086446,1,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.038561,-0.11701,-0.11763,1,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.0090226,-0.11709,-0.1772,1,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.029719,-0.11788,-0.10436,1,0
4,GO PROTEIN POLYGLUTAMYLATION,0.036948,-0.11798,-0.10902,1,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.047551,-0.11875,-0.12497,1,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00038934,-0.11946,-0.12076,1,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.054842,-0.1198,-0.16239,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.004408,-0.12055,-0.22704,1,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.001986,-0.12098,-0.10226,1,0
4,GO REGULATION OF ORGAN GROWTH,0.027188,-0.12104,-0.12753,1,0
4,GO NUCLEOSOME ORGANIZATION,0.0029794,-0.12109,-0.1206,1,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.0099891,-0.12253,-0.14646,1,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.023741,-0.12262,-0.1324,1,0
4,GO REGULATION OF DNA REPAIR,6.0504e-05,-0.12267,-0.12869,1,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.014138,-0.1227,-0.1457,1,0
4,GO CHROMATIN REMODELING,0.001228,-0.12374,-0.10266,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.014138,-0.12413,-0.11963,1,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.038561,-0.12422,-0.1291,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.013798,-0.12496,-0.15391,1,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.022165,-0.12629,-0.15997,1,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.0053338,-0.12644,-0.17539,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0079323,-0.12696,-0.10577,1,0
4,GO HISTONE H4 DEACETYLATION,0.029719,-0.12703,-0.16673,1,0
4,GO CHROMOSOME CONDENSATION,0.00095906,-0.12705,-0.15648,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.049546,-0.12822,-0.14602,1,0
4,GO SNORNA 3 END PROCESSING,0.041967,-0.12868,-0.14836,1,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.043763,-0.12881,-0.10074,1,0
4,GO CENTRIOLE ASSEMBLY,0.029719,-0.13039,-0.093046,1,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.047551,-0.13056,-0.15665,1,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.016339,-0.13121,-0.12113,1,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.0042883,-0.13137,-0.1659,1,0
4,GO TELOMERIC LOOP DISASSEMBLY,0.03245,-0.13223,-0.11452,1,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.030383,-0.13363,-0.12224,1,0
4,GO MITOTIC RECOMBINATION,0.034637,-0.13364,-0.12275,1,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.018836,-0.1353,-0.12111,1,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00032948,-0.13577,-0.1318,1,0
4,GO HISTONE DEUBIQUITINATION,0.0041716,-0.13592,-0.10449,1,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.010245,-0.13635,-0.14881,1,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.0038387,-0.13642,-0.13442,1,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00032948,-0.13657,-0.15919,1,0
4,GO REGULATION OF MYELINATION,0.0019282,-0.13659,-0.16242,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.026586,-0.13718,-0.20626,1,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.030383,-0.13736,-0.18466,1,0
4,GO BONE MORPHOGENESIS,0.017549,-0.1374,-0.1515,1,0
4,GO STEM CELL PROLIFERATION,0.043763,-0.13752,-0.088751,1,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.009256,-0.13794,-0.17227,1,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00095906,-0.13848,-0.12232,1,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.0083534,-0.13866,-0.13536,1,0
4,GO REGULATION OF MRNA PROCESSING,0.00019753,-0.13874,-0.12661,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.052669,-0.13914,-0.18568,1,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.017969,-0.1393,-0.27988,1,0
4,GO FOREBRAIN DEVELOPMENT,0.02068,-0.13957,-0.094114,1,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0034322,-0.13994,-0.16498,1,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.019283,-0.14145,-0.12329,1,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.049546,-0.1418,-0.11887,1,0
4,GO HISTONE H3 K9 METHYLATION,0.023205,-0.1433,-0.12171,1,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.019739,-0.14389,-0.096833,1,0
4,GO DNA REPLICATION CHECKPOINT,0.014486,-0.14412,-0.15276,1,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00028792,-0.14424,-0.11964,1,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,5.2139e-05,-0.14595,-0.14032,1,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0015189,-0.14613,-0.14737,1,0
4,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.047551,-0.1474,-0.20692,1,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.023741,-0.14755,-0.11764,1,0
4,GO SISTER CHROMATID COHESION,0.020205,-0.14776,-0.095159,1,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.053746,-0.14804,-0.10466,1,0
4,GO REGULATION OF LYASE ACTIVITY,0.015574,-0.14808,-0.14798,1,0
4,GO HISTONE H3 K9 ACETYLATION,0.019283,-0.14881,-0.10836,1,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.054842,-0.14893,-0.10712,1,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.046579,-0.14908,-0.15758,1,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0057817,-0.14961,-0.17497,1,0
4,GO PROSTATIC BUD FORMATION,0.043763,-0.15015,-0.25865,1,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.014138,-0.15024,-0.18457,1,0
4,GO NUCLEOSOME ASSEMBLY,0.024288,-0.15041,-0.11859,1,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015574,-0.15071,-0.21069,1,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.0087944,-0.15107,-0.14677,1,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.014841,-0.15141,-0.24221,1,0
4,GO APPENDAGE DEVELOPMENT,0.014486,-0.1515,-0.11605,1,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.026586,-0.15203,-0.14353,1,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0041716,-0.15232,-0.1313,1,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.03245,-0.1525,-0.15518,1,0
4,GO REGULATION OF AXONOGENESIS,0.025414,-0.15277,-0.17973,1,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.014486,-0.15336,-0.12319,1,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.0020453,-0.15351,-0.20528,1,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.0007696,-0.15457,-0.15156,1,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.017137,-0.15475,-0.15451,1,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.547e-05,-0.15503,-0.16117,1,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0064317,-0.15545,-0.16625,1,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.022165,-0.15549,-0.17056,1,0
4,GO REGULATION OF HEART GROWTH,0.014138,-0.15683,-0.14374,1,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0081404,-0.15735,-0.25076,1,0
4,GO RESPONSE TO ACETYLCHOLINE,0.05161,-0.15735,-0.20102,1,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.02166,-0.15782,-0.18587,1,0
4,GO RETROGRADE AXONAL TRANSPORT,0.010506,-0.15792,-0.2218,1,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.009256,-0.1588,-0.12497,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00012964,-0.15905,-0.14879,1,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0094949,-0.16254,-0.14542,1,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.036948,-0.16384,-0.21856,1,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.0010859,-0.16405,-0.17673,1,0
4,GO TELENCEPHALON DEVELOPMENT,0.0081404,-0.1644,-0.1203,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.019739,-0.16454,-0.1032,1,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00014935,-0.16457,-0.15071,1,0
4,GO FOREBRAIN CELL MIGRATION,0.037747,-0.16509,-0.13724,1,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00079435,-0.16543,-0.12593,1,0
4,GO HINDLIMB MORPHOGENESIS,0.023205,-0.16639,-0.17469,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0037331,-0.16821,-0.10653,1,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00059588,-0.16881,-0.14418,1,0
4,GO REPLICATION FORK PROCESSING,0.00038934,-0.16994,-0.20248,1,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.02843,-0.1707,-0.11275,1,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.00090094,-0.17139,-0.2064,1,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.023741,-0.17214,-0.17875,1,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.004408,-0.17247,-0.14016,1,0
4,GO MITOTIC DNA REPLICATION CHECKPOINT,0.024288,-0.17324,-0.17163,1,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0047853,-0.17437,-0.25351,1,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.0097392,-0.17628,-0.13346,1,0
4,GO REGULATION OF STEM CELL DIVISION,0.03245,-0.17765,-0.17597,1,0
4,GO NEURON PROJECTION ORGANIZATION,0.0062634,-0.17796,-0.18589,1,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.025414,-0.1781,-0.23507,1,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.001662,-0.1815,-0.22049,1,0
4,GO TRACHEA DEVELOPMENT,0.041967,-0.18161,-0.17723,1,0
4,GO KINETOCHORE ORGANIZATION,0.018398,-0.18241,-0.15489,1,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.022165,-0.18335,-0.19409,1,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00044439,-0.18429,-0.28153,1,0
4,GO STEM CELL DIVISION,0.053746,-0.18567,-0.13845,1,0
4,GO REGULATION OF HIPPO SIGNALING,0.031059,-0.18804,-0.19711,1,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.0028957,-0.18855,-0.223,1,0
4,GO MITRAL VALVE DEVELOPMENT,0.017969,-0.18856,-0.25021,1,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0017641,-0.18903,-0.19221,1,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.020205,-0.18919,-0.13058,1,0
4,GO LYMPHANGIOGENESIS,0.0099891,-0.18922,-0.21849,1,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.022165,-0.18959,-0.13039,1,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.049546,-0.18964,-0.23246,1,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.016734,-0.19049,-0.20237,1,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0050528,-0.19131,-0.16288,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00021167,-0.1917,-0.17834,1,0
4,GO REPLACEMENT OSSIFICATION,0.034637,-0.19173,-0.16962,1,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.0099891,-0.19177,-0.29019,1,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.0012662,-0.19179,-0.17143,1,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0062634,-0.19314,-0.18623,1,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.025414,-0.19357,-0.18707,1,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.023741,-0.19392,-0.19404,1,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.041967,-0.19459,-0.1404,1,0
4,GO OTIC VESICLE MORPHOGENESIS,0.013465,-0.19579,-0.28058,1,0
4,GO POSTSYNAPSE ORGANIZATION,0.0045306,-0.19652,-0.19088,1,0
4,GO SPINAL CORD DEVELOPMENT,0.014841,-0.1969,-0.15616,1,0
4,GO APPENDAGE MORPHOGENESIS,0.0046564,-0.19721,-0.15668,1,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0056288,-0.19725,-0.17904,1,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.025994,-0.1973,-0.20281,1,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.021165,-0.19758,-0.19647,1,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.0041716,-0.1997,-0.16906,1,0
4,GO SOMATIC STEM CELL DIVISION,0.015953,-0.19999,-0.4037,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0027346,-0.20037,-0.17628,1,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0006154,-0.20231,-0.16251,1,0
4,GO HISTONE H4 K16 ACETYLATION,0.055956,-0.20288,-0.14817,1,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00054072,-0.20432,-0.26122,1,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0051916,-0.20638,-0.16927,1,0
4,GO MICROTUBULE SEVERING,0.046579,-0.20758,-0.13707,1,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.009256,-0.20776,-0.1548,1,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00035231,-0.20789,-0.41856,1,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.042857,-0.20903,-0.15427,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00069957,-0.20981,-0.23195,1,0
4,GO FORELIMB MORPHOGENESIS,0.0056288,-0.21114,-0.23938,1,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.0090226,-0.21162,-0.22572,1,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.00092958,-0.21172,-0.18327,1,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.033166,-0.21285,-0.22743,1,0
4,GO PROSTATE GLAND GROWTH,0.055956,-0.21493,-0.20198,1,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.012203,-0.21498,-0.18942,1,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.0024367,-0.21651,-0.18269,1,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00025131,-0.21658,-0.25032,1,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.011612,-0.21864,-0.15702,1,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.0024367,-0.21866,-0.18943,1,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.001191,-0.21915,-0.22541,1,0
4,GO NEURAL CREST FORMATION,0.015203,-0.22003,-0.22425,1,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0023671,-0.22085,-0.22309,1,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00084609,-0.22164,-0.22544,1,0
4,GO NEURAL CREST CELL MIGRATION,0.0029794,-0.2222,-0.23447,1,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00042998,-0.22275,-0.24646,1,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00014935,-0.22317,-0.20884,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.010245,-0.22443,-0.17681,1,0
4,GO NEURAL TUBE PATTERNING,0.00050664,-0.22628,-0.21388,1,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0045306,-0.22757,-0.16594,1,0
4,GO BONE TRABECULA MORPHOGENESIS,0.031748,-0.22818,-0.26581,1,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.013139,-0.22829,-0.31314,1,0
4,GO DNA LIGATION,0.023741,-0.22878,-0.16081,1,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0017123,-0.22997,-0.22601,1,0
4,GO MUSCLE CELL FATE COMMITMENT,0.0034322,-0.23199,-0.26924,1,0
4,GO PROTEIN DEMETHYLATION,0.00057693,-0.23202,-0.19789,1,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.0024367,-0.23434,-0.19591,1,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.012508,-0.23572,-0.16079,1,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.007729,-0.23579,-0.34917,1,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0011199,-0.23621,-0.25107,1,0
4,GO RECEPTOR CLUSTERING,0.0021062,-0.23733,-0.21996,1,0
4,GO NEUROBLAST PROLIFERATION,0.0018173,-0.23801,-0.20474,1,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.018836,-0.24158,-0.1852,1,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.017969,-0.24229,-0.18809,1,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00074557,-0.24299,-0.31948,1,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0056288,-0.24328,-0.27258,1,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0059384,-0.2434,-0.18156,1,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.04854,-0.24361,-0.18103,1,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0010859,-0.24363,-0.2417,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.037747,-0.24388,-0.20088,1,0
4,GO COCHLEA MORPHOGENESIS,0.00026003,-0.24551,-0.31912,1,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.00353,-0.24677,-0.26913,1,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.0034322,-0.24709,-0.37745,1,0
4,GO HIPPO SIGNALING,0.00059588,-0.24735,-0.30899,1,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,9.7346e-05,-0.24834,-0.28173,1,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.029719,-0.25081,-0.20189,1,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0033369,-0.25099,-0.27963,1,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.015953,-0.2516,-0.25993,1,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.03939,-0.25338,-0.2045,1,0
4,GO BONE GROWTH,0.00067758,-0.25364,-0.29963,1,0
4,GO BRAIN MORPHOGENESIS,0.00047456,-0.25382,-0.19705,1,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0041716,-0.25396,-0.28231,1,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.049546,-0.25636,-0.21963,1,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0025083,-0.25835,-0.35164,1,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00010092,-0.25838,-0.22357,1,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.010245,-0.25911,-0.23135,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.037747,-0.26057,-0.20526,1,0
4,GO MRNA SPLICE SITE SELECTION,0.00011241,-0.26729,-0.24702,1,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00035231,-0.26926,-0.27987,1,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.0047853,-0.26947,-0.30833,1,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.011612,-0.26968,-0.39007,1,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.03939,-0.27091,-0.27049,1,0
4,GO FOREBRAIN MORPHOGENESIS,0.00041602,-0.27196,-0.26261,1,0
4,GO COCHLEA DEVELOPMENT,0.00353,-0.27494,-0.22149,1,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.00010462,-0.27499,-0.28647,1,0
4,GO OTIC VESICLE DEVELOPMENT,0.02843,-0.27501,-0.26142,1,0
4,GO CELL PROLIFERATION IN FOREBRAIN,1.0604e-05,-0.27761,-0.31275,1,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.0010859,-0.27897,-0.22806,1,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0090226,-0.28054,-0.26695,1,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.00044439,-0.28148,-0.24903,1,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.016339,-0.28235,-0.17012,1,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.00042998,-0.28263,-0.31023,1,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.011612,-0.29113,-0.21504,1,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0083534,-0.29136,-0.23508,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0046564,-0.29259,-0.21264,1,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0034322,-0.29602,-0.31982,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0020453,-0.2965,-0.23463,1,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0057817,-0.29687,-0.25595,1,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.00074557,-0.29705,-0.36376,1,0
4,GO TONGUE DEVELOPMENT,0.007729,-0.2995,-0.27129,1,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0083534,-0.29966,-0.22602,1,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00045924,-0.29981,-0.32757,1,0
4,GO SYNAPTIC VESICLE MATURATION,0.029719,-0.30076,-0.2183,1,0
4,GO NEPHRON TUBULE FORMATION,0.015203,-0.30416,-0.28931,1,0
4,GO RESPONSE TO L GLUTAMATE,0.0049174,-0.30437,-0.29846,1,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0025817,-0.30524,-0.3024,1,0
4,GO BONE TRABECULA FORMATION,0.0056288,-0.30536,-0.41413,1,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,4.3218e-05,-0.30595,-0.35105,1,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.019739,-0.30965,-0.27767,1,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,3.1888e-05,-0.31142,-0.30364,1,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.00013433,-0.31239,-0.33471,1,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0040578,-0.31583,-0.23555,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0054795,-0.31959,-0.33213,1,0
4,GO PYRAMIDAL NEURON DIFFERENTIATION,0.011047,-0.32333,-0.28245,1,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.027803,-0.32375,-0.3093,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00023468,-0.32416,-0.3508,1,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0033369,-0.32692,-0.25604,1,0
4,GO FOREBRAIN REGIONALIZATION,0.0049174,-0.3282,-0.25566,1,0
4,GO DENTATE GYRUS DEVELOPMENT,0.015574,-0.32822,-0.23051,1,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,3.3132e-05,-0.32894,-0.39869,1,0
4,GO CARDIOBLAST DIFFERENTIATION,0.00036427,-0.32905,-0.36025,1,0
4,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.0075304,-0.33011,-0.40276,1,0
4,GO CHROMATIN DISASSEMBLY,9.3916e-06,-0.33013,-0.32177,1,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,1.5201e-05,-0.33181,-0.35465,1,0
4,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00092958,-0.3362,-0.40444,1,0
4,GO LATERAL MESODERM DEVELOPMENT,0.0010528,-0.33843,-0.38337,1,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.031059,-0.34193,-0.27443,1,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0028141,-0.34919,-0.28665,1,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,9.7346e-05,-0.35311,-0.45749,1,0
4,GO EMBRYONIC EYE MORPHOGENESIS,2.0784e-06,-0.35329,-0.36342,1,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00012074,-0.35464,-0.40486,1,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0039469,-0.35528,-0.35621,1,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,9.389e-05,-0.3598,-0.39027,1,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0040578,-0.36081,-0.24422,1,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.00013917,-0.36107,-0.36019,1,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.014138,-0.36509,-0.28021,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,6.7596e-05,-0.37158,-0.37558,1,0
4,GO CENTRIOLE CENTRIOLE COHESION,4.1112e-06,-0.37242,-0.37194,1,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.015574,-0.37635,-0.23763,1,0
4,GO PHAGOCYTOSIS RECOGNITION,0.00012074,-0.38175,-0.38352,1,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0064317,-0.38257,-0.36942,1,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00026003,-0.38906,-0.33688,1,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.014486,-0.38976,-0.35457,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.014138,-0.40191,-0.32043,1,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,1.2962e-05,-0.40814,-0.37436,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0184e-05,-0.40968,-0.48948,1,0
4,GO MYOBLAST MIGRATION,0.00084609,-0.41782,-0.42401,1,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,9.7346e-05,-0.43029,-0.39008,1,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.001872,-0.43302,-0.3541,1,0
4,GO TELENCEPHALON REGIONALIZATION,0.0079323,-0.43577,-0.37288,1,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0030654,-0.4393,-0.36855,1,0
4,GO VOCALIZATION BEHAVIOR,0.014486,-0.44779,-0.38362,1,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,3.5759e-05,-0.48436,-0.51652,1,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0014299,-0.48837,-0.36755,1,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0054795,-0.49257,-0.3767,1,0
4,GO CORPUS CALLOSUM DEVELOPMENT,2.0833e-05,-0.49918,-0.4288,1,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.0033e-05,-0.5039,-0.59182,1,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00019079,-0.50419,-0.4659,1,0
4,GO TONGUE MORPHOGENESIS,0.017969,-0.50904,-0.32834,1,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00020448,-0.52005,-0.56289,1,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,1.7806e-05,-0.52063,-0.54248,1,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.00018427,-0.52074,-0.55097,1,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,5.6174e-05,-0.5251,-0.53391,1,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00095906,-0.52966,-0.44065,1,0
4,GO POSTSYNAPSE ASSEMBLY,0.00030804,-0.53775,-0.52251,1,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00090094,-0.54163,-0.44207,1,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00045924,-0.54755,-0.6755,1,0
4,GO LIMB BUD FORMATION,0.00032948,-0.54785,-0.47239,1,0
4,GO CARDIAC CHAMBER FORMATION,9.7801e-06,-0.56791,-0.61433,1,0
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00012964,-0.57532,-0.47195,1,0
4,GO CARDIAC VENTRICLE FORMATION,1.8521e-05,-0.62213,-0.63174,1,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0081404,-0.63943,-0.45033,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,4.8379e-05,-0.66265,-0.59149,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00014418,-0.70595,-0.70705,1,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.068167,0.37987,0.24451,0,1
4,GO HEPARIN METABOLIC PROCESS,0.088862,0.3642,0.16632,0,1
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.095625,0.36085,0.21455,0,1
4,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.085627,0.35483,0.1897,0,1
4,GO BASEMENT MEMBRANE ORGANIZATION,0.10096,0.33434,0.16482,0,1
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.13814,0.32939,0.1749,0,1
4,GO EPITHELIAL CELL FATE COMMITMENT,0.082489,0.28892,0.19007,0,1
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10096,0.27698,0.17204,0,1
4,GO FAT CELL PROLIFERATION,0.13583,0.27606,0.16884,0,1
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.32938,0.27325,0.13111,0,1
4,GO MALE MEIOSIS I,0.093897,0.26686,0.16625,0,1
4,GO RESPONSE TO WATER,0.068167,0.2625,0.18144,0,1
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.35607,0.25738,0.1318,0,1
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.064293,0.253,0.20173,0,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.097379,0.25085,0.20242,0,1
4,GO INTERLEUKIN 13 PRODUCTION,0.057089,0.24605,0.16036,0,1
4,GO NADPH REGENERATION,0.20621,0.2441,0.14091,0,1
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.084046,0.24295,0.22469,0,1
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.063042,0.24182,0.2387,0,1
4,GO REGULATION OF ACTION POTENTIAL,0.063042,0.23777,0.1401,0,1
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.072231,0.23389,0.23975,0,1
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.073629,0.22881,0.21875,0,1
4,GO INTERLEUKIN 5 PRODUCTION,0.11039,0.22251,0.15706,0,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.077957,0.21939,0.1342,0,1
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.11636,0.2183,0.16034,0,1
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.21256,0.21736,0.13936,0,1
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.16294,0.21601,0.10754,0,1
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.075049,0.21551,0.11414,0,1
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.11235,0.21449,0.22504,0,1
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.12259,0.21256,0.096758,0,1
4,GO REGULATION OF EXCRETION,0.076492,0.21196,0.12474,0,1
4,GO EPOXYGENASE P450 PATHWAY,0.063042,0.21092,0.219,0,1
4,GO RESPONSE TO UV B,0.3746,0.20646,0.033222,0,1
4,GO SYNAPTIC VESICLE BUDDING,0.075049,0.20362,0.13365,0,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.093897,0.20112,0.1684,0,1
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.16559,0.1993,0.13721,0,1
4,GO MITOCHONDRIAL TRANSLATION,0.060602,0.19666,0.13228,0,1
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.066855,0.19526,0.14447,0,1
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.093897,0.19418,0.13037,0,1
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.060602,0.19301,0.13338,0,1
4,GO REGULATION OF RESPONSE TO FOOD,0.14526,0.19231,0.071184,0,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.10465,0.19208,0.092426,0,1
4,GO CYTOPLASM ORGANIZATION,0.095625,0.18941,0.15317,0,1
4,GO AMMONIUM TRANSPORT,0.092194,0.18921,0.10669,0,1
4,GO ZINC ION HOMEOSTASIS,0.080955,0.18804,0.14194,0,1
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.14285,0.18704,0.10242,0,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.14526,0.18698,0.11165,0,1
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.14769,0.18696,0.05964,0,1
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.23245,0.18653,0.089812,0,1
4,GO PODOSOME ASSEMBLY,0.44924,0.18575,0.027562,0,1
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.25001,0.18345,0.10102,0,1
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.073629,0.18177,0.16677,0,1
4,GO LAMELLIPODIUM MORPHOGENESIS,0.084046,0.18144,0.15373,0,1
4,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.24288,0.18134,0.080608,0,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.22905,0.17936,0.054142,0,1
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.084046,0.178,0.13863,0,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.072231,0.17674,0.12394,0,1
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.063042,0.17632,0.17708,0,1
4,GO I KAPPAB PHOSPHORYLATION,0.066855,0.17602,0.11855,0,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.12259,0.17549,0.14797,0,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.1028,0.17501,0.10225,0,1
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.060602,0.17369,0.20601,0,1
4,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.25363,0.17357,0.071141,0,1
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.24288,0.17117,0.05361,0,1
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.13355,0.17093,0.1291,0,1
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.079444,0.17042,0.15057,0,1
4,GO NOREPINEPHRINE TRANSPORT,0.076492,0.17012,0.13484,0,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.059411,0.16998,0.0992,0,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.34256,0.16964,0.073866,0,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.15517,0.16878,0.0716,0,1
4,GO LYMPHOCYTE CHEMOTAXIS,0.088862,0.16853,0.070065,0,1
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.11636,0.16786,0.12417,0,1
4,GO NAD BIOSYNTHETIC PROCESS,0.10096,0.16571,0.14182,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.19393,0.16444,0.11367,0,1
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.066855,0.16311,0.10569,0,1
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.17099,0.16254,0.12518,0,1
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.12473,0.16181,0.10744,0,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.15264,0.16127,0.13349,0,1
4,GO RESPONSE TO AMINE,0.23245,0.15883,0.075841,0,1
4,GO RESPONSE TO VITAMIN,0.19095,0.15855,0.068653,0,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.12908,0.15841,0.09948,0,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.11235,0.15839,0.10964,0,1
4,GO PLASMA MEMBRANE FUSION,0.16559,0.15772,0.11916,0,1
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.50337,0.15693,0.10883,0,1
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.20937,0.15479,0.080145,0,1
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.14526,0.15375,0.05547,0,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.090515,0.15252,0.12138,0,1
4,GO REGULATION OF PHAGOCYTOSIS,0.066855,0.15218,0.089835,0,1
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.18219,0.1521,0.067017,0,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.12908,0.15191,0.19659,0,1
4,GO CELLULAR ANION HOMEOSTASIS,0.22568,0.15183,0.046042,0,1
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.22568,0.15162,0.045932,0,1
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.11636,0.15056,0.1158,0,1
4,GO RESPONSE TO LIGHT INTENSITY,0.057089,0.15037,0.12735,0,1
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.064293,0.14952,0.13418,0,1
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.13814,0.14847,0.063456,0,1
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.099158,0.14795,0.10057,0,1
4,GO MYELOID CELL APOPTOTIC PROCESS,0.15015,0.147,0.085791,0,1
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.30815,0.14666,0.046358,0,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.095625,0.14648,0.084604,0,1
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.15773,0.14645,0.12171,0,1
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.39858,0.14593,0.051684,0,1
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.088862,0.1458,0.089039,0,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.092194,0.14501,0.06855,0,1
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.073629,0.14478,0.16603,0,1
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.057089,0.14359,0.19714,0,1
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.05824,0.14171,0.1147,0,1
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.10465,0.14116,0.10168,0,1
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.16294,0.14107,0.063713,0,1
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.51459,0.14039,0.0094189,0,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.21256,0.13984,0.072826,0,1
4,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.67776,0.13853,-0.037444,0,1
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.095625,0.13838,0.079222,0,1
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.17934,0.13811,0.042498,0,1
4,GO NEURON REMODELING,0.31232,0.13773,0.055172,0,1
4,GO REGULATION OF PODOSOME ASSEMBLY,0.38408,0.13666,0.035102,0,1
4,GO SUBPALLIUM DEVELOPMENT,0.19095,0.13655,0.14533,0,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.066855,0.13549,0.10639,0,1
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.29586,0.13546,0.084189,0,1
4,GO ACYLGLYCEROL HOMEOSTASIS,0.0695,0.13525,0.14598,0,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.079444,0.13434,0.1076,0,1
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.30402,0.13359,0.13197,0,1
4,GO HEART TRABECULA FORMATION,0.13814,0.13345,0.18482,0,1
4,GO REGULATION OF RUFFLE ASSEMBLY,0.12689,0.13323,0.10631,0,1
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.087232,0.13303,0.092042,0,1
4,GO ENDOCYTOSIS,0.093897,0.13243,0.070227,0,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.092194,0.13232,0.074083,0,1
4,GO ERBB SIGNALING PATHWAY,0.068167,0.13219,0.10028,0,1
4,GO AROMATIC AMINO ACID TRANSPORT,0.13814,0.13187,0.14931,0,1
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.4978,0.1308,0.047553,0,1
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.13814,0.13017,0.093241,0,1
4,GO ADHERENS JUNCTION ORGANIZATION,0.15264,0.12717,0.084413,0,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.24288,0.12709,0.071198,0,1
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.11434,0.12554,0.089194,0,1
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.24288,0.12478,0.18927,0,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.077957,0.12354,0.10727,0,1
4,GO GRANULOCYTE DIFFERENTIATION,0.22905,0.12336,0.12297,0,1
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.14285,0.12295,0.076172,0,1
4,GO MITOTIC DNA REPLICATION,0.17374,0.12255,0.081118,0,1
4,GO ONE CARBON METABOLIC PROCESS,0.092194,0.12208,0.096826,0,1
4,GO AXONEME ASSEMBLY,0.17374,0.12147,0.078395,0,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.097379,0.12116,0.062978,0,1
4,GO RESPONSE TO UV C,0.087232,0.12114,0.096459,0,1
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.075049,0.12096,0.083535,0,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.095625,0.12034,0.091299,0,1
4,GO RETINA HOMEOSTASIS,0.18508,0.11974,0.03581,0,1
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.072231,0.11955,0.089558,0,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.12473,0.11776,0.077205,0,1
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.11039,0.11765,0.10186,0,1
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.066855,0.11689,0.12671,0,1
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.18219,0.11666,0.12004,0,1
4,GO KERATINOCYTE MIGRATION,0.14285,0.11659,0.083157,0,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.063042,0.11648,0.086772,0,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.21905,0.11627,0.07375,0,1
4,GO CARDIAC CONDUCTION,0.17099,0.11568,0.068276,0,1
4,GO RESPONSE TO NITRIC OXIDE,0.14048,0.11429,0.055483,0,1
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.2839,0.11392,0.044994,0,1
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.22568,0.11336,0.051662,0,1
4,GO MODIFIED AMINO ACID TRANSPORT,0.080955,0.11324,0.10809,0,1
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.19095,0.11233,0.074446,0,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.076492,0.11205,0.11269,0,1
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.11841,0.11191,0.089806,0,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.4978,0.11161,0.026776,0,1
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.2,0.11008,0.052297,0,1
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.05824,0.1091,0.083416,0,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.076492,0.10908,0.10806,0,1
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.25001,0.10906,0.036928,0,1
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.097379,0.10864,0.097833,0,1
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.11841,0.1082,0.06913,0,1
4,GO HEART TRABECULA MORPHOGENESIS,0.18508,0.10813,0.083802,0,1
4,GO REGULATION OF ENDOCYTOSIS,0.084046,0.10791,0.067894,0,1
4,GO TERPENOID METABOLIC PROCESS,0.060602,0.10774,0.13904,0,1
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.29992,0.10677,0.027588,0,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.065563,0.10533,0.077341,0,1
4,GO REGULATION OF HAIR CYCLE,0.17374,0.10471,0.077388,0,1
4,GO MITOCHONDRIAL FISSION,0.073629,0.10456,0.14673,0,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.40349,0.10336,0.025325,0,1
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.39371,0.10284,0.037352,0,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.20621,0.10206,0.053568,0,1
4,GO NUCLEOSIDE SALVAGE,0.26098,0.10125,0.046763,0,1
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.14526,0.10118,0.063577,0,1
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.11636,0.10036,0.05362,0,1
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.05824,0.10015,0.098826,0,1
4,GO OOGENESIS,0.30402,0.099865,0.047843,0,1
4,GO DEPHOSPHORYLATION,0.064293,0.099114,0.054034,0,1
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.40349,0.098893,0.032716,0,1
4,GO RESPONSE TO GLUCAGON,0.070855,0.098468,0.11615,0,1
4,GO CARBOHYDRATE PHOSPHORYLATION,0.32938,0.098023,0.063671,0,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.64605,0.097984,0.0055385,0,1
4,GO POSTREPLICATION REPAIR,0.13583,0.097952,0.050816,0,1
4,GO GLIAL CELL DEVELOPMENT,0.22568,0.097947,0.063972,0,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.1313,0.097828,0.085837,0,1
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.064293,0.097126,0.061573,0,1
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.25363,0.097123,0.049624,0,1
4,GO REGULATION OF GOLGI ORGANIZATION,0.16559,0.097108,0.089505,0,1
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.52025,0.096521,0.033253,0,1
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.44402,0.096217,0.029523,0,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.068167,0.096031,0.10422,0,1
4,GO DETOXIFICATION,0.29184,0.096005,0.11193,0,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13583,0.09592,0.04986,0,1
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.11235,0.0947,0.13683,0,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.27227,0.094653,0.056517,0,1
4,GO SPROUTING ANGIOGENESIS,0.31232,0.094636,0.036171,0,1
4,GO SULFATE TRANSPORT,0.087232,0.094187,0.077891,0,1
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.18508,0.093036,0.12281,0,1
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.42855,0.092942,0.0074331,0,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.090515,0.09264,0.075937,0,1
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.073629,0.092636,0.068907,0,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.066855,0.091909,0.1398,0,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.082489,0.089756,0.11647,0,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.22568,0.089585,0.080015,0,1
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.092194,0.089229,0.10231,0,1
4,GO TUMOR NECROSIS FACTOR SECRETION,0.48678,0.0891,0.023527,0,1
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.10845,0.088036,0.07352,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.097379,0.08756,0.054275,0,1
4,GO REGULATION OF PROTON TRANSPORT,0.11841,0.087534,0.13444,0,1
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.53167,0.087516,0.010018,0,1
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.66501,0.087339,0.017976,0,1
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.29992,0.087039,0.042571,0,1
4,GO REPRODUCTION,0.057089,0.086636,0.062733,0,1
4,GO POSITIVE REGULATION OF OSSIFICATION,0.15773,0.086475,0.081233,0,1
4,GO THYMIC T CELL SELECTION,0.095625,0.084616,0.059862,0,1
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.20309,0.083801,0.058947,0,1
4,GO MESONEPHROS DEVELOPMENT,0.19695,0.083211,0.059958,0,1
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.36064,0.082188,0.058527,0,1
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.073629,0.081251,0.057124,0,1
4,GO BONE MINERALIZATION,0.070855,0.081228,0.092155,0,1
4,GO TUBE MORPHOGENESIS,0.19095,0.080824,0.047701,0,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.60883,0.080243,0.030625,0,1
4,GO ARTERY MORPHOGENESIS,0.14769,0.079635,0.038904,0,1
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.090515,0.079595,0.073482,0,1
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.079444,0.079115,0.064762,0,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.31653,0.078822,0.048536,0,1
4,GO NEGATIVE REGULATION OF SIGNALING,0.085627,0.077685,0.062052,0,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.20937,0.077202,0.044837,0,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.12259,0.076261,0.049096,0,1
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.12908,0.07551,0.058784,0,1
4,GO REGULATION OF ERAD PATHWAY,0.27999,0.07538,0.043186,0,1
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.073629,0.074387,0.094721,0,1
4,GO CARDIOCYTE DIFFERENTIATION,0.36526,0.0734,0.036517,0,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15517,0.07296,0.054777,0,1
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.26471,0.072569,0.045155,0,1
4,GO MUSCLE CELL DIFFERENTIATION,0.11841,0.072526,0.063933,0,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.084046,0.072455,0.057095,0,1
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.11841,0.072139,0.044296,0,1
4,GO PLACENTA DEVELOPMENT,0.25001,0.071397,0.063418,0,1
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.35607,0.070088,0.022544,0,1
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.1028,0.07005,0.048472,0,1
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.10465,0.069147,0.065507,0,1
4,GO RESPONSE TO GROWTH FACTOR,0.188,0.068979,0.047258,0,1
4,GO REGULATION OF GLIAL CELL MIGRATION,0.13583,0.068966,0.077071,0,1
4,GO STRESS FIBER ASSEMBLY,0.50337,0.068927,0.027238,0,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.061812,0.067635,0.059621,0,1
4,GO TUBE DEVELOPMENT,0.13355,0.067629,0.0579,0,1
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.066855,0.067596,0.062266,0,1
4,GO REGULATION OF CELLULAR LOCALIZATION,0.072231,0.067529,0.051221,0,1
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.21905,0.067191,0.038875,0,1
4,GO CELL JUNCTION ASSEMBLY,0.20309,0.06715,0.062689,0,1
4,GO REGULATION OF GTPASE ACTIVITY,0.072231,0.067148,0.06279,0,1
4,GO PEPTIDYL SERINE MODIFICATION,0.075049,0.066736,0.055568,0,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.18219,0.066152,0.044164,0,1
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.14526,0.065858,0.05852,0,1
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.27227,0.065397,0.024344,0,1
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.16828,0.064975,0.07898,0,1
4,GO PROTEIN AUTOPHOSPHORYLATION,0.15517,0.064385,0.045795,0,1
4,GO VISUAL BEHAVIOR,0.42855,0.063027,0.058425,0,1
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.17374,0.062963,0.049083,0,1
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.60883,0.062823,0.032686,0,1
4,GO PIGMENT GRANULE ORGANIZATION,0.20937,0.061725,0.062304,0,1
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.087232,0.06153,0.048025,0,1
4,GO CELLULAR RESPONSE TO CAMP,0.24288,0.061006,0.069803,0,1
4,GO DEVELOPMENTAL MATURATION,0.090515,0.06095,0.077725,0,1
4,GO MALE SEX DIFFERENTIATION,0.092194,0.059969,0.072383,0,1
4,GO RESPONSE TO LIGHT STIMULUS,0.64605,0.059834,0.0046447,0,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.52594,0.059785,0.029483,0,1
4,GO GERM CELL DEVELOPMENT,0.19393,0.058595,0.041241,0,1
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.21579,0.058371,0.037956,0,1
4,GO REGULATION OF TORC1 SIGNALING,0.080955,0.057218,0.080272,0,1
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.36991,0.055733,0.024767,0,1
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.072231,0.05544,0.064974,0,1
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.25363,0.055113,0.02826,0,1
4,GO PROTEIN DEPHOSPHORYLATION,0.54903,0.054489,0.012631,0,1
4,GO LIPID PHOSPHORYLATION,0.26098,0.054209,0.061809,0,1
4,GO RESPONSE TO RADIATION,0.28785,0.053743,0.022855,0,1
4,GO SEXUAL REPRODUCTION,0.11434,0.053738,0.044937,0,1
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.52025,0.052946,0.023721,0,1
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.10465,0.052792,0.054176,0,1
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.24288,0.051817,0.042448,0,1
4,GO NEPHRON DEVELOPMENT,0.21905,0.051774,0.048581,0,1
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.057089,0.050765,0.0679,0,1
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.2839,0.050625,0.043849,0,1
4,GO POSITIVE REGULATION OF GROWTH,0.32938,0.050131,0.03032,0,1
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.23245,0.049223,0.028745,0,1
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.26098,0.04472,0.033557,0,1
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.17934,0.044593,0.059857,0,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.11841,0.044257,0.052483,0,1
4,GO C4 DICARBOXYLATE TRANSPORT,0.18508,0.042909,0.053388,0,1
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.15264,0.041989,0.037004,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.26471,0.040691,0.032556,0,1
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.1028,0.039709,0.048585,0,1
4,GO REGULATION OF DEPHOSPHORYLATION,0.53167,0.039034,0.013335,0,1
4,GO REGULATION OF JUN KINASE ACTIVITY,0.17099,0.038374,0.060797,0,1
4,GO POSITIVE REGULATION OF CELL DIVISION,0.38408,0.038121,0.028442,0,1
4,GO MALE GAMETE GENERATION,0.21256,0.036755,0.036741,0,1
4,GO METHYLATION,0.48678,0.035895,0.0031439,0,1
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.44402,0.035733,0.024917,0,1
4,GO GAMETE GENERATION,0.23589,0.03566,0.03398,0,1
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.16559,0.035328,0.03362,0,1
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.27999,0.028988,0.02856,0,1
4,GO ORGANELLE LOCALIZATION,0.25001,0.027762,0.032901,0,1
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.40843,0.027405,0.046082,0,1
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.33812,0.027151,0.022995,0,1
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.89215,0.022066,-0.0056445,0,1
4,GO REFLEX,0.0007696,0.48134,0.41111,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.22568,0.3255,0.17747,0,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.61497,0.30659,0.040993,0,0
4,GO RESPONSE TO MAGNESIUM ION,0.0025817,0.30245,0.36912,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.05824,0.30244,0.18072,0,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028141,0.30162,0.30263,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.0050528,0.29942,0.30436,0,0
4,GO NEURONAL ACTION POTENTIAL,0.00095906,0.29028,0.37934,0,0
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.11235,0.28648,0.2142,0,0
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.16559,0.27136,0.14385,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.15773,0.26848,0.13505,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.13355,0.26394,0.16364,0,0
4,GO DETECTION OF CALCIUM ION,0.024846,0.25138,0.26157,0,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.082489,0.24596,0.1233,0,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.13355,0.24508,0.23695,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.11636,0.24334,0.1673,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.16559,0.24281,0.099096,0,0
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.00029782,0.24068,0.34405,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.37932,0.23568,0.058028,0,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00032948,0.2354,0.26528,0,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.52025,0.23125,0.12325,0,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.092194,0.22296,0.12216,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.077957,0.22274,0.17161,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.19095,0.21971,0.083402,0,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.14526,0.21789,0.24423,0,0
4,GO ENAMEL MINERALIZATION,0.082489,0.21513,0.17111,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.67137,0.21476,0.0093738,0,0
4,GO LIVER REGENERATION,0.1028,0.20865,0.099449,0,0
4,GO MIDGUT DEVELOPMENT,0.05824,0.20779,0.19508,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.23589,0.2064,0.14093,0,0
4,GO ADRENAL GLAND DEVELOPMENT,0.0057817,0.20559,0.30465,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.21579,0.20546,0.16224,0,0
4,GO GLYCINE TRANSPORT,0.066855,0.20491,0.21679,0,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.17374,0.20487,0.099342,0,0
4,GO INCLUSION BODY ASSEMBLY,0.017137,0.2047,0.23765,0,0
4,GO PINOCYTOSIS,0.11841,0.1991,0.063697,0,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.060602,0.19619,0.13113,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.24643,0.19582,0.042758,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.14769,0.19529,0.14089,0,0
4,GO HEMIDESMOSOME ASSEMBLY,0.3746,0.19434,0.11004,0,0
4,GO NOREPINEPHRINE SECRETION,0.14526,0.19302,0.13414,0,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.17653,0.19287,0.080648,0,0
4,GO HETEROTYPIC CELL CELL ADHESION,0.038561,0.19219,0.15393,0,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.18508,0.18964,0.079802,0,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.85768,0.18896,-0.031327,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0025083,0.18826,0.18473,0,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.17374,0.18687,0.16334,0,0
4,GO HEART INDUCTION,0.19695,0.18519,0.17147,0,0
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.24288,0.18501,0.056091,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.14769,0.18344,0.11228,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.18508,0.18323,0.10592,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.1028,0.18284,0.1445,0,0
4,GO CATECHOLAMINE UPTAKE,0.043763,0.1816,0.20693,0,0
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.001986,0.1814,0.19058,0,0
4,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.44402,0.18006,0.057703,0,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.11039,0.17968,0.1382,0,0
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.079444,0.17842,0.12354,0,0
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.01282,0.17826,0.27233,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.33373,0.17802,0.051947,0,0
4,GO PARENTAL BEHAVIOR,0.17374,0.17567,0.1395,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.26847,0.17565,0.10047,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.21905,0.17557,0.026004,0,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.13583,0.17477,0.12004,0,0
4,GO TRANSLATIONAL TERMINATION,0.12908,0.17218,0.10173,0,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0695,0.17157,0.17224,0,0
4,GO COLLAGEN CATABOLIC PROCESS,0.064293,0.17111,0.094352,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.099158,0.17029,0.1163,0,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.11434,0.17,0.119,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.52594,0.16997,-0.0012826,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.10654,0.16974,0.14286,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.0695,0.16946,0.15272,0,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.02068,0.16907,0.23582,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.34702,0.16897,0.14352,0,0
4,GO RESPONSE TO HYPEROXIA,0.17099,0.16776,0.06559,0,0
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.073629,0.16758,0.23843,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.070855,0.16505,0.22111,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.77618,0.16318,0.034605,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.14048,0.16223,0.090049,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.26098,0.16192,0.10535,0,0
4,GO PROTEIN OXIDATION,0.16032,0.16153,0.06761,0,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.076492,0.16096,0.17294,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.92682,0.16018,-0.03053,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.17374,0.16007,0.14288,0,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.073629,0.15935,0.19241,0,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.065563,0.15861,0.12365,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.17099,0.15848,0.15245,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.13583,0.15824,0.095268,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.072231,0.15531,0.10918,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.024288,0.15486,0.24198,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.31653,0.15465,0.04067,0,0
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.12908,0.15452,0.20295,0,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.027188,0.15413,0.17589,0,0
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.059411,0.15369,0.089618,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.36991,0.15207,0.02542,0,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.079444,0.15173,0.12585,0,0
4,GO LINOLEIC ACID METABOLIC PROCESS,0.18219,0.15161,0.1507,0,0
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.033166,0.15107,0.16183,0,0
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.22905,0.15018,0.094637,0,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.16828,0.14927,0.11379,0,0
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.25729,0.14851,0.11661,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.093897,0.14834,0.11163,0,0
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.075049,0.14794,0.081547,0,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.56666,0.14746,0.050788,0,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.36991,0.14735,0.068013,0,0
4,GO TRANSPOSITION,0.075049,0.14724,0.16936,0,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.027803,0.14701,0.15962,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.31232,0.14697,0.055226,0,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.095625,0.14691,0.093058,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.16559,0.14668,0.10031,0,0
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.24643,0.14655,0.062736,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.10845,0.14622,0.13429,0,0
4,GO MEMBRANE RAFT ASSEMBLY,0.23937,0.14558,0.12544,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.94769,0.14429,-0.023669,0,0
4,GO ADENOHYPOPHYSIS DEVELOPMENT,0.44402,0.14356,0.11276,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.19393,0.1417,0.076462,0,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.064293,0.14111,0.10045,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.012508,0.1406,0.24034,0,0
4,GO PARAXIAL MESODERM DEVELOPMENT,0.29586,0.1404,0.095593,0,0
4,GO REGULATION OF DENDRITE EXTENSION,0.038561,0.1401,0.25374,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.25001,0.13965,0.068389,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.83713,0.13944,-0.0028371,0,0
4,GO CHEMOSENSORY BEHAVIOR,0.22568,0.13902,0.054901,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.79636,0.13899,0.080746,0,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.2839,0.13881,0.10718,0,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.16032,0.13818,0.11943,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.15015,0.13676,0.14423,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.064293,0.13674,0.21367,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.22568,0.13671,0.067219,0,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.097379,0.13613,0.12791,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0071468,0.13557,0.12767,0,0
4,GO DECIDUALIZATION,0.65234,0.13548,0.029765,0,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.24643,0.13545,0.083483,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.076492,0.13453,0.099557,0,0
4,GO ENDODERM FORMATION,0.33373,0.13431,0.040164,0,0
4,GO ALDITOL METABOLIC PROCESS,0.13355,0.13338,0.093667,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.084046,0.13333,0.053897,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.1028,0.13306,0.07622,0,0
4,GO RESPONSE TO ESTROGEN,0.18219,0.13266,0.072886,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.073629,0.13252,0.1652,0,0
4,GO MEMBRANE FISSION,0.23937,0.13252,0.10757,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.11636,0.13191,0.21829,0,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.32506,0.13168,0.053035,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.87144,0.1314,-0.024808,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.066855,0.13101,0.1312,0,0
4,GO ENDOCARDIUM DEVELOPMENT,0.20621,0.13017,0.11504,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.97557,0.12994,-0.06033,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.35153,0.12982,0.10571,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0695,0.12931,0.12048,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.2,0.12927,0.037866,0,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.11636,0.1289,0.067273,0,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.53167,0.12851,0.071835,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.059411,0.12801,0.073553,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.49227,0.12764,0.062084,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.22568,0.12721,0.13079,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.057089,0.12695,0.22377,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.42347,0.12682,0.050351,0,0
4,GO ESTROUS CYCLE,0.39371,0.12643,0.079101,0,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.21256,0.1257,0.039889,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.10845,0.12542,0.13444,0,0
4,GO REGULATION OF TRANSPOSITION,0.14048,0.12457,0.14473,0,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.05824,0.1245,0.082131,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.10845,0.1245,0.20591,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.076492,0.12408,0.10633,0,0
4,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.22905,0.12307,0.095914,0,0
4,GO MAINTENANCE OF CELL POLARITY,0.35607,0.12299,0.085264,0,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0695,0.12253,0.10564,0,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.079444,0.12243,0.15407,0,0
4,GO RNA INTERFERENCE,0.34702,0.12227,0.065703,0,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.20621,0.12208,0.091938,0,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.30402,0.12167,0.076,0,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.30402,0.12115,0.10052,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0081404,0.1211,0.19855,0,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.077957,0.12104,0.13596,0,0
4,GO FATTY ACID HOMEOSTASIS,0.14048,0.12065,0.1451,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.41341,0.12013,0.11465,0,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.11039,0.12012,0.12209,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.14048,0.12011,0.06047,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.25729,0.12006,0.13872,0,0
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.31653,0.12003,0.099681,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.63978,0.11996,0.018858,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.19695,0.11921,0.080633,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.11039,0.1192,0.095463,0,0
4,GO TRNA 5 LEADER REMOVAL,0.1313,0.11912,0.10177,0,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.26098,0.11902,0.19243,0,0
4,GO MACROPHAGE MIGRATION,0.16828,0.11855,0.0668,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.15264,0.11837,0.13894,0,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.62113,0.11829,0.031631,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.32938,0.11813,0.042723,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.32938,0.11732,0.053539,0,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.061812,0.11732,0.21615,0,0
4,GO GLIAL CELL ACTIVATION,0.095625,0.11723,0.086274,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.093897,0.11705,0.0666,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.32506,0.11696,0.060304,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.0083534,0.11664,0.17275,0,0
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.092194,0.11624,0.12714,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.16559,0.11603,0.10201,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.097379,0.11598,0.19541,0,0
4,GO REGENERATION,0.1313,0.11584,0.053977,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.3746,0.11564,0.052358,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.55487,0.11543,0.03894,0,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.30402,0.11534,0.066631,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.50896,0.11523,0.08956,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.12049,0.11493,0.14712,0,0
4,GO GLOMERULUS DEVELOPMENT,0.079444,0.11491,0.11733,0,0
4,GO OSTEOCLAST DEVELOPMENT,0.49227,0.11467,0.035008,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.98255,0.11454,-0.032018,0,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.19695,0.11453,0.064476,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.079444,0.11452,0.086981,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.090515,0.1143,0.11849,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.11235,0.11397,0.15548,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.53742,0.11352,-0.0051905,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.29992,0.11338,0.072363,0,0
4,GO RIBOSOME ASSEMBLY,0.58456,0.11331,0.053999,0,0
4,GO REGULATION OF CELL AGING,0.38888,0.11307,0.03549,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.67776,0.11306,-0.040162,0,0
4,GO VIRAL RNA GENOME REPLICATION,0.097379,0.11281,0.075687,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.27999,0.11267,0.11856,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.67137,0.11257,-0.04402,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.35607,0.11231,0.077402,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.11434,0.11215,0.073765,0,0
4,GO IMMATURE B CELL DIFFERENTIATION,0.19393,0.11209,0.096393,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.34702,0.11168,0.091708,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.48131,0.11141,0.042332,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.28785,0.11101,0.057597,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.079444,0.11075,0.11123,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.011904,0.1106,0.13617,0,0
4,GO CRISTAE FORMATION,0.26471,0.11056,0.07963,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.25363,0.11032,0.067364,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.32506,0.11031,0.035002,0,0
4,GO MEMBRANE REPOLARIZATION,0.079444,0.10991,0.10319,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.10096,0.10954,0.074546,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.36526,0.10945,0.076183,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.24643,0.10905,0.046669,0,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.14526,0.1089,0.081154,0,0
4,GO RESPONSE TO VITAMIN D,0.91987,0.10849,-0.014027,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.38888,0.10846,0.10507,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.188,0.10838,0.052508,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.029068,0.10781,0.094669,0,0
4,GO STORE OPERATED CALCIUM ENTRY,0.25729,0.10762,0.10627,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.65234,0.10732,0.047749,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.077957,0.10727,0.090583,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.5726,0.10698,0.054348,0,0
4,GO RNA MODIFICATION,0.16828,0.10638,0.05476,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.46512,0.10622,0.04683,0,0
4,GO CELL SUBSTRATE ADHESION,0.14048,0.10613,0.058746,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.13355,0.10608,0.063457,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.12473,0.10568,0.070429,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.1028,0.10531,0.12901,0,0
4,GO REGULATION OF CELL PROJECTION SIZE,0.080955,0.10531,0.17701,0,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.11039,0.10502,0.06422,0,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.095625,0.1045,0.10876,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.063042,0.10418,0.10475,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.21905,0.10399,0.065353,0,0
4,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.34702,0.10398,0.078043,0,0
4,GO TRNA METABOLIC PROCESS,0.22235,0.10353,0.055977,0,0
4,GO RESPONSE TO AMPHETAMINE,0.17374,0.10345,0.11774,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.16559,0.10328,0.066517,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.28785,0.10325,0.13661,0,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.21905,0.1031,0.10122,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.16559,0.10289,0.039168,0,0
4,GO NERVE DEVELOPMENT,0.28785,0.10286,0.074758,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.19695,0.10281,0.026477,0,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.63354,0.10267,0.039078,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.095625,0.10248,0.12585,0,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.10654,0.1024,0.047246,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.61497,0.10229,0.032797,0,0
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.031059,0.10226,0.17878,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.21256,0.10203,0.080506,0,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.12049,0.10201,0.1217,0,0
4,GO RESPONSE TO CAMP,0.050569,0.1017,0.11688,0,0
4,GO GDP METABOLIC PROCESS,0.43883,0.10169,0.068851,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.53167,0.10166,0.012501,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.066855,0.10163,0.10017,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.27611,0.10124,0.028045,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.51459,0.10089,-0.00042986,0,0
4,GO TRNA METHYLATION,0.53742,0.09965,0.029296,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.085627,0.099615,0.26382,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.72969,0.099499,-0.031009,0,0
4,GO REPRODUCTIVE BEHAVIOR,0.15264,0.099384,0.091667,0,0
4,GO OOCYTE MATURATION,0.084046,0.099311,0.075675,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.090515,0.099159,0.068181,0,0
4,GO EPIBOLY,0.54321,0.098934,-0.014661,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.36064,0.098864,0.060742,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.24288,0.098672,0.070277,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.3746,0.098668,0.080179,0,0
4,GO RRNA CATABOLIC PROCESS,0.073629,0.098336,0.11401,0,0
4,GO LACTATE METABOLIC PROCESS,0.17099,0.098324,0.078414,0,0
4,GO ASTROCYTE ACTIVATION,0.52594,0.098223,0.018598,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.18508,0.098216,0.19476,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.58456,0.098063,0.02801,0,0
4,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.22568,0.098051,0.14297,0,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.15015,0.097491,0.097541,0,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.076492,0.097224,0.10537,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.63354,0.097091,0.023632,0,0
4,GO RESPONSE TO INTERLEUKIN 12,0.18508,0.09687,0.070868,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.75615,0.09664,0.020356,0,0
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.29586,0.096319,0.095152,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.41842,0.096201,0.046865,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.26471,0.095994,-0.0020156,0,0
4,GO PEPTIDYL HISTIDINE MODIFICATION,0.47049,0.095813,0.043736,0,0
4,GO VESICLE CARGO LOADING,0.26471,0.095769,0.093265,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.21579,0.095717,0.061029,0,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.070855,0.095577,0.23522,0,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.25363,0.094988,0.15432,0,0
4,GO RESPONSE TO RETINOIC ACID,0.40843,0.094934,0.040821,0,0
4,GO IMP METABOLIC PROCESS,0.76948,0.094778,0.026159,0,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.093897,0.094683,0.11565,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.41341,0.094539,0.033956,0,0
4,GO PENTOSE METABOLIC PROCESS,0.30402,0.094259,0.10286,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.23589,0.093799,0.093753,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.066855,0.093695,0.08474,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.49227,0.093247,-0.0048618,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.24288,0.093164,0.0687,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.15264,0.093145,0.11877,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.56666,0.092984,0.027409,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.30815,0.092834,0.1092,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.32506,0.092721,0.18561,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.23937,0.092674,0.083961,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.52594,0.092512,-0.02301,0,0
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.13355,0.09242,0.062813,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.67137,0.092367,0.005728,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.3746,0.092268,0.050851,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.33812,0.092153,0.050723,0,0
4,GO KERATINOCYTE PROLIFERATION,0.13583,0.09215,0.086213,0,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.12049,0.092126,0.0616,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.38888,0.091961,0.1076,0,0
4,GO PROTEIN LOCALIZATION TO AXON,0.40349,0.091773,0.10383,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.093897,0.091721,0.15207,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.18219,0.091266,0.059386,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.49227,0.090957,0.021943,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.17653,0.09063,0.081852,0,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.91987,0.090466,-0.02143,0,0
4,GO AMP METABOLIC PROCESS,0.22235,0.090395,0.1301,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.37932,0.089812,0.067346,0,0
4,GO GLAND MORPHOGENESIS,0.10465,0.089623,0.090605,0,0
4,GO STRIATUM DEVELOPMENT,0.16032,0.089591,0.11546,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.56666,0.089452,0.025993,0,0
4,GO PROTEIN PALMITOYLATION,0.1313,0.089353,0.083158,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.15264,0.088913,0.16586,0,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.063042,0.088701,0.10529,0,0
4,GO MYOBLAST DIFFERENTIATION,0.40349,0.088499,0.01538,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.14285,0.088419,0.079477,0,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.92682,0.088212,-0.002964,0,0
4,GO ENDODERM DEVELOPMENT,0.27999,0.087951,0.05286,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.26471,0.087858,0.14044,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.11636,0.087768,0.094402,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.14526,0.087192,0.049452,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.76281,0.087063,0.040218,0,0
4,GO REGULATION OF PROTEIN FOLDING,0.087232,0.086668,0.085052,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.088862,0.086648,0.097021,0,0
4,GO GLIAL CELL MIGRATION,0.8303,0.086554,-0.012077,0,0
4,GO GASTRULATION,0.26847,0.086313,0.050653,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.59059,0.086204,0.11723,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.58456,0.086203,0.049006,0,0
4,GO INNERVATION,0.57857,0.08619,0.10304,0,0
4,GO ANIMAL ORGAN MATURATION,0.10096,0.085967,0.094806,0,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.19393,0.085802,0.069821,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.14526,0.085765,0.07542,0,0
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.27999,0.085375,0.032414,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.13583,0.085354,0.093493,0,0
4,GO PRIMARY MIRNA PROCESSING,0.17653,0.085246,0.051193,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.14048,0.08515,0.087718,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.48131,0.084748,0.044319,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.21256,0.08466,0.048694,0,0
4,GO PHOSPHATE ION TRANSPORT,0.087232,0.084552,0.089266,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.55487,0.084455,0.058075,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.18508,0.084384,0.058028,0,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.05824,0.084021,0.069681,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.05824,0.083956,0.11651,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.32077,0.08389,0.03131,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.4545,0.083772,0.040844,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.3746,0.083544,0.13996,0,0
4,GO REGULATION OF SYSTEM PROCESS,0.072231,0.083507,0.069206,0,0
4,GO VASCULATURE DEVELOPMENT,0.23245,0.08318,0.042772,0,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.16559,0.082923,0.068523,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.093897,0.082693,0.0753,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.079444,0.082231,0.10278,0,0
4,GO PROTEIN TARGETING,0.10845,0.082081,0.066907,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.40843,0.082048,0.040323,0,0
4,GO TRNA 5 END PROCESSING,0.27999,0.081992,0.069201,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.17099,0.081989,0.030767,0,0
4,GO RESPONSE TO INACTIVITY,0.20309,0.081965,0.10405,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0695,0.081704,0.14507,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.25001,0.081518,0.050605,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.25001,0.081495,0.080578,0,0
4,GO CRANIAL NERVE DEVELOPMENT,0.40843,0.080918,0.055993,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.39858,0.080878,0.073774,0,0
4,GO SEX DETERMINATION,0.50896,0.080557,0.030398,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.52025,0.080309,0.010421,0,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.30815,0.080236,0.1243,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.10654,0.080197,0.12133,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.11434,0.080042,0.11869,0,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.17653,0.079945,0.10837,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.58456,0.079689,0.079605,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.061812,0.079502,0.084893,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.25001,0.07917,0.082595,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.29992,0.079108,0.076498,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.63354,0.0791,0.025993,0,0
4,GO OVULATION CYCLE,0.26471,0.078843,0.055713,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.80312,0.078834,0.0074604,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.56075,0.078679,0.04347,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.10465,0.078648,0.086387,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.48131,0.078488,0.074115,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.97557,0.078428,-0.031991,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.64605,0.07833,0.023838,0,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.085627,0.078252,0.069034,0,0
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.1028,0.078,0.10305,0,0
4,GO REGULATION OF URINE VOLUME,0.4978,0.077562,0.0261,0,0
4,GO MEMBRANE INVAGINATION,0.065563,0.077385,0.089145,0,0
4,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.19393,0.077148,0.16946,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.4598,0.077106,0.026315,0,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.80312,0.077098,0.0065839,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.41341,0.077001,-0.033752,0,0
4,GO APOPTOTIC CELL CLEARANCE,0.36064,0.076956,-0.014875,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.66501,0.076898,0.011397,0,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.063042,0.076876,0.10494,0,0
4,GO STRIATED MUSCLE CONTRACTION,0.095625,0.076821,0.088729,0,0
4,GO REGULATION OF GTP BINDING,0.78962,0.076457,0.0039018,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.85768,0.075851,0.013483,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.188,0.07566,0.12433,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.36991,0.0754,0.13183,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.085627,0.075348,0.077283,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.94073,0.075337,-0.052297,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.43883,0.075212,0.031419,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.15264,0.0751,0.064781,0,0
4,GO PHOTOTRANSDUCTION,0.12908,0.075027,0.038882,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.12049,0.074993,0.05413,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.33812,0.074843,0.026732,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.16032,0.074711,0.078676,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.89215,0.074561,-0.0089486,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.13583,0.074535,0.18977,0,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.50896,0.074529,0.042994,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.073629,0.074484,0.085436,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.62732,0.074441,0.02689,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.26098,0.074381,0.080752,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.15517,0.074144,0.041171,0,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.17099,0.073878,0.048921,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.1028,0.07387,0.065036,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.085627,0.073863,0.16462,0,0
4,GO NAD METABOLIC PROCESS,0.24288,0.073826,0.098754,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.13355,0.073784,0.092096,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.48678,0.073714,0.055166,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.11636,0.073668,0.081488,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.36526,0.073623,0.057297,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.25363,0.07361,0.084999,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.27999,0.073525,0.063801,0,0
4,GO PERICARDIUM DEVELOPMENT,0.98255,0.073507,-0.03477,0,0
4,GO L SERINE METABOLIC PROCESS,0.86455,0.073462,-0.025855,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.065563,0.073307,0.065083,0,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.063042,0.073299,0.1248,0,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.4978,0.073191,0.018239,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.35153,0.073181,0.060441,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.17099,0.073086,0.061037,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.15773,0.072838,0.079686,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.42347,0.072635,0.029626,0,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.17653,0.072621,0.036618,0,0
4,GO ASSOCIATIVE LEARNING,0.25363,0.072506,0.058108,0,0
4,GO CELL FATE DETERMINATION,0.52025,0.072288,0.042191,0,0
4,GO MATING BEHAVIOR,0.31232,0.072279,0.062275,0,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.41341,0.072208,0.029606,0,0
4,GO NADH METABOLIC PROCESS,0.28785,0.072194,0.10592,0,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.32938,0.072163,0.05102,0,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.085627,0.072068,0.069722,0,0
4,GO TRNA MODIFICATION,0.75615,0.071986,0.0043037,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.27227,0.071682,0.066608,0,0
4,GO OVULATION CYCLE PROCESS,0.38408,0.071528,0.062023,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.17653,0.071383,0.049359,0,0
4,GO REGULATION OF MRNA BINDING,0.67776,0.070897,-0.004338,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.28785,0.070893,0.089624,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.23589,0.070834,0.028119,0,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.19393,0.07074,0.097333,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.72313,0.070737,0.029341,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.079444,0.070679,0.1977,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.2839,0.070642,0.024817,0,0
4,GO REGULATION OF BIOMINERALIZATION,0.15517,0.070283,0.063662,0,0
4,GO PANCREATIC JUICE SECRETION,0.4598,0.070236,0.078607,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.12908,0.070168,0.075807,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.13583,0.069982,0.049455,0,0
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.85082,0.069961,0.045127,0,0
4,GO PHOTOPERIODISM,0.25001,0.069783,0.071633,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.20937,0.069679,0.11251,0,0
4,GO RESPONSE TO NICOTINE,0.27227,0.069581,0.07113,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.39858,0.069559,0.14207,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.72969,0.069436,0.0013459,0,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.53167,0.069369,0.027402,0,0
4,GO ASTROCYTE DEVELOPMENT,0.65234,0.0691,0.030806,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.59664,0.069055,0.0046259,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.188,0.068956,0.085854,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.20937,0.068751,0.049479,0,0
4,GO DNA DEMETHYLATION,0.30815,0.068732,0.062076,0,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.16828,0.06872,0.053289,0,0
4,GO ORGAN INDUCTION,0.47588,0.068696,0.016876,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.44924,0.068621,0.023569,0,0
4,GO SKIN MORPHOGENESIS,0.59059,0.068428,-0.1323,0,0
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.20309,0.068395,0.043808,0,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.25729,0.068283,0.048898,0,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.25363,0.068208,0.086386,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.63354,0.068201,0.041194,0,0
4,GO REGULATION OF ODONTOGENESIS,0.75615,0.068154,-0.034948,0,0
4,GO EMBRYONIC BODY MORPHOGENESIS,0.36064,0.068068,0.055673,0,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.22235,0.067914,0.028838,0,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.19095,0.067821,0.037173,0,0
4,GO AORTA MORPHOGENESIS,0.67137,0.067731,0.013057,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.48678,0.067635,0.0080925,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.2839,0.067585,0.040327,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.61497,0.067584,0.013374,0,0
4,GO REGULATION OF DNA METHYLATION,0.7495,0.067283,0.0067616,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.18508,0.066969,0.10404,0,0
4,GO TRNA PROCESSING,0.71658,0.066902,0.0082952,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.62113,0.066869,-0.032458,0,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.4598,0.066868,0.017845,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.075049,0.066341,0.073528,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.59664,0.066235,0.014879,0,0
4,GO RNA 5 END PROCESSING,0.31232,0.066031,0.063899,0,0
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.23589,0.065711,0.086305,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.83713,0.065611,-0.030383,0,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.34702,0.065587,0.10969,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.29586,0.065101,0.084284,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.12473,0.064877,0.084621,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.67776,0.064639,0.00014174,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.11039,0.064405,0.076811,0,0
4,GO POTASSIUM ION TRANSPORT,0.17374,0.064237,0.080714,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.34256,0.064146,0.070146,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.35607,0.064088,0.028405,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.86455,0.063896,-0.0040235,0,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.047551,0.063718,0.14749,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.40349,0.063634,0.03452,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.74288,0.063525,-0.032765,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.20309,0.063426,0.030166,0,0
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.14048,0.062931,0.083873,0,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.42347,0.062817,0.0079121,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.080955,0.062473,0.07946,0,0
4,GO SNRNA PROCESSING,0.31232,0.062384,0.014135,0,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.19095,0.062379,0.064358,0,0
4,GO CELLULAR RESPONSE TO DRUG,0.67776,0.062043,0.020412,0,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.81668,0.061993,-0.020649,0,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.44924,0.061905,0.035322,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.83713,0.061889,-0.0014261,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.80312,0.061769,0.017078,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.52594,0.061752,0.03131,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.97557,0.061581,-0.030345,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.99651,0.061539,-0.0021864,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.75615,0.061476,-0.056785,0,0
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.24288,0.061469,0.035687,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.19695,0.061446,0.085786,0,0
4,GO TRNA CATABOLIC PROCESS,0.21256,0.061185,0.15873,0,0
4,GO NCRNA METABOLIC PROCESS,0.36526,0.061117,0.035752,0,0
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.33373,0.060709,0.090938,0,0
4,GO ADULT FEEDING BEHAVIOR,0.56666,0.060621,-0.068341,0,0
4,GO HEART FIELD SPECIFICATION,0.76281,0.060562,-0.034161,0,0
4,GO RESPONSE TO MUSCLE INACTIVITY,0.16559,0.060478,0.1213,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.15773,0.060333,0.044221,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.085627,0.060332,0.064802,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.9686,0.060327,-0.0449,0,0
4,GO INTERACTION WITH SYMBIONT,0.21579,0.060316,0.029563,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.95466,0.060256,-0.118,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.82348,0.060108,0.0019611,0,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.20937,0.060078,0.05609,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.56666,0.060036,0.028011,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.41341,0.059957,0.067483,0,0
4,GO ERYTHROCYTE DEVELOPMENT,0.26098,0.059867,0.043832,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.21256,0.05976,0.060609,0,0
4,GO REGULATION OF PINOCYTOSIS,0.67776,0.059651,-0.037499,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.39858,0.059366,0.026543,0,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.33373,0.059364,0.034581,0,0
4,GO GONADOTROPIN SECRETION,0.2,0.059158,0.10225,0,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.98255,0.059144,-0.017329,0,0
4,GO LEUKOCYTE TETHERING OR ROLLING,0.097379,0.059009,0.063803,0,0
4,GO RNA METHYLATION,0.56666,0.058595,0.022884,0,0
4,GO TISSUE REGENERATION,0.29992,0.058509,0.06068,0,0
4,GO MESODERM MORPHOGENESIS,0.38888,0.058442,0.02897,0,0
4,GO LUNG MORPHOGENESIS,0.36991,0.058301,0.046907,0,0
4,GO CARDIAC MUSCLE CONTRACTION,0.16032,0.058266,0.073561,0,0
4,GO FOCAL ADHESION ASSEMBLY,0.31232,0.058149,0.033066,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.188,0.058139,0.070832,0,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.50337,0.058001,0.10397,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.17934,0.05792,0.02393,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.61497,0.057818,0.028763,0,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.21905,0.057511,0.019625,0,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.29586,0.057387,0.066562,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.24643,0.057342,0.14983,0,0
4,GO OXYGEN TRANSPORT,0.65234,0.057158,-0.1163,0,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.092194,0.057115,0.10261,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.20621,0.057021,0.053471,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.50896,0.056992,0.078678,0,0
4,GO MYOFIBRIL ASSEMBLY,0.059411,0.056969,0.085348,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.22235,0.056944,0.043933,0,0
4,GO DEVELOPMENTAL INDUCTION,0.3746,0.056558,0.048113,0,0
4,GO OVULATION,0.24643,0.056294,0.094843,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.60272,0.056035,0.02416,0,0
4,GO PIGMENT GRANULE MATURATION,0.69061,0.055791,-0.001752,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.21905,0.05567,0.11608,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.24643,0.055651,0.070021,0,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.095625,0.055513,0.067638,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.36526,0.055373,0.025996,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.18219,0.0553,0.033998,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.78289,0.055262,-0.068385,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.36991,0.055238,0.039792,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.31232,0.055123,0.094078,0,0
4,GO RELAXATION OF MUSCLE,0.41842,0.0548,0.053765,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.23937,0.054779,0.056269,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.46512,0.054245,0.046226,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.068167,0.054159,0.15626,0,0
4,GO ATP TRANSPORT,0.34256,0.054153,0.046807,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.34256,0.054129,0.068433,0,0
4,GO ACTIN FILAMENT ORGANIZATION,0.12908,0.054104,0.055995,0,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.21905,0.053942,0.092795,0,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.33812,0.053866,0.02768,0,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.27227,0.053692,0.058829,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.78962,0.053662,-0.10709,0,0
4,GO SEGMENT SPECIFICATION,0.88523,0.05363,-0.022454,0,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.057089,0.053593,0.10072,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.38408,0.053563,0.036732,0,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.14526,0.053438,0.069093,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.89215,0.053364,-0.020683,0,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.072231,0.053313,0.041689,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.29184,0.053299,0.040199,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.5726,0.053284,0.045699,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.1313,0.053284,0.057191,0,0
4,GO TRANSLATIONAL ELONGATION,0.27227,0.053258,0.058702,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.57857,0.053236,0.0020688,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.48131,0.05302,0.022543,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.35153,0.052984,0.048546,0,0
4,GO TISSUE MORPHOGENESIS,0.19095,0.05288,0.034393,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.15264,0.052525,0.14315,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.14285,0.052439,0.10717,0,0
4,GO PROTEIN IMPORT,0.19095,0.052419,0.050629,0,0
4,GO EXTRACELLULAR TRANSPORT,0.39371,0.052048,0.052836,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.38888,0.051793,0.074587,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.59059,0.050852,0.028316,0,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.64605,0.050849,0.035801,0,0
4,GO DNA DEALKYLATION,0.62732,0.050825,0.027923,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.66501,0.050378,0.02069,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.76281,0.050335,-0.0074568,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.34256,0.05031,0.026406,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.2839,0.05031,0.10924,0,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.55487,0.050255,0.09212,0,0
4,GO RNA CATABOLIC PROCESS,0.68418,0.050177,0.0075908,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.070855,0.050164,0.050659,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.48131,0.05016,0.083239,0,0
4,GO SOMITE DEVELOPMENT,0.23937,0.050049,0.034068,0,0
4,GO RNA DECAPPING,0.66501,0.050027,-0.023452,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.27999,0.049909,0.023662,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.48131,0.049722,0.034752,0,0
4,GO PIGMENT ACCUMULATION,0.53167,0.04968,0.033048,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.89215,0.049624,-0.019109,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.16294,0.049561,0.063389,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.82348,0.049416,0.0048445,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.26098,0.049161,0.055739,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.054842,0.04915,0.14867,0,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.077957,0.048929,0.058172,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.4598,0.048713,0.072271,0,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.12473,0.048709,0.1909,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.13583,0.048414,0.056357,0,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.46512,0.048305,0.039744,0,0
4,GO BLASTOCYST DEVELOPMENT,0.035393,0.048255,0.074589,0,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.188,0.048136,0.037875,0,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.27227,0.048134,0.058349,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.89215,0.048091,-0.014142,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.51459,0.04801,0.035424,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.34702,0.047925,0.042741,0,0
4,GO ADULT LOCOMOTORY BEHAVIOR,0.17099,0.047841,0.10676,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.34702,0.047419,0.037809,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.8303,0.047278,-0.0061651,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.47588,0.047143,0.057361,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.68418,0.046984,0.0025645,0,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.188,0.046847,0.050915,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.68418,0.046828,0.030658,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.35607,0.046673,0.044282,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.59664,0.04659,0.024409,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.36064,0.046589,0.095082,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.44402,0.046548,0.048428,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.73628,0.046509,-0.063859,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.99651,0.046491,0.0038392,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.48131,0.046364,0.028805,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.47588,0.046352,0.067315,0,0
4,GO RESPONSE TO MANGANESE ION,0.27611,0.046312,0.099335,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.51459,0.046104,0.023684,0,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.11636,0.046009,0.065496,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.21256,0.045843,0.095617,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.76281,0.045835,-0.022615,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.4978,0.045573,0.024654,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.96163,0.045387,-0.026395,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.37932,0.045374,0.049193,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.16032,0.045279,0.054942,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.91987,0.045261,0.0036144,0,0
4,GO PRO B CELL DIFFERENTIATION,0.17653,0.045148,0.099191,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.32938,0.04514,0.17005,0,0
4,GO IMMATURE T CELL PROLIFERATION,0.76948,0.045125,0.062535,0,0
4,GO STEROID CATABOLIC PROCESS,0.05824,0.045124,0.21337,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.065563,0.04512,0.050343,0,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.83713,0.045008,0.020649,0,0
4,GO PROTEIN TRIMERIZATION,0.30815,0.044984,0.059335,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.72313,0.044907,-0.0017529,0,0
4,GO EMBRYO IMPLANTATION,0.43367,0.044889,0.063915,0,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.50337,0.044639,0.074371,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.72313,0.044633,-0.014251,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.80989,0.044454,-0.11663,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.57857,0.044226,0.016973,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.41842,0.044077,0.00046162,0,0
4,GO BLASTOCYST FORMATION,0.188,0.043822,0.086838,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.71006,0.043812,-0.010413,0,0
4,GO ACROSOME REACTION,0.095625,0.043671,0.14304,0,0
4,GO RESPONSE TO ZINC ION,0.53742,0.043216,0.035557,0,0
4,GO TRANSLATIONAL INITIATION,0.94073,0.043062,-0.008234,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.39371,0.043051,0.021453,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.10096,0.042784,0.097354,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.61497,0.04268,0.019124,0,0
4,GO FEAR RESPONSE,0.188,0.042654,0.075286,0,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,1,0.042481,-0.013024,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.48131,0.042437,0.065731,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.24288,0.042406,0.058224,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.80989,0.042209,-0.035491,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.75615,0.041928,-0.10704,0,0
4,GO RESPONSE TO HEAT,0.19095,0.041921,0.073434,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.46512,0.041881,0.03551,0,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.92682,0.041876,0.017209,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.71658,0.041666,0.015589,0,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.12049,0.04166,0.079712,0,0
4,GO DETECTION OF ABIOTIC STIMULUS,0.16828,0.041456,0.054794,0,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.26471,0.041208,0.10949,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.75615,0.041133,0.00090635,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.42347,0.041015,0.019664,0,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.28785,0.040956,0.038949,0,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.53742,0.040633,0.010653,0,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.23937,0.040595,0.14235,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.83713,0.040515,-0.016061,0,0
4,GO CELL GROWTH,0.54321,0.040454,0.02404,0,0
4,GO NEGATIVE REGULATION OF CELL SIZE,0.48131,0.040414,0.036717,0,0
4,GO URETER DEVELOPMENT,0.80312,0.040287,-0.01474,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.35607,0.04025,0.044278,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.19095,0.040189,0.08761,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.83713,0.040036,-0.0044938,0,0
4,GO FEVER GENERATION,0.9686,0.03996,-0.004288,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.27611,0.039909,0.027068,0,0
4,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.72313,0.039877,0.054245,0,0
4,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.85768,0.03981,0.0085959,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.25363,0.039809,0.021572,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.64605,0.039756,-0.055332,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.37932,0.039664,0.036388,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.58456,0.039629,0.13889,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.54903,0.039541,0.014759,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.17374,0.039499,0.051537,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.97557,0.039447,-0.011145,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.29586,0.039372,0.03796,0,0
4,GO ENSHEATHMENT OF NEURONS,0.62732,0.039353,0.017092,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.89907,0.039276,-0.0021716,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.47049,0.039229,0.038304,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.62113,0.039224,-0.08709,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.32506,0.039049,0.019469,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.68418,0.038959,0.01619,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.63978,0.038932,-0.0089174,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.62732,0.038923,0.0028946,0,0
4,GO METANEPHROS MORPHOGENESIS,0.67137,0.038904,0.034459,0,0
4,GO NCRNA 3 END PROCESSING,0.3746,0.0389,0.0090726,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.32938,0.038862,0.051614,0,0
4,GO PORE COMPLEX ASSEMBLY,0.87144,0.038711,0.015414,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.8303,0.038615,0.078857,0,0
4,GO CELL CYCLE ARREST,0.25363,0.038508,0.033199,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.43367,0.038405,0.029768,0,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.11235,0.038364,0.091257,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.72313,0.038295,0.010366,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.32938,0.038271,0.052862,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.72313,0.037879,0.024615,0,0
4,GO POSITIVE REGULATION OF MYELINATION,0.61497,0.037409,0.015283,0,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.8303,0.037374,0.00076904,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.94073,0.037372,-0.042789,0,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.28785,0.037304,0.059679,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.60272,0.036943,0.06331,0,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.33812,0.036855,0.037525,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.4978,0.036722,0.058025,0,0
4,GO LACTATION,0.31653,0.036634,0.062045,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.75615,0.036555,-0.0024729,0,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.98255,0.036548,-0.022985,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.72313,0.036545,-0.00091536,0,0
4,GO NOTCH RECEPTOR PROCESSING,0.27611,0.036393,0.16212,0,0
4,GO SEX DIFFERENTIATION,0.31653,0.036358,0.040509,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.60272,0.03633,0.018494,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.27611,0.036166,0.042197,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.74288,0.036134,0.012227,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.81668,0.036071,0.02479,0,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.85768,0.036027,-0.0026331,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.25729,0.035977,0.054829,0,0
4,GO FEMALE GAMETE GENERATION,0.41842,0.035761,0.030615,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,1,0.035722,-0.014978,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.43883,0.035697,0.016889,0,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.39858,0.035419,0.088591,0,0
4,GO HYPEROSMOTIC RESPONSE,0.74288,0.035385,0.027252,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.4978,0.035313,0.020287,0,0
4,GO RECEPTOR METABOLIC PROCESS,0.95466,0.035309,-0.0031373,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.38408,0.03527,0.024126,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.57857,0.035234,0.01415,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.17653,0.034995,0.18205,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.44402,0.034918,0.015746,0,0
4,GO REGULATION OF GROWTH,0.34702,0.034819,0.034183,0,0
4,GO CILIUM MOVEMENT,0.32938,0.03478,0.017227,0,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.48678,0.034767,0.068984,0,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.32077,0.034692,0.041926,0,0
4,GO STARTLE RESPONSE,0.92682,0.034676,0.0030402,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.36991,0.034579,0.12441,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.9686,0.034505,-0.024945,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.55487,0.034494,0.0096407,0,0
4,GO ACTIN CROSSLINK FORMATION,0.53742,0.034401,-0.057998,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.75615,0.034331,0.032614,0,0
4,GO MOLTING CYCLE,0.40349,0.034224,0.025571,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.95466,0.03422,-0.0071001,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.46512,0.034163,0.030134,0,0
4,GO DETECTION OF LIGHT STIMULUS,0.62732,0.033895,-0.0088169,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.99651,0.03373,-0.0038909,0,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.36526,0.033721,0.026218,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.99651,0.033716,-0.0018626,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.80989,0.03362,0.020313,0,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.38888,0.033459,0.041113,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.71658,0.033381,0.029,0,0
4,GO NCRNA PROCESSING,0.71658,0.033378,0.0078814,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.81668,0.03335,-0.0081978,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.42347,0.033307,0.086852,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.19393,0.033291,0.030931,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.77618,0.033243,-0.029925,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.54903,0.033115,0.032915,0,0
4,GO HISTONE H2B UBIQUITINATION,0.15264,0.032924,0.060052,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.8303,0.0327,0.0034773,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.39371,0.032492,0.051378,0,0
4,GO CYTOPLASMIC TRANSLATION,0.94769,0.03245,-0.020723,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.31653,0.032312,0.051541,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.48678,0.032303,0.0053567,0,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.97557,0.032224,-0.004714,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.89907,0.032179,-0.026461,0,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.34256,0.032002,0.043695,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.95466,0.032,-0.01526,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.99651,0.031991,-0.00049735,0,0
4,GO MEIOTIC CELL CYCLE,0.17374,0.031908,0.039286,0,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.30815,0.031638,0.046234,0,0
4,GO TRABECULA MORPHOGENESIS,0.80312,0.031577,-0.0069923,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.76948,0.03153,0.037744,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.33373,0.031386,0.025703,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.13355,0.030767,0.065614,0,0
4,GO AUTOPHAGIC CELL DEATH,0.35153,0.030618,0.053081,0,0
4,GO NEURON APOPTOTIC PROCESS,0.44924,0.030602,0.024302,0,0
4,GO RUFFLE ASSEMBLY,0.67137,0.030404,0.031888,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.92682,0.030074,-0.0055134,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.74288,0.030074,-0.025252,0,0
4,GO ONE CARBON COMPOUND TRANSPORT,0.32938,0.03006,0.070726,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.47049,0.029805,0.024786,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.71006,0.029686,0.019761,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.92682,0.029671,-0.022834,0,0
4,GO LOCOMOTORY BEHAVIOR,0.54903,0.029616,0.053822,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.4598,0.029474,0.023645,0,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.87833,0.029261,-0.027651,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.4545,0.029226,0.068559,0,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.4978,0.029206,0.024309,0,0
4,GO SERTOLI CELL DIFFERENTIATION,0.47049,0.029185,0.034642,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.87833,0.028984,0.0087673,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.81668,0.028896,0.052402,0,0
4,GO MATURATION OF 5 8S RRNA,0.99651,0.028711,-0.014183,0,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.60272,0.028633,-0.11964,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.76948,0.028484,-0.053052,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.4598,0.028458,0.042588,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.44924,0.028439,0.022652,0,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.70355,0.02836,0.016294,0,0
4,GO DNA MODIFICATION,0.38408,0.028009,0.026725,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.89215,0.027805,-0.0050203,0,0
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.22235,0.027773,0.053659,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.38888,0.027732,0.030379,0,0
4,GO EPITHELIAL CELL MATURATION,0.4978,0.027377,0.08291,0,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.48131,0.027355,0.021028,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.82348,0.027346,-0.028652,0,0
4,GO BODY MORPHOGENESIS,1,0.027249,-0.012956,0,0
4,GO IMPORT INTO NUCLEUS,0.41842,0.02698,0.025864,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.8303,0.026917,0.0073967,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.1028,0.026844,0.067902,0,0
4,GO SARCOMERE ORGANIZATION,0.27227,0.026711,0.063209,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.91987,0.026589,0.020653,0,0
4,GO HISTONE DEACETYLATION,0.96163,0.026523,-0.011961,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.13583,0.026511,0.12017,0,0
4,GO FACE DEVELOPMENT,0.96163,0.026484,-0.014727,0,0
4,GO GENITALIA DEVELOPMENT,0.42855,0.02644,0.038745,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.22568,0.026361,0.090356,0,0
4,GO RESPONSE TO FOOD,0.54903,0.026134,0.029361,0,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.65234,0.026092,0.0077574,0,0
4,GO RECEPTOR RECYCLING,0.44402,0.025806,0.048244,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.91293,0.025275,-0.011852,0,0
4,GO RESPONSE TO SALT,0.41341,0.025113,0.044697,0,0
4,GO GASTRIC ACID SECRETION,0.26847,0.025026,0.088463,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.49227,0.024969,0.032473,0,0
4,GO GLIAL CELL FATE COMMITMENT,0.57857,0.024863,0.098057,0,0
4,GO PROTEIN NITROSYLATION,0.70355,0.024743,-0.071245,0,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.93377,0.024707,-0.017014,0,0
4,GO SPERMATID DIFFERENTIATION,0.30815,0.024681,0.03722,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.78289,0.024658,0.00803,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.88523,0.024623,-0.032315,0,0
4,GO BRONCHUS DEVELOPMENT,0.88523,0.024547,0.03253,0,0
4,GO PROTEIN DENEDDYLATION,0.78962,0.024506,0.019874,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.48678,0.024084,0.016485,0,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.32938,0.024066,0.099738,0,0
4,GO MRNA MODIFICATION,0.67137,0.023998,0.02122,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.85768,0.02399,-0.018218,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.65234,0.023748,0.040799,0,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.56666,0.023542,0.0087702,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.54903,0.023273,0.043988,0,0
4,GO DNA BIOSYNTHETIC PROCESS,0.87144,0.023242,-0.0026806,0,0
4,GO ACTIN FILAMENT BASED PROCESS,0.26098,0.023224,0.039735,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.75615,0.023192,0.0056008,0,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.63978,0.023069,-0.0083319,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.37932,0.022807,0.025099,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.34256,0.022727,0.038137,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.90599,0.022674,-0.009806,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.26847,0.022501,0.034931,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.26847,0.022489,0.16624,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.46512,0.022487,0.040035,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.17653,0.022483,0.074891,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.89215,0.022216,-0.0078244,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.75615,0.022186,0.0010973,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.94073,0.021996,-0.0096576,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.50896,0.021989,0.033831,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.26847,0.021889,0.036957,0,0
4,GO REGULATION OF CIRCADIAN RHYTHM,0.29184,0.02181,0.058796,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.89215,0.021736,-0.038166,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.4545,0.021599,0.028665,0,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.31653,0.021547,0.05716,0,0
4,GO GLYCINE METABOLIC PROCESS,0.94769,0.021534,0.08707,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.84397,0.021438,-0.0056168,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.47049,0.021408,0.064327,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.85768,0.021391,-0.042082,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.90599,0.02132,-0.018373,0,0
4,GO SEGMENTATION,0.65866,0.021313,0.022422,0,0
4,GO BLASTODERM SEGMENTATION,0.99651,0.021177,-0.015313,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.82348,0.020762,0.0093173,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.80989,0.020745,0.0078337,0,0
4,GO REGULATION OF PROTEIN TARGETING,0.52594,0.020632,0.03583,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.69061,0.020619,-0.060352,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.52025,0.020617,0.017348,0,0
4,GO NEUROTRANSMITTER REUPTAKE,0.37932,0.020591,0.079793,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.69707,0.020557,0.045685,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.73628,0.020381,-0.046895,0,0
4,GO PLASMA MEMBRANE TUBULATION,0.93377,0.020267,-0.020974,0,0
4,GO SEROTONIN SECRETION,0.94769,0.020188,0.026966,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.79636,0.019978,-0.030128,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.49227,0.019969,0.06439,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.43883,0.019562,0.0057885,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.59059,0.019287,0.040018,0,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.91987,0.019251,-0.030934,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.92682,0.019149,-0.0041078,0,0
4,GO GLIOGENESIS,0.67776,0.018974,0.024821,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.54321,0.018955,0.022312,0,0
4,GO HEAD MORPHOGENESIS,0.98255,0.018931,-0.031455,0,0
4,GO SNRNA METABOLIC PROCESS,0.36526,0.018928,0.023017,0,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.72969,0.018797,-0.020081,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.61497,0.018709,0.022735,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.78289,0.018631,-0.020255,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.24288,0.018452,0.093813,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.91293,0.018295,0.027554,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.29992,0.018219,0.04835,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.97557,0.018212,-0.013188,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.79636,0.018045,-0.00039339,0,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.27227,0.018002,0.036909,0,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.29992,0.017907,0.048847,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.7495,0.017675,-0.081853,0,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.25363,0.017513,0.087477,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.23589,0.017499,0.037854,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.85768,0.017339,-0.053734,0,0
4,GO REGULATION OF HEAT GENERATION,0.91987,0.017297,0.017165,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.89215,0.017118,0.0021691,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.87833,0.017115,-0.019245,0,0
4,GO RESPONSE TO BMP,0.48678,0.016908,0.016538,0,0
4,GO REGULATION OF HISTONE MODIFICATION,0.46512,0.016863,0.019069,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.29992,0.016499,0.023529,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.35153,0.016483,0.1408,0,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.51459,0.016436,0.076544,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.68418,0.016401,0.024167,0,0
4,GO ODONTOGENESIS,0.56666,0.016367,-0.06226,0,0
4,GO COENZYME A METABOLIC PROCESS,0.69707,0.016211,0.037332,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.87833,0.016195,-0.024787,0,0
4,GO REGULATION OF GASTRULATION,0.78962,0.015912,-0.038016,0,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.59059,0.015701,0.1932,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.80989,0.015612,0.0024792,0,0
4,GO NUCLEUS ORGANIZATION,0.55487,0.015495,0.030046,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.94769,0.015467,-0.0047848,0,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.23937,0.015461,0.036018,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.29992,0.015395,0.053097,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.34702,0.015339,-0.083584,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.91293,0.015208,0.014519,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.83713,0.015179,0.0053891,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.4545,0.015178,0.0452,0,0
4,GO VAGINA DEVELOPMENT,0.70355,0.014969,0.0008191,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.71006,0.014916,0.031017,0,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.38888,0.014859,0.036177,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.53167,0.014662,0.02032,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.48678,0.014618,0.01374,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.87833,0.01454,0.0051385,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.75615,0.014524,0.0050762,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.92682,0.014506,-0.020122,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.14048,0.014497,0.1683,0,0
4,GO EPITHELIAL TUBE FORMATION,0.44402,0.014419,-0.065134,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.72969,0.014398,-0.013575,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.85082,0.014365,-7.042e-06,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.40349,0.014326,0.024386,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.76281,0.014261,-0.024809,0,0
4,GO HISTONE H3 ACETYLATION,0.48678,0.014106,-0.027345,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.4978,0.014061,0.12429,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.56075,0.014054,-0.058666,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.32506,0.013914,0.060094,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.86455,0.013868,0.0086491,0,0
4,GO BONE DEVELOPMENT,0.40349,0.013781,-0.057518,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.69707,0.013689,0.018569,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.72969,0.013663,-0.030731,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.89907,0.013659,0.003936,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.56666,0.013613,0.032777,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.57857,0.013605,0.010181,0,0
4,GO MACROMOLECULE DEACYLATION,0.40349,0.013492,0.023933,0,0
4,GO BLEB ASSEMBLY,0.79636,0.013363,-0.10575,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.8303,0.013283,0.014401,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.54321,0.01327,0.013465,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.62732,0.013244,0.039535,0,0
4,GO CARTILAGE DEVELOPMENT,0.91987,0.013,-0.025354,0,0
4,GO GMP METABOLIC PROCESS,0.99651,0.012972,0.00084549,0,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.52594,0.012886,0.028323,0,0
4,GO RNA POLYADENYLATION,0.2839,0.012778,-0.054369,0,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.48678,0.012713,0.029897,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.76281,0.012508,0.010164,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.69707,0.012368,-0.015541,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.71006,0.012165,0.077246,0,0
4,GO ASYMMETRIC CELL DIVISION,0.80989,0.012129,0.012344,0,0
4,GO RESPONSE TO HYDROXYUREA,0.58456,0.011993,0.040348,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.89907,0.01191,-0.013067,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.74288,0.011648,0.021946,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.90599,0.011371,-0.00335,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.95466,0.011006,0.00033086,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.87144,0.010941,-0.0076613,0,0
4,GO BEHAVIOR,0.54321,0.01077,0.030463,0,0
4,GO TAXIS,0.91987,0.01056,-0.0061003,0,0
4,GO HEAT GENERATION,0.79636,0.010427,0.020969,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.97557,0.010398,0.010868,0,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.27611,0.01029,0.042963,0,0
4,GO RESPONSE TO CATECHOLAMINE,0.22905,0.010136,0.071955,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.71006,0.010072,-0.018353,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.87833,0.0099877,0.021437,0,0
4,GO KIDNEY MORPHOGENESIS,0.91987,0.0099393,-0.0070146,0,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.72313,0.0098537,0.0089616,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.7495,0.0098461,0.013173,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.29184,0.0098277,0.049396,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.59664,0.0097919,-0.053868,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.40349,0.0094737,-0.1046,0,0
4,GO MINERALOCORTICOID METABOLIC PROCESS,0.63978,0.0093804,0.068084,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.95466,0.009366,-0.055077,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.66501,0.0093188,0.16235,0,0
4,GO REGULATION OF CELL SHAPE,0.27611,0.0092255,0.034292,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.81668,0.0090588,0.008445,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.78962,0.008992,-0.0050982,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.82348,0.0088082,-0.011488,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.66501,0.0087602,0.026758,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.52025,0.0086416,-0.036679,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.50337,0.0085769,0.018142,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.67776,0.008517,0.0068125,0,0
4,GO NERVOUS SYSTEM PROCESS,0.27611,0.0084899,0.037729,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.94769,0.0083922,-0.0026915,0,0
4,GO NOTOCHORD DEVELOPMENT,0.46512,0.0083182,-0.14375,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.48678,0.0083163,-0.092216,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.91987,0.008274,-0.022591,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.40843,0.008067,-0.062338,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.65866,0.0079118,0.018316,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.99651,0.0078998,-0.0067119,0,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.97557,0.0077803,0.11092,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.98255,0.0076632,-0.022069,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.58456,0.007654,-0.047476,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.74288,0.0076114,0.012752,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.50337,0.0075902,-0.060999,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.88523,0.0075867,0.0017742,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.94073,0.0075736,-0.0029904,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.56075,0.0074925,0.017626,0,0
4,GO SCHWANN CELL DEVELOPMENT,0.97557,0.0073948,-0.0044723,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.4545,0.0072392,0.051992,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.64605,0.0070735,0.02101,0,0
4,GO NEPHRON MORPHOGENESIS,0.91987,0.007042,-0.00027271,0,0
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.76948,0.0069291,0.016966,0,0
4,GO ANIMAL ORGAN MORPHOGENESIS,0.8303,0.0068524,0.0039817,0,0
4,GO VIRAL GENE EXPRESSION,0.78289,0.0067181,0.0037734,0,0
4,GO METANEPHROS DEVELOPMENT,0.78962,0.0066448,0.010346,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.98953,0.0065511,0.019045,0,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.67776,0.0065422,0.030639,0,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.87833,0.0063608,-0.0065539,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.89907,0.0061545,0.013856,0,0
4,GO NEGATIVE REGULATION OF GROWTH,0.27227,0.0060093,0.055626,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.83713,0.0058758,0.015215,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.91987,0.0057576,0.011032,0,0
4,GO CGMP MEDIATED SIGNALING,0.99651,0.0056485,0.0034318,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.50337,0.0055479,-0.04644,0,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.65866,0.0055021,-0.019123,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.89215,0.005478,0.0037676,0,0
4,GO T CELL CHEMOTAXIS,0.99651,0.0053125,-0.016015,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.63978,0.0052359,-0.10124,0,0
4,GO PROTEIN NEDDYLATION,0.77618,0.0049875,-0.019564,0,0
4,GO CENTROSOME SEPARATION,0.89215,0.0049136,0.029898,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.75615,0.0047908,0.012033,0,0
4,GO PROTEIN POLYMERIZATION,0.61497,0.0047163,0.012373,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.80312,0.0046825,0.015763,0,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.72969,0.0045486,0.040542,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.80989,0.0041994,-0.035031,0,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.55487,0.0041961,-0.034873,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.39858,0.0040917,0.057295,0,0
4,GO RIBOSOME BIOGENESIS,0.76948,0.0040756,0.014656,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.9686,0.0039272,-0.016918,0,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.29992,0.0038577,-0.077846,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.61497,0.0038422,-0.033086,0,0
4,GO DIENCEPHALON DEVELOPMENT,0.68418,0.0036023,0.039834,0,0
4,GO MALE SEX DETERMINATION,0.39858,0.0035987,0.080669,0,0
4,GO PEPTIDYL THREONINE MODIFICATION,0.4545,0.0033647,0.03333,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.093897,0.0033056,0.050529,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.53742,0.0032827,0.03062,0,0
4,GO ORGANELLE FISSION,0.94073,0.0032523,0.0017291,0,0
4,GO AXIS SPECIFICATION,0.92682,0.0032499,0.0058658,0,0
4,GO RESPONSE TO POTASSIUM ION,0.94769,0.0032238,-0.0029782,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.56075,0.0031868,0.023366,0,0
4,GO GOLGI LOCALIZATION,0.83713,0.0030965,-0.016859,0,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.42855,0.0029735,0.040481,0,0
4,GO REGULATION OF RNA BINDING,0.59059,0.002972,-0.055721,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.78289,0.0029673,-0.050619,0,0
4,GO PULMONARY VALVE DEVELOPMENT,0.69707,0.0028385,0.03145,0,0
4,GO CELL JUNCTION MAINTENANCE,0.54321,0.0028239,-0.052231,0,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.98255,0.0025997,-0.0023246,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.67776,0.0025523,0.014198,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.58456,0.0023163,-0.028778,0,0
4,GO TOOTH MINERALIZATION,0.76948,0.0022929,-0.037127,0,0
4,GO MAST CELL MIGRATION,0.96163,0.002289,-0.014245,0,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.50896,0.0022679,-0.034504,0,0
4,GO REGULATION OF CILIUM BEAT FREQUENCY,0.94769,0.0022233,-0.0084233,0,0
4,GO MRNA TRANSCRIPTION,0.87833,0.0021508,-0.021784,0,0
4,GO GLIAL CELL APOPTOTIC PROCESS,0.52594,0.002079,0.059783,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.56666,0.0020556,0.0027822,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.55487,0.0018717,-0.065477,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.9686,0.0016742,-0.0053923,0,0
4,GO EAR DEVELOPMENT,0.89907,0.0015968,-0.016293,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.62113,0.001562,-0.048169,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.8303,0.0014475,0.020558,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.66501,0.001291,0.018869,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.74288,0.0010624,-0.035238,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.61497,0.0010561,-0.05175,0,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.80312,0.00096374,-0.023168,0,0
4,GO SPERM MOTILITY,0.8303,0.00093353,-0.0064082,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.91987,0.00088492,0.011595,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.86455,0.0007506,-0.017462,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.67776,0.00056326,0.014527,0,0
4,GO DOSAGE COMPENSATION,0.57857,0.00053274,-0.031453,0,0
4,GO RRNA METABOLIC PROCESS,0.74288,0.00051828,0.015798,0,0
4,GO CELLULAR RESPONSE TO ATP,0.72313,0.00045333,0.033687,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.88523,0.00034271,0.0099663,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.46512,0.00032438,0.046843,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.72313,0.00026113,0.018574,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.61497,0.0002362,0.029697,0,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.69707,0.00021749,-0.019969,0,0
4,GO CELL CELL SIGNALING,0.51459,0.00020379,0.025062,0,0
4,GO ORGANELLE ASSEMBLY,0.91293,0.00019558,0.003668,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.57857,0.00017365,-0.065385,0,0
4,GO MESENCHYME MORPHOGENESIS,0.94769,0.00014379,-0.029816,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.98255,3.143e-05,-0.0049814,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.67137,-5.2752e-05,0.11376,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.82348,-0.00023917,0.023741,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.69707,-0.00027321,-0.021992,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.94073,-0.00041905,0.0061251,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.89215,-0.00061503,-0.01714,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.70355,-0.00076126,-0.013486,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.9686,-0.00094744,-0.013404,0,0
4,GO MESODERM DEVELOPMENT,0.39371,-0.0011554,-0.053377,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.88523,-0.0012563,-0.0064341,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.59664,-0.0013225,-0.024045,0,0
4,GO HYPOTONIC RESPONSE,0.50337,-0.0013745,-0.090012,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.54903,-0.0014883,-0.044458,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.80989,-0.0016108,-0.010397,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.97557,-0.0018631,-0.047323,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.91987,-0.0018792,-0.0082538,0,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.19393,-0.0022656,0.2109,0,0
4,GO RECEPTOR INTERNALIZATION,0.38888,-0.0022673,-0.060263,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.8303,-0.0024292,-0.01764,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.71006,-0.0024903,-0.021052,0,0
4,GO SPERM AXONEME ASSEMBLY,0.42855,-0.0029629,-0.042547,0,0
4,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.90599,-0.0030053,0.019797,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.30402,-0.0033305,-0.066229,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.63354,-0.0033367,-0.044403,0,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.82348,-0.0034182,0.0186,0,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.91293,-0.0034763,-0.016598,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.49227,-0.0035097,-0.048828,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.73628,-0.0035286,-0.017394,0,0
4,GO RESPONSE TO AMYLOID BETA,0.80312,-0.0035766,0.022674,0,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.44402,-0.0037018,-0.051958,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.82348,-0.0037232,0.01983,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.72313,-0.00377,-0.0041967,0,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.99651,-0.0038262,-0.011568,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.99651,-0.0040207,-0.0079934,0,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.81668,-0.0040434,0.011177,0,0
4,GO PEPTIDE CROSS LINKING,0.58456,-0.0041389,0.018853,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.39858,-0.0042473,0.0464,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.63354,-0.0042487,0.022221,0,0
4,GO REGULATION OF GLIOGENESIS,0.71006,-0.0047407,0.034403,0,0
4,GO MISMATCH REPAIR,0.90599,-0.0048811,-0.0074517,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.93377,-0.0049153,-0.0062448,0,0
4,GO GROWTH HORMONE SECRETION,0.89215,-0.0049312,0.042769,0,0
4,GO MITOTIC CYTOKINESIS,0.48131,-0.004985,-0.026431,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.82348,-0.0050449,0.0017085,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.86455,-0.005348,0.012513,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.48678,-0.0055749,-0.045067,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.78962,-0.0055898,0.008006,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.9686,-0.0059843,0.0075129,0,0
4,GO MYOBLAST PROLIFERATION,0.83713,-0.0059937,-0.029642,0,0
4,GO RRNA TRANSCRIPTION,0.63978,-0.0062005,-0.034446,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.80312,-0.0062157,-0.016362,0,0
4,GO CELL JUNCTION ORGANIZATION,0.76281,-0.0064762,0.010985,0,0
4,GO MYELIN ASSEMBLY,0.59059,-0.0069621,0.046142,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.89215,-0.006995,-0.0023134,0,0
4,GO CYTOKINESIS,0.58456,-0.0072337,-0.014834,0,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.65866,-0.0073879,0.086371,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.99651,-0.0074415,-9.4705e-05,0,0
4,GO EXIT FROM MITOSIS,0.92682,-0.0074765,0.0040397,0,0
4,GO GROWTH,0.94073,-0.0077548,-0.0042276,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.79636,-0.0077853,-0.0061734,0,0
4,GO MICROVILLUS ASSEMBLY,0.84397,-0.0078592,0.0060659,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.69707,-0.0078619,-0.041329,0,0
4,GO PENILE ERECTION,0.81668,-0.0078825,-0.012821,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.71658,-0.0080399,0.012408,0,0
4,GO MESENCHYME DEVELOPMENT,0.52025,-0.0080495,-0.054336,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.85768,-0.0081162,-0.027501,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.91987,-0.0081449,0.010891,0,0
4,GO HISTONE ARGININE METHYLATION,0.85768,-0.0085445,0.0094237,0,0
4,GO EMBRYO DEVELOPMENT,0.71006,-0.0086607,-0.013709,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.88523,-0.0087704,-0.031858,0,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.89215,-0.0089284,-0.029666,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.76948,-0.0089942,-0.037093,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.42347,-0.0090192,-0.052184,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.83713,-0.00915,0.010311,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.47588,-0.0092874,-0.019211,0,0
4,GO HETEROCHROMATIN ORGANIZATION,0.23589,-0.0093427,-0.05838,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.92682,-0.0095844,-0.056707,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.67776,-0.0096388,0.024111,0,0
4,GO REGULATION OF DNA BINDING,0.72313,-0.0096431,-0.0044353,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.84397,-0.0096833,0.015725,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.85768,-0.010015,0.0070021,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.77618,-0.010061,-0.0071816,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.94769,-0.010131,-0.015591,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.57857,-0.010176,-0.11843,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.34702,-0.010269,-0.051624,0,0
4,GO NUCLEUS LOCALIZATION,0.71658,-0.010331,-0.042334,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.71658,-0.010414,0.038382,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.15015,-0.010478,0.078207,0,0
4,GO AORTA DEVELOPMENT,0.27999,-0.010619,-0.10552,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.97557,-0.010894,-0.023605,0,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.50337,-0.011124,0.058224,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.4598,-0.011444,-0.021112,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.75615,-0.01176,-0.012115,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.89907,-0.011818,-0.043428,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.53167,-0.011825,0.054492,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.85082,-0.012035,-0.017937,0,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.94769,-0.01211,-0.012183,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.75615,-0.01227,-0.036999,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.91987,-0.012396,-0.035135,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.44402,-0.01274,-0.020287,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.85082,-0.012818,-0.050475,0,0
4,GO EXPLORATION BEHAVIOR,0.48131,-0.012843,-0.10285,0,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.95466,-0.013051,-0.0031984,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.92682,-0.013085,0.068479,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.95466,-0.013199,-0.011561,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.47588,-0.013205,-0.051193,0,0
4,GO RNA PROCESSING,0.4978,-0.013411,-0.033989,0,0
4,GO PROTEIN ACYLATION,0.5726,-0.013425,-0.011571,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.60272,-0.013676,-0.018751,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.15264,-0.013802,-0.073919,0,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.53167,-0.013829,0.017567,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.83713,-0.014215,-0.010432,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.88523,-0.014327,0.0081724,0,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.75615,-0.014489,-0.032103,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.32506,-0.014666,-0.036299,0,0
4,GO CELL FATE COMMITMENT,0.66501,-0.014725,-0.01848,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.64605,-0.014783,-0.033813,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.44924,-0.015098,-0.043509,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.70355,-0.015121,-0.043112,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.53742,-0.01518,-0.057228,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.36526,-0.01521,-0.11704,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.73628,-0.015257,-0.072192,0,0
4,GO CELLULAR RESPONSE TO PH,0.54321,-0.015291,-0.045644,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.50896,-0.015331,-0.0077788,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.63354,-0.015478,-0.014089,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.47049,-0.015625,0.056415,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.98255,-0.015676,0.018399,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.51459,-0.015683,0.025098,0,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.96163,-0.015723,-0.037613,0,0
4,GO REGULATION OF GENE SILENCING,0.75615,-0.015886,-0.026757,0,0
4,GO NEURAL TUBE FORMATION,0.35607,-0.016178,-0.066229,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.36064,-0.016214,0.072485,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,1,-0.016333,-0.0050281,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.69061,-0.016352,0.0604,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.56075,-0.016416,0.066764,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.3746,-0.016849,-0.068444,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.40349,-0.016938,-0.081474,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.60883,-0.01695,-0.043073,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.59664,-0.017132,0.079617,0,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.73628,-0.017134,-0.031287,0,0
4,GO POST EMBRYONIC DEVELOPMENT,0.39371,-0.017421,-0.035404,0,0
4,GO TELOMERE CAPPING,0.4978,-0.017604,-0.018946,0,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.31232,-0.017751,-0.050447,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.80989,-0.017773,0.00094095,0,0
4,GO MEMORY,0.96163,-0.017808,0.0094233,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.87833,-0.017958,0.0058063,0,0
4,GO DNA METHYLATION,0.67776,-0.017981,-0.018583,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.84397,-0.018023,-0.01281,0,0
4,GO SKELETAL MUSCLE ADAPTATION,0.55487,-0.018164,0.064949,0,0
4,GO TELOMERE ORGANIZATION,0.42347,-0.018284,-0.038348,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.96163,-0.018416,-0.0032387,0,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.80989,-0.018418,0.018505,0,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.23245,-0.018624,-0.058448,0,0
4,GO DENDRITE EXTENSION,0.78962,-0.018793,0.051432,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.23937,-0.018833,-0.048551,0,0
4,GO NUCLEAR TRANSPORT,0.69707,-0.019068,-0.01819,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.80989,-0.019243,0.017391,0,0
4,GO MEMBRANE HYPERPOLARIZATION,0.4545,-0.019426,0.05871,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.90599,-0.019454,0.0063148,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.64605,-0.019768,-0.054007,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.29184,-0.019774,-0.15519,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.64605,-0.01984,-0.0095175,0,0
4,GO RHYTHMIC BEHAVIOR,0.75615,-0.020152,0.041584,0,0
4,GO CYTOSKELETON ORGANIZATION,0.84397,-0.020354,-0.0062546,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.61497,-0.020547,-0.016975,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.72969,-0.02061,-0.029591,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.60272,-0.020641,0.083415,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.98255,-0.020659,-0.00021139,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.46512,-0.020858,-0.017596,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.20621,-0.020929,-0.086334,0,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.41842,-0.020983,-0.037067,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.63978,-0.020999,-0.029897,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.39858,-0.021001,-0.078099,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.98255,-0.021024,0.013232,0,0
4,GO FIBROBLAST ACTIVATION,0.63978,-0.021258,-0.057285,0,0
4,GO CELL CELL SIGNALING BY WNT,0.41842,-0.021332,-0.028801,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.32938,-0.021375,-0.13011,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.52594,-0.021608,-0.020896,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.88523,-0.021617,-0.00203,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.7495,-0.021625,-0.024142,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.93377,-0.021704,0.016331,0,0
4,GO ADULT BEHAVIOR,0.84397,-0.021775,0.043999,0,0
4,GO MEMBRANE DOCKING,0.84397,-0.021876,-0.00124,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.41341,-0.021981,-0.046417,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.78962,-0.022024,0.044179,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.72313,-0.022109,-0.030852,0,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.62732,-0.022192,0.033976,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.84397,-0.022235,0.020358,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.71658,-0.022461,0.042796,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.97557,-0.022531,-0.013611,0,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.31653,-0.022566,-0.073779,0,0
4,GO P BODY ASSEMBLY,0.79636,-0.022697,-0.015712,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.56666,-0.022717,-0.065893,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.54321,-0.022818,-0.049143,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.26098,-0.022855,-0.03781,0,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.66501,-0.022927,0.011125,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.63978,-0.022941,-0.063889,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.44402,-0.022951,-0.061382,0,0
4,GO TRNA TRANSPORT,0.44924,-0.02296,-0.056256,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.72969,-0.023122,0.027298,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.64605,-0.023164,0.03941,0,0
4,GO FIBROBLAST MIGRATION,0.95466,-0.023296,-0.015837,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.91293,-0.023306,0.014884,0,0
4,GO RETINA LAYER FORMATION,0.84397,-0.023466,0.062796,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,1,-0.023496,0.00067686,0,0
4,GO TUBE FORMATION,0.31232,-0.023794,-0.069855,0,0
4,GO PROTEIN KINASE A SIGNALING,0.60272,-0.023796,-0.037165,0,0
4,GO RRNA METHYLATION,0.76281,-0.023954,-0.01614,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.79636,-0.02399,-0.020802,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.85768,-0.024105,-0.012266,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.69061,-0.02417,-0.018065,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.33373,-0.024296,-0.061873,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.11841,-0.024304,-0.08049,0,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.30815,-0.024459,-0.048499,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.62732,-0.024511,-0.04903,0,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.78962,-0.024549,-0.019989,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.98255,-0.024603,-0.0067306,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.47049,-0.024615,-0.047118,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.32077,-0.024652,-0.021005,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.20937,-0.024703,-0.061398,0,0
4,GO CHROMOSOME LOCALIZATION,0.5726,-0.024795,-0.0093049,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.73628,-0.024796,0.042167,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.48678,-0.025085,0.045342,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.40843,-0.025157,-0.03251,0,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.98255,-0.025713,-0.02687,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.62732,-0.025747,-0.021898,0,0
4,GO HEART DEVELOPMENT,0.76948,-0.02577,-0.014605,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.47588,-0.025899,-0.082069,0,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.43883,-0.025932,-0.047556,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.85082,-0.026352,-0.0080646,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.83713,-0.026485,0.050841,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.71006,-0.026678,-0.041732,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.89907,-0.026689,0.01237,0,0
4,GO MRNA METHYLATION,0.34256,-0.026689,-0.059465,0,0
4,GO RESPONSE TO COCAINE,0.74288,-0.026744,-0.015484,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.38408,-0.026756,-0.093256,0,0
4,GO REGULATION OF CELL CYCLE,0.83713,-0.02683,0.0079311,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.16294,-0.026987,-0.1038,0,0
4,GO REGULATION OF CELL SIZE,0.26098,-0.027114,-0.067232,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.25729,-0.027206,-0.075728,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.28785,-0.027244,-0.0491,0,0
4,GO GENE SILENCING,0.85768,-0.02735,-0.017149,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.88523,-0.027499,-0.017255,0,0
4,GO RNA LOCALIZATION,0.097379,-0.027643,-0.074878,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.52594,-0.027847,-0.012986,0,0
4,GO PROTEIN SUMOYLATION,0.30402,-0.027905,-0.032604,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.33373,-0.027922,-0.065795,0,0
4,GO RRNA 3 END PROCESSING,0.77618,-0.02818,-0.0097393,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.48131,-0.028385,0.063052,0,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.14769,-0.028433,-0.075872,0,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.96163,-0.028502,0.0033586,0,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.46512,-0.028559,-0.084513,0,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.22568,-0.028806,-0.074381,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.56075,-0.028843,-0.04821,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.98255,-0.028958,-0.012682,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.52025,-0.029635,0.054659,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.41341,-0.029703,-0.05467,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.48678,-0.029792,-0.033653,0,0
4,GO CELL PROJECTION ASSEMBLY,0.41341,-0.029898,-0.017774,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.46512,-0.029987,-0.03561,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.77618,-0.03034,-0.049371,0,0
4,GO SNRNA TRANSCRIPTION,0.17099,-0.030362,-0.048365,0,0
4,GO MRNA CLEAVAGE,0.3746,-0.030407,-0.03558,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.77618,-0.030421,-0.021288,0,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.23589,-0.030474,-0.075081,0,0
4,GO THYMUS DEVELOPMENT,0.57857,-0.030483,-0.036906,0,0
4,GO RNA SURVEILLANCE,0.63354,-0.030699,-0.021208,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.89907,-0.030846,-0.016557,0,0
4,GO RESPONSE TO ATP,0.97557,-0.030905,0.014557,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.76281,-0.030909,0.026698,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.15264,-0.030917,-0.044531,0,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.30402,-0.030934,-0.035922,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.69707,-0.030935,-0.045656,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.87144,-0.031066,-0.026598,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.85082,-0.031253,-0.024462,0,0
4,GO SECONDARY PALATE DEVELOPMENT,0.97557,-0.031283,-0.0017281,0,0
4,GO NUCLEAR EXPORT,0.25729,-0.031527,-0.052824,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.94769,-0.031549,0.0037307,0,0
4,GO RESPONSE TO VITAMIN A,0.56666,-0.031562,-0.051153,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.34256,-0.03162,-0.11846,0,0
4,GO RRNA MODIFICATION,0.89907,-0.031854,-0.021139,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.21905,-0.031875,-0.038115,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.48678,-0.031879,-0.067685,0,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.33373,-0.031977,-0.049977,0,0
4,GO GANGLION DEVELOPMENT,0.88523,-0.032265,0.086925,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.67776,-0.032279,0.038555,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.53167,-0.032293,-0.027899,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.9686,-0.032373,0.012037,0,0
4,GO HISTONE PHOSPHORYLATION,0.54903,-0.032402,-0.020798,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.63354,-0.032744,-0.00086355,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.41842,-0.033118,-0.059754,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.4598,-0.033173,-0.083185,0,0
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.87144,-0.033252,0.02063,0,0
4,GO SULFATION,0.61497,-0.033342,-0.044074,0,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.42855,-0.034009,-0.051127,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.17653,-0.034042,-0.07414,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.84397,-0.034094,-0.051974,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.36991,-0.034096,0.074457,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.56075,-0.034184,-0.054073,0,0
4,GO ARTERY DEVELOPMENT,0.54903,-0.034261,-0.056459,0,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.7495,-0.034716,0.0060072,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.65234,-0.034717,-0.024415,0,0
4,GO STEM CELL DIFFERENTIATION,0.44924,-0.034843,-0.031194,0,0
4,GO GAS TRANSPORT,0.42855,-0.03486,-0.13751,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.085627,-0.034938,-0.068087,0,0
4,GO SPINDLE ASSEMBLY,0.23245,-0.035121,-0.03374,0,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.38888,-0.035155,-0.044242,0,0
4,GO AXONAL FASCICULATION,0.16032,-0.035244,-0.17442,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.11841,-0.035305,-0.088475,0,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.19095,-0.035306,-0.032347,0,0
4,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.98953,-0.035351,0.056412,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.20937,-0.035373,-0.11392,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.98953,-0.035376,0.036365,0,0
4,GO CHONDROCYTE PROLIFERATION,0.35607,-0.035419,-0.11445,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.36064,-0.035904,-0.048521,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.86455,-0.035978,-0.0080545,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.95466,-0.036027,0.03403,0,0
4,GO HISTONE H3 DEACETYLATION,0.4978,-0.036186,-0.048611,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.34702,-0.036202,-0.05049,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.77618,-0.036456,0.019418,0,0
4,GO DNA METABOLIC PROCESS,0.21579,-0.036492,-0.026798,0,0
4,GO VIRAL TRANSLATION,0.42347,-0.036513,-0.085711,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.4978,-0.036581,-0.055235,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.50337,-0.036615,-0.023726,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.4598,-0.03662,-0.057045,0,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.97557,-0.036625,0.0099194,0,0
4,GO NCRNA TRANSCRIPTION,0.38888,-0.036639,-0.042016,0,0
4,GO PROTEIN ACETYLATION,0.13814,-0.036801,-0.029298,0,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.3746,-0.036884,-0.025147,0,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.67776,-0.036898,-0.011644,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.54321,-0.036972,-0.024674,0,0
4,GO SUCKLING BEHAVIOR,0.51459,-0.036978,-0.074872,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.2839,-0.037281,-0.02789,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.39858,-0.037415,-0.059615,0,0
4,GO CELL CYCLE,0.76948,-0.03751,-0.0037167,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.61497,-0.03801,-0.033733,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.42347,-0.038102,-0.078155,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.51459,-0.038178,-0.027804,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.4545,-0.038231,-0.085943,0,0
4,GO REGULATION OF BEHAVIOR,0.28785,-0.038367,-0.072341,0,0
4,GO FOREGUT MORPHOGENESIS,0.21256,-0.038503,-0.12114,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.55487,-0.038676,-0.068418,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.80989,-0.038713,-0.020449,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.82348,-0.038822,-0.001187,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.61497,-0.038838,-0.095711,0,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.69707,-0.039076,-0.031089,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.93377,-0.039461,-0.034232,0,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.2839,-0.039534,-0.10566,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.53742,-0.03958,-0.040532,0,0
4,GO METAPHASE PLATE CONGRESSION,0.62732,-0.039602,-0.0064338,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.87833,-0.039876,0.0059662,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.44924,-0.039981,-0.023961,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.98255,-0.040107,0.012521,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.35607,-0.040415,-0.037535,0,0
4,GO RRNA PSEUDOURIDINE SYNTHESIS,0.94769,-0.040564,-0.017737,0,0
4,GO NEUROMUSCULAR PROCESS,0.4978,-0.040712,-0.031268,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.79636,-0.04072,-0.0079768,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.35153,-0.040822,-0.031597,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.59059,-0.040838,-0.019675,0,0
4,GO MITOTIC CELL CYCLE,0.33373,-0.040979,-0.018558,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.11841,-0.041224,-0.080492,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.90599,-0.041379,0.0022373,0,0
4,GO RESPONSE TO UV,0.17934,-0.041453,-0.048929,0,0
4,GO HISTONE H4 ACETYLATION,0.059411,-0.04151,-0.057385,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.97557,-0.041528,0.021176,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.4598,-0.041662,-0.01978,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.25001,-0.041869,-0.046265,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.64605,-0.042012,-0.019287,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.10654,-0.042041,-0.078705,0,0
4,GO MIRNA METABOLIC PROCESS,0.36526,-0.042062,-0.044464,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.52594,-0.042396,-0.042594,0,0
4,GO MRNA METABOLIC PROCESS,0.23589,-0.042447,-0.043441,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.53167,-0.042688,-0.042878,0,0
4,GO PROTEIN MONOUBIQUITINATION,0.18508,-0.042937,-0.04536,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.50337,-0.043142,-0.08354,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.25363,-0.043304,-0.084259,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.188,-0.043328,-0.094309,0,0
4,GO HISTONE MONOUBIQUITINATION,0.12689,-0.043372,-0.075993,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.82348,-0.043499,-0.052393,0,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.095625,-0.043522,-0.11809,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.70355,-0.043699,-0.0099291,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.79636,-0.043927,-0.018073,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.41842,-0.044345,-0.036957,0,0
4,GO PROTEIN METHYLATION,0.26847,-0.044478,-0.031655,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.38888,-0.044625,-0.047409,0,0
4,GO PRE MIRNA PROCESSING,0.44924,-0.044684,-0.057777,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.51459,-0.04478,-0.03575,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.78962,-0.044846,-0.019704,0,0
4,GO MIDBRAIN DEVELOPMENT,0.26098,-0.044878,-0.043879,0,0
4,GO REGULATION OF CELL DIVISION,0.75615,-0.045086,-0.0096528,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.2,-0.045107,-0.030758,0,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.69707,-0.045129,-0.016655,0,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.070855,-0.045272,-0.050557,0,0
4,GO ORGAN GROWTH,0.18219,-0.045302,-0.068724,0,0
4,GO RESPONSE TO SALT STRESS,0.63354,-0.045335,-0.060794,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.5726,-0.045588,-0.062943,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.17374,-0.045621,-0.055355,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.65866,-0.045826,-0.081935,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.70355,-0.04598,-0.067401,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.83713,-0.046158,0.027169,0,0
4,GO MUSCLE FIBER DEVELOPMENT,0.62113,-0.046184,-0.018074,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.49227,-0.04623,-0.037651,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.87833,-0.046545,0.015242,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.63354,-0.046673,-0.032457,0,0
4,GO EAR MORPHOGENESIS,0.21579,-0.046932,-0.071846,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.32938,-0.047076,-0.044905,0,0
4,GO DEMETHYLATION,0.89215,-0.047104,-0.0054026,0,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.85082,-0.047396,-0.041538,0,0
4,GO OXIDATIVE DEMETHYLATION,0.47588,-0.047426,-0.025331,0,0
4,GO CELL CYCLE CHECKPOINT,0.29586,-0.047528,-0.023468,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.33812,-0.047613,-0.059516,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.89215,-0.047661,-0.024459,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.99651,-0.047909,0.051986,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.4978,-0.048077,-0.071502,0,0
4,GO RNA CAPPING,0.35153,-0.04816,-0.043353,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.56075,-0.048219,0.022909,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.47049,-0.048406,-0.042219,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.97557,-0.048629,-0.028888,0,0
4,GO NOSE DEVELOPMENT,0.83713,-0.048631,0.11523,0,0
4,GO SYNAPSE MATURATION,0.46512,-0.048701,-0.11107,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.47588,-0.048796,-0.04675,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.66501,-0.048869,-0.03852,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.81668,-0.049377,-0.0058709,0,0
4,GO VIRAL LATENCY,0.20309,-0.049427,-0.11198,0,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.25729,-0.049676,-0.047317,0,0
4,GO RNA 3 END PROCESSING,0.1313,-0.049772,-0.068282,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.17934,-0.049922,-0.079746,0,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.17653,-0.05017,-0.098313,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.5726,-0.0504,-0.027515,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.25363,-0.05048,-0.080363,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.62113,-0.050813,-0.059058,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.19393,-0.05087,-0.06187,0,0
4,GO REGULATION OF OOGENESIS,0.95466,-0.050907,0.033158,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.4598,-0.051283,-0.032322,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.12689,-0.051587,-0.079116,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.51459,-0.052352,-0.064947,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.21579,-0.0524,-0.086588,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.16032,-0.052833,-0.08755,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.39371,-0.052881,-0.038161,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.2,-0.052968,-0.052687,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.37932,-0.053081,0.0052898,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.32938,-0.053159,-0.096671,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.48678,-0.05332,-0.049947,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.7495,-0.053366,-0.035852,0,0
4,GO GENITALIA MORPHOGENESIS,0.60883,-0.053563,-0.051053,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.50896,-0.053803,-0.04036,0,0
4,GO REGULATION OF CYTOKINESIS,0.38408,-0.053949,-0.017738,0,0
4,GO HISTONE H3 K4 METHYLATION,0.15264,-0.053956,-0.067976,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.188,-0.05403,-0.15044,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.54321,-0.054086,-0.070936,0,0
4,GO HISTONE METHYLATION,0.05161,-0.054181,-0.07081,0,0
4,GO EYE MORPHOGENESIS,0.46512,-0.054255,-0.038507,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.35607,-0.054359,-0.060508,0,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.61497,-0.054513,-0.044035,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.88523,-0.054832,-0.013398,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.20621,-0.055343,-0.035643,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.057089,-0.055481,-0.14099,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.20937,-0.055492,-0.059838,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.24288,-0.055537,-0.066245,0,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.17653,-0.05563,-0.065641,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.52025,-0.055759,-0.031158,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.22568,-0.055838,-0.065941,0,0
4,GO SPECIFICATION OF SYMMETRY,0.17374,-0.055865,-0.064944,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.36526,-0.055916,-0.031349,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.41341,-0.056041,-0.048723,0,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.12473,-0.056323,-0.12059,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.18508,-0.056451,-0.11042,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.64605,-0.056686,0.0016763,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.56666,-0.056888,-0.019951,0,0
4,GO PEPTIDYL ARGININE METHYLATION,0.54903,-0.056979,-0.027919,0,0
4,GO ESTABLISHMENT OF CELL POLARITY,0.41842,-0.057001,-0.022057,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.17653,-0.05711,-0.13543,0,0
4,GO ERYTHROCYTE MATURATION,0.4978,-0.057178,-0.07317,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.35607,-0.05722,-0.041204,0,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.25363,-0.057294,-0.070416,0,0
4,GO CELL CYCLE PROCESS,0.17374,-0.057386,-0.02239,0,0
4,GO HEART VALVE DEVELOPMENT,0.59664,-0.057566,-0.045016,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.98953,-0.057652,0.0037054,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.72313,-0.057803,-0.03325,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.18508,-0.057896,-0.051871,0,0
4,GO RENAL FILTRATION,0.90599,-0.05813,0.010313,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.30402,-0.058473,-0.07558,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.92682,-0.058518,-0.00094409,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.40843,-0.058609,-0.065727,0,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.17374,-0.058914,-0.079778,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.19095,-0.059315,-0.06452,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.34702,-0.059502,-0.060829,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.67137,-0.059506,-0.0092768,0,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.63978,-0.059665,-0.023901,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.36526,-0.059678,-0.078331,0,0
4,GO MATURATION OF SSU RRNA,0.91293,-0.059903,-0.015847,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.90599,-0.060074,-0.03081,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.63978,-0.060419,-0.0041563,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.90599,-0.060701,-0.010725,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.22235,-0.060819,-0.024507,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.35607,-0.060835,-0.051503,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.65234,-0.061135,-0.038624,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.62732,-0.06124,-0.02104,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.85768,-0.06132,-0.025729,0,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.072231,-0.061425,-0.086057,0,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.17099,-0.061464,-0.083969,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.23245,-0.061903,-0.063238,0,0
4,GO RESPONSE TO DOPAMINE,0.88523,-0.062094,0.012897,0,0
4,GO HINDBRAIN DEVELOPMENT,0.97557,-0.062292,0.011641,0,0
4,GO SHORT TERM MEMORY,0.47588,-0.062439,-0.089433,0,0
4,GO PRENYLATION,0.7495,-0.062448,-0.025626,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.98953,-0.062455,0.039396,0,0
4,GO RESPONSE TO AUDITORY STIMULUS,0.59664,-0.062636,-0.045126,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.72969,-0.062651,-0.049897,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.16828,-0.062683,-0.051783,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.12689,-0.062732,-0.070595,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.072231,-0.062836,-0.067691,0,0
4,GO SPINDLE LOCALIZATION,0.11235,-0.062885,-0.061616,0,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.2,-0.062908,-0.083449,0,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.63978,-0.063148,-0.017213,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.3746,-0.063353,-0.086703,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.15517,-0.063508,-0.14644,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.66501,-0.063552,-0.030456,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.21905,-0.063924,-0.094244,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.13583,-0.064535,-0.064707,0,0
4,GO CILIUM ORGANIZATION,0.12049,-0.064798,-0.052173,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.15773,-0.06481,-0.13649,0,0
4,GO METENCEPHALON DEVELOPMENT,0.59059,-0.064856,-0.00073365,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.43883,-0.064883,-0.021093,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.065563,-0.065236,-0.090618,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.38888,-0.065248,-0.058358,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.090515,-0.065303,-0.096595,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.98953,-0.065332,0.01891,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.2,-0.06546,-0.061927,0,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.30815,-0.065671,-0.042851,0,0
4,GO VASCULOGENESIS,0.42347,-0.065787,-0.091859,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.40349,-0.06581,-0.036285,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.27611,-0.065814,-0.084654,0,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.21905,-0.065927,-0.051405,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.12689,-0.065992,-0.17074,0,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.27611,-0.066412,-0.1201,0,0
4,GO PEPTIDYL ARGININE N METHYLATION,0.53742,-0.066702,-0.049519,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.41341,-0.066741,-0.10174,0,0
4,GO DEVELOPMENTAL GROWTH,0.21905,-0.067364,-0.050616,0,0
4,GO HEART GROWTH,0.4598,-0.067502,-0.037724,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.32506,-0.067526,-0.089666,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.26471,-0.067591,-0.077747,0,0
4,GO RNA DESTABILIZATION,0.16294,-0.0679,-0.08068,0,0
4,GO INNER EAR MORPHOGENESIS,0.15773,-0.06799,-0.0793,0,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.12049,-0.068014,-0.043797,0,0
4,GO SEQUESTERING OF METAL ION,0.47049,-0.068442,-0.064673,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.27999,-0.068657,-0.050618,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.11841,-0.068691,-0.15149,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.27611,-0.068802,-0.069081,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.32506,-0.068974,-0.084815,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.33812,-0.069016,-0.033105,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.53167,-0.069037,-0.03401,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.36064,-0.069452,-0.079728,0,0
4,GO HEART MORPHOGENESIS,0.32938,-0.069578,-0.048336,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.21579,-0.070153,-0.13714,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.14526,-0.070244,-0.053831,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.4978,-0.070252,-0.11486,0,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.22568,-0.070312,-0.086644,0,0
4,GO V D J RECOMBINATION,0.27999,-0.070326,-0.10054,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.32506,-0.070626,-0.05896,0,0
4,GO MICROTUBULE NUCLEATION,0.15517,-0.070664,-0.062387,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.1028,-0.070807,-0.061345,0,0
4,GO SYNAPTIC VESICLE PRIMING,0.65866,-0.071178,0.10777,0,0
4,GO WALKING BEHAVIOR,0.19095,-0.071501,-0.095585,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.11434,-0.071526,-0.07239,0,0
4,GO CELL RECOGNITION,0.33812,-0.071583,-0.059377,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.31653,-0.071634,-0.0224,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.14048,-0.072011,-0.11593,0,0
4,GO SEROTONIN TRANSPORT,0.96163,-0.072133,0.021027,0,0
4,GO SNORNA METABOLIC PROCESS,0.13583,-0.072186,-0.11054,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.1028,-0.072602,-0.07392,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.65866,-0.073092,-0.12303,0,0
4,GO TUBULIN DEACETYLATION,0.44402,-0.073117,-0.040682,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.18508,-0.07314,-0.1086,0,0
4,GO SLEEP,0.94769,-0.073439,0.011036,0,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.31653,-0.073805,-0.034367,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.36991,-0.073905,-0.046458,0,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.38408,-0.073953,-0.038202,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.25363,-0.073997,-0.069875,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.17374,-0.074135,-0.09617,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.085627,-0.074162,-0.12017,0,0
4,GO RESPONSE TO AXON INJURY,0.50337,-0.074214,-0.025219,0,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.080955,-0.074422,-0.10357,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.77618,-0.074427,-0.02002,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.56666,-0.074571,-0.022383,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.8303,-0.074635,-0.01813,0,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.061812,-0.075006,-0.092804,0,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.80312,-0.075429,-0.010705,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0046564,-0.075545,-0.072058,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.090515,-0.075656,-0.076638,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.4598,-0.075677,-0.11545,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.099158,-0.076021,-0.1209,0,0
4,GO NUCLEAR MIGRATION,0.26098,-0.076057,-0.089368,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.47588,-0.076061,-0.045665,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.15773,-0.076064,-0.06111,0,0
4,GO BONE MATURATION,0.28785,-0.076261,-0.085371,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.13583,-0.076352,-0.053044,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.31653,-0.076385,-0.049741,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.23245,-0.076682,-0.052503,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.16828,-0.076809,-0.049891,0,0
4,GO DISTAL TUBULE DEVELOPMENT,0.36526,-0.07687,-0.073148,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.077957,-0.076926,-0.11349,0,0
4,GO COGNITION,0.38888,-0.077142,-0.044752,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.065563,-0.07739,-0.084397,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.54321,-0.077418,-0.058045,0,0
4,GO LONG TERM MEMORY,0.29586,-0.077917,-0.082235,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.066855,-0.078621,-0.091149,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.19695,-0.078783,-0.11406,0,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.076492,-0.078922,-0.1282,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.11235,-0.07939,-0.12677,0,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.080955,-0.079487,-0.078078,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.11235,-0.07957,-0.077251,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.48678,-0.079617,-0.048209,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.81668,-0.079759,-0.0379,0,0
4,GO THALAMUS DEVELOPMENT,0.3746,-0.079857,-0.074167,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.40349,-0.079862,-0.06386,0,0
4,GO MUSCLE FILAMENT SLIDING,0.087232,-0.079992,-0.15781,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.027188,-0.080132,-0.11857,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.36526,-0.080335,-0.058667,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.31653,-0.080535,-0.054885,0,0
4,GO CELL CYCLE DNA REPLICATION,0.02068,-0.080856,-0.10691,0,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.85082,-0.081018,0.0047145,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.69061,-0.081034,-0.04886,0,0
4,GO MICROTUBULE BASED PROCESS,0.0057817,-0.081194,-0.067568,0,0
4,GO DEVELOPMENTAL CELL GROWTH,0.16559,-0.081372,-0.072685,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.1028,-0.081692,-0.11995,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.22568,-0.081712,-0.13306,0,0
4,GO ACROSOME ASSEMBLY,0.1028,-0.081818,-0.10947,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.41341,-0.081967,-0.085841,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.63354,-0.082189,0.010091,0,0
4,GO PREPULSE INHIBITION,0.51459,-0.082202,-0.077786,0,0
4,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.23937,-0.082311,-0.13309,0,0
4,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.76281,-0.082426,-0.036004,0,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.40843,-0.082932,-0.03216,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.53742,-0.083439,-0.053085,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.79636,-0.08345,-0.0049525,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.05161,-0.083746,-0.10866,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.044685,-0.08396,-0.10939,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.0040578,-0.08404,-0.086492,0,0
4,GO TRABECULA FORMATION,0.63978,-0.084074,-0.054961,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.57857,-0.084554,-0.092919,0,0
4,GO NODAL SIGNALING PATHWAY,0.19695,-0.084581,-0.086042,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.13814,-0.084604,-0.10507,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.041967,-0.084822,-0.090373,0,0
4,GO ECTODERM DEVELOPMENT,0.10654,-0.084882,-0.090229,0,0
4,GO HEAD DEVELOPMENT,0.16294,-0.08492,-0.046716,0,0
4,GO CELL PROJECTION ORGANIZATION,0.12473,-0.084935,-0.054568,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.54321,-0.084991,-0.052795,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.16032,-0.085014,-0.13323,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.13583,-0.085128,-0.087606,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.99651,-0.085441,0.0079887,0,0
4,GO THYROID GLAND DEVELOPMENT,0.031748,-0.086085,-0.19976,0,0
4,GO L GLUTAMATE IMPORT,0.17099,-0.086152,-0.11317,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.50896,-0.08621,-0.040939,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.73628,-0.086706,0.034682,0,0
4,GO MICROTUBULE ANCHORING,0.038561,-0.08702,-0.083096,0,0
4,GO ACTIVATION OF JNKK ACTIVITY,0.36064,-0.087145,-0.090322,0,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.29992,-0.087193,-0.09329,0,0
4,GO DNA STRAND ELONGATION,0.11235,-0.087274,-0.090792,0,0
4,GO HAIR FOLLICLE MATURATION,0.13814,-0.087492,-0.14133,0,0
4,GO CHROMATIN SILENCING,0.018836,-0.087528,-0.11875,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.15264,-0.087585,-0.090155,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.34702,-0.087605,-0.059604,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.30815,-0.087821,-0.059511,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.23589,-0.087843,-0.043926,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.8303,-0.088076,-0.037259,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.26847,-0.088169,-0.058267,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.10096,-0.08883,-0.11591,0,0
4,GO REGIONALIZATION,0.42855,-0.088851,-0.028276,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.13814,-0.089028,-0.091564,0,0
4,GO MEMBRANE DISASSEMBLY,0.092194,-0.089165,-0.11941,0,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.50337,-0.089924,-0.040749,0,0
4,GO CELL MORPHOGENESIS,0.11841,-0.089966,-0.075149,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.22235,-0.090161,-0.088461,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.55487,-0.090202,-0.048404,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.11235,-0.090484,-0.068991,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.041967,-0.090564,-0.084827,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.17934,-0.090668,-0.047995,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.013798,-0.090723,-0.12817,0,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.014138,-0.090917,-0.065198,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.14769,-0.091008,-0.077684,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.095625,-0.09115,-0.25169,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.46512,-0.091463,-0.068804,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.16828,-0.091532,-0.099335,0,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.0079323,-0.091533,-0.10833,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.52025,-0.091546,-0.030155,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.087232,-0.091923,-0.11742,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.35153,-0.09214,-0.081115,0,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.35153,-0.092227,-0.075599,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.42855,-0.092227,-0.067542,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0042883,-0.092326,-0.095794,0,0
4,GO GLUTAMATE SECRETION,0.33373,-0.092648,-0.05012,0,0
4,GO SISTER CHROMATID SEGREGATION,0.027803,-0.093074,-0.071278,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.63354,-0.093107,-0.032017,0,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.24643,-0.09332,-0.07814,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.16559,-0.093445,-0.1148,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.38408,-0.093702,-0.052647,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.4598,-0.094068,-0.079219,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.40349,-0.09409,-0.072142,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.013465,-0.09498,-0.13432,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.12908,-0.095342,-0.14744,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.24288,-0.095519,-0.052738,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.20309,-0.095605,-0.10099,0,0
4,GO REGULATION OF DNA REPLICATION,0.15264,-0.096523,-0.048828,0,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0085714,-0.096581,-0.11378,0,0
4,GO CELLULAR RESPONSE TO UV,0.085627,-0.096676,-0.072636,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.21579,-0.097017,-0.097131,0,0
4,GO REGULATION OF CELL DEVELOPMENT,0.20937,-0.097036,-0.051103,0,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.21579,-0.097048,-0.061057,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.22235,-0.097955,-0.03994,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.38408,-0.098024,-0.082869,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.17099,-0.098749,-0.12724,0,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.03245,-0.098776,-0.069912,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.60883,-0.098876,-0.074256,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.36991,-0.099118,-0.088731,0,0
4,GO NEUROGENESIS,0.11235,-0.099735,-0.066636,0,0
4,GO LEARNING,0.14769,-0.099909,-0.092204,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.031748,-0.099942,-0.11063,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.26847,-0.099953,-0.05435,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.24288,-0.10171,-0.10462,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.13355,-0.10199,-0.1576,0,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.27999,-0.10223,-0.063904,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.17653,-0.10266,-0.10417,0,0
4,GO DNA REPLICATION,0.0081404,-0.10355,-0.085219,0,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.68418,-0.10398,0.040358,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.44402,-0.10399,-0.067191,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.065563,-0.10412,-0.10807,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.53742,-0.10416,-0.054603,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.20309,-0.10428,-0.16602,0,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.16032,-0.10432,-0.053677,0,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.077957,-0.10435,-0.18038,0,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.080955,-0.10446,-0.09272,0,0
4,GO BLASTOCYST GROWTH,0.26471,-0.10459,-0.041916,0,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.27611,-0.10484,-0.098621,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.25001,-0.1058,-0.051912,0,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.17374,-0.10599,-0.072952,0,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.22235,-0.10607,-0.052494,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.82348,-0.10618,-0.0095131,0,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.18508,-0.1062,-0.075826,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.041967,-0.10634,-0.13022,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.022165,-0.10671,-0.070987,0,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.26471,-0.10673,-0.011735,0,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.097379,-0.10683,-0.069634,0,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.073629,-0.10721,-0.070481,0,0
4,GO MICROTUBULE POLYMERIZATION,0.013798,-0.1074,-0.12909,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.27999,-0.10757,-0.10308,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.29184,-0.108,-0.082355,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.027188,-0.10823,-0.17141,0,0
4,GO CENTROSOME DUPLICATION,0.22568,-0.10833,-0.051402,0,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.018398,-0.1088,-0.15054,0,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.057089,-0.1095,-0.11806,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.38408,-0.10978,-0.12887,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0016129,-0.11018,-0.13701,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.16559,-0.11027,-0.097131,0,0
4,GO MITOCHONDRION LOCALIZATION,0.009256,-0.11062,-0.10751,0,0
4,GO HISTONE H4 K5 ACETYLATION,0.12259,-0.11078,-0.09906,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.28785,-0.11132,-0.11592,0,0
4,GO NEURON DEVELOPMENT,0.082489,-0.11147,-0.080094,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.2839,-0.11162,-0.1225,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.15517,-0.11165,-0.10399,0,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.061812,-0.1117,-0.14776,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.63978,-0.11185,-0.016441,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.15015,-0.11194,-0.063542,0,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.075049,-0.11222,-0.13873,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.12689,-0.11227,-0.081698,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.63978,-0.1125,-0.077205,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0041716,-0.11306,-0.13184,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.15264,-0.11323,-0.11378,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.065563,-0.11351,-0.092259,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.34256,-0.11363,-0.049182,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.041967,-0.11419,-0.12773,0,0
4,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.29184,-0.11421,-0.14065,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.15773,-0.11437,-0.15766,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.21256,-0.11453,-0.04342,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.59059,-0.11481,-0.021386,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.17934,-0.11536,-0.1152,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.093897,-0.11538,-0.15062,0,0
4,GO RESPONSE TO X RAY,0.12259,-0.11556,-0.12828,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.14769,-0.11558,-0.062887,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.061812,-0.11576,-0.086584,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.72969,-0.11656,-0.063492,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.10845,-0.11672,-0.070572,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.10465,-0.11684,-0.20665,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.15015,-0.11685,-0.093053,0,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.080955,-0.11707,-0.13704,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.090515,-0.11723,-0.072335,0,0
4,GO SYNAPTIC SIGNALING,0.31653,-0.11748,-0.052475,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.51459,-0.11753,-0.0464,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.42347,-0.11795,-0.058169,0,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.39858,-0.1181,-0.060252,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.19095,-0.11812,-0.1566,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.04854,-0.11819,-0.084449,0,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.29586,-0.11852,-0.069984,0,0
4,GO COLLATERAL SPROUTING,0.17374,-0.11856,-0.11533,0,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.15773,-0.11882,-0.072729,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.12049,-0.11905,-0.097125,0,0
4,GO DNA DEPENDENT DNA REPLICATION,0.0012662,-0.11916,-0.12907,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.17653,-0.11928,-0.10013,0,0
4,GO UV PROTECTION,0.22568,-0.12043,-0.12334,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.15264,-0.1205,-0.088101,0,0
4,GO HISTONE H3 K9 MODIFICATION,0.015203,-0.12058,-0.10982,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.85082,-0.12121,-0.015601,0,0
4,GO TRANSPORT ALONG MICROTUBULE,0.00098941,-0.12129,-0.12408,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.11636,-0.12143,-0.19662,0,0
4,GO GTP METABOLIC PROCESS,0.066855,-0.12148,-0.13945,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.14769,-0.12152,-0.12552,0,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.12908,-0.12154,-0.09709,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.088862,-0.12182,-0.11838,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.05824,-0.12198,-0.069543,0,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.10845,-0.12205,-0.078683,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.23245,-0.12207,-0.061331,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.85768,-0.12245,0.028828,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.43883,-0.12268,-0.073934,0,0
4,GO HISTONE H2A ACETYLATION,0.070855,-0.12277,-0.1086,0,0
4,GO DIVALENT METAL ION EXPORT,0.27611,-0.12294,-0.12962,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.15517,-0.12323,-0.12944,0,0
4,GO NEURON DIFFERENTIATION,0.068167,-0.12426,-0.084048,0,0
4,GO MATURATION OF LSU RRNA,0.76281,-0.12426,-0.043784,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.21905,-0.12445,-0.089108,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.095625,-0.12455,-0.056496,0,0
4,GO MITOCHONDRION DISTRIBUTION,0.072231,-0.12537,-0.10894,0,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.43883,-0.12673,-0.064692,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.15015,-0.12693,-0.10937,0,0
4,GO NEUROTRANSMITTER SECRETION,0.25363,-0.12753,-0.023122,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.17653,-0.12804,-0.088518,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.11636,-0.12814,-0.097682,0,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.063042,-0.1297,-0.090806,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.42347,-0.12999,-0.047346,0,0
4,GO AXO DENDRITIC TRANSPORT,0.011326,-0.13006,-0.12749,0,0
4,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.17934,-0.13052,-0.099947,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.33373,-0.13058,-0.099197,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.26847,-0.13084,-0.208,0,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.53167,-0.13097,-0.03669,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.31232,-0.13098,-0.062343,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.21905,-0.13108,-0.077535,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.10096,-0.13116,-0.084271,0,0
4,GO SYNAPSE ORGANIZATION,0.090515,-0.13154,-0.10413,0,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.33812,-0.13303,-0.049975,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.072231,-0.13336,-0.18627,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.040234,-0.13361,-0.11581,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.13814,-0.13362,-0.071642,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.11039,-0.13382,-0.14937,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.010245,-0.13446,-0.10516,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.14048,-0.13448,-0.1126,0,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0695,-0.13478,-0.14963,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.39858,-0.13502,-0.078118,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.49227,-0.13551,-0.058964,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.19695,-0.13558,-0.11057,0,0
4,GO ADULT HEART DEVELOPMENT,0.15264,-0.13568,-0.14296,0,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.13583,-0.13579,-0.096454,0,0
4,GO REGULATION OF AXON GUIDANCE,0.02166,-0.13593,-0.16595,0,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0083534,-0.13649,-0.1704,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.34702,-0.13655,-0.06768,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.43883,-0.13668,-0.061108,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.12259,-0.13674,-0.13305,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.079444,-0.13734,-0.11827,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.19393,-0.13755,-0.062401,0,0
4,GO MECHANOSENSORY BEHAVIOR,0.72969,-0.13792,-0.056866,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.23589,-0.13805,-0.084946,0,0
4,GO FILOPODIUM ASSEMBLY,0.11636,-0.13873,-0.10067,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.10845,-0.14036,-0.14121,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.41341,-0.14137,-0.027923,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.19095,-0.14143,-0.11275,0,0
4,GO CELL FATE SPECIFICATION,0.095625,-0.14174,-0.087902,0,0
4,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.52594,-0.14218,-0.11458,0,0
4,GO NEURON PROJECTION ARBORIZATION,0.085627,-0.14237,-0.13326,0,0
4,GO DNA PACKAGING,0.0015189,-0.1424,-0.10059,0,0
4,GO G0 TO G1 TRANSITION,0.0025083,-0.14272,-0.15927,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.15015,-0.14327,-0.14542,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.92682,-0.14382,0.010973,0,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.2,-0.14414,-0.098431,0,0
4,GO INTRACILIARY TRANSPORT,0.010773,-0.14417,-0.15976,0,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.057089,-0.14433,-0.11247,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.13814,-0.14606,-0.085703,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.17653,-0.14651,-0.088991,0,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.15264,-0.147,-0.074807,0,0
4,GO PALLIUM DEVELOPMENT,0.0079323,-0.14721,-0.109,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.19095,-0.14731,-0.11577,0,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.10096,-0.14762,-0.15213,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.02068,-0.14926,-0.16928,0,0
4,GO AXONAL TRANSPORT,0.0085714,-0.14933,-0.13741,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.090515,-0.14941,-0.20247,0,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.072231,-0.14982,-0.23954,0,0
4,GO GENETIC IMPRINTING,0.093897,-0.15022,-0.14459,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.23245,-0.15097,-0.068244,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.22905,-0.15099,-0.11305,0,0
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.50896,-0.15111,-0.095673,0,0
4,GO RESPONSE TO LEAD ION,0.031748,-0.15156,-0.11411,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.20621,-0.15256,-0.087894,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.53742,-0.15409,-0.052765,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.024288,-0.15476,-0.14851,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.036164,-0.15489,-0.18247,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.17653,-0.15499,-0.1182,0,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0062634,-0.15505,-0.12864,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.35607,-0.1551,-0.10533,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.065563,-0.15571,-0.10231,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.079444,-0.15579,-0.13869,0,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.19695,-0.15599,-0.11737,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.15015,-0.15678,-0.14731,0,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.084046,-0.15709,-0.086018,0,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.093897,-0.15726,-0.15098,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.2,-0.15728,-0.095115,0,0
4,GO CELL PART MORPHOGENESIS,0.0099891,-0.15882,-0.14749,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.31653,-0.15883,-0.080846,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.20937,-0.16004,-0.21689,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.068167,-0.16058,-0.13158,0,0
4,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.023205,-0.16142,-0.22365,0,0
4,GO SYNAPSE ASSEMBLY,0.32938,-0.16143,-0.062623,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.60883,-0.16154,-0.011201,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.22235,-0.16173,-0.076674,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.14285,-0.16269,-0.092513,0,0
4,GO NEURON PROJECTION REGENERATION,0.068167,-0.16318,-0.11866,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.15773,-0.16344,-0.086759,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0026572,-0.16374,-0.19307,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.46512,-0.16455,-0.053915,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.011326,-0.16487,-0.1386,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0059384,-0.16487,-0.1736,0,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.12473,-0.16528,-0.081606,0,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.16828,-0.16631,-0.18207,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.47588,-0.16724,-0.04189,0,0
4,GO NEURON FATE COMMITMENT,0.1313,-0.16894,-0.12151,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.072231,-0.16995,-0.17865,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.055956,-0.1706,-0.15847,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.13814,-0.1718,-0.11638,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.31653,-0.1719,-0.11472,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.065563,-0.17217,-0.088461,0,0
4,GO AXIS ELONGATION,0.084046,-0.1725,-0.15311,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.02166,-0.17267,-0.18027,0,0
4,GO NUCLEAR PORE ORGANIZATION,0.087232,-0.17298,-0.1243,0,0
4,GO PRESYNAPSE ORGANIZATION,0.13814,-0.17328,-0.1306,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.17653,-0.17423,-0.13197,0,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.059411,-0.17463,-0.1575,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.079444,-0.17482,-0.16679,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.17934,-0.17509,-0.11846,0,0
4,GO MEMBRANE BIOGENESIS,0.15773,-0.17523,-0.12031,0,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.004408,-0.17524,-0.15393,0,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.0069616,-0.17552,-0.17476,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.17099,-0.17566,-0.20148,0,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.11841,-0.17568,-0.21227,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.37932,-0.17757,-0.077455,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.22905,-0.17944,-0.054798,0,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0011549,-0.17981,-0.22949,0,0
4,GO AXON EXTENSION,0.0022332,-0.17989,-0.20815,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.045624,-0.18003,-0.12281,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00353,-0.18013,-0.17204,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.21579,-0.18018,-0.066061,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.063042,-0.18071,-0.12075,0,0
4,GO NEURON PROJECTION EXTENSION,0.030383,-0.18121,-0.14049,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.63354,-0.18309,-0.033277,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.18508,-0.18382,-0.12587,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0062634,-0.18402,-0.1473,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.89215,-0.18404,0.070397,0,0
4,GO NEGATIVE CHEMOTAXIS,0.087232,-0.18428,-0.17955,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0045306,-0.18516,-0.17938,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.013798,-0.18584,-0.13561,0,0
4,GO CELL AGGREGATION,0.085627,-0.18603,-0.13965,0,0
4,GO KINETOCHORE ASSEMBLY,0.066855,-0.18656,-0.13057,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.14285,-0.18662,-0.13886,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.049546,-0.18742,-0.14084,0,0
4,GO UTERUS DEVELOPMENT,0.063042,-0.18809,-0.19824,0,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.15517,-0.18875,-0.089419,0,0
4,GO SIALYLATION,0.60883,-0.19032,-0.055454,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.011612,-0.19048,-0.15123,0,0
4,GO HISTONE H3 K27 METHYLATION,0.00069957,-0.19206,-0.19805,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.54321,-0.19265,-0.056842,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.061812,-0.19323,-0.19248,0,0
4,GO HEART FORMATION,0.088862,-0.19327,-0.12726,0,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0010528,-0.19342,-0.2029,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.15264,-0.19402,-0.10671,0,0
4,GO SECRETORY GRANULE LOCALIZATION,0.4598,-0.19483,-0.053448,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.082489,-0.19618,-0.10383,0,0
4,GO DENDRITE DEVELOPMENT,0.018398,-0.19635,-0.12165,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.066855,-0.19706,-0.17175,0,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0040578,-0.1971,-0.20408,0,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.088862,-0.19753,-0.19501,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.1028,-0.20064,-0.19549,0,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0038387,-0.20195,-0.16624,0,0
4,GO TRACHEA MORPHOGENESIS,0.068167,-0.20224,-0.13931,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.11039,-0.20413,-0.18142,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.0075304,-0.20463,-0.22366,0,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.022165,-0.20518,-0.18181,0,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.060602,-0.20722,-0.16994,0,0
4,GO CONVERGENT EXTENSION,0.035393,-0.20726,-0.20853,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.041093,-0.20903,-0.16429,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.010773,-0.21155,-0.15857,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.14769,-0.21307,-0.15077,0,0
4,GO ELASTIC FIBER ASSEMBLY,0.10096,-0.21343,-0.24703,0,0
4,GO AXON DEVELOPMENT,0.0046564,-0.21349,-0.19499,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.2839,-0.21385,-0.1146,0,0
4,GO BIOLOGICAL PHASE,0.33373,-0.21531,-0.10715,0,0
4,GO RESPIRATORY SYSTEM PROCESS,0.00036427,-0.21594,-0.23297,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.14526,-0.21597,-0.094721,0,0
4,GO NEUROBLAST DIVISION,0.072231,-0.2183,-0.17662,0,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.30815,-0.21869,-0.093802,0,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.0081404,-0.2196,-0.18284,0,0
4,GO SPINAL CORD PATTERNING,0.52025,-0.21995,-0.049554,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.94769,-0.22002,0.11617,0,0
4,GO NEURON PROJECTION GUIDANCE,0.00095906,-0.22061,-0.232,0,0
4,GO CGMP METABOLIC PROCESS,0.3746,-0.22097,-0.069356,0,0
4,GO LEUKOCYTE AGGREGATION,0.070855,-0.22376,-0.26742,0,0
4,GO REGULATION OF NEURON MIGRATION,0.0010859,-0.23088,-0.26665,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.007729,-0.23121,-0.19164,0,0
4,GO HISTONE H3 K36 METHYLATION,0.070855,-0.23148,-0.13396,0,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0071468,-0.23234,-0.18524,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.14526,-0.23321,-0.17549,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.39858,-0.23409,-0.047328,0,0
4,GO DENDRITE SELF AVOIDANCE,0.0079323,-0.235,-0.2601,0,0
4,GO NEURON MIGRATION,0.016339,-0.2353,-0.16784,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.26471,-0.23633,-0.11886,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.063042,-0.23884,-0.14752,0,0
4,GO NEURON CELL CELL ADHESION,0.52594,-0.24015,-0.043978,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.053746,-0.24054,-0.13924,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.016339,-0.24059,-0.23681,0,0
4,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.2839,-0.24205,-0.17002,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.017137,-0.24459,-0.19039,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.010506,-0.24718,-0.21962,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.026586,-0.24917,-0.19151,0,0
4,GO DENDRITE MORPHOGENESIS,0.0064317,-0.25272,-0.16534,0,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0060989,-0.25332,-0.35752,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.38408,-0.25438,-0.086842,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.95466,-0.25493,0.0010028,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.029719,-0.25502,-0.21994,0,0
4,GO PLASMA MEMBRANE REPAIR,0.12259,-0.26061,-0.15293,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.0099891,-0.26089,-0.21311,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0013872,-0.26481,-0.19989,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0030654,-0.26507,-0.26041,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.025414,-0.26608,-0.15199,0,0
4,GO NEURON RECOGNITION,0.03245,-0.26709,-0.21271,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.049546,-0.26814,-0.1747,0,0
4,GO CARDIOBLAST PROLIFERATION,0.017137,-0.2685,-0.39873,0,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.10845,-0.26916,-0.22502,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0038387,-0.27161,-0.2421,0,0
4,GO NEURON FATE SPECIFICATION,0.44402,-0.27179,-0.055672,0,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.0025817,-0.27251,-0.22503,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0071468,-0.2731,-0.28275,0,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0064317,-0.27411,-0.20687,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.02166,-0.27423,-0.26488,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0097392,-0.27581,-0.28354,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.087232,-0.27923,-0.13452,0,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00095906,-0.28545,-0.25363,0,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00037661,-0.28757,-0.26784,0,0
4,GO DENDRITIC TRANSPORT,0.0013054,-0.29505,-0.28904,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0021062,-0.30531,-0.27454,0,0
4,GO HEART VALVE FORMATION,0.05824,-0.30686,-0.22824,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.019739,-0.30751,-0.30411,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.031748,-0.30906,-0.29642,0,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.00022676,-0.31325,-0.2592,0,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.010506,-0.31346,-0.32141,0,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.009256,-0.31892,-0.25416,0,0
4,GO CARTILAGE MORPHOGENESIS,0.016734,-0.32189,-0.31263,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.024846,-0.32372,-0.31852,0,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,5.6174e-05,-0.32422,-0.32607,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.011326,-0.32558,-0.32553,0,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0025817,-0.33098,-0.25282,0,0
4,GO DENDRITIC SPINE MORPHOGENESIS,0.00045924,-0.3431,-0.28078,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.11841,-0.34548,-0.30084,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0038387,-0.36258,-0.28735,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.37932,-0.37274,-0.11337,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.00095906,-0.38229,-0.36706,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0041716,-0.39681,-0.37586,0,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.00045924,-0.40846,-0.31093,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0014299,-0.4347,-0.39724,0,0
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.017969,-0.44294,-0.36537,0,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00045924,-0.46857,-0.5297,0,0
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00098941,-0.51041,-0.40578,0,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.6597e-05,-0.56983,-0.59189,0,0
4,GO SYNAPTIC VESICLE CLUSTERING,0.00021167,-0.63203,-0.59807,0,0
5,GO CYTIDINE TO URIDINE EDITING,0.0047853,0.82483,0.52936,1,1
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00074557,0.82014,0.56826,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00057693,0.80179,0.50418,1,1
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00029782,0.77265,0.67509,1,1
5,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,5.4977e-07,0.7605,0.76517,1,1
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0097392,0.75154,0.74455,1,1
5,GO PROSTATIC BUD FORMATION,0.0038387,0.73154,0.48891,1,1
5,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.73075,0.65829,1,1
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,5.0683e-06,0.71793,0.62147,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00074557,0.71584,0.50699,1,1
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00084609,0.70951,0.60566,1,1
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0031536,0.69984,0.46054,1,1
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00010092,0.67978,0.59847,1,1
5,GO NEGATIVE REGULATION OF CELL KILLING,0.0012662,0.67488,0.44085,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.349e-05,0.67393,0.53301,1,1
5,GO ANATOMICAL STRUCTURE REGRESSION,0.00022676,0.66502,0.48306,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS,1.9904e-06,0.65156,0.54354,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.0073e-05,0.64544,0.55382,1,1
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,2.1663e-05,0.6448,0.48535,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,8.3127e-06,0.6404,0.60884,1,1
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,2.5308e-05,0.63619,0.54663,1,1
5,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,1.2862e-06,0.63274,0.60611,1,1
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,7.5427e-07,0.63049,0.58971,1,1
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,1.4609e-05,0.62414,0.60449,1,1
5,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00052342,0.6181,0.64212,1,1
5,GO GLIAL CELL FATE COMMITMENT,0.00010845,0.61446,0.52351,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00054072,0.61139,0.50559,1,1
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,6.7728e-06,0.60835,0.58231,1,1
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.00022676,0.60818,0.49489,1,1
5,GO PROSTATE GLAND MORPHOGENESIS,7.0571e-06,0.59841,0.57043,1,1
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.004408,0.59809,0.44156,1,1
5,GO RENAL ABSORPTION,0.00021167,0.59695,0.46293,1,1
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,5.508e-06,0.59517,0.49847,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,2.1702e-06,0.59407,0.56008,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,2.4346e-05,0.58982,0.45033,1,1
5,GO TOLERANCE INDUCTION,7.8282e-05,0.58641,0.55875,1,1
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,1.4039e-05,0.58373,0.45636,1,1
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,5.0226e-05,0.58212,0.55134,1,1
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00081984,0.57874,0.38437,1,1
5,GO SYNAPTIC MEMBRANE ADHESION,0.00052342,0.57765,0.47147,1,1
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00012074,0.57338,0.45089,1,1
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,4.8612e-06,0.57096,0.64609,1,1
5,GO LABYRINTHINE LAYER MORPHOGENESIS,7.8282e-05,0.57015,0.56007,1,1
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,4.6597e-05,0.56942,0.5202,1,1
5,GO TYPE B PANCREATIC CELL PROLIFERATION,1.7806e-05,0.56878,0.55073,1,1
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.00059588,0.56539,0.5692,1,1
5,GO MICROVILLUS ASSEMBLY,0.00021909,0.5606,0.43302,1,1
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00026903,0.5589,0.51948,1,1
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,9.0179e-06,0.55402,0.64513,1,1
5,GO REGULATION OF TRANSPOSITION,0.00012964,0.54879,0.41466,1,1
5,GO ECTODERMAL PLACODE DEVELOPMENT,4.6623e-06,0.54724,0.58016,1,1
5,GO DETECTION OF OTHER ORGANISM,0.00027832,0.54592,0.45755,1,1
5,GO SYNAPSE MATURATION,0.00023468,0.54509,0.53483,1,1
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,2.0033e-05,0.543,0.5084,1,1
5,GO REGULATION OF RECEPTOR CLUSTERING,1.349e-05,0.54249,0.50888,1,1
5,GO REGULATION OF PLATELET AGGREGATION,7.0571e-06,0.53961,0.51231,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.3218e-05,0.53755,0.42896,1,1
5,GO KERATINOCYTE DEVELOPMENT,0.0049174,0.53692,0.43316,1,1
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00042998,0.5351,0.47937,1,1
5,GO EOSINOPHIL MIGRATION,0.010245,0.53149,0.36335,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00055855,0.53111,0.43005,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,2.2524e-05,0.52938,0.51147,1,1
5,GO EOSINOPHIL CHEMOTAXIS,0.011326,0.52758,0.39189,1,1
5,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00037661,0.524,0.51252,1,1
5,GO TRANSPOSITION,3.7791e-06,0.52267,0.45156,1,1
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,2.7343e-05,0.52005,0.50577,1,1
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.00013433,0.51867,0.55983,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,5.4121e-05,0.51846,0.4934,1,1
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,6.0504e-05,0.51812,0.57014,1,1
5,GO TONGUE DEVELOPMENT,2.1663e-05,0.51144,0.48409,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0013457,0.51139,0.38974,1,1
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00047456,0.50882,0.47603,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00040247,0.50492,0.38686,1,1
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,4.6597e-05,0.50447,0.46373,1,1
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.5308e-05,0.50326,0.43098,1,1
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00036427,0.50107,0.40001,1,1
5,GO REGULATION OF GLIAL CELL PROLIFERATION,6.2985e-07,0.50042,0.43404,1,1
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,3.0576e-06,0.4983,0.46293,1,1
5,GO LUNG CELL DIFFERENTIATION,0.00024286,0.49553,0.46502,1,1
5,GO RESPONSE TO TYPE I INTERFERON,0.00072223,0.49498,0.47295,1,1
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0038387,0.49416,0.3448,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0001547,0.49362,0.61768,1,1
5,GO REGULATION OF TOLERANCE INDUCTION,2.7343e-05,0.4931,0.52217,1,1
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,6.2786e-05,0.49306,0.49521,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.00054072,0.49138,0.37529,1,1
5,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.00010845,0.49109,0.50283,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,2.3418e-05,0.49045,0.47885,1,1
5,GO ENDOTHELIAL CELL MORPHOGENESIS,5.0226e-05,0.4902,0.47578,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,1.349e-05,0.48935,0.4963,1,1
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,1.8251e-06,0.4892,0.45749,1,1
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00019753,0.48727,0.41887,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.7145e-05,0.48723,0.3918,1,1
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,7.547e-05,0.48691,0.40783,1,1
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,1.2454e-05,0.48397,0.57006,1,1
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.029719,0.48274,0.40646,1,1
5,GO DNA DEAMINATION,0.02268,0.4824,0.28461,1,1
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,1.6729e-06,0.48109,0.41696,1,1
5,GO SOMATIC STEM CELL DIVISION,0.0018173,0.47968,0.41643,1,1
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.00028792,0.47914,0.36403,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00014418,0.47755,0.3748,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00031859,0.47717,0.47149,1,1
5,GO REGULATION OF VASCULOGENESIS,3.8583e-05,0.47686,0.49664,1,1
5,GO ADENOHYPOPHYSIS DEVELOPMENT,0.0087944,0.4763,0.37973,1,1
5,GO CORTICOSTEROID HORMONE SECRETION,0.00019753,0.47421,0.39519,1,1
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,5.2139e-05,0.47386,0.43592,1,1
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.4346e-05,0.46692,0.39535,1,1
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0026572,0.46632,0.52321,1,1
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00054072,0.46565,0.42248,1,1
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00012512,0.46463,0.39101,1,1
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0011199,0.46382,0.38111,1,1
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0041716,0.46004,0.31594,1,1
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,6.2786e-05,0.45974,0.46618,1,1
5,GO RESPONSE TO WATER,0.00010462,0.45845,0.41967,1,1
5,GO REGULATORY T CELL DIFFERENTIATION,2.3418e-05,0.4581,0.39911,1,1
5,GO COCHLEA MORPHOGENESIS,3.7145e-05,0.45766,0.4163,1,1
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,6.2786e-05,0.45697,0.42499,1,1
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,9.3916e-06,0.45687,0.40169,1,1
5,GO URETER DEVELOPMENT,0.0013872,0.4555,0.33524,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,6.5149e-05,0.45482,0.32751,1,1
5,GO SIALYLATION,0.0006154,0.4534,0.36226,1,1
5,GO RESPONSE TO INTERLEUKIN 18,0.014138,0.45315,0.29282,1,1
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0015189,0.45294,0.35147,1,1
5,GO CELLULAR RESPONSE TO VITAMIN D,5.2139e-05,0.45192,0.40427,1,1
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011549,0.45149,0.39406,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00030804,0.44973,0.39348,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.5816e-05,0.44806,0.46048,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00040247,0.44794,0.39455,1,1
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0010528,0.44729,0.43876,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,9.7801e-06,0.44678,0.39212,1,1
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,4.2876e-06,0.44678,0.38179,1,1
5,GO IMMUNOGLOBULIN SECRETION,0.00074557,0.44617,0.31127,1,1
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00018427,0.44473,0.45978,1,1
5,GO MESENCHYMAL CELL PROLIFERATION,1.5201e-05,0.44419,0.40213,1,1
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,2.5308e-05,0.44415,0.42952,1,1
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.001228,0.44371,0.32125,1,1
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00022676,0.44365,0.48105,1,1
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.015953,0.44363,0.34325,1,1
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00063551,0.44346,0.32049,1,1
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,8.7323e-05,0.44195,0.37684,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00010845,0.44092,0.37595,1,1
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0071468,0.44012,0.36453,1,1
5,GO NEGATIVE REGULATION OF LIPID STORAGE,9.0179e-06,0.43995,0.35609,1,1
5,GO LUNG EPITHELIUM DEVELOPMENT,6.7596e-05,0.43985,0.35973,1,1
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.00013433,0.43893,0.35221,1,1
5,GO HEART VALVE FORMATION,0.00021167,0.43851,0.4801,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.6455e-05,0.438,0.38952,1,1
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,2.7343e-05,0.43759,0.39949,1,1
5,GO RENAL FILTRATION,0.00027832,0.43709,0.45721,1,1
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0014738,0.43661,0.37493,1,1
5,GO REGULATION OF SYNAPSE MATURATION,0.00057693,0.43579,0.4596,1,1
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,3.0689e-05,0.43552,0.42558,1,1
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00023468,0.43494,0.49304,1,1
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0001165,0.43405,0.3839,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,3.0689e-05,0.43383,0.35408,1,1
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,2.7343e-05,0.43358,0.44392,1,1
5,GO GLIAL CELL APOPTOTIC PROCESS,0.0011549,0.43312,0.44395,1,1
5,GO NEPHRIC DUCT MORPHOGENESIS,0.0073363,0.43311,0.3313,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.04854,0.43012,0.19016,1,1
5,GO BRONCHUS DEVELOPMENT,0.0011199,0.42997,0.42288,1,1
5,GO MALE SEX DETERMINATION,8.4205e-05,0.42954,0.39365,1,1
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,2.5774e-06,0.4292,0.38931,1,1
5,GO VOCALIZATION BEHAVIOR,0.0017123,0.42877,0.5347,1,1
5,GO NEURONAL ION CHANNEL CLUSTERING,0.0011199,0.42865,0.46753,1,1
5,GO MAST CELL MIGRATION,0.0021689,0.42725,0.48337,1,1
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.00029782,0.42659,0.41549,1,1
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.2139e-05,0.42652,0.42957,1,1
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0011549,0.42644,0.35038,1,1
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,1.5816e-05,0.4245,0.49866,1,1
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0015189,0.42383,0.33063,1,1
5,GO NEGATIVE REGULATION OF ANOIKIS,0.0001547,0.42355,0.50913,1,1
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,7.9801e-06,0.42158,0.34324,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,1.4039e-05,0.42157,0.38996,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,5.6174e-05,0.42103,0.39634,1,1
5,GO REGULATION OF ODONTOGENESIS,0.0014299,0.42084,0.35159,1,1
5,GO N GLYCAN PROCESSING,0.0014299,0.42044,0.32161,1,1
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.00021167,0.42039,0.34635,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.00012074,0.4187,0.38944,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0025817,0.41816,0.33978,1,1
5,GO LABYRINTHINE LAYER DEVELOPMENT,8.6584e-06,0.41812,0.37517,1,1
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.0034322,0.418,0.41311,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,3.7145e-05,0.41796,0.47725,1,1
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.0051916,0.41687,0.26771,1,1
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,5.2837e-06,0.41674,0.40437,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.00010092,0.41512,0.40271,1,1
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0050528,0.41409,0.27224,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0025817,0.41402,0.31537,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00092958,0.41382,0.30685,1,1
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00013433,0.41338,0.33353,1,1
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,1.3441e-06,0.41288,0.38008,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00081984,0.41165,0.2785,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.001662,0.41139,0.33573,1,1
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0028957,0.41134,0.35772,1,1
5,GO RESPONSE TO HYPEROXIA,0.00050664,0.41127,0.32249,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00018427,0.40995,0.37229,1,1
5,GO LIPID DROPLET FORMATION,0.0056288,0.40943,0.40114,1,1
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,4.1617e-05,0.40936,0.42476,1,1
5,GO GLAND MORPHOGENESIS,6.7728e-06,0.409,0.38609,1,1
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.0779e-06,0.40865,0.36169,1,1
5,GO NERVE DEVELOPMENT,1.0604e-05,0.40855,0.3536,1,1
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,5.6174e-05,0.4084,0.42555,1,1
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00013917,0.40785,0.42132,1,1
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.0011549,0.40744,0.33573,1,1
5,GO VITAMIN CATABOLIC PROCESS,0.0031536,0.40731,0.33396,1,1
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0087944,0.40727,0.43,1,1
5,GO GLIAL CELL PROLIFERATION,2.8418e-05,0.40677,0.31935,1,1
5,GO MYELIN ASSEMBLY,0.00010462,0.40616,0.32668,1,1
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.027803,0.40604,0.31113,1,1
5,GO REGULATION OF PLATELET ACTIVATION,0.00012074,0.40419,0.35208,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,6.8936e-07,0.4039,0.43384,1,1
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00021167,0.40384,0.35814,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0056288,0.4028,0.25922,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,1.7806e-05,0.40168,0.31794,1,1
5,GO THALAMUS DEVELOPMENT,0.00024286,0.39983,0.37506,1,1
5,GO REVERSE CHOLESTEROL TRANSPORT,0.00042998,0.39876,0.33987,1,1
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,7.2754e-05,0.39771,0.3278,1,1
5,GO LEFT RIGHT AXIS SPECIFICATION,0.00098941,0.39753,0.3279,1,1
5,GO RESPONSE TO AUDITORY STIMULUS,0.00021167,0.39724,0.3827,1,1
5,GO LUNG MORPHOGENESIS,0.00017186,0.39688,0.29963,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00035231,0.3968,0.33921,1,1
5,GO PROTEIN KINASE C SIGNALING,0.0021062,0.39665,0.28755,1,1
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,6.0504e-05,0.39591,0.36682,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,9.4334e-07,0.395,0.42283,1,1
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,3.17e-07,0.39427,0.39154,1,1
5,GO EPOXYGENASE P450 PATHWAY,0.0024367,0.39367,0.33763,1,1
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.00036427,0.39359,0.29201,1,1
5,GO CELLULAR RESPONSE TO VITAMIN,1.6455e-05,0.39359,0.42525,1,1
5,GO FORELIMB MORPHOGENESIS,1.2454e-05,0.39286,0.38449,1,1
5,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00030804,0.39273,0.36316,1,1
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0037331,0.3921,0.36549,1,1
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0014299,0.39157,0.3671,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,2.4692e-06,0.39036,0.42406,1,1
5,GO ESTROUS CYCLE,7.013e-05,0.39026,0.38532,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00013433,0.38984,0.39696,1,1
5,GO VIRAL GENOME REPLICATION,0.0021689,0.38938,0.25365,1,1
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.010773,0.38796,0.2571,1,1
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.013465,0.38599,0.2864,1,1
5,GO ALPHA BETA T CELL PROLIFERATION,0.00037661,0.38594,0.31042,1,1
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00072223,0.38593,0.46061,1,1
5,GO RETINAL ROD CELL DIFFERENTIATION,0.00031859,0.38518,0.38788,1,1
5,GO XENOBIOTIC CATABOLIC PROCESS,0.030383,0.38473,0.30674,1,1
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.001228,0.38428,0.39779,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00028792,0.38265,0.4149,1,1
5,GO MYOBLAST FUSION,0.00084609,0.38234,0.31333,1,1
5,GO AMMONIUM TRANSPORT,6.5896e-07,0.38227,0.42565,1,1
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00044439,0.3812,0.34071,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,4.2876e-06,0.38105,0.31725,1,1
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0051916,0.38076,0.39088,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,4.1617e-05,0.38023,0.31271,1,1
5,GO SEROTONIN METABOLIC PROCESS,0.0007696,0.37964,0.43886,1,1
5,GO MYOBLAST MIGRATION,0.024288,0.37955,0.25,1,1
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,6.5149e-05,0.37937,0.4328,1,1
5,GO ENDOCARDIUM DEVELOPMENT,2.1663e-05,0.37883,0.43591,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,7.8282e-05,0.37854,0.29271,1,1
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0083534,0.37848,0.26363,1,1
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00023468,0.37803,0.38835,1,1
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00040247,0.37799,0.36402,1,1
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0087944,0.37785,0.27534,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00026003,0.37697,0.37309,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,4.1112e-06,0.37517,0.32368,1,1
5,GO CERAMIDE CATABOLIC PROCESS,0.046579,0.37505,0.19681,1,1
5,GO SKIN MORPHOGENESIS,0.0090226,0.37494,0.28966,1,1
5,GO CELLULAR RESPONSE TO NUTRIENT,1.8521e-05,0.3749,0.35633,1,1
5,GO MATURE B CELL DIFFERENTIATION,0.045624,0.37445,0.23175,1,1
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.00021167,0.3741,0.33209,1,1
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.015574,0.37391,0.29237,1,1
5,GO PROSTATE GLAND DEVELOPMENT,4.4878e-05,0.37381,0.32675,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.00017186,0.37366,0.35981,1,1
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,4.3218e-05,0.37366,0.30329,1,1
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0006154,0.37347,0.27113,1,1
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.0053338,0.3734,0.45306,1,1
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,2.5308e-05,0.37336,0.33395,1,1
5,GO SECONDARY PALATE DEVELOPMENT,2.0833e-05,0.37313,0.36706,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.4121e-05,0.37289,0.32841,1,1
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.018398,0.37286,0.29564,1,1
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0037331,0.37247,0.26162,1,1
5,GO BASEMENT MEMBRANE ORGANIZATION,0.0027346,0.37233,0.33292,1,1
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.0013872,0.37221,0.3073,1,1
5,GO LUNG ALVEOLUS DEVELOPMENT,0.00012074,0.37163,0.31203,1,1
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.00081984,0.37105,0.38726,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,8.1192e-05,0.37102,0.35297,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0053338,0.3687,0.35985,1,1
5,GO MINERALOCORTICOID METABOLIC PROCESS,0.036164,0.36869,0.22881,1,1
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00030804,0.3686,0.32454,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,8.3127e-06,0.36798,0.34564,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.00087311,0.3679,0.30172,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,3.8583e-05,0.36789,0.29828,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,5.508e-06,0.36784,0.3069,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,3.3132e-05,0.3677,0.38276,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00055855,0.36653,0.41866,1,1
5,GO CRANIAL NERVE DEVELOPMENT,9.3916e-06,0.36617,0.34257,1,1
5,GO FUCOSE METABOLIC PROCESS,0.0030654,0.36614,0.24419,1,1
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.00010845,0.36541,0.2873,1,1
5,GO ASTROCYTE ACTIVATION,0.00059588,0.36483,0.31585,1,1
5,GO POSITIVE REGULATION OF CILIUM MOVEMENT,2.6307e-05,0.36483,0.34181,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.349e-05,0.36278,0.31022,1,1
5,GO REGULATION OF GTP BINDING,0.0037331,0.36272,0.28104,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.9263e-05,0.36246,0.3735,1,1
5,GO RESPONSE TO COLD,0.00026003,0.36201,0.28753,1,1
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.00057693,0.36189,0.33396,1,1
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00017186,0.36174,0.28213,1,1
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00069957,0.36128,0.26893,1,1
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00047456,0.36104,0.31063,1,1
5,GO SHORT TERM MEMORY,0.033894,0.36093,0.22061,1,1
5,GO EPITHELIAL CELL MATURATION,0.00084609,0.36085,0.33354,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.00034072,0.36052,0.30835,1,1
5,GO BROWN FAT CELL DIFFERENTIATION,3.6414e-07,0.36035,0.38124,1,1
5,GO MYELIN MAINTENANCE,6.7596e-05,0.36001,0.39505,1,1
5,GO LIVER MORPHOGENESIS,1.9263e-05,0.35981,0.47838,1,1
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,9.389e-05,0.35939,0.35187,1,1
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,2.4346e-05,0.35861,0.28844,1,1
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0024367,0.3583,0.32979,1,1
5,GO MAMMARY GLAND MORPHOGENESIS,7.547e-05,0.35823,0.32361,1,1
5,GO ENERGY HOMEOSTASIS,1.104e-05,0.35819,0.34519,1,1
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.00032948,0.35782,0.31686,1,1
5,GO ANTIBACTERIAL HUMORAL RESPONSE,3.6228e-06,0.35773,0.39986,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0085714,0.35767,0.27211,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.013798,0.35758,0.28351,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0025083,0.357,0.36158,1,1
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,2.8077e-06,0.35675,0.37276,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00063551,0.35605,0.31354,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.8583e-05,0.35603,0.30565,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0040578,0.35592,0.25685,1,1
5,GO AXIS ELONGATION,6.2786e-05,0.35576,0.32168,1,1
5,GO POSITIVE REGULATION OF WOUND HEALING,2.2524e-05,0.35564,0.38825,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.1964e-05,0.35502,0.39758,1,1
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.00032948,0.35463,0.43253,1,1
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0030654,0.35399,0.22391,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00041602,0.35398,0.3426,1,1
5,GO RETINOIC ACID METABOLIC PROCESS,2.0033e-05,0.35379,0.3869,1,1
5,GO STEROID HORMONE SECRETION,0.0001547,0.35364,0.3232,1,1
5,GO GANGLION DEVELOPMENT,0.0081404,0.35347,0.36738,1,1
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.013139,0.35278,0.32475,1,1
5,GO MEMBRANE RAFT ORGANIZATION,0.0090226,0.3526,0.28158,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,9.7346e-05,0.3523,0.24397,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.7145e-05,0.35224,0.30202,1,1
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00011241,0.35216,0.41723,1,1
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.35133,0.29136,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00072223,0.35096,0.27016,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,5.508e-06,0.35093,0.30867,1,1
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.035393,0.35084,0.32044,1,1
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00074557,0.35074,0.2462,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00042998,0.34977,0.32365,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00021167,0.34962,0.27291,1,1
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0013054,0.34962,0.28955,1,1
5,GO DENDRITIC CELL DIFFERENTIATION,0.0013054,0.34931,0.24752,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,3.0576e-06,0.34928,0.30077,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.001986,0.34922,0.31971,1,1
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.0029794,0.34899,0.31046,1,1
5,GO TRACHEA DEVELOPMENT,0.00029782,0.34776,0.35314,1,1
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0013457,0.34775,0.24725,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0085714,0.34762,0.2592,1,1
5,GO SUPEROXIDE ANION GENERATION,0.00019753,0.34749,0.33544,1,1
5,GO ENDOTHELIAL CELL DEVELOPMENT,1.5816e-05,0.34738,0.28282,1,1
5,GO CELL MIGRATION IN HINDBRAIN,0.00014418,0.34684,0.37512,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.4878e-05,0.3467,0.30779,1,1
5,GO MITRAL VALVE DEVELOPMENT,0.0013872,0.3467,0.28602,1,1
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0011199,0.34657,0.28096,1,1
5,GO DENDRITIC CELL MIGRATION,0.020205,0.3464,0.22889,1,1
5,GO EMBRYONIC HEMOPOIESIS,4.1112e-06,0.3462,0.3231,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00021909,0.34588,0.29532,1,1
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0066042,0.34587,0.28057,1,1
5,GO LIPID DROPLET ORGANIZATION,0.00027832,0.34573,0.28802,1,1
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.027803,0.34564,0.21498,1,1
5,GO RESPONSE TO POTASSIUM ION,0.00084609,0.3456,0.30062,1,1
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00016023,0.3452,0.3007,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.007729,0.34458,0.24338,1,1
5,GO INTERLEUKIN 13 PRODUCTION,0.0014299,0.34435,0.31507,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.7806e-05,0.34411,0.42992,1,1
5,GO PHAGOCYTOSIS RECOGNITION,0.009256,0.34384,0.20944,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,7.013e-05,0.34342,0.41933,1,1
5,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.0028141,0.34324,0.25813,1,1
5,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.0016129,0.34291,0.33838,1,1
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,7.9801e-06,0.34255,0.29527,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.00028792,0.34252,0.30065,1,1
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,3.3287e-06,0.34232,0.32757,1,1
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0018173,0.34225,0.24028,1,1
5,GO SERTOLI CELL DIFFERENTIATION,0.00017186,0.3419,0.37991,1,1
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0015189,0.34186,0.27873,1,1
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0017123,0.3416,0.31493,1,1
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,5.9841e-06,0.34145,0.40057,1,1
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00057693,0.34095,0.28253,1,1
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,7.2754e-05,0.3408,0.3621,1,1
5,GO RESPONSE TO TUMOR CELL,0.013798,0.34075,0.24251,1,1
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.0013054,0.34068,0.27131,1,1
5,GO RESPONSE TO THYROID HORMONE,0.0031536,0.3404,0.29467,1,1
5,GO MICROVILLUS ORGANIZATION,0.0083534,0.34039,0.25068,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00040247,0.34012,0.26206,1,1
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.00054072,0.34001,0.25813,1,1
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.0030654,0.33939,0.3307,1,1
5,GO ENDOTHELIUM DEVELOPMENT,2.4692e-06,0.33937,0.29702,1,1
5,GO REGULATION OF FAT CELL DIFFERENTIATION,5.4977e-07,0.33891,0.30533,1,1
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00019753,0.33883,0.33874,1,1
5,GO POSTSYNAPSE ASSEMBLY,0.0066042,0.33865,0.36873,1,1
5,GO SERTOLI CELL DEVELOPMENT,5.6174e-05,0.33852,0.41786,1,1
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00047456,0.33849,0.36015,1,1
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.001228,0.33812,0.42245,1,1
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.00092958,0.338,0.28599,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8282e-05,0.33792,0.26373,1,1
5,GO EXOCRINE SYSTEM DEVELOPMENT,5.8301e-05,0.33777,0.33286,1,1
5,GO RESPONSE TO INTERFERON GAMMA,0.0007696,0.33772,0.32518,1,1
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,5.7413e-06,0.33761,0.27672,1,1
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0056288,0.33759,0.24419,1,1
5,GO RESPONSE TO UV B,0.0022992,0.33738,0.28066,1,1
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0028141,0.33649,0.28763,1,1
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0022992,0.33646,0.37444,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,2.1702e-06,0.3363,0.35456,1,1
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00063551,0.33612,0.23009,1,1
5,GO CGMP METABOLIC PROCESS,0.0059384,0.33602,0.2655,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,7.013e-05,0.33596,0.35701,1,1
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,5.6174e-05,0.33481,0.44,1,1
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00021909,0.33464,0.31205,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,8.1192e-05,0.33452,0.40446,1,1
5,GO ASYMMETRIC CELL DIVISION,0.0060989,0.33444,0.25701,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,4.8612e-06,0.33439,0.39216,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0064317,0.33433,0.24367,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0036303,0.33432,0.2447,1,1
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00010462,0.33415,0.30412,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.7343e-05,0.33398,0.26467,1,1
5,GO LINOLEIC ACID METABOLIC PROCESS,0.0049174,0.33385,0.26218,1,1
5,GO NEURAL CREST CELL MIGRATION,0.015953,0.33337,0.25487,1,1
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.0028141,0.33333,0.23279,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION,1.9904e-06,0.33312,0.29315,1,1
5,GO PSEUDOPODIUM ORGANIZATION,0.0016129,0.33277,0.3661,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,2.2658e-06,0.33272,0.29567,1,1
5,GO FAT CELL DIFFERENTIATION,3.0264e-07,0.33267,0.28463,1,1
5,GO PRO B CELL DIFFERENTIATION,0.0022332,0.33258,0.26971,1,1
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,2.7343e-05,0.33249,0.29196,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0012662,0.3321,0.36575,1,1
5,GO GLIAL CELL DEVELOPMENT,1.1776e-06,0.33196,0.31294,1,1
5,GO NEPHRON MORPHOGENESIS,6.2367e-06,0.3318,0.26927,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.00012512,0.33099,0.35113,1,1
5,GO RESPIRATORY SYSTEM DEVELOPMENT,1.0311e-06,0.33072,0.3021,1,1
5,GO SMOOTH MUSCLE CELL MIGRATION,7.8282e-05,0.33059,0.32703,1,1
5,GO REGULATION OF COAGULATION,0.0022992,0.33044,0.24058,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,5.8301e-05,0.33031,0.34139,1,1
5,GO KERATINOCYTE PROLIFERATION,0.0017123,0.33021,0.26192,1,1
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00092958,0.33001,0.26275,1,1
5,GO REGULATION OF ANOIKIS,0.0013457,0.33001,0.34667,1,1
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.9263e-05,0.32989,0.25844,1,1
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.001662,0.32981,0.33754,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.02166,0.3298,0.30863,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0001165,0.32962,0.27535,1,1
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00018427,0.32947,0.29282,1,1
5,GO ODONTOGENESIS,0.0001547,0.32931,0.2773,1,1
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.011904,0.32921,0.19104,1,1
5,GO HEART TRABECULA FORMATION,0.00010462,0.32908,0.341,1,1
5,GO GLIAL CELL MIGRATION,0.00027832,0.3288,0.2452,1,1
5,GO WHITE FAT CELL DIFFERENTIATION,2.0833e-05,0.32867,0.32586,1,1
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0018173,0.32831,0.31322,1,1
5,GO REGULATION OF POSITIVE CHEMOTAXIS,4.6623e-06,0.32708,0.37816,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0030654,0.32705,0.24077,1,1
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.6455e-05,0.32638,0.35996,1,1
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0047853,0.32619,0.23991,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00067758,0.32611,0.29455,1,1
5,GO POSITIVE REGULATION OF CELL MATURATION,0.030383,0.32495,0.21314,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,2.9532e-05,0.32493,0.30299,1,1
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0054795,0.32491,0.25544,1,1
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00027832,0.32481,0.29369,1,1
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0031536,0.32475,0.24881,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00040247,0.32458,0.22166,1,1
5,GO PREPULSE INHIBITION,0.012508,0.32439,0.36465,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,3.6228e-06,0.32433,0.30368,1,1
5,GO RESPONSE TO AXON INJURY,0.00021909,0.32401,0.26102,1,1
5,GO CELLULAR RESPONSE TO SALT STRESS,0.047551,0.32354,0.17867,1,1
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0024367,0.32351,0.28239,1,1
5,GO DETECTION OF BIOTIC STIMULUS,0.00040247,0.32347,0.33197,1,1
5,GO COCHLEA DEVELOPMENT,4.3218e-05,0.32329,0.3188,1,1
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,2.6307e-05,0.32312,0.31531,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,6.2786e-05,0.32309,0.26192,1,1
5,GO PROTEIN OXIDATION,0.030383,0.32266,0.22035,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,9.7346e-05,0.32243,0.34973,1,1
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.016339,0.32238,0.29139,1,1
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00038934,0.32206,0.26399,1,1
5,GO EPIDERMIS MORPHOGENESIS,8.7323e-05,0.3219,0.3039,1,1
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.001662,0.32186,0.22929,1,1
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0029794,0.32184,0.26169,1,1
5,GO MAST CELL ACTIVATION,1.7806e-05,0.32179,0.2875,1,1
5,GO VASCULAR WOUND HEALING,0.00010092,0.32151,0.39794,1,1
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.025994,0.32111,0.25295,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,5.7413e-06,0.32107,0.39061,1,1
5,GO POSITIVE REGULATION OF CHEMOTAXIS,7.6603e-06,0.32082,0.29046,1,1
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0010528,0.32074,0.27214,1,1
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.045624,0.32064,0.26487,1,1
5,GO REGULATION OF VIRAL LIFE CYCLE,0.0064317,0.31987,0.24345,1,1
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0015189,0.31974,0.20365,1,1
5,GO LEUKOTRIENE METABOLIC PROCESS,0.0014299,0.31875,0.25386,1,1
5,GO ACTIN CROSSLINK FORMATION,0.00054072,0.31858,0.26675,1,1
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0013457,0.31846,0.25274,1,1
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.031748,0.31836,0.31236,1,1
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,9.3916e-06,0.31828,0.27048,1,1
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0040578,0.31818,0.27803,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00041602,0.31804,0.28608,1,1
5,GO KIDNEY MORPHOGENESIS,3.4728e-06,0.318,0.27633,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.02268,0.31781,0.23909,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0094949,0.31771,0.43847,1,1
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,4.0073e-05,0.31727,0.31744,1,1
5,GO RESPONSE TO ACETYLCHOLINE,0.00026903,0.31722,0.32884,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,9.0221e-07,0.31721,0.2899,1,1
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,3.5759e-05,0.31659,0.30059,1,1
5,GO TONGUE MORPHOGENESIS,0.0017641,0.31639,0.46769,1,1
5,GO RECEPTOR CLUSTERING,0.00026003,0.31598,0.24677,1,1
5,GO TISSUE REGENERATION,0.00029782,0.31588,0.26214,1,1
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00081984,0.31586,0.26493,1,1
5,GO ENGULFMENT OF APOPTOTIC CELL,0.00023468,0.3157,0.30771,1,1
5,GO SEQUESTERING OF ACTIN MONOMERS,0.0047853,0.31527,0.32922,1,1
5,GO KETONE CATABOLIC PROCESS,0.011326,0.31474,0.30876,1,1
5,GO ASTROCYTE DIFFERENTIATION,1.4039e-05,0.31471,0.31334,1,1
5,GO REGULATION OF RESPONSE TO WOUNDING,6.5149e-05,0.31462,0.26761,1,1
5,GO EPITHELIAL CELL PROLIFERATION,2.1702e-06,0.31447,0.28905,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.9263e-05,0.31437,0.26653,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00065623,0.3143,0.29364,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.001662,0.31424,0.25704,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0051916,0.31414,0.24026,1,1
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0015189,0.31413,0.30908,1,1
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0015653,0.31397,0.28379,1,1
5,GO REGULATION OF SODIUM ION TRANSPORT,2.5308e-05,0.31383,0.26031,1,1
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.014138,0.31305,0.2709,1,1
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0045306,0.31281,0.34148,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,5.2533e-07,0.31254,0.29447,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0010528,0.31252,0.30497,1,1
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0019282,0.31228,0.27248,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00010462,0.31218,0.26714,1,1
5,GO ENDOTHELIAL CELL PROLIFERATION,1.5201e-05,0.31206,0.28286,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0001547,0.31202,0.2595,1,1
5,GO MAST CELL MEDIATED IMMUNITY,0.00021167,0.31176,0.26967,1,1
5,GO MEMBRANE BIOGENESIS,8.1192e-05,0.31144,0.31273,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.00050664,0.31143,0.32543,1,1
5,GO METANEPHROS MORPHOGENESIS,0.00012074,0.31137,0.29044,1,1
5,GO REGULATION OF CARDIAC CONDUCTION,0.00013917,0.31135,0.25676,1,1
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0045306,0.31123,0.46679,1,1
5,GO OLIGODENDROCYTE DIFFERENTIATION,7.889e-07,0.31107,0.31337,1,1
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0020453,0.31057,0.23375,1,1
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0015189,0.31047,0.27537,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.7145e-05,0.31042,0.25568,1,1
5,GO REGULATION OF CELL MATRIX ADHESION,1.8521e-05,0.31032,0.29391,1,1
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00017186,0.31027,0.23576,1,1
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0038387,0.31009,0.35495,1,1
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.049546,0.30978,0.16897,1,1
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0022992,0.30952,0.24734,1,1
5,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00095906,0.30933,0.19848,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,7.6603e-06,0.30915,0.25621,1,1
5,GO CARDIAC ATRIUM DEVELOPMENT,0.0020453,0.30895,0.21529,1,1
5,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.30895,0.27904,1,1
5,GO PARAXIAL MESODERM DEVELOPMENT,0.016734,0.30893,0.24623,1,1
5,GO NOREPINEPHRINE SECRETION,0.0081404,0.30884,0.28776,1,1
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.013465,0.30867,0.34322,1,1
5,GO TOXIN METABOLIC PROCESS,0.050569,0.30836,0.21543,1,1
5,GO ACUTE INFLAMMATORY RESPONSE,6.5149e-05,0.30833,0.28318,1,1
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.016734,0.30818,0.18368,1,1
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.001986,0.30815,0.35834,1,1
5,GO ATRIAL SEPTUM DEVELOPMENT,0.013139,0.30769,0.24455,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.0226e-05,0.30732,0.2614,1,1
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,7.013e-05,0.30653,0.30201,1,1
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00024286,0.30634,0.33352,1,1
5,GO REGULATION OF CELL SUBSTRATE ADHESION,5.0226e-05,0.30589,0.26601,1,1
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.001872,0.30519,0.2081,1,1
5,GO REGULATION OF WATER LOSS VIA SKIN,0.0028141,0.30517,0.43214,1,1
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00013433,0.30498,0.27798,1,1
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0014299,0.30491,0.21243,1,1
5,GO SPINAL CORD PATTERNING,0.0021062,0.30404,0.34002,1,1
5,GO POSITIVE REGULATION OF COAGULATION,0.00052342,0.30363,0.28474,1,1
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0064317,0.30353,0.21601,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,3.0689e-05,0.30352,0.28625,1,1
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00055855,0.30336,0.29689,1,1
5,GO HINDLIMB MORPHOGENESIS,0.00026003,0.30332,0.29976,1,1
5,GO SEX DETERMINATION,0.00012964,0.30329,0.33227,1,1
5,GO EPITHELIAL CELL CELL ADHESION,0.004408,0.30321,0.32582,1,1
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0011199,0.30309,0.32335,1,1
5,GO GLIAL CELL DIFFERENTIATION,7.5427e-07,0.30308,0.28535,1,1
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.019283,0.30282,0.18293,1,1
5,GO RENAL TUBULE DEVELOPMENT,5.4121e-05,0.30202,0.24403,1,1
5,GO POSITIVE REGULATION OF GLIOGENESIS,7.2111e-07,0.30191,0.2994,1,1
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.038561,0.30184,0.24163,1,1
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.0049174,0.30137,0.32531,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00012512,0.30137,0.26745,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,1.3441e-06,0.30134,0.29052,1,1
5,GO EPITHELIAL CELL FATE COMMITMENT,0.0006154,0.30111,0.49362,1,1
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0023671,0.30093,0.2963,1,1
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00023468,0.30089,0.26187,1,1
5,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.0023671,0.30072,0.35504,1,1
5,GO REGULATION OF WOUND HEALING,0.00040247,0.30072,0.25928,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0090226,0.30071,0.19291,1,1
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0001547,0.30053,0.24331,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.00019753,0.30013,0.34168,1,1
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00087311,0.3001,0.26026,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0010528,0.3,0.32138,1,1
5,GO DEFENSE RESPONSE TO VIRUS,0.0030654,0.29986,0.22974,1,1
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00010092,0.29971,0.30869,1,1
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00045924,0.29933,0.22452,1,1
5,GO NEURON PROJECTION REGENERATION,0.00012074,0.29911,0.26441,1,1
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00044439,0.29891,0.20969,1,1
5,GO SYNCYTIUM FORMATION,0.00079435,0.2989,0.25629,1,1
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0021062,0.29883,0.26566,1,1
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0075304,0.29864,0.29417,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0021689,0.29848,0.22541,1,1
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0020453,0.29848,0.23767,1,1
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0049174,0.29813,0.2364,1,1
5,GO DORSAL AORTA DEVELOPMENT,0.0023671,0.29799,0.28648,1,1
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00029782,0.29788,0.20962,1,1
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0046564,0.29775,0.2302,1,1
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.00034072,0.29744,0.36042,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0018173,0.29733,0.3122,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0056288,0.29719,0.24273,1,1
5,GO LIPID TRANSLOCATION,4.0073e-05,0.29714,0.28065,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0011199,0.29682,0.21626,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0010206,0.29653,0.2595,1,1
5,GO LEUKOCYTE CHEMOTAXIS,7.2754e-05,0.29633,0.22226,1,1
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00063551,0.29619,0.24004,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.4121e-05,0.29608,0.33418,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00020448,0.29606,0.2745,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0025083,0.29559,0.22382,1,1
5,GO RESPONSE TO VITAMIN A,0.00065623,0.29555,0.26485,1,1
5,GO LIPID STORAGE,9.7346e-05,0.29536,0.23457,1,1
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010092,0.2951,0.24617,1,1
5,GO MACROPHAGE CHEMOTAXIS,7.547e-05,0.29496,0.31663,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.010245,0.29443,0.20591,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.2139e-05,0.29409,0.22192,1,1
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.00021909,0.29395,0.23237,1,1
5,GO EMBRYONIC BODY MORPHOGENESIS,0.0019282,0.2939,0.3037,1,1
5,GO INNATE IMMUNE RESPONSE,0.0024367,0.29385,0.1809,1,1
5,GO GLIOGENESIS,9.4334e-07,0.2937,0.27139,1,1
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0024367,0.29368,0.19026,1,1
5,GO HYPOTONIC RESPONSE,0.015953,0.29344,0.21452,1,1
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013054,0.29309,0.20593,1,1
5,GO POSITIVE REGULATION OF OSSIFICATION,2.5308e-05,0.29213,0.31298,1,1
5,GO MUSCLE CELL MIGRATION,3.5759e-05,0.29205,0.31419,1,1
5,GO RESPONSE TO BMP,1.1493e-05,0.29205,0.25566,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.010245,0.29198,0.17052,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,7.3528e-06,0.29151,0.24843,1,1
5,GO LONG TERM SYNAPTIC POTENTIATION,0.00054072,0.29145,0.2522,1,1
5,GO APPENDAGE MORPHOGENESIS,0.00013917,0.29131,0.23298,1,1
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0017123,0.29087,0.27008,1,1
5,GO MACROPHAGE DIFFERENTIATION,0.00030804,0.29034,0.2075,1,1
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,4.4878e-05,0.29022,0.24275,1,1
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0023671,0.29015,0.21763,1,1
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0037331,0.29011,0.3022,1,1
5,GO REGULATION OF EXOSOMAL SECRETION,0.0028141,0.29011,0.22626,1,1
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0079323,0.29009,0.3236,1,1
5,GO BRAIN MORPHOGENESIS,0.00021167,0.28998,0.24189,1,1
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0041716,0.28995,0.29367,1,1
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.00052342,0.28992,0.25151,1,1
5,GO MACROPHAGE MIGRATION,2.0033e-05,0.28975,0.30078,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.2754e-05,0.28966,0.25708,1,1
5,GO REGULATION OF MACROPHAGE MIGRATION,7.9801e-06,0.28961,0.28443,1,1
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0010859,0.28921,0.3539,1,1
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0010859,0.28921,0.41605,1,1
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0027346,0.28919,0.2146,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,1.5816e-05,0.28911,0.27228,1,1
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0007696,0.28866,0.2196,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00023468,0.28854,0.23301,1,1
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0027346,0.28849,0.21261,1,1
5,GO BODY MORPHOGENESIS,0.0001547,0.28847,0.24612,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,2.4692e-06,0.28807,0.28821,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.0604e-05,0.28791,0.28903,1,1
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00030804,0.28756,0.28418,1,1
5,GO RENAL VESICLE DEVELOPMENT,0.010773,0.28746,0.21197,1,1
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0026572,0.28741,0.26377,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,3.4728e-06,0.28718,0.27767,1,1
5,GO PLASMA MEMBRANE FUSION,0.0030654,0.28709,0.30257,1,1
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00055855,0.28684,0.23293,1,1
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0083534,0.28668,0.25342,1,1
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.021165,0.28622,0.17591,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,4.4712e-06,0.28603,0.25132,1,1
5,GO MESENCHYME DEVELOPMENT,8.1192e-05,0.28589,0.21539,1,1
5,GO MEMBRANE DEPOLARIZATION,0.0064317,0.28575,0.20817,1,1
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,1.4039e-05,0.28535,0.27861,1,1
5,GO ADIPOSE TISSUE DEVELOPMENT,1.2454e-05,0.28534,0.27032,1,1
5,GO FATTY ACID HOMEOSTASIS,0.0054795,0.28467,0.31127,1,1
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00098941,0.28455,0.19652,1,1
5,GO REGULATION OF LEUKOCYTE MIGRATION,2.0033e-05,0.28453,0.23961,1,1
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,8.1192e-05,0.2845,0.2278,1,1
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0030654,0.2843,0.23539,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,6.2786e-05,0.2842,0.26492,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,4.8379e-05,0.28416,0.28587,1,1
5,GO MESENCHYMAL CELL DIFFERENTIATION,2.6307e-05,0.28391,0.25267,1,1
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0001165,0.28387,0.29075,1,1
5,GO PLACENTA DEVELOPMENT,6.4994e-06,0.28378,0.26222,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00041602,0.28344,0.27595,1,1
5,GO REGULATION OF CELL KILLING,0.0031536,0.28291,0.17878,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,5.7413e-06,0.28287,0.22455,1,1
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00020448,0.28281,0.25389,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.2454e-05,0.28242,0.26889,1,1
5,GO REGULATION OF CELL ADHESION,2.4346e-05,0.28193,0.23479,1,1
5,GO CAMP BIOSYNTHETIC PROCESS,0.0054795,0.28182,0.25477,1,1
5,GO REGULATION OF RESPONSE TO FOOD,0.00028792,0.28179,0.27819,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0087944,0.28171,0.2359,1,1
5,GO MESONEPHROS DEVELOPMENT,6.4994e-06,0.2817,0.29362,1,1
5,GO CHONDROCYTE DIFFERENTIATION,0.00029782,0.28165,0.22973,1,1
5,GO STEM CELL DIVISION,4.0073e-05,0.28158,0.2566,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.01282,0.28153,0.16905,1,1
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,5.0683e-06,0.28115,0.26197,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00011241,0.28092,0.22829,1,1
5,GO ANOIKIS,0.00012964,0.28083,0.3127,1,1
5,GO OVARIAN FOLLICLE DEVELOPMENT,2.9532e-05,0.28075,0.2808,1,1
5,GO METANEPHROS DEVELOPMENT,6.5149e-05,0.28072,0.24068,1,1
5,GO LACTATE METABOLIC PROCESS,0.0031536,0.28061,0.23974,1,1
5,GO FACIAL NERVE MORPHOGENESIS,0.0022992,0.28019,0.37347,1,1
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0014299,0.28008,0.18042,1,1
5,GO MYOTUBE DIFFERENTIATION,0.0001547,0.28002,0.22764,1,1
5,GO HIPPO SIGNALING,0.011326,0.27999,0.18055,1,1
5,GO KIDNEY EPITHELIUM DEVELOPMENT,1.6455e-05,0.27995,0.26284,1,1
5,GO CELL CELL ADHESION,2.6902e-06,0.27989,0.23643,1,1
5,GO INNERVATION,0.017549,0.27986,0.26915,1,1
5,GO INTERLEUKIN 4 PRODUCTION,5.2139e-05,0.27976,0.26295,1,1
5,GO CELL MATRIX ADHESION,3.3132e-05,0.27968,0.24583,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0017641,0.27966,0.22069,1,1
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00017186,0.27914,0.24793,1,1
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0040578,0.27913,0.21275,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.1493e-05,0.27905,0.23714,1,1
5,GO REGULATION OF CELL CELL ADHESION,5.9841e-06,0.27879,0.25404,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0083534,0.27879,0.22107,1,1
5,GO CHEMOKINE PRODUCTION,6.2786e-05,0.27875,0.288,1,1
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.015203,0.27867,0.30253,1,1
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00036427,0.27823,0.22608,1,1
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.00035231,0.27817,0.28836,1,1
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0012662,0.27815,0.25591,1,1
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0033369,0.27799,0.20953,1,1
5,GO TRANSMISSION OF NERVE IMPULSE,0.0021062,0.27799,0.25705,1,1
5,GO REGULATION OF GLIOGENESIS,2.8077e-06,0.27793,0.26587,1,1
5,GO SPHINGOID METABOLIC PROCESS,0.0017123,0.27776,0.24519,1,1
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.00079435,0.27775,0.21283,1,1
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.0040578,0.2777,0.20508,1,1
5,GO RESPONSE TO VITAMIN D,0.0041716,0.27767,0.24366,1,1
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0028957,0.27758,0.26634,1,1
5,GO MOLTING CYCLE,4.4712e-06,0.27757,0.23613,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0022992,0.27697,0.18021,1,1
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0060989,0.27692,0.24035,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,8.6584e-06,0.27657,0.24193,1,1
5,GO CRANIAL NERVE MORPHOGENESIS,0.00034072,0.27656,0.30009,1,1
5,GO RESPONSE TO VITAMIN,0.00038934,0.27589,0.23561,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,5.508e-06,0.27574,0.2719,1,1
5,GO HAIR CELL DIFFERENTIATION,6.2786e-05,0.27556,0.35734,1,1
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0097392,0.27552,0.23998,1,1
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00022676,0.27549,0.27776,1,1
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0026572,0.27521,0.20057,1,1
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,2.1663e-05,0.27513,0.31451,1,1
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.013798,0.27499,0.24264,1,1
5,GO RESPONSE TO ACIDIC PH,0.0024367,0.27438,0.22608,1,1
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.4039e-05,0.27421,0.23436,1,1
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,4.3218e-05,0.27354,0.26045,1,1
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00049035,0.27342,0.23302,1,1
5,GO ONE CARBON COMPOUND TRANSPORT,0.00059588,0.27337,0.30106,1,1
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00019079,0.27306,0.24773,1,1
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.00098941,0.27302,0.24356,1,1
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.019283,0.27301,0.19785,1,1
5,GO TUBE MORPHOGENESIS,6.2367e-06,0.27298,0.2305,1,1
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.4421e-05,0.27282,0.29873,1,1
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0022992,0.27249,0.22537,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,3.7791e-06,0.27239,0.29139,1,1
5,GO BONE MINERALIZATION,0.00019753,0.27238,0.23341,1,1
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.00042998,0.27232,0.24711,1,1
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.0010206,0.27219,0.29399,1,1
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0028141,0.27208,0.20298,1,1
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.0015653,0.27198,0.2674,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0017641,0.27188,0.25447,1,1
5,GO OPTIC NERVE DEVELOPMENT,0.0017123,0.27141,0.3397,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00038934,0.2714,0.27794,1,1
5,GO DIENCEPHALON DEVELOPMENT,1.1964e-05,0.2714,0.29864,1,1
5,GO RESPONSE TO MECHANICAL STIMULUS,1.5201e-05,0.27125,0.25407,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.0033e-05,0.27115,0.22128,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00065623,0.2708,0.20402,1,1
5,GO GRANULOCYTE CHEMOTAXIS,0.0024367,0.27057,0.17435,1,1
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0030654,0.27051,0.17408,1,1
5,GO NEURAL CREST CELL DIFFERENTIATION,0.00055855,0.27006,0.24768,1,1
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.017137,0.27005,0.15646,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0024367,0.26994,0.324,1,1
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0023671,0.26993,0.167,1,1
5,GO LYMPHOCYTE CHEMOTAXIS,4.4878e-05,0.26993,0.24631,1,1
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0032441,0.26989,0.34932,1,1
5,GO OSTEOBLAST PROLIFERATION,0.0016129,0.26983,0.27328,1,1
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,1.4609e-05,0.26962,0.26506,1,1
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,2.7578e-07,0.2696,0.31859,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,3.1904e-06,0.26952,0.22028,1,1
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.011047,0.26952,0.16935,1,1
5,GO VITAMIN D METABOLIC PROCESS,0.0047853,0.26942,0.23366,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,3.1888e-05,0.26938,0.23955,1,1
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0027346,0.26858,0.26015,1,1
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0017641,0.26827,0.23572,1,1
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0027346,0.26802,0.24631,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0087944,0.26789,0.26449,1,1
5,GO MONOCYTE CHEMOTAXIS,0.013798,0.26768,0.18839,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,9.7801e-06,0.26768,0.2442,1,1
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,4.3218e-05,0.26748,0.24843,1,1
5,GO STRIATED MUSCLE ADAPTATION,0.00010845,0.26747,0.23927,1,1
5,GO DIGESTIVE TRACT MORPHOGENESIS,6.7596e-05,0.2674,0.26129,1,1
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0038387,0.26732,0.21595,1,1
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00055855,0.26724,0.23221,1,1
5,GO BONE MATURATION,0.00084609,0.26713,0.26709,1,1
5,GO LEYDIG CELL DIFFERENTIATION,0.011904,0.26683,0.2859,1,1
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.014138,0.26682,0.20133,1,1
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0022992,0.26656,0.18646,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00037661,0.26655,0.2198,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0041716,0.26638,0.18143,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00059588,0.26599,0.22777,1,1
5,GO RESPIRATORY BURST,0.015953,0.26595,0.196,1,1
5,GO PLATELET AGGREGATION,0.0017123,0.26572,0.21627,1,1
5,GO SKELETAL MUSCLE ADAPTATION,5.2139e-05,0.26534,0.30937,1,1
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.014138,0.26515,0.24657,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0015189,0.2651,0.21282,1,1
5,GO MULTICELLULAR ORGANISM AGING,0.0021689,0.26479,0.18638,1,1
5,GO HISTAMINE SECRETION,0.05161,0.26474,0.28754,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0011199,0.26472,0.23148,1,1
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00032948,0.26471,0.20969,1,1
5,GO RESPONSE TO WOUNDING,0.0001165,0.26398,0.21712,1,1
5,GO CELL SUBSTRATE ADHESION,9.0551e-05,0.26393,0.23939,1,1
5,GO STEROL HOMEOSTASIS,9.389e-05,0.26336,0.22277,1,1
5,GO POTASSIUM ION HOMEOSTASIS,6.4994e-06,0.26328,0.3279,1,1
5,GO NEPHRON TUBULE FORMATION,0.0036303,0.26301,0.30697,1,1
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00035231,0.26298,0.28745,1,1
5,GO RENAL SYSTEM PROCESS,4.4712e-06,0.26291,0.24807,1,1
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,3.1888e-05,0.26284,0.2779,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.0689e-05,0.26276,0.2307,1,1
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.012508,0.26268,0.15859,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.7118e-05,0.26262,0.21556,1,1
5,GO REGULATION OF HAIR CYCLE,9.7346e-05,0.26238,0.24703,1,1
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00011241,0.26237,0.22251,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.016734,0.26234,0.25465,1,1
5,GO CEREBELLAR CORTEX FORMATION,0.0014738,0.26229,0.27509,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.00036427,0.26223,0.2048,1,1
5,GO REGULATION OF TUBULIN DEACETYLATION,0.004408,0.26211,0.26201,1,1
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.00074557,0.26205,0.26949,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.0001547,0.26197,0.26408,1,1
5,GO LEUKOCYTE MIGRATION,5.2139e-05,0.26169,0.21891,1,1
5,GO BIOLOGICAL ADHESION,1.2454e-05,0.26164,0.22256,1,1
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.00045924,0.26158,0.40557,1,1
5,GO NEURON PROJECTION ARBORIZATION,0.0016129,0.26123,0.27425,1,1
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00353,0.26107,0.15368,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0045306,0.26086,0.21774,1,1
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.019283,0.26083,0.17552,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.017137,0.26072,0.21315,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0073363,0.2607,0.23603,1,1
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.001228,0.26058,0.19458,1,1
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,9.7801e-06,0.26025,0.22929,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0032441,0.26023,0.17501,1,1
5,GO INTERLEUKIN 1 PRODUCTION,0.00067758,0.26017,0.2535,1,1
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.025994,0.26017,0.22056,1,1
5,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00090094,0.25992,0.25458,1,1
5,GO REGULATION OF STEM CELL DIVISION,0.00074557,0.25987,0.24885,1,1
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.3132e-05,0.25986,0.19965,1,1
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,1.349e-05,0.25983,0.2907,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0053338,0.25978,0.20936,1,1
5,GO REGULATION OF MAST CELL ACTIVATION,0.0006154,0.25971,0.21555,1,1
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.00027832,0.2595,0.31829,1,1
5,GO DEVELOPMENTAL INDUCTION,0.00016595,0.25929,0.2648,1,1
5,GO SODIUM ION HOMEOSTASIS,0.00016595,0.25919,0.24062,1,1
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00017186,0.25917,0.33446,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,5.0226e-05,0.25887,0.20653,1,1
5,GO BLOOD VESSEL MORPHOGENESIS,5.8301e-05,0.25882,0.22042,1,1
5,GO REGULATION OF STEM CELL PROLIFERATION,0.0034322,0.25879,0.19282,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,1.8521e-05,0.25873,0.30065,1,1
5,GO MYOTUBE CELL DEVELOPMENT,0.0001547,0.25871,0.28001,1,1
5,GO REGULATION OF BIOMINERALIZATION,0.00021167,0.2583,0.21405,1,1
5,GO ECTODERM DEVELOPMENT,0.00019079,0.25828,0.22398,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,8.1192e-05,0.25813,0.19743,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001662,0.25802,0.18989,1,1
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0001165,0.25796,0.24542,1,1
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00052342,0.2579,0.24138,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.00036427,0.25789,0.24688,1,1
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0087944,0.25777,0.22919,1,1
5,GO ENSHEATHMENT OF NEURONS,1.9904e-06,0.25777,0.24437,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,4.1617e-05,0.25772,0.23101,1,1
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.012508,0.25754,0.2347,1,1
5,GO T CELL PROLIFERATION,3.7145e-05,0.25733,0.2272,1,1
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,4.6597e-05,0.25731,0.29755,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,6.5149e-05,0.25724,0.20816,1,1
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,5.9841e-06,0.25719,0.23625,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00018427,0.2571,0.22875,1,1
5,GO WATER HOMEOSTASIS,0.00063551,0.25706,0.24588,1,1
5,GO CELL CHEMOTAXIS,6.2786e-05,0.25706,0.23444,1,1
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00047456,0.25702,0.20025,1,1
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00034072,0.25697,0.28413,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0069616,0.25676,0.21874,1,1
5,GO REGULATION OF SYMBIOTIC PROCESS,0.014486,0.25672,0.15985,1,1
5,GO UROGENITAL SYSTEM DEVELOPMENT,6.2367e-06,0.25669,0.23148,1,1
5,GO MYELOID LEUKOCYTE MIGRATION,0.00012074,0.25659,0.19518,1,1
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,5.0683e-06,0.25657,0.22582,1,1
5,GO PLATELET ACTIVATION,0.00050664,0.25653,0.18907,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,1.2962e-05,0.25645,0.39045,1,1
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0028141,0.25638,0.33769,1,1
5,GO INTERFERON ALPHA PRODUCTION,0.025414,0.25638,0.21443,1,1
5,GO RESPONSE TO VIRUS,0.0039469,0.25636,0.18701,1,1
5,GO INTERLEUKIN 6 PRODUCTION,2.1663e-05,0.25629,0.21819,1,1
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.0012662,0.25619,0.26238,1,1
5,GO POSITIVE REGULATION OF CELL KILLING,0.001228,0.25617,0.20836,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,1.5816e-05,0.25588,0.23027,1,1
5,GO INNER EAR MORPHOGENESIS,7.0571e-06,0.2558,0.28565,1,1
5,GO NEGATIVE REGULATION OF GLIOGENESIS,7.9801e-06,0.2558,0.37376,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.0013872,0.25548,0.23547,1,1
5,GO ALPHA BETA T CELL ACTIVATION,0.00012964,0.25534,0.21644,1,1
5,GO REGULATION OF COLLATERAL SPROUTING,0.0010859,0.25527,0.28322,1,1
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.010245,0.25527,0.24556,1,1
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0037331,0.2552,0.20961,1,1
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,1.4039e-05,0.25459,0.32512,1,1
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0042883,0.25458,0.24265,1,1
5,GO GRANULOCYTE DIFFERENTIATION,0.0011199,0.25457,0.20571,1,1
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0014738,0.25451,0.19713,1,1
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,2.6902e-06,0.25442,0.21692,1,1
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,7.013e-05,0.25439,0.2535,1,1
5,GO APPENDAGE DEVELOPMENT,6.0504e-05,0.25426,0.21456,1,1
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00054072,0.25424,0.23326,1,1
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.034637,0.254,0.19978,1,1
5,GO FIBROBLAST PROLIFERATION,0.00037661,0.25364,0.27629,1,1
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,3.1904e-06,0.25352,0.25821,1,1
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00010845,0.25349,0.32953,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,7.9801e-06,0.25348,0.23431,1,1
5,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0001165,0.25347,0.27447,1,1
5,GO POSITIVE CHEMOTAXIS,0.00034072,0.25328,0.24411,1,1
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00010845,0.25326,0.22976,1,1
5,GO ADHERENS JUNCTION ASSEMBLY,0.00030804,0.25314,0.28321,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,7.547e-05,0.25312,0.29472,1,1
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.0032441,0.25303,0.16713,1,1
5,GO NEGATIVE CHEMOTAXIS,0.02068,0.253,0.26444,1,1
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00011241,0.25294,0.20446,1,1
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00092958,0.25288,0.28726,1,1
5,GO LYMPHOCYTE MIGRATION,0.00010845,0.25253,0.20876,1,1
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0007696,0.25252,0.32773,1,1
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,8.7323e-05,0.2525,0.28118,1,1
5,GO ASTROCYTE DEVELOPMENT,0.00044439,0.25241,0.29724,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001191,0.2524,0.20768,1,1
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0045306,0.25196,0.15577,1,1
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,3.0689e-05,0.25193,0.2312,1,1
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.04854,0.25169,0.16438,1,1
5,GO INTERFERON BETA PRODUCTION,0.012508,0.25129,0.17857,1,1
5,GO REGULATION OF CHEMOTAXIS,4.4878e-05,0.2512,0.2356,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00059588,0.25089,0.19279,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0007696,0.25079,0.20539,1,1
5,GO OUTER DYNEIN ARM ASSEMBLY,0.00038934,0.25079,0.31895,1,1
5,GO RESPONSE TO NICOTINE,0.00016595,0.25071,0.25041,1,1
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,6.2786e-05,0.25053,0.25225,1,1
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00019079,0.25044,0.22212,1,1
5,GO BIOMINERALIZATION,0.0001547,0.2503,0.21633,1,1
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0020453,0.25006,0.32353,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0025083,0.24985,0.22751,1,1
5,GO SPHINGOLIPID METABOLIC PROCESS,0.00041602,0.24985,0.18302,1,1
5,GO CARDIAC CELL DEVELOPMENT,3.8583e-05,0.24973,0.21313,1,1
5,GO IMMUNE EFFECTOR PROCESS,0.0025817,0.24969,0.17698,1,1
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,6.7596e-05,0.2496,0.26416,1,1
5,GO ALPHA BETA T CELL DIFFERENTIATION,0.0001165,0.2495,0.22566,1,1
5,GO GONADOTROPIN SECRETION,0.0030654,0.24943,0.26731,1,1
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.4609e-05,0.24936,0.2518,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.018398,0.24925,0.26693,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.8418e-05,0.24924,0.19747,1,1
5,GO DENDRITIC CELL CHEMOTAXIS,0.045624,0.24923,0.19315,1,1
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0042883,0.24913,0.27049,1,1
5,GO TISSUE REMODELING,0.0021689,0.24892,0.20592,1,1
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.036164,0.24879,0.17248,1,1
5,GO LIPOXYGENASE PATHWAY,0.017969,0.24879,0.28926,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,5.0226e-05,0.24876,0.29262,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0021062,0.24871,0.21122,1,1
5,GO LEFT RIGHT PATTERN FORMATION,0.00044439,0.24868,0.26949,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00090094,0.24858,0.22569,1,1
5,GO DRUG CATABOLIC PROCESS,0.0012662,0.24856,0.19339,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.014138,0.24852,0.18725,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0022992,0.24845,0.21958,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0042883,0.24841,0.25552,1,1
5,GO ANION HOMEOSTASIS,0.0017123,0.24835,0.18496,1,1
5,GO NEPHRON EPITHELIUM DEVELOPMENT,7.013e-05,0.24834,0.23308,1,1
5,GO MITOCHONDRIAL DEPOLARIZATION,0.017969,0.24808,0.21722,1,1
5,GO MONONUCLEAR CELL MIGRATION,0.0060989,0.24806,0.18495,1,1
5,GO EAR DEVELOPMENT,4.6623e-06,0.24798,0.27596,1,1
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.0031536,0.2478,0.38018,1,1
5,GO POSITIVE REGULATION OF CELL DIVISION,8.3127e-06,0.24777,0.24705,1,1
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00063551,0.24773,0.23637,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0060989,0.24762,0.25545,1,1
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00019079,0.24759,0.21756,1,1
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,5.9841e-06,0.24758,0.26368,1,1
5,GO TUBE DEVELOPMENT,3.7791e-06,0.24749,0.22246,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0024367,0.24732,0.2742,1,1
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00028792,0.24727,0.23665,1,1
5,GO VASCULATURE DEVELOPMENT,6.2786e-05,0.24712,0.20431,1,1
5,GO AORTA MORPHOGENESIS,0.0099891,0.24708,0.16991,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,9.7346e-05,0.24701,0.23803,1,1
5,GO MUSCLE CELL DIFFERENTIATION,2.0784e-06,0.24701,0.2245,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.019283,0.24694,0.20589,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.017137,0.24685,0.18003,1,1
5,GO NEURAL TUBE PATTERNING,0.00041602,0.24683,0.21352,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,9.0551e-05,0.24663,0.2384,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,4.1617e-05,0.24662,0.197,1,1
5,GO DRINKING BEHAVIOR,0.021165,0.24652,0.33696,1,1
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.00042998,0.24623,0.2149,1,1
5,GO ACTIN FILAMENT BASED TRANSPORT,0.0030654,0.24585,0.29212,1,1
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.013139,0.24585,0.19686,1,1
5,GO REGULATION OF BONE MINERALIZATION,0.00055855,0.24583,0.22434,1,1
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.2139e-05,0.24567,0.19607,1,1
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00016595,0.24562,0.21066,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,2.4346e-05,0.24554,0.20663,1,1
5,GO REGULATION OF B CELL ACTIVATION,0.0087944,0.24546,0.17523,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,2.7343e-05,0.24542,0.21439,1,1
5,GO WOUND HEALING,0.00030804,0.2452,0.20272,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION,0.00012074,0.2452,0.21935,1,1
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.033166,0.24503,0.27033,1,1
5,GO DNA DEMETHYLATION,0.0064317,0.245,0.17683,1,1
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.036948,0.24477,0.25723,1,1
5,GO RESPONSE TO PROGESTERONE,0.0015653,0.24469,0.23918,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0011549,0.24406,0.19978,1,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00029782,0.24405,0.20572,1,1
5,GO REGULATION OF FATTY ACID TRANSPORT,1.4039e-05,0.24399,0.2615,1,1
5,GO RESPONSE TO STEROL,0.00090094,0.24387,0.20339,1,1
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0007696,0.24364,0.21859,1,1
5,GO ACTIVATED T CELL PROLIFERATION,1.104e-05,0.2435,0.257,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.011326,0.24347,0.23253,1,1
5,GO BILE ACID AND BILE SALT TRANSPORT,0.040234,0.24345,0.12399,1,1
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.010506,0.24342,0.21655,1,1
5,GO HINDBRAIN MORPHOGENESIS,9.7346e-05,0.24324,0.223,1,1
5,GO LEUKOCYTE CELL CELL ADHESION,5.4121e-05,0.24301,0.21982,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,5.8301e-05,0.24297,0.22622,1,1
5,GO SEGMENT SPECIFICATION,0.011612,0.24292,0.28153,1,1
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0011549,0.24257,0.19597,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.1493e-05,0.24254,0.39,1,1
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0045306,0.24252,0.29881,1,1
5,GO T CELL MIGRATION,0.00055855,0.2425,0.19875,1,1
5,GO INTERLEUKIN 10 PRODUCTION,0.00012512,0.2425,0.25617,1,1
5,GO CARDIAC CONDUCTION,0.00036427,0.24239,0.25421,1,1
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.001228,0.24222,0.20659,1,1
5,GO REGULATION OF OSSIFICATION,5.2139e-05,0.24214,0.25138,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00024286,0.24192,0.25893,1,1
5,GO EPIDERMIS DEVELOPMENT,2.7343e-05,0.24191,0.28366,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.03245,0.24154,0.19697,1,1
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0085714,0.24151,0.36872,1,1
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,2.6902e-06,0.24146,0.26768,1,1
5,GO GLAND DEVELOPMENT,1.1776e-06,0.24145,0.22336,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00019753,0.24132,0.22258,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00019079,0.24118,0.18913,1,1
5,GO ORGANIC CATION TRANSPORT,0.00016595,0.24086,0.24376,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.007729,0.24077,0.36096,1,1
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.055956,0.24059,0.13567,1,1
5,GO PROTEIN KINASE B SIGNALING,4.4878e-05,0.24056,0.19693,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0014299,0.24028,0.23906,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0012662,0.24015,0.21443,1,1
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0047853,0.24011,0.13459,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0015653,0.24008,0.22234,1,1
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0036303,0.24001,0.18251,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00032948,0.23992,0.19194,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,5.7413e-06,0.23967,0.21271,1,1
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0015653,0.23953,0.2172,1,1
5,GO SMOOTH MUSCLE CONTRACTION,0.00020448,0.2394,0.19849,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00021167,0.2394,0.22446,1,1
5,GO INTERLEUKIN 8 PRODUCTION,0.023205,0.23935,0.15739,1,1
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00016023,0.23934,0.19021,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,5.508e-06,0.23926,0.20404,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,4.6623e-06,0.23907,0.21328,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,9.7801e-06,0.23897,0.22471,1,1
5,GO HEART VALVE DEVELOPMENT,0.0036303,0.23882,0.18882,1,1
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00024286,0.23865,0.25921,1,1
5,GO GRANULOCYTE MIGRATION,0.0027346,0.23848,0.1713,1,1
5,GO CELL CELL JUNCTION ASSEMBLY,0.00087311,0.23848,0.19365,1,1
5,GO PLASMINOGEN ACTIVATION,0.053746,0.23803,0.1988,1,1
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0031536,0.23789,0.21696,1,1
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0021062,0.23776,0.19058,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,1.4674e-06,0.23766,0.21769,1,1
5,GO LIPID LOCALIZATION,0.00050664,0.2376,0.15507,1,1
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,6.2786e-05,0.23758,0.22319,1,1
5,GO REGENERATION,0.00024286,0.23744,0.18965,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION,5.2139e-05,0.23742,0.18609,1,1
5,GO TUBE FORMATION,1.4609e-05,0.23718,0.20347,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,1.5201e-05,0.23715,0.21424,1,1
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0007696,0.23711,0.19645,1,1
5,GO SODIUM ION TRANSPORT,3.5759e-05,0.23703,0.20887,1,1
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00031859,0.23698,0.20595,1,1
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00026903,0.23684,0.19814,1,1
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,2.1702e-06,0.23645,0.21249,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00027832,0.23644,0.19825,1,1
5,GO RESPONSE TO FOOD,0.00018427,0.2356,0.18895,1,1
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.017137,0.23549,0.20539,1,1
5,GO RESPONSE TO RETINOIC ACID,0.00014935,0.23543,0.22095,1,1
5,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.00032948,0.23515,0.20277,1,1
5,GO THYROID HORMONE METABOLIC PROCESS,9.7346e-05,0.23506,0.25881,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00084609,0.23494,0.24105,1,1
5,GO COLLATERAL SPROUTING,0.0015189,0.23493,0.23322,1,1
5,GO SPERM CAPACITATION,2.2524e-05,0.23485,0.24049,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.010773,0.23453,0.25526,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,5.4121e-05,0.2345,0.24014,1,1
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,3.1888e-05,0.23438,0.2154,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.9532e-05,0.23436,0.20859,1,1
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0069616,0.23426,0.15037,1,1
5,GO REGULATION OF ENDOCRINE PROCESS,4.8379e-05,0.23415,0.23961,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0017123,0.23357,0.15368,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,4.4878e-05,0.23325,0.23389,1,1
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00026003,0.23321,0.25233,1,1
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.001986,0.23304,0.19773,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.004408,0.23297,0.21521,1,1
5,GO CELL MOTILITY,1.1493e-05,0.23295,0.20276,1,1
5,GO MUSCLE CELL DEVELOPMENT,1.4039e-05,0.23291,0.22325,1,1
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0041716,0.23289,0.15894,1,1
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0022992,0.23287,0.27575,1,1
5,GO REGULATION OF MEMBRANE POTENTIAL,0.00059588,0.2328,0.20218,1,1
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,4.1112e-06,0.23277,0.20537,1,1
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0057817,0.23275,0.22338,1,1
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0062634,0.23272,0.22096,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0071468,0.23252,0.40785,1,1
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.03939,0.23237,0.29816,1,1
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,5.2139e-05,0.23236,0.20361,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,2.6902e-06,0.23233,0.19761,1,1
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00018427,0.23206,0.21233,1,1
5,GO FLUID TRANSPORT,0.0094949,0.23186,0.17015,1,1
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.022165,0.23185,0.16709,1,1
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0010206,0.23182,0.18857,1,1
5,GO NEURAL TUBE FORMATION,0.00017796,0.23181,0.17649,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,9.0179e-06,0.23174,0.24103,1,1
5,GO ANIMAL ORGAN MORPHOGENESIS,3.7791e-06,0.23166,0.20551,1,1
5,GO REGULATION OF T CELL ACTIVATION,1.4609e-05,0.2315,0.23058,1,1
5,GO INTERACTION WITH HOST,0.0079323,0.23142,0.14202,1,1
5,GO REGULATION OF CELL ACTIVATION,5.6174e-05,0.23136,0.19566,1,1
5,GO POSITIVE REGULATION OF CELL ACTIVATION,9.7346e-05,0.23127,0.19533,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.00055855,0.23113,0.19561,1,1
5,GO REGULATION OF FIBROBLAST MIGRATION,0.0015189,0.23105,0.19708,1,1
5,GO FUCOSYLATION,0.0015189,0.23104,0.2057,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00065623,0.23088,0.20535,1,1
5,GO PEPTIDYL TYROSINE MODIFICATION,4.0073e-05,0.23088,0.21679,1,1
5,GO CAMP METABOLIC PROCESS,0.025994,0.23086,0.14331,1,1
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,8.6584e-06,0.23079,0.28633,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,7.013e-05,0.23074,0.34971,1,1
5,GO EAR MORPHOGENESIS,1.349e-05,0.23072,0.24732,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0079323,0.23069,0.14123,1,1
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00044439,0.23063,0.23362,1,1
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0047853,0.23046,0.23601,1,1
5,GO ENDOCRINE HORMONE SECRETION,5.9841e-06,0.23028,0.28466,1,1
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00034072,0.23021,0.20105,1,1
5,GO FOAM CELL DIFFERENTIATION,0.00050664,0.23018,0.31082,1,1
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0064317,0.23015,0.24022,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,5.508e-06,0.22988,0.25757,1,1
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.014841,0.22983,0.18812,1,1
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00021909,0.2298,0.21064,1,1
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.0032441,0.22978,0.18059,1,1
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00023468,0.22968,0.20677,1,1
5,GO TISSUE MORPHOGENESIS,7.0571e-06,0.22962,0.198,1,1
5,GO RESPONSE TO PROTOZOAN,0.036948,0.22962,0.19591,1,1
5,GO RESPONSE TO CORTICOSTEROID,0.00074557,0.22953,0.1793,1,1
5,GO REGULATION OF VASOCONSTRICTION,0.00026903,0.22938,0.19544,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00074557,0.22924,0.19854,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0011199,0.22919,0.19801,1,1
5,GO T CELL ACTIVATION,3.1888e-05,0.22899,0.21427,1,1
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,1.1964e-05,0.22888,0.19387,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00067758,0.22887,0.19708,1,1
5,GO APICAL JUNCTION ASSEMBLY,0.00021167,0.22884,0.27446,1,1
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,9.7346e-05,0.22863,0.21735,1,1
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00012074,0.22843,0.23339,1,1
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00017796,0.2284,0.18035,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,1.7806e-05,0.22818,0.19391,1,1
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0029794,0.22815,0.20613,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.015574,0.22809,0.15595,1,1
5,GO OSSIFICATION,4.6597e-05,0.22808,0.23672,1,1
5,GO SPERM AXONEME ASSEMBLY,0.00087311,0.22797,0.27612,1,1
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00013917,0.22794,0.22162,1,1
5,GO MAMMARY GLAND DEVELOPMENT,3.0689e-05,0.22792,0.20518,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,9.7346e-05,0.2274,0.22243,1,1
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0032441,0.22735,0.199,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,2.6902e-06,0.22727,0.21919,1,1
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00055855,0.22715,0.19236,1,1
5,GO SKIN DEVELOPMENT,5.6174e-05,0.22712,0.28211,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.009256,0.22708,0.17856,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.0054795,0.2269,0.17651,1,1
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0006154,0.2267,0.19331,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0019282,0.22667,0.18351,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,1.8521e-05,0.22651,0.19344,1,1
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0085714,0.2262,0.14913,1,1
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0021689,0.2261,0.20984,1,1
5,GO T CELL DIFFERENTIATION IN THYMUS,4.0073e-05,0.22594,0.20474,1,1
5,GO MYOBLAST DIFFERENTIATION,0.00020448,0.22593,0.23058,1,1
5,GO LOCALIZATION WITHIN MEMBRANE,0.00041602,0.2259,0.19233,1,1
5,GO RESPONSE TO BIOTIC STIMULUS,0.0016129,0.22583,0.15232,1,1
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0038387,0.22573,0.18239,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0046564,0.22572,0.20722,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,2.1663e-05,0.22563,0.19224,1,1
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.0073363,0.22547,0.1834,1,1
5,GO MUSCLE ORGAN MORPHOGENESIS,0.00092958,0.2254,0.18466,1,1
5,GO MYELOID LEUKOCYTE ACTIVATION,0.0037331,0.22528,0.15754,1,1
5,GO BONE MORPHOGENESIS,0.0037331,0.22524,0.18858,1,1
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,3.7145e-05,0.22521,0.19772,1,1
5,GO NOTCH SIGNALING PATHWAY,5.4121e-05,0.22498,0.20141,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.0014299,0.22498,0.19402,1,1
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.0045306,0.22491,0.29757,1,1
5,GO MUSCLE HYPERTROPHY,0.00084609,0.22488,0.17555,1,1
5,GO STARTLE RESPONSE,0.011326,0.22486,0.22762,1,1
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.018836,0.2248,0.17806,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.02068,0.22463,0.17418,1,1
5,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00010092,0.22445,0.19874,1,1
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0013457,0.22423,0.18319,1,1
5,GO POSITIVE REGULATION OF JNK CASCADE,9.3916e-06,0.22418,0.20005,1,1
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.6174e-05,0.22398,0.21633,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0069616,0.22371,0.21103,1,1
5,GO ENDOTHELIAL CELL MIGRATION,0.0022992,0.22362,0.18444,1,1
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.016339,0.22355,0.16721,1,1
5,GO DISACCHARIDE METABOLIC PROCESS,0.011047,0.22355,0.17057,1,1
5,GO ENDOCRINE PROCESS,0.00024286,0.22348,0.21471,1,1
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.021165,0.22338,0.19502,1,1
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0038387,0.22337,0.1624,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00067758,0.22308,0.21238,1,1
5,GO RESPONSE TO CADMIUM ION,0.02843,0.22293,0.14754,1,1
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0020453,0.22292,0.25337,1,1
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.00054072,0.22283,0.18169,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,7.3528e-06,0.22277,0.19784,1,1
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.001662,0.22252,0.29184,1,1
5,GO CELL AGGREGATION,0.0030654,0.22249,0.20959,1,1
5,GO CORPUS CALLOSUM DEVELOPMENT,0.0071468,0.22235,0.24151,1,1
5,GO NEPHRON DEVELOPMENT,0.0001165,0.22223,0.20369,1,1
5,GO REGULATION OF APPETITE,0.00012964,0.2221,0.25387,1,1
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00038934,0.22205,0.18075,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00026003,0.22198,0.21624,1,1
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0069616,0.22188,0.20758,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00019079,0.22185,0.23436,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.014486,0.22172,0.17144,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00026003,0.22169,0.24963,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.00035231,0.22155,0.1925,1,1
5,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.0067808,0.22144,0.18207,1,1
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0094949,0.22143,0.20962,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,7.8282e-05,0.22137,0.21433,1,1
5,GO INACTIVATION OF MAPK ACTIVITY,0.0053338,0.22134,0.23291,1,1
5,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0022992,0.22125,0.25881,1,1
5,GO CERAMIDE METABOLIC PROCESS,0.0019282,0.22115,0.16707,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0040578,0.22114,0.16119,1,1
5,GO ANIMAL ORGAN MATURATION,0.00084609,0.22086,0.24555,1,1
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.019739,0.22036,0.19717,1,1
5,GO FIBROBLAST MIGRATION,0.00067758,0.22025,0.19167,1,1
5,GO CELL ACTIVATION,0.00034072,0.22018,0.17293,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0046564,0.22016,0.26672,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,2.2524e-05,0.22014,0.19645,1,1
5,GO DEFENSE RESPONSE,0.00069957,0.22007,0.17263,1,1
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00041602,0.21986,0.17111,1,1
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0014299,0.21973,0.19965,1,1
5,GO B CELL DIFFERENTIATION,9.7346e-05,0.21961,0.17645,1,1
5,GO FEMALE GENITALIA DEVELOPMENT,0.0034322,0.21938,0.22908,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0049174,0.21931,0.21363,1,1
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00049035,0.21919,0.16846,1,1
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,4.8379e-05,0.21911,0.21301,1,1
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0083534,0.2191,0.17479,1,1
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0021062,0.21908,0.19794,1,1
5,GO MYELOID CELL HOMEOSTASIS,0.0001547,0.21902,0.17314,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0011549,0.21894,0.17064,1,1
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,2.9532e-05,0.21876,0.18012,1,1
5,GO REGULATION OF CELL SHAPE,5.4121e-05,0.21871,0.20765,1,1
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.00050664,0.21866,0.18765,1,1
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00072223,0.21866,0.22291,1,1
5,GO ROOF OF MOUTH DEVELOPMENT,0.00065623,0.21864,0.20028,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.013139,0.2185,0.16614,1,1
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0022332,0.21811,0.21586,1,1
5,GO HOMOTYPIC CELL CELL ADHESION,0.0015189,0.21808,0.22713,1,1
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0085714,0.21798,0.19078,1,1
5,GO NEURON MATURATION,0.00074557,0.21797,0.23494,1,1
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0013054,0.2178,0.20262,1,1
5,GO STEROL TRANSPORT,0.0029794,0.21778,0.15338,1,1
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.0053338,0.21773,0.15772,1,1
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0090226,0.21767,0.34076,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00036427,0.21765,0.20352,1,1
5,GO POSTSYNAPSE ORGANIZATION,0.00040247,0.21748,0.24055,1,1
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,1.0184e-05,0.21746,0.2056,1,1
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.014841,0.21728,0.23299,1,1
5,GO EMBRYONIC MORPHOGENESIS,4.2876e-06,0.21725,0.19825,1,1
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0021062,0.21719,0.20954,1,1
5,GO RESPONSE TO MUSCLE ACTIVITY,0.017137,0.21705,0.19456,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0029794,0.21702,0.30679,1,1
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.001191,0.21701,0.2241,1,1
5,GO DIOL METABOLIC PROCESS,0.020205,0.21695,0.16611,1,1
5,GO RESPONSE TO NUTRIENT,0.00037661,0.21689,0.18546,1,1
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00013917,0.21683,0.25795,1,1
5,GO HISTAMINE TRANSPORT,0.02843,0.21677,0.25772,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.00019079,0.21671,0.18762,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.0014299,0.21666,0.17778,1,1
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.0020453,0.21662,0.31247,1,1
5,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.010506,0.21662,0.20316,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,1.0604e-05,0.21659,0.2106,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00087311,0.21656,0.23904,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.045624,0.21636,0.23234,1,1
5,GO SCHWANN CELL DIFFERENTIATION,0.00020448,0.21623,0.19182,1,1
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00021167,0.21616,0.19885,1,1
5,GO AXONEME ASSEMBLY,0.00010462,0.21602,0.27037,1,1
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0056288,0.21576,0.16107,1,1
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00010845,0.21573,0.16524,1,1
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0019282,0.21571,0.17927,1,1
5,GO REGULATION OF ICOSANOID SECRETION,0.0016129,0.21552,0.19774,1,1
5,GO MUSCLE FIBER DEVELOPMENT,6.0504e-05,0.21537,0.23701,1,1
5,GO CAMERA TYPE EYE DEVELOPMENT,1.8521e-05,0.21535,0.17154,1,1
5,GO PEPTIDE SECRETION,1.4039e-05,0.21534,0.17513,1,1
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.00055855,0.21532,0.19711,1,1
5,GO ERYTHROCYTE HOMEOSTASIS,0.00023468,0.21528,0.16177,1,1
5,GO DETECTION OF MECHANICAL STIMULUS,7.9801e-06,0.21525,0.28758,1,1
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.037747,0.21521,0.17397,1,1
5,GO TERPENOID METABOLIC PROCESS,0.00013433,0.21502,0.20458,1,1
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00090094,0.21501,0.15025,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.00050664,0.21497,0.17065,1,1
5,GO EMBRYONIC ORGAN DEVELOPMENT,7.889e-07,0.21494,0.21575,1,1
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0022992,0.21488,0.19232,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0021062,0.21484,0.16568,1,1
5,GO MEMBRANE REPOLARIZATION,0.0057817,0.21407,0.21582,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.027803,0.21395,0.11859,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00049035,0.21386,0.17665,1,1
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.027803,0.21377,0.21404,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00018427,0.21359,0.25041,1,1
5,GO SUPEROXIDE METABOLIC PROCESS,0.00028792,0.21351,0.20398,1,1
5,GO NOSE DEVELOPMENT,0.0045306,0.21343,0.43211,1,1
5,GO TAXIS,2.1702e-06,0.21341,0.21794,1,1
5,GO REGULATION OF CELL MORPHOGENESIS,0.00019753,0.21337,0.18953,1,1
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,7.2754e-05,0.21324,0.21462,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.012203,0.21316,0.15483,1,1
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.013465,0.21307,0.17882,1,1
5,GO CELL KILLING,0.0016129,0.21306,0.1609,1,1
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00032948,0.21301,0.21203,1,1
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.014486,0.21296,0.19281,1,1
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.013465,0.2129,0.20393,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.00057693,0.21284,0.15598,1,1
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.012203,0.21283,0.19532,1,1
5,GO LIPID MODIFICATION,0.00031859,0.2127,0.14306,1,1
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0081404,0.2126,0.22685,1,1
5,GO REGULATION OF CHROMATIN BINDING,0.00092958,0.21251,0.20016,1,1
5,GO PROTEIN PALMITOYLATION,7.547e-05,0.21247,0.23951,1,1
5,GO SEQUESTERING OF TRIGLYCERIDE,0.016734,0.21241,0.212,1,1
5,GO CARDIAC SEPTUM DEVELOPMENT,0.019739,0.21236,0.16672,1,1
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,4.6597e-05,0.21236,0.20083,1,1
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.00087311,0.21191,0.21359,1,1
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.017549,0.21177,0.21037,1,1
5,GO REGULATION OF B CELL DIFFERENTIATION,0.0059384,0.21125,0.19049,1,1
5,GO NATURAL KILLER CELL ACTIVATION,0.0013054,0.21121,0.16848,1,1
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.040234,0.21094,0.19623,1,1
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0010206,0.21083,0.2298,1,1
5,GO TRABECULA FORMATION,0.0099891,0.21079,0.17643,1,1
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,5.6174e-05,0.21074,0.18688,1,1
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0007696,0.21072,0.18721,1,1
5,GO STEM CELL PROLIFERATION,1.1964e-05,0.21063,0.21671,1,1
5,GO SKELETAL MUSCLE CONTRACTION,0.00031859,0.21063,0.24341,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00038934,0.21063,0.17775,1,1
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0051916,0.21054,0.18459,1,1
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0038387,0.21051,0.21994,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00026003,0.2105,0.18389,1,1
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,1.1493e-05,0.21045,0.18124,1,1
5,GO EPITHELIAL TUBE FORMATION,2.0833e-05,0.21042,0.19978,1,1
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.0015653,0.21038,0.21939,1,1
5,GO PANCREAS DEVELOPMENT,0.00069957,0.21034,0.24716,1,1
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0029794,0.21018,0.18118,1,1
5,GO P38MAPK CASCADE,0.0011549,0.21013,0.198,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00023468,0.21002,0.17386,1,1
5,GO EPITHELIUM DEVELOPMENT,4.4712e-06,0.20996,0.20973,1,1
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.00067758,0.20985,0.17191,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,4.8379e-05,0.20974,0.23019,1,1
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00021909,0.20963,0.19743,1,1
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0066042,0.20959,0.16083,1,1
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0010859,0.20952,0.21321,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,2.4346e-05,0.20952,0.17797,1,1
5,GO MALE SEX DIFFERENTIATION,7.9801e-06,0.20948,0.20418,1,1
5,GO LEUKOCYTE PROLIFERATION,9.7346e-05,0.20941,0.21476,1,1
5,GO TISSUE MIGRATION,0.00079435,0.20941,0.18703,1,1
5,GO RESPONSE TO ZINC ION,0.0081404,0.20939,0.19133,1,1
5,GO REGULATION OF SYSTEM PROCESS,1.2962e-05,0.20937,0.20085,1,1
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0024367,0.20934,0.37287,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,1.1964e-05,0.20933,0.18154,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,0.00010845,0.2093,0.20304,1,1
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.018398,0.20929,0.24062,1,1
5,GO REGULATION OF CILIUM MOVEMENT,6.5149e-05,0.20926,0.20825,1,1
5,GO PHOSPHOLIPID TRANSPORT,5.6174e-05,0.20909,0.19249,1,1
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.013e-05,0.20887,0.21715,1,1
5,GO GROWTH HORMONE SECRETION,0.00090094,0.20881,0.33485,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.013e-05,0.20873,0.19039,1,1
5,GO THYMIC T CELL SELECTION,1.8521e-05,0.20868,0.22048,1,1
5,GO CELL JUNCTION ORGANIZATION,3.5759e-05,0.20832,0.2005,1,1
5,GO REGULATION OF TUBE SIZE,0.00027832,0.20831,0.16807,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0037331,0.20828,0.18022,1,1
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0010528,0.20799,0.21334,1,1
5,GO LYMPH VESSEL DEVELOPMENT,0.02166,0.20793,0.15264,1,1
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021062,0.20793,0.18241,1,1
5,GO ORGAN INDUCTION,0.0011549,0.20776,0.23518,1,1
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00050664,0.20775,0.24381,1,1
5,GO FOREBRAIN MORPHOGENESIS,0.027188,0.20769,0.17351,1,1
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.017969,0.20767,0.19041,1,1
5,GO RESPONSE TO DRUG,0.00020448,0.20761,0.16907,1,1
5,GO EYE MORPHOGENESIS,6.0504e-05,0.20759,0.18741,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001191,0.20759,0.1666,1,1
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.050569,0.20747,0.11832,1,1
5,GO PROTEIN DEMANNOSYLATION,0.02268,0.20746,0.15085,1,1
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00081984,0.20741,0.24623,1,1
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0049174,0.20721,0.21121,1,1
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0027346,0.20715,0.19153,1,1
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.4121e-05,0.2071,0.20641,1,1
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.00095906,0.20698,0.20167,1,1
5,GO REGULATION OF GLIAL CELL MIGRATION,0.0010528,0.20689,0.16784,1,1
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0019282,0.20658,0.18286,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE,0.0001165,0.20655,0.18089,1,1
5,GO INSEMINATION,0.0090226,0.20652,0.21529,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,8.4205e-05,0.20639,0.19775,1,1
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.020205,0.20636,0.16157,1,1
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.045624,0.20629,0.15981,1,1
5,GO BONE REMODELING,0.0034322,0.20624,0.22404,1,1
5,GO T CELL DIFFERENTIATION,6.0504e-05,0.20616,0.17583,1,1
5,GO REGULATION OF CELL DIFFERENTIATION,2.1702e-06,0.20606,0.18506,1,1
5,GO EMBRYONIC EYE MORPHOGENESIS,0.0037331,0.20597,0.1872,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0069616,0.20576,0.14982,1,1
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00030804,0.2057,0.17653,1,1
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.001191,0.20561,0.22563,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0066042,0.20559,0.23962,1,1
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0064317,0.20557,0.18915,1,1
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0094949,0.20526,0.16038,1,1
5,GO REGULATION OF CALCIUM ION IMPORT,0.0066042,0.20484,0.15483,1,1
5,GO REGULATION OF PEPTIDE SECRETION,1.1964e-05,0.20472,0.17338,1,1
5,GO CELL JUNCTION ASSEMBLY,6.2786e-05,0.20464,0.19499,1,1
5,GO FEMALE SEX DIFFERENTIATION,4.1617e-05,0.2046,0.19626,1,1
5,GO B CELL ACTIVATION,0.0011549,0.20455,0.16595,1,1
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.00081984,0.20419,0.20817,1,1
5,GO MOTILE CILIUM ASSEMBLY,0.027188,0.20407,0.18977,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.017137,0.20404,0.1289,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,1.5201e-05,0.20402,0.17298,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.02166,0.20363,0.15484,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0028141,0.20357,0.26419,1,1
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00014418,0.20341,0.18132,1,1
5,GO EXTRACELLULAR TRANSPORT,0.018398,0.20341,0.15488,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,0.00019079,0.20341,0.28785,1,1
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.017137,0.20336,0.19384,1,1
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.010506,0.20326,0.13475,1,1
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00027832,0.20288,0.19731,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0019282,0.20288,0.18035,1,1
5,GO CELLULAR RESPONSE TO LIPID,0.00014418,0.20287,0.16118,1,1
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.026586,0.20283,0.17762,1,1
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00023468,0.20264,0.19093,1,1
5,GO REGULATION OF BLOOD CIRCULATION,4.6597e-05,0.20252,0.22478,1,1
5,GO THYMUS DEVELOPMENT,0.0013872,0.20247,0.18974,1,1
5,GO RESPONSE TO PROSTAGLANDIN,0.007729,0.20245,0.14875,1,1
5,GO LOCOMOTORY BEHAVIOR,0.0022992,0.20235,0.19096,1,1
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00069957,0.20219,0.16406,1,1
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00063551,0.20217,0.16538,1,1
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0024367,0.20214,0.16809,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.023205,0.2021,0.13819,1,1
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.02068,0.20204,0.15773,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0045306,0.20202,0.16978,1,1
5,GO RESPONSE TO BACTERIUM,0.0010859,0.20188,0.15837,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00012512,0.20188,0.18997,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,4.4878e-05,0.20186,0.17524,1,1
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0017641,0.20168,0.22459,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0024367,0.20159,0.15383,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.0184e-05,0.20145,0.21726,1,1
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.00036427,0.2014,0.1737,1,1
5,GO INTERLEUKIN 12 PRODUCTION,0.0015653,0.2014,0.19585,1,1
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,3.7145e-05,0.2014,0.21995,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00072223,0.20134,0.17549,1,1
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0027346,0.2013,0.15061,1,1
5,GO REGULATION OF LIPID STORAGE,3.5759e-05,0.20127,0.21897,1,1
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.017549,0.20117,0.11791,1,1
5,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.036164,0.20076,0.21692,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING,2.8418e-05,0.20075,0.23005,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,1.1964e-05,0.20073,0.18756,1,1
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0034322,0.20061,0.17918,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,3.0689e-05,0.20051,0.18245,1,1
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00353,0.2005,0.16962,1,1
5,GO LYMPHOCYTE COSTIMULATION,0.00054072,0.20046,0.19457,1,1
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00021167,0.20044,0.26412,1,1
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0039469,0.20042,0.1602,1,1
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.0057817,0.20038,0.20837,1,1
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00022676,0.20037,0.25045,1,1
5,GO CHONDROCYTE DEVELOPMENT,0.00079435,0.20035,0.28394,1,1
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0059384,0.2003,0.16864,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00026903,0.20024,0.16384,1,1
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.8583e-05,0.19996,0.18431,1,1
5,GO RESPONSE TO KETONE,0.00067758,0.19991,0.15266,1,1
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00092958,0.19991,0.22647,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0047853,0.19986,0.18239,1,1
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.00067758,0.19973,0.1993,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.010506,0.19971,0.16044,1,1
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.001191,0.19959,0.16948,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.0029794,0.19953,0.15996,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0015653,0.19953,0.19663,1,1
5,GO O GLYCAN PROCESSING,0.014486,0.1994,0.23857,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.011904,0.1993,0.18539,1,1
5,GO LYMPHOCYTE ACTIVATION,5.8301e-05,0.19917,0.18157,1,1
5,GO COAGULATION,0.001872,0.19914,0.1563,1,1
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0028957,0.1991,0.1794,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00012964,0.19908,0.19776,1,1
5,GO REGULATION OF BLOOD PRESSURE,0.00023468,0.19907,0.17924,1,1
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00018427,0.19904,0.17785,1,1
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0094949,0.1989,0.15381,1,1
5,GO RESPONSE TO CYTOKINE,0.0013054,0.1989,0.15874,1,1
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0010859,0.19886,0.20645,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,5.0226e-05,0.19882,0.17736,1,1
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0012662,0.1988,0.20151,1,1
5,GO RESPONSE TO AMPHETAMINE,0.03939,0.19879,0.1667,1,1
5,GO REGULATION OF AMYLOID BETA FORMATION,0.021165,0.19876,0.23595,1,1
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.019283,0.19867,0.19406,1,1
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0071468,0.19863,0.1986,1,1
5,GO ACYLGLYCEROL HOMEOSTASIS,0.0010528,0.19855,0.20926,1,1
5,GO POSITIVE REGULATION OF SIGNALING,4.2876e-06,0.19853,0.16645,1,1
5,GO DEVELOPMENTAL MATURATION,2.3418e-05,0.19849,0.18568,1,1
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,9.0551e-05,0.19842,0.16574,1,1
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0017641,0.19818,0.27085,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.020205,0.19764,0.13632,1,1
5,GO MUSCLE STRUCTURE DEVELOPMENT,1.0184e-05,0.19764,0.18615,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,0.011612,0.19745,0.19199,1,1
5,GO CHLORIDE TRANSPORT,0.00016023,0.19736,0.17874,1,1
5,GO REGULATION OF PROTEIN MATURATION,0.0085714,0.19728,0.14314,1,1
5,GO OSTEOBLAST DIFFERENTIATION,0.00067758,0.19721,0.20363,1,1
5,GO HEART MORPHOGENESIS,0.00011241,0.1971,0.19623,1,1
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0021689,0.19709,0.20414,1,1
5,GO LIPID HOMEOSTASIS,6.5149e-05,0.19709,0.16929,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.01282,0.19698,0.1418,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.007729,0.19692,0.16572,1,1
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0030654,0.1968,0.18539,1,1
5,GO SECRETION,8.4205e-05,0.19676,0.14872,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00012964,0.19673,0.21234,1,1
5,GO REPLACEMENT OSSIFICATION,0.0039469,0.19671,0.2344,1,1
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,7.8282e-05,0.19671,0.16769,1,1
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.015574,0.19658,0.32099,1,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00026003,0.19657,0.1871,1,1
5,GO CHOLESTEROL STORAGE,0.00095906,0.19652,0.21225,1,1
5,GO AMYLOID BETA FORMATION,0.010245,0.19646,0.22757,1,1
5,GO EXOCYTOSIS,0.0011549,0.19643,0.14309,1,1
5,GO LEUKOCYTE DIFFERENTIATION,4.0073e-05,0.19642,0.17146,1,1
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0014738,0.19641,0.22389,1,1
5,GO ISOPRENOID METABOLIC PROCESS,0.00050664,0.19624,0.16663,1,1
5,GO RESPONSE TO FATTY ACID,0.0010206,0.1962,0.16805,1,1
5,GO SYNAPSE ORGANIZATION,0.00090094,0.19615,0.20198,1,1
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.00044439,0.1961,0.23779,1,1
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00018427,0.19603,0.16927,1,1
5,GO CELL GROWTH,9.0179e-06,0.19593,0.18554,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,9.0179e-06,0.19565,0.1787,1,1
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0030654,0.19551,0.18124,1,1
5,GO DEVELOPMENTAL GROWTH,4.4878e-05,0.19548,0.17485,1,1
5,GO CONNECTIVE TISSUE DEVELOPMENT,6.7596e-05,0.19538,0.18907,1,1
5,GO HEART DEVELOPMENT,5.2139e-05,0.19528,0.16769,1,1
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0083534,0.19528,0.15688,1,1
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.00018427,0.19522,0.2602,1,1
5,GO TISSUE HOMEOSTASIS,8.7323e-05,0.19509,0.1636,1,1
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.00087311,0.19502,0.17787,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,1.4039e-05,0.19502,0.21179,1,1
5,GO TUBULIN DEACETYLATION,0.0045306,0.19499,0.20765,1,1
5,GO NEURAL TUBE DEVELOPMENT,8.1192e-05,0.19499,0.18371,1,1
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.013139,0.19487,0.27202,1,1
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.050569,0.19484,0.10699,1,1
5,GO REGULATION OF TISSUE REMODELING,0.0027346,0.19467,0.20542,1,1
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.00037661,0.19454,0.19873,1,1
5,GO MUSCLE ATROPHY,0.016339,0.19446,0.17645,1,1
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00023468,0.19444,0.17875,1,1
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,7.9801e-06,0.19432,0.18864,1,1
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00052342,0.19419,0.17937,1,1
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.041093,0.19364,0.22335,1,1
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00028792,0.19362,0.1619,1,1
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0029794,0.19359,0.16991,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00025131,0.19358,0.17914,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,3.5759e-05,0.19356,0.16763,1,1
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.00045924,0.19334,0.25307,1,1
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.001662,0.19324,0.21149,1,1
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00029782,0.19315,0.18369,1,1
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.024288,0.19314,0.15812,1,1
5,GO MUSCLE ADAPTATION,0.00036427,0.19306,0.17866,1,1
5,GO SYNAPSE ASSEMBLY,0.0037331,0.193,0.20454,1,1
5,GO INFLAMMATORY RESPONSE,0.00017796,0.19298,0.1881,1,1
5,GO REGULATION OF DEVELOPMENTAL GROWTH,8.1192e-05,0.19293,0.18746,1,1
5,GO SCHWANN CELL DEVELOPMENT,0.00072223,0.19292,0.17757,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,7.2754e-05,0.19286,0.19098,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00036427,0.19235,0.16305,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,0.0025817,0.19232,0.13496,1,1
5,GO SENSORY ORGAN DEVELOPMENT,3.6228e-06,0.19217,0.20961,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.001662,0.19211,0.1592,1,1
5,GO REGULATION OF PROTEIN DEACETYLATION,0.00017796,0.192,0.17122,1,1
5,GO STRESS FIBER ASSEMBLY,0.00040247,0.19199,0.18937,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.00069957,0.19198,0.22464,1,1
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0094949,0.19193,0.14531,1,1
5,GO MITOTIC CELL CYCLE ARREST,0.0054795,0.19187,0.19518,1,1
5,GO DETECTION OF ABIOTIC STIMULUS,9.7801e-06,0.19161,0.20356,1,1
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.02166,0.19142,0.21516,1,1
5,GO REGULATION OF LIPID TRANSPORT,8.4205e-05,0.1913,0.17517,1,1
5,GO RESPONSE TO GROWTH FACTOR,4.8379e-05,0.19103,0.17961,1,1
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00022676,0.19102,0.16913,1,1
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00037661,0.1909,0.2752,1,1
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0022332,0.19087,0.14079,1,1
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0010859,0.1906,0.13511,1,1
5,GO GANGLIOSIDE METABOLIC PROCESS,0.015953,0.19043,0.12891,1,1
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0015653,0.19031,0.2175,1,1
5,GO GROWTH,3.1904e-06,0.19029,0.17506,1,1
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0010859,0.19026,0.20337,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.0053338,0.19021,0.20674,1,1
5,GO PROTEIN POLYGLUTAMYLATION,0.0016129,0.19014,0.20579,1,1
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.023205,0.19012,0.14525,1,1
5,GO CARDIAC CHAMBER DEVELOPMENT,0.0071468,0.19006,0.14137,1,1
5,GO HORMONE TRANSPORT,3.8583e-05,0.18997,0.19401,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00037661,0.18988,0.15724,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.011904,0.18986,0.11828,1,1
5,GO LIPID EXPORT FROM CELL,0.0047853,0.18985,0.13899,1,1
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.001986,0.18968,0.2197,1,1
5,GO POSITIVE REGULATION OF SECRETION,5.2139e-05,0.18967,0.16833,1,1
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.00037661,0.18963,0.18102,1,1
5,GO SENSORY ORGAN MORPHOGENESIS,6.7728e-06,0.18962,0.20613,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0006154,0.18956,0.16341,1,1
5,GO CYTOKINE PRODUCTION,0.00095906,0.18951,0.17515,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.9532e-05,0.1895,0.18311,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.8379e-05,0.18948,0.15152,1,1
5,GO PHOSPHOLIPID HOMEOSTASIS,0.036948,0.18945,0.14271,1,1
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.013798,0.18938,0.16652,1,1
5,GO REGULATION OF DEFENSE RESPONSE,0.0025083,0.18936,0.13148,1,1
5,GO PROTEIN PROCESSING,0.0034322,0.18936,0.14196,1,1
5,GO POSITIVE T CELL SELECTION,0.00041602,0.18925,0.16203,1,1
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00017186,0.18923,0.15982,1,1
5,GO SENSORY SYSTEM DEVELOPMENT,5.8301e-05,0.18922,0.17136,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,1.8521e-05,0.18914,0.1745,1,1
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0060989,0.18908,0.18394,1,1
5,GO REGULATION OF HORMONE SECRETION,4.8379e-05,0.18905,0.18547,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.9263e-05,0.18903,0.176,1,1
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00059588,0.18893,0.16471,1,1
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0038387,0.18883,0.17313,1,1
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,3.4421e-05,0.18857,0.19178,1,1
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00019079,0.18838,0.20551,1,1
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.042857,0.18824,0.1101,1,1
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0024367,0.18821,0.18682,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,2.7343e-05,0.18791,0.18138,1,1
5,GO POSITIVE THYMIC T CELL SELECTION,0.00014418,0.18788,0.29832,1,1
5,GO HEART PROCESS,4.4878e-05,0.18783,0.22561,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.0083534,0.18781,0.15332,1,1
5,GO LYMPHOCYTE DIFFERENTIATION,3.3132e-05,0.18751,0.16921,1,1
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0022992,0.18745,0.12328,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0028141,0.18744,0.20718,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,2.4346e-05,0.18743,0.23886,1,1
5,GO REGULATION OF AXONOGENESIS,0.0060989,0.18696,0.20232,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,2.2524e-05,0.18688,0.20207,1,1
5,GO REGULATION OF PHOSPHORYLATION,2.8418e-05,0.18687,0.15636,1,1
5,GO POST ANAL TAIL MORPHOGENESIS,0.025414,0.18677,0.16102,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY,2.6307e-05,0.18675,0.16629,1,1
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00063551,0.18666,0.23303,1,1
5,GO KERATINOCYTE DIFFERENTIATION,0.00069957,0.18661,0.28895,1,1
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.033166,0.18647,0.12047,1,1
5,GO T CELL APOPTOTIC PROCESS,0.013465,0.18643,0.14838,1,1
5,GO SPINAL CORD DEVELOPMENT,0.0046564,0.18641,0.19384,1,1
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.00032948,0.1863,0.1841,1,1
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00079435,0.18625,0.15648,1,1
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0024367,0.18621,0.21037,1,1
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.027803,0.18613,0.16663,1,1
5,GO RESPONSE TO CATECHOLAMINE,0.0029794,0.18587,0.15709,1,1
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0087944,0.18584,0.21675,1,1
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00057693,0.18579,0.18442,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.014841,0.18564,0.15906,1,1
5,GO DEVELOPMENTAL CELL GROWTH,0.0016129,0.18545,0.18914,1,1
5,GO ARTERY MORPHOGENESIS,0.007729,0.18543,0.12153,1,1
5,GO SKELETAL SYSTEM DEVELOPMENT,0.00010462,0.1854,0.15613,1,1
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.031059,0.18532,0.20279,1,1
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,7.547e-05,0.18526,0.1807,1,1
5,GO ALANINE TRANSPORT,0.04854,0.1852,0.11555,1,1
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,2.7343e-05,0.18518,0.16213,1,1
5,GO RESPONSE TO INTERLEUKIN 6,0.0029794,0.18511,0.15486,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,7.013e-05,0.1851,0.15643,1,1
5,GO MAINTENANCE OF CELL NUMBER,0.00090094,0.18494,0.12725,1,1
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.0079323,0.1848,0.20545,1,1
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0067808,0.18468,0.21883,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.7806e-05,0.18467,0.15242,1,1
5,GO CELL MATURATION,9.3916e-06,0.18464,0.18074,1,1
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0029794,0.18462,0.18177,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0038387,0.18454,0.15165,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,0.00090094,0.18442,0.12888,1,1
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00027832,0.18433,0.2151,1,1
5,GO SULFATION,0.0066042,0.18426,0.15236,1,1
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,1.5816e-05,0.1842,0.16677,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,2.7343e-05,0.1842,0.17719,1,1
5,GO TRANSLESION SYNTHESIS,0.0019282,0.18412,0.14891,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00017796,0.1839,0.15154,1,1
5,GO INTEGRIN ACTIVATION,0.041967,0.18389,0.15189,1,1
5,GO HUMORAL IMMUNE RESPONSE,3.1888e-05,0.18377,0.24261,1,1
5,GO NEGATIVE REGULATION OF GROWTH,1.1493e-05,0.18368,0.19181,1,1
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0042883,0.18363,0.18913,1,1
5,GO CELLULAR RESPONSE TO FATTY ACID,0.00095906,0.18355,0.18787,1,1
5,GO REGULATION OF LIPID LOCALIZATION,0.00013433,0.18344,0.17461,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00027832,0.18341,0.14114,1,1
5,GO ACTION POTENTIAL,0.0085714,0.18337,0.17839,1,1
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.023741,0.18335,0.11803,1,1
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.00084609,0.18329,0.16718,1,1
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.00057693,0.18328,0.17151,1,1
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.015574,0.18323,0.19029,1,1
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00010462,0.18322,0.23503,1,1
5,GO REGULATION OF CILIUM BEAT FREQUENCY,0.011612,0.18322,0.1757,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.023205,0.18319,0.17048,1,1
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.00065623,0.183,0.14676,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00098941,0.18297,0.2278,1,1
5,GO CHONDROCYTE PROLIFERATION,0.02068,0.18295,0.17329,1,1
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00042998,0.18272,0.15673,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0041716,0.18271,0.28045,1,1
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0015653,0.1827,0.15989,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.024288,0.18267,0.15913,1,1
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.00044439,0.18254,0.18672,1,1
5,GO RESPONSE TO DOPAMINE,0.00098941,0.18251,0.18508,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,7.8282e-05,0.18249,0.15393,1,1
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.024846,0.18222,0.14725,1,1
5,GO DEFENSE RESPONSE TO BACTERIUM,0.00019753,0.18207,0.19268,1,1
5,GO NEURAL RETINA DEVELOPMENT,0.045624,0.18204,0.13451,1,1
5,GO RESPONSE TO ESTRADIOL,9.7346e-05,0.18203,0.17204,1,1
5,GO NEGATIVE T CELL SELECTION,0.010245,0.18198,0.21593,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0079323,0.18194,0.18006,1,1
5,GO REGULATION OF PROTEOLYSIS,0.0012662,0.18193,0.14795,1,1
5,GO ACUTE PHASE RESPONSE,0.0013054,0.18187,0.15137,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0032441,0.18175,0.18699,1,1
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0042883,0.18169,0.27446,1,1
5,GO AMMONIUM ION METABOLIC PROCESS,0.03939,0.18164,0.17788,1,1
5,GO SPROUTING ANGIOGENESIS,0.0021689,0.18161,0.15706,1,1
5,GO NEUROINFLAMMATORY RESPONSE,0.014841,0.18157,0.15609,1,1
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.0022992,0.18151,0.18813,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.9532e-05,0.18144,0.16493,1,1
5,GO CYTOKINE SECRETION,0.001191,0.18136,0.18242,1,1
5,GO REGULATION OF MAPK CASCADE,2.1663e-05,0.18136,0.20757,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00037661,0.18126,0.1373,1,1
5,GO NEUTROPHIL MIGRATION,0.0033369,0.18102,0.12229,1,1
5,GO REGIONALIZATION,0.00010462,0.18087,0.17911,1,1
5,GO RESPONSE TO STEROID HORMONE,9.7346e-05,0.18085,0.17613,1,1
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.01282,0.18079,0.15674,1,1
5,GO PLASMA MEMBRANE ORGANIZATION,0.00098941,0.18074,0.18993,1,1
5,GO RESPONSE TO IRON ION,0.015574,0.18074,0.17554,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0087944,0.18055,0.1202,1,1
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.043763,0.18049,0.12862,1,1
5,GO CELL MORPHOGENESIS,0.00017186,0.18032,0.17475,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,3.1888e-05,0.18025,0.15946,1,1
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00013917,0.18019,0.16311,1,1
5,GO CELLULAR EXTRAVASATION,0.0023671,0.18013,0.14696,1,1
5,GO LIPID METABOLIC PROCESS,0.00092958,0.18009,0.13055,1,1
5,GO NEURON APOPTOTIC PROCESS,1.0604e-05,0.18008,0.15886,1,1
5,GO RESPONSE TO FUNGUS,0.00030804,0.17997,0.23555,1,1
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0083534,0.1799,0.23791,1,1
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.00019079,0.17967,0.15695,1,1
5,GO ANIMAL ORGAN FORMATION,0.0033369,0.17966,0.16682,1,1
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.043763,0.1795,0.11701,1,1
5,GO RESPONSE TO LIPID,0.00016595,0.17948,0.15969,1,1
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.00010845,0.17943,0.21535,1,1
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.05161,0.1794,0.10346,1,1
5,GO MONOAMINE TRANSPORT,0.010245,0.17931,0.25001,1,1
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.02843,0.17923,0.15393,1,1
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0006154,0.17909,0.18925,1,1
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.011904,0.17906,0.13229,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00072223,0.17899,0.24215,1,1
5,GO CELL CELL SIGNALING BY WNT,2.2524e-05,0.17879,0.15846,1,1
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.00067758,0.17867,0.16026,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,2.9532e-05,0.17837,0.21021,1,1
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,3.7145e-05,0.17829,0.15232,1,1
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.02068,0.17824,0.18425,1,1
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00036427,0.17808,0.17303,1,1
5,GO PROTEIN DEMETHYLATION,0.017969,0.17803,0.13897,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00010845,0.17784,0.19353,1,1
5,GO AUTOPHAGY OF NUCLEUS,0.02068,0.17765,0.14421,1,1
5,GO REGULATION OF HEMOPOIESIS,0.00016595,0.17757,0.15564,1,1
5,GO NEUROBLAST PROLIFERATION,2.8418e-05,0.17756,0.25869,1,1
5,GO GLYCOSYLATION,0.0059384,0.17752,0.15785,1,1
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0067808,0.17747,0.15689,1,1
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00010462,0.17745,0.19125,1,1
5,GO PEPTIDE HORMONE SECRETION,0.00022676,0.17733,0.18852,1,1
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,1.5331e-06,0.17726,0.16996,1,1
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,6.5149e-05,0.17716,0.18873,1,1
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.036948,0.17701,0.14686,1,1
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.013465,0.17686,0.21262,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.9263e-05,0.17686,0.1548,1,1
5,GO INORGANIC ANION TRANSPORT,0.00030804,0.17679,0.15309,1,1
5,GO ERBB SIGNALING PATHWAY,0.001228,0.17671,0.17004,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,1.0184e-05,0.17666,0.15721,1,1
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0010859,0.17663,0.18079,1,1
5,GO REGULATION OF NEURON DIFFERENTIATION,0.00030804,0.1765,0.19861,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00092958,0.17643,0.15713,1,1
5,GO CELL CELL SIGNALING,1.4609e-05,0.17634,0.16857,1,1
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.5201e-05,0.17626,0.2059,1,1
5,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.043763,0.17625,0.14828,1,1
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,2.4346e-05,0.17618,0.16461,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,5.4121e-05,0.17618,0.14792,1,1
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00014935,0.17615,0.1638,1,1
5,GO HINDBRAIN DEVELOPMENT,3.4421e-05,0.17603,0.22758,1,1
5,GO STEROL METABOLIC PROCESS,0.016734,0.17595,0.12846,1,1
5,GO RELAXATION OF MUSCLE,0.050569,0.17588,0.15892,1,1
5,GO DIET INDUCED THERMOGENESIS,0.01282,0.17586,0.16566,1,1
5,GO MYELOID CELL DIFFERENTIATION,0.00023468,0.17581,0.1423,1,1
5,GO REGULATION OF HORMONE LEVELS,1.7806e-05,0.17564,0.17387,1,1
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.031748,0.17556,0.16833,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.007729,0.17547,0.18383,1,1
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0033369,0.1754,0.17281,1,1
5,GO REGULATION OF ANION TRANSPORT,0.0059384,0.17536,0.12417,1,1
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,9.0551e-05,0.17534,0.16213,1,1
5,GO CANONICAL WNT SIGNALING PATHWAY,3.0689e-05,0.17531,0.17236,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00045924,0.17528,0.17737,1,1
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0033369,0.17516,0.14466,1,1
5,GO NEGATIVE REGULATION OF SIGNALING,1.1964e-05,0.17514,0.15809,1,1
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0094949,0.17511,0.13028,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.019739,0.17506,0.12179,1,1
5,GO MUSCLE ORGAN DEVELOPMENT,9.0551e-05,0.17494,0.14231,1,1
5,GO APOPTOTIC SIGNALING PATHWAY,0.0010206,0.17493,0.12507,1,1
5,GO SECRETION BY TISSUE,0.025994,0.17478,0.15638,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,2.4346e-05,0.17473,0.17641,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0057817,0.17467,0.25401,1,1
5,GO REPRODUCTION,1.8251e-06,0.17466,0.1561,1,1
5,GO INTERMEMBRANE LIPID TRANSFER,0.011047,0.17462,0.10747,1,1
5,GO MULTICELLULAR ORGANISM GROWTH,7.9801e-06,0.17457,0.16896,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.014841,0.17441,0.17566,1,1
5,GO DORSAL VENTRAL PATTERN FORMATION,0.00081984,0.1744,0.20157,1,1
5,GO REGULATION OF ION TRANSPORT,0.00031859,0.17437,0.15685,1,1
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0019282,0.17406,0.18123,1,1
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,2.4346e-05,0.17401,0.16824,1,1
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.04854,0.17395,0.16242,1,1
5,GO REGULATION OF HEART RATE,0.010245,0.17382,0.16828,1,1
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.022165,0.17367,0.17247,1,1
5,GO RESPONSE TO ACID CHEMICAL,0.00014418,0.17363,0.17487,1,1
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00029782,0.17361,0.1641,1,1
5,GO SARCOMERE ORGANIZATION,0.00027832,0.17352,0.20632,1,1
5,GO CHEMICAL HOMEOSTASIS,1.9263e-05,0.17343,0.15487,1,1
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00038934,0.17337,0.15383,1,1
5,GO BEHAVIOR,0.00045924,0.17327,0.16419,1,1
5,GO POSITIVE REGULATION OF CELL DEATH,5.2139e-05,0.17327,0.15637,1,1
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0033369,0.17324,0.17059,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0021689,0.17322,0.16328,1,1
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00031859,0.173,0.19635,1,1
5,GO FOREGUT MORPHOGENESIS,0.015574,0.17293,0.20493,1,1
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.017969,0.17288,0.15798,1,1
5,GO CIRCULATORY SYSTEM PROCESS,3.4421e-05,0.17266,0.18285,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,2.5308e-05,0.17259,0.1477,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0094949,0.17246,0.13396,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.036948,0.17239,0.15418,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.010773,0.17234,0.16789,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,1.7474e-06,0.17231,0.17497,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00092958,0.17213,0.11711,1,1
5,GO REGULATION OF SECRETION,3.7145e-05,0.17211,0.16167,1,1
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014418,0.17211,0.20788,1,1
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,1.0184e-05,0.17208,0.15334,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,2.6307e-05,0.17206,0.14505,1,1
5,GO EXCRETION,0.00020448,0.17204,0.17694,1,1
5,GO CHOLESTEROL EFFLUX,0.00054072,0.17201,0.16026,1,1
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00063551,0.17193,0.15815,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.010773,0.1719,0.13474,1,1
5,GO ION HOMEOSTASIS,0.0001547,0.1717,0.13661,1,1
5,GO EATING BEHAVIOR,0.00084609,0.17166,0.19791,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,1.349e-05,0.17151,0.17206,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,3.0689e-05,0.1715,0.17898,1,1
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00026003,0.17125,0.17595,1,1
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00028792,0.17094,0.16884,1,1
5,GO EMBRYO DEVELOPMENT,1.4039e-05,0.17087,0.14941,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.049546,0.17085,0.12636,1,1
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00030804,0.1708,0.18387,1,1
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0017123,0.17077,0.19615,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.023205,0.17064,0.18646,1,1
5,GO DENDRITIC SPINE MAINTENANCE,0.013465,0.17063,0.17551,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0087944,0.17058,0.14307,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00065623,0.17041,0.11545,1,1
5,GO FACE DEVELOPMENT,0.0060989,0.17035,0.16271,1,1
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,9.7346e-05,0.17032,0.15693,1,1
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.00035231,0.17026,0.14488,1,1
5,GO WATER TRANSPORT,0.0085714,0.17024,0.17324,1,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00067758,0.17023,0.19082,1,1
5,GO TUMOR NECROSIS FACTOR SECRETION,0.0019282,0.17015,0.1423,1,1
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.001191,0.16992,0.18586,1,1
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0075304,0.1697,0.14062,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00041602,0.16968,0.18315,1,1
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0013054,0.16948,0.15908,1,1
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.010506,0.16948,0.13453,1,1
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00040247,0.16946,0.20566,1,1
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.052669,0.16924,0.10491,1,1
5,GO IMPORT INTO CELL,0.0010206,0.16918,0.16453,1,1
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0079323,0.16904,0.13688,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.018398,0.169,0.26822,1,1
5,GO REGULATION OF REPRODUCTIVE PROCESS,1.6455e-05,0.16897,0.1477,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,7.013e-05,0.16881,0.14588,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,6.0504e-05,0.16877,0.14866,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,2.0033e-05,0.16863,0.15935,1,1
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.035393,0.16854,0.17127,1,1
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0066042,0.16849,0.1433,1,1
5,GO JNK CASCADE,1.349e-05,0.16844,0.16941,1,1
5,GO NEGATIVE REGULATION OF BINDING,3.3132e-05,0.16841,0.15864,1,1
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.0097392,0.16813,0.19085,1,1
5,GO CALCIUM MEDIATED SIGNALING,3.3132e-05,0.16794,0.16638,1,1
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0022332,0.16791,0.1976,1,1
5,GO REGULATION OF GROWTH,1.9904e-06,0.16781,0.17739,1,1
5,GO VACUOLAR TRANSPORT,0.0075304,0.16764,0.10428,1,1
5,GO ESTABLISHMENT OF CELL POLARITY,0.0012662,0.16749,0.13006,1,1
5,GO RESPONSE TO CORTICOSTERONE,0.054842,0.16749,0.14473,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.022165,0.1674,0.14635,1,1
5,GO MESODERM DEVELOPMENT,0.00010462,0.16735,0.16739,1,1
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.014138,0.16712,0.16393,1,1
5,GO POSITIVE REGULATION OF MAPK CASCADE,4.0073e-05,0.167,0.20969,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00010092,0.16686,0.18111,1,1
5,GO CARDIOCYTE DIFFERENTIATION,0.0024367,0.16679,0.1429,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.031748,0.16676,0.12738,1,1
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.00072223,0.16669,0.14521,1,1
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.011326,0.16664,0.28917,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00014418,0.16646,0.15124,1,1
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0006154,0.16639,0.14985,1,1
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.011904,0.16632,0.14346,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.047551,0.16632,0.15653,1,1
5,GO ANATOMICAL STRUCTURE MATURATION,1.4039e-05,0.16607,0.16169,1,1
5,GO SENSORY PERCEPTION OF PAIN,0.0031536,0.16605,0.15312,1,1
5,GO CARTILAGE DEVELOPMENT,0.00063551,0.16579,0.16645,1,1
5,GO HORMONE MEDIATED SIGNALING PATHWAY,1.5816e-05,0.16575,0.1544,1,1
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0036303,0.16575,0.13935,1,1
5,GO METENCEPHALON DEVELOPMENT,0.0017641,0.16562,0.21066,1,1
5,GO NEURAL PRECURSOR CELL PROLIFERATION,1.104e-05,0.16535,0.2178,1,1
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00072223,0.16533,0.1569,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00021909,0.16521,0.204,1,1
5,GO IMMUNE SYSTEM DEVELOPMENT,8.1192e-05,0.16521,0.13794,1,1
5,GO REGULATION OF CELL DEVELOPMENT,8.7323e-05,0.16517,0.18043,1,1
5,GO HOMEOSTATIC PROCESS,9.0551e-05,0.16516,0.12293,1,1
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.00012074,0.16513,0.17451,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0022992,0.16505,0.1734,1,1
5,GO REGULATION OF IMMUNE RESPONSE,0.0028957,0.1648,0.1428,1,1
5,GO CELL VOLUME HOMEOSTASIS,8.7323e-05,0.1647,0.16053,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.045624,0.16446,0.14407,1,1
5,GO RESPONSE TO COPPER ION,0.055956,0.16435,0.19055,1,1
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0064317,0.16434,0.21452,1,1
5,GO RESPONSE TO CALCIUM ION,0.0041716,0.16408,0.14723,1,1
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0024367,0.16397,0.11903,1,1
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.00063551,0.16392,0.17938,1,1
5,GO MUSCLE TISSUE DEVELOPMENT,4.1617e-05,0.16375,0.15051,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,0.00021167,0.16374,0.12538,1,1
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,4.4878e-05,0.16348,0.15419,1,1
5,GO RECEPTOR METABOLIC PROCESS,9.0551e-05,0.16335,0.1601,1,1
5,GO FOREBRAIN CELL MIGRATION,0.029068,0.1632,0.14796,1,1
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.022165,0.16314,0.13096,1,1
5,GO INTERFERON GAMMA PRODUCTION,0.0073363,0.16301,0.12347,1,1
5,GO ACTIVATION OF GTPASE ACTIVITY,0.00050664,0.16273,0.13261,1,1
5,GO T CELL SELECTION,0.0006154,0.16268,0.14656,1,1
5,GO MICROTUBULE SEVERING,0.011047,0.16266,0.16473,1,1
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00035231,0.16266,0.1706,1,1
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.001872,0.16238,0.13166,1,1
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.034637,0.16227,0.13981,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0085714,0.16226,0.090097,1,1
5,GO METAL ION TRANSPORT,0.00019753,0.16224,0.14459,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.016734,0.16222,0.14365,1,1
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00092958,0.16213,0.21429,1,1
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0062634,0.16201,0.17385,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00052342,0.16175,0.15438,1,1
5,GO RESPONSE TO METAL ION,0.00034072,0.16169,0.15255,1,1
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.001872,0.16154,0.15673,1,1
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,6.2786e-05,0.16152,0.14965,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00095906,0.16147,0.13305,1,1
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,4.8379e-05,0.16115,0.14843,1,1
5,GO RETINA HOMEOSTASIS,0.00022676,0.16079,0.14443,1,1
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.024288,0.16061,0.1681,1,1
5,GO BONE DEVELOPMENT,0.00353,0.16058,0.13649,1,1
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.038561,0.16054,0.18456,1,1
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.01282,0.16047,0.13508,1,1
5,GO REGULATION OF ATP METABOLIC PROCESS,0.0056288,0.16031,0.10982,1,1
5,GO EMBRYONIC ORGAN MORPHOGENESIS,1.4039e-05,0.15998,0.1958,1,1
5,GO DETECTION OF STIMULUS,4.0073e-05,0.15991,0.13992,1,1
5,GO REGULATION OF TRANSPORT,5.6174e-05,0.15975,0.13581,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00013917,0.15972,0.15066,1,1
5,GO POTASSIUM ION TRANSPORT,0.00067758,0.15963,0.20082,1,1
5,GO RESPONSE TO HORMONE,0.00027832,0.15957,0.13342,1,1
5,GO FEEDING BEHAVIOR,0.00353,0.15942,0.13923,1,1
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0014299,0.15929,0.17261,1,1
5,GO RESPONSE TO STARVATION,6.2786e-05,0.15918,0.16301,1,1
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.040234,0.15916,0.17463,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,3.0689e-05,0.15914,0.17144,1,1
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.050569,0.15912,0.16278,1,1
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,6.2786e-05,0.15902,0.16168,1,1
5,GO NEGATIVE REGULATION OF CELL GROWTH,6.7596e-05,0.15902,0.17255,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.2876e-06,0.15893,0.16283,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0019282,0.15892,0.25075,1,1
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00069957,0.15887,0.13977,1,1
5,GO REGULATION OF INSULIN SECRETION,0.00087311,0.15883,0.16531,1,1
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0054795,0.15877,0.12045,1,1
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0081404,0.15876,0.14305,1,1
5,GO AMINE CATABOLIC PROCESS,0.013465,0.15864,0.18093,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.053746,0.15863,0.085198,1,1
5,GO POSITIVE REGULATION OF GROWTH,5.2837e-06,0.1586,0.16611,1,1
5,GO ACTIN FILAMENT BASED MOVEMENT,0.00036427,0.15852,0.17873,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,5.8301e-05,0.15847,0.15921,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.018836,0.15843,0.14567,1,1
5,GO LIPID OXIDATION,0.0021689,0.15839,0.16606,1,1
5,GO METAL ION HOMEOSTASIS,0.00012512,0.15832,0.14345,1,1
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,3.7145e-05,0.1582,0.17914,1,1
5,GO STEROID METABOLIC PROCESS,0.0030654,0.15816,0.1429,1,1
5,GO LYSOSOME LOCALIZATION,0.0031536,0.15809,0.12061,1,1
5,GO OSTEOCLAST DIFFERENTIATION,0.0011199,0.15805,0.13774,1,1
5,GO NEGATIVE REGULATION OF NEURON DEATH,2.5308e-05,0.15789,0.14929,1,1
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0087944,0.15747,0.1153,1,1
5,GO B CELL APOPTOTIC PROCESS,0.031748,0.15742,0.2161,1,1
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,7.547e-05,0.1574,0.16079,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00095906,0.15715,0.18272,1,1
5,GO SLEEP,0.00353,0.15709,0.13987,1,1
5,GO AUTOPHAGIC CELL DEATH,0.001872,0.15699,0.21804,1,1
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,4.6597e-05,0.15672,0.16794,1,1
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0010528,0.15671,0.17314,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00090094,0.1566,0.15542,1,1
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.054842,0.15648,0.087396,1,1
5,GO REGULATION OF GLUCOSE IMPORT,0.0027346,0.15615,0.14917,1,1
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.0015653,0.15615,0.19955,1,1
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,2.3418e-05,0.15604,0.13513,1,1
5,GO GLUCOSE IMPORT,0.0015653,0.15603,0.13637,1,1
5,GO CELLULAR RESPONSE TO STARVATION,3.4421e-05,0.15595,0.17175,1,1
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.0019282,0.15593,0.15491,1,1
5,GO NERVOUS SYSTEM PROCESS,0.00019079,0.15592,0.14756,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00063551,0.15588,0.11506,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.038561,0.15576,0.11174,1,1
5,GO FEAR RESPONSE,0.052669,0.15555,0.095152,1,1
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.036948,0.15553,0.11584,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.011904,0.15549,0.11181,1,1
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.016734,0.15535,0.132,1,1
5,GO RESPONSE TO AMYLOID BETA,0.010773,0.15522,0.15231,1,1
5,GO LEUKOCYTE HOMEOSTASIS,0.02166,0.15511,0.12644,1,1
5,GO ERK1 AND ERK2 CASCADE,0.00024286,0.15511,0.22985,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00019079,0.15502,0.13393,1,1
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.030383,0.15493,0.1422,1,1
5,GO RESPONSE TO INSULIN,0.0006154,0.15485,0.12093,1,1
5,GO RESPONSE TO OXYGEN LEVELS,0.00019753,0.15483,0.15631,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.0047853,0.15478,0.12273,1,1
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00040247,0.15465,0.17065,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,2.4346e-05,0.15465,0.13679,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.15454,0.14073,1,1
5,GO EXPLORATION BEHAVIOR,0.02166,0.1545,0.21154,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0001165,0.15413,0.15167,1,1
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.00054072,0.15409,0.15625,1,1
5,GO SINGLE FERTILIZATION,0.00037661,0.154,0.13326,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,7.2754e-05,0.15394,0.14651,1,1
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.004408,0.15366,0.18512,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.011904,0.1536,0.11418,1,1
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.017137,0.15357,0.15235,1,1
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.017549,0.15346,0.16347,1,1
5,GO RESPONSE TO GROWTH HORMONE,0.050569,0.15337,0.14419,1,1
5,GO HEAD MORPHOGENESIS,0.0057817,0.15322,0.17788,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,2.7343e-05,0.15316,0.15878,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.00098941,0.15313,0.2034,1,1
5,GO MUSCLE SYSTEM PROCESS,0.00010092,0.153,0.1572,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,0.014486,0.15278,0.17433,1,1
5,GO HORMONE METABOLIC PROCESS,0.00050664,0.15274,0.13668,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.001191,0.15265,0.16704,1,1
5,GO TEMPERATURE HOMEOSTASIS,8.7323e-05,0.15249,0.16102,1,1
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0022332,0.15246,0.15451,1,1
5,GO CILIUM MOVEMENT,0.00012512,0.15244,0.16996,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.00017796,0.15237,0.1144,1,1
5,GO SPERM MOTILITY,5.4121e-05,0.1523,0.16222,1,1
5,GO RECEPTOR INTERNALIZATION,0.0022992,0.15215,0.14796,1,1
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0029794,0.15203,0.14114,1,1
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.026586,0.15189,0.12822,1,1
5,GO REGULATION OF CELL FATE COMMITMENT,0.0073363,0.15188,0.18539,1,1
5,GO FOREBRAIN DEVELOPMENT,0.00065623,0.1514,0.18935,1,1
5,GO SENSORY PERCEPTION,7.547e-05,0.15126,0.14365,1,1
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.023205,0.15118,0.15339,1,1
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.0079323,0.15114,0.10369,1,1
5,GO CATION TRANSPORT,0.00050664,0.15111,0.13336,1,1
5,GO LIPID CATABOLIC PROCESS,0.0041716,0.15107,0.1227,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00029782,0.15095,0.15785,1,1
5,GO CATION TRANSMEMBRANE TRANSPORT,0.0010859,0.15086,0.13082,1,1
5,GO MULTI ORGANISM PROCESS,2.2524e-05,0.15069,0.1281,1,1
5,GO SEX DIFFERENTIATION,9.7801e-06,0.15067,0.16886,1,1
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.025994,0.15056,0.17501,1,1
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.035393,0.15054,0.15058,1,1
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.016339,0.15049,0.11069,1,1
5,GO ORGAN GROWTH,0.0007696,0.15042,0.13105,1,1
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00057693,0.15035,0.15503,1,1
5,GO NEUROMUSCULAR PROCESS,0.0079323,0.15034,0.1513,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00067758,0.15033,0.13103,1,1
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.023205,0.15011,0.15251,1,1
5,GO PROTEIN MATURATION,0.0075304,0.15003,0.10922,1,1
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0020453,0.15003,0.14916,1,1
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00035231,0.14999,0.17705,1,1
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0051916,0.14975,0.15765,1,1
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.027188,0.14971,0.12383,1,1
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.009256,0.14932,0.11572,1,1
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.00028792,0.14924,0.14134,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.015953,0.14923,0.253,1,1
5,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.02068,0.1488,0.18444,1,1
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0099891,0.14877,0.15169,1,1
5,GO MUSCLE CELL PROLIFERATION,0.0032441,0.14873,0.13185,1,1
5,GO RESPONSE TO OSMOTIC STRESS,0.013798,0.14871,0.11877,1,1
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.009256,0.14861,0.12021,1,1
5,GO HEAD DEVELOPMENT,0.00012074,0.14851,0.1725,1,1
5,GO NUCLEOTIDE PHOSPHORYLATION,0.0075304,0.14849,0.11818,1,1
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0062634,0.14794,0.15478,1,1
5,GO CIRCADIAN RHYTHM,1.7118e-05,0.14784,0.13087,1,1
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.00069957,0.14778,0.12646,1,1
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0047853,0.14774,0.18469,1,1
5,GO RESPONSE TO PEPTIDE,0.00042998,0.14758,0.12198,1,1
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00063551,0.14756,0.14039,1,1
5,GO LYMPHOCYTE HOMEOSTASIS,0.050569,0.14753,0.10283,1,1
5,GO MAINTENANCE OF LOCATION,0.0020453,0.14737,0.12095,1,1
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00092958,0.14728,0.12362,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0054795,0.14725,0.14793,1,1
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0060989,0.1472,0.13685,1,1
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0064317,0.14714,0.15532,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,6.0504e-05,0.14695,0.12017,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00012964,0.14694,0.13213,1,1
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.025414,0.14692,0.11407,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,2.6307e-05,0.14647,0.13152,1,1
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,1.7118e-05,0.1464,0.1331,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.00011241,0.14636,0.15509,1,1
5,GO REGULATION OF MEMBRANE PERMEABILITY,0.00016023,0.14626,0.17068,1,1
5,GO RESPONSE TO INORGANIC SUBSTANCE,0.0011549,0.14614,0.12219,1,1
5,GO ION TRANSPORT,0.00042998,0.14595,0.13066,1,1
5,GO MIDBRAIN DEVELOPMENT,0.00025131,0.14592,0.14527,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0085714,0.14574,0.13509,1,1
5,GO CELL PROJECTION ORGANIZATION,6.0504e-05,0.14571,0.16308,1,1
5,GO ANION TRANSPORT,0.00098941,0.14569,0.10672,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,0.00067758,0.14563,0.13316,1,1
5,GO NEGATIVE REGULATION OF SECRETION,0.00022676,0.14555,0.12125,1,1
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.026586,0.14552,0.11959,1,1
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.00017186,0.14525,0.13677,1,1
5,GO REGULATION OF MUSCLE CONTRACTION,0.0006154,0.14516,0.14859,1,1
5,GO KERATINOCYTE MIGRATION,0.012508,0.14506,0.14862,1,1
5,GO REGULATION OF BINDING,4.3218e-05,0.14501,0.13676,1,1
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.031059,0.145,0.10986,1,1
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.025994,0.14496,0.14293,1,1
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.0027346,0.14454,0.12196,1,1
5,GO REGULATION OF PHOSPHATASE ACTIVITY,6.0504e-05,0.14437,0.12538,1,1
5,GO OVULATION CYCLE,0.0033369,0.1443,0.15401,1,1
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.030383,0.14416,0.090834,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00025131,0.14415,0.1297,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0053338,0.14396,0.11022,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00021909,0.14368,0.1415,1,1
5,GO POSITIVE REGULATION OF CELL GROWTH,5.0226e-05,0.14368,0.16956,1,1
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.001986,0.14363,0.12014,1,1
5,GO ADULT LOCOMOTORY BEHAVIOR,0.029068,0.14354,0.15015,1,1
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0015189,0.14342,0.12679,1,1
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00072223,0.14336,0.12806,1,1
5,GO CORNIFICATION,0.05161,0.14315,0.32643,1,1
5,GO NATURAL KILLER CELL PROLIFERATION,0.016339,0.14303,0.17759,1,1
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00010092,0.14301,0.13328,1,1
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.033894,0.14297,0.20895,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00022676,0.14295,0.1659,1,1
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00050664,0.14288,0.14321,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.012203,0.14252,0.14729,1,1
5,GO NEURON DEVELOPMENT,0.0015189,0.14243,0.17225,1,1
5,GO REGULATION OF CELL SIZE,0.00081984,0.14228,0.16837,1,1
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00014935,0.14222,0.16785,1,1
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0013054,0.14175,0.11425,1,1
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00084609,0.14172,0.18182,1,1
5,GO RESPONSE TO AMINO ACID STARVATION,0.0031536,0.14167,0.14775,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.0051916,0.1416,0.096803,1,1
5,GO REGULATION OF DNA BINDING,9.0551e-05,0.14151,0.14233,1,1
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0027346,0.14148,0.16334,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0010859,0.14145,0.14099,1,1
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0050528,0.1414,0.10518,1,1
5,GO NEUROGENESIS,0.00026903,0.14126,0.17314,1,1
5,GO RESPONSE TO MONOSACCHARIDE,0.0007696,0.14124,0.12112,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.042857,0.14111,0.13428,1,1
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.031059,0.14111,0.12387,1,1
5,GO REGULATION OF RESPONSE TO STRESS,0.0010528,0.14106,0.11045,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,1.6455e-05,0.14103,0.13049,1,1
5,GO HEART TRABECULA MORPHOGENESIS,0.0024367,0.141,0.18456,1,1
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.054842,0.14099,0.15269,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.00074557,0.14099,0.13547,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.7474e-06,0.14092,0.13816,1,1
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00098941,0.14056,0.13073,1,1
5,GO APOPTOTIC PROCESS,0.00010845,0.1405,0.12516,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00017796,0.14027,0.12542,1,1
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0025083,0.14019,0.12368,1,1
5,GO LYSOSOMAL TRANSPORT,0.0025083,0.14013,0.12895,1,1
5,GO REGULATION OF TRANSFERASE ACTIVITY,6.7596e-05,0.1401,0.12968,1,1
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.014841,0.13997,0.13115,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.010773,0.13988,0.12775,1,1
5,GO ACTIN MEDIATED CELL CONTRACTION,0.0032441,0.13985,0.15379,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.00047456,0.13973,0.12355,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0028141,0.13967,0.14831,1,1
5,GO RESPONSE TO ETHANOL,0.00098941,0.13955,0.14299,1,1
5,GO CELL RECOGNITION,0.036948,0.1392,0.11897,1,1
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.00049035,0.13914,0.15878,1,1
5,GO DEMETHYLATION,1.5201e-05,0.13904,0.16001,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00084609,0.13896,0.13196,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.00044439,0.13884,0.11861,1,1
5,GO TRANSMEMBRANE TRANSPORT,0.001872,0.13881,0.11003,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.016339,0.13873,0.083173,1,1
5,GO REGULATION OF GTPASE ACTIVITY,0.00067758,0.13863,0.11763,1,1
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.022165,0.13848,0.20588,1,1
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.0017641,0.13832,0.14607,1,1
5,GO ENDOCYTIC RECYCLING,0.00072223,0.13822,0.15066,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.0016129,0.13817,0.11886,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00021909,0.1381,0.1237,1,1
5,GO NEURON DEATH,1.0184e-05,0.13808,0.15043,1,1
5,GO LENS FIBER CELL DIFFERENTIATION,0.0018173,0.13794,0.20808,1,1
5,GO NEGATIVE REGULATION OF CELL DEATH,0.00038934,0.13782,0.12217,1,1
5,GO CHEMOSENSORY BEHAVIOR,0.0083534,0.13775,0.24107,1,1
5,GO CATECHOLAMINE SECRETION,0.047551,0.13774,0.25487,1,1
5,GO NEUTROPHIL CHEMOTAXIS,0.0073363,0.13766,0.11156,1,1
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.00353,0.13725,0.14222,1,1
5,GO RESPONSE TO SALT,0.0075304,0.13723,0.12205,1,1
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00027832,0.13702,0.19674,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,0.0013054,0.13669,0.11242,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.0020453,0.13661,0.11304,1,1
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00084609,0.13661,0.11332,1,1
5,GO NEURON DIFFERENTIATION,0.001191,0.13641,0.17314,1,1
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00045924,0.13641,0.10384,1,1
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00095906,0.13634,0.1397,1,1
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.038561,0.13628,0.10655,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00012964,0.13625,0.1351,1,1
5,GO OUTFLOW TRACT MORPHOGENESIS,0.033166,0.1362,0.16097,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.0039469,0.13617,0.12295,1,1
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.021165,0.13616,0.10594,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0094949,0.13599,0.14652,1,1
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.015203,0.13598,0.15812,1,1
5,GO CELL PROJECTION ASSEMBLY,7.2754e-05,0.13597,0.1325,1,1
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0053338,0.13589,0.10268,1,1
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.0028141,0.13577,0.11856,1,1
5,GO STRIATED MUSCLE CONTRACTION,0.0011549,0.13572,0.17123,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0059384,0.13562,0.14188,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,0.00041602,0.13558,0.11283,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.0013457,0.13464,0.10518,1,1
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0001165,0.13451,0.11857,1,1
5,GO REGULATION OF MYELINATION,0.0050528,0.13448,0.14065,1,1
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00054072,0.13415,0.127,1,1
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.024288,0.13415,0.10306,1,1
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0030654,0.13407,0.15934,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.00084609,0.134,0.12439,1,1
5,GO PIGMENTATION,0.0054795,0.13377,0.12071,1,1
5,GO RUFFLE ASSEMBLY,0.024288,0.13353,0.12522,1,1
5,GO AXIS SPECIFICATION,0.001986,0.13331,0.17429,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,3.1904e-06,0.13324,0.13998,1,1
5,GO REGULATION OF ENDOCYTOSIS,0.014841,0.13312,0.094225,1,1
5,GO ACTIVATION OF IMMUNE RESPONSE,0.027803,0.13312,0.10607,1,1
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.020205,0.13301,0.14165,1,1
5,GO CELLULAR ION HOMEOSTASIS,0.00047456,0.13299,0.1223,1,1
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.010773,0.13298,0.1009,1,1
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.012203,0.13288,0.11333,1,1
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.027188,0.13238,0.085818,1,1
5,GO PATTERN SPECIFICATION PROCESS,0.00065623,0.13222,0.15517,1,1
5,GO REGULATION OF LYASE ACTIVITY,0.033166,0.13198,0.11507,1,1
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0045306,0.13192,0.12337,1,1
5,GO PROTEOLYSIS,0.0019282,0.13189,0.096603,1,1
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.00029782,0.13183,0.1333,1,1
5,GO TRABECULA MORPHOGENESIS,0.0075304,0.13178,0.12705,1,1
5,GO SMOOTHENED SIGNALING PATHWAY,0.00067758,0.13175,0.15039,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0030654,0.13169,0.10965,1,1
5,GO ADAPTIVE THERMOGENESIS,0.00035231,0.13151,0.14577,1,1
5,GO REGULATION OF CELL DEATH,0.00021909,0.1314,0.12169,1,1
5,GO ENDOCYTOSIS,0.0017641,0.1314,0.11405,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.038561,0.13129,0.12229,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,0.0019282,0.13088,0.11523,1,1
5,GO RESPONSE TO ALCOHOL,0.0039469,0.13083,0.113,1,1
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0039469,0.1307,0.11411,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.007729,0.13062,0.092164,1,1
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.011904,0.13051,0.11845,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.0025817,0.13042,0.1222,1,1
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.030383,0.13041,0.14158,1,1
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.0042883,0.13038,0.15554,1,1
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.02268,0.13033,0.12362,1,1
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.042857,0.13014,0.19308,1,1
5,GO REGULATION OF CELL DIVISION,0.00040247,0.12999,0.12451,1,1
5,GO MUSCLE CONTRACTION,0.00031859,0.12987,0.15406,1,1
5,GO B CELL PROLIFERATION,0.045624,0.1298,0.14453,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.00090094,0.12977,0.12834,1,1
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.024846,0.12974,0.091171,1,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0041716,0.12973,0.12265,1,1
5,GO MEMBRANE ORGANIZATION,0.0024367,0.12969,0.10305,1,1
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.014138,0.12953,0.11844,1,1
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0062634,0.12936,0.15152,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0075304,0.12925,0.11954,1,1
5,GO SYNAPTIC SIGNALING,0.0054795,0.12849,0.16748,1,1
5,GO GERM CELL DEVELOPMENT,0.00010092,0.12849,0.13588,1,1
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.035393,0.1284,0.095322,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0056288,0.12836,0.088684,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0017123,0.12836,0.10663,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.017969,0.12816,0.1179,1,1
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0021689,0.12811,0.15847,1,1
5,GO PEPTIDYL AMINO ACID MODIFICATION,8.1192e-05,0.12799,0.093861,1,1
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0021689,0.12783,0.15545,1,1
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,9.389e-05,0.12764,0.13453,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0045306,0.12758,0.12954,1,1
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0030654,0.12758,0.17719,1,1
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00055855,0.12754,0.11538,1,1
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,8.1192e-05,0.12752,0.12985,1,1
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.035393,0.12739,0.093226,1,1
5,GO POSTREPLICATION REPAIR,0.011326,0.12734,0.10021,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.031059,0.12684,0.095095,1,1
5,GO CELLULAR RESPONSE TO ALCOHOL,0.0039469,0.12661,0.1233,1,1
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00067758,0.1266,0.11652,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.001228,0.12657,0.14589,1,1
5,GO REGULATION OF VACUOLE ORGANIZATION,0.0075304,0.1265,0.11779,1,1
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.03939,0.12636,0.089041,1,1
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.015574,0.12632,0.17433,1,1
5,GO GLUCOSE METABOLIC PROCESS,0.00031859,0.1263,0.12225,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0013872,0.12602,0.14323,1,1
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.0060989,0.126,0.13263,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00026903,0.1259,0.14359,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.01282,0.12574,0.11013,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00019079,0.12535,0.11718,1,1
5,GO RHYTHMIC PROCESS,6.2786e-05,0.12504,0.11752,1,1
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.017137,0.12493,0.17878,1,1
5,GO CELLULAR RESPONSE TO ALKALOID,0.015203,0.12485,0.13791,1,1
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0007696,0.12475,0.13176,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.018836,0.12464,0.096727,1,1
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0081404,0.12439,0.096985,1,1
5,GO AMYLOID FIBRIL FORMATION,0.02166,0.12439,0.23001,1,1
5,GO MULTICELLULAR ORGANISM REPRODUCTION,3.8583e-05,0.12412,0.12076,1,1
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.00084609,0.12379,0.12223,1,1
5,GO OOGENESIS,0.001872,0.12328,0.11556,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.010773,0.12271,0.109,1,1
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.054842,0.12266,0.095079,1,1
5,GO CELLULAR HOMEOSTASIS,0.0012662,0.12261,0.10807,1,1
5,GO REGULATION OF PROTEIN BINDING,0.00035231,0.12256,0.14043,1,1
5,GO ACID SECRETION,0.0069616,0.12226,0.18527,1,1
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,1.4044e-06,0.12219,0.12695,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.022165,0.12218,0.13229,1,1
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.010773,0.1221,0.16932,1,1
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0064317,0.12198,0.13058,1,1
5,GO RHYTHMIC BEHAVIOR,0.029719,0.12161,0.086777,1,1
5,GO SIGNAL RELEASE,0.00021909,0.12149,0.15777,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.018836,0.12139,0.11388,1,1
5,GO STEM CELL DIFFERENTIATION,0.0011199,0.12139,0.11443,1,1
5,GO CARBOHYDRATE TRANSPORT,0.00087311,0.12131,0.1301,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,0.05161,0.12103,0.080967,1,1
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0024367,0.12072,0.1527,1,1
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.019283,0.1207,0.13643,1,1
5,GO PHOSPHATE ION TRANSPORT,0.055956,0.1206,0.083681,1,1
5,GO GOLGI ORGANIZATION,0.020205,0.12045,0.074523,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0042883,0.12043,0.11676,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0022992,0.12041,0.11663,1,1
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.03939,0.12033,0.087938,1,1
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0017641,0.12002,0.12054,1,1
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.11973,0.12459,1,1
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.042857,0.11959,0.065885,1,1
5,GO SOMITE DEVELOPMENT,0.017137,0.11957,0.12227,1,1
5,GO RESPONSE TO OXIDATIVE STRESS,0.014486,0.11914,0.086744,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00014935,0.11911,0.11394,1,1
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.001228,0.11897,0.12049,1,1
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.013139,0.11893,0.12047,1,1
5,GO SEXUAL REPRODUCTION,8.1192e-05,0.11867,0.11844,1,1
5,GO HISTONE H2A UBIQUITINATION,0.021165,0.11843,0.099866,1,1
5,GO PROTEIN AUTOUBIQUITINATION,0.00038934,0.1182,0.12114,1,1
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.001191,0.11795,0.12471,1,1
5,GO RESPONSE TO CHEMOKINE,0.009256,0.1177,0.11089,1,1
5,GO ORGANIC ANION TRANSPORT,0.0028957,0.11766,0.096723,1,1
5,GO PROTEIN DESTABILIZATION,0.015574,0.11766,0.099227,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.038561,0.1175,0.075326,1,1
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0017641,0.11744,0.12569,1,1
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.0015653,0.11739,0.17959,1,1
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,2.2658e-06,0.11732,0.11372,1,1
5,GO RUFFLE ORGANIZATION,0.047551,0.1173,0.10302,1,1
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,3.5759e-05,0.11714,0.12007,1,1
5,GO T CELL LINEAGE COMMITMENT,0.040234,0.11698,0.094652,1,1
5,GO CEREBRAL CORTEX DEVELOPMENT,0.014138,0.11657,0.13499,1,1
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.013139,0.11627,0.11948,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.013139,0.11597,0.097574,1,1
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,1.7118e-05,0.11554,0.10873,1,1
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.0059384,0.11546,0.10315,1,1
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.0073363,0.11543,0.11232,1,1
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0066042,0.1154,0.10416,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0028141,0.11535,0.087781,1,1
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0099891,0.11527,0.14185,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.016734,0.11515,0.14146,1,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.010245,0.11513,0.094534,1,1
5,GO POSITIVE REGULATION OF BINDING,0.0081404,0.11472,0.097023,1,1
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0013457,0.1146,0.12898,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0011199,0.11455,0.11488,1,1
5,GO PROTEIN DEPHOSPHORYLATION,0.0006154,0.11431,0.09693,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00042998,0.11417,0.10633,1,1
5,GO B CELL HOMEOSTASIS,0.035393,0.11384,0.15079,1,1
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0025083,0.11371,0.098324,1,1
5,GO DEFENSE RESPONSE TO FUNGUS,0.02843,0.11356,0.17776,1,1
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.0039469,0.11314,0.16497,1,1
5,GO CELLULAR RESPONSE TO CAMP,0.0017641,0.11312,0.1364,1,1
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.010773,0.11309,0.17776,1,1
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0012662,0.11295,0.11307,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.043763,0.11293,0.071287,1,1
5,GO PEPTIDYL SERINE MODIFICATION,0.0018173,0.11263,0.093586,1,1
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00012074,0.11258,0.11964,1,1
5,GO FERTILIZATION,0.001191,0.11209,0.11006,1,1
5,GO RESPONSE TO ACTIVITY,0.0038387,0.11194,0.11866,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.010245,0.11168,0.084958,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0033369,0.11156,0.11613,1,1
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.01282,0.11153,0.11209,1,1
5,GO LIMBIC SYSTEM DEVELOPMENT,0.0062634,0.11151,0.15414,1,1
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0064317,0.11148,0.11706,1,1
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.045624,0.11146,0.1222,1,1
5,GO LENS FIBER CELL DEVELOPMENT,0.049546,0.11107,0.21797,1,1
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.011326,0.11091,0.099927,1,1
5,GO BONE RESORPTION,0.025414,0.11088,0.16765,1,1
5,GO CELL FATE COMMITMENT,0.00045924,0.11084,0.17669,1,1
5,GO DEPHOSPHORYLATION,0.00012512,0.11064,0.10949,1,1
5,GO GAMETE GENERATION,0.00012964,0.11053,0.11845,1,1
5,GO CARDIAC MUSCLE CONTRACTION,0.0099891,0.11037,0.14505,1,1
5,GO SENSORY PERCEPTION OF TASTE,0.0075304,0.11034,0.11579,1,1
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.00098941,0.11017,0.13274,1,1
5,GO TELENCEPHALON DEVELOPMENT,0.0094949,0.10935,0.1591,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00054072,0.1093,0.11331,1,1
5,GO CYTOSKELETON ORGANIZATION,0.00019753,0.10916,0.11968,1,1
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0020453,0.10904,0.11467,1,1
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0037331,0.10904,0.10683,1,1
5,GO REGULATION OF AUTOPHAGY,0.0011199,0.10868,0.096791,1,1
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0017123,0.10859,0.11372,1,1
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.029719,0.10781,0.077882,1,1
5,GO DNA DEALKYLATION,0.015953,0.10746,0.13211,1,1
5,GO NEGATIVE REGULATION OF TRANSPORT,0.0017641,0.10732,0.092626,1,1
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.017969,0.10723,0.089775,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0050528,0.10716,0.10577,1,1
5,GO PROTEIN LOCALIZATION TO CILIUM,0.015574,0.10677,0.12803,1,1
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.00055855,0.10669,0.097604,1,1
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.025994,0.10629,0.13574,1,1
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.011904,0.10611,0.099459,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.023205,0.1054,0.093413,1,1
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.016339,0.1052,0.095514,1,1
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.015574,0.10514,0.094355,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00090094,0.10483,0.10772,1,1
5,GO HISTONE H3 K9 DEMETHYLATION,0.052669,0.10439,0.17285,1,1
5,GO GLOMERULUS DEVELOPMENT,0.02843,0.10388,0.15148,1,1
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0066042,0.10351,0.15439,1,1
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.024846,0.10335,0.14434,1,1
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.015203,0.10301,0.095477,1,1
5,GO SPECIFICATION OF SYMMETRY,0.00098941,0.10296,0.1226,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.045624,0.10272,0.060476,1,1
5,GO REGULATION OF CELLULAR LOCALIZATION,0.00069957,0.10265,0.099265,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.046579,0.10221,0.084081,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.017549,0.10195,0.085665,1,1
5,GO MYOFIBRIL ASSEMBLY,0.0051916,0.10177,0.13424,1,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,6.2367e-06,0.10144,0.10066,1,1
5,GO BICARBONATE TRANSPORT,0.035393,0.10133,0.16358,1,1
5,GO CELL CYCLE ARREST,0.0010528,0.10088,0.099012,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.0047853,0.10083,0.11599,1,1
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.043763,0.10081,0.073495,1,1
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.017549,0.10072,0.085869,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.0045306,0.1007,0.11864,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.02166,0.1006,0.10535,1,1
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0064317,0.10038,0.074943,1,1
5,GO CARBOHYDRATE METABOLIC PROCESS,0.0028957,0.10027,0.10522,1,1
5,GO MALE GAMETE GENERATION,0.00026003,0.099246,0.11538,1,1
5,GO REGULATION OF T CELL MIGRATION,0.0057817,0.099242,0.12135,1,1
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00098941,0.09922,0.10544,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0087944,0.099192,0.16115,1,1
5,GO REGULATION OF DEPHOSPHORYLATION,9.7346e-05,0.098771,0.1049,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0022992,0.098345,0.097377,1,1
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,8.4205e-05,0.098029,0.10098,1,1
5,GO AGING,0.020205,0.097676,0.086052,1,1
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.026586,0.09748,0.14273,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.012203,0.097146,0.086035,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0015653,0.096828,0.099937,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0045306,0.096687,0.11353,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.00090094,0.095754,0.075254,1,1
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.040234,0.09568,0.1221,1,1
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.00028792,0.095538,0.1431,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.004408,0.09484,0.084207,1,1
5,GO REGULATION OF TOR SIGNALING,0.0013054,0.094837,0.10067,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0028957,0.094816,0.13417,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.015574,0.09465,0.11945,1,1
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.016339,0.094331,0.083555,1,1
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.001662,0.094326,0.096694,1,1
5,GO CALCIUM ION IMPORT,0.01282,0.093836,0.14003,1,1
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.027188,0.093596,0.12172,1,1
5,GO CELLULAR RESPONSE TO RADIATION,0.031748,0.093348,0.057404,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.0067808,0.091673,0.087245,1,1
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0054795,0.091651,0.072651,1,1
5,GO REGULATION OF PH,0.023205,0.091447,0.068791,1,1
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.019739,0.090498,0.099155,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0017123,0.089441,0.079964,1,1
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0071468,0.089362,0.12104,1,1
5,GO PROTEIN HOMOOLIGOMERIZATION,0.0056288,0.089207,0.090966,1,1
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.023205,0.089113,0.079422,1,1
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0056288,0.088871,0.12403,1,1
5,GO ORGANIC ACID TRANSPORT,0.019283,0.088257,0.066943,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.014138,0.08794,0.091763,1,1
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.011904,0.087691,0.0844,1,1
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.017549,0.087668,0.13638,1,1
5,GO REGULATION OF CYCLASE ACTIVITY,0.034637,0.087212,0.13392,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0050528,0.086812,0.072222,1,1
5,GO MACROMOLECULE DEACYLATION,0.0020453,0.085935,0.088244,1,1
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.02068,0.085563,0.1556,1,1
5,GO HIPPOCAMPUS DEVELOPMENT,0.035393,0.085294,0.13531,1,1
5,GO VESICLE ORGANIZATION,0.031748,0.085221,0.073685,1,1
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.011612,0.084601,0.085086,1,1
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.024846,0.08421,0.1592,1,1
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.044685,0.083753,0.092407,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0064317,0.083568,0.078927,1,1
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.02166,0.083512,0.10046,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE,0.0007696,0.082993,0.074265,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.015203,0.081522,0.094452,1,1
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.052669,0.081285,0.11135,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.017137,0.08092,0.069066,1,1
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.013139,0.079737,0.19389,1,1
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.0083534,0.079329,0.10975,1,1
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.027803,0.079261,0.068895,1,1
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0057817,0.077498,0.077274,1,1
5,GO HEART GROWTH,0.017549,0.076523,0.10268,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.023205,0.076109,0.099763,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.045624,0.075945,0.14581,1,1
5,GO RESPONSE TO LIGHT STIMULUS,0.015953,0.075622,0.057164,1,1
5,GO PEPTIDYL THREONINE MODIFICATION,0.040234,0.074804,0.068302,1,1
5,GO MICROTUBULE BASED MOVEMENT,0.018398,0.073812,0.081188,1,1
5,GO PROTEIN LOCALIZATION TO MEMBRANE,0.019739,0.071923,0.075693,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0025817,0.071713,0.073711,1,1
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.024288,0.070075,0.078499,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.036948,0.069286,0.065638,1,1
5,GO DNA CATABOLIC PROCESS,0.040234,0.069039,0.067377,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.013139,0.067488,0.069906,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.020205,0.067344,0.075167,1,1
5,GO SPERMATID DIFFERENTIATION,0.0018173,0.067195,0.11161,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0037331,0.064353,0.08886,1,1
5,GO REGULATION OF EXOCYTOSIS,0.033166,0.063527,0.1273,1,1
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0015189,0.061494,0.064379,1,1
5,GO TOR SIGNALING,0.0087944,0.060726,0.065304,1,1
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.050569,0.059121,0.07459,1,1
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.021165,0.056726,0.054126,1,1
5,GO REGULATION OF CELL CYCLE,0.0025083,0.05389,0.055456,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.017137,0.053726,0.059142,1,1
5,GO CELL CYCLE,0.037747,0.043089,0.038775,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0033369,0.87273,0.80209,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0019282,0.65988,0.72111,1,0
5,GO BLEB ASSEMBLY,0.00023468,0.55461,0.66741,1,0
5,GO ELASTIC FIBER ASSEMBLY,0.029068,0.55007,0.29149,1,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0011199,0.53691,0.42383,1,0
5,GO RESPONSE TO INTERFERON ALPHA,0.013798,0.53174,0.44668,1,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00037661,0.4852,0.35314,1,0
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.010506,0.46822,0.34746,1,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.001191,0.46523,0.32253,1,0
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.017549,0.46148,0.34151,1,0
5,GO MEMBRANE RAFT ASSEMBLY,0.019283,0.44205,0.38424,1,0
5,GO T CELL EXTRAVASATION,0.00034072,0.43177,0.43175,1,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.020205,0.43047,0.25239,1,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00072223,0.42909,0.44642,1,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.049546,0.41227,0.28842,1,0
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0090226,0.40991,0.30308,1,0
5,GO EPIBOLY,0.0018173,0.4093,0.26855,1,0
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.011047,0.3944,0.19306,1,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.013139,0.3892,0.27432,1,0
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.011904,0.38427,0.35937,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00037661,0.3813,0.35935,1,0
5,GO NEGATIVE REGULATION OF COAGULATION,0.011326,0.38019,0.21656,1,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00069957,0.37711,0.29846,1,0
5,GO VASCULOGENESIS,0.00010462,0.36971,0.30359,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.017549,0.36874,0.29203,1,0
5,GO T HELPER 1 CELL DIFFERENTIATION,0.015574,0.36524,0.22493,1,0
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0014299,0.36353,0.31858,1,0
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00014418,0.36082,0.46271,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0049174,0.3554,0.307,1,0
5,GO T HELPER 2 CELL DIFFERENTIATION,0.0040578,0.34523,0.36589,1,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0013872,0.34293,0.23932,1,0
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.024288,0.33871,0.21695,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0083534,0.33798,0.30294,1,0
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.014486,0.3287,0.21792,1,0
5,GO ENTRY INTO HOST,0.0059384,0.32609,0.19994,1,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.011904,0.32523,0.35019,1,0
5,GO ACTIN FILAMENT NETWORK FORMATION,0.011612,0.3175,0.32844,1,0
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.02068,0.31497,0.2334,1,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0038387,0.31387,0.28022,1,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0026572,0.31365,0.25628,1,0
5,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.022165,0.30332,0.33078,1,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0026572,0.29741,0.28963,1,0
5,GO ZYMOGEN ACTIVATION,0.0010859,0.29622,0.31482,1,0
5,GO ARGININE METABOLIC PROCESS,0.02068,0.29422,0.1915,1,0
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.001191,0.29401,0.29886,1,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.03245,0.29368,0.21624,1,0
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0007696,0.29294,0.23379,1,0
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.0026572,0.28924,0.18855,1,0
5,GO BASIC AMINO ACID TRANSPORT,0.0097392,0.28898,0.13889,1,0
5,GO TYPE 2 IMMUNE RESPONSE,0.0014299,0.28846,0.36988,1,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.016339,0.28837,0.17582,1,0
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0006154,0.28698,0.25697,1,0
5,GO COLLAGEN METABOLIC PROCESS,0.0050528,0.28671,0.18951,1,0
5,GO TOOTH MINERALIZATION,0.0021062,0.28661,0.28099,1,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.02268,0.28537,0.25892,1,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0059384,0.28386,0.19012,1,0
5,GO T CELL MEDIATED CYTOTOXICITY,0.0071468,0.28269,0.30728,1,0
5,GO MOVEMENT IN HOST ENVIRONMENT,0.010245,0.27738,0.16273,1,0
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.043763,0.2767,0.24947,1,0
5,GO IMMUNE RESPONSE TO TUMOR CELL,0.035393,0.27563,0.24878,1,0
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0038387,0.27502,0.3206,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.055956,0.27446,0.15262,1,0
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.013139,0.27326,0.16031,1,0
5,GO COLLAGEN CATABOLIC PROCESS,0.0020453,0.2731,0.21152,1,0
5,GO NOTOCHORD DEVELOPMENT,0.0015653,0.27063,0.3051,1,0
5,GO ENAMEL MINERALIZATION,0.012508,0.2696,0.23955,1,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0010859,0.26459,0.24378,1,0
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.034637,0.26395,0.31968,1,0
5,GO RESPONSE TO DIETARY EXCESS,0.03245,0.26395,0.22507,1,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.02068,0.26321,0.23422,1,0
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0066042,0.26312,0.27422,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0046564,0.26053,0.22716,1,0
5,GO MYELOID CELL APOPTOTIC PROCESS,0.0010859,0.25895,0.22415,1,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0028957,0.25762,0.26296,1,0
5,GO VAGINA DEVELOPMENT,0.026586,0.25371,0.17026,1,0
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.018398,0.25356,0.26579,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.013798,0.25254,0.257,1,0
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.010773,0.25233,0.19134,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.043763,0.25201,0.14481,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0051916,0.25132,0.2007,1,0
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.030383,0.25108,0.24147,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0051916,0.24914,0.16211,1,0
5,GO ENDODERM DEVELOPMENT,0.0083534,0.24911,0.19366,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.031059,0.24815,0.30135,1,0
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0054795,0.24776,0.25998,1,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0027346,0.24694,0.19157,1,0
5,GO PROTEIN ACTIVATION CASCADE,0.011904,0.24627,0.1817,1,0
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.030383,0.24579,0.15421,1,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0071468,0.24176,0.17067,1,0
5,GO CYTOLYSIS,0.001228,0.24096,0.26061,1,0
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0097392,0.239,0.42576,1,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0053338,0.23899,0.16184,1,0
5,GO STEROID ESTERIFICATION,0.020205,0.23878,0.31627,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0014738,0.23861,0.18888,1,0
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.011904,0.2385,0.21547,1,0
5,GO CELL PROLIFERATION IN HINDBRAIN,0.0051916,0.23833,0.25953,1,0
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.001986,0.23789,0.21223,1,0
5,GO AMELOGENESIS,0.0036303,0.23699,0.23268,1,0
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0085714,0.23581,0.26338,1,0
5,GO BONE GROWTH,0.025414,0.23574,0.17377,1,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.044685,0.23474,0.13863,1,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.029719,0.23349,0.13226,1,0
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0036303,0.23112,0.57465,1,0
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.031059,0.23096,0.17183,1,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.02166,0.22992,0.16011,1,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.015953,0.22951,0.13945,1,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0071468,0.22649,0.1748,1,0
5,GO B CELL MEDIATED IMMUNITY,0.0028957,0.22435,0.2718,1,0
5,GO ADULT FEEDING BEHAVIOR,0.0015653,0.22285,0.32507,1,0
5,GO BILE ACID METABOLIC PROCESS,0.0013457,0.222,0.19614,1,0
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.012508,0.22037,0.18191,1,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0053338,0.21892,0.24448,1,0
5,GO STORE OPERATED CALCIUM ENTRY,0.016734,0.21758,0.15949,1,0
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0022992,0.21711,0.15878,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0027346,0.21639,0.2082,1,0
5,GO REGULATION OF RESPIRATORY BURST,0.0057817,0.21539,0.24019,1,0
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0036303,0.21523,0.2025,1,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.018836,0.215,0.15524,1,0
5,GO REGULATION OF RECEPTOR BINDING,0.012203,0.21484,0.19296,1,0
5,GO GDP METABOLIC PROCESS,0.049546,0.21437,0.18705,1,0
5,GO DIVALENT METAL ION EXPORT,0.017969,0.21357,0.21543,1,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0032441,0.21308,0.32496,1,0
5,GO FIBROBLAST APOPTOTIC PROCESS,0.0022332,0.2122,0.21119,1,0
5,GO PHOSPHOLIPID EFFLUX,0.041967,0.21095,0.13595,1,0
5,GO REGULATION OF PHAGOCYTOSIS,0.00047456,0.21073,0.20565,1,0
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.014486,0.21034,0.15554,1,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.02843,0.21012,0.21106,1,0
5,GO PLATELET DEGRANULATION,0.0069616,0.2098,0.20202,1,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.016339,0.20946,0.14911,1,0
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.025414,0.20928,0.16408,1,0
5,GO ENDODERM FORMATION,0.04854,0.209,0.13006,1,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.043763,0.20894,0.25272,1,0
5,GO SALIVARY GLAND DEVELOPMENT,0.0097392,0.20894,0.22927,1,0
5,GO ZYMOGEN INHIBITION,0.022165,0.20863,0.18793,1,0
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.05161,0.20608,0.11851,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.013798,0.20547,0.16998,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.027803,0.20518,0.27087,1,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.044685,0.2051,0.23166,1,0
5,GO NOREPINEPHRINE TRANSPORT,0.025994,0.20472,0.20885,1,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0060989,0.20411,0.18691,1,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.007729,0.20392,0.18169,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0025817,0.20357,0.2234,1,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0057817,0.20346,0.16531,1,0
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.019283,0.20185,0.12312,1,0
5,GO VIRAL LIFE CYCLE,0.011904,0.20158,0.13929,1,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,0.054842,0.19973,0.14528,1,0
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.03245,0.19958,0.14036,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.013139,0.19957,0.26737,1,0
5,GO NEUTROPHIL HOMEOSTASIS,0.017549,0.19856,0.17607,1,0
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.029719,0.19741,0.29564,1,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,0.025994,0.19728,0.23194,1,0
5,GO CELLULAR RESPONSE TO ETHANOL,0.017969,0.1969,0.19841,1,0
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.053746,0.19688,0.16468,1,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,0.0090226,0.19677,0.18768,1,0
5,GO PARTURITION,0.033166,0.1961,0.2367,1,0
5,GO IRON COORDINATION ENTITY TRANSPORT,0.0028141,0.19576,0.24083,1,0
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0024367,0.19572,0.21033,1,0
5,GO GLYCOLIPID CATABOLIC PROCESS,0.046579,0.19531,0.17636,1,0
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.035393,0.19525,0.29824,1,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0039469,0.19495,0.25162,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0026572,0.19472,0.22973,1,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0020453,0.19364,0.19608,1,0
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0028957,0.19276,0.22829,1,0
5,GO EXCITATORY SYNAPSE ASSEMBLY,0.03939,0.19249,0.27488,1,0
5,GO FORMATION OF PRIMARY GERM LAYER,0.009256,0.19213,0.15321,1,0
5,GO PROTEIN HYDROXYLATION,0.052669,0.19171,0.13367,1,0
5,GO KERATAN SULFATE METABOLIC PROCESS,0.026586,0.19088,0.14923,1,0
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0046564,0.1908,0.20682,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0018173,0.19023,0.22179,1,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.037747,0.18994,0.2344,1,0
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.027803,0.18973,0.28195,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.049546,0.18904,0.15454,1,0
5,GO IMMUNOGLOBULIN PRODUCTION,0.029719,0.18854,0.094949,1,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0017641,0.18826,0.22823,1,0
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0049174,0.188,0.18085,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0050528,0.18721,0.16261,1,0
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.035393,0.18579,0.15266,1,0
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.047551,0.1857,0.17742,1,0
5,GO DECIDUALIZATION,0.0090226,0.18386,0.20726,1,0
5,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0025817,0.18379,0.21761,1,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.053746,0.18375,0.18243,1,0
5,GO ANIMAL ORGAN REGENERATION,0.013139,0.1816,0.12883,1,0
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.018836,0.1807,0.25326,1,0
5,GO T CELL MEDIATED IMMUNITY,0.0040578,0.18068,0.21996,1,0
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.0033369,0.18061,0.18132,1,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0040578,0.18045,0.17132,1,0
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0016129,0.18018,0.19075,1,0
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0014738,0.18016,0.18385,1,0
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.017969,0.18003,0.2045,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.026586,0.17989,0.15905,1,0
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.040234,0.17943,0.10793,1,0
5,GO PHAGOCYTOSIS,0.0062634,0.17941,0.13824,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0032441,0.17855,0.1796,1,0
5,GO RESPONSE TO DEXAMETHASONE,0.047551,0.17854,0.11707,1,0
5,GO LEARNING,0.010773,0.17835,0.16309,1,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,0.036164,0.17801,0.12797,1,0
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0054795,0.17761,0.1512,1,0
5,GO MULTI ORGANISM CELLULAR PROCESS,0.017969,0.17755,0.21005,1,0
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0031536,0.17655,0.16077,1,0
5,GO ADAPTIVE IMMUNE RESPONSE,0.0021062,0.17621,0.22571,1,0
5,GO APOPTOTIC CELL CLEARANCE,0.0025083,0.1759,0.31131,1,0
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0057817,0.17523,0.25238,1,0
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0067808,0.17518,0.17204,1,0
5,GO MUSCLE CELL FATE COMMITMENT,0.042857,0.17498,0.15518,1,0
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0037331,0.17414,0.18129,1,0
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0029794,0.17177,0.18002,1,0
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0053338,0.17112,0.19086,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.015574,0.17081,0.12013,1,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.020205,0.17047,0.13114,1,0
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0057817,0.17022,0.19023,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.046579,0.16955,0.2548,1,0
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0045306,0.16924,0.18154,1,0
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0024367,0.16906,0.19756,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00069957,0.16891,0.22385,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0014299,0.16883,0.15111,1,0
5,GO FOREBRAIN REGIONALIZATION,0.009256,0.16626,0.25581,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0090226,0.16597,0.24528,1,0
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.016734,0.16545,0.11411,1,0
5,GO CELLULAR ANION HOMEOSTASIS,0.025414,0.16405,0.19218,1,0
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0090226,0.1638,0.18128,1,0
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.027803,0.16376,0.15086,1,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.015203,0.16362,0.25386,1,0
5,GO EMBRYO IMPLANTATION,0.014138,0.1636,0.13406,1,0
5,GO INSULIN SECRETION,0.0006154,0.16356,0.17373,1,0
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.016734,0.16327,0.22642,1,0
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.010245,0.16283,0.14533,1,0
5,GO GASTRULATION,0.0045306,0.1626,0.14987,1,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.043763,0.16158,0.20214,1,0
5,GO OXALATE TRANSPORT,0.018836,0.16121,0.1477,1,0
5,GO GENITALIA MORPHOGENESIS,0.0060989,0.16118,0.36824,1,0
5,GO RESPONSE TO ELECTRICAL STIMULUS,0.0049174,0.16115,0.1901,1,0
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.042857,0.16082,0.08598,1,0
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.0083534,0.16056,0.21412,1,0
5,GO CELLULAR KETONE METABOLIC PROCESS,0.030383,0.15908,0.095923,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.04854,0.15833,0.1044,1,0
5,GO MESODERM MORPHOGENESIS,0.011326,0.15745,0.12294,1,0
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0090226,0.15744,0.12171,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.023205,0.15742,0.20263,1,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.014841,0.15596,0.16701,1,0
5,GO REGULATION OF BONE REMODELING,0.0039469,0.15588,0.2172,1,0
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.007729,0.1556,0.15054,1,0
5,GO PROTEIN DEGLYCOSYLATION,0.054842,0.15558,0.13672,1,0
5,GO MAGNESIUM ION TRANSPORT,0.0046564,0.15547,0.19549,1,0
5,GO AMINO SUGAR METABOLIC PROCESS,0.013798,0.15493,0.1682,1,0
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.022165,0.15482,0.20854,1,0
5,GO COPPER ION HOMEOSTASIS,0.047551,0.15469,0.1372,1,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0090226,0.15356,0.12762,1,0
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.053746,0.15308,0.13445,1,0
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.016339,0.15306,0.13923,1,0
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.0018173,0.15298,0.18995,1,0
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.05161,0.15207,0.088326,1,0
5,GO KETONE BIOSYNTHETIC PROCESS,0.045624,0.15183,0.10183,1,0
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.011326,0.15178,0.13595,1,0
5,GO RESPONSE TO ESTROGEN,0.013798,0.15118,0.1279,1,0
5,GO T CELL CYTOKINE PRODUCTION,0.0026572,0.15113,0.18004,1,0
5,GO ER NUCLEUS SIGNALING PATHWAY,0.021165,0.15082,0.10545,1,0
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.021165,0.1503,0.16444,1,0
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0099891,0.14878,0.16774,1,0
5,GO REGULATION OF STEROL TRANSPORT,0.012508,0.14874,0.11961,1,0
5,GO PYRUVATE METABOLIC PROCESS,0.016339,0.14865,0.10159,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.05161,0.14815,0.1096,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0038387,0.14811,0.16322,1,0
5,GO MEMBRANE INVAGINATION,0.023205,0.14808,0.10677,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.023741,0.14799,0.095322,1,0
5,GO REGULATION OF NECROTIC CELL DEATH,0.027188,0.14737,0.17362,1,0
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.007729,0.14724,0.18388,1,0
5,GO ICOSANOID METABOLIC PROCESS,0.0071468,0.14724,0.18493,1,0
5,GO IMMATURE B CELL DIFFERENTIATION,0.036948,0.14704,0.15473,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.018398,0.14667,0.11011,1,0
5,GO RESPONSE TO TESTOSTERONE,0.03245,0.14603,0.15694,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.047551,0.14593,0.12918,1,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.012203,0.14567,0.18204,1,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.05161,0.14562,0.21482,1,0
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0029794,0.14539,0.15539,1,0
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.055956,0.14535,0.1078,1,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.016339,0.14498,0.13663,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.004408,0.14485,0.15631,1,0
5,GO TRACHEA MORPHOGENESIS,0.014138,0.14484,0.2195,1,0
5,GO AUTOPHAGOSOME ORGANIZATION,0.0021062,0.14463,0.12014,1,0
5,GO DENTATE GYRUS DEVELOPMENT,0.02166,0.14429,0.29018,1,0
5,GO AMINE TRANSPORT,0.034637,0.14398,0.21084,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.021165,0.14382,0.17847,1,0
5,GO HORMONE BIOSYNTHETIC PROCESS,0.037747,0.14311,0.1145,1,0
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0019282,0.14288,0.14346,1,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.029719,0.14222,0.14836,1,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,0.050569,0.14201,0.18259,1,0
5,GO CYTOKINE METABOLIC PROCESS,0.014486,0.14187,0.19043,1,0
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.010506,0.14141,0.16411,1,0
5,GO MATERNAL PLACENTA DEVELOPMENT,0.020205,0.14087,0.15886,1,0
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.04854,0.14078,0.13259,1,0
5,GO SOMITOGENESIS,0.0066042,0.14028,0.11262,1,0
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0037331,0.14012,0.15045,1,0
5,GO TRANSITION METAL ION HOMEOSTASIS,0.029068,0.13898,0.093809,1,0
5,GO FATTY ACID METABOLIC PROCESS,0.0050528,0.13874,0.13201,1,0
5,GO RESPONSE TO INTERLEUKIN 2,0.019739,0.13634,0.17879,1,0
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.012203,0.13628,0.2079,1,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.025994,0.13612,0.10524,1,0
5,GO RECEPTOR CATABOLIC PROCESS,0.049546,0.13606,0.089773,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.036164,0.13554,0.11133,1,0
5,GO NEURON PROJECTION ORGANIZATION,0.017137,0.13513,0.15797,1,0
5,GO PLASMA MEMBRANE TUBULATION,0.046579,0.1343,0.12968,1,0
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.017969,0.13384,0.11147,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.053746,0.13329,0.10711,1,0
5,GO DIGESTION,0.0067808,0.13289,0.12692,1,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.034637,0.13259,0.18474,1,0
5,GO CORONARY VASCULATURE MORPHOGENESIS,0.014138,0.13229,0.25112,1,0
5,GO RESPONSE TO ISCHEMIA,0.0050528,0.13165,0.14302,1,0
5,GO INTRACELLULAR LIPID TRANSPORT,0.0083534,0.13078,0.14325,1,0
5,GO POLYAMINE METABOLIC PROCESS,0.042857,0.13025,0.12099,1,0
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.01282,0.13008,0.15439,1,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.023741,0.12975,0.17185,1,0
5,GO COMPLEMENT ACTIVATION,0.017137,0.12949,0.26152,1,0
5,GO RETINOL METABOLIC PROCESS,0.02166,0.12944,0.11998,1,0
5,GO CELLULAR RESPONSE TO ATP,0.029068,0.12901,0.13687,1,0
5,GO DETOXIFICATION,0.041093,0.12878,0.096212,1,0
5,GO ALCOHOL CATABOLIC PROCESS,0.026586,0.12876,0.10476,1,0
5,GO RESPONSE TO PH,0.014138,0.12836,0.14194,1,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0039469,0.12802,0.16704,1,0
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.019739,0.12748,0.097597,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0062634,0.12647,0.13205,1,0
5,GO KERATINIZATION,0.036164,0.12628,0.27006,1,0
5,GO DIGESTIVE SYSTEM PROCESS,0.0047853,0.12544,0.13777,1,0
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.044685,0.12542,0.23198,1,0
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.042857,0.12495,0.14603,1,0
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.040234,0.12491,0.15592,1,0
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0062634,0.1249,0.14652,1,0
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.046579,0.12466,0.11966,1,0
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.014841,0.12426,0.081595,1,0
5,GO RESPONSE TO PROSTAGLANDIN E,0.047551,0.1241,0.1222,1,0
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0067808,0.12391,0.10633,1,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.053746,0.12312,0.12904,1,0
5,GO INTRACELLULAR STEROL TRANSPORT,0.027803,0.1229,0.14912,1,0
5,GO ASSOCIATIVE LEARNING,0.017969,0.12267,0.13009,1,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0085714,0.12235,0.14724,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.013139,0.12161,0.12998,1,0
5,GO FATTY ACID TRANSPORT,0.0059384,0.1213,0.10538,1,0
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0036303,0.1207,0.12106,1,0
5,GO CELLULAR RESPONSE TO VIRUS,0.038561,0.12035,0.09047,1,0
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.013139,0.1196,0.11921,1,0
5,GO RESPONSE TO LITHIUM ION,0.018836,0.11944,0.26589,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.017969,0.11937,0.15218,1,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.019739,0.11935,0.1326,1,0
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.03245,0.11931,0.1499,1,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.053746,0.11917,0.098555,1,0
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.016734,0.11906,0.12338,1,0
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.052669,0.119,0.13678,1,0
5,GO ALCOHOL METABOLIC PROCESS,0.018836,0.11726,0.079605,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.043763,0.11632,0.12752,1,0
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.0039469,0.11628,0.11147,1,0
5,GO ACTIVATION OF JNKK ACTIVITY,0.015953,0.11578,0.1913,1,0
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.054842,0.11504,0.17387,1,0
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.021165,0.11496,0.16588,1,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.04854,0.11427,0.088121,1,0
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.038561,0.11419,0.10259,1,0
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.0071468,0.1136,0.089875,1,0
5,GO RENAL WATER HOMEOSTASIS,0.020205,0.11244,0.11439,1,0
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.011904,0.11242,0.2233,1,0
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.02843,0.11225,0.11941,1,0
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.011326,0.11154,0.10778,1,0
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00079435,0.11152,0.19843,1,0
5,GO SECONDARY METABOLIC PROCESS,0.053746,0.11103,0.087052,1,0
5,GO NEGATIVE REGULATION OF TOR SIGNALING,0.0042883,0.11029,0.12826,1,0
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.023205,0.1102,0.24817,1,0
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.026586,0.10982,0.13549,1,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.010245,0.1094,0.10631,1,0
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.042857,0.10937,0.35257,1,0
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0081404,0.1087,0.1165,1,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.024288,0.10806,0.12987,1,0
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.034637,0.10779,0.10478,1,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.042857,0.10753,0.12906,1,0
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.050569,0.10603,0.078802,1,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.015953,0.10592,0.16104,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,0.0094949,0.10542,0.087602,1,0
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.031059,0.10414,0.1869,1,0
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.011612,0.10331,0.11701,1,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.031059,0.10224,0.13185,1,0
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.011326,0.10162,0.13021,1,0
5,GO VACUOLE ORGANIZATION,0.029719,0.10134,0.076738,1,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.035393,0.1007,0.095313,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0087944,0.10023,0.2141,1,0
5,GO FATTY ACID CATABOLIC PROCESS,0.031059,0.098711,0.096959,1,0
5,GO POSITIVE REGULATION OF NEURON DEATH,0.0066042,0.098124,0.13144,1,0
5,GO DOPAMINE METABOLIC PROCESS,0.043763,0.097819,0.18078,1,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.023205,0.096709,0.067063,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0069616,0.095602,0.07346,1,0
5,GO MAINTENANCE OF LOCATION IN CELL,0.046579,0.094885,0.083013,1,0
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.029068,0.09465,0.093135,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0039469,0.09306,0.10808,1,0
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.03245,0.091554,0.13679,1,0
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.022165,0.090906,0.1019,1,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.037747,0.090158,0.16777,1,0
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.024288,0.089356,0.083247,1,0
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.05161,0.089267,0.14222,1,0
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.018398,0.089145,0.088106,1,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.041093,0.08794,0.29378,1,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.055956,0.087638,0.064719,1,0
5,GO GOLGI RIBBON FORMATION,0.029068,0.086552,0.13558,1,0
5,GO CELL CELL RECOGNITION,0.018836,0.085753,0.11606,1,0
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.011612,0.084845,0.077526,1,0
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.052669,0.084738,0.19242,1,0
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.038561,0.084459,0.11681,1,0
5,GO REGULATION OF CATABOLIC PROCESS,0.023205,0.084369,0.055803,1,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.019739,0.084115,0.14227,1,0
5,GO SULFATE TRANSPORT,0.029719,0.082816,0.10113,1,0
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.029719,0.082594,0.13104,1,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.024846,0.082407,0.12334,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.027188,0.082399,0.059623,1,0
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.015953,0.082328,0.079629,1,0
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.021165,0.081477,0.19208,1,0
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.010245,0.078875,0.12718,1,0
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.03939,0.078334,0.050679,1,0
5,GO POLYOL METABOLIC PROCESS,0.05161,0.078279,0.068921,1,0
5,GO NECROTIC CELL DEATH,0.0083534,0.077994,0.18954,1,0
5,GO MACROPHAGE ACTIVATION,0.03939,0.077946,0.15676,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.043763,0.077508,0.059153,1,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.053746,0.076936,0.12554,1,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0064317,0.076746,0.19344,1,0
5,GO PROTEIN TETRAMERIZATION,0.026586,0.076287,0.081835,1,0
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.049546,0.075257,0.061614,1,0
5,GO PROTEIN CATABOLIC PROCESS,0.044685,0.074,0.051364,1,0
5,GO DETERMINATION OF ADULT LIFESPAN,0.038561,0.073961,0.12922,1,0
5,GO FEMALE GAMETE GENERATION,0.031748,0.072587,0.071067,1,0
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.034637,0.072487,0.080725,1,0
5,GO RESPONSE TO ANTIBIOTIC,0.049546,0.072258,0.10655,1,0
5,GO REGULATION OF LIPASE ACTIVITY,0.036164,0.072152,0.11877,1,0
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0079323,0.071377,0.077608,1,0
5,GO PROGRAMMED NECROTIC CELL DEATH,0.019739,0.071029,0.18096,1,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.025994,0.068661,0.055629,1,0
5,GO POSITIVE REGULATION OF DNA REPAIR,0.036164,0.066943,0.076212,1,0
5,GO RESPONSE TO UV,0.015574,0.065308,0.067366,1,0
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.017549,0.063936,0.11402,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.052669,0.063627,0.075804,1,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.054842,0.062064,0.094948,1,0
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.026586,0.062062,0.055991,1,0
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.03939,0.062,0.045324,1,0
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.024288,0.061707,0.066168,1,0
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.018836,0.059696,0.14319,1,0
5,GO HISTONE DEACETYLATION,0.029068,0.047769,0.080606,1,0
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.038561,0.046015,0.097328,1,0
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.050569,0.044524,0.1378,1,0
5,GO REGULATION OF MACROAUTOPHAGY,0.017137,0.043847,0.062021,1,0
5,GO REGULATION OF ATPASE ACTIVITY,0.055956,0.04026,0.054073,1,0
5,GO SENSORY PERCEPTION OF SMELL,0.041093,0.038894,0.065158,1,0
5,GO RESPONSE TO RADIATION,0.020205,0.037962,0.050177,1,0
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.046579,0.037807,0.045272,1,0
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.03939,0.026988,0.16768,1,0
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.036164,-0.030971,-0.067363,1,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.036948,-0.050136,-0.074923,1,0
5,GO BASE EXCISION REPAIR,0.019739,-0.050552,-0.08947,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.050569,-0.059589,-0.06139,1,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.037747,-0.059921,-0.070976,1,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.040234,-0.060095,-0.089854,1,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.031748,-0.067097,-0.091592,1,0
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.041967,-0.069821,-0.081568,1,0
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.023741,-0.070248,-0.089631,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.041967,-0.072061,-0.070022,1,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.010245,-0.072724,-0.10044,1,0
5,GO DNA GEOMETRIC CHANGE,0.052669,-0.07317,-0.067411,1,0
5,GO RNA STABILIZATION,0.02268,-0.073212,-0.1097,1,0
5,GO DNA CONFORMATION CHANGE,0.03939,-0.073441,-0.053984,1,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.029719,-0.073901,-0.079945,1,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.046579,-0.075354,-0.1031,1,0
5,GO MRNA TRANSPORT,0.03245,-0.075582,-0.083048,1,0
5,GO SNRNA TRANSCRIPTION,0.0010528,-0.075716,-0.08941,1,0
5,GO RNA SPLICING,0.0097392,-0.07727,-0.09033,1,0
5,GO REGULATION OF TELOMERASE ACTIVITY,0.053746,-0.078382,-0.095434,1,0
5,GO MRNA PROCESSING,0.0083534,-0.079743,-0.084985,1,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.053746,-0.079924,-0.11751,1,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.013798,-0.081102,-0.088303,1,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.017969,-0.081598,-0.078054,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.029068,-0.082512,-0.10187,1,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0033369,-0.085615,-0.084999,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.041967,-0.086697,-0.077052,1,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.053746,-0.088109,-0.096949,1,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.019283,-0.088295,-0.086118,1,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.011612,-0.088918,-0.097162,1,0
5,GO TRICARBOXYLIC ACID CYCLE,0.0071468,-0.090255,-0.17737,1,0
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0039469,-0.090434,-0.10777,1,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0042883,-0.090701,-0.093256,1,0
5,GO NUCLEOSOME ORGANIZATION,0.041967,-0.092171,-0.06961,1,0
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.011904,-0.092209,-0.07648,1,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.020205,-0.092212,-0.088396,1,0
5,GO NCRNA EXPORT FROM NUCLEUS,0.046579,-0.092518,-0.12677,1,0
5,GO RNA MODIFICATION,0.0014299,-0.093401,-0.15359,1,0
5,GO DNA REPLICATION INITIATION,0.0075304,-0.094588,-0.12615,1,0
5,GO MRNA 3 END PROCESSING,0.025994,-0.095147,-0.076019,1,0
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.024288,-0.095164,-0.2174,1,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.0036303,-0.095446,-0.13918,1,0
5,GO CHROMOSOME SEPARATION,0.0094949,-0.095944,-0.091592,1,0
5,GO TRNA TRANSPORT,0.0085714,-0.096025,-0.15091,1,0
5,GO RECOMBINATIONAL REPAIR,0.027188,-0.09634,-0.061678,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.031748,-0.096862,-0.090217,1,0
5,GO MRNA METABOLIC PROCESS,0.0038387,-0.097198,-0.11519,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.055956,-0.098205,-0.086189,1,0
5,GO STRESS GRANULE ASSEMBLY,0.044685,-0.098431,-0.1006,1,0
5,GO HISTONE H3 K4 TRIMETHYLATION,0.026586,-0.098903,-0.10304,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00065623,-0.099924,-0.12285,1,0
5,GO TELOMERE ORGANIZATION,0.00067758,-0.10015,-0.11099,1,0
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.047551,-0.10044,-0.10185,1,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0028141,-0.10282,-0.10357,1,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,0.0049174,-0.10476,-0.12327,1,0
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.053746,-0.10507,-0.088461,1,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0010206,-0.10785,-0.14795,1,0
5,GO RNA CATABOLIC PROCESS,0.0099891,-0.10922,-0.1396,1,0
5,GO RNA LOCALIZATION,0.001986,-0.10958,-0.12231,1,0
5,GO MIRNA METABOLIC PROCESS,0.0028957,-0.11049,-0.14914,1,0
5,GO PROTEIN NEDDYLATION,0.011047,-0.1115,-0.1285,1,0
5,GO DNA REPLICATION CHECKPOINT,0.030383,-0.11366,-0.12526,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0001547,-0.11402,-0.14268,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.045624,-0.11411,-0.10923,1,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.033166,-0.11429,-0.17588,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.018398,-0.11472,-0.13747,1,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00014418,-0.11518,-0.12363,1,0
5,GO NUCLEOTIDE EXCISION REPAIR,0.00028792,-0.1163,-0.11182,1,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.036164,-0.11667,-0.092009,1,0
5,GO HISTONE DEUBIQUITINATION,0.0071468,-0.11675,-0.11307,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE,0.00013917,-0.11884,-0.14252,1,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.004408,-0.11945,-0.11277,1,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,0.0020453,-0.11981,-0.16414,1,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.02166,-0.11992,-0.10798,1,0
5,GO NCRNA TRANSCRIPTION,1.1493e-05,-0.12006,-0.14499,1,0
5,GO RNA POLYADENYLATION,0.00353,-0.12024,-0.11134,1,0
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0001165,-0.12148,-0.13858,1,0
5,GO TRNA METHYLATION,0.0059384,-0.12285,-0.16987,1,0
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.050569,-0.12317,-0.13768,1,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.00016595,-0.12317,-0.12655,1,0
5,GO MRNA CLEAVAGE,0.0013872,-0.12328,-0.12974,1,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0034322,-0.12425,-0.14344,1,0
5,GO FOLIC ACID METABOLIC PROCESS,0.044685,-0.12426,-0.1653,1,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00010462,-0.12469,-0.14364,1,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.036948,-0.12662,-0.27241,1,0
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,6.0504e-05,-0.12707,-0.14409,1,0
5,GO PEPTIDE METABOLIC PROCESS,0.017137,-0.12741,-0.10941,1,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.022165,-0.12978,-0.1093,1,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.025414,-0.13139,-0.094315,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.011904,-0.1316,-0.16603,1,0
5,GO CHROMOSOME CONDENSATION,0.034637,-0.13334,-0.090936,1,0
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.015953,-0.13539,-0.15658,1,0
5,GO AEROBIC RESPIRATION,0.0047853,-0.13765,-0.16028,1,0
5,GO MRNA EXPORT FROM NUCLEUS,0.0042883,-0.13889,-0.11548,1,0
5,GO AMIDE BIOSYNTHETIC PROCESS,0.015574,-0.13937,-0.11406,1,0
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.014486,-0.14001,-0.086048,1,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0010528,-0.14126,-0.22908,1,0
5,GO CRISTAE FORMATION,0.007729,-0.14169,-0.18106,1,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00013917,-0.14262,-0.14896,1,0
5,GO RESPONSE TO PARATHYROID HORMONE,0.017969,-0.14354,-0.2108,1,0
5,GO CELLULAR RESPIRATION,0.0029794,-0.14725,-0.16022,1,0
5,GO RNA PROCESSING,7.547e-05,-0.14999,-0.15007,1,0
5,GO RNA METHYLATION,0.00018427,-0.15021,-0.17917,1,0
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.055956,-0.1505,-0.11477,1,0
5,GO RNA EXPORT FROM NUCLEUS,0.00084609,-0.15096,-0.13618,1,0
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,6.7596e-05,-0.15175,-0.20917,1,0
5,GO MITOCHONDRIAL DNA REPLICATION,0.0083534,-0.15205,-0.15225,1,0
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.00034072,-0.1523,-0.1627,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.031748,-0.1528,-0.14373,1,0
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.014486,-0.15425,-0.13962,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.00087311,-0.15551,-0.15982,1,0
5,GO OXIDATIVE PHOSPHORYLATION,0.00353,-0.15556,-0.17043,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.042857,-0.15557,-0.1872,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0010206,-0.15558,-0.19272,1,0
5,GO TRNA MODIFICATION,0.00030804,-0.15733,-0.20667,1,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0010859,-0.15809,-0.14099,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.022165,-0.1586,-0.10298,1,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0071468,-0.15881,-0.17072,1,0
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,3.0689e-05,-0.15981,-0.18055,1,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.010245,-0.16025,-0.12833,1,0
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0022332,-0.1613,-0.15289,1,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.019739,-0.1613,-0.1296,1,0
5,GO PROTEASOME ASSEMBLY,0.0060989,-0.16145,-0.20017,1,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0036303,-0.1615,-0.2222,1,0
5,GO TRNA METABOLIC PROCESS,0.00013917,-0.16172,-0.20001,1,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0015189,-0.16183,-0.15985,1,0
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0019282,-0.16233,-0.19232,1,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0027346,-0.16243,-0.18323,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.013465,-0.16393,-0.1393,1,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.0042883,-0.16554,-0.1599,1,0
5,GO TRANSLATIONAL TERMINATION,0.0007696,-0.16598,-0.27577,1,0
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0024367,-0.16665,-0.18404,1,0
5,GO RNA CAPPING,0.00010845,-0.16708,-0.14649,1,0
5,GO MRNA MODIFICATION,0.001872,-0.1675,-0.18106,1,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0030654,-0.1676,-0.20123,1,0
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0013054,-0.16807,-0.27213,1,0
5,GO RNA 3 END PROCESSING,0.00010845,-0.16839,-0.1467,1,0
5,GO NUCLEAR PORE ORGANIZATION,0.010773,-0.16977,-0.19642,1,0
5,GO MITOCHONDRIAL TRANSLATION,0.00045924,-0.17097,-0.26494,1,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.00069957,-0.17113,-0.18622,1,0
5,GO TRNA 5 END PROCESSING,0.001662,-0.17137,-0.24552,1,0
5,GO BLASTOCYST GROWTH,0.001872,-0.17619,-0.18028,1,0
5,GO HISTONE ARGININE METHYLATION,0.00026003,-0.17722,-0.18623,1,0
5,GO RNA 5 END PROCESSING,0.00036427,-0.17846,-0.27205,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00010092,-0.1808,-0.22555,1,0
5,GO REGULATION OF RNA BINDING,0.00072223,-0.181,-0.20078,1,0
5,GO SNRNA METABOLIC PROCESS,3.3287e-06,-0.18136,-0.2521,1,0
5,GO MITOTIC DNA REPLICATION CHECKPOINT,0.046579,-0.18168,-0.15971,1,0
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0023671,-0.1843,-0.20682,1,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00045924,-0.18461,-0.26878,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00072223,-0.18571,-0.17692,1,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00092958,-0.18828,-0.12754,1,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.0099891,-0.18993,-0.17859,1,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.038561,-0.18993,-0.20955,1,0
5,GO MITOCHONDRIAL GENE EXPRESSION,0.00032948,-0.19063,-0.26194,1,0
5,GO TRNA PROCESSING,6.5149e-05,-0.19139,-0.21238,1,0
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.00054072,-0.19302,-0.22008,1,0
5,GO TRANSLATIONAL ELONGATION,0.00037661,-0.19681,-0.22708,1,0
5,GO TRNA 5 LEADER REMOVAL,0.001872,-0.19782,-0.2364,1,0
5,GO REGULATION OF MRNA BINDING,0.00065623,-0.19802,-0.2467,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0071468,-0.20005,-0.20768,1,0
5,GO MITOCHONDRIAL TRANSCRIPTION,0.0099891,-0.20048,-0.22093,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00045924,-0.20066,-0.27938,1,0
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.023205,-0.20149,-0.15971,1,0
5,GO TRANSLATIONAL INITIATION,0.0049174,-0.20156,-0.27556,1,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0099891,-0.20241,-0.22232,1,0
5,GO PEPTIDYL ARGININE METHYLATION,0.00013917,-0.20256,-0.19818,1,0
5,GO TRNA WOBBLE BASE MODIFICATION,0.00084609,-0.20284,-0.20109,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00030804,-0.20754,-0.24484,1,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.00032948,-0.20873,-0.23339,1,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00045924,-0.20908,-0.21812,1,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0013054,-0.21215,-0.17743,1,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0018173,-0.21222,-0.22134,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0011199,-0.21454,-0.27166,1,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,0.0025083,-0.21512,-0.24429,1,0
5,GO SNRNA PROCESSING,7.0571e-06,-0.21614,-0.28353,1,0
5,GO VIRAL GENE EXPRESSION,0.0083534,-0.21701,-0.23769,1,0
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0022992,-0.21825,-0.20103,1,0
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0085714,-0.21932,-0.2913,1,0
5,GO NCRNA METABOLIC PROCESS,9.3916e-06,-0.21955,-0.24537,1,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0018173,-0.22008,-0.2432,1,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0025817,-0.22206,-0.25165,1,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.00049035,-0.22384,-0.22437,1,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.0022332,-0.22579,-0.2007,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0049174,-0.22762,-0.22689,1,0
5,GO PEPTIDYL HISTIDINE MODIFICATION,0.00018427,-0.22931,-0.23649,1,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,1.1964e-05,-0.22975,-0.25312,1,0
5,GO RRNA 3 END PROCESSING,0.00045924,-0.23412,-0.22483,1,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0016129,-0.23619,-0.20741,1,0
5,GO SECRETORY GRANULE LOCALIZATION,0.023741,-0.23802,-0.23298,1,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,1.104e-05,-0.24137,-0.25561,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00010845,-0.242,-0.27318,1,0
5,GO IMP METABOLIC PROCESS,0.0085714,-0.24258,-0.27151,1,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.00016595,-0.24284,-0.23944,1,0
5,GO NCRNA PROCESSING,6.2367e-06,-0.24381,-0.27302,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,2.7343e-05,-0.24613,-0.21101,1,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,1.5201e-05,-0.24779,-0.20801,1,0
5,GO PEPTIDYL ARGININE N METHYLATION,0.00079435,-0.25068,-0.23001,1,0
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00026003,-0.2533,-0.2961,1,0
5,GO PROTEIN DENEDDYLATION,7.013e-05,-0.25376,-0.23885,1,0
5,GO NCRNA 3 END PROCESSING,3.0576e-06,-0.2582,-0.2834,1,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00038934,-0.25915,-0.30723,1,0
5,GO REGULATION OF PROTEIN SUMOYLATION,0.00029782,-0.25919,-0.24042,1,0
5,GO RRNA METHYLATION,2.6307e-05,-0.25948,-0.27553,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.011047,-0.25975,-0.35025,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0017641,-0.26034,-0.28571,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,1.4609e-05,-0.26046,-0.23936,1,0
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,9.7346e-05,-0.26079,-0.26216,1,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,4.1617e-05,-0.26318,-0.29124,1,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0046564,-0.26405,-0.29616,1,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,9.0179e-06,-0.26667,-0.27891,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,1.6729e-06,-0.27097,-0.26093,1,0
5,GO RRNA TRANSCRIPTION,1.0184e-05,-0.27113,-0.28094,1,0
5,GO VIRAL TRANSLATION,0.0022992,-0.27418,-0.27865,1,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,1.9263e-05,-0.27467,-0.33223,1,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00029782,-0.27744,-0.25865,1,0
5,GO CYTOPLASMIC TRANSLATION,0.00079435,-0.28045,-0.32906,1,0
5,GO MITOCHONDRIAL TRNA PROCESSING,0.00081984,-0.28174,-0.2698,1,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.8583e-05,-0.28478,-0.32213,1,0
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,9.389e-05,-0.2881,-0.28171,1,0
5,GO MATURATION OF 5 8S RRNA,3.4421e-05,-0.2886,-0.33805,1,0
5,GO RRNA METABOLIC PROCESS,6.7728e-06,-0.28927,-0.30481,1,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,4.0073e-05,-0.29034,-0.35271,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,7.3528e-06,-0.29089,-0.2873,1,0
5,GO RRNA MODIFICATION,2.3654e-06,-0.29139,-0.3454,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0075304,-0.29418,-0.35152,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,9.0551e-05,-0.29442,-0.35114,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0007696,-0.29452,-0.33232,1,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.00026903,-0.29987,-0.29404,1,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00044439,-0.30295,-0.31629,1,0
5,GO PSEUDOURIDINE SYNTHESIS,4.6623e-06,-0.30426,-0.41255,1,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.015574,-0.30433,-0.37658,1,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.2962e-05,-0.30672,-0.35317,1,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,9.0551e-05,-0.30946,-0.323,1,0
5,GO AMINO ACID ACTIVATION,7.6603e-06,-0.30983,-0.3396,1,0
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.00041602,-0.31209,-0.42015,1,0
5,GO MATURATION OF SSU RRNA,5.508e-06,-0.31768,-0.36738,1,0
5,GO TELOMERASE RNA LOCALIZATION,2.1663e-05,-0.32025,-0.36108,1,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00049035,-0.32406,-0.37173,1,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,1.349e-05,-0.32608,-0.37336,1,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0033369,-0.32763,-0.2661,1,0
5,GO RIBOSOME BIOGENESIS,4.6623e-06,-0.33854,-0.33972,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,1.6455e-05,-0.33958,-0.3461,1,0
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,3.1888e-05,-0.34431,-0.4418,1,0
5,GO ETHANOL OXIDATION,0.0047853,-0.34898,-0.37186,1,0
5,GO RIBOSOME ASSEMBLY,2.7343e-05,-0.35923,-0.4089,1,0
5,GO RNA SURVEILLANCE,3.9418e-06,-0.3598,-0.31408,1,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,4.4712e-06,-0.37349,-0.35268,1,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0001165,-0.37802,-0.39263,1,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,1.1964e-05,-0.37933,-0.43067,1,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00014418,-0.37946,-0.4492,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,9.8628e-07,-0.38398,-0.40484,1,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,4.4712e-06,-0.39078,-0.43367,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,1.104e-05,-0.39281,-0.39335,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,7.3528e-06,-0.39344,-0.40746,1,0
5,GO RRNA PSEUDOURIDINE SYNTHESIS,5.4977e-07,-0.40434,-0.51553,1,0
5,GO SNORNA METABOLIC PROCESS,6.5149e-05,-0.425,-0.35749,1,0
5,GO MATURATION OF LSU RRNA,2.0033e-05,-0.43629,-0.42195,1,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,8.4205e-05,-0.44195,-0.43521,1,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,1.0184e-05,-0.4549,-0.44332,1,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,3.4728e-06,-0.50475,-0.42366,1,0
5,GO SNORNA 3 END PROCESSING,1.4609e-05,-0.51014,-0.42609,1,0
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.15264,0.41234,0.20811,0,1
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.24288,0.40576,0.20833,0,1
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.16828,0.40448,0.22794,0,1
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.092194,0.38003,0.31997,0,1
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.079444,0.36468,0.20847,0,1
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.057089,0.36196,0.23398,0,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.068167,0.34954,0.21332,0,1
5,GO RELAXATION OF CARDIAC MUSCLE,0.072231,0.33035,0.2024,0,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.057089,0.32936,0.16381,0,1
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.16559,0.30638,0.12466,0,1
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.1028,0.30567,0.18045,0,1
5,GO RESPONSE TO MUSCLE STRETCH,0.065563,0.30146,0.20705,0,1
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.10465,0.2995,0.17166,0,1
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.075049,0.29887,0.24244,0,1
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.16032,0.29254,0.15702,0,1
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.12908,0.28777,0.15639,0,1
5,GO RESPONSE TO PAIN,0.057089,0.28208,0.18931,0,1
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.10096,0.28031,0.26706,0,1
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.065563,0.26646,0.13523,0,1
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.064293,0.25784,0.2477,0,1
5,GO LAMELLIPODIUM MORPHOGENESIS,0.1028,0.25654,0.12715,0,1
5,GO PROTEIN LOCALIZATION TO AXON,0.0695,0.25308,0.26937,0,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.060602,0.25254,0.13047,0,1
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.061812,0.24996,0.19019,0,1
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.088862,0.24673,0.18556,0,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.1028,0.24319,0.12443,0,1
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.073629,0.23842,0.11147,0,1
5,GO RESPONSE TO INSECTICIDE,0.059411,0.23322,0.18446,0,1
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.18508,0.2329,0.11176,0,1
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.073629,0.23217,0.20128,0,1
5,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.093897,0.22854,0.11629,0,1
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.10465,0.22757,0.12034,0,1
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.087232,0.22684,0.13032,0,1
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.11636,0.22178,0.1419,0,1
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.073629,0.2201,0.14658,0,1
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.14048,0.21786,0.14106,0,1
5,GO TYPE I INTERFERON PRODUCTION,0.15015,0.21748,0.10778,0,1
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.11841,0.21693,0.17496,0,1
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.12049,0.2143,0.14893,0,1
5,GO MIDDLE EAR MORPHOGENESIS,0.060602,0.21386,0.15983,0,1
5,GO POSITIVE REGULATION OF HEART RATE,0.087232,0.21247,0.17639,0,1
5,GO QUINONE METABOLIC PROCESS,0.073629,0.21232,0.079824,0,1
5,GO NAD BIOSYNTHETIC PROCESS,0.097379,0.2118,0.13993,0,1
5,GO DIOL BIOSYNTHETIC PROCESS,0.05824,0.20939,0.10742,0,1
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.077957,0.20606,0.14775,0,1
5,GO BASEMENT MEMBRANE ASSEMBLY,0.072231,0.20491,0.28807,0,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.084046,0.20458,0.21532,0,1
5,GO CELLULAR RESPONSE TO COPPER ION,0.13583,0.20421,0.19155,0,1
5,GO NEURAL CREST FORMATION,0.11841,0.20374,0.12199,0,1
5,GO REGULATION OF ACROSOME REACTION,0.15015,0.20222,0.1183,0,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.29992,0.20211,0.096903,0,1
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.35153,0.19805,0.034879,0,1
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.14048,0.19674,0.066356,0,1
5,GO REGULATION OF B CELL PROLIFERATION,0.077957,0.19617,0.16917,0,1
5,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.13583,0.19222,0.13711,0,1
5,GO RESPONSE TO CAFFEINE,0.063042,0.19091,0.16403,0,1
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.059411,0.18995,0.15313,0,1
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.12473,0.18834,0.23127,0,1
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.090515,0.18777,0.14504,0,1
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.061812,0.18748,0.13458,0,1
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.188,0.18694,0.1304,0,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.085627,0.18614,0.10358,0,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.092194,0.18463,0.15216,0,1
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.063042,0.1841,0.2244,0,1
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.10465,0.18363,0.12803,0,1
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.11434,0.18362,0.10807,0,1
5,GO GLYCOSIDE METABOLIC PROCESS,0.12473,0.1831,0.053759,0,1
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.075049,0.18248,0.22109,0,1
5,GO VASODILATION,0.065563,0.18241,0.15948,0,1
5,GO MAGNESIUM ION HOMEOSTASIS,0.11841,0.18091,0.15312,0,1
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.057089,0.1786,0.15228,0,1
5,GO RESPONSE TO AMINE,0.10845,0.1777,0.099857,0,1
5,GO OTIC VESICLE MORPHOGENESIS,0.15015,0.17571,0.15519,0,1
5,GO PROGESTERONE METABOLIC PROCESS,0.24288,0.17456,0.036913,0,1
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.060602,0.17435,0.1178,0,1
5,GO AORTIC VALVE DEVELOPMENT,0.15015,0.17283,0.083865,0,1
5,GO AMINE METABOLIC PROCESS,0.15773,0.17202,0.065267,0,1
5,GO REGULATION OF RUFFLE ASSEMBLY,0.060602,0.16665,0.14275,0,1
5,GO REGULATION OF CELL PROJECTION SIZE,0.11039,0.16635,0.13932,0,1
5,GO CARNITINE METABOLIC PROCESS,0.10465,0.16623,0.12595,0,1
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.090515,0.16593,0.12739,0,1
5,GO POSITIVE REGULATION OF FERTILIZATION,0.23589,0.16523,0.13446,0,1
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.11434,0.16486,0.20196,0,1
5,GO RESPONSE TO MAGNESIUM ION,0.15773,0.16337,0.12981,0,1
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.097379,0.16228,0.22655,0,1
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.061812,0.16202,0.088319,0,1
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.12259,0.16188,0.055331,0,1
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.36064,0.16184,0.043113,0,1
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.22235,0.15841,0.14634,0,1
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.11636,0.15599,0.17078,0,1
5,GO ER OVERLOAD RESPONSE,0.076492,0.15524,0.12365,0,1
5,GO INTERLEUKIN 5 PRODUCTION,0.11039,0.15488,0.1452,0,1
5,GO REGULATION OF EXIT FROM MITOSIS,0.065563,0.1544,0.09564,0,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.077957,0.15437,0.18771,0,1
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.19095,0.15433,0.11452,0,1
5,GO REGULATION OF HEART MORPHOGENESIS,0.082489,0.15251,0.14031,0,1
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.21579,0.15206,0.062025,0,1
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.097379,0.15033,0.15665,0,1
5,GO CGMP MEDIATED SIGNALING,0.070855,0.1499,0.12155,0,1
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.14048,0.14651,0.065965,0,1
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.11039,0.146,0.14376,0,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.17374,0.14565,0.080555,0,1
5,GO ZINC ION TRANSPORT,0.064293,0.14484,0.08768,0,1
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.073629,0.1437,0.14778,0,1
5,GO REGULATION OF EXCRETION,0.097379,0.14319,0.10283,0,1
5,GO RESPONSE TO MINERALOCORTICOID,0.063042,0.14301,0.11156,0,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.082489,0.14296,0.10655,0,1
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.26847,0.14222,0.055585,0,1
5,GO CELLULAR DEFENSE RESPONSE,0.085627,0.14162,0.12114,0,1
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.13355,0.1414,0.077754,0,1
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.34256,0.14089,0.042603,0,1
5,GO SPHINGOMYELIN METABOLIC PROCESS,0.16032,0.14053,0.11247,0,1
5,GO REPRODUCTIVE BEHAVIOR,0.15517,0.13878,0.090488,0,1
5,GO RESPONSE TO PEPTIDOGLYCAN,0.16032,0.13835,0.085544,0,1
5,GO NEGATIVE REGULATION OF DNA REPLICATION,0.11841,0.13823,0.10935,0,1
5,GO PROSTAGLANDIN TRANSPORT,0.095625,0.13725,0.08054,0,1
5,GO MESENCHYME MORPHOGENESIS,0.085627,0.1342,0.086365,0,1
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.17934,0.13387,0.07543,0,1
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.060602,0.13197,0.082633,0,1
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.057089,0.13193,0.05363,0,1
5,GO REGULATION OF FERTILIZATION,0.16032,0.13062,0.092022,0,1
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.060602,0.13029,0.12667,0,1
5,GO ARTERY DEVELOPMENT,0.060602,0.12997,0.076419,0,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.13583,0.12927,0.15474,0,1
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.090515,0.12896,0.098948,0,1
5,GO MEMBRANE FUSION,0.079444,0.12857,0.091572,0,1
5,GO DRUG METABOLIC PROCESS,0.061812,0.12773,0.1355,0,1
5,GO MATING,0.17099,0.12749,0.06271,0,1
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.14048,0.12704,0.063491,0,1
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.46512,0.12688,0.026483,0,1
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.23245,0.12678,0.081247,0,1
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.1313,0.12599,0.076299,0,1
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.060602,0.12504,0.18128,0,1
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.4978,0.12489,0.02758,0,1
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.088862,0.12414,0.11158,0,1
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.099158,0.1233,0.049211,0,1
5,GO LEUKOCYTE AGGREGATION,0.46512,0.12127,0.18175,0,1
5,GO STEROID CATABOLIC PROCESS,0.084046,0.11967,0.12285,0,1
5,GO STRIATUM DEVELOPMENT,0.56075,0.11896,0.057172,0,1
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.24288,0.11798,0.092489,0,1
5,GO VESICLE DOCKING,0.16032,0.11663,0.081707,0,1
5,GO HISTONE H3 DEACETYLATION,0.077957,0.11595,0.080945,0,1
5,GO DEFINITIVE HEMOPOIESIS,0.17099,0.11589,0.097147,0,1
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.063042,0.1157,0.17603,0,1
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.26847,0.11563,0.046357,0,1
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.080955,0.11472,0.1207,0,1
5,GO ERYTHROCYTE MATURATION,0.58456,0.11361,0.021162,0,1
5,GO STEROL IMPORT,0.11636,0.11272,0.071259,0,1
5,GO REGULATION OF PODOSOME ASSEMBLY,0.066855,0.11269,0.17459,0,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.15517,0.11235,0.09899,0,1
5,GO PERICARDIUM DEVELOPMENT,0.15015,0.11212,0.094369,0,1
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.35607,0.11175,0.048624,0,1
5,GO POSITIVE REGULATION OF MYELINATION,0.25001,0.11152,0.059761,0,1
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.10465,0.11083,0.12003,0,1
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0695,0.1107,0.11485,0,1
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.3746,0.11056,0.055828,0,1
5,GO NEUROTRANSMITTER UPTAKE,0.33373,0.109,0.068387,0,1
5,GO MANNOSYLATION,0.066855,0.10786,0.12428,0,1
5,GO REGULATION OF PROTEIN STABILITY,0.059411,0.10782,0.060193,0,1
5,GO HISTONE H2A MONOUBIQUITINATION,0.085627,0.10637,0.088977,0,1
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.079444,0.10632,0.068306,0,1
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.17653,0.10566,0.068438,0,1
5,GO RESPONSE TO GLUCAGON,0.099158,0.10275,0.068088,0,1
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.079444,0.10065,0.077338,0,1
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.073629,0.1,0.086943,0,1
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.4545,0.097722,0.057455,0,1
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.060602,0.096676,0.11863,0,1
5,GO REGULATION OF MEMBRANE INVAGINATION,0.28785,0.096371,0.065968,0,1
5,GO CELLULAR PIGMENTATION,0.05824,0.096235,0.084034,0,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.18219,0.093005,0.055419,0,1
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.061812,0.092856,0.069111,0,1
5,GO EXIT FROM MITOSIS,0.065563,0.091301,0.08567,0,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.2,0.088489,0.075912,0,1
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.12689,0.088317,0.10874,0,1
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.085627,0.087682,0.083786,0,1
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.19695,0.085119,0.046906,0,1
5,GO LYTIC VACUOLE ORGANIZATION,0.60272,0.084673,0.023628,0,1
5,GO GENITALIA DEVELOPMENT,0.080955,0.084526,0.079479,0,1
5,GO PIGMENT GRANULE ORGANIZATION,0.19095,0.083696,0.0495,0,1
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.13814,0.082644,0.034898,0,1
5,GO TRANSCYTOSIS,0.19695,0.081156,0.056552,0,1
5,GO MICROTUBULE BASED TRANSPORT,0.072231,0.078625,0.063453,0,1
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.13583,0.077254,0.073624,0,1
5,GO PHOTOPERIODISM,0.13583,0.073775,0.066499,0,1
5,GO REGULATION OF CELLULAR PH,0.14526,0.073209,0.039068,0,1
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.05824,0.072508,0.10046,0,1
5,GO IRON ION TRANSPORT,0.16559,0.07203,0.051378,0,1
5,GO REGULATION OF RECEPTOR INTERNALIZATION,0.072231,0.067806,0.10313,0,1
5,GO PROTEIN INSERTION INTO MEMBRANE,0.092194,0.067166,0.077074,0,1
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.15773,0.06631,0.099306,0,1
5,GO RECEPTOR RECYCLING,0.075049,0.06611,0.08108,0,1
5,GO GPI ANCHOR METABOLIC PROCESS,0.1028,0.064577,0.090439,0,1
5,GO POLYOL CATABOLIC PROCESS,0.085627,0.064424,0.099158,0,1
5,GO REGULATION OF CELL CYCLE ARREST,0.13583,0.062997,0.060528,0,1
5,GO ARACHIDONIC ACID SECRETION,0.16032,0.062816,0.046175,0,1
5,GO TRANSPORT ALONG MICROTUBULE,0.20309,0.062691,0.045966,0,1
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.05824,0.058571,0.044981,0,1
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.2839,0.057219,0.029065,0,1
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.087232,0.055807,0.053335,0,1
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.53167,0.055804,0.021499,0,1
5,GO POSITIVE REGULATION OF DNA BINDING,0.39858,0.054478,0.032076,0,1
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.27611,0.05233,0.026958,0,1
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.17653,0.052285,0.067013,0,1
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.075049,0.041028,0.072669,0,1
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.084046,0.039408,0.039775,0,1
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.21256,0.037709,0.032754,0,1
5,GO REGULATION OF DNA REPLICATION,0.15264,0.037608,0.051603,0,1
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.16559,0.035912,0.049368,0,1
5,GO PROTEIN ACYLATION,0.15015,0.035739,0.036114,0,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.11841,0.032186,0.030073,0,1
5,GO CYTOSOLIC TRANSPORT,0.37932,0.02997,0.026329,0,1
5,GO CELL CYCLE PROCESS,0.11841,0.029931,0.026881,0,1
5,GO COVALENT CHROMATIN MODIFICATION,0.079444,0.02989,0.04849,0,1
5,GO REGULATION OF MITOTIC CELL CYCLE,0.14526,0.025285,0.03507,0,1
5,GO RESPONSE TO INTERFERON BETA,0.31232,0.45184,0.22604,0,0
5,GO MUCUS SECRETION,0.063042,0.43387,0.26249,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.15517,0.38901,0.14348,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.090515,0.3767,0.17699,0,0
5,GO MECHANOSENSORY BEHAVIOR,0.046579,0.36756,0.29277,0,0
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00040247,0.35905,0.39975,0,0
5,GO PARENTAL BEHAVIOR,0.013465,0.34393,0.22017,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.010245,0.33831,0.36456,0,0
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00026903,0.33637,0.32141,0,0
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0060989,0.33442,0.40927,0,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0094949,0.32432,0.32214,0,0
5,GO GAP JUNCTION ASSEMBLY,0.072231,0.3209,0.2048,0,0
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.084046,0.30443,0.18817,0,0
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.10845,0.30265,0.14643,0,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0023671,0.30055,0.3598,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.00018427,0.29906,0.33356,0,0
5,GO REFLEX,0.033166,0.28828,0.34319,0,0
5,GO MIDGUT DEVELOPMENT,0.0021689,0.28779,0.34716,0,0
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.009256,0.28748,0.30621,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.1313,0.27865,0.2218,0,0
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.38408,0.27684,0.11801,0,0
5,GO REGULATION OF ISOTYPE SWITCHING,0.085627,0.27401,0.18063,0,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.092194,0.27103,0.14079,0,0
5,GO NEUROBLAST DIVISION,0.0087944,0.26353,0.2436,0,0
5,GO CARDIOBLAST PROLIFERATION,0.16294,0.26324,0.2614,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00057693,0.26279,0.32584,0,0
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.041093,0.26086,0.33734,0,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.084046,0.25887,0.1911,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.029068,0.25666,0.2195,0,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.15015,0.25537,0.15842,0,0
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.34256,0.25439,0.13695,0,0
5,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.014138,0.25426,0.28882,0,0
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.066855,0.24807,0.22122,0,0
5,GO GERMINAL CENTER FORMATION,0.1313,0.24617,0.23753,0,0
5,GO TRIGEMINAL NERVE DEVELOPMENT,0.044685,0.2458,0.28321,0,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00010845,0.24038,0.31667,0,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.11039,0.23999,0.11751,0,0
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.061812,0.23852,0.19807,0,0
5,GO ENDODERMAL CELL DIFFERENTIATION,0.05824,0.23688,0.11605,0,0
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.049546,0.23582,0.20425,0,0
5,GO NEURON CELL CELL ADHESION,0.023741,0.23449,0.39016,0,0
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.044685,0.23409,0.1841,0,0
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.12473,0.23332,0.12438,0,0
5,GO PEPTIDYL PROLINE HYDROXYLATION,0.064293,0.23238,0.20163,0,0
5,GO NEURON FATE SPECIFICATION,0.053746,0.23108,0.33353,0,0
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.061812,0.22979,0.19525,0,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.40843,0.22802,0.087906,0,0
5,GO GLYCINE TRANSPORT,0.12259,0.2257,0.16456,0,0
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.44924,0.22514,0.058622,0,0
5,GO SYNAPTIC VESICLE MATURATION,0.16294,0.22471,0.22135,0,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.050569,0.22355,0.2807,0,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,0.13355,0.2235,0.1569,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.15015,0.22259,0.095173,0,0
5,GO CELL FATE DETERMINATION,0.031748,0.2224,0.17006,0,0
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0056288,0.22132,0.23087,0,0
5,GO RETINAL METABOLIC PROCESS,0.064293,0.21846,0.13367,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.050569,0.21784,0.16439,0,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.24288,0.21752,0.08721,0,0
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.029719,0.21653,0.18028,0,0
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.11636,0.21626,0.14393,0,0
5,GO LATERAL MESODERM DEVELOPMENT,0.073629,0.21621,0.21156,0,0
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.12049,0.21572,0.12672,0,0
5,GO CATECHOLAMINE UPTAKE,0.03245,0.21456,0.19027,0,0
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.015203,0.21352,0.22756,0,0
5,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.72313,0.21327,0.014598,0,0
5,GO BLOOD VESSEL REMODELING,0.095625,0.21256,0.098539,0,0
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.22905,0.21209,0.12765,0,0
5,GO LONG TERM MEMORY,0.036948,0.21102,0.15487,0,0
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0014299,0.2105,0.27205,0,0
5,GO HETEROTYPIC CELL CELL ADHESION,0.0053338,0.20953,0.19409,0,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.014486,0.20863,0.35746,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.15773,0.20796,0.20681,0,0
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0081404,0.20487,0.16944,0,0
5,GO DETECTION OF CALCIUM ION,0.12049,0.20362,0.17276,0,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.18219,0.20304,0.15345,0,0
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0016129,0.20196,0.2427,0,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0056288,0.20081,0.17628,0,0
5,GO REGULATION OF DOPAMINE SECRETION,0.13583,0.20068,0.24824,0,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.099158,0.20057,0.14894,0,0
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.060602,0.19997,0.099081,0,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.0695,0.19968,0.1476,0,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.054842,0.19962,0.22802,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.40843,0.19724,0.05548,0,0
5,GO NEURAL NUCLEUS DEVELOPMENT,0.0030654,0.19699,0.22467,0,0
5,GO COLLAGEN FIBRIL ORGANIZATION,0.11434,0.19688,0.093148,0,0
5,GO NEURONAL ACTION POTENTIAL,0.090515,0.19677,0.20089,0,0
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.075049,0.19671,0.18845,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.025414,0.19514,0.22896,0,0
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.17653,0.19513,0.11583,0,0
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0050528,0.19337,0.17961,0,0
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.14285,0.19275,0.28849,0,0
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0027346,0.19244,0.20223,0,0
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.13583,0.19182,0.089626,0,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.087232,0.19156,0.15223,0,0
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.15773,0.18958,0.12903,0,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.1313,0.18945,0.22484,0,0
5,GO HYALURONAN METABOLIC PROCESS,0.16559,0.1893,0.075981,0,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.22568,0.18767,0.2044,0,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.53167,0.18689,0.07074,0,0
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.19393,0.18651,0.085923,0,0
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.24643,0.18621,0.04859,0,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.05824,0.18525,0.097597,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.061812,0.18498,0.19524,0,0
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.097379,0.18343,0.12079,0,0
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0042883,0.18293,0.1974,0,0
5,GO AMINE BIOSYNTHETIC PROCESS,0.11636,0.18221,0.13711,0,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.2839,0.18217,0.079377,0,0
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.29586,0.18194,0.091852,0,0
5,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.082489,0.1812,0.22267,0,0
5,GO HEPARIN METABOLIC PROCESS,0.19095,0.18068,0.13539,0,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.11636,0.18027,0.12962,0,0
5,GO SEROTONIN TRANSPORT,0.085627,0.17972,0.17008,0,0
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.0014738,0.17965,0.18024,0,0
5,GO RESPONSE TO LEUCINE,0.17934,0.17943,0.12425,0,0
5,GO BONE TRABECULA FORMATION,0.43883,0.17925,0.04923,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,0.11434,0.17838,0.25965,0,0
5,GO ADRENAL GLAND DEVELOPMENT,0.0049174,0.17805,0.24428,0,0
5,GO COLLECTING DUCT DEVELOPMENT,0.095625,0.17786,0.14959,0,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.099158,0.17778,0.1276,0,0
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.061812,0.17742,0.10305,0,0
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.084046,0.17683,0.16629,0,0
5,GO RESPONSE TO FLUID SHEAR STRESS,0.093897,0.17657,0.1042,0,0
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.031748,0.17649,0.17605,0,0
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.30402,0.17524,0.091487,0,0
5,GO OTIC VESICLE DEVELOPMENT,0.14526,0.17481,0.15638,0,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.71006,0.17459,0.017748,0,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.42347,0.17335,0.052291,0,0
5,GO MEMORY,0.0010528,0.17312,0.1916,0,0
5,GO PROSTANOID METABOLIC PROCESS,0.20937,0.17216,0.069859,0,0
5,GO REGULATION OF EXTENT OF CELL GROWTH,0.0060989,0.17158,0.20541,0,0
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.057089,0.17147,0.11065,0,0
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0066042,0.17113,0.28743,0,0
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0695,0.171,0.17089,0,0
5,GO INNER DYNEIN ARM ASSEMBLY,0.03245,0.17093,0.27498,0,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.38888,0.16983,0.10735,0,0
5,GO MICROTUBULE BUNDLE FORMATION,0.00035231,0.16973,0.19409,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.060602,0.16969,0.17574,0,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.057089,0.1689,0.21861,0,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.22235,0.16887,0.095939,0,0
5,GO BEHAVIORAL RESPONSE TO PAIN,0.090515,0.16886,0.23647,0,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.48678,0.16883,0.026376,0,0
5,GO REGULATION OF MYOBLAST FUSION,0.088862,0.16827,0.18974,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.023741,0.16818,0.18903,0,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.088862,0.16799,0.13254,0,0
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.066855,0.16785,0.16467,0,0
5,GO MEMBRANE FISSION,0.011047,0.16784,0.20025,0,0
5,GO MEMBRANE HYPERPOLARIZATION,0.0079323,0.16686,0.23673,0,0
5,GO NEURON FATE COMMITMENT,0.10465,0.16565,0.21855,0,0
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.011326,0.16526,0.19604,0,0
5,GO NEPHRIC DUCT DEVELOPMENT,0.05161,0.16454,0.17508,0,0
5,GO PROTEIN TARGETING TO LYSOSOME,0.097379,0.16441,0.16407,0,0
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.060602,0.16392,0.18642,0,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.01282,0.16379,0.18467,0,0
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0020453,0.16307,0.16986,0,0
5,GO DOPAMINE TRANSPORT,0.10845,0.16252,0.2136,0,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.18219,0.16239,0.031732,0,0
5,GO CELL FATE SPECIFICATION,0.00081984,0.16216,0.25157,0,0
5,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.075049,0.16214,0.11066,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.065563,0.16199,0.16624,0,0
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.23589,0.1619,0.25104,0,0
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.30815,0.16159,0.17885,0,0
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.27611,0.16111,0.064577,0,0
5,GO COGNITION,0.0019282,0.16098,0.15616,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0013872,0.16087,0.18597,0,0
5,GO AMINO SUGAR CATABOLIC PROCESS,0.34702,0.16064,0.079474,0,0
5,GO SEGMENTATION,0.0097392,0.16052,0.13866,0,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.011904,0.16022,0.21017,0,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,0.30815,0.16,0.045612,0,0
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.085627,0.15937,0.2227,0,0
5,GO ZINC ION HOMEOSTASIS,0.080955,0.15792,0.11527,0,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.15015,0.15786,0.073873,0,0
5,GO PRESYNAPSE ORGANIZATION,0.034637,0.15769,0.15989,0,0
5,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.18219,0.15758,0.081775,0,0
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.62113,0.15714,0.072647,0,0
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.26847,0.15679,0.082321,0,0
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.16294,0.15644,0.12906,0,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.27227,0.15643,0.077908,0,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.080955,0.15597,0.14861,0,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.0695,0.15594,0.1374,0,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.070855,0.1558,0.11266,0,0
5,GO CELLULAR OXIDANT DETOXIFICATION,0.17934,0.15506,0.066915,0,0
5,GO REGULATION OF AMINO ACID TRANSPORT,0.070855,0.15439,0.15042,0,0
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.049546,0.15408,0.26153,0,0
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.05161,0.15387,0.16604,0,0
5,GO FIBRINOLYSIS,0.059411,0.15334,0.13307,0,0
5,GO RESPONSE TO L GLUTAMATE,0.12049,0.15291,0.19402,0,0
5,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.070855,0.15287,0.12819,0,0
5,GO SEROTONIN SECRETION,0.029719,0.15141,0.29902,0,0
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.03245,0.15137,0.13178,0,0
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.085627,0.15121,0.16033,0,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.13583,0.15117,0.10672,0,0
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.12259,0.15107,0.1548,0,0
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.16032,0.15052,0.068393,0,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.27611,0.15016,0.2149,0,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15517,0.15009,0.10447,0,0
5,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.084046,0.15007,0.26403,0,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.17934,0.14954,0.093313,0,0
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.14769,0.14915,0.10937,0,0
5,GO RESPONSE TO FORSKOLIN,0.16294,0.14913,0.14719,0,0
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.076492,0.14874,0.16559,0,0
5,GO HYALURONAN CATABOLIC PROCESS,0.44402,0.14865,0.05188,0,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.17374,0.14846,0.08946,0,0
5,GO INTRACELLULAR MRNA LOCALIZATION,0.17653,0.1482,0.092556,0,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.32077,0.14816,0.086326,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0097392,0.14736,0.19532,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.10654,0.14694,0.12431,0,0
5,GO BONE TRABECULA MORPHOGENESIS,0.27611,0.14684,0.071108,0,0
5,GO PROTEIN N LINKED GLYCOSYLATION,0.075049,0.14669,0.11888,0,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.27999,0.14631,0.063247,0,0
5,GO CORONARY VASCULATURE DEVELOPMENT,0.05824,0.14631,0.12549,0,0
5,GO ETHER METABOLIC PROCESS,0.2839,0.14612,0.076796,0,0
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.009256,0.14566,0.20272,0,0
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0059384,0.14565,0.1716,0,0
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.11636,0.14541,0.071419,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.30815,0.14516,0.073538,0,0
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.035393,0.14492,0.15911,0,0
5,GO DENDRITIC SPINE DEVELOPMENT,0.0037331,0.14479,0.17352,0,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.16032,0.1439,0.1755,0,0
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.48131,0.1437,0.059454,0,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.080955,0.14368,0.15215,0,0
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.18508,0.14321,0.11402,0,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.064293,0.14297,0.11878,0,0
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.082489,0.14296,0.24548,0,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.057089,0.14281,0.10622,0,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.82348,0.1428,0.026065,0,0
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.44924,0.14222,0.071728,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.50896,0.14203,0.034305,0,0
5,GO ONE CARBON METABOLIC PROCESS,0.079444,0.14174,0.10834,0,0
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.084046,0.141,0.18971,0,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.46512,0.13939,0.072807,0,0
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.15015,0.13923,0.10156,0,0
5,GO BLASTODERM SEGMENTATION,0.16828,0.13894,0.14826,0,0
5,GO MUSCLE FILAMENT SLIDING,0.17653,0.13843,0.10099,0,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.19393,0.13798,0.082581,0,0
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.12049,0.13773,0.071408,0,0
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.57857,0.13725,0.00053524,0,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.16828,0.13717,0.056106,0,0
5,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.64605,0.137,0.079254,0,0
5,GO CILIUM ORGANIZATION,0.00013433,0.13649,0.1398,0,0
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.34702,0.13647,0.058926,0,0
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.23245,0.13631,0.070012,0,0
5,GO UV PROTECTION,0.16032,0.1363,0.099132,0,0
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.14769,0.1362,0.11155,0,0
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.11039,0.1362,0.2559,0,0
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.17653,0.13557,0.098975,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.22568,0.1354,0.23064,0,0
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.35153,0.13533,0.053229,0,0
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.057089,0.13525,0.13883,0,0
5,GO TRNA CATABOLIC PROCESS,0.25363,0.13503,0.14117,0,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.4978,0.135,0.040502,0,0
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0029794,0.13487,0.15672,0,0
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.063042,0.13471,0.12646,0,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.16559,0.13462,0.10373,0,0
5,GO PROSTATE GLAND GROWTH,0.12259,0.13462,0.17252,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.017969,0.13456,0.17108,0,0
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.14285,0.13424,0.18503,0,0
5,GO RENAL SODIUM EXCRETION,0.14526,0.13344,0.10648,0,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.12689,0.13331,0.129,0,0
5,GO RESPONSE TO INTERLEUKIN 15,0.12259,0.13314,0.15049,0,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.13355,0.13313,0.11134,0,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0695,0.13305,0.11972,0,0
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.095625,0.13303,0.12824,0,0
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.96163,0.13287,-0.025768,0,0
5,GO INCLUSION BODY ASSEMBLY,0.17374,0.13204,0.12494,0,0
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.24643,0.1318,0.0063422,0,0
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.23937,0.1317,0.089964,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.14285,0.13163,0.14813,0,0
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.090515,0.13117,0.19518,0,0
5,GO REGULATION OF INTEGRIN ACTIVATION,0.072231,0.13059,0.10182,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.44402,0.13004,-0.014898,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.036948,0.12964,0.15832,0,0
5,GO INTERLEUKIN 2 PRODUCTION,0.092194,0.12941,0.0725,0,0
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.23245,0.12933,0.072834,0,0
5,GO MACROPHAGE APOPTOTIC PROCESS,0.31653,0.12933,0.093528,0,0
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.090515,0.12862,0.11872,0,0
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.061812,0.12822,0.16804,0,0
5,GO THYMOCYTE APOPTOTIC PROCESS,0.063042,0.12809,0.18096,0,0
5,GO NEURON PROJECTION EXTENSION,0.017137,0.12787,0.1764,0,0
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.024846,0.12785,0.15844,0,0
5,GO LYMPH VESSEL MORPHOGENESIS,0.15264,0.12783,0.12848,0,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.63978,0.12747,0.023656,0,0
5,GO FAT CELL PROLIFERATION,0.16559,0.12712,0.14966,0,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.072231,0.12708,0.096829,0,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.053746,0.12692,0.1651,0,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.40349,0.12678,0.1348,0,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.40843,0.12675,0.049392,0,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,0.23245,0.12672,0.073984,0,0
5,GO RESPONSE TO INTERLEUKIN 1,0.13814,0.12664,0.066079,0,0
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.023205,0.12653,0.16154,0,0
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.079444,0.12607,0.065123,0,0
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.16294,0.12567,0.15456,0,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.15517,0.12548,0.09764,0,0
5,GO ADAPTATION OF SIGNALING PATHWAY,0.17374,0.12541,0.070177,0,0
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.12049,0.12538,0.0866,0,0
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.23937,0.12533,0.22729,0,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.097379,0.12533,0.13619,0,0
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.03939,0.12512,0.26464,0,0
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.05824,0.12495,0.2436,0,0
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.17653,0.1244,0.10704,0,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0087944,0.12421,0.21422,0,0
5,GO NEGATIVE REGULATION OF AXON EXTENSION,0.12259,0.12346,0.17633,0,0
5,GO CELLULAR RESPONSE TO DSRNA,0.073629,0.12312,0.10386,0,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.079444,0.12302,0.15881,0,0
5,GO REGULATION OF CELL FATE SPECIFICATION,0.043763,0.12301,0.21108,0,0
5,GO CELLULAR RESPONSE TO IRON ION,0.11235,0.12298,0.11253,0,0
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.16828,0.12291,0.052752,0,0
5,GO AMINO ACID IMPORT,0.1028,0.12279,0.089012,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.11636,0.12253,0.07519,0,0
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.060602,0.12249,0.05614,0,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.26098,0.12233,0.10469,0,0
5,GO MACROPHAGE PROLIFERATION,0.25001,0.12223,0.17701,0,0
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.18508,0.12221,0.062321,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.23937,0.1222,0.050211,0,0
5,GO AXON EXTENSION,0.087232,0.12181,0.15135,0,0
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0087944,0.12174,0.14814,0,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.53742,0.12167,0.06615,0,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.10654,0.12138,0.11805,0,0
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.088862,0.12131,0.080128,0,0
5,GO AORTA DEVELOPMENT,0.10465,0.12125,0.08066,0,0
5,GO POSITIVE REGULATION OF AXONOGENESIS,0.033166,0.12105,0.1747,0,0
5,GO REGULATION OF TORC1 SIGNALING,0.018398,0.12077,0.10155,0,0
5,GO POLYOL BIOSYNTHETIC PROCESS,0.065563,0.12018,0.073545,0,0
5,GO GLUTAMATE METABOLIC PROCESS,0.082489,0.11915,0.088307,0,0
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.16294,0.11913,0.062755,0,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.093897,0.11865,0.047831,0,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.59664,0.1184,0.020895,0,0
5,GO ACROSOME REACTION,0.013798,0.1182,0.18483,0,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.42347,0.11783,0.06456,0,0
5,GO POSITIVE REGULATION OF AXON EXTENSION,0.047551,0.11776,0.1603,0,0
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.085627,0.11769,0.16155,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.10096,0.11753,0.079973,0,0
5,GO REGULATION OF NEURON MIGRATION,0.061812,0.11752,0.16357,0,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.15264,0.11736,0.047323,0,0
5,GO CARDIOBLAST DIFFERENTIATION,0.54903,0.11717,0.035508,0,0
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.20309,0.11709,0.053157,0,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,0.093897,0.11691,0.1402,0,0
5,GO RESPONSE TO UV C,0.2,0.11659,0.06819,0,0
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.10654,0.11657,0.18637,0,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.10654,0.1164,0.15139,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.4598,0.11627,0.21908,0,0
5,GO DEVELOPMENTAL PIGMENTATION,0.19695,0.11604,0.057887,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.038561,0.11593,0.18275,0,0
5,GO LIVER REGENERATION,0.11039,0.11549,0.038424,0,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.30402,0.11544,0.12953,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.18508,0.11499,0.074044,0,0
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.80989,0.11489,-0.00025079,0,0
5,GO ADULT BEHAVIOR,0.018398,0.11479,0.16558,0,0
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.013139,0.11436,0.1152,0,0
5,GO THIOESTER METABOLIC PROCESS,0.29992,0.11434,0.043342,0,0
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.15517,0.11365,0.09094,0,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.20621,0.11337,0.067551,0,0
5,GO MYOBLAST PROLIFERATION,0.50896,0.11331,0.0097669,0,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.88523,0.11327,0.013507,0,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.072231,0.1131,0.073998,0,0
5,GO VENTRICULAR SYSTEM DEVELOPMENT,0.017549,0.11282,0.11509,0,0
5,GO CARBOHYDRATE PHOSPHORYLATION,0.14769,0.11264,0.081744,0,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.68418,0.11264,0.02638,0,0
5,GO REGULATION OF NEURON MATURATION,0.090515,0.11234,0.1515,0,0
5,GO CELL JUNCTION MAINTENANCE,0.10465,0.11217,0.12824,0,0
5,GO AXON DEVELOPMENT,0.0040578,0.11197,0.19239,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.20937,0.11193,0.15897,0,0
5,GO DENDRITIC SPINE MORPHOGENESIS,0.034637,0.1118,0.16587,0,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17374,0.11177,0.091799,0,0
5,GO BIOLOGICAL PHASE,0.19393,0.11147,0.15948,0,0
5,GO REGULATION OF SENSORY PERCEPTION,0.031059,0.11131,0.11931,0,0
5,GO CELLULAR RESPONSE TO PH,0.17934,0.11125,0.07499,0,0
5,GO ERAD PATHWAY,0.24288,0.11094,0.023247,0,0
5,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.33812,0.11086,0.079053,0,0
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.23937,0.11061,0.08892,0,0
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.065563,0.11055,0.17878,0,0
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.19695,0.11027,0.15622,0,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.65234,0.11001,0.018346,0,0
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.32506,0.10977,0.11739,0,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.072231,0.10976,0.15109,0,0
5,GO ADHERENS JUNCTION ORGANIZATION,0.029719,0.10976,0.1326,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.090515,0.10975,0.16022,0,0
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.27999,0.10967,0.045111,0,0
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.15517,0.10927,0.087323,0,0
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.21256,0.10916,0.088938,0,0
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.053746,0.10875,0.12654,0,0
5,GO RESPONSE TO HYDROPEROXIDE,0.16032,0.1082,0.10046,0,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.12049,0.10808,0.083279,0,0
5,GO HEMIDESMOSOME ASSEMBLY,0.62113,0.10805,0.0255,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.10845,0.10673,0.14532,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.42347,0.10654,0.1151,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.51459,0.10631,0.049329,0,0
5,GO DENDRITE MORPHOGENESIS,0.041967,0.10617,0.13062,0,0
5,GO CELL PART MORPHOGENESIS,0.018836,0.10596,0.16153,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.025414,0.10576,0.14024,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.29586,0.10547,0.096599,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.24643,0.10536,0.05545,0,0
5,GO RESPONSE TO IMMOBILIZATION STRESS,0.12049,0.10509,0.17173,0,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.71006,0.10488,-0.00738,0,0
5,GO RIG I SIGNALING PATHWAY,0.69707,0.10485,0.0032697,0,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.32506,0.10471,0.035369,0,0
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0056288,0.1047,0.15588,0,0
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.077957,0.10417,0.13069,0,0
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.34256,0.10379,0.10108,0,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.1313,0.10359,0.056586,0,0
5,GO SEQUESTERING OF METAL ION,0.11039,0.10351,0.20115,0,0
5,GO REGULATION OF CHLORIDE TRANSPORT,0.54903,0.10349,0.040088,0,0
5,GO I KAPPAB PHOSPHORYLATION,0.073629,0.10326,0.10554,0,0
5,GO REGULATION OF URINE VOLUME,0.073629,0.10324,0.077145,0,0
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.04854,0.10302,0.13212,0,0
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.20621,0.10256,0.052927,0,0
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.060602,0.10253,0.18576,0,0
5,GO CELL CELL JUNCTION MAINTENANCE,0.29184,0.10222,0.080957,0,0
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.11039,0.10209,0.12463,0,0
5,GO ACROSOME ASSEMBLY,0.077957,0.10203,0.12407,0,0
5,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.40843,0.10196,0.093315,0,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.70355,0.10181,0.032142,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION,0.068167,0.10179,0.071748,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.3746,0.10171,0.04933,0,0
5,GO GOLGI LOCALIZATION,0.025414,0.10155,0.12289,0,0
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.63978,0.10153,0.028868,0,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.37932,0.10152,0.059758,0,0
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.025414,0.10146,0.17429,0,0
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.1028,0.10143,0.10312,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.1028,0.10125,0.11608,0,0
5,GO FATTY ACYL COA METABOLIC PROCESS,0.36064,0.10083,0.061256,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.58456,0.10072,0.058155,0,0
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.12049,0.10072,0.05945,0,0
5,GO PLASMA MEMBRANE REPAIR,0.74288,0.10039,-0.047425,0,0
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.36064,0.10022,0.036806,0,0
5,GO NEUROTRANSMITTER REUPTAKE,0.43367,0.10009,0.064919,0,0
5,GO INTRACILIARY TRANSPORT,0.033894,0.099891,0.1581,0,0
5,GO APICAL PROTEIN LOCALIZATION,0.13583,0.099714,0.16654,0,0
5,GO GLIAL CELL ACTIVATION,0.13814,0.099668,0.12757,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.076492,0.099629,0.10481,0,0
5,GO LYMPH NODE DEVELOPMENT,0.059411,0.099473,0.11641,0,0
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.49227,0.099312,0.10871,0,0
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.44924,0.099298,0.073634,0,0
5,GO G0 TO G1 TRANSITION,0.14769,0.099234,0.051302,0,0
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.020205,0.099224,0.10275,0,0
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.11235,0.099065,0.086264,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.29184,0.098891,0.10323,0,0
5,GO RNA DESTABILIZATION,0.20309,0.098868,0.041097,0,0
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.068167,0.098845,0.080242,0,0
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.25363,0.098501,0.18926,0,0
5,GO NIK NF KAPPAB SIGNALING,0.088862,0.098488,0.060375,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.073629,0.09838,0.07357,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.066855,0.098199,0.16294,0,0
5,GO REGULATION OF HEART GROWTH,0.25729,0.098121,0.052399,0,0
5,GO GASTRIC ACID SECRETION,0.066855,0.097959,0.16713,0,0
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.10465,0.097935,0.12514,0,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,0.084046,0.097583,0.14488,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.088862,0.097455,0.17357,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.095625,0.097392,0.07869,0,0
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.52594,0.097352,0.09896,0,0
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.34702,0.097048,0.05372,0,0
5,GO CEREBRAL CORTEX CELL MIGRATION,0.066855,0.096983,0.12948,0,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.72969,0.096867,-0.003066,0,0
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.40349,0.096731,0.035058,0,0
5,GO IRON ION HOMEOSTASIS,0.10465,0.096657,0.078942,0,0
5,GO NOTCH RECEPTOR PROCESSING,0.10096,0.09639,0.18699,0,0
5,GO THYROID GLAND DEVELOPMENT,0.12908,0.096316,0.12997,0,0
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.011326,0.096314,0.11452,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0695,0.096268,0.1085,0,0
5,GO REGULATION OF AXON GUIDANCE,0.3746,0.09606,0.12948,0,0
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.050569,0.09593,0.086618,0,0
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.32077,0.095817,0.022864,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.015574,0.095485,0.18704,0,0
5,GO VIRAL RNA GENOME REPLICATION,0.10096,0.095176,0.089304,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.023741,0.095043,0.16553,0,0
5,GO PROTEIN STABILIZATION,0.070855,0.094842,0.0595,0,0
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.25729,0.094796,0.058028,0,0
5,GO VESICLE BUDDING FROM MEMBRANE,0.29184,0.094785,0.041298,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.055956,0.094714,0.086458,0,0
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.29586,0.094442,0.035635,0,0
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.17374,0.094304,0.11961,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.27611,0.094261,0.10639,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.36526,0.094032,0.052576,0,0
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.25001,0.094004,0.047101,0,0
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.14048,0.093541,0.12186,0,0
5,GO INTERLEUKIN 17 PRODUCTION,0.077957,0.093452,0.06623,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.12689,0.093335,0.08318,0,0
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.21579,0.093302,0.10794,0,0
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.055956,0.093275,0.12056,0,0
5,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.83713,0.093274,-0.01468,0,0
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.19095,0.093181,0.083303,0,0
5,GO RESPONSE TO STEROL DEPLETION,0.14285,0.093115,0.097199,0,0
5,GO PODOSOME ASSEMBLY,0.093897,0.093029,0.13538,0,0
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.13814,0.092734,0.10609,0,0
5,GO AXONAL FASCICULATION,0.22905,0.092694,0.14699,0,0
5,GO COPULATION,0.11636,0.092656,0.10945,0,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.26471,0.092512,0.095768,0,0
5,GO HEPATOCYTE DIFFERENTIATION,0.2,0.092453,0.12647,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.063042,0.092386,0.14263,0,0
5,GO PIGMENT CELL DIFFERENTIATION,0.50337,0.092367,0.03295,0,0
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.011612,0.092302,0.14278,0,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.4978,0.092205,0.023672,0,0
5,GO REGULATION OF ORGAN GROWTH,0.079444,0.091965,0.073962,0,0
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.092194,0.091814,0.10775,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.072231,0.091743,0.16178,0,0
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.29184,0.091486,0.10695,0,0
5,GO REGULATION OF NUCLEASE ACTIVITY,0.14285,0.091455,0.062337,0,0
5,GO DENDRITE DEVELOPMENT,0.043763,0.091015,0.12509,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.090515,0.090866,0.10461,0,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.18508,0.090785,0.085357,0,0
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.39371,0.09065,0.044736,0,0
5,GO TELENCEPHALON REGIONALIZATION,0.16559,0.090645,0.18385,0,0
5,GO FATTY ACID BETA OXIDATION,0.084046,0.090439,0.067061,0,0
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.25363,0.090399,0.21452,0,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.21579,0.090369,0.048112,0,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.94073,0.090244,-0.026118,0,0
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.013798,0.09007,0.12137,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.15015,0.089728,0.10533,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.32506,0.089553,0.12674,0,0
5,GO PEPTIDE CATABOLIC PROCESS,0.2,0.089379,0.065061,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.32077,0.089199,0.054201,0,0
5,GO RESPONSE TO LEPTIN,0.2,0.088541,0.075716,0,0
5,GO CYTOPLASM ORGANIZATION,0.60883,0.088472,0.031156,0,0
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.010506,0.088349,0.17929,0,0
5,GO NEURON PROJECTION GUIDANCE,0.013139,0.088005,0.20855,0,0
5,GO CONVERGENT EXTENSION,0.25729,0.087946,0.097416,0,0
5,GO INTESTINAL ABSORPTION,0.070855,0.08792,0.11052,0,0
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.093897,0.087738,0.0579,0,0
5,GO PINOCYTOSIS,0.33373,0.08753,0.047863,0,0
5,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.25729,0.087512,0.066389,0,0
5,GO LYSINE METABOLIC PROCESS,0.69061,0.087457,-0.087707,0,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.034637,0.087068,0.21092,0,0
5,GO HISTONE H3 K27 METHYLATION,0.20937,0.086841,0.079497,0,0
5,GO RESPONSE TO COCAINE,0.068167,0.086398,0.12082,0,0
5,GO GLUCOSE CATABOLIC PROCESS,0.67776,0.0863,0.022661,0,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.13355,0.086273,0.079325,0,0
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.20309,0.086069,0.044865,0,0
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.67776,0.086067,0.02964,0,0
5,GO CELL JUNCTION DISASSEMBLY,0.29992,0.086027,0.04915,0,0
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.11434,0.085797,0.070826,0,0
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.12259,0.085711,0.047753,0,0
5,GO SPERM EGG RECOGNITION,0.22905,0.085634,0.05391,0,0
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.38888,0.085627,0.048276,0,0
5,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.090515,0.085243,0.13074,0,0
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.40349,0.085221,0.022891,0,0
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.16828,0.085204,0.086686,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.065563,0.085087,0.057892,0,0
5,GO PULMONARY VALVE DEVELOPMENT,0.51459,0.084846,0.065146,0,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.25729,0.084605,0.080674,0,0
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.095625,0.084369,0.1519,0,0
5,GO RESPONSE TO CAMP,0.0073363,0.084362,0.10713,0,0
5,GO CELLULAR RESPONSE TO DRUG,0.38888,0.084173,0.042383,0,0
5,GO BARBED END ACTIN FILAMENT CAPPING,0.29992,0.084163,0.050534,0,0
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.068167,0.083949,0.045232,0,0
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.072231,0.083916,0.13723,0,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.43367,0.083561,0.031226,0,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.92682,0.083506,-0.015758,0,0
5,GO ENDOSOME ORGANIZATION,0.16294,0.083271,0.046403,0,0
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.27999,0.083199,0.055209,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.12473,0.083011,0.054192,0,0
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.14285,0.083009,0.1185,0,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.23589,0.082727,0.11912,0,0
5,GO POSITIVE REGULATION OF LIPID STORAGE,0.088862,0.08265,0.095546,0,0
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.27611,0.082234,0.054128,0,0
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.18508,0.081998,0.047567,0,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.13583,0.08193,0.065071,0,0
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.18219,0.081804,0.065675,0,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.47049,0.081088,0.038991,0,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.32938,0.080878,0.11424,0,0
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.077957,0.080831,0.13663,0,0
5,GO HISTONE H3 K9 MODIFICATION,0.16559,0.080319,0.094749,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.12908,0.080303,0.065155,0,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.16032,0.080148,0.066058,0,0
5,GO REGULATION OF PROTEIN TARGETING,0.015203,0.080132,0.077663,0,0
5,GO ERBB2 SIGNALING PATHWAY,0.11636,0.080082,0.071485,0,0
5,GO NEURON MIGRATION,0.087232,0.079953,0.14317,0,0
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.23589,0.079927,0.040264,0,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.63354,0.079721,0.049121,0,0
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.75615,0.079639,-0.0059762,0,0
5,GO CATECHOLAMINE METABOLIC PROCESS,0.11636,0.079603,0.14898,0,0
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.64605,0.079553,-0.069001,0,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.066855,0.079346,0.1562,0,0
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.26471,0.079201,0.046499,0,0
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.21256,0.079147,0.065348,0,0
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.59664,0.078969,0.044938,0,0
5,GO LIPID IMPORT INTO CELL,0.21579,0.078969,0.088844,0,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.89215,0.078968,-0.019269,0,0
5,GO CELLULAR COMPONENT MAINTENANCE,0.014138,0.078796,0.1311,0,0
5,GO RETINA LAYER FORMATION,0.17374,0.078403,0.1936,0,0
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.34256,0.078258,0.041026,0,0
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.11841,0.078226,0.10273,0,0
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.085627,0.077961,0.15639,0,0
5,GO NEURON CELLULAR HOMEOSTASIS,0.23589,0.077943,0.12617,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.33373,0.077897,0.036733,0,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.35153,0.077894,0.040463,0,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.18508,0.077871,0.080312,0,0
5,GO CELLULAR RESPONSE TO X RAY,0.1028,0.077737,0.017614,0,0
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.62113,0.077694,0.041163,0,0
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.68418,0.077445,-0.0089693,0,0
5,GO OLIGOPEPTIDE TRANSPORT,0.59664,0.077032,0.0067548,0,0
5,GO MAINTENANCE OF CELL POLARITY,0.11235,0.077024,0.10126,0,0
5,GO REPLICATIVE SENESCENCE,0.30402,0.07702,0.076033,0,0
5,GO FC RECEPTOR SIGNALING PATHWAY,0.25729,0.076972,0.042392,0,0
5,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.56666,0.076898,0.047075,0,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.076492,0.076621,0.15119,0,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.48131,0.07651,0.010799,0,0
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.13814,0.076099,0.076862,0,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.20937,0.075974,0.098657,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.43883,0.07592,0.051902,0,0
5,GO PIGMENT GRANULE LOCALIZATION,0.2,0.075884,0.087923,0,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.084046,0.075744,0.14109,0,0
5,GO POST EMBRYONIC DEVELOPMENT,0.087232,0.075369,0.099255,0,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.36526,0.075314,0.033356,0,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.25363,0.07521,0.020139,0,0
5,GO OVULATION CYCLE PROCESS,0.15517,0.075127,0.085776,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.15015,0.07512,0.085053,0,0
5,GO HISTONE H3 K9 METHYLATION,0.16294,0.075016,0.10197,0,0
5,GO MRNA TRANSCRIPTION,0.082489,0.074924,0.084143,0,0
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.20937,0.074769,0.11515,0,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.4545,0.074522,0.12106,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.24643,0.073935,0.055071,0,0
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.05824,0.073885,0.077445,0,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.24643,0.073844,0.050896,0,0
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.22235,0.073488,0.041146,0,0
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.44924,0.073376,0.041835,0,0
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.090515,0.073325,0.11407,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.59664,0.07293,0.0053646,0,0
5,GO PORE COMPLEX ASSEMBLY,0.10096,0.07245,0.068475,0,0
5,GO RESPONSE TO ALKALOID,0.10845,0.072439,0.067385,0,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.94769,0.072414,-0.011571,0,0
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.33373,0.072275,0.1324,0,0
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.11039,0.072271,0.048348,0,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.11434,0.072183,0.096164,0,0
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.11434,0.072055,0.069867,0,0
5,GO MANGANESE ION TRANSPORT,0.59664,0.072033,-0.0034201,0,0
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.2,0.072011,0.072853,0,0
5,GO CHROMATIN SILENCING AT TELOMERE,0.4545,0.071844,0.054719,0,0
5,GO PROSTAGLANDIN SECRETION,0.50337,0.071842,0.018684,0,0
5,GO REGULATION OF CIRCADIAN RHYTHM,0.011047,0.071827,0.093218,0,0
5,GO PEROXISOMAL TRANSPORT,0.15264,0.071631,0.081117,0,0
5,GO DETECTION OF VISIBLE LIGHT,0.14048,0.071616,0.034485,0,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.35607,0.071351,0.028593,0,0
5,GO POSITIVE REGULATION OF URINE VOLUME,0.064293,0.071298,0.097492,0,0
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.090515,0.071249,0.093014,0,0
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.40349,0.071072,0.12761,0,0
5,GO ANDROGEN METABOLIC PROCESS,0.090515,0.070873,0.062939,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.65234,0.070733,0.011938,0,0
5,GO TRANSITION METAL ION TRANSPORT,0.11636,0.07063,0.048914,0,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.32938,0.070509,0.10244,0,0
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.76948,0.070433,0.025108,0,0
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.78962,0.070141,0.00075356,0,0
5,GO RESPONSE TO ANGIOTENSIN,0.11235,0.06992,0.077554,0,0
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.93377,0.069913,0.04529,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.81668,0.069774,0.02193,0,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.4978,0.069756,0.034046,0,0
5,GO OVULATION,0.39858,0.069728,0.029249,0,0
5,GO PROTEIN TARGETING TO VACUOLE,0.32506,0.069642,0.067951,0,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.54903,0.069617,0.028886,0,0
5,GO CHYLOMICRON ASSEMBLY,0.56075,0.069555,0.0032402,0,0
5,GO REGULATION OF DENDRITE MORPHOGENESIS,0.11235,0.069494,0.098678,0,0
5,GO RESPONSE TO X RAY,0.39858,0.06918,0.01167,0,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.5726,0.069154,-0.0073253,0,0
5,GO REGULATION OF DENDRITE EXTENSION,0.2,0.069137,0.21112,0,0
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.084046,0.068967,0.12526,0,0
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.061812,0.068571,0.058439,0,0
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.47588,0.068347,0.034018,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.21905,0.067973,0.12408,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.41842,0.06786,0.057795,0,0
5,GO ORGANELLE MEMBRANE FUSION,0.48678,0.067646,0.037936,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.12689,0.067611,0.13189,0,0
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.095625,0.067451,0.13948,0,0
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.2839,0.067432,0.030786,0,0
5,GO AMYLOID BETA CLEARANCE,0.20937,0.067383,0.070706,0,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.38888,0.067317,0.059359,0,0
5,GO MESODERMAL CELL DIFFERENTIATION,0.41341,0.067302,0.026239,0,0
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.46512,0.067287,0.019703,0,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.33812,0.067268,0.048433,0,0
5,GO FILOPODIUM ASSEMBLY,0.19695,0.067105,0.097466,0,0
5,GO CELLULAR IRON ION HOMEOSTASIS,0.21905,0.067082,0.04959,0,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.32938,0.066919,0.09291,0,0
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.30402,0.066899,0.02367,0,0
5,GO ORGANIC ACID METABOLIC PROCESS,0.085627,0.06671,0.056114,0,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.35607,0.066625,0.036718,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.13355,0.066565,0.12407,0,0
5,GO ORGANIC ACID CATABOLIC PROCESS,0.14769,0.066478,0.046036,0,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.188,0.065891,0.15519,0,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.40349,0.065861,0.036604,0,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.35607,0.065826,0.10991,0,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.26471,0.065636,0.080921,0,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.3746,0.065618,0.051219,0,0
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.56666,0.065363,-0.0078957,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.22568,0.065163,0.18785,0,0
5,GO ESTROGEN METABOLIC PROCESS,0.05824,0.065088,0.07747,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.26847,0.06503,0.065829,0,0
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.57857,0.06496,-0.012736,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.40349,0.064932,0.048921,0,0
5,GO HISTONE H4 K5 ACETYLATION,0.16294,0.064921,0.09409,0,0
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.046579,0.064843,0.12326,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.78289,0.064641,0.05886,0,0
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.23589,0.064634,0.064331,0,0
5,GO HISTONE H4 K16 ACETYLATION,0.21579,0.064553,0.061165,0,0
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.5726,0.064498,0.014215,0,0
5,GO OOCYTE DIFFERENTIATION,0.26098,0.064447,0.056011,0,0
5,GO MITOCHONDRIAL FISSION,0.12259,0.064413,0.05659,0,0
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.65866,0.064234,0.11332,0,0
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.35153,0.064171,0.10234,0,0
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.39371,0.063919,0.041259,0,0
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.084046,0.063888,0.090487,0,0
5,GO NUCLEAR MIGRATION,0.26471,0.063857,0.10515,0,0
5,GO NUCLEUS LOCALIZATION,0.23245,0.063817,0.10222,0,0
5,GO PALLIUM DEVELOPMENT,0.04854,0.063583,0.1231,0,0
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.12908,0.062927,0.040729,0,0
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.41842,0.062861,0.015052,0,0
5,GO ESCRT COMPLEX DISASSEMBLY,0.79636,0.062696,0.026527,0,0
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.17653,0.062635,0.042115,0,0
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.63354,0.062521,0.06835,0,0
5,GO GOLGI TO VACUOLE TRANSPORT,0.39858,0.062488,0.034105,0,0
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.27611,0.062465,0.057353,0,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.095625,0.061817,0.087168,0,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.38888,0.061816,0.0068379,0,0
5,GO UBIQUINONE METABOLIC PROCESS,0.69061,0.061779,-0.036328,0,0
5,GO SULFUR COMPOUND METABOLIC PROCESS,0.60272,0.061218,0.014756,0,0
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.65866,0.061189,0.004485,0,0
5,GO HISTONE H3 K4 METHYLATION,0.71658,0.061166,-0.012915,0,0
5,GO OXIDATION REDUCTION PROCESS,0.085627,0.061155,0.06281,0,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.8303,0.061054,-0.0084094,0,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.24288,0.060914,0.18508,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.18508,0.060856,0.10505,0,0
5,GO LIPOPROTEIN LOCALIZATION,0.34702,0.060566,0.030725,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.99651,0.060207,0.004683,0,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.53167,0.060096,0.066407,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.087232,0.059942,0.084406,0,0
5,GO HISTONE H4 ACETYLATION,0.10654,0.059855,0.052795,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17099,0.059724,0.052924,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.25363,0.059383,0.047076,0,0
5,GO REGULATION OF CILIUM ASSEMBLY,0.21905,0.059278,0.057454,0,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.16294,0.059214,0.048876,0,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.060602,0.059123,0.11847,0,0
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.18219,0.059103,0.061122,0,0
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.17653,0.05907,0.035727,0,0
5,GO EMBRYONIC AXIS SPECIFICATION,0.085627,0.059024,0.12355,0,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.23589,0.059005,0.12144,0,0
5,GO RESPONSE TO GONADOTROPIN,0.46512,0.058984,0.037385,0,0
5,GO RESPONSE TO SALT STRESS,0.44924,0.058721,0.026173,0,0
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16559,0.058615,0.12809,0,0
5,GO SYNAPTIC VESICLE BUDDING,0.63354,0.05851,0.05034,0,0
5,GO SIGNAL PEPTIDE PROCESSING,0.71658,0.058505,-0.063661,0,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.15015,0.058253,0.22784,0,0
5,GO RESPIRATORY SYSTEM PROCESS,0.25001,0.058144,0.065414,0,0
5,GO CHRONIC INFLAMMATORY RESPONSE,0.42855,0.058138,0.12799,0,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.24288,0.058006,0.058607,0,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.50896,0.057853,-0.03246,0,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.26847,0.057775,0.073264,0,0
5,GO REGULATION OF ACTION POTENTIAL,0.087232,0.057568,0.11531,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.27227,0.057495,0.044061,0,0
5,GO SYMBIOTIC PROCESS,0.12259,0.057441,0.041714,0,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.47588,0.057328,0.016962,0,0
5,GO PRESYNAPTIC ENDOCYTOSIS,0.17934,0.057191,0.10979,0,0
5,GO SECRETORY GRANULE ORGANIZATION,0.54903,0.057181,0.038325,0,0
5,GO GOLGI VESICLE TRANSPORT,0.21905,0.057175,0.032914,0,0
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.19695,0.057144,0.056012,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.42855,0.056995,0.093702,0,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,0.076492,0.056861,0.14121,0,0
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.42855,0.056814,0.024755,0,0
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.20621,0.056608,0.054309,0,0
5,GO REGULATION OF RECEPTOR RECYCLING,0.26471,0.056557,0.065807,0,0
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.15015,0.056546,0.074812,0,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.47588,0.056397,0.028066,0,0
5,GO GENETIC IMPRINTING,0.15015,0.056227,0.083136,0,0
5,GO AMINO ACID TRANSPORT,0.32506,0.056026,0.041553,0,0
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.29586,0.055999,0.055574,0,0
5,GO ETHER BIOSYNTHETIC PROCESS,0.90599,0.055719,-0.06117,0,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.62732,0.055555,-0.058198,0,0
5,GO MIDBODY ABSCISSION,0.67137,0.055534,0.042948,0,0
5,GO LAMELLIPODIUM ORGANIZATION,0.15773,0.055358,0.060463,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.24288,0.055323,0.099332,0,0
5,GO POSITIVE REGULATION OF CELL SIZE,0.72969,0.055065,0.0019237,0,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.29586,0.05494,0.048566,0,0
5,GO REGULATION OF CELL MATURATION,0.1028,0.054674,0.074285,0,0
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.80989,0.054287,-0.013777,0,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.077957,0.054145,0.14272,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.29586,0.053899,0.11653,0,0
5,GO LYMPHANGIOGENESIS,0.51459,0.053871,0.079548,0,0
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.095625,0.0536,0.092226,0,0
5,GO REGULATION OF HISTONE MODIFICATION,0.090515,0.053481,0.059749,0,0
5,GO ATP BIOSYNTHETIC PROCESS,0.42855,0.05302,0.019476,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.26098,0.052997,0.065186,0,0
5,GO RESPONSE TO INACTIVITY,0.59664,0.052981,0.022732,0,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.095625,0.052949,0.090419,0,0
5,GO SEQUESTERING OF CALCIUM ION,0.20937,0.052757,0.077362,0,0
5,GO HISTONE H3 K9 TRIMETHYLATION,0.077957,0.052494,0.095952,0,0
5,GO VITAMIN METABOLIC PROCESS,0.41842,0.05201,0.018876,0,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.32938,0.051932,0.05864,0,0
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.095625,0.051909,0.098618,0,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.42347,0.051878,0.02258,0,0
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.095625,0.051815,0.40999,0,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,0.31232,0.051488,0.11546,0,0
5,GO PEROXISOME ORGANIZATION,0.17934,0.051407,0.071204,0,0
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.070855,0.051164,0.047649,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.19095,0.050641,0.044001,0,0
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.11434,0.050484,0.04997,0,0
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.60272,0.050481,0.0010618,0,0
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.22905,0.050371,0.084293,0,0
5,GO HYPOTHALAMUS DEVELOPMENT,0.50337,0.050363,0.055072,0,0
5,GO PROTEIN HOMOTETRAMERIZATION,0.063042,0.049935,0.073304,0,0
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.75615,0.049883,0.033196,0,0
5,GO POSITIVE REGULATION OF MITOPHAGY,0.98953,0.04959,-0.024659,0,0
5,GO CELLULAR RESPONSE TO UV,0.095625,0.049464,0.070337,0,0
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.24288,0.04945,0.072926,0,0
5,GO GLUTATHIONE METABOLIC PROCESS,0.75615,0.049279,-0.0026348,0,0
5,GO REGULATION OF MRNA 3 END PROCESSING,0.3746,0.049133,0.025649,0,0
5,GO NON RECOMBINATIONAL REPAIR,0.3746,0.04909,0.028242,0,0
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.24288,0.048887,0.029103,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.15015,0.048884,0.048357,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.10845,0.048713,0.045041,0,0
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.62732,0.048631,0.018085,0,0
5,GO HISTONE H4 DEACETYLATION,0.22568,0.048518,0.086075,0,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.025414,0.048376,0.10213,0,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,0.31232,0.048282,0.06839,0,0
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.24288,0.048236,0.14237,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.26098,0.048106,0.049464,0,0
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.37932,0.04791,0.076294,0,0
5,GO PH REDUCTION,0.53167,0.047852,0.010684,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.41842,0.047698,0.087045,0,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.15264,0.047473,0.045957,0,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.22905,0.047406,0.041575,0,0
5,GO REGULATION OF BEHAVIOR,0.14769,0.047185,0.081591,0,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.68418,0.047164,-0.035609,0,0
5,GO BLASTOCYST DEVELOPMENT,0.12689,0.046987,0.039537,0,0
5,GO INOSITOL METABOLIC PROCESS,0.18508,0.04696,0.080898,0,0
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.064293,0.046877,0.10905,0,0
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.25729,0.046803,0.078103,0,0
5,GO HEMOGLOBIN METABOLIC PROCESS,0.74288,0.046802,-0.024008,0,0
5,GO CYCLOOXYGENASE PATHWAY,0.88523,0.04677,-0.035393,0,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.20309,0.046695,0.095993,0,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.16032,0.046624,0.2057,0,0
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.47049,0.046377,0.016458,0,0
5,GO PANCREATIC JUICE SECRETION,0.38888,0.046241,0.027797,0,0
5,GO TETRAPYRROLE METABOLIC PROCESS,0.80989,0.04616,-0.030926,0,0
5,GO CD40 SIGNALING PATHWAY,0.62732,0.046119,0.0008766,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.19095,0.046081,0.061643,0,0
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.22905,0.045891,0.085843,0,0
5,GO RESPONSE TO DSRNA,0.5726,0.04585,0.015887,0,0
5,GO PROTEIN MANNOSYLATION,0.188,0.045804,0.0761,0,0
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.19095,0.045787,0.066167,0,0
5,GO LOCOMOTOR RHYTHM,0.62113,0.045743,0.029594,0,0
5,GO HISTONE H3 K14 ACETYLATION,0.72969,0.045462,0.013322,0,0
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.17374,0.045335,0.071607,0,0
5,GO OXYGEN TRANSPORT,0.60272,0.045261,-0.13752,0,0
5,GO DETECTION OF LIGHT STIMULUS,0.060602,0.045165,0.058161,0,0
5,GO REGULATION OF CHROMATIN ORGANIZATION,0.057089,0.04501,0.059967,0,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,0.71658,0.044918,-0.056237,0,0
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.63354,0.044697,0.011091,0,0
5,GO EMBRYONIC PATTERN SPECIFICATION,0.12473,0.044597,0.10157,0,0
5,GO PROTEIN POLYUBIQUITINATION,0.095625,0.04457,0.044779,0,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.66501,0.044555,0.00021015,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.24643,0.044439,0.056748,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.25363,0.044434,0.024015,0,0
5,GO L GLUTAMATE IMPORT,0.37932,0.044411,0.038147,0,0
5,GO ESTROGEN BIOSYNTHETIC PROCESS,0.52025,0.044043,0.022517,0,0
5,GO RESPONSE TO HEAT,0.25729,0.044019,0.033541,0,0
5,GO REGULATION OF HIPPO SIGNALING,0.62113,0.043929,0.04438,0,0
5,GO REGULATION OF PINOCYTOSIS,0.14769,0.043635,0.077085,0,0
5,GO RNA DECAPPING,0.85082,0.043558,-0.0070373,0,0
5,GO MALE GENITALIA DEVELOPMENT,0.39858,0.043546,0.054686,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.47049,0.043474,-0.10074,0,0
5,GO LONG TERM SYNAPTIC DEPRESSION,0.28785,0.043437,0.16104,0,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.97557,0.043395,0.0096512,0,0
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.63354,0.043344,0.023925,0,0
5,GO PHAGOSOME ACIDIFICATION,0.81668,0.043166,-0.006695,0,0
5,GO UTERUS DEVELOPMENT,0.74288,0.043115,0.027671,0,0
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.22905,0.043008,0.045178,0,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.97557,0.042972,0.01782,0,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.36991,0.042971,0.1027,0,0
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.44924,0.042905,0.041545,0,0
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.30815,0.042881,0.054875,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.42855,0.042874,0.083365,0,0
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.36526,0.042586,0.031989,0,0
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.14048,0.042442,0.030782,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.69707,0.042168,0.028867,0,0
5,GO VITAMIN TRANSPORT,0.54321,0.042077,0.0075432,0,0
5,GO XENOBIOTIC TRANSPORT,0.48131,0.041707,0.012594,0,0
5,GO AUTOPHAGY OF MITOCHONDRION,0.32077,0.041649,0.02658,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.12689,0.041541,0.083881,0,0
5,GO INTERACTION WITH SYMBIONT,0.44924,0.041522,0.011303,0,0
5,GO SUCKLING BEHAVIOR,0.85768,0.041331,0.012425,0,0
5,GO ENDOSOMAL TRANSPORT,0.087232,0.041257,0.049116,0,0
5,GO HORMONE CATABOLIC PROCESS,0.72969,0.041249,0.022599,0,0
5,GO MICROTUBULE ANCHORING,0.20621,0.040838,0.062395,0,0
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.10096,0.040745,0.041819,0,0
5,GO REGULATION OF PROTEIN FOLDING,0.55487,0.040618,0.02563,0,0
5,GO CARTILAGE MORPHOGENESIS,0.73628,0.040526,0.036197,0,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.30815,0.040523,0.060789,0,0
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.52025,0.040141,0.028615,0,0
5,GO PROTEIN KINASE A SIGNALING,0.53167,0.039922,0.0062561,0,0
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.059411,0.039714,0.080679,0,0
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.17934,0.039693,0.077807,0,0
5,GO REGULATION OF HISTONE METHYLATION,0.35153,0.039491,0.033307,0,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.48131,0.039356,0.047865,0,0
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.72969,0.03912,-0.027431,0,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.88523,0.039036,-0.038347,0,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.75615,0.038963,-0.0039834,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.084046,0.038923,0.045751,0,0
5,GO RESPONSE TO IONIZING RADIATION,0.46512,0.0389,0.025942,0,0
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.79636,0.038895,0.014425,0,0
5,GO POSITIVE REGULATION OF HEART GROWTH,0.90599,0.038025,0.0038657,0,0
5,GO MATING BEHAVIOR,0.86455,0.037945,-0.0068429,0,0
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.47588,0.037894,0.03616,0,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.75615,0.037834,-0.026112,0,0
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.12049,0.03769,0.027174,0,0
5,GO NEURON REMODELING,0.30402,0.037518,0.10724,0,0
5,GO HEART FORMATION,0.34702,0.037213,0.099849,0,0
5,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.86455,0.037191,-0.0061395,0,0
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.64605,0.036896,0.040813,0,0
5,GO LIMB BUD FORMATION,0.29586,0.036887,0.19965,0,0
5,GO EXOCYTIC PROCESS,0.33373,0.036688,0.06882,0,0
5,GO GALACTOSE METABOLIC PROCESS,0.18219,0.036475,0.13503,0,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.15517,0.036406,0.10536,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.38408,0.036322,0.042994,0,0
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.14285,0.036319,0.090695,0,0
5,GO IMMATURE T CELL PROLIFERATION,0.73628,0.036257,0.015389,0,0
5,GO MISMATCH REPAIR,0.066855,0.036178,0.078017,0,0
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.26471,0.036037,0.082193,0,0
5,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.29184,0.035961,0.12384,0,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.20621,0.035876,0.02647,0,0
5,GO L AMINO ACID TRANSPORT,0.43883,0.035867,0.020908,0,0
5,GO LIPID PHOSPHORYLATION,0.099158,0.035842,0.080238,0,0
5,GO POLYOL TRANSPORT,0.53167,0.035568,0.040843,0,0
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.68418,0.035519,-0.0032656,0,0
5,GO ORGANELLE FUSION,0.60883,0.035345,0.024178,0,0
5,GO DENDRITE SELF AVOIDANCE,0.67776,0.035305,0.06938,0,0
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.74288,0.035228,0.0086168,0,0
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.99651,0.035141,-0.0002487,0,0
5,GO HYPEROSMOTIC RESPONSE,0.52025,0.035099,0.066209,0,0
5,GO CARNITINE SHUTTLE,0.32938,0.034952,0.066494,0,0
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.23245,0.034888,0.10383,0,0
5,GO REGULATION OF SISTER CHROMATID COHESION,0.32077,0.034787,0.041058,0,0
5,GO TORC1 SIGNALING,0.32938,0.034771,0.028924,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.041967,0.034684,0.11784,0,0
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.20621,0.034652,0.12055,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.62113,0.034611,0.0091361,0,0
5,GO HEAT GENERATION,0.27999,0.034493,0.087609,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.41341,0.03447,0.02129,0,0
5,GO PEPTIDE CROSS LINKING,0.19695,0.034345,0.19394,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.19393,0.03426,0.060169,0,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.59059,0.034156,0.019229,0,0
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.65234,0.033997,0.050887,0,0
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.36064,0.03399,0.093488,0,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.72969,0.033549,0.041261,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.85082,0.03351,-0.02295,0,0
5,GO COENZYME A METABOLIC PROCESS,0.72969,0.033455,-0.015443,0,0
5,GO MICROTUBULE BASED PROCESS,0.072231,0.0333,0.058611,0,0
5,GO HISTONE MONOUBIQUITINATION,0.36526,0.033203,0.031387,0,0
5,GO RESPONSE TO HYDROXYUREA,0.26847,0.032989,0.068769,0,0
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.53167,0.032862,0.036919,0,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.072231,0.03283,0.10146,0,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.7495,0.032562,-0.0011047,0,0
5,GO SYNAPTIC VESICLE RECYCLING,0.23245,0.032533,0.095755,0,0
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.95466,0.032377,0.0060279,0,0
5,GO LAMELLIPODIUM ASSEMBLY,0.30402,0.032228,0.050044,0,0
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.20937,0.032195,0.066368,0,0
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.53742,0.032183,0.010707,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.90599,0.032169,0.023369,0,0
5,GO LEUKOCYTE TETHERING OR ROLLING,0.095625,0.032014,0.071221,0,0
5,GO T CELL CHEMOTAXIS,0.13814,0.031932,0.063894,0,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.4545,0.03176,0.041414,0,0
5,GO GOLGI TO ENDOSOME TRANSPORT,0.52025,0.031757,0.025225,0,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.69707,0.031741,0.0058712,0,0
5,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.39371,0.03171,0.061494,0,0
5,GO TRANSEPITHELIAL TRANSPORT,0.58456,0.031605,0.0086553,0,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.86455,0.031603,-0.048416,0,0
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.59664,0.031417,-0.070257,0,0
5,GO TOXIN TRANSPORT,0.79636,0.030954,0.012296,0,0
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.42347,0.030849,0.017475,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.46512,0.030674,0.025011,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.94769,0.03035,0.0052482,0,0
5,GO RESPONSE TO ETHER,0.54903,0.030261,0.019725,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.50337,0.029871,0.018883,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.1313,0.029759,0.055627,0,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.52025,0.029496,0.051677,0,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.88523,0.029434,-0.0071589,0,0
5,GO MELANOCYTE DIFFERENTIATION,0.29992,0.029405,0.094159,0,0
5,GO MEGAKARYOCYTE DEVELOPMENT,0.95466,0.029403,0.034456,0,0
5,GO GOLGI VESICLE BUDDING,0.59059,0.029388,0.011927,0,0
5,GO MACROAUTOPHAGY,0.10465,0.029316,0.038861,0,0
5,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1,0.02916,-0.022817,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.32506,0.029114,0.052491,0,0
5,GO REGULATION OF HEAT GENERATION,0.32077,0.028899,0.11358,0,0
5,GO REGULATION OF CELL CYCLE PROCESS,0.19695,0.028764,0.026887,0,0
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.15773,0.028592,0.037652,0,0
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.80312,0.028026,-0.039832,0,0
5,GO TRANSFERRIN TRANSPORT,0.69061,0.027979,0.0053439,0,0
5,GO PYRAMIDAL NEURON DIFFERENTIATION,0.66501,0.027946,0.096567,0,0
5,GO CYTOKINETIC PROCESS,0.67776,0.027877,0.010672,0,0
5,GO MEMBRANE DOCKING,0.061812,0.027863,0.065609,0,0
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.89907,0.027736,-0.016441,0,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.69061,0.027674,0.051396,0,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.29586,0.027619,0.025491,0,0
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.095625,0.027559,0.071824,0,0
5,GO HISTONE H3 K36 METHYLATION,0.84397,0.027547,0.011055,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.42347,0.027408,0.051979,0,0
5,GO SELECTIVE AUTOPHAGY,0.75615,0.02732,-0.0099441,0,0
5,GO HISTONE PHOSPHORYLATION,0.59664,0.027158,0.0059447,0,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22568,0.027113,0.037655,0,0
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.076492,0.026907,0.053338,0,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.67137,0.026832,-0.030349,0,0
5,GO HEME METABOLIC PROCESS,0.76948,0.026802,-0.070912,0,0
5,GO MACROMOLECULE CATABOLIC PROCESS,0.34702,0.026667,0.012433,0,0
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.87833,0.026662,0.0072598,0,0
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.89215,0.026528,-0.0048958,0,0
5,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.93377,0.026417,-0.0445,0,0
5,GO RESPONSE TO EPINEPHRINE,0.82348,0.026287,-0.035176,0,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.92682,0.02628,-0.024512,0,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.33812,0.026226,0.073774,0,0
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.5726,0.026222,0.22794,0,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.16559,0.026126,0.027607,0,0
5,GO HEART INDUCTION,0.80989,0.025998,-0.019284,0,0
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.53167,0.025991,0.091735,0,0
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.80989,0.025736,-0.018802,0,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.21905,0.025733,0.10593,0,0
5,GO REGULATION OF DNA RECOMBINATION,0.50337,0.025669,0.023701,0,0
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.38408,0.025651,0.030597,0,0
5,GO INTRACELLULAR TRANSPORT,0.19393,0.025459,0.023064,0,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.85082,0.025427,0.00085872,0,0
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.76281,0.025359,0.004443,0,0
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.99651,0.02533,0.021096,0,0
5,GO DOSAGE COMPENSATION,0.53742,0.025258,0.022218,0,0
5,GO BODY FLUID SECRETION,0.26471,0.025016,0.053011,0,0
5,GO ENDOCARDIAL CUSHION FORMATION,0.81668,0.024985,0.015676,0,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.5726,0.024915,-0.0051949,0,0
5,GO ORGANELLE ASSEMBLY,0.030383,0.024897,0.052344,0,0
5,GO NEURON RECOGNITION,0.56666,0.024896,0.094725,0,0
5,GO POSITIVE REGULATION OF CELL AGING,0.44924,0.024889,0.034902,0,0
5,GO IMPORT INTO NUCLEUS,0.47049,0.024557,0.010669,0,0
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.64605,0.02415,0.025766,0,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.87833,0.024146,-0.030615,0,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.87833,0.024044,-0.00073145,0,0
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.24288,0.023676,0.076941,0,0
5,GO MEIOTIC CELL CYCLE,0.39371,0.023456,0.033706,0,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.94073,0.023396,-0.01303,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.80989,0.023333,-0.03018,0,0
5,GO CELL DIVISION,0.18508,0.02333,0.03487,0,0
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.27999,0.023269,0.019219,0,0
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.27227,0.023081,0.028859,0,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.34256,0.02305,0.04933,0,0
5,GO ACTIN FILAMENT SEVERING,0.86455,0.023045,-0.013557,0,0
5,GO DICARBOXYLIC ACID TRANSPORT,0.62732,0.022974,0.035609,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.13583,0.022677,0.10336,0,0
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.91293,0.022512,0.0061346,0,0
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.30815,0.022298,0.055459,0,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.39858,0.022243,0.056084,0,0
5,GO PROTEIN AUTOPROCESSING,0.19393,0.022223,0.11582,0,0
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.23589,0.022166,0.094172,0,0
5,GO VESICLE TARGETING,0.53742,0.022115,0.026444,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.5726,0.022066,0.0042373,0,0
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.91293,0.022065,0.00039674,0,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.50337,0.021909,0.029365,0,0
5,GO PEPTIDYL LYSINE METHYLATION,0.59059,0.021878,0.014842,0,0
5,GO REGULATION OF PROTEIN IMPORT,0.48131,0.021811,0.0074332,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.23937,0.021807,0.021572,0,0
5,GO RESPONSE TO MUSCLE INACTIVITY,0.89215,0.021339,-0.029403,0,0
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.32077,0.021201,0.030473,0,0
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.79636,0.021158,-0.0032282,0,0
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.22905,0.020899,0.052884,0,0
5,GO REGULATION OF OOGENESIS,0.42347,0.020857,0.035712,0,0
5,GO VIRAL BUDDING,0.91987,0.020638,0.012018,0,0
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.83713,0.02022,0.030217,0,0
5,GO REGULATION OF NUCLEAR DIVISION,0.22905,0.020173,0.035512,0,0
5,GO CENTRIOLE ASSEMBLY,0.69707,0.020046,0.016407,0,0
5,GO NADPH REGENERATION,0.59664,0.020002,-0.068301,0,0
5,GO ENDODERMAL CELL FATE COMMITMENT,0.67776,0.0199,-0.030297,0,0
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.98255,0.019844,0.0093607,0,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.60883,0.019807,0.026447,0,0
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.33812,0.019743,0.09049,0,0
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.8303,0.019663,-0.010287,0,0
5,GO MONOSACCHARIDE CATABOLIC PROCESS,0.76281,0.019622,-0.025788,0,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.76281,0.019464,0.020666,0,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.92682,0.019379,-0.038993,0,0
5,GO RESPONSE TO ATP,0.12689,0.019306,0.11186,0,0
5,GO REGULATION OF FIBRINOLYSIS,0.4545,0.019095,0.085043,0,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.36991,0.019091,0.023098,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.77618,0.019015,-0.028602,0,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.94769,0.018992,0.012255,0,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.92682,0.018836,-0.029675,0,0
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.34702,0.018832,0.028883,0,0
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.82348,0.018682,0.00094652,0,0
5,GO CHROMATIN ORGANIZATION,0.19095,0.018679,0.033358,0,0
5,GO RESPONSE TO NITROSATIVE STRESS,0.22235,0.018576,0.13878,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.85768,0.018549,-0.015678,0,0
5,GO T CELL HOMEOSTASIS,0.40349,0.01853,0.062702,0,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.65866,0.018466,0.028006,0,0
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.25001,0.018453,0.075029,0,0
5,GO PROTEIN POLYMERIZATION,0.17934,0.018122,0.058545,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.43367,0.018115,0.089145,0,0
5,GO DNA BIOSYNTHETIC PROCESS,0.82348,0.01807,-0.019198,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.20309,0.01794,0.17265,0,0
5,GO PROTEIN NITROSYLATION,0.78289,0.017785,0.033018,0,0
5,GO PROTEIN IMPORT,0.92682,0.01777,-0.0064737,0,0
5,GO NEGATIVE REGULATION OF CELL AGING,0.71658,0.017649,-0.045875,0,0
5,GO VISUAL BEHAVIOR,0.27227,0.017199,0.060671,0,0
5,GO CENTRIOLE CENTRIOLE COHESION,0.50896,0.016346,0.063076,0,0
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.52025,0.015991,0.0153,0,0
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.59059,0.015881,0.05086,0,0
5,GO REGULATION OF ERAD PATHWAY,0.69061,0.015795,0.0057662,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.29586,0.015583,0.032326,0,0
5,GO DNA INTEGRITY CHECKPOINT,0.72313,0.01532,0.0073147,0,0
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.30815,0.015227,0.1042,0,0
5,GO REGULATION OF CELL AGING,0.61497,0.015133,0.013186,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.76281,0.015119,-0.029053,0,0
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.65866,0.015049,0.0028967,0,0
5,GO NON MOTILE CILIUM ASSEMBLY,0.25363,0.0148,0.060406,0,0
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.46512,0.014796,0.040493,0,0
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.60883,0.014705,-0.029204,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.84397,0.014517,-0.00078785,0,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.90599,0.014508,0.010594,0,0
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.2839,0.014327,0.16738,0,0
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.75615,0.014292,0.09875,0,0
5,GO INTESTINAL LIPID ABSORPTION,0.76948,0.014131,-0.01435,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.69707,0.014122,0.01794,0,0
5,GO BONE CELL DEVELOPMENT,0.60883,0.014113,0.022869,0,0
5,GO NADH METABOLIC PROCESS,0.79636,0.013851,0.018848,0,0
5,GO DENDRITE EXTENSION,0.27999,0.013581,0.17855,0,0
5,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.91987,0.013221,-0.0002957,0,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.74288,0.013189,0.039817,0,0
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.94073,0.013155,-0.013076,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.4598,0.013006,-0.042221,0,0
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.41842,0.012736,0.043999,0,0
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.24288,0.011786,0.099042,0,0
5,GO G2 DNA DAMAGE CHECKPOINT,0.47588,0.011767,0.040741,0,0
5,GO ORGANELLE LOCALIZATION,0.13814,0.01176,0.045435,0,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.80989,0.011717,0.0081684,0,0
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.30402,0.011467,0.046059,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.91987,0.011295,-8.8665e-05,0,0
5,GO HISTONE UBIQUITINATION,0.94073,0.011028,0.0057097,0,0
5,GO SULFUR COMPOUND TRANSPORT,0.60272,0.010996,0.014283,0,0
5,GO PEPTIDYL LYSINE ACETYLATION,0.24643,0.010859,0.035061,0,0
5,GO ACIDIC AMINO ACID TRANSPORT,0.72969,0.010746,0.036597,0,0
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.25729,0.010665,0.064632,0,0
5,GO HEXOSE CATABOLIC PROCESS,0.65234,0.010623,-0.036303,0,0
5,GO ORGANELLE FISSION,0.7495,0.010454,0.013714,0,0
5,GO TELOMERIC LOOP DISASSEMBLY,0.51459,0.010387,-0.062063,0,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.8303,0.010359,-0.043935,0,0
5,GO CENTROSOME DUPLICATION,0.71006,0.010319,0.02623,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.91293,0.010313,-0.035472,0,0
5,GO REGULATION OF MICROTUBULE BASED PROCESS,0.22905,0.010165,0.045672,0,0
5,GO RESPONSE TO GAMMA RADIATION,0.61497,0.010147,0.019918,0,0
5,GO REGULATION OF GLUTAMATE SECRETION,0.70355,0.009981,0.066296,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.80312,0.0099796,-0.023473,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.65866,0.0099293,-0.04757,0,0
5,GO NUCLEOTIDE TRANSPORT,0.52025,0.0097934,0.040646,0,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.60883,0.0097295,0.078284,0,0
5,GO RESPONSE TO NITRIC OXIDE,0.73628,0.0092326,-0.0013752,0,0
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.62113,0.0091932,0.044428,0,0
5,GO RESPONSE TO LIGHT INTENSITY,0.43367,0.0091868,0.078687,0,0
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.91987,0.0089318,0.0015796,0,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.37932,0.0088504,-0.087487,0,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.68418,0.0088201,0.011116,0,0
5,GO VESICLE LOCALIZATION,0.32938,0.0086765,0.029762,0,0
5,GO NEUROTRANSMITTER TRANSPORT,0.47588,0.0086721,0.094052,0,0
5,GO INTRACELLULAR PROTEIN TRANSPORT,0.73628,0.0086139,0.0049888,0,0
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.38408,0.008552,0.17465,0,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.48131,0.0083289,0.01501,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.4978,0.0082967,0.033969,0,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.39858,0.0081485,-0.098422,0,0
5,GO REGULATION OF GLUCONEOGENESIS,0.62732,0.0078765,0.013776,0,0
5,GO PHAGOSOME MATURATION,0.84397,0.0077229,-0.034394,0,0
5,GO PROTEIN DEPOLYMERIZATION,0.59664,0.007443,0.044892,0,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.71006,0.0074273,0.0039497,0,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.27227,0.007356,0.1254,0,0
5,GO HISTONE H2B UBIQUITINATION,0.72313,0.0073105,-0.03,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.9686,0.0070818,-0.0038633,0,0
5,GO STEROL BIOSYNTHETIC PROCESS,0.8303,0.007077,-0.043402,0,0
5,GO MULTI ORGANISM LOCALIZATION,0.89215,0.0070005,-0.035239,0,0
5,GO SPINDLE LOCALIZATION,0.96163,0.0069697,0.00048667,0,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.60272,0.00694,-0.055,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.4978,0.0069114,0.084193,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.26471,0.006906,0.036267,0,0
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.81668,0.0068909,0.0042586,0,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.80312,0.0067553,-0.011124,0,0
5,GO PULMONARY VALVE MORPHOGENESIS,0.9686,0.0062392,0.026047,0,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.72969,0.0059213,0.088037,0,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.47049,0.005641,-0.05986,0,0
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.65866,0.005634,0.027339,0,0
5,GO CHROMATIN SILENCING,0.76281,0.0055247,-0.050707,0,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.97557,0.0052576,-0.0016922,0,0
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.75615,0.004997,-0.00077336,0,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.49227,0.00488,0.061366,0,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.90599,0.0047992,0.0053707,0,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.73628,0.004704,-0.034218,0,0
5,GO MITOCHONDRION MORPHOGENESIS,0.67776,0.0045307,-0.017803,0,0
5,GO REGULATION OF SPINDLE ASSEMBLY,0.60883,0.0045099,0.03698,0,0
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.94769,0.0045043,-0.01034,0,0
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.83713,0.0044422,0.025702,0,0
5,GO OSTEOBLAST DEVELOPMENT,0.69707,0.0043954,0.00079097,0,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.68418,0.0043262,-0.024871,0,0
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.79636,0.0042434,-0.010131,0,0
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.29586,0.0042149,0.047995,0,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.20309,0.0041995,-0.14783,0,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.89215,0.0041395,-0.018899,0,0
5,GO CYTOKINESIS,0.90599,0.0039555,0.011508,0,0
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.93377,0.0039221,-0.037767,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.76281,0.0038773,-0.0023325,0,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.93377,0.0038656,0.020571,0,0
5,GO AUTOPHAGOSOME MATURATION,0.72313,0.0037332,0.016554,0,0
5,GO PEPTIDYL ARGININE MODIFICATION,0.99651,0.0036487,-0.0086686,0,0
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.56666,0.0036281,-0.037097,0,0
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.60883,0.0033776,0.046875,0,0
5,GO OSTEOCLAST DEVELOPMENT,0.9686,0.0029394,0.012569,0,0
5,GO PEPTIDYL LYSINE MODIFICATION,0.82348,0.0028389,0.0072987,0,0
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.77618,0.0027182,0.024929,0,0
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.75615,0.0027076,-0.016068,0,0
5,GO UV DAMAGE EXCISION REPAIR,0.29992,0.0024375,0.045151,0,0
5,GO DNA MODIFICATION,0.79636,0.0023403,0.011005,0,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.86455,0.0021179,-0.014774,0,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.95466,0.0020386,-0.016195,0,0
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.9686,0.0018787,-0.014753,0,0
5,GO COPII COATED VESICLE BUDDING,0.74288,0.001817,-0.0025496,0,0
5,GO MITOCHONDRIAL FUSION,0.70355,0.0017165,-0.024528,0,0
5,GO REGULATION OF RNA SPLICING,0.91293,0.0016835,-0.014095,0,0
5,GO CELLULAR RESPONSE TO HEAT,0.7495,0.0016531,-0.0029374,0,0
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.89215,0.0014581,-0.013039,0,0
5,GO MODIFIED AMINO ACID TRANSPORT,0.76281,0.0013228,-0.036097,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.96163,0.0011501,-0.0040451,0,0
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.62732,0.0011118,0.01687,0,0
5,GO MULTIVESICULAR BODY ORGANIZATION,0.98953,0.0010433,-0.0041624,0,0
5,GO HISTONE H3 K9 ACETYLATION,0.70355,0.00083081,-0.024661,0,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.84397,0.00078403,-0.048038,0,0
5,GO DNA METHYLATION OR DEMETHYLATION,0.75615,0.00062356,0.022862,0,0
5,GO SYNAPTIC VESICLE EXOCYTOSIS,0.76948,0.00055696,0.08082,0,0
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.91987,0.00047048,0.0014326,0,0
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.78289,0.0002432,0.025743,0,0
5,GO VIRION ASSEMBLY,0.82348,-8.871e-05,-0.019729,0,0
5,GO FIBROBLAST ACTIVATION,0.9686,-0.00056816,-0.0057343,0,0
5,GO NADP METABOLIC PROCESS,0.41341,-0.00075748,-0.090212,0,0
5,GO HISTONE METHYLATION,0.75615,-0.00076821,-0.0073397,0,0
5,GO PROTEIN LOCALIZATION TO ORGANELLE,0.74288,-0.00090813,0.0045272,0,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.85082,-0.00096354,-0.011771,0,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,0.94769,-0.0012128,-0.0024359,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.74288,-0.0015045,0.0025722,0,0
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.36526,-0.0015887,-0.068581,0,0
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.77618,-0.0017514,0.01235,0,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.89907,-0.001848,0.009646,0,0
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.91987,-0.0020074,-0.0015339,0,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.76281,-0.0022025,-0.0090779,0,0
5,GO MEIOTIC SPINDLE ORGANIZATION,0.79636,-0.0024555,-0.0040146,0,0
5,GO REGULATION OF MRNA PROCESSING,0.52025,-0.0024743,-0.025042,0,0
5,GO MYELOID CELL DEVELOPMENT,0.53167,-0.0027218,0.031704,0,0
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.27611,-0.0029709,-0.069221,0,0
5,GO CELL CYCLE CHECKPOINT,0.94073,-0.0031353,-0.00016601,0,0
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.84397,-0.0032378,0.02374,0,0
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.43883,-0.0032521,0.047594,0,0
5,GO VIRAL RELEASE FROM HOST CELL,0.77618,-0.0033327,0.0073791,0,0
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.31653,-0.0034552,0.048518,0,0
5,GO REGULATION OF MITOPHAGY,0.80312,-0.0034961,-0.020902,0,0
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.19695,-0.0035752,0.19276,0,0
5,GO V D J RECOMBINATION,0.51459,-0.0036741,0.053994,0,0
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.64605,-0.0037023,0.093232,0,0
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.63978,-0.0037463,0.037443,0,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.32077,-0.0037486,0.14783,0,0
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.56666,-0.0044018,0.085033,0,0
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.85768,-0.0044698,-0.017541,0,0
5,GO MOTOR NEURON AXON GUIDANCE,0.98953,-0.0045811,0.026243,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.94073,-0.0052763,-0.0078778,0,0
5,GO LACTATION,0.7495,-0.0052913,0.011836,0,0
5,GO SISTER CHROMATID COHESION,0.72969,-0.0053598,-0.0030605,0,0
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.53742,-0.00549,0.03522,0,0
5,GO PROTON TRANSMEMBRANE TRANSPORT,0.64605,-0.0056538,-0.035716,0,0
5,GO NUCLEOSIDE METABOLIC PROCESS,1,-0.005773,-0.010421,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.47049,-0.0059308,0.026665,0,0
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.9686,-0.0059469,-0.0021916,0,0
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.90599,-0.0063497,-0.0017344,0,0
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.59059,-0.0065449,0.060573,0,0
5,GO PROTEIN METHYLATION,0.93377,-0.0065482,-0.0078004,0,0
5,GO MITOPHAGY,0.61497,-0.0066498,-0.042042,0,0
5,GO MITOTIC CYTOKINETIC PROCESS,0.98255,-0.0067293,0.00073124,0,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.95466,-0.0068154,0.011117,0,0
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.47049,-0.0069657,0.086724,0,0
5,GO PHOTOTRANSDUCTION,0.52025,-0.0072736,0.0063219,0,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.72313,-0.0072742,-0.065793,0,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,0.81668,-0.0074083,-0.039488,0,0
5,GO REGULATION OF FEEDING BEHAVIOR,0.59059,-0.0074995,-0.028507,0,0
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.64605,-0.0075599,-0.018507,0,0
5,GO CELL REDOX HOMEOSTASIS,0.94073,-0.0076027,-0.018691,0,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.69707,-0.0076198,-0.021297,0,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.47049,-0.0077878,-0.050507,0,0
5,GO RESPONSE TO LEAD ION,0.85082,-0.0079682,-0.0166,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.31653,-0.0080691,0.054651,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY,0.63978,-0.0080708,-0.016624,0,0
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.81668,-0.0083136,0.00075085,0,0
5,GO SPLEEN DEVELOPMENT,0.56075,-0.00832,0.029477,0,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.77618,-0.0085606,0.0012662,0,0
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.66501,-0.0085821,0.0188,0,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.84397,-0.0086369,0.01927,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.87144,-0.0087699,-0.022338,0,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,0.68418,-0.0088176,0.032296,0,0
5,GO PURINE NUCLEOTIDE TRANSPORT,0.78289,-0.0088575,0.018884,0,0
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.88523,-0.008892,-0.015378,0,0
5,GO RESPONSE TO MISFOLDED PROTEIN,0.96163,-0.0089378,-0.00078302,0,0
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.82348,-0.0089849,0.0073759,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.87144,-0.0090742,-0.0019823,0,0
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.37932,-0.0091312,-0.080214,0,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.96163,-0.00932,-0.0042431,0,0
5,GO REGULATION OF GASTRULATION,0.91293,-0.0095077,-0.010631,0,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.94073,-0.0096178,-0.021703,0,0
5,GO URONIC ACID METABOLIC PROCESS,0.56075,-0.0096573,-0.051526,0,0
5,GO P BODY ASSEMBLY,0.87833,-0.0098878,-0.0078835,0,0
5,GO DE NOVO PROTEIN FOLDING,0.96163,-0.0099993,-0.0067184,0,0
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.83713,-0.010018,-0.027253,0,0
5,GO REGULATION OF DNA METHYLATION,0.36526,-0.010042,-0.04663,0,0
5,GO T HELPER CELL LINEAGE COMMITMENT,0.8303,-0.010159,0.0071114,0,0
5,GO NUCLEUS ORGANIZATION,0.41341,-0.010183,-0.021533,0,0
5,GO REGULATION OF CELLULAR RESPIRATION,0.85082,-0.010522,0.010632,0,0
5,GO HISTONE H3 ACETYLATION,0.99651,-0.010587,-0.00019542,0,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.81668,-0.010674,-0.014051,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.4598,-0.010705,-0.0855,0,0
5,GO CARDIOLIPIN METABOLIC PROCESS,0.48678,-0.01072,-0.0834,0,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.89907,-0.010958,0.0016166,0,0
5,GO ATP TRANSPORT,0.78289,-0.011078,-0.014618,0,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.51459,-0.01111,0.011927,0,0
5,GO MITOTIC CELL CYCLE,0.76948,-0.011114,0.0082988,0,0
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.93377,-0.011193,0.045837,0,0
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.96163,-0.011283,-0.00091409,0,0
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.74288,-0.011357,-0.023929,0,0
5,GO L PHENYLALANINE METABOLIC PROCESS,0.99651,-0.011417,-0.027966,0,0
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.88523,-0.011518,-0.004581,0,0
5,GO GAS TRANSPORT,0.7495,-0.011546,-0.07818,0,0
5,GO PRIMARY MIRNA PROCESSING,0.53742,-0.011591,-0.054963,0,0
5,GO HETEROCHROMATIN ORGANIZATION,0.80989,-0.011802,-0.0051776,0,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.3746,-0.011873,0.12749,0,0
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.91987,-0.011893,0.00092799,0,0
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.84397,-0.011958,0.025738,0,0
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.4545,-0.012098,-0.086127,0,0
5,GO C4 DICARBOXYLATE TRANSPORT,0.75615,-0.012116,-0.026147,0,0
5,GO CHROMOSOME ORGANIZATION,0.79636,-0.01239,-0.0049729,0,0
5,GO MITOCHONDRION LOCALIZATION,0.56666,-0.012431,0.050068,0,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.75615,-0.012507,0.0098692,0,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.71658,-0.012849,-0.0068825,0,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.60272,-0.012915,-0.02237,0,0
5,GO ATP METABOLIC PROCESS,0.96163,-0.013062,-0.006512,0,0
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.81668,-0.013828,-0.0082171,0,0
5,GO HOMOLOGOUS RECOMBINATION,0.75615,-0.014102,-0.017576,0,0
5,GO REGULATION OF CYTOKINESIS,0.78962,-0.014154,0.015935,0,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.59059,-0.014414,0.030854,0,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.96163,-0.01452,-0.001346,0,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.81668,-0.014558,0.032472,0,0
5,GO MALE MEIOSIS I,0.35607,-0.01473,-0.071207,0,0
5,GO NUCLEOSIDE SALVAGE,0.65866,-0.014814,-0.05904,0,0
5,GO MITOTIC DNA REPLICATION,0.63354,-0.014883,0.024353,0,0
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.2839,-0.014988,-0.097978,0,0
5,GO RRNA CATABOLIC PROCESS,0.87833,-0.015022,-0.0071755,0,0
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.67137,-0.015051,-0.040829,0,0
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.50896,-0.015081,-0.054141,0,0
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.53167,-0.015254,-0.030741,0,0
5,GO ALPHA AMINO ACID METABOLIC PROCESS,0.64605,-0.015719,-0.033572,0,0
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.62113,-0.015801,-0.045414,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.59059,-0.015872,0.043193,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.85768,-0.015934,0.0026732,0,0
5,GO LIPID DIGESTION,0.77618,-0.015994,-0.055576,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.78962,-0.016104,0.019915,0,0
5,GO CELL CYCLE PHASE TRANSITION,0.81668,-0.016168,0.0040988,0,0
5,GO AXONAL TRANSPORT,0.4978,-0.01617,-0.030165,0,0
5,GO NEUROTRANSMITTER SECRETION,0.64605,-0.016303,0.091312,0,0
5,GO PROTEIN HETEROOLIGOMERIZATION,0.90599,-0.016445,0.0023747,0,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.21905,-0.016501,-0.097057,0,0
5,GO TROPHOBLAST CELL MIGRATION,0.73628,-0.016523,-0.10674,0,0
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.99651,-0.016532,0.0013193,0,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.79636,-0.016784,0.018993,0,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.46512,-0.016856,-0.02199,0,0
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.8303,-0.016886,0.024274,0,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.70355,-0.016925,0.028146,0,0
5,GO ORGANELLE DISASSEMBLY,0.90599,-0.016933,-0.0025641,0,0
5,GO DNA REPLICATION,0.72969,-0.016997,0.018508,0,0
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.87833,-0.017293,-0.016244,0,0
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.52025,-0.017355,-0.023037,0,0
5,GO BLASTOCYST FORMATION,0.90599,-0.01754,-0.013419,0,0
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.69061,-0.017695,-0.01156,0,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,0.97557,-0.017711,-0.017354,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.84397,-0.01775,-0.031157,0,0
5,GO PEPTIDYL PROLINE MODIFICATION,0.65234,-0.018233,-0.030026,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.99651,-0.018618,-0.010634,0,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.64605,-0.018685,0.020949,0,0
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.94073,-0.018861,-0.012592,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.33812,-0.018936,-0.04085,0,0
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.21256,-0.019061,-0.085229,0,0
5,GO MITOCHONDRION ORGANIZATION,0.2839,-0.019555,-0.035172,0,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,0.82348,-0.019563,0.0055656,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.43367,-0.020303,-0.038374,0,0
5,GO AXO DENDRITIC TRANSPORT,0.49227,-0.020433,-0.027288,0,0
5,GO MITOCHONDRION DISTRIBUTION,1,-0.020531,0.036984,0,0
5,GO APOPTOTIC DNA FRAGMENTATION,0.8303,-0.020715,-0.0081961,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.81668,-0.020744,-0.010095,0,0
5,GO NUCLEAR TRANSPORT,0.35153,-0.020748,-0.034201,0,0
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.48678,-0.020971,-0.049119,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.93377,-0.021112,-0.0067435,0,0
5,GO PRE MIRNA PROCESSING,0.52594,-0.021336,-0.045031,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.59059,-0.021344,-0.020168,0,0
5,GO REGULATION OF MICROTUBULE BINDING,0.40843,-0.021358,-0.036492,0,0
5,GO REGULATION OF DNA METABOLIC PROCESS,0.40843,-0.021406,-0.017011,0,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.93377,-0.021422,0.012845,0,0
5,GO PROTEIN TRIMERIZATION,0.7495,-0.021571,-0.03977,0,0
5,GO POSITIVE REGULATION OF RNA SPLICING,0.40843,-0.021722,-0.043317,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.34702,-0.021764,0.15895,0,0
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.72313,-0.022029,-0.013716,0,0
5,GO RESPONSE TO INTERLEUKIN 4,0.70355,-0.022669,-0.016985,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.18219,-0.022727,-0.063226,0,0
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.67137,-0.022858,-0.019604,0,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.54321,-0.022959,-0.011526,0,0
5,GO SYNAPTIC VESICLE DOCKING,0.93377,-0.023021,0.058777,0,0
5,GO RESPONSE TO INTERLEUKIN 12,0.90599,-0.023252,-0.021899,0,0
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.91293,-0.02347,0.017706,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.97557,-0.023589,0.086357,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.36526,-0.023605,-0.058556,0,0
5,GO GENE SILENCING,0.27611,-0.023645,-0.034208,0,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.7495,-0.023815,-0.055848,0,0
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.47588,-0.023938,-0.059019,0,0
5,GO CERAMIDE TRANSPORT,0.64605,-0.024027,0.022309,0,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.75615,-0.024062,0.0141,0,0
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.41842,-0.024362,-0.047821,0,0
5,GO SYNAPTIC VESICLE LOCALIZATION,0.83713,-0.024824,0.026921,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.99651,-0.024896,0.015848,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.20621,-0.025069,-0.066267,0,0
5,GO SYNAPTIC VESICLE CLUSTERING,0.39371,-0.025122,0.21062,0,0
5,GO DNA RECOMBINATION,0.51459,-0.025165,-0.013677,0,0
5,GO PLATELET MORPHOGENESIS,0.4598,-0.025399,-0.052761,0,0
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.88523,-0.025561,0.0099873,0,0
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.76281,-0.025694,0.087539,0,0
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.53742,-0.025765,-0.039865,0,0
5,GO REPLICATION FORK PROCESSING,0.17653,-0.025864,-0.054497,0,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.52594,-0.025873,0.044934,0,0
5,GO VACUOLAR ACIDIFICATION,0.55487,-0.026211,-0.058596,0,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.73628,-0.02626,0.013001,0,0
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.69061,-0.026536,0.034103,0,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.25729,-0.027073,-0.039387,0,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.65866,-0.027148,-0.043091,0,0
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.77618,-0.027656,0.040054,0,0
5,GO ANTEROGRADE AXONAL TRANSPORT,0.39858,-0.027672,-0.036518,0,0
5,GO HEART FIELD SPECIFICATION,0.74288,-0.02774,-0.030003,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.93377,-0.028284,0.025427,0,0
5,GO NAD METABOLIC PROCESS,0.98953,-0.02876,0.0010772,0,0
5,GO PROTEIN FOLDING,0.69707,-0.028764,-0.030247,0,0
5,GO REGULATION OF T CELL CHEMOTAXIS,0.87833,-0.028922,-0.0076525,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.25363,-0.02943,-0.040034,0,0
5,GO PROTEIN ACETYLATION,0.70355,-0.029519,-0.0011077,0,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.41341,-0.029583,-0.03645,0,0
5,GO CELL CYCLE DNA REPLICATION,0.55487,-0.029864,-0.015943,0,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.36991,-0.029878,-0.050842,0,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.23589,-0.030274,-0.06373,0,0
5,GO DNA METABOLIC PROCESS,0.42347,-0.030661,-0.012959,0,0
5,GO METHYLATION,0.095625,-0.030921,-0.045887,0,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.36064,-0.031533,-0.042107,0,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.60272,-0.03154,-0.05513,0,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.52025,-0.031545,-0.030643,0,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.12908,-0.03196,-0.064628,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.97557,-0.032136,-0.017949,0,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.96163,-0.032397,0.021983,0,0
5,GO REGULATION OF DNA REPAIR,0.96163,-0.032519,0.00011888,0,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.50896,-0.032584,-0.091601,0,0
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.87144,-0.032902,-0.001702,0,0
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.89215,-0.032904,-0.012471,0,0
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.98953,-0.033089,-0.017182,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.70355,-0.033132,0.0065465,0,0
5,GO RESPONSE TO OXYGEN RADICAL,0.80312,-0.033601,0.010383,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.42347,-0.033647,-0.046283,0,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.90599,-0.033651,-0.00063739,0,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.7495,-0.033738,-0.071251,0,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.71006,-0.033776,-0.0035288,0,0
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.78289,-0.033861,-0.031597,0,0
5,GO PROTEIN MONOUBIQUITINATION,0.89215,-0.033869,-0.0064757,0,0
5,GO MICROTUBULE POLYMERIZATION,1,-0.034105,0.028469,0,0
5,GO VESICLE CARGO LOADING,0.60272,-0.034114,-0.054554,0,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.14526,-0.034285,-0.049001,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.27227,-0.03437,-0.030424,0,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.17374,-0.034723,-0.066851,0,0
5,GO PROTEIN SUMOYLATION,0.080955,-0.034738,-0.062892,0,0
5,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.95466,-0.035001,0.020041,0,0
5,GO CHROMATIN DISASSEMBLY,0.57857,-0.035187,-0.032997,0,0
5,GO NUCLEOTIDE SALVAGE,0.81668,-0.035321,-0.051445,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.36526,-0.035591,-0.041493,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.1028,-0.035661,-0.035552,0,0
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.27999,-0.035769,-0.026514,0,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.39371,-0.03627,-0.047733,0,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.2,-0.036477,-0.14144,0,0
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.99651,-0.03722,0.012102,0,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.38408,-0.037459,-0.025279,0,0
5,GO HAIR FOLLICLE MATURATION,0.7495,-0.037671,-0.0073176,0,0
5,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.61497,-0.037694,0.081177,0,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.73628,-0.03781,-0.053431,0,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.38408,-0.037875,-0.046379,0,0
5,GO ERYTHROCYTE DEVELOPMENT,0.80989,-0.037914,0.016158,0,0
5,GO REGULATION OF CHROMOSOME ORGANIZATION,0.14526,-0.037963,-0.023461,0,0
5,GO ACETYL COA METABOLIC PROCESS,0.32938,-0.038284,-0.065299,0,0
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.91293,-0.038826,-0.0081219,0,0
5,GO CHROMATIN REMODELING,0.38408,-0.038894,-0.019332,0,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.44402,-0.038907,-0.01941,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.97557,-0.039272,0.010488,0,0
5,GO CENTROSOME SEPARATION,0.78289,-0.039471,-0.0010356,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.188,-0.039591,-0.068434,0,0
5,GO MICROTUBULE DEPOLYMERIZATION,0.89215,-0.039692,0.018439,0,0
5,GO REGULATION OF ACTIN NUCLEATION,0.62732,-0.040005,-0.014334,0,0
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.43367,-0.04041,-0.086679,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.82348,-0.040837,0.059039,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.48131,-0.041255,-0.037687,0,0
5,GO CARDIAC VENTRICLE FORMATION,0.97557,-0.04126,0.0065635,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.34702,-0.041441,-0.056861,0,0
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.32938,-0.0416,-0.059028,0,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.51459,-0.041739,-0.01627,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.3746,-0.042044,-0.03603,0,0
5,GO REGULATION OF MRNA POLYADENYLATION,0.16828,-0.042127,-0.057236,0,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.33812,-0.042769,-0.080399,0,0
5,GO ALDITOL METABOLIC PROCESS,0.73628,-0.042985,-0.028874,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.41341,-0.042997,-0.028132,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.50896,-0.043213,-0.046561,0,0
5,GO MACROMOLECULE DEPALMITOYLATION,0.37932,-0.043293,-0.06321,0,0
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.80989,-0.044054,0.072378,0,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.070855,-0.044077,-0.059782,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.16032,-0.0444,-0.085103,0,0
5,GO MITOCHONDRIAL TRANSPORT,0.26847,-0.044696,-0.036711,0,0
5,GO RESPONSE TO INTERLEUKIN 7,0.15015,-0.044811,-0.087025,0,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.67776,-0.044897,-0.019085,0,0
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.18508,-0.045002,-0.089255,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.30815,-0.045023,-0.073234,0,0
5,GO DNA DEPENDENT DNA REPLICATION,0.16828,-0.045309,-0.039321,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.92682,-0.045434,0.012951,0,0
5,GO ACTIN NUCLEATION,0.3746,-0.045576,-0.017582,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.41842,-0.045632,-0.022956,0,0
5,GO NCRNA CATABOLIC PROCESS,0.17374,-0.045636,-0.07491,0,0
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.50337,-0.045649,-0.047789,0,0
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.65866,-0.045882,0.0028322,0,0
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.54903,-0.045972,-0.026058,0,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.85768,-0.046097,-0.020609,0,0
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.87144,-0.046137,0.024331,0,0
5,GO COPPER ION TRANSPORT,0.92682,-0.04719,0.050836,0,0
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.23245,-0.047219,-0.06656,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.85768,-0.047808,0.079567,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.21256,-0.047815,-0.063252,0,0
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.72969,-0.047857,-0.0012918,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.19393,-0.048141,-0.044555,0,0
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.188,-0.048534,-0.04975,0,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.1313,-0.048895,-0.16556,0,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.21256,-0.049147,-0.082244,0,0
5,GO RESPONSE TO MANGANESE ION,0.90599,-0.049283,-0.010888,0,0
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.39858,-0.049528,-0.022906,0,0
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.32938,-0.049537,-0.07087,0,0
5,GO NUCLEOSOME ASSEMBLY,0.32506,-0.049605,-0.039165,0,0
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.92682,-0.04969,0.018062,0,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.76281,-0.049708,-0.039849,0,0
5,GO WALKING BEHAVIOR,0.55487,-0.049749,-0.016114,0,0
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.18508,-0.049765,-0.11398,0,0
5,GO CLATHRIN COAT ASSEMBLY,0.78289,-0.049768,0.033542,0,0
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.082489,-0.049825,-0.16449,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.26847,-0.050042,-0.06684,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.066855,-0.050416,-0.079712,0,0
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.30402,-0.050506,-0.057099,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.48131,-0.050559,-0.057346,0,0
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.090515,-0.0508,-0.057652,0,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.65866,-0.05089,-0.023509,0,0
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.5726,-0.051081,-0.067966,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.87833,-0.051364,-0.029631,0,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,0.20621,-0.051474,-0.083729,0,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.53167,-0.051581,-0.058994,0,0
5,GO DENDRITIC TRANSPORT,0.24288,-0.051688,-0.073565,0,0
5,GO MITOTIC RECOMBINATION,0.38408,-0.052105,-0.04926,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.41341,-0.052371,-0.021865,0,0
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.68418,-0.052634,0.1204,0,0
5,GO REGULATION OF GENE SILENCING,0.05824,-0.052674,-0.081614,0,0
5,GO DNA REPAIR,0.11434,-0.053308,-0.03125,0,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.63354,-0.053435,-0.0086007,0,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.26471,-0.053764,-0.056743,0,0
5,GO NUCLEAR EXPORT,0.057089,-0.05406,-0.068354,0,0
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.53742,-0.054185,-0.013549,0,0
5,GO COBALAMIN METABOLIC PROCESS,0.36064,-0.054192,-0.040276,0,0
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.066855,-0.054233,-0.046311,0,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.67137,-0.054258,0.050859,0,0
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.14526,-0.054492,-0.075744,0,0
5,GO RESPONSE TO HISTAMINE,0.81668,-0.054522,0.024366,0,0
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.21905,-0.054584,-0.044545,0,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.20937,-0.054609,-0.096268,0,0
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.18219,-0.054717,-0.044631,0,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.41341,-0.054791,-0.045774,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.40843,-0.054825,-0.037519,0,0
5,GO REGULATION OF CENTROSOME CYCLE,0.88523,-0.055316,0.0098185,0,0
5,GO REGULATION OF BONE DEVELOPMENT,0.47588,-0.055592,-0.038862,0,0
5,GO REGULATION OF HISTONE UBIQUITINATION,0.12049,-0.055668,-0.076501,0,0
5,GO DISTAL TUBULE DEVELOPMENT,0.59664,-0.055704,-0.036151,0,0
5,GO ORGANELLE INHERITANCE,0.22905,-0.055873,-0.039565,0,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.090515,-0.055907,-0.076629,0,0
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.29184,-0.055924,-0.064456,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.52025,-0.055964,-0.0414,0,0
5,GO PHAGOLYSOSOME ASSEMBLY,0.29992,-0.05611,-0.086482,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.22568,-0.056318,-0.085068,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.80312,-0.056429,-0.027957,0,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.39371,-0.05678,-0.069215,0,0
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.36991,-0.056951,-0.02281,0,0
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.39371,-0.05701,-0.047333,0,0
5,GO SPINDLE ASSEMBLY,0.21905,-0.057223,-0.038144,0,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.32938,-0.057394,-0.046452,0,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.25001,-0.057704,-0.03484,0,0
5,GO MITOTIC NUCLEAR DIVISION,0.38408,-0.057946,-0.013773,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.84397,-0.058169,-0.0060398,0,0
5,GO CELL AGING,0.53742,-0.0583,-0.029978,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.54903,-0.058883,-0.072045,0,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,0.96163,-0.058986,-0.0068066,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.42347,-0.0594,-0.056748,0,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.95466,-0.059635,0.011146,0,0
5,GO RESPONSE TO REDOX STATE,0.54903,-0.060306,-0.035846,0,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.60272,-0.060371,-0.036969,0,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.1313,-0.060759,-0.084353,0,0
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.23245,-0.06129,-0.044577,0,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.99651,-0.061449,-0.0052021,0,0
5,GO NEUTRAL AMINO ACID TRANSPORT,0.21256,-0.061768,-0.074368,0,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,0.91293,-0.062013,-0.044357,0,0
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.21905,-0.062339,-0.028656,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.36526,-0.062374,-0.043419,0,0
5,GO PENTOSE METABOLIC PROCESS,0.20937,-0.062437,-0.12915,0,0
5,GO FEVER GENERATION,0.43883,-0.062445,-0.046306,0,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.30402,-0.062783,-0.087891,0,0
5,GO PROTEIN TARGETING,0.13814,-0.063034,-0.065039,0,0
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.38888,-0.06315,-0.051066,0,0
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.35153,-0.064103,-0.033348,0,0
5,GO GMP METABOLIC PROCESS,0.76281,-0.064447,0.040844,0,0
5,GO LATERAL VENTRICLE DEVELOPMENT,0.84397,-0.064567,0.023538,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.11235,-0.064601,-0.073334,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.16828,-0.064803,-0.064836,0,0
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.38888,-0.065363,-0.05483,0,0
5,GO DOUBLE STRAND BREAK REPAIR,0.082489,-0.065398,-0.037955,0,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.98953,-0.065777,0.029618,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.11039,-0.066897,-0.080446,0,0
5,GO CHROMOSOME SEGREGATION,0.20937,-0.06715,-0.0319,0,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.29992,-0.067329,-0.039316,0,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.22568,-0.067371,-0.070975,0,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.093897,-0.06779,-0.073922,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.8303,-0.068093,-0.029579,0,0
5,GO SINGLE STRAND BREAK REPAIR,0.35153,-0.068196,-0.061627,0,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.78962,-0.068351,-0.027117,0,0
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.87833,-0.068352,0.061156,0,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.42347,-0.068514,-0.065229,0,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.85082,-0.068523,-0.0091477,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.87833,-0.068598,-0.025501,0,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.084046,-0.06901,-0.055252,0,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,0.13355,-0.069015,-0.064882,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.26471,-0.069072,-0.057561,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.18219,-0.069342,-0.041736,0,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.44402,-0.069477,-0.040901,0,0
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.13355,-0.069492,-0.066964,0,0
5,GO NODAL SIGNALING PATHWAY,0.72969,-0.069517,0.020273,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.34702,-0.069958,-0.042398,0,0
5,GO DNA METHYLATION,0.29992,-0.070268,-0.044544,0,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.42347,-0.070552,-0.051669,0,0
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.23937,-0.070615,-0.079587,0,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.085627,-0.070825,-0.075036,0,0
5,GO REGULATION OF LIGASE ACTIVITY,0.39371,-0.070921,-0.069091,0,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.98255,-0.071953,0.006316,0,0
5,GO SUBPALLIUM DEVELOPMENT,0.84397,-0.071999,0.042852,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.060602,-0.072184,-0.11176,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.56075,-0.072208,-0.024841,0,0
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.31232,-0.072292,-0.01967,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.32077,-0.072339,-0.035369,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.18508,-0.072891,-0.054511,0,0
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.16032,-0.072954,-0.083813,0,0
5,GO SYNAPTIC VESICLE PRIMING,0.38888,-0.072964,-0.0028821,0,0
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.32506,-0.073239,-0.055435,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.12049,-0.073244,-0.19169,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.17934,-0.073545,-0.065113,0,0
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.13355,-0.073752,-0.12008,0,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.80312,-0.073772,0.022731,0,0
5,GO SPINDLE ORGANIZATION,0.18508,-0.07391,-0.037777,0,0
5,GO REGULATION OF HELICASE ACTIVITY,0.67137,-0.074063,-0.0012343,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.15264,-0.07408,-0.073193,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.44924,-0.074123,-0.011337,0,0
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.42347,-0.074161,-0.060829,0,0
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.53742,-0.074268,-0.0094966,0,0
5,GO REGULATION OF GOLGI ORGANIZATION,0.17099,-0.074565,-0.059566,0,0
5,GO MITOTIC SPINDLE ORGANIZATION,0.33812,-0.075032,-0.028608,0,0
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.16828,-0.075387,-0.063101,0,0
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.17653,-0.075776,-0.081846,0,0
5,GO NEGATIVE REGULATION OF CELL SIZE,0.65866,-0.076619,-0.026536,0,0
5,GO PIRNA METABOLIC PROCESS,0.47049,-0.077604,-0.044364,0,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.40843,-0.078408,-0.014663,0,0
5,GO PIGMENT ACCUMULATION,0.50896,-0.078574,-0.038882,0,0
5,GO MITOTIC CYTOKINESIS,0.36064,-0.07876,-0.037046,0,0
5,GO PIGMENT METABOLIC PROCESS,0.34256,-0.079445,-0.078169,0,0
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.070855,-0.080395,-0.06013,0,0
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.17653,-0.080666,-0.092172,0,0
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.082489,-0.080781,-0.098646,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.68418,-0.081667,-0.030186,0,0
5,GO METAPHASE PLATE CONGRESSION,0.099158,-0.081802,-0.041229,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.05824,-0.08183,-0.080214,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.51459,-0.081831,-0.094755,0,0
5,GO CELL PROLIFERATION IN FOREBRAIN,0.63354,-0.082268,-0.037461,0,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.22568,-0.082393,-0.077033,0,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.26098,-0.082494,-0.003372,0,0
5,GO OXIDATIVE DEMETHYLATION,0.095625,-0.082778,-0.06398,0,0
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.12049,-0.082893,-0.078851,0,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.82348,-0.08324,-0.0033729,0,0
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.63978,-0.083742,-0.0071946,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.8303,-0.083992,-0.0032868,0,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.22235,-0.084308,-0.046611,0,0
5,GO POSITIVE REGULATION OF TRANSLATION,0.070855,-0.08454,-0.10082,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.066855,-0.08495,-0.060113,0,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.17653,-0.085225,-0.10647,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.17653,-0.085867,-0.10025,0,0
5,GO HISTONE EXCHANGE,0.22905,-0.086745,-0.044866,0,0
5,GO CELLULAR SENESCENCE,0.13814,-0.087463,-0.055595,0,0
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.30815,-0.087485,-0.048424,0,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,0.38888,-0.087598,-0.069983,0,0
5,GO VIRAL LATENCY,0.18219,-0.087924,-0.071457,0,0
5,GO AMP METABOLIC PROCESS,0.4545,-0.088274,-0.075935,0,0
5,GO OOCYTE MATURATION,0.27999,-0.088378,-0.054464,0,0
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.085627,-0.088505,-0.11405,0,0
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.89215,-0.088547,0.13898,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.17099,-0.08875,-0.059302,0,0
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.054842,-0.088931,-0.11859,0,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.085627,-0.089575,-0.16421,0,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.16559,-0.090128,-0.055183,0,0
5,GO GLUTAMATE SECRETION,0.71658,-0.09014,-0.0033508,0,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.097379,-0.090429,-0.095706,0,0
5,GO CHROMOSOME LOCALIZATION,0.080955,-0.090878,-0.04287,0,0
5,GO PROTEIN REFOLDING,0.53167,-0.090996,-0.051268,0,0
5,GO DNA PACKAGING,0.095625,-0.091707,-0.046754,0,0
5,GO GTP METABOLIC PROCESS,0.5726,-0.091831,-0.043743,0,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.13583,-0.091992,-0.090967,0,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.63978,-0.09216,-0.054526,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.51459,-0.0922,-0.073231,0,0
5,GO ADULT HEART DEVELOPMENT,0.36064,-0.092291,-0.052188,0,0
5,GO ELECTRON TRANSPORT CHAIN,0.087232,-0.092388,-0.097794,0,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.37932,-0.093139,-0.013921,0,0
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.17374,-0.093531,-0.10616,0,0
5,GO NUCLEAR BODY ORGANIZATION,0.34256,-0.093664,-0.061232,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.088862,-0.093814,-0.06791,0,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.29184,-0.094422,-0.10089,0,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.16294,-0.094634,-0.063413,0,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.18219,-0.095239,-0.082582,0,0
5,GO GROOMING BEHAVIOR,0.18219,-0.095367,-0.092548,0,0
5,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.65866,-0.095659,0.068211,0,0
5,GO METHIONINE METABOLIC PROCESS,0.090515,-0.095774,-0.096181,0,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.063042,-0.095823,-0.11642,0,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.068167,-0.096584,-0.10511,0,0
5,GO ALDEHYDE CATABOLIC PROCESS,0.24643,-0.096674,-0.061266,0,0
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.53167,-0.097352,-0.011659,0,0
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.56075,-0.097861,-0.056794,0,0
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.33812,-0.09789,-0.037369,0,0
5,GO CENTROMERE COMPLEX ASSEMBLY,0.27611,-0.098324,-0.052761,0,0
5,GO PEPTIDYL LYSINE DIMETHYLATION,0.30402,-0.098646,-0.065126,0,0
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.1028,-0.098862,-0.07265,0,0
5,GO SPINDLE MIDZONE ASSEMBLY,0.073629,-0.099444,-0.10621,0,0
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.20309,-0.099488,-0.065913,0,0
5,GO TELOMERE CAPPING,0.1028,-0.10146,-0.039789,0,0
5,GO SISTER CHROMATID SEGREGATION,0.066855,-0.10197,-0.059497,0,0
5,GO GLYCINE METABOLIC PROCESS,0.26471,-0.10271,-0.12614,0,0
5,GO MITOTIC CHROMOSOME CONDENSATION,0.30402,-0.10299,-0.0352,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.69707,-0.10331,-0.077076,0,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.073629,-0.10525,-0.10343,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.075049,-0.10542,-0.1108,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.17934,-0.10633,-0.10842,0,0
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.024288,-0.10638,-0.11932,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.42347,-0.10663,-0.065048,0,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.33812,-0.10667,-0.0039698,0,0
5,GO REGULATION OF PROTEIN ACETYLATION,0.013139,-0.10695,-0.090093,0,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.60883,-0.10725,-0.045217,0,0
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.4598,-0.10727,-0.041629,0,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.11434,-0.10735,-0.14003,0,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.12908,-0.10847,-0.056092,0,0
5,GO FRUCTOSE METABOLIC PROCESS,0.53742,-0.10867,-0.1136,0,0
5,GO MICROTUBULE NUCLEATION,0.10654,-0.10896,-0.03512,0,0
5,GO MRNA SPLICE SITE SELECTION,0.94769,-0.10914,0.0077392,0,0
5,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.093897,-0.11029,-0.1425,0,0
5,GO MRNA METHYLATION,0.061812,-0.11118,-0.11094,0,0
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.24288,-0.11147,-0.053038,0,0
5,GO COPII COATED VESICLE CARGO LOADING,0.072231,-0.11198,-0.085151,0,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.070855,-0.11225,-0.13991,0,0
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.89215,-0.11292,0.015643,0,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.99651,-0.11296,-0.013001,0,0
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.18219,-0.11404,-0.07812,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.20621,-0.11413,-0.090535,0,0
5,GO CARDIAC MYOFIBRIL ASSEMBLY,0.87144,-0.1151,0.013089,0,0
5,GO CHROMATIN REMODELING AT CENTROMERE,0.10845,-0.11578,-0.079767,0,0
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.18508,-0.11587,-0.058576,0,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.082489,-0.11632,-0.14877,0,0
5,GO MITOTIC SISTER CHROMATID COHESION,0.66501,-0.11702,-0.033249,0,0
5,GO HISTONE H2A ACETYLATION,0.075049,-0.11839,-0.082341,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.024288,-0.11895,-0.14696,0,0
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.22568,-0.1197,-0.093818,0,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.10654,-0.12144,-0.14376,0,0
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.77618,-0.12249,0.033709,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.32506,-0.12285,-0.084941,0,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.095625,-0.12313,-0.11634,0,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.23245,-0.12416,-0.073543,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.11039,-0.12572,-0.062761,0,0
5,GO PENILE ERECTION,0.39371,-0.12779,-0.0085744,0,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.188,-0.12951,-0.090923,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.61497,-0.13034,0.15864,0,0
5,GO KETONE BODY METABOLIC PROCESS,0.16032,-0.13035,-0.12878,0,0
5,GO CARDIAC CHAMBER FORMATION,0.88523,-0.1305,-0.034221,0,0
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.11235,-0.13171,-0.068357,0,0
5,GO REGULATION OF VESICLE FUSION,0.18508,-0.13223,-0.11652,0,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.86455,-0.13281,0.031857,0,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.11434,-0.13491,-0.10275,0,0
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.91293,-0.13501,0.018192,0,0
5,GO REGULATION OF TELOMERE CAPPING,0.066855,-0.13517,-0.066074,0,0
5,GO RNA INTERFERENCE,0.063042,-0.13724,-0.12149,0,0
5,GO L SERINE METABOLIC PROCESS,0.34702,-0.13743,-0.094278,0,0
5,GO DNA STRAND ELONGATION,0.077957,-0.13766,-0.08511,0,0
5,GO ETHANOL CATABOLIC PROCESS,0.52594,-0.14132,-0.056212,0,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.027188,-0.14252,-0.13865,0,0
5,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.46512,-0.14257,-0.076052,0,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.10845,-0.14258,-0.16274,0,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.37932,-0.14353,-0.10313,0,0
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.093897,-0.14404,-0.1202,0,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.17934,-0.14459,-0.13844,0,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.39371,-0.1477,-0.10976,0,0
5,GO MEMBRANE DISASSEMBLY,0.14769,-0.14795,-0.075677,0,0
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.19393,-0.14818,-0.11273,0,0
5,GO RETROGRADE AXONAL TRANSPORT,0.12049,-0.14864,-0.082176,0,0
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.0066042,-0.15061,-0.18901,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.1028,-0.15107,-0.12885,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.67137,-0.1516,0.01243,0,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.10845,-0.15352,-0.14226,0,0
5,GO KINETOCHORE ORGANIZATION,0.32938,-0.15491,-0.054908,0,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.16828,-0.15508,-0.096519,0,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.17374,-0.15532,-0.061966,0,0
5,GO GLUTAMINE METABOLIC PROCESS,0.12473,-0.15701,-0.089309,0,0
5,GO SNARE COMPLEX ASSEMBLY,0.40843,-0.15893,-0.039315,0,0
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.044685,-0.15918,-0.10869,0,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.15773,-0.16049,-0.12822,0,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.16559,-0.16327,-0.078011,0,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.13814,-0.16696,-0.13038,0,0
5,GO CYSTEINE METABOLIC PROCESS,0.15517,-0.16723,-0.20994,0,0
5,GO AROMATIC AMINO ACID TRANSPORT,0.25001,-0.16725,-0.11298,0,0
5,GO PRENYLATION,0.045624,-0.16947,-0.12574,0,0
5,GO VASCULAR TRANSPORT,0.21579,-0.16996,-0.18327,0,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.40349,-0.17078,-0.0058536,0,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.088862,-0.17423,-0.10311,0,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.087232,-0.17801,-0.19161,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.030383,-0.17911,-0.19635,0,0
5,GO PIGMENT GRANULE MATURATION,0.13583,-0.18284,-0.11395,0,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.27227,-0.18355,-0.15499,0,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.072231,-0.19041,-0.13804,0,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.061812,-0.19058,-0.10504,0,0
5,GO ETHANOL METABOLIC PROCESS,0.0695,-0.19465,-0.15563,0,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.0036303,-0.19711,-0.25685,0,0
5,GO DNA LIGATION,0.17099,-0.20498,-0.094529,0,0
5,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.16828,-0.23237,-0.11414,0,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.077957,-0.23855,-0.16946,0,0
5,GO KINETOCHORE ASSEMBLY,0.1028,-0.25016,-0.099151,0,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0028957,-0.26908,-0.2214,0,0
5,GO DENSE CORE GRANULE TRANSPORT,0.041093,-0.31132,-0.27244,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,1.9263e-05,-0.31812,-0.28695,0,0
5,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,4.2876e-06,-0.72207,-0.65844,0,0
6,GO FOREBRAIN NEURON FATE COMMITMENT,3.3132e-05,0.73192,0.85109,1,1
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00098941,0.51584,0.43184,1,1
6,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00087311,0.45703,0.44827,1,1
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00037661,0.45535,0.49967,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.011904,0.45069,0.37421,1,1
6,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.014841,0.43031,0.31298,1,1
6,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,3.5759e-05,0.39074,0.448,1,1
6,GO NEURON FATE COMMITMENT,2.0033e-05,0.38593,0.42326,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00036427,0.37051,0.36109,1,1
6,GO SPINAL CORD PATTERNING,0.00084609,0.35532,0.35146,1,1
6,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0020453,0.35448,0.33071,1,1
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00049035,0.33125,0.35724,1,1
6,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.018836,0.31501,0.24453,1,1
6,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.4878e-05,0.29094,0.37931,1,1
6,GO NOSE DEVELOPMENT,0.00353,0.28387,0.44223,1,1
6,GO GDP METABOLIC PROCESS,0.05161,0.28053,0.18573,1,1
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.022165,0.27874,0.22835,1,1
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.009256,0.2714,0.35031,1,1
6,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00018427,0.26317,0.23519,1,1
6,GO GENETIC IMPRINTING,0.0001547,0.25871,0.25477,1,1
6,GO MRNA SPLICE SITE SELECTION,9.0179e-06,0.25779,0.29662,1,1
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00353,0.25472,0.21321,1,1
6,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0099891,0.25445,0.20113,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.25061,0.21502,1,1
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.024288,0.24932,0.24109,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0075304,0.24014,0.3144,1,1
6,GO VIRAL LATENCY,0.0042883,0.23801,0.19469,1,1
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.0022332,0.23757,0.2029,1,1
6,GO KINETOCHORE ORGANIZATION,0.0062634,0.23327,0.18494,1,1
6,GO MEGAKARYOCYTE DEVELOPMENT,0.023205,0.22117,0.21043,1,1
6,GO KINETOCHORE ASSEMBLY,0.011612,0.22035,0.16201,1,1
6,GO CELL MIGRATION IN HINDBRAIN,0.040234,0.22009,0.17935,1,1
6,GO REGULATION OF SISTER CHROMATID COHESION,0.0046564,0.21515,0.15872,1,1
6,GO SINGLE STRAND BREAK REPAIR,0.0034322,0.21509,0.17425,1,1
6,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0097392,0.21392,0.19931,1,1
6,GO HISTONE H4 K16 ACETYLATION,7.9801e-06,0.21251,0.23235,1,1
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0007696,0.20918,0.22266,1,1
6,GO CHROMATIN REMODELING AT CENTROMERE,0.001872,0.20273,0.18606,1,1
6,GO CENTROMERE COMPLEX ASSEMBLY,0.004408,0.20111,0.16519,1,1
6,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0097392,0.197,0.16307,1,1
6,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.027803,0.19044,0.17106,1,1
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00035231,0.18908,0.17086,1,1
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00027832,0.18532,0.18874,1,1
6,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0031536,0.18185,0.15044,1,1
6,GO HISTONE H4 K5 ACETYLATION,0.00011241,0.17844,0.22651,1,1
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.026586,0.17694,0.12292,1,1
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0060989,0.17428,0.15715,1,1
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.00087311,0.17415,0.16394,1,1
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00013433,0.17326,0.17998,1,1
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0010528,0.17228,0.16334,1,1
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00072223,0.17221,0.16973,1,1
6,GO HISTONE H2A MONOUBIQUITINATION,0.0010206,0.16842,0.18492,1,1
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.034637,0.1682,0.1365,1,1
6,GO CEREBELLAR CORTEX MORPHOGENESIS,0.027803,0.16694,0.13963,1,1
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0017641,0.16668,0.18627,1,1
6,GO TELENCEPHALON REGIONALIZATION,0.045624,0.16516,0.26758,1,1
6,GO SPINAL CORD DEVELOPMENT,0.0085714,0.16356,0.13818,1,1
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.037747,0.15956,0.16048,1,1
6,GO HISTONE H3 K9 TRIMETHYLATION,0.0056288,0.15933,0.14128,1,1
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.055956,0.158,0.11887,1,1
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.0094949,0.15284,0.11647,1,1
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.020205,0.1525,0.14234,1,1
6,GO MITOTIC SISTER CHROMATID COHESION,0.0042883,0.15103,0.16939,1,1
6,GO ESCRT COMPLEX DISASSEMBLY,0.04854,0.15078,0.12932,1,1
6,GO MITOTIC CHROMOSOME CONDENSATION,0.00034072,0.14936,0.19726,1,1
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0007696,0.14674,0.1531,1,1
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0032441,0.14432,0.12346,1,1
6,GO HISTONE H2A ACETYLATION,0.00026903,0.14419,0.18664,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0012662,0.14322,0.15234,1,1
6,GO RETROGRADE AXONAL TRANSPORT,0.013139,0.14261,0.16907,1,1
6,GO DORSAL VENTRAL PATTERN FORMATION,0.0067808,0.14087,0.14206,1,1
6,GO MITOTIC DNA REPLICATION CHECKPOINT,0.049546,0.14012,0.1059,1,1
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0036303,0.13993,0.13846,1,1
6,GO HISTONE H3 K4 TRIMETHYLATION,0.0069616,0.13756,0.13577,1,1
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0066042,0.13695,0.15578,1,1
6,GO NUCLEOSOME ASSEMBLY,0.0037331,0.13487,0.13886,1,1
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.037747,0.13456,0.13376,1,1
6,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0051916,0.13346,0.15907,1,1
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00016023,0.13182,0.14422,1,1
6,GO HISTONE EXCHANGE,0.013465,0.13085,0.10882,1,1
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.010506,0.12863,0.17398,1,1
6,GO HISTONE H3 K9 ACETYLATION,0.055956,0.12512,0.077122,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.054842,0.12123,0.087401,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0066042,0.12098,0.10935,1,1
6,GO HISTONE H4 ACETYLATION,0.00013433,0.11952,0.12798,1,1
6,GO ATP DEPENDENT CHROMATIN REMODELING,0.0024367,0.11811,0.12892,1,1
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.031059,0.11504,0.07915,1,1
6,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.053746,0.11466,0.093333,1,1
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0038387,0.11379,0.1201,1,1
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,7.547e-05,0.11264,0.13793,1,1
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0075304,0.11063,0.13901,1,1
6,GO HISTONE H3 K4 METHYLATION,0.00095906,0.10834,0.15222,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.015953,0.10752,0.099032,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0013872,0.10656,0.10721,1,1
6,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0056288,0.10605,0.099486,1,1
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.014841,0.10452,0.091512,1,1
6,GO NUCLEOSOME ORGANIZATION,0.0026572,0.10243,0.10649,1,1
6,GO REPLICATION FORK PROCESSING,0.019283,0.10103,0.093241,1,1
6,GO HISTONE H2A UBIQUITINATION,0.026586,0.099834,0.10552,1,1
6,GO REGULATION OF MRNA PROCESSING,0.023205,0.099215,0.07496,1,1
6,GO HISTONE H3 K9 METHYLATION,0.034637,0.097482,0.10901,1,1
6,GO HISTONE MONOUBIQUITINATION,0.0066042,0.093619,0.09856,1,1
6,GO PEPTIDYL LYSINE METHYLATION,0.0069616,0.093503,0.092374,1,1
6,GO PEPTIDYL LYSINE ACETYLATION,0.0001165,0.093328,0.09633,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.02068,0.09331,0.087296,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.018836,0.092093,0.086271,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.02166,0.09197,0.074868,1,1
6,GO SISTER CHROMATID COHESION,0.0079323,0.091481,0.11709,1,1
6,GO NEGATIVE REGULATION OF RNA SPLICING,0.0050528,0.085769,0.11654,1,1
6,GO PROTEIN ACETYLATION,0.0022992,0.085217,0.067771,1,1
6,GO POSITIVE REGULATION OF DNA REPAIR,0.010506,0.082791,0.093656,1,1
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.034637,0.081689,0.098053,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.025994,0.081414,0.081536,1,1
6,GO RECOMBINATIONAL REPAIR,0.0094949,0.078542,0.073622,1,1
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0073363,0.07494,0.093764,1,1
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.02166,0.072404,0.068573,1,1
6,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.021165,0.069938,0.096137,1,1
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.041093,0.069155,0.072929,1,1
6,GO REGULATION OF DNA REPAIR,0.019739,0.066759,0.062184,1,1
6,GO CHROMATIN REMODELING,0.033166,0.0633,0.067563,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.047551,0.057433,0.097255,1,1
6,GO REGULATION OF RNA SPLICING,0.037747,0.056808,0.051269,1,1
6,GO PEPTIDYL LYSINE MODIFICATION,0.037747,0.054375,0.041699,1,1
6,GO CHROMATIN ORGANIZATION,0.036164,0.044399,0.046437,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.010506,0.32701,0.36495,1,0
6,GO ATRIAL SEPTUM MORPHOGENESIS,0.019283,0.30885,0.25787,1,0
6,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0045306,0.24026,0.24024,1,0
6,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0097392,0.23519,0.2709,1,0
6,GO COMMISSURAL NEURON AXON GUIDANCE,0.053746,0.21977,0.19864,1,0
6,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.038561,0.20938,0.2272,1,0
6,GO FOREBRAIN REGIONALIZATION,0.0042883,0.20821,0.23201,1,0
6,GO GLIAL CELL FATE COMMITMENT,0.041967,0.20498,0.30058,1,0
6,GO THALAMUS DEVELOPMENT,0.036164,0.20426,0.21794,1,0
6,GO CARDIAC VENTRICLE FORMATION,0.025414,0.20359,0.34508,1,0
6,GO CEREBELLAR CORTEX FORMATION,0.015953,0.19282,0.18844,1,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.038561,0.19038,0.19986,1,0
6,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.015203,0.17844,0.22256,1,0
6,GO CARDIAC CHAMBER FORMATION,0.054842,0.1749,0.2746,1,0
6,GO CARDIOBLAST DIFFERENTIATION,0.021165,0.17204,0.18127,1,0
6,GO MICROTUBULE SEVERING,0.02068,0.16813,0.16253,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.054842,0.12531,0.15435,1,0
6,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.045624,0.12232,0.15503,1,0
6,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.015203,0.11914,0.24833,1,0
6,GO CENTRIOLE ASSEMBLY,0.042857,0.105,0.083072,1,0
6,GO SPERMATID NUCLEUS DIFFERENTIATION,0.055956,0.099975,0.10021,1,0
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.044685,0.092177,0.098487,1,0
6,GO CHROMOSOME LOCALIZATION,0.053746,0.080118,0.057794,1,0
6,GO INTERSTRAND CROSS LINK REPAIR,0.02166,0.043461,0.074885,1,0
6,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.043763,0.038777,0.076551,1,0
6,GO ACTIVATION OF GTPASE ACTIVITY,0.034637,-0.019983,-0.096452,1,0
6,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.034637,-0.020635,-0.050465,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE,0.025994,-0.031722,-0.055161,1,0
6,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.055956,-0.033782,-0.04975,1,0
6,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.049546,-0.034523,-0.046049,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.029719,-0.046049,-0.060389,1,0
6,GO RHYTHMIC BEHAVIOR,0.041967,-0.047952,-0.087191,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.038561,-0.049819,-0.12944,1,0
6,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.010773,-0.050912,-0.072175,1,0
6,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.024288,-0.050977,-0.059047,1,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.025414,-0.051045,-0.063272,1,0
6,GO NUCLEAR TRANSPORT,0.03245,-0.051726,-0.062095,1,0
6,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.031748,-0.052352,-0.09548,1,0
6,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.053746,-0.052477,-0.072902,1,0
6,GO AMELOGENESIS,0.049546,-0.052518,-0.18913,1,0
6,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.053746,-0.052679,-0.060642,1,0
6,GO REGULATION OF CELL DIFFERENTIATION,0.0069616,-0.053832,-0.083551,1,0
6,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.018398,-0.053961,-0.084015,1,0
6,GO SENSORY PERCEPTION OF SMELL,0.0083534,-0.054567,-0.11226,1,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0038387,-0.054582,-0.078073,1,0
6,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.021165,-0.054628,-0.098889,1,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0030654,-0.054639,-0.061816,1,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.05161,-0.054898,-0.045748,1,0
6,GO MULTI ORGANISM PROCESS,0.014138,-0.05558,-0.067905,1,0
6,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.03245,-0.055777,-0.070337,1,0
6,GO RHYTHMIC PROCESS,0.052669,-0.056553,-0.063891,1,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0033369,-0.056804,-0.059497,1,0
6,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.001228,-0.05702,-0.071969,1,0
6,GO REGULATION OF ORGANELLE ORGANIZATION,0.0017641,-0.057575,-0.067442,1,0
6,GO CELL CELL SIGNALING,0.043763,-0.057666,-0.062039,1,0
6,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.054842,-0.058637,-0.13312,1,0
6,GO REGULATION OF WNT SIGNALING PATHWAY,0.043763,-0.058986,-0.082679,1,0
6,GO MULTICELLULAR ORGANISM GROWTH,0.023741,-0.059081,-0.072148,1,0
6,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.029068,-0.059353,-0.080122,1,0
6,GO REGULATION OF ATPASE ACTIVITY,0.029068,-0.059507,-0.079575,1,0
6,GO PROTEIN AUTOUBIQUITINATION,0.047551,-0.060685,-0.060391,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.054842,-0.061007,-0.14223,1,0
6,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0041716,-0.061395,-0.083141,1,0
6,GO ACTIN NUCLEATION,0.036948,-0.061457,-0.084877,1,0
6,GO UBIQUINONE METABOLIC PROCESS,0.049546,-0.061824,-0.1111,1,0
6,GO RESPIRATORY SYSTEM DEVELOPMENT,0.034637,-0.061825,-0.095221,1,0
6,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.0085714,-0.062026,-0.094121,1,0
6,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00353,-0.062545,-0.087036,1,0
6,GO CALCINEURIN MEDIATED SIGNALING,0.033894,-0.063151,-0.095459,1,0
6,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.022165,-0.063634,-0.12753,1,0
6,GO REGULATION OF VIRAL TRANSCRIPTION,0.015203,-0.063982,-0.11069,1,0
6,GO SKELETAL SYSTEM MORPHOGENESIS,0.031748,-0.064262,-0.1135,1,0
6,GO TISSUE HOMEOSTASIS,0.011904,-0.064598,-0.10413,1,0
6,GO MIDBRAIN DEVELOPMENT,0.045624,-0.064641,-0.075343,1,0
6,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.046579,-0.064949,-0.11363,1,0
6,GO ANIMAL ORGAN FORMATION,0.041967,-0.065435,-0.12023,1,0
6,GO ENDOSOMAL TRANSPORT,0.027803,-0.066107,-0.064586,1,0
6,GO SEX DIFFERENTIATION,0.0059384,-0.06613,-0.095563,1,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.007729,-0.066192,-0.082884,1,0
6,GO MRNA METABOLIC PROCESS,0.053746,-0.066225,-0.068247,1,0
6,GO DETECTION OF STIMULUS,0.0017641,-0.066344,-0.084589,1,0
6,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0042883,-0.066562,-0.10209,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.02068,-0.066567,-0.12324,1,0
6,GO CELLULAR SENESCENCE,0.014841,-0.066893,-0.098037,1,0
6,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.0075304,-0.067147,-0.10049,1,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00090094,-0.067454,-0.066899,1,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.015203,-0.06779,-0.082742,1,0
6,GO DNA BIOSYNTHETIC PROCESS,0.014138,-0.067834,-0.06696,1,0
6,GO LIPOPROTEIN METABOLIC PROCESS,0.0071468,-0.068036,-0.12047,1,0
6,GO REGULATION OF DEVELOPMENTAL GROWTH,0.024288,-0.068202,-0.082201,1,0
6,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.00050664,-0.068239,-0.082646,1,0
6,GO HISTONE DEACETYLATION,0.02068,-0.068263,-0.081593,1,0
6,GO GLUCOSE IMPORT,0.044685,-0.068296,-0.083909,1,0
6,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.018836,-0.068495,-0.10792,1,0
6,GO ENDOSOME ORGANIZATION,0.055956,-0.068834,-0.082208,1,0
6,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.016339,-0.069394,-0.071356,1,0
6,GO REPRODUCTION,0.03245,-0.069452,-0.066969,1,0
6,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.013798,-0.069786,-0.077097,1,0
6,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.05161,-0.070033,-0.11008,1,0
6,GO CYTOSKELETON ORGANIZATION,0.0083534,-0.070265,-0.082264,1,0
6,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.040234,-0.070431,-0.10561,1,0
6,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.023205,-0.071152,-0.094203,1,0
6,GO STEM CELL DIFFERENTIATION,0.054842,-0.071381,-0.068943,1,0
6,GO EPITHELIAL TUBE FORMATION,0.047551,-0.071536,-0.090315,1,0
6,GO PEPTIDYL AMINO ACID MODIFICATION,0.00020448,-0.071733,-0.083719,1,0
6,GO NEURON DEATH,0.036948,-0.071911,-0.057856,1,0
6,GO CYTOSOLIC TRANSPORT,0.0071468,-0.071948,-0.089188,1,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.045624,-0.072185,-0.063604,1,0
6,GO AMINO ACID TRANSPORT,0.023741,-0.072577,-0.082201,1,0
6,GO MESODERM DEVELOPMENT,0.004408,-0.072697,-0.12621,1,0
6,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.00037661,-0.07295,-0.11401,1,0
6,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.023741,-0.072979,-0.1055,1,0
6,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.012508,-0.073008,-0.10361,1,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0073363,-0.073193,-0.077093,1,0
6,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0015653,-0.073303,-0.069847,1,0
6,GO ORGANELLE INHERITANCE,0.029719,-0.073372,-0.092808,1,0
6,GO REGULATION OF TELOMERASE ACTIVITY,0.02268,-0.073632,-0.11599,1,0
6,GO NEGATIVE REGULATION OF JNK CASCADE,0.033894,-0.073826,-0.1045,1,0
6,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.036948,-0.073976,-0.12116,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.015953,-0.074461,-0.12671,1,0
6,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0037331,-0.07451,-0.094418,1,0
6,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.011326,-0.075099,-0.079042,1,0
6,GO IMPORT INTO NUCLEUS,0.0013457,-0.075215,-0.099327,1,0
6,GO REGULATION OF CELLULAR PH,0.01282,-0.075512,-0.086663,1,0
6,GO EMBRYO DEVELOPMENT,0.047551,-0.075514,-0.074819,1,0
6,GO PROTEIN LOCALIZATION TO LYSOSOME,0.038561,-0.075763,-0.12889,1,0
6,GO EPITHELIAL TUBE MORPHOGENESIS,0.011904,-0.075906,-0.10848,1,0
6,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0047853,-0.076042,-0.1122,1,0
6,GO GOLGI ORGANIZATION,0.0010859,-0.076158,-0.11592,1,0
6,GO REGULATION OF PINOCYTOSIS,0.047551,-0.076298,-0.17497,1,0
6,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0087944,-0.076317,-0.098653,1,0
6,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.02166,-0.076424,-0.11507,1,0
6,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.025414,-0.076538,-0.076625,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.017549,-0.076593,-0.073239,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00095906,-0.076935,-0.096123,1,0
6,GO RIG I SIGNALING PATHWAY,0.02166,-0.077211,-0.1506,1,0
6,GO REGULATION OF MEMBRANE REPOLARIZATION,0.046579,-0.07772,-0.1239,1,0
6,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.037747,-0.077795,-0.079254,1,0
6,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.026586,-0.078668,-0.10322,1,0
6,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0036303,-0.078792,-0.12793,1,0
6,GO NUCLEAR ENVELOPE ORGANIZATION,0.023741,-0.078932,-0.078107,1,0
6,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.034637,-0.079175,-0.13869,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0064317,-0.079212,-0.10468,1,0
6,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.027803,-0.0793,-0.093573,1,0
6,GO TAXIS,0.0025817,-0.080104,-0.11004,1,0
6,GO REGULATION OF CELL SIZE,0.055956,-0.080179,-0.074338,1,0
6,GO IN UTERO EMBRYONIC DEVELOPMENT,0.010506,-0.080263,-0.082313,1,0
6,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.043763,-0.080351,-0.11221,1,0
6,GO CELL CELL SIGNALING BY WNT,0.004408,-0.080448,-0.096666,1,0
6,GO RESPONSE TO IONIZING RADIATION,0.0079323,-0.080605,-0.090838,1,0
6,GO WHITE FAT CELL DIFFERENTIATION,0.036948,-0.080894,-0.153,1,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0011549,-0.081105,-0.111,1,0
6,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0050528,-0.081214,-0.075792,1,0
6,GO RESPONSE TO INTERLEUKIN 6,0.03939,-0.081537,-0.11739,1,0
6,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0029794,-0.08202,-0.12907,1,0
6,GO PROTEIN DEPHOSPHORYLATION,0.010773,-0.082266,-0.07278,1,0
6,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.015953,-0.082609,-0.093331,1,0
6,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.027803,-0.08339,-0.10133,1,0
6,GO RETINA HOMEOSTASIS,0.050569,-0.083457,-0.075717,1,0
6,GO HEART VALVE DEVELOPMENT,0.042857,-0.083786,-0.15661,1,0
6,GO CELL CYCLE ARREST,0.0013872,-0.083956,-0.097148,1,0
6,GO POSITIVE REGULATION OF GROWTH,0.013465,-0.083977,-0.080459,1,0
6,GO REGULATION OF DEPHOSPHORYLATION,0.017549,-0.084099,-0.061437,1,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0031536,-0.08411,-0.10839,1,0
6,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.052669,-0.084188,-0.11876,1,0
6,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0087944,-0.084208,-0.12796,1,0
6,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0060989,-0.084226,-0.10306,1,0
6,GO EXECUTION PHASE OF APOPTOSIS,0.054842,-0.084331,-0.064212,1,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0013054,-0.084454,-0.088492,1,0
6,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.014841,-0.084772,-0.14078,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.042857,-0.084799,-0.084104,1,0
6,GO SENSORY PERCEPTION,0.0054795,-0.085206,-0.084589,1,0
6,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0011549,-0.085211,-0.089824,1,0
6,GO REGULATION OF ORGANELLE ASSEMBLY,0.027803,-0.085252,-0.059046,1,0
6,GO VESICLE DOCKING,0.013798,-0.085359,-0.11497,1,0
6,GO TRANSLESION SYNTHESIS,0.02068,-0.085613,-0.09216,1,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.018836,-0.085852,-0.075187,1,0
6,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.053746,-0.085877,-0.095727,1,0
6,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00055855,-0.086048,-0.080895,1,0
6,GO EMBRYONIC ORGAN DEVELOPMENT,0.027803,-0.086376,-0.092011,1,0
6,GO PROTON TRANSMEMBRANE TRANSPORT,0.0029794,-0.086461,-0.11201,1,0
6,GO MALE SEX DIFFERENTIATION,0.012508,-0.086464,-0.11677,1,0
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.041967,-0.086706,-0.14631,1,0
6,GO REGULATION OF PH,0.01282,-0.086768,-0.087384,1,0
6,GO CALCIUM ION IMPORT,0.024288,-0.086817,-0.099917,1,0
6,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00069957,-0.086862,-0.093546,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0090226,-0.086995,-0.09889,1,0
6,GO CELLULAR MACROMOLECULE LOCALIZATION,3.6228e-06,-0.087129,-0.097632,1,0
6,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.001986,-0.087141,-0.11067,1,0
6,GO LEUKOCYTE TETHERING OR ROLLING,0.036164,-0.087395,-0.078818,1,0
6,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.031748,-0.087453,-0.083977,1,0
6,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.041967,-0.087549,-0.12901,1,0
6,GO OLIGODENDROCYTE DEVELOPMENT,0.033166,-0.088271,-0.13409,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.007729,-0.088334,-0.077428,1,0
6,GO RESPONSE TO ALKALOID,0.047551,-0.088527,-0.085101,1,0
6,GO REGULATION OF PHOSPHATASE ACTIVITY,0.017969,-0.088739,-0.066238,1,0
6,GO RESPONSE TO BMP,0.029068,-0.088741,-0.10984,1,0
6,GO EMBRYONIC ORGAN MORPHOGENESIS,0.055956,-0.088831,-0.09123,1,0
6,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0040578,-0.089082,-0.12198,1,0
6,GO HISTONE PHOSPHORYLATION,0.013465,-0.08925,-0.12102,1,0
6,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.035393,-0.089488,-0.12282,1,0
6,GO NEUTROPHIL CHEMOTAXIS,0.0045306,-0.089553,-0.12986,1,0
6,GO DEPHOSPHORYLATION,0.0029794,-0.089878,-0.086071,1,0
6,GO DEVELOPMENTAL GROWTH,0.004408,-0.089895,-0.094764,1,0
6,GO ALPHA BETA T CELL DIFFERENTIATION,0.017969,-0.090255,-0.13161,1,0
6,GO ANATOMICAL STRUCTURE HOMEOSTASIS,8.1192e-05,-0.090272,-0.1009,1,0
6,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.013e-05,-0.090928,-0.10237,1,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0021062,-0.090963,-0.1101,1,0
6,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00050664,-0.091008,-0.11571,1,0
6,GO SENSORY PERCEPTION OF TASTE,0.025994,-0.091031,-0.1153,1,0
6,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.024288,-0.091085,-0.1113,1,0
6,GO REGULATION OF ANION TRANSPORT,0.011904,-0.091112,-0.10841,1,0
6,GO LYMPHOCYTE DIFFERENTIATION,0.0016129,-0.091149,-0.11585,1,0
6,GO ESTABLISHMENT OF CELL POLARITY,0.025994,-0.091348,-0.076071,1,0
6,GO UROGENITAL SYSTEM DEVELOPMENT,0.010506,-0.091578,-0.12557,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.033894,-0.091827,-0.088672,1,0
6,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0015653,-0.091835,-0.097337,1,0
6,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.011904,-0.092165,-0.089891,1,0
6,GO CELL GROWTH,0.0013457,-0.092285,-0.11281,1,0
6,GO PROTEIN O LINKED GLYCOSYLATION,0.0028957,-0.092433,-0.16297,1,0
6,GO T CELL DIFFERENTIATION,0.0097392,-0.092483,-0.11154,1,0
6,GO TUBE FORMATION,0.020205,-0.092492,-0.103,1,0
6,GO RNA METHYLATION,0.018836,-0.09267,-0.11314,1,0
6,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,3.6228e-06,-0.092802,-0.099549,1,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00353,-0.092942,-0.084474,1,0
6,GO REGULATION OF TRANSLATIONAL INITIATION,0.00090094,-0.092948,-0.12572,1,0
6,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.0069616,-0.093115,-0.13929,1,0
6,GO ASTROCYTE DIFFERENTIATION,0.033166,-0.093149,-0.13884,1,0
6,GO TRABECULA MORPHOGENESIS,0.023741,-0.093172,-0.14723,1,0
6,GO GLIOGENESIS,0.018836,-0.093349,-0.1075,1,0
6,GO REGULATION OF PROTEIN FOLDING,0.0064317,-0.093641,-0.12944,1,0
6,GO RNA MODIFICATION,0.0045306,-0.093646,-0.13029,1,0
6,GO MOLTING CYCLE,0.0067808,-0.093714,-0.13451,1,0
6,GO PROTEOLYSIS,4.4878e-05,-0.093768,-0.12188,1,0
6,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.054842,-0.094003,-0.13733,1,0
6,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0023671,-0.094042,-0.090779,1,0
6,GO REGULATION OF CELLULAR LOCALIZATION,0.00092958,-0.094146,-0.086789,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION,0.00050664,-0.094158,-0.096549,1,0
6,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00063551,-0.094295,-0.12547,1,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0027346,-0.094684,-0.079003,1,0
6,GO CANONICAL WNT SIGNALING PATHWAY,0.0038387,-0.094777,-0.11146,1,0
6,GO AUTOPHAGY OF MITOCHONDRION,0.001191,-0.094846,-0.12057,1,0
6,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.015203,-0.095038,-0.11132,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.010245,-0.095168,-0.1077,1,0
6,GO SINGLE FERTILIZATION,0.010773,-0.095207,-0.10686,1,0
6,GO EAR MORPHOGENESIS,0.045624,-0.095577,-0.089289,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.017969,-0.095885,-0.069675,1,0
6,GO IMMUNOGLOBULIN PRODUCTION,0.0036303,-0.095958,-0.12114,1,0
6,GO REGULATION OF GROWTH,0.00042998,-0.096024,-0.11779,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.027188,-0.09609,-0.1367,1,0
6,GO ALPHA BETA T CELL ACTIVATION,0.0026572,-0.096205,-0.15194,1,0
6,GO IMMUNE SYSTEM DEVELOPMENT,0.00031859,-0.096215,-0.12164,1,0
6,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0025083,-0.096476,-0.11059,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.012508,-0.096535,-0.10813,1,0
6,GO PEPTIDYL ARGININE MODIFICATION,0.0054795,-0.096552,-0.13239,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.010773,-0.096775,-0.15532,1,0
6,GO REGULATION OF SECRETION,0.011047,-0.09695,-0.089999,1,0
6,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.016339,-0.096975,-0.093819,1,0
6,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.027803,-0.096986,-0.07401,1,0
6,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.025994,-0.096994,-0.1009,1,0
6,GO MANGANESE ION TRANSPORT,0.037747,-0.097153,-0.12267,1,0
6,GO CELL RECOGNITION,0.037747,-0.097222,-0.096473,1,0
6,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00049035,-0.097344,-0.11872,1,0
6,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.017549,-0.097381,-0.21727,1,0
6,GO MUSCLE ORGAN DEVELOPMENT,0.00042998,-0.097404,-0.12046,1,0
6,GO RESPONSE TO ESTRADIOL,0.0028957,-0.097743,-0.12347,1,0
6,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.013139,-0.097893,-0.12406,1,0
6,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0045306,-0.097946,-0.094924,1,0
6,GO RESPONSE TO IRON ION,0.025994,-0.097964,-0.13256,1,0
6,GO KILLING OF CELLS OF OTHER ORGANISM,0.047551,-0.098013,-0.075806,1,0
6,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0073363,-0.098119,-0.099601,1,0
6,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.047551,-0.09834,-0.11252,1,0
6,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0019282,-0.098544,-0.083406,1,0
6,GO AORTA DEVELOPMENT,0.02068,-0.0986,-0.15909,1,0
6,GO GROWTH,0.00027832,-0.098954,-0.11106,1,0
6,GO RRNA METHYLATION,0.0099891,-0.099042,-0.16871,1,0
6,GO EMBRYONIC MORPHOGENESIS,0.026586,-0.099183,-0.10215,1,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.047551,-0.099348,-0.19251,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.02268,-0.099417,-0.12324,1,0
6,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.036948,-0.099603,-0.10251,1,0
6,GO BONE DEVELOPMENT,0.011326,-0.099689,-0.1083,1,0
6,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.016339,-0.099721,-0.10589,1,0
6,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0046564,-0.099805,-0.11425,1,0
6,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.018398,-0.099861,-0.16145,1,0
6,GO MACROPHAGE DIFFERENTIATION,0.0042883,-0.099924,-0.18936,1,0
6,GO MORPHOGENESIS OF AN EPITHELIUM,0.00095906,-0.099974,-0.13385,1,0
6,GO DEFENSE RESPONSE TO FUNGUS,0.02843,-0.099995,-0.11137,1,0
6,GO PROTEIN KINASE A SIGNALING,0.018836,-0.10019,-0.10767,1,0
6,GO REGULATION OF HORMONE LEVELS,0.0040578,-0.10019,-0.12058,1,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0090226,-0.10043,-0.15025,1,0
6,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0041716,-0.10058,-0.11775,1,0
6,GO CELLULAR RESPONSE TO VIRUS,0.029719,-0.10062,-0.12102,1,0
6,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0046564,-0.10072,-0.13009,1,0
6,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.049546,-0.10086,-0.31199,1,0
6,GO ORGAN GROWTH,0.0064317,-0.10101,-0.11242,1,0
6,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00026003,-0.10107,-0.097163,1,0
6,GO INTESTINAL LIPID ABSORPTION,0.05161,-0.10113,-0.2188,1,0
6,GO LYSOSOME LOCALIZATION,0.013139,-0.10115,-0.096585,1,0
6,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.011326,-0.10129,-0.093762,1,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.015574,-0.10155,-0.094097,1,0
6,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0027346,-0.10159,-0.10049,1,0
6,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025817,-0.10163,-0.1852,1,0
6,GO REGULATION OF SYSTEM PROCESS,0.0026572,-0.10182,-0.12334,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0029794,-0.10195,-0.17408,1,0
6,GO LYMPHOCYTE HOMEOSTASIS,0.0079323,-0.10196,-0.10629,1,0
6,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0064317,-0.10214,-0.17065,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.023741,-0.10226,-0.16653,1,0
6,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0047853,-0.10234,-0.10955,1,0
6,GO OVULATION CYCLE,0.027188,-0.10239,-0.11476,1,0
6,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0051916,-0.10242,-0.084,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0032441,-0.10246,-0.14106,1,0
6,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00098941,-0.10258,-0.11676,1,0
6,GO PROTEIN LOCALIZATION TO VACUOLE,0.0069616,-0.10271,-0.13287,1,0
6,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0032441,-0.1028,-0.15186,1,0
6,GO MACROAUTOPHAGY,6.0504e-05,-0.10281,-0.12154,1,0
6,GO MACROMOLECULE DEACYLATION,0.001872,-0.10282,-0.088469,1,0
6,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.036164,-0.10284,-0.12528,1,0
6,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.015203,-0.10289,-0.15316,1,0
6,GO NEUTRAL AMINO ACID TRANSPORT,0.0069616,-0.10313,-0.17665,1,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.046579,-0.10313,-0.099724,1,0
6,GO INTERFERON BETA PRODUCTION,0.055956,-0.10316,-0.12109,1,0
6,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.03939,-0.10316,-0.14809,1,0
6,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0032441,-0.10336,-0.14545,1,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0037331,-0.10347,-0.081499,1,0
6,GO AMINE METABOLIC PROCESS,0.0011199,-0.10351,-0.13997,1,0
6,GO PROTEIN N LINKED GLYCOSYLATION,0.0025083,-0.10352,-0.14538,1,0
6,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0040578,-0.10361,-0.16024,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.023205,-0.10398,-0.1242,1,0
6,GO ERAD PATHWAY,0.0013457,-0.10405,-0.13821,1,0
6,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00090094,-0.10406,-0.11157,1,0
6,GO EPITHELIUM DEVELOPMENT,0.0039469,-0.10411,-0.11896,1,0
6,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.02268,-0.10423,-0.10325,1,0
6,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0019282,-0.10425,-0.12081,1,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0025083,-0.10426,-0.094329,1,0
6,GO REGULATION OF MITOCHONDRION ORGANIZATION,7.547e-05,-0.10432,-0.12648,1,0
6,GO ACID SECRETION,0.02166,-0.10443,-0.13456,1,0
6,GO SKELETAL SYSTEM DEVELOPMENT,0.0031536,-0.10444,-0.11563,1,0
6,GO INTERLEUKIN 6 PRODUCTION,0.018398,-0.10475,-0.10948,1,0
6,GO STEROL BIOSYNTHETIC PROCESS,0.023205,-0.1048,-0.13017,1,0
6,GO REGULATION OF T CELL DIFFERENTIATION,0.007729,-0.10482,-0.11318,1,0
6,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.013465,-0.10488,-0.11077,1,0
6,GO PEPTIDYL SERINE MODIFICATION,0.0037331,-0.10513,-0.08395,1,0
6,GO PROTEIN CATABOLIC PROCESS,2.9532e-05,-0.1053,-0.10386,1,0
6,GO REGULATION OF HEART GROWTH,0.037747,-0.10538,-0.11116,1,0
6,GO MITOCHONDRIAL DNA REPLICATION,0.018836,-0.10541,-0.116,1,0
6,GO GOLGI VESICLE TRANSPORT,0.00035231,-0.10549,-0.11434,1,0
6,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.013465,-0.10558,-0.12765,1,0
6,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,8.7323e-05,-0.1058,-0.12118,1,0
6,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,3.6228e-06,-0.1061,-0.12198,1,0
6,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0051916,-0.10613,-0.13571,1,0
6,GO REGULATION OF MIRNA METABOLIC PROCESS,0.023741,-0.10616,-0.14852,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.015953,-0.10618,-0.13547,1,0
6,GO REGULATION OF TOR SIGNALING,0.0028141,-0.10627,-0.097575,1,0
6,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.026586,-0.10634,-0.11588,1,0
6,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.034637,-0.10638,-0.11915,1,0
6,GO BONE MORPHOGENESIS,0.02843,-0.10644,-0.1369,1,0
6,GO REGULATION OF TRANSPORT,0.00052342,-0.10671,-0.10987,1,0
6,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.016339,-0.10689,-0.16183,1,0
6,GO POLYOL CATABOLIC PROCESS,0.0075304,-0.10694,-0.11945,1,0
6,GO NCRNA CATABOLIC PROCESS,0.025994,-0.10722,-0.12926,1,0
6,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.049546,-0.10727,-0.10607,1,0
6,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.035393,-0.10751,-0.13849,1,0
6,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.016734,-0.10756,-0.075822,1,0
6,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.029068,-0.10769,-0.11698,1,0
6,GO LIPOSACCHARIDE METABOLIC PROCESS,0.024288,-0.10774,-0.12044,1,0
6,GO GOLGI TO VACUOLE TRANSPORT,0.040234,-0.10778,-0.11137,1,0
6,GO REGULATION OF GASTRULATION,0.031748,-0.10789,-0.14088,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0039469,-0.10802,-0.1572,1,0
6,GO REGULATION OF MUSCLE ADAPTATION,0.0031536,-0.10804,-0.15308,1,0
6,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0083534,-0.10806,-0.14574,1,0
6,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0013054,-0.10828,-0.12279,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.014486,-0.10846,-0.12989,1,0
6,GO PROTEIN IMPORT,4.4878e-05,-0.10857,-0.13376,1,0
6,GO CELLULAR PROTEIN CATABOLIC PROCESS,2.6307e-05,-0.10873,-0.10314,1,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0042883,-0.10878,-0.10904,1,0
6,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00032948,-0.10894,-0.1137,1,0
6,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0060989,-0.10932,-0.18485,1,0
6,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.018836,-0.1094,-0.17999,1,0
6,GO POSITIVE REGULATION OF SECRETION,0.0067808,-0.10961,-0.099253,1,0
6,GO EPITHELIAL CELL DEVELOPMENT,0.0064317,-0.10974,-0.14727,1,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0038387,-0.1098,-0.16413,1,0
6,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00050664,-0.10994,-0.098797,1,0
6,GO REGULATION OF B CELL ACTIVATION,0.0032441,-0.11001,-0.14915,1,0
6,GO VACUOLAR TRANSPORT,0.0034322,-0.11002,-0.11561,1,0
6,GO REGULATION OF PEPTIDE TRANSPORT,0.00098941,-0.11016,-0.096102,1,0
6,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.00038934,-0.11018,-0.10523,1,0
6,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.012508,-0.11019,-0.10992,1,0
6,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0027346,-0.11019,-0.1656,1,0
6,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.017549,-0.11027,-0.12719,1,0
6,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.036164,-0.11034,-0.14536,1,0
6,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.033166,-0.1106,-0.14576,1,0
6,GO REGULATION OF LIPID KINASE ACTIVITY,0.0017123,-0.11064,-0.14209,1,0
6,GO FEMALE SEX DIFFERENTIATION,0.00353,-0.11066,-0.13299,1,0
6,GO CELLULAR PIGMENTATION,0.0013872,-0.11072,-0.13723,1,0
6,GO CELL CELL JUNCTION ORGANIZATION,0.055956,-0.11081,-0.10767,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.031059,-0.11092,-0.20266,1,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0015653,-0.11103,-0.11819,1,0
6,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.012203,-0.1111,-0.13615,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO STRESS,2.8418e-05,-0.11112,-0.11329,1,0
6,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0032441,-0.1112,-0.11391,1,0
6,GO REGULATION OF CELL POPULATION PROLIFERATION,7.8282e-05,-0.1113,-0.13962,1,0
6,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0038387,-0.11143,-0.14437,1,0
6,GO MULTI ORGANISM LOCALIZATION,0.001191,-0.11161,-0.15112,1,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00079435,-0.11164,-0.11979,1,0
6,GO NEUROINFLAMMATORY RESPONSE,0.0085714,-0.11164,-0.16053,1,0
6,GO ANIMAL ORGAN MORPHOGENESIS,0.0046564,-0.11181,-0.11379,1,0
6,GO RENAL SYSTEM PROCESS,0.023741,-0.11184,-0.12517,1,0
6,GO REGULATION OF GTP BINDING,0.054842,-0.11198,-0.16747,1,0
6,GO TOR SIGNALING,0.00044439,-0.11205,-0.10035,1,0
6,GO EPIDERMIS DEVELOPMENT,0.014841,-0.11224,-0.14042,1,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.033166,-0.11228,-0.12005,1,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.017969,-0.11229,-0.12333,1,0
6,GO MESENCHYME DEVELOPMENT,0.0010528,-0.11246,-0.15028,1,0
6,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.00012512,-0.11246,-0.13832,1,0
6,GO PROTEIN HETEROOLIGOMERIZATION,0.054842,-0.11251,-0.097503,1,0
6,GO MUSCLE TISSUE DEVELOPMENT,0.0010528,-0.11266,-0.10903,1,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.004408,-0.1127,-0.16048,1,0
6,GO CELLULAR RESPONSE TO INSULIN STIMULUS,3.8583e-05,-0.1127,-0.14608,1,0
6,GO METHIONINE METABOLIC PROCESS,0.0045306,-0.11275,-0.16166,1,0
6,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.010245,-0.11283,-0.17853,1,0
6,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.004408,-0.11295,-0.14559,1,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00069957,-0.11321,-0.13561,1,0
6,GO GLYCOSYLATION,0.00063551,-0.11329,-0.14562,1,0
6,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.010245,-0.11332,-0.13528,1,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0012662,-0.11335,-0.18373,1,0
6,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00023468,-0.11342,-0.14595,1,0
6,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00026903,-0.11355,-0.1319,1,0
6,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.0073e-05,-0.11356,-0.12052,1,0
6,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.042857,-0.11356,-0.12157,1,0
6,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0066042,-0.11358,-0.12286,1,0
6,GO DEVELOPMENTAL PIGMENTATION,0.0040578,-0.11358,-0.13193,1,0
6,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0006154,-0.11366,-0.12989,1,0
6,GO CELL CELL JUNCTION ASSEMBLY,0.026586,-0.11369,-0.12211,1,0
6,GO INTERLEUKIN 4 PRODUCTION,0.0073363,-0.11374,-0.16416,1,0
6,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00031859,-0.11374,-0.12049,1,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00013433,-0.114,-0.12379,1,0
6,GO SMOOTH MUSCLE CELL MIGRATION,0.0049174,-0.114,-0.21868,1,0
6,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.017549,-0.11402,-0.13139,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.012203,-0.11409,-0.19441,1,0
6,GO PHOSPHATE ION TRANSPORT,0.023741,-0.11411,-0.10282,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.00026003,-0.11416,-0.15125,1,0
6,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00019079,-0.11419,-0.14422,1,0
6,GO ARACHIDONIC ACID SECRETION,0.0011549,-0.11421,-0.16831,1,0
6,GO MITOCHONDRION ORGANIZATION,2.0833e-05,-0.11422,-0.12552,1,0
6,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,2.0833e-05,-0.11426,-0.14279,1,0
6,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.013465,-0.1143,-0.12434,1,0
6,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0059384,-0.11434,-0.2001,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.012203,-0.11449,-0.13521,1,0
6,GO PRE MIRNA PROCESSING,0.044685,-0.11457,-0.13368,1,0
6,GO RESPONSE TO NITRIC OXIDE,0.030383,-0.11458,-0.087416,1,0
6,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.014841,-0.11458,-0.16724,1,0
6,GO INTRACELLULAR TRANSPORT,1.5331e-06,-0.11466,-0.10687,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0037331,-0.11472,-0.14073,1,0
6,GO OSTEOCLAST DIFFERENTIATION,0.004408,-0.11481,-0.1274,1,0
6,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,4.8379e-05,-0.11483,-0.10525,1,0
6,GO LIPOPROTEIN CATABOLIC PROCESS,0.017137,-0.11491,-0.19309,1,0
6,GO MESODERMAL CELL DIFFERENTIATION,0.052669,-0.11499,-0.15409,1,0
6,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0034322,-0.11525,-0.17866,1,0
6,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.047551,-0.11529,-0.11582,1,0
6,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0071468,-0.11534,-0.07438,1,0
6,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0090226,-0.11539,-0.16566,1,0
6,GO T CELL DIFFERENTIATION IN THYMUS,0.027188,-0.11544,-0.10493,1,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00012512,-0.11547,-0.16903,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.017969,-0.11568,-0.18037,1,0
6,GO HEART TRABECULA MORPHOGENESIS,0.010506,-0.11568,-0.15288,1,0
6,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.029719,-0.11583,-0.2416,1,0
6,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.014486,-0.11584,-0.10841,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.011612,-0.11586,-0.11392,1,0
6,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0030654,-0.11586,-0.11209,1,0
6,GO LEUKOCYTE HOMEOSTASIS,0.00059588,-0.11588,-0.15112,1,0
6,GO REGULATION OF PROTEIN DEACETYLATION,0.019283,-0.11591,-0.1039,1,0
6,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.017969,-0.11592,-0.13031,1,0
6,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0011199,-0.11595,-0.14386,1,0
6,GO SYNAPTIC TRANSMISSION GABAERGIC,0.027803,-0.11596,-0.12292,1,0
6,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00074557,-0.11609,-0.10688,1,0
6,GO MATURATION OF 5 8S RRNA,0.027188,-0.11609,-0.18723,1,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.019739,-0.11609,-0.11399,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.004408,-0.11634,-0.12724,1,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.054842,-0.11638,-0.17584,1,0
6,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.0099891,-0.11638,-0.14802,1,0
6,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0012662,-0.11663,-0.11143,1,0
6,GO ORGANELLE DISASSEMBLY,0.00041602,-0.11668,-0.11435,1,0
6,GO GLAND DEVELOPMENT,0.00081984,-0.1167,-0.13483,1,0
6,GO PROTEIN LOCALIZATION TO ORGANELLE,4.1112e-06,-0.11688,-0.11133,1,0
6,GO FERTILIZATION,0.0034322,-0.11698,-0.1141,1,0
6,GO CARDIOLIPIN METABOLIC PROCESS,0.0013457,-0.11698,-0.21087,1,0
6,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0071468,-0.117,-0.11678,1,0
6,GO CHEMOKINE PRODUCTION,0.0046564,-0.11711,-0.1893,1,0
6,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0022992,-0.11728,-0.17166,1,0
6,GO FEEDING BEHAVIOR,0.046579,-0.11743,-0.084099,1,0
6,GO REGULATION OF HISTONE DEACETYLATION,0.03245,-0.11744,-0.1221,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.037747,-0.11753,-0.16305,1,0
6,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.018836,-0.11755,-0.16452,1,0
6,GO REGULATION OF ACTIN FILAMENT LENGTH,0.00054072,-0.11763,-0.12296,1,0
6,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0034322,-0.1179,-0.16538,1,0
6,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.053746,-0.11795,-0.14041,1,0
6,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.045624,-0.11799,-0.16716,1,0
6,GO INTRACELLULAR PROTEIN TRANSPORT,2.3654e-06,-0.11815,-0.1126,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.014841,-0.11816,-0.11645,1,0
6,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.02166,-0.11821,-0.12073,1,0
6,GO MACROMOLECULE CATABOLIC PROCESS,9.8628e-07,-0.11832,-0.13194,1,0
6,GO BASIC AMINO ACID TRANSPORT,0.037747,-0.11833,-0.19539,1,0
6,GO NEGATIVE REGULATION OF ION TRANSPORT,0.00090094,-0.11835,-0.11186,1,0
6,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.011326,-0.11842,-0.15066,1,0
6,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,4.4878e-05,-0.11858,-0.12582,1,0
6,GO EPIDERMAL CELL DIFFERENTIATION,0.016339,-0.11875,-0.13574,1,0
6,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.020205,-0.11882,-0.16973,1,0
6,GO REGULATION OF HEMOPOIESIS,0.00014418,-0.11888,-0.14967,1,0
6,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.013139,-0.11892,-0.091113,1,0
6,GO PROTEIN TARGETING TO VACUOLE,0.0014738,-0.11897,-0.15921,1,0
6,GO POSITIVE REGULATION OF SIGNALING,9.389e-05,-0.11917,-0.12508,1,0
6,GO I KAPPAB PHOSPHORYLATION,0.015953,-0.11935,-0.16116,1,0
6,GO DEFENSE RESPONSE TO VIRUS,0.013465,-0.11941,-0.18374,1,0
6,GO TISSUE MORPHOGENESIS,0.0006154,-0.11953,-0.1389,1,0
6,GO RENAL SODIUM EXCRETION,0.047551,-0.11955,-0.12635,1,0
6,GO RESPONSE TO ABIOTIC STIMULUS,3.0576e-06,-0.11957,-0.13975,1,0
6,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00079435,-0.11963,-0.15622,1,0
6,GO NEUTROPHIL MIGRATION,0.00036427,-0.11965,-0.1653,1,0
6,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.012508,-0.11974,-0.20503,1,0
6,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.018398,-0.11979,-0.17899,1,0
6,GO HEMOGLOBIN METABOLIC PROCESS,0.0094949,-0.11986,-0.15973,1,0
6,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00012074,-0.11991,-0.13026,1,0
6,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0054795,-0.11994,-0.12273,1,0
6,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0015189,-0.12001,-0.16104,1,0
6,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0041716,-0.12004,-0.11803,1,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0030654,-0.1201,-0.13037,1,0
6,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,7.2754e-05,-0.12012,-0.1355,1,0
6,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.033894,-0.12013,-0.15712,1,0
6,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.02166,-0.12014,-0.14964,1,0
6,GO REGULATION OF ENDOCRINE PROCESS,0.0057817,-0.12023,-0.15651,1,0
6,GO REGULATION OF RESPONSE TO STRESS,8.3127e-06,-0.12026,-0.14381,1,0
6,GO PEPTIDYL METHIONINE MODIFICATION,0.036164,-0.12031,-0.14702,1,0
6,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00047456,-0.12039,-0.12971,1,0
6,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.017549,-0.12054,-0.16188,1,0
6,GO HEART DEVELOPMENT,0.00052342,-0.12056,-0.13155,1,0
6,GO REGULATION OF NEUTROPHIL MIGRATION,0.052669,-0.12059,-0.11887,1,0
6,GO TRNA MODIFICATION,0.014841,-0.1207,-0.13229,1,0
6,GO REGULATION OF URINE VOLUME,0.0073363,-0.12079,-0.14355,1,0
6,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.017549,-0.1208,-0.18409,1,0
6,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.023741,-0.12106,-0.13143,1,0
6,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.027188,-0.12108,-0.22668,1,0
6,GO RESPONSE TO ACTIVITY,0.0014299,-0.12116,-0.14013,1,0
6,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.043763,-0.12118,-0.11218,1,0
6,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.050569,-0.12121,-0.15025,1,0
6,GO NEPHRON MORPHOGENESIS,0.014486,-0.1213,-0.11374,1,0
6,GO B CELL DIFFERENTIATION,0.0038387,-0.12149,-0.12563,1,0
6,GO REGULATION OF PROTEIN MODIFICATION PROCESS,1.7118e-05,-0.12157,-0.12831,1,0
6,GO AUTOPHAGOSOME ORGANIZATION,0.0015653,-0.12164,-0.154,1,0
6,GO MAST CELL MEDIATED IMMUNITY,0.017137,-0.12168,-0.13835,1,0
6,GO REGULATION OF PROTEIN STABILITY,3.1904e-06,-0.12173,-0.14288,1,0
6,GO POSITIVE REGULATION OF TRANSPORT,0.00026903,-0.12181,-0.12001,1,0
6,GO CYTOKINE SECRETION,0.010245,-0.12183,-0.11915,1,0
6,GO MYELOID CELL DIFFERENTIATION,6.2786e-05,-0.12187,-0.15536,1,0
6,GO DENDRITIC CELL MIGRATION,0.013798,-0.12189,-0.20763,1,0
6,GO REGULATION OF HYDROLASE ACTIVITY,1.6455e-05,-0.12191,-0.14465,1,0
6,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.029068,-0.122,-0.090767,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0021062,-0.12207,-0.12659,1,0
6,GO RENAL VESICLE DEVELOPMENT,0.049546,-0.12209,-0.17523,1,0
6,GO REGULATION OF CYCLASE ACTIVITY,0.03245,-0.12218,-0.12124,1,0
6,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0010859,-0.12219,-0.15598,1,0
6,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0017641,-0.12221,-0.15085,1,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.0049174,-0.1224,-0.17945,1,0
6,GO REGULATION OF T CELL ACTIVATION,0.001191,-0.12243,-0.14612,1,0
6,GO CALCIUM MEDIATED SIGNALING,0.00092958,-0.12252,-0.10627,1,0
6,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,8.6584e-06,-0.12292,-0.14651,1,0
6,GO ARTERY DEVELOPMENT,0.0071468,-0.12295,-0.14815,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0022332,-0.12315,-0.1171,1,0
6,GO NEGATIVE REGULATION OF CELL DEATH,7.9801e-06,-0.12318,-0.14584,1,0
6,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.1663e-05,-0.12325,-0.13663,1,0
6,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.043763,-0.12335,-0.093665,1,0
6,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.004408,-0.12338,-0.16881,1,0
6,GO IRON ION TRANSPORT,0.00037661,-0.12347,-0.14302,1,0
6,GO PEPTIDE SECRETION,0.0013457,-0.1235,-0.12026,1,0
6,GO RESPONSE TO MONOSACCHARIDE,0.00010845,-0.12357,-0.14208,1,0
6,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00013917,-0.1236,-0.15607,1,0
6,GO APOPTOTIC PROCESS,3.7791e-06,-0.12366,-0.13987,1,0
6,GO REGULATION OF TRANSPORTER ACTIVITY,0.0038387,-0.12369,-0.14078,1,0
6,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.00024286,-0.12391,-0.15717,1,0
6,GO NEGATIVE REGULATION OF CELL GROWTH,0.0022992,-0.12416,-0.12703,1,0
6,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.050569,-0.12419,-0.12048,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0073363,-0.12419,-0.12608,1,0
6,GO REGULATION OF INSULIN SECRETION,0.027188,-0.12444,-0.090438,1,0
6,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00012512,-0.12446,-0.14093,1,0
6,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.049546,-0.12455,-0.19115,1,0
6,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00087311,-0.12469,-0.15841,1,0
6,GO MESONEPHROS DEVELOPMENT,0.030383,-0.12472,-0.13449,1,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00054072,-0.12475,-0.13975,1,0
6,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.020205,-0.12481,-0.14494,1,0
6,GO REGULATION OF CELL DEATH,4.2876e-06,-0.12482,-0.13888,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00069957,-0.12484,-0.17394,1,0
6,GO BRANCH ELONGATION OF AN EPITHELIUM,0.013139,-0.12487,-0.35498,1,0
6,GO FC RECEPTOR SIGNALING PATHWAY,0.0017123,-0.12498,-0.12658,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.016734,-0.12506,-0.16201,1,0
6,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00032948,-0.12512,-0.13196,1,0
6,GO REGULATION OF FERTILIZATION,0.013798,-0.12515,-0.164,1,0
6,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,1.2454e-05,-0.12515,-0.12775,1,0
6,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00026903,-0.12518,-0.16423,1,0
6,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.001986,-0.12528,-0.16536,1,0
6,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00037661,-0.12537,-0.14044,1,0
6,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.018398,-0.12542,-0.15704,1,0
6,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0029794,-0.12544,-0.17122,1,0
6,GO INOSITOL LIPID MEDIATED SIGNALING,0.00041602,-0.12545,-0.14931,1,0
6,GO ACTIVATION OF JNKK ACTIVITY,0.047551,-0.12549,-0.11017,1,0
6,GO POTASSIUM ION TRANSPORT,0.046579,-0.12557,-0.088664,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00019753,-0.1256,-0.15896,1,0
6,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.021165,-0.1256,-0.18213,1,0
6,GO REGULATION OF ORGAN GROWTH,0.0081404,-0.12566,-0.13614,1,0
6,GO PEPTIDYL ASPARAGINE MODIFICATION,0.004408,-0.12566,-0.15327,1,0
6,GO NEGATIVE REGULATION OF SIGNALING,3.8583e-05,-0.12599,-0.13143,1,0
6,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0022992,-0.1262,-0.13601,1,0
6,GO HOMEOSTATIC PROCESS,1.0779e-06,-0.12623,-0.13718,1,0
6,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0056288,-0.12628,-0.14183,1,0
6,GO RESPONSE TO MECHANICAL STIMULUS,0.0079323,-0.12633,-0.13473,1,0
6,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0023671,-0.12634,-0.15495,1,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.00095906,-0.12643,-0.14148,1,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS,5.4121e-05,-0.12647,-0.11181,1,0
6,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0034322,-0.1265,-0.13945,1,0
6,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0042883,-0.12659,-0.096337,1,0
6,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00057693,-0.12671,-0.12465,1,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0045306,-0.12695,-0.18833,1,0
6,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,8.7323e-05,-0.12703,-0.14718,1,0
6,GO INTERLEUKIN 2 PRODUCTION,0.00047456,-0.12711,-0.18517,1,0
6,GO RESPONSE TO OXYGEN RADICAL,0.047551,-0.12714,-0.10639,1,0
6,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0066042,-0.12725,-0.16734,1,0
6,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00069957,-0.12726,-0.16891,1,0
6,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,7.5427e-07,-0.12736,-0.14202,1,0
6,GO REGULATION OF GTPASE ACTIVITY,0.00021167,-0.12739,-0.13146,1,0
6,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00012074,-0.12741,-0.1611,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0030654,-0.12741,-0.1749,1,0
6,GO TYPE I INTERFERON PRODUCTION,0.0045306,-0.12768,-0.17166,1,0
6,GO RESPONSE TO AMYLOID BETA,0.030383,-0.12769,-0.12511,1,0
6,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00081984,-0.12787,-0.17549,1,0
6,GO LYMPHOCYTE ACTIVATION,0.0001547,-0.12818,-0.15073,1,0
6,GO REGULATION OF MACROAUTOPHAGY,1.7806e-05,-0.12822,-0.14039,1,0
6,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.00036427,-0.12833,-0.12453,1,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0010528,-0.12834,-0.1643,1,0
6,GO CELLULAR RESPONSE TO PEPTIDE,2.4346e-05,-0.12836,-0.14285,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION,0.00049035,-0.12844,-0.13999,1,0
6,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00016595,-0.12848,-0.15226,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0090226,-0.12856,-0.12158,1,0
6,GO NEGATIVE REGULATION OF TRANSPORT,6.5149e-05,-0.12868,-0.12918,1,0
6,GO ATP BIOSYNTHETIC PROCESS,0.011326,-0.12869,-0.1622,1,0
6,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0087944,-0.12874,-0.17426,1,0
6,GO VACUOLAR ACIDIFICATION,0.0041716,-0.12876,-0.17064,1,0
6,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.6228e-06,-0.12877,-0.14621,1,0
6,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0059384,-0.12885,-0.19129,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00018427,-0.12889,-0.14099,1,0
6,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.014138,-0.12897,-0.14184,1,0
6,GO PEPTIDYL CYSTEINE MODIFICATION,0.0085714,-0.12902,-0.10549,1,0
6,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.017549,-0.12912,-0.17006,1,0
6,GO VESICLE BUDDING FROM MEMBRANE,0.0001547,-0.12913,-0.16393,1,0
6,GO NUCLEOTIDE TRANSPORT,0.011047,-0.12914,-0.12135,1,0
6,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0027346,-0.12915,-0.17015,1,0
6,GO PURINE NUCLEOTIDE TRANSPORT,0.013798,-0.12917,-0.13327,1,0
6,GO POSITIVE REGULATION OF HEART GROWTH,0.0056288,-0.12919,-0.17776,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00020448,-0.1292,-0.14081,1,0
6,GO CELLULAR RESPONSE TO ALCOHOL,0.0057817,-0.12921,-0.12329,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.021165,-0.12934,-0.14307,1,0
6,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0066042,-0.12937,-0.14355,1,0
6,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00069957,-0.12939,-0.21361,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0034322,-0.12944,-0.1736,1,0
6,GO INSULIN SECRETION,0.040234,-0.12947,-0.088634,1,0
6,GO MECHANORECEPTOR DIFFERENTIATION,0.011612,-0.12951,-0.15567,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00027832,-0.12971,-0.11441,1,0
6,GO REGULATION OF REPRODUCTIVE PROCESS,4.1617e-05,-0.12975,-0.13707,1,0
6,GO CELLULAR RESPONSE TO HORMONE STIMULUS,7.6603e-06,-0.12975,-0.15012,1,0
6,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0054795,-0.12982,-0.15991,1,0
6,GO HEART MORPHOGENESIS,0.011047,-0.12986,-0.11466,1,0
6,GO LEUKOCYTE DIFFERENTIATION,4.1617e-05,-0.12994,-0.16043,1,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.036948,-0.12998,-0.18629,1,0
6,GO NEPHRON EPITHELIUM DEVELOPMENT,0.01282,-0.13,-0.13107,1,0
6,GO RESPONSE TO CARBOHYDRATE,4.1617e-05,-0.13005,-0.14978,1,0
6,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00063551,-0.13007,-0.15763,1,0
6,GO PROSTATE GLAND DEVELOPMENT,0.038561,-0.13025,-0.1844,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0038387,-0.1303,-0.17262,1,0
6,GO MESENCHYMAL CELL DIFFERENTIATION,0.0019282,-0.1305,-0.16512,1,0
6,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00045924,-0.13051,-0.14172,1,0
6,GO REGULATION OF CATION CHANNEL ACTIVITY,0.016339,-0.13061,-0.13834,1,0
6,GO RESPONSE TO SALT STRESS,0.025994,-0.13066,-0.14572,1,0
6,GO CATION TRANSPORT,0.00044439,-0.13067,-0.12731,1,0
6,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,2.3418e-05,-0.13068,-0.15812,1,0
6,GO REGULATION OF TRANSLATIONAL TERMINATION,0.035393,-0.1307,-0.15726,1,0
6,GO TRANSEPITHELIAL TRANSPORT,0.0010859,-0.13075,-0.17005,1,0
6,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00038934,-0.13083,-0.16581,1,0
6,GO REGULATION OF ION TRANSPORT,0.0015189,-0.13086,-0.13535,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.031059,-0.13094,-0.13802,1,0
6,GO REGULATION OF CATABOLIC PROCESS,1.6015e-06,-0.13097,-0.13415,1,0
6,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,6.5149e-05,-0.13099,-0.15154,1,0
6,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0025083,-0.13099,-0.13752,1,0
6,GO OSSIFICATION,8.4205e-05,-0.13106,-0.17376,1,0
6,GO CARBOHYDRATE TRANSPORT,0.00038934,-0.13111,-0.14309,1,0
6,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00092958,-0.13112,-0.14666,1,0
6,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.014841,-0.13118,-0.19933,1,0
6,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.02268,-0.13122,-0.11914,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00012964,-0.13137,-0.13936,1,0
6,GO REGULATION OF BINDING,0.00026003,-0.13145,-0.12039,1,0
6,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.053746,-0.13157,-0.15075,1,0
6,GO PROTEIN TARGETING TO MITOCHONDRION,0.00030804,-0.13159,-0.1531,1,0
6,GO NEGATIVE REGULATION OF OSSIFICATION,0.0032441,-0.13167,-0.17813,1,0
6,GO INTERLEUKIN 10 PRODUCTION,0.019739,-0.13168,-0.12555,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.001662,-0.13171,-0.15547,1,0
6,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0097392,-0.13181,-0.1449,1,0
6,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.033166,-0.13188,-0.11335,1,0
6,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0007696,-0.1319,-0.19063,1,0
6,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0099891,-0.13194,-0.14068,1,0
6,GO LYMPH VESSEL MORPHOGENESIS,0.011904,-0.13203,-0.17836,1,0
6,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.007729,-0.13215,-0.16461,1,0
6,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.012508,-0.13225,-0.15995,1,0
6,GO RESPONSE TO AMINO ACID STARVATION,0.0073363,-0.13228,-0.13541,1,0
6,GO RENAL TUBULE DEVELOPMENT,0.0066042,-0.13237,-0.1461,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0019282,-0.13251,-0.1588,1,0
6,GO OSTEOBLAST DIFFERENTIATION,0.00020448,-0.13255,-0.18887,1,0
6,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0016129,-0.13263,-0.12799,1,0
6,GO PROTEIN STABILIZATION,5.0683e-06,-0.1327,-0.15294,1,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,2.8418e-05,-0.13272,-0.13521,1,0
6,GO BILE ACID METABOLIC PROCESS,0.024846,-0.13277,-0.15875,1,0
6,GO CELLULAR DEFENSE RESPONSE,0.0045306,-0.1329,-0.20252,1,0
6,GO REGULATION OF CGMP MEDIATED SIGNALING,0.036948,-0.13293,-0.23183,1,0
6,GO CONNECTIVE TISSUE DEVELOPMENT,0.00092958,-0.13303,-0.14964,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0025817,-0.13308,-0.13931,1,0
6,GO REGULATION OF HAIR CYCLE,0.011047,-0.13308,-0.189,1,0
6,GO NEGATIVE REGULATION OF CELL SIZE,0.013139,-0.13314,-0.15053,1,0
6,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0028957,-0.13327,-0.12578,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0032441,-0.13329,-0.12072,1,0
6,GO REGULATION OF SODIUM ION TRANSPORT,0.015203,-0.1333,-0.14419,1,0
6,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0071468,-0.13333,-0.15775,1,0
6,GO T CELL ACTIVATION,0.00047456,-0.13356,-0.15866,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0018173,-0.13363,-0.1697,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0073363,-0.13363,-0.13579,1,0
6,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0019282,-0.13382,-0.15334,1,0
6,GO RESPONSE TO PEPTIDE,4.2876e-06,-0.13383,-0.15632,1,0
6,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.010773,-0.13385,-0.12152,1,0
6,GO REGULATION OF CELL ACTIVATION,0.00031859,-0.13401,-0.15606,1,0
6,GO POSITIVE REGULATION OF CELL DEATH,5.2139e-05,-0.1341,-0.14134,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,1.4039e-05,-0.13411,-0.15072,1,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,8.7323e-05,-0.13419,-0.14215,1,0
6,GO ENDODERMAL CELL DIFFERENTIATION,0.0010206,-0.13419,-0.31242,1,0
6,GO CATION TRANSMEMBRANE TRANSPORT,0.00055855,-0.13424,-0.12735,1,0
6,GO CERAMIDE METABOLIC PROCESS,0.00020448,-0.13434,-0.16567,1,0
6,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.053746,-0.1344,-0.081667,1,0
6,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.014138,-0.13448,-0.16066,1,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0049174,-0.13449,-0.15767,1,0
6,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.021165,-0.13457,-0.19924,1,0
6,GO ERBB SIGNALING PATHWAY,0.00049035,-0.13459,-0.16307,1,0
6,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.010506,-0.13471,-0.10954,1,0
6,GO IMMUNOGLOBULIN SECRETION,0.0054795,-0.13471,-0.21725,1,0
6,GO TOXIN TRANSPORT,0.041967,-0.13474,-0.10103,1,0
6,GO TRNA METHYLATION,0.019283,-0.13483,-0.13765,1,0
6,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00045924,-0.13491,-0.1449,1,0
6,GO NUCLEOBASE METABOLIC PROCESS,0.0041716,-0.13493,-0.19009,1,0
6,GO ENDOCYTIC RECYCLING,0.010245,-0.13502,-0.12121,1,0
6,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0042883,-0.1351,-0.10699,1,0
6,GO PEPTIDYL ARGININE METHYLATION,0.055956,-0.13514,-0.1113,1,0
6,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.054842,-0.13518,-0.22324,1,0
6,GO PRIMARY MIRNA PROCESSING,0.0069616,-0.13521,-0.17898,1,0
6,GO REGULATION OF TRANSFERASE ACTIVITY,1.9263e-05,-0.13523,-0.13833,1,0
6,GO ION TRANSMEMBRANE TRANSPORT,0.00016595,-0.13535,-0.13236,1,0
6,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.001191,-0.13555,-0.14978,1,0
6,GO ENDOTHELIAL CELL DEVELOPMENT,0.0038387,-0.13556,-0.18259,1,0
6,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0064317,-0.13576,-0.16026,1,0
6,GO APOPTOTIC SIGNALING PATHWAY,1.104e-05,-0.1358,-0.1608,1,0
6,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,9.3916e-06,-0.13583,-0.14218,1,0
6,GO LYSOSOMAL TRANSPORT,0.0011549,-0.13587,-0.13741,1,0
6,GO O GLYCAN PROCESSING,0.017969,-0.13598,-0.19285,1,0
6,GO MEMBRANE LIPID METABOLIC PROCESS,0.00042998,-0.13599,-0.16925,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0026572,-0.13602,-0.12239,1,0
6,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00042998,-0.13603,-0.13375,1,0
6,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00042998,-0.13605,-0.13493,1,0
6,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0006154,-0.13605,-0.12148,1,0
6,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.018398,-0.13618,-0.14657,1,0
6,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00028792,-0.13618,-0.1647,1,0
6,GO PROTEIN KINASE B SIGNALING,0.0012662,-0.13619,-0.14671,1,0
6,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00044439,-0.13623,-0.13969,1,0
6,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,2.9532e-05,-0.13628,-0.15365,1,0
6,GO CELLULAR RESPONSE TO CAMP,0.0097392,-0.13645,-0.13834,1,0
6,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00063551,-0.13647,-0.17592,1,0
6,GO TRANSMEMBRANE TRANSPORT,1.9263e-05,-0.13654,-0.13966,1,0
6,GO VIRAL GENOME REPLICATION,0.0025817,-0.1366,-0.21917,1,0
6,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0060989,-0.13662,-0.19816,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.015203,-0.13665,-0.16586,1,0
6,GO ENERGY HOMEOSTASIS,0.011047,-0.13665,-0.18061,1,0
6,GO VESICLE ORGANIZATION,9.389e-05,-0.13671,-0.14346,1,0
6,GO CARTILAGE DEVELOPMENT,0.0019282,-0.13674,-0.15222,1,0
6,GO GOLGI TO ENDOSOME TRANSPORT,0.0081404,-0.13678,-0.16333,1,0
6,GO CHONDROCYTE DIFFERENTIATION,0.0050528,-0.13691,-0.15926,1,0
6,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0045306,-0.13698,-0.20238,1,0
6,GO CELL MOTILITY,0.00017796,-0.13706,-0.14958,1,0
6,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00020448,-0.13719,-0.13764,1,0
6,GO GLYCOPROTEIN METABOLIC PROCESS,8.1192e-05,-0.13719,-0.16045,1,0
6,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.001662,-0.1372,-0.19237,1,0
6,GO LUNG ALVEOLUS DEVELOPMENT,0.02268,-0.13723,-0.14454,1,0
6,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0023671,-0.13732,-0.18353,1,0
6,GO REGULATION OF PROTEIN MATURATION,0.00065623,-0.13738,-0.18817,1,0
6,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0018173,-0.13738,-0.13134,1,0
6,GO NEGATIVE REGULATION OF BINDING,0.0025083,-0.13749,-0.11592,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00037661,-0.13751,-0.17439,1,0
6,GO POSITIVE REGULATION OF ANION TRANSPORT,0.016339,-0.13757,-0.13789,1,0
6,GO MYOBLAST DIFFERENTIATION,0.007729,-0.13758,-0.16107,1,0
6,GO TRANSITION METAL ION TRANSPORT,6.0504e-05,-0.13769,-0.13642,1,0
6,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.7145e-05,-0.13792,-0.18488,1,0
6,GO REGULATION OF MITOCHONDRIAL FISSION,0.001986,-0.13793,-0.14722,1,0
6,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00016023,-0.13797,-0.19523,1,0
6,GO ACTIN FILAMENT ORGANIZATION,8.1192e-05,-0.13804,-0.15295,1,0
6,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.011904,-0.13804,-0.13089,1,0
6,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0019282,-0.13808,-0.19675,1,0
6,GO NIK NF KAPPAB SIGNALING,0.00055855,-0.13812,-0.17733,1,0
6,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,2.3418e-05,-0.13819,-0.15423,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,5.8301e-05,-0.13833,-0.17161,1,0
6,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,5.4121e-05,-0.13837,-0.13482,1,0
6,GO CERAMIDE BIOSYNTHETIC PROCESS,0.001986,-0.13852,-0.15764,1,0
6,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.033894,-0.13865,-0.2721,1,0
6,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,3.8583e-05,-0.13895,-0.1383,1,0
6,GO RESPONSE TO ENDOGENOUS STIMULUS,1.1964e-05,-0.139,-0.14229,1,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.036948,-0.13907,-0.14682,1,0
6,GO RESPONSE TO INTERLEUKIN 1,5.2837e-06,-0.13931,-0.19817,1,0
6,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.054842,-0.13931,-0.10794,1,0
6,GO SKIN DEVELOPMENT,0.0094949,-0.13935,-0.15868,1,0
6,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.00353,-0.13935,-0.16966,1,0
6,GO MITOCHONDRIAL TRANSPORT,3.4728e-06,-0.13938,-0.13791,1,0
6,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.036948,-0.13941,-0.1242,1,0
6,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00023468,-0.13943,-0.20957,1,0
6,GO TUBE DEVELOPMENT,0.00049035,-0.13946,-0.15126,1,0
6,GO ENDOCRINE HORMONE SECRETION,0.0097392,-0.13947,-0.15433,1,0
6,GO METAL ION TRANSPORT,0.00026003,-0.1395,-0.13292,1,0
6,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0045306,-0.1395,-0.16255,1,0
6,GO CELLULAR COMPONENT DISASSEMBLY,3.6228e-06,-0.13951,-0.14785,1,0
6,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,3.4421e-05,-0.13952,-0.16233,1,0
6,GO REGULATION OF PEPTIDE SECRETION,0.0028141,-0.13952,-0.11332,1,0
6,GO RESPONSE TO VITAMIN,0.018836,-0.13965,-0.14655,1,0
6,GO JNK CASCADE,7.3528e-06,-0.13966,-0.16233,1,0
6,GO CELL AGING,0.0007696,-0.13967,-0.12754,1,0
6,GO MUSCLE CELL MIGRATION,0.010506,-0.13967,-0.18391,1,0
6,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.004408,-0.13988,-0.22652,1,0
6,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0033369,-0.13993,-0.17417,1,0
6,GO POSITIVE REGULATION OF CATABOLIC PROCESS,6.4994e-06,-0.13995,-0.15713,1,0
6,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.05161,-0.14009,-0.18872,1,0
6,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0001165,-0.14013,-0.14462,1,0
6,GO ACTIN FILAMENT BASED PROCESS,0.00017796,-0.14022,-0.14438,1,0
6,GO CIRCULATORY SYSTEM PROCESS,8.7323e-05,-0.14023,-0.15765,1,0
6,GO MITOCHONDRIAL RNA PROCESSING,0.035393,-0.14027,-0.18427,1,0
6,GO DIACYLGLYCEROL METABOLIC PROCESS,0.04854,-0.14031,-0.12557,1,0
6,GO CELL JUNCTION ASSEMBLY,0.0081404,-0.14032,-0.11108,1,0
6,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.015574,-0.14037,-0.16726,1,0
6,GO ORGANIC ACID TRANSPORT,2.8077e-06,-0.1405,-0.16002,1,0
6,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,5.508e-06,-0.1405,-0.14843,1,0
6,GO SECOND MESSENGER MEDIATED SIGNALING,0.00017796,-0.14061,-0.13646,1,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0033369,-0.14077,-0.18587,1,0
6,GO RESPONSE TO LEPTIN,0.016339,-0.14085,-0.1503,1,0
6,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0007696,-0.14089,-0.17004,1,0
6,GO CELL JUNCTION ORGANIZATION,0.010506,-0.14092,-0.11286,1,0
6,GO POSITIVE REGULATION OF TOR SIGNALING,0.00067758,-0.14092,-0.1318,1,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.014841,-0.14094,-0.15583,1,0
6,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0031536,-0.14098,-0.22748,1,0
6,GO RESPONSE TO VIRUS,0.001662,-0.14098,-0.18343,1,0
6,GO LUNG MORPHOGENESIS,0.0090226,-0.14099,-0.17714,1,0
6,GO CRISTAE FORMATION,0.0013457,-0.1411,-0.22766,1,0
6,GO CARDIOCYTE DIFFERENTIATION,0.001872,-0.14113,-0.14819,1,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0062634,-0.14131,-0.11882,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00029782,-0.14142,-0.15321,1,0
6,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0085714,-0.14149,-0.17381,1,0
6,GO DRUG CATABOLIC PROCESS,9.7346e-05,-0.1415,-0.22694,1,0
6,GO MUSCLE CELL DIFFERENTIATION,9.7346e-05,-0.14166,-0.14351,1,0
6,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0083534,-0.14182,-0.10639,1,0
6,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,9.7801e-06,-0.14188,-0.16178,1,0
6,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.010773,-0.14194,-0.18015,1,0
6,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,2.3418e-05,-0.1422,-0.16076,1,0
6,GO PROTEIN TRANSMEMBRANE TRANSPORT,1.7118e-05,-0.14225,-0.16588,1,0
6,GO KIDNEY EPITHELIUM DEVELOPMENT,0.011904,-0.14225,-0.14183,1,0
6,GO LIPID BIOSYNTHETIC PROCESS,1.8251e-06,-0.14229,-0.17667,1,0
6,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,4.1112e-06,-0.14241,-0.13362,1,0
6,GO KERATINOCYTE DIFFERENTIATION,0.010506,-0.14244,-0.16459,1,0
6,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,1.4609e-05,-0.14249,-0.16131,1,0
6,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00065623,-0.14255,-0.14053,1,0
6,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00032948,-0.14258,-0.14724,1,0
6,GO METANEPHROS DEVELOPMENT,0.011612,-0.14259,-0.13609,1,0
6,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.00057693,-0.14273,-0.16862,1,0
6,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.011904,-0.14274,-0.17843,1,0
6,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.00095906,-0.1428,-0.14283,1,0
6,GO CELLULAR RESPONSE TO HEAT,0.00012964,-0.14287,-0.14872,1,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0010859,-0.14291,-0.1868,1,0
6,GO MUSCLE ADAPTATION,0.00014418,-0.14292,-0.20079,1,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.054842,-0.14299,-0.15772,1,0
6,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.040234,-0.14309,-0.18659,1,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00011241,-0.14327,-0.16478,1,0
6,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00014935,-0.14328,-0.14328,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,7.9801e-06,-0.1433,-0.1433,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0011199,-0.1434,-0.22794,1,0
6,GO SMOOTH MUSCLE CONTRACTION,6.7596e-05,-0.14351,-0.18263,1,0
6,GO CELLULAR EXTRAVASATION,0.0066042,-0.14359,-0.14043,1,0
6,GO MEMBRANE ORGANIZATION,6.4994e-06,-0.14361,-0.14911,1,0
6,GO CELLULAR RESPONSE TO AMYLOID BETA,0.018398,-0.14361,-0.14495,1,0
6,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00019753,-0.14368,-0.16718,1,0
6,GO GLUTAMINE METABOLIC PROCESS,0.0039469,-0.14386,-0.16516,1,0
6,GO DIGESTION,0.0051916,-0.14392,-0.1544,1,0
6,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.034637,-0.14396,-0.17912,1,0
6,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0027346,-0.14405,-0.17217,1,0
6,GO HUMORAL IMMUNE RESPONSE,1.2962e-05,-0.14409,-0.19276,1,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0014299,-0.14412,-0.16835,1,0
6,GO CELLULAR RESPONSE TO KETONE,0.00030804,-0.14416,-0.17061,1,0
6,GO ENSHEATHMENT OF NEURONS,0.0023671,-0.14421,-0.13301,1,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.053746,-0.14423,-0.17087,1,0
6,GO REGULATION OF BLOOD CIRCULATION,0.0016129,-0.14428,-0.15538,1,0
6,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,9.0179e-06,-0.14439,-0.14142,1,0
6,GO SULFATE TRANSPORT,0.0016129,-0.14442,-0.17115,1,0
6,GO REGULATION OF PHOSPHORYLATION,9.3916e-06,-0.14448,-0.14963,1,0
6,GO REGULATION OF DEFENSE RESPONSE,1.5816e-05,-0.14449,-0.17275,1,0
6,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.02268,-0.1445,-0.16934,1,0
6,GO RESPONSE TO RETINOIC ACID,9.0551e-05,-0.14451,-0.22151,1,0
6,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00010462,-0.14458,-0.16288,1,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0001547,-0.14461,-0.15837,1,0
6,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,1.6455e-05,-0.14461,-0.14775,1,0
6,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025817,-0.14464,-0.19111,1,0
6,GO COPII COATED VESICLE CARGO LOADING,0.00072223,-0.14465,-0.17318,1,0
6,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00024286,-0.1447,-0.17296,1,0
6,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00019079,-0.14493,-0.18894,1,0
6,GO REGULATION OF CELLULAR CATABOLIC PROCESS,6.8936e-07,-0.14496,-0.15441,1,0
6,GO SPHINGOLIPID METABOLIC PROCESS,8.7323e-05,-0.14501,-0.18976,1,0
6,GO RESPONSE TO PEPTIDE HORMONE,1.906e-06,-0.14508,-0.16309,1,0
6,GO AGING,3.9418e-06,-0.14512,-0.16902,1,0
6,GO L AMINO ACID TRANSPORT,0.0016129,-0.14517,-0.16903,1,0
6,GO INORGANIC ANION TRANSPORT,3.7145e-05,-0.14521,-0.15497,1,0
6,GO CARDIAC CHAMBER DEVELOPMENT,0.0027346,-0.14522,-0.14817,1,0
6,GO TRNA PROCESSING,0.024288,-0.14527,-0.11104,1,0
6,GO NEGATIVE REGULATION OF LIPID TRANSPORT,4.3218e-05,-0.14544,-0.22519,1,0
6,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0060989,-0.14547,-0.19343,1,0
6,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0006154,-0.14548,-0.13203,1,0
6,GO ANION TRANSPORT,1.9904e-06,-0.14548,-0.16159,1,0
6,GO NEGATIVE REGULATION OF CELL ADHESION,0.001872,-0.14556,-0.17261,1,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00092958,-0.14561,-0.13749,1,0
6,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.007729,-0.14587,-0.21828,1,0
6,GO FAT CELL DIFFERENTIATION,0.00030804,-0.14597,-0.17549,1,0
6,GO CHYLOMICRON ASSEMBLY,0.00049035,-0.14611,-0.21588,1,0
6,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0062634,-0.14625,-0.14114,1,0
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0014738,-0.1463,-0.19797,1,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.010245,-0.14638,-0.1683,1,0
6,GO ORGANIC ANION TRANSPORT,1.0779e-06,-0.1465,-0.1682,1,0
6,GO SODIUM ION TRANSPORT,0.0019282,-0.14658,-0.13488,1,0
6,GO REGULATION OF CALCIUM ION IMPORT,0.0018173,-0.14678,-0.16675,1,0
6,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,5.2139e-05,-0.14687,-0.15191,1,0
6,GO POSITIVE REGULATION OF TRANSLATION,3.7145e-05,-0.14693,-0.1942,1,0
6,GO RECEPTOR INTERNALIZATION,0.00098941,-0.14707,-0.13865,1,0
6,GO MYOBLAST PROLIFERATION,0.047551,-0.14719,-0.14005,1,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,6.2786e-05,-0.14727,-0.15033,1,0
6,GO GLIAL CELL PROLIFERATION,0.013139,-0.14743,-0.14665,1,0
6,GO MYELOID LEUKOCYTE DIFFERENTIATION,1.7118e-05,-0.14755,-0.195,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0030654,-0.14756,-0.16492,1,0
6,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0081404,-0.14759,-0.26245,1,0
6,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0054795,-0.14762,-0.14586,1,0
6,GO RESPONSE TO INSULIN,4.4712e-06,-0.1477,-0.16814,1,0
6,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,1.1964e-05,-0.14776,-0.14532,1,0
6,GO RESPONSE TO GROWTH FACTOR,0.0001165,-0.14782,-0.14822,1,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0099891,-0.14783,-0.19469,1,0
6,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00010092,-0.14788,-0.1684,1,0
6,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.042857,-0.14796,-0.29541,1,0
6,GO REGULATION OF CELL AGING,0.0022332,-0.14801,-0.15598,1,0
6,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00087311,-0.14837,-0.15392,1,0
6,GO NEPHRON DEVELOPMENT,0.0056288,-0.14842,-0.14383,1,0
6,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,4.0073e-05,-0.14867,-0.16226,1,0
6,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.011326,-0.14872,-0.1316,1,0
6,GO INTERMEMBRANE LIPID TRANSFER,0.00021167,-0.14877,-0.16926,1,0
6,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0083534,-0.14886,-0.18325,1,0
6,GO REGULATION OF GLUCONEOGENESIS,0.0099891,-0.14887,-0.11293,1,0
6,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00095906,-0.14898,-0.14751,1,0
6,GO MUSCLE FIBER DEVELOPMENT,0.0011549,-0.14904,-0.15046,1,0
6,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00084609,-0.14922,-0.15786,1,0
6,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00042998,-0.14923,-0.14416,1,0
6,GO MRNA TRANSCRIPTION,0.049546,-0.1493,-0.13455,1,0
6,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.030383,-0.14936,-0.18651,1,0
6,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0056288,-0.14939,-0.19619,1,0
6,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00027832,-0.14939,-0.15676,1,0
6,GO PIGMENTATION,0.00012074,-0.1498,-0.16226,1,0
6,GO CELL CELL ADHESION,0.00034072,-0.14983,-0.15504,1,0
6,GO MUSCLE CELL PROLIFERATION,0.00018427,-0.14985,-0.19203,1,0
6,GO TRANSLATIONAL TERMINATION,0.0042883,-0.14989,-0.19511,1,0
6,GO FACE DEVELOPMENT,0.035393,-0.14993,-0.12971,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0025817,-0.14997,-0.21048,1,0
6,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.00017186,-0.15002,-0.13422,1,0
6,GO CELLULAR ION HOMEOSTASIS,1.5331e-06,-0.15009,-0.16403,1,0
6,GO TRANSLATIONAL ELONGATION,0.0014299,-0.1501,-0.19952,1,0
6,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.020205,-0.1502,-0.1159,1,0
6,GO ODONTOGENESIS,0.02166,-0.15024,-0.14129,1,0
6,GO CELLULAR RESPONSE TO CALCIUM ION,0.0026572,-0.15026,-0.20554,1,0
6,GO PROTEIN HOMOOLIGOMERIZATION,1.104e-05,-0.15029,-0.14894,1,0
6,GO REGULATION OF SYMBIOTIC PROCESS,0.0017123,-0.15034,-0.19189,1,0
6,GO ION TRANSPORT,7.2754e-05,-0.15037,-0.14355,1,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.021165,-0.15042,-0.23948,1,0
6,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.035393,-0.15042,-0.17111,1,0
6,GO LEUKOCYTE CELL CELL ADHESION,0.00013917,-0.15042,-0.18642,1,0
6,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.00069957,-0.15051,-0.19973,1,0
6,GO OSTEOBLAST DEVELOPMENT,0.017137,-0.15052,-0.17987,1,0
6,GO NCRNA PROCESSING,0.0071468,-0.15062,-0.16772,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0017123,-0.15073,-0.15981,1,0
6,GO LIPID HOMEOSTASIS,2.7343e-05,-0.15074,-0.18594,1,0
6,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.8379e-05,-0.15074,-0.17494,1,0
6,GO PROTEIN COMPLEX OLIGOMERIZATION,3.3287e-06,-0.15087,-0.16508,1,0
6,GO CORONARY VASCULATURE DEVELOPMENT,0.001872,-0.15087,-0.18602,1,0
6,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.8583e-05,-0.15088,-0.17115,1,0
6,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,9.0551e-05,-0.1509,-0.16637,1,0
6,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.02068,-0.15094,-0.20752,1,0
6,GO KERATINOCYTE PROLIFERATION,0.036948,-0.151,-0.18105,1,0
6,GO ALPHA AMINO ACID CATABOLIC PROCESS,1.4609e-05,-0.15105,-0.20854,1,0
6,GO RESPONSE TO KETONE,5.2139e-05,-0.15116,-0.18374,1,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0099891,-0.15117,-0.21047,1,0
6,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0023671,-0.15118,-0.19767,1,0
6,GO LIPOPROTEIN LOCALIZATION,0.0083534,-0.15127,-0.15155,1,0
6,GO GRANULOCYTE CHEMOTAXIS,7.2754e-05,-0.15168,-0.20092,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00049035,-0.15172,-0.19597,1,0
6,GO REGULATION OF IMMUNE SYSTEM PROCESS,2.0833e-05,-0.1518,-0.16875,1,0
6,GO LEUKOTRIENE METABOLIC PROCESS,0.004408,-0.1519,-0.19964,1,0
6,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.053746,-0.1519,-0.1937,1,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.014486,-0.15193,-0.19846,1,0
6,GO NUCLEOSIDE CATABOLIC PROCESS,0.0026572,-0.15194,-0.22848,1,0
6,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00059588,-0.15197,-0.17595,1,0
6,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.8379e-05,-0.15203,-0.15783,1,0
6,GO MULTICELLULAR ORGANISMAL SIGNALING,0.02166,-0.15208,-0.12828,1,0
6,GO REGULATION OF GLIAL CELL PROLIFERATION,0.052669,-0.15226,-0.11769,1,0
6,GO REGULATION OF TUBE SIZE,0.00028792,-0.15227,-0.16514,1,0
6,GO RESPONSE TO NITROGEN COMPOUND,1.104e-05,-0.1523,-0.13832,1,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.7806e-05,-0.15238,-0.1638,1,0
6,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00029782,-0.15238,-0.2687,1,0
6,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.4609e-05,-0.15246,-0.17827,1,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0075304,-0.15248,-0.13867,1,0
6,GO MUSCLE STRUCTURE DEVELOPMENT,4.6597e-05,-0.15271,-0.14999,1,0
6,GO CHEMICAL HOMEOSTASIS,2.8077e-06,-0.15271,-0.16207,1,0
6,GO AMMONIUM ION METABOLIC PROCESS,0.03939,-0.15274,-0.19198,1,0
6,GO REGULATION OF CELL SHAPE,0.0033369,-0.15276,-0.13707,1,0
6,GO LIPID MODIFICATION,4.6623e-06,-0.15289,-0.18105,1,0
6,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.0094949,-0.15302,-0.23122,1,0
6,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,6.4994e-06,-0.15304,-0.15181,1,0
6,GO SECRETION,3.0576e-06,-0.15324,-0.16834,1,0
6,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0030654,-0.15331,-0.12398,1,0
6,GO REGULATION OF MYELOID CELL DIFFERENTIATION,9.389e-05,-0.15337,-0.17126,1,0
6,GO REGULATION OF PROTEOLYSIS,6.4994e-06,-0.15342,-0.17151,1,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0014299,-0.15343,-0.13149,1,0
6,GO PROTEASOME ASSEMBLY,0.023741,-0.15346,-0.14917,1,0
6,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00049035,-0.15351,-0.1868,1,0
6,GO STRIATED MUSCLE CELL DIFFERENTIATION,6.7596e-05,-0.15353,-0.15898,1,0
6,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00014418,-0.15357,-0.19753,1,0
6,GO REGULATION OF T CELL MIGRATION,0.0014738,-0.15357,-0.17463,1,0
6,GO REGULATION OF B CELL PROLIFERATION,0.0017123,-0.15368,-0.18787,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00025131,-0.15375,-0.17267,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,2.1663e-05,-0.15376,-0.17825,1,0
6,GO ACTIVATION OF IMMUNE RESPONSE,5.2139e-05,-0.15386,-0.16571,1,0
6,GO MESODERM MORPHOGENESIS,0.0017641,-0.15403,-0.19749,1,0
6,GO VESICLE TARGETING,0.00026003,-0.15407,-0.17776,1,0
6,GO GLIAL CELL ACTIVATION,0.00034072,-0.15408,-0.22284,1,0
6,GO PHOSPHOLIPID METABOLIC PROCESS,1.2862e-06,-0.15411,-0.1608,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00027832,-0.15424,-0.16081,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0029794,-0.15425,-0.22596,1,0
6,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00019753,-0.15434,-0.18628,1,0
6,GO REGULATION OF PROTEIN KINASE ACTIVITY,5.4121e-05,-0.15442,-0.14725,1,0
6,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0022992,-0.15458,-0.15407,1,0
6,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0062634,-0.15467,-0.18996,1,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00014418,-0.15468,-0.22841,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION,0.0060989,-0.15473,-0.13201,1,0
6,GO ADIPOSE TISSUE DEVELOPMENT,0.011326,-0.15474,-0.12532,1,0
6,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0014738,-0.15485,-0.12991,1,0
6,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.010506,-0.15493,-0.17032,1,0
6,GO PIGMENT CELL DIFFERENTIATION,0.004408,-0.15494,-0.15781,1,0
6,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,5.4121e-05,-0.15505,-0.16504,1,0
6,GO REGULATION OF EXOSOMAL SECRETION,0.050569,-0.15506,-0.14871,1,0
6,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00047456,-0.15513,-0.18723,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0014299,-0.1552,-0.19532,1,0
6,GO ESTABLISHMENT OF TISSUE POLARITY,0.00013433,-0.15537,-0.158,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.00017186,-0.15542,-0.1611,1,0
6,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00040247,-0.15547,-0.18727,1,0
6,GO REGULATION OF METAL ION TRANSPORT,2.8418e-05,-0.1555,-0.16356,1,0
6,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,2.0833e-05,-0.15552,-0.16519,1,0
6,GO SYMBIOTIC PROCESS,8.2505e-07,-0.15557,-0.18135,1,0
6,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,2.4346e-05,-0.15561,-0.14863,1,0
6,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0010528,-0.1557,-0.16756,1,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.017549,-0.15601,-0.21099,1,0
6,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0021062,-0.15604,-0.21428,1,0
6,GO LIPID EXPORT FROM CELL,0.0031536,-0.15617,-0.15852,1,0
6,GO ALPHA BETA T CELL PROLIFERATION,0.016339,-0.15624,-0.17751,1,0
6,GO ANION TRANSMEMBRANE TRANSPORT,7.6603e-06,-0.1564,-0.16459,1,0
6,GO OVULATION,0.033894,-0.15647,-0.19756,1,0
6,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0047853,-0.15648,-0.15332,1,0
6,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0013872,-0.15664,-0.1792,1,0
6,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00018427,-0.15686,-0.1594,1,0
6,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.031748,-0.15694,-0.17002,1,0
6,GO NOTCH SIGNALING PATHWAY,0.0028957,-0.15699,-0.1513,1,0
6,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,3.0689e-05,-0.15702,-0.16051,1,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0031536,-0.15717,-0.1754,1,0
6,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.001986,-0.15718,-0.13809,1,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00353,-0.1575,-0.21608,1,0
6,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00079435,-0.15752,-0.15936,1,0
6,GO TEMPERATURE HOMEOSTASIS,5.6174e-05,-0.15762,-0.1687,1,0
6,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00025131,-0.15769,-0.17658,1,0
6,GO CORPUS CALLOSUM DEVELOPMENT,0.055956,-0.15771,-0.16434,1,0
6,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.054842,-0.15773,-0.14577,1,0
6,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0071468,-0.15775,-0.13626,1,0
6,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0017641,-0.15785,-0.17623,1,0
6,GO OUTFLOW TRACT MORPHOGENESIS,0.007729,-0.15794,-0.17749,1,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,8.4205e-05,-0.15796,-0.13351,1,0
6,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.027188,-0.15798,-0.13421,1,0
6,GO DIGESTIVE SYSTEM PROCESS,0.0021062,-0.15801,-0.15957,1,0
6,GO RESPONSE TO ACID CHEMICAL,5.6174e-05,-0.15802,-0.17556,1,0
6,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.02843,-0.15805,-0.14364,1,0
6,GO ALCOHOL BIOSYNTHETIC PROCESS,1.9263e-05,-0.15806,-0.17541,1,0
6,GO METAL ION HOMEOSTASIS,1.1267e-06,-0.15806,-0.17251,1,0
6,GO NON CANONICAL WNT SIGNALING PATHWAY,1.8521e-05,-0.15824,-0.17053,1,0
6,GO ELECTRON TRANSPORT CHAIN,0.00055855,-0.15836,-0.17772,1,0
6,GO CARBOHYDRATE HOMEOSTASIS,0.00010092,-0.15837,-0.16253,1,0
6,GO ORGAN INDUCTION,0.0027346,-0.15842,-0.19027,1,0
6,GO REGULATION OF IMMUNE EFFECTOR PROCESS,9.0551e-05,-0.15853,-0.20335,1,0
6,GO REGULATION OF FATTY ACID TRANSPORT,0.010506,-0.15854,-0.15769,1,0
6,GO STEM CELL DIVISION,0.0071468,-0.15856,-0.15742,1,0
6,GO REGULATION OF AUTOPHAGY,2.9301e-06,-0.15878,-0.17165,1,0
6,GO POSITIVE REGULATION OF IMMUNE RESPONSE,1.8521e-05,-0.15879,-0.1749,1,0
6,GO POSITIVE REGULATION OF FERTILIZATION,0.042857,-0.15885,-0.19238,1,0
6,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.019739,-0.15885,-0.13037,1,0
6,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0057817,-0.15897,-0.14327,1,0
6,GO COPII COATED VESICLE BUDDING,4.6597e-05,-0.15901,-0.17148,1,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,8.4205e-05,-0.15901,-0.21636,1,0
6,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0013054,-0.15909,-0.17,1,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.011047,-0.15917,-0.16798,1,0
6,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0017641,-0.15924,-0.13965,1,0
6,GO TUBE MORPHOGENESIS,0.00013917,-0.15924,-0.17394,1,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00030804,-0.15928,-0.14415,1,0
6,GO APICAL JUNCTION ASSEMBLY,0.020205,-0.1593,-0.14144,1,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00063551,-0.15934,-0.21158,1,0
6,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0001547,-0.1594,-0.17314,1,0
6,GO BIOLOGICAL ADHESION,7.8282e-05,-0.15945,-0.17859,1,0
6,GO FEAR RESPONSE,0.00081984,-0.15945,-0.17299,1,0
6,GO REGULATION OF JUN KINASE ACTIVITY,0.00059588,-0.15973,-0.15326,1,0
6,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.018836,-0.15977,-0.2664,1,0
6,GO REGULATION OF MACROPHAGE MIGRATION,0.00087311,-0.15984,-0.19439,1,0
6,GO HYALURONAN METABOLIC PROCESS,0.00019079,-0.15988,-0.22718,1,0
6,GO GRANULOCYTE MIGRATION,1.0604e-05,-0.15992,-0.21953,1,0
6,GO GLIAL CELL DEVELOPMENT,0.0016129,-0.16,-0.16988,1,0
6,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0022992,-0.16004,-0.202,1,0
6,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,3.6228e-06,-0.16021,-0.15645,1,0
6,GO NCRNA METABOLIC PROCESS,0.0026572,-0.16031,-0.16256,1,0
6,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.037747,-0.16041,-0.11587,1,0
6,GO DENDRITIC CELL CHEMOTAXIS,0.0053338,-0.16054,-0.20514,1,0
6,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.7145e-05,-0.16057,-0.17229,1,0
6,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0026572,-0.16064,-0.1856,1,0
6,GO NEGATIVE REGULATION OF SECRETION,0.0001547,-0.16064,-0.13747,1,0
6,GO CARDIAC SEPTUM DEVELOPMENT,0.0097392,-0.16069,-0.15783,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,9.389e-05,-0.16073,-0.1757,1,0
6,GO RRNA MODIFICATION,0.020205,-0.16075,-0.17131,1,0
6,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0018173,-0.16076,-0.20624,1,0
6,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.014138,-0.16081,-0.18454,1,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0094949,-0.16085,-0.19291,1,0
6,GO MEMBRANE REPOLARIZATION,0.0054795,-0.16087,-0.16617,1,0
6,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.042857,-0.1609,-0.22421,1,0
6,GO PLATELET ACTIVATION,0.00081984,-0.16091,-0.17373,1,0
6,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.010773,-0.16097,-0.15849,1,0
6,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0047853,-0.16098,-0.13311,1,0
6,GO RESPONSE TO INTERLEUKIN 4,2.2524e-05,-0.16101,-0.21082,1,0
6,GO B CELL ACTIVATION,0.00034072,-0.1611,-0.15393,1,0
6,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1.8251e-06,-0.16112,-0.18195,1,0
6,GO POSITIVE REGULATION OF CELL KILLING,0.0028141,-0.16114,-0.20411,1,0
6,GO AMYLOID BETA CLEARANCE,0.0062634,-0.16123,-0.20794,1,0
6,GO ZINC ION TRANSPORT,0.00042998,-0.16127,-0.1911,1,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00035231,-0.16127,-0.1799,1,0
6,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,1.0311e-06,-0.16129,-0.21069,1,0
6,GO GOLGI VESICLE BUDDING,2.1663e-05,-0.1614,-0.1813,1,0
6,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.00054072,-0.1615,-0.14707,1,0
6,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00024286,-0.16152,-0.17103,1,0
6,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00047456,-0.16154,-0.1944,1,0
6,GO GLUTAMATE METABOLIC PROCESS,0.0028957,-0.16157,-0.1402,1,0
6,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0030654,-0.16158,-0.27733,1,0
6,GO REGULATION OF PROTEIN IMPORT,0.0019282,-0.16159,-0.18227,1,0
6,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0010206,-0.16164,-0.20284,1,0
6,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0033369,-0.16168,-0.1576,1,0
6,GO HEART GROWTH,0.012203,-0.16176,-0.12364,1,0
6,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0064317,-0.162,-0.16153,1,0
6,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00067758,-0.16208,-0.17666,1,0
6,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.2454e-05,-0.16218,-0.15797,1,0
6,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00012074,-0.16227,-0.16667,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.5759e-05,-0.16227,-0.22802,1,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00018427,-0.16234,-0.20494,1,0
6,GO REPLACEMENT OSSIFICATION,0.05161,-0.1624,-0.16883,1,0
6,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,1.8521e-05,-0.16245,-0.17162,1,0
6,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,8.6584e-06,-0.16262,-0.16091,1,0
6,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.030383,-0.16265,-0.12142,1,0
6,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.1112e-06,-0.16279,-0.16263,1,0
6,GO POSITIVE REGULATION OF CELL AGING,0.0025817,-0.16297,-0.24651,1,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0022992,-0.16297,-0.20036,1,0
6,GO MYELOID CELL HOMEOSTASIS,9.389e-05,-0.16298,-0.17361,1,0
6,GO RESPONSE TO PROSTAGLANDIN,0.027188,-0.16299,-0.16354,1,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,6.5149e-05,-0.16302,-0.15362,1,0
6,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.00019079,-0.16306,-0.18836,1,0
6,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.053746,-0.1631,-0.12036,1,0
6,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0051916,-0.16315,-0.22378,1,0
6,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00032948,-0.16321,-0.15343,1,0
6,GO REGULATION OF BODY FLUID LEVELS,5.0226e-05,-0.16331,-0.17948,1,0
6,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,9.0179e-06,-0.16354,-0.15201,1,0
6,GO ISOPRENOID METABOLIC PROCESS,0.00065623,-0.16354,-0.19218,1,0
6,GO ER NUCLEUS SIGNALING PATHWAY,0.001228,-0.16383,-0.17819,1,0
6,GO RESPONSE TO ANGIOTENSIN,0.0033369,-0.16398,-0.21577,1,0
6,GO TERPENOID METABOLIC PROCESS,0.00084609,-0.16399,-0.20028,1,0
6,GO CELLULAR RESPONSE TO OXYGEN LEVELS,3.4728e-06,-0.16407,-0.18227,1,0
6,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0079323,-0.16412,-0.21108,1,0
6,GO EXPLORATION BEHAVIOR,0.03245,-0.16413,-0.16631,1,0
6,GO BILE ACID BIOSYNTHETIC PROCESS,0.0046564,-0.16415,-0.18644,1,0
6,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.025414,-0.16417,-0.17867,1,0
6,GO PROTEIN MATURATION,2.1663e-05,-0.16425,-0.17527,1,0
6,GO POSITIVE REGULATION OF ION TRANSPORT,0.00013917,-0.16428,-0.1606,1,0
6,GO REGULATION OF BLOOD PRESSURE,8.7323e-05,-0.16429,-0.17477,1,0
6,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0028141,-0.16433,-0.15802,1,0
6,GO INTESTINAL ABSORPTION,0.0073363,-0.16433,-0.22354,1,0
6,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00032948,-0.16437,-0.18488,1,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.031748,-0.16445,-0.1437,1,0
6,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0038387,-0.16445,-0.26773,1,0
6,GO GASTRIC ACID SECRETION,0.043763,-0.16446,-0.15271,1,0
6,GO VIRAL LIFE CYCLE,3.5759e-05,-0.16446,-0.20741,1,0
6,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00052342,-0.16448,-0.19165,1,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0007696,-0.16451,-0.18473,1,0
6,GO POST GOLGI VESICLE MEDIATED TRANSPORT,5.6174e-05,-0.16453,-0.1749,1,0
6,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00011241,-0.16454,-0.18015,1,0
6,GO RESPONSE TO HORMONE,1.3441e-06,-0.16455,-0.17945,1,0
6,GO INNATE IMMUNE RESPONSE,2.0833e-05,-0.16458,-0.21178,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,9.0179e-06,-0.16472,-0.17529,1,0
6,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,2.7343e-05,-0.16472,-0.21899,1,0
6,GO RESPONSE TO EXTRACELLULAR STIMULUS,3.0576e-06,-0.16475,-0.17538,1,0
6,GO B CELL PROLIFERATION,0.00017186,-0.16476,-0.19199,1,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,6.7596e-05,-0.16478,-0.18989,1,0
6,GO PINOCYTOSIS,0.00067758,-0.16483,-0.23726,1,0
6,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.04854,-0.16511,-0.16113,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0014299,-0.16513,-0.22732,1,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0099891,-0.16526,-0.182,1,0
6,GO RESPONSE TO FATTY ACID,3.3132e-05,-0.16535,-0.21973,1,0
6,GO PIGMENT ACCUMULATION,0.014138,-0.16541,-0.17088,1,0
6,GO CHLORIDE TRANSPORT,0.0013054,-0.16546,-0.14016,1,0
6,GO INTERACTION WITH SYMBIONT,3.6228e-06,-0.16546,-0.20354,1,0
6,GO CELLULAR RESPIRATION,0.00030804,-0.1655,-0.20151,1,0
6,GO GLUCOSE METABOLIC PROCESS,2.5308e-05,-0.16551,-0.16413,1,0
6,GO EPITHELIAL CELL PROLIFERATION,0.00012964,-0.16559,-0.19303,1,0
6,GO DIVALENT INORGANIC CATION TRANSPORT,3.5759e-05,-0.16565,-0.15327,1,0
6,GO RESPONSE TO INTERLEUKIN 2,0.033166,-0.16586,-0.15079,1,0
6,GO CELL ACTIVATION,4.6623e-06,-0.16603,-0.19715,1,0
6,GO PHOSPHOLIPID TRANSPORT,4.8379e-05,-0.16623,-0.19085,1,0
6,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,1.2962e-05,-0.16627,-0.16324,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00013433,-0.16634,-0.17075,1,0
6,GO URONIC ACID METABOLIC PROCESS,0.00019079,-0.16645,-0.20807,1,0
6,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.00010845,-0.16653,-0.17885,1,0
6,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,2.6902e-06,-0.16661,-0.16509,1,0
6,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,7.013e-05,-0.1667,-0.19649,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00079435,-0.16672,-0.18939,1,0
6,GO CELL KILLING,2.8418e-05,-0.16676,-0.20819,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.001872,-0.16682,-0.15657,1,0
6,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.02068,-0.16683,-0.18118,1,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00084609,-0.16683,-0.24743,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.0021062,-0.16689,-0.18241,1,0
6,GO GLYCEROLIPID METABOLIC PROCESS,1.9904e-06,-0.16698,-0.16944,1,0
6,GO CELLULAR KETONE METABOLIC PROCESS,2.0033e-05,-0.16699,-0.19438,1,0
6,GO CD40 SIGNALING PATHWAY,0.00353,-0.16713,-0.24864,1,0
6,GO MODULATION BY HOST OF SYMBIONT PROCESS,3.1888e-05,-0.16718,-0.20202,1,0
6,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00021909,-0.16719,-0.17717,1,0
6,GO RESPONSE TO PROSTAGLANDIN E,0.0059384,-0.1672,-0.14705,1,0
6,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,3.5759e-05,-0.16733,-0.19517,1,0
6,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,2.7578e-07,-0.16734,-0.19055,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,1.7118e-05,-0.16741,-0.18182,1,0
6,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0022992,-0.16745,-0.26861,1,0
6,GO TRNA METABOLIC PROCESS,0.0069616,-0.16759,-0.13627,1,0
6,GO TRICARBOXYLIC ACID CYCLE,0.0025817,-0.16766,-0.20171,1,0
6,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,3.4728e-06,-0.16774,-0.18026,1,0
6,GO RESPONSE TO NUTRIENT,0.00017186,-0.16777,-0.18756,1,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.0012662,-0.16777,-0.19947,1,0
6,GO LAMELLIPODIUM ASSEMBLY,0.0020453,-0.16788,-0.15238,1,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.031059,-0.16788,-0.12654,1,0
6,GO MONOCARBOXYLIC ACID TRANSPORT,1.7474e-06,-0.16793,-0.18386,1,0
6,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00036427,-0.16796,-0.35207,1,0
6,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,3.4421e-05,-0.16805,-0.17174,1,0
6,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,1.5816e-05,-0.1681,-0.15994,1,0
6,GO VESICLE CARGO LOADING,8.1192e-05,-0.16815,-0.21711,1,0
6,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.00098941,-0.16816,-0.1884,1,0
6,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.040234,-0.1682,-0.21634,1,0
6,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.00049035,-0.16822,-0.20951,1,0
6,GO RESPONSE TO SALT,0.00084609,-0.16827,-0.15935,1,0
6,GO ALCOHOL CATABOLIC PROCESS,0.00019753,-0.16833,-0.17725,1,0
6,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,6.5149e-05,-0.16833,-0.1721,1,0
6,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0066042,-0.16837,-0.16036,1,0
6,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,4.8379e-05,-0.16852,-0.2087,1,0
6,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,1.4039e-05,-0.16856,-0.18596,1,0
6,GO NUCLEAR ENVELOPE REASSEMBLY,0.011904,-0.16861,-0.12044,1,0
6,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00040247,-0.16864,-0.20697,1,0
6,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0097392,-0.1687,-0.17302,1,0
6,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00011241,-0.16884,-0.15694,1,0
6,GO RESPONSE TO HEAT,7.6603e-06,-0.16891,-0.17514,1,0
6,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0057817,-0.16894,-0.16416,1,0
6,GO GLYCOSYL COMPOUND METABOLIC PROCESS,4.4878e-05,-0.16898,-0.1808,1,0
6,GO ADAPTIVE THERMOGENESIS,6.0504e-05,-0.16898,-0.17523,1,0
6,GO REGULATION OF MONOOXYGENASE ACTIVITY,5.8301e-05,-0.16901,-0.19486,1,0
6,GO REGULATION OF INFLAMMATORY RESPONSE,2.4692e-06,-0.16905,-0.21571,1,0
6,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00047456,-0.16908,-0.17278,1,0
6,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,3.8131e-07,-0.1691,-0.17652,1,0
6,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.00010845,-0.16919,-0.19063,1,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.030383,-0.16924,-0.13671,1,0
6,GO POSITIVE REGULATION OF BINDING,0.00014418,-0.16929,-0.14845,1,0
6,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00019753,-0.1693,-0.22802,1,0
6,GO PROTEIN AUTOPHOSPHORYLATION,5.8301e-05,-0.16935,-0.15631,1,0
6,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00072223,-0.16949,-0.22744,1,0
6,GO COAGULATION,3.8583e-05,-0.16954,-0.19813,1,0
6,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.0075304,-0.16958,-0.19665,1,0
6,GO RESPONSE TO CORTICOSTERONE,0.011904,-0.16975,-0.22966,1,0
6,GO REGULATION OF IMMUNE RESPONSE,7.6603e-06,-0.16976,-0.18559,1,0
6,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.00029782,-0.1698,-0.16933,1,0
6,GO CELLULAR RESPONSE TO LIPID,3.9418e-06,-0.16988,-0.18633,1,0
6,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.040234,-0.16995,-0.19916,1,0
6,GO RESPONSE TO ALCOHOL,8.1192e-05,-0.17,-0.16096,1,0
6,GO REGULATION OF SYNAPSE ASSEMBLY,0.047551,-0.17014,-0.12371,1,0
6,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,5.2139e-05,-0.17014,-0.19768,1,0
6,GO REGULATION OF CHOLESTEROL EFFLUX,0.0041716,-0.17031,-0.16284,1,0
6,GO STRESS FIBER ASSEMBLY,0.00095906,-0.17052,-0.20089,1,0
6,GO CELLULAR HOMEOSTASIS,6.5896e-07,-0.17057,-0.16242,1,0
6,GO PEPTIDYL HISTIDINE MODIFICATION,0.0099891,-0.17067,-0.17769,1,0
6,GO SELECTIVE AUTOPHAGY,2.9532e-05,-0.17076,-0.20391,1,0
6,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.0184e-05,-0.17079,-0.19554,1,0
6,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00034072,-0.17084,-0.18914,1,0
6,GO RESPONSE TO AXON INJURY,0.018836,-0.17084,-0.12142,1,0
6,GO ORGANELLE FUSION,2.8418e-05,-0.17105,-0.16008,1,0
6,GO ANATOMICAL STRUCTURE REGRESSION,0.013798,-0.1711,-0.22954,1,0
6,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,9.8628e-07,-0.17116,-0.18375,1,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0015189,-0.17133,-0.17454,1,0
6,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.017549,-0.17135,-0.13886,1,0
6,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,1.906e-06,-0.17139,-0.16701,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,2.9532e-05,-0.17147,-0.23767,1,0
6,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0049174,-0.17162,-0.23427,1,0
6,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00027832,-0.17165,-0.1996,1,0
6,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,8.6584e-06,-0.17167,-0.18464,1,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00019753,-0.17168,-0.15647,1,0
6,GO CELLULAR IRON ION HOMEOSTASIS,0.00012964,-0.17171,-0.17548,1,0
6,GO PEPTIDE BIOSYNTHETIC PROCESS,6.0504e-05,-0.17176,-0.19858,1,0
6,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00065623,-0.17191,-0.20519,1,0
6,GO DEFENSE RESPONSE TO OTHER ORGANISM,1.2454e-05,-0.17204,-0.20734,1,0
6,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0017641,-0.17207,-0.19336,1,0
6,GO REGULATION OF CELL ADHESION,7.8282e-05,-0.17209,-0.20046,1,0
6,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00017186,-0.17212,-0.19735,1,0
6,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0013872,-0.17213,-0.24325,1,0
6,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00011241,-0.17214,-0.16776,1,0
6,GO REGULATION OF ATP METABOLIC PROCESS,4.8612e-06,-0.17217,-0.17769,1,0
6,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0006154,-0.17222,-0.24589,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.017549,-0.17229,-0.20432,1,0
6,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.014138,-0.1724,-0.20278,1,0
6,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.027803,-0.17261,-0.15155,1,0
6,GO ASTROCYTE DEVELOPMENT,0.0067808,-0.17272,-0.21622,1,0
6,GO GASTRULATION,0.00037661,-0.17286,-0.20302,1,0
6,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.013139,-0.1729,-0.20751,1,0
6,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00034072,-0.17293,-0.23451,1,0
6,GO IMMATURE T CELL PROLIFERATION,0.0057817,-0.17299,-0.21112,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0001165,-0.17319,-0.20012,1,0
6,GO RECEPTOR METABOLIC PROCESS,9.389e-05,-0.1732,-0.15745,1,0
6,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.017549,-0.17321,-0.18318,1,0
6,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0012662,-0.17323,-0.27217,1,0
6,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.014486,-0.17327,-0.14767,1,0
6,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0021062,-0.17331,-0.25788,1,0
6,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.023205,-0.17343,-0.15401,1,0
6,GO CELLULAR LIPID METABOLIC PROCESS,5.0194e-07,-0.17361,-0.19455,1,0
6,GO T CELL CHEMOTAXIS,0.0001165,-0.17364,-0.20452,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0011549,-0.17374,-0.19834,1,0
6,GO PROTEIN LIPID COMPLEX ASSEMBLY,7.8282e-05,-0.17375,-0.19635,1,0
6,GO RESPONSE TO OXYGEN LEVELS,2.6322e-07,-0.17383,-0.21967,1,0
6,GO PROTEIN LOCALIZATION TO MEMBRANE,1.8251e-06,-0.17391,-0.14988,1,0
6,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0051916,-0.17397,-0.17796,1,0
6,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0030654,-0.17399,-0.1768,1,0
6,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,4.6597e-05,-0.17407,-0.16682,1,0
6,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.01282,-0.17408,-0.21137,1,0
6,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,9.389e-05,-0.17411,-0.21479,1,0
6,GO REGULATION OF VIRAL LIFE CYCLE,0.0033369,-0.17413,-0.23157,1,0
6,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0025817,-0.17417,-0.17826,1,0
6,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00037661,-0.1742,-0.18639,1,0
6,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00092958,-0.17426,-0.16837,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0013872,-0.17427,-0.24579,1,0
6,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.018836,-0.17432,-0.32272,1,0
6,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040247,-0.17432,-0.25602,1,0
6,GO RESPONSE TO ISCHEMIA,0.00063551,-0.17446,-0.18129,1,0
6,GO REGULATION OF MUSCLE HYPERTROPHY,0.00098941,-0.17447,-0.18739,1,0
6,GO DEFENSE RESPONSE TO BACTERIUM,7.9801e-06,-0.17448,-0.2063,1,0
6,GO ACTIVATION OF MAPK ACTIVITY,2.5308e-05,-0.17451,-0.16961,1,0
6,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.0027346,-0.17457,-0.173,1,0
6,GO CELLULAR AMINO ACID CATABOLIC PROCESS,1.7118e-05,-0.17461,-0.21456,1,0
6,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,7.013e-05,-0.17465,-0.17598,1,0
6,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00040247,-0.17468,-0.19703,1,0
6,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.055956,-0.17471,-0.15065,1,0
6,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00017796,-0.17473,-0.19511,1,0
6,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.3441e-06,-0.17484,-0.18545,1,0
6,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0013872,-0.17495,-0.18161,1,0
6,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.025414,-0.175,-0.21215,1,0
6,GO VACUOLE ORGANIZATION,7.0571e-06,-0.175,-0.17833,1,0
6,GO PARAXIAL MESODERM DEVELOPMENT,0.036948,-0.17502,-0.19642,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,3.8583e-05,-0.17515,-0.22231,1,0
6,GO MUSCLE ORGAN MORPHOGENESIS,0.0029794,-0.17519,-0.14933,1,0
6,GO CARNITINE METABOLIC PROCESS,0.053746,-0.17523,-0.14235,1,0
6,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0018173,-0.17529,-0.19085,1,0
6,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0030654,-0.17529,-0.18202,1,0
6,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0021689,-0.1756,-0.21384,1,0
6,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00014418,-0.17563,-0.1833,1,0
6,GO RESPONSE TO REACTIVE OXYGEN SPECIES,1.5331e-06,-0.17579,-0.2093,1,0
6,GO PURINE NUCLEOSIDE METABOLIC PROCESS,1.6729e-06,-0.17581,-0.20944,1,0
6,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,5.2139e-05,-0.17587,-0.23205,1,0
6,GO CYTOSOLIC CALCIUM ION TRANSPORT,9.389e-05,-0.17589,-0.17698,1,0
6,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.6307e-05,-0.17592,-0.25657,1,0
6,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0081404,-0.17595,-0.12662,1,0
6,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0022992,-0.17598,-0.17158,1,0
6,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.00026003,-0.17599,-0.19173,1,0
6,GO PROTEIN PROCESSING,0.00014935,-0.17604,-0.18049,1,0
6,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.012203,-0.17607,-0.15945,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00031859,-0.17614,-0.18512,1,0
6,GO CARDIAC CONDUCTION,0.011047,-0.17614,-0.15404,1,0
6,GO ENDOCYTOSIS,2.3418e-05,-0.17616,-0.1631,1,0
6,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.4878e-05,-0.17623,-0.20013,1,0
6,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00023468,-0.17639,-0.2558,1,0
6,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.024846,-0.17641,-0.1623,1,0
6,GO RESPIRATORY BURST,0.001986,-0.17644,-0.23467,1,0
6,GO ION HOMEOSTASIS,7.889e-07,-0.17644,-0.17418,1,0
6,GO COLLAGEN FIBRIL ORGANIZATION,0.0012662,-0.17657,-0.28149,1,0
6,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.001228,-0.17667,-0.21621,1,0
6,GO TRNA 5 END PROCESSING,0.0062634,-0.17668,-0.1717,1,0
6,GO RESPONSE TO ETHANOL,4.6597e-05,-0.17677,-0.18109,1,0
6,GO DIVALENT INORGANIC CATION HOMEOSTASIS,3.4728e-06,-0.17702,-0.17551,1,0
6,GO REGULATION OF FATTY ACID BETA OXIDATION,0.018398,-0.17715,-0.15099,1,0
6,GO HEART PROCESS,0.00079435,-0.17716,-0.16986,1,0
6,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.0001547,-0.17731,-0.16552,1,0
6,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00081984,-0.17736,-0.22883,1,0
6,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00012964,-0.17745,-0.18519,1,0
6,GO PROTEIN FOLDING,9.4334e-07,-0.1776,-0.20101,1,0
6,GO MEMBRANE FUSION,0.0001165,-0.17784,-0.17138,1,0
6,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0030654,-0.17788,-0.20721,1,0
6,GO ACETYL COA METABOLIC PROCESS,0.0014299,-0.17788,-0.18329,1,0
6,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,1.2308e-06,-0.17796,-0.20292,1,0
6,GO RECEPTOR RECYCLING,0.001228,-0.17798,-0.16051,1,0
6,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0014738,-0.17802,-0.21648,1,0
6,GO REGULATION OF MULTI ORGANISM PROCESS,9.0179e-06,-0.17804,-0.20585,1,0
6,GO CARDIAC CHAMBER MORPHOGENESIS,0.0053338,-0.17816,-0.16066,1,0
6,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.00010845,-0.17825,-0.16625,1,0
6,GO NEGATIVE REGULATION OF GROWTH,7.547e-05,-0.17826,-0.17854,1,0
6,GO INTERLEUKIN 1 BETA PRODUCTION,0.0010206,-0.17829,-0.23912,1,0
6,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,3.9418e-06,-0.17834,-0.17817,1,0
6,GO REGULATION OF CELL CELL ADHESION,0.00021167,-0.17845,-0.19272,1,0
6,GO TRIGLYCERIDE CATABOLIC PROCESS,0.054842,-0.17851,-0.11647,1,0
6,GO RESPONSE TO BIOTIC STIMULUS,2.1702e-06,-0.17853,-0.206,1,0
6,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0039469,-0.17857,-0.19456,1,0
6,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00010462,-0.17869,-0.18502,1,0
6,GO VASCULATURE DEVELOPMENT,4.1617e-05,-0.17872,-0.20554,1,0
6,GO RESPONSE TO TEMPERATURE STIMULUS,1.1267e-06,-0.17878,-0.17518,1,0
6,GO PROTEIN TARGETING TO LYSOSOME,0.004408,-0.17879,-0.20274,1,0
6,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00027832,-0.17882,-0.2472,1,0
6,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0049174,-0.17901,-0.19087,1,0
6,GO RESPONSE TO OXIDATIVE STRESS,7.889e-07,-0.17905,-0.2039,1,0
6,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.037747,-0.17913,-0.30659,1,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0045306,-0.17927,-0.16098,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0025817,-0.17932,-0.16789,1,0
6,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00045924,-0.17946,-0.17851,1,0
6,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0030654,-0.17955,-0.19164,1,0
6,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,1.5816e-05,-0.1797,-0.19328,1,0
6,GO T CELL PROLIFERATION,0.00019753,-0.17977,-0.20031,1,0
6,GO CYTOLYSIS,0.007729,-0.17989,-0.22569,1,0
6,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00063551,-0.17989,-0.19239,1,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS,1.0604e-05,-0.17997,-0.17822,1,0
6,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,2.4692e-06,-0.18,-0.19193,1,0
6,GO RESPONSE TO OSMOTIC STRESS,8.4205e-05,-0.18,-0.1991,1,0
6,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.031059,-0.18007,-0.15263,1,0
6,GO NEGATIVE REGULATION OF PHOSPHORYLATION,2.1663e-05,-0.18011,-0.17961,1,0
6,GO RESPONSE TO STEROL,0.00054072,-0.18014,-0.22321,1,0
6,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.044685,-0.18014,-0.20013,1,0
6,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00057693,-0.18015,-0.2096,1,0
6,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0090226,-0.18031,-0.17993,1,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0042883,-0.18031,-0.17527,1,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0049174,-0.18032,-0.18695,1,0
6,GO REGULATION OF VIRAL GENOME REPLICATION,0.0075304,-0.18036,-0.23422,1,0
6,GO REVERSE CHOLESTEROL TRANSPORT,0.0094949,-0.18038,-0.24413,1,0
6,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00022676,-0.1804,-0.17417,1,0
6,GO RIBOSOME BIOGENESIS,0.0057817,-0.18041,-0.2081,1,0
6,GO CELLULAR RESPONSE TO SALT STRESS,0.009256,-0.18045,-0.24426,1,0
6,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0041716,-0.18058,-0.19624,1,0
6,GO RNA 5 END PROCESSING,0.0046564,-0.18059,-0.18409,1,0
6,GO OXIDATIVE PHOSPHORYLATION,0.00031859,-0.18061,-0.20924,1,0
6,GO CYTOKINE PRODUCTION,2.0833e-05,-0.18062,-0.20057,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.041967,-0.18063,-0.12905,1,0
6,GO TRNA 5 LEADER REMOVAL,0.0047853,-0.18063,-0.19528,1,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00047456,-0.18064,-0.171,1,0
6,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2308e-06,-0.18066,-0.24439,1,0
6,GO CELLULAR RESPONSE TO ATP,0.00095906,-0.18067,-0.17803,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,6.0504e-05,-0.18074,-0.28445,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.001986,-0.18086,-0.18691,1,0
6,GO FATTY ACID DERIVATIVE TRANSPORT,0.00019079,-0.18087,-0.17734,1,0
6,GO LYMPHOCYTE MIGRATION,3.5759e-05,-0.18096,-0.20269,1,0
6,GO REGULATION OF LIPASE ACTIVITY,2.1702e-06,-0.18108,-0.219,1,0
6,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,7.3528e-06,-0.18109,-0.1843,1,0
6,GO REGULATION OF LYASE ACTIVITY,0.0067808,-0.18109,-0.15772,1,0
6,GO FOCAL ADHESION ASSEMBLY,0.00029782,-0.18113,-0.22652,1,0
6,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0038387,-0.18128,-0.24281,1,0
6,GO SEQUESTERING OF METAL ION,0.0029794,-0.18137,-0.19949,1,0
6,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0037331,-0.18138,-0.20219,1,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.02268,-0.18143,-0.16587,1,0
6,GO RESPONSE TO ORGANOPHOSPHORUS,4.4712e-06,-0.1815,-0.20442,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00022676,-0.18156,-0.18739,1,0
6,GO INTERLEUKIN 17 PRODUCTION,0.00010462,-0.18164,-0.24077,1,0
6,GO FATTY ACID BETA OXIDATION,3.0689e-05,-0.18171,-0.22273,1,0
6,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,2.4346e-05,-0.18173,-0.16292,1,0
6,GO COENZYME A METABOLIC PROCESS,0.0015189,-0.18186,-0.19581,1,0
6,GO RRNA METABOLIC PROCESS,0.0039469,-0.18193,-0.20034,1,0
6,GO RESPONSE TO DSRNA,0.00013433,-0.182,-0.20592,1,0
6,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0041716,-0.18206,-0.16176,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00012074,-0.18222,-0.20243,1,0
6,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0001547,-0.18225,-0.18714,1,0
6,GO AUTOPHAGY OF NUCLEUS,0.015203,-0.18231,-0.15736,1,0
6,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,1.2308e-06,-0.18231,-0.19461,1,0
6,GO ERYTHROCYTE HOMEOSTASIS,0.00012074,-0.18234,-0.16635,1,0
6,GO METANEPHRIC NEPHRON DEVELOPMENT,0.010773,-0.18239,-0.17153,1,0
6,GO ALPHA AMINO ACID METABOLIC PROCESS,3.1904e-06,-0.18242,-0.21465,1,0
6,GO REGULATION OF CELL KILLING,0.00081984,-0.18247,-0.20504,1,0
6,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00052342,-0.18251,-0.20485,1,0
6,GO MITOCHONDRIAL TRANSLATION,0.0015653,-0.18285,-0.20633,1,0
6,GO RESPONSE TO TUMOR NECROSIS FACTOR,3.1888e-05,-0.18286,-0.22011,1,0
6,GO MAST CELL ACTIVATION,0.0059384,-0.18286,-0.1641,1,0
6,GO REGULATION OF LYSOSOMAL LUMEN PH,0.031059,-0.18288,-0.14914,1,0
6,GO CYTOCHROME COMPLEX ASSEMBLY,0.0033369,-0.18295,-0.20644,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,3.5759e-05,-0.18306,-0.19878,1,0
6,GO CELLULAR RESPONSE TO FATTY ACID,0.0022332,-0.18312,-0.20621,1,0
6,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.03245,-0.18316,-0.2663,1,0
6,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00011241,-0.1833,-0.22424,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00014935,-0.18339,-0.21701,1,0
6,GO BONE MINERALIZATION,0.00017186,-0.18342,-0.21533,1,0
6,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0001165,-0.18343,-0.22588,1,0
6,GO REGULATION OF TISSUE REMODELING,0.00035231,-0.18346,-0.21496,1,0
6,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0060989,-0.18355,-0.29568,1,0
6,GO NEPHRIC DUCT MORPHOGENESIS,0.014486,-0.1836,-0.2821,1,0
6,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.2962e-05,-0.1837,-0.20779,1,0
6,GO SECONDARY METABOLIC PROCESS,0.018836,-0.18371,-0.18612,1,0
6,GO RHO PROTEIN SIGNAL TRANSDUCTION,3.1888e-05,-0.18374,-0.22087,1,0
6,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0025817,-0.18375,-0.22873,1,0
6,GO RNA CATABOLIC PROCESS,0.0001547,-0.18378,-0.1817,1,0
6,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,7.2754e-05,-0.18384,-0.19538,1,0
6,GO REGULATION OF STEROL TRANSPORT,4.3218e-05,-0.18387,-0.25198,1,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0010528,-0.18387,-0.19075,1,0
6,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.012508,-0.1839,-0.1739,1,0
6,GO VENTRICULAR SEPTUM DEVELOPMENT,0.016734,-0.18397,-0.16325,1,0
6,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,8.6584e-06,-0.18405,-0.20934,1,0
6,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,5.7413e-06,-0.18409,-0.1694,1,0
6,GO REGULATION OF FAT CELL DIFFERENTIATION,0.00040247,-0.18412,-0.18961,1,0
6,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.01282,-0.18417,-0.18544,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0017641,-0.18422,-0.21033,1,0
6,GO REGULATION OF PEPTIDASE ACTIVITY,7.8282e-05,-0.18424,-0.19078,1,0
6,GO NUCLEOSIDE METABOLIC PROCESS,7.6603e-06,-0.1843,-0.18386,1,0
6,GO LIVER REGENERATION,0.00031859,-0.18438,-0.24967,1,0
6,GO RIBONUCLEOSIDE METABOLIC PROCESS,5.0683e-06,-0.1844,-0.22741,1,0
6,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013798,-0.18441,-0.21256,1,0
6,GO ENDODERM DEVELOPMENT,0.0014299,-0.1845,-0.26661,1,0
6,GO LIPID METABOLIC PROCESS,4.7955e-07,-0.1846,-0.19008,1,0
6,GO RESPONSE TO ESTROGEN,1.4039e-05,-0.1847,-0.25339,1,0
6,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.047551,-0.18475,-0.17598,1,0
6,GO RESPONSE TO STEROID HORMONE,4.8612e-06,-0.18487,-0.20516,1,0
6,GO INTEGRIN ACTIVATION,0.0034322,-0.18496,-0.20698,1,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,5.7413e-06,-0.18515,-0.23098,1,0
6,GO CELLULAR RESPONSE TO STARVATION,7.2754e-05,-0.1852,-0.17338,1,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0057817,-0.18522,-0.18657,1,0
6,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0060989,-0.18523,-0.15383,1,0
6,GO REGULATION OF BIOMINERALIZATION,0.00057693,-0.18527,-0.1992,1,0
6,GO PROTEIN KINASE C SIGNALING,0.0094949,-0.18528,-0.17666,1,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00045924,-0.1853,-0.17885,1,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.5816e-05,-0.18533,-0.20522,1,0
6,GO EXOCYTOSIS,1.3441e-06,-0.18543,-0.20793,1,0
6,GO REGULATION OF PHAGOCYTOSIS,0.00025131,-0.18545,-0.20982,1,0
6,GO FATTY ACID TRANSPORT,1.6729e-06,-0.18549,-0.20962,1,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.007729,-0.18551,-0.16826,1,0
6,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.023741,-0.18553,-0.14813,1,0
6,GO INTRACELLULAR STEROL TRANSPORT,0.00044439,-0.18578,-0.2442,1,0
6,GO CARDIAC VENTRICLE DEVELOPMENT,0.011326,-0.1858,-0.14149,1,0
6,GO MEMBRANE BIOGENESIS,0.026586,-0.18581,-0.16633,1,0
6,GO P38MAPK CASCADE,0.00040247,-0.1859,-0.21889,1,0
6,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,8.1192e-05,-0.18592,-0.17155,1,0
6,GO CELLULAR RESPONSE TO DSRNA,0.0067808,-0.18592,-0.19504,1,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,9.389e-05,-0.18593,-0.18246,1,0
6,GO DEFENSE RESPONSE,3.1904e-06,-0.18594,-0.20307,1,0
6,GO BONE RESORPTION,0.00050664,-0.18595,-0.20977,1,0
6,GO LEUKOCYTE CHEMOTAXIS,8.1192e-05,-0.18596,-0.19929,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.013465,-0.18597,-0.19728,1,0
6,GO RESPONSE TO MINERALOCORTICOID,0.001228,-0.18599,-0.22258,1,0
6,GO MACROPHAGE MIGRATION,0.00014935,-0.18609,-0.23389,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.010773,-0.18633,-0.20432,1,0
6,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0013872,-0.18638,-0.19996,1,0
6,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00092958,-0.18653,-0.17874,1,0
6,GO FLUID TRANSPORT,0.0012662,-0.18654,-0.1763,1,0
6,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,1.2366e-07,-0.18654,-0.19116,1,0
6,GO AUTOPHAGOSOME MATURATION,0.00067758,-0.18659,-0.19036,1,0
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.035393,-0.18674,-0.16367,1,0
6,GO REGULATION OF OSSIFICATION,0.00020448,-0.18698,-0.19591,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00013917,-0.18706,-0.20073,1,0
6,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.019739,-0.18709,-0.21247,1,0
6,GO REGULATION OF LIPID METABOLIC PROCESS,6.8936e-07,-0.18713,-0.20449,1,0
6,GO LINOLEIC ACID METABOLIC PROCESS,0.00353,-0.18715,-0.30854,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,1.1237e-07,-0.18724,-0.18987,1,0
6,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.02843,-0.18727,-0.19154,1,0
6,GO PROTEIN TETRAMERIZATION,1.7118e-05,-0.18738,-0.16888,1,0
6,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,6.2786e-05,-0.18738,-0.23168,1,0
6,GO PROTEIN ACTIVATION CASCADE,9.0551e-05,-0.18742,-0.27201,1,0
6,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00069957,-0.18744,-0.173,1,0
6,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00065623,-0.18749,-0.24219,1,0
6,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00023468,-0.18751,-0.2718,1,0
6,GO ANIMAL ORGAN MATURATION,0.054842,-0.18754,-0.12285,1,0
6,GO POSITIVE REGULATION OF COAGULATION,0.0056288,-0.18757,-0.19582,1,0
6,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00081984,-0.18758,-0.22468,1,0
6,GO AXIS ELONGATION,0.024846,-0.18764,-0.21354,1,0
6,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.036948,-0.18765,-0.19622,1,0
6,GO RESPONSE TO TOXIC SUBSTANCE,2.4346e-05,-0.18769,-0.19964,1,0
6,GO ANTIMICROBIAL HUMORAL RESPONSE,1.6015e-06,-0.1877,-0.22852,1,0
6,GO PROTEIN HOMOTETRAMERIZATION,7.9801e-06,-0.18773,-0.17444,1,0
6,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.03939,-0.18776,-0.15389,1,0
6,GO ELASTIC FIBER ASSEMBLY,0.017137,-0.18779,-0.33629,1,0
6,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.017137,-0.18786,-0.14476,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0021689,-0.18791,-0.23755,1,0
6,GO STRIATED MUSCLE ADAPTATION,0.0013872,-0.18791,-0.19531,1,0
6,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,2.3654e-06,-0.18796,-0.18377,1,0
6,GO REGULATION OF MUSCLE SYSTEM PROCESS,4.0073e-05,-0.18821,-0.1737,1,0
6,GO NEUTRAL LIPID METABOLIC PROCESS,2.9301e-06,-0.18826,-0.21529,1,0
6,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.055956,-0.18829,-0.12984,1,0
6,GO AMINO ACID IMPORT,0.00037661,-0.1883,-0.23648,1,0
6,GO TETRAHYDROFOLATE INTERCONVERSION,0.0059384,-0.18833,-0.20931,1,0
6,GO NUCLEOSIDE SALVAGE,0.009256,-0.18845,-0.22552,1,0
6,GO ETHER BIOSYNTHETIC PROCESS,0.011612,-0.18845,-0.28373,1,0
6,GO FATTY ACID CATABOLIC PROCESS,5.508e-06,-0.18847,-0.22734,1,0
6,GO ENGULFMENT OF APOPTOTIC CELL,0.0030654,-0.18855,-0.20244,1,0
6,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0030654,-0.18865,-0.19971,1,0
6,GO POLYSACCHARIDE METABOLIC PROCESS,0.00017796,-0.18941,-0.1825,1,0
6,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.2862e-06,-0.18941,-0.237,1,0
6,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,6.0504e-05,-0.18951,-0.19178,1,0
6,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0050528,-0.18951,-0.1405,1,0
6,GO IMPORT INTO CELL,0.00020448,-0.18955,-0.17923,1,0
6,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.00014418,-0.18957,-0.18508,1,0
6,GO OXALATE TRANSPORT,8.4205e-05,-0.18964,-0.28036,1,0
6,GO RESPONSE TO CHEMOKINE,4.1112e-06,-0.18966,-0.209,1,0
6,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.001662,-0.18966,-0.22097,1,0
6,GO VITAMIN METABOLIC PROCESS,8.4205e-05,-0.18987,-0.18801,1,0
6,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.001228,-0.18995,-0.24682,1,0
6,GO MUSCLE CONTRACTION,2.3654e-06,-0.18997,-0.19806,1,0
6,GO SULFUR COMPOUND TRANSPORT,2.1663e-05,-0.19004,-0.19762,1,0
6,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0001547,-0.19008,-0.27285,1,0
6,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0090226,-0.19014,-0.25685,1,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,8.2505e-07,-0.19022,-0.19302,1,0
6,GO MAMMARY GLAND DEVELOPMENT,8.4205e-05,-0.19026,-0.19248,1,0
6,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00069957,-0.19027,-0.22197,1,0
6,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00050664,-0.1903,-0.20892,1,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00079435,-0.19041,-0.16302,1,0
6,GO ATP METABOLIC PROCESS,1.0779e-06,-0.19047,-0.19513,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00016595,-0.1905,-0.24955,1,0
6,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,8.1192e-05,-0.19051,-0.26155,1,0
6,GO TISSUE REMODELING,0.00065623,-0.19051,-0.21728,1,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0041716,-0.19054,-0.14823,1,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0067808,-0.19056,-0.18757,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0059384,-0.19068,-0.18922,1,0
6,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,7.3528e-06,-0.1908,-0.17922,1,0
6,GO REGULATION OF LIPID TRANSPORT,1.7806e-05,-0.19081,-0.20484,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.8612e-06,-0.19089,-0.18125,1,0
6,GO IMMUNE EFFECTOR PROCESS,4.1112e-06,-0.19092,-0.22601,1,0
6,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00019079,-0.19093,-0.20353,1,0
6,GO SERTOLI CELL DEVELOPMENT,0.03245,-0.191,-0.18494,1,0
6,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,3.6414e-07,-0.19101,-0.25691,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00069957,-0.19103,-0.29667,1,0
6,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,4.4878e-05,-0.19107,-0.22186,1,0
6,GO REGULATION OF RECEPTOR BINDING,0.017969,-0.19112,-0.23876,1,0
6,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,5.0683e-06,-0.19118,-0.22238,1,0
6,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0036303,-0.19124,-0.2351,1,0
6,GO PIGMENT GRANULE MATURATION,0.0026572,-0.19125,-0.25492,1,0
6,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.4346e-05,-0.19155,-0.19143,1,0
6,GO GLIAL CELL MIGRATION,0.0026572,-0.1916,-0.19609,1,0
6,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,1.6015e-06,-0.1916,-0.20741,1,0
6,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.04854,-0.19161,-0.19097,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00010462,-0.19173,-0.2411,1,0
6,GO ANOIKIS,0.017549,-0.19189,-0.18085,1,0
6,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,9.0551e-05,-0.19191,-0.17878,1,0
6,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,2.5122e-07,-0.19191,-0.20134,1,0
6,GO REGULATION OF VASCULAR PERMEABILITY,0.00016023,-0.19206,-0.22379,1,0
6,GO REGULATION OF RESPIRATORY BURST,0.019283,-0.19207,-0.20114,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0010528,-0.19207,-0.22024,1,0
6,GO ORGANOPHOSPHATE METABOLIC PROCESS,9.7275e-08,-0.1921,-0.18363,1,0
6,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,8.6584e-06,-0.19219,-0.22797,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION,4.1617e-05,-0.1923,-0.24035,1,0
6,GO PROSTANOID METABOLIC PROCESS,0.0025817,-0.19231,-0.29196,1,0
6,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0081404,-0.19241,-0.23362,1,0
6,GO ORGANIC CATION TRANSPORT,0.0018173,-0.19251,-0.19129,1,0
6,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.014486,-0.19263,-0.1756,1,0
6,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.042857,-0.19269,-0.26325,1,0
6,GO LIPID OXIDATION,2.6902e-06,-0.19272,-0.23509,1,0
6,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,6.7728e-06,-0.19275,-0.26108,1,0
6,GO STEROID METABOLIC PROCESS,6.8936e-07,-0.19278,-0.22942,1,0
6,GO REGULATION OF GONAD DEVELOPMENT,0.031059,-0.1928,-0.15973,1,0
6,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00022676,-0.19283,-0.17474,1,0
6,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,4.4712e-06,-0.19286,-0.20523,1,0
6,GO NEGATIVE REGULATION OF CELL ACTIVATION,5.0226e-05,-0.19301,-0.21732,1,0
6,GO AMIDE BIOSYNTHETIC PROCESS,4.1112e-06,-0.19314,-0.20312,1,0
6,GO ENDOCRINE PROCESS,0.00035231,-0.19324,-0.20541,1,0
6,GO B CELL HOMEOSTASIS,0.00017186,-0.19328,-0.21379,1,0
6,GO LYMPHOCYTE CHEMOTAXIS,1.349e-05,-0.19339,-0.21992,1,0
6,GO MEMBRANE DEPOLARIZATION,0.04854,-0.19344,-0.13739,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,5.0194e-07,-0.19346,-0.1872,1,0
6,GO NEUROPEPTIDE SIGNALING PATHWAY,0.049546,-0.19349,-0.12101,1,0
6,GO PSEUDOURIDINE SYNTHESIS,0.0087944,-0.19356,-0.23204,1,0
6,GO NEGATIVE REGULATION OF MAPK CASCADE,6.4994e-06,-0.19366,-0.21175,1,0
6,GO LIPID LOCALIZATION,1.2862e-06,-0.1937,-0.21119,1,0
6,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00063551,-0.19371,-0.22335,1,0
6,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.017549,-0.19381,-0.20914,1,0
6,GO MUSCLE SYSTEM PROCESS,1.2862e-06,-0.19385,-0.1976,1,0
6,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00069957,-0.19396,-0.21257,1,0
6,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0014738,-0.19401,-0.25849,1,0
6,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0028957,-0.19403,-0.19963,1,0
6,GO REGULATION OF BONE MINERALIZATION,0.00032948,-0.19405,-0.22011,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00095906,-0.1942,-0.23865,1,0
6,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.031059,-0.19426,-0.21673,1,0
6,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00019079,-0.1943,-0.15664,1,0
6,GO REGULATION OF VASCULATURE DEVELOPMENT,4.8379e-05,-0.19436,-0.22078,1,0
6,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00010845,-0.19437,-0.27641,1,0
6,GO BONE GROWTH,0.019739,-0.1945,-0.21087,1,0
6,GO ORGANIC ACID BIOSYNTHETIC PROCESS,2.6322e-07,-0.19455,-0.21789,1,0
6,GO AMINE CATABOLIC PROCESS,0.0013872,-0.19457,-0.27791,1,0
6,GO CARBOHYDRATE METABOLIC PROCESS,3.0264e-07,-0.19461,-0.19948,1,0
6,GO REGULATION OF RIBOSOME BIOGENESIS,0.0024367,-0.19479,-0.25559,1,0
6,GO RESPONSE TO ANTIBIOTIC,0.0051916,-0.19481,-0.13689,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,1.349e-05,-0.19481,-0.19933,1,0
6,GO GENITALIA DEVELOPMENT,7.547e-05,-0.19482,-0.19288,1,0
6,GO REGULATION OF NUCLEASE ACTIVITY,0.00011241,-0.19486,-0.22121,1,0
6,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.021165,-0.19493,-0.21663,1,0
6,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,7.547e-05,-0.19494,-0.20735,1,0
6,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00029782,-0.19498,-0.25109,1,0
6,GO ORGANELLE MEMBRANE FUSION,0.00012512,-0.19503,-0.1806,1,0
6,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00014418,-0.19505,-0.26756,1,0
6,GO INFLAMMATORY RESPONSE,5.9841e-06,-0.19513,-0.2167,1,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0011199,-0.19514,-0.27783,1,0
6,GO BLOOD VESSEL MORPHOGENESIS,3.8583e-05,-0.19515,-0.21897,1,0
6,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,3.8583e-05,-0.19545,-0.25377,1,0
6,GO REGULATION OF ENDOCYTOSIS,4.0073e-05,-0.19549,-0.16831,1,0
6,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00023468,-0.19549,-0.41127,1,0
6,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0020453,-0.19551,-0.29683,1,0
6,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,1.4039e-05,-0.19552,-0.21921,1,0
6,GO INTERLEUKIN 1 PRODUCTION,0.00045924,-0.1956,-0.25434,1,0
6,GO NEUTRAL LIPID CATABOLIC PROCESS,0.025414,-0.19576,-0.13493,1,0
6,GO STEROL HOMEOSTASIS,5.0226e-05,-0.19585,-0.23352,1,0
6,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00020448,-0.19589,-0.22084,1,0
6,GO PROSTAGLANDIN TRANSPORT,0.0023671,-0.19593,-0.18534,1,0
6,GO RESPONSE TO CYTOKINE,1.2308e-06,-0.196,-0.2249,1,0
6,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,1.725e-07,-0.19617,-0.21144,1,0
6,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,2.3418e-05,-0.19635,-0.17989,1,0
6,GO PLASMA MEMBRANE TUBULATION,0.001662,-0.19642,-0.20251,1,0
6,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0011549,-0.19652,-0.18563,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00028792,-0.19653,-0.23589,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,3.5759e-05,-0.19666,-0.21267,1,0
6,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,6.5896e-07,-0.1968,-0.24083,1,0
6,GO REGULATION OF MUSCLE CONTRACTION,1.8521e-05,-0.19717,-0.19371,1,0
6,GO RESPONSE TO LIPID,3.0576e-06,-0.19717,-0.19402,1,0
6,GO RESPONSE TO PEPTIDOGLYCAN,0.00040247,-0.1972,-0.22813,1,0
6,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0029794,-0.1972,-0.18344,1,0
6,GO PROTEIN TARGETING,9.8628e-07,-0.19722,-0.21432,1,0
6,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00016023,-0.19729,-0.21235,1,0
6,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0090226,-0.19739,-0.20147,1,0
6,GO B CELL MEDIATED IMMUNITY,0.0014299,-0.19742,-0.19766,1,0
6,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0024367,-0.19746,-0.2157,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.047551,-0.19747,-0.16504,1,0
6,GO THYROID HORMONE METABOLIC PROCESS,0.0094949,-0.19751,-0.13061,1,0
6,GO LONG CHAIN FATTY ACID TRANSPORT,1.4674e-06,-0.19752,-0.21223,1,0
6,GO CHOLESTEROL EFFLUX,2.1663e-05,-0.19766,-0.23291,1,0
6,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.029068,-0.19772,-0.19026,1,0
6,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.017969,-0.19784,-0.23782,1,0
6,GO REGULATION OF CALCIUM ION TRANSPORT,7.9801e-06,-0.19817,-0.19793,1,0
6,GO LAMELLIPODIUM ORGANIZATION,0.00019753,-0.19824,-0.18749,1,0
6,GO REGULATION OF PROTEIN BINDING,5.0683e-06,-0.1984,-0.19584,1,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0045306,-0.19847,-0.21807,1,0
6,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.033894,-0.19859,-0.24987,1,0
6,GO LYTIC VACUOLE ORGANIZATION,9.389e-05,-0.19859,-0.19993,1,0
6,GO MACROPHAGE CHEMOTAXIS,5.2139e-05,-0.19887,-0.25614,1,0
6,GO PEPTIDYL TYROSINE MODIFICATION,0.00027832,-0.19888,-0.17074,1,0
6,GO ORGANIC ACID METABOLIC PROCESS,8.4155e-08,-0.19891,-0.21031,1,0
6,GO AMYLOID FIBRIL FORMATION,0.018398,-0.19902,-0.22884,1,0
6,GO REGULATION OF RECEPTOR RECYCLING,0.0056288,-0.19908,-0.18096,1,0
6,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.017549,-0.19911,-0.16542,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00016023,-0.19916,-0.21913,1,0
6,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0017123,-0.19927,-0.17198,1,0
6,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0097392,-0.19942,-0.2946,1,0
6,GO NEGATIVE REGULATION OF AUTOPHAGY,5.2139e-05,-0.19951,-0.20224,1,0
6,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.6455e-05,-0.19959,-0.25944,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.0032441,-0.1996,-0.19703,1,0
6,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00013917,-0.19964,-0.16529,1,0
6,GO INTERACTION WITH HOST,2.8418e-05,-0.19972,-0.22386,1,0
6,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,8.6584e-06,-0.19972,-0.23619,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0017641,-0.1999,-0.17116,1,0
6,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,1.6452e-07,-0.19999,-0.20944,1,0
6,GO POLYOL BIOSYNTHETIC PROCESS,1.8251e-06,-0.20017,-0.22194,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.012508,-0.20018,-0.19736,1,0
6,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.001986,-0.20021,-0.24861,1,0
6,GO STEROID HORMONE SECRETION,0.0094949,-0.20021,-0.20435,1,0
6,GO GOLGI RIBBON FORMATION,0.0047853,-0.20021,-0.15972,1,0
6,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0069616,-0.20022,-0.22754,1,0
6,GO REGULATION OF LIPID LOCALIZATION,3.0576e-06,-0.20025,-0.22772,1,0
6,GO CYTOKINE METABOLIC PROCESS,1.8521e-05,-0.20028,-0.25228,1,0
6,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,4.0073e-05,-0.20034,-0.20163,1,0
6,GO PROTEIN LOCALIZATION TO CELL SURFACE,3.9418e-06,-0.20055,-0.21173,1,0
6,GO REGULATION OF RUFFLE ASSEMBLY,0.0028141,-0.20075,-0.17015,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.011326,-0.20078,-0.21884,1,0
6,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00017186,-0.20078,-0.20955,1,0
6,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.010773,-0.20086,-0.25223,1,0
6,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0025083,-0.20092,-0.23932,1,0
6,GO SEMI LUNAR VALVE DEVELOPMENT,0.0053338,-0.20097,-0.26655,1,0
6,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00047456,-0.201,-0.19973,1,0
6,GO PIGMENT GRANULE ORGANIZATION,6.7596e-05,-0.2011,-0.22263,1,0
6,GO ACUTE PHASE RESPONSE,0.00018427,-0.20113,-0.23277,1,0
6,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0021689,-0.20119,-0.16605,1,0
6,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.03245,-0.20121,-0.1611,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION,4.8379e-05,-0.20151,-0.22138,1,0
6,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.016339,-0.20154,-0.26254,1,0
6,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00057693,-0.20162,-0.29272,1,0
6,GO SUPEROXIDE METABOLIC PROCESS,0.0027346,-0.20163,-0.17999,1,0
6,GO RESPONSE TO AMPHETAMINE,0.0027346,-0.20164,-0.24627,1,0
6,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,3.5759e-05,-0.20183,-0.19218,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.010245,-0.20186,-0.2406,1,0
6,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0006154,-0.20186,-0.27729,1,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0031536,-0.20194,-0.18676,1,0
6,GO STEROID BIOSYNTHETIC PROCESS,4.1112e-06,-0.202,-0.21296,1,0
6,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0087944,-0.20207,-0.26273,1,0
6,GO DIET INDUCED THERMOGENESIS,0.00063551,-0.20207,-0.2268,1,0
6,GO LEUKOCYTE MEDIATED IMMUNITY,1.1776e-06,-0.20212,-0.24307,1,0
6,GO SMOOTH MUSCLE CELL PROLIFERATION,4.3218e-05,-0.20216,-0.24309,1,0
6,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0049174,-0.20228,-0.17081,1,0
6,GO MYELOID LEUKOCYTE MIGRATION,2.0033e-05,-0.20228,-0.22279,1,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0021689,-0.20231,-0.24287,1,0
6,GO RESPONSE TO INORGANIC SUBSTANCE,1.6015e-06,-0.20235,-0.19346,1,0
6,GO MYOTUBE DIFFERENTIATION,0.00017796,-0.20235,-0.18073,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.547e-05,-0.20236,-0.21606,1,0
6,GO SARCOMERE ORGANIZATION,0.0038387,-0.20239,-0.16035,1,0
6,GO REGULATION OF FIBRINOLYSIS,2.9532e-05,-0.20243,-0.36739,1,0
6,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00037661,-0.20244,-0.17812,1,0
6,GO POSITIVE REGULATION OF OSSIFICATION,0.00034072,-0.20245,-0.22845,1,0
6,GO ADAPTATION OF SIGNALING PATHWAY,0.012203,-0.20245,-0.18903,1,0
6,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.012203,-0.20249,-0.17463,1,0
6,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00014935,-0.20257,-0.2336,1,0
6,GO LEUKOCYTE PROLIFERATION,3.4421e-05,-0.2026,-0.20726,1,0
6,GO CELL SUBSTRATE JUNCTION ORGANIZATION,8.1192e-05,-0.2027,-0.25969,1,0
6,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.017969,-0.20278,-0.30796,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00031859,-0.2028,-0.22231,1,0
6,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00010462,-0.20283,-0.20526,1,0
6,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.011047,-0.20289,-0.18987,1,0
6,GO INTERFERON GAMMA PRODUCTION,7.547e-05,-0.20311,-0.19803,1,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.021165,-0.20313,-0.17278,1,0
6,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0014299,-0.20315,-0.22197,1,0
6,GO ACYLGLYCEROL HOMEOSTASIS,4.6597e-05,-0.2033,-0.24247,1,0
6,GO STORE OPERATED CALCIUM ENTRY,0.0022332,-0.20343,-0.23209,1,0
6,GO IRON SULFUR CLUSTER ASSEMBLY,0.001191,-0.20349,-0.22967,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0033369,-0.20356,-0.26969,1,0
6,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.02268,-0.20376,-0.16948,1,0
6,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00023468,-0.20384,-0.23118,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00079435,-0.20391,-0.19612,1,0
6,GO REGULATION OF MAST CELL ACTIVATION,0.001191,-0.20392,-0.19913,1,0
6,GO ETHER METABOLIC PROCESS,0.0010528,-0.20397,-0.24384,1,0
6,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0029794,-0.20419,-0.17776,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,3.7145e-05,-0.20422,-0.20124,1,0
6,GO BIOMINERALIZATION,0.00012512,-0.20427,-0.2014,1,0
6,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00090094,-0.20444,-0.21022,1,0
6,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00010845,-0.2047,-0.27646,1,0
6,GO AMINO SUGAR METABOLIC PROCESS,0.00013917,-0.20472,-0.21246,1,0
6,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.041967,-0.20502,-0.19759,1,0
6,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.023741,-0.20507,-0.2094,1,0
6,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,3.4728e-06,-0.20515,-0.22474,1,0
6,GO ORGANIC ACID CATABOLIC PROCESS,1.1267e-06,-0.20519,-0.22778,1,0
6,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0017641,-0.20533,-0.28796,1,0
6,GO PEPTIDE METABOLIC PROCESS,1.7474e-06,-0.20536,-0.21015,1,0
6,GO RESPONSE TO CALCIUM ION,8.4205e-05,-0.20537,-0.21276,1,0
6,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,1.1964e-05,-0.20548,-0.20998,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,1.4039e-05,-0.20551,-0.20802,1,0
6,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0010528,-0.20553,-0.22443,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00021909,-0.20553,-0.23496,1,0
6,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,9.0221e-07,-0.20569,-0.19163,1,0
6,GO MEMBRANE INVAGINATION,5.0226e-05,-0.20579,-0.23651,1,0
6,GO MUSCLE CELL DEVELOPMENT,9.7801e-06,-0.20593,-0.20294,1,0
6,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.8583e-05,-0.20593,-0.23329,1,0
6,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0021062,-0.20597,-0.23413,1,0
6,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00012512,-0.20622,-0.25846,1,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,6.4994e-06,-0.20652,-0.21572,1,0
6,GO PROTEIN DEMANNOSYLATION,0.00095906,-0.20692,-0.26046,1,0
6,GO REGULATION OF CHEMOTAXIS,0.00020448,-0.20714,-0.18055,1,0
6,GO ORGANOPHOSPHATE CATABOLIC PROCESS,3.9926e-07,-0.20714,-0.20564,1,0
6,GO TISSUE REGENERATION,0.00022676,-0.20717,-0.24965,1,0
6,GO OSTEOCLAST DEVELOPMENT,0.014841,-0.20723,-0.18127,1,0
6,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0054795,-0.20724,-0.16199,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0059384,-0.20724,-0.32294,1,0
6,GO RESPONSE TO STARVATION,9.0179e-06,-0.20732,-0.1997,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00020448,-0.20736,-0.2453,1,0
6,GO COMPLEMENT ACTIVATION,0.00026903,-0.20738,-0.23019,1,0
6,GO REGULATION OF MAPK CASCADE,5.2837e-06,-0.2074,-0.19827,1,0
6,GO REGULATION OF LIPID STORAGE,5.0226e-05,-0.2074,-0.26043,1,0
6,GO PHOSPHOLIPID CATABOLIC PROCESS,9.0179e-06,-0.20745,-0.26357,1,0
6,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,2.2524e-05,-0.20748,-0.23789,1,0
6,GO TRIGLYCERIDE METABOLIC PROCESS,1.7474e-06,-0.20751,-0.23908,1,0
6,GO STRIATED MUSCLE CONTRACTION,0.00031859,-0.20755,-0.19536,1,0
6,GO BLASTODERM SEGMENTATION,0.020205,-0.20756,-0.24833,1,0
6,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,3.1904e-06,-0.20759,-0.20622,1,0
6,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,1.1237e-07,-0.2076,-0.20181,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00029782,-0.20766,-0.22183,1,0
6,GO RIBOSE PHOSPHATE METABOLIC PROCESS,8.8325e-08,-0.20767,-0.20941,1,0
6,GO PODOSOME ASSEMBLY,0.027188,-0.20768,-0.18726,1,0
6,GO FORMATION OF PRIMARY GERM LAYER,0.00023468,-0.20768,-0.25414,1,0
6,GO CELLULAR AMIDE METABOLIC PROCESS,2.0829e-07,-0.20771,-0.20931,1,0
6,GO GLYCINE METABOLIC PROCESS,0.0027346,-0.2078,-0.31252,1,0
6,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,6.2367e-06,-0.20794,-0.21734,1,0
6,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,1.2366e-07,-0.20805,-0.21354,1,0
6,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,1.8521e-05,-0.20812,-0.22787,1,0
6,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,7.5427e-07,-0.20817,-0.22754,1,0
6,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.001986,-0.20821,-0.30732,1,0
6,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.017969,-0.20829,-0.19596,1,0
6,GO ASYMMETRIC CELL DIVISION,0.0071468,-0.20846,-0.20439,1,0
6,GO FOLIC ACID METABOLIC PROCESS,0.0011199,-0.20854,-0.21961,1,0
6,GO INOSITOL PHOSPHATE METABOLIC PROCESS,3.6228e-06,-0.20858,-0.20396,1,0
6,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,3.7145e-05,-0.2086,-0.2575,1,0
6,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.016339,-0.2086,-0.20371,1,0
6,GO EXCRETION,0.00049035,-0.20861,-0.17624,1,0
6,GO TYPE B PANCREATIC CELL PROLIFERATION,0.012508,-0.20874,-0.32037,1,0
6,GO CYTOKINE MEDIATED SIGNALING PATHWAY,9.0179e-06,-0.20883,-0.24128,1,0
6,GO HORMONE METABOLIC PROCESS,4.4878e-05,-0.20894,-0.21054,1,0
6,GO CELLULAR RESPONSE TO CHEMICAL STRESS,3.1904e-06,-0.20914,-0.21685,1,0
6,GO RESPONSE TO PURINE CONTAINING COMPOUND,5.4977e-07,-0.20919,-0.21728,1,0
6,GO DE NOVO PROTEIN FOLDING,0.00016023,-0.20948,-0.20982,1,0
6,GO REGENERATION,9.0179e-06,-0.20952,-0.22465,1,0
6,GO CARDIAC VENTRICLE MORPHOGENESIS,0.027803,-0.20953,-0.12884,1,0
6,GO BLOOD VESSEL REMODELING,0.0001547,-0.20959,-0.28103,1,0
6,GO MONOSACCHARIDE METABOLIC PROCESS,6.8936e-07,-0.20967,-0.21824,1,0
6,GO SPROUTING ANGIOGENESIS,0.00044439,-0.20985,-0.1986,1,0
6,GO AMYLOID BETA FORMATION,0.0017123,-0.20992,-0.21126,1,0
6,GO AUTOPHAGIC CELL DEATH,0.011904,-0.20993,-0.1701,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,2.7343e-05,-0.21,-0.30945,1,0
6,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.2454e-05,-0.21002,-0.23481,1,0
6,GO LACTATION,0.0001547,-0.21003,-0.22818,1,0
6,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.022165,-0.21006,-0.15555,1,0
6,GO ADAPTIVE IMMUNE RESPONSE,2.8418e-05,-0.21008,-0.2394,1,0
6,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.5774e-06,-0.21008,-0.21782,1,0
6,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00025131,-0.21027,-0.2289,1,0
6,GO NEGATIVE CHEMOTAXIS,0.001872,-0.21028,-0.25014,1,0
6,GO PLATELET MORPHOGENESIS,0.00016023,-0.21037,-0.20335,1,0
6,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0066042,-0.21047,-0.26084,1,0
6,GO MAINTENANCE OF LOCATION,1.1267e-06,-0.21056,-0.20139,1,0
6,GO MYELOID LEUKOCYTE ACTIVATION,3.8131e-07,-0.21068,-0.25881,1,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00092958,-0.21071,-0.19292,1,0
6,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0060989,-0.21076,-0.19128,1,0
6,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.00030804,-0.2108,-0.20917,1,0
6,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.023205,-0.21085,-0.21994,1,0
6,GO MACROPHAGE ACTIVATION,1.2962e-05,-0.21085,-0.22557,1,0
6,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,2.0033e-05,-0.21089,-0.28889,1,0
6,GO ALCOHOL METABOLIC PROCESS,1.6452e-07,-0.21094,-0.23411,1,0
6,GO CELL CELL RECOGNITION,4.8612e-06,-0.21096,-0.25592,1,0
6,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00081984,-0.21102,-0.21528,1,0
6,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00054072,-0.21106,-0.21424,1,0
6,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,2.9532e-05,-0.21119,-0.21276,1,0
6,GO PROTEIN AUTOPROCESSING,0.0001547,-0.21125,-0.25362,1,0
6,GO RESPONSE TO WOUNDING,5.4121e-05,-0.21129,-0.21299,1,0
6,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,5.4121e-05,-0.21135,-0.31967,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.1964e-05,-0.21137,-0.21296,1,0
6,GO DETOXIFICATION,2.9301e-06,-0.2114,-0.27214,1,0
6,GO SPHINGOID METABOLIC PROCESS,7.8282e-05,-0.21147,-0.27148,1,0
6,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00037661,-0.21151,-0.23986,1,0
6,GO LEUKOCYTE MEDIATED CYTOTOXICITY,3.8583e-05,-0.21154,-0.25479,1,0
6,GO FEVER GENERATION,0.0090226,-0.21154,-0.19204,1,0
6,GO CERAMIDE TRANSPORT,0.0026572,-0.21163,-0.22696,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0010206,-0.2119,-0.19878,1,0
6,GO IRON ION HOMEOSTASIS,8.3127e-06,-0.212,-0.22203,1,0
6,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00067758,-0.21202,-0.22357,1,0
6,GO MYOFIBRIL ASSEMBLY,0.00044439,-0.21212,-0.17416,1,0
6,GO RESPONSE TO PH,0.00013433,-0.21224,-0.24984,1,0
6,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00047456,-0.21231,-0.21444,1,0
6,GO RESPONSE TO COLD,0.00012512,-0.21243,-0.29397,1,0
6,GO EXOCRINE SYSTEM DEVELOPMENT,0.00353,-0.21252,-0.24251,1,0
6,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.001662,-0.21259,-0.15025,1,0
6,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.0689e-05,-0.21263,-0.24258,1,0
6,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00011241,-0.21263,-0.22364,1,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0025083,-0.21269,-0.2245,1,0
6,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0019282,-0.2129,-0.2935,1,0
6,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.025994,-0.21301,-0.16332,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0014738,-0.21312,-0.21058,1,0
6,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0016129,-0.21322,-0.27347,1,0
6,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.00054072,-0.21327,-0.35119,1,0
6,GO AEROBIC RESPIRATION,2.7343e-05,-0.21336,-0.24275,1,0
6,GO CELLULAR AMINO ACID METABOLIC PROCESS,8.3127e-06,-0.2134,-0.20137,1,0
6,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00032948,-0.21348,-0.36624,1,0
6,GO DENDRITIC CELL DIFFERENTIATION,0.0025817,-0.21357,-0.28145,1,0
6,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0022992,-0.2136,-0.21286,1,0
6,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00020448,-0.21367,-0.24631,1,0
6,GO LIPID CATABOLIC PROCESS,5.2533e-07,-0.21369,-0.22055,1,0
6,GO LEUKOCYTE MIGRATION,2.0033e-05,-0.2137,-0.21302,1,0
6,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0026572,-0.21407,-0.24182,1,0
6,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,6.0504e-05,-0.2141,-0.25747,1,0
6,GO PYRUVATE METABOLIC PROCESS,5.0194e-07,-0.21421,-0.22572,1,0
6,GO RESPONSE TO METAL ION,1.1964e-05,-0.21426,-0.19143,1,0
6,GO T CELL APOPTOTIC PROCESS,0.00018427,-0.21431,-0.22187,1,0
6,GO GLYCEROL ETHER METABOLIC PROCESS,0.00036427,-0.21438,-0.25009,1,0
6,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,4.8379e-05,-0.2144,-0.18937,1,0
6,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,5.4977e-07,-0.21487,-0.26766,1,0
6,GO TRANSITION METAL ION HOMEOSTASIS,1.2308e-06,-0.21503,-0.23488,1,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,3.5759e-05,-0.21506,-0.22214,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00034072,-0.2151,-0.24265,1,0
6,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0053338,-0.21523,-0.30474,1,0
6,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.019739,-0.21535,-0.23675,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0007696,-0.21537,-0.21685,1,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00012074,-0.21539,-0.19261,1,0
6,GO CHEMOSENSORY BEHAVIOR,0.00012512,-0.21539,-0.24008,1,0
6,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00012512,-0.21546,-0.25269,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00052342,-0.21546,-0.22101,1,0
6,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0006154,-0.21547,-0.1854,1,0
6,GO IMPORT ACROSS PLASMA MEMBRANE,3.4421e-05,-0.21558,-0.19894,1,0
6,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00090094,-0.21571,-0.1756,1,0
6,GO RESPONSE TO MUSCLE ACTIVITY,0.001986,-0.21574,-0.25344,1,0
6,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,4.3218e-05,-0.21593,-0.24307,1,0
6,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.6623e-06,-0.216,-0.24876,1,0
6,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0053338,-0.21617,-0.19704,1,0
6,GO REGULATION OF CARDIAC CONDUCTION,0.00054072,-0.2162,-0.20194,1,0
6,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,8.1192e-05,-0.21621,-0.21574,1,0
6,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0067808,-0.21631,-0.22139,1,0
6,GO DICARBOXYLIC ACID METABOLIC PROCESS,1.349e-05,-0.21643,-0.22412,1,0
6,GO REGULATION OF ACROSOME REACTION,0.014138,-0.21662,-0.23392,1,0
6,GO SIGNAL PEPTIDE PROCESSING,0.029068,-0.217,-0.1798,1,0
6,GO CELLULAR HORMONE METABOLIC PROCESS,5.0226e-05,-0.21711,-0.25074,1,0
6,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0030654,-0.21714,-0.19788,1,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,4.8612e-06,-0.21719,-0.23632,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00074557,-0.21728,-0.22465,1,0
6,GO CELLULAR RESPONSE TO IRON ION,0.0085714,-0.21729,-0.22393,1,0
6,GO ICOSANOID METABOLIC PROCESS,0.00098941,-0.21742,-0.22117,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0006154,-0.21743,-0.37063,1,0
6,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.020205,-0.21762,-0.19074,1,0
6,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,5.6174e-05,-0.21772,-0.22057,1,0
6,GO RESPONSE TO TESTOSTERONE,0.001872,-0.21785,-0.21133,1,0
6,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00013433,-0.2179,-0.21241,1,0
6,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,1.8958e-07,-0.2179,-0.24121,1,0
6,GO NUCLEOTIDE PHOSPHORYLATION,1.1776e-06,-0.21803,-0.22371,1,0
6,GO ENERGY RESERVE METABOLIC PROCESS,0.0001165,-0.21812,-0.2036,1,0
6,GO REGULATION OF BONE DEVELOPMENT,0.00074557,-0.21823,-0.21137,1,0
6,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.031748,-0.21827,-0.22626,1,0
6,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0085714,-0.21827,-0.26087,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00087311,-0.21832,-0.2333,1,0
6,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.00081984,-0.21832,-0.24148,1,0
6,GO HYPOTONIC RESPONSE,0.0011199,-0.21836,-0.26323,1,0
6,GO CARDIAC MUSCLE CONTRACTION,0.00040247,-0.2184,-0.1977,1,0
6,GO MYELOID CELL APOPTOTIC PROCESS,0.00027832,-0.21852,-0.28524,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.023741,-0.21855,-0.26079,1,0
6,GO SMALL MOLECULE CATABOLIC PROCESS,1.3605e-07,-0.21865,-0.22465,1,0
6,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,8.3127e-06,-0.21872,-0.23183,1,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,4.6623e-06,-0.21881,-0.26506,1,0
6,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00013917,-0.21886,-0.29101,1,0
6,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00027832,-0.21887,-0.22326,1,0
6,GO PULMONARY VALVE DEVELOPMENT,0.0013054,-0.21893,-0.37371,1,0
6,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0018173,-0.2192,-0.2297,1,0
6,GO BONE REMODELING,0.00055855,-0.21924,-0.2288,1,0
6,GO POSITIVE REGULATION OF MAPK CASCADE,3.9418e-06,-0.21926,-0.20559,1,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.018398,-0.21944,-0.20241,1,0
6,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.010773,-0.21948,-0.18096,1,0
6,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00049035,-0.21965,-0.23248,1,0
6,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,1.2862e-06,-0.21987,-0.25206,1,0
6,GO RADIAL GLIAL CELL DIFFERENTIATION,0.031059,-0.22011,-0.23365,1,0
6,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00037661,-0.22016,-0.24545,1,0
6,GO EPITHELIAL CELL APOPTOTIC PROCESS,3.3132e-05,-0.22025,-0.2513,1,0
6,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.031059,-0.22027,-0.16139,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00050664,-0.22028,-0.21546,1,0
6,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,2.6307e-05,-0.22044,-0.27001,1,0
6,GO REGULATION OF AMYLOID BETA CLEARANCE,0.004408,-0.22048,-0.27108,1,0
6,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0021062,-0.22048,-0.27286,1,0
6,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.00034072,-0.22057,-0.26968,1,0
6,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,5.4121e-05,-0.22062,-0.23813,1,0
6,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.9263e-05,-0.22065,-0.23699,1,0
6,GO CELL CHEMOTAXIS,3.1888e-05,-0.22079,-0.22342,1,0
6,GO SPERM EGG RECOGNITION,1.9263e-05,-0.22088,-0.24193,1,0
6,GO BONE TRABECULA FORMATION,0.041093,-0.22091,-0.3406,1,0
6,GO OXIDATION REDUCTION PROCESS,5.986e-08,-0.22096,-0.23031,1,0
6,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,7.013e-05,-0.22096,-0.20568,1,0
6,GO NEGATIVE REGULATION OF GENE SILENCING,0.0010859,-0.22103,-0.20676,1,0
6,GO CELLULAR RESPONSE TO DRUG,2.8077e-06,-0.22116,-0.22015,1,0
6,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,5.8301e-05,-0.22116,-0.22971,1,0
6,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,3.6414e-07,-0.22158,-0.23929,1,0
6,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0015189,-0.22168,-0.23422,1,0
6,GO WOUND HEALING,2.8418e-05,-0.22183,-0.23188,1,0
6,GO ACTION POTENTIAL,0.0075304,-0.22184,-0.1559,1,0
6,GO RESPONSE TO INTERLEUKIN 7,0.00013917,-0.2219,-0.20518,1,0
6,GO FATTY ACID BIOSYNTHETIC PROCESS,3.4772e-07,-0.22199,-0.27176,1,0
6,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00052342,-0.22206,-0.19569,1,0
6,GO REGULATION OF MACROPHAGE ACTIVATION,4.1112e-06,-0.22208,-0.24605,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0016129,-0.22214,-0.24328,1,0
6,GO CELLULAR RESPONSE TO STEROL,0.0022332,-0.22238,-0.21719,1,0
6,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,7.2111e-07,-0.22253,-0.23968,1,0
6,GO MYELIN MAINTENANCE,0.0020453,-0.22259,-0.32615,1,0
6,GO PHAGOCYTOSIS,2.0784e-06,-0.22281,-0.24854,1,0
6,GO STEROL METABOLIC PROCESS,4.1112e-06,-0.22309,-0.21982,1,0
6,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,3.3287e-06,-0.22314,-0.20881,1,0
6,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0067808,-0.22314,-0.26621,1,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0025083,-0.22321,-0.19793,1,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0021062,-0.22333,-0.21797,1,0
6,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0036303,-0.22351,-0.2809,1,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,4.6597e-05,-0.22362,-0.26244,1,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,2.5308e-05,-0.22362,-0.24273,1,0
6,GO AMYLOID BETA METABOLIC PROCESS,0.0021689,-0.22366,-0.19709,1,0
6,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.0021689,-0.22375,-0.22748,1,0
6,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0011199,-0.22377,-0.18665,1,0
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0094949,-0.22378,-0.33609,1,0
6,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.011904,-0.22396,-0.27421,1,0
6,GO POSITIVE CHEMOTAXIS,0.00017186,-0.224,-0.2309,1,0
6,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.04854,-0.22411,-0.2009,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.014841,-0.2242,-0.33032,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00037661,-0.2242,-0.23244,1,0
6,GO ERK1 AND ERK2 CASCADE,1.349e-05,-0.22423,-0.22968,1,0
6,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00092958,-0.22447,-0.22569,1,0
6,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.00023468,-0.22467,-0.2486,1,0
6,GO MOVEMENT IN HOST ENVIRONMENT,1.4609e-05,-0.2247,-0.26486,1,0
6,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00022676,-0.2247,-0.20503,1,0
6,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0014738,-0.22472,-0.26413,1,0
6,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.019739,-0.22473,-0.24003,1,0
6,GO RESPONSE TO BACTERIUM,5.2533e-07,-0.22479,-0.23845,1,0
6,GO POSITIVE REGULATION OF JNK CASCADE,7.9801e-06,-0.22512,-0.19738,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,7.0571e-06,-0.22523,-0.24898,1,0
6,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0033369,-0.22528,-0.25399,1,0
6,GO SKELETAL MUSCLE CONTRACTION,0.00074557,-0.22528,-0.22151,1,0
6,GO RESPONSE TO DRUG,1.5331e-06,-0.22532,-0.23312,1,0
6,GO NEGATIVE REGULATION OF PROTEIN BINDING,2.3418e-05,-0.22544,-0.19965,1,0
6,GO MITOCHONDRIAL GENE EXPRESSION,0.00084609,-0.2255,-0.21641,1,0
6,GO SCHWANN CELL DIFFERENTIATION,0.00024286,-0.2255,-0.18826,1,0
6,GO FATTY ACID METABOLIC PROCESS,2.1831e-07,-0.22556,-0.24358,1,0
6,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0010859,-0.22563,-0.30051,1,0
6,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00050664,-0.22567,-0.20113,1,0
6,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,8.1192e-05,-0.22568,-0.30387,1,0
6,GO REGULATION OF MAP KINASE ACTIVITY,3.3287e-06,-0.22574,-0.20071,1,0
6,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0011199,-0.22589,-0.20677,1,0
6,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00013917,-0.22599,-0.25991,1,0
6,GO REGULATION OF T CELL CHEMOTAXIS,0.00021909,-0.226,-0.21488,1,0
6,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.02268,-0.22606,-0.21323,1,0
6,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00014935,-0.22616,-0.31972,1,0
6,GO RESPONSE TO REDOX STATE,0.001986,-0.22628,-0.22358,1,0
6,GO RESPONSE TO CADMIUM ION,0.001228,-0.22628,-0.26537,1,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,4.4878e-05,-0.22656,-0.23286,1,0
6,GO T CELL CYTOKINE PRODUCTION,0.00012512,-0.22669,-0.23778,1,0
6,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0015653,-0.22671,-0.22145,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0059384,-0.22671,-0.31654,1,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.0046564,-0.22674,-0.26143,1,0
6,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00021167,-0.22679,-0.20758,1,0
6,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,1.1267e-06,-0.2275,-0.23178,1,0
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00092958,-0.2275,-0.33619,1,0
6,GO INTERLEUKIN 8 PRODUCTION,2.7343e-05,-0.22755,-0.2666,1,0
6,GO SULFUR COMPOUND METABOLIC PROCESS,7.6379e-08,-0.22765,-0.24925,1,0
6,GO REGULATION OF PLATELET ACTIVATION,0.0012662,-0.22776,-0.29172,1,0
6,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,6.4994e-06,-0.22783,-0.24167,1,0
6,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00074557,-0.22789,-0.22577,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.011904,-0.22809,-0.21152,1,0
6,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00055855,-0.22818,-0.20102,1,0
6,GO COLLAGEN CATABOLIC PROCESS,0.00021167,-0.22873,-0.27584,1,0
6,GO REGULATION OF BONE REMODELING,0.0034322,-0.22882,-0.21492,1,0
6,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0010206,-0.2291,-0.21182,1,0
6,GO CELL JUNCTION DISASSEMBLY,0.0013872,-0.22917,-0.22371,1,0
6,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,3.6414e-07,-0.2292,-0.25179,1,0
6,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.046579,-0.22935,-0.19947,1,0
6,GO PENTOSE METABOLIC PROCESS,0.00014418,-0.22937,-0.32017,1,0
6,GO FOAM CELL DIFFERENTIATION,0.00012964,-0.22955,-0.27237,1,0
6,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0001547,-0.22974,-0.24152,1,0
6,GO POSITIVE REGULATION OF LIPID LOCALIZATION,5.7413e-06,-0.22987,-0.24468,1,0
6,GO BROWN FAT CELL DIFFERENTIATION,0.00038934,-0.22991,-0.2287,1,0
6,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00012964,-0.22994,-0.23972,1,0
6,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00069957,-0.22996,-0.24607,1,0
6,GO RECEPTOR MEDIATED ENDOCYTOSIS,2.2524e-05,-0.23017,-0.18124,1,0
6,GO GLAND MORPHOGENESIS,0.0016129,-0.23026,-0.24448,1,0
6,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.4994e-06,-0.23026,-0.28478,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00059588,-0.23046,-0.36636,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.00017796,-0.23051,-0.29066,1,0
6,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.0604e-05,-0.23067,-0.22102,1,0
6,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00016023,-0.23068,-0.21977,1,0
6,GO AORTIC VALVE DEVELOPMENT,0.0066042,-0.23084,-0.26233,1,0
6,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,7.9801e-06,-0.23085,-0.27154,1,0
6,GO AMEBOIDAL TYPE CELL MIGRATION,1.9263e-05,-0.23091,-0.23389,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00027832,-0.23093,-0.25907,1,0
6,GO MODULATION BY HOST OF VIRAL PROCESS,1.104e-05,-0.23111,-0.2724,1,0
6,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0051916,-0.23112,-0.40534,1,0
6,GO REGULATION OF KERATINOCYTE MIGRATION,0.001986,-0.23119,-0.20689,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,7.8282e-05,-0.23128,-0.22686,1,0
6,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00044439,-0.23128,-0.25211,1,0
6,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.00023468,-0.23153,-0.31436,1,0
6,GO LIPID STORAGE,0.00013433,-0.23157,-0.24077,1,0
6,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,2.3654e-06,-0.23165,-0.24921,1,0
6,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00026003,-0.23168,-0.20664,1,0
6,GO OSTEOBLAST PROLIFERATION,0.0027346,-0.23197,-0.26451,1,0
6,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00012074,-0.23199,-0.27161,1,0
6,GO MUSCLE HYPERTROPHY,0.00013917,-0.23201,-0.2096,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0090226,-0.23205,-0.20697,1,0
6,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,6.2367e-06,-0.23212,-0.20464,1,0
6,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,5.2139e-05,-0.23214,-0.20896,1,0
6,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00065623,-0.23219,-0.21489,1,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0010528,-0.23227,-0.28547,1,0
6,GO CELLULAR OXIDANT DETOXIFICATION,7.2754e-05,-0.23239,-0.21853,1,0
6,GO POSITIVE REGULATION OF MACROAUTOPHAGY,2.9301e-06,-0.23241,-0.21114,1,0
6,GO VITAMIN TRANSPORT,0.00013433,-0.23241,-0.24347,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00095906,-0.23243,-0.21874,1,0
6,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00014418,-0.23244,-0.2386,1,0
6,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.0013457,-0.23259,-0.25564,1,0
6,GO MAINTENANCE OF LOCATION IN CELL,2.8077e-06,-0.23282,-0.20846,1,0
6,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00022676,-0.23287,-0.26386,1,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0019282,-0.23302,-0.31196,1,0
6,GO EXPORT ACROSS PLASMA MEMBRANE,0.0051916,-0.23307,-0.18623,1,0
6,GO PROTEIN TARGETING TO MEMBRANE,0.00017796,-0.23324,-0.24987,1,0
6,GO RESPONSE TO ACIDIC PH,0.00010092,-0.23333,-0.33451,1,0
6,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.00069957,-0.23333,-0.20654,1,0
6,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00036427,-0.23362,-0.20949,1,0
6,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.011612,-0.23368,-0.17876,1,0
6,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,7.5427e-07,-0.23369,-0.258,1,0
6,GO CAMP METABOLIC PROCESS,0.0016129,-0.23389,-0.22963,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,6.2786e-05,-0.23397,-0.25493,1,0
6,GO MATURATION OF SSU RRNA,0.0016129,-0.23397,-0.26963,1,0
6,GO PRIMARY ALCOHOL METABOLIC PROCESS,1.1493e-05,-0.23413,-0.28826,1,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0047853,-0.2343,-0.19785,1,0
6,GO RESPONSE TO INTERLEUKIN 12,3.3132e-05,-0.23432,-0.2876,1,0
6,GO AMINOGLYCAN METABOLIC PROCESS,6.2786e-05,-0.23445,-0.23046,1,0
6,GO POLYOL METABOLIC PROCESS,3.0264e-07,-0.23451,-0.23084,1,0
6,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,6.2985e-07,-0.23457,-0.27832,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.00037661,-0.23464,-0.22439,1,0
6,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00041602,-0.23485,-0.24683,1,0
6,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,4.3763e-07,-0.23497,-0.23795,1,0
6,GO ACTIN FILAMENT BASED MOVEMENT,2.2524e-05,-0.23497,-0.23735,1,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00026003,-0.2352,-0.28686,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00020448,-0.23531,-0.21878,1,0
6,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0056288,-0.23531,-0.21779,1,0
6,GO REGULATION OF STEROID METABOLIC PROCESS,2.0784e-06,-0.23551,-0.28024,1,0
6,GO XENOBIOTIC TRANSPORT,4.1617e-05,-0.23568,-0.2597,1,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.0184e-05,-0.23569,-0.25748,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0013457,-0.23574,-0.28004,1,0
6,GO T CELL MIGRATION,6.7596e-05,-0.23581,-0.24818,1,0
6,GO MUSCLE CELL APOPTOTIC PROCESS,9.7801e-06,-0.23596,-0.23371,1,0
6,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,3.6228e-06,-0.23609,-0.28745,1,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00012964,-0.23612,-0.30455,1,0
6,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00024286,-0.23613,-0.2361,1,0
6,GO PIGMENT BIOSYNTHETIC PROCESS,8.1192e-05,-0.23635,-0.23306,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0007696,-0.23642,-0.33958,1,0
6,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0019282,-0.23648,-0.21887,1,0
6,GO REGULATION OF LIPID CATABOLIC PROCESS,1.2454e-05,-0.23654,-0.21419,1,0
6,GO RESPONSE TO CORTICOSTEROID,7.2111e-07,-0.2366,-0.28927,1,0
6,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,7.547e-05,-0.23678,-0.25995,1,0
6,GO FEMALE GENITALIA DEVELOPMENT,0.0015189,-0.23685,-0.22223,1,0
6,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0021062,-0.237,-0.3065,1,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.7596e-05,-0.23709,-0.30427,1,0
6,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0013054,-0.2371,-0.24783,1,0
6,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.00016023,-0.23715,-0.31113,1,0
6,GO GAP JUNCTION ASSEMBLY,0.019739,-0.2372,-0.24634,1,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00045924,-0.23732,-0.2515,1,0
6,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00045924,-0.23744,-0.20535,1,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0021062,-0.23767,-0.19978,1,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.6584e-06,-0.23776,-0.31125,1,0
6,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00050664,-0.23786,-0.24881,1,0
6,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0006154,-0.23801,-0.30367,1,0
6,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0064317,-0.23833,-0.23304,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00036427,-0.23835,-0.23391,1,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.04854,-0.23838,-0.20389,1,0
6,GO SYNCYTIUM FORMATION,9.3916e-06,-0.23847,-0.28202,1,0
6,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,6.0198e-07,-0.23854,-0.26966,1,0
6,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00072223,-0.23854,-0.2154,1,0
6,GO TROPHOBLAST CELL MIGRATION,0.00052342,-0.23861,-0.37673,1,0
6,GO INTRACELLULAR LIPID TRANSPORT,0.00010462,-0.2387,-0.23015,1,0
6,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.019283,-0.23881,-0.1922,1,0
6,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.001191,-0.23884,-0.21899,1,0
6,GO ENTRY INTO HOST,3.1904e-06,-0.23888,-0.3189,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00024286,-0.23903,-0.25787,1,0
6,GO ENTRY OF BACTERIUM INTO HOST CELL,0.015203,-0.23906,-0.3113,1,0
6,GO POSITIVE REGULATION OF ENDOCYTOSIS,3.1888e-05,-0.23911,-0.22621,1,0
6,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00074557,-0.23914,-0.21792,1,0
6,GO PHAGOCYTOSIS RECOGNITION,0.007729,-0.23927,-0.26762,1,0
6,GO CARDIAC CELL DEVELOPMENT,7.0571e-06,-0.23939,-0.23739,1,0
6,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.6174e-05,-0.23941,-0.28082,1,0
6,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.00047456,-0.23961,-0.23185,1,0
6,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.00010845,-0.23964,-0.30858,1,0
6,GO DIOL METABOLIC PROCESS,0.00012512,-0.24003,-0.2575,1,0
6,GO TETRAPYRROLE METABOLIC PROCESS,5.9841e-06,-0.24017,-0.27241,1,0
6,GO REGULATION OF LEUKOCYTE MIGRATION,1.9263e-05,-0.24026,-0.22013,1,0
6,GO RESPONSE TO DEXAMETHASONE,4.0073e-05,-0.24043,-0.30084,1,0
6,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.00042998,-0.24077,-0.24335,1,0
6,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00074557,-0.24084,-0.27018,1,0
6,GO REGULATION OF AUTOPHAGOSOME MATURATION,1.4609e-05,-0.24099,-0.29542,1,0
6,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,3.1888e-05,-0.24103,-0.25852,1,0
6,GO URETER DEVELOPMENT,0.0020453,-0.24113,-0.25319,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00016023,-0.24127,-0.27436,1,0
6,GO SERTOLI CELL DIFFERENTIATION,0.0071468,-0.24127,-0.21188,1,0
6,GO CYTOPLASMIC TRANSLATION,0.0015189,-0.24157,-0.30013,1,0
6,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,9.8628e-07,-0.24167,-0.25628,1,0
6,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0014299,-0.24184,-0.22612,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.6455e-05,-0.2419,-0.25011,1,0
6,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00038934,-0.24195,-0.23473,1,0
6,GO COCHLEA MORPHOGENESIS,0.0053338,-0.24206,-0.22396,1,0
6,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.019739,-0.24212,-0.21531,1,0
6,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00011241,-0.24228,-0.21499,1,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.01282,-0.24235,-0.2092,1,0
6,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.906e-06,-0.24236,-0.2634,1,0
6,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00014418,-0.24239,-0.30954,1,0
6,GO CHOLESTEROL STORAGE,0.00063551,-0.24239,-0.26225,1,0
6,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00026903,-0.24276,-0.29392,1,0
6,GO CELLULAR LIPID CATABOLIC PROCESS,5.753e-07,-0.24328,-0.23732,1,0
6,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.001191,-0.2433,-0.27467,1,0
6,GO STEROL TRANSPORT,2.6902e-06,-0.2437,-0.26333,1,0
6,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0006154,-0.24378,-0.23595,1,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.010245,-0.2438,-0.24473,1,0
6,GO PEPTIDE CATABOLIC PROCESS,6.7596e-05,-0.24396,-0.25063,1,0
6,GO REGULATION OF FATTY ACID METABOLIC PROCESS,4.8379e-05,-0.24408,-0.21599,1,0
6,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.1493e-05,-0.24413,-0.30198,1,0
6,GO ENDOTHELIAL CELL PROLIFERATION,2.1663e-05,-0.24419,-0.24246,1,0
6,GO LENS FIBER CELL DEVELOPMENT,0.00057693,-0.24423,-0.32846,1,0
6,GO RESPONSE TO FLUID SHEAR STRESS,0.00050664,-0.24435,-0.25493,1,0
6,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.001191,-0.24437,-0.22549,1,0
6,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0056288,-0.24451,-0.2453,1,0
6,GO MULTI ORGANISM CELLULAR PROCESS,0.0021689,-0.24457,-0.31168,1,0
6,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0037331,-0.2447,-0.24077,1,0
6,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0001547,-0.24473,-0.23938,1,0
6,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,2.3418e-05,-0.24477,-0.25243,1,0
6,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0037331,-0.24489,-0.23305,1,0
6,GO PEROXISOME ORGANIZATION,2.8891e-07,-0.24494,-0.28441,1,0
6,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,8.7323e-05,-0.24505,-0.21088,1,0
6,GO REGULATION OF KIDNEY DEVELOPMENT,7.013e-05,-0.24519,-0.24616,1,0
6,GO DIOL BIOSYNTHETIC PROCESS,0.0011549,-0.24522,-0.22014,1,0
6,GO T HELPER 1 CELL DIFFERENTIATION,0.0025817,-0.24545,-0.34504,1,0
6,GO RESPONSE TO INTERFERON ALPHA,0.024288,-0.24566,-0.39887,1,0
6,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00081984,-0.24568,-0.29078,1,0
6,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.023205,-0.24583,-0.23083,1,0
6,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00019079,-0.24586,-0.26678,1,0
6,GO ANION HOMEOSTASIS,0.001191,-0.24591,-0.20321,1,0
6,GO LYMPHOCYTE APOPTOTIC PROCESS,3.7145e-05,-0.24601,-0.22219,1,0
6,GO ENDODERM FORMATION,0.00050664,-0.24605,-0.31412,1,0
6,GO DRUG METABOLIC PROCESS,5.2837e-06,-0.24617,-0.31055,1,0
6,GO MALE GENITALIA DEVELOPMENT,0.0011549,-0.24621,-0.24022,1,0
6,GO POSITIVE REGULATION OF T CELL MIGRATION,2.1663e-05,-0.24636,-0.24584,1,0
6,GO LIVER MORPHOGENESIS,0.0099891,-0.24646,-0.25012,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0039469,-0.24651,-0.19135,1,0
6,GO PLATELET AGGREGATION,0.00017186,-0.24659,-0.26884,1,0
6,GO MITOCHONDRIAL DEPOLARIZATION,0.0021689,-0.24665,-0.25651,1,0
6,GO ESTROGEN METABOLIC PROCESS,4.8379e-05,-0.24688,-0.25408,1,0
6,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.00019753,-0.24689,-0.26772,1,0
6,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0027346,-0.24705,-0.23422,1,0
6,GO VITAMIN D METABOLIC PROCESS,0.0033369,-0.24731,-0.24333,1,0
6,GO POSITIVE REGULATION OF AUTOPHAGY,1.7474e-06,-0.24745,-0.2329,1,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0013457,-0.24767,-0.24736,1,0
6,GO CELL MATRIX ADHESION,1.349e-05,-0.2477,-0.27113,1,0
6,GO SEQUESTERING OF CALCIUM ION,1.1493e-05,-0.24804,-0.23418,1,0
6,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,6.5149e-05,-0.24808,-0.28995,1,0
6,GO EXTRACELLULAR STRUCTURE ORGANIZATION,7.9801e-06,-0.24893,-0.29108,1,0
6,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0025083,-0.24904,-0.30515,1,0
6,GO REGULATION OF HEART RATE,0.001228,-0.24923,-0.21855,1,0
6,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00049035,-0.24926,-0.35402,1,0
6,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,4.1617e-05,-0.24926,-0.31727,1,0
6,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.104e-05,-0.24938,-0.28967,1,0
6,GO RESPONSE TO XENOBIOTIC STIMULUS,1.8521e-05,-0.24952,-0.25769,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,6.7596e-05,-0.24959,-0.27372,1,0
6,GO BODY FLUID SECRETION,7.2111e-07,-0.24967,-0.25394,1,0
6,GO PLASMA MEMBRANE ORGANIZATION,1.6455e-05,-0.25082,-0.24262,1,0
6,GO PROSTAGLANDIN SECRETION,0.00010092,-0.25088,-0.25967,1,0
6,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00026903,-0.25116,-0.23491,1,0
6,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00019079,-0.25128,-0.24541,1,0
6,GO HAIR FOLLICLE MATURATION,0.00079435,-0.25132,-0.30425,1,0
6,GO SCHWANN CELL DEVELOPMENT,2.0833e-05,-0.2514,-0.22677,1,0
6,GO REGULATION OF FATTY ACID OXIDATION,0.00024286,-0.25145,-0.24424,1,0
6,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00052342,-0.25168,-0.24936,1,0
6,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0029794,-0.25182,-0.33276,1,0
6,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0029794,-0.25207,-0.28545,1,0
6,GO LEUKOCYTE APOPTOTIC PROCESS,2.9532e-05,-0.2523,-0.24637,1,0
6,GO BLOOD COAGULATION INTRINSIC PATHWAY,3.4728e-06,-0.25248,-0.28557,1,0
6,GO RESPONSE TO DIETARY EXCESS,0.011047,-0.25281,-0.2351,1,0
6,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,2.6902e-06,-0.25288,-0.2718,1,0
6,GO RESPONSE TO PROTOZOAN,7.8282e-05,-0.25306,-0.26324,1,0
6,GO HISTONE SERINE PHOSPHORYLATION,1.104e-05,-0.25309,-0.31827,1,0
6,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,2.4346e-05,-0.25328,-0.3058,1,0
6,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00010092,-0.25355,-0.29972,1,0
6,GO LENS FIBER CELL DIFFERENTIATION,0.0019282,-0.25363,-0.22292,1,0
6,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00021167,-0.25366,-0.25916,1,0
6,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.02268,-0.25371,-0.31108,1,0
6,GO THIOESTER METABOLIC PROCESS,4.1802e-07,-0.25384,-0.26598,1,0
6,GO MATURATION OF LSU RRNA,0.009256,-0.25387,-0.26194,1,0
6,GO CELL SUBSTRATE ADHESION,1.2454e-05,-0.25397,-0.26771,1,0
6,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.013465,-0.25405,-0.26549,1,0
6,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0025817,-0.25412,-0.38255,1,0
6,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00065623,-0.25412,-0.28342,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.00084609,-0.2542,-0.2484,1,0
6,GO MUSCLE ATROPHY,0.029068,-0.25429,-0.18437,1,0
6,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,7.547e-05,-0.25432,-0.29278,1,0
6,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00098941,-0.25465,-0.241,1,0
6,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.011047,-0.25469,-0.27377,1,0
6,GO GLYCEROLIPID CATABOLIC PROCESS,0.00013917,-0.25477,-0.2094,1,0
6,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.011904,-0.25485,-0.20346,1,0
6,GO BICARBONATE TRANSPORT,1.0604e-05,-0.25489,-0.26101,1,0
6,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.001872,-0.25495,-0.39323,1,0
6,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00014935,-0.25514,-0.24795,1,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,7.8282e-05,-0.25531,-0.25123,1,0
6,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.027803,-0.25571,-0.27689,1,0
6,GO REGULATION OF RESPONSE TO TUMOR CELL,1.1964e-05,-0.25573,-0.30419,1,0
6,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0041716,-0.25584,-0.24292,1,0
6,GO REGULATION OF VESICLE FUSION,0.017969,-0.25589,-0.23611,1,0
6,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,4.4878e-05,-0.2559,-0.27716,1,0
6,GO RESPONSE TO HYDROGEN PEROXIDE,3.8131e-07,-0.25606,-0.28258,1,0
6,GO REGULATION OF RESPONSE TO WOUNDING,0.00030804,-0.25627,-0.23266,1,0
6,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00026003,-0.25638,-0.25352,1,0
6,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0064317,-0.25652,-0.23946,1,0
6,GO REGULATION OF CELLULAR EXTRAVASATION,0.0007696,-0.25695,-0.27831,1,0
6,GO REGULATION OF CELL PROJECTION SIZE,0.031748,-0.25707,-0.20572,1,0
6,GO BLASTOCYST FORMATION,1.7806e-05,-0.25718,-0.22478,1,0
6,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.033894,-0.25751,-0.19375,1,0
6,GO REGULATION OF MEMBRANE INVAGINATION,0.015203,-0.25786,-0.23402,1,0
6,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.046579,-0.25795,-0.27008,1,0
6,GO RESPONSE TO MISFOLDED PROTEIN,0.00032948,-0.25805,-0.22337,1,0
6,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,2.9301e-06,-0.25824,-0.28385,1,0
6,GO REGULATION OF T CELL CYTOKINE PRODUCTION,8.7323e-05,-0.25829,-0.2968,1,0
6,GO AMINO SUGAR CATABOLIC PROCESS,0.00014935,-0.25863,-0.27621,1,0
6,GO REGULATION OF COAGULATION,7.2754e-05,-0.25951,-0.31147,1,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00010092,-0.25979,-0.33954,1,0
6,GO POSITIVE REGULATION OF PROTEIN BINDING,1.4039e-05,-0.25992,-0.22582,1,0
6,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.004408,-0.25997,-0.2708,1,0
6,GO PLASMA MEMBRANE FUSION,0.0018173,-0.26,-0.295,1,0
6,GO FIBRINOLYSIS,5.4121e-05,-0.26005,-0.38468,1,0
6,GO T CELL MEDIATED IMMUNITY,2.6902e-06,-0.26038,-0.34226,1,0
6,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0032441,-0.26043,-0.2838,1,0
6,GO RESPONSE TO TYPE I INTERFERON,0.0013872,-0.26053,-0.40314,1,0
6,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0057817,-0.2606,-0.28496,1,0
6,GO GLOMERULUS DEVELOPMENT,0.00031859,-0.26061,-0.27245,1,0
6,GO HEPATOCYTE DIFFERENTIATION,0.0026572,-0.26086,-0.30151,1,0
6,GO KETONE BIOSYNTHETIC PROCESS,1.349e-05,-0.2611,-0.29242,1,0
6,GO FIBROBLAST APOPTOTIC PROCESS,0.0041716,-0.26115,-0.21193,1,0
6,GO CARBOHYDRATE CATABOLIC PROCESS,5.1671e-08,-0.26115,-0.24972,1,0
6,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.0023671,-0.26139,-0.2937,1,0
6,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0079323,-0.26142,-0.238,1,0
6,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.00012512,-0.26148,-0.27059,1,0
6,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.00014418,-0.2615,-0.27478,1,0
6,GO CELLULAR ALDEHYDE METABOLIC PROCESS,3.3287e-06,-0.26162,-0.30985,1,0
6,GO PROGRAMMED NECROTIC CELL DEATH,0.00012512,-0.26166,-0.29856,1,0
6,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.010506,-0.2618,-0.24945,1,0
6,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.0604e-05,-0.26181,-0.27178,1,0
6,GO PROTEIN DEGLYCOSYLATION,1.6455e-05,-0.2619,-0.34656,1,0
6,GO HOMOCYSTEINE METABOLIC PROCESS,0.00092958,-0.26197,-0.35466,1,0
6,GO FIBROBLAST PROLIFERATION,3.0689e-05,-0.26213,-0.28714,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.6623e-06,-0.26225,-0.32435,1,0
6,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,1.5816e-05,-0.26242,-0.24138,1,0
6,GO HYPEROSMOTIC RESPONSE,0.004408,-0.26243,-0.20468,1,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,9.7346e-05,-0.26252,-0.31785,1,0
6,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0023671,-0.26271,-0.30019,1,0
6,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,3.1888e-05,-0.2628,-0.33559,1,0
6,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,3.1888e-05,-0.26287,-0.28358,1,0
6,GO BARBED END ACTIN FILAMENT CAPPING,0.0062634,-0.26324,-0.26031,1,0
6,GO CHRONIC INFLAMMATORY RESPONSE,0.00090094,-0.26355,-0.299,1,0
6,GO POSITIVE REGULATION OF WOUND HEALING,0.001986,-0.26364,-0.24006,1,0
6,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0018173,-0.26402,-0.27133,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,4.2876e-06,-0.26412,-0.2526,1,0
6,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0087944,-0.26413,-0.22114,1,0
6,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00019079,-0.26427,-0.26894,1,0
6,GO SULFUR COMPOUND CATABOLIC PROCESS,1.9904e-06,-0.26431,-0.29022,1,0
6,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0025817,-0.26442,-0.20525,1,0
6,GO SPHINGOMYELIN METABOLIC PROCESS,2.4346e-05,-0.26478,-0.32262,1,0
6,GO RESPONSE TO INTERLEUKIN 15,5.9841e-06,-0.26495,-0.35687,1,0
6,GO REGULATION OF VACUOLE ORGANIZATION,1.6015e-06,-0.26498,-0.26637,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,9.0551e-05,-0.26499,-0.28902,1,0
6,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.0576e-06,-0.26506,-0.33403,1,0
6,GO B CELL APOPTOTIC PROCESS,0.00079435,-0.26508,-0.24129,1,0
6,GO RETINAL METABOLIC PROCESS,0.0060989,-0.26523,-0.34189,1,0
6,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,5.4121e-05,-0.26533,-0.26042,1,0
6,GO GLUCOCORTICOID METABOLIC PROCESS,0.00023468,-0.26558,-0.2694,1,0
6,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0081404,-0.26564,-0.29452,1,0
6,GO ALDITOL METABOLIC PROCESS,1.9263e-05,-0.26579,-0.2981,1,0
6,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.029068,-0.26591,-0.18703,1,0
6,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.010245,-0.26592,-0.29169,1,0
6,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,6.8936e-07,-0.26597,-0.34923,1,0
6,GO POLYSACCHARIDE CATABOLIC PROCESS,1.3441e-06,-0.26628,-0.28913,1,0
6,GO REGULATION OF CELL MATRIX ADHESION,3.3132e-05,-0.26644,-0.29669,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0001165,-0.26647,-0.43731,1,0
6,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,7.6603e-06,-0.26648,-0.2972,1,0
6,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,2.9301e-06,-0.26655,-0.27743,1,0
6,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00031859,-0.26659,-0.3495,1,0
6,GO SULFUR AMINO ACID METABOLIC PROCESS,1.4039e-05,-0.26694,-0.26949,1,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00054072,-0.26716,-0.24111,1,0
6,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00031859,-0.26727,-0.31176,1,0
6,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.037747,-0.26728,-0.14021,1,0
6,GO VIRAL GENE EXPRESSION,0.00042998,-0.26745,-0.28685,1,0
6,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0022332,-0.26749,-0.24395,1,0
6,GO MUSCLE CELL FATE COMMITMENT,0.00074557,-0.26753,-0.2985,1,0
6,GO CELLULAR RESPONSE TO CADMIUM ION,0.0060989,-0.26758,-0.30314,1,0
6,GO REGULATION OF AMYLOID BETA FORMATION,0.00054072,-0.26782,-0.26303,1,0
6,GO ACTIVATION OF MAPKKK ACTIVITY,0.0026572,-0.26797,-0.25509,1,0
6,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00014418,-0.26801,-0.23523,1,0
6,GO TRABECULA FORMATION,0.0029794,-0.26805,-0.28134,1,0
6,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,2.0833e-05,-0.26816,-0.32311,1,0
6,GO MATURE B CELL DIFFERENTIATION,0.00034072,-0.26834,-0.33365,1,0
6,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0028957,-0.2684,-0.27432,1,0
6,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,1.7806e-05,-0.2686,-0.28378,1,0
6,GO NADP METABOLIC PROCESS,0.00047456,-0.26879,-0.25005,1,0
6,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00029782,-0.26903,-0.26541,1,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00027832,-0.26903,-0.28429,1,0
6,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00049035,-0.26909,-0.29421,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0013457,-0.26933,-0.2651,1,0
6,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.004408,-0.26937,-0.2702,1,0
6,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,4.6623e-06,-0.26938,-0.34278,1,0
6,GO REGULATION OF TOLERANCE INDUCTION,0.0023671,-0.26976,-0.35265,1,0
6,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00050664,-0.26995,-0.28426,1,0
6,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00047456,-0.27019,-0.24671,1,0
6,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00011241,-0.27026,-0.275,1,0
6,GO APOPTOTIC CELL CLEARANCE,2.3418e-05,-0.27075,-0.33317,1,0
6,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,9.7346e-05,-0.27076,-0.2716,1,0
6,GO TRANSLATIONAL INITIATION,0.00022676,-0.27079,-0.31851,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,3.4728e-06,-0.2711,-0.28295,1,0
6,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,1.7806e-05,-0.27122,-0.29333,1,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00026903,-0.27141,-0.23318,1,0
6,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,6.8936e-07,-0.27196,-0.28349,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00013433,-0.27222,-0.26292,1,0
6,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,2.1663e-05,-0.27262,-0.28826,1,0
6,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.5331e-06,-0.2728,-0.29304,1,0
6,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,5.2139e-05,-0.27287,-0.29188,1,0
6,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00029782,-0.27296,-0.33972,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.9904e-06,-0.27304,-0.334,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.036948,-0.27316,-0.25713,1,0
6,GO HEART TRABECULA FORMATION,0.0018173,-0.27323,-0.28144,1,0
6,GO PEROXISOMAL TRANSPORT,2.5122e-07,-0.27336,-0.30566,1,0
6,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0033369,-0.27396,-0.22817,1,0
6,GO EMBRYO IMPLANTATION,0.0013872,-0.27426,-0.22645,1,0
6,GO C21 STEROID HORMONE METABOLIC PROCESS,7.2754e-05,-0.27426,-0.3575,1,0
6,GO MYELIN ASSEMBLY,0.00092958,-0.27429,-0.25304,1,0
6,GO CARBOHYDRATE PHOSPHORYLATION,0.00012964,-0.27435,-0.25273,1,0
6,GO KERATAN SULFATE METABOLIC PROCESS,7.0571e-06,-0.2747,-0.32849,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.8379e-05,-0.27537,-0.39626,1,0
6,GO MEMBRANE LIPID CATABOLIC PROCESS,1.5816e-05,-0.27566,-0.33355,1,0
6,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.00026003,-0.27568,-0.27846,1,0
6,GO MYOBLAST FUSION,6.2367e-06,-0.27575,-0.32874,1,0
6,GO REGULATION OF CELL SUBSTRATE ADHESION,2.8418e-05,-0.27599,-0.27067,1,0
6,GO SKELETAL MUSCLE TISSUE REGENERATION,3.7791e-06,-0.27604,-0.33532,1,0
6,GO NECROTIC CELL DEATH,5.0226e-05,-0.2767,-0.30549,1,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,4.0073e-05,-0.27672,-0.29996,1,0
6,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,5.0683e-06,-0.27683,-0.39771,1,0
6,GO KERATINOCYTE MIGRATION,9.0551e-05,-0.27741,-0.25709,1,0
6,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,7.3528e-06,-0.27747,-0.27697,1,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.00018427,-0.27747,-0.28735,1,0
6,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0001165,-0.27767,-0.31233,1,0
6,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00047456,-0.2781,-0.25532,1,0
6,GO REGULATION OF MONOCYTE CHEMOTAXIS,8.4205e-05,-0.27817,-0.2879,1,0
6,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.3287e-06,-0.27835,-0.28874,1,0
6,GO REGULATION OF T CELL APOPTOTIC PROCESS,8.4205e-05,-0.27837,-0.28678,1,0
6,GO REGULATION OF WATER LOSS VIA SKIN,0.014138,-0.27842,-0.26078,1,0
6,GO POSITIVE REGULATION OF HAIR CYCLE,0.009256,-0.2785,-0.29149,1,0
6,GO MUSCLE FILAMENT SLIDING,7.013e-05,-0.2785,-0.29379,1,0
6,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,5.4272e-08,-0.27895,-0.29987,1,0
6,GO ETHANOL METABOLIC PROCESS,0.0019282,-0.27901,-0.27569,1,0
6,GO PROTEIN REFOLDING,0.00084609,-0.27914,-0.23986,1,0
6,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00016595,-0.28006,-0.33735,1,0
6,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00353,-0.2804,-0.27834,1,0
6,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0026572,-0.28045,-0.26243,1,0
6,GO REGULATION OF PODOSOME ASSEMBLY,0.043763,-0.28062,-0.21413,1,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,2.8077e-06,-0.28124,-0.34821,1,0
6,GO VASCULOGENESIS,0.00014935,-0.28149,-0.32371,1,0
6,GO GENITALIA MORPHOGENESIS,0.0040578,-0.28151,-0.29399,1,0
6,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,5.7413e-06,-0.28178,-0.3809,1,0
6,GO RESPONSE TO MANGANESE ION,0.00023468,-0.28273,-0.26925,1,0
6,GO MACROPHAGE PROLIFERATION,0.009256,-0.28295,-0.30074,1,0
6,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00063551,-0.28298,-0.30843,1,0
6,GO DETECTION OF OTHER ORGANISM,0.00067758,-0.28306,-0.35857,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00069957,-0.28342,-0.2898,1,0
6,GO THIOESTER BIOSYNTHETIC PROCESS,5.0194e-07,-0.28368,-0.31121,1,0
6,GO COLLAGEN METABOLIC PROCESS,0.00010462,-0.28377,-0.30558,1,0
6,GO ZINC ION HOMEOSTASIS,0.0022992,-0.28445,-0.28837,1,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.3528e-06,-0.28484,-0.31672,1,0
6,GO PEPTIDE CROSS LINKING,0.00014935,-0.28504,-0.34155,1,0
6,GO HYALURONAN CATABOLIC PROCESS,0.00044439,-0.28508,-0.37999,1,0
6,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0050528,-0.28513,-0.27102,1,0
6,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0064317,-0.28524,-0.23815,1,0
6,GO MAMMARY GLAND MORPHOGENESIS,0.00041602,-0.28546,-0.28636,1,0
6,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.6174e-05,-0.28571,-0.31407,1,0
6,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0021062,-0.28577,-0.31111,1,0
6,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0046564,-0.28578,-0.23146,1,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,2.2524e-05,-0.28586,-0.32661,1,0
6,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0073363,-0.2861,-0.27859,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00016023,-0.28624,-0.38978,1,0
6,GO CORTICOSTEROID HORMONE SECRETION,0.00353,-0.28626,-0.26455,1,0
6,GO CHAPERONE MEDIATED PROTEIN FOLDING,7.547e-05,-0.28632,-0.24599,1,0
6,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,5.4121e-05,-0.28635,-0.31307,1,0
6,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.00057693,-0.28635,-0.38155,1,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0046564,-0.28668,-0.23126,1,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.00063551,-0.28671,-0.35912,1,0
6,GO CELL REDOX HOMEOSTASIS,1.2454e-05,-0.28687,-0.28136,1,0
6,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0013457,-0.287,-0.23588,1,0
6,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00031859,-0.28712,-0.34792,1,0
6,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,1.0779e-06,-0.28712,-0.34197,1,0
6,GO REGULATION OF MEMBRANE DEPOLARIZATION,5.8301e-05,-0.28777,-0.27673,1,0
6,GO VIRAL TRANSLATION,0.0023671,-0.28783,-0.2693,1,0
6,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,5.4121e-05,-0.28796,-0.31794,1,0
6,GO SUPEROXIDE ANION GENERATION,0.0012662,-0.28798,-0.31316,1,0
6,GO RESPONSE TO PAIN,0.00021167,-0.28811,-0.32402,1,0
6,GO RESPONSE TO ZINC ION,0.00052342,-0.28845,-0.2891,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.0033e-05,-0.28865,-0.34991,1,0
6,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.8251e-06,-0.28876,-0.33614,1,0
6,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00027832,-0.2889,-0.39022,1,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.001228,-0.28952,-0.27963,1,0
6,GO DETECTION OF BIOTIC STIMULUS,3.0689e-05,-0.28975,-0.3489,1,0
6,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.349e-05,-0.29007,-0.30599,1,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.8521e-05,-0.29021,-0.30216,1,0
6,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,2.9532e-05,-0.29029,-0.39672,1,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00054072,-0.2905,-0.31751,1,0
6,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,2.0784e-06,-0.29106,-0.30987,1,0
6,GO PLATELET DEGRANULATION,1.3441e-06,-0.29121,-0.3341,1,0
6,GO RIBOSOME ASSEMBLY,0.001228,-0.29128,-0.30581,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,2.1663e-05,-0.29139,-0.26013,1,0
6,GO ARACHIDONIC ACID METABOLIC PROCESS,5.2139e-05,-0.29145,-0.28751,1,0
6,GO ANDROGEN METABOLIC PROCESS,0.00027832,-0.29196,-0.25562,1,0
6,GO REGULATION OF MYOBLAST FUSION,0.00010845,-0.29208,-0.35124,1,0
6,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,3.7145e-05,-0.29228,-0.32556,1,0
6,GO PSEUDOPODIUM ORGANIZATION,0.02268,-0.2927,-0.28265,1,0
6,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,6.0504e-05,-0.2928,-0.33858,1,0
6,GO BILE ACID AND BILE SALT TRANSPORT,0.010506,-0.29289,-0.25012,1,0
6,GO REGULATION OF MONONUCLEAR CELL MIGRATION,5.7413e-06,-0.29313,-0.29003,1,0
6,GO RESPONSE TO GONADOTROPIN,2.0833e-05,-0.29335,-0.31848,1,0
6,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0016129,-0.29356,-0.29273,1,0
6,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0067808,-0.29359,-0.23543,1,0
6,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.001872,-0.29384,-0.32849,1,0
6,GO REGULATION OF NECROTIC CELL DEATH,0.00074557,-0.29392,-0.30473,1,0
6,GO PROTEIN OXIDATION,5.2139e-05,-0.29468,-0.35211,1,0
6,GO MONOSACCHARIDE CATABOLIC PROCESS,3.0264e-07,-0.29475,-0.33605,1,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS,6.4994e-06,-0.29519,-0.33626,1,0
6,GO PIGMENT METABOLIC PROCESS,4.6623e-06,-0.29535,-0.28485,1,0
6,GO SEQUESTERING OF TRIGLYCERIDE,0.00059588,-0.29554,-0.36272,1,0
6,GO PULMONARY VALVE MORPHOGENESIS,0.0012662,-0.29566,-0.45209,1,0
6,GO PEPTIDYL PROLINE MODIFICATION,4.2876e-06,-0.29582,-0.30748,1,0
6,GO CARNITINE SHUTTLE,0.0040578,-0.2961,-0.22174,1,0
6,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.0060989,-0.29613,-0.34387,1,0
6,GO RESPONSE TO GROWTH HORMONE,7.6603e-06,-0.29614,-0.33592,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00044439,-0.29662,-0.35906,1,0
6,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.041093,-0.29683,-0.18872,1,0
6,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.015574,-0.29691,-0.2751,1,0
6,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,2.0033e-05,-0.29746,-0.36219,1,0
6,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00021909,-0.29748,-0.28338,1,0
6,GO REGULATION OF ANOIKIS,0.00084609,-0.29759,-0.33305,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0060989,-0.29762,-0.32143,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0025817,-0.29824,-0.27685,1,0
6,GO STEROID ESTERIFICATION,6.5149e-05,-0.29867,-0.39316,1,0
6,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00059588,-0.29872,-0.24583,1,0
6,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,1.2962e-05,-0.29873,-0.27347,1,0
6,GO MACROPHAGE CYTOKINE PRODUCTION,0.0014299,-0.29882,-0.30475,1,0
6,GO RECEPTOR CATABOLIC PROCESS,1.7806e-05,-0.29908,-0.28749,1,0
6,GO INACTIVATION OF MAPK ACTIVITY,0.00057693,-0.29912,-0.30441,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.349e-05,-0.2992,-0.38533,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00042998,-0.29943,-0.29687,1,0
6,GO FATTY ACYL COA METABOLIC PROCESS,4.0073e-05,-0.29954,-0.27723,1,0
6,GO REGULATION OF EPITHELIAL CELL MIGRATION,1.8251e-06,-0.29974,-0.30558,1,0
6,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,4.3218e-05,-0.29975,-0.30115,1,0
6,GO OLIGOPEPTIDE TRANSPORT,0.0030654,-0.30017,-0.33788,1,0
6,GO AMINOGLYCAN CATABOLIC PROCESS,9.389e-05,-0.3003,-0.32948,1,0
6,GO PHOSPHOLIPID EFFLUX,0.00081984,-0.30044,-0.29883,1,0
6,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0097392,-0.30045,-0.32275,1,0
6,GO RESPONSE TO MUSCLE STRETCH,0.0031536,-0.30074,-0.29972,1,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0015653,-0.30076,-0.33857,1,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.004408,-0.30103,-0.32379,1,0
6,GO IMP METABOLIC PROCESS,0.0060989,-0.30131,-0.30786,1,0
6,GO TYPE 2 IMMUNE RESPONSE,8.3127e-06,-0.30139,-0.37293,1,0
6,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0028141,-0.30151,-0.33069,1,0
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.013798,-0.30159,-0.26489,1,0
6,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00014935,-0.30162,-0.35999,1,0
6,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00019079,-0.30176,-0.27071,1,0
6,GO GLUTATHIONE METABOLIC PROCESS,1.0184e-05,-0.3023,-0.3722,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,2.8418e-05,-0.30239,-0.39184,1,0
6,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,1.6455e-05,-0.30264,-0.31414,1,0
6,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.9532e-05,-0.30286,-0.30801,1,0
6,GO CERAMIDE CATABOLIC PROCESS,2.0033e-05,-0.30332,-0.3955,1,0
6,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,4.4712e-06,-0.30355,-0.32142,1,0
6,GO SECRETION BY TISSUE,0.0001165,-0.30368,-0.28572,1,0
6,GO ACUTE INFLAMMATORY RESPONSE,6.8936e-07,-0.30405,-0.34571,1,0
6,GO NEGATIVE REGULATION OF HIPPO SIGNALING,8.4205e-05,-0.30557,-0.43295,1,0
6,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042998,-0.30559,-0.30775,1,0
6,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00098941,-0.30602,-0.36294,1,0
6,GO NADPH REGENERATION,0.00098941,-0.30605,-0.26905,1,0
6,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00016023,-0.30618,-0.34878,1,0
6,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0030654,-0.30639,-0.27987,1,0
6,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.8418e-05,-0.3066,-0.29304,1,0
6,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0025083,-0.30713,-0.32948,1,0
6,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.001191,-0.30715,-0.28709,1,0
6,GO RESPONSE TO EPINEPHRINE,0.017137,-0.30741,-0.30406,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00014935,-0.30744,-0.27122,1,0
6,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.4421e-05,-0.30771,-0.29262,1,0
6,GO COPPER ION TRANSPORT,3.7145e-05,-0.30808,-0.30694,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00013917,-0.30809,-0.37536,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,1.9904e-06,-0.30848,-0.41376,1,0
6,GO INTERMEDIATE FILAMENT ORGANIZATION,3.3132e-05,-0.30867,-0.31956,1,0
6,GO PLASMA MEMBRANE REPAIR,0.050569,-0.30889,-0.17616,1,0
6,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,4.6623e-06,-0.3092,-0.33681,1,0
6,GO SKIN MORPHOGENESIS,0.0013872,-0.30928,-0.37006,1,0
6,GO RETINOL METABOLIC PROCESS,3.3132e-05,-0.30947,-0.32763,1,0
6,GO COPPER ION HOMEOSTASIS,6.2786e-05,-0.30992,-0.3046,1,0
6,GO REGULATION OF B CELL APOPTOTIC PROCESS,2.7343e-05,-0.31029,-0.33131,1,0
6,GO REGULATION OF WOUND HEALING,7.547e-05,-0.31047,-0.28332,1,0
6,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.00055855,-0.31098,-0.36471,1,0
6,GO HORMONE BIOSYNTHETIC PROCESS,8.628e-07,-0.31108,-0.32141,1,0
6,GO FUCOSYLATION,6.7596e-05,-0.31112,-0.29545,1,0
6,GO ACTIN MEDIATED CELL CONTRACTION,7.6603e-06,-0.31117,-0.28671,1,0
6,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0037331,-0.31122,-0.26908,1,0
6,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.5201e-05,-0.31152,-0.30493,1,0
6,GO REGULATION OF THE FORCE OF HEART CONTRACTION,5.0226e-05,-0.31207,-0.31817,1,0
6,GO RELAXATION OF MUSCLE,3.7145e-05,-0.31207,-0.32425,1,0
6,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00079435,-0.31216,-0.36117,1,0
6,GO TISSUE MIGRATION,4.1112e-06,-0.31262,-0.28895,1,0
6,GO KERATAN SULFATE CATABOLIC PROCESS,4.2876e-06,-0.31321,-0.37422,1,0
6,GO RESPONSE TO INTERFERON GAMMA,2.1702e-06,-0.31347,-0.40263,1,0
6,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.014841,-0.31347,-0.30466,1,0
6,GO HEXOSE CATABOLIC PROCESS,1.2308e-06,-0.31407,-0.35117,1,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.3441e-06,-0.31485,-0.37537,1,0
6,GO CELLULAR RESPONSE TO COPPER ION,0.0062634,-0.31519,-0.38056,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,9.389e-05,-0.31554,-0.33414,1,0
6,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,5.9841e-06,-0.31596,-0.33876,1,0
6,GO NEGATIVE REGULATION OF WOUND HEALING,1.8521e-05,-0.31653,-0.32679,1,0
6,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00031859,-0.31696,-0.3212,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.6603e-06,-0.31703,-0.3695,1,0
6,GO ANIMAL ORGAN REGENERATION,7.2111e-07,-0.3171,-0.3206,1,0
6,GO ETHANOL OXIDATION,0.0029794,-0.31769,-0.41268,1,0
6,GO FUCOSE METABOLIC PROCESS,0.00055855,-0.31784,-0.28618,1,0
6,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0001165,-0.31813,-0.35599,1,0
6,GO ENDOTHELIAL CELL MIGRATION,1.0184e-05,-0.31834,-0.291,1,0
6,GO MICROVILLUS ORGANIZATION,4.0073e-05,-0.32037,-0.36362,1,0
6,GO CELLULAR COPPER ION HOMEOSTASIS,0.00011241,-0.32045,-0.31664,1,0
6,GO DISACCHARIDE METABOLIC PROCESS,0.00032948,-0.32105,-0.30507,1,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,3.1888e-05,-0.32119,-0.41748,1,0
6,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.5331e-06,-0.32454,-0.35596,1,0
6,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0059384,-0.32458,-0.27273,1,0
6,GO SNARE COMPLEX ASSEMBLY,0.00065623,-0.32473,-0.26339,1,0
6,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,7.9801e-06,-0.32524,-0.49344,1,0
6,GO MONONUCLEAR CELL MIGRATION,2.5774e-06,-0.32533,-0.30716,1,0
6,GO CELLULAR RESPONSE TO ZINC ION,0.0029794,-0.32567,-0.43523,1,0
6,GO LIPID IMPORT INTO CELL,1.7474e-06,-0.32579,-0.33929,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0041716,-0.32598,-0.35432,1,0
6,GO DETOXIFICATION OF INORGANIC COMPOUND,0.029068,-0.32656,-0.53746,1,0
6,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0046564,-0.32668,-0.29954,1,0
6,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0038387,-0.32688,-0.29764,1,0
6,GO NEURON REMODELING,0.00087311,-0.32714,-0.33218,1,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00032948,-0.32742,-0.34993,1,0
6,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.010506,-0.32751,-0.30113,1,0
6,GO CELL ADHESION MEDIATED BY INTEGRIN,1.9873e-07,-0.32803,-0.44727,1,0
6,GO AMINO ACID ACTIVATION,0.00035231,-0.3282,-0.25425,1,0
6,GO MICROVILLUS ASSEMBLY,0.00010845,-0.32843,-0.3621,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00045924,-0.32868,-0.3191,1,0
6,GO INTERLEUKIN 5 PRODUCTION,0.0024367,-0.32887,-0.28815,1,0
6,GO VAGINA DEVELOPMENT,4.0073e-05,-0.32927,-0.3473,1,0
6,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012074,-0.32945,-0.33554,1,0
6,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.00069957,-0.32958,-0.39089,1,0
6,GO BEHAVIORAL RESPONSE TO PAIN,1.9263e-05,-0.33,-0.46116,1,0
6,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0025817,-0.33088,-0.29549,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,4.3218e-05,-0.33108,-0.3488,1,0
6,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.027188,-0.33128,-0.24697,1,0
6,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.0036303,-0.33147,-0.30462,1,0
6,GO RESPONSE TO HYPEROXIA,5.0226e-05,-0.33168,-0.36332,1,0
6,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00026003,-0.33248,-0.28554,1,0
6,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00065623,-0.33254,-0.36926,1,0
6,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,1.9904e-06,-0.33258,-0.31389,1,0
6,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00079435,-0.33263,-0.30595,1,0
6,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0019282,-0.33283,-0.32018,1,0
6,GO HEMIDESMOSOME ASSEMBLY,0.016339,-0.33285,-0.38454,1,0
6,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.022165,-0.33285,-0.32636,1,0
6,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0016129,-0.33293,-0.35357,1,0
6,GO GLUCOSE CATABOLIC PROCESS,3.1888e-05,-0.33304,-0.34773,1,0
6,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.011326,-0.33356,-0.30896,1,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,3.0689e-05,-0.33372,-0.31172,1,0
6,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,3.4728e-06,-0.33416,-0.30979,1,0
6,GO SALIVARY GLAND DEVELOPMENT,0.00079435,-0.33433,-0.30456,1,0
6,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00012512,-0.33478,-0.31616,1,0
6,GO L SERINE METABOLIC PROCESS,0.031748,-0.33614,-0.22293,1,0
6,GO GERMINAL CENTER FORMATION,0.00010845,-0.33621,-0.44067,1,0
6,GO RESPONSE TO TUMOR CELL,6.0198e-07,-0.3365,-0.42125,1,0
6,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.00017796,-0.33653,-0.37786,1,0
6,GO THYMOCYTE APOPTOTIC PROCESS,0.00023468,-0.33668,-0.32777,1,0
6,GO HOMOTYPIC CELL CELL ADHESION,0.00013433,-0.33751,-0.29998,1,0
6,GO REGULATION OF CELLULAR RESPIRATION,9.4334e-07,-0.33757,-0.36976,1,0
6,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0049174,-0.33783,-0.28268,1,0
6,GO ZYMOGEN INHIBITION,0.00021167,-0.33785,-0.35577,1,0
6,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00055855,-0.33792,-0.31873,1,0
6,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,7.8282e-05,-0.33823,-0.34302,1,0
6,GO RESPONSE TO CAFFEINE,4.6597e-05,-0.33875,-0.31053,1,0
6,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.001872,-0.33951,-0.33578,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,2.8418e-05,-0.33978,-0.31333,1,0
6,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00012512,-0.34111,-0.3459,1,0
6,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.001228,-0.34136,-0.31639,1,0
6,GO RESPONSE TO THYROID HORMONE,5.2837e-06,-0.34168,-0.39469,1,0
6,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00081984,-0.34172,-0.41473,1,0
6,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.2658e-06,-0.34248,-0.3266,1,0
6,GO NEGATIVE REGULATION OF COAGULATION,5.9841e-06,-0.34316,-0.40367,1,0
6,GO CELLULAR METABOLIC COMPOUND SALVAGE,1.4039e-05,-0.34328,-0.30095,1,0
6,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,4.0073e-05,-0.34389,-0.3013,1,0
6,GO EPIBOLY,0.00036427,-0.34435,-0.34909,1,0
6,GO T CELL EXTRAVASATION,0.0011199,-0.34546,-0.39219,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00026903,-0.34624,-0.41172,1,0
6,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00087311,-0.34674,-0.38764,1,0
6,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00059588,-0.34703,-0.3298,1,0
6,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,1.0184e-05,-0.34749,-0.36672,1,0
6,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0097392,-0.34805,-0.22969,1,0
6,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.001872,-0.34968,-0.36519,1,0
6,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,8.3127e-06,-0.34997,-0.43059,1,0
6,GO NAD METABOLIC PROCESS,6.2367e-06,-0.35002,-0.36929,1,0
6,GO FRUCTOSE METABOLIC PROCESS,0.00353,-0.35068,-0.38663,1,0
6,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,6.2786e-05,-0.35095,-0.31399,1,0
6,GO EXTRACELLULAR MATRIX DISASSEMBLY,2.6307e-05,-0.35134,-0.3325,1,0
6,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.4609e-05,-0.35211,-0.38653,1,0
6,GO MACROPHAGE APOPTOTIC PROCESS,0.0007696,-0.35261,-0.29795,1,0
6,GO REGULATION OF COLLAGEN METABOLIC PROCESS,6.2786e-05,-0.35263,-0.36676,1,0
6,GO PURINE CONTAINING COMPOUND SALVAGE,2.8418e-05,-0.35412,-0.37937,1,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,2.8418e-05,-0.35436,-0.39924,1,0
6,GO T CELL MEDIATED CYTOTOXICITY,1.2962e-05,-0.35451,-0.49672,1,0
6,GO ACTIN FILAMENT SEVERING,7.013e-05,-0.35545,-0.41379,1,0
6,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0017641,-0.35595,-0.3869,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,7.5427e-07,-0.3576,-0.37106,1,0
6,GO POSITIVE REGULATION OF ACTION POTENTIAL,5.508e-06,-0.35889,-0.41275,1,0
6,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,2.5774e-06,-0.35917,-0.38728,1,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.027188,-0.35929,-0.27197,1,0
6,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0050528,-0.35983,-0.34244,1,0
6,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,3.3132e-05,-0.35995,-0.32922,1,0
6,GO MONOCYTE CHEMOTAXIS,1.5331e-06,-0.3602,-0.35493,1,0
6,GO POLYOL TRANSPORT,0.00014418,-0.36122,-0.31814,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.4728e-06,-0.36168,-0.41583,1,0
6,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,1.104e-05,-0.36192,-0.41112,1,0
6,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00353,-0.36227,-0.45959,1,0
6,GO CELLULAR RESPONSE TO ETHANOL,0.00026903,-0.36229,-0.29925,1,0
6,GO NEGATIVE REGULATION OF BONE REMODELING,8.4205e-05,-0.36229,-0.38381,1,0
6,GO DENDRITIC CELL APOPTOTIC PROCESS,9.0179e-06,-0.36246,-0.4411,1,0
6,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,5.9841e-06,-0.36269,-0.36315,1,0
6,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,1.9263e-05,-0.3635,-0.39825,1,0
6,GO INFLAMMATORY CELL APOPTOTIC PROCESS,8.6584e-06,-0.36387,-0.40401,1,0
6,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,4.6597e-05,-0.3642,-0.40227,1,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,1.8521e-05,-0.36475,-0.3453,1,0
6,GO GLYCINE TRANSPORT,0.0023671,-0.36479,-0.34055,1,0
6,GO NEGATIVE REGULATION OF TISSUE REMODELING,3.1888e-05,-0.3648,-0.38782,1,0
6,GO RESPONSE TO STEROL DEPLETION,4.8379e-05,-0.36508,-0.33881,1,0
6,GO STEROID HORMONE BIOSYNTHETIC PROCESS,7.2111e-07,-0.36563,-0.3892,1,0
6,GO PLASMINOGEN ACTIVATION,5.9841e-06,-0.36598,-0.44182,1,0
6,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.001228,-0.36648,-0.44626,1,0
6,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00034072,-0.36661,-0.39885,1,0
6,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,3.1888e-05,-0.36676,-0.44721,1,0
6,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.0085714,-0.36726,-0.34658,1,0
6,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.017137,-0.36843,-0.39071,1,0
6,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.001191,-0.36908,-0.32906,1,0
6,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0047853,-0.36971,-0.36671,1,0
6,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,8.3127e-06,-0.37081,-0.45221,1,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0007696,-0.37139,-0.34747,1,0
6,GO ZYMOGEN ACTIVATION,3.1888e-05,-0.37143,-0.40693,1,0
6,GO MINERALOCORTICOID METABOLIC PROCESS,0.00021167,-0.37161,-0.4005,1,0
6,GO BASEMENT MEMBRANE ASSEMBLY,0.015203,-0.37184,-0.30624,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.00032948,-0.37202,-0.33739,1,0
6,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.104e-05,-0.37213,-0.42109,1,0
6,GO HEME METABOLIC PROCESS,1.7118e-05,-0.37226,-0.39718,1,0
6,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,2.4692e-06,-0.3741,-0.42393,1,0
6,GO RESPONSE TO INTERLEUKIN 18,0.010245,-0.37427,-0.38511,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.0017123,-0.37443,-0.35636,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,8.628e-07,-0.37504,-0.36302,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00052342,-0.377,-0.38781,1,0
6,GO GLYCOPROTEIN CATABOLIC PROCESS,6.5149e-05,-0.3774,-0.48913,1,0
6,GO RELAXATION OF CARDIAC MUSCLE,0.00026903,-0.37771,-0.36871,1,0
6,GO REGULATION OF HORMONE METABOLIC PROCESS,3.1904e-06,-0.37836,-0.42859,1,0
6,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.0033e-05,-0.37864,-0.51655,1,0
6,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,7.547e-05,-0.37869,-0.51213,1,0
6,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,3.8583e-05,-0.3798,-0.33626,1,0
6,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0006154,-0.38023,-0.36506,1,0
6,GO CHAPERONE MEDIATED AUTOPHAGY,0.00014935,-0.38092,-0.45212,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00029782,-0.38099,-0.4611,1,0
6,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,6.7596e-05,-0.38099,-0.4466,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,5.6174e-05,-0.38145,-0.41008,1,0
6,GO REGULATION OF METANEPHROS DEVELOPMENT,7.547e-05,-0.38226,-0.46333,1,0
6,GO COLLAGEN BIOSYNTHETIC PROCESS,0.00013433,-0.38246,-0.40719,1,0
6,GO NEGATIVE REGULATION OF ANOIKIS,0.0015653,-0.38324,-0.3831,1,0
6,GO GAS TRANSPORT,0.0007696,-0.38375,-0.37573,1,0
6,GO NEUTROPHIL HOMEOSTASIS,2.8418e-05,-0.38436,-0.44132,1,0
6,GO VASODILATION,2.0833e-05,-0.38502,-0.3695,1,0
6,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0001547,-0.38526,-0.45235,1,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,2.0033e-05,-0.38538,-0.45933,1,0
6,GO POSITIVE REGULATION OF HEART RATE,0.00040247,-0.38635,-0.34926,1,0
6,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00081984,-0.38648,-0.40697,1,0
6,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00026003,-0.38664,-0.36881,1,0
6,GO RESPONSE TO INTERFERON BETA,0.00065623,-0.3878,-0.47786,1,0
6,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,3.6228e-06,-0.38805,-0.41765,1,0
6,GO CYSTEINE METABOLIC PROCESS,0.00013917,-0.38819,-0.46932,1,0
6,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00047456,-0.38859,-0.44323,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.00040247,-0.38863,-0.29476,1,0
6,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0013457,-0.38891,-0.44882,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,2.4346e-05,-0.38917,-0.46297,1,0
6,GO T HELPER 2 CELL DIFFERENTIATION,0.00016595,-0.38919,-0.47473,1,0
6,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,4.1617e-05,-0.38919,-0.41645,1,0
6,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.8418e-05,-0.38952,-0.40016,1,0
6,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.0036303,-0.3899,-0.29108,1,0
6,GO NOTOCHORD DEVELOPMENT,0.00045924,-0.39014,-0.36575,1,0
6,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00021909,-0.39044,-0.41957,1,0
6,GO BASEMENT MEMBRANE ORGANIZATION,4.1617e-05,-0.39073,-0.4185,1,0
6,GO EPOXYGENASE P450 PATHWAY,0.00011241,-0.39131,-0.36242,1,0
6,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,5.7413e-06,-0.39229,-0.47089,1,0
6,GO STEROL IMPORT,3.3287e-06,-0.393,-0.39451,1,0
6,GO GLYCOLIPID CATABOLIC PROCESS,6.7728e-06,-0.39504,-0.46075,1,0
6,GO INTERLEUKIN 13 PRODUCTION,0.00087311,-0.39557,-0.32266,1,0
6,GO FATTY ACID HOMEOSTASIS,3.4728e-06,-0.39599,-0.43642,1,0
6,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00012964,-0.39707,-0.48321,1,0
6,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.001228,-0.39727,-0.40581,1,0
6,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,3.3287e-06,-0.39753,-0.46546,1,0
6,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00026903,-0.39862,-0.38023,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00034072,-0.39935,-0.41774,1,0
6,GO MEMBRANE RAFT ORGANIZATION,2.9532e-05,-0.39962,-0.54048,1,0
6,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,4.6623e-06,-0.40016,-0.42646,1,0
6,GO GTP METABOLIC PROCESS,2.1663e-05,-0.40145,-0.35356,1,0
6,GO L ASCORBIC ACID METABOLIC PROCESS,0.00050664,-0.40152,-0.40366,1,0
6,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,6.4994e-06,-0.40158,-0.51564,1,0
6,GO PROTEIN HYDROXYLATION,2.8077e-06,-0.40281,-0.44755,1,0
6,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,5.0683e-06,-0.40332,-0.41717,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0010206,-0.4044,-0.28276,1,0
6,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.01282,-0.40503,-0.33426,1,0
6,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.7118e-05,-0.4059,-0.4111,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,7.3528e-06,-0.4061,-0.42982,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,5.2837e-06,-0.40734,-0.38114,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,8.4205e-05,-0.40841,-0.43081,1,0
6,GO EOSINOPHIL MIGRATION,9.389e-05,-0.40881,-0.43025,1,0
6,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00018427,-0.4089,-0.45677,1,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00055855,-0.41127,-0.44962,1,0
6,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.00017796,-0.41185,-0.515,1,0
6,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,5.4121e-05,-0.41277,-0.45551,1,0
6,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.00055855,-0.41431,-0.40208,1,0
6,GO ARGININE METABOLIC PROCESS,3.5759e-05,-0.41435,-0.42553,1,0
6,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,1.7474e-06,-0.41617,-0.42863,1,0
6,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,1.725e-07,-0.41695,-0.42312,1,0
6,GO TOLERANCE INDUCTION,4.4878e-05,-0.4171,-0.52287,1,0
6,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,4.2876e-06,-0.41736,-0.4024,1,0
6,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00010845,-0.41778,-0.41523,1,0
6,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00021909,-0.41867,-0.42162,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00063551,-0.41954,-0.35339,1,0
6,GO AMP METABOLIC PROCESS,1.7474e-06,-0.42023,-0.45841,1,0
6,GO POSITIVE REGULATION OF LIPID STORAGE,1.5331e-06,-0.42052,-0.40453,1,0
6,GO MITOCHONDRIAL TRANSCRIPTION,5.9841e-06,-0.42075,-0.39061,1,0
6,GO L PHENYLALANINE METABOLIC PROCESS,3.7145e-05,-0.42246,-0.39567,1,0
6,GO ESTROGEN BIOSYNTHETIC PROCESS,2.7343e-05,-0.42256,-0.37422,1,0
6,GO IMMUNE RESPONSE TO TUMOR CELL,4.7955e-07,-0.42353,-0.5146,1,0
6,GO NUCLEOTIDE SALVAGE,2.8077e-06,-0.42656,-0.50713,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.9904e-06,-0.43185,-0.52994,1,0
6,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00029782,-0.43427,-0.3726,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0025083,-0.43434,-0.32822,1,0
6,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.2524e-05,-0.43626,-0.49384,1,0
6,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,9.3916e-06,-0.43675,-0.45281,1,0
6,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0010859,-0.43702,-0.41629,1,0
6,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00010092,-0.43869,-0.42815,1,0
6,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,2.9301e-06,-0.4397,-0.48247,1,0
6,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,2.5308e-05,-0.43979,-0.51145,1,0
6,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,5.9841e-06,-0.44194,-0.48153,1,0
6,GO INFLAMMATORY RESPONSE TO WOUNDING,0.018398,-0.4421,-0.34561,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.00028792,-0.44253,-0.49405,1,0
6,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,8.4205e-05,-0.44486,-0.60257,1,0
6,GO BIOLOGICAL PHASE,0.00049035,-0.44525,-0.48843,1,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,9.0179e-06,-0.44561,-0.44142,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00013917,-0.44614,-0.55774,1,0
6,GO RESPONSE TO COPPER ION,9.389e-05,-0.44641,-0.4194,1,0
6,GO ACTIN FILAMENT NETWORK FORMATION,0.00027832,-0.44645,-0.41941,1,0
6,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00016023,-0.45097,-0.36883,1,0
6,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00010092,-0.45421,-0.49408,1,0
6,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,1.7118e-05,-0.45794,-0.44362,1,0
6,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00021909,-0.45909,-0.41975,1,0
6,GO ADHESION OF SYMBIONT TO HOST,0.00013917,-0.46019,-0.39991,1,0
6,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,2.5774e-06,-0.46281,-0.48647,1,0
6,GO CYCLOOXYGENASE PATHWAY,5.4121e-05,-0.46481,-0.55832,1,0
6,GO NEGATIVE REGULATION OF CELL KILLING,2.5308e-05,-0.46664,-0.55811,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.8521e-05,-0.47001,-0.50962,1,0
6,GO MONOACYLGLYCEROL METABOLIC PROCESS,2.5308e-05,-0.47033,-0.43216,1,0
6,GO ALDEHYDE BIOSYNTHETIC PROCESS,2.5774e-06,-0.47052,-0.51855,1,0
6,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00025131,-0.47054,-0.41138,1,0
6,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,1.5816e-05,-0.47411,-0.54374,1,0
6,GO XENOBIOTIC CATABOLIC PROCESS,0.00072223,-0.47482,-0.51517,1,0
6,GO HISTAMINE TRANSPORT,1.4609e-05,-0.48089,-0.49224,1,0
6,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0001165,-0.48356,-0.53962,1,0
6,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.3528e-06,-0.48765,-0.47393,1,0
6,GO MONONUCLEAR CELL DIFFERENTIATION,3.0264e-07,-0.48971,-0.51452,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,1.8251e-06,-0.49342,-0.45692,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00025131,-0.49367,-0.59162,1,0
6,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0045306,-0.49563,-0.43741,1,0
6,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.5331e-06,-0.49791,-0.60189,1,0
6,GO REGULATION OF PLASMINOGEN ACTIVATION,3.0689e-05,-0.498,-0.58551,1,0
6,GO EOSINOPHIL CHEMOTAXIS,0.00010462,-0.49912,-0.47347,1,0
6,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.016734,-0.50291,-0.30407,1,0
6,GO CYTIDINE TO URIDINE EDITING,0.033166,-0.50638,-0.36934,1,0
6,GO REGULATION OF MONOCYTE DIFFERENTIATION,1.104e-05,-0.51125,-0.51901,1,0
6,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00014418,-0.51384,-0.6339,1,0
6,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,5.8301e-05,-0.52426,-0.54359,1,0
6,GO GALACTOSE METABOLIC PROCESS,2.5122e-07,-0.53972,-0.57385,1,0
6,GO HISTAMINE SECRETION,2.7343e-05,-0.54022,-0.50267,1,0
6,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,4.6597e-05,-0.54096,-0.5088,1,0
6,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00012074,-0.55527,-0.56339,1,0
6,GO OXYGEN TRANSPORT,0.001228,-0.5612,-0.48368,1,0
6,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.906e-06,-0.57026,-0.57791,1,0
6,GO REGULATION OF VASCULOGENESIS,0.00026003,-0.57698,-0.5042,1,0
6,GO PEPTIDYL PROLINE HYDROXYLATION,1.8251e-06,-0.58649,-0.56494,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00081984,-0.59036,-0.74656,1,0
6,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,2.5122e-07,-0.60164,-0.54264,1,0
6,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,5.4272e-08,-0.61269,-0.65418,1,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,1.4268e-07,-0.62409,-0.6615,1,0
6,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,7.2754e-05,-0.64522,-0.56202,1,0
6,GO MUCUS SECRETION,3.7145e-05,-0.67923,-0.66133,1,0
6,GO BLEB ASSEMBLY,4.0073e-05,-0.72073,-0.68937,1,0
6,GO MEMBRANE RAFT ASSEMBLY,1.7118e-05,-0.74451,-0.88226,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00057693,-0.90743,-0.96185,1,0
6,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.065563,0.27578,0.30272,0,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.061812,0.24096,0.16137,0,1
6,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.48678,0.22,0.084455,0,1
6,GO LIMB BUD FORMATION,0.11636,0.21142,0.14158,0,1
6,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.27227,0.18087,0.091745,0,1
6,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.087232,0.18064,0.099009,0,1
6,GO ESTROUS CYCLE,0.19695,0.16533,0.11646,0,1
6,GO ERYTHROCYTE MATURATION,0.10845,0.16374,0.079595,0,1
6,GO NEPHRON TUBULE FORMATION,0.67137,0.1576,0.023136,0,1
6,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.079444,0.15628,0.16146,0,1
6,GO MAINTENANCE OF ORGANELLE LOCATION,0.11235,0.14059,0.06531,0,1
6,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.10096,0.1257,0.12215,0,1
6,GO PROTEIN AUTO ADP RIBOSYLATION,0.087232,0.11731,0.1544,0,1
6,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.066855,0.11577,0.11144,0,1
6,GO NEURAL TUBE PATTERNING,0.17653,0.10777,0.070031,0,1
6,GO REGULATION OF HELICASE ACTIVITY,0.20309,0.10752,0.10038,0,1
6,GO DNA DOUBLE STRAND BREAK PROCESSING,0.095625,0.10504,0.079839,0,1
6,GO POST ANAL TAIL MORPHOGENESIS,0.23937,0.10139,0.063556,0,1
6,GO REGULATION OF HISTONE H4 ACETYLATION,0.14526,0.10134,0.094058,0,1
6,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.15015,0.10088,0.079583,0,1
6,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.092194,0.098337,0.064607,0,1
6,GO COLLECTING DUCT DEVELOPMENT,0.2,0.096176,0.09474,0,1
6,GO DNA REPLICATION INITIATION,0.072231,0.092783,0.080246,0,1
6,GO MRNA EXPORT FROM NUCLEUS,0.085627,0.092347,0.059401,0,1
6,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.72969,0.091865,-1.9205e-05,0,1
6,GO DNA DEPENDENT DNA REPLICATION,0.059411,0.091365,0.063047,0,1
6,GO DNA REPLICATION CHECKPOINT,0.090515,0.087445,0.088101,0,1
6,GO REGULATION OF PROTEIN ACETYLATION,0.0695,0.080598,0.057595,0,1
6,GO MRNA 3 END PROCESSING,0.20309,0.080523,0.038782,0,1
6,GO HISTONE H3 K36 METHYLATION,0.17934,0.073423,0.066868,0,1
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.073629,0.063284,0.05134,0,1
6,GO DNA CONFORMATION CHANGE,0.088862,0.061588,0.045226,0,1
6,GO SNRNA TRANSCRIPTION,0.18219,0.060957,0.029119,0,1
6,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.42347,0.058468,0.021815,0,1
6,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.25001,0.057897,0.045902,0,1
6,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.8303,0.057894,0.011737,0,1
6,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.16032,0.057214,0.085594,0,1
6,GO RNA SPLICING,0.084046,0.05624,0.047429,0,1
6,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.2839,0.050998,0.025875,0,1
6,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.42855,0.050266,0.038392,0,1
6,GO HISTONE METHYLATION,0.095625,0.049497,0.055666,0,1
6,GO PROTEIN METHYLATION,0.16294,0.045038,0.040809,0,1
6,GO CELL CYCLE CHECKPOINT,0.064293,0.040607,0.04415,0,1
6,GO DNA INTEGRITY CHECKPOINT,0.11636,0.039621,0.036073,0,1
6,GO DNA REPLICATION,0.18219,0.035557,0.032096,0,1
6,GO PROTEIN ACYLATION,0.088862,0.032013,0.037778,0,1
6,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.090515,0.029893,0.051864,0,1
6,GO TRIGEMINAL NERVE DEVELOPMENT,0.0026572,0.53452,0.38298,0,0
6,GO CARDIOBLAST PROLIFERATION,0.0012662,0.46292,0.45408,0,0
6,GO NEURON FATE SPECIFICATION,0.00041602,0.44567,0.46736,0,0
6,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.014486,0.40173,0.54293,0,0
6,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0085714,0.34415,0.3695,0,0
6,GO GABAERGIC NEURON DIFFERENTIATION,0.060602,0.27735,0.3439,0,0
6,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.27227,0.27433,0.143,0,0
6,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.082489,0.25968,0.29043,0,0
6,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.037747,0.25183,0.26698,0,0
6,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.027803,0.24995,0.25516,0,0
6,GO NEURON CELL CELL ADHESION,0.075049,0.24316,0.27344,0,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0025083,0.23277,0.20926,0,0
6,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00057693,0.23235,0.39544,0,0
6,GO GANGLION DEVELOPMENT,0.088862,0.22849,0.24386,0,0
6,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.10845,0.21555,0.21523,0,0
6,GO OLFACTORY LOBE DEVELOPMENT,0.015953,0.21213,0.21703,0,0
6,GO VOCALIZATION BEHAVIOR,0.16559,0.21054,0.20413,0,0
6,GO DENDRITE SELF AVOIDANCE,0.037747,0.20622,0.1523,0,0
6,GO RESPONSE TO FORSKOLIN,0.097379,0.20354,0.17324,0,0
6,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.27999,0.20277,0.167,0,0
6,GO V D J RECOMBINATION,0.0045306,0.20033,0.22077,0,0
6,GO MICROTUBULE DEPOLYMERIZATION,0.02268,0.19858,0.16793,0,0
6,GO POSITIVE REGULATION OF BEHAVIOR,0.059411,0.19603,0.13954,0,0
6,GO SYNAPTIC VESICLE CLUSTERING,0.076492,0.19285,0.31274,0,0
6,GO ADENOHYPOPHYSIS DEVELOPMENT,0.36991,0.19153,0.12661,0,0
6,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.018836,0.18849,0.26739,0,0
6,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.072231,0.18601,0.19697,0,0
6,GO SUBPALLIUM DEVELOPMENT,0.029719,0.18469,0.20745,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.084046,0.18278,0.15153,0,0
6,GO GAMMA DELTA T CELL DIFFERENTIATION,0.14048,0.1806,0.22768,0,0
6,GO CELL FATE SPECIFICATION,0.013465,0.1787,0.14805,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.080955,0.17733,0.16815,0,0
6,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.10096,0.17639,0.12739,0,0
6,GO MYOBLAST MIGRATION,0.70355,0.1742,-0.010057,0,0
6,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0073363,0.17385,0.14663,0,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.47049,0.17374,0.060053,0,0
6,GO APICAL PROTEIN LOCALIZATION,0.0038387,0.17141,0.17981,0,0
6,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.17374,0.17092,0.13103,0,0
6,GO CARDIAC CELL FATE COMMITMENT,0.017549,0.17027,0.28185,0,0
6,GO REGULATION OF GROWTH HORMONE SECRETION,0.0695,0.16973,0.21873,0,0
6,GO SEGMENT SPECIFICATION,0.19695,0.16928,0.13616,0,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0067808,0.16856,0.15731,0,0
6,GO ECTODERMAL PLACODE DEVELOPMENT,0.67776,0.16707,0.013115,0,0
6,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.16828,0.16282,0.23632,0,0
6,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.092194,0.15881,0.18046,0,0
6,GO SECONDARY HEART FIELD SPECIFICATION,0.26471,0.15737,0.12993,0,0
6,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.47588,0.15715,0.077956,0,0
6,GO INTRACILIARY TRANSPORT,0.013465,0.15679,0.1957,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.25363,0.15672,0.13939,0,0
6,GO NOREPINEPHRINE METABOLIC PROCESS,0.087232,0.15568,0.19649,0,0
6,GO FOREBRAIN NEURON DIFFERENTIATION,0.063042,0.1555,0.18858,0,0
6,GO REGULATION OF RECEPTOR CLUSTERING,0.30815,0.15495,0.12792,0,0
6,GO RETINAL GANGLION CELL AXON GUIDANCE,0.11434,0.1549,0.23486,0,0
6,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.23589,0.15159,0.088567,0,0
6,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.02166,0.15069,0.17123,0,0
6,GO CEREBELLAR CORTEX DEVELOPMENT,0.070855,0.15055,0.1144,0,0
6,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.077957,0.14885,0.31209,0,0
6,GO RETINA LAYER FORMATION,0.095625,0.14856,0.17974,0,0
6,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.22905,0.14833,0.11537,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.32077,0.1479,0.076844,0,0
6,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.075049,0.14744,0.16688,0,0
6,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.20621,0.14648,0.14717,0,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.15264,0.14504,0.14246,0,0
6,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.11636,0.14503,0.14462,0,0
6,GO REGULATION OF STEM CELL DIVISION,0.12473,0.14422,0.10682,0,0
6,GO REGULATION OF MICROTUBULE BINDING,0.012203,0.14103,0.188,0,0
6,GO DNA LIGATION,0.14285,0.1405,0.10339,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.017137,0.13758,0.14068,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.063042,0.13727,0.1326,0,0
6,GO AXO DENDRITIC PROTEIN TRANSPORT,0.36064,0.13555,0.073539,0,0
6,GO PARENTAL BEHAVIOR,0.15517,0.13536,0.19092,0,0
6,GO DNA STRAND ELONGATION,0.0079323,0.13516,0.11851,0,0
6,GO NEURON PROJECTION ARBORIZATION,0.1313,0.13232,0.11647,0,0
6,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.10654,0.13164,0.16994,0,0
6,GO RESPONSE TO ACETYLCHOLINE,0.23937,0.13014,0.093774,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.29586,0.12991,0.0638,0,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.13355,0.12976,0.11247,0,0
6,GO CELL CYCLE DNA REPLICATION,0.015574,0.1278,0.092613,0,0
6,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.014138,0.12734,0.16339,0,0
6,GO PROTEIN LOCALIZATION TO CHROMATIN,0.04854,0.12701,0.079288,0,0
6,GO LONG TERM SYNAPTIC DEPRESSION,0.11841,0.125,0.11789,0,0
6,GO FOREBRAIN GENERATION OF NEURONS,0.079444,0.12496,0.14073,0,0
6,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.13583,0.12401,0.18452,0,0
6,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.15264,0.12262,0.12083,0,0
6,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.92682,0.12217,-0.020984,0,0
6,GO NEURAL RETINA DEVELOPMENT,0.059411,0.12116,0.12345,0,0
6,GO PHOTORECEPTOR CELL DEVELOPMENT,0.046579,0.11977,0.11243,0,0
6,GO BRANCHING MORPHOGENESIS OF A NERVE,0.26098,0.11949,0.12501,0,0
6,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.012203,0.11797,0.16071,0,0
6,GO SIALYLATION,0.35607,0.11632,0.086016,0,0
6,GO CELL FATE DETERMINATION,0.39371,0.11583,0.064281,0,0
6,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.23937,0.11556,0.10411,0,0
6,GO RETINAL ROD CELL DIFFERENTIATION,0.082489,0.11457,0.1876,0,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.04854,0.11022,0.13417,0,0
6,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.0695,0.10915,0.10298,0,0
6,GO CELL JUNCTION MAINTENANCE,0.076492,0.109,0.13329,0,0
6,GO NON MOTILE CILIUM ASSEMBLY,0.026586,0.10895,0.13251,0,0
6,GO FOREBRAIN MORPHOGENESIS,0.76948,0.10739,0.006316,0,0
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.016339,0.10704,0.12535,0,0
6,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.085627,0.10657,0.12506,0,0
6,GO NATURAL KILLER CELL PROLIFERATION,0.44924,0.1062,0.044572,0,0
6,GO EMBRYONIC BRAIN DEVELOPMENT,0.37932,0.10587,0.052557,0,0
6,GO LATERAL MESODERM DEVELOPMENT,0.54321,0.10434,0.014268,0,0
6,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.082489,0.10375,0.11331,0,0
6,GO SYNAPTIC VESICLE LOCALIZATION,0.018398,0.10371,0.18994,0,0
6,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.084046,0.10289,0.1236,0,0
6,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.14526,0.10239,0.11389,0,0
6,GO ACROSOME ASSEMBLY,0.25729,0.10123,0.065586,0,0
6,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.46512,0.10055,0.033325,0,0
6,GO ATRIAL SEPTUM DEVELOPMENT,0.34256,0.10049,0.098271,0,0
6,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.65234,0.10008,0.037447,0,0
6,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0695,0.098849,0.1123,0,0
6,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.34702,0.098835,0.048676,0,0
6,GO CARDIAC ATRIUM MORPHOGENESIS,0.17099,0.09824,0.10031,0,0
6,GO MEIOTIC CHROMOSOME SEPARATION,0.14769,0.098045,0.064919,0,0
6,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.36991,0.097869,0.10106,0,0
6,GO G0 TO G1 TRANSITION,0.0036303,0.09776,0.1328,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.076492,0.097634,0.10677,0,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.10465,0.097617,0.098595,0,0
6,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.17374,0.097382,0.03893,0,0
6,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.63978,0.097287,0.032247,0,0
6,GO FORELIMB MORPHOGENESIS,0.19393,0.097118,0.079272,0,0
6,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.1028,0.095809,0.15072,0,0
6,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.084046,0.095707,0.087489,0,0
6,GO AXONAL TRANSPORT,0.12049,0.095515,0.082646,0,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.12689,0.094873,0.050193,0,0
6,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.17374,0.094643,0.21606,0,0
6,GO HISTONE H3 K27 METHYLATION,0.05161,0.093439,0.083675,0,0
6,GO REGULATION OF STEM CELL PROLIFERATION,0.095625,0.092976,0.061181,0,0
6,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.16828,0.092847,0.068101,0,0
6,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.56666,0.092514,0.017053,0,0
6,GO INTRACILIARY RETROGRADE TRANSPORT,0.71006,0.091808,0.058818,0,0
6,GO CENTROSOME DUPLICATION,0.02166,0.091052,0.10366,0,0
6,GO REGULATION OF CILIUM ASSEMBLY,0.024288,0.09034,0.097426,0,0
6,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.14769,0.089315,0.11435,0,0
6,GO MITOTIC DNA REPLICATION,0.35153,0.088831,0.066864,0,0
6,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.19095,0.088751,0.10261,0,0
6,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.30815,0.088499,0.10951,0,0
6,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.33373,0.086395,0.087781,0,0
6,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.18219,0.086364,0.075965,0,0
6,GO RETINAL CONE CELL DIFFERENTIATION,0.53742,0.086114,0.024445,0,0
6,GO REGULATION OF CENTRIOLE REPLICATION,0.14769,0.086087,0.054706,0,0
6,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.27999,0.085742,0.083213,0,0
6,GO SEROTONIN SECRETION,0.36526,0.08558,0.087544,0,0
6,GO POSITIVE REGULATION OF MRNA PROCESSING,0.084046,0.085534,0.064561,0,0
6,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.17099,0.085095,0.064971,0,0
6,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.55487,0.084848,0.046859,0,0
6,GO DENDRITIC SPINE MORPHOGENESIS,0.61497,0.084545,0.022758,0,0
6,GO DENSE CORE GRANULE TRANSPORT,0.34702,0.083989,0.17726,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.25001,0.083168,0.085248,0,0
6,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.24288,0.082367,0.058447,0,0
6,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.17653,0.081163,0.082612,0,0
6,GO ERYTHROCYTE DEVELOPMENT,0.12473,0.080411,0.052437,0,0
6,GO REGULATION OF CILIUM BEAT FREQUENCY,0.14769,0.079403,0.08652,0,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.17934,0.078777,0.074013,0,0
6,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.188,0.078638,0.10746,0,0
6,GO HISTONE UBIQUITINATION,0.070855,0.078599,0.057603,0,0
6,GO REGULATION OF NEUROBLAST PROLIFERATION,0.15517,0.078,0.094867,0,0
6,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.52025,0.077922,0.054106,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.076492,0.077402,0.091815,0,0
6,GO OTIC VESICLE DEVELOPMENT,0.3746,0.076922,0.087206,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.80312,0.076724,-0.006645,0,0
6,GO PROTEIN DEMETHYLATION,0.31232,0.076659,0.052217,0,0
6,GO DENDRITE MORPHOGENESIS,0.17653,0.076199,0.09307,0,0
6,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.11039,0.075243,0.070498,0,0
6,GO TONGUE DEVELOPMENT,0.72969,0.075098,0.0061015,0,0
6,GO SECRETORY GRANULE LOCALIZATION,0.69707,0.074619,0.044664,0,0
6,GO MESODERMAL CELL FATE SPECIFICATION,0.56666,0.073818,0.050609,0,0
6,GO FAT CELL PROLIFERATION,0.29992,0.073712,0.085238,0,0
6,GO AXO DENDRITIC TRANSPORT,0.29184,0.073696,0.05803,0,0
6,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.53742,0.07332,0.041211,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.41341,0.072121,0.049439,0,0
6,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.52594,0.071922,0.01514,0,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.4978,0.071715,0.12914,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.8303,0.071679,-0.02782,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.95466,0.071439,-0.010508,0,0
6,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.48678,0.070848,0.08817,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.41842,0.070764,0.059865,0,0
6,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.60883,0.070728,0.028127,0,0
6,GO HISTONE H3 K9 MODIFICATION,0.027803,0.070623,0.10067,0,0
6,GO CHROMATIN SILENCING,0.065563,0.07048,0.073496,0,0
6,GO PANCREAS DEVELOPMENT,0.48678,0.070065,0.040504,0,0
6,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.13814,0.069824,0.044805,0,0
6,GO NEURAL NUCLEUS DEVELOPMENT,0.17653,0.069467,0.11755,0,0
6,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.065563,0.069302,0.054434,0,0
6,GO DENDRITIC TRANSPORT,0.16559,0.069041,0.12436,0,0
6,GO RESPONSE TO POTASSIUM ION,0.50337,0.068943,0.068888,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.60883,0.068244,0.033811,0,0
6,GO RESPONSE TO DOPAMINE,0.55487,0.068055,0.028451,0,0
6,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0695,0.067625,0.11646,0,0
6,GO MITOTIC SISTER CHROMATID SEGREGATION,0.075049,0.067278,0.062549,0,0
6,GO LIPID DROPLET FORMATION,0.78289,0.067187,-0.051989,0,0
6,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.47588,0.067167,0.041236,0,0
6,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.63978,0.06655,0.047538,0,0
6,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.041093,0.066519,0.087361,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.63354,0.06604,0.034856,0,0
6,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.38888,0.06592,0.055999,0,0
6,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.188,0.065576,0.0718,0,0
6,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.99651,0.065141,0.042094,0,0
6,GO MITOTIC SPINDLE ASSEMBLY,0.29992,0.06504,0.028229,0,0
6,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.89215,0.064557,-0.017519,0,0
6,GO NON RECOMBINATIONAL REPAIR,0.21905,0.064368,0.038991,0,0
6,GO NEURON RECOGNITION,0.21256,0.064218,0.11188,0,0
6,GO ANTEROGRADE AXONAL TRANSPORT,0.17099,0.063987,0.065909,0,0
6,GO SYNAPTIC VESICLE TRANSPORT,0.065563,0.063664,0.13226,0,0
6,GO MICROTUBULE ANCHORING AT CENTROSOME,0.095625,0.063644,0.10455,0,0
6,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.92682,0.063382,0.0075847,0,0
6,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.29184,0.063262,0.050711,0,0
6,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.14048,0.063019,0.13514,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.065563,0.062995,0.069495,0,0
6,GO INSEMINATION,0.78289,0.062962,0.0072892,0,0
6,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.61497,0.062432,0.046836,0,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.4978,0.062409,0.019648,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.17934,0.062394,0.035169,0,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.05824,0.061882,0.053788,0,0
6,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.23589,0.061442,0.064757,0,0
6,GO RNA EXPORT FROM NUCLEUS,0.50896,0.061053,0.017034,0,0
6,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.84397,0.060934,0.0038771,0,0
6,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.038561,0.060384,0.20034,0,0
6,GO MRNA METHYLATION,0.48131,0.060299,0.021937,0,0
6,GO METAPHASE PLATE CONGRESSION,0.20621,0.060288,0.03761,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.30815,0.060274,0.092923,0,0
6,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.25729,0.059877,0.049319,0,0
6,GO RESPONSE TO HYDROXYUREA,0.038561,0.059611,0.15627,0,0
6,GO RESPIRATORY SYSTEM PROCESS,0.41341,0.059272,0.051152,0,0
6,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.53167,0.059201,0.027095,0,0
6,GO T HELPER CELL LINEAGE COMMITMENT,0.42347,0.058913,0.033334,0,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.52025,0.058576,0.016629,0,0
6,GO DNA PACKAGING,0.0090226,0.058161,0.083645,0,0
6,GO RESPONSE TO AUDITORY STIMULUS,0.22905,0.057525,0.15829,0,0
6,GO CHROMATIN DISASSEMBLY,0.61497,0.057267,0.029917,0,0
6,GO SISTER CHROMATID SEGREGATION,0.036948,0.057006,0.066304,0,0
6,GO RESPONSE TO LITHIUM ION,0.46512,0.056877,0.13416,0,0
6,GO CELL CELL JUNCTION MAINTENANCE,0.34256,0.056477,0.099472,0,0
6,GO REGULATION OF DENDRITE MORPHOGENESIS,0.4545,0.056262,0.041401,0,0
6,GO AXONAL TRANSPORT OF MITOCHONDRION,0.99651,0.055986,-0.032733,0,0
6,GO PROTEIN K11 LINKED UBIQUITINATION,0.75615,0.055538,0.0024247,0,0
6,GO OXIDATIVE DEMETHYLATION,0.11039,0.055398,0.069056,0,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.47049,0.055373,0.054258,0,0
6,GO NEGATIVE REGULATION OF DNA BINDING,0.36064,0.055316,0.04641,0,0
6,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.65234,0.055247,0.0068664,0,0
6,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.55487,0.055204,0.020557,0,0
6,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.44924,0.054703,-0.12298,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.44924,0.054373,0.037004,0,0
6,GO EMBRYONIC HEMOPOIESIS,0.65234,0.054335,0.0439,0,0
6,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.43367,0.054214,0.021373,0,0
6,GO PROTEIN MONOUBIQUITINATION,0.2,0.054171,0.026933,0,0
6,GO LUNG CELL DIFFERENTIATION,0.79636,0.053863,0.07846,0,0
6,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.29992,0.053647,0.091604,0,0
6,GO REGULATION OF MICROTUBULE BASED PROCESS,0.29992,0.05354,0.031424,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.75615,0.053251,-0.0013418,0,0
6,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.81668,0.05308,0.0077485,0,0
6,GO METENCEPHALON DEVELOPMENT,0.25363,0.052974,0.065302,0,0
6,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.94073,0.052908,-0.001402,0,0
6,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.095625,0.052631,0.12347,0,0
6,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.50896,0.052625,0.035225,0,0
6,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.47588,0.052449,0.10434,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.32938,0.052395,0.051551,0,0
6,GO MRNA PROCESSING,0.12049,0.052379,0.037369,0,0
6,GO NOREPINEPHRINE SECRETION,0.26847,0.052232,0.078024,0,0
6,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.83713,0.051985,-0.012965,0,0
6,GO MESODERMAL CELL FATE COMMITMENT,0.9686,0.051912,-0.0091096,0,0
6,GO REGULATION OF CIRCADIAN RHYTHM,0.17099,0.051899,0.036966,0,0
6,GO PYRAMIDAL NEURON DIFFERENTIATION,0.60272,0.051769,0.050742,0,0
6,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.13814,0.051717,0.045722,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.54321,0.051637,0.028147,0,0
6,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.39371,0.051142,0.030232,0,0
6,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.54321,0.051086,0.036693,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.15264,0.050627,0.063683,0,0
6,GO DENTATE GYRUS DEVELOPMENT,0.8303,0.050285,-0.037464,0,0
6,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.22905,0.050024,0.072508,0,0
6,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.29992,0.050011,0.057044,0,0
6,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.34702,0.049705,0.043241,0,0
6,GO REGULATION OF ANIMAL ORGAN FORMATION,0.70355,0.049634,9.0173e-05,0,0
6,GO CELL DIFFERENTIATION IN HINDBRAIN,0.21579,0.049549,0.098442,0,0
6,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.32938,0.049343,0.063392,0,0
6,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.98255,0.049,-0.0044181,0,0
6,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.11039,0.048793,0.080628,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.62732,0.048636,-0.062132,0,0
6,GO INNER CELL MASS CELL PROLIFERATION,0.62732,0.048572,-0.0011027,0,0
6,GO DOSAGE COMPENSATION,0.12049,0.04846,0.059529,0,0
6,GO TRANSCYTOSIS,0.71006,0.047945,0.0022709,0,0
6,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.50337,0.047707,0.023203,0,0
6,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.48678,0.047663,0.047214,0,0
6,GO PHOTORECEPTOR CELL MAINTENANCE,0.29992,0.047448,0.041233,0,0
6,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.075049,0.047026,0.072904,0,0
6,GO HINDBRAIN MORPHOGENESIS,0.33373,0.047012,0.041795,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.94769,0.046918,0.033902,0,0
6,GO SPERM AXONEME ASSEMBLY,0.36991,0.046763,0.080643,0,0
6,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.62732,0.046555,0.059907,0,0
6,GO CENTROSOME SEPARATION,0.19393,0.04649,0.09956,0,0
6,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.84397,0.04648,0.022115,0,0
6,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.41341,0.046337,0.05026,0,0
6,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.27999,0.046036,0.081558,0,0
6,GO CHROMOSOME SEGREGATION,0.0695,0.046019,0.047017,0,0
6,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.066855,0.045618,0.12055,0,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.36064,0.045315,0.052591,0,0
6,GO SMOOTHENED SIGNALING PATHWAY,0.56075,0.045121,0.014719,0,0
6,GO DORSAL AORTA DEVELOPMENT,0.96163,0.045042,0.0045161,0,0
6,GO NEURAL PRECURSOR CELL PROLIFERATION,0.16559,0.044715,0.057483,0,0
6,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.30815,0.044585,0.067235,0,0
6,GO MALE SEX DETERMINATION,0.50896,0.044559,0.073975,0,0
6,GO UV DAMAGE EXCISION REPAIR,0.50896,0.044542,0.026705,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.10654,0.044468,0.064482,0,0
6,GO BRAIN MORPHOGENESIS,0.33373,0.044444,0.036941,0,0
6,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.20621,0.044414,0.085636,0,0
6,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.63978,0.044275,0.031307,0,0
6,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.85768,0.044188,0.0023645,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.76948,0.044031,0.025095,0,0
6,GO CILIUM ORGANIZATION,0.11434,0.043466,0.07481,0,0
6,GO CHROMOSOME CONDENSATION,0.095625,0.043203,0.074871,0,0
6,GO REGULATION OF CENTROSOME CYCLE,0.188,0.043096,0.058297,0,0
6,GO PROTEIN LOCALIZATION TO SYNAPSE,0.48678,0.042983,0.06255,0,0
6,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.37932,0.042962,0.073981,0,0
6,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.56666,0.042838,0.0075484,0,0
6,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.40349,0.042617,0.032228,0,0
6,GO CELLULAR RESPONSE TO LITHIUM ION,0.7495,0.042235,0.035094,0,0
6,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.23589,0.041966,0.052338,0,0
6,GO CALCIUM ION IMPORT INTO CYTOSOL,0.91293,0.04169,0.0067158,0,0
6,GO ASTRAL MICROTUBULE ORGANIZATION,0.075049,0.041564,0.12162,0,0
6,GO SNORNA 3 END PROCESSING,0.41842,0.040992,0.067073,0,0
6,GO MITOTIC METAPHASE PLATE CONGRESSION,0.11841,0.04094,0.063304,0,0
6,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.18219,0.040622,0.03231,0,0
6,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.52594,0.040433,0.025785,0,0
6,GO NUCLEAR CHROMOSOME SEGREGATION,0.082489,0.040325,0.047691,0,0
6,GO MATERNAL PLACENTA DEVELOPMENT,0.75615,0.040184,0.0227,0,0
6,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.56075,0.040085,0.039883,0,0
6,GO POSTSYNAPSE ASSEMBLY,0.69061,0.039747,0.046292,0,0
6,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.79636,0.039506,-0.01236,0,0
6,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.73628,0.039325,0.0046976,0,0
6,GO ERROR PRONE TRANSLESION SYNTHESIS,0.32506,0.039191,0.046986,0,0
6,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.76948,0.039029,0.029023,0,0
6,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.78962,0.038779,-0.027178,0,0
6,GO 3 UTR MEDIATED MRNA STABILIZATION,0.50896,0.038712,0.03373,0,0
6,GO IMMATURE B CELL DIFFERENTIATION,0.71006,0.038633,0.03666,0,0
6,GO DOUBLE STRAND BREAK REPAIR,0.05824,0.038609,0.047289,0,0
6,GO IMMUNOLOGICAL MEMORY PROCESS,0.63354,0.038474,0.040152,0,0
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.46512,0.038428,0.017983,0,0
6,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.74288,0.038271,0.039201,0,0
6,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.82348,0.03826,-0.0085917,0,0
6,GO NCRNA TRANSCRIPTION,0.60272,0.038185,0.011703,0,0
6,GO DIGESTIVE TRACT MORPHOGENESIS,0.85768,0.038129,-0.0064029,0,0
6,GO AROMATIC AMINO ACID TRANSPORT,0.98255,0.038067,-0.047165,0,0
6,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.75615,0.037949,0.0083733,0,0
6,GO REGULATION OF SPINDLE ORGANIZATION,0.83713,0.037852,0.0030269,0,0
6,GO POSITIVE T CELL SELECTION,0.41341,0.037788,0.030339,0,0
6,GO REGULATION OF COLLATERAL SPROUTING,0.47588,0.03778,0.055975,0,0
6,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.57857,0.037605,0.058953,0,0
6,GO PARTURITION,0.76281,0.037549,-0.0020992,0,0
6,GO DNA METHYLATION,0.82348,0.0375,0.012777,0,0
6,GO UTERUS DEVELOPMENT,0.80312,0.037289,0.024354,0,0
6,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.38408,0.036987,0.03327,0,0
6,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.2839,0.036816,0.019807,0,0
6,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.27227,0.036731,0.043582,0,0
6,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.20621,0.036612,0.030474,0,0
6,GO MITOTIC CELL CYCLE CHECKPOINT,0.17934,0.036377,0.034034,0,0
6,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.30402,0.03616,0.073085,0,0
6,GO HISTONE H3 K14 ACETYLATION,0.30815,0.036064,0.045362,0,0
6,GO MEIOTIC CHROMOSOME SEGREGATION,0.32938,0.035789,0.036316,0,0
6,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.17374,0.035746,0.038612,0,0
6,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.74288,0.035284,0.0010763,0,0
6,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.42855,0.035099,0.042796,0,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.63978,0.034988,0.039684,0,0
6,GO RENAL WATER HOMEOSTASIS,0.41341,0.034951,0.052925,0,0
6,GO TRANSPORT ALONG MICROTUBULE,0.14285,0.03493,0.052183,0,0
6,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.4598,0.034452,0.059198,0,0
6,GO HISTONE H3 ACETYLATION,0.3746,0.034399,0.020126,0,0
6,GO CEREBRAL CORTEX DEVELOPMENT,0.66501,0.03427,0.020732,0,0
6,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.79636,0.034263,-0.040511,0,0
6,GO REGULATION OF TRANSPOSITION,0.85082,0.034244,-0.043136,0,0
6,GO REGULATION OF MESODERM DEVELOPMENT,0.54903,0.034214,0.038654,0,0
6,GO REGULATION OF ODONTOGENESIS,0.72969,0.034106,-0.056416,0,0
6,GO HINDBRAIN DEVELOPMENT,0.43883,0.034104,0.046173,0,0
6,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.87144,0.033612,0.0028104,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.91987,0.033567,-0.005238,0,0
6,GO REGULATION OF AXONOGENESIS,0.82348,0.033526,0.015773,0,0
6,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.94073,0.033375,-0.022133,0,0
6,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.89215,0.032958,-0.0017201,0,0
6,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.21579,0.032383,0.034962,0,0
6,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.85082,0.032382,0.030316,0,0
6,GO MAGNESIUM ION HOMEOSTASIS,0.80989,0.03237,-0.039334,0,0
6,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.97557,0.03218,-0.021442,0,0
6,GO CAMERA TYPE EYE MORPHOGENESIS,0.41842,0.031762,0.026553,0,0
6,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.50896,0.031685,0.056457,0,0
6,GO SUBSTANTIA NIGRA DEVELOPMENT,0.63978,0.031616,0.023876,0,0
6,GO CARDIAC ATRIUM DEVELOPMENT,0.43367,0.03157,0.053678,0,0
6,GO DEMETHYLATION,0.48131,0.031288,0.017491,0,0
6,GO REGULATION OF HISTONE METHYLATION,0.092194,0.031257,0.070437,0,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.88523,0.031126,-0.0095067,0,0
6,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.98953,0.031097,-0.01305,0,0
6,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.68418,0.031091,0.055076,0,0
6,GO CHROMOSOME ORGANIZATION,0.10465,0.031072,0.025509,0,0
6,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.38888,0.030787,0.05044,0,0
6,GO CHROMATIN SILENCING AT TELOMERE,0.91987,0.030476,0.011419,0,0
6,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.94769,0.030422,-0.0058791,0,0
6,GO REGULATION OF SPINDLE CHECKPOINT,0.40843,0.030394,0.043942,0,0
6,GO LEFT RIGHT PATTERN FORMATION,0.94769,0.030164,3.2626e-05,0,0
6,GO REGULATION OF HISTONE PHOSPHORYLATION,0.70355,0.030126,-0.057089,0,0
6,GO NOTCH RECEPTOR PROCESSING,0.51459,0.030091,0.05711,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.36991,0.029971,-0.072699,0,0
6,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.84397,0.029932,-0.00086855,0,0
6,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.35607,0.029665,0.062021,0,0
6,GO MITOTIC SPINDLE ORGANIZATION,0.67137,0.029455,0.0047437,0,0
6,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.33812,0.029404,0.033871,0,0
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,1,0.029401,-0.016457,0,0
6,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.67776,0.029394,0.013277,0,0
6,GO RNA CAPPING,0.93377,0.029243,-0.0077779,0,0
6,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.97557,0.029117,0.023706,0,0
6,GO OLIGODENDROCYTE DIFFERENTIATION,0.98953,0.029046,-0.0032707,0,0
6,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.41842,0.028956,0.027513,0,0
6,GO REGULATION OF CHROMATIN BINDING,0.63978,0.028881,0.030249,0,0
6,GO P BODY ASSEMBLY,0.39858,0.02874,0.028186,0,0
6,GO CELLULAR COMPONENT MAINTENANCE,0.48678,0.028612,0.045245,0,0
6,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.67137,0.028546,0.014443,0,0
6,GO PALLIUM DEVELOPMENT,0.68418,0.028451,0.020948,0,0
6,GO INNER DYNEIN ARM ASSEMBLY,0.77618,0.027981,0.091094,0,0
6,GO COVALENT CHROMATIN MODIFICATION,0.10096,0.027949,0.03414,0,0
6,GO NEURON PROJECTION GUIDANCE,0.69707,0.027829,0.02236,0,0
6,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.44924,0.027465,0.041899,0,0
6,GO NATURAL KILLER CELL DIFFERENTIATION,0.88523,0.027116,0.010177,0,0
6,GO HIPPOCAMPUS DEVELOPMENT,0.48678,0.026985,0.032422,0,0
6,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.97557,0.02692,0.0034986,0,0
6,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.64605,0.026445,0.034456,0,0
6,GO CELL FATE COMMITMENT,0.56075,0.026355,0.01199,0,0
6,GO RESPONSE TO FOOD,0.62732,0.02596,0.022882,0,0
6,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.4598,0.025705,0.04139,0,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.30402,0.025656,0.062905,0,0
6,GO DENDRITE DEVELOPMENT,0.46512,0.025559,0.047439,0,0
6,GO REGULATION OF CENTROSOME DUPLICATION,0.56075,0.025558,0.033243,0,0
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.44924,0.025433,0.0072306,0,0
6,GO REGULATION OF CELL MATURATION,0.76281,0.025396,0.012707,0,0
6,GO OOGENESIS,0.76948,0.02532,0.016275,0,0
6,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.62732,0.025289,0.024665,0,0
6,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.75615,0.025158,0.012358,0,0
6,GO MYELOID CELL DEVELOPMENT,0.44402,0.025049,0.028515,0,0
6,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.31653,0.024872,0.065079,0,0
6,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.34256,0.024826,0.10789,0,0
6,GO REGULATION OF CHROMOSOME SEGREGATION,0.54321,0.024777,0.025915,0,0
6,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.95466,0.024765,-0.04705,0,0
6,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.95466,0.024728,-0.022638,0,0
6,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.56075,0.024664,0.028314,0,0
6,GO DNA REPAIR,0.17653,0.024574,0.02368,0,0
6,GO RNA 3 END PROCESSING,0.9686,0.024382,-0.010468,0,0
6,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.15015,0.024361,-0.20237,0,0
6,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.71006,0.02428,0.0046902,0,0
6,GO NEUROTROPHIN SIGNALING PATHWAY,0.8303,0.024219,0.0078433,0,0
6,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.78962,0.024065,-0.066666,0,0
6,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.93377,0.023724,-0.00050317,0,0
6,GO REPRODUCTIVE BEHAVIOR,0.85082,0.023641,-0.01857,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.80312,0.023412,-0.0025993,0,0
6,GO PROTEIN LOCALIZATION TO CILIUM,0.26847,0.023121,0.081925,0,0
6,GO PITUITARY GLAND DEVELOPMENT,0.59059,0.022893,0.050034,0,0
6,GO SPLEEN DEVELOPMENT,0.86455,0.022887,0.0075703,0,0
6,GO DNA GEOMETRIC CHANGE,0.58456,0.02282,0.017214,0,0
6,GO MRNA TRANSPORT,0.88523,0.022756,-0.0070144,0,0
6,GO T CELL LINEAGE COMMITMENT,0.65866,0.022719,0.025817,0,0
6,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.91987,0.022545,0.00058805,0,0
6,GO T CELL SELECTION,0.60272,0.022542,0.027671,0,0
6,GO PROTEIN NEDDYLATION,0.95466,0.022477,-0.016737,0,0
6,GO POSITIVE REGULATION OF AXONOGENESIS,0.57857,0.022431,0.038357,0,0
6,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.38888,0.022372,0.022285,0,0
6,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.36991,0.022344,0.11395,0,0
6,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.94769,0.022268,-0.012866,0,0
6,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.88523,0.02209,0.039652,0,0
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.49227,0.022085,0.032995,0,0
6,GO REGULATION OF MRNA POLYADENYLATION,0.40843,0.022048,0.025449,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.56075,0.021711,0.025581,0,0
6,GO AMINE BIOSYNTHETIC PROCESS,0.91987,0.021508,-0.0055151,0,0
6,GO DENDRITIC SPINE DEVELOPMENT,0.70355,0.02145,-0.03519,0,0
6,GO HISTONE DEUBIQUITINATION,0.78962,0.021439,0.007017,0,0
6,GO PROTEIN INSERTION INTO MEMBRANE,0.47588,0.021235,0.02837,0,0
6,GO PHAGOSOME ACIDIFICATION,0.99651,0.020982,-0.020283,0,0
6,GO REGULATION OF CYTOKINESIS,0.77618,0.020645,-0.0024313,0,0
6,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.97557,0.020504,-0.004486,0,0
6,GO REGULATION OF DNA METABOLIC PROCESS,0.44924,0.020359,0.01002,0,0
6,GO ECTODERM DEVELOPMENT,0.66501,0.020182,0.00036367,0,0
6,GO POSITIVE REGULATION OF RNA SPLICING,0.63354,0.020003,0.017858,0,0
6,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.87144,0.019954,-0.033596,0,0
6,GO CELLULAR RESPONSE TO X RAY,0.89907,0.019887,-0.044461,0,0
6,GO STEM CELL PROLIFERATION,0.33373,0.01978,0.031366,0,0
6,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.89907,0.01977,-0.028988,0,0
6,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.80312,0.019284,-0.0096841,0,0
6,GO MICROTUBULE NUCLEATION,0.77618,0.019108,-0.017825,0,0
6,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.52025,0.019072,-0.072273,0,0
6,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.48678,0.018924,0.043293,0,0
6,GO ENDODERMAL CELL FATE COMMITMENT,0.71006,0.018771,-0.025202,0,0
6,GO MULTICELLULAR ORGANISM AGING,0.58456,0.018723,-0.033425,0,0
6,GO REGULATION OF NEURON PROJECTION REGENERATION,0.97557,0.018542,-0.0040276,0,0
6,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.82348,0.018168,0.0078855,0,0
6,GO STRIATUM DEVELOPMENT,0.83713,0.018156,-0.031369,0,0
6,GO RESPONSE TO COCAINE,0.9686,0.01813,0.014005,0,0
6,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.52025,0.018048,0.048303,0,0
6,GO ADRENAL GLAND DEVELOPMENT,0.88523,0.018036,0.0024112,0,0
6,GO REGULATION OF NEURON MIGRATION,0.4978,0.018035,0.039387,0,0
6,GO DNA RECOMBINATION,0.17374,0.017825,0.032223,0,0
6,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.69061,0.017804,0.056116,0,0
6,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.36526,0.017643,0.02987,0,0
6,GO TELOMERE CAPPING,0.4978,0.017522,0.023241,0,0
6,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.63354,0.017437,0.013956,0,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.71658,0.017267,-0.027232,0,0
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.94769,0.017059,0.016517,0,0
6,GO MICROTUBULE BASED PROCESS,0.63978,0.01688,0.015149,0,0
6,GO DNA DEMETHYLATION,0.53742,0.016693,0.027233,0,0
6,GO NEGATIVE REGULATION OF DNA REPAIR,0.85082,0.016663,-0.01581,0,0
6,GO HETEROCHROMATIN ORGANIZATION,0.14526,0.016597,0.060371,0,0
6,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.68418,0.016445,0.061741,0,0
6,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.52025,0.016215,-0.032197,0,0
6,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.98255,0.016066,-0.052172,0,0
6,GO TELOMERIC LOOP DISASSEMBLY,0.67776,0.016047,0.026707,0,0
6,GO CLATHRIN COAT ASSEMBLY,0.87833,0.01581,0.02366,0,0
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.31232,0.015772,0.032119,0,0
6,GO MITRAL VALVE DEVELOPMENT,0.84397,0.015636,-0.019889,0,0
6,GO MICROTUBULE BUNDLE FORMATION,0.39371,0.015466,0.079705,0,0
6,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.76281,0.015442,-0.0075052,0,0
6,GO REGULATION OF CHROMOSOME SEPARATION,0.94073,0.015097,-0.00059133,0,0
6,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.92682,0.015053,-0.013155,0,0
6,GO REGULATION OF HISTONE MODIFICATION,0.8303,0.014848,0.0027819,0,0
6,GO REGULATION OF RECEPTOR INTERNALIZATION,0.73628,0.014171,-0.029431,0,0
6,GO SPINDLE ORGANIZATION,0.70355,0.014062,0.0045983,0,0
6,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.89907,0.013872,0.0032026,0,0
6,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.85082,0.013602,0.013503,0,0
6,GO NEURON MIGRATION,0.33373,0.0135,0.092166,0,0
6,GO DORSAL SPINAL CORD DEVELOPMENT,0.55487,0.013499,0.11351,0,0
6,GO REGULATION OF DNA RECOMBINATION,0.53167,0.013457,0.0099281,0,0
6,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.99651,0.013437,-0.056084,0,0
6,GO AXONAL FASCICULATION,0.89215,0.013388,0.0074479,0,0
6,GO FOREBRAIN DEVELOPMENT,0.69061,0.013351,0.016461,0,0
6,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.65234,0.013069,0.0093714,0,0
6,GO PROTEIN SUMOYLATION,0.91293,0.012951,-0.00013337,0,0
6,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.80989,0.012815,0.013192,0,0
6,GO NEGATIVE REGULATION OF ERAD PATHWAY,1,0.012778,-0.019423,0,0
6,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.20937,0.012653,-0.15893,0,0
6,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.80312,0.012325,-0.049541,0,0
6,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.53167,0.012172,0.045469,0,0
6,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.44924,0.012078,-0.063595,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.34256,0.012055,0.094591,0,0
6,GO HISTONE H3 DEACETYLATION,0.47049,0.011863,-0.032612,0,0
6,GO CELLULAR RESPONSE TO VITAMIN,0.9686,0.011808,-0.043016,0,0
6,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.91293,0.011763,0.0071117,0,0
6,GO DETECTION OF VISIBLE LIGHT,0.62113,0.011543,0.0016731,0,0
6,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,1,0.011524,-0.0033873,0,0
6,GO SYNAPTIC VESICLE MATURATION,0.94073,0.01147,0.055281,0,0
6,GO REGULATION OF CELL FATE COMMITMENT,0.92682,0.011444,0.0073903,0,0
6,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.64605,0.011439,0.01116,0,0
6,GO SUCKLING BEHAVIOR,0.82348,0.011409,0.027842,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.37932,0.01139,-0.076404,0,0
6,GO SPINDLE LOCALIZATION,0.93377,0.011378,0.0044468,0,0
6,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.59664,0.01136,-0.034148,0,0
6,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.78962,0.011358,0.012405,0,0
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.87833,0.011232,-0.0038434,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.65234,0.011132,-0.067285,0,0
6,GO DNA METABOLIC PROCESS,0.98255,0.011018,-0.0033859,0,0
6,GO MEIOTIC SPINDLE ORGANIZATION,1,0.010855,-0.0060204,0,0
6,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.96163,0.010848,0.0027313,0,0
6,GO CELL CYCLE G2 M PHASE TRANSITION,0.60272,0.010642,0.0069044,0,0
6,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.81668,0.010475,-0.0078282,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.69061,0.010119,-0.049299,0,0
6,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.96163,0.010113,2.8806e-05,0,0
6,GO MITOTIC NUCLEAR DIVISION,0.43367,0.010072,0.02313,0,0
6,GO REGULATION OF FIBROBLAST MIGRATION,0.96163,0.010014,-0.027422,0,0
6,GO MEGAKARYOCYTE DIFFERENTIATION,0.8303,0.0098229,0.0045139,0,0
6,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.63978,0.0097055,0.0063466,0,0
6,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.65234,0.009633,0.018098,0,0
6,GO REGULATION OF MITOTIC CELL CYCLE,0.42347,0.0095393,-0.024095,0,0
6,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.36064,0.0095074,-0.046476,0,0
6,GO VISUAL BEHAVIOR,0.86455,0.0092512,-0.0071527,0,0
6,GO DNA CATABOLIC PROCESS,0.59664,0.0089392,0.020812,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.62113,0.0086197,0.021361,0,0
6,GO RESPONSE TO CATECHOLAMINE,0.66501,0.0085754,-0.024864,0,0
6,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.59059,0.0085327,-0.046552,0,0
6,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.73628,0.008486,-0.10512,0,0
6,GO APPENDAGE MORPHOGENESIS,0.80312,0.0084306,-0.0066754,0,0
6,GO CEREBRAL CORTEX CELL MIGRATION,0.85768,0.008349,-0.011616,0,0
6,GO CIRCADIAN RHYTHM,0.31653,0.0082685,-0.046812,0,0
6,GO REGULATION OF SPINDLE ASSEMBLY,0.96163,0.0081677,-0.018883,0,0
6,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.50337,0.0080185,0.03073,0,0
6,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.75615,0.0080183,-0.041482,0,0
6,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.87833,0.0078669,-0.025003,0,0
6,GO CENTRIOLE CENTRIOLE COHESION,0.28785,0.0077789,0.082762,0,0
6,GO PHOTOPERIODISM,0.70355,0.0077406,-0.02432,0,0
6,GO MICROTUBULE POLYMERIZATION,0.99651,0.0077295,-0.00032413,0,0
6,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.80312,0.0076711,-0.010274,0,0
6,GO ERROR FREE TRANSLESION SYNTHESIS,0.72313,0.0075882,-0.027756,0,0
6,GO SYNAPTIC VESICLE PRIMING,0.99651,0.0074894,0.068822,0,0
6,GO REGULATION OF PROTEIN SUMOYLATION,0.65866,0.0074047,-0.024116,0,0
6,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.48678,0.0073303,0.062087,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.68418,0.0073287,0.02284,0,0
6,GO REPLICATIVE SENESCENCE,0.32506,0.0071939,-0.13766,0,0
6,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.87144,0.0071646,0.014658,0,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.57857,0.0070509,0.018681,0,0
6,GO MICROTUBULE BASED TRANSPORT,0.36526,0.006862,0.036847,0,0
6,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.68418,0.0068484,-0.022472,0,0
6,GO RESPONSE TO INACTIVITY,0.60272,0.0068093,-0.07706,0,0
6,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.59664,0.0065413,0.10653,0,0
6,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.72313,0.0064373,-0.016786,0,0
6,GO SPINDLE ASSEMBLY,0.72969,0.0060739,0.0073723,0,0
6,GO REGULATION OF GOLGI ORGANIZATION,0.79636,0.0059992,0.018974,0,0
6,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.89907,0.0059142,-0.033797,0,0
6,GO DNA DEALKYLATION,0.91987,0.0058135,-0.0037434,0,0
6,GO MALE GAMETE GENERATION,0.63978,0.0057034,-0.016693,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.75615,0.0056635,0.025672,0,0
6,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.79636,0.0056276,0.038887,0,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.29184,0.0055145,0.08185,0,0
6,GO EYE MORPHOGENESIS,0.80989,0.0054502,-0.00094512,0,0
6,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.85768,0.0054063,-0.0050394,0,0
6,GO TELENCEPHALON DEVELOPMENT,0.80989,0.0053775,0.0071769,0,0
6,GO GENE SILENCING,0.67776,0.0053355,-0.014432,0,0
6,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.69061,0.0053224,-0.011574,0,0
6,GO CELL PROLIFERATION IN FOREBRAIN,0.80312,0.004961,-0.007757,0,0
6,GO NUCLEAR BODY ORGANIZATION,0.71658,0.004624,0.028552,0,0
6,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.94073,0.0046045,0.035245,0,0
6,GO PHOTOTRANSDUCTION,0.81668,0.0043157,-0.026461,0,0
6,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.56075,0.0042931,-0.024724,0,0
6,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.44924,0.0041946,-0.035225,0,0
6,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.64605,0.0041524,0.093998,0,0
6,GO REGULATION OF LIGASE ACTIVITY,0.68418,0.0040852,-0.04853,0,0
6,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.98953,0.0040119,0.029792,0,0
6,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.4978,0.003995,-0.032239,0,0
6,GO DISTAL TUBULE DEVELOPMENT,0.69707,0.0039225,0.0097176,0,0
6,GO NEURON PROJECTION ORGANIZATION,0.91987,0.0037366,-0.012256,0,0
6,GO DETERMINATION OF ADULT LIFESPAN,0.69707,0.0033718,-0.029044,0,0
6,GO REGULATION OF DNA BINDING,0.80989,0.0033538,0.0062847,0,0
6,GO NEURAL CREST FORMATION,0.88523,0.0032835,0.014522,0,0
6,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.83713,0.0030706,0.014489,0,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.73628,0.0030072,-0.00093082,0,0
6,GO REGULATION OF SENSORY PERCEPTION,0.29184,0.0028578,-0.075887,0,0
6,GO ROOF OF MOUTH DEVELOPMENT,0.89215,0.0025864,0.0035104,0,0
6,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.69061,0.0025323,0.035288,0,0
6,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.63978,0.0024794,0.056714,0,0
6,GO PROXIMAL DISTAL PATTERN FORMATION,0.59664,0.0024344,0.063937,0,0
6,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.9686,0.002336,-0.032242,0,0
6,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.84397,0.0022929,0.002439,0,0
6,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.8303,0.0020487,-0.016722,0,0
6,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.81668,0.0020362,0.0084771,0,0
6,GO NEGATIVE T CELL SELECTION,0.83713,0.0016768,-0.062109,0,0
6,GO EMBRYONIC AXIS SPECIFICATION,0.53167,0.0016639,-0.039292,0,0
6,GO SOMITE DEVELOPMENT,0.50896,0.0016402,-0.043073,0,0
6,GO REGULATION OF EXTENT OF CELL GROWTH,0.66501,0.0013691,-0.025884,0,0
6,GO REGULATION OF CHROMATIN ORGANIZATION,0.94769,0.0013444,-0.0006733,0,0
6,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.87833,0.0011127,-0.010301,0,0
6,GO SULFATION,0.8303,0.001101,-0.022469,0,0
6,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.41842,0.001082,0.093228,0,0
6,GO PROTEIN K48 LINKED UBIQUITINATION,0.91293,0.0010611,-0.012861,0,0
6,GO CELL PROLIFERATION IN HINDBRAIN,0.65866,0.00085196,0.042382,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.65866,0.00045416,0.012421,0,0
6,GO DETECTION OF ABIOTIC STIMULUS,0.56666,0.00044403,-0.019978,0,0
6,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.29992,0.00021558,-0.093312,0,0
6,GO POSITIVE REGULATION OF DNA BINDING,0.98953,0.00018966,0.00055202,0,0
6,GO MALE MEIOSIS I,0.67137,0.00015913,-0.060532,0,0
6,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.98255,-6.3461e-05,-0.0066929,0,0
6,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.82348,-0.00010375,0.00070964,0,0
6,GO CELLULAR RESPONSE TO VITAMIN D,0.94073,-0.00033488,-0.020733,0,0
6,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.71006,-0.00036798,0.020726,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.41341,-0.00046375,-0.049303,0,0
6,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.63354,-0.00048821,0.026706,0,0
6,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.41341,-0.0005193,-0.10789,0,0
6,GO GAMETE GENERATION,0.73628,-0.00073838,-0.010852,0,0
6,GO SEROTONIN TRANSPORT,0.80312,-0.00084754,-0.050006,0,0
6,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.94073,-0.0010382,-0.021487,0,0
6,GO ORGANELLE LOCALIZATION,0.2839,-0.0010384,-0.022536,0,0
6,GO VESICLE CYTOSKELETAL TRAFFICKING,0.81668,-0.0011678,0.016233,0,0
6,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.84397,-0.0012745,-0.0087083,0,0
6,GO DNA METHYLATION OR DEMETHYLATION,0.67137,-0.0015056,0.014174,0,0
6,GO LEFT RIGHT AXIS SPECIFICATION,0.72969,-0.00151,-0.052652,0,0
6,GO APOPTOTIC DNA FRAGMENTATION,0.8303,-0.001539,-0.0038482,0,0
6,GO REGULATION OF GLUTAMATE SECRETION,0.24643,-0.0016738,0.17907,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.36526,-0.0016829,-0.036221,0,0
6,GO NUCLEOTIDE EXCISION REPAIR,0.9686,-0.0016958,-0.0016275,0,0
6,GO DIENCEPHALON DEVELOPMENT,0.61497,-0.0018012,0.045361,0,0
6,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.69061,-0.0018018,-0.017935,0,0
6,GO RESPONSE TO ETHER,0.97557,-0.0018388,0.0027757,0,0
6,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.76281,-0.0018558,-0.027393,0,0
6,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.32938,-0.0019928,-0.090757,0,0
6,GO CYTOKINESIS,0.52025,-0.0022524,-0.024687,0,0
6,GO LONG TERM SYNAPTIC POTENTIATION,0.60272,-0.002494,-0.042555,0,0
6,GO REGULATION OF CHROMATIN ASSEMBLY,0.9686,-0.002534,0.007122,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.50896,-0.0026263,-0.027852,0,0
6,GO GMP METABOLIC PROCESS,0.89907,-0.002654,-0.020485,0,0
6,GO SECRETORY GRANULE ORGANIZATION,0.87144,-0.0026978,-0.017186,0,0
6,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.87833,-0.002818,-0.069829,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.84397,-0.0031439,0.019389,0,0
6,GO REGULATION OF SYNAPTIC PLASTICITY,0.94769,-0.0032189,0.0033609,0,0
6,GO SHORT TERM MEMORY,0.65234,-0.0035064,0.02898,0,0
6,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.30815,-0.0035446,0.13357,0,0
6,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.77618,-0.0037153,-0.0050339,0,0
6,GO REGULATION OF CELL CYCLE PROCESS,0.66501,-0.0039861,-0.014975,0,0
6,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.87144,-0.0040588,-0.018359,0,0
6,GO REGULATION OF CELL CYCLE,0.17934,-0.004061,-0.031889,0,0
6,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.95466,-0.0040941,-0.005535,0,0
6,GO MEMBRANE HYPERPOLARIZATION,0.43883,-0.0042289,-0.095328,0,0
6,GO MITOCHONDRION LOCALIZATION,0.92682,-0.0042296,0.0059408,0,0
6,GO MAINTENANCE OF CELL NUMBER,0.60883,-0.0042654,-0.040566,0,0
6,GO COLLATERAL SPROUTING,0.69061,-0.0043095,-0.017307,0,0
6,GO GRANULOCYTE DIFFERENTIATION,0.21579,-0.0044369,-0.10312,0,0
6,GO RESPONSE TO NERVE GROWTH FACTOR,0.5726,-0.0046022,0.038068,0,0
6,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.50337,-0.0048515,0.069362,0,0
6,GO PERICARDIUM DEVELOPMENT,0.64605,-0.0049451,-0.045134,0,0
6,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.76948,-0.0050971,0.042286,0,0
6,GO NEUROBLAST PROLIFERATION,0.51459,-0.0054861,0.046035,0,0
6,GO AXON DEVELOPMENT,0.94769,-0.0057366,0.006767,0,0
6,GO TRANSPOSITION,1,-0.0057428,-0.0072134,0,0
6,GO GERM CELL DEVELOPMENT,0.78962,-0.0058289,0.017794,0,0
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.78289,-0.0059124,0.044355,0,0
6,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.93377,-0.0060631,-0.0151,0,0
6,GO COPULATION,0.53167,-0.006072,0.046763,0,0
6,GO DRINKING BEHAVIOR,0.3746,-0.0062278,-0.10495,0,0
6,GO MEIOSIS I CELL CYCLE PROCESS,0.98953,-0.006435,0.0029867,0,0
6,GO MITOTIC CELL CYCLE,0.48131,-0.0065397,-0.022099,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.9686,-0.0066003,-0.0077236,0,0
6,GO CELL CYCLE PHASE TRANSITION,0.57857,-0.0066149,-0.021004,0,0
6,GO CARTILAGE MORPHOGENESIS,0.88523,-0.0066979,0.010004,0,0
6,GO REGULATION OF DENDRITE DEVELOPMENT,0.81668,-0.0068189,0.016352,0,0
6,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.79636,-0.0068607,0.024462,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.87833,-0.0071062,-0.0072316,0,0
6,GO REGULATION OF AMINO ACID TRANSPORT,0.92682,-0.0073004,0.002167,0,0
6,GO BONE CELL DEVELOPMENT,0.8303,-0.0073455,0.0030603,0,0
6,GO MULTIVESICULAR BODY ORGANIZATION,0.9686,-0.0073519,0.0038442,0,0
6,GO REGULATION OF CELL CYCLE ARREST,0.83713,-0.0073838,-0.0064801,0,0
6,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.71658,-0.0073956,-0.032324,0,0
6,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.91987,-0.0074541,-0.056219,0,0
6,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.75615,-0.007579,-0.010103,0,0
6,GO ADULT HEART DEVELOPMENT,0.90599,-0.0075896,-0.018146,0,0
6,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.59059,-0.0076195,-0.031457,0,0
6,GO SOMATIC STEM CELL DIVISION,0.54321,-0.0076638,0.12322,0,0
6,GO TRANSCRIPTION BY RNA POLYMERASE III,0.4598,-0.0077006,-0.034455,0,0
6,GO CHROMOSOME SEPARATION,0.59664,-0.0077159,0.022534,0,0
6,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.94073,-0.007723,-0.01376,0,0
6,GO POSITIVE REGULATION OF CELL DIVISION,0.91293,-0.0078062,-0.022152,0,0
6,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.71006,-0.0079377,-0.015971,0,0
6,GO HISTONE H3 K9 DEMETHYLATION,0.68418,-0.0082402,-0.018479,0,0
6,GO RETINOIC ACID METABOLIC PROCESS,0.7495,-0.008357,-0.038205,0,0
6,GO POTASSIUM ION HOMEOSTASIS,0.86455,-0.008539,-0.018244,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.31232,-0.008576,-0.097284,0,0
6,GO REGULATION OF DNA CATABOLIC PROCESS,0.59664,-0.0087678,-0.02023,0,0
6,GO REGULATION OF CHROMOSOME ORGANIZATION,0.94769,-0.0087815,0.0053344,0,0
6,GO MIDDLE EAR MORPHOGENESIS,0.81668,-0.0088361,-0.04664,0,0
6,GO DETECTION OF LIGHT STIMULUS,0.7495,-0.0088382,-0.031505,0,0
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.59664,-0.0090746,-0.033036,0,0
6,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.99651,-0.0091361,-0.028001,0,0
6,GO EMBRYONIC EYE MORPHOGENESIS,0.69707,-0.0092857,0.020867,0,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.35607,-0.0093343,-0.10573,0,0
6,GO RECEPTOR CLUSTERING,0.88523,-0.0094306,0.0073358,0,0
6,GO SYNAPTIC VESICLE BUDDING,0.59664,-0.0094909,-0.03815,0,0
6,GO REGULATION OF NEURON DIFFERENTIATION,0.71006,-0.0095447,-0.013203,0,0
6,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.59664,-0.0097441,-0.040749,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.9686,-0.009832,-0.002608,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.98953,-0.0098367,-0.01164,0,0
6,GO CELL DIVISION,0.89215,-0.0098541,-0.0041,0,0
6,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.4598,-0.0098696,-0.097343,0,0
6,GO MRNA CLEAVAGE,0.70355,-0.0099233,-0.0115,0,0
6,GO INTRACELLULAR MRNA LOCALIZATION,0.78962,-0.009937,-0.031459,0,0
6,GO REGULATION OF HIPPO SIGNALING,0.13355,-0.010256,-0.17546,0,0
6,GO QUINONE METABOLIC PROCESS,0.38888,-0.010312,-0.14568,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.65234,-0.010326,-0.04831,0,0
6,GO ADULT BEHAVIOR,0.85768,-0.010358,0.017773,0,0
6,GO ADHERENS JUNCTION ORGANIZATION,0.53742,-0.010376,-0.027033,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.38888,-0.010531,-0.090582,0,0
6,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.79636,-0.010689,-0.020911,0,0
6,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.72313,-0.010725,-0.022076,0,0
6,GO PROTEIN DENEDDYLATION,0.78962,-0.010766,-0.016984,0,0
6,GO REGULATION OF GLUCOSE IMPORT,0.36064,-0.010916,-0.042371,0,0
6,GO AMMONIUM TRANSPORT,0.68418,-0.011019,-0.025253,0,0
6,GO G2 DNA DAMAGE CHECKPOINT,0.69707,-0.011029,-0.019361,0,0
6,GO CELL PROJECTION ASSEMBLY,0.39858,-0.01106,-0.022403,0,0
6,GO MEIOTIC CELL CYCLE PROCESS,0.62113,-0.011126,-0.01161,0,0
6,GO REGIONALIZATION,0.62113,-0.011279,-0.026921,0,0
6,GO FOREBRAIN NEURON DEVELOPMENT,0.89907,-0.011324,0.03698,0,0
6,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.89907,-0.011644,0.0078276,0,0
6,GO POSITIVE REGULATION OF BONE RESORPTION,0.66501,-0.011672,-0.03995,0,0
6,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.39858,-0.011857,-0.069039,0,0
6,GO AXON EXTENSION,0.56075,-0.011971,-0.032908,0,0
6,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.88523,-0.01204,0.020162,0,0
6,GO EXCITATORY SYNAPSE ASSEMBLY,0.9686,-0.012094,-0.0071614,0,0
6,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.4978,-0.012178,-0.066537,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.87144,-0.012265,0.018108,0,0
6,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.52025,-0.012276,-0.010186,0,0
6,GO CELL PART MORPHOGENESIS,0.9686,-0.012319,0.0081911,0,0
6,GO HEAD DEVELOPMENT,0.68418,-0.012408,-0.0094017,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE,0.21905,-0.012471,-0.02655,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.67137,-0.012551,-0.014756,0,0
6,GO OTIC VESICLE MORPHOGENESIS,0.87833,-0.01258,-0.011136,0,0
6,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.38408,-0.012681,-0.040801,0,0
6,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.4545,-0.012701,-0.069714,0,0
6,GO MYOTUBE CELL DEVELOPMENT,0.82348,-0.012723,-0.022987,0,0
6,GO REGULATION OF TELOMERE CAPPING,0.59059,-0.012736,-0.024125,0,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.39371,-0.012815,-0.042784,0,0
6,GO MITOCHONDRIAL GENOME MAINTENANCE,0.54321,-0.012873,0.030093,0,0
6,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.76281,-0.012916,0.015119,0,0
6,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.71006,-0.012994,0.021589,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.8303,-0.013138,-0.0054013,0,0
6,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.67137,-0.013164,-0.06055,0,0
6,GO REGULATION OF TELOMERE MAINTENANCE,0.52594,-0.013176,-0.031056,0,0
6,GO REGULATION OF APPETITE,0.4598,-0.013257,-0.044809,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.36991,-0.013278,-0.02896,0,0
6,GO EPITHELIAL CELL FATE COMMITMENT,0.61497,-0.01333,-0.032676,0,0
6,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.82348,-0.01334,0.021012,0,0
6,GO CELL CYCLE,0.21256,-0.013364,-0.026647,0,0
6,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.61497,-0.013539,-0.020793,0,0
6,GO BASE EXCISION REPAIR,0.65234,-0.013571,-0.022344,0,0
6,GO SPERMATID DIFFERENTIATION,0.89215,-0.013787,0.016684,0,0
6,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.89215,-0.01392,0.046605,0,0
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.60883,-0.01397,-0.12635,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.55487,-0.014177,-0.027109,0,0
6,GO ENDOCARDIUM DEVELOPMENT,0.4978,-0.014257,0.096031,0,0
6,GO RESPONSE TO UV,0.60272,-0.014277,-0.019174,0,0
6,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.39858,-0.014299,-0.027534,0,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.98953,-0.014354,-0.012248,0,0
6,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.43367,-0.014388,0.11596,0,0
6,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.92682,-0.014655,0.0038428,0,0
6,GO PATTERN SPECIFICATION PROCESS,1,-0.014656,-0.0099727,0,0
6,GO MICROTUBULE BASED MOVEMENT,0.67776,-0.014668,0.021601,0,0
6,GO SPERM CAPACITATION,0.88523,-0.014678,-0.013145,0,0
6,GO SODIUM ION HOMEOSTASIS,0.94769,-0.014806,0.0097657,0,0
6,GO MISMATCH REPAIR,0.59664,-0.015182,-0.022535,0,0
6,GO REGULATION OF MRNA METABOLIC PROCESS,0.25363,-0.015227,-0.040996,0,0
6,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.40843,-0.015362,-0.080366,0,0
6,GO SYNAPTIC SIGNALING,0.78289,-0.015446,0.0041952,0,0
6,GO RNA DECAPPING,0.39371,-0.015721,-0.058163,0,0
6,GO HISTONE MRNA METABOLIC PROCESS,0.69061,-0.015739,-0.022631,0,0
6,GO GROWTH HORMONE SECRETION,0.67776,-0.015914,0.073252,0,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.62113,-0.016018,-0.011642,0,0
6,GO MEMBRANE DOCKING,0.63978,-0.016263,-0.012267,0,0
6,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.25363,-0.016486,-0.030359,0,0
6,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.86455,-0.016602,0.013025,0,0
6,GO TRNA WOBBLE URIDINE MODIFICATION,0.77618,-0.016775,-0.030987,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.39371,-0.016895,-0.047393,0,0
6,GO REGULATION OF BEHAVIOR,0.43367,-0.017139,-0.050121,0,0
6,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.72969,-0.017198,-0.026371,0,0
6,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.74288,-0.017219,-0.03747,0,0
6,GO CGMP METABOLIC PROCESS,0.54321,-0.017292,-0.061481,0,0
6,GO ACROSOME REACTION,0.19393,-0.017317,-0.10239,0,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.50337,-0.017335,0.034247,0,0
6,GO MEIOTIC CELL CYCLE,0.85768,-0.01747,-0.004023,0,0
6,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.71658,-0.017472,0.048423,0,0
6,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.25363,-0.017546,-0.076845,0,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.89907,-0.017796,-0.00052313,0,0
6,GO POSTSYNAPSE ORGANIZATION,0.91987,-0.017947,-0.0046838,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.78289,-0.017979,-0.03724,0,0
6,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.36991,-0.018027,-0.019666,0,0
6,GO CELLULAR RESPONSE TO RADIATION,0.35153,-0.01805,-0.03828,0,0
6,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.23589,-0.01809,-0.10183,0,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.4978,-0.018281,-0.033269,0,0
6,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.82348,-0.018434,0.013623,0,0
6,GO CELL CYCLE PROCESS,0.23245,-0.018521,-0.029465,0,0
6,GO DETECTION OF TEMPERATURE STIMULUS,0.96163,-0.01856,-0.00037006,0,0
6,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.4598,-0.018602,-0.023592,0,0
6,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.83713,-0.018697,-0.022413,0,0
6,GO SEXUAL REPRODUCTION,0.26847,-0.018857,-0.031662,0,0
6,GO NEURON DIFFERENTIATION,0.87833,-0.019021,0.0006179,0,0
6,GO SNRNA METABOLIC PROCESS,0.40349,-0.019139,-0.085177,0,0
6,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.97557,-0.019258,0.033636,0,0
6,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.52025,-0.019343,-0.023323,0,0
6,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.55487,-0.019424,-0.026741,0,0
6,GO LYMPHOCYTE COSTIMULATION,0.41842,-0.019664,-0.045341,0,0
6,GO MEMORY,0.32938,-0.019828,-0.050712,0,0
6,GO DNA MODIFICATION,0.43883,-0.019912,-0.017958,0,0
6,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.084046,-0.020063,-0.2362,0,0
6,GO LUNG EPITHELIUM DEVELOPMENT,0.90599,-0.020107,0.007514,0,0
6,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.33373,-0.020108,-0.064365,0,0
6,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.71658,-0.020166,-0.022111,0,0
6,GO PH REDUCTION,0.91293,-0.020183,-0.01267,0,0
6,GO GAMMA DELTA T CELL ACTIVATION,0.5726,-0.020197,0.074589,0,0
6,GO VESICLE LOCALIZATION,0.097379,-0.020215,-0.051597,0,0
6,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.93377,-0.020268,-0.0016744,0,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.43367,-0.02039,-0.04913,0,0
6,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.26098,-0.020467,-0.052251,0,0
6,GO TUMOR NECROSIS FACTOR SECRETION,0.44402,-0.020484,-0.042056,0,0
6,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.58456,-0.020509,-0.038233,0,0
6,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.43367,-0.020526,-0.063856,0,0
6,GO DECIDUALIZATION,0.94769,-0.020552,-0.0096013,0,0
6,GO LIMBIC SYSTEM DEVELOPMENT,0.76948,-0.020665,-0.017181,0,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.38888,-0.020667,-0.038129,0,0
6,GO BLASTOCYST GROWTH,0.7495,-0.020689,-0.034649,0,0
6,GO PROTEIN ADP RIBOSYLATION,0.39858,-0.020786,-0.038826,0,0
6,GO NUCLEUS ORGANIZATION,0.41842,-0.020836,-0.031497,0,0
6,GO REGULATION OF CELL FATE SPECIFICATION,0.66501,-0.02084,-0.026216,0,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.20621,-0.020985,-0.045589,0,0
6,GO REGULATION OF CILIUM MOVEMENT,0.89907,-0.021202,0.0056926,0,0
6,GO SENSORY PERCEPTION OF BITTER TASTE,0.12908,-0.021304,-0.099642,0,0
6,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.31232,-0.021313,-0.06041,0,0
6,GO MITOCHONDRIAL FUSION,0.26098,-0.021377,-0.050431,0,0
6,GO RNA LOCALIZATION,0.28785,-0.021507,-0.054902,0,0
6,GO REGULATION OF ERAD PATHWAY,0.24288,-0.021514,-0.052412,0,0
6,GO POSITIVE THYMIC T CELL SELECTION,0.63354,-0.02163,-0.026909,0,0
6,GO MULTICELLULAR ORGANISM REPRODUCTION,0.26847,-0.021648,-0.033145,0,0
6,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.60272,-0.021753,-0.027443,0,0
6,GO POSITIVE REGULATION OF TISSUE REMODELING,0.62732,-0.02187,-0.035163,0,0
6,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.53167,-0.022085,-0.016908,0,0
6,GO REGULATION OF CELL DIVISION,0.65866,-0.022087,-0.019594,0,0
6,GO REGULATION OF MRNA 3 END PROCESSING,0.59059,-0.022144,-0.031836,0,0
6,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.81668,-0.022294,0.010701,0,0
6,GO REGULATION OF TORC1 SIGNALING,0.29184,-0.022351,-0.057107,0,0
6,GO INTRA S DNA DAMAGE CHECKPOINT,0.46512,-0.022406,-0.032607,0,0
6,GO MEMBRANE FISSION,0.79636,-0.022511,0.028221,0,0
6,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.68418,-0.022855,-0.037102,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.89215,-0.022863,-0.0067249,0,0
6,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.71658,-0.022988,-0.020581,0,0
6,GO N GLYCAN PROCESSING,0.52025,-0.023022,-0.053929,0,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.91293,-0.023044,0.0075725,0,0
6,GO CELLULAR RESPONSE TO NUTRIENT,0.44924,-0.023063,-0.078174,0,0
6,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.31232,-0.023075,-0.023546,0,0
6,GO CARDIAC MUSCLE CELL PROLIFERATION,0.31232,-0.023086,-0.073619,0,0
6,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.79636,-0.023171,0.015052,0,0
6,GO CRANIAL NERVE DEVELOPMENT,0.30815,-0.023212,-0.086073,0,0
6,GO RNA POLYADENYLATION,0.34256,-0.023236,-0.048531,0,0
6,GO ORGANELLE FISSION,0.87833,-0.023246,-0.00806,0,0
6,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.0053338,-0.023307,-0.059688,0,0
6,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.25363,-0.023338,-0.048091,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.34702,-0.023346,-0.041436,0,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.69707,-0.023381,0.028952,0,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.79636,-0.023429,-0.026811,0,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.65866,-0.023523,-0.0046285,0,0
6,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.87144,-0.023555,-0.019422,0,0
6,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.48131,-0.023608,-0.025043,0,0
6,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.59664,-0.023609,-0.045076,0,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.38888,-0.023683,-0.073556,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.40843,-0.023701,-0.11766,0,0
6,GO EXIT FROM MITOSIS,0.75615,-0.02378,-0.014415,0,0
6,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.43367,-0.023825,-0.052503,0,0
6,GO NEURON APOPTOTIC PROCESS,0.55487,-0.023825,-0.00935,0,0
6,GO MICROTUBULE ANCHORING,0.94073,-0.023845,0.0020879,0,0
6,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.89907,-0.023949,-0.0564,0,0
6,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.94073,-0.023972,-0.0041183,0,0
6,GO REGULATION OF MYELINATION,0.46512,-0.023982,-0.039981,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.71006,-0.024042,-0.026957,0,0
6,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.16559,-0.024049,-0.048568,0,0
6,GO GLUTAMATE SECRETION,0.87833,-0.024263,0.041231,0,0
6,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.83713,-0.024283,-0.0014884,0,0
6,GO HOMOLOGOUS RECOMBINATION,0.62113,-0.024677,-0.020874,0,0
6,GO RESPONSE TO LIGHT STIMULUS,0.28785,-0.024848,-0.027259,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.82348,-0.024868,0.020471,0,0
6,GO SKELETAL MUSCLE CELL PROLIFERATION,0.38888,-0.024915,-0.091823,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.60272,-0.024924,-0.048569,0,0
6,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.65866,-0.024971,-0.11881,0,0
6,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.080955,-0.025037,-0.068047,0,0
6,GO SENSORY ORGAN DEVELOPMENT,0.21905,-0.025392,-0.047373,0,0
6,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.75615,-0.025412,-0.036673,0,0
6,GO LEUKOCYTE AGGREGATION,0.48131,-0.025463,-0.093334,0,0
6,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.88523,-0.025562,-0.021781,0,0
6,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.62113,-0.025682,-0.04363,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.3746,-0.025689,-0.044495,0,0
6,GO CELL PROJECTION ORGANIZATION,0.36991,-0.025871,-0.030816,0,0
6,GO NEUROGENESIS,0.52025,-0.025913,-0.0197,0,0
6,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.91987,-0.025964,0.0051386,0,0
6,GO ACIDIC AMINO ACID TRANSPORT,0.67776,-0.026068,-0.0083017,0,0
6,GO RRNA CATABOLIC PROCESS,0.69707,-0.026204,-0.010578,0,0
6,GO THYMIC T CELL SELECTION,0.41341,-0.026331,-0.037993,0,0
6,GO NEURAL TUBE DEVELOPMENT,0.25729,-0.0264,-0.067929,0,0
6,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.32506,-0.026403,-0.051788,0,0
6,GO ER OVERLOAD RESPONSE,0.35153,-0.02642,-0.053874,0,0
6,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.75615,-0.026535,-0.047271,0,0
6,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.87144,-0.026535,0.029878,0,0
6,GO POSITIVE REGULATION OF NEURON MIGRATION,0.38408,-0.026778,-0.097722,0,0
6,GO NEURON DEVELOPMENT,0.65866,-0.02679,-0.016397,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.26847,-0.026825,-0.062405,0,0
6,GO CELLULAR RESPONSE TO UV,0.54903,-0.026909,-0.028416,0,0
6,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.50337,-0.02696,-0.054068,0,0
6,GO FEMALE GAMETE GENERATION,0.32506,-0.026992,-0.035669,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.25363,-0.027029,-0.12618,0,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.59059,-0.027201,-0.018809,0,0
6,GO ASTROCYTE ACTIVATION,0.24643,-0.027489,-0.11176,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.26847,-0.027493,-0.086493,0,0
6,GO HISTONE H4 DEACETYLATION,0.56666,-0.027548,-0.039085,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.30815,-0.027575,-0.029443,0,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.36991,-0.027795,-0.12217,0,0
6,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.52025,-0.027836,-0.042081,0,0
6,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.21579,-0.027914,-0.037589,0,0
6,GO LOCALIZATION WITHIN MEMBRANE,0.87144,-0.027968,-0.011824,0,0
6,GO REGULATION OF GENE SILENCING,0.060602,-0.027979,-0.081562,0,0
6,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.53742,-0.028089,-0.029643,0,0
6,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.2,-0.028191,-0.14915,0,0
6,GO REGULATION OF DNA REPLICATION,0.76281,-0.02826,-0.011182,0,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.65866,-0.028494,-0.020875,0,0
6,GO ERBB2 SIGNALING PATHWAY,0.62113,-0.028515,-0.04368,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.27999,-0.028521,-0.043404,0,0
6,GO METHYLATION,0.085627,-0.028678,-0.040964,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.56666,-0.028678,-0.014848,0,0
6,GO RESPONSE TO L GLUTAMATE,0.72969,-0.028861,0.040906,0,0
6,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.4978,-0.029005,-0.053854,0,0
6,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.95466,-0.029087,0.016068,0,0
6,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.2,-0.029166,-0.047054,0,0
6,GO SEQUESTERING OF ACTIN MONOMERS,0.91987,-0.02921,0.070024,0,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.63978,-0.029276,-0.041335,0,0
6,GO COBALAMIN METABOLIC PROCESS,0.34256,-0.029396,-0.089038,0,0
6,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.62113,-0.029442,-0.033375,0,0
6,GO MITOTIC CYTOKINETIC PROCESS,0.56666,-0.029484,-0.022961,0,0
6,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.59664,-0.029604,-0.037417,0,0
6,GO PENILE ERECTION,0.90599,-0.029639,0.021482,0,0
6,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.27611,-0.029641,-0.070583,0,0
6,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.56666,-0.029749,-0.034865,0,0
6,GO POSITIVE REGULATION OF DNA REPLICATION,0.53167,-0.029815,-0.021231,0,0
6,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.79636,-0.029938,0.029251,0,0
6,GO VENTRICULAR SYSTEM DEVELOPMENT,0.64605,-0.030035,-0.029362,0,0
6,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.56075,-0.030412,-0.019541,0,0
6,GO T CELL HOMEOSTASIS,0.69061,-0.030473,-0.014297,0,0
6,GO DETECTION OF MECHANICAL STIMULUS,0.48678,-0.030536,-0.014652,0,0
6,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.87833,-0.030721,0.011851,0,0
6,GO HYPEROSMOTIC SALINITY RESPONSE,0.40843,-0.030797,-0.040059,0,0
6,GO NUCLEAR EXPORT,0.33812,-0.031117,-0.037765,0,0
6,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.99651,-0.031193,-0.0019261,0,0
6,GO PIRNA METABOLIC PROCESS,0.44402,-0.031241,-0.072227,0,0
6,GO CAMERA TYPE EYE DEVELOPMENT,0.2839,-0.031294,-0.041281,0,0
6,GO CELLULAR COMPONENT MORPHOGENESIS,0.61497,-0.031363,-0.012397,0,0
6,GO SPECIFICATION OF SYMMETRY,0.69061,-0.031429,-0.004746,0,0
6,GO REGULATION OF CELL DEVELOPMENT,0.31653,-0.031642,-0.037216,0,0
6,GO PROTEIN DEPOLYMERIZATION,0.56075,-0.031725,-0.01874,0,0
6,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.81668,-0.031797,-0.003134,0,0
6,GO KERATINOCYTE DEVELOPMENT,0.64605,-0.031819,-0.025049,0,0
6,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.71006,-0.031973,0.049896,0,0
6,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.39371,-0.03211,-0.094277,0,0
6,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.56666,-0.032127,-0.073357,0,0
6,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.85082,-0.03213,-0.0033187,0,0
6,GO RESPONSE TO RADIATION,0.095625,-0.032183,-0.041375,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.56666,-0.032202,-0.093472,0,0
6,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.22905,-0.032249,-0.049822,0,0
6,GO FOREGUT MORPHOGENESIS,0.52594,-0.032265,-0.075498,0,0
6,GO SYNAPTIC VESICLE RECYCLING,0.66501,-0.032392,-0.013203,0,0
6,GO HEART VALVE FORMATION,0.3746,-0.032595,-0.1176,0,0
6,GO GLIAL CELL APOPTOTIC PROCESS,0.4978,-0.0326,-0.058945,0,0
6,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.35607,-0.032711,-0.044975,0,0
6,GO APPENDAGE DEVELOPMENT,0.49227,-0.032874,-0.043966,0,0
6,GO AXONEME ASSEMBLY,0.49227,-0.032947,0.10188,0,0
6,GO EPITHELIAL CELL MATURATION,0.64605,-0.032975,0.061667,0,0
6,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.26471,-0.033,-0.06646,0,0
6,GO BONE TRABECULA MORPHOGENESIS,0.27227,-0.033,-0.16066,0,0
6,GO MITOCHONDRION MORPHOGENESIS,0.68418,-0.033275,-0.02388,0,0
6,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.36526,-0.033475,-0.040766,0,0
6,GO SEX DETERMINATION,0.89215,-0.033506,0.0037899,0,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.98255,-0.033509,0.032251,0,0
6,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.81668,-0.033565,-0.021209,0,0
6,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.33373,-0.033602,-0.048162,0,0
6,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.43883,-0.033609,-0.020328,0,0
6,GO REGULATION OF OOGENESIS,0.72313,-0.033887,-0.021498,0,0
6,GO CELL CYCLE G1 S PHASE TRANSITION,0.19393,-0.034017,-0.041181,0,0
6,GO REGULATION OF INTEGRIN ACTIVATION,0.31653,-0.034032,-0.096208,0,0
6,GO MITOTIC CYTOKINESIS,0.48678,-0.034165,-0.030152,0,0
6,GO POLYAMINE BIOSYNTHETIC PROCESS,0.60883,-0.034174,-0.044785,0,0
6,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.19695,-0.034181,-0.11735,0,0
6,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.61497,-0.034285,-0.046806,0,0
6,GO RNA PROCESSING,0.16559,-0.034313,-0.056324,0,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.14769,-0.034598,-0.053336,0,0
6,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.80989,-0.034782,-0.01097,0,0
6,GO HEART FORMATION,0.87144,-0.034826,0.013588,0,0
6,GO COGNITION,0.77618,-0.034938,-0.014462,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.23589,-0.035043,-0.12432,0,0
6,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.44402,-0.035163,-0.036419,0,0
6,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.98255,-0.035284,0.040618,0,0
6,GO NEUROTRANSMITTER SECRETION,0.69061,-0.035366,0.024077,0,0
6,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.80989,-0.035371,-0.042154,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE,0.7495,-0.03538,-0.028865,0,0
6,GO MOTOR NEURON AXON GUIDANCE,0.51459,-0.03556,-0.0336,0,0
6,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.52025,-0.035622,-0.013906,0,0
6,GO LEARNING,0.87833,-0.035666,-0.0029181,0,0
6,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.85082,-0.035684,-0.022789,0,0
6,GO ESTABLISHMENT OF RNA LOCALIZATION,0.24288,-0.035923,-0.054561,0,0
6,GO RESPONSE TO GLUCAGON,0.32506,-0.036217,-0.05287,0,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.26098,-0.036311,-0.07608,0,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.11235,-0.036328,-0.075851,0,0
6,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.25363,-0.036336,-0.054262,0,0
6,GO SENSORY SYSTEM DEVELOPMENT,0.34702,-0.036386,-0.036498,0,0
6,GO NEGATIVE REGULATION OF GLIOGENESIS,0.83713,-0.036453,0.014097,0,0
6,GO SYNAPTIC VESICLE EXOCYTOSIS,0.68418,-0.036584,0.033609,0,0
6,GO ENDOCRINE PANCREAS DEVELOPMENT,0.35153,-0.036867,-0.058576,0,0
6,GO SPERM MOTILITY,0.67137,-0.037154,-0.0028213,0,0
6,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.19695,-0.037218,-0.11056,0,0
6,GO EMBRYONIC PATTERN SPECIFICATION,0.42347,-0.037219,-0.047678,0,0
6,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.67776,-0.037452,0.00516,0,0
6,GO FOREBRAIN CELL MIGRATION,0.74288,-0.037564,-0.0070962,0,0
6,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.24643,-0.037637,-0.086498,0,0
6,GO RESPONSE TO UV B,0.68418,-0.038125,-0.027945,0,0
6,GO PEPTIDYL LYSINE DIMETHYLATION,0.88523,-0.038293,0.0044252,0,0
6,GO SNORNA METABOLIC PROCESS,0.89907,-0.038299,-0.012222,0,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION,0.26847,-0.038333,-0.048582,0,0
6,GO INHIBITORY SYNAPSE ASSEMBLY,0.8303,-0.038481,0.02326,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.70355,-0.038642,-0.050325,0,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.95466,-0.038771,0.045202,0,0
6,GO POST EMBRYONIC DEVELOPMENT,0.23937,-0.038792,-0.047804,0,0
6,GO WATER HOMEOSTASIS,0.42855,-0.038924,-0.057388,0,0
6,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.5726,-0.039049,-0.022076,0,0
6,GO CELLULAR RESPONSE TO MANGANESE ION,0.4545,-0.039084,-0.043797,0,0
6,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.29586,-0.039166,-0.019242,0,0
6,GO DENDRITE EXTENSION,0.93377,-0.039204,0.086851,0,0
6,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.073629,-0.039473,-0.066487,0,0
6,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.4978,-0.039485,-0.030535,0,0
6,GO REGULATION OF NUCLEAR DIVISION,0.39371,-0.03989,-0.026076,0,0
6,GO DEVELOPMENTAL CELL GROWTH,0.15517,-0.039937,-0.06083,0,0
6,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.60883,-0.039956,-0.063357,0,0
6,GO HISTONE H2B UBIQUITINATION,0.52594,-0.039983,-0.033034,0,0
6,GO AXIS SPECIFICATION,0.11235,-0.04002,-0.086336,0,0
6,GO POLYAMINE METABOLIC PROCESS,0.40843,-0.040252,-0.048624,0,0
6,GO REGULATION OF DNA METHYLATION,0.27227,-0.040356,-0.067222,0,0
6,GO OOCYTE MATURATION,0.47588,-0.04042,-0.027919,0,0
6,GO PROTEIN MANNOSYLATION,0.38408,-0.040793,-0.048483,0,0
6,GO BEHAVIORAL RESPONSE TO COCAINE,0.96163,-0.040794,0.042873,0,0
6,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.188,-0.040929,-0.1778,0,0
6,GO PROTEIN POLYGLUTAMYLATION,0.53742,-0.040948,0.075561,0,0
6,GO RESPONSE TO MUSCLE INACTIVITY,0.81668,-0.041278,-0.0056906,0,0
6,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.19695,-0.04132,-0.080848,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.81668,-0.041402,-0.016457,0,0
6,GO REGULATION OF MEIOTIC CELL CYCLE,0.3746,-0.041551,-0.029959,0,0
6,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.17653,-0.041693,-0.086069,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.36991,-0.041793,-0.079561,0,0
6,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.37932,-0.041841,-0.062085,0,0
6,GO ALDEHYDE CATABOLIC PROCESS,0.5726,-0.041858,-0.052731,0,0
6,GO HYPOTHALAMUS DEVELOPMENT,0.36526,-0.041917,-0.074448,0,0
6,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.37932,-0.041938,-0.029173,0,0
6,GO NEURON PROJECTION EXTENSION,0.47049,-0.041947,-0.036988,0,0
6,GO POSITIVE REGULATION OF CELL GROWTH,0.18508,-0.04211,-0.047896,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.63354,-0.042178,-0.032343,0,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.17653,-0.042208,-0.052956,0,0
6,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.85082,-0.042246,-0.023276,0,0
6,GO CELLULAR RESPONSE TO ALKALOID,0.21905,-0.042305,-0.062952,0,0
6,GO ENDOCRINE SYSTEM DEVELOPMENT,0.95466,-0.042478,0.0021518,0,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.53167,-0.04254,-0.025099,0,0
6,GO REGULATION OF RNA BINDING,0.36064,-0.042615,-0.076081,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.22905,-0.042802,-0.066108,0,0
6,GO RESPONSE TO VITAMIN D,0.62113,-0.04293,-0.054723,0,0
6,GO ORGANELLE ASSEMBLY,0.076492,-0.042988,-0.03941,0,0
6,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.16294,-0.043012,-0.078586,0,0
6,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.73628,-0.04316,-0.044496,0,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.087232,-0.043236,-0.080825,0,0
6,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.21579,-0.043302,-0.13235,0,0
6,GO CELL MATURATION,0.19695,-0.043436,-0.047103,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.25729,-0.043515,-0.089194,0,0
6,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.10096,-0.043546,-0.058482,0,0
6,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.43883,-0.043566,-0.037308,0,0
6,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.75615,-0.043684,-0.0025915,0,0
6,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.31653,-0.043783,-0.045952,0,0
6,GO REGULATION OF HISTONE UBIQUITINATION,0.34256,-0.043796,-0.036493,0,0
6,GO NEGATIVE REGULATION OF NEURON DEATH,0.15264,-0.043964,-0.040101,0,0
6,GO SNRNA PROCESSING,0.31653,-0.043965,-0.11021,0,0
6,GO REGULATION OF GLIOGENESIS,0.95466,-0.043994,-0.0041992,0,0
6,GO ARTERY MORPHOGENESIS,0.15773,-0.044005,-0.0898,0,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.14769,-0.044023,-0.055182,0,0
6,GO EMBRYONIC BODY MORPHOGENESIS,0.76281,-0.044143,-0.01518,0,0
6,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.15773,-0.044177,-0.052612,0,0
6,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.29586,-0.044262,-0.040021,0,0
6,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.29992,-0.044311,-0.069562,0,0
6,GO MRNA MODIFICATION,0.24643,-0.044329,-0.082413,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.89907,-0.044544,0.011316,0,0
6,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.33812,-0.044569,-0.015967,0,0
6,GO RNA STABILIZATION,0.52594,-0.044656,-0.036444,0,0
6,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.060602,-0.044757,-0.081761,0,0
6,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.60883,-0.044792,-0.063135,0,0
6,GO SENSORY ORGAN MORPHOGENESIS,0.33373,-0.044931,-0.040523,0,0
6,GO RRNA 3 END PROCESSING,0.54321,-0.044931,-0.044466,0,0
6,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.072231,-0.044933,-0.13826,0,0
6,GO TRNA WOBBLE BASE MODIFICATION,0.25729,-0.045076,-0.079584,0,0
6,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.39371,-0.04529,-0.041481,0,0
6,GO SPINDLE MIDZONE ASSEMBLY,0.26471,-0.045364,-0.062401,0,0
6,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.099158,-0.045474,-0.053586,0,0
6,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.093897,-0.045652,-0.066537,0,0
6,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.068167,-0.045688,-0.11745,0,0
6,GO SYNAPTIC VESICLE DOCKING,0.62113,-0.045829,0.025442,0,0
6,GO PROTEIN DESTABILIZATION,0.085627,-0.045857,-0.068629,0,0
6,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.2,-0.045914,-0.082252,0,0
6,GO WALKING BEHAVIOR,0.89907,-0.046297,0.028608,0,0
6,GO POSITIVE REGULATION OF GLIOGENESIS,0.75615,-0.046419,-0.0068392,0,0
6,GO NCRNA EXPORT FROM NUCLEUS,0.21579,-0.046449,-0.073831,0,0
6,GO LYMPHANGIOGENESIS,0.25729,-0.046572,-0.10638,0,0
6,GO VIRAL BUDDING,0.91987,-0.046672,0.016607,0,0
6,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.2839,-0.046775,-0.071188,0,0
6,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.5726,-0.046796,0.0021904,0,0
6,GO POSITIVE REGULATION OF HORMONE SECRETION,0.32077,-0.047026,-0.039676,0,0
6,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.59664,-0.047063,-0.04426,0,0
6,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.092194,-0.047083,-0.063227,0,0
6,GO CHONDROCYTE DEVELOPMENT,0.46512,-0.047288,-0.077545,0,0
6,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.92682,-0.047325,0.049326,0,0
6,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.53742,-0.047489,-0.072503,0,0
6,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.19695,-0.047588,-0.14113,0,0
6,GO ACTIVATION OF MAPKK ACTIVITY,0.13583,-0.047796,-0.092322,0,0
6,GO VESICLE FUSION TO PLASMA MEMBRANE,0.5726,-0.047809,0.020955,0,0
6,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.31653,-0.047826,-0.047803,0,0
6,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.17099,-0.047875,-0.19459,0,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.28785,-0.047919,-0.14384,0,0
6,GO MITOTIC RECOMBINATION,0.78962,-0.047953,0.019808,0,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.41842,-0.04812,-0.07897,0,0
6,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.1313,-0.048148,-0.063617,0,0
6,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.12908,-0.048332,-0.072217,0,0
6,GO STRESS GRANULE ASSEMBLY,0.12259,-0.048436,-0.083482,0,0
6,GO EPITHELIAL STRUCTURE MAINTENANCE,0.21905,-0.048492,-0.078205,0,0
6,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.057089,-0.048505,-0.055539,0,0
6,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.19095,-0.048573,-0.074024,0,0
6,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.48131,-0.048727,-0.047489,0,0
6,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.23245,-0.048794,-0.049429,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.65866,-0.048894,-0.0065068,0,0
6,GO MIDBODY ABSCISSION,0.62732,-0.048947,0.0080512,0,0
6,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.30815,-0.048974,-0.057432,0,0
6,GO TELOMERASE RNA LOCALIZATION,0.25001,-0.049081,-0.12436,0,0
6,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.57857,-0.049206,-0.026392,0,0
6,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.26471,-0.0493,-0.13187,0,0
6,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.10465,-0.04931,-0.082889,0,0
6,GO AMINE TRANSPORT,0.38408,-0.049444,-0.024657,0,0
6,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.48131,-0.049544,-0.036875,0,0
6,GO GANGLIOSIDE METABOLIC PROCESS,0.60272,-0.049629,-0.039019,0,0
6,GO CAMP BIOSYNTHETIC PROCESS,0.86455,-0.04977,0.024518,0,0
6,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.080955,-0.049895,-0.10092,0,0
6,GO C4 DICARBOXYLATE TRANSPORT,0.52025,-0.050021,-0.034429,0,0
6,GO MALE MEIOTIC NUCLEAR DIVISION,0.39858,-0.050026,-0.06825,0,0
6,GO POSITIVE REGULATION OF AXON EXTENSION,0.44924,-0.050249,-0.033491,0,0
6,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.79636,-0.050265,-0.017216,0,0
6,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.26471,-0.050277,-0.14864,0,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.11235,-0.050328,-0.12291,0,0
6,GO REGULATION OF ORGANIC ACID TRANSPORT,0.26098,-0.050387,-0.07784,0,0
6,GO PRESYNAPSE ORGANIZATION,0.36991,-0.050399,-0.04542,0,0
6,GO POSITIVE REGULATION OF CYTOKINESIS,0.24643,-0.0504,-0.034769,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.084046,-0.050425,-0.11031,0,0
6,GO PRESYNAPTIC ENDOCYTOSIS,0.55487,-0.050607,-0.017333,0,0
6,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.24288,-0.050884,-0.086555,0,0
6,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.30402,-0.050915,-0.039313,0,0
6,GO PROTEIN POLYUBIQUITINATION,0.090515,-0.051033,-0.051632,0,0
6,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.14769,-0.051066,-0.059425,0,0
6,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.43367,-0.051307,-0.077891,0,0
6,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.32077,-0.051372,-0.052141,0,0
6,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.53167,-0.051393,-0.032372,0,0
6,GO RESPONSE TO UV C,0.78962,-0.051877,-0.02005,0,0
6,GO SLEEP,0.16828,-0.051978,-0.075524,0,0
6,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.32077,-0.052067,-0.047899,0,0
6,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.3746,-0.052149,-0.032882,0,0
6,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.36991,-0.052186,-0.024521,0,0
6,GO PROTEIN K63 LINKED UBIQUITINATION,0.075049,-0.052279,-0.05944,0,0
6,GO NEGATIVE REGULATION OF AXON EXTENSION,0.52594,-0.052397,-0.05147,0,0
6,GO CELL VOLUME HOMEOSTASIS,0.1028,-0.052518,-0.070928,0,0
6,GO CYTOPLASM ORGANIZATION,0.44402,-0.052521,-0.062358,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.13355,-0.052841,-0.058586,0,0
6,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.35607,-0.052924,-0.065566,0,0
6,GO THYMUS DEVELOPMENT,0.92682,-0.053047,0.0054795,0,0
6,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.092194,-0.053077,-0.11073,0,0
6,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.12049,-0.053156,-0.0893,0,0
6,GO LOCOMOTORY BEHAVIOR,0.35607,-0.053222,-0.032366,0,0
6,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.85082,-0.053446,-0.015318,0,0
6,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.084046,-0.053446,-0.096602,0,0
6,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.43367,-0.053496,-0.045007,0,0
6,GO PREPULSE INHIBITION,0.94769,-0.053689,0.03651,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.43367,-0.053953,-0.022837,0,0
6,GO SKIN EPIDERMIS DEVELOPMENT,0.059411,-0.054021,-0.12287,0,0
6,GO NEUROTRANSMITTER TRANSPORT,0.39858,-0.05407,-0.0084844,0,0
6,GO COCHLEA DEVELOPMENT,0.56075,-0.054114,-0.020025,0,0
6,GO REGULATION OF HEART MORPHOGENESIS,0.60272,-0.054127,-0.072694,0,0
6,GO RUFFLE ASSEMBLY,0.33812,-0.054147,-0.046979,0,0
6,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.080955,-0.054278,-0.15205,0,0
6,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.31232,-0.054434,-0.051208,0,0
6,GO BEHAVIOR,0.25729,-0.054547,-0.045228,0,0
6,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.56666,-0.054721,-0.019899,0,0
6,GO RNA SURVEILLANCE,0.9686,-0.055273,0.014432,0,0
6,GO LIPID DIGESTION,0.16032,-0.055273,-0.15974,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.11434,-0.055335,-0.087249,0,0
6,GO TELOMERE ORGANIZATION,0.18219,-0.055342,-0.047774,0,0
6,GO LAYER FORMATION IN CEREBRAL CORTEX,0.41341,-0.055342,-0.060669,0,0
6,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.36526,-0.055417,-0.13005,0,0
6,GO WATER TRANSPORT,0.30402,-0.055673,-0.026479,0,0
6,GO PEPTIDYL THREONINE MODIFICATION,0.070855,-0.055699,-0.059556,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.9686,-0.055855,-0.0079983,0,0
6,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.43883,-0.055894,-0.025003,0,0
6,GO NERVOUS SYSTEM PROCESS,0.097379,-0.055952,-0.052072,0,0
6,GO RESPONSE TO ELECTRICAL STIMULUS,0.73628,-0.056179,-0.022275,0,0
6,GO REGULATION OF ENDOCYTIC RECYCLING,0.16294,-0.05622,-0.10322,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.69061,-0.05631,-0.037595,0,0
6,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.40843,-0.056477,-0.0080531,0,0
6,GO LYSINE METABOLIC PROCESS,0.64605,-0.056585,-0.06507,0,0
6,GO GPI ANCHOR METABOLIC PROCESS,0.073629,-0.056798,-0.10105,0,0
6,GO RNA INTERFERENCE,0.26098,-0.056833,-0.071767,0,0
6,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.23589,-0.056901,-0.084919,0,0
6,GO RESPONSE TO LEAD ION,0.23937,-0.056966,-0.072492,0,0
6,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.18219,-0.057124,-0.064183,0,0
6,GO CELL MORPHOGENESIS,0.16559,-0.05718,-0.049051,0,0
6,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.54903,-0.057182,-0.091036,0,0
6,GO NUCLEUS LOCALIZATION,0.23589,-0.057287,-0.069255,0,0
6,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.50896,-0.057393,-0.049227,0,0
6,GO PROTEIN PALMITOYLATION,0.27999,-0.057637,-0.041419,0,0
6,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.36526,-0.057929,-0.044964,0,0
6,GO LACTATE METABOLIC PROCESS,0.60272,-0.058058,-0.030164,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.60272,-0.058073,-0.080674,0,0
6,GO CATECHOLAMINE METABOLIC PROCESS,0.62732,-0.058111,-0.0077244,0,0
6,GO POSITIVE REGULATION OF NEURON DEATH,0.15015,-0.058289,-0.052968,0,0
6,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.23937,-0.058336,-0.030109,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.14048,-0.058405,-0.096842,0,0
6,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.47049,-0.058407,-0.037544,0,0
6,GO MOTILE CILIUM ASSEMBLY,0.57857,-0.058486,0.072683,0,0
6,GO MIRNA METABOLIC PROCESS,0.061812,-0.058515,-0.082438,0,0
6,GO HINDLIMB MORPHOGENESIS,0.26098,-0.058552,-0.083671,0,0
6,GO LIPID DROPLET ORGANIZATION,0.16828,-0.058632,-0.096539,0,0
6,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.52594,-0.058644,-0.037989,0,0
6,GO RNA DESTABILIZATION,0.31232,-0.058896,-0.052032,0,0
6,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.35153,-0.058949,-0.043317,0,0
6,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.35153,-0.059072,-0.053505,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.13355,-0.059171,-0.080618,0,0
6,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.072231,-0.059204,-0.13477,0,0
6,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.064293,-0.059213,-0.099621,0,0
6,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.34702,-0.059351,-0.064343,0,0
6,GO ADULT FEEDING BEHAVIOR,0.46512,-0.059382,-0.073646,0,0
6,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.11434,-0.059566,-0.13219,0,0
6,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.29992,-0.059708,-0.054569,0,0
6,GO PIGMENT GRANULE LOCALIZATION,0.52594,-0.059812,-0.036357,0,0
6,GO MAST CELL MIGRATION,0.5726,-0.060096,-0.063055,0,0
6,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.85082,-0.060296,0.0044022,0,0
6,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.33373,-0.060398,-0.061453,0,0
6,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.05824,-0.060494,-0.091412,0,0
6,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.94073,-0.060588,-0.01053,0,0
6,GO BRONCHUS DEVELOPMENT,0.65866,-0.060641,-0.085669,0,0
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.10845,-0.060667,-0.18725,0,0
6,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.22905,-0.060718,-0.043941,0,0
6,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.18508,-0.060718,-0.094614,0,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.54903,-0.060816,-0.026692,0,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.092194,-0.060816,-0.15835,0,0
6,GO PROTEIN LOCALIZATION TO ENDOSOME,0.29184,-0.061101,-0.071454,0,0
6,GO ACTIN CYTOSKELETON REORGANIZATION,0.088862,-0.061205,-0.082856,0,0
6,GO TONGUE MORPHOGENESIS,0.94769,-0.061223,-0.010272,0,0
6,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.24643,-0.061336,-0.067559,0,0
6,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.082489,-0.061514,-0.10604,0,0
6,GO SEGMENTATION,0.063042,-0.061633,-0.087988,0,0
6,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.95466,-0.061989,0.0044539,0,0
6,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.41341,-0.06204,-0.047595,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.47588,-0.062055,-0.075801,0,0
6,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.13814,-0.062076,-0.092677,0,0
6,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.10845,-0.062268,-0.087429,0,0
6,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.095625,-0.062281,-0.11037,0,0
6,GO PHOSPHOLIPID HOMEOSTASIS,0.36064,-0.06246,-0.088655,0,0
6,GO REGULATION OF ACTIN NUCLEATION,0.15517,-0.062489,-0.088787,0,0
6,GO EAR DEVELOPMENT,0.061812,-0.062498,-0.082994,0,0
6,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.061812,-0.062644,-0.13294,0,0
6,GO TRANSFERRIN TRANSPORT,0.061812,-0.0627,-0.11143,0,0
6,GO POSITIVE REGULATION OF URINE VOLUME,0.13355,-0.062727,-0.10463,0,0
6,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.7495,-0.062765,-0.025159,0,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.62113,-0.062842,-0.095903,0,0
6,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.3746,-0.062946,-0.065933,0,0
6,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.15015,-0.063086,-0.057696,0,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.10845,-0.063472,-0.073993,0,0
6,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.14769,-0.063545,-0.1083,0,0
6,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.27611,-0.063561,-0.044616,0,0
6,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.17653,-0.063572,-0.12357,0,0
6,GO STRIATED MUSCLE CELL PROLIFERATION,0.13814,-0.063586,-0.083059,0,0
6,GO LIPID PHOSPHORYLATION,0.064293,-0.063612,-0.069394,0,0
6,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.40349,-0.063877,-0.055279,0,0
6,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.53167,-0.063926,-0.031634,0,0
6,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.26847,-0.063954,-0.060269,0,0
6,GO MITOPHAGY,0.079444,-0.064012,-0.086595,0,0
6,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.19095,-0.064122,-0.13384,0,0
6,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.16032,-0.064164,-0.1082,0,0
6,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.065563,-0.064241,-0.10781,0,0
6,GO RRNA TRANSCRIPTION,0.21905,-0.064322,-0.080643,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.29586,-0.064431,-0.069931,0,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.11039,-0.064486,-0.12814,0,0
6,GO NEURON PROJECTION REGENERATION,0.26098,-0.064508,-0.062286,0,0
6,GO RESPONSE TO PROGESTERONE,0.087232,-0.064623,-0.14902,0,0
6,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.26847,-0.064722,-0.10254,0,0
6,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.25363,-0.064818,-0.11277,0,0
6,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.075049,-0.064902,-0.15613,0,0
6,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.26098,-0.065162,-0.066114,0,0
6,GO VIRION ASSEMBLY,0.10845,-0.065234,-0.065106,0,0
6,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.087232,-0.065318,-0.050828,0,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.21579,-0.065407,-0.10554,0,0
6,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.38408,-0.065435,-0.037088,0,0
6,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.84397,-0.065592,0.029774,0,0
6,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.20309,-0.065607,-0.082495,0,0
6,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.17653,-0.06564,-0.11334,0,0
6,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.19695,-0.065706,-0.067817,0,0
6,GO MULTIVESICULAR BODY SORTING PATHWAY,0.1313,-0.065733,-0.06249,0,0
6,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.16828,-0.065769,-0.15879,0,0
6,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.90599,-0.065842,0.01521,0,0
6,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.16032,-0.066092,-0.1637,0,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.40349,-0.066264,-0.078449,0,0
6,GO MONOAMINE TRANSPORT,0.22235,-0.066387,-0.037563,0,0
6,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.027188,-0.066576,-0.092685,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.61497,-0.066735,-0.031415,0,0
6,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.22905,-0.066813,-0.053761,0,0
6,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.26471,-0.066833,-0.059116,0,0
6,GO NCRNA 3 END PROCESSING,0.34702,-0.066995,-0.08441,0,0
6,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.16032,-0.067363,-0.093298,0,0
6,GO REGULATION OF MITOPHAGY,0.33373,-0.067387,-0.054863,0,0
6,GO FIBROBLAST MIGRATION,0.10465,-0.067415,-0.087941,0,0
6,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.18219,-0.067517,-0.071795,0,0
6,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.14769,-0.067656,-0.088029,0,0
6,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.073629,-0.067778,-0.11896,0,0
6,GO SOMITOGENESIS,0.05824,-0.067824,-0.083436,0,0
6,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.41341,-0.067863,-0.040188,0,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.79636,-0.067902,0.032249,0,0
6,GO REGULATION OF STEM CELL DIFFERENTIATION,0.097379,-0.067964,-0.10845,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0695,-0.068146,-0.10613,0,0
6,GO REFLEX,0.65234,-0.068162,-0.055549,0,0
6,GO ASSOCIATIVE LEARNING,0.17374,-0.068188,-0.064212,0,0
6,GO HAIR CELL DIFFERENTIATION,0.11636,-0.068228,-0.10463,0,0
6,GO PROGESTERONE METABOLIC PROCESS,0.23245,-0.068284,-0.25436,0,0
6,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.24288,-0.068355,-0.11245,0,0
6,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.24288,-0.068641,-0.10801,0,0
6,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.76281,-0.068925,-0.026779,0,0
6,GO ADULT LOCOMOTORY BEHAVIOR,0.48131,-0.068973,-0.027163,0,0
6,GO POSITIVE REGULATION OF CELL MATURATION,0.4598,-0.069024,-0.11862,0,0
6,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.12259,-0.069664,-0.1606,0,0
6,GO TOOTH MINERALIZATION,0.10465,-0.069721,-0.16938,0,0
6,GO REGULATION OF CELL MORPHOGENESIS,0.097379,-0.069769,-0.064411,0,0
6,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.093897,-0.069855,-0.080063,0,0
6,GO OOCYTE DIFFERENTIATION,0.11434,-0.06989,-0.079485,0,0
6,GO REGULATION OF EXIT FROM MITOSIS,0.3746,-0.069925,-0.042518,0,0
6,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.15517,-0.069951,-0.10758,0,0
6,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.43367,-0.070006,-0.04198,0,0
6,GO REGULATION OF HEAT GENERATION,0.56666,-0.070009,0.0019879,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.14769,-0.070118,-0.091385,0,0
6,GO NUCLEAR MIGRATION,0.30402,-0.070136,-0.064542,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.12259,-0.070365,-0.081317,0,0
6,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.10096,-0.070502,-0.072245,0,0
6,GO SECONDARY PALATE DEVELOPMENT,0.3746,-0.070578,-0.071687,0,0
6,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.073629,-0.070607,-0.13028,0,0
6,GO MACROMOLECULE DEPALMITOYLATION,0.12473,-0.07091,-0.12548,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.084046,-0.071063,-0.06397,0,0
6,GO GLIAL CELL DIFFERENTIATION,0.066855,-0.071276,-0.091215,0,0
6,GO CYTOKINETIC PROCESS,0.085627,-0.071416,-0.10153,0,0
6,GO PRENYLATION,0.19695,-0.071491,-0.077331,0,0
6,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.2839,-0.071735,-0.048554,0,0
6,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.15773,-0.071814,-0.073662,0,0
6,GO REGULATION OF MRNA BINDING,0.079444,-0.071819,-0.14903,0,0
6,GO NUCLEAR PORE ORGANIZATION,0.44402,-0.072048,-0.061724,0,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.25363,-0.072085,-0.06213,0,0
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.19393,-0.072317,-0.079237,0,0
6,GO DORSAL VENTRAL AXIS SPECIFICATION,0.62113,-0.072692,-0.053603,0,0
6,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.67776,-0.072855,-0.0048085,0,0
6,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.35153,-0.07287,-0.060756,0,0
6,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.62113,-0.072912,-0.053464,0,0
6,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.18508,-0.073172,-0.021369,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.59059,-0.073208,-0.046705,0,0
6,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.43883,-0.073245,-0.038343,0,0
6,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.3746,-0.073295,-0.1122,0,0
6,GO TORC1 SIGNALING,0.070855,-0.073326,-0.075869,0,0
6,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.63978,-0.073411,-0.048785,0,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.3746,-0.073441,-0.11163,0,0
6,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.20937,-0.073514,-0.06597,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.11841,-0.07352,-0.059231,0,0
6,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.077957,-0.073978,-0.11743,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.050569,-0.073999,-0.083259,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.32938,-0.074211,-0.080937,0,0
6,GO STARTLE RESPONSE,0.68418,-0.074389,-0.027766,0,0
6,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.05824,-0.074431,-0.10186,0,0
6,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.14285,-0.074447,-0.082151,0,0
6,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.1313,-0.074474,-0.074671,0,0
6,GO RESPONSE TO WATER,0.29184,-0.074536,-0.098649,0,0
6,GO MECHANOSENSORY BEHAVIOR,0.95466,-0.074826,0.053422,0,0
6,GO CILIUM MOVEMENT,0.35607,-0.074954,-0.012874,0,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.41341,-0.075165,-0.052867,0,0
6,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.093897,-0.075285,-0.086812,0,0
6,GO NODAL SIGNALING PATHWAY,0.63978,-0.075354,-0.020902,0,0
6,GO KETONE CATABOLIC PROCESS,0.22235,-0.075367,-0.15847,0,0
6,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.41842,-0.075595,-0.0631,0,0
6,GO CHLORIDE ION HOMEOSTASIS,0.17934,-0.075631,-0.092143,0,0
6,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.95466,-0.075721,0.095154,0,0
6,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.10845,-0.075731,-0.082184,0,0
6,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.075049,-0.075878,-0.077217,0,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.2,-0.075903,-0.062276,0,0
6,GO MITOCHONDRION DISTRIBUTION,0.42347,-0.075942,-0.028541,0,0
6,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.11235,-0.075979,-0.1092,0,0
6,GO NEGATIVE REGULATION OF AXONOGENESIS,0.54903,-0.076089,-0.035728,0,0
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.29586,-0.076129,-0.10032,0,0
6,GO NEURAL TUBE FORMATION,0.057089,-0.076228,-0.092367,0,0
6,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.43367,-0.076257,-0.060257,0,0
6,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.14048,-0.076279,-0.067063,0,0
6,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.22568,-0.076567,-0.057825,0,0
6,GO PROSTATE GLAND GROWTH,0.25729,-0.076974,-0.13449,0,0
6,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.082489,-0.077012,-0.077724,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.063042,-0.077031,-0.12168,0,0
6,GO MATING,0.10096,-0.077064,-0.066478,0,0
6,GO DIGESTIVE SYSTEM DEVELOPMENT,0.21256,-0.077245,-0.068286,0,0
6,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.91987,-0.07751,0.022477,0,0
6,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.31653,-0.077641,-0.065878,0,0
6,GO REGULATION OF POTASSIUM ION TRANSPORT,0.24288,-0.077747,-0.067499,0,0
6,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.073629,-0.077862,-0.059435,0,0
6,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.093897,-0.077893,-0.12008,0,0
6,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.059411,-0.077929,-0.1377,0,0
6,GO NATURAL KILLER CELL ACTIVATION,0.19095,-0.077985,-0.078635,0,0
6,GO NAD BIOSYNTHETIC PROCESS,0.15773,-0.078145,-0.11189,0,0
6,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.076492,-0.078185,-0.084012,0,0
6,GO MANNOSYLATION,0.14285,-0.078312,-0.077616,0,0
6,GO SYNAPSE ASSEMBLY,0.53167,-0.078365,-0.011169,0,0
6,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.10465,-0.078439,-0.074838,0,0
6,GO MATING BEHAVIOR,0.38408,-0.078492,-0.058025,0,0
6,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.30815,-0.078643,-0.081182,0,0
6,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.088862,-0.0787,-0.070283,0,0
6,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.44402,-0.078729,-0.051138,0,0
6,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.25001,-0.07881,-0.1055,0,0
6,GO PORE COMPLEX ASSEMBLY,0.090515,-0.079008,-0.1022,0,0
6,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.11636,-0.079068,-0.06552,0,0
6,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.54903,-0.079402,-0.042906,0,0
6,GO TRNA TRANSPORT,0.22235,-0.079574,-0.069772,0,0
6,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.19695,-0.079609,-0.060063,0,0
6,GO ACTIVATED T CELL PROLIFERATION,0.2,-0.079632,-0.072014,0,0
6,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.090515,-0.079635,-0.22387,0,0
6,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.077957,-0.079903,-0.1449,0,0
6,GO UV PROTECTION,0.26847,-0.079925,-0.10056,0,0
6,GO MEMBRANE DISASSEMBLY,0.27999,-0.079933,-0.079417,0,0
6,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.36526,-0.07997,-0.070578,0,0
6,GO REGULATION OF GLIAL CELL MIGRATION,0.52594,-0.080064,-0.034974,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.37932,-0.080073,-0.033039,0,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.064293,-0.080153,-0.12137,0,0
6,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.51459,-0.08021,-0.075601,0,0
6,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.18219,-0.080223,-0.083265,0,0
6,GO HISTONE ARGININE METHYLATION,0.11434,-0.080326,-0.076003,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.21905,-0.080527,-0.11607,0,0
6,GO TRANSMISSION OF NERVE IMPULSE,0.17934,-0.080535,-0.083418,0,0
6,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.14769,-0.080686,-0.072341,0,0
6,GO REGULATION OF PROTEIN POLYMERIZATION,0.043763,-0.080737,-0.0665,0,0
6,GO NERVE DEVELOPMENT,0.11039,-0.080784,-0.11119,0,0
6,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.14526,-0.080794,-0.088091,0,0
6,GO REGULATION OF VASOCONSTRICTION,0.093897,-0.080797,-0.10664,0,0
6,GO NEGATIVE REGULATION OF DNA REPLICATION,0.38888,-0.080843,-0.062374,0,0
6,GO EXTRACELLULAR VESICLE BIOGENESIS,0.33812,-0.080851,-0.057393,0,0
6,GO CATECHOLAMINE SECRETION,0.27227,-0.080933,-0.021351,0,0
6,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.32077,-0.080956,-0.060968,0,0
6,GO CORONARY VASCULATURE MORPHOGENESIS,0.12259,-0.081039,-0.13163,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.188,-0.081293,-0.12834,0,0
6,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.25363,-0.081296,-0.10232,0,0
6,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.36991,-0.081807,-0.1064,0,0
6,GO AORTA MORPHOGENESIS,0.53167,-0.081856,-0.056543,0,0
6,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.16828,-0.08187,-0.12447,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.40349,-0.081927,-0.028489,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.075049,-0.081966,-0.16368,0,0
6,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.44402,-0.082051,-0.13063,0,0
6,GO CELLULAR SODIUM ION HOMEOSTASIS,0.7495,-0.082056,-0.029669,0,0
6,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.22568,-0.082259,-0.075225,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.25729,-0.082389,-0.083503,0,0
6,GO BLASTOCYST DEVELOPMENT,0.0007696,-0.082667,-0.10067,0,0
6,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.11636,-0.083027,-0.13754,0,0
6,GO EPIDERMIS MORPHOGENESIS,0.15264,-0.083096,-0.12705,0,0
6,GO PHAGOSOME MATURATION,0.14285,-0.083214,-0.083711,0,0
6,GO DEVELOPMENTAL MATURATION,0.12689,-0.083273,-0.066187,0,0
6,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.15773,-0.083275,-0.080948,0,0
6,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.21579,-0.08328,-0.085751,0,0
6,GO NEUROTRANSMITTER METABOLIC PROCESS,0.30815,-0.083407,-0.08021,0,0
6,GO PROSTATE GLAND MORPHOGENESIS,0.48131,-0.083594,-0.1084,0,0
6,GO HORMONE TRANSPORT,0.070855,-0.083839,-0.074298,0,0
6,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.57857,-0.084069,-0.049093,0,0
6,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.53167,-0.084117,-0.1089,0,0
6,GO DENDRITIC SPINE MAINTENANCE,0.23245,-0.084173,-0.077639,0,0
6,GO GOLGI LOCALIZATION,0.090515,-0.084349,-0.10536,0,0
6,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.11039,-0.084497,-0.066442,0,0
6,GO REGULATION OF ISOTYPE SWITCHING,0.40843,-0.084545,-0.094942,0,0
6,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.15773,-0.084576,-0.17405,0,0
6,GO DICARBOXYLIC ACID TRANSPORT,0.15015,-0.084685,-0.050514,0,0
6,GO REGULATION OF EXOCYTOSIS,0.073629,-0.084876,-0.059468,0,0
6,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.27227,-0.084953,-0.072619,0,0
6,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.33373,-0.085041,-0.081468,0,0
6,GO NEURAL CREST CELL DIFFERENTIATION,0.097379,-0.085267,-0.10549,0,0
6,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.26471,-0.085326,-0.067351,0,0
6,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.076492,-0.08533,-0.11926,0,0
6,GO MAGNESIUM ION TRANSPORT,0.063042,-0.085362,-0.10821,0,0
6,GO SIGNAL RELEASE,0.077957,-0.085549,-0.054081,0,0
6,GO TRANSCRIPTION BY RNA POLYMERASE I,0.19695,-0.085636,-0.067591,0,0
6,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.4978,-0.085713,-0.054085,0,0
6,GO ADHERENS JUNCTION ASSEMBLY,0.25363,-0.085794,-0.072125,0,0
6,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.20309,-0.086032,-0.059616,0,0
6,GO FIBROBLAST ACTIVATION,0.11841,-0.086105,-0.12569,0,0
6,GO REGULATION OF HORMONE SECRETION,0.077957,-0.086126,-0.07233,0,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.20937,-0.08613,-0.054806,0,0
6,GO NEURONAL ION CHANNEL CLUSTERING,0.14048,-0.086155,-0.1905,0,0
6,GO THYROID GLAND DEVELOPMENT,0.5726,-0.086256,-0.032369,0,0
6,GO RESPONSE TO GAMMA RADIATION,0.064293,-0.086348,-0.080204,0,0
6,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.14769,-0.086371,-0.11436,0,0
6,GO POSTREPLICATION REPAIR,0.061812,-0.086425,-0.06478,0,0
6,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.69707,-0.086466,-0.066407,0,0
6,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.11235,-0.086561,-0.11067,0,0
6,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.27999,-0.086634,-0.046341,0,0
6,GO SENSORY PERCEPTION OF PAIN,0.13583,-0.086695,-0.056374,0,0
6,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.22568,-0.086949,-0.13446,0,0
6,GO L GLUTAMATE IMPORT,0.066855,-0.086977,-0.14169,0,0
6,GO DEVELOPMENTAL INDUCTION,0.057089,-0.086995,-0.10803,0,0
6,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.12049,-0.087061,-0.070341,0,0
6,GO SYNAPSE MATURATION,0.18508,-0.087167,-0.14473,0,0
6,GO EMBRYONIC DIGIT MORPHOGENESIS,0.19695,-0.087238,-0.079314,0,0
6,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.34256,-0.087246,-0.068418,0,0
6,GO LYMPH VESSEL DEVELOPMENT,0.064293,-0.087362,-0.14181,0,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.11039,-0.087609,-0.093992,0,0
6,GO EATING BEHAVIOR,0.084046,-0.087718,-0.079475,0,0
6,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.088862,-0.087808,-0.13364,0,0
6,GO PROTEIN POLYMERIZATION,0.0087944,-0.087914,-0.078277,0,0
6,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.093897,-0.088393,-0.10144,0,0
6,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.11841,-0.088519,-0.065369,0,0
6,GO TERPENOID BIOSYNTHETIC PROCESS,0.53167,-0.088656,-0.066106,0,0
6,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0695,-0.088702,-0.12996,0,0
6,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.057089,-0.089242,-0.11452,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.4978,-0.089906,-0.041402,0,0
6,GO REGULATION OF B CELL DIFFERENTIATION,0.34702,-0.090228,-0.071541,0,0
6,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.53167,-0.090234,-0.099125,0,0
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.24288,-0.090501,-0.121,0,0
6,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.36526,-0.090508,-0.02856,0,0
6,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.16828,-0.090767,-0.10803,0,0
6,GO PLACENTA DEVELOPMENT,0.05824,-0.090821,-0.11221,0,0
6,GO PHAGOLYSOSOME ASSEMBLY,0.12473,-0.090909,-0.15548,0,0
6,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.11841,-0.091007,-0.095058,0,0
6,GO PROSTATIC BUD FORMATION,0.24643,-0.091046,-0.18589,0,0
6,GO LIPID TRANSLOCATION,0.16828,-0.091101,-0.1019,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.66501,-0.091106,-0.028413,0,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.38408,-0.091194,-0.083333,0,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.57857,-0.091501,-0.055313,0,0
6,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.19695,-0.091696,-0.11312,0,0
6,GO NEURAL CREST CELL MIGRATION,0.16294,-0.09175,-0.11627,0,0
6,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.24288,-0.091847,-0.11683,0,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.13583,-0.091958,-0.08749,0,0
6,GO POSITIVE REGULATION OF HEAT GENERATION,0.31232,-0.091985,-0.036849,0,0
6,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.25363,-0.091999,-0.063179,0,0
6,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.05824,-0.092066,-0.10178,0,0
6,GO SKELETAL MUSCLE ADAPTATION,0.16828,-0.092134,-0.091648,0,0
6,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.29586,-0.09219,-0.13063,0,0
6,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.12908,-0.092322,-0.11149,0,0
6,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.26471,-0.092332,-0.085187,0,0
6,GO CRANIAL NERVE MORPHOGENESIS,0.19095,-0.09246,-0.14777,0,0
6,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0695,-0.092512,-0.1539,0,0
6,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.29586,-0.092542,-0.044895,0,0
6,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.085627,-0.092667,-0.13299,0,0
6,GO DOPAMINE METABOLIC PROCESS,0.59059,-0.092752,-0.013783,0,0
6,GO REGULATION OF PROTON TRANSPORT,0.33812,-0.092789,-0.057558,0,0
6,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.12259,-0.092814,-0.10794,0,0
6,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.029719,-0.092869,-0.095733,0,0
6,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.21256,-0.092918,-0.16904,0,0
6,GO INTERFERON ALPHA PRODUCTION,0.10654,-0.093216,-0.11054,0,0
6,GO RESPONSE TO NICOTINE,0.32506,-0.093424,-0.034397,0,0
6,GO PANCREATIC JUICE SECRETION,0.072231,-0.093464,-0.12492,0,0
6,GO OVARIAN FOLLICLE DEVELOPMENT,0.061812,-0.093471,-0.096933,0,0
6,GO REGULATION OF RESPONSE TO FOOD,0.11039,-0.093778,-0.096301,0,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.22905,-0.093926,-0.12932,0,0
6,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.31232,-0.093944,-0.060385,0,0
6,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.75615,-0.094059,-0.0086057,0,0
6,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.077957,-0.094221,-0.095434,0,0
6,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.32938,-0.094721,-0.05138,0,0
6,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.088862,-0.094756,-0.13049,0,0
6,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.014841,-0.094771,-0.11343,0,0
6,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.17374,-0.094772,-0.11143,0,0
6,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.27227,-0.095127,-0.1341,0,0
6,GO FILOPODIUM ASSEMBLY,0.29586,-0.095144,-0.05498,0,0
6,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.68418,-0.095241,-0.038205,0,0
6,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.15517,-0.095497,-0.052746,0,0
6,GO NOREPINEPHRINE TRANSPORT,0.52025,-0.095632,-0.037182,0,0
6,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.045624,-0.095796,-0.098112,0,0
6,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.11039,-0.096008,-0.090206,0,0
6,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.17934,-0.096142,-0.089942,0,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.093897,-0.096273,-0.095192,0,0
6,GO RUFFLE ORGANIZATION,0.087232,-0.096319,-0.076684,0,0
6,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.29184,-0.096326,-0.15109,0,0
6,GO GROOMING BEHAVIOR,0.85082,-0.09652,0.026788,0,0
6,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.19393,-0.096556,-0.083967,0,0
6,GO RESPONSE TO INSECTICIDE,0.57857,-0.096832,-0.037799,0,0
6,GO HEAD MORPHOGENESIS,0.11841,-0.096923,-0.086225,0,0
6,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.088862,-0.097188,-0.10435,0,0
6,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.090515,-0.097336,-0.25796,0,0
6,GO ACTIN CROSSLINK FORMATION,0.31653,-0.097361,-0.076206,0,0
6,GO LIPOXYGENASE PATHWAY,0.17653,-0.097787,-0.16421,0,0
6,GO PROTEIN O LINKED MANNOSYLATION,0.27999,-0.09808,-0.052775,0,0
6,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.34256,-0.098212,-0.090142,0,0
6,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.39858,-0.098213,-0.043922,0,0
6,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.079444,-0.098313,-0.20464,0,0
6,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.18508,-0.098349,-0.096516,0,0
6,GO RESPONSE TO PARATHYROID HORMONE,0.18508,-0.098403,-0.12512,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0040578,-0.098509,-0.093118,0,0
6,GO NEURON MATURATION,0.16294,-0.098585,-0.078841,0,0
6,GO EPITHELIAL CELL CELL ADHESION,0.23589,-0.09859,-0.10266,0,0
6,GO REGULATION OF MEMBRANE PERMEABILITY,0.11235,-0.09872,-0.064226,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.095625,-0.098821,-0.18185,0,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.080955,-0.098917,-0.22845,0,0
6,GO ETHANOL CATABOLIC PROCESS,0.13583,-0.099359,-0.12121,0,0
6,GO CGMP MEDIATED SIGNALING,0.023205,-0.099401,-0.15595,0,0
6,GO NEGATIVE REGULATION OF TOR SIGNALING,0.063042,-0.099531,-0.087063,0,0
6,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.2839,-0.099543,-0.10232,0,0
6,GO REGULATION OF MEMBRANE POTENTIAL,0.064293,-0.099694,-0.08309,0,0
6,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.11039,-0.10001,-0.083546,0,0
6,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.55487,-0.10002,-0.032777,0,0
6,GO INNER EAR MORPHOGENESIS,0.099158,-0.10007,-0.08282,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.065563,-0.10011,-0.14735,0,0
6,GO MYELOID DENDRITIC CELL ACTIVATION,0.065563,-0.10029,-0.11501,0,0
6,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.25729,-0.10056,-0.083237,0,0
6,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.10096,-0.10057,-0.082981,0,0
6,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.095625,-0.10072,-0.12117,0,0
6,GO REGULATION OF AXON GUIDANCE,0.22905,-0.10091,-0.071764,0,0
6,GO HIPPO SIGNALING,0.23589,-0.10096,-0.1362,0,0
6,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.31232,-0.10115,-0.1219,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.12259,-0.10137,-0.12444,0,0
6,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.093897,-0.10142,-0.11921,0,0
6,GO REGULATION OF DENDRITE EXTENSION,0.29992,-0.10144,-0.015718,0,0
6,GO HEPATOCYTE APOPTOTIC PROCESS,0.55487,-0.1015,0.031997,0,0
6,GO VIRAL RELEASE FROM HOST CELL,0.063042,-0.10163,-0.10052,0,0
6,GO SYNAPTIC MEMBRANE ADHESION,0.59059,-0.1017,-0.070987,0,0
6,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.084046,-0.10171,-0.14426,0,0
6,GO REGULATION OF PLATELET AGGREGATION,0.092194,-0.10171,-0.19229,0,0
6,GO PEPTIDE HORMONE SECRETION,0.093897,-0.10193,-0.066033,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.13355,-0.1022,-0.057888,0,0
6,GO REGULATION OF BMP SIGNALING PATHWAY,0.063042,-0.10239,-0.11912,0,0
6,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.054842,-0.10264,-0.13247,0,0
6,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.29184,-0.10276,-0.096986,0,0
6,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.40349,-0.1029,-0.066934,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.10096,-0.10291,-0.15159,0,0
6,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.064293,-0.10306,-0.097748,0,0
6,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.44924,-0.10312,-0.058355,0,0
6,GO TELENCEPHALON GLIAL CELL MIGRATION,0.43883,-0.10342,-0.073354,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.188,-0.10344,-0.060497,0,0
6,GO REGULATION OF PROTEIN TARGETING,0.0030654,-0.10353,-0.10706,0,0
6,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.23937,-0.10354,-0.11633,0,0
6,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.059411,-0.10357,-0.108,0,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.90599,-0.10372,0.0097083,0,0
6,GO ALANINE TRANSPORT,0.097379,-0.10376,-0.13515,0,0
6,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.060602,-0.10407,-0.12523,0,0
6,GO ANATOMICAL STRUCTURE MATURATION,0.12259,-0.10411,-0.063344,0,0
6,GO DIVALENT METAL ION EXPORT,0.23589,-0.1043,-0.10121,0,0
6,GO HEAT GENERATION,0.20621,-0.10455,-0.053876,0,0
6,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.25363,-0.10486,-0.081139,0,0
6,GO RESPONSE TO IMMOBILIZATION STRESS,0.073629,-0.10488,-0.1633,0,0
6,GO GLYCOSIDE METABOLIC PROCESS,0.23589,-0.1049,-0.21492,0,0
6,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.095625,-0.10496,-0.13189,0,0
6,GO REGULATION OF RENAL SYSTEM PROCESS,0.14769,-0.10556,-0.11301,0,0
6,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.54321,-0.10557,-0.093065,0,0
6,GO ACTIN FILAMENT BASED TRANSPORT,0.40843,-0.10596,-0.042026,0,0
6,GO REGULATION OF MITOCHONDRIAL FUSION,0.038561,-0.10597,-0.14153,0,0
6,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.89215,-0.10599,0.031684,0,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.18508,-0.10601,-0.16153,0,0
6,GO CELL AGGREGATION,0.32938,-0.1061,-0.070071,0,0
6,GO MESENCHYME MORPHOGENESIS,0.054842,-0.1063,-0.14818,0,0
6,GO PROTEIN HETEROTETRAMERIZATION,0.066855,-0.1063,-0.10113,0,0
6,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0695,-0.10661,-0.088772,0,0
6,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.15773,-0.10668,-0.091938,0,0
6,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.22905,-0.10674,-0.062433,0,0
6,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.94769,-0.1069,0.060595,0,0
6,GO POSITIVE REGULATION OF ERAD PATHWAY,0.077957,-0.10696,-0.12264,0,0
6,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.059411,-0.10697,-0.18652,0,0
6,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.25729,-0.10822,-0.10603,0,0
6,GO TUBULIN DEACETYLATION,0.10096,-0.10828,-0.10228,0,0
6,GO TONIC SMOOTH MUSCLE CONTRACTION,0.082489,-0.10838,-0.1645,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.11434,-0.10915,-0.095405,0,0
6,GO DERMATAN SULFATE METABOLIC PROCESS,0.27999,-0.10987,-0.16323,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.099158,-0.11036,-0.0845,0,0
6,GO KIDNEY MORPHOGENESIS,0.18219,-0.1104,-0.06614,0,0
6,GO COENZYME A BIOSYNTHETIC PROCESS,0.0097392,-0.11064,-0.18668,0,0
6,GO RESPONSE TO X RAY,0.25001,-0.11065,-0.10763,0,0
6,GO KERATINIZATION,0.15517,-0.11083,-0.10055,0,0
6,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.18219,-0.11103,-0.18062,0,0
6,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.11841,-0.11114,-0.099482,0,0
6,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.072231,-0.11142,-0.12242,0,0
6,GO DEFINITIVE HEMOPOIESIS,0.23245,-0.11143,-0.094137,0,0
6,GO ENDOTHELIUM DEVELOPMENT,0.063042,-0.11148,-0.10252,0,0
6,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.033166,-0.11191,-0.1072,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.084046,-0.11228,-0.1052,0,0
6,GO MELANOCYTE DIFFERENTIATION,0.082489,-0.11254,-0.11735,0,0
6,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.25729,-0.11262,-0.11202,0,0
6,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.070855,-0.11288,-0.14477,0,0
6,GO METHIONINE BIOSYNTHETIC PROCESS,0.009256,-0.11323,-0.2036,0,0
6,GO NEUROMUSCULAR PROCESS,0.064293,-0.11326,-0.086963,0,0
6,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.085627,-0.11352,-0.13154,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.14526,-0.11368,-0.083776,0,0
6,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.060602,-0.11382,-0.12041,0,0
6,GO HETEROTYPIC CELL CELL ADHESION,0.15015,-0.11384,-0.094621,0,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19095,-0.11386,-0.099641,0,0
6,GO REGULATION OF DOPAMINE SECRETION,0.20937,-0.11423,-0.090287,0,0
6,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.23589,-0.11441,-0.15064,0,0
6,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.36064,-0.11449,-0.073489,0,0
6,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.188,-0.11454,-0.089943,0,0
6,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.12908,-0.11487,-0.17327,0,0
6,GO INOSITOL METABOLIC PROCESS,0.093897,-0.11493,-0.1082,0,0
6,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.29586,-0.11507,-0.11826,0,0
6,GO RESPONSE TO FUNGUS,0.080955,-0.11525,-0.075932,0,0
6,GO IRON COORDINATION ENTITY TRANSPORT,0.15517,-0.11526,-0.098308,0,0
6,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.095625,-0.11583,-0.11788,0,0
6,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.17934,-0.11626,-0.1219,0,0
6,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.065563,-0.11643,-0.193,0,0
6,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.073629,-0.11655,-0.1366,0,0
6,GO REGULATION OF GASTRIC ACID SECRETION,0.093897,-0.11723,-0.15317,0,0
6,GO ONE CARBON COMPOUND TRANSPORT,0.12049,-0.11731,-0.12883,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.33373,-0.11745,-0.039808,0,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.35153,-0.11805,-0.10369,0,0
6,GO DETECTION OF CALCIUM ION,0.48131,-0.11819,-0.070412,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.05161,-0.11819,-0.1267,0,0
6,GO INTERLEUKIN 12 PRODUCTION,0.059411,-0.11827,-0.094509,0,0
6,GO REGULATION OF FILOPODIUM ASSEMBLY,0.188,-0.11843,-0.076695,0,0
6,GO VIRAL RNA GENOME REPLICATION,0.090515,-0.11847,-0.10605,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.095625,-0.11887,-0.12914,0,0
6,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.49227,-0.11895,-0.065905,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.13583,-0.11902,-0.13133,0,0
6,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.037747,-0.1191,-0.17102,0,0
6,GO REGULATION OF FEEDING BEHAVIOR,0.036164,-0.11915,-0.14563,0,0
6,GO SYNAPSE ORGANIZATION,0.23589,-0.11922,-0.055974,0,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.085627,-0.11925,-0.11932,0,0
6,GO METANEPHROS MORPHOGENESIS,0.35607,-0.11928,-0.055712,0,0
6,GO NEGATIVE REGULATION OF CELL DIVISION,0.33812,-0.11973,-0.077694,0,0
6,GO EXOCYTIC PROCESS,0.095625,-0.11983,-0.064634,0,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.045624,-0.11989,-0.14525,0,0
6,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.068167,-0.12043,-0.14888,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.10465,-0.12048,-0.095392,0,0
6,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.44924,-0.12069,-0.07771,0,0
6,GO PRO B CELL DIFFERENTIATION,0.74288,-0.12073,-0.028331,0,0
6,GO BODY MORPHOGENESIS,0.077957,-0.1208,-0.097862,0,0
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.088862,-0.12107,-0.12229,0,0
6,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.27227,-0.12111,-0.13159,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.057089,-0.12122,-0.105,0,0
6,GO BASE EXCISION REPAIR AP SITE FORMATION,0.075049,-0.1215,-0.1086,0,0
6,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.077957,-0.12158,-0.18369,0,0
6,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.085627,-0.12206,-0.086245,0,0
6,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.059411,-0.12206,-0.12269,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.068167,-0.12243,-0.13282,0,0
6,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.079444,-0.12244,-0.22108,0,0
6,GO MODULATION BY VIRUS OF HOST PROCESS,0.066855,-0.12249,-0.09335,0,0
6,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.50337,-0.12277,-0.079853,0,0
6,GO NEGATIVE REGULATION OF BEHAVIOR,0.16559,-0.12336,-0.091655,0,0
6,GO NEURONAL ACTION POTENTIAL,0.37932,-0.12371,-0.060808,0,0
6,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.13814,-0.12371,-0.11119,0,0
6,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.16828,-0.12375,-0.11544,0,0
6,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.21579,-0.12402,-0.10702,0,0
6,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.046579,-0.12425,-0.10809,0,0
6,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.27999,-0.1243,-0.052175,0,0
6,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.25001,-0.12471,-0.092583,0,0
6,GO CATECHOLAMINE UPTAKE,0.054842,-0.12532,-0.16739,0,0
6,GO PROTEOGLYCAN METABOLIC PROCESS,0.02268,-0.12537,-0.12379,0,0
6,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.36526,-0.12577,-0.099566,0,0
6,GO NEURON CELLULAR HOMEOSTASIS,0.21905,-0.1259,-0.11589,0,0
6,GO RESPONSE TO LEUCINE,0.21579,-0.12594,-0.087471,0,0
6,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.29184,-0.126,-0.097358,0,0
6,GO MAINTENANCE OF CELL POLARITY,0.011612,-0.12647,-0.1612,0,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.061812,-0.12662,-0.20878,0,0
6,GO CELLULAR ANION HOMEOSTASIS,0.097379,-0.12672,-0.13003,0,0
6,GO RENAL ABSORPTION,0.060602,-0.12682,-0.26721,0,0
6,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.42855,-0.12696,-0.012974,0,0
6,GO ENDOTHELIAL CELL MORPHOGENESIS,0.33373,-0.12712,-0.13349,0,0
6,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.21579,-0.12756,-0.094097,0,0
6,GO BONE MATURATION,0.15773,-0.12756,-0.084373,0,0
6,GO TRACHEA MORPHOGENESIS,0.35607,-0.12768,-0.068106,0,0
6,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.17653,-0.12851,-0.1308,0,0
6,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.12259,-0.12855,-0.21466,0,0
6,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.021165,-0.12863,-0.14494,0,0
6,GO VASCULAR WOUND HEALING,0.088862,-0.12896,-0.1816,0,0
6,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.079444,-0.12913,-0.29175,0,0
6,GO RESPONSE TO MURAMYL DIPEPTIDE,0.2,-0.12914,-0.12629,0,0
6,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.24288,-0.12971,-0.12909,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.070855,-0.13077,-0.10081,0,0
6,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.30402,-0.13077,-0.077231,0,0
6,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.077957,-0.13128,-0.1153,0,0
6,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.32077,-0.13174,-0.081709,0,0
6,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.2,-0.13187,-0.084623,0,0
6,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.20309,-0.13197,-0.092636,0,0
6,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.057089,-0.13216,-0.11642,0,0
6,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.59664,-0.13241,-0.025259,0,0
6,GO PEPTIDYL ARGININE N METHYLATION,0.063042,-0.1328,-0.1339,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.05824,-0.13292,-0.14303,0,0
6,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.17653,-0.13332,-0.17397,0,0
6,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.063042,-0.13368,-0.14373,0,0
6,GO POSITIVE REGULATION OF EXOCYTOSIS,0.072231,-0.13434,-0.085916,0,0
6,GO REGULATORY T CELL DIFFERENTIATION,0.17934,-0.13448,-0.12074,0,0
6,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.17653,-0.13491,-0.15554,0,0
6,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.073629,-0.13501,-0.13702,0,0
6,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.070855,-0.13519,-0.1897,0,0
6,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.11039,-0.13553,-0.09451,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.093897,-0.13555,-0.15949,0,0
6,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.54321,-0.13617,-0.060359,0,0
6,GO CONVERGENT EXTENSION,0.068167,-0.13624,-0.12913,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.10465,-0.13659,-0.090715,0,0
6,GO LYMPH NODE DEVELOPMENT,0.079444,-0.13764,-0.10238,0,0
6,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.00069957,-0.13799,-0.13414,0,0
6,GO HEART FIELD SPECIFICATION,0.81668,-0.13802,-0.0045365,0,0
6,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.22568,-0.13879,-0.069837,0,0
6,GO RESPONSE TO HISTAMINE,0.23589,-0.13882,-0.17627,0,0
6,GO REGULATION OF NEURON MATURATION,0.37932,-0.1396,-0.059964,0,0
6,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25363,-0.13971,-0.091228,0,0
6,GO LATERAL VENTRICLE DEVELOPMENT,0.095625,-0.14015,-0.15914,0,0
6,GO HORMONE CATABOLIC PROCESS,0.25001,-0.14046,-0.097445,0,0
6,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.061812,-0.14066,-0.11162,0,0
6,GO MITOCHONDRIAL FISSION,0.0007696,-0.14118,-0.15219,0,0
6,GO LOCOMOTOR RHYTHM,0.087232,-0.14191,-0.14306,0,0
6,GO MESENCHYMAL CELL PROLIFERATION,0.080955,-0.14195,-0.15713,0,0
6,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.23589,-0.14199,-0.082936,0,0
6,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.30815,-0.14225,-0.1099,0,0
6,GO TRACHEA DEVELOPMENT,0.087232,-0.14254,-0.15888,0,0
6,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.020205,-0.1426,-0.14136,0,0
6,GO REGULATION OF POSITIVE CHEMOTAXIS,0.068167,-0.14285,-0.13163,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.10845,-0.14288,-0.12669,0,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.099158,-0.14305,-0.13545,0,0
6,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.092194,-0.14307,-0.15078,0,0
6,GO ATP TRANSPORT,0.010245,-0.1431,-0.12739,0,0
6,GO DNA DEAMINATION,0.50337,-0.14374,-0.11924,0,0
6,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.068167,-0.14412,-0.17279,0,0
6,GO EPITHELIAL CELL MORPHOGENESIS,0.27227,-0.1447,-0.095166,0,0
6,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.71006,-0.1455,0.022458,0,0
6,GO RESPONSE TO NITROSATIVE STRESS,0.11235,-0.14595,-0.20944,0,0
6,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.15015,-0.1464,-0.05531,0,0
6,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.060602,-0.14677,-0.14262,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.017137,-0.14722,-0.12399,0,0
6,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.099158,-0.14742,-0.20595,0,0
6,GO MODIFIED AMINO ACID TRANSPORT,0.0014299,-0.14803,-0.18489,0,0
6,GO INNERVATION,0.39371,-0.14806,-0.042886,0,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.087232,-0.14815,-0.1201,0,0
6,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.088862,-0.14815,-0.11002,0,0
6,GO EXTRACELLULAR TRANSPORT,0.30402,-0.14822,-0.04791,0,0
6,GO LONG TERM MEMORY,0.063042,-0.14844,-0.13562,0,0
6,GO TOXIN METABOLIC PROCESS,0.095625,-0.14866,-0.17065,0,0
6,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.027188,-0.14889,-0.17766,0,0
6,GO PROTEIN NITROSYLATION,0.007729,-0.14897,-0.19832,0,0
6,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.33373,-0.14898,-0.095802,0,0
6,GO REGULATION OF DEACETYLASE ACTIVITY,0.025994,-0.14931,-0.14217,0,0
6,GO VITAMIN CATABOLIC PROCESS,0.23245,-0.15001,-0.13326,0,0
6,GO EMBRYONIC PLACENTA DEVELOPMENT,0.10845,-0.1502,-0.11497,0,0
6,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.037747,-0.15042,-0.18198,0,0
6,GO OVULATION CYCLE PROCESS,0.0060989,-0.15056,-0.15956,0,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.079444,-0.15202,-0.17493,0,0
6,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.22568,-0.15229,-0.10966,0,0
6,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,4.3218e-05,-0.15263,-0.17078,0,0
6,GO ENDOCARDIAL CUSHION FORMATION,0.11039,-0.15289,-0.16266,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.059411,-0.15313,-0.12279,0,0
6,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.63978,-0.15416,-0.011422,0,0
6,GO MITOCHONDRIAL TRNA PROCESSING,0.11841,-0.15455,-0.14583,0,0
6,GO REGULATION OF ICOSANOID SECRETION,0.090515,-0.15457,-0.10754,0,0
6,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.075049,-0.15503,-0.11201,0,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.25001,-0.15524,-0.17826,0,0
6,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.11841,-0.15642,-0.094348,0,0
6,GO RESPONSE TO VITAMIN A,0.22568,-0.15662,-0.087917,0,0
6,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.057089,-0.15671,-0.13243,0,0
6,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.54903,-0.15709,-0.084707,0,0
6,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.064293,-0.15763,-0.14933,0,0
6,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15015,-0.15765,-0.13371,0,0
6,GO CARDIAC MYOFIBRIL ASSEMBLY,0.25363,-0.15779,-0.077496,0,0
6,GO CARDIAC SEPTUM MORPHOGENESIS,0.11636,-0.15821,-0.13349,0,0
6,GO POSITIVE REGULATION OF MITOPHAGY,0.14769,-0.15828,-0.1026,0,0
6,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.4545,-0.15928,-0.13881,0,0
6,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.13583,-0.15933,-0.13001,0,0
6,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.00034072,-0.16104,-0.15939,0,0
6,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.014486,-0.1613,-0.16733,0,0
6,GO REGULATION OF EXCRETION,0.17374,-0.16133,-0.096342,0,0
6,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.21256,-0.16157,-0.10432,0,0
6,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.15264,-0.16164,-0.11112,0,0
6,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.15015,-0.16276,-0.17244,0,0
6,GO LABYRINTHINE LAYER DEVELOPMENT,0.12049,-0.1629,-0.11194,0,0
6,GO RESPONSE TO ATP,0.00049035,-0.16433,-0.15799,0,0
6,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.11636,-0.1647,-0.14811,0,0
6,GO SEROTONIN METABOLIC PROCESS,0.51459,-0.16586,-0.064504,0,0
6,GO REGULATION OF CHLORIDE TRANSPORT,0.068167,-0.16644,-0.15343,0,0
6,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.05824,-0.16662,-0.1441,0,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.061812,-0.16668,-0.16509,0,0
6,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.00044439,-0.16671,-0.15133,0,0
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.28785,-0.1671,-0.13418,0,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.023741,-0.16718,-0.14708,0,0
6,GO RRNA PSEUDOURIDINE SYNTHESIS,0.073629,-0.16721,-0.1859,0,0
6,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.18508,-0.1694,-0.15087,0,0
6,GO VASCULAR TRANSPORT,0.092194,-0.1696,-0.22411,0,0
6,GO LEYDIG CELL DIFFERENTIATION,0.25729,-0.16961,-0.12786,0,0
6,GO DOPAMINE TRANSPORT,0.075049,-0.17075,-0.12067,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.32938,-0.17099,-0.083938,0,0
6,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.11039,-0.17159,-0.17598,0,0
6,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.13355,-0.17192,-0.11794,0,0
6,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.060602,-0.17239,-0.23187,0,0
6,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.10654,-0.173,-0.13975,0,0
6,GO TRIPARTITE REGIONAL SUBDIVISION,0.099158,-0.17316,-0.19329,0,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.33373,-0.17317,-0.10104,0,0
6,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.32938,-0.17402,-0.095858,0,0
6,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.18219,-0.17414,-0.14737,0,0
6,GO MIDGUT DEVELOPMENT,0.05824,-0.17453,-0.20957,0,0
6,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0087944,-0.1751,-0.1788,0,0
6,GO STEROID CATABOLIC PROCESS,0.013798,-0.17602,-0.16883,0,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.10465,-0.17676,-0.15236,0,0
6,GO ENAMEL MINERALIZATION,0.080955,-0.17724,-0.22327,0,0
6,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.11841,-0.1774,-0.14985,0,0
6,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0032441,-0.17883,-0.18215,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0027346,-0.17905,-0.1479,0,0
6,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.21905,-0.17928,-0.08741,0,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.15517,-0.17944,-0.071128,0,0
6,GO NEUROTRANSMITTER UPTAKE,0.033894,-0.18146,-0.14601,0,0
6,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.14769,-0.18261,-0.113,0,0
6,GO REGULATION OF SYNAPSE MATURATION,0.22568,-0.18277,-0.14909,0,0
6,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0015189,-0.18349,-0.19329,0,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.05824,-0.18367,-0.19103,0,0
6,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.087232,-0.18371,-0.12473,0,0
6,GO POSITIVE REGULATION OF MYELINATION,0.0010528,-0.18474,-0.18846,0,0
6,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.15015,-0.18536,-0.17321,0,0
6,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.10465,-0.18551,-0.10785,0,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.12908,-0.18724,-0.068677,0,0
6,GO NEGATIVE REGULATION OF CELL AGING,0.12049,-0.18786,-0.14349,0,0
6,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.010506,-0.18809,-0.14561,0,0
6,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0079323,-0.18874,-0.20289,0,0
6,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.011612,-0.18877,-0.21302,0,0
6,GO CELLULAR RESPONSE TO PH,0.0049174,-0.18954,-0.17166,0,0
6,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.11235,-0.19017,-0.18324,0,0
6,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.066855,-0.19046,-0.12181,0,0
6,GO CHONDROCYTE PROLIFERATION,0.20621,-0.19153,-0.14741,0,0
6,GO REGULATION OF ACTION POTENTIAL,0.0040578,-0.19207,-0.17981,0,0
6,GO REGULATION OF TUBULIN DEACETYLATION,0.092194,-0.19236,-0.12729,0,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS,0.072231,-0.19348,-0.075934,0,0
6,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.24288,-0.194,-0.089372,0,0
6,GO STABILIZATION OF MEMBRANE POTENTIAL,0.088862,-0.19429,-0.20123,0,0
6,GO OPTIC NERVE DEVELOPMENT,0.188,-0.19468,-0.13902,0,0
6,GO RENAL FILTRATION,0.34256,-0.19613,-0.13059,0,0
6,GO LABYRINTHINE LAYER MORPHOGENESIS,0.23937,-0.19618,-0.11779,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.088862,-0.1966,-0.15524,0,0
6,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00059588,-0.19711,-0.26016,0,0
6,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.072231,-0.19745,-0.14639,0,0
6,GO KIDNEY MESENCHYME DEVELOPMENT,0.030383,-0.19797,-0.19997,0,0
6,GO RESPONSE TO CAMP,1.0604e-05,-0.19863,-0.21761,0,0
6,GO PARAXIAL MESODERM MORPHOGENESIS,0.1028,-0.19958,-0.17501,0,0
6,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.050569,-0.20007,-0.12191,0,0
6,GO OUTER DYNEIN ARM ASSEMBLY,0.22905,-0.20145,-0.052699,0,0
6,GO INDOLALKYLAMINE METABOLIC PROCESS,0.15517,-0.20176,-0.12162,0,0
6,GO FACIAL NERVE MORPHOGENESIS,0.17653,-0.20243,-0.15749,0,0
6,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00011241,-0.20301,-0.19153,0,0
6,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.16294,-0.20327,-0.14621,0,0
6,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.14526,-0.20439,-0.09016,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.085627,-0.20509,-0.15761,0,0
6,GO POSITIVE REGULATION OF CELL SIZE,0.072231,-0.20606,-0.13591,0,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.14285,-0.20624,-0.12643,0,0
6,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.20309,-0.20625,-0.10015,0,0
6,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.00032948,-0.20761,-0.24479,0,0
6,GO LAMELLIPODIUM MORPHOGENESIS,0.0030654,-0.20792,-0.2489,0,0
6,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.072231,-0.20839,-0.1812,0,0
6,GO REGULATION OF GLOMERULAR FILTRATION,0.48678,-0.20936,-0.086994,0,0
6,GO CORNIFICATION,0.077957,-0.21001,-0.15482,0,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02268,-0.2108,-0.2094,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.21905,-0.21151,-0.086849,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0079323,-0.21233,-0.17533,0,0
6,GO NEUROTRANSMITTER REUPTAKE,0.036164,-0.21285,-0.18465,0,0
6,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.21905,-0.21305,-0.13598,0,0
6,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.036948,-0.21393,-0.18357,0,0
6,GO MITOTIC CELL CYCLE ARREST,0.084046,-0.21477,-0.11867,0,0
6,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.11235,-0.21553,-0.22535,0,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0011549,-0.21577,-0.20008,0,0
6,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.068167,-0.21607,-0.18595,0,0
6,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.18508,-0.21659,-0.14149,0,0
6,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.12049,-0.2171,-0.19068,0,0
6,GO RESPONSE TO LIGHT INTENSITY,0.009256,-0.21811,-0.21226,0,0
6,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.059411,-0.22234,-0.17243,0,0
6,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.060602,-0.22343,-0.1616,0,0
6,GO TRNA CATABOLIC PROCESS,0.21905,-0.22578,-0.15339,0,0
6,GO GASTRULATION WITH MOUTH FORMING SECOND,0.059411,-0.22673,-0.1378,0,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0021689,-0.22691,-0.20133,0,0
6,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,1.2454e-05,-0.22729,-0.20051,0,0
6,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0039469,-0.22962,-0.18017,0,0
6,GO VITAMIN BIOSYNTHETIC PROCESS,0.0057817,-0.23346,-0.21156,0,0
6,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.082489,-0.23349,-0.15898,0,0
6,GO RESPONSE TO MAGNESIUM ION,0.011326,-0.23382,-0.26921,0,0
6,GO ONE CARBON METABOLIC PROCESS,0.00010462,-0.23449,-0.22295,0,0
6,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.079444,-0.23617,-0.1375,0,0
6,GO PROTEIN LOCALIZATION TO AXON,0.29992,-0.23665,-0.11615,0,0
6,GO VITAMIN D BIOSYNTHETIC PROCESS,0.099158,-0.23879,-0.20788,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00013917,-0.23937,-0.2482,0,0
6,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.11039,-0.2408,-0.17714,0,0
6,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.00052342,-0.24249,-0.23201,0,0
6,GO NEPHRIC DUCT DEVELOPMENT,0.0047853,-0.2536,-0.27272,0,0
6,GO KETONE BODY METABOLIC PROCESS,0.001228,-0.25729,-0.28657,0,0
6,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.066855,-0.25928,-0.16592,0,0
6,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.00016023,-0.25988,-0.2571,0,0
6,GO CARDIAC MUSCLE CELL CONTRACTION,0.00079435,-0.26022,-0.21537,0,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.00042998,-0.2607,-0.27791,0,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00014935,-0.26107,-0.28444,0,0
6,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.18219,-0.262,-0.15792,0,0
6,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.29992,-0.26228,-0.09246,0,0
6,GO GONADOTROPIN SECRETION,0.077957,-0.26309,-0.13804,0,0
6,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.0060989,-0.26341,-0.19537,0,0
6,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.05824,-0.26496,-0.25736,0,0
6,GO RESPONSE TO AMINE,3.0689e-05,-0.26613,-0.29249,0,0
6,GO RESPONSE TO HYDROPEROXIDE,0.02166,-0.27121,-0.22951,0,0
6,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.099158,-0.2731,-0.16079,0,0
6,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00014935,-0.27868,-0.27615,0,0
6,GO PROTEIN TRIMERIZATION,0.0001547,-0.28139,-0.36306,0,0
6,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0013457,-0.28177,-0.26633,0,0
6,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00026003,-0.28235,-0.24926,0,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.010245,-0.28366,-0.19652,0,0
6,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.001662,-0.28863,-0.34879,0,0
6,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00018427,-0.29274,-0.32234,0,0
6,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0046564,-0.29321,-0.25668,0,0
6,GO INCLUSION BODY ASSEMBLY,0.00074557,-0.29453,-0.27438,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.00095906,-0.29512,-0.26088,0,0
6,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.17653,-0.29649,-0.16901,0,0
6,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0059384,-0.29999,-0.2964,0,0
6,GO NEUROBLAST DIVISION,0.00052342,-0.3002,-0.32614,0,0
6,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.082489,-0.30332,-0.29053,0,0
6,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00090094,-0.30463,-0.22115,0,0
6,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.060602,-0.30617,-0.43459,0,0
6,GO DOPAMINE BIOSYNTHETIC PROCESS,0.43883,-0.3086,-0.11771,0,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00019079,-0.3133,-0.33728,0,0
6,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.32506,-0.31552,-0.11605,0,0
6,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00028792,-0.33964,-0.262,0,0
6,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00067758,-0.35161,-0.25613,0,0
6,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0014738,-0.358,-0.35871,0,0
6,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0013872,-0.35906,-0.32893,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.0039469,-0.35932,-0.31383,0,0
6,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0025083,-0.36457,-0.29022,0,0
6,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00034072,-0.36828,-0.32551,0,0
6,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.00026003,-0.36885,-0.33111,0,0
6,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.016339,-0.37879,-0.29536,0,0
6,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.00081984,-0.38407,-0.32246,0,0
6,GO NADH METABOLIC PROCESS,1.8521e-05,-0.39543,-0.35015,0,0
6,GO MUSCLE CELL CELLULAR HOMEOSTASIS,1.0311e-06,-0.39996,-0.46367,0,0
6,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,1.5816e-05,-0.40073,-0.49948,0,0
6,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.014138,-0.40543,-0.26138,0,0
6,GO HEPARIN METABOLIC PROCESS,0.00027832,-0.40901,-0.39342,0,0
6,GO HEART INDUCTION,0.018836,-0.45443,-0.26882,0,0
6,GO POSITIVE REGULATION OF VESICLE FUSION,0.00067758,-0.53146,-0.49594,0,0
